PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Han, SJ; Hawkins, SM; Begum, K; Jung, SY; Kovanci, E; Qin, J; Lydon, JP; DeMayo, FJ; O'Malley, BW				Han, Sang Jun; Hawkins, Shannon M.; Begum, Khurshida; Jung, Sung Yun; Kovanci, Ertug; Qin, Jun; Lydon, John P.; DeMayo, Francesco J.; O'Malley, Bert W.			A new isoform of steroid receptor coactivator-1 is crucial for pathogenic progression of endometriosis	NATURE MEDICINE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA; EPITHELIAL-CELLS; PROGESTERONE-RECEPTORS; OVARIAN ENDOMETRIOSIS; STROMAL CELLS; IN-VITRO; KAPPA-B; EXPRESSION; MODEL	Endometriosis is considered to be an estrogen-dependent inflammatory disease, but its etiology is unclear. Thus far, a mechanistic role for steroid receptor coactivators (SRCs) in the progression of endometriosis has not been elucidated. An SRC-1-null mouse model reveals that the mouse SRC-1 gene has an essential role in endometriosis progression. Notably, a previously unidentified 70-kDa SRC-1 proteolytic isoform is highly elevated both in the endometriotic tissue of mice with surgically induced endometriosis and in endometriotic stromal cells biopsied from patients with endometriosis compared to normal endometrium. Tnf(-/-) and Mmp9(-/-) mice with surgically induced endometriosis showed that activation of tumor necrosis factor alpha (TNF-alpha)-induced matrix metallopeptidase 9 (MMP9) activity mediates formation of the 70-kDa SRC-1 C-terminal isoform in endometriotic mouse tissue. In contrast to full-length SRC-1, the endometriotic 70-kDa SRC-1 C-terminal fragment prevents TNF-alpha-mediated apoptosis in human endometrial epithelial cells and causes the epithelial-mesenchymal transition and the invasion of human endometrial cells that are hallmarks of progressive endometriosis. Collectively, the newly identified TNF-alpha-MMP9-SRC-1 isoform functional axis promotes pathogenic progression of endometriosis.	[Han, Sang Jun; Begum, Khurshida; Jung, Sung Yun; Qin, Jun; Lydon, John P.; DeMayo, Francesco J.; O'Malley, Bert W.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Hawkins, Shannon M.; Kovanci, Ertug] Baylor Coll Med, Dept Gynecol, Houston, TX 77030 USA; [Hawkins, Shannon M.; Kovanci, Ertug] Baylor Coll Med, Dept Obstet, Houston, TX 77030 USA; [Jung, Sung Yun; Qin, Jun] Baylor Coll Med, Dept Biochem & Mol Biol, Ctr Mol Discovery, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	O'Malley, BW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	berto@bcm.tmc.edu	DeMayo, Francesco/C-6255-2019; Hawkins, Shannon/AAX-5216-2020; Hawkins, Shannon M/B-7095-2015	DeMayo, Francesco/0000-0002-9480-7336; Hawkins, Shannon/0000-0002-0727-3971; Hawkins, Shannon M/0000-0002-0727-3971; Jung, Sung Yun/0000-0003-1521-7977	US National Institutes of Health-designated Diabetes; Endocrinology Research Center; Proteomics Core in the Dan L. Duncan Cancer Center at Baylor College of Medicine; US National Institute of Diabetes and Digestive and Kidney Diseases [U54HD0077495, 5K12HD050128, U54HD007495, R01 HD08188]; US National Cancer Institute [R01 CA077030]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD007857, U54HD007495, R03HD077495, R01HD008188] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD050128, P30HD007495] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA077530, P50CA098258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK059820] Funding Source: NIH RePORTER	US National Institutes of Health-designated Diabetes; Endocrinology Research Center; Proteomics Core in the Dan L. Duncan Cancer Center at Baylor College of Medicine; US National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C.J. Lockwood (Department of Obstetrics, Gynecology and Reproductive Science and Department of Genetics, Yale University School of Medicine) and T. Klonisch (Department of Human Anatomy and Cell Science, University of Manitoba) for providing immortalized human endometrial stromal and epithelial cells for this work. We thank M.J. Park for her technical support in animal experiments. We also thank the US National Institutes of Health-designated Diabetes and Endocrinology Research Center and the Proteomics Core in the Dan L. Duncan Cancer Center at Baylor College of Medicine for supporting this work. This work was supported by grants from the US National Institute of Diabetes and Digestive and Kidney Diseases (U54HD0077495 and 5K12HD050128 to S.M.H., U54HD007495 to F.J.D., R01 HD08188 to B.W.O. and a U54HD007495 pilot grant to S.J.H.) and a grant from the US National Cancer Institute (R01 CA077030 to J.P.L.).	Banu SK, 2009, FERTIL STERIL, V91, P2199, DOI 10.1016/j.fertnstert.2008.06.050; Bedaiwy MA, 2002, HUM REPROD, V17, P426, DOI 10.1093/humrep/17.2.426; Bergqvist A, 2001, FERTIL STERIL, V75, P489, DOI 10.1016/S0015-0282(00)01752-0; Berkkanoglu M, 2003, AM J REPROD IMMUNOL, V50, P48, DOI 10.1034/j.1600-0897.2003.00042.x; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Chishima F, 2002, AM J REPROD IMMUNOL, V48, P50, DOI 10.1034/j.1600-0897.2002.01101.x; CUMMINGS AM, 1995, REPROD TOXICOL, V9, P233, DOI 10.1016/0890-6238(95)00004-T; Dufour A, 2010, J BIOL CHEM, V285, P35944, DOI 10.1074/jbc.M109.091769; Efstathiou JA, 2005, FERTIL STERIL, V83, P171, DOI 10.1016/j.fertnstert.2004.06.058; Falconer H, 2006, HUM REPROD, V21, P1856, DOI 10.1093/humrep/del044; Fang ZJ, 2004, FERTIL STERIL, V82, P673, DOI 10.1016/j.fertnstert.2004.01.048; Fedele L, 2000, AM J OBSTET GYNECOL, V183, P1462, DOI 10.1067/mob.2000.108021; Fujimoto J, 1999, MOL HUM REPROD, V5, P742, DOI 10.1093/molehr/5.8.742; Grund EM, 2008, MOL PHARMACOL, V73, P1394, DOI 10.1124/mol.107.042176; Han SJ, 2005, MOL CELL BIOL, V25, P8150, DOI 10.1128/MCB.25.18.8150-8165.2005; Harris HA, 2005, HUM REPROD, V20, P936, DOI 10.1093/humrep/deh711; Hawkins SM, 2011, MOL ENDOCRINOL, V25, P821, DOI 10.1210/me.2010-0371; Hirata T, 2011, FERTIL STERIL, V96, P113, DOI 10.1016/j.fertnstert.2011.04.060; Hombach-Klonisch S, 2005, J MOL ENDOCRINOL, V34, P517, DOI 10.1677/jme.1.01550; Imai A, 2000, AM J OBSTET GYNECOL, V182, P1142, DOI 10.1067/mob.2000.104804; Islimye M, 2011, EUR J OBSTET GYN R B, V159, P184, DOI 10.1016/j.ejogrb.2011.06.029; Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606; Kumagami A, 2011, J OBSTET GYNAECOL RE, V37, P1269, DOI 10.1111/j.1447-0756.2010.01509.x; Leite RS, 2004, FASEB J, V18, P1418, DOI 10.1096/fj.04-1684fje; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; Matsuzaki S, 2001, FERTIL STERIL, V75, P1198, DOI 10.1016/S0015-0282(01)01783-6; MELDRUM DR, 1982, J CLIN ENDOCR METAB, V54, P1081, DOI 10.1210/jcem-54-5-1081; Missmer SA, 2003, OBSTET GYN CLIN N AM, V30, P3; Nap AW, 2004, HUM REPROD, V19, P2180, DOI 10.1093/humrep/deh408; Noble LS, 1996, J CLIN ENDOCR METAB, V81, P174, DOI 10.1210/jc.81.1.174; Osteen KG, 2003, SEMIN REPROD MED, V21, P155; Overton C, 1996, HUM REPROD, V11, P380, DOI 10.1093/HUMREP/11.2.380; Pino M, 2009, REPRODUCTION, V138, P837, DOI 10.1530/REP-09-0196; Rubel CA, 2010, SEMIN REPROD MED, V28, P27, DOI 10.1055/s-0029-1242990; Sanz AB, 2008, J AM SOC NEPHROL, V19, P1634, DOI 10.1681/ASN.2007121336; Scott KA, 2004, ONCOGENE, V23, P6954, DOI 10.1038/sj.onc.1207915; Shakiba K, 2006, HUM REPROD, V21, P2417, DOI 10.1093/humrep/del179; Simsa P, 2007, WOMENS HEALTH, V3, P617, DOI 10.2217/17455057.3.5.617; Suzuki A, 2010, VIRCHOWS ARCH, V456, P433, DOI 10.1007/s00428-010-0884-x; Vilen ST, 2008, EXP CELL RES, V314, P914, DOI 10.1016/j.yexcr.2007.10.025; Wang Han-bi, 2005, Zhonghua Yi Xue Za Zhi, V85, P1555; Wang XL, 2009, MOL IMMUNOL, V46, P2413, DOI 10.1016/j.molimm.2009.04.014; Wu RC, 2002, MOL CELL BIOL, V22, P3549, DOI 10.1128/MCB.22.10.3549-3561.2002; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922; Zhang H, 2009, MOL HUM REPROD, V15, P653, DOI 10.1093/molehr/gap069	45	91	95	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2012	18	7					1102	+		10.1038/nm.2826	http://dx.doi.org/10.1038/nm.2826			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22660634	Green Accepted			2022-12-25	WOS:000306121600040
J	Harakalova, M; van Harssel, JJT; Terhal, PA; van Lieshout, S; Duran, K; Renkens, I; Amor, DJ; Wilson, LC; Kirk, EP; Turner, CLS; Shears, D; Garcia-Minaur, S; Lees, MM; Ross, A; Venselaar, H; Vriend, G; Takanari, H; Rook, MB; van der Heyden, MAG; Asselbergs, FW; Breur, HM; Swinkels, ME; Scurr, IJ; Smithson, SF; Knoers, NV; van der Smagt, JJ; Nijman, IJ; Kloosterman, WP; van Haelst, MM; van Haaften, G; Cuppen, E				Harakalova, Magdalena; van Harssel, Jeske J. T.; Terhal, Paulien A.; van Lieshout, Stef; Duran, Karen; Renkens, Ivo; Amor, David J.; Wilson, Louise C.; Kirk, Edwin P.; Turner, Claire L. S.; Shears, Debbie; Garcia-Minaur, Sixto; Lees, Melissa M.; Ross, Alison; Venselaar, Hanka; Vriend, Gert; Takanari, Hiroki; Rook, Martin B.; van der Heyden, Marcel A. G.; Asselbergs, Folkert W.; Breur, Hans M.; Swinkels, Marielle E.; Scurr, Ingrid J.; Smithson, Sarah F.; Knoers, Nine V.; van der Smagt, Jasper J.; Nijman, Isaac J.; Kloosterman, Wigard P.; van Haelst, Mieke M.; van Haaften, Gijs; Cuppen, Edwin			Dominant missense mutations in ABCC9 cause Cantu syndrome	NATURE GENETICS			English	Article							K-ATP CHANNELS; CONGENITAL HYPERTRICHOSIS; GENOMIC ENRICHMENT; OSTEOCHONDRODYSPLASIA; SUR; INHERITANCE; PATIENT; OPENERS	Cantu syndrome is characterized by congenital hypertrichosis, distinctive facial features, osteochondrodysplasia and cardiac defects. By using family-based exome sequencing, we identified a de novo mutation in ABCC9. Subsequently, we discovered novel dominant missense mutations in ABCC9 in 14 of the 16 individuals with Cantu syndrome examined. The ABCC9 protein is part of an ATP-dependent potassium (K-ATP) channel that couples the metabolic state of a cell with its electrical activity. All mutations altered amino acids in or close to the transmembrane domains of ABCC9. Using electrophysiological measurements, we show that mutations in ABCC9 reduce the ATP-mediated potassium channel inhibition, resulting in channel opening. Moreover, similarities between the phenotype of individuals with Cantu syndrome and side effects from the K-ATP channel agonist minoxidil indicate that the mutations in ABCC9 result in channel opening. Given the availability of ABCC9 antagonists, our findings may have direct implications for the treatment of individuals with Cantu syndrome.	[Harakalova, Magdalena; van Harssel, Jeske J. T.; Terhal, Paulien A.; van Lieshout, Stef; Duran, Karen; Renkens, Ivo; Swinkels, Marielle E.; Knoers, Nine V.; van der Smagt, Jasper J.; Nijman, Isaac J.; Kloosterman, Wigard P.; van Haelst, Mieke M.; van Haaften, Gijs; Cuppen, Edwin] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Amor, David J.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Amor, David J.] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Wilson, Louise C.; Lees, Melissa M.] Great Ormond St Hosp Sick Children, Dept Clin Genet, London, England; [Kirk, Edwin P.] Sydney Childrens Hosp, Dept Med Genet, Sydney, NSW, Australia; [Turner, Claire L. S.] Royal Devon & Exeter Hosp, Dept Clin Genet, Exeter EX2 5DW, Devon, England; [Shears, Debbie] Churchill Hosp, Dept Clin Genet, Oxford OX3 7LJ, England; [Garcia-Minaur, Sixto] La Paz Univ Hosp, Inst Med & Mol Genet, Madrid, Spain; [Ross, Alison] Dept Clin Genet, Aberdeen, Scotland; [Venselaar, Hanka; Vriend, Gert] CMBI, Nijmegen, Netherlands; [Venselaar, Hanka; Vriend, Gert] Radboud Univ Nijmegen, Med Ctr, NCMLS, NL-6525 ED Nijmegen, Netherlands; [Takanari, Hiroki; Rook, Martin B.; van der Heyden, Marcel A. G.] Univ Med Ctr Utrecht, Dept Med Physiol, Utrecht, Netherlands; [Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Cardiol, Utrecht, Netherlands; [Breur, Hans M.] Univ Med Ctr Utrecht, Dept Pediat Cardiol, Utrecht, Netherlands; [Scurr, Ingrid J.; Smithson, Sarah F.] St Michaels Hosp, Dept Clin Genet, Bristol, Avon, England; [van Haelst, Mieke M.] Univ London Imperial Coll Sci Technol & Med, Sect Genom Med, London, England; [Cuppen, Edwin] Univ Med Ctr Utrecht, Royal Dutch Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Sydney; University of Exeter; University of Oxford; Hospital Universitario La Paz; University of Aberdeen; Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Imperial College London; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Cuppen, E (corresponding author), Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands.	g.vanhaaften@umcutrecht.nl; e.cuppen@hubrecht.eu	Cuppen, Edwin/H-2389-2016; Venselaar, Hanka/D-2009-2016; Cuppen, Edwin/F-5696-2011; Amor, David J/A-6478-2018; van Haaften, Gijs/G-7832-2012; Vriend, G./H-8112-2014; breur, hans/AAY-2340-2020; Asselbergs, Folkert W./ABD-6752-2021	Cuppen, Edwin/0000-0002-0400-9542; Venselaar, Hanka/0000-0001-9824-6559; Cuppen, Edwin/0000-0002-0400-9542; Amor, David J/0000-0001-7191-8511; van Haaften, Gijs/0000-0003-3033-0329; Asselbergs, Folkert W./0000-0002-1692-8669; van der Heyden, Marcel/0000-0002-4225-7942; Kirk, Edwin/0000-0002-4662-0024; Nijman, Isaac/0000-0002-1840-1158	Netherlands Organisation for Health Research and Development (ZonMw) [90700342]; Veni Grant from the Netherlands Organisation for Health Research and Development; University Medical Center Utrecht	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Veni Grant from the Netherlands Organisation for Health Research and Development; University Medical Center Utrecht	We thank the families of our subjects for participating in this study. We thank J.A. Sanchez-Chapula (Centro Universitario de Investigaciones Biomedicas de la Universidad de Colima) for providing wild-type KCNJ11 and ABCC9 expression constructs and N. Lansu and E. de Bruijn for technical support. F.W.A. is supported by a clinical fellowship from the Netherlands Organisation for Health Research and Development (ZonMw; 90700342). G.v.H. is supported by a Veni Grant from the Netherlands Organisation for Health Research and Development. This study was financially supported by the Child Health Priority Program of the University Medical Center Utrecht.	Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Bienengraeber M, 2004, NAT GENET, V36, P382, DOI 10.1038/ng1329; CANTU JM, 1982, HUM GENET, V60, P36, DOI 10.1007/BF00281261; Concolino D, 2000, AM J MED GENET, V92, P191, DOI 10.1002/(SICI)1096-8628(20000529)92:3<191::AID-AJMG6>3.0.CO;2-K; Engels H, 2002, AM J MED GENET, V111, P205, DOI 10.1002/ajmg.10560; Flagg TP, 2010, PHYSIOL REV, V90, P799, DOI 10.1152/physrev.00027.2009; GarciaCruz D, 1997, AM J MED GENET, V69, P138, DOI 10.1002/(SICI)1096-8628(19970317)69:2<138::AID-AJMG5>3.0.CO;2-L; Grange DK, 2006, AM J MED GENET A, V140A, P1673, DOI 10.1002/ajmg.a.31348; Graziadio C, 2011, AM J MED GENET A, V155A, P1184, DOI 10.1002/ajmg.a.33904; Harakalova M, 2011, NAT PROTOC, V6, P1870, DOI 10.1038/nprot.2011.396; Ishihara K, 2004, J PHYSIOL-LONDON, V556, P61, DOI 10.1113/jphysiol.2003.055434; Lazalde B, 2000, AM J MED GENET, V94, P421, DOI 10.1002/1096-8628(20001023)94:5<421::AID-AJMG15>3.0.CO;2-9; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mikhailov MV, 2005, EMBO J, V24, P4166, DOI 10.1038/sj.emboj.7600877; Mokry M, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq072; Moreau C, 2005, J MOL CELL CARDIOL, V38, P951, DOI 10.1016/j.yjmcc.2004.11.030; Nevin NC, 1996, AM J MED GENET, V66, P33, DOI 10.1002/(SICI)1096-8628(19961202)66:1<33::AID-AJMG8>3.3.CO;2-3; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nijman IJ, 2010, NAT METHODS, V7, P913, DOI 10.1038/nmeth.1516; Olson TM, 2007, NAT CLIN PRACT CARD, V4, P110, DOI 10.1038/ncpcardio0792; Rafiq M, 2008, DIABETES CARE, V31, P204, DOI 10.2337/dc07-1785; Robertson SP, 1999, AM J MED GENET, V85, P395, DOI 10.1002/(SICI)1096-8628(19990806)85:4<395::AID-AJMG17>3.3.CO;2-9; Rosser EM, 1998, CLIN DYSMORPHOL, V7, P79, DOI 10.1097/00019605-199804000-00001; Schwanstecher M, 1998, EMBO J, V17, P5529, DOI 10.1093/emboj/17.19.5529; Scurr I, 2011, AM J MED GENET A, V155A, P508, DOI 10.1002/ajmg.a.33885; Shi NQ, 2005, J MOL CELL CARDIOL, V39, P51, DOI 10.1016/j.yjmcc.2004.11.024; Shorter K, 2008, FASEB J, V22, P1725, DOI 10.1096/fj.07-099424; Tan TY, 2005, AM J MED GENET A, V139A, P216, DOI 10.1002/ajmg.a.31013	28	123	128	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2012	44	7					793	U223		10.1038/ng.2324	http://dx.doi.org/10.1038/ng.2324			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967DP	22610116				2022-12-25	WOS:000305886900014
J	Avraham-Davidi, I; Ely, Y; Pham, VN; Castranova, D; Grunspan, M; Malkinson, G; Gibbs-Bar, L; Mayseless, O; Allmog, G; Lo, B; Warren, CM; Chen, TT; Ungos, J; Kidd, K; Shaw, K; Rogachev, I; Wan, WZ; Murphy, PM; Farber, SA; Carmel, L; Shelness, GS; Iruela-Arispe, ML; Weinstein, BM; Yaniv, K				Avraham-Davidi, Inbal; Ely, Yona; Pham, Van N.; Castranova, Daniel; Grunspan, Moshe; Malkinson, Guy; Gibbs-Bar, Liron; Mayseless, Oded; Allmog, Gabriella; Lo, Brigid; Warren, Carmen M.; Chen, Tom T.; Ungos, Josette; Kidd, Kameha; Shaw, Kenna; Rogachev, Ilana; Wan, Wuzhou; Murphy, Philip M.; Farber, Steven A.; Carmel, Liran; Shelness, Gregory S.; Iruela-Arispe, M. Luisa; Weinstein, Brant M.; Yaniv, Karina			ApoB-containing lipoproteins regulate angiogenesis by modulating expression of VEGF receptor 1	NATURE MEDICINE			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; ENDOTHELIAL-CELLS; APOLIPOPROTEIN-B; ZEBRAFISH; HYPERCHOLESTEROLEMIA; ABETALIPOPROTEINEMIA; METABOLISM; VERTEBRATE; PLASMA; GENES	Despite the clear major contribution of hyperlipidemia to the prevalence of cardiovascular disease in the developed world, the direct effects of lipoproteins on endothelial cells have remained obscure and are under debate. Here we report a previously uncharacterized mechanism of vessel growth modulation by lipoprotein availability. Using a genetic screen for vascular defects in zebrafish, we initially identified a mutation, stalactite (stl), in the gene encoding microsomal triglyceride transfer protein (mtp), which is involved in the biosynthesis of apolipoprotein B (ApoB)-containing lipoproteins. By manipulating lipoprotein concentrations in zebrafish, we found that ApoB negatively regulates angiogenesis and that it is the ApoB protein particle, rather than lipid moieties within ApoB-containing lipoproteins, that is primarily responsible for this effect. Mechanistically, we identified downregulation of vascular endothelial growth factor receptor 1 (VEGFR1), which acts as a decoy receptor for VEGF, as a key mediator of the endothelial response to lipoproteins, and we observed VEGFR1 downregulation in hyperlipidemic mice. These findings may open new avenues for the treatment of lipoprotein-related vascular disorders.	[Avraham-Davidi, Inbal; Ely, Yona; Grunspan, Moshe; Malkinson, Guy; Gibbs-Bar, Liron; Mayseless, Oded; Allmog, Gabriella; Yaniv, Karina] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Pham, Van N.; Castranova, Daniel; Lo, Brigid; Ungos, Josette; Kidd, Kameha; Shaw, Kenna; Weinstein, Brant M.] NICHHD, Mol Genet Lab, US Natl Inst Hlth NIH, Bethesda, MD USA; [Warren, Carmen M.; Chen, Tom T.; Iruela-Arispe, M. Luisa] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Rogachev, Ilana] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; [Wan, Wuzhou; Murphy, Philip M.] NIAID, Lab Mol Immunol, NIH, Bethesda, MD USA; [Farber, Steven A.] Carnegie Inst Sci, Dept Embryol, Baltimore, MD USA; [Carmel, Liran] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Genet, Jerusalem, Israel; [Shelness, Gregory S.] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Winston Salem, NC 27103 USA	Weizmann Institute of Science; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California Los Angeles; Weizmann Institute of Science; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Carnegie Institution for Science; Hebrew University of Jerusalem; Wake Forest University; Wake Forest Baptist Medical Center	Yaniv, K (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	karina.yaniv@weizmann.ac.il	Farber, Steven A/G-5851-2012; Iruela-Arispe, M. Luisa/AAJ-1297-2020; Wan, Wuhzou/H-8556-2013	Farber, Steven A/0000-0002-8037-7312; Iruela-Arispe, M. Luisa/0000-0002-3050-4168; Mayseless, Oded/0000-0002-9556-8541; Malkinson, Guy/0000-0001-7339-3659	Israel Science Foundation [748/2009]; Marie Curie Actions-International Reintegration [FP7-PEOPLE-2009-RG 256393]; Yeda-Sela Center; Israel Cancer Research Foundation; US National Institutes of Health (NIH) [RO1CA126935]; NIH [T32HL069766, HL049373, R56DK093399, R01GM063904]; Carnegie Institution for Science endowment; G. Harold and Leila Y. Mathers Charitable Foundation; National Institute of Child Health and Human Development, NIH,; Foundation Leducq; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001011] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA126935] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069766, P01HL049373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK093399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063904] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); Marie Curie Actions-International Reintegration; Yeda-Sela Center; Israel Cancer Research Foundation; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carnegie Institution for Science endowment; G. Harold and Leila Y. Mathers Charitable Foundation; National Institute of Child Health and Human Development, NIH,(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Foundation Leducq(Leducq Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank G. Palardy, R. Miyares, N. Nevo, I. Harel, T. Berkutzki, I. Raviv, R. Oren and C. Rot for technical assistance; A. Aharoni for help with GC-MS analyses; E. Zelzer (Weizmann Institute, Israel) for providing the Ldlr-null mice, K. Tordjman (Sourasky Medical Center, Israel) for providing the ApoE-null mice, S. Schulte-Merker (Hubrecht Institute) for providing the vegfr1 plasmid and the Tg(flt1: YFP)<SUP>hu4624</SUP> transgenic line; J. Berliner (University of California Los Angeles, California) for providing human aortic endothelial cells (HAECs); D. Haratz, I. Groskop and A. Shaish for advice regarding lipid analyses; A. Harmelin and N. Stettner for animal care; and I. B. Dawid, E. Tzahor, A. Gross, B. Shilo and J. Torres-Vazquez for critical reading of the manuscript. The authors are grateful to all the members of the Yaniv and Weinstein labs for discussion, technical assistance and continuous support. This work was supported in part by Israel Science Foundation 748/2009 (to K.Y.), Marie Curie Actions-International Reintegration grants FP7-PEOPLE-2009-RG 256393 (to K.Y.), the Yeda-Sela Center (to K.Y.), the Israel Cancer Research Foundation Postdoctoral Fellowship (to I.A.-D.), US National Institutes of Health (NIH) RO1CA126935 (to M. L. I.-A.), NIH T32HL069766 (training grant for T. T. C. and C. M. W.) and NIH HL049373 (to G. S. S.). S. A. F. is funded by the NIH (R56DK093399 and R01GM063904), the Carnegie Institution for Science endowment and the G. Harold and Leila Y. Mathers Charitable Foundation. B. M. W. is supported by the intramural program of the National Institute of Child Health and Human Development, NIH, and by the Foundation Leducq.	Amack JD, 2004, CURR BIOL, V14, P685, DOI 10.1016/j.cub.2004.04.002; Anderson JL, 2011, METHOD CELL BIOL, V101, P111, DOI 10.1016/B978-0-12-387036-0.00005-0; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Babin PJ, 2009, PROG LIPID RES, V48, P73, DOI 10.1016/j.plipres.2008.11.002; Babin PJ, 1997, P NATL ACAD SCI USA, V94, P8622, DOI 10.1073/pnas.94.16.8622; Berriot-Varoqueaux N, 2000, ANNU REV NUTR, V20, P663, DOI 10.1146/annurev.nutr.20.1.663; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Breckenridge W C, 1986, Adv Exp Med Biol, V201, P211; Bussmann J, 2010, DEVELOPMENT, V137, P2653, DOI 10.1242/dev.048207; Chappell JC, 2009, DEV CELL, V17, P377, DOI 10.1016/j.devcel.2009.07.011; CONNELLY PW, 1987, J CLIN INVEST, V80, P1597, DOI 10.1172/JCI113246; Farber SA, 2001, SCIENCE, V292, P1385, DOI 10.1126/science.1060418; Fazio S, 2001, FRONT BIOSCI-LANDMRK, V6, pD515, DOI 10.2741/Fazio; Fraisl P, 2008, DEV CELL, V14, P313, DOI 10.1016/j.devcel.2008.02.009; Gore AV, 2008, DIS MODEL MECH, V1, P275, DOI 10.1242/dmm.000513; Habeck H, 2002, CURR BIOL, V12, P1405, DOI 10.1016/S0960-9822(02)01044-8; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; HEGELE RA, 1991, DIS MARKERS, V9, P73; Hegele RA, 2009, NAT REV GENET, V10, P109, DOI 10.1038/nrg2481; HENRY PD, 1993, AM J CARDIOL, V72, pC61, DOI 10.1016/0002-9149(93)90257-D; HESSLER JR, 1979, ATHEROSCLEROSIS, V32, P213, DOI 10.1016/0021-9150(79)90166-7; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Hussain MM, 2008, CURR OPIN LIPIDOL, V19, P277, DOI 10.1097/MOL.0b013e3282feea85; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Itkin M, 2011, PLANT CELL, V23, P4507, DOI 10.1105/tpc.111.088732; Kearney JB, 2002, BLOOD, V99, P2397, DOI 10.1182/blood.V99.7.2397; Landmesser U, 2000, SEMIN THROMB HEMOST, V26, P529, DOI 10.1055/s-2000-13209; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Marza E, 2005, DEV DYNAM, V232, P506, DOI 10.1002/dvdy.20251; Nicoli S, 2009, J CELL MOL MED, V13, P2061, DOI 10.1111/j.1582-4934.2008.00432.x; Pham VN, 2007, DEV BIOL, V303, P772, DOI 10.1016/j.ydbio.2006.10.030; Pickart MA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000104; Raabe M, 1998, P NATL ACAD SCI USA, V95, P8686, DOI 10.1073/pnas.95.15.8686; RADER DJ, 1993, JAMA-J AM MED ASSOC, V270, P865, DOI 10.1001/jama.270.7.865; Roman BL, 2002, DEVELOPMENT, V129, P3009; Schlegel A, 2007, PLOS GENET, V3, P2037, DOI 10.1371/journal.pgen.0030199; Schlegel A, 2006, BIOCHEMISTRY-US, V45, P15179, DOI 10.1021/bi0619268; Sellers JA, 2003, J BIOL CHEM, V278, P20367, DOI 10.1074/jbc.M300271200; Sethuraman G, 2007, PEDIATR DERMATOL, V24, P230, DOI 10.1111/j.1525-1470.2007.00391.x; Shelness GS, 2003, J BIOL CHEM, V278, P44702, DOI 10.1074/jbc.M307562200; Shelton JM, 2000, J LIPID RES, V41, P532; SHIREMAN R, 1977, P NATL ACAD SCI USA, V74, P5150, DOI 10.1073/pnas.74.11.5150; SHOULDERS CC, 1993, HUM MOL GENET, V2, P2109, DOI 10.1093/hmg/2.12.2109; Stoletov K, 2009, CIRC RES, V104, P952, DOI 10.1161/CIRCRESAHA.108.189803; Takada N, 2010, DEV DYNAM, V239, P2041, DOI 10.1002/dvdy.22338; Thorpe JL, 2004, DEV CELL, V6, P295, DOI 10.1016/S1534-5807(04)00032-2; Usui R, 2007, EMBO REP, V8, P1155, DOI 10.1038/sj.embor.7401103; Wouters K, 2005, CLIN CHEM LAB MED, V43, P470, DOI 10.1515/CCLM.2005.085; Yaniv K, 2006, NAT MED, V12, P711, DOI 10.1038/nm1427; Yla-Herttuala S, 2007, EMBO REP, V8, P1127, DOI 10.1038/sj.embor.7401124; Zygmunt T, 2011, DEV CELL, V21, P301, DOI 10.1016/j.devcel.2011.06.033	53	86	90	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2012	18	6					967	+		10.1038/nm.2759	http://dx.doi.org/10.1038/nm.2759			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22581286	Green Accepted			2022-12-25	WOS:000305116600036
J	Dannhauser, PN; Ungewickell, EJ				Dannhauser, Philip N.; Ungewickell, Ernst J.			Reconstitution of clathrin-coated bud and vesicle formation with minimal components	NATURE CELL BIOLOGY			English	Article							MEMBRANE CURVATURE; PLASMA-MEMBRANE; IN-VITRO; ENDOCYTOSIS; PROTEINS; DYNAMIN; DOMAIN; BINDING; PURIFICATION; DISSOCIATION	During the process of clathrin-mediated endocytosis an essentially planar area of membrane has to undergo a gross deformation to form a spherical bud. Three ways have been recognized by which membranes can be induced to transform themselves locally from a planar state to one of high curvature: a change in lipid distribution between the leaflets, insertion of a protein into one leaflet and formation of a protein scaffold over the surface(1). Such a scaffold is spontaneously generated by clathrin(2-5). Conjectures that the attachment of clathrin was the cause of the change in curvature were challenged on theoretical grounds(6), and also by the discovery of a number of clathrin-associated proteins with the capacity to induce membrane curvature(7-9). We have now developed a cell-free system that has enabled us to demonstrate that clathrin polymerization alone is sufficient to generate spherical buds in a membrane. This process is reversible, as shown by the reassimilation of the buds into the planar membrane when the intra-clathrin contacts are dissociated by the chaperone Hsc70. We further show that the final step in the formation of coated vesicles ensues when clathrin-coated buds are released through the action of dynamin.	[Dannhauser, Philip N.; Ungewickell, Ernst J.] Hannover Med Sch, Ctr Anat, Dept Cell Biol, D-30625 Hannover, Germany	Hannover Medical School	Ungewickell, EJ (corresponding author), Hannover Med Sch, Ctr Anat, Dept Cell Biol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	ungewickell.ernst@mh-hannover.de	Dannhauser, Philip/A-5675-2018	Dannhauser, Philip/0000-0002-6749-7678	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	We thank H. Boning, C. Lemke and H. Ungewickell for expert technical assistance. Special thanks go to W. B. Gratzer and A. Ungewickell for their critical comments on this work. The German Research Foundation (DFG) supported early stages of this study.	AHLE S, 1988, EMBO J, V7, P919, DOI 10.1002/j.1460-2075.1988.tb02897.x; Chebotareva NA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1239, DOI 10.1007/s10541-005-0070-y; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; den Otter WK, 2011, TRAFFIC, V12, P1407, DOI 10.1111/j.1600-0854.2011.01241.x; Drake MT, 2001, J BIOL CHEM, V276, P28700, DOI 10.1074/jbc.M104226200; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Higgins MK, 2005, METHOD ENZYMOL, V404, P597, DOI 10.1016/S0076-6879(05)04052-8; ISRAELACHVILI JN, 1975, BIOCHIM BIOPHYS ACTA, V389, P13, DOI 10.1016/0005-2736(75)90381-8; Kalthoff C, 2002, J BIOL CHEM, V277, P8209, DOI 10.1074/jbc.M111587200; KEEN JH, 1979, CELL, V16, P303, DOI 10.1016/0092-8674(79)90007-2; KIRCHHAUSEN T, 1981, CELL, V23, P755, DOI 10.1016/0092-8674(81)90439-6; Lata S, 2005, J AM CHEM SOC, V127, P10205, DOI 10.1021/ja050690c; LINDNER R, 1992, J BIOL CHEM, V267, P16567; Lud SQ, 2006, CHEMPHYSCHEM, V7, P379, DOI 10.1002/cphc.200500484; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Meyerholz A, 2005, TRAFFIC, V6, P1225, DOI 10.1111/j.1600-0854.2005.00355.x; Morgan JR, 2000, J NEUROSCI, V20, P8667; NORRIS FA, 1995, J BIOL CHEM, V270, P214, DOI 10.1074/jbc.270.1.214; Nossal R, 2002, CURR BIOL, V12, pR770, DOI 10.1016/S0960-9822(02)01289-7; Nossal R, 2001, TRAFFIC, V2, P138, DOI 10.1034/j.1600-0854.2001.020208.x; PEARSE BMF, 1975, J MOL BIOL, V97, P93, DOI 10.1016/S0022-2836(75)80024-6; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Ramachandran R, 2008, EMBO J, V27, P27, DOI 10.1038/sj.emboj.7601961; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Scheele U, 2003, J BIOL CHEM, V278, P25357, DOI 10.1074/jbc.M303738200; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; Semerdjieva S, 2008, J CELL BIOL, V183, P499, DOI 10.1083/jcb.200806016; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Traub LM, 2005, BBA-MOL CELL RES, V1744, P415, DOI 10.1016/j.bbamcr.2005.04.005; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; UNGEWICKELL E, 1981, NATURE, V289, P420, DOI 10.1038/289420a0; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; WOODWARD MP, 1978, P NATL ACAD SCI USA, V75, P4394, DOI 10.1073/pnas.75.9.4394; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	39	116	117	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2012	14	6					634	+		10.1038/ncb2478	http://dx.doi.org/10.1038/ncb2478			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	949TW	22522172				2022-12-25	WOS:000304599900013
J	Miyamoto, T; DeRose, R; Suarez, A; Ueno, T; Chen, M; Sun, TP; Wolfgang, MJ; Mukherjee, C; Meyers, DJ; Inoue, T				Miyamoto, Takafumi; DeRose, Robert; Suarez, Allison; Ueno, Tasuku; Chen, Melinda; Sun, Tai-ping; Wolfgang, Michael J.; Mukherjee, Chandrani; Meyers, David J.; Inoue, Takanari			Rapid and orthogonal logic gating with a gibberellin-induced dimerization system	NATURE CHEMICAL BIOLOGY			English	Article							GENE-EXPRESSION; RECEPTOR GID1; CELLS; PROTEIN; LIGANDS; GATE; RECOGNITION; ACTIVATION; MECHANISM; CIRCUITS	Using a newly synthesized gibberellin analog containing an acetoxymethyl group (GA(3)-AM) and its binding proteins, we developed an efficient chemically inducible dimerization (CID) system that is completely orthogonal to existing rapamycin-mediated protein dimerization. Combining the two systems should allow applications that have been difficult or impossible with only one CID system. By using both chemical inputs (rapamycin and GA(3)-AM), we designed and synthesized Boolean logic gates in living mammalian cells. These gates produced output signals such as fluorescence and membrane ruffling on a timescale of seconds, substantially faster than earlier intracellular logic gates. The use of two orthogonal dimerization systems in the same cell also allows for finer modulation of protein perturbations than is possible with a single dimerizer.	[Miyamoto, Takafumi; DeRose, Robert; Suarez, Allison; Ueno, Tasuku; Chen, Melinda; Inoue, Takanari] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Ctr Cell Dynam, Baltimore, MD 21218 USA; [Sun, Tai-ping] Duke Univ, Dept Biol, Durham, NC USA; [Wolfgang, Michael J.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Mukherjee, Chandrani; Meyers, David J.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Synthet Core Facil, Baltimore, MD 21205 USA	Johns Hopkins University; Duke University; Johns Hopkins University; Johns Hopkins University	Miyamoto, T (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Ctr Cell Dynam, Baltimore, MD 21218 USA.	jctinoue@jhmi.edu	Miyamoto, Takafumi/T-6950-2019; Ueno, Tasuku/AAD-8371-2021	Ueno, Tasuku/0000-0001-6657-8209; Miyamoto, Takafumi/0000-0001-9363-2864	US National Institutes of Health (NIH) [GM092930, DK090868, NS072241]; US National Science Foundation [IOS-0641548, MCB-0923723]; National Center for Research Resources of the NIH; NIH Roadmap for Medical Research [UL1 RR 025005]; Japanese Society for the Promotion of Science; Provost's Undergraduate Research Award; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, P30DK090868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092930, R01GM100051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072241] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); National Center for Research Resources of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Provost's Undergraduate Research Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported in part by the US National Institutes of Health (NIH; GM092930 and DK090868 to T. I. and NS072241 to M.J.W), the US National Science Foundation (IOS-0641548 and MCB-0923723 to T. S.) and the National Center for Research Resources of the NIH and NIH Roadmap for Medical Research (UL1 RR 025005 to C. M. and D.J.M). T. U. is a recipient of a fellowship from the Japanese Society for the Promotion of Science. M. C. is a recipient of the Provost's Undergraduate Research Award.	Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Bayle JH, 2006, CHEM BIOL, V13, P99, DOI 10.1016/j.chembiol.2005.10.017; Bronson JE, 2008, MOL BIOSYST, V4, P56, DOI 10.1039/b713852k; Czlapinski JL, 2008, J AM CHEM SOC, V130, P13186, DOI 10.1021/ja8037728; Fegan A, 2010, CHEM REV, V110, P3315, DOI 10.1021/cr8002888; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Hirano K, 2008, TRENDS PLANT SCI, V13, P192, DOI 10.1016/j.tplants.2008.02.005; Hirano K, 2010, PLANT CELL, V22, P2680, DOI 10.1105/tpc.110.075549; Ho SN, 1996, NATURE, V382, P822, DOI 10.1038/382822a0; Ihara S, 2006, J CELL SCI, V119, P500, DOI 10.1242/jcs.02767; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Katz E, 2010, CHEM SOC REV, V39, P1835, DOI 10.1039/b806038j; Komatsu T, 2010, NAT METHODS, V7, P206, DOI [10.1038/nmeth.1428, 10.1038/NMETH.1428]; Korzeniowski MK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001122; Liang FS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001449; Liberles SD, 1997, P NATL ACAD SCI USA, V94, P7825, DOI 10.1073/pnas.94.15.7825; MALGAROLI A, 1987, J CELL BIOL, V105, P2145, DOI 10.1083/jcb.105.5.2145; Mayo AE, 2006, PLOS BIOL, V4, P555, DOI 10.1371/journal.pbio.0040045; Murase K, 2008, NATURE, V456, P459, DOI 10.1038/nature07519; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Qian L, 2011, J R SOC INTERFACE, V8, P1281, DOI 10.1098/rsif.2010.0729; Rackham O, 2005, J AM CHEM SOC, V127, P17584, DOI 10.1021/ja055338d; Regot S, 2011, NATURE, V469, P207, DOI 10.1038/nature09679; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Rivera VM, 1996, NAT MED, V2, P1028, DOI 10.1038/nm0996-1028; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Schreiber SL, 2007, CHEM BIOL SMALL MOL; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Shimada A, 2008, NATURE, V456, P520, DOI 10.1038/nature07546; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Stojanovic MN, 2008, PROG NUCLEIC ACID RE, V82, P199, DOI 10.1016/S0079-6603(08)00006-8; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Swanson SJ, 1996, PLANT CELL, V8, P2211, DOI 10.1105/tpc.8.12.2211; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Tojima T, 2007, NAT NEUROSCI, V10, P58, DOI 10.1038/nn1814; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Ueguchi-Tanaka M, 2007, PLANT CELL, V19, P2140, DOI 10.1105/tpc.106.043729; Ueno T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002033; Yoshida W, 2007, CHEM COMMUN, P195, DOI 10.1039/b613201d	41	123	129	2	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2012	8	5					465	470		10.1038/NCHEMBIO.922	http://dx.doi.org/10.1038/NCHEMBIO.922			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	928DY	22446836	Green Accepted			2022-12-25	WOS:000302962500013
J	Yang, J; Ferreira, T; Morris, AP; Medland, SE; Madden, PAF; Heath, AC; Martin, NG; Montgomery, GW; Weedon, MN; Loos, RJ; Frayling, TM; McCarthy, MI; Hirschhorn, JN; Goddard, ME; Visscher, PM				Yang, Jian; Ferreira, Teresa; Morris, Andrew P.; Medland, Sarah E.; Madden, Pamela A. F.; Heath, Andrew C.; Martin, Nicholas G.; Montgomery, Grant W.; Weedon, Michael N.; Loos, Ruth J.; Frayling, Timothy M.; McCarthy, Mark I.; Hirschhorn, Joel N.; Goddard, Michael E.; Visscher, Peter M.		Genetic Invest ANthropometric Trai; DIAbet Genetics Replication Meta-A	Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; COMMON SNPS; SUSCEPTIBILITY LOCI; GENETIC-VARIATION; HUMAN HEIGHT; HERITABILITY; DISEASE; RISK; MAP	We present an approximate conditional and joint association analysis that can use summary-level statistics from a meta-analysis of genome-wide association studies (GWAS) and estimated linkage disequilibrium (LD) from a reference sample with individual-level genotype data. Using this method, we analyzed meta-analysis summary data from the GIANT Consortium for height and body mass index (BMI), with the LD structure estimated from genotype data in two independent cohorts. We identified 36 loci with multiple associated variants for height (38 leading and 49 additional SNPs, 87 in total) via a genome-wide SNP selection procedure. The 49 new SNPs explain approximately 1.3% of variance, nearly doubling the heritability explained at the 36 loci. We did not find any locus showing multiple associated SNPs for BMI. The method we present is computationally fast and is also applicable to case-control data, which we demonstrate in an example from meta-analysis of type 2 diabetes by the DIAGRAM Consortium.	[Yang, Jian; Medland, Sarah E.; Martin, Nicholas G.; Montgomery, Grant W.; Visscher, Peter M.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Yang, Jian; Visscher, Peter M.] Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld, Australia; [Ferreira, Teresa; Morris, Andrew P.; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Madden, Pamela A. F.; Heath, Andrew C.] Washington Univ, Dept Psychiat, St Louis, MO USA; [Weedon, Michael N.; Frayling, Timothy M.] Univ Exeter, Peninsula Coll Med & Dent, Exeter, Devon, England; [Loos, Ruth J.] Addenbrookes Hosp, MRC, Epidemiol Unit, Inst Metab Sci, Cambridge, England; [McCarthy, Mark I.] Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Hirschhorn, Joel N.] Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Broad Inst, Cambridge, MA USA; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Goddard, Michael E.] Univ Melbourne, Dept Food & Agr Syst, Parkville, Vic 3052, Australia; [Goddard, Michael E.] Dept Primary Ind, Biosci Res Div, Bundoora, Vic, Australia; [Visscher, Peter M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; University of Oxford; Wellcome Centre for Human Genetics; Washington University (WUSTL); University of Exeter; University of Plymouth; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; University of Melbourne; University of Queensland	Visscher, PM (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.	peter.visscher@uq.edu.au	Yang, Jian/A-5852-2010; Medland, Sarah E/C-7630-2013; Loos, Ruth J F/Q-2862-2016; Martin, Nicholas/R-9235-2019; Loos, Ruth/GON-5877-2022; Montgomery, Grant W/B-7148-2008; Medland, Sarah/AAT-7595-2020; Visscher, Peter/ABB-6151-2020; Meitinger, Thomas/O-1318-2015; McCarthy, Mark/M-3763-2015	Yang, Jian/0000-0003-2001-2474; Medland, Sarah E/0000-0003-1382-380X; Loos, Ruth J F/0000-0002-8532-5087; Martin, Nicholas/0000-0003-4069-8020; Montgomery, Grant W/0000-0002-4140-8139; Medland, Sarah/0000-0003-1382-380X; Visscher, Peter/0000-0002-2143-8760; Goddard, Michael/0000-0001-9917-7946; McCarthy, Mark/0000-0002-4393-0510; Weedon, Michael/0000-0002-6174-6135	Australian National Health and Medical Research Council (NHMRC) [241944, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 496688, 552485, 613672, 613601, 1011506]; US National Institutes of Health [AA07535, AA10248, AA014041, AA13320, AA13321, AA13326, DA12854, HHSN268200625226C]; Australian Research Council (ARC) [DP0770096, DP1093502]; Wellcome Trust [WT081682/Z/06/Z, WT083270]; National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; XXX [R01HL087641, R01HL59367, R01HL086694]; US National Human Genome Research Institute [U01HG004402]; NIH Roadmap for Medical Research [UL1RR025005]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087641, R01HL059367, R01HL086694] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA007535, R01AA013320, R01AA014041, R01AA013326, K05AA017688, R01AA013321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012854, R56DA012854] Funding Source: NIH RePORTER; MRC [MC_U106188470] Funding Source: UKRI; Medical Research Council [MC_U106188470] Funding Source: researchfish	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council (ARC)(Australian Research Council); Wellcome Trust(Wellcome TrustEuropean Commission); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); XXX; US National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank the staff and participants of the ARIC study for their important contributions. We thank all referees for many constructive comments and suggestions. We acknowledge funding from the Australian National Health and Medical Research Council (NHMRC; 241944, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 496688, 552485, 613672, 613601 and 1011506), the US National Institutes of Health (AA07535, AA10248, AA014041, AA13320, AA13321, AA13326 and DA12854) and the Australian Research Council (ARC; DP0770096 and DP1093502). A.P.M. acknowledges financial support from the Wellcome Trust (WT081682/Z/06/Z). M.I.M. acknowledges financial support from the Wellcome Trust (WT083270). The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by contracts with the National Heart, Lung, and Blood Institute (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C and HHSN268201100012C), the XXX (R01HL087641, R01HL59367 and R01HL086694), the US National Human Genome Research Institute (U01HG004402) and the US National Institutes of Health (HHSN268200625226C). Infrastructure was partly supported by a component of the US National Institutes of Health and NIH Roadmap for Medical Research (UL1RR025005).	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Galarneau G, 2010, NAT GENET, V42, P1049, DOI 10.1038/ng.707; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Ke XY, 2004, HUM MOL GENET, V13, P2557, DOI 10.1093/hmg/ddh294; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Magnusson P. K. E., 2002, International Journal of Obesity, V26, P1225, DOI 10.1038/sj.ijo.0802041; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Pardo L, 2009, EUR J HUM GENET, V17, P802, DOI 10.1038/ejhg.2008.248; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Sanna S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002198; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409; Shea J, 2011, NAT GENET, V43, P801, DOI 10.1038/ng.871; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Sonesson AK, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-41; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Teo YY, 2009, GENOME RES, V19, P1849, DOI 10.1101/gr.092189.109; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Weir BS, 1990, GENETIC DATA ANAL; Wood AR, 2011, HUM MOL GENET, V20, P4082, DOI 10.1093/hmg/ddr328; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	33	744	752	5	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2012	44	4					369	U170		10.1038/ng.2213	http://dx.doi.org/10.1038/ng.2213			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	916VF	22426310	Green Accepted			2022-12-25	WOS:000302130600008
J	Blum, B; Hrvatin, S; Schuetz, C; Bonal, C; Rezania, A; Melton, DA				Blum, Barak; Hrvatin, Sinisa; Schuetz, Christian; Bonal, Claire; Rezania, Alireza; Melton, Douglas A.			Functional beta-cell maturation is marked by an increased glucose threshold and by expression of urocortin 3	NATURE BIOTECHNOLOGY			English	Article							INSULIN-SECRETION; IN-VIVO; PANCREAS; CHANNELS; MAINTAIN; ISLETS	Insulin-expressing cells that have been differentiated from human pluripotent stem cells in vitro lack the glucose responsiveness characteristic of mature beta cells. Beta-cell maturation in mice was studied to find genetic markers that enable screens for factors that induce bona fide beta cells in vitro. We find that functional beta-cell maturation is marked by an increase in the glucose threshold for insulin secretion and by expression of the gene urocortin 3.	[Blum, Barak; Hrvatin, Sinisa; Schuetz, Christian; Bonal, Claire; Melton, Douglas A.] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Rezania, Alireza] Janssen Res & Dev LLC, BetaL Venture, Raritan, NJ USA	Harvard University; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Melton, DA (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	dmelton@harvard.edu	Schuetz, Christian/K-5234-2013; Young, Richard A/F-6495-2012	Schuetz, Christian/0000-0002-6828-4543; Young, Richard A/0000-0001-8855-8647; Blum, Barak/0000-0002-5308-4194; Hrvatin, Sinisa/0000-0001-7303-4218	European Molecular Biology Organization; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK072505, U01DK072473] Funding Source: NIH RePORTER	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank W. Vale (Salk Institute) for providing anti-human Ucn3 antibody, K. Blum for writing the MATLAB BioGUI for analysis of GSIS, A. Kweudjeu for help with transcriptional arrays, C. Honore for help with FACS analyses, A. Roose, A. Cheng and F. Deng for excellent technical assistance, and D. Cohen, Y. Mayshar and F. Pagliuca for critical reading of the manuscript. We are grateful to all members of the Melton laboratory and the Harvard Medical School Critical Discussion Group for helpful discussions and experimental advice. B. B. was supported by European Molecular Biology Organization and Juvenile Diabetes Research Foundation post-doctoral fellowships. D. A. M. is an Investigator of the Howard Hughes Medical Institute.	Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Carvalho CPF, 2010, DIABETOLOGIA, V53, P1428, DOI 10.1007/s00125-010-1726-8; Gao N, 2010, MOL ENDOCRINOL, V24, P1594, DOI 10.1210/me.2009-0513; Gu CY, 2010, CELL METAB, V11, P298, DOI 10.1016/j.cmet.2010.03.006; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Li C, 2003, ENDOCRINOLOGY, V144, P3216, DOI 10.1210/en.2002-0087; Li C, 2007, P NATL ACAD SCI USA, V104, P4206, DOI 10.1073/pnas.0611641104; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Richardson CC, 2007, DIABETOLOGIA, V50, P1000, DOI 10.1007/s00125-007-0644-x; RORSMAN P, 1989, P NATL ACAD SCI USA, V86, P4505, DOI 10.1073/pnas.86.12.4505; Rozzo A, 2009, ANN NY ACAD SCI, V1152, P53, DOI 10.1111/j.1749-6632.2008.04003.x; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; Taniguchi S, 2000, HORM METAB RES, V32, P97, DOI 10.1055/s-2007-978598	13	238	241	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2012	30	3					261	264		10.1038/nbt.2141	http://dx.doi.org/10.1038/nbt.2141			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	905VI	22371083	Green Accepted			2022-12-25	WOS:000301303800022
J	Lipson, D; Capelletti, M; Yelensky, R; Otto, G; Parker, A; Jarosz, M; Curran, JA; Balasubramanian, S; Bloom, T; Brennan, KW; Donahue, A; Downing, SR; Frampton, GM; Garcia, L; Juhn, F; Mitchell, KC; White, E; White, J; Zwirko, Z; Peretz, T; Nechushtan, H; Soussan-Gutman, L; Kim, J; Sasaki, H; Kim, HR; Park, SI; Ercan, D; Sheehan, CE; Ross, JS; Cronin, MT; Janne, PA; Stephens, PJ				Lipson, Doron; Capelletti, Marzia; Yelensky, Roman; Otto, Geoff; Parker, Alex; Jarosz, Mirna; Curran, John A.; Balasubramanian, Sohail; Bloom, Troy; Brennan, Kristina W.; Donahue, Amy; Downing, Sean R.; Frampton, Garrett M.; Garcia, Lazaro; Juhn, Frank; Mitchell, Kathy C.; White, Emily; White, Jared; Zwirko, Zac; Peretz, Tamar; Nechushtan, Hovav; Soussan-Gutman, Lior; Kim, Jhingook; Sasaki, Hidefumi; Kim, Hyeong Ryul; Park, Seung-il; Ercan, Dalia; Sheehan, Christine E.; Ross, Jeffrey S.; Cronin, Maureen T.; Jaenne, Pasi A.; Stephens, Philip J.			Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies	NATURE MEDICINE			English	Article							MUTATIONS; SENSITIVITY; CARCINOMAS; ACTIVATION; INHIBITOR; GEFITINIB; ERLOTINIB; CETUXIMAB; PATHWAYS; TUMORS	Applying a next-generation sequencing assay targeting 145 cancer-relevant genes in 40 colorectal cancer and 24 non-small cell lung cancer formalin-fixed paraffin-embedded tissue specimens identified at least one clinically relevant genomic alteration in 59% of the samples and revealed two gene fusions, C2orf44-ALK in a colorectal cancer sample and KIF5B-RET in a lung adenocarcinoma. Further screening of 561 lung adenocarcinomas identified 11 additional tumors with KIF5B-RET gene fusions (2.0%; 95% CI 0.8-3.1%). Cells expressing oncogenic KIF5B-RET are sensitive to multi-kinase inhibitors that inhibit RET.	[Lipson, Doron; Yelensky, Roman; Otto, Geoff; Parker, Alex; Jarosz, Mirna; Curran, John A.; Balasubramanian, Sohail; Bloom, Troy; Brennan, Kristina W.; Donahue, Amy; Downing, Sean R.; Frampton, Garrett M.; Garcia, Lazaro; Juhn, Frank; Mitchell, Kathy C.; White, Emily; White, Jared; Zwirko, Zac; Ross, Jeffrey S.; Cronin, Maureen T.; Stephens, Philip J.] Fdn Med, Cambridge, MA USA; [Capelletti, Marzia; Ercan, Dalia; Jaenne, Pasi A.] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA; [Peretz, Tamar; Nechushtan, Hovav] Hadassah Hebrew Univ Med Ctr, Sharett Inst Oncol, Jerusalem, Israel; [Soussan-Gutman, Lior] Oncotest Teva Pharmaceut Ind, Petah Tiqwa, Israel; [Kim, Jhingook] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac Surg, Seoul, South Korea; [Sasaki, Hidefumi] Nagoya City Univ, Dept Oncol Immunol & Surg 2, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Kim, Hyeong Ryul; Park, Seung-il] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Thorac Surg, Seoul, South Korea; [Sheehan, Christine E.; Ross, Jeffrey S.] Albany Med Ctr, Dept Pathol, Albany, NY USA	Foundation Medicine; Harvard University; Dana-Farber Cancer Institute; Hebrew University of Jerusalem; Teva Pharmaceutical Industries; Sungkyunkwan University (SKKU); Samsung Medical Center; Nagoya City University; University of Ulsan; Asan Medical Center; Albany Medical College	Stephens, PJ (corresponding author), Fdn Med, Cambridge, MA USA.	mcronin@foundationmedicine.com; pjanne@partners.org; pstephens@foundationmedicine.com	nechushtan, hovav/Z-3564-2019; Sheehan, Christine E./AAW-1429-2021; Capelletti, Marzia/L-6317-2016	Capelletti, Marzia/0000-0001-5095-7060; Frampton, Garrett/0000-0002-2361-2750	Dana Farber/Harvard Cancer Center Lung Cancer SPORE [P50 CA090578]; Cammarata Family Foundation; Dana-Farber Cancer Institute; Japan Society for the Promotion of Science (JSPS) [23659674, 21390394, 21591820]; NATIONAL CANCER INSTITUTE [R01CA136851, P50CA090578] Funding Source: NIH RePORTER	Dana Farber/Harvard Cancer Center Lung Cancer SPORE; Cammarata Family Foundation; Dana-Farber Cancer Institute; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank M. Hawryluk for his help in preparing this manuscript. This work is supported by the Dana Farber/Harvard Cancer Center Lung Cancer SPORE P50 CA090578 (P.A.J.), the Cammarata Family Foundation Research Fund (M. C. and P.A.J.), the Nirenberg Fellowship at the Dana-Farber Cancer Institute (M. C. and P.A.J.) and the Japan Society for the Promotion of Science (JSPS), grant references 23659674, 21390394 and 21591820 (H.S.).	Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Di Nicolantonio F, 2010, J CLIN INVEST, V120, P2858, DOI 10.1172/JCI37539; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; FUSCO A, 1987, NATURE, V328, P170, DOI 10.1038/328170a0; Henderson YC, 2008, CLIN CANCER RES, V14, P4908, DOI 10.1158/1078-0432.CCR-07-1772; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Toogood PL, 2005, J MED CHEM, V48, P2388, DOI 10.1021/jm049354h; Turner N, 2005, CURR OPIN PHARMACOL, V5, P388, DOI 10.1016/j.coph.2005.03.006; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wang YC, 2009, BLOOD, V114, P5024, DOI 10.1182/blood-2009-05-222133; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Wilson CH, 2010, ONCOGENE, V29, P4567, DOI 10.1038/onc.2010.202; Wong DWS, 2011, CANCER-AM CANCER SOC, V117, P2709, DOI 10.1002/cncr.25843	20	628	685	4	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2012	18	3					382	384		10.1038/nm.2673	http://dx.doi.org/10.1038/nm.2673			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22327622	Green Accepted			2022-12-25	WOS:000301264800038
J	Young, ND; Jex, AR; Li, B; Liu, SP; Yang, LF; Xiong, ZJ; Li, YR; Cantacessi, C; Hall, RS; Xu, X; Chen, FY; Wu, X; Zerlotini, A; Oliveira, G; Hofmann, A; Zhang, GJ; Fang, XD; Kang, Y; Campbell, BE; Loukas, A; Ranganathan, S; Rollinson, D; Rinaldi, G; Brindley, PJ; Yang, HM; Wang, J; Wang, J; Gasser, RB				Young, Neil D.; Jex, Aaron R.; Li, Bo; Liu, Shiping; Yang, Linfeng; Xiong, Zijun; Li, Yingrui; Cantacessi, Cinzia; Hall, Ross S.; Xu, Xun; Chen, Fangyuan; Wu, Xuan; Zerlotini, Adhemar; Oliveira, Guilherme; Hofmann, Andreas; Zhang, Guojie; Fang, Xiaodong; Kang, Yi; Campbell, Bronwyn E.; Loukas, Alex; Ranganathan, Shoba; Rollinson, David; Rinaldi, Gabriel; Brindley, Paul J.; Yang, Huanming; Wang, Jun; Wang, Jian; Gasser, Robin B.			Whole-genome sequence of Schistosoma haematobium	NATURE GENETICS			English	Article							HUMAN BLOOD FLUKE; GENETIC MANIPULATION; MANSONI; JAPONICUM; PATHOGEN; IMMUNITY; TARGETS; HEALTH	Schistosomiasis is a neglected tropical disease caused by blood flukes (genus Schistosoma; schistosomes) and affecting 200 million people worldwide(1). No vaccines are available, and treatment relies on one drug, praziquantel(2). Schistosoma haematobium has come into the spotlight as a major cause of urogenital disease, as an agent linked to bladder cancer(1,3) and as a predisposing factor for HIV/AIDS(4,5). The parasite is transmitted to humans from freshwater snails'. Worms dwell in blood vessels and release eggs that become embedded in the bladder wall to elicit chronic immune-mediated disease(6) and induce squamous cell carcinoma(7). Here we sequenced the 385-Mb genome of S. haematobium using Illumina-based technology at 74-fold coverage and compared it to sequences from related parasites(8,9). We included genome annotation based on function, gene ontology, networking and pathway mapping. This genome now provides an unprecedented resource for many fundamental research areas and shows great promise for the design of new disease interventions.	[Young, Neil D.; Jex, Aaron R.; Cantacessi, Cinzia; Hall, Ross S.; Hofmann, Andreas; Campbell, Bronwyn E.; Gasser, Robin B.] Univ Melbourne, Fac Vet Sci, Melbourne, Vic 3010, Australia; [Li, Bo; Liu, Shiping; Yang, Linfeng; Xiong, Zijun; Li, Yingrui; Xu, Xun; Chen, Fangyuan; Wu, Xuan; Zhang, Guojie; Fang, Xiaodong; Kang, Yi; Yang, Huanming; Wang, Jun; Wang, Jian] BGI Shenzhen, Shenzhen, Peoples R China; [Zerlotini, Adhemar; Oliveira, Guilherme] Inst Pesquisa Rene Rachou Fiocruz, Inst Nacl Ciencia & Tecnol Doencas Tropicais, Belo Horizonte, MG, Brazil; [Hofmann, Andreas] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia; [Loukas, Alex] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Cairns, Qld, Australia; [Ranganathan, Shoba] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Ranganathan, Shoba] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Rollinson, David] Nat Hist Museum, London SW7 5BD, England; [Rinaldi, Gabriel] Univ Republica, Dept Genet, Montevideo, Uruguay; [Rinaldi, Gabriel; Brindley, Paul J.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA	University of Melbourne; Beijing Genomics Institute (BGI); Fundacao Oswaldo Cruz; Griffith University; James Cook University; Macquarie University; National University of Singapore; Natural History Museum London; Universidad de la Republica, Uruguay; George Washington University	Gasser, RB (corresponding author), Univ Melbourne, Fac Vet Sci, Melbourne, Vic 3010, Australia.	wangjian@genomics.org.cn wangjian@genomics.org.cn; wangjian@genomics.org.cn wangjian@genomics.org.cn	Cantacessi, Cinzia/B-7356-2014; Hofmann, Andreas/B-9515-2008; Jex, Aaron/AGZ-7897-2022; Xu, Xun/AAI-6763-2020; Yang, Linfeng/AAZ-8792-2020; Hofmann, Andreas/M-9870-2019; Zhang, Guojie/J-7273-2019; Loukas, Alex/B-7355-2014; Gasser, Robin/ABH-6185-2020; Zhang, Guojie/B-6188-2014; Rollinson, David/C-7406-2009; Li, Yingrui/K-1064-2015; Fang, Xiaodong/K-6743-2018; Wang, Jun/A-7261-2013; Young, Neil David/AAU-4572-2020; DoenÃas Tropicais, Inct/K-2308-2013; Zerlotini, Adhemar/E-6533-2012; Wang, Jun/C-8434-2016; Oliveira, Guilherme/E-2624-2014; Wang, Jun/B-9503-2016	Cantacessi, Cinzia/0000-0001-6863-2950; Hofmann, Andreas/0000-0003-4408-5467; Jex, Aaron/0000-0002-1285-7947; Xu, Xun/0000-0002-5338-5173; Hofmann, Andreas/0000-0003-4408-5467; Zhang, Guojie/0000-0001-6860-1521; Loukas, Alex/0000-0002-0896-8441; Gasser, Robin/0000-0002-4423-1690; Zhang, Guojie/0000-0001-6860-1521; Fang, Xiaodong/0000-0001-7061-3337; Young, Neil David/0000-0001-8756-229X; Zerlotini, Adhemar/0000-0002-7739-0284; Wang, Jun/0000-0002-8540-8931; LIU, Shiping/0000-0003-0019-619X; Oliveira, Guilherme/0000-0003-0054-3438; Campbell, Bronwyn/0000-0001-9090-764X; Wang, Jun/0000-0002-2113-5874; Ranganathan, Shoba/0000-0002-8290-813X; Brindley, Paul J./0000-0003-1765-0002; Rinaldi, Gabriel/0000-0002-7767-4922; Xiong, Zijun/0000-0003-3923-0703	Australian Research Council; BGI; National Health and Medical Research Council (NHMRC) of Australia; Australian Academy of Science; Australian-American Fulbright Commission; Melbourne Water Corporation; Victorian Life Sciences Computation Initiative (VLSCI); IBM Collaboratory; NHMRC; Liang of the Biomedical Research Institute, under NIAID-NIH [HHSN272201000005I]; NIH-Fogarty [TW007012]; FAPEMIG [CBB-1181/08]; CNPq [573839/2008-5]; FOGARTY INTERNATIONAL CENTER [D43TW007012] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); BGI; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Academy of Science; Australian-American Fulbright Commission; Melbourne Water Corporation; Victorian Life Sciences Computation Initiative (VLSCI); IBM Collaboratory(International Business Machines (IBM)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Liang of the Biomedical Research Institute, under NIAID-NIH; NIH-Fogarty(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This project was funded by the Australian Research Council (R.B.G. and H.M.Y.) and BGI. We are grateful for other support from the National Health and Medical Research Council (NHMRC) of Australia (R.B.G.), the Australian Academy of Science, the Australian-American Fulbright Commission, Melbourne Water Corporation, the Victorian Life Sciences Computation Initiative (VLSCI) and the IBM Collaboratory. N.D.Y. (Early Career Research Fellow) and A.R.J. (CDA1 Fellow) were supported by NHMRC fellowships. We thank staff of BGI-Shenzhen, including Q. Nan, P. Na, B. Min and P. Ni for their contributions. Schistosoma haematobium-infected hamsters were provided by F.A. Lewis and Y.-S. Liang of the Biomedical Research Institute, under NIAID-NIH contract HHSN272201000005I. G.O. is supported by NIH-Fogarty TW007012, FAPEMIG CBB-1181/08 and CNPq 573839/2008-5.	Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Botelho MC, 2010, VIRULENCE, V1, P84, DOI 10.4161/viru.1.2.10487; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Brindley PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000538; Caffrey CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004413; Criscione CD, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r71; Doenhoff MJ, 2008, CURR OPIN INFECT DIS, V21, P659, DOI 10.1097/QCO.0b013e328318978f; Fitzpatrick JM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000543; Geyer KK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1433; Gobert GN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-128; Gomes MD, 2011, GENOMICS, V98, P96, DOI 10.1016/j.ygeno.2011.05.007; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000430; Kjetland EF, 2006, AIDS, V20, P593, DOI 10.1097/01.aids.0000210614.45212.0a; Liu F, 2009, MOL CELL PROTEOMICS, V8, P1236, DOI 10.1074/mcp.M800538-MCP200; Mann VH, 2010, PARASITOLOGY, V137, P451, DOI 10.1017/S0031182009991211; Mathieson W, 2010, INT J PARASITOL, V40, P617, DOI 10.1016/j.ijpara.2009.10.014; Paez JG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh069; Palumbo E, 2007, INFECT DIS CLIN PRAC, V15, P145, DOI 10.1097/01.idc.0000269904.90155.ce; Rinaldi G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001348; Rollinson D, 2009, PARASITOLOGY, V136, P1593, DOI 10.1017/S0031182009990552; Schistosoma japonicum Genome Sequencing and Functional Analysis Consortium, 2009, NATURE, V460, P345; Schramm G, 2007, J IMMUNOL, V178, P6023, DOI 10.4049/jimmunol.178.10.6023; SHORT RB, 1960, J PARASITOL, V46, P273, DOI 10.2307/3275488; Valentim CLL, 2009, MOL BIOCHEM PARASIT, V166, P81, DOI 10.1016/j.molbiopara.2009.02.010; Verjovski-Almeida S, 2011, J PROTEOMICS, V74, P1515, DOI 10.1016/j.jprot.2011.03.022; Webster BL, 2006, INT J PARASITOL, V36, P947, DOI 10.1016/j.ijpara.2006.03.005	30	307	319	6	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2012	44	2					221	225		10.1038/ng.1065	http://dx.doi.org/10.1038/ng.1065			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	22246508	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000299664400024
J	Zelinski, T; Coghlan, G; Liu, XQ; Reid, ME				Zelinski, Teresa; Coghlan, Gail; Liu, Xiao-Qing; Reid, Marion E.			ABCG2 null alleles define the Jr(a-) blood group phenotype	NATURE GENETICS			English	Article							CANCER RESISTANCE PROTEIN; TRANSPORTER; IDENTIFICATION; POLYMORPHISMS	The high-incidence erythrocyte blood group antigen Jr(a) has been known in transfusion medicine for over 40 years. To identify the gene encoding Jr(a), we performed SNP analysis of genomic DNA from six Jr(a-) individuals. All individuals shared a homozygous region of 397,000 bp at chromosome 4q22.1 that contained the gene ABCG2, and DNA sequence analysis showed that ABCG2 null alleles define the Jr(a-) phenotype.	[Zelinski, Teresa; Coghlan, Gail] Univ Manitoba, Fac Med, Dept Pediat & Child Hlth, Rh Lab, Winnipeg, MB, Canada; [Zelinski, Teresa; Liu, Xiao-Qing] Univ Manitoba, Fac Med, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Liu, Xiao-Qing] Univ Manitoba, Fac Med, Dept Obstet & Gynecol, Winnipeg, MB, Canada; [Reid, Marion E.] New York Blood Ctr, Lab Immunochem, New York, NY 10021 USA	University of Manitoba; University of Manitoba; University of Manitoba; New York Blood Center	Zelinski, T (corresponding author), Univ Manitoba, Fac Med, Dept Pediat & Child Hlth, Rh Lab, Winnipeg, MB, Canada.	zelinski@cc.umanitoba.ca		Liu, Xiao-Qing/0000-0002-4034-5156	Winnipeg Rh Institute Foundation	Winnipeg Rh Institute Foundation	We would like to thank K. McManus for preparing Supplementary Figure 1. The authors are grateful to B. Triggs-Raine, S. Israels and K. McManus for critically reading the manuscript. The study was supported by an operating grant from The Winnipeg Rh Institute Foundation (to T.Z.).	Daniels G, 2002, HUMAN BLOOD GROUPS, P505; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Gedeon C, 2008, PLACENTA, V29, P39, DOI 10.1016/j.placenta.2007.08.004; Huls M, 2009, J PHARMACOL EXP THER, V328, P3, DOI 10.1124/jpet.107.132225; Jonker JW, 2005, NAT MED, V11, P127, DOI 10.1038/nm1186; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Lee SS, 2007, DRUG METAB DISPOS, V35, P623, DOI 10.1124/dmd.106.012302; Leimanis ML, 2007, BIOCHEM BIOPH RES CO, V354, P345, DOI 10.1016/j.bbrc.2006.12.219; Matsuo H, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000237; Mizuarai S, 2004, INT J CANCER, V109, P238, DOI 10.1002/ijc.11669; NAKAJIMA H, 1978, VOX SANG, V35, P265, DOI 10.1111/j.1423-0410.1978.tb02932.x; Stroup M., 1970, P 23 ANN M AM ASS A, pA86; van Herwaarden AE, 2007, MOL CELL BIOL, V27, P1247, DOI 10.1128/MCB.01621-06; Woodward OM, 2011, FEBS J, V278, P3215, DOI 10.1111/j.1742-4658.2011.08171.x; Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106	15	55	56	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2012	44	2					131	132		10.1038/ng.1075	http://dx.doi.org/10.1038/ng.1075			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	22246507				2022-12-25	WOS:000299664400008
J	Zhu, S; Pan, W; Song, XY; Liu, Y; Shao, XR; Tang, YJ; Liang, D; He, DY; Wang, HL; Liu, WJ; Shi, YF; Harley, JB; Shen, N; Qian, YC				Zhu, Shu; Pan, Wen; Song, Xinyang; Liu, Yan; Shao, Xinrui; Tang, Yuanjia; Liang, Dong; He, Dongyi; Wang, Honglin; Liu, Wenjun; Shi, Yufang; Harley, John B.; Shen, Nan; Qian, Youcun			The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-alpha	NATURE MEDICINE			English	Article							CD4(+) T-CELLS; RHEUMATOID-ARTHRITIS; LUPUS NEPHRITIS; MESSENGER-RNA; EXPRESSION; INTERLEUKIN-17; PROTEIN; MECHANISMS; DISEASE; GENES	Inflammatory cytokines such as interleukin-17 (IL-17) promote inflammatory autoimmune diseases. Although several microRNAs (miRNAs) have been shown to regulate autoimmune pathogenesis by affecting lymphocyte development and function, the role of miRNAs in resident cells present in inflammatory lesions remains unclear. Here we show that miR-23b is downregulated in inflammatory lesions of humans with lupus or rheumatoid arthritis, as well as in the mouse models of lupus, rheumatoid arthritis or multiple sclerosis. IL-17 downregulates miR-23b expression in human fibroblast-like synoviocytes, mouse primary kidney cells and astrocytes and is essential for the downregulation of miR-23b during autoimmune pathogenesis. In turn, miR-23b suppresses IL-17-, tumor necrosis factor alpha (TNF-alpha)- or IL-1 beta-induced NF-kappa B activation and inflammatory cytokine expression by targeting TGF-beta-activated kinase 1/MAP3K7 binding protein 2 (TAB2), TAB3 and inhibitor of nuclear factor kappa-B kinase subunit alpha (IKK-alpha) and, consequently, represses autoimmune inflammation. Thus, IL-17 contributes to autoimmune pathogenesis by suppressing miR-23b expression in radio-resident cells and promoting proinflammatory cytokine expression.	[Zhu, Shu; Pan, Wen; Song, Xinyang; Liu, Yan; Shao, Xinrui; Shi, Yufang; Shen, Nan; Qian, Youcun] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Stem Cell Biol, Inst Hlth Sci, Shanghai 200031, Peoples R China; [Tang, Yuanjia; Shen, Nan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Renji Hosp, Shanghai Inst Rheumatol, Shanghai 200030, Peoples R China; [Liang, Dong; Harley, John B.; Shen, Nan] Cincinnati Childrens Hosp Med Ctr, Div Rheumatol, Cincinnati, OH USA; [Liang, Dong; Harley, John B.; Shen, Nan] Cincinnati Childrens Hosp Med Ctr, CAGE, Cincinnati, OH USA; [Wang, Honglin] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai Inst Immunol, Shanghai 200030, Peoples R China; [He, Dongyi] Guanghua Rheumatol Hosp, Shanghai, Peoples R China; [Liu, Wenjun] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Harley, John B.] US Dept Vet Affairs, Med Ctr, Cincinnati, OH USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Chinese Academy of Sciences; Shanghai Jiao Tong University; University of Manitoba; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Qian, YC (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Stem Cell Biol, Inst Hlth Sci, Shanghai 200031, Peoples R China.	nanshensibs@gmail.com; ycqian@sibs.ac.cn	Pan, Wen/I-9965-2016; Song, Xinyang/AAL-7495-2021; Shen, Nan/AGK-6807-2022; Zhu, Shu/P-6163-2018; Shi, Yufang/AAE-4431-2020; WANG, Honglin/AAJ-2708-2020	Zhu, Shu/0000-0002-8163-0869; Shi, Yufang/0000-0001-8964-319X; WANG, Honglin/0000-0001-6302-6927; tang, yuan jia/0000-0002-2044-5424; Shen, Nan/0000-0002-5875-4417; Song, Xinyang/0000-0002-3422-6927	National Natural Science Foundation of China and 973 program [30930084, 2010CB529705, 91029708, 30871298]; Chinese Academy of Sciences [KSCX2-YW-R-146]; Science and Technology Commission of Shanghai Municipality [10JC1416600]; National Natural Science Foundation of China [30971632, 81025016]; Chinese Ministry of Health [201202008]; Program of the Shanghai Commission of Science and Technology [10JC1409300]	National Natural Science Foundation of China and 973 program(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Health; Program of the Shanghai Commission of Science and Technology	We thank R. Flavell (Yale University) for providing Pi 17a-deficient mice. This work is supported by grants from National Natural Science Foundation of China and 973 program (30930084, 2010CB529705, 91029708 and 30871298), Chinese Academy of Sciences (KSCX2-YW-R-146) and the Science and Technology Commission of Shanghai Municipality (10JC1416600) to Y.Q.; as well as National Natural Science Foundation of China (30971632 and 81025016), Chinese Ministry of Health (201202008) and the Program of the Shanghai Commission of Science and Technology (10JC1409300) to N. S.	AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75; Bulek K, 2011, NAT IMMUNOL, V12, P844, DOI 10.1038/ni.2080; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Dai Y, 2009, RHEUMATOL INT, V29, P749, DOI 10.1007/s00296-008-0758-6; De Santis G, 2010, J NEUROIMMUNOL, V226, P165, DOI 10.1016/j.jneuroim.2010.06.009; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Geyer M, 2010, CURR OPIN RHEUMATOL, V22, P246, DOI 10.1097/BOR.0b013e3283373fa0; Hartupee J, 2009, J IMMUNOL, V182, P1660, DOI 10.4049/jimmunol.182.3.1660; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Junker A, 2009, BRAIN, V132, P3342, DOI 10.1093/brain/awp300; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kao CY, 2008, J BIOL CHEM, V283, P15309, DOI [10.1074/jbc.M708289200, 10.1074/jbc.M804331200]; Li JY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3006; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Liu CN, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000382; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Moreth K, 2010, J CLIN INVEST, V120, P4251, DOI 10.1172/JCI42213; Nakamachi Y, 2009, ARTHRITIS RHEUM-US, V60, P1294, DOI 10.1002/art.24475; Nakasa T, 2008, ARTHRITIS RHEUM-US, V58, P1284, DOI 10.1002/art.23429; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Qian YC, 2010, CELL MOL IMMUNOL, V7, P328, DOI 10.1038/cmi.2010.27; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Shen F, 2005, J LEUKOCYTE BIOL, V77, P388, DOI 10.1189/jlb.0904490; Shen F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000066; Shi PQ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001653; Smolen JS, 2005, LUPUS, V14, P189, DOI 10.1191/0961203305lu2134oa; Sonder SU, 2011, J BIOL CHEM, V286, P12881, DOI 10.1074/jbc.M110.199547; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Williams RO, 2007, CURR OPIN PHARMACOL, V7, P412, DOI 10.1016/j.coph.2007.06.001; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Zhang HS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1555; Zhu S, 2012, CLIN SCI, V122, P487, DOI 10.1042/CS20110496; Zhu S, 2010, J EXP MED, V207, P2647, DOI 10.1084/jem.20100703	58	330	360	1	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2012	18	7					1077	+		10.1038/nm.2815	http://dx.doi.org/10.1038/nm.2815			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22660635				2022-12-25	WOS:000306121600037
J	Irani, NG; Di Rubbo, S; Mylle, E; Van den Begin, J; Schneider-Pizon, J; Hnilikova, J; Sisa, M; Buyst, D; Vilarrasa-Blasi, J; Szatmari, AM; Van Damme, D; Mishev, K; Codreanu, MC; Kohout, L; Strnad, M; Cano-Delgado, AI; Friml, J; Madder, A; Russinova, E				Irani, Niloufer G.; Di Rubbo, Simone; Mylle, Evelien; Van den Begin, Jos; Schneider-Pizon, Joanna; Hnilikova, Jaroslava; Sisa, Miroslav; Buyst, Dieter; Vilarrasa-Blasi, Josep; Szatmari, Anna-Maria; Van Damme, Daniel; Mishev, Kiril; Codreanu, Mirela-Corina; Kohout, Ladislav; Strnad, Miroslav; Cano-Delgado, Ana I.; Friml, Jiri; Madder, Annemieke; Russinova, Eugenia			Fluorescent castasterone reveals BRI1 signaling from the plasma membrane	NATURE CHEMICAL BIOLOGY			English	Article							STEROID-BINDING PROTEIN-1; BRASSINOSTEROID RECEPTORS; DEPENDENT ENDOCYTOSIS; AUXIN TRANSPORT; ARABIDOPSIS; CLATHRIN; INHIBITION; TRANSDUCTION; GOLGI; PHOSPHORYLATION	Receptor-mediated endocytosis is an integral part of signal transduction as it mediates signal attenuation and provides spatial and temporal dimensions to signaling events. One of the best-studied leucine-rich repeat receptor-like kinases in plants, BRASSINOSTEROID INSENSITIVE 1 (BRI1), perceives its ligand, the brassinosteroid (BR) hormone, at the cell surface and is constitutively endocytosed. However, the importance of endocytosis for BR signaling remains unclear. Here we developed a bioactive, fluorescent BR analog, Alexa Fluor 647-castasterone (AFCS), and visualized the endocytosis of BRI1-AFCS complexes in living Arabidopsis thaliana cells. Impairment of endocytosis dependent on clathrin and the guanine nucleotide exchange factor for ARF GTPases (ARF-GEF) GNOM enhanced BR signaling by retaining active BRI1-ligand complexes at the plasma membrane. Increasing the trans-Golgi network/early endosome pool of BRI1-BR complexes did not affect BR signaling. Our findings provide what is to our knowledge the first visualization of receptor-ligand complexes in plants and reveal clathrin- and ARF-GEF-dependent endocytic regulation of BR signaling from the plasma membrane.	[Irani, Niloufer G.; Di Rubbo, Simone; Mylle, Evelien; Schneider-Pizon, Joanna; Szatmari, Anna-Maria; Van Damme, Daniel; Mishev, Kiril; Codreanu, Mirela-Corina; Friml, Jiri; Russinova, Eugenia] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Irani, Niloufer G.; Di Rubbo, Simone; Mylle, Evelien; Schneider-Pizon, Joanna; Szatmari, Anna-Maria; Van Damme, Daniel; Mishev, Kiril; Codreanu, Mirela-Corina; Friml, Jiri; Russinova, Eugenia] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium; [Van den Begin, Jos; Buyst, Dieter; Madder, Annemieke] Univ Ghent, Lab Organ & Biomimet Chem, Dept Organ Chem, B-9000 Ghent, Belgium; [Hnilikova, Jaroslava; Kohout, Ladislav] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic; [Sisa, Miroslav; Strnad, Miroslav] Palacky Univ, Lab Growth Regulators, CR-77147 Olomouc, Czech Republic; [Sisa, Miroslav; Strnad, Miroslav] Acad Sci Czech Republ, Inst Expt Bot, Olomouc, Czech Republic; [Vilarrasa-Blasi, Josep; Cano-Delgado, Ana I.] Ctr Res Agr Genom, Dept Mol Genet, Barcelona, Spain	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG)	Irani, NG (corresponding author), Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium.	jenny.russinova@psb.vib-ugent.be	Friml, Jiri/D-9511-2012; Buyst, Dieter/X-3309-2019; Mishev, Kiril/Q-2631-2017; Sisa, Miroslav/E-6803-2015; Strnad, Miroslav/H-1858-2014; van damme, daniel/ABA-1397-2020; van damme, daniel/F-6139-2014; Vilarrasa-Blasi, Josep/AAB-9586-2021	Friml, Jiri/0000-0002-8302-7596; Mishev, Kiril/0000-0001-5849-8786; Strnad, Miroslav/0000-0002-2806-794X; van damme, daniel/0000-0002-9385-4851; van damme, daniel/0000-0002-9385-4851; Vilarrasa-Blasi, Josep/0000-0003-4328-4798; Russinova, Eugenia/0000-0002-0569-1977; Madder, Annemieke/0000-0003-0179-7608; Irani, Niloufer/0000-0003-3252-4493	Research Foundation-Flanders; BRAVISSIMO Marie-Curie Initial Training Network; Agency for Innovation by Science and Technology; Ghent University; Free University of Brussels; University of Antwerp via the Flemish Government;  [1M06030];  [Z4 055 0506]	Research Foundation-Flanders(FWO); BRAVISSIMO Marie-Curie Initial Training Network; Agency for Innovation by Science and Technology; Ghent University(Ghent University); Free University of Brussels; University of Antwerp via the Flemish Government; ; 	We thank N. Geldner, Y. Yin, S. Clouse, Xiaofeng Wang, S. Huber and Xuelu Wang for sharing materials and protocols; S. Figaroli for technical assistance; M. De Cock for the help with manuscript preparation; and J. Martins for NMR and structure analysis. This work is supported by the Odysseus program of the Research Foundation-Flanders (to J.F.), the BRAVISSIMO Marie-Curie Initial Training Network (predoctoral fellowships to S.D.R. and J.S.-P.), the Research Foundation-Flanders (postdoctoral fellowship to D.V.D.), the Agency for Innovation by Science and Technology (postdoctoral fellowship to K.M.), the Research Foundation-Flanders (research grant to E.R.) and projects 1M06030 and Z4 055 0506 (to J.H., M.S. and L.K.). The 700-MHz equipment of the Interuniversitary NMR Facility used in this work was financed by Ghent University, the Free University of Brussels and the University of Antwerp via the 'Zware Apparatuur' Incentive of the Flemish Government.	Asami T, 2000, PLANT PHYSIOL, V123, P93, DOI 10.1104/pp.123.1.93; Banbury AN, 2003, J BIOL CHEM, V278, P12022, DOI 10.1074/jbc.M211966200; Barberon M, 2011, P NATL ACAD SCI USA, V108, pE450, DOI 10.1073/pnas.1100659108; Cano-Delgado A, 2004, DEVELOPMENT, V131, P5341, DOI 10.1242/dev.01403; Chen X, 2011, CURR OPIN PLANT BIOL, V14, P674, DOI 10.1016/j.pbi.2011.08.006; Clouse SD, 2011, PLANT CELL, V23, P1219, DOI 10.1105/tpc.111.084475; De Rybel B, 2009, CHEM BIOL, V16, P594, DOI 10.1016/j.chembiol.2009.04.008; De Smet I, 2009, NAT CELL BIOL, V11, P1166, DOI 10.1038/ncb1009-1166; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Dhonukshe P, 2006, DEV CELL, V10, P137, DOI 10.1016/j.devcel.2005.11.015; Dhonukshe P, 2008, NATURE, V456, P962, DOI 10.1038/nature07409; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Gampala SS, 2007, DEV CELL, V13, P177, DOI 10.1016/j.devcel.2007.06.009; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Geldner N, 2007, GENE DEV, V21, P1598, DOI 10.1101/gad.1561307; Geldner N, 2009, PLANT J, V59, P169, DOI 10.1111/j.1365-313X.2009.03851.x; Gonzalez-Garcia MP, 2011, DEVELOPMENT, V138, P849, DOI 10.1242/dev.057331; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hothorn M, 2011, NATURE, V474, P467, DOI 10.1038/nature10153; Irani NG, 2009, CURR OPIN PLANT BIOL, V12, P653, DOI 10.1016/j.pbi.2009.09.011; Jaillais Y, 2008, PLANT J, V53, P237, DOI 10.1111/j.1365-313X.2007.03338.x; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Naramoto S, 2010, P NATL ACAD SCI USA, V107, P21890, DOI 10.1073/pnas.1016260107; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Richter S, 2007, NATURE, V448, P488, DOI 10.1038/nature05967; Robert S, 2010, CELL, V143, P111, DOI 10.1016/j.cell.2010.09.027; Russinova E, 2004, PLANT CELL, V16, P3216, DOI 10.1105/tpc.104.025387; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; She J, 2011, NATURE, V474, P472, DOI 10.1038/nature10178; Song L, 2009, CELL RES, V19, P864, DOI 10.1038/cr.2009.66; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Tanaka K, 2005, PLANT PHYSIOL, V138, P1117, DOI 10.1104/pp.104.058040; Tang WQ, 2008, SCIENCE, V321, P557, DOI 10.1126/science.1156973; Teh OK, 2007, NATURE, V448, P493, DOI 10.1038/nature06023; Van Damme D, 2011, P NATL ACAD SCI USA, V108, P615, DOI 10.1073/pnas.1017890108; Vert G, 2006, NATURE, V441, P96, DOI 10.1038/nature04681; Viotti C, 2010, PLANT CELL, V22, P1344, DOI 10.1105/tpc.109.072637; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang XL, 2006, SCIENCE, V313, P1118, DOI 10.1126/science.1127593; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Wilde A, 1999, CELL, V96, P677, DOI 10.1016/S0092-8674(00)80578-4; Yang XH, 2005, PLANT CELL, V17, P116, DOI 10.1105/tpc.104.028381; Yano K, 2004, PLANT CELL PHYSIOL, V45, P951, DOI 10.1093/pcp/pch105; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3	49	150	156	2	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2012	8	6					583	589		10.1038/NCHEMBIO.958	http://dx.doi.org/10.1038/NCHEMBIO.958			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	945ET	22561410				2022-12-25	WOS:000304256300015
J	Li, JL; Chen, JM; Ricupero, CL; Hart, RP; Schwartz, MS; Kusnecov, A; Herrup, K				Li, Jiali; Chen, Jianmin; Ricupero, Christopher L.; Hart, Ronald P.; Schwartz, Melanie S.; Kusnecov, Alexander; Herrup, Karl			Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia	NATURE MEDICINE			English	Article							HISTONE DEACETYLASE 4; INTRACELLULAR TRAFFICKING; GENE-EXPRESSION; MOUSE-BRAIN; DNA-DAMAGE; CELL-DEATH; MUSCLE; YEAST; TRICHOSTATIN; INHIBITION	Ataxia telangiectasia is a neurodegenerative disease caused by mutation of the Atm gene. Here we report that ataxia telangiectasia mutated (ATM) deficiency causes nuclear accumulation of histone deacetylase 4 (HDAC4) in neurons and promotes neurodegeneration. Nuclear HDAC4 binds to chromatin, as well as to myocyte enhancer factor 2A (MEF2A) and cAMP-responsive element binding protein (CREB), leading to histone deacetylation and altered neuronal gene expression. Blocking either HDAC4 activity or its nuclear accumulation blunts these neurodegenerative changes and rescues several behavioral abnormalities of ATM-deficient mice. Full rescue of the neurodegeneration, however, also requires the presence of HDAC4 in the cytoplasm, suggesting that the ataxia telangiectasia phenotype results both from a loss of cytoplasmic HDAC4 as well as its nuclear accumulation. To remain cytoplasmic, HDAC4 must be phosphorylated. The activity of the HDAC4 phosphatase, protein phosphatase 2A (PP2A), is downregulated by ATM-mediated phosphorylation. In ATM deficiency, enhanced PP2A activity leads to HDAC4 dephosphorylation and the nuclear accumulation of HDAC4. Our results define a crucial role of the cellular localization of HDAC4 in the events leading to ataxia telangiectasia neurodegeneration.	[Li, Jiali; Chen, Jianmin; Ricupero, Christopher L.; Hart, Ronald P.; Herrup, Karl] Rutgers State Univ, Nelson Biol Labs, Dept Cell Biol & Neurosci, Piscataway, NJ 08855 USA; [Schwartz, Melanie S.; Kusnecov, Alexander] Rutgers State Univ, Dept Psychol, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Herrup, K (corresponding author), Rutgers State Univ, Nelson Biol Labs, Dept Cell Biol & Neurosci, Piscataway, NJ 08855 USA.	herrup@biology.rutgers.edu	Hart, Ronald P/G-6530-2019; li, Jiali/HGF-2395-2022; Hart, Ronald P/D-5219-2009; Herrup, Karl/C-5313-2014	Hart, Ronald P/0000-0003-4836-8712; li, Jiali/0000-0001-6202-7741; Hart, Ronald P/0000-0003-4836-8712; Li, Jiali/0000-0002-0039-3671; Herrup, Karl/0000-0001-7786-5844	National Institute of Child Health and Human Development (NICHD) Brain and Tissue Bank for Developmental Disorders [N01-HD-4-3368, N01-HD-4-3383]; Ataxia Telangiectasia Children's Project; US National Institutes of Health [NS20591, NS71022, R21 MH085088, MH60706, NIEHS P30ES05022]; NATIONAL CANCER INSTITUTE [RC1CA147187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH085088, R01MH060706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071022, R01NS020591] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NICHD) Brain and Tissue Bank for Developmental Disorders; Ataxia Telangiectasia Children's Project; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Xu (University of California San Diego) for providing homozygous mice carrying the Atm knockout mutation, tm1Bal. We thank R. Gatti (University of California Los Angeles) for sharing human ataxia telangiectasia paraffin-fixed samples. Human frozen tissue was obtained from the National Institute of Child Health and Human Development (NICHD) Brain and Tissue Bank for Developmental Disorders (NICHD contracts N01-HD-4-3368 and N01-HD-4-3383). We thank M.B. Kastan (Duke University), T. Yao (Duke University) and S. Schreiber (Harvard University) for providing the wild-type and kinase-dead Flag-ATM, GFP-HDAC4 and Flag-HADC4 plasmids. M. Swerdel prepared the SOLiD ChIP-seq libraries. The long-term support of the Ataxia Telangiectasia Children's Project to K.H. is gratefully acknowledged. This work was also supported by grants from the US National Institutes of Health (NS20591 and NS71022) to K.H., R.P.H. (R21 MH085088) and A.K. (MH60706 and NIEHS P30ES05022). C.L.R. is a National Science Foundation Integrative Graduate Education and Research Traineeship fellow.	Backs J, 2008, MOL CELL BIOL, V28, P3437, DOI 10.1128/MCB.01611-07; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Barzilai A, 2008, DNA REPAIR, V7, P1010, DOI 10.1016/j.dnarep.2008.03.005; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; BUNDEY S, 1994, INT J RADIAT BIOL, V66, pS23; Chan JKL, 2003, J BIOL CHEM, V278, P23515, DOI 10.1074/jbc.M301922200; Chen B, 2009, SCIENCE, V323, P256, DOI 10.1126/science.1166226; Cooper JF, 2007, NEUROSCIENCE, V148, P1048, DOI 10.1016/j.neuroscience.2007.07.034; Cortes ML, 2006, NEUROSCIENCE, V141, P1247, DOI 10.1016/j.neuroscience.2006.05.055; D'Mello SR, 2009, DRUG NEWS PERSPECT, V22, P513, DOI [10.1358/dnp.2009.22.9.1437959, 10.1358/dnp.2009.9.1428871]; Darcy MJ, 2010, J COMP NEUROL, V518, P722, DOI 10.1002/cne.22241; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Kaemmerer WF, 2000, MOL THER, V2, P446, DOI 10.1006/mthe.2000.0134; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Kuljis RO, 1997, P NATL ACAD SCI USA, V94, P12688, DOI 10.1073/pnas.94.23.12688; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu YW, 2005, J CELL BIOL, V168, P887, DOI 10.1083/jcb.200408128; Majdzadeh N, 2008, DEV NEUROBIOL, V68, P1076, DOI 10.1002/dneu.20637; Majdzadeh N, 2008, FRONT BIOSCI-LANDMRK, V13, P1072, DOI 10.2741/2745; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Mejat A, 2005, NAT NEUROSCI, V8, P313, DOI 10.1038/nn1408; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Nervi C, 2001, CANCER RES, V61, P1247; Paroni G, 2008, MOL BIOL CELL, V19, P655, DOI 10.1091/mbc.E07-06-0623; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SEDGWICK RP, 1960, NEUROLOGY, V10, P705, DOI 10.1212/WNL.10.7.705; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Wang AH, 1999, MOL CELL BIOL, V19, P7816; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Youn HD, 2000, J BIOL CHEM, V275, P22563, DOI 10.1074/jbc.C000304200; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200	40	149	157	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					783	U182		10.1038/nm.2709	http://dx.doi.org/10.1038/nm.2709			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22466704	Green Accepted			2022-12-25	WOS:000303763500046
J	Li, M; Du, X; Villaruz, AE; Diep, BA; Wang, DC; Song, Y; Tian, YR; Hu, JH; Yu, FY; Lu, Y; Otto, M				Li, Min; Du, Xin; Villaruz, Amer E.; Diep, Binh An; Wang, Decheng; Song, Yan; Tian, Yueru; Hu, Jinhui; Yu, Fangyou; Lu, Yuan; Otto, Michael			MRSA epidemic linked to a quickly spreading colonization and virulence determinant	NATURE MEDICINE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; NASAL COLONIZATION; GENOME SEQUENCE; 2 HOSPITALS; INFECTIONS; EVOLUTION; ADHERENCE; CARRIAGE; STRAINS; EVASION	The molecular processes underlying epidemic waves of methicillin-resistant Staphylococcus aureus (MRSA) infection are poorly understood(1). Although a major role has been attributed to the acquisition of virulence determinants by horizontal gene transfer(2), there are insufficient epidemiological and functional data supporting that concept. We here report the spread of clones containing a previously extremely rare(3,4) mobile genetic element-encoded gene, sasX. We demonstrate that sasX has a key role in MRSA colonization and pathogenesis, substantially enhancing nasal colonization, lung disease and abscess formation and promoting mechanisms of immune evasion. Moreover, we observed the recent spread of sasX from sequence type 239 (ST239) to invasive clones belonging to other sequence types. Our study identifies sasX as a quickly spreading crucial determinant of MRSA pathogenic success and a promising target for therapeutic interference. Our results provide proof of principle that horizontal gene transfer of key virulence determinants drives MRSA epidemic waves.	[Villaruz, Amer E.; Otto, Michael] NIAID, Pathogen Mol Genet Sect, Lab Human Bacterial Pathogenesis, NIH, Bethesda, MD 20892 USA; [Li, Min; Du, Xin; Song, Yan; Tian, Yueru; Hu, Jinhui; Lu, Yuan] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Lab Med, Shanghai 200433, Peoples R China; [Diep, Binh An] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA USA; [Wang, Decheng] Fudan Univ, Shanghai Med Coll, Inst Med Microbiol, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Wang, Decheng] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Yu, Fangyou] Wenzhou Med Coll, Affiliated Hosp 1, Dept Lab Med, Wenzhou, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fudan University; University of California System; University of California San Francisco; Fudan University; Fudan University; Wenzhou Medical University	Otto, M (corresponding author), NIAID, Pathogen Mol Genet Sect, Lab Human Bacterial Pathogenesis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	yuanlu@hsh.stn.sh.cn; motto@niaid.nih.gov	Du, Xin/AAG-4635-2022; WANG, DECHENG/AGO-5098-2022; Ren, Guogang/P-4540-2017; Hu, Jinhui/AAG-9000-2021; Du, Xin/ABD-4327-2022	Du, Xin/0000-0002-6907-3609; WANG, DECHENG/0000-0002-1742-7460; Ren, Guogang/0000-0001-8865-1526; Du, Xin/0000-0002-6907-3609; Otto, Michael/0000-0002-2222-4115	China National Clinical Key Subject; National Natural Science Foundation of China [30900026, 81171623]; Shanghai Pujiang Program [09PJ1402300]; National Institute of Allergy and Infectious Diseases, US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001080, ZIAAI000904] Funding Source: NIH RePORTER	China National Clinical Key Subject; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); National Institute of Allergy and Infectious Diseases, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a grant from the China National Clinical Key Subject to Y.L., the National Natural Science Foundation of China (grants 30900026 and 81171623) and the Shanghai Pujiang Program (grant 09PJ1402300) to M.L., and the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, US National Institutes of Health (to M.O.).	Arakere G, 2005, J CLIN MICROBIOL, V43, P3198, DOI 10.1128/JCM.43.7.3198-3202.2005; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Corrigan RM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-22; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P159, DOI [10.1128/JCM.41.1.159-163.2002, 10.1128/JCM.41.1.159-163.2003]; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Diep BA, 2006, J INFECT DIS, V193, P1495, DOI 10.1086/503777; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Hiramatsu K, 2001, TRENDS MICROBIOL, V9, P486, DOI 10.1016/S0966-842X(01)02175-8; Holden MTG, 2010, J BACTERIOL, V192, P888, DOI 10.1128/JB.01255-09; Ip M, 2003, J CLIN MICROBIOL, V41, P4980, DOI 10.1128/JCM.41.11.4980-4985.2003; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Ko KS, 2005, J CLIN MICROBIOL, V43, P421, DOI 10.1128/JCM.43.1.421-426.2005; Koh SS, 2009, MODERN PATHOL, V22, P538, DOI 10.1038/modpathol.2009.8; Li Y, 2011, J BACTERIOL, V193, P3411, DOI 10.1128/JB.05135-11; Liu YD, 2009, ANTIMICROB AGENTS CH, V53, P512, DOI 10.1128/AAC.00804-08; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; O'Brien LM, 2002, CELL MICROBIOL, V4, P759, DOI 10.1046/j.1462-5822.2002.00231.x; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Otto M, 2006, CURR TOP MICROBIOL, V306, P251; Soderquist B, 2009, J MED MICROBIOL, V58, P1395, DOI 10.1099/jmm.0.008771-0; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Vuong C, 2000, J INFECT DIS, V182, P1688, DOI 10.1086/317606; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Wertheim HFL, 2008, PLOS MED, V5, P104, DOI 10.1371/journal.pmed.0050017; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4	30	184	215	0	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2012	18	5					816	U217		10.1038/nm.2692	http://dx.doi.org/10.1038/nm.2692			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22522561	Green Accepted			2022-12-25	WOS:000303763500050
J	Choi, C; Ganji, SK; DeBerardinis, RJ; Hatanpaa, KJ; Rakheja, D; Kovacs, Z; Yang, XL; Mashimo, T; Raisanen, JM; Marin-Valencia, I; Pascual, JM; Madden, CJ; Mickey, BE; Malloy, CR; Bachoo, RM; Maher, EA				Choi, Changho; Ganji, Sandeep K.; DeBerardinis, Ralph J.; Hatanpaa, Kimmo J.; Rakheja, Dinesh; Kovacs, Zoltan; Yang, Xiao-Li; Mashimo, Tomoyuki; Raisanen, Jack M.; Marin-Valencia, Isaac; Pascual, Juan M.; Madden, Christopher J.; Mickey, Bruce E.; Malloy, Craig R.; Bachoo, Robert M.; Maher, Elizabeth A.			2-hydroxyglutarate detection by magnetic resonance spectroscopy in subjects with IDH-mutated gliomas	NATURE MEDICINE			English	Article							METABOLITE QUANTIFICATION; BRAIN-METABOLITES; RELAXATION-TIMES; NMR-SPECTRA; PROTON; H-1; MUTATIONS; ACIDURIA; TUMORS; WATER	Mutations in isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) have been shown to be present in most World Health Organization grade 2 and grade 3 gliomas in adults. These mutations are associated with the accumulation of 2-hydroxyglutarate (2HG) in the tumor. Here we report the noninvasive detection of 2HG by proton magnetic resonance spectroscopy (MRS). We developed and optimized the pulse sequence with numerical and phantom analyses for 2HG detection, and we estimated the concentrations of 2HG using spectral fitting in the tumors of 30 subjects. Detection of 2HG correlated with mutations in IDH1 or IDH2 and with increased levels of D-2HG by mass spectrometry of the resected tumors. Noninvasive detection of 2HG may prove to be a valuable diagnostic and prognostic biomarker.	[Choi, Changho; Ganji, Sandeep K.; Kovacs, Zoltan; Malloy, Craig R.] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Choi, Changho; Ganji, Sandeep K.; Malloy, Craig R.] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [DeBerardinis, Ralph J.; Marin-Valencia, Isaac; Pascual, Juan M.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [DeBerardinis, Ralph J.; Hatanpaa, Kimmo J.; Yang, Xiao-Li; Mashimo, Tomoyuki; Raisanen, Jack M.; Madden, Christopher J.; Mickey, Bruce E.; Bachoo, Robert M.; Maher, Elizabeth A.] Univ Texas SW Med Ctr Dallas, Harold C Simmons Canc Ctr, Dallas, TX 75390 USA; [Hatanpaa, Kimmo J.; Rakheja, Dinesh; Raisanen, Jack M.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Hatanpaa, Kimmo J.; Yang, Xiao-Li; Mashimo, Tomoyuki; Raisanen, Jack M.; Madden, Christopher J.; Mickey, Bruce E.; Bachoo, Robert M.; Maher, Elizabeth A.] Univ Texas SW Med Ctr Dallas, Annette Strauss Ctr Neurooncol, Dallas, TX 75390 USA; [Rakheja, Dinesh] Childrens Med Ctr, Dallas, TX 75235 USA; [Yang, Xiao-Li; Mashimo, Tomoyuki; Malloy, Craig R.; Bachoo, Robert M.; Maher, Elizabeth A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Pascual, Juan M.; Bachoo, Robert M.; Maher, Elizabeth A.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Pascual, Juan M.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Madden, Christopher J.; Mickey, Bruce E.] Univ Texas SW Med Ctr Dallas, Dept Neurol Surg, Dallas, TX 75390 USA; [Malloy, Craig R.] Vet Affairs N Texas Hlth Care Syst, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Choi, C (corresponding author), Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA.	changho.choi@utsouthwestern.edu; elizabeth.maher@utsouthwestern.edu	Ganji, Sandeep/G-4983-2013	Pascual, Juan/0000-0002-0843-8221; Malloy, Craig/0000-0001-5077-0642	US National Institutes of Health [RC1NS0760675, R21CA159128, RR02584]; Cancer Prevention Research Institute of Texas [RP101243-P04]; NATIONAL CANCER INSTITUTE [R01CA157996, R21CA159128] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS070675] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institutes of Health grants RC1NS0760675, R21CA159128, and RR02584 and by the Cancer Prevention Research Institute of Texas grant RP101243-P04. We thank C. Sheppard for expert management of the patient database and for coordinating research scans and tissue samples; S. McNeil for expert human subject care during scanning; C. Foong for expert assistance with pathological analysis of tumor; and R.L. Boriack for expert assistance with 2HG measurements by mass spectrometry.	Bal D, 2002, MAGN RESON CHEM, V40, P533, DOI 10.1002/mrc.1053; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; BOTTOMLEY PA, 1984, Patent No. 4480228; Choi C, 2011, MAGN RESON MED, V66, P609, DOI 10.1002/mrm.22857; Choi CH, 2010, NMR BIOMED, V23, P1044, DOI 10.1002/nbm.1529; Christensen BC, 2011, JNCI-J NATL CANCER I, V103, DOI 10.1093/jnci/djq497; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Ernst R.R., 1987, PRINCIPLES NUCLEAR M; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Ganji SK, 2012, NMR BIOMED, V25, P523, DOI 10.1002/nbm.1767; Gillies RJ, 2004, IEEE ENG MED BIOL, V23, P57, DOI 10.1109/MEMB.2004.1360409; Goffette SM, 2006, EUR J NEUROL, V13, P499, DOI 10.1111/j.1468-1331.2006.01282.x; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; GRIFFITHS JR, 1991, BRIT J CANCER, V64, P425, DOI 10.1038/bjc.1991.326; Keevil SF, 1998, MAGN RESON IMAGING, V16, P1093, DOI 10.1016/S0730-725X(98)00118-0; Krawczyk H, 2003, J PHARMACEUT BIOMED, V31, P455, DOI 10.1016/S0731-7085(02)00691-X; Maher EA, 2006, CANCER RES, V66, P11502, DOI 10.1158/0008-5472.CAN-06-2072; McLean LA, 2000, AM J PHYSIOL-CELL PH, V278, pC676, DOI 10.1152/ajpcell.2000.278.4.C676; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Mlynarik V, 2001, NMR BIOMED, V14, P325, DOI 10.1002/nbm.713; NORTON WT, 1966, J NEUROPATH EXP NEUR, V25, P582, DOI 10.1097/00005072-196610000-00006; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Rakheja D, 2011, PEDIATR BLOOD CANCER, V56, P379, DOI 10.1002/pbc.22697; Rakheja D, 2011, TUMOR BIOL, V32, P325, DOI 10.1007/s13277-010-0125-6; Sener RN, 2003, J COMPUT ASSIST TOMO, V27, P38, DOI 10.1097/00004728-200301000-00008; Thompson RB, 1999, MAGNET RESON MED, V41, P1162, DOI 10.1002/(SICI)1522-2594(199906)41:6<1162::AID-MRM12>3.0.CO;2-N; Tong ZY, 2004, MAGN RESON IMAGING, V22, P1017, DOI 10.1016/j.mri.2004.02.007; Traber F, 2004, J MAGN RESON IMAGING, V19, P537, DOI 10.1002/jmri.20053; von Deimling A, 2011, BRAIN PATHOL, V21, P74, DOI 10.1111/j.1750-3639.2010.00454.x; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	31	530	545	9	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2012	18	4					624	629		10.1038/nm.2682	http://dx.doi.org/10.1038/nm.2682			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22281806	Green Accepted			2022-12-25	WOS:000302617800042
J	Fluhe, E; Knappe, TA; Gattner, MJ; Schafer, A; Burghaus, O; Linne, U; Marahiel, MA				Fluehe, Eif; Knappe, Thomas A.; Gattner, Michael J.; Schaefer, Antje; Burghaus, Olaf; Linne, Uwe; Marahiel, Mohamed A.			The radical SAM enzyme AlbA catalyzes thioether bond formation in subtilosin A	NATURE CHEMICAL BIOLOGY			English	Article							IRON-SULFUR CLUSTER; CARBON CROSS-LINKS; S-ADENOSYLMETHIONINE; BACILLUS-SUBTILIS; BIOTIN SYNTHASE; 4FE-4S CLUSTERS; BACTERIOCIN SUBTILOSIN; ANTIMICROBIAL PEPTIDE; ESCHERICHIA-COLI; LIPOYL SYNTHASE	Subtilosin A is a 35-residue, ribosomally synthesized bacteriocin encoded by the sbo-alb operon of Bacillus subtilis. It is composed of a head-to-tail circular peptide backbone that is additionally restrained by three unusual thioether bonds between three cysteines and the alpha-carbon of one threonine and two phenylalanines, respectively. In this study, we demonstrate that these bonds are synthesized by the radical S-adenosylmethionine enzyme AlbA, which is encoded by the sbo-alb operon and comprises two [4Fe-4S] clusters. One [4Fe-4S] cluster is coordinated by the prototypical CXXXCXXC motif and is responsible for the observed S-adenosylmethionine cleavage reaction, whereas the second [4Fe-4S] cluster is required for the generation of all three thioether linkages. On the basis of the obtained results, we propose a new radical mechanism for thioether bond formation. In addition, we show that AlbA-directed substrate transformation is leader-peptide dependent, suggesting that thioether bond formation is the first step during subtilosin A maturation.	[Fluehe, Eif; Knappe, Thomas A.; Gattner, Michael J.; Schaefer, Antje; Burghaus, Olaf; Linne, Uwe; Marahiel, Mohamed A.] Univ Marburg, Dept Chem Biochem, Marburg, Germany	Philipps University Marburg	Fluhe, E (corresponding author), Univ Marburg, Dept Chem Biochem, Marburg, Germany.	marahiel@staff.uni-marburg.de			Deutsche Forschungsgemeinschaft; LOEWE Center for Synthetic Microbiology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); LOEWE Center for Synthetic Microbiology	We would like to thank N. Fritzler and J. Bamberger for practical realization of the HPLC-HRMS measurements. In addition, we would like to thank the whole Marahiel group for fruitful discussions. Furthermore, we gratefully acknowledge financial support from the Deutsche Forschungsgemeinschaft and from the LOEWE Center for Synthetic Microbiology.	Albano M, 2005, J BACTERIOL, V187, P2010, DOI 10.1128/JB.187.6.2010-2019.2005; BABASAKI K, 1985, J BIOCHEM, V98, P585, DOI 10.1093/oxfordjournals.jbchem.a135315; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; Cascales L, 2010, ORG BIOMOL CHEM, V8, P5035, DOI 10.1039/c0ob00139b; Chatterjee A, 2008, NAT CHEM BIOL, V4, P758, DOI 10.1038/nchembio.121; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; CHIRPICH TP, 1970, J BIOL CHEM, V245, P1778; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P6378, DOI 10.1021/bi049528x; Duschene KS, 2010, FEBS LETT, V584, P1263, DOI 10.1016/j.febslet.2010.02.041; Duschene KS, 2009, CURR OPIN CHEM BIOL, V13, P74, DOI 10.1016/j.cbpa.2009.01.022; Fang QH, 2004, J BIOL CHEM, V279, P14570, DOI 10.1074/jbc.M313855200; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Grove TL, 2008, BIOCHEMISTRY-US, V47, P7523, DOI 10.1021/bi8004297; Grove TL, 2010, BIOCHEMISTRY-US, V49, P3783, DOI 10.1021/bi9022126; Guianvarc'h D, 1997, BIOCHEM BIOPH RES CO, V236, P402, DOI 10.1006/bbrc.1997.6952; HAGEN KS, 1983, J AM CHEM SOC, V105, P3905, DOI 10.1021/ja00350a028; Hallen HE, 2007, P NATL ACAD SCI USA, V104, P19097, DOI 10.1073/pnas.0707340104; Hanzelmann P, 2006, P NATL ACAD SCI USA, V103, P6829, DOI 10.1073/pnas.0510711103; Hernandez HL, 2007, BIOCHEMISTRY-US, V46, P5140, DOI 10.1021/bi7000449; Huang T, 2009, J BACTERIOL, V191, P5690, DOI 10.1128/JB.00541-09; Kawulka K, 2003, J AM CHEM SOC, V125, P4726, DOI 10.1021/ja029654t; Kawulka KE, 2004, BIOCHEMISTRY-US, V43, P3385, DOI 10.1021/bi0359527; Kulzer R, 1998, J BIOL CHEM, V273, P4897, DOI 10.1074/jbc.273.9.4897; Layer G, 2002, J BIOL CHEM, V277, P34136, DOI 10.1074/jbc.M205247200; Layer G, 2005, BIOL CHEM, V386, P971, DOI 10.1515/BC.2005.113; Lee H, 2009, FEMS MICROBIOL LETT, V299, P205, DOI 10.1111/j.1574-6968.2009.01749.x; Lee KH, 2009, BIOCHEMISTRY-US, V48, P10162, DOI 10.1021/bi900939w; Liu WT, 2010, P NATL ACAD SCI USA, V107, P16286, DOI 10.1073/pnas.1008368107; Maqueda M, 2008, FEMS MICROBIOL REV, V32, P2, DOI 10.1111/j.1574-6976.2007.00087.x; Miller JR, 2000, BIOCHEMISTRY-US, V39, P15166, DOI 10.1021/bi002060n; Murphy K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020852; Nakano MM, 2000, J BACTERIOL, V182, P3274, DOI 10.1128/JB.182.11.3274-3277.2000; Oman TJ, 2010, NAT CHEM BIOL, V6, P9, DOI [10.1038/NCHEMBIO.286, 10.1038/nchembio.286]; Pierrel F, 2004, J BIOL CHEM, V279, P47555, DOI 10.1074/jbc.M408562200; Rea MC, 2010, P NATL ACAD SCI USA, V107, P9352, DOI 10.1073/pnas.0913554107; Roach PL, 1997, NATURE, V387, P827, DOI 10.1038/42990; Santamaria-Araujo JA, 2004, J BIOL CHEM, V279, P15994, DOI 10.1074/jbc.M311815200; Shelburne CE, 2007, J ANTIMICROB CHEMOTH, V59, P297, DOI 10.1093/jac/dkl495; Silkin L, 2008, BIOORG MED CHEM LETT, V18, P3103, DOI 10.1016/j.bmcl.2007.11.024; Sit CS, 2011, ANGEW CHEM INT EDIT, V50, P8718, DOI 10.1002/anie.201102527; Sit CS, 2011, J AM CHEM SOC, V133, P7680, DOI 10.1021/ja201802f; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Sutyak K. E., 2008, INFECT DIS OBSTET GY; Ugulava NB, 2000, BIOCHEMISTRY-US, V39, P5206, DOI 10.1021/bi9926227; Ugulava NB, 2001, BIOCHEMISTRY-US, V40, P8343, DOI 10.1021/bi0104625; Xie LL, 2004, SCIENCE, V303, P679, DOI 10.1126/science.1092600; Yokoyama K, 2007, J AM CHEM SOC, V129, P15147, DOI 10.1021/ja072481t; Zheng GL, 1999, J BACTERIOL, V181, P7346, DOI 10.1128/JB.181.23.7346-7355.1999; Zheng GL, 2000, J BACTERIOL, V182, P3266, DOI 10.1128/JB.182.11.3266-3273.2000	50	135	135	0	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2012	8	4					350	357		10.1038/NCHEMBIO.798	http://dx.doi.org/10.1038/NCHEMBIO.798			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	913PO	22366720				2022-12-25	WOS:000301890100009
J	Santen, GWE; Aten, E; Sun, Y; Almomani, R; Gilissen, C; Nielsen, M; Kant, SG; Snoeck, IN; Peeters, EAJ; Hilhorst-Hofstee, Y; Wessels, MW; den Hollander, NS; Ruivenkamp, CAL; van Ommen, GJB; Breuning, MH; den Dunnen, JT; van Haeringen, A; Kriek, M				Santen, Gijs W. E.; Aten, Emmelien; Sun, Yu; Almomani, Rowida; Gilissen, Christian; Nielsen, Maartje; Kant, Sarina G.; Snoeck, Irina N.; Peeters, Els A. J.; Hilhorst-Hofstee, Yvonne; Wessels, Marja W.; den Hollander, Nicolette S.; Ruivenkamp, Claudia A. L.; van Ommen, Gert-Jan B.; Breuning, Martijn H.; den Dunnen, Johan T.; van Haeringen, Arie; Kriek, Marjolein			Mutations in SWI/SNF chromatin remodeling complex gene ARID1B cause Coffin-Siris syndrome	NATURE GENETICS			English	Article							DNA-SEQUENCING DATA; FRAMEWORK	We identified de novo truncating mutations in ARID1B in three individuals with Coffin-Siris syndrome (CSS) by exome sequencing. Array-based copy-number variation (CNV) analysis in 2,000 individuals with intellectual disability revealed deletions encompassing ARID1B in 3 subjects with phenotypes partially overlapping that of CSS. Taken together with published data, these results indicate that haploinsufficiency of the ARID1B gene, which encodes an epigenetic modifier of chromatin structure, is an important cause of CSS and is potentially a common cause of intellectual disability and speech impairment.	[Santen, Gijs W. E.; Aten, Emmelien; Sun, Yu; Almomani, Rowida; Nielsen, Maartje; Kant, Sarina G.; Hilhorst-Hofstee, Yvonne; den Hollander, Nicolette S.; Ruivenkamp, Claudia A. L.; van Ommen, Gert-Jan B.; Breuning, Martijn H.; den Dunnen, Johan T.; van Haeringen, Arie; Kriek, Marjolein] Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Leiden, Netherlands; [Gilissen, Christian] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Dept Human Genet, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Gilissen, Christian] Radboud Univ Nijmegen, Inst Genet & Metab Disorders, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Snoeck, Irina N.; Peeters, Els A. J.] Haga Teaching Hosp, Juliana Childrens Hosp, Dept Child Neurol, The Hague, Netherlands; [Wessels, Marja W.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [den Dunnen, Johan T.] Leiden Univ, Leiden Genome Technol Ctr, Med Ctr, Leiden, Netherlands; [van Haeringen, Arie] Haga Teaching Hosp, Juliana Childrens Hosp, Dept Clin Genet, The Hague, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Radboud University Nijmegen; Haga Hospital; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Haga Hospital	Santen, GWE (corresponding author), Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Leiden, Netherlands.	santen@lumc.nl	Nielsen, Maartje/AAC-5742-2020; Gilissen, Christian/E-5246-2012; Hilhorst-Hofstee, Yvonne/AAC-5120-2022; dunnen, johan den/ABH-4228-2020; Kant, Sarina/F-8596-2010	Nielsen, Maartje/0000-0002-5351-1870; Gilissen, Christian/0000-0003-1693-9699; Hilhorst-Hofstee, Yvonne/0000-0003-0951-6524; dunnen, johan den/0000-0002-6304-1710; Sun, Yu/0000-0002-2938-0233	European Union [223026, 223143]	European Union(European Commission)	We thank the subjects and their parents for participation in this study. We would like to acknowledge A. Hoischen for his useful suggestions regarding the interpretation of exome sequencing data. We received funding from the European Union Seventh Framework Programme for Research (FP7; 223026 (Development of Targeted DNA-Chips for High Throughput Diagnosis of NeuroMuscular Disorders (NMD-Chip)) and 223143; Technological Innovation of High Throughput Molecular Diagnostics of Clinically and Molecularly Heterogeneous Genetic Disorders (TECHGENE)). All participants in this study provided informed consent. The Leiden University Medical Center ethics committee has approved the protocol describing genetic studies in individuals with intellectual disability of unknown etiology.	Backx L, 2011, CYTOGENET GENOME RES, V132, P135, DOI 10.1159/000321577; CAREY JC, 1978, AM J DIS CHILD, V132, P667, DOI 10.1001/archpedi.1978.02120320027005; COFFIN GS, 1970, AM J DIS CHILD, V119, P433, DOI 10.1001/archpedi.1970.02100050435009; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fleck BJ, 2001, AM J MED GENET, V99, P1, DOI 10.1002/1096-8628(20010215)99:1<1::AID-AJMG1127>3.0.CO;2-A; Flores-Alcantar A, 2011, CELL TISSUE RES, V345, P137, DOI 10.1007/s00441-011-1182-x; Gilissen C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-228; Halgren C, 2012, CLIN GENET, V82, P248, DOI 10.1111/j.1399-0004.2011.01755.x; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; HARPER PS, 2004, PRACTICAL GENETIC CO; HASPESLAGH M, 1984, CLIN GENET, V26, P374; LEVY P, 1991, J MED GENET, V28, P338, DOI 10.1136/jmg.28.5.338; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; van Bokhoven H, 2011, ANNU REV GENET, V45, P81, DOI 10.1146/annurev-genet-110410-132512; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982	15	250	259	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2012	44	4					379	380		10.1038/ng.2217	http://dx.doi.org/10.1038/ng.2217			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	916VF	22426309				2022-12-25	WOS:000302130600010
J	Jilek, BL; Zarr, M; Sampah, ME; Rabi, SA; Bullen, CK; Lai, J; Shen, L; Siliciano, RF				Jilek, Benjamin L.; Zarr, Melissa; Sampah, Maame E.; Rabi, S. Alireza; Bullen, Cynthia K.; Lai, Jun; Shen, Lin; Siliciano, Robert F.			A quantitative basis for antiretroviral therapy for HIV-1 infection	NATURE MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; TREATMENT-NAIVE PATIENTS; RESPONSE CURVE SLOPE; DYNAMICS IN-VIVO; COMBINATION THERAPY; CONTROLLED-TRIAL; VIRAL DYNAMICS; ZIDOVUDINE; LAMIVUDINE; INHIBITOR	Highly active antiretroviral therapy (HAART)(1-3) has dramatically decreased mortality from HIV-1 infection(4) and is a major achievement of modern medicine. However, there is no fundamental theory of HAART. Elegant models describe the dynamics of viral replication(3,5-9), but a metric for the antiviral activity of drug combinations relative to a target value needed for control of replication is lacking. Treatment guidelines(10,11) are based on empirical results of clinical trials in which other factors such as regimen tolerability also affect outcome. Why only certain drug combinations control viral replication remains unclear. Here we quantify the intrinsic antiviral activity of antiretroviral drug combinations. We show that most single antiretroviral drugs show previously unappreciated complex nonlinear pharmacodynamics that determine their inhibitory potential at clinical concentrations. We demonstrate that neither of the major theories for drug combinations accurately predicts the combined effects of multiple antiretrovirals. However, the combined effects can be understood with a new approach that considers the degree of independence of drug effects. This analysis allows a direct comparison of the inhibitory potential of different drug combinations under clinical concentrations, reconciles the results of clinical trials, defines a target level of inhibition associated with treatment success and provides a rational basis for treatment simplification and optimization.	[Jilek, Benjamin L.; Sampah, Maame E.; Rabi, S. Alireza; Bullen, Cynthia K.; Lai, Jun; Shen, Lin; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Zarr, Melissa; Shen, Lin; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Siliciano, RF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	rsiliciano@jhmi.edu			US National Institutes of Health [AI081600]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081600] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Blankson, A. Spivak, C. Durand, J. Gallant, J. Cofrancesco and W. Greco for helpful discussions. This work was supported by US National Institutes of Health grant AI081600 and by the Howard Hughes Medical Institute.	[Anonymous], 2009, GUID US ANT AG HIV 1; Bierman WFW, 2009, AIDS, V23, P279, DOI 10.1097/QAD.0b013e32831c54e5; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; CHOU TC, 1976, J THEOR BIOL, V59, P253, DOI 10.1016/0022-5193(76)90169-7; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Cooper DA, 2010, J INFECT DIS, V201, P803, DOI 10.1086/650697; Ferguson NM, 2001, TRENDS PHARMACOL SCI, V22, P97, DOI 10.1016/S0165-6147(00)01615-1; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Gallant JE, 2005, J INFECT DIS, V192, P1921, DOI 10.1086/498069; GRECO WR, 1995, PHARMACOL REV, V47, P331; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Havlir DV, 2000, J INFECT DIS, V182, P321, DOI 10.1086/315683; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hoggard PG, 1997, ANTIMICROB AGENTS CH, V41, P1231, DOI 10.1128/AAC.41.6.1231; HOLFORD NHG, 1981, CLIN PHARMACOKINET, V6, P429, DOI 10.2165/00003088-198106060-00002; Katlama C, 2010, AIDS, V24, P2365, DOI 10.1097/QAD.0b013e32833dec20; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; Loewe S, 1926, N-S ARCH EX PATH PH, V114, P313; Markowitz M, 2007, JAIDS-J ACQ IMM DEF, V46, P125, DOI 10.1097/QAI.0b013e318157131c; Muller B, 2009, J BIOL CHEM, V284, P29692, DOI 10.1074/jbc.M109.027144; Murakami T, 2004, J VIROL, V78, P1026, DOI 10.1128/JVI.78.2.1026-1031.2004; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Perez-Valero I, 2011, CURR OPIN INFECT DIS, V24, P7, DOI 10.1097/QCO.0b013e3283422cdf; Sampah MES, 2011, P NATL ACAD SCI USA, V108, P7613, DOI 10.1073/pnas.1018360108; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Shen L, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002304; Siliciano JD, 2010, CURR OPIN HIV AIDS, V5, P491, DOI 10.1097/COH.0b013e32833f206f; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Walmsley S, 2002, NEW ENGL J MED, V346, P2039, DOI 10.1056/NEJMoa012354; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wodarz D, 2002, BIOESSAYS, V24, P1178, DOI 10.1002/bies.10196; Wyma DJ, 2004, J VIROL, V78, P3429, DOI 10.1128/JVI.78.7.3429-3435.2004	40	112	115	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2012	18	3					446	U211		10.1038/nm.2649	http://dx.doi.org/10.1038/nm.2649			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22344296	Green Accepted, Green Published			2022-12-25	WOS:000301264800048
J	Kuchroo, VK; Ohashi, PS; Sartor, RB; Vinuesa, CG				Kuchroo, Vijay K.; Ohashi, Pamela S.; Sartor, R. Balfour; Vinuesa, Carola G.			Dysregulation of immune homeostasis in autoimmune diseases	NATURE MEDICINE			English	Article							REGULATORY T-CELLS; ARYL-HYDROCARBON RECEPTOR; INFLAMMATORY-BOWEL-DISEASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTIGEN-PRESENTING CELLS; TOLL-LIKE RECEPTORS; DENDRITIC CELLS; CROHNS-DISEASE; ULCERATIVE-COLITIS; UNIQUE POPULATION	Great strides have been made in our understanding of the pathogenesis of autoimmune diseases. Research has identified genetic associations, new functional subsets of effector and regulatory T cells and the gut microbiota as crucial environmental factors in regulating immune function. This commentary discusses recent advances in our understanding of genetic and environmental factors as well as the role of innate and adaptive immune responses in driving immune-mediated tissue injury.	[Kuchroo, Vijay K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Ohashi, Pamela S.] Univ Toronto, Ontario Canc Inst, Dept Med Biophys, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Ohashi, Pamela S.] Univ Toronto, Ontario Canc Inst, Dept Immunol, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Sartor, R. Balfour] Univ N Carolina, Dept Med, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC USA; [Sartor, R. Balfour] Univ N Carolina, Dept Microbiol & Immunol, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC USA; [Vinuesa, Carola G.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Australian National University; John Curtin School of Medical Research	Kuchroo, VK (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	vkuchroo@rics.bwh.harvard.edu	Vinuesa, Carola G/B-1108-2010	Vinuesa, Carola G/0000-0001-9799-0298; Ohashi, Pamela S./0000-0003-2915-9317				Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Bayry J, 2007, DRUG DISCOV TODAY, V12, P548, DOI 10.1016/j.drudis.2007.05.002; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Cao DJ, 2004, ARTHRITIS RES THER, V6, pR335, DOI 10.1186/ar1192; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Cipolletta D, 2011, SEMIN IMMUNOL, V23, P431, DOI 10.1016/j.smim.2011.06.002; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Croker BA, 2008, P NATL ACAD SCI USA, V105, P15028, DOI 10.1073/pnas.0806619105; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Dissanayake D, 2011, NAT MED, V17, P1663, DOI 10.1038/nm.2556; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Fantini MC, 2009, GASTROENTEROLOGY, V136, P1308, DOI 10.1053/j.gastro.2008.12.053; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Freeman HJ, 2000, CAN J GASTROENTEROL, V14, P21, DOI 10.1155/2000/349082; Fujikado N, 2008, NAT MED, V14, P176, DOI 10.1038/nm1697; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Garza KM, 2000, J EXP MED, V191, P2021, DOI 10.1084/jem.191.11.2021; Green NM, 2011, SEMIN IMMUNOL, V23, P106, DOI 10.1016/j.smim.2011.01.016; Gross G, 2010, J AGR FOOD CHEM, V58, P10236, DOI 10.1021/jf101475m; He XL, 2002, IMMUNITY, V17, P83, DOI 10.1016/S1074-7613(02)00340-0; Hellwig K, 2011, J NEUROL, V258, P1920, DOI 10.1007/s00415-011-6116-8; Hill JA, 2007, NAT IMMUNOL, V8, P124, DOI 10.1038/ni0207-124; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Klareskog L, 2011, SEMIN IMMUNOL, V23, P92, DOI 10.1016/j.smim.2011.01.014; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Kranich J, 2011, SEMIN IMMUNOL, V23, P139, DOI 10.1016/j.smim.2011.01.011; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Lang KS, 2005, NAT MED, V11, P138, DOI 10.1038/nm1176; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Millar DG, 2003, NAT MED, V9, P1469, DOI 10.1038/nm962; Mohamadzadeh M, 2011, P NATL ACAD SCI USA, V108, P4623, DOI 10.1073/pnas.1005066107; Montgomery SM, 1999, EUR J GASTROEN HEPAT, V11, P543, DOI 10.1097/00042737-199905000-00013; Ochoa-Reparaz J, 2010, MUCOSAL IMMUNOL, V3, P487, DOI 10.1038/mi.2010.29; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Platzer B, 2009, J IMMUNOL, V183, P66, DOI 10.4049/jimmunol.0802997; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Quintana FJ, 2009, EUR J IMMUNOL, V39, P655, DOI 10.1002/eji.200839198; Rai E, 2011, SEMIN IMMUNOL, V23, P67, DOI 10.1016/j.smim.2011.01.015; Rajan TV, 2006, PERSPECT BIOL MED, V49, P171, DOI 10.1353/pbm.2006.0029; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Santacruz A, 2010, BRIT J NUTR, V104, P83, DOI 10.1017/S0007114510000176; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Sartor RB, 2010, GASTROENTEROLOGY, V139, P1816, DOI 10.1053/j.gastro.2010.10.036; Sashio H, 2002, IMMUNOGENETICS, V53, P1020, DOI 10.1007/s00251-001-0423-7; Selmi C, 2004, GASTROENTEROLOGY, V127, P485, DOI 10.1053/j.gastro.2004.05.005; Shen N, 2010, P NATL ACAD SCI USA, V107, P15838, DOI 10.1073/pnas.1001337107; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Stockinger B, 2011, SEMIN IMMUNOL, V23, P99, DOI 10.1016/j.smim.2011.01.008; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Todd JA, 2010, CELL, V141, P1114, DOI 10.1016/j.cell.2010.06.015; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Trowsdale J, 2005, CURR OPIN IMMUNOL, V17, P498, DOI 10.1016/j.coi.2005.07.015; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vinuesa CG, 2010, IMMUNOL REV, V237, P72, DOI 10.1111/j.1600-065X.2010.00937.x; Waldner H, 2004, J CLIN INVEST, V113, P990, DOI 10.1172/JCI200419388; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Wucherpfennig KW, 2011, SEMIN IMMUNOL, V23, P84, DOI 10.1016/j.smim.2011.01.007; Young VB, 2012, CURR OPIN GASTROEN, V28, P63, DOI 10.1097/MOG.0b013e32834d61e9	76	73	78	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2012	18	1					42	47		10.1038/nm.2621	http://dx.doi.org/10.1038/nm.2621			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22227671				2022-12-25	WOS:000299018600026
J	Good, MF; Hill, AVS				Good, Michael F.; Hill, Adrian V. S.			Mixed results for a malaria vaccine	NATURE MEDICINE			English	Editorial Material							FOLLOW-UP; EFFICACY; CHILDREN; PROTEIN	Although malaria can be effectively controlled in high-risk endemic areas using measures such as bed nets, insecticides and antimalarial drugs, the complete eradication of the malaria-causing parasite is still a considerable challenge. An effective vaccine would offer hope for reaching this ambitious goal. A recent study describes the interim results from an ongoing phase 3 trial to assess the candidate malaria vaccine RTS, S/AS01 (ref. 1). This vaccine is composed of a hepatitis B surface antigen fused to a recombinant antigen from part of the malaria circumsporozoite protein (CSP) in the AS01 adjuvant. The vaccine was shown to offer some protection against both clinical and severe malaria. We asked three experts to comment on what the implications of this trial are for the future of the RTS, S vaccine, as well as for general strategies to eradicate malaria. [GRAPHICS] .	[Good, Michael F.] Griffith Univ, Inst Glyc, Gold Coast, Australia; [Hill, Adrian V. S.] Univ Oxford, Jenner Inst, Oxford, England	Griffith University; University of Oxford; Jenner Institute	Good, MF (corresponding author), Griffith Univ, Inst Glyc, Gold Coast, Australia.				Wellcome Trust [090532] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Asante KP, 2011, LANCET INFECT DIS, V11, P741, DOI 10.1016/S1473-3099(11)70100-1; Barry AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008497; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Cohen J, 2010, HUM VACCINES, V6, P90, DOI 10.4161/hv.6.1.9677; Good MF, 2011, CELL MOL LIFE SCI, V68, P1105, DOI 10.1007/s00018-011-0634-5; Moorthy Vasee, 2007, Vaccine, V25, P5115, DOI 10.1016/j.vaccine.2007.01.085; Stewart VA, 2007, INFECT IMMUN, V75, P2283, DOI 10.1128/IAI.01879-06	10	8	8	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2011	17	12					1560	1561		10.1038/nm1211-1560	http://dx.doi.org/10.1038/nm1211-1560			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22146460				2022-12-25	WOS:000297978000023
J	Crespo, MD; Puorger, C; Scharer, MA; Eidam, O; Grutter, MG; Capitani, G; Glockshuber, R				Crespo, Maria D.; Puorger, Chasper; Schaerer, Martin A.; Eidam, Oliv; Gruetter, Markus G.; Capitani, Guido; Glockshuber, Rudi			Quality control of disulfide bond formation in pilus subunits by the chaperone FimC	NATURE CHEMICAL BIOLOGY			English	Article							DONOR-STRAND EXCHANGE; STRUCTURAL BASIS; TYPE-1 PILI; COMPLEX RECOGNITION; CRYSTAL-STRUCTURE; DSB PROTEINS; ADHESIN FIMH; BIOGENESIS; ISOMERASE; MECHANISM	Type 1 pili from uropathogenic Escherichia coli are filamentous, noncovalent protein complexes mediating bacterial adhesion to the host tissue. All structural pilus subunits are homologous proteins sharing an invariant disulfide bridge. Here we show that disulfide bond formation in the unfolded subunits, catalyzed by the periplasmic oxidoreductase DsbA, is required for subunit recognition by the assembly chaperone FimC and for FimC-catalyzed subunit folding. FimC thus guarantees quantitative disulfide bond formation in each of the up to 3,000 subunits of the pilus. The X-ray structure of the complex between FimC and the main pilus subunit FimA and the kinetics of FimC-catalyzed FimA folding indicate that FimC accelerates folding of pilus subunits by lowering their topological complexity. The kinetic data, together with the measured in vivo concentrations of DsbA and FimC, predict an in vivo half-life of 2 s for oxidative folding of FimA in the periplasm.	[Crespo, Maria D.; Puorger, Chasper; Glockshuber, Rudi] Swiss Fed Inst Technol, Dept Biol, Inst Mol Biol & Biophys, Zurich, Switzerland; [Schaerer, Martin A.; Capitani, Guido] Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland; [Eidam, Oliv; Gruetter, Markus G.; Capitani, Guido] Univ Zurich, Dept Biochem, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Zurich	Glockshuber, R (corresponding author), Swiss Fed Inst Technol, Dept Biol, Inst Mol Biol & Biophys, Zurich, Switzerland.	rudi@mol.biol.ethz.ch			Swiss National Science Foundation [310030B-138657, 31003A-122095]; Swiss Federal Institute of Technology Zurich within the framework of the Swiss National Center for Competence in Research Structural Biology Program; Research Committee of the Paul Scherrer Institute [FK-05.08.1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Federal Institute of Technology Zurich within the framework of the Swiss National Center for Competence in Research Structural Biology Program; Research Committee of the Paul Scherrer Institute	This work was supported by the Swiss National Science Foundation (grants 310030B-138657 and 31003A-122095 to R. G.) and the Swiss Federal Institute of Technology Zurich within the framework of the Swiss National Center for Competence in Research Structural Biology Program. The PhD position of M. A. S. was supported by a grant from the Research Committee of the Paul Scherrer Institute (FK-05.08.1) to G.C.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balbach J., 2000, MECH PROTEIN FOLDING, P212; Bann JG, 2004, P NATL ACAD SCI USA, V101, P17389, DOI 10.1073/pnas.0408072101; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Barnhart MM, 2000, P NATL ACAD SCI USA, V97, P7709, DOI 10.1073/pnas.130183897; Bringer MA, 2007, J BACTERIOL, V189, P4860, DOI 10.1128/JB.00233-07; Capitani G, 2006, MICROBES INFECT, V8, P2284, DOI 10.1016/j.micinf.2006.03.013; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; DIEDERICHS K, 1995, PROTEINS, V23, P187, DOI 10.1002/prot.340230208; DODD DC, 1984, J BACTERIOL, V160, P227, DOI 10.1128/JB.160.1.227-232.1984; Eidam O, 2008, FEBS LETT, V582, P651, DOI 10.1016/j.febslet.2008.01.030; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; Hennecke J, 1997, BIOCHEMISTRY-US, V36, P6391, DOI 10.1021/bi963017w; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Hiniker A, 2005, J BIOL CHEM, V280, P33785, DOI 10.1074/jbc.M505742200; Hiniker A, 2004, J BIOL CHEM, V279, P12967, DOI 10.1074/jbc.M311391200; Hung DL, 1996, EMBO J, V15, P3792, DOI 10.1002/j.1460-2075.1996.tb00753.x; JACOBDUBUISSON F, 1994, J BIOL CHEM, V269, P12447; JACOBDUBUISSON F, 1994, P NATL ACAD SCI USA, V91, P11552, DOI 10.1073/pnas.91.24.11552; JONES CH, 1993, P NATL ACAD SCI USA, V90, P8397, DOI 10.1073/pnas.90.18.8397; JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kelley LA, 1997, PROTEIN SCI, V6, P2628; Kobayashi T, 1999, EMBO J, V18, P1192, DOI 10.1093/emboj/18.5.1192; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUEHN MJ, 1993, SCIENCE, V262, P1234, DOI 10.1126/science.7901913; Lasica AM, 2007, FEMS MICROBIOL REV, V31, P626, DOI 10.1111/j.1574-6976.2007.00081.x; Le Trong I, 2010, J STRUCT BIOL, V172, P380, DOI 10.1016/j.jsb.2010.06.002; Le Trong I, 2010, CELL, V141, P645, DOI 10.1016/j.cell.2010.03.038; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MISSIAKAS D, 1994, EMBO J, V13, P2013, DOI 10.1002/j.1460-2075.1994.tb06471.x; Nishiyama M, 2005, EMBO J, V24, P2075, DOI 10.1038/sj.emboj.7600693; Nishiyama M, 2008, SCIENCE, V320, P376, DOI 10.1126/science.1154994; Pellecchia M, 1999, NAT STRUCT BIOL, V6, P336; Phan G, 2011, NATURE, V474, P49, DOI 10.1038/nature10109; Puorger C, 2011, J MOL BIOL, V412, P520, DOI 10.1016/j.jmb.2011.07.044; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; Remaut H, 2006, MOL CELL, V22, P831, DOI 10.1016/j.molcel.2006.05.033; Sauer FG, 2002, CELL, V111, P543, DOI 10.1016/S0092-8674(02)01050-4; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Saulino ET, 1998, EMBO J, V17, P2177, DOI 10.1093/emboj/17.8.2177; SCHMID FX, 1983, BIOCHEMISTRY-US, V22, P4690, DOI 10.1021/bi00289a013; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; Totsika M, 2009, J BACTERIOL, V191, P3901, DOI 10.1128/JB.00143-09; Vetsch M, 2004, NATURE, V431, P329, DOI 10.1038/nature02891; Vetsch M, 2006, EMBO REP, V7, P734, DOI 10.1038/sj.embor.7400722; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; WUNDERLICH M, 1993, BIOCHEMISTRY-US, V32, P12251, DOI 10.1021/bi00096a039; Yu J, 1999, MICROBES INFECT, V1, P1221, DOI 10.1016/S1286-4579(99)00239-7; Zavialov AV, 2003, CELL, V113, P587, DOI 10.1016/S0092-8674(03)00351-9	50	39	39	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2012	8	8					707	713		10.1038/NCHEMBIO.1019	http://dx.doi.org/10.1038/NCHEMBIO.1019			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975RC	22772153	Green Accepted			2022-12-25	WOS:000306527600010
J	Ruan, YC; Guo, JH; Liu, XM; Zhang, RJ; Tsang, LL; Dong, JD; Chen, H; Yu, MK; Jiang, XH; Zhang, XH; Fok, KL; Chung, YW; Huang, HF; Zhou, WL; Chan, HC				Ruan, Ye Chun; Guo, Jing Hui; Liu, Xinmei; Zhang, Runju; Tsang, Lai Ling; Dong, Jian Da; Chen, Hui; Yu, Mei Kuen; Jiang, Xiaohua; Zhang, Xiao Hu; Fok, Kin Lam; Chung, Yiu Wa; Huang, Hefeng; Zhou, Wen Liang; Chan, Hsiao Chang			Activation of the epithelial Na+ channel triggers prostaglandin E-2 release and production required for embryo implantation	NATURE MEDICINE			English	Article							UTERINE LUMINAL EPITHELIUM; DECIDUAL CELL REACTION; SODIUM-CHANNEL; IN-VITRO; PHOSPHOLIPASE A(2); GUINEA-PIG; MOUSE; ENAC; MICE; RAT	Embryo implantation remains a poorly understood process. We demonstrate here that activation of the epithelial Na+ channel (ENaC) in mouse endometrial epithelial cells by an embryo-released serine protease, trypsin, triggers Ca2+ influx that leads to prostaglandin E-2 (PGE(2)) release, phosphorylation of the transcription factor CREB and upregulation of cyclooxygenase 2, the enzyme required for prostaglandin production and implantation(1-3). We detected maximum ENaC activation, as indicated by ENaC cleavage(4), at the time of implantation in mice. Blocking or knocking down uterine ENaC in mice resulted in implantation failure. Furthermore, we found that uterine ENaC expression before in vitro fertilization (IVF) treatment is markedly lower in women with implantation failure as compared to those with successful pregnancy. These results indicate a previously undefined role of ENaC in regulating the PGE(2) production and release required for embryo implantation, defects that may be a cause of miscarriage and low success rates in IVF.	[Ruan, Ye Chun; Guo, Jing Hui; Tsang, Lai Ling; Dong, Jian Da; Chen, Hui; Yu, Mei Kuen; Jiang, Xiaohua; Zhang, Xiao Hu; Fok, Kin Lam; Chung, Yiu Wa; Chan, Hsiao Chang] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Epithelial Cell Biol Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Ruan, Ye Chun; Dong, Jian Da; Zhou, Wen Liang] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Xinmei; Zhang, Runju; Huang, Hefeng] Zhejiang Univ, Minist Educ Peoples Republ China, Dept Reprod Endocrinol, Sch Med,Key Lab Reprod Genet,Womens Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Jiang, Xiaohua; Chan, Hsiao Chang] Ji Nan Univ Chinese Univ Hong Kong, Minist Educ Peoples Republ China, Key Lab Regenerat Med, Hong Kong, Hong Kong, Peoples R China; [Chan, Hsiao Chang] Sichuan Univ Chinese Univ Hong Kong Joint Lab Rep, Chengdu, Peoples R China	Chinese University of Hong Kong; Sun Yat Sen University; Zhejiang University; Chinese University of Hong Kong; Chinese University of Hong Kong	Chan, HC (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Epithelial Cell Biol Res Ctr, Hong Kong, Hong Kong, Peoples R China.	huanghefg@hotmail.com; lsszwl@yahoo.com.cn; hsiaocchan@cuhk.edu.hk	Huang, Hefeng/ABF-1117-2020; Chan, Hsiao Chang/E-1507-2016; Huang, He-Feng/AAN-7985-2020; Fok, Ellis/M-2784-2019; Fok, Kin Lam/G-2757-2017; Huang, Hefeng/AAR-7184-2021; Dong, Jianda/C-3338-2018; Ruan, Ye Chun/T-7531-2019; jiang, cynthia xiaohua/F-7580-2017; RUAN, Ye Chun/T-5919-2017	Huang, He-Feng/0000-0003-4344-8019; Fok, Ellis/0000-0003-3038-1337; Fok, Kin Lam/0000-0003-3038-1337; Dong, Jianda/0000-0001-5583-0210; Ruan, Ye Chun/0000-0002-4266-6789; jiang, cynthia xiaohua/0000-0002-7372-4961; RUAN, Ye Chun/0000-0002-4266-6789; Zhang, Xiaohu/0000-0002-5329-1599	National 973 projects of China [2012CB944900, 2009CB522102, 2010CB945403]; Natural Science Foundation of China [30770817, 81161120006, 31071019]; Fundamental Research Funds for the Central Universities (Ji Nan University); Focused Investment Scheme; Li Ka Shing Institute of Health Sciences of The Chinese University of Hong Kong; Morningside Foundation	National 973 projects of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities (Ji Nan University); Focused Investment Scheme; Li Ka Shing Institute of Health Sciences of The Chinese University of Hong Kong(Chinese University of Hong Kong); Morningside Foundation	This work was supported in part by National 973 projects of China (2012CB944900, 2009CB522102, 2010CB945403), Natural Science Foundation of China (No. 30770817; No. 81161120006; No. 31071019), the Fundamental Research Funds for the Central Universities (Ji Nan University), the Focused Investment Scheme and Li Ka Shing Institute of Health Sciences of The Chinese University of Hong Kong, and the Morningside Foundation.	Almog B, 2010, FERTIL STERIL, V94, P2026, DOI 10.1016/j.fertnstert.2009.12.075; ANSELL JD, 1974, J EMBRYOL EXP MORPH, V31, P223; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; BRAUNER T, 1984, BIOCHIM BIOPHYS ACTA, V771, P208, DOI 10.1016/0005-2736(84)90535-2; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Chan LN, 2002, J MEMBRANE BIOL, V185, P165, DOI 10.1007/s00232-001-0117-y; Chan LN, 2000, BBA-MOL CELL RES, V1497, P261, DOI 10.1016/S0167-4889(00)00057-4; Dolphin AC, 2006, BRIT J PHARMACOL, V147, pS56, DOI 10.1038/sj.bjp.0706442; Donaldson SH, 2002, J BIOL CHEM, V277, P8338, DOI 10.1074/jbc.M105044200; Enders A C, 1978, Ciba Found Symp, P3; FINN CA, 1966, J ENDOCRINOL, V36, P239, DOI 10.1677/joe.0.0360239; Fronius M, 2008, PFLUG ARCH EUR J PHY, V455, P775, DOI 10.1007/s00424-007-0332-1; HEDLUND K, 1972, J REPROD FERTIL, V29, P131; Kawabe A, 2004, LIFE SCI, V75, P21, DOI 10.1016/j.lfs.2003.11.022; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kennedy TG, 2007, REPRODUCTION, V134, P635, DOI 10.1530/REP-07-0328; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Krotz F, 2004, ARTERIOSCL THROM VAS, V24, P595, DOI 10.1161/01.ATV.0000116219.09040.8c; LEJEUNE B, 1982, J REPROD FERTIL, V66, P519; LEJEUNE B, 1981, J REPROD FERTIL, V61, P235; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; MARTIN L, 1970, J REPROD FERTIL, V21, P461; Nashta AAF, 2004, J ENDOCRINOL, V181, P477, DOI 10.1677/joe.0.1810477; Nesterov V, 2008, AM J PHYSIOL-RENAL, V295, pF1052, DOI 10.1152/ajprenal.00031.2008; Nie HG, 2009, J PHYSIOL-LONDON, V587, P2663, DOI 10.1113/jphysiol.2009.170324; OREHEK J, 1975, J PHARMACOL EXP THER, V194, P554; Pakrasi PL, 2008, PLACENTA, V29, P523, DOI 10.1016/j.placenta.2008.03.001; PARKENING TA, 1979, J GERONTOL, V34, P335, DOI 10.1093/geronj/34.3.335; Rastogi P, 2008, AM J PHYSIOL-LUNG C, V295, pL925, DOI 10.1152/ajplung.90230.2008; Ruan YC, 2008, J PHYSIOL-LONDON, V586, P4843, DOI 10.1113/jphysiol.2008.154096; Ruan YC, 2011, PHYSIOLOGY, V26, P156, DOI 10.1152/physiol.00036.2010; Sakoff JA, 1996, BIOCHEM MOL MED, V57, P81, DOI 10.1006/bmme.1996.0013; Salamonsen LA, 2007, SEMIN REPROD MED, V25, P437, DOI 10.1055/s-2007-991041; Salamonsen Lois A, 2002, Rev Endocr Metab Disord, V3, P133, DOI 10.1023/A:1015407012559; Salker MS, 2011, NAT MED, V17, P1509, DOI 10.1038/nm.2498; SAWADA H, 1990, J EXP ZOOL, V254, P83, DOI 10.1002/jez.1402540112; STRAUSS O, 1994, J CELL PHYSIOL, V160, P89, DOI 10.1002/jcp.1041600111; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Toth B, 2011, J REPROD IMMUNOL, V90, P117, DOI 10.1016/j.jri.2011.05.002; Tsatsanis C, 2006, INT J BIOCHEM CELL B, V38, P1654, DOI 10.1016/j.biocel.2006.03.021; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Yang JZ, 2004, CELL BIOL INT, V28, P433, DOI 10.1016/j.cellbi.2004.03.011; YEE GM, 1993, PROSTAG OTH LIPID M, V46, P117, DOI 10.1016/0090-6980(93)90038-9	43	116	124	2	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2012	18	7					1112	+		10.1038/nm.2771	http://dx.doi.org/10.1038/nm.2771			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22729284				2022-12-25	WOS:000306121600041
J	Stanger, K; Steffek, M; Zhou, LJ; Pozniak, CD; Quan, C; Franke, Y; Tom, J; Tam, C; Elliott, JM; Lewcock, JW; Zhang, YN; Murray, J; Hannoush, RN				Stanger, Karen; Steffek, Micah; Zhou, Lijuan; Pozniak, Christine D.; Quan, Clifford; Franke, Yvonne; Tom, Jeff; Tam, Christine; Elliott, J. Michael; Lewcock, Joseph W.; Zhang, Yingnan; Murray, Jeremy; Hannoush, Rami N.			Allosteric peptides bind a caspase zymogen and mediate caspase tetramerization	NATURE CHEMICAL BIOLOGY			English	Article							MUTANT HUNTINGTIN; ALZHEIMER-DISEASE; CRYSTAL-STRUCTURE; SELF-ACTIVATION; CELL-DEATH; IN-VIVO; APOPTOSIS; CLEAVAGE; SITE; INHIBITION	The caspases are a family of cytosolic proteases with essential roles in inflammation and apoptosis. Drug discovery efforts have focused on developing molecules directed against the active sites of caspases, but this approach has proved challenging and has not yielded any approved therapeutics. Here we describe a new strategy for generating inhibitors of caspase-6, a potential therapeutic target in neurodegenerative disorders, by screening against its zymogen form. Using phage display to discover molecules that bind the zymogen, we report the identification of a peptide that specifically impairs the function of caspase-6 in vitro and in neuronal cells. Remarkably, the peptide binds at a tetramerization interface that is uniquely present in zymogen caspase-6, rather than binding into the active site, and acts via a new allosteric mechanism that promotes caspase tetramerization. Our data illustrate that screening against the zymogen holds promise as an approach for targeting caspases in drug discovery.	[Stanger, Karen; Zhou, Lijuan; Quan, Clifford; Tom, Jeff; Zhang, Yingnan; Hannoush, Rami N.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Steffek, Micah; Franke, Yvonne; Tam, Christine; Murray, Jeremy] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Pozniak, Christine D.; Lewcock, Joseph W.] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; [Elliott, J. Michael] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Hannoush, RN (corresponding author), Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA.	hannoush.rami@gene.com	Zhou, Li/GSE-4531-2022					Albrecht S, 2007, AM J PATHOL, V170, P1200, DOI 10.2353/ajpath.2007.060974; Albrecht S, 2009, J NEUROPATH EXP NEUR, V68, P1282, DOI 10.1097/NEN.0b013e3181c1da10; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Callus BA, 2007, CELL DEATH DIFFER, V14, P73, DOI 10.1038/sj.cdd.4402034; Chai JJ, 2001, CELL, V107, P399, DOI 10.1016/S0092-8674(01)00544-X; Datta D, 2008, J MOL BIOL, V381, P1157, DOI 10.1016/j.jmb.2008.06.040; Denault JB, 2002, CHEM REV, V102, P4489, DOI 10.1021/cr010183n; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Graham RK, 2010, J NEUROSCI, V30, P15019, DOI 10.1523/JNEUROSCI.2071-10.2010; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; Klaiman G, 2008, MOL CELL PROTEOMICS, V7, P1541, DOI 10.1074/mcp.M800007-MCP200; Klaiman G, 2009, BBA-MOL CELL RES, V1793, P592, DOI 10.1016/j.bbamcr.2008.12.004; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Linton SD, 2005, CURR TOP MED CHEM, V5, P1697, DOI 10.2174/156802605775009720; Mintzer R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030376; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Orth K, 1996, J BIOL CHEM, V271, P16443, DOI 10.1074/jbc.271.28.16443; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Riedl SJ, 2001, P NATL ACAD SCI USA, V98, P14790, DOI 10.1073/pnas.221580098; Ruchaud S, 2002, EMBO J, V21, P1967, DOI 10.1093/emboj/21.8.1967; Salvesen G.S., 2010, HDB CELL SIGNALING, V2nd ed., P1297; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Shi YG, 2004, PROTEIN SCI, V13, P1979, DOI 10.1110/ps.04789804; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; SMITH CK, 1995, SCIENCE, V270, P980, DOI 10.1126/science.270.5238.980; Sohn D, 2005, J BIOL CHEM, V280, P5267, DOI 10.1074/jbc.M408585200; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Stennicke HR, 2000, BBA-PROTEIN STRUCT M, V1477, P299, DOI 10.1016/S0167-4838(99)00281-2; Takahashi A, 1996, P NATL ACAD SCI USA, V93, P8395, DOI 10.1073/pnas.93.16.8395; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Vaidya S, 2011, J MOL BIOL, V406, P75, DOI 10.1016/j.jmb.2010.11.031; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Wang XJ, 2010, EMBO REP, V11, P841, DOI 10.1038/embor.2010.141; Wellington CL, 2002, J NEUROSCI, V22, P7862; Williams ST, 2003, APOPTOSIS, V8, P353, DOI 10.1023/A:1024168901003; Xu GZ, 2001, NATURE, V410, P494, DOI 10.1038/35068604; Yu JW, 2009, P NATL ACAD SCI USA, V106, P8169, DOI 10.1073/pnas.0812453106; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152	47	29	30	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2012	8	7					655	660		10.1038/NCHEMBIO.967	http://dx.doi.org/10.1038/NCHEMBIO.967			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961NJ	22683611				2022-12-25	WOS:000305471400013
J	Bonnard, C; Strobl, AC; Shboul, M; Lee, H; Merriman, B; Nelson, SF; Ababneh, OH; Uz, E; Guran, T; Kayserili, H; Hamamy, H; Reversade, B				Bonnard, Carine; Strobl, Anna C.; Shboul, Mohammad; Lee, Hane; Merriman, Barry; Nelson, Stanley F.; Ababneh, Osama H.; Uz, Elif; Guran, Tulay; Kayserili, Hulya; Hamamy, Hanan; Reversade, Bruno			Mutations in IRX5 impair craniofacial development and germ cell migration via SDF1	NATURE GENETICS			English	Article							NEURAL CREST; GENE; PROTEIN	Using homozygosity mapping and locus resequencing, we found that alterations in the homeodomain of the IRX5 transcription factor cause a recessive congenital disorder affecting face, brain, blood, heart, bone and gonad development. We found through in vivo modeling in Xenopus laevis embryos that Irx5 modulates the migration of progenitor cell populations in branchial arches and gonads by repressing Sdf1. We further found that transcriptional control by Irx5 is modulated by direct protein-protein interaction with two GATA zinc-finger proteins, GATA3 and TRPS1; disruptions of these proteins also cause craniofacial dysmorphisms. Our findings suggest that IRX proteins integrate combinatorial transcriptional inputs to regulate key signaling molecules involved in the ontogeny of multiple organs during embryogenesis and homeostasis.	[Bonnard, Carine; Shboul, Mohammad; Reversade, Bruno] ASTAR, Inst Med Biol, Singapore, Singapore; [Strobl, Anna C.] Med Res Council Natl Inst Med Res, Div Syst Biol, London, England; [Lee, Hane; Merriman, Barry; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Ababneh, Osama H.] Univ Jordan, Fac Med, Dept Ophthalmol, Amman, Jordan; [Uz, Elif] Duzce Univ, Dept Biol, Fac Arts & Sci, Duzce, Turkey; [Uz, Elif] Hacettepe Univ, Fac Med, Dept Med Genet, Gene Mapping Lab, TR-06100 Ankara, Turkey; [Guran, Tulay] Marmara Univ Hosp, Istanbul, Turkey; [Kayserili, Hulya] Istanbul Univ, Dept Med Genet, Istanbul Fac Med, Istanbul, Turkey; [Hamamy, Hanan] Univ Hosp Geneva, Dept Genet Med & Dev, Geneva, Switzerland; [Hamamy, Hanan] Natl Ctr Diabet Endocrinol & Genet, Amman, Jordan; [Reversade, Bruno] Natl Univ Singapore, Dept Pediat, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); MRC National Institute for Medical Research; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Jordan; Duzce University; Hacettepe University; Marmara University; Istanbul University; University of Geneva; National University of Singapore	Reversade, B (corresponding author), ASTAR, Inst Med Biol, Singapore, Singapore.	bruno@reversade.com	Nelson, Stanley F/D-4771-2009; Kayserili, Hülya/AAA-5593-2021	Nelson, Stanley F/0000-0002-2082-3114; Kayserili, Hülya/0000-0003-0376-499X; REVERSADE, Bruno/0000-0002-4070-7997	Scientific and Technological Research Council of Turkey [108S418, 108S420]; consortium CRANIRARE; European Research Area Network [R07197KS]; A<SUP>star</SUP>STAR; Branco Weiss Foundation	Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); consortium CRANIRARE; European Research Area Network; A<SUP>star</SUP>STAR; Branco Weiss Foundation	We are indebted to both families for agreeing to participate in this study. We thank N. Akarsu for the mapping analysis carried out on the Turkish family. We thank people from the Reversade laboratory, C. S. Chin, D. Solter and M. Escande for help and advice, and M. Seielstad for allowing genotyping experiments at the Genome Institute of Singapore. We also thank the following people for sharing materials: B. Bruneau (The Gladstone Institute), R. Morishita (Osaka University), C. Canning (Institute of Medical Biology), R. V. Thakker (University of Oxford), A. Caruz (University of Jaen) and RIKEN BioResource Center (BRC) through the National Bio-Resource Project, Japan. The authors dedicate this article to the memory of the late A. S. Teebi, a pioneer in diagnosing genetic conditions in Arab populations. This study was supported by a Singapore International Graduate Award (SINGA) fellowship to C. B., grants (108S418 and 108S420) from the Scientific and Technological Research Council of Turkey and the consortium CRANIRARE, supported by the European Research Area Network (project R07197KS). B. R. is funded by A<SUP>star</SUP>STAR and the Branco Weiss Foundation.	Bawle EV, 1998, TERATOLOGY, V57, P51, DOI 10.1002/(SICI)1096-9926(199802)57:2<51::AID-TERA2>3.0.CO;2-9; Cavodeassi F, 2001, DEVELOPMENT, V128, P2847; Chang CF, 2010, AM J MED GENET A, V152A, P2365, DOI 10.1002/ajmg.a.33580; Cheng CW, 2005, DEV BIOL, V287, P48, DOI 10.1016/j.ydbio.2005.08.029; Chi YI, 2005, HUM GENET, V116, P433, DOI 10.1007/s00439-004-1252-1; Costantini DL, 2005, CELL, V123, P347, DOI 10.1016/j.cell.2005.08.004; Day A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r112; French D, 2009, BLOOD, V113, P4512, DOI 10.1182/blood-2008-07-172106; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; Garcia-Moruja C, 2005, J MOL BIOL, V348, P43, DOI 10.1016/j.jmb.2005.02.016; Grigorieva IV, 2010, J CLIN INVEST, V120, P2144, DOI 10.1172/JCI42021; Hall BK, 2008, J BIOSCIENCES, V33, P781, DOI 10.1007/s12038-008-0098-4; Hamamy HA, 2007, AM J MED GENET A, V143A, P229, DOI 10.1002/ajmg.a.31594; He W, 2009, CARDIOVASC RES, V81, P64, DOI 10.1093/cvr/cvn259; Kayserili H, 2009, HUM MOL GENET, V18, P4357, DOI 10.1093/hmg/ddp391; Le Douarin NM, 2007, BRAIN RES REV, V55, P237, DOI 10.1016/j.brainresrev.2007.06.023; Lee H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-646; Malik TH, 2001, EMBO J, V20, P1715, DOI 10.1093/emboj/20.7.1715; Momeni P, 2000, NAT GENET, V24, P71, DOI 10.1038/71717; O'Connor BD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S12-S2; Reversade B, 2009, NAT GENET, V41, P1016, DOI 10.1038/ng.413; Rodriguez-Seguel E, 2009, DEV BIOL, V329, P258, DOI 10.1016/j.ydbio.2009.02.028; Rohmann E, 2006, NAT GENET, V38, P414, DOI 10.1038/ng1757; Staton AA, 2011, NAT GENET, V43, P204, DOI 10.1038/ng.758; Takeuchi T, 2010, MECH DEVELOP, V127, P146, DOI 10.1016/j.mod.2009.09.005; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Tian J, 2010, AM J HUM GENET, V87, P768, DOI 10.1016/j.ajhg.2010.11.005; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088; Wilkie AOM, 2001, NAT REV GENET, V2, P458, DOI 10.1038/35076601	29	49	52	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2012	44	6					709	U140		10.1038/ng.2259	http://dx.doi.org/10.1038/ng.2259			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	949BT	22581230				2022-12-25	WOS:000304551100021
J	Leshan, RL; Greenwald-Yarnell, M; Patterson, CM; Gonzalez, IE; Myers, MG				Leshan, Rebecca L.; Greenwald-Yarnell, Megan; Patterson, Christa M.; Gonzalez, Ian E.; Myers, Martin G., Jr.			Leptin action through hypothalamic nitric oxide synthase-1-expressing neurons controls energy balance	NATURE MEDICINE			English	Article							VENTRAL PREMAMMILLARY NUCLEUS; MESOLIMBIC DOPAMINE SYSTEM; DIRECT INNERVATION; RECEPTOR NEURONS; BODY-WEIGHT; FOOD-INTAKE; SYNTHASE; MODULATION; EXPRESSION; HINDBRAIN	Few effective measures exist to combat the worldwide obesity epidemic(1), and the identification of potential therapeutic targets requires a deeper understanding of the mechanisms that control energy balance. Leptin, an adipocyte-derived hormone that signals the long-term status of bodily energy stores, acts through multiple types of leptin receptor long isoform (LepRb)-expressing neurons (called here LepRb neurons) in the brain to control feeding, energy expenditure and endocrine function(2-4). The modest contributions to energy balance that are attributable to leptin action in many LepRb populations(5-9) suggest that other previously unidentified hypothalamic LepRb neurons have key roles in energy balance. Here we examine the role of LepRb in neuronal nitric oxide synthase (NOS1)-expressing LebRb (LepRb(NOS1)) neurons that comprise approximately 20% of the total hypothalamic LepRb neurons. Nos1(cre)-mediated genetic ablation of LepRb (Lepr(Nos1KO)) in mice produces hyperphagic obesity, decreased energy expenditure and hyperglycemia approaching that seen in whole-body LepRb-null mice. In contrast, the endocrine functions in Lepr(Nos1KO) mice are only modestly affected by the genetic ablation of LepRb in these neurons. Thus, hypothalamic LepRb(NOS1) neurons are a key site of action of the leptin-mediated control of systemic energy balance.	[Leshan, Rebecca L.; Greenwald-Yarnell, Megan; Patterson, Christa M.; Gonzalez, Ian E.; Myers, Martin G., Jr.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Leshan, Rebecca L.; Myers, Martin G., Jr.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Greenwald-Yarnell, Megan; Myers, Martin G., Jr.] Univ Michigan, Dept Neurosci, Grad Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Greenwald-Yarnell, M (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.	mgmyers@umich.edu		Gonzalez, Ian/0000-0002-4571-909X	Marilyn H. Vincent Foundation; American Diabetes Association; US National Institutes of Health (NIH) [DK057768]; NIH [T32GM008322, T32HL007853]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057768, P30DK020572, P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS076401] Funding Source: NIH RePORTER	Marilyn H. Vincent Foundation; American Diabetes Association(American Diabetes Association); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Amylin Pharmaceuticals for the generous gift of leptin; S. Chua (Albert Einstein College of Medicine), B. Lowell (Beth Israel-Deaconess Medical Center) and G. Barsh (Stanford University) for the gift of Lepr<SUP>flox/flox</SUP>, Agrp<SUP>cre</SUP> and Pomc<SUP>cre</SUP> mice, respectively; and members of the Myers lab for helpful discussions and technical support. Core support (animal phenotyping, Cell and Molecular Biology (CMB); clinical, Microscopy and Image Analysis Core (MIAC)) was provided by the Michigan Diabetes Research and Training Center and Nutrition and Obesity Research Center. This work was supported by the Marilyn H. Vincent Foundation and grants from the American Diabetes Association (M. G. M.), the American Heart Association (M. G. M. and R. L. L.) and the US National Institutes of Health (NIH) (DK057768 to M. G. M.). M. G.-Y. is supported by NIH grant T32GM008322; C. M. P. was supported by NIH grant T32HL007853.	Ahima RS, 2000, FRONT NEUROENDOCRIN, V21, P263, DOI 10.1006/frne.2000.0197; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Bray GA, 2011, PSYCHIAT CLIN N AM, V34, P871, DOI 10.1016/j.psc.2011.08.013; de Wall EV, 2008, ENDOCRINOLOGY, V149, P1773, DOI 10.1210/en.2007-1132; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Donato J, 2011, J CLIN INVEST, V121, P355, DOI 10.1172/JCI45106; Donato J, 2010, ENDOCRINOLOGY, V151, P5415, DOI 10.1210/en.2010-0651; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Farooqi IS, 2009, AM J CLIN NUTR, V89, p980S, DOI 10.3945/ajcn.2008.26788C; Feil Robert, 2008, V184, P529; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Grill HJ, 2006, OBESITY, V14, P216, DOI 10.1038/oby.2006.312; Hayes MR, 2010, CELL METAB, V11, P77, DOI 10.1016/j.cmet.2009.10.009; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Huang PL, 2000, J AM SOC NEPHROL, V11, pS120; Lam DD, 2011, CELL METAB, V13, P584, DOI 10.1016/j.cmet.2011.03.016; Leinninger GM, 2011, CELL METAB, V14, P313, DOI 10.1016/j.cmet.2011.06.016; Leinninger GM, 2009, CELL METAB, V10, P89, DOI 10.1016/j.cmet.2009.06.011; Leshan RL, 2010, J NEUROSCI, V30, P5713, DOI 10.1523/JNEUROSCI.1001-10.2010; Leshan RL, 2009, J NEUROSCI, V29, P3138, DOI 10.1523/JNEUROSCI.0155-09.2009; Liu J, 2011, MOL PSYCHIATR, V16, P1024, DOI 10.1038/mp.2011.36; Louis GW, 2010, J NEUROSCI, V30, P11278, DOI 10.1523/JNEUROSCI.1340-10.2010; McMinn JE, 2004, MAMM GENOME, V15, P677, DOI 10.1007/s00335-004-2340-1; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; Munzberg H, 2007, J NEUROSCI, V27, P69, DOI 10.1523/JNEUROSCI.3168-06.2007; Myers MG, 2009, CELL METAB, V9, P117, DOI 10.1016/j.cmet.2008.12.001; Patterson CM, 2011, BRAIN RES, V1378, P18, DOI 10.1016/j.brainres.2011.01.010; Ring LE, 2010, J CLIN INVEST, V120, P2931, DOI 10.1172/JCI41985; Scott MM, 2011, J CLIN INVEST, V121, P2413, DOI 10.1172/JCI43703; Scott MM, 2009, J COMP NEUROL, V514, P518, DOI 10.1002/cne.22025; Soliman GA, 2007, TRANSGENIC RES, V16, P665, DOI 10.1007/s11248-007-9110-2; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Williams KW, 2011, J NEUROSCI, V31, P13147, DOI 10.1523/JNEUROSCI.2602-11.2011; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051; Yokosuka M, 1997, DEV BRAIN RES, V99, P226, DOI 10.1016/S0165-3806(96)00217-9	38	102	105	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					820	U236		10.1038/nm.2724	http://dx.doi.org/10.1038/nm.2724			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22522563	Green Accepted			2022-12-25	WOS:000303763500051
J	Kopp, F; Stratton, CF; Akella, LB; Tan, DS				Kopp, Felix; Stratton, Christopher F.; Akella, Lakshmi B.; Tan, Derek S.			A diversity-oriented synthesis approach to macrocycles via oxidative ring expansion	NATURE CHEMICAL BIOLOGY			English	Article							DIELS-ALDER REACTION; INNER-OUTER-RING; POLYCYCLIC STRUCTURES; BOUND CONFORMATION; NATURAL-PRODUCTS; DRUG DISCOVERY; ANSA-STEROIDS; SIZED RINGS; INHIBITORS; LIBRARY	Macrocycles are key structural elements in numerous bioactive small molecules and are attractive targets in the diversity-oriented synthesis of natural product-based libraries. However, efficient and systematic access to diverse collections of macrocycles has proven difficult using classical macrocyclization reactions. To address this problem, we have developed a concise, modular approach to the diversity-oriented synthesis of macrolactones and macrolactams involving oxidative cleavage of a bridging double bond in polycyclic enol ethers and enamines. These substrates are assembled in only four or five synthetic steps and undergo ring expansion to afford highly functionalized macrocycles bearing handles for further diversification. In contrast to macrocyclization reactions of corresponding seco acids, the ring expansion reactions are efficient and insensitive to ring size and stereochemistry, overcoming key limitations of conventional approaches to systematic macrocycle synthesis. Cheminformatic analysis indicates that these macrocycles access regions of chemical space that overlap with natural products, distinct from currently targeted synthetic drugs.	[Kopp, Felix; Tan, Derek S.] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10021 USA; [Stratton, Christopher F.; Tan, Derek S.] Mem Sloan Kettering Canc Ctr, Triinst Training Program Chem Biol, New York, NY 10021 USA; [Akella, Lakshmi B.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA; [Tan, Derek S.] Mem Sloan Kettering Canc Ctr, Triinst Res Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Memorial Sloan Kettering Cancer Center	Kopp, F (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, 1275 York Ave, New York, NY 10021 USA.	tand@mskcc.org			NIH [P41 GM076267]; Starr Foundation; Alfred P. Sloan Foundation; Deutscher Akademischer Austauschdienst (DAAD); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM076267] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dedicated to the memory of our colleague and mentor, David Y. Gin (1967-2011). We thank I. Shiina (Tokyo University of Science) for the generous gift of MNBA; G. Sukenick, H. Liu, H. Fang and S. Rusli (Memorial Sloan-Kettering Cancer Center Analytical Core Facility) for expert mass spectral analyses; and K. Kirschbaum (University of Toledo) for X-ray crystallographic analysis. Financial support from the NIH (P41 GM076267), Starr Foundation, Alfred P. Sloan Foundation (Research Fellowship to D.S.T.) and Deutscher Akademischer Austauschdienst (DAAD, postdoctoral fellowship to F.K.) is gratefully acknowledged.	Akritopoulou-Zanze I, 2007, DRUG DISCOV TODAY, V12, P948, DOI 10.1016/j.drudis.2007.08.017; Bauer RA, 2010, CURR OPIN CHEM BIOL, V14, P308, DOI 10.1016/j.cbpa.2010.02.001; Baurle S, 2004, TETRAHEDRON LETT, V45, P9569, DOI 10.1016/j.tetlet.2004.11.017; Baurle S, 2003, ANGEW CHEM INT EDIT, V42, P3961, DOI 10.1002/anie.200351385; Beeler AB, 2005, J COMB CHEM, V7, P673, DOI 10.1021/cc050064b; Benfield AP, 2006, ANGEW CHEM INT EDIT, V45, P6830, DOI 10.1002/anie.200600844; Blankenstein J, 2005, EUR J ORG CHEM, V2005, P1949, DOI 10.1002/ejoc.200400751; Borowitz I.J., 1964, TETRAHEDRON LETT, V5, P1151; Borowitz I.J., 1965, TETRAHEDR LETT, V6, P3813; BOROWITZ IJ, 1969, J ORG CHEM, V34, P1370, DOI 10.1021/jo01257a038; Bostrom J, 1998, J COMPUT AID MOL DES, V12, P383, DOI 10.1023/A:1008007507641; BROWN DS, 1995, J CHEM SOC PERK T 1, P1137, DOI 10.1039/p19950001137; Canales A, 2008, CHEM-EUR J, V14, P7557, DOI 10.1002/chem.200800039; CARLSEN PHJ, 1981, J ORG CHEM, V46, P3936, DOI 10.1021/jo00332a045; DANISHEFSKY S, 1982, J AM CHEM SOC, V104, P358, DOI 10.1021/ja00365a095; Dossetter AG, 1999, ANGEW CHEM INT EDIT, V38, P2398, DOI 10.1002/(SICI)1521-3773(19990816)38:16<2398::AID-ANIE2398>3.0.CO;2-E; Driggers EM, 2008, NAT REV DRUG DISCOV, V7, P608, DOI 10.1038/nrd2590; Dumez E, 2002, J ORG CHEM, V67, P4882, DOI 10.1021/jo025615o; Ganesan A, 2008, CURR OPIN CHEM BIOL, V12, P306, DOI 10.1016/j.cbpa.2008.03.016; GEMAL AL, 1981, J AM CHEM SOC, V103, P5454, DOI 10.1021/ja00408a029; Gradillas A, 2006, ANGEW CHEM INT EDIT, V45, P6086, DOI 10.1002/anie.200600641; Huckel W, 1929, LIEBIGS ANN CHEM, V474, P121; ILLUMINATI G, 1981, ACCOUNTS CHEM RES, V14, P95, DOI 10.1021/ar00064a001; Inokuchi T, 2001, J ORG CHEM, V66, P8059, DOI 10.1021/jo010575u; Khan AR, 1998, BIOCHEMISTRY-US, V37, P16839, DOI 10.1021/bi9821364; Knust H, 2003, HELV CHIM ACTA, V86, P1871, DOI 10.1002/hlca.200390151; Kumar N, 2005, ORG LETT, V7, P2535, DOI 10.1021/ol0504345; Marcaurelle LA, 2010, J AM CHEM SOC, V132, P16962, DOI 10.1021/ja105119r; Patil ML, 2002, TETRAHEDRON, V58, P6615, DOI 10.1016/S0040-4020(02)00740-8; Rincon S, 2006, TETRAHEDRON, V62, P2594, DOI 10.1016/j.tet.2005.12.036; ROXBURGH CJ, 1995, TETRAHEDRON, V51, P9767, DOI 10.1016/0040-4020(95)00629-M; ROXBURGH CJ, 1993, TETRAHEDRON, V49, P10749, DOI 10.1016/S0040-4020(01)80232-5; Sanchez-Pedregal VM, 2006, ANGEW CHEM INT EDIT, V45, P7388, DOI 10.1002/anie.200602793; Sauer WHB, 2003, J CHEM INF COMP SCI, V43, P987, DOI 10.1021/ci025599w; Schmidt DR, 2004, J COMB CHEM, V6, P286, DOI 10.1021/cc020076m; SEEBACH D, 1981, HELV CHIM ACTA, V64, P716, DOI 10.1002/hlca.19810640313; Sestelo JP, 2001, J ORG CHEM, V66, P1395, DOI 10.1021/jo0015319; Sestelo JP, 1999, TETRAHEDRON LETT, V40, P985; Shiina I, 2004, J ORG CHEM, V69, P1822, DOI 10.1021/jo030367x; Shiina I, 2002, TETRAHEDRON LETT, V43, P7535, DOI 10.1016/S0040-4039(02)01819-1; STACH H, 1988, TETRAHEDRON, V44, P1573, DOI 10.1016/S0040-4020(01)86717-X; Su QB, 2003, ORG LETT, V5, P2149, DOI 10.1021/ol034608z; Tan DS, 2005, NAT CHEM BIOL, V1, P74, DOI 10.1038/nchembio0705-74; TANNER D, 1988, TETRAHEDRON, V44, P613, DOI 10.1016/S0040-4020(01)85848-8; TORII S, 1985, J ORG CHEM, V50, P4980, DOI 10.1021/jo00224a071; Udugamasooriya DG, 2008, BIOPOLYMERS, V89, P653, DOI 10.1002/bip.20983; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Wessjohann LA, 2005, MOL DIVERS, V9, P171, DOI 10.1007/s11030-005-1314-x; WOODWARD RB, 1981, J AM CHEM SOC, V103, P3213, DOI 10.1021/ja00401a050; Yang D, 2001, J ORG CHEM, V66, P4814, DOI 10.1021/jo010122p	50	109	110	2	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2012	8	4					358	365		10.1038/NCHEMBIO.911	http://dx.doi.org/10.1038/NCHEMBIO.911			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	913PO	22406518	Green Accepted			2022-12-25	WOS:000301890100010
J	Morales, M; Bonci, A				Morales, Marisela; Bonci, Antonello			Hooking CB2 receptor into drug abuse?	NATURE MEDICINE			English	Editorial Material							CANNABINOID RECEPTOR; BRAIN; EXPRESSION; MICROGLIA; SYSTEM		[Morales, Marisela; Bonci, Antonello] NIDA, Intramural Res Program, Baltimore, MD USA; [Bonci, Antonello] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Bonci, Antonello] Johns Hopkins Univ, Sch Med, Solomon H Snyder Neurosci Inst, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of California System; University of California San Francisco; Johns Hopkins University	Morales, M (corresponding author), NIDA, Intramural Res Program, Baltimore, MD USA.	antonello.bonci@nih.gov			Intramural NIH HHS [Z99 DA999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.x; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Gamaleddin I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029900; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Klein TW, 2003, J LEUKOCYTE BIOL, V74, P486, DOI 10.1189/jlb.0303101; Lanciego JL, 2011, J PSYCHOPHARMACOL, V25, P97, DOI 10.1177/0269881110367732; Mackie K, 2008, J NEUROENDOCRINOL, V20, P10, DOI 10.1111/j.1365-2826.2008.01671.x; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Xi ZX, 2011, NAT NEUROSCI, V14, P1160, DOI 10.1038/nn.2874	14	21	23	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2012	18	4					504	505		10.1038/nm.2722	http://dx.doi.org/10.1038/nm.2722			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22481411				2022-12-25	WOS:000302617800026
J	Carroll, MJ; Mauldin, RV; Gromova, AV; Singleton, SF; Collins, EJ; Lee, AL				Carroll, Mary J.; Mauldin, Randall V.; Gromova, Anna V.; Singleton, Scott F.; Collins, Edward J.; Lee, Andrew L.			Evidence for dynamics in proteins as a mechanism for ligand dissociation	NATURE CHEMICAL BIOLOGY			English	Article							COLI DIHYDROFOLATE-REDUCTASE; DISPERSION NMR-SPECTROSCOPY; BINDING; STATES; LOOP; RECOGNITION; FLEXIBILITY; LANDSCAPE; SUBSTRATE; CATALYSIS	Signal transduction, regulatory processes and pharmaceutical responses are highly dependent upon ligand residence times. Gaining insight into how physical factors influence residence times (1/k(off)), should enhance our ability to manipulate biological interactions. We report experiments that yield structural insight into k(off) involving a series of eight 2,4-diaminopyrimidine inhibitors of dihydrofolate reductase whose binding affinities vary by six orders of magnitude. NMR relaxation-dispersion experiments revealed a common set of residues near the binding site that undergo a concerted millisecond-timescale switching event to a previously unidentified conformation. The rate of switching from ground to excited conformations correlates exponentially with the binding affinity K-i and k(off), suggesting that protein dynamics serves as a mechanical initiator of ligand dissociation within this series and potentially for other macromolecule-ligand systems. Although the forward rate of conformational exchange, k(conf,forward,) is faster than k(offr), the use of the ligand series allowed for connections to be drawn between kinetic events on different timescales.	[Carroll, Mary J.; Gromova, Anna V.; Singleton, Scott F.; Lee, Andrew L.] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27515 USA; [Mauldin, Randall V.; Collins, Edward J.; Lee, Andrew L.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [Collins, Edward J.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Carroll, MJ (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27515 USA.	drewlee@unc.edu	, UNC Biomolecular NMR Facility/AAD-7901-2022; Lee, Andrew/GVU-2817-2022	Singleton, Scott/0000-0001-8797-4438	ACS Division of Medicinal Chemistry; Pfizer Global RD; American Foundation for Pharmaceutical Education; Rho Chi Society and Schering-Plough; Graduate School at UNC; US National Institutes of Health [GM083059]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083059] Funding Source: NIH RePORTER	ACS Division of Medicinal Chemistry; Pfizer Global RD(Pfizer); American Foundation for Pharmaceutical Education; Rho Chi Society and Schering-Plough; Graduate School at UNC; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank G. Young (University of North Carolina at Chapel Hill Biomolecular NMR Facility) and K. Koshlap (University of North Carolina at Chapel Hill Eshelman School of Pharmacy NMR Facility) for their excellent technical assistance. We also acknowledge H. Kohn for assistance in assigning and interpreting the small-molecule NMR spectra as well as N. Kett for chiral resolution of 3 and the lab of P. Guengerich for use of their stopped-flow fluorimeter. M.J.C. gratefully acknowledges predoctoral fellowships from the ACS Division of Medicinal Chemistry (supported by Pfizer Global R&D), the American Foundation for Pharmaceutical Education (supported by the Rho Chi Society and Schering-Plough) and the Graduate School at UNC. This work was funded by US National Institutes of Health grant GM083059 to A.L.L.	APPLEMAN JR, 1988, J BIOL CHEM, V263, P9187; BACCANARI DP, 1981, BIOCHEMISTRY-US, V20, P1710, DOI 10.1021/bi00510a002; BERGER ARIEH, 1957, ARCH BIOCHEM AND BIOPHYS, V69, P106, DOI 10.1016/0003-9861(57)90478-2; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Boehr DD, 2010, P NATL ACAD SCI USA, V107, P1373, DOI 10.1073/pnas.0914163107; Bourgeois D, 2003, P NATL ACAD SCI USA, V100, P8704, DOI 10.1073/pnas.1430900100; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Carroll MJ, 2011, J AM CHEM SOC, V133, P6422, DOI 10.1021/ja2005253; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; FIERKE CA, 1987, BIOCHEMISTRY-US, V26, P4085, DOI 10.1021/bi00387a052; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; GANGJEE A, 1995, J HETEROCYCLIC CHEM, V32, P243, DOI 10.1002/jhet.5570320141; Hansen DF, 2008, J BIOMOL NMR, V41, P113, DOI 10.1007/s10858-008-9251-5; Hansen DF, 2008, J AM CHEM SOC, V130, P2667, DOI 10.1021/ja078337p; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; Ishima R, 1999, STRUCTURE, V7, P1047, DOI 10.1016/S0969-2126(99)80172-5; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Labeikovsky W, 2007, J MOL BIOL, V367, P1370, DOI 10.1016/j.jmb.2007.01.049; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; Lu H, 2010, CURR OPIN CHEM BIOL, V14, P467, DOI 10.1016/j.cbpa.2010.06.176; Masterson LR, 2010, NAT CHEM BIOL, V6, P821, DOI 10.1038/NCHEMBIO.452; MATTHEWS DA, 1977, SCIENCE, V197, P452, DOI 10.1126/science.17920; Mauldin RV, 2009, STRUCTURE, V17, P386, DOI 10.1016/j.str.2009.01.005; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Namanja AT, 2010, J AM CHEM SOC, V132, P5607, DOI 10.1021/ja9096779; Olson JS, 1996, J BIOL CHEM, V271, P17593, DOI 10.1074/jbc.271.30.17593; Osborne MJ, 2003, PROTEIN SCI, V12, P2230, DOI 10.1110/ps.03219603; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Sapienza PJ, 2011, J MOL BIOL, V405, P378, DOI 10.1016/j.jmb.2010.10.037; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P586, DOI 10.1021/bi962337c; Skrynnikov NR, 2002, J AM CHEM SOC, V124, P12352, DOI 10.1021/ja0207089; Summerfield RL, 2006, J MED CHEM, V49, P6977, DOI 10.1021/jm060570v; Tummino PJ, 2008, BIOCHEMISTRY-US, V47, P5481, DOI 10.1021/bi8002023; Wider G, 2006, J AM CHEM SOC, V128, P2571, DOI 10.1021/ja055336t; Zolli-Juran M, 2003, BIOORG MED CHEM LETT, V13, P2493, DOI 10.1016/S0960-894X(03)00480-3	37	69	72	0	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2012	8	3					246	252		10.1038/NCHEMBIO.769	http://dx.doi.org/10.1038/NCHEMBIO.769			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896VR	22246400	Green Accepted, Green Submitted			2022-12-25	WOS:000300600000009
J	Thu, MS; Bryant, LH; Coppola, T; Jordan, EK; Budde, MD; Lewis, BK; Chaudhry, A; Ren, JQ; Varma, NRS; Arbab, AS; Frank, JA				Thu, Mya S.; Bryant, L. Henry; Coppola, Tiziana; Jordan, E. Kay; Budde, Matthew D.; Lewis, Bobbi K.; Chaudhry, Aneeka; Ren, Jiaqiang; Varma, Nadimpalli Ravi S.; Arbab, Ali S.; Frank, Joseph A.			Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging	NATURE MEDICINE			English	Article							STEM-CELLS; DELIVERY-SYSTEM; LABELED CELLS; IRON; NANOPARTICLES; MRI; OPTIMIZATION; FERUMOXIDES; EXPRESSION; DRUGS	We report on a new straightforward magnetic cell-labeling approach that combines three US Food and Drug Administration (FDA)-approved drugs-ferumoxytol, heparin and protamine-in serum-free medium to form self-assembling nanocomplexes that effectively label cells for in vivo magnetic resonance imaging (MRI). We observed that the ferumoxytol-heparin-protamine (HPF) nanocomplexes were stable in serum-free cell culture medium. HPF nanocomplexes show a threefold increase in T2 relaxivity compared to ferumoxytol. Electron microscopy showed internalized HPF in endosomes, which we confirmed by Prussian blue staining of labeled cells. There was no long-term effect or toxicity on cellular physiology or function of HPF-labeled hematopoietic stem cells, bone marrow stromal cells, neural stem cells or T cells when compared to controls. In vivo MRI detected 1,000 HPF-labeled cells implanted in rat brains. This HPF labeling method should facilitate the monitoring by MRI of infused or implanted cells in clinical trials.	[Thu, Mya S.; Bryant, L. Henry; Coppola, Tiziana; Jordan, E. Kay; Budde, Matthew D.; Lewis, Bobbi K.; Chaudhry, Aneeka; Frank, Joseph A.] NIH, Frank Lab, Bethesda, MD 20892 USA; [Thu, Mya S.; Bryant, L. Henry; Coppola, Tiziana; Jordan, E. Kay; Budde, Matthew D.; Lewis, Bobbi K.; Chaudhry, Aneeka; Frank, Joseph A.] NIH, Lab Diagnost Radiol Res, Dept Radiol & Imaging Sci, Bethesda, MD 20892 USA; [Ren, Jiaqiang] NIH, Cell Proc Sect, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA; [Varma, Nadimpalli Ravi S.; Arbab, Ali S.] Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA; [Frank, Joseph A.] NIH, Natl Inst Biomed Imaging & Bioengn, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Henry Ford Health System; Henry Ford Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Frank, JA (corresponding author), NIH, Frank Lab, Bldg 10, Bethesda, MD 20892 USA.	jafrank@helix.nih.gov	Arbab, Ali/AAS-1933-2020; Frank, Joseph/W-2021-2019		Clinical Center of the US National Institutes of Health (NIH); NIH [R01CA122031]; NATIONAL CANCER INSTITUTE [R01CA122031] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL090007] Funding Source: NIH RePORTER	Clinical Center of the US National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CLINICAL CENTER	This work was supported by and performed in part in the intramural research program at the Clinical Center of the US National Institutes of Health (NIH). BMSCs were provided from the Center for Bone Marrow Stromal Cell Transplantation at the NIH. NSCs were provided as part of a material transfer agreement with K. Aboody (City of Hope Medical Center). The authors would like to acknowledge the Clinical Image Processing Section at the NIH. This work was also supported by NIH grant R01CA122031.	ABORG CH, 1968, ACTA PHYSIOL SCAND, V74, P552, DOI 10.1111/j.1748-1716.1968.tb04267.x; [Anonymous], 2010, MED LETT DRUGS THER, V52, P23; Arbab AS, 2009, CURR MED IMAGING, V5, P19, DOI 10.2174/157340509787354697; Arbab Ali Syed, 2004, Mol Imaging, V3, P24, DOI 10.1162/153535004773861697; Arbab AS, 2005, NMR BIOMED, V18, P383, DOI 10.1002/nbm.970; Arbab AS, 2004, BLOOD, V104, P1217, DOI 10.1182/blood-2004-02-0655; Auerbach M, 2008, AM J KIDNEY DIS, V52, P826, DOI 10.1053/j.ajkd.2008.09.006; Balakumaran A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011462; Boutry S, 2008, CONTRAST MEDIA MOL I, V3, P223, DOI 10.1002/cmmi.256; Bulte JWM, 2009, AM J ROENTGENOL, V193, P314, DOI 10.2214/AJR.09.3107; Castaneda R.T., 2011, J VIS EXP, V4, pe3482; Corot C, 2006, ADV DRUG DELIVER REV, V58, P1471, DOI 10.1016/j.addr.2006.09.013; Daley GQ, 2002, CURR OPIN GENET DEV, V12, P607, DOI 10.1016/S0959-437X(02)00346-5; Engberink RDO, 2007, RADIOLOGY, V243, P467, DOI 10.1148/radiol.2432060120; Golovko DM, 2010, EUR RADIOL, V20, P640, DOI 10.1007/s00330-009-1585-1; Janic B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005873; Josephson L, 1999, BIOCONJUGATE CHEM, V10, P186, DOI 10.1021/bc980125h; Kemp MM, 2010, WIRES NANOMED NANOBI, V2, P77, DOI 10.1002/wnan.68; Khurshid H, 2009, J APPL PHYS, V105, DOI 10.1063/1.3068018; Liang JF, 2002, J CONTROL RELEASE, V78, P67, DOI 10.1016/S0168-3659(01)00484-9; Liang JF, 2000, J PHARM SCI-US, V89, P664, DOI 10.1002/(SICI)1520-6017(200005)89:5<664::AID-JPS12>3.3.CO;2-0; Liu W, 2009, EUR J RADIOL, V70, P258, DOI 10.1016/j.ejrad.2008.09.021; Modo M, 2008, CURR OPIN ORGAN TRAN, V13, P654, DOI 10.1097/MOT.0b013e328317a43c; Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005; Motaln H, 2010, CANCER-AM CANCER SOC, V116, P2519, DOI 10.1002/cncr.25056; Neuwelt EA, 2007, NEUROSURGERY, V60, P601, DOI 10.1227/01.NEU.0000255350.71700.37; Neuwelt EA, 2009, KIDNEY INT, V75, P465, DOI 10.1038/ki.2008.496; Pawelczyk E, 2006, NMR BIOMED, V19, P581, DOI 10.1002/nbm.1038; Pawelczyk E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006712; Provenzano R, 2009, CLIN J AM SOC NEPHRO, V4, P386, DOI 10.2215/CJN.02840608; Rad AM, 2007, BIOTECHNIQUES, V43, P627, DOI 10.2144/000112599; ROSSMANN P, 1982, VIRCHOWS ARCH B, V40, P81, DOI 10.1007/BF02932853; Santoro L, 2009, J MAGN RESON IMAGING, V30, P1012, DOI 10.1002/jmri.21937; Schwenk MH, 2010, PHARMACOTHERAPY, V30, P70, DOI 10.1592/phco.30.1.70; Walczak P, 2007, MAGN RESON MED, V58, P261, DOI 10.1002/mrm.21280; Walczak P, 2005, MAGN RESON MED, V54, P769, DOI 10.1002/mrm.20701; Xie DH, 2010, NMR BIOMED, V23, P480, DOI 10.1002/nbm.1485; Yaghoubi SS, 2006, NAT PROTOC, V1, P3069, DOI 10.1038/nprot.2006.459	38	154	162	8	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2012	18	3					463	U165		10.1038/nm.2666	http://dx.doi.org/10.1038/nm.2666			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22366951	Green Accepted			2022-12-25	WOS:000301264800051
J	Zloza, A; Kohlhapp, FJ; Lyons, GE; Schenkel, JM; Moore, TV; Lacek, AT; O'Sullivan, JA; Varanasi, V; Williams, JW; Jagoda, MC; Bellavance, EC; Marzo, AL; Thomas, PG; Zafirova, B; Polic, B; Al-Harthi, L; Sperling, AI; Guevara-Patino, JA				Zloza, Andrew; Kohlhapp, Frederick J.; Lyons, Gretchen E.; Schenkel, Jason M.; Moore, Tamson V.; Lacek, Andrew T.; O'Sullivan, Jeremy A.; Varanasi, Vineeth; Williams, Jesse W.; Jagoda, Michael C.; Bellavance, Emily C.; Marzo, Amanda L.; Thomas, Paul G.; Zafirova, Biljana; Polic, Bojan; Al-Harthi, Lena; Sperling, Anne I.; Guevara-Patino, Jose A.			NKG2D signaling on CD8(+) T cells represses T-bet and rescues CD4-unhelped CD8(+) T cell memory recall but not effector responses	NATURE MEDICINE			English	Article							NK CELLS; CUTTING EDGE; CD8-T-CELL MEMORY; IMMUNE-RESPONSE; CD4-T-CELL HELP; ACUTE INFECTION; CELIAC-DISEASE; TUMOR-IMMUNITY; HIV-INFECTION; KILLER-CELLS	CD4-unhelped CD8(+) T cells are functionally defective T cells primed in the absence of CD4(+) T cell help. Given the co-stimulatory role of natural-killer group 2, member D protein (NKG2D) on CD8(+) T cells, we investigated its ability to rescue these immunologically impotent cells. We demonstrate that augmented co-stimulation through NKG2D during priming paradoxically rescues memory, but not effector, CD8(+) T cell responses. NKG2D-mediated rescue is characterized by reversal of elevated transcription factor T-box expressed in T cells (T-bet) expression and recovery of interleukin-2 and interferon-g production and cytolytic responses. Rescue is abrogated in CD8(+) T cells lacking NKG2D. Augmented co-stimulation through NKG2D confers a high rate of survival to mice lacking CD4(+) T cells in a CD4-dependent influenza model and rescues HIV-specific CD8(+) T cell responses from CD4-deficient HIV-positive donors. These findings demonstrate that augmented co-stimulation through NKG2D is effective in rescuing CD4-unhelped CD8(+) T cells from their pathophysiological fate and may provide therapeutic benefits.	[Zloza, Andrew; Kohlhapp, Frederick J.; Lyons, Gretchen E.; Moore, Tamson V.; Lacek, Andrew T.; O'Sullivan, Jeremy A.; Jagoda, Michael C.; Bellavance, Emily C.; Guevara-Patino, Jose A.] Univ Chicago, Dept Surg, Comm Immunol, Chicago, IL 60637 USA; [Zloza, Andrew; Moore, Tamson V.; O'Sullivan, Jeremy A.; Guevara-Patino, Jose A.] Loyola Univ Chicago, Dept Surg, Inst Oncol, Cardinal Bernardin Canc Ctr, Maywood, IL USA; [Schenkel, Jason M.] Univ Minnesota, Dept Microbiol, Ctr Immunol, Minneapolis, MN 55455 USA; [Varanasi, Vineeth] Univ Chicago, Dept Pathol, Comm Immunol, Chicago, IL 60637 USA; [Williams, Jesse W.; Sperling, Anne I.] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, Comm Immunol, Chicago, IL 60637 USA; [Marzo, Amanda L.; Al-Harthi, Lena] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA; [Marzo, Amanda L.; Al-Harthi, Lena] Rush Univ, Med Ctr, Dev Ctr AIDS Res, Chicago, IL 60612 USA; [Marzo, Amanda L.] Rush Univ, Med Ctr, Ctr Canc, Chicago, IL 60612 USA; [Thomas, Paul G.] St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA; [Zafirova, Biljana; Polic, Bojan] Univ Rijeka, Sch Med, Dept Histol & Embryol, Rijeka, Croatia	University of Chicago; Loyola University Chicago; University of Minnesota System; University of Minnesota Twin Cities; University of Chicago; University of Chicago; Rush University; Rush University; Rush University; St Jude Children's Research Hospital; University of Rijeka	Guevara-Patino, JA (corresponding author), Univ Chicago, Dept Surg, Comm Immunol, Chicago, IL 60637 USA.	jaguevara@lumc.edu	Polic, Bojan/B-8622-2014; Guevara, Jose/AAD-6707-2020; Thomas, Paul G./H-1063-2018; Sperling, Anne/ACZ-2351-2022; Schenkel, Jason/AAV-8184-2020	Polic, Bojan/0000-0003-3930-9630; Thomas, Paul G./0000-0001-7955-0256; Schenkel, Jason/0000-0003-4641-6872; Williams, Jesse/0000-0003-3815-0891; Varanasi, Vineeth/0000-0002-6542-5777; Marzo, amanda/0000-0002-5839-0430; Sperling, Anne I./0000-0002-4265-9212; O'Sullivan, Jeremy/0000-0002-3862-202X; Zloza, Andrew/0000-0001-8844-6493	US National Cancer Institute Cancer Center [5P30CA014599-35]; American Cancer Society [ACSLIB112496-RSG]; American Cancer Society-Illinois Division [07-20]; Croatian Ministry of Science, Education and Sports [062-0621261-1271]; Croatian-Israeli Grant; US National Institutes of Health [R21CA127037, PO1AI082971, K22AI077714]; Immunology Training Grant [T32]; University of Chicago [5T32AI007090]; Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R21CA127037, P30CA014599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI077714, T32AI007090, P01AI082971] Funding Source: NIH RePORTER	US National Cancer Institute Cancer Center; American Cancer Society(American Cancer Society); American Cancer Society-Illinois Division(American Cancer Society); Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia); Croatian-Israeli Grant; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Immunology Training Grant; University of Chicago(University of Chicago); Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	For their kind gifts, we thank: A. Houghton (pCRAN vector and OVA DNA; Memorial Sloan-Kettering Cancer Center); V. Kumar and L. Chlewicki (non-Rae-1 epsilon-expressing EL-4 cells; The University of Chicago); L. Lanier (genes encoding Rae-1 epsilon, Rae-1 epsilon-GFP, and H60; University of California, San Francisco); A. Tenorio (HIV-positive donor identification; Rush University Medical Center); W. Yokoyama (NKG2D-deficient mouse spleens; Washington University School of Medicine in St. Louis), and D. Raulet (NKG2D-decifient mice, University of California, Berkeley). We thank B. Jabri, A. Bendelac, M. I. Nishimura and M.J. Turk for constructive discussions and manuscript edits. We are grateful to the flow cytometry facilities at The University of Chicago and at Loyola University Chicago for their invaluable support and to the Frank W. Fitch Monoclonal Antibody Facility of The University of Chicago Cancer Center (funded by US National Cancer Institute Cancer Center Support Grant 5P30CA014599-35) for CD4 depletion antibody production. HMG2D-specific antibody was used with permission from H. Yagita (Juntendo University School of Medicine). This work was supported in part by the American Cancer Society (ACSLIB112496-RSG) to J.A.G.-P.; American Cancer Society-Illinois Division (Young Investigator Award Grant 07-20) to J.A.G.-P.; Croatian Ministry of Science, Education and Sports (062-0621261-1271), as well as the Croatian-Israeli Grant to B. P.; the US National Institutes of Health R21CA127037 to J.A.G.-P., PO1AI082971 to L. A.-H., K22AI077714 to P. G. T.; T32 Immunology Training Grant, The University of Chicago, 5T32AI007090 to A.Z., F.J.K. and J.A.O.; and the Cancer Research Foundation (Young Investigator Award) to J.A.G.-P.	Bachmann MF, 2005, J IMMUNOL, V175, P4677, DOI 10.4049/jimmunol.175.7.4677; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bellavance EC, 2011, J IMMUNOL, V186, P3309, DOI 10.4049/jimmunol.1002549; Blonska M, 2007, IMMUNITY, V26, P55, DOI 10.1016/j.immuni.2006.11.008; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Byers AM, 2003, J IMMUNOL, V171, P17, DOI 10.4049/jimmunol.171.1.17; Carayannopoulos LN, 2002, J IMMUNOL, V169, P4079, DOI 10.4049/jimmunol.169.8.4079; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(09)00098-3; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 2003, EUR J IMMUNOL, V33, P381, DOI 10.1002/immu.200310012; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Flecknell P, 2000, PAIN MANAGEMENT ANIM; Fuller MJ, 2004, J IMMUNOL, V172, P4204, DOI 10.4049/jimmunol.172.7.4204; Gonzalez S, 2008, TRENDS IMMUNOL, V29, P397, DOI 10.1016/j.it.2008.04.007; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Guevara-Patino JA, 2006, J CLIN INVEST, V116, P1382, DOI 10.1172/JCI25591; Hersperger AR, 2011, BLOOD, V117, P3799, DOI 10.1182/blood-2010-12-322727; Horng T, 2007, NAT IMMUNOL, V8, P1345, DOI 10.1038/ni1524; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2003, SCIENCE, V300, P263, DOI 10.1126/science.1084511; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Kuerten S, 2008, AIDS RES HUM RETROV, V24, P1175, DOI 10.1089/aid.2008.0062; Kuerten S, 2008, AIDS RES HUM RETROV, V24, P62, DOI 10.1089/aid.2007.0125; Lodoen M, 2003, J EXP MED, V197, P1245, DOI 10.1084/jem.20021973; Matthews K, 2007, SCAND J IMMUNOL, V65, P298, DOI 10.1111/j.1365-3083.2007.01902.x; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Mueller KL, 2007, J IMMUNOL, V179, P3559, DOI 10.4049/jimmunol.179.6.3559; Novy P, 2007, J IMMUNOL, V179, P8243, DOI 10.4049/jimmunol.179.12.8243; Oh S, 2008, P NATL ACAD SCI USA, V105, P5201, DOI 10.1073/pnas.0801003105; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Prlic M, 2007, CURR OPIN IMMUNOL, V19, P315, DOI 10.1016/j.coi.2007.04.010; RAULET DH, 1995, CELL, V82, P697, DOI 10.1016/0092-8674(95)90466-2; Roberts AI, 2001, J IMMUNOL, V167, P5527, DOI 10.4049/jimmunol.167.10.5527; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Schmidt CS, 2007, EXPERT REV VACCINES, V6, P391, DOI 10.1586/14760584.6.3.391; Schnizlein-Bick CT, 2000, CLIN DIAGN LAB IMMUN, V7, P336, DOI 10.1128/CDLI.7.3.336-343.2000; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Tang FM, 2009, J EXP MED, V206, P707, DOI 10.1084/jem.20071887; Tao J, 2007, EUR J IMMUNOL, V37, P818, DOI 10.1002/eji.200636726; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Upshaw JL, 2006, NAT IMMUNOL, V7, P524, DOI 10.1038/ni1325; Van Belle TL, 2009, MOL IMMUNOL, V47, P8, DOI 10.1016/j.molimm.2009.02.023; Zafirova B, 2009, IMMUNITY, V31, P270, DOI 10.1016/j.immuni.2009.06.017; Zhang BN, 1997, J EXP MED, V186, P1677, DOI 10.1084/jem.186.10.1677; Zloza A, 2011, AUTOIMMUNITY, V44, P599, DOI 10.3109/08916934.2011.593599; Zloza A, 2011, CANCER IMMUNOL IMMUN, V60, P291, DOI 10.1007/s00262-010-0962-6; Zloza A, 2009, BLOOD, V114, P3841, DOI 10.1182/blood-2009-02-202481	57	44	45	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2012	18	3					422	U184		10.1038/nm.2683	http://dx.doi.org/10.1038/nm.2683			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22366950	Green Accepted			2022-12-25	WOS:000301264800044
J	Liu, L; Feng, D; Chen, G; Chen, M; Zheng, QX; Song, PP; Ma, Q; Zhu, CZ; Wang, R; Qi, WJ; Huang, L; Xue, P; Li, BW; Wang, XH; Jin, HJ; Wang, J; Yang, FQ; Liu, PS; Zhu, YS; Sui, SF; Chen, Q				Liu, Lei; Feng, Du; Chen, Guo; Chen, Ming; Zheng, Qiaoxia; Song, Pingping; Ma, Qi; Zhu, Chongzhuo; Wang, Rui; Qi, Wanjun; Huang, Lei; Xue, Peng; Li, Baowei; Wang, Xiaohui; Jin, Haijing; Wang, Jun; Yang, Fuquan; Liu, Pingsheng; Zhu, Yushan; Sui, Senfang; Chen, Quan			Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells	NATURE CELL BIOLOGY			English	Article							PHOSPHORYLATION SITES; OXIDATIVE STRESS; AUTOPHAGY; PARKIN; ATG32; SRC; DEGRADATION; DYSFUNCTION; P62/SQSTM1; MATURATION	Accumulating evidence has shown that dysfunctional mitochondria can be selectively removed by mitophagy. Dysregulation of mitophagy is implicated in the development of neurodegenerative disease and metabolic disorders. How individual mitochondria are recognized for removal and how this process is regulated remain poorly understood. Here we report that FUNDC1, an integral mitochondrial outer-membrane protein, is a receptor for hypoxia-induced mitophagy. FUNDC1 interacted with LC3 through its typical LC3-binding motif Y(18)xxL(21), and mutation of the LC3-interaction region impaired its interaction with LC3 and the subsequent induction of mitophagy. Knockdown of endogenous FUNDC1 significantly prevented hypoxia-induced mitophagy, which could be reversed by the expression of wild-type FUNDC1, but not LC3-interaction-deficient FUNDC1 mutants. Mechanistic studies further revealed that hypoxia induced dephosphorylation of FUNDC1 and enhanced its interaction with LC3 for selective mitophagy. Our findings thus offer insights into mitochondrial quality control in mammalian cells.	[Liu, Lei; Chen, Ming; Zheng, Qiaoxia; Ma, Qi; Zhu, Chongzhuo; Wang, Rui; Li, Baowei; Wang, Xiaohui; Jin, Haijing; Wang, Jun; Chen, Quan] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100101, Peoples R China; [Liu, Lei; Chen, Ming; Zheng, Qiaoxia; Ma, Qi; Zhu, Chongzhuo; Li, Baowei; Liu, Pingsheng; Chen, Quan] Chinese Acad Sci, Grad Sch, Beijing 100101, Peoples R China; [Feng, Du; Chen, Guo; Song, Pingping; Qi, Wanjun; Zhu, Yushan; Chen, Quan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Huang, Lei; Sui, Senfang] Tsinghua Univ, Coll Life Sci, Beijing 100084, Peoples R China; [Huang, Lei] Tsinghua Univ, Ctr Biomed Anal, Beijing 100084, Peoples R China; [Xue, Peng; Yang, Fuquan] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Nankai University; Tsinghua University; Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Chen, Q (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100101, Peoples R China.	chenq@ioz.ac.cn	Liu, Pingsheng/B-7124-2012	Feng, Du/0000-0002-2489-4702; Chen, Quan/0000-0001-7539-8728	Ministry of Science and Technology (China) [2011CB910903, 2010CB912204]; National Natural Science Foundation of China [81130045, 90713006]	Ministry of Science and Technology (China)(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We wish to thank H. Zhang from the National Institute of Biological Sciences, China, and L. Yu from Tsinghua University, China, for their suggestions and critical reading of the manuscript. We thank Y. G. Chen from Tsinghua University for providing PGEX4T1-GABARAP and PGEX4T1-GABARAPL2 constructs. We wish to thank M. Bartlam from Nankai University and A. Zhou from Cleveland State University in Ohio for improvement of the English of the manuscript. The Chen laboratory was supported by the 973 project of the Ministry of Science and Technology (China) (2011CB910903 and 2010CB912204) and by grants from the National Natural Science Foundation of China (81130045, 90713006).	Aoki Y, 2011, MOL BIOL CELL, V22, P3206, DOI 10.1091/mbc.E11-02-0145; Arachiche A, 2008, J BIOL CHEM, V283, P24406, DOI 10.1074/jbc.M709217200; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Chen Y, 2010, P NATL ACAD SCI USA, V107, P9035, DOI 10.1073/pnas.0914013107; Gao P, 2010, J BIOL CHEM, V285, P25570, DOI 10.1074/jbc.M110.118125; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Goldman SJ, 2010, MITOCHONDRION, V10, P309, DOI 10.1016/j.mito.2010.01.005; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Miyazaki T, 2003, J CELL BIOL, V160, P709, DOI 10.1083/jcb.200209098; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Novak I, 2011, AUTOPHAGY, V7, P301, DOI 10.4161/auto.7.3.14509; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Rikka S, 2011, CELL DEATH DIFFER, V18, P721, DOI 10.1038/cdd.2010.146; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhao LX, 2010, AUTOPHAGY, V6, P386, DOI 10.4161/auto.6.3.11289; Zhu YS, 2010, PROTEIN CELL, V1, P468, DOI 10.1007/s13238-010-0048-4	40	934	980	13	249	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2012	14	2					177	185		10.1038/ncb2422	http://dx.doi.org/10.1038/ncb2422			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	893CF	22267086				2022-12-25	WOS:000300332500012
J	Sainz, B; Barretto, N; Martin, DN; Hiraga, N; Imamura, M; Hussain, S; Marsh, KA; Yu, XM; Chayama, K; Alrefai, WA; Uprichard, SL				Sainz, Bruno, Jr.; Barretto, Naina; Martin, Danyelle N.; Hiraga, Nobuhiko; Imamura, Michio; Hussain, Snawar; Marsh, Katherine A.; Yu, Xuemei; Chayama, Kazuaki; Alrefai, Waddah A.; Uprichard, Susan L.			Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor	NATURE MEDICINE			English	Article							B TYPE-I; VIRION-ASSOCIATED CHOLESTEROL; NPC1L1; INFECTION; EZETIMIBE; PROTEIN; CD81; HEPATOCYTES; SECRETION; DENSITY	Hepatitis C virus (HCV) is a leading cause of liver disease worldwide. With similar to 170 million individuals infected and current interferon-based treatment having toxic side effects and marginal efficacy, more effective antivirals are crucially needed(1). Although HCV protease inhibitors were just approved by the US Food and Drug Administration (FDA), optimal HCV therapy, analogous to HIV therapy, will probably require a combination of antivirals targeting multiple aspects of the viral lifecycle. Viral entry represents a potential multifaceted target for antiviral intervention; however, to date, FDA-approved inhibitors of HCV cell entry are unavailable. Here we show that the cellular Niemann-Pick C1-like 1 (NPC1L1) cholesterol uptake receptor is an HCV entry factor amendable to therapeutic intervention. Specifically, NPC1L1 expression is necessary for HCV infection, as silencing or antibody-mediated blocking of NPC1L1 impairs cell culture-derived HCV (HCVcc) infection initiation. In addition, the clinically available FDA-approved NPC1L1 antagonist ezetimibe(2,3) potently blocks HCV uptake in vitro via a virion cholesterol-dependent step before virion-cell membrane fusion. Moreover, ezetimibe inhibits infection by all major HCV genotypes in vitro and in vivo delays the establishment of HCV genotype 1b infection in mice with human liver grafts. Thus, we have not only identified NPC1L1 as an HCV cell entry factor but also discovered a new antiviral target and potential therapeutic agent.	[Sainz, Bruno, Jr.; Barretto, Naina; Hussain, Snawar; Yu, Xuemei; Alrefai, Waddah A.; Uprichard, Susan L.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Martin, Danyelle N.; Marsh, Katherine A.; Uprichard, Susan L.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA; [Hiraga, Nobuhiko; Imamura, Michio; Chayama, Kazuaki] Hiroshima Univ, Dept Med & Mol Sci, Grad Sch Biomed Sci, Hiroshima, Japan; [Alrefai, Waddah A.] Jesse Brown Virginia Med Ctr, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Hiroshima University	Sainz, B (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60612 USA.	bsainz@uic.edu; sluprich@uic.edu	Anding, Bruno Sainz/ABH-5365-2020; HUSSAIN, SNAWAR/M-4373-2016	Anding, Bruno Sainz/0000-0003-4829-7651; HUSSAIN, SNAWAR/0000-0002-9765-0565; Marsh, Katherine/0000-0002-7051-3819; Chayama, Kazuaki/0000-0002-5530-5341	US National Institutes of Health Public Health Service [R01-AI070827, R03-AI085226]; American Cancer Society [RSG-09-076-01]; UIC Center for Clinical and Translational Science NIH [UL1RR029879]; UIC Council; Ministry of Education, Culture, Sports, Science and Technology-Japan, Ministry of Health, Labour and Welfare-Japan; Grants-in-Aid for Scientific Research [24659368, 22659147] Funding Source: KAKEN; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070827, R03AI085226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071596] Funding Source: NIH RePORTER	US National Institutes of Health Public Health Service; American Cancer Society(American Cancer Society); UIC Center for Clinical and Translational Science NIH; UIC Council; Ministry of Education, Culture, Sports, Science and Technology-Japan, Ministry of Health, Labour and Welfare-Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank T. Wakita (National Institute of Infectious Diseases, Japan) for JFH1-based plasmids, F. Chisari (The Scripps Research Institute) for Huh7 cells, J. Buhk (Copenhagen University Hospital Hepatitis C Program) for JFH-1-based intergenotypic HCV clones, Y. loannou (Mount Sinai School of Medicine) for the antibody (Bsn4052) against NPC1L1, D. Burton and M. Law (The Scripps Research Institute) for the antibody (C1) against the HCV glycoprotein E2 and C. Rice (The Rockefeller Institute) for the antibody (E910) against the HCV nonstructural protein NS5A. We would also like to thank P. Corcoran for outstanding technical assistance, H. Dahari for assistance with statistical analyses and T. Layden and S. Cotler for editing the manuscript. We also thank J. Graves of the University of Illinois at Chicago (UIC) Research Resources Center Flow Cytometry laboratory and K. Ma of the UIC Research Resources Center Confocal Microscopy laboratory for technical assistance. This work was supported by the US National Institutes of Health Public Health Service grants R01-AI070827 and R03-AI085226 (S.L.U.), the American Cancer Society Research Scholar Grant RSG-09-076-01 (S.L.U.), the UIC Center for Clinical and Translational Science NIH grant UL1RR029879, the UIC Council to Support Gastrointestinal and Liver Disease and a grant from the Ministry of Education, Culture, Sports, Science and Technology-Japan, Ministry of Health, Labour and Welfare-Japan (K.C.).	Aizaki H, 2008, J VIROL, V82, P5715, DOI 10.1128/JVI.02530-07; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Bays Harold E, 2008, Expert Rev Cardiovasc Ther, V6, P447, DOI 10.1586/14779072.6.4.447; Betters JL, 2010, CLIN PHARMACOL THER, V87, P117, DOI 10.1038/clpt.2009.209; Chang TY, 2008, CELL METAB, V7, P469, DOI 10.1016/j.cmet.2008.05.001; Coller KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000702; Davies JP, 2005, J BIOL CHEM, V280, P12710, DOI 10.1074/jbc.M409110200; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Farquhar MJ, 2008, J VIRAL HEPATITIS, V15, P849, DOI 10.1111/j.1365-2893.2008.01051.x; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Grove J, 2007, J VIROL, V81, P3162, DOI 10.1128/JVI.02356-06; Gupta Eric K, 2002, Heart Dis, V4, P399, DOI 10.1097/00132580-200211000-00011; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; Kneteman Norman M., 2009, V510, P383, DOI 10.1007/978-1-59745-394-3_29; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Matsumura T, 2009, GASTROENTEROLOGY, V137, P673, DOI 10.1053/j.gastro.2009.04.048; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Sane AT, 2006, J LIPID RES, V47, P2112, DOI 10.1194/jlr.M600174-JLR200; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Sweeney ME, 2007, EXPERT OPIN DRUG MET, V3, P441, DOI 10.1517/17425255.3.3.441; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Uprichard Susan L., 2010, Virologica Sinica, V25, P227, DOI 10.1007/s12250-010-3134-0; Weinglass AB, 2008, P NATL ACAD SCI USA, V105, P11140, DOI 10.1073/pnas.0800936105; Yamamoto M, 2011, J GEN VIROL, V92, P2082, DOI 10.1099/vir.0.032391-0; Yu LQ, 2008, CURR OPIN LIPIDOL, V19, P263, DOI 10.1097/MOL.0b013e3282f9b563; Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131; Zhang JH, 2011, J BIOL CHEM, V286, P25088, DOI 10.1074/jbc.M111.244475; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06	35	342	353	0	40	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					281	285		10.1038/nm.2581	http://dx.doi.org/10.1038/nm.2581			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22231557	Green Accepted			2022-12-25	WOS:000300140300043
J	Paulsen, CE; Truong, TH; Garcia, FJ; Homann, A; Gupta, V; Leonard, SE; Carroll, KS				Paulsen, Candice E.; Truong, Thu H.; Garcia, Francisco J.; Homann, Arne; Gupta, Vinayak; Leonard, Stephen E.; Carroll, Kate S.			Peroxide-dependent sulfenylation of the EGFR catalytic site enhances kinase activity	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; SULFENIC ACID FORMATION; HYDROGEN-PEROXIDE; REVERSIBLE INACTIVATION; SIGNAL-TRANSDUCTION; REDOX REGULATION; FLUORESCENT; DIMEDONE; PROBES; SRC	Protein sulfenylation is a post-translational modification of emerging importance in higher eukaryotes. However, investigation of its diverse roles remains challenging, particularly within a native cellular environment. Herein we report the development and application of DYn-2, a new chemoselective probe for detecting sulfenylated proteins in human cells. These studies show that epidermal growth factor receptor-mediated signaling results in H2O2 production and oxidation of downstream proteins. In addition, we demonstrate that DYn-2 has the ability to detect differences in sulfenylation rates within the cell, which are associated with differences in target protein localization. We also show that the direct modification of epidermal growth factor receptor by H2O2 at a critical active site cysteine (Cys797) enhances its tyrosine kinase activity. Collectively, our findings reveal sulfenylation as a global signaling mechanism that is akin to phosphorylation and has regulatory implications for other receptor tyrosine kinases and irreversible inhibitors that target oxidant-sensitive cysteines in proteins.	[Paulsen, Candice E.; Leonard, Stephen E.] Univ Michigan, Chem Biol Grad Program, Ann Arbor, MI 48109 USA; [Truong, Thu H.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Garcia, Francisco J.; Homann, Arne; Gupta, Vinayak; Carroll, Kate S.] Scripps Res Inst, Dept Chem, Jupiter, FL USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Scripps Research Institute	Paulsen, CE (corresponding author), Univ Michigan, Chem Biol Grad Program, Ann Arbor, MI 48109 USA.	kcarroll@scripps.edu	Gupta, Vinayak/I-4302-2019	Gupta, Vinayak/0000-0003-1567-1037; Paulsen, Candice/0000-0001-5317-773X; Carroll, Kate/0000-0002-7624-9617	Camille Henry Dreyfus Teacher Scholar Award; American Heart Association [0835419N]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102187] Funding Source: NIH RePORTER	Camille Henry Dreyfus Teacher Scholar Award; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge funding from the Camille Henry Dreyfus Teacher Scholar Award (to K. S. C.) and the American Heart Association Scientist Development Award (0835419N to K. S. C.). The authors also wish to thank R. Petter for helpful discussions.	Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BENITEZ LV, 1974, J BIOL CHEM, V249, P6234; Charles RL, 2007, MOL CELL PROTEOMICS, V6, P1473, DOI 10.1074/mcp.M700065-MCP200; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; Chen CY, 2009, BIOCHEMISTRY-US, V48, P1399, DOI 10.1021/bi801973z; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Cuddihy SL, 2011, ANTIOXID REDOX SIGN, V15, P167, DOI 10.1089/ars.2010.3843; Cunnick JM, 1998, J BIOL CHEM, V273, P14468, DOI 10.1074/jbc.273.23.14468; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; Dickinson BC, 2011, NAT CHEM BIOL, V7, P106, DOI 10.1038/NCHEMBIO.497; Dickinson BC, 2010, J AM CHEM SOC, V132, P5906, DOI 10.1021/ja1014103; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Go YM, 2008, BBA-GEN SUBJECTS, V1780, P1271, DOI 10.1016/j.bbagen.2008.01.011; Kemble DJ, 2009, P NATL ACAD SCI USA, V106, P5070, DOI 10.1073/pnas.0806117106; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Leonard SE, 2011, ANGEW CHEM INT EDIT, V50, P4423, DOI 10.1002/anie.201007871; Leonard SE, 2011, CURR OPIN CHEM BIOL, V15, P88, DOI 10.1016/j.cbpa.2010.11.012; Leonard SE, 2009, ACS CHEM BIOL, V4, P783, DOI 10.1021/cb900105q; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Michalek RD, 2007, J IMMUNOL, V179, P6456, DOI 10.4049/jimmunol.179.10.6456; Miller EW, 2007, NAT CHEM BIOL, V3, P349, DOI 10.1038/nchembio0607-349; Nelson KJ, 2010, METHOD ENZYMOL, V473, P95, DOI 10.1016/S0076-6879(10)73004-4; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Paulsen CE, 2009, CHEM BIOL, V16, P217, DOI 10.1016/j.chembiol.2009.01.003; Poole LB, 2007, BIOCONJUGATE CHEM, V18, P2004, DOI 10.1021/bc700257a; Reddie KG, 2008, MOL BIOSYST, V4, P521, DOI 10.1039/b719986d; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Roos G, 2011, FREE RADICAL BIO MED, V51, P314, DOI 10.1016/j.freeradbiomed.2011.04.031; Seo YH, 2011, ANGEW CHEM INT EDIT, V50, P1342, DOI 10.1002/anie.201007175; Seo YH, 2009, P NATL ACAD SCI USA, V106, P16163, DOI 10.1073/pnas.0903015106; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Singh J, 2010, CURR OPIN CHEM BIOL, V14, P475, DOI 10.1016/j.cbpa.2010.06.168; Takanishi CL, 2011, J PROTEOME RES, V10, P2715, DOI 10.1021/pr1009542; Tang H, 2005, J BIOL CHEM, V280, P23918, DOI 10.1074/jbc.M503498200; Tanner JJ, 2011, ANTIOXID REDOX SIGN, V15, P77, DOI 10.1089/ars.2010.3611; Truong TH, 2011, BIOORG MED CHEM LETT, V21, P5015, DOI 10.1016/j.bmcl.2011.04.115; Wani R, 2011, P NATL ACAD SCI USA, V108, P10550, DOI 10.1073/pnas.1011665108; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009	46	320	326	6	106	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					57	64		10.1038/nchembio.736	http://dx.doi.org/10.1038/nchembio.736			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22158416	Green Accepted			2022-12-25	WOS:000298414100012
J	Roep, B; Buckner, J; Sawcer, S; Toes, R; Zipp, F				Roep, Bart; Buckner, Jane; Sawcer, Stephen; Toes, Rene; Zipp, Frauke			The problems and promises of research into human immunology and autoimmune disease	NATURE MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; CITRULLINATED PROTEIN ANTIBODY; TYPE-1 DIABETES-MELLITUS; PLACEBO-CONTROLLED TRIAL; MULTIPLE-SCLEROSIS; T-CELLS; RHEUMATOID-ARTHRITIS; NEUROMYELITIS-OPTICA; INTERFERON-BETA; LIGAND TRAIL	Translational research in autoimmunity is hampered by a number of hurdles, including a lack of knowledge regarding initiating and pathologically relevant autoantigens, the low frequency of autoreactive pathogenic B and T cells, difficulty in accessing the affected tissue, differences between self-reactive and pathogen-specific lymphocytes, a lack of etiologically relevant preclinical animal models and the heterogeneity of disease presentation. Given the need for biomarkers and new therapeutics, it is imperative that these hurdles be surmounted.	[Roep, Bart] Leiden Univ, Med Ctr, Natl Diabet Expert Ctr, Dept Immunohaematol & Blood Transfus, Leiden, Netherlands; [Buckner, Jane] Benaroya Res Inst, Translat Res Program, Seattle, WA USA; [Sawcer, Stephen] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Toes, Rene] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [Zipp, Frauke] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Univ Med Mainz, Klin & Poliklin Neurol, Mainz, Germany	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Benaroya Research Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Johannes Gutenberg University of Mainz	Roep, B (corresponding author), Leiden Univ, Med Ctr, Natl Diabet Expert Ctr, Dept Immunohaematol & Blood Transfus, Leiden, Netherlands.	boroep@lumc.nl	Zipp, Frauke/C-9968-2015; Roep, Bart/AAD-7609-2021	Zipp, Frauke/0000-0002-1231-1928; Toes, Rene/0000-0002-9618-6414				Aktas O, 2005, NEURON, V46, P421, DOI 10.1016/j.neuron.2005.03.018; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Amagai M, 1999, J AM ACAD DERMATOL, V40, P167, DOI 10.1016/S0190-9622(99)70183-0; Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bos WH, 2010, ANN RHEUM DIS, V69, P490, DOI 10.1136/ard.2008.105759; Bos WH, 2010, ANN RHEUM DIS, V69, P571, DOI 10.1136/ard.2008.105767; Castaldo P, 2011, CURR DRUG METAB, V12, P278, DOI 10.2174/138920011795101840; Clayton DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000540; COPPIETERS KT, J EXP MED IN PRESS; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Davis MM, 2011, NAT REV IMMUNOL, V11, P551, DOI 10.1038/nri3020; De Grijse J, 2010, DIABETOLOGIA, V53, P517, DOI 10.1007/s00125-009-1618-y; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Farina C, 2001, BRAIN, V124, P705, DOI 10.1093/brain/124.4.705; Gale EAM, 2004, LANCET, V363, P925, DOI 10.1016/S0140-6736(04)15786-3; Gibson G, 2010, NAT GENET, V42, P558, DOI 10.1038/ng0710-558; Gillard P, 2009, DIABETES CARE, V32, P1817, DOI 10.2337/dc08-2339; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Halteren AGS, 2005, DIABETOLOGIA, V48, P75, DOI 10.1007/s00125-004-1613-2; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hinson SR, 2008, J EXP MED, V205, P2473, DOI 10.1084/jem.20081241; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Huurman VAL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002435; Ioan-Facsinay A, 2008, ARTHRITIS RHEUM-US, V58, P3000, DOI 10.1002/art.23763; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kaas A, 2010, CLIN EXP IMMUNOL, V161, P444, DOI 10.1111/j.1365-2249.2010.04193.x; Kemppinen A, 2011, BRIEF FUNCT GENOMICS, V10, P61, DOI 10.1093/bfgp/elr004; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Klareskog L, 2006, CURR OPIN IMMUNOL, V18, P650, DOI 10.1016/j.coi.2006.06.004; Leray E, 2010, BRAIN, V133, P1900, DOI 10.1093/brain/awq076; Li N, 2003, J EXP MED, V197, P1501, DOI 10.1084/jem.20022031; Long SA, 2010, DIABETES, V59, P407, DOI 10.2337/db09-0694; Maier LM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000322; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Martin S, 2001, NEW ENGL J MED, V345, P1036, DOI 10.1056/NEJMoa010465; Matthews JB, 2010, CLIN EXP IMMUNOL, V160, P176, DOI 10.1111/j.1365-2249.2010.04153.x; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Naik RG, 2004, J AUTOIMMUN, V23, P55, DOI 10.1016/j.jaut.2004.04.002; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Oksenberg JR, 2010, NAT REV NEUROL, V6, P429, DOI 10.1038/nrneurol.2010.91; Orban T, 2011, LANCET, V378, P412, DOI 10.1016/S0140-6736(11)60886-6; Paul F, 2007, PLOS MED, V4, P669, DOI 10.1371/journal.pmed.0040133; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Petersen LD, 1999, DIABETOLOGIA, V42, P443; Pinkse GGM, 2005, P NATL ACAD SCI USA, V102, P18425, DOI 10.1073/pnas.0508621102; Pollinger B, 2009, J EXP MED, V206, P1303, DOI 10.1084/jem.20090299; Qin OY, 2006, DIABETES, V55, P3068, DOI 10.2337/db06-0065; Reijonen H, 2002, DIABETES, V51, P1375, DOI 10.2337/diabetes.51.5.1375; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Roep BO, 2011, LANCET, V378, P376, DOI 10.1016/S0140-6736(11)60977-X; Roep BO, 2010, NAT REV IMMUNOL, V10, P145, DOI 10.1038/nri2705; Roep BO, 1996, EUR J IMMUNOL, V26, P1285, DOI 10.1002/eji.1830260616; Roep BO, 2004, NAT REV IMMUNOL, V4, P989, DOI 10.1038/nri1502; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sawcer S, 2010, ANN NEUROL, V67, P3, DOI 10.1002/ana.21911; Schulze-Topphoff U, 2009, NAT MED, V15, P788, DOI 10.1038/nm.1980; Sharpe AH, 2006, NEW ENGL J MED, V355, P973, DOI 10.1056/NEJMp068087; Sherry N, 2011, LANCET, V378, P487, DOI 10.1016/S0140-6736(11)60931-8; Siffrin V, 2010, IMMUNITY, V33, P424, DOI 10.1016/j.immuni.2010.08.018; Siffrin V, 2010, TRENDS NEUROSCI, V33, P202, DOI 10.1016/j.tins.2010.01.002; Skyler JS, 2002, NEW ENGL J MED, V346, P1685; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Steinman L, 2006, ANN NEUROL, V60, P12, DOI 10.1002/ana.20913; TOYKA KV, 1975, SCIENCE, V190, P397, DOI 10.1126/science.1179220; Tree TIM, 2006, ANN NY ACAD SCI, V1079, P9, DOI 10.1196/annals.1375.002; Tree TIM, 2010, DIABETES, V59, P1451, DOI 10.2337/db09-0503; Unger WW, 2011, J AUTOIMMUN, V37, P151, DOI 10.1016/j.jaut.2011.05.012; Valle A, 2009, DIABETES, V58, P875, DOI 10.2337/db08-1432; van de Stadt LA, 2011, ARTHRITIS RHEUM-US, V63, P3226, DOI 10.1002/art.30537; van der Helm-van Mil AHM, 2005, ARTHRITIS RES THER, V7, pR949, DOI 10.1186/ar1767; van der Woude D, 2010, ANN RHEUM DIS, V69, P1554, DOI 10.1136/ard.2009.124537; Velthuis JH, 2009, DIABETOLOGIA, V52, P494, DOI 10.1007/s00125-008-1237-z; Velthuis JH, 2010, DIABETES, V59, P1721, DOI 10.2337/db09-1486; Vogt J, 2009, ANN NEUROL, V66, P310, DOI 10.1002/ana.21719; Voltarelli JC, 2007, JAMA-J AM MED ASSOC, V297, P1568, DOI 10.1001/jama.297.14.1568; Wandinger KP, 2003, LANCET, V361, P2036, DOI 10.1016/S0140-6736(03)13641-0; Wessels JAM, 2007, ARTHRITIS RHEUM-US, V56, P1765, DOI 10.1002/art.22640; Willemze A, 2012, ANN RHEUM DIS, V71, P268, DOI 10.1136/annrheumdis-2011-200421; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Wuerfel J, 2004, BRAIN, V127, P111, DOI 10.1093/brain/awh007; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	90	43	54	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					48	53		10.1038/nm.2626	http://dx.doi.org/10.1038/nm.2626			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22227672				2022-12-25	WOS:000299018600027
J	Wekerle, H; Flugel, A; Fugger, L; Schett, G; Serreze, D				Wekerle, Hartmut; Fluegel, Alexander; Fugger, Lars; Schett, Georg; Serreze, David			Autoimmunity's next top models	NATURE MEDICINE			English	Article							MYELIN BASIC-PROTEIN; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; MULTIPLE-SCLEROSIS; T-CELLS; RHEUMATOID-ARTHRITIS; ANIMAL-MODELS; NOD MICE; HEALTHY-INDIVIDUALS; CROSS-REACTIVITY; HUMAN IMMUNOLOGY	Animal models are indispensable for studying disease pathogenesis and discovering new treatments for human organ-specific autoimmune diseases. However, there is a need of more refined paradigms for these models. Ideally, a small-animal model should represent the clinical features of human disease in their entirety. Disease in the animals should develop spontaneously, should be followed over an extended period of time and should involve the genetic, molecular and cellular elements that contribute to human pathogenesis.	[Wekerle, Hartmut] Max Planck Inst Neurobiol, Dept Neuroimmunol, Munich, Germany; [Fluegel, Alexander] Inst Multiple Sclerosis Res, Dept Neuroimmunol, Gottingen, Germany; [Fugger, Lars] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DU, England; [Fugger, Lars] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Schett, Georg] Univ Erlangen Nurnberg, Inst Clin Immunol, Dept Internal Med 3, Erlangen, Germany; [Serreze, David] Jackson Lab, Dept Immunol Inflammat & Hematol, Bar Harbor, ME 04609 USA	Max Planck Society; University of Oxford; University of Oxford; University of Erlangen Nuremberg; Jackson Laboratory	Wekerle, H (corresponding author), Max Planck Inst Neurobiol, Dept Neuroimmunol, Munich, Germany.	hwekerle@neuro.mpg.de			Medical Research Council [G1000800i] Funding Source: researchfish; Medical Research Council [G1000800I] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Bach JF, 2001, ANNU REV IMMUNOL, V19, P131, DOI 10.1146/annurev.immunol.19.1.131; Bajramovic J., 2008, DRUG DISCOV TODAY, V5, P97, DOI [DOI 10.1016/J.DDMOD.2008.06.001, 10.1016/j.ddmod.2008.06.001]; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; BENNUN A, 1981, EUR J IMMUNOL, V11, P195, DOI 10.1002/eji.1830110307; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Bevaart L, 2010, ARTHRITIS RHEUM-US, V62, P2192, DOI 10.1002/art.27503; Billiau A, 2001, J LEUKOCYTE BIOL, V70, P849; BRENNAN FM, 1989, LANCET, V2, P244; Cayrol R, 2008, NAT IMMUNOL, V9, P137, DOI 10.1038/ni1551; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Cho JH, 2011, NEW ENGL J MED, V365, P1612, DOI 10.1056/NEJMra1100030; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Fabriek BO, 2005, J NEUROIMMUNOL, V161, P190, DOI 10.1016/j.jneuroim.2004.12.018; Flugel A, 1999, NAT MED, V5, P843, DOI 10.1038/10567; GENAIN CP, 1994, J CLIN INVEST, V94, P1339, DOI 10.1172/JCI117454; Gregersen JW, 2006, NATURE, V443, P574, DOI 10.1038/nature05133; Harkiolaki M, 2009, IMMUNITY, V30, P348, DOI 10.1016/j.immuni.2009.01.009; Jarchum I, 2007, DIABETES, V56, P2551, DOI 10.2337/db07-0332; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Kollias G, 2011, ANN RHEUM DIS, V70, P1357, DOI 10.1136/ard.2010.148551; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; LAMPETER EF, 1993, LANCET, V341, P1243, DOI 10.1016/0140-6736(93)91148-F; Lang HLE, 2002, NAT IMMUNOL, V3, P940, DOI 10.1038/ni835; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; LININGTON C, 1988, AM J PATHOL, V130, P443; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; MARTIN R, 1990, J IMMUNOL, V145, P540; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Meinl E, 1997, AM J PATHOL, V150, P445; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Nossal GJV, 2001, NATURE, V412, P685, DOI 10.1038/35089152; PETTE M, 1990, NEUROLOGY, V40, P1770, DOI 10.1212/WNL.40.11.1770; Pollinger B, 2009, J EXP MED, V206, P1303, DOI 10.1084/jem.20090299; Polychronakos C, 2011, NAT REV GENET, V12, P781, DOI 10.1038/nrg3069; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; SCHLUESENER HJ, 1985, J IMMUNOL, V135, P3128; Serreze DV, 2005, TRENDS IMMUNOL, V26, P603, DOI 10.1016/j.it.2005.08.012; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Steinman L, 2005, TRENDS IMMUNOL, V26, P565, DOI 10.1016/j.it.2005.08.014; Takaki T, 2006, J IMMUNOL, V176, P3257, DOI 10.4049/jimmunol.176.5.3257; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; WEKERLE H, 1986, TRENDS NEUROSCI, V9, P271, DOI 10.1016/0166-2236(86)90077-9; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wiendl H, 2009, NEUROLOGY, V72, P1008, DOI 10.1212/01.wnl.0000344417.42972.54; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253	50	36	45	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					66	70		10.1038/nm.2635	http://dx.doi.org/10.1038/nm.2635			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22227675				2022-12-25	WOS:000299018600030
J	Chambers, SM; Qi, YC; Mica, Y; Lee, G; Zhang, XJ; Niu, L; Bilsland, J; Cao, LS; Stevens, E; Whiting, P; Shi, SH; Studer, L				Chambers, Stuart M.; Qi, Yuchen; Mica, Yvonne; Lee, Gabsang; Zhang, Xin-Jun; Niu, Lei; Bilsland, James; Cao, Lishuang; Stevens, Edward; Whiting, Paul; Shi, Song-Hai; Studer, Lorenz			Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors	NATURE BIOTECHNOLOGY			English	Article							SENSORY NEURON DEVELOPMENT; FATE SPECIFICATION; SODIUM-CHANNELS; HUMAN ES; CREST; DIFFERENTIATION; RECEPTOR; DISTINCT; NEUROGENESIS; DERIVATION	Considerable progress has been made in identifying signaling pathways that direct the differentiation of human pluripotent stem cells (hPSCs) into specialized cell types, including neurons. However, differentiation of hPSCs with extrinsic factors is a slow, step-wise process, mimicking the protracted timing of human development. Using a small-molecule screen, we identified a combination of five small-molecule pathway inhibitors that yield hPSC-derived neurons at >75% efficiency within 10 d of differentiation. The resulting neurons express canonical markers and functional properties of human nociceptors, including tetrodotoxin (TTX)-resistant, SCN10A-dependent sodium currents and response to nociceptive stimuli such as ATP and capsaicin. Neuronal fate acquisition occurs about threefold faster than during in vivo development(1), suggesting that use of small-molecule pathway inhibitors could become a general strategy for accelerating developmental timing in vitro. The quick and high-efficiency derivation of nociceptors offers unprecedented access to this medically relevant cell type for studies of human pain.	[Chambers, Stuart M.; Qi, Yuchen; Mica, Yvonne; Lee, Gabsang; Studer, Lorenz] Sloan Kettering Inst, Ctr Stem Cell Biol, New York, NY USA; [Chambers, Stuart M.; Qi, Yuchen; Mica, Yvonne; Lee, Gabsang; Zhang, Xin-Jun; Niu, Lei; Shi, Song-Hai; Studer, Lorenz] Sloan Kettering Inst, Dev Biol Program, New York, NY USA; [Qi, Yuchen] Cornell Univ, Weill Cornell Grad Sch Med Sci, New York, NY 10021 USA; [Mica, Yvonne] Gerstner Sloan Kettering Grad Sch Biomed Sci, Sloan Kettering Inst, New York, NY USA; [Bilsland, James; Cao, Lishuang; Stevens, Edward; Whiting, Paul] Pfizer Global Res & Dev, Neusentis, Cambridge, England; [Studer, Lorenz] Sloan Kettering Inst, Dept Neurosurg, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; Pfizer; Memorial Sloan Kettering Cancer Center	Studer, L (corresponding author), Sloan Kettering Inst, Ctr Stem Cell Biol, New York, NY USA.	chambers@mskcc.org; studerl@mskcc.org	Niu, Lei/G-5066-2012; Studer, Lorenz/ABH-1491-2021; Zhang, Xin-Jun/O-2994-2013	Studer, Lorenz/0000-0003-0741-7987; Whiting, Paul/0000-0002-4121-1379; Qi, Yuchen/0000-0003-2036-9852; Zhang, Xin-Jun/0000-0002-0846-0584	National Institute of Neurological Disorders and Stroke/US National Institutes of Health (NIH) [NS066390]; New York State Stem Cell Science (NYSTEM) [C026447]; National Institute on Drug Abuse/NIH [R01DA024681]; National Institute of Mental Health/NIH [PO1NS048120]; NYSTEM [C026399]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066390, P01NS048120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024681] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke/US National Institutes of Health (NIH); New York State Stem Cell Science (NYSTEM); National Institute on Drug Abuse/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NYSTEM; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Hendrikx (SKI Flow Cytometry Core lab), A. Viale (SKI Genomics Core lab), E. Tu (SKI stem cell facility), and M. Tomishima (SKI stem cell facility) for excellent technical support. We also thank R. McKernan for support of functional analysis, M. Postlethwaite for assistance with electrophysiology, C. Benn for help in gene expression analysis and S. Kriks for assistance with hPSC culturing. The work was supported in part through grants NS066390 from National Institute of Neurological Disorders and Stroke/US National Institutes of Health (NIH) and C026447 from New York State Stem Cell Science (NYSTEM) to L.S., R01DA024681 from the National Institute on Drug Abuse/NIH to S.-H.S., PO1NS048120 from the National Institute of Mental Health/NIH to S.-H.S., and C026399 from NYSTEM to S.M.C.	Aoki Y, 2003, DEV BIOL, V259, P19, DOI 10.1016/S0012-1606(03)00161-1; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Bystron I, 2006, NAT NEUROSCI, V9, P880, DOI 10.1038/nn1726; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Cornell RA, 2002, DEVELOPMENT, V129, P2639; Dib-Hajj SD, 1999, FEBS LETT, V462, P117, DOI 10.1016/S0014-5793(99)01519-7; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Fasano CA, 2010, CELL STEM CELL, V6, P336, DOI 10.1016/j.stem.2010.03.001; Gascon E, 2010, J NEUROSCI, V30, P12414, DOI 10.1523/JNEUROSCI.3135-10.2010; George L, 2007, NAT NEUROSCI, V10, P1287, DOI 10.1038/nn1962; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; GERRERO MR, 1993, P NATL ACAD SCI USA, V90, P10841, DOI 10.1073/pnas.90.22.10841; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Ibanez CF, 2007, NEURON, V54, P673, DOI 10.1016/j.neuron.2007.05.023; Jarvis MF, 2002, P NATL ACAD SCI USA, V99, P17179, DOI 10.1073/pnas.252537299; Kim DS, 2010, STEM CELL REV REP, V6, P270, DOI 10.1007/s12015-010-9138-1; Kitao Y, 1996, J COMP NEUROL, V371, P249, DOI 10.1002/(SICI)1096-9861(19960722)371:2<249::AID-CNE5>3.0.CO;2-2; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; North R Alan, 2003, Curr Opin Investig Drugs, V4, P833; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Placantonakis DG, 2009, STEM CELLS, V27, P521, DOI 10.1634/stemcells.2008-0884; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Schlosser G, 2000, J COMP NEUROL, V418, P121; Schlosser G, 2006, DEV BIOL, V294, P303, DOI 10.1016/j.ydbio.2006.03.009; Sun L, 1999, J MED CHEM, V42, P5120, DOI 10.1021/jm9904295; Sun YF, 2008, NAT NEUROSCI, V11, P1283, DOI 10.1038/nn.2209; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016; Yoshikawa M, 2007, DEV BIOL, V303, P663, DOI 10.1016/j.ydbio.2006.12.007; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Zhang XQ, 2010, METHODS MOL BIOL, V584, P355, DOI 10.1007/978-1-60761-369-5_19; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017; Zhou JX, 2010, STEM CELLS, V28, P1741, DOI 10.1002/stem.504	45	359	376	1	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					715	+		10.1038/nbt.2249	http://dx.doi.org/10.1038/nbt.2249			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22750882	Green Accepted			2022-12-25	WOS:000306293400031
J	Kentsis, A; Reed, C; Rice, KL; Sanda, T; Rodig, SJ; Tholouli, E; Christie, A; Valk, PJM; Delwel, R; Ngo, V; Kutok, JL; Dahlberg, SE; Moreau, LA; Byers, RJ; Christensen, JG; Woude, GV; Licht, JD; Kung, AL; Staudt, LM; Look, AT				Kentsis, Alex; Reed, Casie; Rice, Kim L.; Sanda, Takaomi; Rodig, Scott J.; Tholouli, Eleni; Christie, Amanda; Valk, Peter J. M.; Delwel, Ruud; Vu Ngo; Kutok, Jeffery L.; Dahlberg, Suzanne E.; Moreau, Lisa A.; Byers, Richard J.; Christensen, James G.; Woude, George Vande; Licht, Jonathan D.; Kung, Andrew L.; Staudt, Louis M.; Look, A. Thomas			Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia	NATURE MEDICINE			English	Article							CANCER-CELLS; INHIBITOR; SCREEN; AML; CLASSIFICATION; PATHWAYS; TARGETS; FLT3	Although the treatment of acute myeloid leukemia (AML) has improved substantially in the past three decades, more than half of all patients develop disease that is refractory to intensive chemotherapy(1,2). Functional genomics approaches offer a means to discover specific molecules mediating the aberrant growth and survival of cancer cells(3-8). Thus, using a loss-of-function RNA interference genomic screen, we identified the aberrant expression of hepatocyte growth factor (HGF) as a crucial element in AML pathogenesis. We found HGF expression leading to autocrine activation of its receptor tyrosine kinase, MET, in nearly half of the AML cell lines and clinical samples we studied. Genetic depletion of HGF or MET potently inhibited the growth and survival of HGF-expressing AML cells. However, leukemic cells treated with the specific MET kinase inhibitor crizotinib developed resistance resulting from compensatory upregulation of HGF expression, leading to the restoration of MET signaling. In cases of AML where MET is coactivated with other tyrosine kinases, such as fibroblast growth factor receptor 1 (FGFR1)(9), concomitant inhibition of FGFR1 and MET blocked this compensatory HGF upregulation, resulting in sustained logarithmic cell killing both in vitro and in xenograft models in vivo. Our results show a widespread dependence of AML cells on autocrine activation of MET, as well as the key role of compensatory upregulation of HGF expression in maintaining leukemogenic signaling by this receptor. We anticipate that these findings will lead to the design of additional strategies to block adaptive cellular responses that drive compensatory ligand expression as an essential component of the targeted inhibition of oncogenic receptors in human cancers.	[Kentsis, Alex; Reed, Casie; Sanda, Takaomi; Christie, Amanda; Moreau, Lisa A.; Kung, Andrew L.; Look, A. Thomas] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Kentsis, Alex; Reed, Casie; Sanda, Takaomi; Christie, Amanda; Moreau, Lisa A.; Kung, Andrew L.; Look, A. Thomas] Harvard Univ, Sch Med, Childrens Hosp Boston, Div Hematol & Oncol, Boston, MA USA; [Rice, Kim L.; Licht, Jonathan D.] Northwestern Univ, Feinberg Sch Med, Div Hematol & Oncol, Chicago, IL 60611 USA; [Rodig, Scott J.; Kutok, Jeffery L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Tholouli, Eleni; Byers, Richard J.] Cent Manchester Univ Hosp Natl Hlth Serv Fdn Trus, Manchester Royal Infirm, Dept Haematol, Manchester, Lancs, England; [Tholouli, Eleni; Byers, Richard J.] Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Christie, Amanda; Kung, Andrew L.] Dana Farber Canc Inst, Lurie Family Imaging Ctr, Boston, MA 02115 USA; [Valk, Peter J. M.; Delwel, Ruud] Erasmus MC, Dept Hematol, Rotterdam, Netherlands; [Vu Ngo] City Hope Natl Med Ctr, Div Hematopoiet Stem Cell & Leukemia Res, Duarte, CA 91010 USA; [Dahlberg, Suzanne E.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Byers, Richard J.] Univ Manchester, Fac Med & Human Sci, Sch Canc & Enabling Sci, Manchester, Lancs, England; [Christensen, James G.] Pfizer Global Res & Dev, Dept Res Pharmacol, La Jolla, CA USA; [Woude, George Vande] Van Andel Res Inst, Dept Mol Oncol, Grand Rapids, MI USA; [Staudt, Louis M.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Northwestern University; Feinberg School of Medicine; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Manchester; University of Manchester; Harvard University; Dana-Farber Cancer Institute; Erasmus University Rotterdam; Erasmus MC; City of Hope; Harvard University; Dana-Farber Cancer Institute; University of Manchester; Pfizer; Van Andel Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Look, AT (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA.	thomas_look@dfci.harvard.edu	Staudt, Louis/AAC-5324-2019; Valk, Peter/AAX-2823-2020; Kung, Andrew L/AEU-0826-2022; Kung, Andrew/AAL-2384-2020; Rodig, Scott/Y-3889-2019; Licht, Jonathan/L-4239-2019; Licht, Jonathan/AAL-9184-2020; Dahlberg, Suzanne/L-2622-2019	Kung, Andrew L/0000-0002-9091-488X; Licht, Jonathan/0000-0002-3942-1369; Dahlberg, Suzanne/0000-0001-5139-831X; Ngo, Vu/0000-0002-9501-6990; Byers, Richard/0000-0003-0796-0365; Kentsis, Alex/0000-0002-8063-9191	US National Institutes of Health grant [K08CA160660]; William Lawrence and Blanche Hughes Foundation; Samuel Waxman Cancer Research Foundation; V Foundation; Intramural Research Program of the National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011007, K08CA160660] Funding Source: NIH RePORTER	US National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Lawrence and Blanche Hughes Foundation; Samuel Waxman Cancer Research Foundation; V Foundation; Intramural Research Program of the National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Gutierrez, M. Mansour and E. Gjini for critical discussions and J. Gilbert for editorial advice. This research was supported by the US National Institutes of Health grant K08CA160660 (A.K.), the William Lawrence and Blanche Hughes Foundation (T.S.), the Samuel Waxman Cancer Research Foundation (J.D.L.), the V Foundation (A.T.L.) and the Intramural Research Program of the National Cancer Institute, Center for Cancer Research (L.M.S.).	Armstrong SA, 2003, CANCER CELL, V3, P173, DOI 10.1016/S1535-6108(03)00003-5; Bernards R, 2006, NAT METHODS, V3, P701, DOI 10.1038/NMETH921; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; CHEN W, 1989, LEUKEMIA, V3, P264; Grimwade D, 2001, BLOOD, V98, P1312, DOI 10.1182/blood.V98.5.1312; Gu TL, 2006, BLOOD, V108, P4202, DOI 10.1182/blood-2006-06-026666; Haq R, 2002, CANCER RES, V62, P5076; Heinrichs S, 2009, LEUKEMIA, V23, P1605, DOI 10.1038/leu.2009.82; Loriaux MM, 2008, BLOOD, V111, P4788, DOI 10.1182/blood-2007-07-101394; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; Mathew P, 2001, NEOPLASIA, V3, P105, DOI 10.1038/sj.neo.7900146; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Sato T, 2011, BLOOD, V117, P3286, DOI 10.1182/blood-2010-01-266742; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; SPORN MB, 1980, NEW ENGL J MED, V303, P878, DOI 10.1056/NEJM198010093031511; Turner NC, 2008, EMBO J, V27, P1368, DOI 10.1038/emboj.2008.61; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Westbrook TF, 2005, COLD SH Q B, V70, P435, DOI 10.1101/sqb.2005.70.031; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Zheng R, 2004, LEUKEMIA RES, V28, P121, DOI 10.1016/S0145-2126(03)00184-X; Zhou JB, 2009, BLOOD, V113, P4052, DOI 10.1182/blood-2008-05-156422; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443	25	137	150	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2012	18	7					1118	+		10.1038/nm.2819	http://dx.doi.org/10.1038/nm.2819			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22683780	Green Accepted, Green Submitted			2022-12-25	WOS:000306121600042
J	Pena-LlopiS, S; Vega-Rubin-De-Celis, S; Liao, A; Leng, N; Pavia-Jimenez, A; Wang, S; Yamasaki, T; Zhrebker, L; Sivanand, S; Spence, P; Kinch, L; Hambuch, T; Jain, S; Lotan, Y; Margulis, V; Sagalowsky, AI; Summerour, PB; Kabbani, W; Wong, SWW; Grishin, N; Laurent, M; Xie, XJ; Haudenschild, CD; Ross, MT; Bentley, DR; Kapur, P; Brugarolas, J				Pena-LlopiS, Samuel; Vega-Rubin-de-Celis, Silvia; Liao, Arnold; Leng, Nan; Pavia-Jimenez, Andrea; Wang, Shanshan; Yamasaki, Toshinari; Zhrebker, Leah; Sivanand, Sharanya; Spence, Patrick; Kinch, Lisa; Hambuch, Tina; Jain, Suneer; Lotan, Yair; Margulis, Vitaly; Sagalowsky, Arthur I.; Summerour, Pia Banerji; Kabbani, Wareef; Wong, S. W. Wendy; Grishin, Nick; Laurent, Marc; Xie, Xian-Jin; Haudenschild, Christian D.; Ross, Mark T.; Bentley, David R.; Kapur, Payal; Brugarolas, James			BAP1 loss defines a new class of renal cell carcinoma	NATURE GENETICS			English	Article							BRCA1-ASSOCIATED PROTEIN-1; OCULOCUTANEOUS ALBINISM; UBIQUITIN HYDROLASE; SOMATIC MUTATIONS; FREQUENT MUTATION; TUMOR-SUPPRESSOR; GENE-EXPRESSION; FACTOR-I; P-GENE; COMPLEX	The molecular pathogenesis of renal cell carcinoma (RCC) is poorly understood. Whole-genome and exome sequencing followed by innovative tumorgraft analyses (to accurately determine mutant allele ratios) identified several putative two-hit tumor suppressor genes, including BAP1. The BAP1 protein, a nuclear deubiquitinase, is inactivated in 15% of clear cell RCCs. BAP1 cofractionates with and binds to HCF-1 in tumorgrafts. Mutations disrupting the HCF-1 binding motif impair BAP1-mediated suppression of cell proliferation but not deubiquitination of monoubiquitinated histone 2A lysine 119 (H2AK119ub1). BAP1 loss sensitizes RCC cells in vitro to genotoxic stress. Notably, mutations in BAP1 and PBRM1 anticorrelate in tumors (P = 3 x 10(-5)), and combined loss of BAP1 and PBRM1 in a few RCCs was associated with rhabdoid features (q = 0.0007). BAP1 and PBRM1 regulate seemingly different gene expression programs, and BAP1 loss was associated with high tumor grade (q = 0.0005). Our results establish the foundation for an integrated pathological and molecular genetic classification of RCC, paving the way for subtype-specific treatments exploiting genetic vulnerabilities.	[Vega-Rubin-de-Celis, Silvia; Pavia-Jimenez, Andrea; Wang, Shanshan; Yamasaki, Toshinari; Sivanand, Sharanya; Spence, Patrick; Brugarolas, James] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Pena-LlopiS, Samuel; Vega-Rubin-de-Celis, Silvia; Pavia-Jimenez, Andrea; Wang, Shanshan; Yamasaki, Toshinari; Zhrebker, Leah; Sivanand, Sharanya; Brugarolas, James] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Pena-LlopiS, Samuel; Vega-Rubin-de-Celis, Silvia; Pavia-Jimenez, Andrea; Wang, Shanshan; Yamasaki, Toshinari; Zhrebker, Leah; Sivanand, Sharanya; Spence, Patrick; Summerour, Pia Banerji; Xie, Xian-Jin; Brugarolas, James] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Liao, Arnold; Leng, Nan; Hambuch, Tina; Jain, Suneer; Laurent, Marc; Haudenschild, Christian D.] Illumina Inc, San Diego, CA USA; [Kinch, Lisa; Grishin, Nick] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Lotan, Yair; Margulis, Vitaly; Sagalowsky, Arthur I.] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA; [Summerour, Pia Banerji] Univ Texas SW Med Ctr Dallas, Dept Clin Genet, Dallas, TX 75390 USA; [Kabbani, Wareef; Kapur, Payal] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Wong, S. W. Wendy; Ross, Mark T.; Bentley, David R.] Illumina Cambridge Ltd, Saffron Walden, England	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Illumina; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Illumina	Brugarolas, J (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	james.brugarolas@utsouthwestern.edu	Peña-Llopis, Samuel/ABH-2358-2020	Sivanand, Sharanya/0000-0002-2559-9270; Pena-Llopis, Samuel/0000-0003-3847-1353; Brugarolas, James/0000-0002-8575-499X; Kinch, Lisa/0000-0003-3041-2615	Generalitat Valenciana [BPOSTDOC06/004]; Cancer Prevention and Research Institute of Texas [RP101075]; Doris Duke Charitable Foundation; American Cancer Society [115739]; US. National Institutes of Health [RO1 CA129387]; US National Cancer Institute (NCI) [1P30CA142543]; NATIONAL CANCER INSTITUTE [P30CA142543, R01CA129387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094575] Funding Source: NIH RePORTER	Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Cancer Prevention and Research Institute of Texas; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); American Cancer Society(American Cancer Society); US. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We recognize the individuals who participated in the study and who donated samples. We thank O. Sepulveda, A. Husain and A. Yadlapalli for technical support, S. Cohenour and D. Sheppard for assistance with contracts and regulatory considerations, Y. Machida (Mayo Clinic) for providing plasmids, B. Grossman (MD Anderson Cancer Center) for providing the UMRC cells, C. Camacho and N. Tomimatsu for irradiating cells, and the staff of the UT Southwestern Tissue Resource. This work was supported by a fellowship of excellence from Generalitat Valenciana (BPOSTDOC06/004 to S.P.-L.) and by the following awards to J.B.: a grant from the Cancer Prevention and Research Institute of Texas (RP101075), a Clinical Scientist Development Award from the Doris Duke Charitable Foundation, an American Cancer Society Research Scholar grant (115739) and a grant from the US. National Institutes of Health (RO1 CA129387). The tissue management shared resource is supported in part by the US National Cancer Institute (NCI) (1P30CA142543). J.B. is a Virginia Murchison Linthicum Scholar in Medical Research at UT Southwestern. The content herein is solely the responsibility of the authors and does not represent the official views of any of the granting agencies.	Abdel-Rahman MH, 2011, J MED GENET, V48, P856, DOI 10.1136/jmedgenet-2011-100156; Baldewijns MML, 2008, BBA-REV CANCER, V1785, P133, DOI 10.1016/j.bbcan.2007.12.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Bott M, 2011, NAT GENET, V43, P668, DOI 10.1038/ng.855; BRETHEAU D, 1995, CANCER, V76, P2543, DOI 10.1002/1097-0142(19951215)76:12<2543::AID-CNCR2820761221>3.0.CO;2-S; Brugarolas J, 2007, NEW ENGL J MED, V356, P185, DOI 10.1056/NEJMe068263; Brugarolas J, 2012, RENAL CELL CARCINOMA: TRANSLATIONAL BIOLOGY, PERSONALIZED MEDICINE, AND NOVEL THERAPEUTIC TARGETS, P161, DOI 10.1007/978-1-4614-2400-0_8; Chapman-Fredricks JR, 2011, ANN DIAGN PATHOL, V15, P333, DOI 10.1016/j.anndiagpath.2011.03.002; Chen M, 2009, INT J CANCER, V125, P2342, DOI 10.1002/ijc.24642; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Eletr ZM, 2011, CELL BIOCHEM BIOPHYS, V60, P3, DOI 10.1007/s12013-011-9184-6; Ficarra V, 2010, EUR UROL, V58, P655, DOI 10.1016/j.eururo.2010.08.001; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gasparre G, 2011, BBA-BIOENERGETICS, V1807, P633, DOI 10.1016/j.bbabio.2010.08.006; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gokden N, 2000, AM J SURG PATHOL, V24, P1329; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; HAHN SA, 1995, CANCER RES, V55, P4670; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Kaelin WG, 2012, RENAL CELL CARCINOMA: TRANSLATIONAL BIOLOGY, PERSONALIZED MEDICINE, AND NOVEL THERAPEUTIC TARGETS, P27, DOI 10.1007/978-1-4614-2400-0_2; Knez J, 2006, MOL CELL BIOCHEM, V288, P79, DOI 10.1007/s11010-006-9122-x; Kristie TM, 2010, BBA-GENE REGUL MECH, V1799, P257, DOI 10.1016/j.bbagrm.2009.08.003; Kucejova B, 2011, MOL CANCER RES, V9, P1255, DOI 10.1158/1541-7786.MCR-11-0302; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; LEE ST, 1994, NEW ENGL J MED, V330, P529, DOI 10.1056/NEJM199402243300803; Liang Y, 2009, NAT MED, V15, P1312, DOI 10.1038/nm.2051; Machida YJ, 2009, J BIOL CHEM, V284, P34179, DOI 10.1074/jbc.M109.046755; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Narayanan A, 2007, P NATL ACAD SCI USA, V104, P10835, DOI 10.1073/pnas.0704351104; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Nishikawa H, 2009, CANCER RES, V69, P111, DOI 10.1158/0008-5472.CAN-08-3355; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pantuck AJ, 2007, CANCER-AM CANCER SOC, V109, P2257, DOI 10.1002/cncr.22677; Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sivanand S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003643; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Suzuki T, 2003, J INVEST DERMATOL, V120, P781, DOI 10.1046/j.1523-1747.2003.12127.x; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Ventii KH, 2008, CANCER RES, V68, P6953, DOI 10.1158/0008-5472.CAN-08-0365; Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yu H, 2010, MOL CELL BIOL, V30, P5071, DOI 10.1128/MCB.00396-10	58	639	653	5	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2012	44	7					751	U174		10.1038/ng.2323	http://dx.doi.org/10.1038/ng.2323			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967DP	22683710	Green Accepted			2022-12-25	WOS:000305886900007
J	Simpson, JC; Joggerst, B; Laketa, V; Verissimo, F; Cetin, C; Erfle, H; Bexiga, MG; Singan, VR; Heriche, JK; Neumann, B; Mateos, A; Blake, J; Bechtel, S; Benes, V; Wiemann, S; Ellenberg, J; Pepperkok, R				Simpson, Jeremy C.; Joggerst, Brigitte; Laketa, Vibor; Verissimo, Fatima; Cetin, Cihan; Erfle, Holger; Bexiga, Mariana G.; Singan, Vasanth R.; Heriche, Jean-Karim; Neumann, Beate; Mateos, Alvaro; Blake, Jonathon; Bechtel, Stephanie; Benes, Vladimir; Wiemann, Stefan; Ellenberg, Jan; Pepperkok, Rainer			Genome-wide RNAi screening identifies human proteins with a regulatory function in the early secretory pathway	NATURE CELL BIOLOGY			English	Article							COPII VESICLE FORMATION; TO-GOLGI TRANSPORT; ENDOPLASMIC-RETICULUM; MOLECULAR-MECHANISMS; MAMMALIAN-CELLS; GLOBAL ANALYSIS; RAB GTPASE; TRAFFICKING; REVEALS; LOCALIZATION	The secretory pathway in mammalian cells has evolved to facilitate the transfer of cargo molecules to internal and cell surface membranes. Use of automated microscopy-based genome-wide RNA interference screens in cultured human cells allowed us to identify 554 proteins influencing secretion. Cloning, fluorescent-tagging and subcellular localization analysis of 179 of these proteins revealed that more than two-thirds localize to either the cytoplasm or membranes of the secretory and endocytic pathways. The depletion of 143 of them resulted in perturbations in the organization of the COPII and/or COPI vesicular coat complexes of the early secretory pathway, or the morphology of the Golgi complex. Network analyses revealed a so far unappreciated link between early secretory pathway function, small GTP-binding protein regulation, actin cytoskeleton organization and EGF-receptor-mediated signalling. This work provides an important resource for an integrative understanding of global cellular organization and regulation of the secretory pathway in mammalian cells.	[Simpson, Jeremy C.; Bexiga, Mariana G.; Singan, Vasanth R.] Natl Univ Ireland Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 4, Ireland; [Simpson, Jeremy C.; Bexiga, Mariana G.; Singan, Vasanth R.] Natl Univ Ireland Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland; [Joggerst, Brigitte; Laketa, Vibor; Verissimo, Fatima; Cetin, Cihan; Erfle, Holger; Mateos, Alvaro; Ellenberg, Jan; Pepperkok, Rainer] EMBL, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Heriche, Jean-Karim; Neumann, Beate; Ellenberg, Jan] EMBL, MitoCheck Project Grp, D-69117 Heidelberg, Germany; [Blake, Jonathon; Benes, Vladimir] EMBL, Gene Core, D-69117 Heidelberg, Germany; [Bechtel, Stephanie; Wiemann, Stefan] German Canc Res Ctr, Div Mol Genome Anal, D-69120 Heidelberg, Germany	University College Dublin; University College Dublin; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ)	Simpson, JC (corresponding author), Natl Univ Ireland Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 4, Ireland.	jeremy.simpson@ucd.ie; pepperko@embl.de	Ellenberg, Jan/I-4688-2014; Wiemann, Stefan/E-4424-2013	Ellenberg, Jan/0000-0001-5909-701X; Wiemann, Stefan/0000-0003-4683-3174; Singan, Vasanth/0000-0002-9983-5707; Benes, Vladimir/0000-0002-0352-2547; Simpson, Jeremy/0000-0002-7956-7805; Godinho Bexiga, Mariana/0000-0003-2906-4975; Pepperkok, Rainer/0000-0002-9762-3583; Neumann, Beate/0000-0002-6899-502X; Heriche, Jean-Karim/0000-0001-6867-9425; Laketa, Vibor/0000-0002-9472-2738	MitoCheck consortium by European Commission [FP6-503464]; Federal Ministry of Education and Research (BMBF) in the framework of the National Genome Research Network (NGFN) (NGFN-2 SMP-RNAi) [FKZ01GR0403]; EU; Spanish Ministry of Education and Science (MEC); Science Foundation Ireland (SFI) [09/IN.1/B2604]; BMBF NGFN2 SMP-Cell; Baden Wurttemberg Stiftung, Germany, Programme 'siRNA'; NGFN-Plus IG-CSG	MitoCheck consortium by European Commission; Federal Ministry of Education and Research (BMBF) in the framework of the National Genome Research Network (NGFN) (NGFN-2 SMP-RNAi)(Federal Ministry of Education & Research (BMBF)); EU(European Commission); Spanish Ministry of Education and Science (MEC)(Spanish Government); Science Foundation Ireland (SFI)(Science Foundation Ireland); BMBF NGFN2 SMP-Cell(Federal Ministry of Education & Research (BMBF)); Baden Wurttemberg Stiftung, Germany, Programme 'siRNA'; NGFN-Plus IG-CSG	We thank OSIS, Olympus Europe and the ALMF team at EMBL, Heidelberg for support. In addition, we acknowledge technical and bioinformatic help from J. Bulkescher, C. Conrad, U. Liebel, P. Rogers, C. Tischer and T. Walter. This project was financially supported by grants to J.E. within the MitoCheck consortium by the European Commission (FP6-503464) as well as by the Federal Ministry of Education and Research (BMBF) in the framework of the National Genome Research Network (NGFN) (NGFN-2 SMP-RNAi, FKZ01GR0403); and R.P. and S.W. (BMBF NGFN2 SMP-Cell and NGFN-Plus IG-CSG); and R.P. (Baden Wurttemberg Stiftung, Germany, Programme 'siRNA'). The R.P. laboratory is also supported by the EU-funded network of excellence 'Systems Microscopy'. A.M. was supported by a fellowship of the programme of Becas de Especializacion en Organismos Internacionales of the Spanish Ministry of Education and Science (MEC). The J.C.S. laboratory is supported by a Principal Investigator (PI) award (09/IN.1/B2604) from Science Foundation Ireland (SFI).	Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Beck R, 2009, FEBS LETT, V583, P2701, DOI 10.1016/j.febslet.2009.07.032; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Belgareh-Touze N, 2003, TRAFFIC, V4, P607, DOI 10.1034/j.1600-0854.2003.00116.x; Berg TJ, 2010, J BIOL CHEM, V285, P35255, DOI 10.1074/jbc.M110.129916; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Chuang YY, 2007, J CELL SCI, V120, P1927, DOI 10.1242/jcs.03456; Dejgaard SY, 2008, J CELL SCI, V121, P2768, DOI 10.1242/jcs.021808; Farhan H, 2011, J CELL SCI, V124, P171, DOI 10.1242/jcs.076455; Farhan H, 2010, J CELL BIOL, V189, P997, DOI 10.1083/jcb.200912082; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Gordon DE, 2010, TRAFFIC, V11, P1191, DOI 10.1111/j.1600-0854.2010.01087.x; Gougeon PY, 2002, J BIOL CHEM, V277, P36408, DOI 10.1074/jbc.M205026200; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Gurkan C, 2005, MOL BIOL CELL, V16, P3847, DOI 10.1091/mbc.E05-01-0062; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hutt DM, 2000, J BIOL CHEM, V275, P18511, DOI 10.1074/jbc.M909309199; Iinuma T, 2009, J CELL SCI, V122, P1680, DOI 10.1242/jcs.036103; Jacquier N, 2011, J CELL SCI, V124, P2424, DOI 10.1242/jcs.076836; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Lee MCS, 2007, SEMIN CELL DEV BIOL, V18, P424, DOI 10.1016/j.semcdb.2007.06.007; Liu HP, 2006, EMBO J, V25, P4120, DOI 10.1038/sj.emboj.7601282; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Meng X, 2009, J MOL BIOL, V387, P320, DOI 10.1016/j.jmb.2009.01.059; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; NUOFFER C, 1994, J CELL BIOL, V125, P225, DOI 10.1083/jcb.125.2.225; Pepperkok R, 2001, GENOME BIOL, V2; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; Rojas Jose M, 2011, Genes Cancer, V2, P298, DOI 10.1177/1947601911408078; Rollason R, 2009, J CELL BIOL, V184, P721, DOI 10.1083/jcb.200804154; Sato K, 2007, FEBS LETT, V581, P2076, DOI 10.1016/j.febslet.2007.01.091; Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/nmeth.1855, 10.1038/NMETH.1855]; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Simpson JC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-240; Simpson JC, 2007, J BIOTECHNOL, V129, P352, DOI 10.1016/j.jbiotec.2006.12.027; Simpson JC, 2009, SEMIN CELL DEV BIOL, V20, P903, DOI 10.1016/j.semcdb.2009.07.005; Singh H, 2007, FEBS J, V274, P6306, DOI 10.1111/j.1742-4658.2007.06145.x; Sivars U, 2003, NATURE, V425, P856, DOI 10.1038/nature02057; Stephens DJ, 2000, J CELL SCI, V113, P2177; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Uemura T, 2009, MOL CELL BIOL, V29, P1869, DOI 10.1128/MCB.01089-08; Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893; Wendler F, 2010, EMBO J, V29, P304, DOI 10.1038/emboj.2009.350; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; YANG CZ, 1994, J BIOL CHEM, V269, P31891; ZILBERSTEIN A, 1980, CELL, V21, P417, DOI 10.1016/0092-8674(80)90478-X	47	125	127	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2012	14	7					764	774		10.1038/ncb2510	http://dx.doi.org/10.1038/ncb2510			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	967PV	22660414				2022-12-25	WOS:000305921200016
J	Zhang, L; Zhou, FF; Drabsch, Y; Gao, R; Snaar-Jagalska, BE; Mickanin, C; Huang, HZ; Sheppard, KA; Porter, JA; Lu, CX; ten Dijke, P				Zhang, Long; Zhou, FangFang; Drabsch, Yvette; Gao, Rui; Snaar-Jagalska, B. Ewa; Mickanin, Craig; Huang, Huizhe; Sheppard, Kelly-Ann; Porter, Jeff A.; Lu, Chris X.; ten Dijke, Peter			USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-beta type I receptor	NATURE CELL BIOLOGY			English	Article							MESENCHYMAL TRANSITION; DEPENDENT DEGRADATION; UBIQUITIN LIGASE; TARGETS; GROWTH; INHIBITION; SMURF2; TRANSCRIPTION; METASTASIS; ACTIVATION	The stability and membrane localization of the transforming growth factor-beta (TGF-beta) type I receptor (T beta RI) determines the levels of TGF-beta signalling. T beta RI is targeted for ubiquitylation-mediated degradation by the SMAD7-SMURF2 complex. Here we performed a genome-wide gain-of-function screen and identified ubiquitin-specific protease (USP) 4 as a strong inducer of TGF-beta signalling. USP4 was found to directly interact with T beta RI and act as a deubiquitylating enzyme, thereby controlling T beta RI levels at the plasma membrane. Depletion of USP4 mitigates TGF-beta-induced epithelial to mesenchymal transition and metastasis. Importantly, AKT (also known as protein kinase B), which has been associated with poor prognosis in breast cancer, directly associates with and phosphorylates USP4. AKT-mediated phosphorylation relocates nuclear USP4 to the cytoplasm and membrane and is required for maintaining its protein stability. Moreover, AKT-induced breast cancer cell migration was inhibited by USP4 depletion and T beta RI kinase inhibition. Our results uncover USP4 as an important determinant for crosstalk between TGF-beta and AKT signalling pathways.	[Zhang, Long; Zhou, FangFang; Drabsch, Yvette; ten Dijke, Peter] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands; [Gao, Rui] Xiamen Univ Ctr, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China; [Snaar-Jagalska, B. Ewa] Leiden Univ, Inst Biol, NL-2333 CC Leiden, Netherlands; [Mickanin, Craig; Sheppard, Kelly-Ann; Porter, Jeff A.; Lu, Chris X.] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Huang, Huizhe] Chonqing Med Univ, Fac Basic Med Sci, Chongqing 400016, Peoples R China	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Novartis; Chongqing Medical University	Zhou, FF (corresponding author), Leiden Univ, Med Ctr, Dept Mol Cell Biol, Postbus 9600, NL-2300 RC Leiden, Netherlands.	F.zhou@lumc.nl; p.ten_dijke@lumc.nl	Dijke, Peter ten/AAG-4660-2021; Zhang, Long/AAT-6571-2021	Dijke, Peter ten/0000-0002-7234-342X; Zhang, Long/0000-0001-8139-0474	Netherlands Organization of Scientific Research [MW-NWO 918.66.606]; Centre for Biomedical Genetics	Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); Centre for Biomedical Genetics	We are grateful to M. van Dinther for performing the <SUP>125</SUP>I-TGF-beta labelling experiment, A. Teunisse and A. G. Jochemsen (Leiden University Medical Center, Leiden, The Netherlands) for 14-3-3 expression plasmids and purification of GST 14-3-3 fusion proteins, and H. van Dam for critical reading of the manuscript. We thank K. Iwata, S. Lin and S. Piccolo for reagents. This work was supported by a Netherlands Organization of Scientific Research grant (MW-NWO 918.66.606) and the Centre for Biomedical Genetics.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bandyopadhyay A, 2006, CANCER RES, V66, P6714, DOI 10.1158/0008-5472.CAN-05-3565; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Conery AR, 2004, NAT CELL BIOL, V6, P366, DOI 10.1038/ncb1117; Daly AC, 2010, J BIOL CHEM, V285, P6489, DOI 10.1074/jbc.M109.043877; De Boeck M, 2012, UPSALA J MED SCI, V117, P153, DOI 10.3109/03009734.2012.654858; Eichhorn PJA, 2012, NAT MED, V18, P429, DOI 10.1038/nm.2619; Fan YH, 2011, CELL DEATH DIFFER, V18, P1547, DOI 10.1038/cdd.2011.11; Freeman AK, 2011, SEMIN CELL DEV BIOL, V22, P681, DOI 10.1016/j.semcdb.2011.08.009; Guglielmo GM, 2003, NAT CELL BIOL, V5, P680, DOI 10.1038/ncb0703-680d; Han SU, 2004, ONCOGENE, V23, P1333, DOI 10.1038/sj.onc.1207259; He S., 2012, J PATHOL; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Inui M, 2011, NAT CELL BIOL, V13, P1368, DOI 10.1038/ncb2346; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Lamouille S, 2012, J CELL SCI, V125, P1259, DOI 10.1242/jcs.095299; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Lo RS, 1999, NAT CELL BIOL, V1, P472, DOI 10.1038/70258; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Muraoka-Cook RS, 2006, ONCOGENE, V25, P3408, DOI 10.1038/sj.onc.1208964; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Parvani JG, 2011, J MAMMARY GLAND BIOL, V16, P127, DOI 10.1007/s10911-011-9207-3; PIETENPOL JA, 1990, CELL, V61, P777, DOI 10.1016/0092-8674(90)90188-K; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Smith AP, 2009, ONCOGENE, V28, P422, DOI 10.1038/onc.2008.395; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Suzuki C, 2002, J BIOL CHEM, V277, P39919, DOI 10.1074/jbc.M201901200; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tran Hien, 2003, Sci STKE, V2003, pRE5, DOI 10.1126/stke.2003.172.re5; Wada K, 2006, BIOCHEM BIOPH RES CO, V342, P253, DOI 10.1016/j.bbrc.2006.01.144; Williams SA, 2011, CELL, V146, P917, DOI 10.1016/j.cell.2011.07.040; Xiao N, 2012, BIOCHEM J, V441, P979, DOI 10.1042/BJ20111358; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Zhang XN, 2011, EMBO J, V30, P2177, DOI 10.1038/emboj.2011.125; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhou FF, 2012, J BIOL CHEM, V287, P11002, DOI 10.1074/jbc.M111.328187; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	50	229	239	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2012	14	7					717	726		10.1038/ncb2522	http://dx.doi.org/10.1038/ncb2522			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	967PV	22706160				2022-12-25	WOS:000305921200011
J	Debnath, A; Parsonage, D; Andrade, RM; He, C; Cobo, ER; Hirata, K; Chen, S; Garcia-Rivera, G; Orozco, E; Martinez, MB; Gunatilleke, SS; Barrios, AM; Arkin, MR; Poole, LB; McKerrow, JH; Reed, SL				Debnath, Anjan; Parsonage, Derek; Andrade, Rosa M.; He, Chen; Cobo, Eduardo R.; Hirata, Ken; Chen, Steven; Garcia-Rivera, Guillermina; Orozco, Esther; Martinez, Maximo B.; Gunatilleke, Shamila S.; Barrios, Amy M.; Arkin, Michelle R.; Poole, Leslie B.; McKerrow, James H.; Reed, Sharon L.			A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target	NATURE MEDICINE			English	Article							THIOREDOXIN REDUCTASE; METRONIDAZOLE RESISTANCE; SUPEROXIDE-DISMUTASE; CYSTEINE PROTEINASE; OXIDATIVE STRESS; ARSENIC TRIOXIDE; IN-VITRO; METABOLISM; CELLS; GLUTATHIONE	Entamoeba histolytica, a protozoan intestinal parasite, is the causative agent of human amebiasis. Amebiasis is the fourth leading cause of death and the third leading cause of morbidity due to protozoan infections worldwide(1), resulting in similar to 70,000 deaths annually. E. histolytica has been listed by the National Institutes of Health as a category B priority biodefense pathogen in the United States. Treatment relies on metronidazole(2), which has adverse effects(3), and potential resistance of E. histolytica to the drug is an increasing concern(4,5). To facilitate drug screening for this anaerobic protozoan, we developed and validated an automated, high-throughput screen (HTS). This screen identified auranofin, a US Food and Drug Administration (FDA)-approved drug used therapeutically for rheumatoid arthritis, as active against E. histolytica in culture. Auranofin was ten times more potent against E. histolytica than metronidazole. Transcriptional profiling and thioredoxin reductase assays suggested that auranofin targets the E. histolytica thioredoxin reductase, preventing the reduction of thioredoxin and enhancing sensitivity of trophozoites to reactive oxygen-mediated killing. In a mouse model of amebic colitis and a hamster model of amebic liver abscess, oral auranofin markedly decreased the number of parasites, the detrimental host inflammatory response and hepatic damage. This new use of auranofin represents a promising therapy for amebiasis, and the drug has been granted orphan-drug status from the FDA.	[Andrade, Rosa M.; He, Chen; Cobo, Eduardo R.; Hirata, Ken; Reed, Sharon L.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Debnath, Anjan; Gunatilleke, Shamila S.; McKerrow, James H.] Univ Calif San Francisco, Sandler Ctr Drug Discovery, San Francisco, CA 94143 USA; [Parsonage, Derek; Poole, Leslie B.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC USA; [Andrade, Rosa M.; Reed, Sharon L.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Chen, Steven; Arkin, Michelle R.] Univ Calif San Francisco, Small Mol Discovery Ctr, San Francisco, CA 94143 USA; [Garcia-Rivera, Guillermina; Orozco, Esther; Martinez, Maximo B.] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Expt Pathol, Mexico City, DF, Mexico; [Barrios, Amy M.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA	University of California System; University of California San Diego; University of California System; University of California San Francisco; Wake Forest University; University of California System; University of California San Diego; University of California System; University of California San Francisco; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Utah System of Higher Education; University of Utah	Reed, SL (corresponding author), Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA.	anjan.debnath@ucsf.edu; slreed@ucsd.edu	Cobo, Eduardo R/AAF-2656-2021; arkin, michelle/AAN-4298-2021; Arkin, Michelle/AAO-2009-2021	Cobo, Eduardo R/0000-0001-5450-7673; arkin, michelle/0000-0002-9366-6770; Debnath, Anjan/0000-0001-9294-3927; Poole, Leslie/0000-0003-0334-7328	Sandler Foundation; US National Institute of Allergy and Infectious Diseases [5U01AI077822];  [R01 GM050389]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI077822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050389] Funding Source: NIH RePORTER	Sandler Foundation; US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Sandler Foundation and US National Institute of Allergy and Infectious Diseases grant 5U01AI077822; we also acknowledge support from R01 GM050389. E. histolytica microarray slides were kindly provided by S. L. Stanley Jr. (Stony Brook University, New York), and the E. histolytica thioredoxin-specific antibody was a kind gift from S. Adrian-Guerrero (Universidad Nacional del Litoral). We thank G. Hwang and C. Le for their help with the mouse surgery and K. Ang and J. Gut for sharing their expertise.	Angelucci F, 2009, J BIOL CHEM, V284, P28977, DOI 10.1074/jbc.M109.020701; Arias DG, 2007, FREE RADICAL BIO MED, V42, P1496, DOI 10.1016/j.freeradbiomed.2007.02.012; Arnaud-Dabernat S, 2004, EXP CELL RES, V301, P293, DOI 10.1016/j.yexcr.2004.07.026; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Bersani NA, 2002, METHOD ENZYMOL, V347, P317; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; Bonilla M, 2008, J BIOL CHEM, V283, P17898, DOI 10.1074/jbc.M710609200; Crechet JB, 2003, BIOCHEMISTRY-US, V42, P14903, DOI 10.1021/bi0349928; Davis PH, 2007, MOL BIOCHEM PARASIT, V151, P118, DOI 10.1016/j.molbiopara.2006.10.014; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; FAHEY RC, 1984, SCIENCE, V224, P70, DOI 10.1126/science.6322306; Freeman CD, 1997, DRUGS, V54, P679, DOI 10.2165/00003495-199754050-00003; Ghosh S, 2004, J MED CHEM, V47, P175, DOI 10.1021/jm030084x; GOTTLIEB NL, 1986, SCAND J RHEUMATOL, P19; He C, 2010, J BIOL CHEM, V285, P18516, DOI 10.1074/jbc.M109.086181; Hirt RP, 2002, TRENDS PARASITOL, V18, P302, DOI 10.1016/S1471-4922(02)02293-6; Houpt ER, 2002, J IMMUNOL, V169, P4496, DOI 10.4049/jimmunol.169.8.4496; Ilari A, 2012, AMINO ACIDS, V42, P803, DOI 10.1007/s00726-011-0997-9; Jeelani G, 2010, J BIOL CHEM, V285, P26889, DOI 10.1074/jbc.M110.106310; Krogstad D. J., 1988, Amebiasis: human infection by Entamoeba histolytica., P741; Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lobanov AV, 2006, NUCLEIC ACIDS RES, V34, P4012, DOI 10.1093/nar/gkl541; Lu J, 2007, P NATL ACAD SCI USA, V104, P12288, DOI 10.1073/pnas.0701549104; Makioka A, 2001, PARASITOL RES, V87, P833, DOI 10.1007/s004360100453; MARKIEWICZ VR, 1988, FUND APPL TOXICOL, V11, P277, DOI 10.1016/0272-0590(88)90152-2; Melendez-Lopez SG, 2007, EUKARYOT CELL, V6, P1130, DOI 10.1128/EC.00094-07; Mulrooney SB, 1997, PROTEIN EXPRES PURIF, V9, P372, DOI 10.1006/prep.1996.0698; PARKS RE, 1973, COMP BIOCHEM PHYSIOL, V45, P355, DOI 10.1016/0305-0491(73)90070-9; Samarawickrema NA, 1997, J ANTIMICROB CHEMOTH, V40, P833, DOI 10.1093/jac/40.6.833; Sannella AR, 2008, FEBS LETT, V582, P844, DOI 10.1016/j.febslet.2008.02.028; Sayed AA, 2008, NAT MED, V14, P407, DOI 10.1038/nm1737; Seifert K, 2001, ANTIMICROB AGENTS CH, V45, P1505, DOI 10.1128/AAC.45.5.1505-1510.2001; Sen A, 2007, EUKARYOT CELL, V6, P664, DOI 10.1128/EC.00308-06; Singh S, 2005, BIOORG MED CHEM LETT, V15, P5424, DOI 10.1016/j.bmcl.2005.08.103; Sok J, 2001, CELL STRESS CHAPERON, V6, P6, DOI 10.1379/1466-1268(2001)006<0006:AIRAPA>2.0.CO;2; Talbot S, 2008, BRIT J PHARMACOL, V154, P940, DOI 10.1038/bjp.2008.161; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Wassmann C, 1999, J BIOL CHEM, V274, P26051, DOI 10.1074/jbc.274.37.26051; WHO (World Health Organization), 1998, WORLD HLTH REP 1998; Williams CH, 2000, EUR J BIOCHEM, V267, P6110, DOI 10.1046/j.1432-1327.2000.01702.x	41	221	228	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2012	18	6					956	+		10.1038/nm.2758	http://dx.doi.org/10.1038/nm.2758			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22610278	Green Submitted, Green Accepted			2022-12-25	WOS:000305116600034
J	Drukker, M; Tang, C; Ardehali, R; Rinkevich, Y; Seita, J; Lee, AS; Mosley, AR; Weissman, IL; Soen, Y				Drukker, Micha; Tang, Chad; Ardehali, Reza; Rinkevich, Yuval; Seita, Jun; Lee, Andrew S.; Mosley, Adriane R.; Weissman, Irving L.; Soen, Yoav			Isolation of primitive endoderm, mesoderm, vascular endothelial and trophoblast progenitors from human pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							BONE MORPHOGENETIC PROTEIN-4; TRANSCRIPTION FACTOR; HUMAN PLACENTA; MOUSE; EXPRESSION; DIFFERENTIATION; RECEPTOR; GENE; IDENTIFICATION; LOCALIZATION	To identify early populations of committed progenitors derived from human embryonic stem cells (hESCs), we screened self-renewing, BMP4-treated and retinoic acid-treated cultures with >400 antibodies recognizing cell-surface antigens. Sorting of >30 subpopulations followed by transcriptional analysis of developmental genes identified four distinct candidate progenitor groups. Subsets detected in self-renewing cultures, including CXCR4(+) cells, expressed primitive endoderm genes. Expression of Cxcr4 in primitive endoderm was confirmed in visceral endoderm of mouse embryos. BMP4-induced progenitors exhibited gene signatures of mesoderm, trophoblast and vascular endothelium, suggesting correspondence to gastrulation-stage primitive streak, chorion and allantois precursors, respectively. Functional studies in vitro and in vivo confirmed that ROR2(+) cells produce mesoderm progeny, APA(+) cells generate syncytiotrophoblasts and CD87(+) cells give rise to vasculature. The same progenitor classes emerged during the differentiation of human induced pluripotent stem cells (hiPSCs). These markers and progenitors provide tools for purifying human tissue-regenerating progenitors and for studying the commitment of pluripotent stem cells to lineage progenitors.	[Drukker, Micha; Tang, Chad; Ardehali, Reza; Rinkevich, Yuval; Seita, Jun; Mosley, Adriane R.; Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Lee, Andrew S.] Stanford Univ, Sch Med, Dept Radiol, Div Cardiol, Stanford, CA 94305 USA; [Lee, Andrew S.] Stanford Univ, Dept Med, Sch Med, Div Cardiol, Stanford, CA 94305 USA; [Soen, Yoav] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Stanford University; Stanford University; Stanford University; Weizmann Institute of Science	Drukker, M (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munich, Inst Stem Cell Res, Neuherberg, Germany.	dmicha@stanford.edu; irv@stanford.edu; yoavs@weizmann.ac.il	Rinkevich, Yuval/B-7854-2018; Seita, Jun/AAM-1478-2020; Lee, Andrew/GVU-2817-2022; Rinkevich, Yuval/B-7647-2018; Palmer, Theo/GSI-6635-2022	Rinkevich, Yuval/0000-0001-6290-7271; Seita, Jun/0000-0002-3008-3615; Rinkevich, Yuval/0000-0002-9022-7668; Drukker, Micha/0000-0002-4279-1125	California Institute of Regenerative Medicine (CIRM) [RC1-00354-1, RT2-02060]; Human Frontier Science Organization (HFSPO) [CDA0063/2007-C]; Stanford Medical Scholars Program; Human Frontier Science Program (HFSP) Long Term Fellowship; NATIONAL CANCER INSTITUTE [R01CA086065] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099995, U01HL099999] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Human Frontier Science Organization (HFSPO); Stanford Medical Scholars Program; Human Frontier Science Program (HFSP) Long Term Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by funds provided by the California Institute of Regenerative Medicine (CIRM) (Comprehensive grants RC1-00354-1, RT2-02060). Y.S. was supported by a CDA award from the Human Frontier Science Organization (HFSPO, CDA0063/2007-C). C. T. and A. S. L. are supported by the Howard Hughes Medical Institute Medical Fellows and the Stanford Medical Scholars Program. Y.R. is supported by a Human Frontier Science Program (HFSP) Long Term Fellowship. M. D., C. T. and R. A. are supported by CIRM (Comprehensive grants RC1-00354-1, RT2-02060). We would like to thank C. Chan for pentachrome stainings.	Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akeson AL, 2001, MICROVASC RES, V61, P75, DOI 10.1006/mvre.2000.2257; Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; Apps R, 2011, PLACENTA, V32, P33, DOI 10.1016/j.placenta.2010.10.010; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Aydin S, 2008, AM J PHYSIOL-CELL PH, V294, pC543, DOI 10.1152/ajpcell.00307.2007; Baldwin HS, 1996, CARDIOVASC RES, V31, pE34; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Bondue A, 2008, CELL STEM CELL, V3, P69, DOI 10.1016/j.stem.2008.06.009; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chen CP, 2008, PLACENTA, V29, P309, DOI 10.1016/j.placenta.2008.01.002; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Evseenko D, 2010, P NATL ACAD SCI USA, V107, P13742, DOI 10.1073/pnas.1002077107; Fujiwara T, 2001, P NATL ACAD SCI USA, V98, P13739, DOI 10.1073/pnas.241508898; GARVEY W, 1986, STAIN TECHNOL, V61, P60, DOI 10.3109/10520298609110708; GURTNER GC, 1995, GENE DEV, V9, P1, DOI 10.1101/gad.9.1.1; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Inman KE, 2007, GENESIS, V45, P237, DOI 10.1002/dvg.20281; Inman KE, 2006, GENE EXPR PATTERNS, V6, P783, DOI 10.1016/j.modgep.2006.01.010; Ito N, 2003, EARLY HUM DEV, V71, P29, DOI 10.1016/S0378-3782(02)00112-3; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kukk E, 1996, DEVELOPMENT, V122, P3829; Leksa V, 2005, J CELL SCI, V118, P4577, DOI 10.1242/jcs.02587; Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999; Lu CC, 2001, CURR OPIN GENET DEV, V11, P384, DOI 10.1016/S0959-437X(00)00208-2; Mao QC, 2008, PHARM RES-DORDR, V25, P1244, DOI 10.1007/s11095-008-9537-z; Matsuda T, 2001, MECH DEVELOP, V105, P153, DOI 10.1016/S0925-4773(01)00383-5; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; Mitsui T, 2003, MOL MED, V9, P57, DOI 10.1007/BF03402108; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Peng LH, 2004, MOL ENDOCRINOL, V18, P2049, DOI 10.1210/me.2004-0028; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Pfister S, 2007, GENE EXPR PATTERNS, V7, P558, DOI 10.1016/j.modgep.2007.01.005; Pierleoni C, 2003, PLACENTA, V24, P677, DOI 10.1016/S0143-4004(03)00082-1; Rivera-Perez JA, 2003, DEV BIOL, V261, P470, DOI 10.1016/S0012-1606(03)00302-6; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; ROSSANT J, 1979, DEV BIOL, V70, P255, DOI 10.1016/0012-1606(79)90022-8; SALIDO EC, 1990, J CLIN ENDOCR METAB, V70, P1564, DOI 10.1210/jcem-70-6-1564; Schwabe GC, 2004, DEV DYNAM, V229, P400, DOI 10.1002/dvdy.10466; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3; Sirbu IO, 2006, NAT CELL BIOL, V8, P271, DOI 10.1038/ncb1374; Solberg H, 2003, DEVELOPMENT, V130, P4439, DOI 10.1242/dev.00642; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Wang P, 2011, CELL STEM CELL, V8, P335, DOI 10.1016/j.stem.2011.01.017; Wang ZZ, 2007, NAT BIOTECHNOL, V25, P317, DOI 10.1038/nbt1287; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; WILSON V, 1993, DEVELOPMENT, V117, P1321; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yamada K, 1999, J BIOL CHEM, V274, P32279, DOI 10.1074/jbc.274.45.32279; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yusuf F, 2005, ANAT EMBRYOL, V210, P35, DOI 10.1007/s00429-005-0013-9; Zhang HB, 1996, DEVELOPMENT, V122, P2977; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	70	78	84	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2012	30	6					531	+		10.1038/nbt.2239	http://dx.doi.org/10.1038/nbt.2239			14	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	957JV	22634564	Green Accepted			2022-12-25	WOS:000305158600023
J	Panizzi, JR; Becker-Heck, A; Castleman, VH; Al-Mutairi, DA; Liu, Y; Loges, NT; Pathak, N; Austin-Tse, C; Sheridan, E; Schmidts, M; Olbrich, H; Werner, C; Haffner, K; Hellman, N; Chodhari, R; Gupta, A; Kramer-Zucker, A; Olale, F; Burdine, RD; Schier, AF; O'Callaghan, C; Chung, EMK; Reinhardt, R; Mitchison, HM; King, SM; Omran, H; Drummond, IA				Panizzi, Jennifer R.; Becker-Heck, Anita; Castleman, Victoria H.; Al-Mutairi, Dalal A.; Liu, Yan; Loges, Niki T.; Pathak, Narendra; Austin-Tse, Christina; Sheridan, Eamonn; Schmidts, Miriam; Olbrich, Heike; Werner, Claudius; Haeffner, Karsten; Hellman, Nathan; Chodhari, Rahul; Gupta, Amar; Kramer-Zucker, Albrecht; Olale, Felix; Burdine, Rebecca D.; Schier, Alexander F.; O'Callaghan, Christopher; Chung, Eddie M. K.; Reinhardt, Richard; Mitchison, Hannah M.; King, Stephen M.; Omran, Heymut; Drummond, Iain A.			CCDC103 mutations cause primary ciliary dyskinesia by disrupting assembly of ciliary dynein arms	NATURE GENETICS			English	Article							ZEBRAFISH PRONEPHROS; PROTEIN; REQUIREMENT; EXPRESSION; ENCODES; GENES	Cilia are essential for fertilization, respiratory clearance, cerebrospinal fluid circulation and establishing laterality(1). Cilia motility defects cause primary ciliary dyskinesia (PCD, MIM244400), a disorder affecting 1: 15,000-30,000 births. Cilia motility requires the assembly of multisubunit dynein arms that drive ciliary bending(2). Despite progress in understanding the genetic basis of PCD, mutations remain to be identified for several PCD-linked loci(3). Here we show that the zebrafish cilia paralysis mutant schmalhans (smh(tn222)) encodes the coiled-coil domain containing 103 protein (Ccdc103), a foxj1a-regulated gene product. Screening 146 unrelated PCD families identified individuals in six families with reduced outer dynein arms who carried mutations in CCDC103. Dynein arm assembly in smh mutant zebrafish was rescued by wild-type but not mutant human CCDC103. Chlamydomonas Ccdc103/Pr46b functions as a tightly bound, axoneme-associated protein. These results identify Ccdc103 as a dynein arm attachment factor that causes primary ciliary dyskinesia when mutated.	[Panizzi, Jennifer R.; Liu, Yan; Pathak, Narendra; Hellman, Nathan; Gupta, Amar; Drummond, Iain A.] Massachusetts Gen Hosp, Div Neurol, Charlestown, MA 02129 USA; [Panizzi, Jennifer R.; Pathak, Narendra; Hellman, Nathan; Drummond, Iain A.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Becker-Heck, Anita] Univ Hosp Freiburg, Dept Pediat, Freiburg, Germany; [Becker-Heck, Anita; Loges, Niki T.; Olbrich, Heike; Werner, Claudius; Omran, Heymut] Univ Klinikum Munster, Klin & Poliklin Kinder & Jugendmed Allgemeine Pae, Munster, Germany; [Castleman, Victoria H.] UCL, Mol Med Unit, Inst Child Hlth, London, England; [Al-Mutairi, Dalal A.; Sheridan, Eamonn] St James Univ Hosp, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Al-Mutairi, Dalal A.] Kuwait Univ, Fac Med, Dept Pathol, Kuwait, Kuwait; [Austin-Tse, Christina] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Chodhari, Rahul; Chung, Eddie M. K.] UCL, Inst Child Hlth, Gen & Adolescent Paediat Unit, London, England; [Kramer-Zucker, Albrecht] Univ Hosp Freiburg, Div Renal, Freiburg, Germany; [Olale, Felix] NYU, Sch Med, Skirball Inst Biomol Med, New York, NY USA; [Burdine, Rebecca D.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Schier, Alexander F.] Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA; [O'Callaghan, Christopher] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Reinhardt, Richard] Max Planck Inst Plant Breeding Res, Genome Ctr Cologne, Cologne, Germany; [King, Stephen M.] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Freiburg; University of Munster; University of London; University College London; Saint James's University Hospital; University of Leeds; Kuwait University; Harvard University; Harvard Medical School; University of London; University College London; University of Freiburg; New York University; Princeton University; Harvard University; University of Leicester; Max Planck Society; University of Connecticut	Drummond, IA (corresponding author), Massachusetts Gen Hosp, Div Neurol, Charlestown, MA 02129 USA.	king@neuron.uchc.edu; heymut.omran@ukmuenster.de; idrummon@receptor.mgh.harvard.edu	Austin-Tse, Christina/AFR-2048-2022; Schmidts, Miriam/A-3777-2012	Austin-Tse, Christina/0000-0001-6492-6716; Schmidts, Miriam/0000-0002-1714-6749; Burdine, Rebecca/0000-0001-6620-5015; Omran, Heymut/0000-0003-0282-6765; Reinhardt, Richard/0000-0001-9376-2132; Mitchison, Hannah/0000-0002-3163-6293; Schier, Alexander Franz/0000-0001-7645-5325	PCD Family Support Group (UK); German patient support group 'Kartagener Syndrom und Primaere Ciliaere Dyskinesie e.V.'; US National Institutes of Health [DK053093, GM051293]; National Research Service Award [F32DK083868]; American Heart Association; Deutsche Forschungsgemeinschaft (DFG) [DFG Om 6/4, GRK1109, SFB592]; EU; IZKF [Om2/009/12]; Kindness for Kids grant; Medical Research Council UK; Wellcome Trust; Fondation Milena Carvajal-ProKartagener; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK083868, R01DK053093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051293, R01GM056211] Funding Source: NIH RePORTER; Action Medical Research [1773] Funding Source: researchfish	PCD Family Support Group (UK); German patient support group 'Kartagener Syndrom und Primaere Ciliaere Dyskinesie e.V.'; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); EU(European Commission); IZKF; Kindness for Kids grant; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Fondation Milena Carvajal-ProKartagener; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Action Medical Research	We thank the patients and their families for their participation and acknowledge support from the PCD Family Support Group (UK) and the German patient support group 'Kartagener Syndrom und Primaere Ciliaere Dyskinesie e.V.'. We thank R. Mark Gardiner and E. Moya for their help and involvement in the study. We thank R. Hirst and A. Rutman for electron microscopy. We thank A. Heer, C. Warmt, D. Nergenau, R. S. Patel-King and L. Luo for excellent technical assistance. This work was funded by US National Institutes of Health grants DK053093 (I. A. D.) and GM051293 (S. M. K.), National Research Service Award fellowship grant F32DK083868 (J.R.P.), an American Heart Association Established Investigator Award (A. F. S.), Deutsche Forschungsgemeinschaft (DFG) grants (DFG Om 6/4, GRK1109 and SFB592), EU grant SYSCILIA, IZKF-project (Om2/009/12), and Kindness for Kids grant (H. Omran), the Medical Research Council UK, the Wellcome Trust and the Fondation Milena Carvajal-ProKartagener.	Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Brand M, 1996, DEVELOPMENT, V123, P129; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Fliegauf M, 2005, AM J RESP CRIT CARE, V171, P1343, DOI 10.1164/rccm.200411-1583OC; Hellman NE, 2010, P NATL ACAD SCI USA, V107, P18499, DOI 10.1073/pnas.1005998107; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KING SM, 1995, METHOD CELL BIOL, V47, P9, DOI 10.1016/S0091-679X(08)60783-9; Koutoulis A, 1997, J CELL BIOL, V137, P1069, DOI 10.1083/jcb.137.5.1069; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Milewski WM, 1998, ENDOCRINOLOGY, V139, P1440, DOI 10.1210/en.139.3.1440; O'Callaghan C, 2010, ARCH DIS CHILD, V95, P51, DOI 10.1136/adc.2009.158493; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Panizzi JR, 2007, DEVELOPMENT, V134, P921, DOI 10.1242/dev.02776; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; SOLNICAKREZEL L, 1994, GENETICS, V136, P1401; Stoetzel C, 2006, NAT GENET, V38, P521, DOI 10.1038/ng1771; TAKADA S, 1994, J CELL BIOL, V126, P737, DOI 10.1083/jcb.126.3.737; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tsukui T, 1999, P NATL ACAD SCI USA, V96, P11376, DOI 10.1073/pnas.96.20.11376; Wessely O, 2008, FRONT BIOSCI-LANDMRK, V13, P1866, DOI 10.2741/2806; Wirschell M, 2004, MOL BIOL CELL, V15, P2729, DOI 10.1091/mbc.E03-11-0820; WITMAN GB, 1986, METHOD ENZYMOL, V134, P280; Yan YT, 1999, GENE DEV, V13, P2527, DOI 10.1101/gad.13.19.2527; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406; Yu XW, 2008, NAT GENET, V40, P1445, DOI 10.1038/ng.263; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301	28	160	169	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2012	44	6					714	U148		10.1038/ng.2277	http://dx.doi.org/10.1038/ng.2277			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	949BT	22581229	Green Accepted			2022-12-25	WOS:000304551100022
J	Eckle, T; Hartmann, K; Bonney, S; Reithel, S; Mittelbronn, M; Walker, LA; Lowes, BD; Han, J; Borchers, CH; Buttrick, PM; Kominsky, DJ; Colgan, SP; Eltzschig, HK				Eckle, Tobias; Hartmann, Katherine; Bonney, Stephanie; Reithel, Susan; Mittelbronn, Michel; Walker, Lori A.; Lowes, Brian D.; Han, Jun; Borchers, Christoph H.; Buttrick, Peter M.; Kominsky, Douglas J.; Colgan, Sean P.; Eltzschig, Holger K.			Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia	NATURE MEDICINE			English	Article							CIRCADIAN CLOCK; GLUCOSE-METABOLISM; TISSUE-DAMAGE; INFARCT SIZE; MOUSE MODEL; ADENOSINE; HYPOXIA; REPERFUSION; MECHANISMS; EXPRESSION	Adenosine signaling has been implicated in cardiac adaptation to limited oxygen availability. In a wide search for adenosine receptor A2b (Adora2b)-elicited cardioadaptive responses, we identified the circadian rhythm protein period 2 (Per2) as an Adora2b target. Adora2b signaling led to Per2 stabilization during myocardial ischemia, and in this setting, Per2(-/-) mice had larger infarct sizes compared to wild-type mice and loss of the cardioprotection conferred by ischemic preconditioning. Metabolic studies uncovered a limited ability of ischemic hearts in Per2(-/-) mice to use carbohydrates for oxygen-efficient glycolysis. This impairment was caused by a failure to stabilize hypoxia-inducible factor-1 alpha (Hif-1 alpha). Moreover, stabilization of Per2 in the heart by exposing mice to intense light resulted in the transcriptional induction of glycolytic enzymes and Per2-dependent cardioprotection from ischemia. Together, these studies identify adenosine-elicited stabilization of Per2 in the control of HIF-dependent cardiac metabolism and ischemia tolerance and implicate Per2 stabilization as a potential new strategy for treating myocardial ischemia.	[Eckle, Tobias; Hartmann, Katherine; Bonney, Stephanie; Reithel, Susan; Kominsky, Douglas J.; Eltzschig, Holger K.] Univ Colorado Denver, Dept Anesthesiol, Mucosal Inflammat Program, Aurora, CO USA; [Mittelbronn, Michel] Goethe Univ Frankfurt, Edinger Inst, Inst Neurol, Frankfurt, Germany; [Walker, Lori A.; Lowes, Brian D.; Buttrick, Peter M.] Univ Colorado Denver, Div Cardiol, Dept Med, Aurora, CO USA; [Han, Jun; Borchers, Christoph H.] Univ Victoria, Dept Biochem & Microbiol, Genome BC Prote Ctr, Victoria, BC, Canada; [Colgan, Sean P.] Univ Colorado Denver, Dept Med, Mucosal Inflammat Program, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Goethe University Frankfurt; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Victoria; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Eckle, T (corresponding author), Univ Colorado Denver, Dept Anesthesiol, Mucosal Inflammat Program, Aurora, CO USA.	tobias.eckle@ucdenver.edu	Eckle, Tobias/AAE-6705-2020; Walker, Lori/J-7098-2013; BORCHERS, Christoph/U-5964-2019; Lowes, Brian/M-9020-2017	Eckle, Tobias/0000-0002-6065-4669; Walker, Lori/0000-0003-2556-8076; Hartmann, Katherine/0000-0002-3048-2210; Mittelbronn, Michel/0000-0002-2998-052X; Lowes, Brian/0000-0002-5919-2540; , Susan/0000-0003-4136-8488	National Heart, Lung and Blood Institute [R01-HL092188, R01-DK083385, R01-HL098294, R01-HL060569, 1K08HL102267]; Foundation for Anesthesia Education and Research; American Heart Association; Crohn's and Colitis Foundation of America; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060569, R01HL092188, R01HL098294, K08HL102267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095491, R01DK083385, R37DK050189] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Foundation for Anesthesia Education and Research; American Heart Association(American Heart Association); Crohn's and Colitis Foundation of America; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge S.A. Eltzschig (Mucosal Inflammation Program, Department of Anesthesiology, University of Colorado Denver, Aurora, Colorado, USA) for artwork during manuscript preparation, A. Medway (Division of Cardiology, Department of Medicine, University of Colorado Denver, Aurora, Colorado, USA), K. Hoffmann, J. Macas and C. Zachskorn (Institute of Neurology (Edinger Institute), University of Frankfurt, Frankfurt, Germany) and M. Bonney (Mucosal Inflammation Program, Department of Anesthesiology, University of Colorado Denver, Aurora, Colorado, USA) for technical assistance and C.-C. Lee (Department of Biochemistry and Molecular Biology, University of Texas Health Science Center, Houston, Texas, USA) for providing the Per1<SUP>-/-</SUP> mice. The present research work is supported by National Heart, Lung and Blood Institute grants R01-HL092188, R01-DK083385 and R01-HL098294 to H.K.E., R01-HL060569 to S.P.C. and 1K08HL102267 to T.E., Foundation for Anesthesia Education and Research grants to T.E. and H.K.E., an American Heart Association grant to T.E. and a Crohn's and Colitis Foundation of America grant to H.K.E.	Albrecht U, 2002, J APPL PHYSIOL, V92, P1348, DOI 10.1152/japplphysiol.00759.2001; Aragones J, 2009, CELL METAB, V9, P11, DOI 10.1016/j.cmet.2008.10.001; Bendova Z, 2006, PHYSIOL RES, V55, P623, DOI 10.33549/physiolres.930849; Daniels IS, 2010, J BIOL CHEM, V285, P20716, DOI 10.1074/jbc.M109.090845; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Durgan DJ, 2010, CIRC RES, V106, P647, DOI 10.1161/CIRCRESAHA.109.209957; Durgan DJ, 2010, CIRC RES, V106, P546, DOI 10.1161/CIRCRESAHA.109.209346; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Eckle T, 2006, AM J PHYSIOL-HEART C, V291, pH2533, DOI 10.1152/ajpheart.00472.2006; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; FINEGAN BA, 1993, CIRCULATION, V87, P900, DOI 10.1161/01.CIR.87.3.900; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Grimaldi B, 2010, CELL METAB, V12, P509, DOI 10.1016/j.cmet.2010.10.005; Hyvarinen J, 2010, J BIOL CHEM, V285, P13646, DOI 10.1074/jbc.M109.084855; Jaswal JS, 2011, BBA-MOL CELL RES, V1813, P1333, DOI 10.1016/j.bbamcr.2011.01.015; JENNINGS RB, 1991, ANNU REV MED, V42, P225, DOI 10.1146/annurev.med.42.1.225; Khoury J, 2007, J CLIN INVEST, V117, P703, DOI 10.1172/JCI30049; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Leibetseder V, 2009, CHRONOBIOL INT, V26, P621, DOI 10.1080/07420520902924939; Lopaschuk GD, 1997, CIRCULATION, V95, P313; Mikus P, 2005, SEMIN CELL DEV BIOL, V16, P462, DOI 10.1016/j.semcdb.2005.03.002; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Nossuli TO, 2000, AM J PHYSIOL-HEART C, V278, pH1049, DOI 10.1152/ajpheart.2000.278.4.H1049; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Peliciari-Garcia RA, 2011, CHRONOBIOL INT, V28, P21, DOI 10.3109/07420528.2010.525675; Petrzilka S, 2009, J BIOL RHYTHM, V24, P283, DOI 10.1177/0748730409336579; Reiter R, 2012, CIRC RES, V110, P105, DOI 10.1161/CIRCRESAHA.111.254284; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Roenneberg T, 2007, CURR BIOL, V17, pR44, DOI 10.1016/j.cub.2006.12.011; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Ryan HE, 2000, CANCER RES, V60, P4010; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Schulte G, 2003, EXP CELL RES, V290, P168, DOI 10.1016/S0014-4827(03)00324-0; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Suarez-Barrientos A, 2011, HEART, V97, P970, DOI 10.1136/hrt.2010.212621; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Tian R, 2001, CIRCULATION, V103, P2961, DOI 10.1161/01.CIR.103.24.2961; Virag JAI, 2010, AM J PHYSIOL-HEART C, V298, pH1088, DOI 10.1152/ajpheart.01280.2008; Viswambharan H, 2007, CIRCULATION, V115, P2188, DOI 10.1161/CIRCULATIONAHA.106.653303; Walker LA, 2010, J MOL CELL CARDIOL, V48, P1180, DOI 10.1016/j.yjmcc.2009.09.010; Wang CY, 2008, CIRCULATION, V118, P2166, DOI 10.1161/CIRCULATIONAHA.108.790469; Wolff Andrew A, 2002, Heart Fail Rev, V7, P187, DOI 10.1023/A:1015384710373; Wolska BM, 1996, AM J PHYSIOL-HEART C, V271, pH1250, DOI 10.1152/ajpheart.1996.271.3.H1250; Wu JT, 2005, NAT CELL BIOL, V7, P1014, DOI 10.1038/ncb1301; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	60	225	229	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					774	U173		10.1038/nm.2728	http://dx.doi.org/10.1038/nm.2728			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22504483	Green Accepted			2022-12-25	WOS:000303763500045
J	Forster, D; Luschnig, S				Foerster, Dominique; Luschnig, Stefan			Src42A-dependent polarized cell shape changes mediate epithelial tube elongation in Drosophila	NATURE CELL BIOLOGY			English	Article							ASYMMETRIC LOCALIZATION; ADHERENS JUNCTIONS; E-CADHERIN; MORPHOGENESIS; PROTEIN; SRC; INTERCALATION; SECRETION; ENDOCYTOSIS; MATRIX	Although many organ functions rely on epithelial tubes with correct dimensions, mechanisms underlying tube size control are poorly understood. We analyse the cellular mechanism of tracheal tube elongation in Drosophila, and describe an essential role of the conserved tyrosine kinase Src42A in this process. We show that Src42A is required for polarized cell shape changes and cell rearrangements that mediate tube elongation. In contrast, diametric expansion is controlled by apical secretion independently of Src42A. Constitutive activation of Src42A induces axial cell stretching and tracheal overelongation, indicating that Src42A acts instructively in this process. We propose that Src42A-dependent recycling of E-Cadherin at adherens junctions is limiting for cell shape changes and rearrangements in the axial dimension of the tube. Thus, we define distinct cellular processes that independently control axial and diametric expansion of a cylindrical epithelium in a developing organ. Whereas exocytosis-dependent membrane growth drives circumferential tube expansion, Src42A is required to orient membrane growth in the axial dimension of the tube.	[Foerster, Dominique; Luschnig, Stefan] Univ Zurich, IMLS, CH-8057 Zurich, Switzerland; [Foerster, Dominique; Luschnig, Stefan] Univ Zurich, PhD Program Mol Life Sci, CH-8057 Zurich, Switzerland	University of Zurich; University of Zurich	Luschnig, S (corresponding author), Univ Zurich, IMLS, CH-8057 Zurich, Switzerland.	stefan.luschnig@imls.uzh.ch	Förster, Dominique/D-5490-2012; Luschnig, Stefan E/A-7253-2010	Förster, Dominique/0000-0002-7821-6755; Luschnig, Stefan E/0000-0002-0634-3368	German Research Foundation [DFG LU-1398/1-1]; Swiss National Science Foundation [SNF 3100A0_120713]; RPH-Promotor Stiftung; Julius Klaus-Stiftung Zurich; University of Zurich; Kanton Zurich; Muller fellowship of the Zurich Ph.D. programme in Molecular Life Sciences; Forschungskredit of the University of Zurich	German Research Foundation(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); RPH-Promotor Stiftung; Julius Klaus-Stiftung Zurich; University of Zurich; Kanton Zurich; Muller fellowship of the Zurich Ph.D. programme in Molecular Life Sciences; Forschungskredit of the University of Zurich	We are indebted to K. Armbruster and S. Limmer, who isolated the Src42A mutants, and to T. Aegerter-Wilmsen for help with MATLAB analyses. We thank R. Guttinger for help with cell tracking, T. Aegerter-Wilmsen, C. Aegerter, M. Gonzalez-Gaitan, J. Grosshans, R. Metzger and D. Strutt for advice and comments on the manuscript and C. Lehner for support and discussions. We thank M. Affolter, K. Basler, E. Caussinus, J. Grosshans, S. Hayashi, Y. Hong, T. Kojima, T. Lecuit, A. Muller, D. Strutt, R. Ward and T. Xu for providing antibodies and fly stocks and J. Livet for providing Brainbow plasmids. We apologize to colleagues whose work could not be cited owing to space limitations. This work was supported by the German Research Foundation (DFG LU-1398/1-1), the Swiss National Science Foundation (SNF 3100A0_120713), the RPH-Promotor Stiftung, the Julius Klaus-Stiftung Zurich, the University of Zurich and the Kanton Zurich. D.F. was supported by a Muller fellowship of the Zurich Ph.D. programme in Molecular Life Sciences and by the Forschungskredit of the University of Zurich.	Aubouy M, 2003, GRANUL MATTER, V5, P67, DOI 10.1007/s10035-003-0126-x; Beitel GJ, 2000, DEVELOPMENT, V127, P3271; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Caussinus E, 2008, CURR BIOL, V18, P1727, DOI 10.1016/j.cub.2008.10.062; Choi WS, 2011, MOL BIOL CELL, V22, P2010, DOI 10.1091/mbc.E10-12-1014; Chung S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000746; Datta A, 2011, CURR BIOL, V21, pR126, DOI 10.1016/j.cub.2010.12.003; Devine WP, 2005, P NATL ACAD SCI USA, V102, P17014, DOI 10.1073/pnas.0506676102; Forster D, 2010, CURR BIOL, V20, P62, DOI 10.1016/j.cub.2009.11.062; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; Grieder NC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003241; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Han B, 2004, J BIOL CHEM, V279, P54793, DOI 10.1074/jbc.M406880200; Huang J, 2009, P NATL ACAD SCI USA, V106, P8284, DOI 10.1073/pnas.0900641106; Levina EM, 1996, EXP CELL RES, V229, P159, DOI 10.1006/excr.1996.0354; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Matusek T, 2006, DEVELOPMENT, V133, P957, DOI 10.1242/dev.02266; Oda H, 1999, DEV GENES EVOL, V209, P218, DOI 10.1007/s004270050246; Pedraza LG, 2004, ONCOGENE, V23, P4754, DOI 10.1038/sj.onc.1207635; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Ribeiro C, 2004, CURR BIOL, V14, P2197, DOI 10.1016/j.cub.2004.11.056; Shaye DD, 2008, NAT CELL BIOL, V10, P964, DOI 10.1038/ncb1756; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; Shindo M, 2008, DEVELOPMENT, V135, P1355, DOI 10.1242/dev.015982; Strutt D, 2002, CURR BIOL, V12, P813, DOI 10.1016/S0960-9822(02)00841-2; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Sweeney WE, 2008, J AM SOC NEPHROL, V19, P1331, DOI 10.1681/ASN.2007060665; Takahashi F, 1996, GENE DEV, V10, P1645, DOI 10.1101/gad.10.13.1645; Takahashi M, 2005, DEVELOPMENT, V132, P2547, DOI 10.1242/dev.01850; Tateno M, 2000, SCIENCE, V287, P324, DOI 10.1126/science.287.5451.324; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Zhang L, 2009, DEV BIOL, V336, P201, DOI 10.1016/j.ydbio.2009.09.040	40	72	72	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2012	14	5					526	U166		10.1038/ncb2456	http://dx.doi.org/10.1038/ncb2456			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	936NW	22446736				2022-12-25	WOS:000303598300013
J	Kircher, MF; de la Zerda, A; Jokerst, JV; Zavaleta, CL; Kempen, PJ; Mittra, E; Pitter, K; Huang, RM; Campos, C; Habte, F; Sinclair, R; Brennan, CW; Mellinghoff, IK; Holland, EC; Gambhir, SS				Kircher, Moritz F.; de la Zerda, Adam; Jokerst, Jesse V.; Zavaleta, Cristina L.; Kempen, Paul J.; Mittra, Erik; Pitter, Ken; Huang, Ruimin; Campos, Carl; Habte, Frezghi; Sinclair, Robert; Brennan, Cameron W.; Mellinghoff, Ingo K.; Holland, Eric C.; Gambhir, Sanjiv S.			A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle	NATURE MEDICINE			English	Article							LIVING MICE; 5-AMINOLEVULINIC ACID; MALIGNANT GLIOMA; CARBON NANOTUBES; SPECTROSCOPY; RESECTION; FLUORESCENCE; AGENTS; SENSITIVITY; MICROSCOPY	The difficulty in delineating brain tumor margins is a major obstacle in the path toward better outcomes for patients with brain tumors. Current imaging methods are often limited by inadequate sensitivity, specificity and spatial resolution. Here we show that a unique triple-modality magnetic resonance imaging-photoacoustic imaging-Raman imaging nanoparticle (termed here MPR nanoparticle) can accurately help delineate the margins of brain tumors in living mice both preoperatively and intraoperatively. The MPRs were detected by all three modalities with at least a picomolar sensitivity both in vitro and in living mice. Intravenous injection of MPRs into glioblastoma-bearing mice led to MPR accumulation and retention by the tumors, with no MPR accumulation in the surrounding healthy tissue, allowing for a noninvasive tumor delineation using all three modalities through the intact skull. Raman imaging allowed for guidance of intraoperative tumor resection, and a histological correlation validated that Raman imaging was accurately delineating the brain tumor margins. This new triple-modality-nanoparticle approach has promise for enabling more accurate brain tumor imaging and resection.	[Kircher, Moritz F.; de la Zerda, Adam; Jokerst, Jesse V.; Zavaleta, Cristina L.; Mittra, Erik; Habte, Frezghi; Gambhir, Sanjiv S.] Stanford Univ, Dept Radiol, Mol Imaging Program Stanford, Stanford, CA 94305 USA; [Kircher, Moritz F.; Huang, Ruimin] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA; [Kircher, Moritz F.] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Kircher, Moritz F.; Pitter, Ken; Huang, Ruimin; Brennan, Cameron W.; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10021 USA; [de la Zerda, Adam] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Kempen, Paul J.; Sinclair, Robert; Gambhir, Sanjiv S.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Pitter, Ken; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA; [Huang, Ruimin; Mellinghoff, Ingo K.; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA; [Campos, Carl; Brennan, Cameron W.; Mellinghoff, Ingo K.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Brennan, Cameron W.; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10021 USA; [Brennan, Cameron W.; Holland, Eric C.] Weill Cornell Med Coll, Dept Neurosurg, New York, NY USA; [Mellinghoff, Ingo K.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Gambhir, Sanjiv S.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Gambhir, Sanjiv S.] Stanford Univ, Bio X Program, Stanford, CA 94305 USA	Stanford University; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Stanford University; Stanford University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Stanford University; Stanford University	Gambhir, SS (corresponding author), Stanford Univ, Dept Radiol, Mol Imaging Program Stanford, Stanford, CA 94305 USA.	sgambhir@stanford.edu	Zavaleta, Cristina/AAC-2306-2020; Kempen, Paul/J-6098-2014; Brennan, Cameron/R-7082-2019	Zavaleta, Cristina/0000-0001-7314-2446; Kempen, Paul/0000-0003-2179-2257; Brennan, Cameron/0000-0003-4064-8891; Campos, Carl/0000-0002-7616-8518; Pitter, Kenneth/0000-0002-9450-313X	National Cancer Institute [CCNE U54 CA119367, CCNE U54 U54CA151459, ICMIC P50 CA114747, 5R25CA118681]; Ben and Catherine Ivy Foundation; Canary Foundation; Sir Peter Michael Foundation; Bio-X Graduate Student Fellowship; Department of Defense [BC083014]; NATIONAL CANCER INSTITUTE [U54CA119367, U54CA151459, P50CA114747, U01CA141502, R25CA118681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS076028] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ben and Catherine Ivy Foundation; Canary Foundation; Sir Peter Michael Foundation; Bio-X Graduate Student Fellowship; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Gozin for help with ICP-AES, L. Pisani for assistance with quantifying and acquiring magnetic resonance data, S. M. Korn and S. Bodapati for assistance in conducting the photoacoustic experiments, J. Rosenberg for assistance with the statistical analysis and the Memorial Sloan-Kettering Cancer Center Animal Imaging Core Facility (J. Koutcher and C. C. Le) for technical assistance. M. F. K. would like to thank R. Herfkens and the Stanford Department of Radiology for providing academic time to perform the study. We would like to acknowledge the following funding sources: National Cancer Institute grants CCNE U54 CA119367 (S. S. G.), CCNE U54 U54CA151459 (S. S. G.) and ICMIC P50 CA114747 (S. S. G.); The Ben and Catherine Ivy Foundation (S. S. G.); the Canary Foundation (S. S. G.); the Sir Peter Michael Foundation (S. S. G.); the Bio-X Graduate Student Fellowship (A.d.l.Z.); the Department of Defense Breast Cancer Research Program-Pre-doctoral Traineeship Award BC083014 (A.d.l.Z.) and the National Cancer Institute SMIS R25T Fellowship 5R25CA118681 (J. V. J.). The authors would also like to thank T. F. Massoud, D. Akin, H. E. Daldrup-Link, S. Bohndiek, S. Harmsen and J. Samii for critical review of the manuscript and B. T. Khuri-Yakub, S. Vaithilingam, O. Oralkan, E. E. Graves and H. Fan-Minogue for helpful discussions.	Adiseshaiah PP, 2010, WIRES NANOMED NANOBI, V2, P99, DOI 10.1002/wnan.66; American National Standards Institute, 2000, Z13612000 ANSI INC; Beljebbar A, 2010, ANAL BIOANAL CHEM, V398, P477, DOI 10.1007/s00216-010-3910-6; Bucci MK, 2004, CANCER-AM CANCER SOC, V101, P817, DOI 10.1002/cncr.20422; De La Zerda A, 2008, NAT NANOTECHNOL, V3, P557, DOI 10.1038/nnano.2008.231; de la Zerda A, 2011, CONTRAST MEDIA MOL I, V6, P346, DOI 10.1002/cmmi.455; de la Zerda A, 2010, MOL IMAGING BIOL, V12, P500, DOI 10.1007/s11307-009-0290-4; de la Zerda A, 2010, NANO LETT, V10, P2168, DOI 10.1021/nl100890d; de la Zerda A, 2010, OPT LETT, V35, P270, DOI 10.1364/OL.35.000270; Ermilov SA, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3086616; Graves EE, 2007, TECHNOL CANCER RES T, V6, P111, DOI 10.1177/153303460700600207; Kantelhardt SR, 2008, LASER SURG MED, V40, P273, DOI 10.1002/lsm.20623; Keren S, 2008, P NATL ACAD SCI USA, V105, P5844, DOI 10.1073/pnas.0710575105; Kircher MF, 2011, NAT REV CLIN ONCOL, V8, P677, DOI 10.1038/nrclinonc.2011.141; Knauth M, 2001, NEURORADIOLOGY, V43, P254, DOI 10.1007/PL00006047; Knauth M, 1999, AM J NEURORADIOL, V20, P1547; Koljenovic S, 2007, ANAL CHEM, V79, P557, DOI 10.1021/ac0616512; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Ludemann L, 2000, MAGN RESON IMAGING, V18, P1201, DOI 10.1016/S0730-725X(00)00223-X; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Manohar S, 2007, OPT EXPRESS, V15, P12277, DOI 10.1364/OE.15.012277; Orringer DA, 2010, NEUROSURGERY, V66, P736, DOI 10.1227/01.NEU.0000367631.02903.50; Ozawa T, 2005, NEUROSURGERY, V57, P1041, DOI 10.1227/01.NEU.0000180036.42193.f6; Reinges MHT, 2004, ACTA NEUROCHIR, V146, P369, DOI 10.1007/s00701-003-0204-1; Shinoda J, 2003, J NEUROSURG, V99, P597, DOI 10.3171/jns.2003.99.3.0597; Short MA, 2008, OPT LETT, V33, P711, DOI 10.1364/OL.33.000711; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stupp R, 2006, ONCOLOGIST, V11, P165, DOI 10.1634/theoncologist.11-2-165; Thakor AS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001963; Thakor AS, 2011, SMALL, V7, P126, DOI 10.1002/smll.201001466; Toms SA, 2005, NEUROSURGERY, V57, P382, DOI 10.1227/01.NEU.000176855.39826.2D; Trehin R, 2006, NEOPLASIA, V8, P302, DOI 10.1593/neo.05751; Vivanco I, 2010, P NATL ACAD SCI USA, V107, P6459, DOI 10.1073/pnas.0911188107; Wang LV, 2009, NAT PHOTONICS, V3, P503, DOI 10.1038/NPHOTON.2009.157; Zavaleta C, 2008, NANO LETT, V8, P2800, DOI 10.1021/nl801362a; Zavaleta CL, 2011, J NUCL MED, V52, P1839, DOI 10.2967/jnumed.111.087775; Zavaleta CL, 2011, SMALL, V7, P2232, DOI 10.1002/smll.201002317; Zavaleta CL, 2009, P NATL ACAD SCI USA, V106, P13511, DOI 10.1073/pnas.0813327106; Zuin S, 2011, NANOTOXICOLOGY, V5, P445, DOI 10.3109/17435390.2010.512986	39	785	818	31	639	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					829	U235		10.1038/nm.2721	http://dx.doi.org/10.1038/nm.2721			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22504484	Green Accepted			2022-12-25	WOS:000303763500053
J	Siewert, K; Malotka, J; Kawakami, N; Wekerle, H; Hohlfeld, R; Dornmair, K				Siewert, Katherina; Malotka, Joachim; Kawakami, Naoto; Wekerle, Hartmut; Hohlfeld, Reinhard; Dornmair, Klaus			Unbiased identification of target antigens of CD8(+) T cells with combinatorial libraries coding for short peptides	NATURE MEDICINE			English	Article							RECEPTOR; RECOGNITION; LYMPHOCYTES; AUTOANTIGEN; RESPONSES; CHAIN; CDNA	Cytotoxic CD8(+) T cells recognize the antigenic peptides presented by class I major histocompatibility complex (MHC) molecules. These T cells have key roles in infectious diseases, autoimmunity and tumor immunology, but there is currently no unbiased method for the reliable identification of their target antigens. This is because of the low affinities of antigen-specific T cell receptors (TCR) to their target MHC-peptide complexes, the polyspecificity of these TCRs and the requirement that these TCRs recognize protein antigens that have been processed by antigen-presenting cells (APCs). Here we describe a technology for the unbiased identification of the antigenic peptides presented by MHC class I molecules. The technology uses plasmid-encoded combinatorial peptide libraries and a single-cell detection system. We validated this approach using a well-characterized influenza-virus-specific TCR, MHC and peptide combination. Single APCs carrying antigenic peptides can be detected among several million APCs that carry irrelevant peptides. The identified peptide sequences showed a converging pattern of mimotopes that revealed the parent influenza antigen. This technique should be generally applicable to the identification of disease-relevant T cell antigens.	[Siewert, Katherina; Hohlfeld, Reinhard; Dornmair, Klaus] Univ Munich, Inst Clin Neuroimmunol, Munich, Germany; [Siewert, Katherina; Malotka, Joachim; Kawakami, Naoto; Wekerle, Hartmut; Hohlfeld, Reinhard; Dornmair, Klaus] Max Planck Inst Neurobiol, Dept Neuroimmunol, Martinsried, Germany	University of Munich; Max Planck Society	Dornmair, K (corresponding author), Univ Munich, Inst Clin Neuroimmunol, Munich, Germany.	klaus.dornmair@med.uni-muenchen.de		Siewert, Katherina/0000-0003-0380-1594; Kawakami, Naoto/0000-0001-7693-3489	Deutsche Forschungsgemeinschaft [SFB 571 A1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank E. Meinl and W. E. F. Klinkert for comments on the manuscript, D. Hackl and M. Ackmann for help with synthesizing the plasmid pcDNA-NFAT-sGFP, I. Bartholomaus and M. Mues for advice regarding fluorescence microscopy, I. Eiglmeier for expert technical assistance and K. Ogston for editing the manuscript. This work was supported by the Deutsche Forschungsgemeinschaft (grant SFB 571 A1).	Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Bansal A, 2010, J EXP MED, V207, P51, DOI 10.1084/jem.20092060; Bendle GM, 2010, NAT MED, V16, P565, DOI 10.1038/nm.2128; Bettinotti MP, 2003, J IMMUNOL METHODS, V279, P143, DOI 10.1016/S0022-1759(03)00233-3; BLANK U, 1993, EUR J IMMUNOL, V23, P3057, DOI 10.1002/eji.1830231203; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Crawford F, 2006, IMMUNOL REV, V210, P156, DOI 10.1111/j.0105-2896.2006.00365.x; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; Friese MA, 2009, ANN NEUROL, V66, P132, DOI 10.1002/ana.21744; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GOTCH F, 1987, NATURE, V326, P881, DOI 10.1038/326881a0; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Hammer GE, 2007, IMMUNITY, V26, P397, DOI 10.1016/j.immuni.2007.04.003; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Hemmer B, 1999, NAT MED, V5, P1375; Ishizuka J, 2008, IMMUNITY, V28, P171, DOI 10.1016/j.immuni.2007.12.018; KARTTUNEN J, 1991, P NATL ACAD SCI USA, V88, P3972, DOI 10.1073/pnas.88.9.3972; Kaufmann SHE, 2007, NAT REV MICROBIOL, V5, P491, DOI 10.1038/nrmicro1688; Kawakami N, 2005, J EXP MED, V201, P1805, DOI 10.1084/jem.20050011; LEHNER PJ, 1995, J EXP MED, V181, P79, DOI 10.1084/jem.181.1.79; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Nino-Vasquez JJ, 2004, MOL IMMUNOL, V40, P1063, DOI 10.1016/j.molimm.2003.11.005; PIRCHER H, 1989, EMBO J, V8, P719, DOI 10.1002/j.1460-2075.1989.tb03431.x; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Seitz S, 2006, P NATL ACAD SCI USA, V103, P12057, DOI 10.1073/pnas.0604247103; Smith ES, 2001, NAT MED, V7, P967, DOI 10.1038/91017; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Venturi V, 2008, NAT REV IMMUNOL, V8, P231, DOI 10.1038/nri2260; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Walter U, 2005, CURR OPIN IMMUNOL, V17, P624, DOI 10.1016/j.coi.2005.09.014; Wong FS, 1999, NAT MED, V5, P1026, DOI 10.1038/12465; Wucherpfennig KW, 2007, SEMIN IMMUNOL, V19, P216, DOI 10.1016/j.smim.2007.02.012; Zhao YD, 2001, J IMMUNOL, V167, P2130, DOI 10.4049/jimmunol.167.4.2130	36	39	44	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					824	U228		10.1038/nm.2720	http://dx.doi.org/10.1038/nm.2720			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22484809				2022-12-25	WOS:000303763500052
J	Albers, CA; Paul, DS; Schulze, H; Freson, K; Stephens, JC; Smethurst, PA; Jolley, JD; Cvejic, A; Kostadima, M; Bertone, P; Breuning, MH; Debili, N; Deloukas, P; Favier, R; Fiedler, J; Hobbs, CM; Huang, N; Hurles, ME; Kiddle, G; Krapels, I; Nurden, P; Ruivenkamp, CAL; Sambrook, JG; Smith, K; Stemple, DL; Strauss, G; Thys, C; van Geet, C; Newbury-Ecob, R; Ouwehand, WH; Ghevaert, C				Albers, Cornelis A.; Paul, Dirk S.; Schulze, Harald; Freson, Kathleen; Stephens, Jonathan C.; Smethurst, Peter A.; Jolley, Jennifer D.; Cvejic, Ana; Kostadima, Myrto; Bertone, Paul; Breuning, Martijn H.; Debili, Najet; Deloukas, Panos; Favier, Remi; Fiedler, Janine; Hobbs, Catherine M.; Huang, Ni; Hurles, Matthew E.; Kiddle, Graham; Krapels, Ingrid; Nurden, Paquita; Ruivenkamp, Claudia A. L.; Sambrook, Jennifer G.; Smith, Kenneth; Stemple, Derek L.; Strauss, Gabriele; Thys, Chantal; van Geet, Chris; Newbury-Ecob, Ruth; Ouwehand, Willem H.; Ghevaert, Cedric			Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome	NATURE GENETICS			English	Article							DEVELOPMENTAL DISORDER; THROMBOCYTOPENIA; BINDING; COMPONENT; GENE; EXPRESSION	The exon-junction complex (EJC) performs essential RNA processing tasks(1-5). Here, we describe the first human disorder, thrombocytopenia with absent radii (TAR)(6), caused by deficiency in one of the four EJC subunits. Compound inheritance of a rare null allele and one of two low-frequency SNPs in the regulatory regions of RBM8A, encoding the Y14 subunit of EJC, causes TAR. We found that this inheritance mechanism explained 53 of 55 cases (P < 5 x 10(-228)) of the rare congenital malformation syndrome. Of the 53 cases with this inheritance pattern, 51 carried a submicroscopic deletion of 1q21.1 that has previously been associated with TAR(7), and two carried a truncation or frameshift null mutation in RBM8A. We show that the two regulatory SNPs result in diminished RBM8A transcription in vitro and that Y14 expression is reduced in platelets from individuals with TAR. Our data implicate Y14 insufficiency and, presumably, an EJC defect as the cause of TAR syndrome.	[Albers, Cornelis A.; Stephens, Jonathan C.; Smethurst, Peter A.; Jolley, Jennifer D.; Cvejic, Ana; Hobbs, Catherine M.; Kiddle, Graham; Sambrook, Jennifer G.; Ouwehand, Willem H.; Ghevaert, Cedric] Univ Cambridge, Dept Haematol, Cambridge, England; [Albers, Cornelis A.; Stephens, Jonathan C.; Smethurst, Peter A.; Jolley, Jennifer D.; Cvejic, Ana; Hobbs, Catherine M.; Kiddle, Graham; Sambrook, Jennifer G.; Ouwehand, Willem H.; Ghevaert, Cedric] Natl Hlth Serv NHS Blood & Transplant, Cambridge, England; [Albers, Cornelis A.; Paul, Dirk S.; Cvejic, Ana; Deloukas, Panos; Huang, Ni; Hurles, Matthew E.; Stemple, Derek L.; Ouwehand, Willem H.] Wellcome Trust Sanger Inst, Cambridge, England; [Schulze, Harald] Charite, Inst Transfus Med, D-13353 Berlin, Germany; [Schulze, Harald; Fiedler, Janine] Charite, Lab Pediat Mol Biol, D-13353 Berlin, Germany; [Freson, Kathleen; Thys, Chantal; van Geet, Chris] Univ Leuven, Ctr Mol & Vasc Biol, Louvain, Belgium; [Kostadima, Myrto; Bertone, Paul] EBI, EMBL, Cambridge, England; [Breuning, Martijn H.; Ruivenkamp, Claudia A. L.] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; [Debili, Najet; Favier, Remi] INSERM, U790, Villejuif, France; [Fiedler, Janine] Free Univ Berlin, Dept Biol Chem & Pharm, Berlin, Germany; [Krapels, Ingrid] Maastricht Univ, Med Ctr, Dept Clin Genet, Maastricht, Netherlands; [Nurden, Paquita] Hop Xavier Arnozan, Ctr Reference Pathol Plaquettaires, Hematol Lab, Pessac, France; [Smith, Kenneth; Newbury-Ecob, Ruth] Univ Bristol, Div Child Hlth, Bristol, Avon, England; [Smith, Kenneth; Newbury-Ecob, Ruth] St Michaels Hosp, Dept Clin Genet, Bristol, Avon, England; [Strauss, Gabriele] Charite, Dept Pediat Oncol & Hematol, D-13353 Berlin, Germany; [van Geet, Chris] Univ Ziekenhuis Leuven, Dept Pediat, Louvain, Belgium	University of Cambridge; Wellcome Trust Sanger Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; KU Leuven; European Molecular Biology Laboratory (EMBL); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Institut National de la Sante et de la Recherche Medicale (Inserm); Free University of Berlin; Maastricht University; CHU Bordeaux; University of Bristol; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; KU Leuven; University Hospital Leuven	Albers, CA (corresponding author), Univ Cambridge, Dept Haematol, Cambridge, England.	caa@sanger.ac.uk; cg348@cam.ac.uk	Bertone, Paul/A-6600-2013; Paul, Dirk S./H-3469-2019; Bertone, Paul/Z-3734-2019; Albers, Kees/A-4170-2015; Deloukas, Panos/B-2922-2013	Bertone, Paul/0000-0001-5059-4829; Paul, Dirk S./0000-0002-8230-0116; Bertone, Paul/0000-0001-5059-4829; Albers, Kees/0000-0003-4115-3727; Deloukas, Panos/0000-0001-9251-070X; Stephens, Jonathan/0000-0003-2020-9330; Cvejic, Ana/0000-0003-3204-9311; Kostadima, Myrto Areti/0000-0002-1818-4050; Ouwehand, Willem/0000-0002-7744-1790; Ghevaert, Cedric/0000-0002-9251-0934; freson, kathleen/0000-0002-4381-2442	National Institutes for Health Research (NIHR) [RP-PG-0310-1002, RBAG096]; British Heart Foundation [FS/09/039, RG/09/12/28096]; Wellcome Trust [WT-082597/Z/07/Z, WT-084183/2/07/2, WT091310]; Deutsche Forschungsgemeinschaft [SCHU1421/3-1]; Sanitatsrat Dr. Emil Alexander Hubner-und-Gemahlin-Stiftung [T114/17644/2008/sm]; Excellentie Financiering KULeuven [EF/05/013]; Fonds Wetenschappelijk Onderzoek-Vlaanderen [G.0490.10N, G.0743.09]; Research Council of the University of Leuven (Onderzoeksraad-K.U. Leuven) [GOA/2009/13]; Marie-Curie NetSim Initial Training Network [EC-215820]; Gis-Maladies Rares, Diagnostic Differentiel des Purpuras Thrombopeniques Idiopathiques Chroniques et des Thrombopenies Congenitales (DIATROC); INSERM [ANR-08-GENO-028-03]; British Heart Foundation [FS/09/039/27788, RG/09/012/28096, RG/08/014/24067] Funding Source: researchfish; National Institute for Health Research [RP-PG-0310-1002] Funding Source: researchfish	National Institutes for Health Research (NIHR); British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome Trust); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sanitatsrat Dr. Emil Alexander Hubner-und-Gemahlin-Stiftung; Excellentie Financiering KULeuven(KU Leuven); Fonds Wetenschappelijk Onderzoek-Vlaanderen(FWO); Research Council of the University of Leuven (Onderzoeksraad-K.U. Leuven); Marie-Curie NetSim Initial Training Network; Gis-Maladies Rares, Diagnostic Differentiel des Purpuras Thrombopeniques Idiopathiques Chroniques et des Thrombopenies Congenitales (DIATROC); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank C. Langford and P. Ellis for performing the enrichment for the exome sequencing, S. Balasubramaniam for assistance with data processing and the Wellcome Trust Sanger Institute sequencing core for sequencing. We thank V. Mooser from GlaxoSmithKline, G. Waeber and P. Vollenweider from CoLaus and J. Durham, C. Scott and colleagues at the Sanger Institute for providing access to their collection of whole-exome sequencing data for the CoLaus cohort<SUP>12</SUP>. We thank R. Durbin, B. Gottgens and I. Palacios for comments on the manuscript. This study makes use of data generated by the UK10K Consortium, which were derived from samples from the TwinsUK cohort. A full list of the investigators who contributed to the generation of the data is available from their website (see URLs). The study was supported by grants from the National Institutes for Health Research (NIHR; RP-PG-0310-1002 to C.G., G.K., P.A.S. and W.H.O.), the British Heart Foundation (FS/09/039 to C.G. and RG/09/12/28096 to C.A.A.), project grants from the Wellcome Trust (WT-082597/Z/07/Z to A.C. and WT-084183/2/07/2 to J.C.S.), grants by the Deutsche Forschungsgemeinschaft (SCHU1421/3-1 to H.S.) and the Sanitatsrat Dr. Emil Alexander Hubner-und-Gemahlin-Stiftung (T114/17644/2008/sm to H.S.), by the Excellentie Financiering KULeuven (EF/05/013), by research grants from the Fonds Wetenschappelijk Onderzoek-Vlaanderen (G.0490.10N and G.0743.09) and by a grant from the Research Council of the University of Leuven (Onderzoeksraad-K.U. Leuven; GOA/2009/13 to C.T., K.F. and C.v.G.). The project made use of NHS Blood and Transplant donors from the Cambridge BioResource (see URLs). This local resource for genotype-phenotype association studies is supported by a grant from the NIHR to the Cambridge Biomedical Research Centre (RBAG096 to J.C.S. and J.D.J.). D.S.P. and M.K. were supported by a Marie-Curie NetSim Initial Training Network grant (EC-215820). The French cases were collected with support from the Gis-Maladies Rares, Diagnostic Differentiel des Purpuras Thrombopeniques Idiopathiques Chroniques et des Thrombopenies Congenitales (DIATROC) program and INSERM (ANR-08-GENO-028-03). Funding for UK10K was provided by the Wellcome Trust (WT091310).	Albers CA, 2011, NAT GENET, V43, P735, DOI 10.1038/ng.885; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Coffey AJ, 2011, EUR J HUM GENET, V19, P827, DOI 10.1038/ejhg.2011.28; Edery P, 2011, SCIENCE, V332, P240, DOI 10.1126/science.1202205; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Freson K, 2001, BLOOD, V98, P85, DOI 10.1182/blood.V98.1.85; Freson K, 2007, J HYPERTENS, V25, P117, DOI 10.1097/HJH.0b013e3280109c6c; Geddis AE, 2006, SEMIN HEMATOL, V43, P196, DOI 10.1053/j.seminhematol.2006.04.003; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Gnatenko DV, 2003, BLOOD, V101, P2285, DOI 10.1182/blood-2002-09-2797; Greenhalgh KL, 2002, J MED GENET, V39, P876, DOI 10.1136/jmg.39.12.876; Hachet O, 2001, CURR BIOL, V11, P1666, DOI 10.1016/S0960-9822(01)00508-5; HALL JG, 1969, MEDICINE, V48, P411, DOI 10.1097/00005792-196948060-00001; Haremaki T, 2010, DEV DYNAM, V239, P1977, DOI 10.1002/dvdy.22330; He HL, 2011, SCIENCE, V332, P238, DOI 10.1126/science.1200587; Kim VN, 2001, SCIENCE, V293, P1832, DOI 10.1126/science.1062829; Klopocki E, 2007, AM J HUM GENET, V80, P232, DOI 10.1086/510919; Lawrence M, 2009, BIOINFORMATICS, V25, P1841, DOI 10.1093/bioinformatics/btp328; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lykke-Andersen J, 2001, SCIENCE, V293, P1836, DOI 10.1126/science.1062786; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Paul DS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002139; PERKINS AS, 1991, DEVELOPMENT, V111, P479; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Salicioni AM, 2000, GENOMICS, V69, P54, DOI 10.1006/geno.2000.6315; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Tarpey PS, 2007, NAT GENET, V39, P1127, DOI 10.1038/ng2100; Tijssen MR, 2011, DEV CELL, V20, P597, DOI 10.1016/j.devcel.2011.04.008; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808; Wiegand HL, 2003, P NATL ACAD SCI USA, V100, P11327, DOI 10.1073/pnas.1934877100; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057	36	273	278	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2012	44	4					435	U248		10.1038/ng.1083	http://dx.doi.org/10.1038/ng.1083			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	916VF	22366785	Green Accepted			2022-12-25	WOS:000302130600019
J	Kang, MJ; Chung, J; Ryoo, HD				Kang, Min-Ji; Chung, Jaehoon; Ryoo, Hyung Don			CDK5 and MEKK1 mediate pro-apoptotic signalling following endoplasmic reticulum stress in an autosomal dominant retinitis pigmentosa model	NATURE CELL BIOLOGY			English	Article							UNFOLDED PROTEIN RESPONSE; GENE-EXPRESSION; CELL-DEATH; RETINAL DEGENERATION; RHODOPSIN MUTATIONS; OXIDATIVE STRESS; TERMINAL KINASE; CASPASE DRONC; DROSOPHILA; P35	Chronic stress in the endoplasmic reticulum (ER) underlies many degenerative and metabolic diseases involving apoptosis of vital cells. A well-established example is autosomal dominant retinitis pigmentosa (ADRP), an age-related retinal degenerative disease caused by mutant rhodopsins(1,2). Similar mutant alleles of Drosophila Rhodopsin-1 also impose stress on the ER and cause age-related retinal degeneration in that organism(3). Well-characterized signalling responses to ER stress, referred to as the unfolded protein response(4) (UPR), induce various ER quality control genes that can suppress such retinal degeneration(5). However, how cells activate cell death programs after chronic ER stress remains poorly understood. Here, we report the identification of a signalling pathway mediated by cdk5 and mekk1 required for ER-stress-induced apoptosis. Inactivation of these genes specifically suppressed apoptosis, without affecting other protective branches of the UPR. CDK5 phosphorylates MEKK1, and together, they activate the JNK pathway for apoptosis. Moreover, disruption of this pathway can delay the course of age-related retinal degeneration in a Drosophila model of ADRP. These findings establish a previously unrecognized branch of ER-stress response signalling involved in degenerative diseases.	[Kang, Min-Ji; Chung, Jaehoon; Ryoo, Hyung Don] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University	Ryoo, HD (corresponding author), NYU, Sch Med, Dept Cell Biol, 550 1st Ave, New York, NY 10016 USA.	Hyungdon.Ryoo@nyumc.org		Ryoo, Hyung Don/0000-0002-1046-535X	National Institutes of Health [R01EY020866]; NATIONAL EYE INSTITUTE [R01EY020866] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank E. Giniger (NIH, USA), K. Matsumoto (Nagoya University, Japan), M. Miura (Tokyo University, Japan), the VDRC and Bloomington stock centres for reagents, E. Robbins, M. Pagano and E. Zito for technical advice, and D. Ron for discussions and critical comments on the manuscript. This work was supported by the National Institutes of Health grant R01EY020866. H.D.R. is an Ellison Medical Foundation New Scholar.	Armknecht S, 2005, METHOD ENZYMOL, V392, P55, DOI 10.1016/S0076-6879(04)92004-6; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chew SK, 2004, DEV CELL, V7, P897, DOI 10.1016/j.devcel.2004.09.016; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; COLLEY NJ, 1995, P NATL ACAD SCI USA, V92, P3070, DOI 10.1073/pnas.92.7.3070; Connell-Crowley L, 2000, CURR BIOL, V10, P599, DOI 10.1016/S0960-9822(00)00487-5; Connell-Crowley L, 2007, MECH DEVELOP, V124, P341, DOI 10.1016/j.mod.2007.02.002; Dhavan R, 2002, J NEUROSCI, V22, P7879; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; ELBEIN AD, 1983, METHOD ENZYMOL, V98, P135; Glise B, 1997, GENE DEV, V11, P1738, DOI 10.1101/gad.11.13.1738; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Hewes RS, 2000, GENETICS, V155, P1711; Inoue H, 2001, EMBO J, V20, P5421, DOI 10.1093/emboj/20.19.5421; Kang MJ, 2009, P NATL ACAD SCI USA, V106, P17043, DOI 10.1073/pnas.0905566106; KURADA P, 1995, NEURON, V14, P571, DOI 10.1016/0896-6273(95)90313-5; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Li G, 2010, J CELL BIOL, V191, P1113, DOI 10.1083/jcb.201006121; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Morrison DK, 2000, J CELL BIOL, V150, pF57, DOI 10.1083/jcb.150.2.F57; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Pichaud F, 2001, DEVELOPMENT, V128, P815; Qu D, 2007, NEURON, V55, P37, DOI 10.1016/j.neuron.2007.05.033; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Saito T, 2007, J NEUROCHEM, V102, P133, DOI 10.1111/j.1471-4159.2007.04540.x; Seong KH, 2011, CELL, V145, P1049, DOI 10.1016/j.cell.2011.05.029; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; Timmins JM, 2009, J CLIN INVEST, V119, P2925, DOI 10.1172/JCI38857; TOMLINSON A, 1985, J EMBRYOL EXP MORPH, V89, P313; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; Xu DB, 2005, DEVELOPMENT, V132, P2125, DOI 10.1242/dev.01790; XU T, 1993, DEVELOPMENT, V117, P1223; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Zhang YP, 2008, DEV CELL, V14, P481, DOI 10.1016/j.devcel.2008.01.018	45	63	68	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2012	14	4					409	+		10.1038/ncb2447	http://dx.doi.org/10.1038/ncb2447			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	921UM	22388889	Green Accepted			2022-12-25	WOS:000302503300014
J	Lee, SH; DeCandia, TR; Ripke, S; Yang, J; Sullivan, PF; Goddard, ME; Keller, MC; Visscher, PM; Wray, NR				Lee, S. Hong; DeCandia, Teresa R.; Ripke, Stephan; Yang, Jian; Sullivan, Patrick F.; Goddard, Michael E.; Keller, Matthew C.; Visscher, Peter M.; Wray, Naomi R.		Schizophrenia Psychiat Genome-Wide; Int Schizophrenia Consortium ISC; Mol Genetics Schizophrenia	Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs	NATURE GENETICS			English	Article							VARIANTS; DISEASE; TRAIT	Schizophrenia is a complex disorder caused by both genetic and environmental factors. Using 9,087 affected individuals, 12,171 controls and 915,354 imputed SNPs from the Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium (PGC-SCZ), we estimate that 23% (s.e. = 1%) of variation in liability to schizophrenia is captured by SNPs. We show that a substantial proportion of this variation must be the result of common causal variants, that the variance explained by each chromosome is linearly related to its length (r = 0.89, P = 2.6 x 10(-8)), that the genetic basis of schizophrenia is the same in males and females, and that a disproportionate proportion of variation is attributable to a set of 2,725 genes expressed in the central nervous system (CNS; P = 7.6 x 10(-8)). These results are consistent with a polygenic genetic architecture and imply more individual SNP associations will be detected for this disease as sample size increases.	[Lee, S. Hong; Visscher, Peter M.; Wray, Naomi R.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Lee, S. Hong; Yang, Jian; Visscher, Peter M.; Wray, Naomi R.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [DeCandia, Teresa R.; Keller, Matthew C.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [DeCandia, Teresa R.; Keller, Matthew C.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Ripke, Stephan] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Ripke, Stephan] MIT, Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02139 USA; [Ripke, Stephan] Harvard Univ, Cambridge, MA 02138 USA; [Yang, Jian; Visscher, Peter M.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld 4102, Australia; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Goddard, Michael E.] Univ Melbourne, Dept Agr & Food Syst, Melbourne, Vic, Australia; [Goddard, Michael E.] Dept Primary Ind, Biosci Res Div, Melbourne, Vic, Australia	University of Queensland; QIMR Berghofer Medical Research Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; University of Queensland; University of North Carolina; University of North Carolina Chapel Hill; University of Melbourne	Wray, NR (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	naomi.wray@uq.edu.au	Wray, Naomi/C-8639-2015; Konte, Bettina/AAT-1142-2021; Yang, Jian/A-5852-2010; Ripke, Stephan/AAK-5486-2021; van Os, Jim/C-2113-2014; Visscher, Peter/ABB-6151-2020; Hansen, Thomas Folkmann/O-5965-2014; Hartmann, Annette/AAS-6331-2021; Lee, Sang Hong/A-2569-2011; Andreassen, Ole A./AAY-7531-2020; Mowry, Bryan/G-5046-2010	Wray, Naomi/0000-0001-7421-3357; Konte, Bettina/0000-0001-5287-308X; Yang, Jian/0000-0003-2001-2474; Visscher, Peter/0000-0002-2143-8760; Hansen, Thomas Folkmann/0000-0001-6703-7762; Lee, Sang Hong/0000-0001-9701-2718; Goddard, Michael/0000-0001-9917-7946; KELLER, MATTHEW/0000-0002-6075-9882; ripke, stephan/0000-0003-3622-835X; Mowry, Bryan/0000-0002-4115-5645	Australian National Health and Medical Research Council [389892, 442915, 496688, 613672, 613601]; Australian Research Council [DP0770096, DP1093502, FT0991360]; US National Institute of Mental Health [MH085812]; Netherlands Scientific Organization (NWO) [480-05-003]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278, M01RR018535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061675, U01MH079470, P30MH074543, P50MH066392, R01MH077139, R01MH061884, R01MH084098, R01MH085542, U01MH046289, R01MH079800, R01MH078075, K23MH001760, R01MH059587, U01MH046276, R01MH059571, U01MH085520, K01MH085812, R01MH058693, R01MH060870, U01MH079469, R01MH085548, R01MH059586, R01MH067257, R01MH074027, R01MH081800, R01MH071681, N01MH090001, U01MH046318, R01MH052618, R01MH060879, R01MH059566, R01MH059588, R01MH080403, R01MH059565] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Netherlands Scientific Organization (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank S. D. Gordon for technical assistance. We acknowledge funding from the Australian National Health and Medical Research Council (389892, 442915, 496688, 613672 and 613601), the Australian Research Council (DP0770096, DP1093502 and FT0991360) and the US National Institute of Mental Health (MH085812). This research utilized the Cluster Computer, which is funded by the Netherlands Scientific Organization (NWO; 480-05-003). Acknowledgments for PGC-SCZ are listed in the Supplementary Note.	Abel KM, 2010, INT REV PSYCHIATR, V22, P417, DOI 10.3109/09540261.2010.515205; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.3.CO;2-L; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Craddock N, 2007, BRIT J PSYCHIAT, V190, P200, DOI 10.1192/bjp.bp.106.033761; Gilmour A., 2006, ASREML USER GUIDE RE; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lee SH, 2006, GENET SEL EVOL, V38, P25, DOI 10.1051/gse:2005025; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; McClellan J, 2010, JAMA-J AM MED ASSOC, V303, P2523, DOI 10.1001/jama.2010.869; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; McClellan JM, 2007, BRIT J PSYCHIAT, V190, P194, DOI 10.1192/bjp.bp.106.025585; Moskvina V, 2009, MOL PSYCHIATR, V14, P252, DOI 10.1038/mp.2008.133; Powell JE, 2010, NAT REV GENET, V11, P800, DOI 10.1038/nrg2865; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Visscher PM, 2012, MOL PSYCHIATR, V17, P474, DOI 10.1038/mp.2011.65; Wray NR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000579; Wray NR, 2005, TWIN RES HUM GENET, V8, P87; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yang J, 2010, GENET EPIDEMIOL, V34, P254, DOI 10.1002/gepi.20456	27	421	424	0	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2012	44	3					247	U35		10.1038/ng.1108	http://dx.doi.org/10.1038/ng.1108			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	899VC	22344220	Green Accepted, Green Submitted			2022-12-25	WOS:000300843600006
J	Bird-Lieberman, EL; Neves, AA; Lao-Sirieix, P; O'Donovan, M; Novelli, M; Lovat, LB; Eng, WS; Mahal, LK; Brindle, KM; Fitzgerald, RC				Bird-Lieberman, Elizabeth L.; Neves, Andre A.; Lao-Sirieix, Pierre; O'Donovan, Maria; Novelli, Marco; Lovat, Laurence B.; Eng, William S.; Mahal, Lara K.; Brindle, Kevin M.; Fitzgerald, Rebecca C.			Molecular imaging using fluorescent lectins permits rapid endoscopic identification of dysplasia in Barrett's esophagus	NATURE MEDICINE			English	Article							WHEAT-GERM-AGGLUTININ; HIGH-GRADE DYSPLASIA; CANCER; ADENOCARCINOMA; BIOPSY; SPECTROSCOPY; MICROARRAY; NEOPLASIA; SURVIVAL; JUNCTION	Barrett's esophagus is an example of a pre-invasive state, for which current endoscopic surveillance methods to detect dysplasia are time consuming and inadequate. The prognosis of cancer arising in Barrett's esophagus is improved by early detection at the stage of mucosal carcinoma or high-grade dysplasia. Molecular imaging methods could revolutionize the detection of dysplasia, provided they permit a wide field of view and highlight abnormalities in real time. We show here that cell-surface glycans are altered in the progression from Barrett's esophagus to adenocarcinoma and lead to specific changes in lectin binding patterns. We chose wheat germ agglutinin as a candidate lectin with clinical potential. The binding of wheat germ agglutinin to human tissue was determined to be specific, and we validated this specific binding by successful endoscopic visualization of high-grade dysplastic lesions, which were not detectable by conventional endoscopy, with a high signal-to-background ratio of over 5.	[Bird-Lieberman, Elizabeth L.; Lao-Sirieix, Pierre; Fitzgerald, Rebecca C.] Hutchison MRC Res Ctr, Med Res Council Canc Cell Unit, Cambridge, England; [Neves, Andre A.; Brindle, Kevin M.] Univ Cambridge, Canc Res UK Cambridge Res Inst, Cambridge, England; [Neves, Andre A.; Brindle, Kevin M.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [O'Donovan, Maria] Addenbrookes Hosp, Dept Pathol, Cambridge, England; [Novelli, Marco] UCL, Dept Pathol, London, England; [Lovat, Laurence B.] UCL, Dept Gastroenterol, London, England; [Eng, William S.; Mahal, Lara K.] NYU, Dept Chem, New York, NY 10003 USA	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London; University of London; University College London; New York University	Fitzgerald, RC (corresponding author), Hutchison MRC Res Ctr, Med Res Council Canc Cell Unit, Cambridge, England.	rcf29@hutchison-mrc.cam.ac.uk	Mahal, Lara/GRY-7287-2022; Lovat, Laurence/C-1986-2009; Neves, Andre/B-8397-2011	Lovat, Laurence/0000-0003-4542-3915; Neves, Andre/0000-0003-2740-5166; Mahal, Lara/0000-0003-4791-8524; Bird-Lieberman, Elizabeth/0000-0002-5273-7536; Fitzgerald, Rebecca/0000-0002-3434-3568	GlaxoSmithKline; Medical Research Centre; Cambridge Experimental Medicine Centre; National Institute for Health Research Cambridge Biomedical Research Centre; Cancer Research UK; New York University; US National Institutes of Health; Department of Health's NIHR Biomedical Research Centre; MRC [MC_U105365007] Funding Source: UKRI; Medical Research Council [MC_U105365007] Funding Source: researchfish	GlaxoSmithKline(GlaxoSmithKline); Medical Research Centre; Cambridge Experimental Medicine Centre; National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); New York University; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health's NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a research fellowship from GlaxoSmithKline awarded to E.L.B.-L. The authors thank J. Ong, C. Peters, S. Hilborne, E. Moore, N. Shannon, B. Spencer, R. Cayado-Lopez, B. Haynes, J. Gray, W. Howat, J. Harris and S. Reichelt for their advice and support and the Moritex Corporation for lending the evanescent lectin array equipment (Glycostation). This work was supported by a Medical Research Centre core grant (R.C.F.), the Cambridge Experimental Medicine Centre (R.C.F.), the National Institute for Health Research Cambridge Biomedical Research Centre (R.C.F.), a Cancer Research UK core grant (K.M.B.) and a Clinical Research Fellowship from GlaxoSmithKline (E.L.B.-L.). The work undertaken in the Department of Chemistry, University of New York was supported by a New York University startup fund and by the US National Institutes of Health (W.S.E. and L.K.M.). The work undertaken at UCLH/UCL was supported in part by funding from the Department of Health's NIHR Biomedical Research Centre's funding scheme and also by a grant from Cancer Research UK to the Experimental Cancer Research Centre, UCL. The views expressed in this publication are those of the authors and not necessarily those of the UK Department of Health.	Cook MB, 2009, BRIT J CANCER, V101, P855, DOI 10.1038/sj.bjc.6605246; Curvers WL, 2011, GASTROINTEST ENDOSC, V73, P195, DOI 10.1016/j.gie.2010.10.014; DENNIS J, 1982, NATURE, V300, P274, DOI 10.1038/300274a0; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Evans JA, 2007, GASTROINTEST ENDOSC, V65, P50, DOI 10.1016/j.gie.2006.04.027; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gabor F, 2004, ADV DRUG DELIVER REV, V56, P459, DOI 10.1016/j.addr.2003.10.015; Hsiung PL, 2008, NAT MED, V14, P454, DOI 10.1038/nm1692; Kendall C, 2003, J PATHOL, V200, P602, DOI 10.1002/path.1376; Kobayashi H, 2004, CLIN CANCER RES, V10, P7712, DOI 10.1158/1078-0432.CCR-04-1175; KRONIS KA, 1982, BIOCHEMISTRY-US, V21, P3050, DOI 10.1021/bi00256a003; Kuno A, 2005, NAT METHODS, V2, P851, DOI 10.1038/NMETH803; Laughlin ST, 2009, P NATL ACAD SCI USA, V106, P12, DOI 10.1073/pnas.0811481106; Li M, 2010, GASTROENTEROLOGY, V139, P1472, DOI 10.1053/j.gastro.2010.07.007; Lovat LB, 2006, GUT, V55, P1078, DOI 10.1136/gut.2005.081467; Medarova Z, 2009, CANCER RES, V69, P1182, DOI 10.1158/0008-5472.CAN-08-2001; MIYAKE M, 1992, NEW ENGL J MED, V327, P14, DOI 10.1056/NEJM199207023270103; NAGATA Y, 1972, J BIOL CHEM, V247, P2248; Peters CJ, 2010, GASTROENTEROLOGY, V139, P1995, DOI 10.1053/j.gastro.2010.05.080; Pilobello KT, 2007, P NATL ACAD SCI USA, V104, P11534, DOI 10.1073/pnas.0704954104; Pohl H, 2008, GUT, V57, P1648, DOI 10.1136/gut.2008.157461; Pyhtila JW, 2007, GASTROINTEST ENDOSC, V65, P487, DOI 10.1016/j.gie.2006.10.016; Qiu L, 2010, NAT MED, V16, P603, DOI 10.1038/nm.2138; Reid BJ, 2000, AM J GASTROENTEROL, V95, P1669, DOI 10.1111/j.1572-0241.2000.02196.x; REID BJ, 1988, GASTROENTEROLOGY, V94, P81, DOI 10.1016/0016-5085(88)90613-0; Reid BJ, 2000, AM J GASTROENTEROL, V95, P3089, DOI 10.1111/j.1572-0241.2000.03182.x; Reid BJ, 2010, NAT REV CANCER, V10, P87, DOI 10.1038/nrc2773; Shaheen NJ, 2009, NEW ENGL J MED, V360, P2277, DOI 10.1056/NEJMoa0808145; Shen YQ, 2004, BIOL CHEM, V385, P145, DOI 10.1515/BC.2004.033; Soukos NS, 2001, CANCER RES, V61, P4490; Spechler SJ, 2010, GASTROENTEROLOGY, V138, P854, DOI 10.1053/j.gastro.2010.01.002; Themelis G., 2010, BIOMEDICAL OPTICS; YOGEESWARAN G, 1981, SCIENCE, V212, P1514, DOI 10.1126/science.7233237	33	175	177	0	42	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					315	321		10.1038/nm.2616	http://dx.doi.org/10.1038/nm.2616			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22245781				2022-12-25	WOS:000300140300049
J	Vollmer, W				Vollmer, Waldemar			Bacterial outer membrane evolution via sporulation?	NATURE CHEMICAL BIOLOGY			English	Article							PEPTIDOGLYCAN STRUCTURE; ARCHITECTURE; MECHANISM		Newcastle Univ, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Vollmer, W (corresponding author), Newcastle Univ, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	w.vollmer@ncl.ac.uk			Biotechnology and Biological Sciences Research Council [BB/I020012/1] Funding Source: Medline; BBSRC [BB/I020012/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Atrih A, 1996, J BACTERIOL, V178, P6173, DOI 10.1128/jb.178.21.6173-6183.1996; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Broder DH, 2006, CELL, V126, P917, DOI 10.1016/j.cell.2006.06.053; Bui NK, 2009, J BACTERIOL, V191, P494, DOI 10.1128/JB.00608-08; Cava F, 2004, MOL MICROBIOL, V52, P677, DOI 10.1111/j.1365-2958.2004.04011.x; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Gupta RS, 2011, ANTON LEEUW INT J G, V100, P171, DOI 10.1007/s10482-011-9616-8; Hayhurst EJ, 2008, P NATL ACAD SCI USA, V105, P14603, DOI 10.1073/pnas.0804138105; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; Kaiser D, 2003, NAT REV MICROBIOL, V1, P45, DOI 10.1038/nrmicro733; Kleanthous C, 2010, NAT REV MICROBIOL, V8, P843, DOI 10.1038/nrmicro2454; Kleinschnitz EM, 2011, MOL MICROBIOL, V79, P1367, DOI 10.1111/j.1365-2958.2010.07529.x; Kojima S, 2011, J BACTERIOL, V193, P2347, DOI 10.1128/JB.00106-11; Ludwig W., 2005, BERGEYS MANUAL SYSTE, P49, DOI DOI 10.1007/0-387-28021-9_; Meyer P, 2010, MOL MICROBIOL, V76, P956, DOI 10.1111/j.1365-2958.2010.07155.x; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Sutcliffe IC, 2010, TRENDS MICROBIOL, V18, P464, DOI 10.1016/j.tim.2010.06.005; Tocheva EI, 2011, CELL, V146, P799, DOI 10.1016/j.cell.2011.07.029; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; Vollmer W, 2008, BBA-BIOMEMBRANES, V1778, P1714, DOI 10.1016/j.bbamem.2007.06.007; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Vollmer W, 2010, TRENDS MICROBIOL, V18, P59, DOI 10.1016/j.tim.2009.12.004	24	16	16	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					14	18		10.1038/nchembio.748	http://dx.doi.org/10.1038/nchembio.748			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22173345				2022-12-25	WOS:000298414100005
J	Wang, HC; Falck, JR; Hall, TMT; Shears, SB				Wang, Huanchen; Falck, J. R.; Hall, Traci M. Tanaka; Shears, Stephen B.			Structural basis for an inositol pyrophosphate kinase surmounting phosphate crowding	NATURE CHEMICAL BIOLOGY			English	Article							CRYSTAL-STRUCTURE; DIPHOSPHOINOSITOL PENTAKISPHOSPHATE; HEXAKISPHOSPHATE; BINDING; IDENTIFICATION; POLYPHOSPHATES; PURIFICATION; SPECIFICITY; ENZYMES; FAMILY	Inositol pyrophosphates (such as IP7 and IP8) are multifunctional signaling molecules that regulate diverse cellular activities. Inositol pyrophosphates have 'high-energy' phosphoanhydride bonds, so their enzymatic synthesis requires that a substantial energy barrier to the transition state be overcome. Additionally, inositol pyrophosphate kinases can show stringent ligand specificity, despite the need to accommodate the steric bulk and intense electronegativity of nature's most concentrated three-dimensional array of phosphate groups. Here we examine how these catalytic challenges are met by describing the structure and reaction cycle of an inositol pyrophosphate kinase at the atomic level. We obtained crystal structures of the kinase domain of human PPIP5K2 complexed with nucleotide cofactors and either substrates, product or a MgF3- transition-state mimic. We describe the enzyme's conformational dynamics, its unprecedented topological presentation of nucleotide and inositol phosphate, and the charge balance that facilitates partly associative in-line phosphoryl transfer.	[Wang, Huanchen; Shears, Stephen B.] NIEHS, Inositol Signaling Grp, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA; [Falck, J. R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Hall, Traci M. Tanaka] NIEHS, Macromol Struct Grp, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wang, HC (corresponding author), NIEHS, Inositol Signaling Grp, Lab Signal Transduct, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	wangh7@niehs.nih.gov	Falck, John R/B-3030-2011; Hall, Traci/F-5849-2019; Shears, Stephen B/C-6335-2019	Falck, John R/0000-0002-9219-7845; Hall, Traci/0000-0001-6166-3009; Shears, Stephen B/0000-0001-7309-8916; Wang, Huanchen/0000-0003-2701-7155	US Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; National Institutes of Health; National Institute of Environmental Health Sciences (NIEHS); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080046] Funding Source: NIH RePORTER	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Data were collected at the Southeast Regional Collaborative Access Team 22-ID/22-BM beamline at the Advanced Photon Source, Argonne National Laboratory. Supporting institutions may be found at http://www.ser-cat.org/members.html. The use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. W-31-109-Eng-38. This work was supported by the Intramural Research Program of the National Institutes of Health and National Institute of Environmental Health Sciences (NIEHS). We are grateful to L. C. Pedersen for advice and support. We also thank H. Ke for his assistance in writing the manuscript. Expression vectors were prepared by the NIEHS Protein Expression Core Facility.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albert C, 1997, BIOCHEM J, V327, P553, DOI 10.1042/bj3270553; Barker CJ, 2009, CELL MOL LIFE SCI, V66, P3851, DOI 10.1007/s00018-009-0115-2; Burton A, 2009, J CELL PHYSIOL, V220, P8, DOI 10.1002/jcp.21763; Cannon WR, 1996, NAT STRUCT BIOL, V3, P821, DOI 10.1038/nsb1096-821; Chakraborty A, 2010, CELL, V143, P897, DOI 10.1016/j.cell.2010.11.032; Chamberlain PP, 2007, J BIOL CHEM, V282, P28117, DOI 10.1074/jbc.M703121200; Choi JH, 2007, J BIOL CHEM, V282, P30763, DOI 10.1074/jbc.M704655200; Draskovic P, 2008, CHEM BIOL, V15, P274, DOI 10.1016/j.chembiol.2008.01.011; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fridy PC, 2007, J BIOL CHEM, V282, P30754, DOI 10.1074/jbc.M704656200; Gokhale NA, 2011, BIOCHEM J, V434, P415, DOI 10.1042/BJ20101437; Gonzalez B, 2004, MOL CELL, V15, P689, DOI 10.1016/j.molcel.2004.08.004; Gonzalez B, 2010, P NATL ACAD SCI USA, V107, P9608, DOI 10.1073/pnas.0912979107; Graham DL, 2002, CHEM BIOL, V9, P375, DOI 10.1016/S1074-5521(02)00112-6; Hand CE, 2007, BIOORG MED CHEM LETT, V17, P183, DOI 10.1016/j.bmcl.2006.09.066; HERSCHLAG D, 1988, BIOORG CHEM, V16, P62, DOI 10.1016/0045-2068(88)90038-7; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holmes W, 2006, J BIOL CHEM, V281, P38109, DOI 10.1074/jbc.M606883200; Lee D, 2007, NAT REV MOL CELL BIO, V8, P995, DOI 10.1038/nrm2281; Lee YS, 2008, NAT CHEM BIOL, V4, P25, DOI 10.1038/nchembio.2007.52; Lin HY, 2009, J BIOL CHEM, V284, P1863, DOI 10.1074/jbc.M805686200; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; Mildvan AS, 1997, PROTEINS, V29, P401, DOI 10.1002/(SICI)1097-0134(199712)29:4<401::AID-PROT1>3.3.CO;2-#; Miller GJ, 2005, MOL CELL, V18, P201, DOI 10.1016/j.molcel.2005.03.016; Miller GJ, 2004, MOL CELL, V15, P703, DOI 10.1016/j.molcel.2004.08.005; Monserrate JP, 2010, CURR OPIN CELL BIOL, V22, P365, DOI 10.1016/j.ceb.2010.03.006; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prasad A, 2011, NAT IMMUNOL, V12, P752, DOI 10.1038/ni.2052; Reddy KM, 1997, TETRAHEDRON LETT, V38, P4951, DOI 10.1016/S0040-4039(97)01088-5; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2001, J BIOL CHEM, V276, P39179, DOI 10.1074/jbc.M106842200; Shears SB, 2004, BIOCHEM J, V377, P265, DOI 10.1042/BJ20031428; Shears SB, 2009, MOL PHARMACOL, V76, P236, DOI 10.1124/mol.109.055897; STEPHENS L, 1993, J BIOL CHEM, V268, P4009; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2	40	81	91	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					111	116		10.1038/nchembio.733	http://dx.doi.org/10.1038/nchembio.733			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22119861	Green Accepted			2022-12-25	WOS:000298414100019
J	Xu, X; Liu, X; Ge, S; Jensen, JD; Hu, FY; Li, X; Dong, Y; Gutenkunst, RN; Fang, L; Huang, L; Li, JX; He, WM; Zhang, GJ; Zheng, XM; Zhang, FM; Li, YR; Yu, C; Kristiansen, K; Zhang, XQ; Wang, J; Wright, M; McCouch, S; Nielsen, R; Wang, J; Wang, W				Xu, Xun; Liu, Xin; Ge, Song; Jensen, Jeffrey D.; Hu, Fengyi; Li, Xin; Dong, Yang; Gutenkunst, Ryan N.; Fang, Lin; Huang, Lei; Li, Jingxiang; He, Weiming; Zhang, Guojie; Zheng, Xiaoming; Zhang, Fumin; Li, Yingrui; Yu, Chang; Kristiansen, Karsten; Zhang, Xiuqing; Wang, Jian; Wright, Mark; McCouch, Susan; Nielsen, Rasmus; Wang, Jun; Wang, Wen			Resequencing 50 accessions of cultivated and wild rice yields markers for identifying agronomically important genes	NATURE BIOTECHNOLOGY			English	Article							GENOME-WIDE ASSOCIATION; ARTIFICIAL SELECTION; STRUCTURAL VARIATION; ORYZA-SATIVA; DOMESTICATION PROCESS; DIVERSITY; SEQUENCE; GENETICS; MAIZE; LOCI	Rice is a staple crop that has undergone substantial phenotypic and physiological changes during domestication. Here we resequenced the genomes of 40 cultivated accessions selected from the major groups of rice and 10 accessions of their wild progenitors (Oryza rufipogon and Oryza nivara) to >15 x raw data coverage. We investigated genome-wide variation patterns in rice and obtained 6.5 million high-quality single nucleotide polymorphisms (SNPs) after excluding sites with missing data in any accession. Using these population SNP data, we identified thousands of genes with significantly lower diversity in cultivated but not wild rice, which represent candidate regions selected during domestication. Some of these variants are associated with important biological features, whereas others have yet to be functionally characterized. The molecular markers we have identified should be valuable for breeding and for identifying agronomically important genes in rice.	[Xu, Xun; Li, Xin; Dong, Yang; Zhang, Guojie; Nielsen, Rasmus; Wang, Wen] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, CAS Max Planck Jr Res Grp Evolutionary Genom, Kunming, Peoples R China; [Xu, Xun; Liu, Xin; Fang, Lin; Li, Jingxiang; He, Weiming; Zhang, Guojie; Li, Yingrui; Yu, Chang; Kristiansen, Karsten; Zhang, Xiuqing; Wang, Jian; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Xu, Xun; Huang, Lei; Zheng, Xiaoming; Zhang, Fumin] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Ge, Song; Huang, Lei; Zhang, Guojie; Zheng, Xiaoming] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Jensen, Jeffrey D.] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Hu, Fengyi] Yunnan Acad Agr Sci, Food Crops Res Inst, Kunming, Peoples R China; [Gutenkunst, Ryan N.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [He, Weiming] S China Univ Technol, Guangzhou, Guangdong, Peoples R China; [Kristiansen, Karsten; Nielsen, Rasmus; Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wright, Mark; McCouch, Susan] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	Chinese Academy of Sciences; Kunming Institute of Zoology; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Yunnan Academy of Agricultural Sciences; University of Arizona; South China University of Technology; University of Copenhagen; Cornell University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Wang, W (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, CAS Max Planck Jr Res Grp Evolutionary Genom, Kunming, Peoples R China.	rasmus_nielsen@berkeley.edu; wangj@genomics.org.cn; wwang@mail.kiz.ac.cn	Li, Xin/A-4137-2011; Zhang, Guojie/B-6188-2014; Kristiansen, Karsten/J-5148-2014; Nielsen, Rasmus/D-4405-2009; Li, Yingrui/K-1064-2015; Wang, Wen/AAP-9873-2020; Xu, Xun/AAI-6763-2020; Zhang, Guojie/J-7273-2019; , zhengxiaoming/K-2325-2019; Jensen, Jeffrey/S-1084-2016; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Li, Xin/0000-0001-8328-4894; Zhang, Guojie/0000-0001-6860-1521; Kristiansen, Karsten/0000-0002-6024-0917; Nielsen, Rasmus/0000-0003-0513-6591; Xu, Xun/0000-0002-5338-5173; Zhang, Guojie/0000-0001-6860-1521; Liu, Xin/0000-0003-3256-2940; Jensen, Jeffrey/0000-0002-4786-8064; Wang, Jun/0000-0002-2113-5874; Wang, Wen/0000-0002-7801-2066; Wang, Jun/0000-0002-8540-8931; Wright, Mark/0000-0001-8036-1161	Chinese 973 program [2007CB815700]; National Natural Science Foundation of China [30990242]; Provincial Key Grant of Yunnan Province [2008CC017, 2008GA002]; Shenzhen Municipal Government; Yantian District local government of Shenzhen; Danish Natural Science Research Council; CAS-Max Planck Society; CAS; Chinese Ministry of Agriculture; Shenzhen Municipal Government of China; Shenzhen Bureau of Science Technology & Information, China [ZYC200903240077A, CXB200903110066A]; Direct For Biological Sciences [1026555] Funding Source: National Science Foundation	Chinese 973 program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Key Grant of Yunnan Province; Shenzhen Municipal Government; Yantian District local government of Shenzhen; Danish Natural Science Research Council(Danish Natural Science Research Council); CAS-Max Planck Society(Max Planck Society); CAS(Chinese Academy of Sciences); Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs); Shenzhen Municipal Government of China; Shenzhen Bureau of Science Technology & Information, China; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank C.-H. Shi (Zhejiang University, China) and X.-H. Wei (China National Rice Research Institute) for assistance in growing rice materials. We are grateful to the International Rice Research Institute (Los Banos, Philippines) for providing most seed samples. This work was supported by the Chinese 973 program (2007CB815700), the National Natural Science Foundation of China (30990242), the Provincial Key Grant of Yunnan Province (2008CC017; 2008GA002), the Shenzhen Municipal Government and the Yantian District local government of Shenzhen, the Ole Romer grant from the Danish Natural Science Research Council, and a CAS-Max Planck Society Fellowship and the 100 talent program of CAS to W.W., J.W. and S.G. We also acknowledge funding support from the Chinese Ministry of Agriculture (948 program), the Shenzhen Municipal Government of China and grants from Shenzhen Bureau of Science Technology & Information, China (ZYC200903240077A; CXB200903110066A).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Fu HH, 2002, P NATL ACAD SCI USA, V99, P9573, DOI 10.1073/pnas.132259199; Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; GLASZMANN JC, 1987, THEOR APPL GENET, V74, P21, DOI 10.1007/BF00290078; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; He ZW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002100; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; HUDSON RR, 1992, GENETICS, V132, P583; Jain M, 2009, FEBS J, V276, P3148, DOI 10.1111/j.1742-4658.2009.07033.x; Jin J, 2008, NAT GENET, V40, P1365, DOI 10.1038/ng.247; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li YR, 2011, NAT BIOTECHNOL, V29, P723, DOI 10.1038/nbt.1904; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Paponov IA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-126; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Retief J D, 2000, Methods Mol Biol, V132, P243; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sang T, 2007, CURR OPIN GENET DEV, V17, P533, DOI 10.1016/j.gde.2007.09.005; SECOND G, 1982, JPN J GENET, V57, P25, DOI 10.1266/jjg.57.25; Springer NM, 2007, GENOME RES, V17, P264, DOI 10.1101/gr.5347007; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; Tanaka T, 2008, NUCLEIC ACIDS RES, V36, pD1028, DOI 10.1093/nar/gkm978; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tenaillon MI, 2004, MOL BIOL EVOL, V21, P1214, DOI 10.1093/molbev/msh102; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wright S., 1977, EVOLUTION GENETICS P, V3; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Yamasaki M, 2005, PLANT CELL, V17, P2859, DOI 10.1105/tpc.105.037242; Yamasaki M, 2007, ANN BOT-LONDON, V100, P967, DOI 10.1093/aob/mcm173; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhu QH, 2005, NEW PHYTOL, V167, P249, DOI 10.1111/j.1469-8137.2005.01406.x; Zhu QH, 2007, MOL BIOL EVOL, V24, P875, DOI 10.1093/molbev/msm005	63	588	629	18	310	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2012	30	1					105	U157		10.1038/nbt.2050	http://dx.doi.org/10.1038/nbt.2050			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	876MC	22158310				2022-12-25	WOS:000299110600027
J	Ersoy, BA; Pardo, L; Zhang, SM; Thompson, DA; Millhauser, G; Govaerts, C; Vaisse, C				Ersoy, Baran A.; Pardo, Leonardo; Zhang, Sumei; Thompson, Darren A.; Millhauser, Glenn; Govaerts, Cedric; Vaisse, Christian			Mechanism of N-terminal modulation of activity at the melanocortin-4 receptor GPCR	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-COUPLED RECEPTORS; AGOUTI-RELATED PROTEIN; CONSTITUTIVE ACTIVITY; INVERSE AGONISM; DRUG DISCOVERY; IN-VITRO; ACTIVATION; MUTATIONS; BINDING; OBESITY	Most of our understanding of G protein-coupled receptor (GPCR) activation has been focused on the direct interaction between diffusible ligands and their seven-transmembrane domains. However, a number of these receptors depend on their extracellular N-terminal domain for ligand recognition and activation. To dissect the molecular interactions underlying both modes of activation at a single receptor, we used the unique properties of the melanocortin-4 receptor (MC4R), a GPCR that shows constitutive activity maintained by its N-terminal domain and is physiologically activated by the peptide alpha-melanocyte stimulating hormone (alpha MSH). We find that activation by the N-terminal domain and alpha MSH relies on different key residues in the transmembrane region. We also demonstrate that agouti-related protein, a physiological antagonist of MC4R, acts as an inverse agonist by inhibiting N terminus-mediated activation, leading to the speculation that a number of constitutively active orphan GPCRs could have physiological inverse agonists as sole regulators.	[Ersoy, Baran A.; Zhang, Sumei; Vaisse, Christian] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Ersoy, Baran A.; Zhang, Sumei; Vaisse, Christian] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Pardo, Leonardo] Univ Autonoma Barcelona, Lab Med Computac, Unitat Bioestadist, E-08193 Barcelona, Spain; [Thompson, Darren A.; Millhauser, Glenn] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Govaerts, Cedric] Univ Libre Bruxelles, Brussels, Belgium	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Autonomous University of Barcelona; University of California System; University of California Santa Cruz; Universite Libre de Bruxelles	Vaisse, C (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	vaisse@medicine.ucsf.edu	Ersoy, Baran/F-8192-2012; Vaisse, Christian/F-1067-2011	Pardo, Leonardo/0000-0003-1778-7420; Thompson, Darren/0000-0002-3725-7112	US National Institutes of Health (NIH) [DK60540]; American Heart Association; NIH [DK064265]; NIH National Research Service; Spanish Ministry of Science and Innovation Award [SAF2010-22198-C02-02]; Fonds National de la Recherche Scientifique; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060540, R01DK064265] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Science and Innovation Award; Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by US National Institutes of Health (NIH) grant DK60540 and an American Heart Association Established Investigator Award to C. V., NIH DK064265 to G. M., an American Heart Association Predoctoral Fellowship and NIH National Research Service Award Endocrinology Training Grant to B. A. E. and a Spanish Ministry of Science and Innovation Award (SAF2010-22198-C02-02) to L. P. C. G. is funded as a Chercheur Qualifie by the Fonds National de la Recherche Scientifique. We would like to thank H. Bourne, B. Conklin and G. Vassart for reviewing the initial version of the manuscript and providing insightful comments.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Behan D P, 2001, Curr Opin Drug Discov Devel, V4, P548; Bond RA, 2006, TRENDS PHARMACOL SCI, V27, P92, DOI 10.1016/j.tips.2005.12.007; Breit A, 2011, MOL CELL ENDOCRINOL, V331, P232, DOI 10.1016/j.mce.2010.07.007; Bromberg Y, 2009, FASEB J, V23, P3059, DOI 10.1096/fj.08-127530; Calton MA, 2009, HUM MOL GENET, V18, P1140, DOI 10.1093/hmg/ddn431; Chai BX, 2003, PEPTIDES, V24, P603, DOI 10.1016/S0196-9781(03)00104-9; Chen G, 2000, MOL PHARMACOL, V57, P125; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Civelli O, 2005, TRENDS PHARMACOL SCI, V26, P15, DOI 10.1016/j.tips.2004.11.005; COSTA T, 1989, P NATL ACAD SCI USA, V86, P7321, DOI 10.1073/pnas.86.19.7321; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Haskell-Luevano C, 2001, BIOCHEMISTRY-US, V40, P6164, DOI 10.1021/bi010025q; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; Jongejan A, 2005, NAT CHEM BIOL, V1, P98, DOI 10.1038/nchembio714; Kenakin T, 2004, MOL PHARMACOL, V65, P2, DOI 10.1124/mol.65.1.2; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lubrano-Berthelier C, 2006, J CLIN ENDOCR METAB, V91, P1811, DOI 10.1210/jc.2005-1411; Lubrano-Berthelier C, 2003, HUM MOL GENET, V12, P145, DOI 10.1093/hmg/ddg016; Nijenhuis WAJ, 2001, MOL ENDOCRINOL, V15, P164, DOI 10.1210/me.15.1.164; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Patel MP, 2010, J MOL BIOL, V404, P45, DOI 10.1016/j.jmb.2010.08.054; Pellissier LP, 2009, MOL PHARMACOL, V75, P982, DOI 10.1124/mol.108.053686; Peter JC, 2007, AM J PHYSIOL-REG I, V292, pR2151, DOI 10.1152/ajpregu.00878.2006; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; SCARBOROUGH RM, 1992, J BIOL CHEM, V267, P13146; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Srinivasan S, 2004, J CLIN INVEST, V114, P1158, DOI 10.1172/JCI200421927; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; Tolle V, 2008, DIABETES, V57, P86, DOI 10.2337/db07-0733; Toyooka M, 2009, J NEUROSCI RES, V87, P1329, DOI 10.1002/jnr.21955; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Vassart G, 2004, TRENDS BIOCHEM SCI, V29, P119, DOI 10.1016/j.tibs.2004.01.006; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793	40	42	42	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2012	8	8					725	730		10.1038/NCHEMBIO.1008	http://dx.doi.org/10.1038/NCHEMBIO.1008			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975RC	22729149	Green Accepted			2022-12-25	WOS:000306527600012
J	Gonzalez, JM; Meini, MR; Tomatis, PE; Martin, FJM; Cricco, JA; Vila, AJ				Gonzalez, Javier M.; Meini, Maria-Rocio; Tomatis, Pablo E.; Medrano Martin, Francisco J.; Cricco, Julia A.; Vila, Alejandro J.			Metallo-beta-lactamases withstand low Zn(II) conditions by tuning metal-ligand interactions	NATURE CHEMICAL BIOLOGY			English	Article							BACILLUS-CEREUS; ACTIVE-SITE; CRYSTAL-STRUCTURE; BINDING; ENZYME; HYDROLYSIS; RESISTANCE; TURNOVER; CO(II); FOLD	A number of multiresistant bacterial pathogens inactivate antibiotics by producing Zn(II)-dependent beta-lactamases. We show that metal uptake leading to an active dinuclear enzyme in the periplasmic space of Gram-negative bacteria is ensured by a cysteine residue, an unusual metal ligand in oxidizing environments. Kinetic, structural and affinity data show that such Zn(II)-cysteine interaction is an adaptive trait that tunes the metal binding affinity, thus enabling antibiotic resistance at restrictive Zn(II) concentrations.	[Gonzalez, Javier M.; Meini, Maria-Rocio; Tomatis, Pablo E.; Cricco, Julia A.; Vila, Alejandro J.] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, CONICET, Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Santa Fe, Argentina; [Medrano Martin, Francisco J.] Lab Nacl Luz Sincrotron, Sao Paulo, Brazil	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Laboratorio Nacional de Luz Sincrotron (LNLS)	Cricco, JA (corresponding author), Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, CONICET, Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Santa Fe, Argentina.	cricco@ibr.gov.ar; vila@ibr.gov.ar	Medrano, Francisco Javier/ABF-9860-2020; Tomatis, Pablo Emiliano/AAV-2524-2020; Meini, María Rocío/AAC-2031-2021	Tomatis, Pablo Emiliano/0000-0002-1126-8200; Meini, María Rocío/0000-0003-2166-8707; Cricco, Julia Alejandra/0000-0002-8993-3880; Vila, Alejandro/0000-0002-7978-3233; Medrano, Francisco/0000-0002-8185-9751; Gonzalez, Javier Marcelo/0000-0002-3298-2235	CONICET; Howard Hughes Medical Institute; Agencia Nacional de Promocion Cientifica y Tecnologica; US National Institutes of Health [1R01AI100560]; Laboratorio Nacional de Luz Sincrotron, Campinas, Brazil; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100560] Funding Source: NIH RePORTER	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Laboratorio Nacional de Luz Sincrotron, Campinas, Brazil; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been supported by CONICET and by grants from the Howard Hughes Medical Institute, Agencia Nacional de Promocion Cientifica y Tecnologica, US National Institutes of Health (1R01AI100560 to A.J.V.) and Laboratorio Nacional de Luz Sincrotron, Campinas, Brazil. A.J.V. is a fellow of the John Simon Guggenheim Foundation.	Badarau A, 2006, BIOCHEMISTRY-US, V45, P11012, DOI 10.1021/bi0610146; CARFI A, 1995, EMBO J, V14, P4914, DOI 10.1002/j.1460-2075.1995.tb00174.x; Crowder MW, 2006, ACCOUNTS CHEM RES, V39, P721, DOI 10.1021/ar0400241; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; Davis AV, 2008, NAT CHEM BIOL, V4, P148, DOI 10.1038/nchembio0308-148; Fabiane SM, 1998, BIOCHEMISTRY-US, V37, P12404, DOI 10.1021/bi980506i; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Gonzalez JM, 2010, BIOCHEMISTRY-US, V49, P7930, DOI 10.1021/bi100894r; Haruta S, 2000, ANTIMICROB AGENTS CH, V44, P2304, DOI 10.1128/AAC.44.9.2304-2309.2000; Hawk MJ, 2009, J AM CHEM SOC, V131, P10753, DOI 10.1021/ja900296u; Hu ZX, 2008, J AM CHEM SOC, V130, P14207, DOI 10.1021/ja8035916; Jacquin O, 2009, J MOL BIOL, V392, P1278, DOI 10.1016/j.jmb.2009.07.092; Llarrull LI, 2007, J BIOL CHEM, V282, P30586, DOI 10.1074/jbc.M704613200; Llarrull LI, 2008, J AM CHEM SOC, V130, P15842, DOI 10.1021/ja801168r; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Moran-Barrio J, 2009, ANTIMICROB AGENTS CH, V53, P2908, DOI 10.1128/AAC.01637-08; Murphy TA, 2006, J MOL BIOL, V357, P890, DOI 10.1016/j.jmb.2006.01.003; Orellano EG, 1998, BIOCHEMISTRY-US, V37, P10173, DOI 10.1021/bi980309j; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Rasia RM, 2004, J BIOL CHEM, V279, P26046, DOI 10.1074/jbc.M311373200; Simona F, 2009, J BIOL CHEM, V284, P28164, DOI 10.1074/jbc.M109.049502; Tioni MF, 2008, J AM CHEM SOC, V130, P15852, DOI 10.1021/ja801169j; Wommer S, 2002, J BIOL CHEM, V277, P24142, DOI 10.1074/jbc.M202467200	23	39	39	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2012	8	8					698	700		10.1038/NCHEMBIO.1005	http://dx.doi.org/10.1038/NCHEMBIO.1005			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975RC	22729148	Green Accepted			2022-12-25	WOS:000306527600008
J	Wang, SK; Wu, K; Yuan, QB; Liu, XY; Liu, ZB; Lin, XY; Zeng, RZ; Zhu, HT; Dong, GJ; Qian, Q; Zhang, GQ; Fu, XD				Wang, Shaokui; Wu, Kun; Yuan, Qingbo; Liu, Xueying; Liu, Zhengbin; Lin, Xiaoyan; Zeng, Ruizhen; Zhu, Haitao; Dong, Guojun; Qian, Qian; Zhang, Guiquan; Fu, Xiangdong			Control of grain size, shape and quality by OsSPL16 in rice	NATURE GENETICS			English	Article							ORYZA-SATIVA L.; SBP-BOX GENE; ARABIDOPSIS-THALIANA; NATURAL VARIATION; TRANSCRIPTION FACTORS; YIELD; QTL; ARCHITECTURE; EXPRESSION; RESPONSES	Grain size and shape are important components of grain yield and quality and have been under selection since cereals were first domesticated. Here, we show that a quantitative trait locus GW8 is synonymous with OsSPL16, which encodes a protein that is a positive regulator of cell proliferation. Higher expression of this gene promotes cell division and grain filling, with positive consequences for grain width and yield in rice. Conversely, a loss-of-function mutation in Basmati rice is associated with the formation of a more slender grain and better quality of appearance. The correlation between grain size and allelic variation at the GW8 locus suggests that mutations within the promoter region were likely selected in rice breeding programs. We also show that a marker-assisted strategy targeted at elite alleles of GS3 and OsSPL16 underlying grain size and shape can be effectively used to simultaneously improve grain quality and yield.	[Wang, Shaokui; Wu, Kun; Yuan, Qingbo; Liu, Xueying; Liu, Zhengbin; Fu, Xiangdong] Chinese Acad Sci, State Key Lab Plant Cell & Chromosome Engn, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, Beijing, Peoples R China; [Wang, Shaokui; Lin, Xiaoyan; Zeng, Ruizhen; Zhu, Haitao; Zhang, Guiquan] S China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China; [Dong, Guojun; Qian, Qian] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; South China Agricultural University; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS	Fu, XD (corresponding author), Chinese Acad Sci, State Key Lab Plant Cell & Chromosome Engn, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, Beijing, Peoples R China.	gqzhang@scau.edu.cn; xdfu@genetics.ac.cn	zhu, HAITAO/GVL-0589-2022; wang, shaokui/GPX-7207-2022; qian, qian/AAH-8708-2021	wang, shaokui/0000-0002-7767-4033; Liu, Zhengbin/0000-0001-6638-2708	Ministry of Science and Technology of China [2011CB915403, 2012AA10A301, 2009CB941501]; Chinese Academy of Sciences [KSCX2EW-N-01, KSCX2-EW-J-4]; National Natural Science Foundation [31130070, U1031002, 30830074]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	We thank X. Wei and the China National Rice Research Institute for providing rice germplasm samples. We also thank S. Ge for providing accessions of wild rice and W. Wang for help with nucleotide diversity analysis. This work was supported by grants from the Ministry of Science and Technology of China (2011CB915403, 2012AA10A301 and 2009CB941501), the Chinese Academy of Sciences (KSCX2EW-N-01 and KSCX2-EW-J-4) and the National Natural Science Foundation (31130070, U1031002 and 30830074).	Berckmans B, 2009, CURR OPIN PLANT BIOL, V12, P599, DOI 10.1016/j.pbi.2009.07.005; Cardon GH, 1997, PLANT J, V12, P367, DOI 10.1046/j.1365-313X.1997.12020367.x; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Fu XD, 2001, PLANT CELL, V13, P1791, DOI 10.1105/tpc.13.8.1791; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Jain S, 2004, THEOR APPL GENET, V109, P965, DOI 10.1007/s00122-004-1700-2; Jiang CF, 2007, PLANT PHYSIOL, V145, P1460, DOI 10.1104/pp.107.103788; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Khush G. S., 2000, P5; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Nagaraju J, 2002, P NATL ACAD SCI USA, V99, P5836, DOI 10.1073/pnas.042099099; Sakamoto T, 2008, CURR OPIN PLANT BIOL, V11, P209, DOI 10.1016/j.pbi.2008.01.009; Schwarz S, 2008, PLANT MOL BIOL, V67, P183, DOI 10.1007/s11103-008-9310-z; She KC, 2010, PLANT CELL, V22, P3280, DOI 10.1105/tpc.109.070821; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Unte US, 2003, PLANT CELL, V15, P1009, DOI 10.1105/tpc.010678; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wang JW, 2008, PLANT CELL, V20, P1231, DOI 10.1105/tpc.108.058180; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xi ZY, 2006, GENOME, V49, P476, DOI 10.1139/G06-005; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Zhang G Q, 2004, RICE GENET NEWSL, V21, P85; Zhou LJ, 2009, THEOR APPL GENET, V118, P581, DOI 10.1007/s00122-008-0922-0	28	702	876	24	504	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2012	44	8					950	+		10.1038/ng.2327	http://dx.doi.org/10.1038/ng.2327			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	979WV	22729225				2022-12-25	WOS:000306854700024
J	Arboleda, VA; Lee, H; Parnaik, R; Fleming, A; Banerjee, A; Ferraz-de-Souza, B; Delot, EC; Rodriguez-Fernandez, IA; Braslavsky, D; Bergada, I; Dell'Angelica, EC; Nelson, SF; Martinez-Agosto, JA; Achermann, JC; Vilain, E				Arboleda, Valerie A.; Lee, Hane; Parnaik, Rahul; Fleming, Alice; Banerjee, Abhik; Ferraz-de-Souza, Bruno; Delot, Emmanuele C.; Rodriguez-Fernandez, Imilce A.; Braslavsky, Debora; Bergada, Ignacio; Dell'Angelica, Esteban C.; Nelson, Stanley F.; Martinez-Agosto, Julian A.; Achermann, John C.; Vilain, Eric			Mutations in the PCNA-binding domain of CDKN1C cause IMAGe syndrome	NATURE GENETICS			English	Article							DEPENDENT KINASE INHIBITOR; ADRENAL HYPOPLASIA; P57(KIP2); ASSOCIATION; UBIQUITIN; FAMILY; PROLIFERATION; EXPRESSION; ALIGNMENT; KVDMR1	IMAGe syndrome (intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita and genital anomalies) is an undergrowth developmental disorder with life-threatening consequences(1). An identity-by-descent analysis in a family with IMAGe syndrome(2) identified a 17.2-Mb locus on chromosome 11p15 that segregated in the affected family members. Targeted exon array capture of the disease locus, followed by high-throughput genomic sequencing and validation by dideoxy sequencing, identified missense mutations in the imprinted gene CDKN1C (also known as P57KIP2) in two familial and four unrelated patients. A familial analysis showed an imprinted mode of inheritance in which only maternal transmission of the mutation resulted in IMAGe syndrome. CDKN1C inhibits cell-cycle progression(3), and we found that targeted expression of IMAGe-associated CDKN1C mutations in Drosophila caused severe eye growth defects compared to wild-type CDKN1C, suggesting a gain-of-function mechanism. All IMAGe-associated mutations clustered in the PCNA-binding domain of CDKN1C and resulted in loss of PCNA binding, distinguishing them from the mutations of CDKN1C that cause Beckwith-Wiedemann syndrome, an overgrowth syndrome(4).	[Arboleda, Valerie A.; Lee, Hane; Fleming, Alice; Banerjee, Abhik; Rodriguez-Fernandez, Imilce A.; Dell'Angelica, Esteban C.; Nelson, Stanley F.; Martinez-Agosto, Julian A.; Vilain, Eric] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Lee, Hane; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Parnaik, Rahul; Ferraz-de-Souza, Bruno; Achermann, John C.] UCL, Inst Child Hlth, Clin & Mol Genet Unit, Dev Endocrinol Res Grp, London, England; [Ferraz-de-Souza, Bruno] Univ Sao Paulo, Sch Med, Lab Med Invest LIM18, Dept Endocrinol, Sao Paulo, Brazil; [Delot, Emmanuele C.; Martinez-Agosto, Julian A.; Vilain, Eric] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Braslavsky, Debora; Bergada, Ignacio] Hosp Ninos Dr Ricardo Gutierrez, Div Endocrinol, Buenos Aires, DF, Argentina; [Vilain, Eric] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of London; University College London; Universidade de Sao Paulo; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Vilain, E (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.	evilain@ucla.edu	Martinez-Agosto, Julian A/I-9435-2019; Nelson, Stanley F/D-4771-2009; Achermann, John/C-5476-2008; Ferraz-de-Souza, Bruno/G-1069-2010; Achermann, John/N-2906-2019; Arboleda, Valerie A/C-9608-2011	Martinez-Agosto, Julian A/0000-0001-6776-6949; Nelson, Stanley F/0000-0002-2082-3114; Achermann, John/0000-0001-8787-6272; Ferraz-de-Souza, Bruno/0000-0003-4863-2544; Achermann, John/0000-0001-8787-6272; Arboleda, Valerie A/0000-0002-9687-9122; Delot, Emmanuele/0000-0003-3541-3190; Rodriguez-Fernandez, Imilce A/0000-0002-5112-4834	Doris Duke Charitable Foundation; National Institute of Child Health and Human Development [RO1HD068138]; US National Institutes of Health (NIH) [1 F31HD068136]; Joint Medical Research Council [G0700089]; Wellcome Trust [GR082557, 079666]; MRC [G9900837, G0700089] Funding Source: UKRI; Medical Research Council [G9900837, G0700089] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068138] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F31HD068136] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joint Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Doris Duke Charitable Foundation and National Institute of Child Health and Human Development RO1HD068138. V.A.A. was supported by the US National Institutes of Health (NIH) 1 F31HD068136 training grant. The human embryonic and fetal material was provided by the Joint Medical Research Council (grant G0700089) and Wellcome Trust (grant GR082557) Human Developmental Biology Resource (www.hdbr.org). J.C.A. was supported by a Wellcome Trust Senior Research Fellowship in Clinical Science (079666). We thank R. Matera (NIH) for kindly providing the pCI-neo-(HA)<INF>3</INF>-human ubiquitin construct. We thank E.R.B. McCabe for initial crucial support of the adrenal research for E.V. and for providing one of the original IMAGe patient's DNA samples. We thank M. Le Merrer and C. Lecointre, who participated in the initial clinical description of IMAGe.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Amano N, 2008, AM J MED GENET A, V146A, P2130, DOI 10.1002/ajmg.a.32425; Balasubramanian M, 2010, AM J MED GENET A, V152A, P3138, DOI 10.1002/ajmg.a.33716; BECKWITH J B, 1969, Birth Defects Original Article Series, V5, P188; Bergada I, 2005, J CLIN ENDOCR METAB, V90, P3186, DOI 10.1210/jc.2004-1589; Bourcigaux N, 2000, J CLIN ENDOCR METAB, V85, P322, DOI 10.1210/jc.85.1.322; BRAND AH, 1993, DEVELOPMENT, V118, P401; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; Diaz-Meyer N, 2003, J MED GENET, V40, P797, DOI 10.1136/jmg.40.11.797; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hatada I, 1996, NAT GENET, V14, P171, DOI 10.1038/ng1096-171; Havens CG, 2011, GENE DEV, V25, P1568, DOI 10.1101/gad.2068611; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Homer N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-175; Hutz JE, 2006, MOL GENET METAB, V88, P66, DOI 10.1016/j.ymgme.2006.01.006; Kirchmaier AL, 2011, FEBS LETT, V585, P2920, DOI 10.1016/j.febslet.2011.08.008; Ko JM, 2007, EUR J PEDIATR, V166, P879, DOI 10.1007/s00431-006-0321-y; Lee H, 2008, HEADACHE, V48, P1460, DOI 10.1111/j.1526-4610.2007.01002.x; Lee H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-646; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li W, 2008, CELL MOL LIFE SCI, V65, P2397, DOI 10.1007/s00018-008-8090-6; Lienhardt A, 2002, HORM RES, V57, P71, DOI 10.1159/000058105; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; Mattera R, 2006, J BIOL CHEM, V281, P6874, DOI 10.1074/jbc.M509939200; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; O'Connor BD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S12-S2; Pedreira CC, 2004, J PEDIATR-US, V144, P274, DOI 10.1016/j.jpeds.2003.09.052; Romanelli V, 2010, AM J MED GENET A, V152A, P1390, DOI 10.1002/ajmg.a.33453; Shin JY, 2008, EMBO J, V27, P168, DOI 10.1038/sj.emboj.7601960; Tan TY, 2006, AM J MED GENET A, V140A, P1778, DOI 10.1002/ajmg.a.31365; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Vilain E, 1999, J CLIN ENDOCR METAB, V84, P4335, DOI 10.1210/jc.84.12.4335; Watanabe H, 1998, P NATL ACAD SCI USA, V95, P1392, DOI 10.1073/pnas.95.4.1392; WIEDEMAN.HR, 1969, Z KINDERHEILKD, V106, P171, DOI 10.1007/BF00473503; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0	37	121	127	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2012	44	7					788	792		10.1038/ng.2275	http://dx.doi.org/10.1038/ng.2275			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967DP	22634751	Green Submitted, Green Accepted			2022-12-25	WOS:000305886900013
J	Grallert, A; Connolly, Y; Smith, DL; Simanis, V; Hagan, IM				Grallert, Agnes; Connolly, Yvonne; Smith, Duncan L.; Simanis, Viesturs; Hagan, Iain M.			The S-pombe cytokinesis NDR kinase Sid2 activates Fin1 NIMA kinase to control mitotic commitment through Pom1/Wee1	NATURE CELL BIOLOGY			English	Article							YEAST SCHIZOSACCHAROMYCES-POMBE; FISSION YEAST; PROTEIN-KINASE; CELL LENGTH; MITOSIS; ONSET; SIZE; SEGREGATION; PROGRESSION; HOMOLOG	Mitotic exit integrates the reversal of the phosphorylation events initiated by mitotic kinases with a controlled cytokinesis event that cleaves the cell in two. The mitotic exit network (MEN) of budding yeast regulates both processes, whereas the fission yeast equivalent, the septum initiation network (SIN), controls only the execution of cytokinesis. The components and architecture of the SIN and MEN are highly conserved(1). At present, it is assumed that the functions of the core SIN-MEN components are restricted to their characterized roles at the end of mitosis. We now show that the NDR (nuclear Dbf2-related) kinase component of the fission yeast SIN, Sid2-Mob1, acts independently of the other known SIN components in G2 phase of the cell cycle to control the timing of mitotic commitment. Sid2-Mob1 promotes mitotic commitment by directly activating the NIMA (Never In Mitosis)-related kinase Fin1. Fin1's activation promotes its own destruction, thereby making Fin1 activation a transient feature of G2 phase. This spike of Fin1 activation modulates the activity of the Pom1/Cdr1/Cdr2 geometry network towards Wee1.	[Grallert, Agnes; Hagan, Iain M.] Paterson Inst Canc Res, CRUK Cell Div Grp, Manchester M20 4BX, Lancs, England; [Connolly, Yvonne; Smith, Duncan L.] Paterson Inst Canc Res, MBCF Biol Mass Spectrometry Facil, Manchester M20 4BX, Lancs, England; [Simanis, Viesturs] EPFL SV ISREC UPSIM, CH-1015 Lausanne, Switzerland	Paterson Institute for Cancer Research; Paterson Institute for Cancer Research; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Grallert, A (corresponding author), Paterson Inst Canc Res, CRUK Cell Div Grp, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	agrallert@picr.man.ac.uk; ihagan@picr.man.ac.uk		Hagan, Iain/0000-0002-5858-9415; Grallert, Agnes/0000-0002-0127-3495	Cancer Research UK (CRUK) [C147/A6058]; Swiss National Science Foundation	Cancer Research UK (CRUK)(Cancer Research UK); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank T. Toda (CRUK London Research Institute, UK), S. Martin (University of Lausanne, Switzerland), P. Nurse (Crick Institute, London, UK), D. McCollum (University of Massachusetts, USA) for strains, K. Gull (Oxford University, UK) for TAT1 antibody, T. Carr (GDSC, UK) for plasmids and B. Hodgson (Paterson Insitute) for FACs analysis. This work was supported by Cancer Research UK (CRUK) grant number C147/A6058 and Swiss National Science Foundation support to V.S.	Breeding CS, 1998, MOL BIOL CELL, V9, P3399, DOI 10.1091/mbc.9.12.3399; Cerutti L, 1999, J CELL SCI, V112, P2313; Chen CT, 2008, CURR BIOL, V18, P1594, DOI 10.1016/j.cub.2008.08.067; FANTES PA, 1981, J BACTERIOL, V146, P746, DOI 10.1128/JB.146.2.746-754.1981; Grallert A, 2004, GENE DEV, V18, P1007, DOI 10.1101/gad.296204; Grallert A, 2002, EMBO J, V21, P3096, DOI 10.1093/emboj/cdf294; Guertin DA, 2000, EMBO J, V19, P1803, DOI 10.1093/emboj/19.8.1803; Kanoh J, 1998, MOL BIOL CELL, V9, P3321, DOI 10.1091/mbc.9.12.3321; Krien MJE, 1998, J CELL SCI, V111, P967; Lehmann A, 2004, FEBS LETT, V566, P77, DOI 10.1016/j.febslet.2004.04.022; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; Meitinger F, 2011, GENE DEV, V25, P875, DOI 10.1101/gad.622411; MITCHISON JM, 1985, J CELL SCI, V75, P357; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; NURSE P, 1980, GENETICS, V96, P627; Petersen J, 2005, NATURE, V435, P507, DOI 10.1038/nature03590; Pines J, 2001, NAT CELL BIOL, V3, pE3, DOI 10.1038/35050676; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Simanis V, 2003, J CELL SCI, V116, P4263, DOI 10.1242/jcs.00807; Sparks CA, 1999, J CELL BIOL, V146, P777, DOI 10.1083/jcb.146.4.777; Sveiczer A, 1996, J CELL SCI, V109, P2947; YE XS, 1995, EMBO J, V14, P986, DOI 10.1002/j.1460-2075.1995.tb07079.x	23	37	39	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2012	14	7					738	745		10.1038/ncb2514	http://dx.doi.org/10.1038/ncb2514			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	967PV	22684255	Green Published, Green Accepted			2022-12-25	WOS:000305921200013
J	Koren, S; Schatz, MC; Walenz, BP; Martin, J; Howard, JT; Ganapathy, G; Wang, Z; Rasko, DA; McCombie, WR; Jarvis, ED; Phillippy, AM				Koren, Sergey; Schatz, Michael C.; Walenz, Brian P.; Martin, Jeffrey; Howard, Jason T.; Ganapathy, Ganeshkumar; Wang, Zhong; Rasko, David A.; McCombie, W. Richard; Jarvis, Erich D.; Phillippy, Adam M.			Hybrid error correction and de novo assembly of single-molecule sequencing reads	NATURE BIOTECHNOLOGY			English	Article							PYROSEQUENCING READS; STRUCTURAL VARIATION; LARGE GENOMES; GENE; EXPRESSION; SPEECH; FOXP2; COMPLEXITY; GENERATION; RECEPTORS	Single-molecule sequencing instruments can generate multikilobase sequences with the potential to greatly improve genome and transcriptome assembly. However, the error rates of single-molecule reads are high, which has limited their use thus far to resequencing bacteria. To address this limitation, we introduce a correction algorithm and assembly strategy that uses short, high-fidelity sequences to correct the error in single-molecule sequences. We demonstrate the utility of this approach on reads generated by a PacBio RS instrument from phage, prokaryotic and eukaryotic whole genomes, including the previously unsequenced genome of the parrot Melopsittacus undulatus, as well as for RNA-Seq reads of the corn (Zea mays) transcriptome. Our long-read correction achieves >99.9% base-call accuracy, leading to substantially better assemblies than current sequencing strategies: in the best example, the median contig size was quintupled relative to high-coverage, second-generation assemblies. Greater gains are predicted if read lengths continue to increase, including the prospect of single-contig bacterial chromosome assembly.	[Koren, Sergey; Phillippy, Adam M.] Natl Biodef Anal & Countermeasures Ctr, Frederick, MD USA; [Koren, Sergey] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Schatz, Michael C.; McCombie, W. Richard] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Walenz, Brian P.] J Craig Venter Inst, Rockville, MD USA; [Martin, Jeffrey; Wang, Zhong] DOE Joint Genome Inst, Walnut Creek, CA USA; [Howard, Jason T.; Ganapathy, Ganeshkumar; Jarvis, Erich D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Neurobiol, Durham, NC 27710 USA; [Rasko, David A.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Inst Genome Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland College Park; Cold Spring Harbor Laboratory; J. Craig Venter Institute; United States Department of Energy (DOE); Duke University; Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore	Koren, S (corresponding author), Natl Biodef Anal & Countermeasures Ctr, Frederick, MD USA.	korens@nbacc.net; phillippya@nbacc.net	Jarvis, Erich D/A-2319-2008; Wang, Zhong/J-3244-2019; Phillippy, Adam M/U-5731-2018; Koren, Sergey/AAE-8314-2019; Schatz, Michael/L-2690-2019	Jarvis, Erich D/0000-0001-8931-5049; Wang, Zhong/0000-0002-6307-0458; Phillippy, Adam M/0000-0003-2983-8934; Schatz, Michael/0000-0002-4118-4446; Howard, Jason/0000-0003-3265-5127; Koren, Sergey/0000-0002-1472-8962; David, Rasko/0000-0002-7337-7154; McCombie, W. Richard/0000-0003-1899-0682	US Department of Homeland Security for the management and operation of the National Biodefense Analysis and Countermeasures Center (NBACC) [HSHQDC-07-C-00020]; Federally Funded Research and Development Center; Office of Science of the US Department of Energy [DE-AC02-05CH11231]; US National Institutes of Health (NIH) [R01-HG006677-12]; NIH [2R01GM077117-04A1]; state of Maryland; National Science Foundation [IOS-1032105]; Howard Hughes Medical Institute; NIH Directors Pioneer Award; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200398, R01HG006677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077117] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000448] Funding Source: NIH RePORTER	US Department of Homeland Security for the management and operation of the National Biodefense Analysis and Countermeasures Center (NBACC)(United States Department of Homeland Security (DHS)); Federally Funded Research and Development Center; Office of Science of the US Department of Energy(United States Department of Energy (DOE)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); state of Maryland; National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH Directors Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Pacific Biosciences, Roche 454, Illumina, BGI and the Duke Genome Center for the generation and/or release of many of the data sets examined herein, and to the Assemblathon working group for the coordination and release of the parrot genome data. This publication was developed and funded in part under Agreement No. HSHQDC-07-C-00020 awarded by the US Department of Homeland Security for the management and operation of the National Biodefense Analysis and Countermeasures Center (NBACC), a Federally Funded Research and Development Center. The views and conclusions contained in this document are those of the authors and should not be interpreted as necessarily representing the official policies, either expressed or implied, of the US Department of Homeland Security. The Department of Homeland Security does not endorse any products or commercial services mentioned in this publication. The work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under Contract No. DE-AC02-05CH11231. This work was also funded in part by the US National Institutes of Health (NIH) R01-HG006677-12 (M.C.S.), NIH 2R01GM077117-04A1 (B.P.W.), the state of Maryland (D.A.R.), National Science Foundation IOS-1032105 to W.R.M., and Howard Hughes Medical Institute and NIH Directors Pioneer Award to E.D.J.	Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2011, CURR OPIN NEUROBIOL, V21, P415, DOI 10.1016/j.conb.2011.04.008; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fraser CM, 2002, J BACTERIOL, V184, P6403, DOI 10.1128/JB.184.23.6403-6405.2002; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Haesler S, 2004, J NEUROSCI, V24, P3164, DOI 10.1523/JNEUROSCI.4369-03.2004; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kingsford C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-21; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li YR, 2011, NAT BIOTECHNOL, V29, P723, DOI 10.1038/nbt.1904; Maes T, 2002, GENOMICS, V80, P21, DOI 10.1006/geno.2002.6799; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matsunaga E, 2009, DEV GROWTH DIFFER, V51, P45, DOI 10.1111/j.1440-169X.2008.01080.x; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; MORGAN JI, 1989, TRENDS NEUROSCI, V12, P459, DOI 10.1016/0166-2236(89)90096-9; Nagarajan N, 2009, J COMPUT BIOL, V16, P897, DOI 10.1089/cmb.2009.0005; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; Pop M, 2004, BRIEF BIOINFORM, V5, P237, DOI 10.1093/bib/5.3.237; Pop M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/bib/bbp026; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schadt EE, 2010, HUM MOL GENET, V19, pR227, DOI 10.1093/hmg/ddq416; Schatz MC, 2013, BRIEF BIOINFORM, V14, P213, DOI 10.1093/bib/bbr074; Schatz MC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-243; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vezzi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031002; Wada K, 2004, J COMP NEUROL, V476, P44, DOI 10.1002/cne.20201; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310	50	671	706	5	211	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					692	+		10.1038/nbt.2280	http://dx.doi.org/10.1038/nbt.2280			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22750884	Green Accepted, Green Submitted			2022-12-25	WOS:000306293400028
J	Mulder, KW; Wang, X; Escriu, C; Ito, Y; Schwarz, RF; Gillis, J; Sirokmany, G; Donati, G; Uribe-Lewis, S; Pavlidis, P; Murrell, A; Markowetz, F; Watt, FM				Mulder, Klaas W.; Wang, Xin; Escriu, Carles; Ito, Yoko; Schwarz, Roland F.; Gillis, Jesse; Sirokmany, Gabor; Donati, Giacomo; Uribe-Lewis, Santiago; Pavlidis, Paul; Murrell, Adele; Markowetz, Florian; Watt, Fiona M.			Diverse epigenetic strategies interact to control epidermal differentiation	NATURE CELL BIOLOGY			English	Article							STEM-CELLS; GENETIC INTERACTION; MICE LACKING; PHD FINGER; CHROMATIN; SKIN; P63; KERATINOCYTES; EXPRESSION; TISSUE	It is becoming clear that interconnected functional gene networks, rather than individual genes, govern stem cell self-renewal and differentiation. To identify epigenetic factors that impact on human epidermal stem cells we performed siRNA-based genetic screens for 332 chromatin modifiers. We developed a Bayesian mixture model to predict putative functional interactions between epigenetic modifiers that regulate differentiation. We discovered a network of genetic interactions involving EZH2, UHRF1 (both known to regulate epidermal self-renewal), ING5 (a MORF complex component), BPTF and SMARCA5 (NURF complex components). Genome-wide localization and global mRNA expression analysis revealed that these factors impact two distinct but functionally related gene sets, including integrin extracellular matrix receptors that mediate anchorage of epidermal stem cells to their niche. Using a competitive epidermal reconstitution assay we confirmed that ING5, BPTF, SMARCA5, EZH2 and UHRF1 control differentiation under physiological conditions. Thus, regulation of distinct gene expression programs through the interplay between diverse epigenetic strategies protects epidermal stem cells from differentiation.	[Mulder, Klaas W.; Escriu, Carles; Donati, Giacomo; Watt, Fiona M.] Canc Res UK Cambridge Res Inst, Epithelial Cell Biol Grp, Cambridge CB2 0RE, England; [Wang, Xin; Schwarz, Roland F.; Markowetz, Florian] Canc Res UK Cambridge Res Inst, Computat Biol Res Grp, Cambridge CB2 0RE, England; [Ito, Yoko; Uribe-Lewis, Santiago; Murrell, Adele] Canc Res UK Cambridge Res Inst, Genom Imprinting Grp, Cambridge CB2 0RE, England; [Gillis, Jesse; Pavlidis, Paul] Ctr High Throughput Biol, Vancouver, BC V6T 1Z4, Canada; [Sirokmany, Gabor; Watt, Fiona M.] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QN, England	Cancer Research UK; CRUK Cambridge Institute; Cancer Research UK; CRUK Cambridge Institute; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Mulder, KW (corresponding author), Canc Res UK Cambridge Res Inst, Epithelial Cell Biol Grp, Robinson Way, Cambridge CB2 0RE, England.	klaas.mulder@cancer.org.uk; fiona.watt@cancer.org.uk	Mulder, Klaas/A-1882-2013; Wang, Xin/A-1130-2012; Watt, Fiona/AHB-0226-2022; Markowetz, Florian/H-6883-2019; Pavlidis, Paul/H-8406-2013	Mulder, Klaas/0000-0001-8516-4458; Wang, Xin/0000-0002-5122-2418; Watt, Fiona/0000-0001-9151-5154; Markowetz, Florian/0000-0002-2784-5308; Pavlidis, Paul/0000-0002-0426-5028; Schwarz, Roland/0000-0001-9155-4268; Gillis, Jesse/0000-0002-0936-9774; DONATI, Giacomo/0000-0002-0370-8288; Escriu, Carles/0000-0003-3638-3202; Murrell, adele/0000-0003-2647-3511	Cancer Research UK (CRUK); Hutchinson Wampoa; University of Cambridge; Marie Curie Fellowship [PIEF-GA-2008-220642]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076990] Funding Source: NIH RePORTER	Cancer Research UK (CRUK)(Cancer Research UK); Hutchinson Wampoa; University of Cambridge(University of Cambridge); Marie Curie Fellowship(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Brenkman, J. Carroll, N. Rosenfeld, M. Narita, D. Odom and Watt laboratory members for critical discussion and comments. This work was supported by Cancer Research UK (CRUK), Hutchinson Wampoa, University of Cambridge (F.M.W.) and a Marie Curie Fellowship (PIEF-GA-2008-220642) to K.W.M. We are indebted to the core facilities of the CRUK Cambridge Research Institute for excellent technical assistance.	Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Champagne KS, 2008, PROTEINS, V72, P1371, DOI 10.1002/prot.22140; Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI 10.1038/ncb2074; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Driskell I, 2012, EMBO J, V31, P616, DOI 10.1038/emboj.2011.421; Eckert RL, 1997, J INVEST DERMATOL, V109, P501, DOI 10.1111/1523-1747.ep12336477; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Gosselet FP, 2007, CELL SIGNAL, V19, P731, DOI 10.1016/j.cellsig.2006.09.006; Green H, 2008, BIOESSAYS, V30, P897, DOI 10.1002/bies.20797; Horn T, 2011, NAT METHODS, V8, P341, DOI 10.1038/NMETH.1581; Indra AK, 2005, DEVELOPMENT, V132, P4533, DOI 10.1242/dev.02019; Kashiwagi M, 2007, DEVELOPMENT, V134, P1571, DOI 10.1242/dev.001750; Kolev V, 2008, NAT CELL BIOL, V10, DOI 10.1038/ncb1750; Kostera MI, 2004, J DERMATOL SCI, V34, P3, DOI 10.1016/j.jdermsci.2003.10.003; Kouwenhoven EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001065; Kuramoto N, 2002, J CLIN INVEST, V109, P243, DOI 10.1172/JCI200213563; LeBoeuf M, 2010, DEV CELL, V19, P807, DOI 10.1016/j.devcel.2010.10.015; LeRoy G, 2000, J BIOL CHEM, V275, P14787, DOI 10.1074/jbc.C000093200; Li AG, 2003, CYTOKINE GROWTH F R, V14, P99, DOI 10.1016/S1359-6101(03)00005-4; Luc PV, 2004, BIOINFORMATICS, V20, P1413, DOI 10.1093/bioinformatics/bth114; Luis NM, 2011, CELL STEM CELL, V9, P233, DOI 10.1016/j.stem.2011.07.013; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Perez-Perez JM, 2009, TRENDS GENET, V25, P368, DOI 10.1016/j.tig.2009.06.004; Matsuki M, 1998, P NATL ACAD SCI USA, V95, P1044, DOI 10.1073/pnas.95.3.1044; Mejetta S, 2011, EMBO J, V30, P3635, DOI 10.1038/emboj.2011.265; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Rahman S, 2011, MOL CELL BIOL, V31, P2641, DOI 10.1128/MCB.01341-10; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wang X, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002566; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815	42	111	113	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2012	14	7					753	763		10.1038/ncb2520	http://dx.doi.org/10.1038/ncb2520			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	967PV	22729083	Green Submitted			2022-12-25	WOS:000305921200015
J	Sauliere, A; Bellot, M; Paris, H; Denis, C; Finana, F; Hansen, JT; Altie, MF; Seguelas, MH; Pathak, A; Hansen, JL; Senard, JM; Gales, C				Sauliere, Aude; Bellot, Morgane; Paris, Herve; Denis, Colette; Finana, Frederic; Hansen, Jonas T.; Altie, Marie-Francoise; Seguelas, Marie-Helene; Pathak, Atul; Hansen, Jakob L.; Senard, Jean-Michel; Gales, Celine			Deciphering biased-agonism complexity reveals a new active AT(1) receptor entity	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-COUPLED RECEPTORS; CONFORMATIONAL-CHANGES; BETA-ARRESTIN; FUNCTIONAL SELECTIVITY; SIGNALING COMPLEXES; ADENYLYL-CYCLASE; ACTIVATION; PATHWAYS; BETA-ARRESTIN-2; INCREASES	Functional selectivity of G protein-coupled receptor (GPCR) ligands toward different downstream signals has recently emerged as a general hallmark of this receptor class. However, pleiotropic and crosstalk signaling of GPCRs makes functional selectivity difficult to decode. To look from the initial active receptor point of view, we developed new, highly sensitive and direct bioluminescence resonance energy transfer-based G protein activation probes specific for all G protein isoforms, and we used them to evaluate the G protein-coupling activity of [(1)Sar(4)Ile(8)Ile]-angiotensin II (SII), previously described as an angiotensin II type 1 (AT(1)) receptor-biased agonist that is G protein independent but beta-arrestin selective. By multiplexing assays sensing sequential signaling events, from receptor conformations to downstream signaling, we decoded SII as an agonist stabilizing a G protein-dependent AT(1A) receptor signaling module different from that of the physiological agonist angiotensin II, both in recombinant and primary cells. Thus, a biased agonist does not necessarily select effects from the physiological agonist but may instead stabilize and create a new distinct active pharmacological receptor entity.	[Sauliere, Aude; Bellot, Morgane; Paris, Herve; Denis, Colette; Altie, Marie-Francoise; Seguelas, Marie-Helene; Pathak, Atul; Senard, Jean-Michel; Gales, Celine] Univ Toulouse III Paul Sabatier, Inst Natl Sante & Rech Med, Inst Maladies Metabol & Cardiovasc, Toulouse, France; [Finana, Frederic] Pierre Fabre Res Inst, Dept Cellular & Mol Biol, Castres, France; [Hansen, Jonas T.] Univ Copenhagen, Dept Diabet NBEs & Obes Biol, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Mol Cardiol Lab, Copenhagen, Denmark; [Pathak, Atul; Senard, Jean-Michel] Ctr Hosp Univ Toulouse, Dept Pharmacol, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Danmarks Grundforskningsfond; University of Copenhagen; CHU de Toulouse	Gales, C (corresponding author), Univ Toulouse III Paul Sabatier, Inst Natl Sante & Rech Med, Inst Maladies Metabol & Cardiovasc, Toulouse, France.	celine.gales@inserm.fr	Denis, Colette/K-1571-2019; Pathak, Atul/ABC-5223-2020; Denis, Colette/U-5267-2017	Denis, Colette/0000-0002-8376-8351; Pathak, Atul/0000-0001-6151-0096; Senard, Jean-Michel/0000-0001-7679-1281; GALES, Celine/0000-0002-4938-1583	French National Research Agency [ANR-06-BLAN-0400-02]; Danish National Research Foundation; Danish Council for Independent Research Medical Sciences; Novo Nordisk Foundation	French National Research Agency(French National Research Agency (ANR)); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Council for Independent Research Medical Sciences(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This paper is dedicated to the memory of Dr. Herve Paris, who passed away suddenly during the process of this work. We thank T. Hebert, J. Javitch and M. Lohse for their critical reading of the manuscript and R. D'Angelo for excellent technical support and advice regarding imaging (Cellular Imaging Facility I2MC, TRI Platform). Wild-type, beta-arrestin 1 knockout, and beta-arrestin 1 and 2 double-knockout MEF cells were generously provided by R. Lefkowitz (Duke University Medical Center). This work was supported by a grant from the French National Research Agency (ANR-06-BLAN-0400-02 to C. G.) J. L. H. is sponsored by the Danish National Research Foundation, the Danish Council for Independent Research Medical Sciences and the Novo Nordisk Foundation.	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Aplin M, 2007, BASIC CLIN PHARMACOL, V100, P289, DOI 10.1111/j.1742-7843.2007.00063.x; Audet N, 2008, J BIOL CHEM, V283, P15078, DOI 10.1074/jbc.M707941200; BAUKAL AJ, 1994, J BIOL CHEM, V269, P24546; Blanpain C, 1999, BLOOD, V94, P1899; Breton B, 2010, FASEB J, V24, P4733, DOI 10.1096/fj.10-164061; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; BURGEN ASV, 1981, FED PROC, V40, P2723; Christensen GL, 2011, MOL CELL ENDOCRINOL, V331, P49, DOI 10.1016/j.mce.2010.08.004; Christensen GL, 2010, MOL CELL PROTEOMICS, V9, P1540, DOI 10.1074/mcp.M900550-MCP200; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Denis C, 2012, CURR PHARM DESIGN, V18, P128, DOI 10.2174/138161212799040466; Dupre DJ, 2006, J BIOL CHEM, V281, P34561, DOI 10.1074/jbc.M605012200; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Hansen JL, 2008, EUR J PHARMACOL, V590, P255, DOI 10.1016/j.ejphar.2008.05.010; Hoffmann C, 2008, BRIT J PHARMACOL, V153, pS358, DOI 10.1038/sj.bjp.0707615; Holloway AC, 2002, MOL PHARMACOL, V61, P768, DOI 10.1124/mol.61.4.768; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; KENAKIN T, 1995, TRENDS PHARMACOL SCI, V16, P232, DOI 10.1016/S0165-6147(00)89032-X; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Kim J, 2009, J BIOL CHEM, V284, P11953, DOI 10.1074/jbc.M808176200; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Leifert WR, 2005, J BIOMOL SCREEN, V10, P765, DOI 10.1177/1087057105280517; Loening AM, 2007, NAT METHODS, V4, P641, DOI 10.1038/NMETH1070; MacrezLepretre N, 1997, J BIOL CHEM, V272, P10095; Mervine SM, 2006, MOL PHARMACOL, V70, P194, DOI 10.1124/mol.106.022616; Nakahata N, 2008, PHARMACOL THERAPEUT, V118, P18, DOI 10.1016/j.pharmthera.2008.01.001; OFFERMANNS S, 1994, MOL PHARMACOL, V45, P890; Ostrom RS, 2003, J BIOL CHEM, V278, P24461, DOI 10.1074/jbc.M212659200; PEPPERL DJ, 1993, MOL PHARMACOL, V44, P802; Rajagopal K, 2006, P NATL ACAD SCI USA, V103, P16284, DOI 10.1073/pnas.0607583103; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Reiner S, 2010, J BIOL CHEM, V285, P36188, DOI 10.1074/jbc.M110.175604; Reversi A, 2005, J BIOL CHEM, V280, P16311, DOI 10.1074/jbc.M409945200; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Sun YT, 2007, EMBO J, V26, P53, DOI 10.1038/sj.emboj.7601502; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Vaidehi N, 2010, CURR OPIN PHARMACOL, V10, P775, DOI 10.1016/j.coph.2010.09.004; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Violin JD, 2010, J PHARMACOL EXP THER, V335, P572, DOI 10.1124/jpet.110.173005; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; WONG SKF, 1990, J BIOL CHEM, V265, P6219; Zhai PY, 2005, J CLIN INVEST, V115, P3045, DOI 10.1172/JCI25330; Zidar DA, 2009, P NATL ACAD SCI USA, V106, P9649, DOI 10.1073/pnas.0904361106	49	148	151	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2012	8	7					622	630		10.1038/NCHEMBIO.961	http://dx.doi.org/10.1038/NCHEMBIO.961			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961NJ	22634635				2022-12-25	WOS:000305471400009
J	Sullivan, KD; Padilla-Just, N; Henry, RE; Porter, CC; Kim, J; Tentler, JJ; Eckhardt, SG; Tan, AC; DeGregori, J; Espinosa, JM				Sullivan, Kelly D.; Padilla-Just, Nuria; Henry, Ryan E.; Porter, Christopher C.; Kim, Jihye; Tentler, John J.; Eckhardt, S. Gail; Tan, Aik Choon; DeGregori, James; Espinosa, Joaquin M.			ATM and MET kinases are synthetic lethal with nongenotoxic activation of p53	NATURE CHEMICAL BIOLOGY			English	Article							CELL LUNG-CANCER; NF-KAPPA-B; DNA-DAMAGE; ATAXIA-TELANGIECTASIA; COLORECTAL-CANCER; RECEPTOR GENE; IN-VIVO; TUMOR; INHIBITOR; RESTORATION	The p53 tumor suppressor orchestrates alternative stress responses including cell cycle arrest and apoptosis, but the mechanisms defining cell fate upon p53 activation are poorly understood. Several small-molecule activators of p53 have been developed, including Nutlin-3, but their therapeutic potential is limited by the fact that they induce reversible cell cycle arrest in most cancer cell types. We report here the results of a genome-wide short hairpin RNA screen for genes that are lethal in combination with p53 activation by Nutlin-3, which showed that the ATM and MET kinases govern cell fate choice upon p53 activation. Genetic or pharmacological interference with ATM or MET activity converts the cellular response from cell cycle arrest into apoptosis in diverse cancer cell types without affecting expression of key p53 target genes. ATM and MET inhibitors also enable Nutlin-3 to kill tumor spheroids. These results identify new pathways controlling the cellular response to p53 activation and aid in the design of p53-based therapies.	[Sullivan, Kelly D.; Padilla-Just, Nuria; Henry, Ryan E.; Espinosa, Joaquin M.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Sullivan, Kelly D.; Padilla-Just, Nuria; Henry, Ryan E.; Espinosa, Joaquin M.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Porter, Christopher C.; DeGregori, James] Univ Colorado, Dept Pediat, Aurora, CO USA; [Kim, Jihye; Tentler, John J.; Eckhardt, S. Gail; Tan, Aik Choon] Univ Colorado, Div Med Oncol, Dept Med, Aurora, CO USA; [DeGregori, James] Univ Colorado, Dept Biochem & Mol Genet, Aurora, CO USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Espinosa, JM (corresponding author), Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.	joaquin.espinosa@colorado.edu	Tan, Aik Choon/A-3135-2011; Porter, Christopher/AAE-8918-2020	Tan, Aik Choon/0000-0003-2955-8369; Porter, Christopher/0000-0001-8774-0180; SULLIVAN, KELLY/0000-0003-2725-0205; DeGregori, James/0000-0002-1287-1976	US National Institutes of Health [RO1 CA117907]; Lung SPORE Pilot Grant [P50 CA058187]; Cancer League of Colorado; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA157850, T32CA082086, P30CA046934, R01CA117907, P50CA058187] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lung SPORE Pilot Grant; Cancer League of Colorado; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by US National Institutes of Health grant RO1 CA117907, a Lung SPORE Pilot Grant (P50 CA058187), a pilot grant from the Cancer League of Colorado and a Career Development Award from The Leukemia and Lymphoma Society to K.D.S. J.M.E. is a Howard Hughes Medical Institute Early Career Scientist. We thank members of the Espinosa lab for support and discussions and H. Kennedy and J. Kruk for inspiration.	Biton S, 2011, CELL, V145, P92, DOI 10.1016/j.cell.2011.02.023; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Chan TA, 2000, GENE DEV, V14, P1584; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Ding J, 2006, TRENDS PHARMACOL SCI, V27, P338, DOI 10.1016/j.tips.2006.04.007; DIRENZO MF, 1995, CLIN CANCER RES, V1, P147; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hadian K, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001712; Henry RE, 2012, EMBO J, V31, P1266, DOI 10.1038/emboj.2011.498; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Huang BY, 2009, MOL CANCER RES, V7, P1497, DOI 10.1158/1541-7786.MCR-09-0144; Hwang CI, 2011, P NATL ACAD SCI USA, V108, P14240, DOI 10.1073/pnas.1017536108; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Jiang H, 2009, GENE DEV, V23, P1895, DOI 10.1101/gad.1815309; Kim J, 2012, METHODS MOL BIOL, V802, P389, DOI 10.1007/978-1-61779-400-1_26; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Levesque AA, 2007, CARCINOGENESIS, V28, P13, DOI 10.1093/carcin/bgl214; Li AH, 2001, CLIN CANCER RES, V7, P3298; Mandinova A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001366; Miyamoto S, 2011, CELL RES, V21, P116, DOI 10.1038/cr.2010.179; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Olivero M, 1996, BRIT J CANCER, V74, P1862, DOI 10.1038/bjc.1996.646; Paris R, 2008, CELL CYCLE, V7, P2427, DOI 10.4161/cc.6420; Porter C.C., 2012, LEUKEMIA        0113, DOI [10.1038/leu.2011.392, DOI 10.1038/LEU.2011.392]; Sattler M, 2003, CANCER RES, V63, P5462; Shaw AT, 2011, CLIN CANCER RES, V17, P2081, DOI 10.1158/1078-0432.CCR-10-1591; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sugai T, 2001, ONCOGENE, V20, P6095, DOI 10.1038/sj.onc.1204731; Sullivan KD, 2012, BBA-REV CANCER, V1825, P229, DOI 10.1016/j.bbcan.2012.01.004; Takhar AS, 2004, SURG-J R COLL SURG E, V2, P251, DOI 10.1016/S1479-666X(04)80093-3; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yamazaki S, 2008, DRUG METAB DISPOS, V36, P1267, DOI 10.1124/dmd.107.019711; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zhang YJ, 2009, MOL BIOL CELL, V20, P3077, DOI 10.1091/mbc.E08-11-1109	49	53	56	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2012	8	7					646	654		10.1038/NCHEMBIO.965	http://dx.doi.org/10.1038/NCHEMBIO.965			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961NJ	22660439	Green Accepted			2022-12-25	WOS:000305471400012
J	Hahn, AS; Kaufmann, JK; Wies, E; Naschberger, E; Panteleev-Ivlev, J; Schmidt, K; Holzer, A; Schmidt, M; Chen, J; Konig, S; Ensser, A; Myoung, J; Brockmeyer, NH; Sturzl, M; Fleckenstein, B; Neipel, F				Hahn, Alexander S.; Kaufmann, Johanna K.; Wies, Effi; Naschberger, Elisabeth; Panteleev-Ivlev, Julia; Schmidt, Katharina; Holzer, Angela; Schmidt, Martin; Chen, Jin; Koenig, Simone; Ensser, Armin; Myoung, Jinjong; Brockmeyer, Norbert H.; Stuerzl, Michael; Fleckenstein, Bernhard; Neipel, Frank			The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma-associated herpesvirus	NATURE MEDICINE			English	Article							HEPARAN-SULFATE; GLYCOPROTEIN-B; DNA-SEQUENCES; EPITHELIAL-CELLS; GENE-EXPRESSION; ENTRY RECEPTOR; SIMPLEX-VIRUS; TARGET-CELLS; IN-VITRO; HUMAN-HERPESVIRUS-8	Kaposi's sarcoma-associated herpesvirus (KSHV) is the causative agent of Kaposi's sarcoma(1), a highly vascularized tumor originating from lymphatic endothelial cells, and of at least two different B cell malignancies(2,3). A dimeric complex formed by the envelope glycoproteins H and L (gH-gL) is required for entry of herpesviruses into host cells(4). We show that the ephrin receptor tyrosine kinase A2 (EphA2) is a cellular receptor for KSHV gH-gL. EphA2 co-precipitated with both gH-gL and KSHV virions. Infection of human epithelial cells with a GFP-expressing recombinant KSHV strain, as measured by FACS analysis, was increased upon overexpression of EphA2. Antibodies against EphA2 and siRNAs directed against EphA2 inhibited infection of endothelial cells. Pretreatment of KSHV with soluble EphA2 resulted in inhibition of KSHV infection by up to 90%. This marked reduction of KSHV infection was seen with all the different epithelial and endothelial cells used in this study. Similarly, pretreating epithelial or endothelial cells with the soluble EphA2 ligand ephrinA4 impaired KSHV infection. Deletion of the gene encoding EphA2 essentially abolished KSHV infection of mouse endothelial cells. Binding of gH-gL to EphA2 triggered EphA2 phosphorylation and endocytosis, a major pathway of KSHV entry(5,6). Quantitative RT-PCR and in situ histochemistry revealed a close correlation between KSHV infection and EphA2 expression both in cultured cells derived from human Kaposi's sarcoma lesions or unaffected human lymphatic endothelium, and in situ in Kaposi's sarcoma specimens, respectively. Taken together, our results identify EphA2, a tyrosine kinase with known functions in neovascularization and oncogenesis, as an entry receptor for KSHV.	[Hahn, Alexander S.; Kaufmann, Johanna K.; Wies, Effi; Panteleev-Ivlev, Julia; Schmidt, Katharina; Holzer, Angela; Schmidt, Martin; Ensser, Armin; Fleckenstein, Bernhard; Neipel, Frank] Univ Klinikum Erlangen, Inst Virol, Erlangen, Germany; [Naschberger, Elisabeth; Stuerzl, Michael] Univ Klinikum Erlangen, Abt Mol & Expt Chirurg, Erlangen, Germany; [Chen, Jin] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Dept Med, Nashville, TN USA; [Chen, Jin] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Dept Canc Biol, Nashville, TN USA; [Chen, Jin] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Dept Cell Biol, Nashville, TN USA; [Chen, Jin] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Dept Dev Biol, Nashville, TN USA; [Chen, Jin] Tennessee Valley Healthcare Syst, Vet Affairs Med Ctr, Nashville, TN USA; [Koenig, Simone] Univ Munster, Interdisciplinary Ctr Clin Res, Munster, Germany; [Myoung, Jinjong] Novartis Inst Biomed Res, Emeryville, CA USA; [Brockmeyer, Norbert H.] Ruhr Univ Bochum, St Josef Hosp, Dept Dermatol, Bochum, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; University of Munster; Novartis; Ruhr University Bochum	Neipel, F (corresponding author), Univ Klinikum Erlangen, Inst Virol, Erlangen, Germany.	frank.neipel@viro.med.uni-erlangen.de	Hahn, Alexander/ABE-5642-2021; Stürzl, Michael/B-3019-2015; König, Simone/B-6504-2008; Naschberger, Elisabeth/AAV-5289-2021	Hahn, Alexander/0000-0003-4171-2744; Stürzl, Michael/0000-0002-9276-2824; König, Simone/0000-0003-0672-7246; Naschberger, Elisabeth/0000-0003-1291-622X; Chen, Jin/0000-0002-5557-2079; Schmidt, Katharina/0000-0003-2797-9952	Akademie der Wissenschaften und der Literatur (Mainz); European Community; Deutsche Forschungsgemeinschaft [643, 1071]; interdisciplinary center for clinical research at the University Hospital of the University of Erlangen; German Cancer Aid; NATIONAL CANCER INSTITUTE [R01CA095004] Funding Source: NIH RePORTER	Akademie der Wissenschaften und der Literatur (Mainz); European Community(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); interdisciplinary center for clinical research at the University Hospital of the University of Erlangen; German Cancer Aid(Deutsche Krebshilfe); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Akademie der Wissenschaften und der Literatur (Mainz), the European Community research project TargetHerpes, Deutsche Forschungsgemeinschaft center grant 643 and graduate school grant 1071 "viruses of the immune system." M. Sturzl, E.N. and F.N. were supported by the interdisciplinary center for clinical research at the University Hospital of the University of Erlangen. M. Sturzl and E.N. were supported by the German Cancer Aid. We thank L. Wall for experimental assistance and R. C. Desrosiers for helpful discussions and critical reading of the manuscript. KSImm cells were kindly provided by A. Albini (Science and Technology Pole, IRCCS MultiMedica). 4G10 mouse hybridoma supernatant was kindly provided by B. Biesinger (Virologisches Institut, Universitatsklinikum Erlangen).	Akula SM, 2003, J VIROL, V77, P7978, DOI 10.1128/JVI.77.14.7978-7990.2003; Akula SM, 2001, VIROLOGY, V284, P235, DOI 10.1006/viro.2001.0921; Albini A, 1997, AIDS, V11, P713, DOI 10.1097/00002030-199706000-00003; BANFIELD BW, 1995, J VIROL, V69, P3290, DOI 10.1128/JVI.69.6.3290-3298.1995; Birkmann A, 2001, J VIROL, V75, P11583, DOI 10.1128/JVI.75.23.11583-11593.2001; Brantley-Sieders DM, 2004, J CELL SCI, V117, P2037, DOI 10.1242/jcs.01061; Campadelli-Fiume G, 2007, REV MED VIROL, V17, P313, DOI 10.1002/rmv.546; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Chandran B, 2010, J VIROL, V84, P2188, DOI 10.1128/JVI.01334-09; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Cheng N, 2002, MOL CANCER RES, V1, P2; Chesnokova LS, 2011, J VIROL, V85, P13214, DOI 10.1128/JVI.05580-11; Chesnokova LS, 2009, P NATL ACAD SCI USA, V106, P20464, DOI 10.1073/pnas.0907508106; Chowdary TK, 2010, NAT STRUCT MOL BIOL, V17, P882, DOI 10.1038/nsmb.1837; Ensser A, 1999, J VIROL, V73, P10551, DOI 10.1128/JVI.73.12.10551-10555.1999; Garrigues HJ, 2008, J VIROL, V82, P1570, DOI 10.1128/JVI.01673-07; Glykofrydes D, 2000, J VIROL, V74, P11919, DOI 10.1128/JVI.74.24.11919-11927.2000; Hahn A, 2009, J VIROL, V83, P396, DOI 10.1128/JVI.01170-08; HERNDIER BG, 1994, AIDS, V8, P575, DOI 10.1097/00002030-199405000-00002; Kaleeba JAR, 2006, SCIENCE, V311, P1921, DOI 10.1126/science.1120878; Kaleeba JAR, 2006, VIROLOGY, V354, P7, DOI 10.1016/j.virol.2006.06.009; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Konig S, 2003, ELECTROPHORESIS, V24, P751, DOI 10.1002/elps.200390090; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Matsuura H, 2010, P NATL ACAD SCI USA, V107, P22641, DOI 10.1073/pnas.1011806108; MCALLISTER RM, 1969, CANCER-AM CANCER SOC, V24, P520, DOI 10.1002/1097-0142(196909)24:3<520::AID-CNCR2820240313>3.0.CO;2-M; Myoung J, 2011, J VIROL METHODS, V174, P12, DOI 10.1016/j.jviromet.2011.03.012; Naranatt PP, 2003, J VIROL, V77, P1524, DOI 10.1128/JVI.77.2.1524-1539.2003; Naschberger E, 2008, INT J CANCER, V123, P2120, DOI 10.1002/ijc.23764; Ogawa K, 2000, ONCOGENE, V19, P6043, DOI 10.1038/sj.onc.1204004; Pertel PE, 2002, J VIROL, V76, P4390, DOI 10.1128/JVI.76.9.4390-4400.2002; Raghu H, 2009, J VIROL, V83, P4895, DOI 10.1128/JVI.02498-08; Rappocciolo G, 2006, J IMMUNOL, V176, P1741, DOI 10.4049/jimmunol.176.3.1741; Ryckman BJ, 2008, P NATL ACAD SCI USA, V105, P14118, DOI 10.1073/pnas.0804365105; Scehnet JS, 2009, BLOOD, V113, P254, DOI 10.1182/blood-2008-02-140020; Schmidt K, 2011, J VIROL, V85, P4530, DOI 10.1128/JVI.02123-10; Sharma-Walia N, 2004, J VIROL, V78, P4207, DOI 10.1128/JVI.78.8.4207-4223.2004; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; STURZL M, 1995, ONCOGENE, V10, P2007; Vanarsdall AL, 2011, J VIROL, V85, P11638, DOI 10.1128/JVI.05659-11; Vieira J, 2004, VIROLOGY, V325, P225, DOI 10.1016/j.virol.2004.03.049; Vleck SE, 2011, P NATL ACAD SCI USA, V108, P18412, DOI 10.1073/pnas.1111333108; Walker-Daniels J, 2002, MOL CANCER RES, V1, P79; Wang FZ, 2001, J VIROL, V75, P7517, DOI 10.1128/JVI.75.16.7517-7527.2001; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Wickramasinghe SR, 2005, BIOTECHNOL BIOENG, V92, P199, DOI 10.1002/bit.20599; Zhu LJ, 1999, VIROLOGY, V262, P237, DOI 10.1006/viro.1999.9900; Zhuang GL, 2007, J BIOL CHEM, V282, P2683, DOI 10.1074/jbc.M608509200	48	125	129	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2012	18	6					961	+		10.1038/nm.2805	http://dx.doi.org/10.1038/nm.2805			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22635007	Green Accepted			2022-12-25	WOS:000305116600035
J	Jacobs, KB; Yeager, M; Zhou, WY; Wacholder, S; Wang, ZM; Rodriguez-Santiago, B; Hutchinson, A; Deng, X; Liu, CW; Horner, MJ; Cullen, M; Epstein, CG; Burdett, L; Dean, MC; Chatterjee, N; Sampson, J; Chung, CC; Kovaks, J; Gapstur, SM; Stevens, VL; Teras, LT; Gaudet, MM; Albanes, D; Weinstein, SJ; Virtamo, J; Taylor, PR; Freedman, ND; Abnet, CC; Goldstein, AM; Hu, N; Yu, K; Yuan, JM; Liao, LD; Ding, T; Qiao, YL; Gao, YT; Koh, WP; Xiang, YB; Tang, ZZ; Fan, JH; Aldrich, MC; Amos, C; Blot, WJ; Bock, CH; Gillanders, EM; Harris, CC; Haiman, CA; Henderson, BE; Kolonel, LN; Le Marchand, L; McNeill, LH; Rybicki, BA; Schwartz, AG; Signorello, LB; Spitz, MR; Wiencke, JK; Wrensch, M; Wu, XF; Zanetti, KA; Ziegler, RG; Figueroa, JD; Garcia-Closas, M; Malats, N; Marenne, G; Prokunina-Olsson, L; Baris, D; Schwenn, M; Johnson, A; Landi, MT; Goldin, L; Consonni, D; Bertazzi, PA; Rotunno, M; Rajaraman, P; Andersson, U; Freeman, LEB; Berg, CD; Buring, JE; Butler, MA; Carreon, T; Feychting, M; Ahlbom, A; Gaziano, JM; Giles, GG; Hallmans, G; Hankinson, SE; Hartge, P; Henriksson, R; Inskip, PD; Johansen, C; Landgren, A; McKean-Cowdin, R; Michaud, DS; Melin, BS; Peters, U; Ruder, AM; Sesso, HD; Severi, G; Shu, XO; Visvanathan, K; White, E; Wolk, A; Zeleniuch-Jacquotte, A; Zheng, W; Silverman, DT; Kogevinas, M; Gonzalez, JR; Villa, O; Li, DH; Duell, EJ; Risch, HA; Olson, SH; Kooperberg, C; Wolpin, BM; Jiao, L; Hassan, M; Wheeler, W; Arslan, AA; Bueno-de-Mesquita, HB; Fuchs, CS; Gallinger, S; Gross, MD; Holly, EA; Klein, AP; LaCroix, A; Mandelson, MT; Petersen, G; Boutron-Ruault, MC; Bracci, PM; Canzian, F; Chang, K; Cotterchio, M; Giovannucci, EL; Goggins, M; Bolton, JAH; Jenab, M; Khaw, KT; Krogh, V; Kurtz, RC; McWilliams, RR; Mendelsohn, JB; Rabe, KG; Riboli, E; Tjonneland, A; Tobias, GS; Trichopoulos, D; Elena, JW; Yu, H; Amundadottir, L; Stolzenberg-Solomon, RZ; Kraft, P; Schumacher, F; Stram, D; Savage, SA; Mirabello, L; Andrulis, IL; Wunder, JS; Garcia, AP; Sierrasesumaga, L; Barkauskas, DA; Gorlick, RG; Purdue, M; Chow, WH; Moore, LE; Schwartz, KL; Davis, FG; Hsing, AW; Berndt, SI; Black, A; Wentzensen, N; Brinton, LA; Lissowska, J; Peplonska, B; McGlynn, KA; Cook, MB; Graubard, BI; Kratz, CP; Greene, MH; Erickson, RL; Hunter, DJ; Thomas, G; Hoover, RN; Real, FX; Fraumeni, JF; Caporaso, NE; Tucker, M; Rothman, N; Perez-Jurado, LA; Chanock, SJ				Jacobs, Kevin B.; Yeager, Meredith; Zhou, Weiyin; Wacholder, Sholom; Wang, Zhaoming; Rodriguez-Santiago, Benjamin; Hutchinson, Amy; Deng, Xiang; Liu, Chenwei; Horner, Marie-Josephe; Cullen, Michael; Epstein, Caroline G.; Burdett, Laurie; Dean, Michael C.; Chatterjee, Nilanjan; Sampson, Joshua; Chung, Charles C.; Kovaks, Joseph; Gapstur, Susan M.; Stevens, Victoria L.; Teras, Lauren T.; Gaudet, Mia M.; Albanes, Demetrius; Weinstein, Stephanie J.; Virtamo, Jarmo; Taylor, Philip R.; Freedman, Neal D.; Abnet, Christian C.; Goldstein, Alisa M.; Hu, Nan; Yu, Kai; Yuan, Jian-Min; Liao, Linda; Ding, Ti; Qiao, You-Lin; Gao, Yu-Tang; Koh, Woon-Puay; Xiang, Yong-Bing; Tang, Ze-Zhong; Fan, Jin-Hu; Aldrich, Melinda C.; Amos, Christopher; Blot, William J.; Bock, Cathryn H.; Gillanders, Elizabeth M.; Harris, Curtis C.; Haiman, Christopher A.; Henderson, Brian E.; Kolonel, Laurence N.; Le Marchand, Loic; McNeill, Lorna H.; Rybicki, Benjamin A.; Schwartz, Ann G.; Signorello, Lisa B.; Spitz, Margaret R.; Wiencke, John K.; Wrensch, Margaret; Wu, Xifeng; Zanetti, Krista A.; Ziegler, Regina G.; Figueroa, Jonine D.; Garcia-Closas, Montserrat; Malats, Nuria; Marenne, Gaelle; Prokunina-Olsson, Ludmila; Baris, Dalsu; Schwenn, Molly; Johnson, Alison; Landi, Maria Teresa; Goldin, Lynn; Consonni, Dario; Bertazzi, Pier Alberto; Rotunno, Melissa; Rajaraman, Preetha; Andersson, Ulrika; Freeman, Laura E. Beane; Berg, Christine D.; Buring, Julie E.; Butler, Mary A.; Carreon, Tania; Feychting, Maria; Ahlbom, Anders; Gaziano, J. Michael; Giles, Graham G.; Hallmans, Goran; Hankinson, Susan E.; Hartge, Patricia; Henriksson, Roger; Inskip, Peter D.; Johansen, Christoffer; Landgren, Annelie; McKean-Cowdin, Roberta; Michaud, Dominique S.; Melin, Beatrice S.; Peters, Ulrike; Ruder, Avima M.; Sesso, Howard D.; Severi, Gianluca; Shu, Xiao-Ou; Visvanathan, Kala; White, Emily; Wolk, Alicja; Zeleniuch-Jacquotte, Anne; Zheng, Wei; Silverman, Debra T.; Kogevinas, Manolis; Gonzalez, Juan R.; Villa, Olaya; Li, Donghui; Duell, Eric J.; Risch, Harvey A.; Olson, Sara H.; Kooperberg, Charles; Wolpin, Brian M.; Jiao, Li; Hassan, Manal; Wheeler, William; Arslan, Alan A.; Bueno-de-Mesquita, H. Bas; Fuchs, Charles S.; Gallinger, Steven; Gross, Myron D.; Holly, Elizabeth A.; Klein, Alison P.; LaCroix, Andrea; Mandelson, Margaret T.; Petersen, Gloria; Boutron-Ruault, Marie-Christine; Bracci, Paige M.; Canzian, Federico; Chang, Kenneth; Cotterchio, Michelle; Giovannucci, Edward L.; Goggins, Michael; Bolton, Judith A. Hoffman; Jenab, Mazda; Khaw, Kay-Tee; Krogh, Vittorio; Kurtz, Robert C.; McWilliams, Robert R.; Mendelsohn, Julie B.; Rabe, Kari G.; Riboli, Elio; Tjonneland, Anne; Tobias, Geoffrey S.; Trichopoulos, Dimitrios; Elena, Joanne W.; Yu, Herbert; Amundadottir, Laufey; Stolzenberg-Solomon, Rachael Z.; Kraft, Peter; Schumacher, Fredrick; Stram, Daniel; Savage, Sharon A.; Mirabello, Lisa; Andrulis, Irene L.; Wunder, Jay S.; Patino Garcia, Ana; Sierrasesumaga, Luis; Barkauskas, Donald A.; Gorlick, Richard G.; Purdue, Mark; Chow, Wong-Ho; Moore, Lee E.; Schwartz, Kendra L.; Davis, Faith G.; Hsing, Ann W.; Berndt, Sonja I.; Black, Amanda; Wentzensen, Nicolas; Brinton, Louise A.; Lissowska, Jolanta; Peplonska, Beata; McGlynn, Katherine A.; Cook, Michael B.; Graubard, Barry I.; Kratz, Christian P.; Greene, Mark H.; Erickson, Ralph L.; Hunter, David J.; Thomas, Gilles; Hoover, Robert N.; Real, Francisco X.; Fraumeni, Joseph F., Jr.; Caporaso, Neil E.; Tucker, Margaret; Rothman, Nathaniel; Perez-Jurado, Luis A.; Chanock, Stephen J.			Detectable clonal mosaicism and its relationship to aging and cancer	NATURE GENETICS			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; GENOMIC IMBALANCES; MAFFUCCI SYNDROME; OLLIER DISEASE; MUTATIONS; SUSCEPTIBILITY; ASSOCIATION; ABERRATIONS; MECHANISMS; ANEUPLOIDY	In an analysis of 31,717 cancer cases and 26,136 cancer-free controls from 13 genome-wide association studies, we observed large chromosomal abnormalities in a subset of clones in DNA obtained from blood or buccal samples. We observed mosaic abnormalities, either aneuploidy or copy-neutral loss of heterozygosity, of > 2 Mb in size in autosomes of 517 individuals (0.89%), with abnormal cell proportions of between 7% and 95%. In cancer-free individuals, frequency increased with age, from 0.23% under 50 years to 1.91% between 75 and 79 years (P = 4.8 x 10(-8)). Mosaic abnormalities were more frequent in individuals with solid tumors (0.97% versus 0.74% in cancer-free individuals; odds ratio (OR) = 1.25; P = 0.016), with stronger association with cases who had DNA collected before diagnosis or treatment (OR = 1.45; P = 0.0005). Detectable mosaicism was also more common in individuals for whom DNA was collected at least 1 year before diagnosis with leukemia compared to cancer-free individuals (OR = 35.4; P = 3.8 x 10(-11)). These findings underscore the time-dependent nature of somatic events in the etiology of cancer and potentially other late-onset diseases.	[Jacobs, Kevin B.; Yeager, Meredith; Zhou, Weiyin; Wacholder, Sholom; Wang, Zhaoming; Hutchinson, Amy; Deng, Xiang; Liu, Chenwei; Horner, Marie-Josephe; Cullen, Michael; Epstein, Caroline G.; Burdett, Laurie; Chatterjee, Nilanjan; Sampson, Joshua; Chung, Charles C.; Kovaks, Joseph; Albanes, Demetrius; Weinstein, Stephanie J.; Taylor, Philip R.; Freedman, Neal D.; Abnet, Christian C.; Goldstein, Alisa M.; Hu, Nan; Yu, Kai; Liao, Linda; Ziegler, Regina G.; Figueroa, Jonine D.; Garcia-Closas, Montserrat; Prokunina-Olsson, Ludmila; Baris, Dalsu; Landi, Maria Teresa; Goldin, Lynn; Rotunno, Melissa; Rajaraman, Preetha; Freeman, Laura E. Beane; Hartge, Patricia; Inskip, Peter D.; Landgren, Annelie; Silverman, Debra T.; Mendelsohn, Julie B.; Tobias, Geoffrey S.; Amundadottir, Laufey; Stolzenberg-Solomon, Rachael Z.; Savage, Sharon A.; Mirabello, Lisa; Purdue, Mark; Chow, Wong-Ho; Moore, Lee E.; Hsing, Ann W.; Berndt, Sonja I.; Black, Amanda; Wentzensen, Nicolas; Brinton, Louise A.; McGlynn, Katherine A.; Cook, Michael B.; Graubard, Barry I.; Kratz, Christian P.; Greene, Mark H.; Hoover, Robert N.; Fraumeni, Joseph F., Jr.; Caporaso, Neil E.; Tucker, Margaret; Rothman, Nathaniel; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Jacobs, Kevin B.; Yeager, Meredith; Zhou, Weiyin; Wang, Zhaoming; Hutchinson, Amy; Deng, Xiang; Liu, Chenwei; Cullen, Michael; Burdett, Laurie] NCI, Core Genotyping Facil, SAIC Frederick Inc, Frederick, MD 21701 USA; [Rodriguez-Santiago, Benjamin; Villa, Olaya; Real, Francisco X.; Perez-Jurado, Luis A.] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain; [Rodriguez-Santiago, Benjamin; Villa, Olaya; Perez-Jurado, Luis A.] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain; [Rodriguez-Santiago, Benjamin; Villa, Olaya] qGenomics, Quantitat Genom Med Lab, Barcelona, Spain; [Dean, Michael C.] NCI, Expt Immunol Lab, Ctr Canc Res, Frederick, MD 21701 USA; [Gapstur, Susan M.; Stevens, Victoria L.; Teras, Lauren T.; Gaudet, Mia M.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Yuan, Jian-Min] Univ Minnesota, Sch Publ Hlth, Dept Epidemiol & Community Hlth, Minneapolis, MN USA; [Yuan, Jian-Min] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Ding, Ti; Tang, Ze-Zhong] Shanxi Canc Hosp, Taiyuan, Peoples R China; [Qiao, You-Lin; Fan, Jin-Hu] Chinese Acad Med Sci, Dept Epidemiol, Canc Inst Hosp, Beijing 100730, Peoples R China; [Gao, Yu-Tang; Xiang, Yong-Bing] Shanghai Canc Inst, Shanghai, Peoples R China; [Koh, Woon-Puay] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Aldrich, Melinda C.] Vanderbilt Univ, Sch Med, Dept Thorac Surg, Nashville, TN 37212 USA; [Aldrich, Melinda C.; Blot, William J.; Signorello, Lisa B.; Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Med Ctr, Dept Med, Div Epidemiol,Vanderbilt Epidemiol Ctr, Nashville, TN USA; [Amos, Christopher; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Div Canc Prevent & Populat Sci, Houston, TX 77030 USA; [Blot, William J.; Signorello, Lisa B.] Int Epidemiol Inst, Rockville, MD USA; [Bock, Cathryn H.; Schwartz, Ann G.] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA; [Bock, Cathryn H.; Schwartz, Ann G.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA; [Gillanders, Elizabeth M.; Zanetti, Krista A.] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; [Harris, Curtis C.; Zanetti, Krista A.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Haiman, Christopher A.; Henderson, Brian E.; McKean-Cowdin, Roberta; Schumacher, Fredrick; Stram, Daniel; Barkauskas, Donald A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Kolonel, Laurence N.; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [McNeill, Lorna H.] Univ Texas MD Anderson Canc Ctr, Dept Hlth Dispar Res, Div Off Vice President Canc Prevent & Populat Sci, Houston, TX 77030 USA; [McNeill, Lorna H.] Univ Texas MD Anderson Canc Ctr, Ctr Community Engaged & Translat Res, Duncan Family Inst, Houston, TX 77030 USA; [Rybicki, Benjamin A.] Henry Ford Hosp, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Signorello, Lisa B.; Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Spitz, Margaret R.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Wiencke, John K.; Wrensch, Margaret] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Garcia-Closas, Montserrat] Inst Canc Res, Div Genet & Epidemiol, London SW3 6JB, England; [Malats, Nuria; Marenne, Gaelle] CNIO, Genet & Mol Epidemiol Grp, Madrid, Spain; [Schwenn, Molly] Maine Canc Registry, Augusta, ME USA; [Johnson, Alison] Vermont Canc Registry, Burlington, VT USA; [Consonni, Dario; Bertazzi, Pier Alberto] Univ Milan, Dept Occupat & Environm Hlth, Milan, Italy; [Consonni, Dario; Bertazzi, Pier Alberto] Osped Maggiore Policlin Mangiagalli & Regina Elen, Unit Epidemiol, Fdn Ist Ricevero & Cura Carattere Sci IRCCS, Milan, Italy; [Andersson, Ulrika; Henriksson, Roger; Melin, Beatrice S.] Umea Univ, Dept Radiat Sci, Umea, Sweden; [Berg, Christine D.; Elena, Joanne W.] NCI, Clin & Translat Epidemiol Branch, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; [Buring, Julie E.] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA; [Buring, Julie E.; Gaziano, J. Michael; Sesso, Howard D.] Harvard Univ, Brigham & Womens Hosp, Div Prevent Med, Sch Med, Boston, MA 02115 USA; [Butler, Mary A.; Carreon, Tania; Ruder, Avima M.] NIOSH, Ctr Dis Control & Prevent, Cincinnati, OH 45226 USA; [Feychting, Maria; Ahlbom, Anders] Karolinska Inst, Inst Environm Med, Div Epidemiol, S-10401 Stockholm, Sweden; [Gaziano, J. Michael] Harvard Univ, Sch Med, Div Aging, Brigham & Womens Hosp, Boston, MA 02115 USA; [Gaziano, J. Michael] Vet Affairs Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr, Massachusetts Vet Epidemiol Res & Informat Ctr, Boston, MA USA; [Giles, Graham G.; Severi, Gianluca] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [Giles, Graham G.; Severi, Gianluca] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Hallmans, Goran] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Hankinson, Susan E.; Wolpin, Brian M.; Fuchs, Charles S.; Giovannucci, Edward L.; Kraft, Peter; Hunter, David J.] Harvard Univ, Sch Med, Channing Lab, Dept Med,Brigham & Womens Hosp, Boston, MA 02115 USA; [Henriksson, Roger] Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden; [Johansen, Christoffer; Tjonneland, Anne] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Michaud, Dominique S.; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Div Epidemiol & Biostat, London, England; [Michaud, Dominique S.] Brown Univ, Div Biol & Med, Dept Epidemiol, Providence, RI 02912 USA; [Peters, Ulrike; White, Emily; Kooperberg, Charles; LaCroix, Andrea; Mandelson, Margaret T.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Peters, Ulrike; White, Emily] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Visvanathan, Kala; Bolton, Judith A. Hoffman] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Wolk, Alicja] Karolinska Inst, Inst Environm Med, Div Nutr Epidemiol, S-10401 Stockholm, Sweden; [Zeleniuch-Jacquotte, Anne] NYU, Dept Environm Med, Sch Med, Div Epidemiol, New York, NY 10016 USA; [Kogevinas, Manolis] Natl Sch Publ Hlth, Athens, Greece; [Kogevinas, Manolis; Gonzalez, Juan R.] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Kogevinas, Manolis; Gonzalez, Juan R.] IMIM, Barcelona, Spain; [Kogevinas, Manolis; Gonzalez, Juan R.] CIBERESP, Barcelona, Spain; [Li, Donghui; Hassan, Manal] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Duell, Eric J.] Inst Invest Biomed Bellvitge IDIBELL, Catalan Inst Oncol ICO, Barcelona, Spain; [Risch, Harvey A.; Yu, Herbert] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Olson, Sara H.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Wolpin, Brian M.; Fuchs, Charles S.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Jiao, Li] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Wheeler, William] Informat Management Serv Inc, Silver Spring, MD USA; [Arslan, Alan A.] NYU, Dept Obstet & Gynecol, Sch Med, New York, NY 10016 USA; [Arslan, Alan A.] NYU, Dept Environm Med, Sch Med, New York, NY 10016 USA; [Arslan, Alan A.] NYU, Inst Canc, New York, NY USA; [Bueno-de-Mesquita, H. Bas] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Bueno-de-Mesquita, H. Bas] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Gallinger, Steven; Andrulis, Irene L.; Wunder, Jay S.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Fred A Litwin Ctr Canc Genet, Toronto, ON M5G 1X5, Canada; [Gross, Myron D.] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Holly, Elizabeth A.; Bracci, Paige M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Klein, Alison P.; Goggins, Michael] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Mandelson, Margaret T.] Grp Hlth Ctr Hlth Studies, Seattle, WA USA; [Petersen, Gloria; Rabe, Kari G.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Boutron-Ruault, Marie-Christine] Univ Paris Sud, INSERM, Inst Gustave Roussy, Villejuif, France; [Canzian, Federico] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Chang, Kenneth] Univ Calif Irvine, Med Ctr, Comprehens Digest Dis Ctr, Orange, CA USA; [Cotterchio, Michelle] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Giovannucci, Edward L.; Trichopoulos, Dimitrios; Kraft, Peter; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Giovannucci, Edward L.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Goggins, Michael] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Goggins, Michael] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Jenab, Mazda] Int Agcy Res Canc, World Hlth Org, F-69372 Lyon, France; [Khaw, Kay-Tee] Univ Cambridge, Addenbrookes Hosp, Dept Publ Hlth & Primary Care, Cambridge CB2 2QQ, England; [Krogh, Vittorio] Ist Nazl Tumori, IRCCS, Nutr Epidemiol Unit, I-20133 Milan, Italy; [Kurtz, Robert C.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [McWilliams, Robert R.] Mayo Clin, Div Med Oncol, Rochester, MN USA; [Trichopoulos, Dimitrios] Acad Athens, Bur Epidemiol Res, Athens, Greece; [Andrulis, Irene L.; Wunder, Jay S.] Mt Sinai Hosp, Christopher Sharp Ctr Surg & Oncol, Toronto, ON M5G 1X5, Canada; [Patino Garcia, Ana; Sierrasesumaga, Luis] Univ Navarra Clin, Dept Pediat, Pamplona, Spain; [Gorlick, Richard G.] Yeshiva Univ, Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY USA; [Gorlick, Richard G.] Yeshiva Univ, Albert Einstein Coll Med, Dept Pediat, Bronx, NY USA; [Schwartz, Kendra L.] Wayne State Univ, Dept Family Med & Publ Hlth Sci, Detroit, MI USA; [Davis, Faith G.] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Lissowska, Jolanta] Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland; [Peplonska, Beata] Nofer Inst Occupat Med, Lodz, Poland; [Kratz, Christian P.] Hannover Med Sch, Klin Padiatr Hematol & Onkol, Zentrum Kinderheilkunde & Jugendmed, D-30623 Hannover, Germany; [Erickson, Ralph L.] Walter Reed Army Inst Res, Silver Spring, MD USA; [Thomas, Gilles] Univ Lyon 1, Ctr Leon Berard, F-69365 Lyon, France; [Real, Francisco X.] CNIO, Epithelial Carcinogenesis Grp, Madrid, Spain	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Cancer Society; Finland National Institute for Health & Welfare; University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Shanghai Jiao Tong University; National University of Singapore; Vanderbilt University; Vanderbilt University; University of Texas System; UTMD Anderson Cancer Center; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Henry Ford Health System; Henry Ford Hospital; Vanderbilt University; Baylor College of Medicine; University of California System; University of California San Francisco; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Centro Nacional de Investigaciones Oncologicas (CNIO); University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Umea University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Karolinska Institutet; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Cancer Council Victoria; University of Melbourne; Umea University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Karolinska Institutet; Karolinska University Hospital; Danish Cancer Society; Imperial College London; Brown University; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Karolinska Institutet; New York University; National & Kapodistrian University of Athens; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Texas System; UTMD Anderson Cancer Center; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Yale University; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Baylor College of Medicine; Information Management Services, Inc.; New York University; New York University; New York University; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; Johns Hopkins University; Mayo Clinic; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Helmholtz Association; German Cancer Research Center (DKFZ); University of California System; University of California Irvine; University of Toronto; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins University; World Health Organization; International Agency for Research on Cancer (IARC); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Fondazione IRCCS Istituto Nazionale Tumori Milan; Memorial Sloan Kettering Cancer Center; Mayo Clinic; Academy of Athens; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Navarra; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Wayne State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Nofer Institute of Occupational Medicine; Hannover Medical School; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; Centro Nacional de Investigaciones Oncologicas (CNIO)	Chanock, SJ (corresponding author), NCI, Div Canc Epidemiol & Genet, Rockville, MD USA.	chanocks@mail.nih.gov	Tobias, Geoffrey S/M-4135-2016; Marenne, Gaelle/AAU-8338-2020; zhang, weihua/GXV-1334-2022; Gao, Yu/HGE-1937-2022; Visvanathan, Kumar/AAC-4349-2020; Rybicki, Benjamin/L-4614-2019; Arribas, Francisco X Real/H-5275-2015; Prokunina-Olsson, Ludmila/V-7960-2019; Henriksson, Roger/AAI-8608-2020; Schumacher, Fredrick/R-6043-2019; Gallinger, Steven/E-4575-2013; Severi, Gianluca/Q-1824-2019; Savage, Sharon/AAB-5160-2019; Severi, Gianluca/H-3774-2018; Freeman, Laura E. Beane/C-4468-2015; Purdue, Mark P/C-9228-2016; Wang, Zhaoming/R-5527-2018; Mirabello, Lisa/H-5594-2018; Stolzenberg-Solomon, Rachael/Y-9280-2018; Yeager, Meredith/AAA-5322-2020; Aldrich, Melinda/C-7783-2013; Berndt, Sonja I/J-8423-2016; Krogh, Vittorio/K-2628-2016; Malats, Nuria/H-7041-2015; Garcia-Closas, Montserrat/F-3871-2015; Boutron-Ruault, Marie-Christine/H-3936-2014; Figueroa, Jonine/GWD-1322-2022; Figueroa, Jonine/AFK-2752-2022; Albanes, Demetrius/B-9749-2015; Khaw, Kay-Tee/AAZ-3209-2021; Garcia-Closas, Montserrat/AAZ-6930-2021; Berg, Christine/K-1047-2014; Consonni, Dario/K-7943-2016; Kratz, Christian/AAC-9726-2021; Dean, Michael C/G-8172-2012; Consonni, Dario/AAM-2947-2020; Zheng, Wei/O-3351-2013; Amundadottir, Laufey T/L-7656-2016; Wentzensen, Nicolas/AAG-8522-2019; Ruder, Avima/I-4155-2012; Johansen, Christoffer/AAG-7916-2020; Dean, Michael/R-7501-2019; Gonzalez, Juan R/B-7860-2018; Gao, Y./GWZ-3665-2022; Qiao, You-Lin/B-4139-2012; Krogh, Vittorio/AAA-9171-2019; Abnet, Christian C/C-4111-2015; Pérez Jurado, Luis Alberto/M-7706-2015; Freedman, Neal David/B-9741-2015; Brinton, Louise A/G-7486-2015; Peplonska, Beata/AAO-1265-2020; Weinstein, Stephanie J/P-1627-2017; Kogevinas, Manolis/C-3918-2017; Andrulis, Irene L./E-7267-2013; Figueroa, Jonine/AAG-1065-2022; gao, yi/HCI-8298-2022; bertazzi, pietro alberto/D-5039-2017; Liao, Linda M/B-3960-2011; Prokunina-Olsson, Ludmila/A-8240-2019; Michaud, Dominique S/I-5231-2014; Canzian, Federico/I-2804-2014; Peplonska, Beata/F-6004-2010; Lissowska, Jolanta/AAH-3252-2020; Cook, Michael B/A-5641-2009; Savage, Sharon A/B-9747-2015; Tucker, Margaret A/B-4297-2015; Patiño-Garcia, Ana/I-4299-2012	Tobias, Geoffrey S/0000-0002-2878-8253; Marenne, Gaelle/0000-0002-4363-7170; Visvanathan, Kumar/0000-0002-1176-5442; Rybicki, Benjamin/0000-0003-3190-3467; Arribas, Francisco X Real/0000-0001-9501-498X; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Schumacher, Fredrick/0000-0002-3073-7463; Severi, Gianluca/0000-0001-7157-419X; Savage, Sharon/0000-0001-6006-0740; Severi, Gianluca/0000-0001-7157-419X; Freeman, Laura E. Beane/0000-0003-1294-4124; Purdue, Mark P/0000-0003-1177-3108; Wang, Zhaoming/0000-0001-7556-3869; Stolzenberg-Solomon, Rachael/0000-0003-3698-7006; Krogh, Vittorio/0000-0003-0122-8624; Malats, Nuria/0000-0003-2538-3784; Garcia-Closas, Montserrat/0000-0003-1033-2650; Boutron-Ruault, Marie-Christine/0000-0002-5956-5693; Figueroa, Jonine/0000-0002-5100-623X; Figueroa, Jonine/0000-0002-5100-623X; Garcia-Closas, Montserrat/0000-0003-1033-2650; Consonni, Dario/0000-0002-8935-3843; Dean, Michael C/0000-0003-2234-0631; Consonni, Dario/0000-0002-8935-3843; Zheng, Wei/0000-0003-1226-070X; Amundadottir, Laufey T/0000-0003-1859-8971; Ruder, Avima/0000-0003-0419-6664; Johansen, Christoffer/0000-0002-4384-206X; Gonzalez, Juan R/0000-0003-3267-2146; Qiao, You-Lin/0000-0001-6380-0871; Krogh, Vittorio/0000-0003-0122-8624; Abnet, Christian C/0000-0002-3008-7843; Freedman, Neal David/0000-0003-0074-1098; Brinton, Louise A/0000-0003-3853-8562; Peplonska, Beata/0000-0003-3915-2872; Weinstein, Stephanie J/0000-0002-3834-1535; Kogevinas, Manolis/0000-0002-9605-0461; Figueroa, Jonine/0000-0002-5100-623X; bertazzi, pietro alberto/0000-0003-3475-2449; Liao, Linda M/0000-0002-1923-5294; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Lissowska, Jolanta/0000-0003-2695-5799; Cook, Michael B/0000-0002-0533-7302; Savage, Sharon A/0000-0001-6006-0740; Patiño-Garcia, Ana/0000-0002-4066-8203; Olson, Sara/0000-0003-0182-2754; Riboli, Elio/0000-0001-6795-6080; Jacobs, Kevin/0000-0002-4657-6473; Giles, Graham/0000-0003-4946-9099; Rodriguez-Santiago, Benjamin/0000-0003-1167-3852; Canzian, Federico/0000-0002-4261-4583; Yuan, Jian-Min/0000-0002-4620-3108; Zeleniuch-Jacquotte, Anne/0000-0001-9350-1303; Arslan, Alan/0000-0002-7775-8085; fan, jinhu/0000-0003-3159-7893; Duell, Eric J/0000-0001-5256-0163; Carreon, Tania/0000-0003-1745-0852; Tjonneland, Anne/0000-0003-4385-2097; Jenab, Mazda/0000-0002-0573-1852; GORLICK, RICHARD/0000-0001-8995-2929	Intramural Research Program; US National Institutes of Health (NIH), NCI [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [P50CA102701, R01CA097193, R01CA098661, ZICCP010178, R01CA092447, R01CA127219, ZIABC011300, P30CA015704] Funding Source: NIH RePORTER; Cancer Research UK [14136] Funding Source: researchfish; Medical Research Council [G0401527, G1000143] Funding Source: researchfish	Intramural Research Program; US National Institutes of Health (NIH), NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by the Intramural Research Program and by contract number HHSN261200800001E of the US National Institutes of Health (NIH), NCI. Support for each contributing study is listed in the Supplementary Note. We thank C. Laurie and B. Weir for constructive discussion and a comparison of methodology and results for the GENEVA study. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the National Cancer Institute, the National Institute for Occupational Safety and Health or the Maryland Cancer Registry.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amary MF, 2011, NAT GENET, V43, P1262, DOI 10.1038/ng.994; Benetatos L, 2011, INT J CANCER, V129, P773, DOI 10.1002/ijc.26052; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Conlin LK, 2010, HUM MOL GENET, V19, P1263, DOI 10.1093/hmg/ddq003; Dellinger AE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq040; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Forsberg LA, 2012, AM J HUM GENET, V90, P217, DOI 10.1016/j.ajhg.2011.12.009; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frio TR, 2010, NEW ENGL J MED, V363, P2628, DOI 10.1056/NEJMoa1006565; Gonzalez JR, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-166; Gurvich N, 2010, P NATL ACAD SCI USA, V107, P22552, DOI 10.1073/pnas.1017092108; Hafner C, 2011, NEW ENGL J MED, V365, P1940, DOI 10.1056/NEJMc1109381; Hedrick PW, 2007, EVOLUTION, V61, P2750, DOI 10.1111/j.1558-5646.2007.00250.x; HSU LYF, 1992, PRENATAL DIAG, V12, P555, DOI 10.1002/pd.1970120702; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lanasa MC, 2011, LEUKEMIA, V25, P1459, DOI 10.1038/leu.2011.117; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Lee S, 2007, P NATL ACAD SCI USA, V104, P13732, DOI 10.1073/pnas.0701771104; Lu XY, 2008, PEDIATRICS, V122, P1310, DOI 10.1542/peds.2008-0297; Marenne G, 2011, HUM MUTAT, V32, P240, DOI 10.1002/humu.21398; Menten B, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039453; Migliazza A, 2001, BLOOD, V97, P2098, DOI 10.1182/blood.V97.7.2098; Mitelman F, 2009, CANC CYTOGENETICS; Notini AJ, 2008, CYTOGENET GENOME RES, V123, P270, DOI 10.1159/000184717; Pansuriya TC, 2011, NAT GENET, V43, P1256, DOI 10.1038/ng.1004; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Pekarsky Y, 2010, SEMIN CANCER BIOL, V20, P370, DOI 10.1016/j.semcancer.2010.09.003; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Pique-Regi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-380; Rodiguez-Santiago B., 2010, AM J HUM GENET, V87, P129; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Snape K, 2011, NAT GENET, V43, P527, DOI 10.1038/ng.822; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Staaf J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-409; Tuna M, 2009, TRENDS MOL MED, V15, P120, DOI 10.1016/j.molmed.2009.01.005; Youssoufian H, 2002, NAT REV GENET, V3, P748, DOI 10.1038/nrg906	43	391	401	0	99	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2012	44	6					651	U68		10.1038/ng.2270	http://dx.doi.org/10.1038/ng.2270			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	949BT	22561519	Green Accepted, Green Submitted			2022-12-25	WOS:000304551100011
J	Kiezun, A; Garimella, K; Do, R; Stitziel, NO; Neale, BM; McLaren, PJ; Gupta, N; Sklar, P; Sullivan, PF; Moran, JL; Hultman, CM; Lichtenstein, P; Magnusson, P; Lehner, T; Shugart, YY; Price, AL; de Bakker, PIW; Purcell, SM; Sunyaev, SR				Kiezun, Adam; Garimella, Kiran; Do, Ron; Stitziel, Nathan O.; Neale, Benjamin M.; McLaren, Paul J.; Gupta, Namrata; Sklar, Pamela; Sullivan, Patrick F.; Moran, Jennifer L.; Hultman, Christina M.; Lichtenstein, Paul; Magnusson, Patrik; Lehner, Thomas; Shugart, Yin Yao; Price, Alkes L.; de Bakker, Paul I. W.; Purcell, Shaun M.; Sunyaev, Shamil R.			Exome sequencing and the genetic basis of complex traits	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISMS; ALLELE FREQUENCY-SPECTRUM; RARE VARIANTS; POPULATION-STRUCTURE; PROTEIN FUNCTION; COMMON DISEASES; PLASMA-LEVELS; MUTATIONS; SELECTION		[Kiezun, Adam; McLaren, Paul J.; de Bakker, Paul I. W.; Sunyaev, Shamil R.] Harvard Univ, Sch Med, Dept Med, Div Genet,Brigham & Womens Hosp, Boston, MA 02114 USA; [Kiezun, Adam; Garimella, Kiran; Do, Ron; Stitziel, Nathan O.; Neale, Benjamin M.; McLaren, Paul J.; Gupta, Namrata; Moran, Jennifer L.; Price, Alkes L.; de Bakker, Paul I. W.; Sunyaev, Shamil R.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Do, Ron; Neale, Benjamin M.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Stitziel, Nathan O.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med, Boston, MA 02115 USA; [Neale, Benjamin M.; Purcell, Shaun M.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Sklar, Pamela] Mt Sinai Sch Med, Dept Psychiat, Friedman Brain Inst, New York, NY USA; [Sklar, Pamela] Mt Sinai Sch Med, Inst Genom & Multiscale Biol, New York, NY USA; [Sullivan, Patrick F.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC USA; [Hultman, Christina M.; Lichtenstein, Paul; Magnusson, Patrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Shugart, Yin Yao] NIMH, Div Neurosci & Basic Behav Sci, Bethesda, MD 20892 USA; [Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Sunyaev, SR (corresponding author), Harvard Univ, Sch Med, Dept Med, Div Genet,Brigham & Womens Hosp, Boston, MA 02114 USA.	ssunyaev@rics.bwh.harvard.edu	Stitziel, Nathan/AAL-8413-2021; Magnusson, Patrik KE/C-4458-2017; de Bakker, Paul IW/B-8730-2009	Stitziel, Nathan/0000-0002-4963-8211; Magnusson, Patrik KE/0000-0002-7315-7899; de Bakker, Paul IW/0000-0001-7735-7858; YAO, YIN/0000-0003-3053-8429; lichtenstein, paul/0000-0003-3037-5287; Kiezun, Adam/0000-0002-6634-1073; McLaren, Paul/0000-0001-6019-7018; Garimella, Kiran/0000-0002-6212-5736; Moran, Jennifer/0000-0002-5664-4716	US National Institutes of Health (NIH) [5R01 MH084676]; Collaboration for AIDS Vaccine Discovery of the Bill and Melinda Gates Foundation; NIH [AI069474, AI069428, AI69467, AI069415, Al32782, AI27661, AI25859, AI28568, AI30914, AI069495, AI069471, AI069532, AI069452, AI069450, AI069556]; Herman Foundation; Stanley Medical Research Institute; National Institute of Mental Health (NIMH) [1R01MH089208-01]; Canadian Institutes of Health Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445, TL1TR000447, KL2TR000446] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975, KL2RR024977, TL1RR024978] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069432, UM1AI069502, U01AI069495, UM1AI069419, UM1AI069495, UM1AI069484, U01AI069477, UM1AI069471, U01AI069513, UM1AI069450, U01AI069501, R01AI030914, UM1AI068634, UM1AI069423, UM1AI069424, U01AI034853, UM1AI069474, UM1AI069501, UM1AI069556, U01AI069471, U01AI069556, UM1AI069467, U01AI034835, R37AI028568, U01AI046370, U01AI069465, U01AI069484, U01AI032782, U01AI069474, U01AI069424, U01AI069415, U01AI025859, UM1AI069428, UM1AI069513, UM1AI069477, R01AI077505, UM1AI069465, UM1AI069472, UM1AI069415, U01AI027661, U01AI069467, UM1AI069452, UM1AI068636, U01AI069450, R01AI028568, U01AI069434, U01AI069532, UM1AI069511, U01AI068634, UM1AI069432, U01AI069502, U01AI069472, U01AI068636, U01AI038844, U01AI069511, U01AI069452, U01AI069419, UM1AI069434, U01AI069428, UM1AI069532, U01AI069423] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095034, ZIAMH002929, ZIAMH002930, R01MH089208, RC2MH089905, R01MH084676] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Collaboration for AIDS Vaccine Discovery of the Bill and Melinda Gates Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Herman Foundation; Stanley Medical Research Institute; National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors are grateful to S. Pollack for assistance with EIGENSOFT. This work was made possible, in part, by the US National Institutes of Health (NIH; grant 5R01 MH084676) and, in part, by the International HIV Controllers Study, supported by the Collaboration for AIDS Vaccine Discovery of the Bill and Melinda Gates Foundation (to P.I.W.d.B.), and the AIDS Clinical Trials Group, supported by the NIH (grants AI069513, AI34835, AI069432, AI069423, AI069477, AI069501, AI069474, AI069428, AI69467, AI069415, Al32782, AI27661, AI25859, AI28568, AI30914, AI069495, AI069471, AI069532, AI069452, AI069450, AI069556, AI069484, AI069472, AI34853, AI069465, AI069511, AI38844, AI069424, AI069434, AI46370, AI68634, AI069502, AI069419, AI068636, RR024975 and AI077505). Sequencing of the SCZ control individuals was funded by the NIH (grant RC2MH089905), the Herman Foundation and the Stanley Medical Research Institute. N.O.S. was supported, in part, by an NIH Training Grant (T32-HL07604-25; Division of Cardiovascular Medicine, Brigham and Women's Hospital). B.M.N. was supported by a National Institute of Mental Health (NIMH) grant (1R01MH089208-01). R. D. is supported by a Canadian Institutes of Health Research Banting Postdoctoral Fellowship. The views expressed in this paper do not necessarily represent the views of the NIMH, NIH, Department of Health and Human Services (HHS) or the US government.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; [Anonymous], 2008, NAT METHODS, V5, P15, DOI 10.1038/NMETH1155; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Basu S, 2011, GENET EPIDEMIOL, V35, P606, DOI 10.1002/gepi.20609; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021097; Clarke J, 2009, NAT NANOTECHNOL, V4, P265, DOI [10.1038/nnano.2009.12, 10.1038/NNANO.2009.12]; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Eyre-Walker A, 2006, GENETICS, V173, P891, DOI 10.1534/genetics.106.057570; Fay JC, 2001, GENETICS, V158, P1227; Fuller CW, 2009, NAT BIOTECHNOL, V27, P1013, DOI 10.1038/nbt.1585; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Hedges DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018595; Hellmann I, 2003, GENOME RES, V13, P831, DOI 10.1101/gr.944903; Hicks S, 2011, HUM MUTAT, V32, P661, DOI 10.1002/humu.21490; Hoffmann TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013584; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Ionita-Laza I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001289; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Jordan DM, 2010, CURR OPIN STRUC BIOL, V20, P342, DOI 10.1016/j.sbi.2010.03.006; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; KIMURA M, 1987, J MOL EVOL, V26, P24, DOI 10.1007/BF02111279; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Lipman PJ, 2011, GENET EPIDEMIOL, V35, P303, DOI 10.1002/gepi.20578; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; MacArthur DG, 2010, HUM MOL GENET, V19, pR125, DOI 10.1093/hmg/ddq365; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Nachman MW, 2000, GENETICS, V156, P297; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Ng SB, 2010, HUM MOL GENET, V19, pR119, DOI 10.1093/hmg/ddq390; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Pierce SB, 2010, AM J HUM GENET, V87, P282, DOI 10.1016/j.ajhg.2010.07.007; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Stitziel NO, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-227; Sul JH, 2011, LECT N BIOINFORMAT, V6577, P452, DOI 10.1007/978-3-642-20036-6_41; Sul JH, 2011, GENETICS, V188, P181, DOI 10.1534/genetics.110.125070; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Tavtigian SV, 2009, AM J HUM GENET, V85, P427, DOI 10.1016/j.ajhg.2009.08.018; Teer JK, 2010, HUM MOL GENET, V19, pR145, DOI 10.1093/hmg/ddq333; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wang JL, 2010, BRAIN, V133, P3510, DOI 10.1093/brain/awq323; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Xue YL, 2009, CURR BIOL, V19, P1453, DOI 10.1016/j.cub.2009.07.032; Yampolsky LY, 2005, HUM MOL GENET, V14, P3191, DOI 10.1093/hmg/ddi350; Zhao Q, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r114	97	288	292	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2012	44	6					623	630		10.1038/ng.2303	http://dx.doi.org/10.1038/ng.2303			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	949BT	22641211	Green Accepted, Green Submitted			2022-12-25	WOS:000304551100006
J	Peinado, H; Aleckovic, M; Lavotshkin, S; Matei, I; Costa-Silva, B; Moreno-Bueno, G; Hergueta-Redondo, M; Williams, C; Garcia-Santos, G; Ghajar, CM; Nitadori-Hoshino, A; Hoffman, C; Badal, K; Garcia, BA; Callahan, MK; Yuan, JD; Martins, VR; Skog, J; Kaplan, RN; Brady, MS; Wolchok, JD; Chapman, PB; Kang, YB; Bromberg, J; Lyden, D				Peinado, Hector; Aleckovic, Masa; Lavotshkin, Simon; Matei, Irina; Costa-Silva, Bruno; Moreno-Bueno, Gema; Hergueta-Redondo, Marta; Williams, Caitlin; Garcia-Santos, Guillermo; Ghajar, Cyrus M.; Nitadori-Hoshino, Ayuko; Hoffman, Caitlin; Badal, Karen; Garcia, Benjamin A.; Callahan, Margaret K.; Yuan, Jianda; Martins, Vilma R.; Skog, Johan; Kaplan, Rosandra N.; Brady, Mary S.; Wolchok, Jedd D.; Chapman, Paul B.; Kang, Yibin; Bromberg, Jacqueline; Lyden, David			Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET	NATURE MEDICINE			English	Article							PREMETASTATIC NICHE; RELEASED EXOSOMES; SIGNALING PATHWAY; C-MET; CANCER; MICROVESICLES; GROWTH; RECRUITMENT; EXPRESSION; MECHANISM	Tumor-derived exosomes are emerging mediators of tumorigenesis. We explored the function of melanoma-derived exosomes in the formation of primary tumors and metastases in mice and human subjects. Exosomes from highly metastatic melanomas increased the metastatic behavior of primary tumors by permanently 'educating' bone marrow progenitors through the receptor tyrosine kinase MET. Melanoma-derived exosomes also induced vascular leakiness at pre-metastatic sites and reprogrammed bone marrow progenitors toward a pro-vasculogenic phenotype that was positive for c-Kit, the receptor tyrosine kinase Tie2 and Met. Reducing Met expression in exosomes diminished the pro-metastatic behavior of bone marrow cells. Notably, MET expression was elevated in circulating CD45(-)C-KIT(low/+)TIE2(+) bone marrow progenitors from individuals with metastatic melanoma. RAB1A, RAB5B, RAB7 and RAB27A, regulators of membrane trafficking and exosome formation, were highly expressed in melanoma cells. Rab27A RNA interference decreased exosome production, preventing bone marrow education and reducing, tumor growth and metastasis. In addition, we identified an exosome-specific melanoma signature with prognostic and therapeutic potential comprised of TYRP2, VLA- 4, HSP70, an HSP90 isoform and the MET oncoprotein. Our data show that exosome production, transfer and education of bone marrow cells supports tumor growth and metastasis, has prognostic value and offers promise for new therapeutic directions in the metastatic process.	[Callahan, Margaret K.; Wolchok, Jedd D.; Chapman, Paul B.; Bromberg, Jacqueline] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Peinado, Hector; Matei, Irina; Costa-Silva, Bruno; Williams, Caitlin; Garcia-Santos, Guillermo; Nitadori-Hoshino, Ayuko; Badal, Karen; Lyden, David] Weill Cornell Med Coll, Dept Pediat, Childrens Canc & Blood Fdn Labs, New York, NY USA; [Peinado, Hector; Matei, Irina; Costa-Silva, Bruno; Williams, Caitlin; Garcia-Santos, Guillermo; Nitadori-Hoshino, Ayuko; Badal, Karen; Lyden, David] Weill Cornell Med Coll, Dept Cell, Childrens Canc & Blood Fdn Labs, New York, NY USA; [Peinado, Hector; Matei, Irina; Costa-Silva, Bruno; Williams, Caitlin; Garcia-Santos, Guillermo; Nitadori-Hoshino, Ayuko; Badal, Karen; Lyden, David] Weill Cornell Med Coll, Dept Dev Biol, Childrens Canc & Blood Fdn Labs, New York, NY USA; [Aleckovic, Masa; Garcia, Benjamin A.; Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Lavotshkin, Simon] Columbia Univ, Coll Phys & Surg, Dept Surg, New York, NY USA; [Costa-Silva, Bruno; Martins, Vilma R.] AC Camargo Hosp, Int Ctr Res & Educ, Sao Paulo, Brazil; [Moreno-Bueno, Gema; Hergueta-Redondo, Marta] Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols, IdiPAZ Inst Invest Sanitaria La Paz, CSIC,Dept Bioquim, Madrid, Spain; [Moreno-Bueno, Gema; Hergueta-Redondo, Marta] Fdn MD Anderson Canc Ctr, Madrid, Spain; [Ghajar, Cyrus M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Hoffman, Caitlin] Weill Cornell Med Coll, Dept Neurosurg, New York, NY USA; [Yuan, Jianda; Wolchok, Jedd D.] Sloan Kettering Inst, Ludwig Ctr Canc Immunotherapy, Dept Immunol, New York, NY USA; [Skog, Johan] Exosome Diagnost Inc, New York, NY USA; [Kaplan, Rosandra N.] NCI, Pediat Oncol Branch, NIH, Bethesda, MD 20892 USA; [Brady, Mary S.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Kang, Yibin] Canc Inst New Jersey, Genom Instabil & Tumor Progress Program, New Brunswick, NJ USA; [Kang, Yibin; Lyden, David] Champalimaud Metastasis Programme, Lisbon, Portugal; [Lyden, David] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University; Princeton University; Columbia University; A.C.Camargo Cancer Center; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); University of Texas System; UTMD Anderson Cancer Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Cornell University; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Fundacao Champalimaud; Memorial Sloan Kettering Cancer Center	Bromberg, J (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.	bromberj@mskcc.org; dcl2001@med.cornell.edu	Hoshino, Ayuko/AHD-6448-2022; Costa-Silva, Bruno/AAY-2266-2020; Peinado, Hector/A-6417-2013; Garcia-Santos, Guillermo/ABG-4631-2020; Moreno-Bueno, Gema/K-9354-2016; Martins, Vilma/N-5446-2019; Neurociencia, Inct/I-1011-2013; Martins, Vilma R/E-2547-2012	Hoshino, Ayuko/0000-0003-4149-5073; Peinado, Hector/0000-0002-4256-3413; Moreno-Bueno, Gema/0000-0002-5030-6687; Martins, Vilma R/0000-0002-2909-8502; Garcia-Santos, Guillermo/0000-0002-4755-2430; Skog, Johan/0000-0002-0926-1691; Kang, Yibin/0000-0002-1626-6730; Costa-Silva, Bruno/0000-0002-5932-6211; Aleckovic, Masa/0000-0001-5653-8502	Children's Cancer and Blood Foundation; Manning Foundation; Hartwell Foundation; Pediatric Oncology Experimental Therapeutics Investigators Consortium; Stavros S. Niarchos Foundation; Champalimaud Foundation; Nancy C. and Daniel P. Paduano Foundation; Mary Kay Foundation; American Hellenic Educational Progressive Association; Malcolm Hewitt Wiener Foundation; George Best Costacos Foundation; NCI [NCI-R01CA 098234-01]; National Foundation for Cancer Research; Susan G. Komen for the Cure; Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia; Fundacion Universidad de Oviedo; Beth C. Tortolani Foundation; Sussman Family Fund; Charles and Marjorie Holloway Foundation; Manhassat Breast Cancer Fund; NIH [CA87637, R01-CA134519, R01-CA141062]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); National Science Foundation [CBET-0941143]; American Society;  [NCI-U54-CA143836]; NATIONAL CANCER INSTITUTE [U54CA143836, R01CA087637, R01CA134519, R01CA098234, ZIABC011334, R01CA141062, ZIABC011332] Funding Source: NIH RePORTER	Children's Cancer and Blood Foundation; Manning Foundation; Hartwell Foundation; Pediatric Oncology Experimental Therapeutics Investigators Consortium; Stavros S. Niarchos Foundation; Champalimaud Foundation; Nancy C. and Daniel P. Paduano Foundation; Mary Kay Foundation; American Hellenic Educational Progressive Association; Malcolm Hewitt Wiener Foundation; George Best Costacos Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Foundation for Cancer Research; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia(Principality of Asturias); Fundacion Universidad de Oviedo; Beth C. Tortolani Foundation; Sussman Family Fund; Charles and Marjorie Holloway Foundation; Manhassat Breast Cancer Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Science Foundation(National Science Foundation (NSF)); American Society(American Cancer Society); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We dedicate this work to the memory of James A. Paduano. We thank M. J. Bissell, A. Cano, J. Wels and S.R. Granitto for critical reading of this paper and suggestions. We also thank the members of our laboratories for helpful discussions and the members of the Weill Cornell Medical College electron microscopy and microarray core facilities for their support. We thank V. Hearing, (US National Institutes of Health (NIH), National Cancer Institute (NCI)) for providing the antibody to TYRP2 and D.C. Bennett (St. George's University of London) for providing the melan-a cell line. Our work is supported by grants from the Children's Cancer and Blood Foundation (H.P. and D.L.), The Manning Foundation (B.C.-S. and D.L.), The Hartwell Foundation (D.L.), Pediatric Oncology Experimental Therapeutics Investigators Consortium (H.P. and D.L.), Stavros S. Niarchos Foundation (D.L.), Champalimaud Foundation (H.P., Y.K. and D.L.), The Nancy C. and Daniel P. Paduano Foundation (H.P. and D.L.), The Mary Kay Foundation (A.N.-H. and D.L.), American Hellenic Educational Progressive Association 5th District (D.L.), The Malcolm Hewitt Wiener Foundation (D.L.), The George Best Costacos Foundation (D.L.), NCI (D.L., grant NCI-R01CA 098234-01), National Foundation for Cancer Research (D.L.), Susan G. Komen for the Cure (H.P. and D.L.), NCI-U54-CA143836 training grant (C.M.G. and D.L.), Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia (G.G.-S.), Fundacion Universidad de Oviedo (G.G.-S.), The Beth C. Tortolani Foundation (H.P., D.L. and J.B.), Sussman Family Fund (J.B.), Charles and Marjorie Holloway Foundation (J.B.), Manhassat Breast Cancer Fund (J.B.), NIH-CA87637 (J.B.), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, V.R.M. and B.C.-S.), NIH (Y.K., grants R01-CA134519 and R01-CA141062), National Science Foundation grant CBET-0941143 and an American Society for Mass Spectrometry research award (B.A.G.).	Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Aliotta JM, 2007, STEM CELLS, V25, P2245, DOI 10.1634/stemcells.2007-0128; Aliotta JM, 2010, EXP HEMATOL, V38, P233, DOI 10.1016/j.exphem.2010.01.002; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Braeuer RR, 2011, SEMIN CANCER BIOL, V21, P83, DOI 10.1016/j.semcancer.2010.12.007; Cecchi F, 2010, EUR J CANCER, V46, P1260, DOI 10.1016/j.ejca.2010.02.028; Christensen JG, 2005, CANCER LETT, V225, P1, DOI 10.1016/j.canlet.2004.09.044; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Ewing J., 1928, NEOPLASTIC DIS TREAT, V3rd; FIDLER IJ, 1976, JNCI-J NATL CANCER I, V57, P1199, DOI 10.1093/jnci/57.5.1199; Fidler IJ, 1996, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 1, NO 2, APRIL 1996, P203; Gao DC, 2009, BBA-REV CANCER, V1796, P33, DOI 10.1016/j.bbcan.2009.05.001; Grammatikakis N, 2002, J BIOL CHEM, V277, P8312, DOI 10.1074/jbc.M109200200; Guise T, 2010, SEMIN ONCOL, V37, pS2, DOI 10.1053/j.seminoncol.2010.10.007; Hao S., 2006, Experimental Oncology, V28, P126; Hendrix A, 2010, JNCI-J NATL CANCER I, V102, P866, DOI 10.1093/jnci/djq153; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Huang YJ, 2009, CANCER RES, V69, P7529, DOI 10.1158/0008-5472.CAN-08-4382; Iero M, 2008, CELL DEATH DIFFER, V15, P80, DOI 10.1038/sj.cdd.4402237; Jalili A, 2010, STEM CELLS DEV, V19, P1143, DOI 10.1089/scd.2009.0376; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Jung T, 2009, NEOPLASIA, V11, P1093, DOI 10.1593/neo.09822; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Lima LG, 2009, CANCER LETT, V283, P168, DOI 10.1016/j.canlet.2009.03.041; Liu YL, 2010, AM J PATHOL, V176, P2490, DOI 10.2353/ajpath.2010.090777; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Lucas R, 2009, BIOCHEM PHARMACOL, V77, P1763, DOI 10.1016/j.bcp.2009.01.014; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Paget S., 1889, LANCET, V1, P571, DOI DOI 10.1016/S0140-6736(00)49915-0; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Peruzzi B, 2006, CLIN CANCER RES, V12, P3657, DOI 10.1158/1078-0432.CCR-06-0818; Psaila Bethan, 2006, Breast Dis, V26, P65; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Scott KL, 2011, CANCER CELL, V20, P92, DOI 10.1016/j.ccr.2011.05.025; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Stella GM, 2010, EXPERT OPIN INV DRUG, V19, P1381, DOI 10.1517/13543784.2010.522988; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; TAYLOR DD, 1988, INT J CANCER, V41, P629, DOI 10.1002/ijc.2910410425; Tesio M, 2011, BLOOD, V117, P419, DOI 10.1182/blood-2009-06-230359; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Wang JS, 2008, MOL CANCER RES, V6, P372, DOI 10.1158/1541-7786.MCR-07-0162; Webber J, 2010, CANCER RES, V70, P9621, DOI 10.1158/0008-5472.CAN-10-1722; Xiang XY, 2009, INT J CANCER, V124, P2621, DOI 10.1002/ijc.24249; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	58	2458	2546	28	725	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2012	18	6					883	+		10.1038/nm.2753	http://dx.doi.org/10.1038/nm.2753			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22635005	Green Accepted, Green Submitted			2022-12-25	WOS:000305116600025
J	Yusuf, RZ; Wang, YH; Scadden, DT				Yusuf, Rushdia Z.; Wang, Ying-Hua; Scadden, David T.			Metabolic priming for AML	NATURE MEDICINE			English	Editorial Material							MYELOID-LEUKEMIA; IDH2 MUTATIONS; THERAPY; CELL		[Yusuf, Rushdia Z.; Wang, Ying-Hua; Scadden, David T.] Harvard Univ, Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02115 USA; [Yusuf, Rushdia Z.; Wang, Ying-Hua; Scadden, David T.] Harvard Univ, Ctr Canc, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University	Yusuf, RZ (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02115 USA.	dscadden@mgh.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100402, R01HL044851] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL044851, U01 HL100402] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Davies SM, 2001, MED PEDIATR ONCOL, V36, P536, DOI 10.1002/mpo.1126; Felix CA, 2001, MED PEDIATR ONCOL, V36, P525, DOI 10.1002/mpo.1125; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Kranendijk M, 2010, SCIENCE, V330, P336, DOI 10.1126/science.1192632; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Li L, 2011, CANCER CELL, V20, P591, DOI 10.1016/j.ccr.2011.09.011; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Rowe JM, 2002, LEUKEMIA, V16, P748, DOI 10.1038/sj.leu.2402456; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; WARBURG O, 1956, Oncologia, V9, P75; Zhang W, 2012, NAT CELL BIOL, V14, P276, DOI 10.1038/ncb2432	18	13	13	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2012	18	6					865	867		10.1038/nm.2831	http://dx.doi.org/10.1038/nm.2831			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22673998	Green Accepted			2022-12-25	WOS:000305116600023
J	Cheung, WC; Beausoleil, SA; Zhang, XW; Sato, S; Schieferl, SM; Wieler, JS; Beaudet, JG; Ramenani, RK; Popova, L; Comb, MJ; Rush, J; Polakiewicz, RD				Cheung, Wan Cheung; Beausoleil, Sean A.; Zhang, Xiaowu; Sato, Shuji; Schieferl, Sandra M.; Wieler, James S.; Beaudet, Jason G.; Ramenani, Ravi K.; Popova, Lana; Comb, Michael J.; Rush, John; Polakiewicz, Roberto D.			A proteomics approach for the identification and cloning of monoclonal antibodies from serum	NATURE BIOTECHNOLOGY			English	Article							PHOSPHORYLATION ANALYSIS; PROTEIN-PHOSPHORYLATION; IMMUNOGLOBULIN GENES; MASS-SPECTROMETRY; PASSIVE-IMMUNITY; B-CELLS; GENERATION; SEQUENCES; VH; REPERTOIRES	We describe a proteomics approach that identifies antigen-specific antibody sequences directly from circulating polyclonal antibodies in the serum of an immunized animal. The approach involves affinity purification of antibodies with high specific activity and then analyzing digested antibody fractions by nano-flow liquid chromatography coupled to tandem mass spectrometry. High-confidence peptide spectral matches of antibody variable regions are obtained by searching a reference database created by next-generation DNA sequencing of the B-cell immunoglobulin repertoire of the immunized animal. Finally, heavy and light chain sequences are paired and expressed as recombinant monoclonal antibodies. Using this technology, we isolated monoclonal antibodies for five antigens from the sera of immunized rabbits and mice. The antigen-specific activities of the monoclonal antibodies recapitulate or surpass those of the original affinity-purified polyclonal antibodies. This technology may aid the discovery and development of vaccines and antibody therapeutics, and help us gain a deeper understanding of the humoral response.	[Cheung, Wan Cheung; Beausoleil, Sean A.; Zhang, Xiaowu; Sato, Shuji; Schieferl, Sandra M.; Wieler, James S.; Beaudet, Jason G.; Ramenani, Ravi K.; Popova, Lana; Comb, Michael J.; Rush, John; Polakiewicz, Roberto D.] Cell Signaling Technol Inc, Danvers, MA 01923 USA		Polakiewicz, RD (corresponding author), Cell Signaling Technol Inc, Danvers, MA 01923 USA.	rpolakiewicz@cellsignal.com						BALTIMORE D, 1981, CELL, V24, P592, DOI 10.1016/0092-8674(81)90082-9; Bandeira N, 2008, NAT BIOTECHNOL, V26, P1336, DOI 10.1038/nbt1208-1336; Barbas C. F., 2001, PHAGE DISPLAY LAB MA; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; BECKER RS, 1990, EUR J IMMUNOL, V20, P397, DOI 10.1002/eji.1830200224; BECKER RS, 1990, CELL, V63, P987, DOI 10.1016/0092-8674(90)90502-6; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Castellana NE, 2011, PROTEOMICS, V11, P395, DOI 10.1002/pmic.201000487; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Doronina VA, 2008, MOL CELL BIOL, V28, P4227, DOI 10.1128/MCB.00421-08; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Fischer N, 2011, MABS-AUSTIN, V3, P17, DOI 10.4161/mabs.3.1.14169; HARLOW E, 1998, USING ANTIBODIES LAB; HOZUMI N, 1976, P NATL ACAD SCI USA, V73, P3628, DOI 10.1073/pnas.73.10.3628; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Keller MA, 2000, CLIN MICROBIOL REV, V13, P602, DOI 10.1128/CMR.13.4.602-614.2000; KIM S, 1981, CELL, V27, P573, DOI 10.1016/0092-8674(81)90399-8; Kircher M, 2010, BIOESSAYS, V32, P524, DOI 10.1002/bies.200900181; KNIGHT KL, 1992, ANNU REV IMMUNOL, V10, P593, DOI 10.1146/annurev.iy.10.040192.003113; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lakhani SR, 2002, J CLIN ONCOL, V20, P2310, DOI 10.1200/JCO.2002.09.023; LAMBERT JS, 1993, ANN NY ACAD SCI, V693, P186, DOI 10.1111/j.1749-6632.1993.tb26267.x; Lanzavecchia A, 2007, CURR OPIN BIOTECH, V18, P523, DOI 10.1016/j.copbio.2007.10.011; Mage RG, 2006, DEV COMP IMMUNOL, V30, P137, DOI 10.1016/j.dci.2005.06.017; Meijer PJ, 2006, J MOL BIOL, V358, P764, DOI 10.1016/j.jmb.2006.02.040; O'Brien PM, 2002, ANTIBODY PHAGE DISPL; Pasqualini R, 2004, P NATL ACAD SCI USA, V101, P257, DOI 10.1073/pnas.0305834101; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Reddy ST, 2010, NAT BIOTECHNOL, V28, P965, DOI 10.1038/nbt.1673; Sullivan Meghan, 2011, F1000 Biol Rep, V3, P17, DOI 10.3410/B3-17; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020	35	131	142	0	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2012	30	5					447	+		10.1038/nbt.2167	http://dx.doi.org/10.1038/nbt.2167			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	939IP	22446692				2022-12-25	WOS:000303803200025
J	Mak, C				Mak, Craig			Drug pipeline: 1Q12	NATURE BIOTECHNOLOGY			English	News Item																			0	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2012	30	5					383	383		10.1038/nbt.2210	http://dx.doi.org/10.1038/nbt.2210			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	939IP	22565954				2022-12-25	WOS:000303803200009
J	Sun, L; Rommens, JM; Corvol, H; Li, WL; Li, X; Chiang, TA; Lin, F; Dorfman, R; Busson, PF; Parekh, RV; Zelenika, D; Blackman, SM; Corey, M; Doshi, VK; Henderson, L; Naughton, KM; O'Neal, WK; Pace, RG; Stonebraker, JR; Wood, SD; Wright, FA; Zielenski, J; Clement, A; Drumm, ML; Boelle, PY; Cutting, GR; Knowles, MR; Durie, PR; Strug, LJ				Sun, Lei; Rommens, Johanna M.; Corvol, Harriet; Li, Weili; Li, Xin; Chiang, Theodore A.; Lin, Fan; Dorfman, Ruslan; Busson, Pierre-Francois; Parekh, Rashmi V.; Zelenika, Diana; Blackman, Scott M.; Corey, Mary; Doshi, Vishal K.; Henderson, Lindsay; Naughton, Kathleen M.; O'Neal, Wanda K.; Pace, Rhonda G.; Stonebraker, Jaclyn R.; Wood, Sally D.; Wright, Fred A.; Zielenski, Julian; Clement, Annick; Drumm, Mitchell L.; Boelle, Pierre-Yves; Cutting, Garry R.; Knowles, Michael R.; Durie, Peter R.; Strug, Lisa J.			Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis	NATURE GENETICS			English	Article							GENOME; LINKAGE; IDENTIFICATION; GENE; ONTOLOGY; CFTR; TOOL	Variants associated with meconium ileus in cystic fibrosis were identified in 3,763 affected individuals by genome-wide association study (GWAS). Five SNPs at two loci near SLC6A14 at Xq23-24 (minimum P = 1.28 x 10(-12) at rs3788766) and SLC26A9 at 1q32.1 (minimum P = 9.88 x 10(-9) at rs4077468) accounted for similar to 5% of phenotypic variability and were replicated in an independent sample of affected individuals (n = 2,372; P = 0.001 and 0.0001, respectively). By incorporating the knowledge that disease-causing mutations in CFTR alter electrolyte and fluid flux across surface epithelium into a hypothesis-driven GWAS (GWAS-HD), we identified associations with the same SNPs in SLC6A14 and SLC26A9 and established evidence for the involvement of SNPs in a third solute carrier gene, SLC9A3. In addition, GWAS-HD provided evidence of association between meconium ileus and multiple genes encoding constituents of the apical plasma membrane where CFTR resides (P = 0.0002; testing of 155 apical membrane genes jointly and in replication, P = 0.022). These findings suggest that modulating activities of apical membrane constituents could complement current therapeutic paradigms for cystic fibrosis.	[Sun, Lei; Li, Weili; Strug, Lisa J.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Biostat, Toronto, ON, Canada; [Sun, Lei] Univ Toronto, Dept Stat, Toronto, ON, Canada; [Rommens, Johanna M.; Lin, Fan; Dorfman, Ruslan; Parekh, Rashmi V.; Zielenski, Julian] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Rommens, Johanna M.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Corvol, Harriet; Clement, Annick] Hosp Trousseau, AP HP, Pediat Pulm Dept, INSERM,U938, Paris, France; [Corvol, Harriet; Clement, Annick; Boelle, Pierre-Yves] Univ Paris 06, Paris, France; [Li, Weili; Li, Xin; Chiang, Theodore A.; Corey, Mary; Strug, Lisa J.] Hosp Sick Children, Program Child Hlth Evaluat Sci, Toronto, ON M5G 1X8, Canada; [Busson, Pierre-Francois; Boelle, Pierre-Yves] Hop St Antoine, AP HP, Dept Biostat, INSERM,UMR S707, F-75571 Paris, France; [Zelenika, Diana] CEA, CNG, Evry, France; [Blackman, Scott M.; Cutting, Garry R.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Doshi, Vishal K.; Henderson, Lindsay; Naughton, Kathleen M.; Cutting, Garry R.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [O'Neal, Wanda K.; Pace, Rhonda G.; Stonebraker, Jaclyn R.; Wood, Sally D.; Knowles, Michael R.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC USA; [Wright, Fred A.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Drumm, Mitchell L.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Drumm, Mitchell L.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Durie, Peter R.] Hosp Sick Children, Program Physiol & Expt Med, Toronto, ON M5G 1X8, Canada; [Durie, Peter R.] Univ Toronto, Dept Pediat, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Johns Hopkins University; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Case Western Reserve University; Case Western Reserve University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Strug, LJ (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Div Biostat, Toronto, ON, Canada.	lisa.strug@utoronto.ca	Corvol, Harriet/N-5922-2018; Busson, Pierre-François/D-3589-2015; Rommens, Johanna/AAT-7465-2021	Corvol, Harriet/0000-0002-7026-7523; Pace, Rhonda/0000-0001-8606-0327; Li, Xin/0000-0002-7414-5734; Boelle, Pierre-Yves/0000-0002-5367-8232; Strug, Lisa/0000-0003-0503-9740; Blackman, Scott/0000-0002-4532-6421; Dorfman, Ruslan/0000-0002-3421-5582	Genome Canada, through the Ontario Genomics Institute [2004-OGI-3-05]; Ontario Research Fund, Research Excellence Program; University of Toronto McLaughlin Centre; Ontario Ministry of Research and Innovation; Natural Sciences and Engineering Research Council; Cystic Fibrosis Canada (CFC); Natural Sciences and Engineering Research Council (NSERC) [F250053-2008]; Canadian Institutes of Health Research (CIHR) [MOP 84287, MOP 258916]; Lloyd Carr-Harris Foundation; US National Institutes of Health [R01 HL68927, K23 DK083551, R01 HL068890, R01 DK066368, R01 HL095396, HG-0004314]; US CFF [CUTTIN06P0, R025-CR07, KNOWLE00A0, RDP-R026-CR07, DRUMM0A00]; Flight Attendant Medical Research Institute [FAMRI2006]; Lawson Wilkins Pediatric Endocrine Society; INSERM; AP-HP; Universite Pierre et Marie Curie Paris; Agence Nationale de la Recherche [R09186DS]; Direction Generale de la Sante; Association Vaincre la Mucoviscidose, Chancellerie des Universites (Legs Poix); Association Agir Informer Contre la Mucoviscidose; Groupement d'Interet Scientifique (GIS)-Institut des Maladies Rares; US CFF; CIHR; Ontario Women's Health Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068927, R01HL095396, R01HL068890] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R03HG004314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066368, K23DK083551, P30DK027651] Funding Source: NIH RePORTER	Genome Canada, through the Ontario Genomics Institute(Genome Canada); Ontario Research Fund, Research Excellence Program; University of Toronto McLaughlin Centre; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cystic Fibrosis Canada (CFC); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Lloyd Carr-Harris Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US CFF; Flight Attendant Medical Research Institute; Lawson Wilkins Pediatric Endocrine Society; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); AP-HP; Universite Pierre et Marie Curie Paris; Agence Nationale de la Recherche(French National Research Agency (ANR)); Direction Generale de la Sante(General Electric); Association Vaincre la Mucoviscidose, Chancellerie des Universites (Legs Poix); Association Agir Informer Contre la Mucoviscidose; Groupement d'Interet Scientifique (GIS)-Institut des Maladies Rares; US CFF; CIHR(Canadian Institutes of Health Research (CIHR)); Ontario Women's Health Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank the study particpiants, the Cystic Fibrosis Foundation (CFF) Patient Registry, the University of North Carolina DNA Laboratory and the Genome Quebec and McGill University Innovation Centre. We thank I. Wong for technical help with the replication genotyping, the computer specialists from the French study J.-F. Vibert and M. Mahloul and clinical research assistants Michon, A. Blondel and P. Touche involved in the study design and subject recruitment of the French sample, E. Hawbaker and A. Dang for data coordination in the Gene Modifier Study, Y. Berthiaume, A. Sandford and P. Pare for ascertainment of Canadian phenotype data and DNA, J. Breaton, M. Christofi, N. Anderson, K. Keenan, C. Taylor and J. Avolio for coordinating and verifying the Canadian data collection, E. Crowdy for database development and management in Canada, S. Norris, A. Kohl, P. Miller, L. Charnin, W. Hannah and S. Adams for recruitment, phenotyping and data entry at the University of North Carolina, W. Wolf for DNA analysis and H. Kelkar, T. Randall and A. Xu for bioinformatics at the University of North Carolina, and N. Wang, K. Kaniecki, J. Bonner and C. Watson for technical assistance at Johns Hopkins University. This work was supported in part by Genome Canada, through the Ontario Genomics Institute per research agreement 2004-OGI-3-05 (to P. R. D.), with the Ontario Research Fund, Research Excellence Program; the University of Toronto McLaughlin Centre (to L. S.); the Ontario Ministry of Research and Innovation Early Researcher award and the Natural Sciences and Engineering Research Council (to L. J. S.); Cystic Fibrosis Canada (CFC; to P. R. D., J.Z. and L. J. S.); the Natural Sciences and Engineering Research Council (NSERC; F250053-2008 to L. S.); the Canadian Institutes of Health Research (CIHR; MOP 84287 to L. S. and MOP 258916 to L. J. S.); the Lloyd Carr-Harris Foundation; the US National Institutes of Health (R01 HL68927 (G. R. C.), K23 DK083551 (S. M. B.), R01 HL068890 (M. R. K.), R01 DK066368 (M. R. K.), R01 HL095396 (M. R. K.) and HG-0004314 (L. J. S.)); the US CFF (CUTTIN06P0, R025-CR07, KNOWLE00A0, RDP-R026-CR07 and DRUMM0A00); the Flight Attendant Medical Research Institute (FAMRI2006 to G. R. C.); the Lawson Wilkins Pediatric Endocrine Society Clinical Scholar Award (to S. M. B.); INSERM; AP-HP; Universite Pierre et Marie Curie Paris; Agence Nationale de la Recherche (R09186DS to H. C.), Direction Generale de la Sante; Association Vaincre la Mucoviscidose, Chancellerie des Universites (Legs Poix); Association Agir Informer Contre la Mucoviscidose; and Groupement d'Interet Scientifique (GIS)-Institut des Maladies Rares. Funds for genome-wide genotyping of North American participants were generously provided by the US CFF. R. D. received a Joint Fellowship from the CIHR and Ontario Women's Health Council.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Bertrand CA, 2009, J GEN PHYSIOL, V133, P421, DOI 10.1085/jgp.200810097; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blackman SM, 2006, GASTROENTEROLOGY, V131, P1030, DOI 10.1053/j.gastro.2006.07.016; Bradford EM, 2009, AM J PHYSIOL-GASTR L, V296, pG886, DOI 10.1152/ajpgi.90520.2008; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chang MH, 2009, J BIOL CHEM, V284, P28306, DOI 10.1074/jbc.M109.001669; Chang MH, 2009, J MEMBRANE BIOL, V228, P125, DOI 10.1007/s00232-009-9165-5; Dorfman R, 2011, PEDIATR PULM, V46, P385, DOI 10.1002/ppul.21372; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Fraga S, 2002, J NUTR, V132, P733, DOI 10.1093/jn/132.4.733; Hodges CA, 2011, AM J PHYSIOL-GASTR L, V301, pG528, DOI 10.1152/ajpgi.00052.2011; Hoglund PJ, 2005, BIOCHEM BIOPH RES CO, V336, P175, DOI 10.1016/j.bbrc.2005.08.048; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Li W, 2011, CLIN GENET, V79, P136, DOI 10.1111/j.1399-0004.2010.01502.x; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pedroso I., 2009, GENETICS COMPLEX HUM, P194; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; Sun L, 2006, GENET EPIDEMIOL, V30, P519, DOI 10.1002/gepi.20164; Thomas Duncan C., 2009, Human Genomics, V4, P21; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Welsh MJ, 2001, METABOLIC MOL BASES, P5121; Wright FA, 2011, NAT GENET, V43, P539, DOI 10.1038/ng.838; Yoo YJ, 2010, GENET EPIDEMIOL, V34, P107, DOI 10.1002/gepi.20438; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422	37	147	147	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2012	44	5					562	+		10.1038/ng.2221	http://dx.doi.org/10.1038/ng.2221			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	934BW	22466613	Green Accepted, Green Submitted			2022-12-25	WOS:000303416300017
J	Kee, HL; Dishinger, JF; Blasius, TL; Liu, CJ; Margolis, B; Verhey, KJ				Kee, Hooi Lynn; Dishinger, John F.; Blasius, T. Lynne; Liu, Chia-Jen; Margolis, Ben; Verhey, Kristen J.			A size-exclusion permeability barrier and nucleoporins characterize a ciliary pore complex that regulates transport into cilia	NATURE CELL BIOLOGY			English	Article							KINESIN-2 MOTOR KIF17; INTRAFLAGELLAR TRANSPORT; BASAL BODY; NUCLEAR; MEMBRANE; PROTEIN; IMPORT; CELLS; CILIOGENESIS; DIFFUSION	The cilium is a microtubule-based organelle that contains a unique complement of proteins for cell motility and signalling functions. Entry into the ciliary compartment is proposed to be regulated at the base of the cilium(1). Recent work demonstrated that components of the nuclear import machinery, including the Ran GTPase and importins, regulate ciliary entry(2-4). We hypothesized that the ciliary base contains a ciliary pore complex whose molecular nature and selective mechanism are similar to those of the nuclear pore complex. By microinjecting fluorescently labelled dextrans and recombinant proteins of various sizes, we characterize a size-dependent diffusion barrier for the entry of cytoplasmic molecules into primary cilia in mammalian cells. We demonstrate that nucleoporins localize to the base of primary and motile cilia and that microinjection of nucleoporin-function-blocking reagents blocks the ciliary entry of kinesin-2 KIF17 motors. Together, this work demonstrates that the physical and molecular nature of the ciliary pore complex is similar to that of the nuclear pore complex, and further extends functional parallels between nuclear and ciliary import.	[Kee, Hooi Lynn; Dishinger, John F.; Blasius, T. Lynne; Verhey, Kristen J.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Liu, Chia-Jen; Margolis, Ben] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Margolis, Ben] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Verhey, KJ (corresponding author), Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.	kjverhey@umich.edu			National Institutes of Health (NIH) [R01GM070862, F32GM089034, 5P60 DK-20572]; funds from the University of Michigan Center for Organogenesis; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070862, F32GM089034] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); funds from the University of Michigan Center for Organogenesis; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants R01GM070862 (to K.J.V.) and F32GM089034 (to J.F.D.) and funds from the University of Michigan Center for Organogenesis (to K.J.V. and B.M.). We thank B. Allen, J. Martens, T. Hurd, S. Fan, M. Barr and Verhey laboratory members for discussions of the project. We thank B. Dauer, V. Doye, M. Hetzer, R. Wozniak, U. Kutay, K. Kontani and F. Hildebrandt for reagents and advice. We are grateful to B. Craige (University of Massachusetts Medical School) for sharing his technique of trachea cell extraction and to G. Kreitzer (Weill Medical College of Cornell University) for advice on microinjection. We gratefully acknowledge S. Lentz and the Morphology and Image Analysis Core of the Michigan Diabetes Research and Training Center, funded by NIH grant 5P60 DK-20572.	ANDERSON RG, 1972, J CELL BIOL, V54, P246, DOI 10.1083/jcb.54.2.246; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Brohawn SG, 2009, STRUCTURE, V17, P1156, DOI 10.1016/j.str.2009.07.014; Calvert PD, 2010, J GEN PHYSIOL, V135, P173, DOI 10.1085/jgp.200910322; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; CLEVER J, 1991, P NATL ACAD SCI USA, V88, P7333, DOI 10.1073/pnas.88.16.7333; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Dishinger JF, 2010, NAT CELL BIOL, V12, P703, DOI 10.1038/ncb2073; Dultz E, 2010, J CELL BIOL, V191, P15, DOI 10.1083/jcb.201007076; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Fan SL, 2011, MOL BIOL CELL, V22, P4539, DOI 10.1091/mbc.E11-03-0267; Francis SS, 2011, J CELL BIOL, V193, P219, DOI 10.1083/jcb.201009001; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; GILULA NB, 1972, J CELL BIOL, V53, P494, DOI 10.1083/jcb.53.2.494; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hammond JW, 2010, J CELL BIOL, V189, P1013, DOI 10.1083/jcb.201001057; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hurd TW, 2011, J CELL SCI, V124, P718, DOI 10.1242/jcs.070839; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; LANG I, 1986, J CELL BIOL, V102, P1183, DOI 10.1083/jcb.102.4.1183; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Murrell JR, 1999, J NEUROSCI, V19, P8260; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Takao D, 2010, BIOPHYS J, V98, P1582, DOI 10.1016/j.bpj.2009.12.4314; Walther TC, 2001, EMBO J, V20, P5703, DOI 10.1093/emboj/20.20.5703; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116	39	212	214	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2012	14	4					431	+		10.1038/ncb2450	http://dx.doi.org/10.1038/ncb2450			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	921UM	22388888	Green Accepted			2022-12-25	WOS:000302503300017
J	Andersen, EC; Gerke, JP; Shapiro, JA; Crissman, JR; Ghosh, R; Bloom, JS; Felix, MA; Kruglyak, L				Andersen, Erik C.; Gerke, Justin P.; Shapiro, Joshua A.; Crissman, Jonathan R.; Ghosh, Rajarshi; Bloom, Joshua S.; Felix, Marie-Anne; Kruglyak, Leonid			Chromosome-scale selective sweeps shape Caenorhabditis elegans genomic diversity	NATURE GENETICS			English	Article							MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; NUCLEOTIDE POLYMORPHISM; LINKAGE DISEQUILIBRIUM; NATURAL-POPULATIONS; WILD POPULATIONS; MUTATION-RATE; LINKED SITES; C. ELEGANS; ASSOCIATION	The nematode Caenorhabditis elegans is central to research in molecular, cell and developmental biology, but nearly all of this research has been conducted on a single strain of C. elegans. Little is known about the population genomic and evolutionary history of this species. We characterized C. elegans genetic variation using high-throughput selective sequencing of a worldwide collection of 200 wild strains and identified 41,188 SNPs. Notably, C. elegans genome variation is dominated by a set of commonly shared haplotypes on four of its six chromosomes, each spanning many megabases. Population genetic modeling showed that this pattern was generated by chromosome-scale selective sweeps that have reduced variation worldwide; at least one of these sweeps probably occurred in the last few hundred years. These sweeps, which we hypothesize to be a result of human activity, have drastically reshaped the global C. elegans population in the recent past.	[Andersen, Erik C.; Gerke, Justin P.; Shapiro, Joshua A.; Crissman, Jonathan R.; Ghosh, Rajarshi; Bloom, Joshua S.; Kruglyak, Leonid] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Andersen, Erik C.; Gerke, Justin P.; Shapiro, Joshua A.; Ghosh, Rajarshi; Kruglyak, Leonid] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Crissman, Jonathan R.; Kruglyak, Leonid] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; [Bloom, Joshua S.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Felix, Marie-Anne] Ecole Normale Super, Inst Biol, F-75231 Paris, France	Princeton University; Princeton University; Howard Hughes Medical Institute; Princeton University; Princeton University; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Kruglyak, L (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	leonid@genomics.princeton.edu	Shapiro, Joshua/B-5948-2008	Shapiro, Joshua/0000-0002-6224-0347; Andersen, Erik/0000-0003-0229-9651	US National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service; Life Science Research Foundation; National Science Foundation; James S. McDonnell Foundation; Howard Hughes Medical Institute; NIH [R01-HG004321, R37-MH59520, P50-GM071508]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059520] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Life Science Research Foundation; National Science Foundation(National Science Foundation (NSF)); James S. McDonnell Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank all the contributors who provided strains to make this study possible, including M. Ailion (University of Washington), A. Cutter (University of Toronto), D. Denver (Oregon State University), S. Estes (Portland State University), J. Hodgkin (University of Oxford), J. Kammenga (Wageningen University), P. McGrath (Rockefeller University), M. Rockman (New York University) and the Caenorhabditis Genetics Center. We also thank the Waksman Genomics Core Facility and the Lewis-Sigler Institute Microarray Facility for the Illumina sequencing. We also thank P. Andolfatto, M. Rockman, H. Seidel, R. Tanny and the members of the Kruglyak laboratory for helpful discussions and comments on the manuscript. This work was supported by a US National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service Award (E. C. A.), the Merck Fellowship of the Life Science Research Foundation (J. P. G.), a National Science Foundation graduate research fellowship (J. S. B.), a James S. McDonnell Foundation Centennial Fellowship, the Howard Hughes Medical Institute and NIH grants R01-HG004321, R37-MH59520 (L. K.) and P50-GM071508 to the Center for Quantitative Biology at the Lewis-Sigler Institute of Princeton University.	Achat G, 2008, GENETICS, V179, P1409, DOI 10.1534/genetics.107.082198; Achaz G, 2009, GENETICS, V183, P249, DOI 10.1534/genetics.109.104042; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; Barriere A, 2007, GENETICS, V176, P999, DOI 10.1534/genetics.106.067223; BRENNER S, 1974, GENETICS, V77, P71; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; Cutter AD, 2006, GENETICS, V172, P171, DOI 10.1534/genetics.105.048207; Cutter AD, 2003, MOL BIOL EVOL, V20, P665, DOI 10.1093/molbev/msg072; Cutter AD, 2008, MOL BIOL EVOL, V25, P778, DOI 10.1093/molbev/msn024; Cutter AD, 2006, GENETICS, V173, P2021, DOI 10.1534/genetics.106.058651; Cutter AD, 2006, GENETICS, V174, P901, DOI 10.1534/genetics.106.061879; Denver DR, 2003, MOL BIOL EVOL, V20, P393, DOI 10.1093/molbev/msg044; Denver DR, 2004, NATURE, V430, P679, DOI 10.1038/nature02697; Dolgin ES, 2008, HEREDITY, V100, P304, DOI 10.1038/sj.hdy.6801079; Ewing G, 2010, BIOINFORMATICS, V26, P2064, DOI 10.1093/bioinformatics/btq322; Falush D, 2003, GENETICS, V164, P1567; Felix MA, 2010, CURR BIOL, V20, pR965, DOI 10.1016/j.cub.2010.09.050; Graustein A, 2002, GENETICS, V161, P99; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Haber M, 2005, MOL BIOL EVOL, V22, P160, DOI 10.1093/molbev/msh264; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Hudson RR, 2001, GENETICS, V159, P1805; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Khan A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000404; Kiontke K, 2004, P NATL ACAD SCI USA, V101, P9003, DOI 10.1073/pnas.0403094101; Koch R, 2000, GENOME RES, V10, P1690, DOI 10.1101/gr.GR-1471R; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McGrath PT, 2009, NEURON, V61, P692, DOI 10.1016/j.neuron.2009.02.012; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Phillips PC, 2006, TRENDS GENET, V22, P405, DOI 10.1016/j.tig.2006.06.001; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reddy KC, 2009, SCIENCE, V323, P382, DOI 10.1126/science.1166527; Riddle D.L., 1997, ELEGANS 2, Vxvii, P1222; Roberts A, 2007, BIOINFORMATICS, V23, pI401, DOI 10.1093/bioinformatics/btm220; Rockman MV, 2010, SCIENCE, V330, P372, DOI 10.1126/science.1194208; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sivasundar A, 2005, CURR BIOL, V15, P1598, DOI 10.1016/j.cub.2005.08.034; Sivasundar A, 2003, GENETICS, V163, P147; Swan KA, 2002, GENOME RES, V12, P1100, DOI 10.1101/gr.208902; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715	44	231	231	1	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2012	44	3					285	U83		10.1038/ng.1050	http://dx.doi.org/10.1038/ng.1050			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	899VC	22286215	Green Accepted, Green Submitted			2022-12-25	WOS:000300843600013
J	Khare, SD; Kipnis, Y; Greisen, PJ; Takeuchi, R; Ashani, Y; Goldsmith, M; Song, YF; Gallaher, JL; Silman, I; Leader, H; Sussman, JL; Stoddard, BL; Tawfik, DS; Baker, D				Khare, Sagar D.; Kipnis, Yakov; Greisen, Per Jr; Takeuchi, Ryo; Ashani, Yacov; Goldsmith, Moshe; Song, Yifan; Gallaher, Jasmine L.; Silman, Israel; Leader, Haim; Sussman, Joel L.; Stoddard, Barry L.; Tawfik, Dan S.; Baker, David			Computational redesign of a mononuclear zinc metalloenzyme for organophosphate hydrolysis	NATURE CHEMICAL BIOLOGY			English	Article							CATALYTIC-ACTIVITY; NERVE AGENTS; DESIGN; PROMISCUITY; MECHANISM; EVOLUTION; MUTATION; ENZYMES	The ability to redesign enzymes to catalyze noncognate chemical transformations would have wide-ranging applications. We developed a computational method for repurposing the reactivity of metalloenzyme active site functional groups to catalyze new reactions. Using this method, we engineered a zinc-containing mouse adenosine deaminase to catalyze the hydrolysis of a model organophosphate with a catalytic efficiency (k(cat)/k(m)) of -10(4) M(-1)s(-1) after directed evolution. In the high-resolution crystal structure of the enzyme, all but one of the designed residues adopt the designed conformation. The designed enzyme efficiently catalyzes the hydrolysis of the R-p isomer of a coumarinyl analog of the nerve agent cyclosarin, and it shows marked substrate selectivity for coumarinyl leaving groups. Computational redesign of native enzyme active sites complements directed evolution methods and offers a general approach for exploring their untapped catalytic potential for new reactivities.	[Khare, Sagar D.; Kipnis, Yakov; Song, Yifan; Gallaher, Jasmine L.; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Greisen, Per Jr] Tech Univ Denmark, Dept Phys, DK-2800 Lyngby, Denmark; [Takeuchi, Ryo; Stoddard, Barry L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Ashani, Yacov; Sussman, Joel L.] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Ashani, Yacov; Silman, Israel] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Goldsmith, Moshe; Tawfik, Dan S.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Leader, Haim] Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Baker, David] Univ Washington, Biomol Struct & Design Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Technical University of Denmark; Fred Hutchinson Cancer Center; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Khare, SD (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Sussman, Joel/0000-0003-0306-3878	Defense Advanced Research Projects Agency; Defense Threat Reduction Agency; Howard Hughes Medical Institute; Novo Nordisk Danmark-Amerika Fondet; Oticon Fonden; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049857] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Novo Nordisk Danmark-Amerika Fondet(Novo Nordisk); Oticon Fonden; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Nivon for assistance with liquid chromatography, O. Khersonsky (Weizmann Institute of Science) for providing substrates and I. Damborsky for comments on the manuscript. This work was supported by the Defense Advanced Research Projects Agency, the Defense Threat Reduction Agency and the Howard Hughes Medical Institute. was supported by Novo Nordisk Danmark-Amerika Fondet and Oticon Fonden.	Afriat L, 2006, BIOCHEMISTRY-US, V45, P13677, DOI 10.1021/bi061268r; Ashani Y, 2010, CHEM-BIOL INTERACT, V187, P362, DOI 10.1016/j.cbi.2010.02.039; Aubert SD, 2004, BIOCHEMISTRY-US, V43, P5707, DOI 10.1021/bi0497805; Baker D, 2010, PROTEIN SCI, V19, P1817, DOI 10.1002/pro.481; Blum MM, 2006, J AM CHEM SOC, V128, P12750, DOI 10.1021/ja061887n; Chen B, 2009, BIOCHEMISTRY-US, V48, P11496, DOI 10.1021/bi9014727; Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010; de Yin L.T, 2010, BIOCHEMISTRY-US, V49, P1931; Dyguda-Kazimierowicz E, 2008, J PHYS CHEM B, V112, P9982, DOI 10.1021/jp800386f; Gerlt JA, 2009, CURR OPIN CHEM BIOL, V13, P10, DOI 10.1016/j.cbpa.2009.01.014; Gupta RD, 2011, NAT CHEM BIOL, V7, P120, DOI [10.1038/nchembio.510, 10.1038/NCHEMBIO.510]; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Jochens H, 2009, ANGEW CHEM INT EDIT, V48, P3532, DOI 10.1002/anie.200806276; Khersonsky O, 2005, BIOCHEMISTRY-US, V44, P6371, DOI 10.1021/bi047440d; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leopoldseder S, 2004, J MOL BIOL, V337, P871, DOI 10.1016/j.jmb.2004.01.062; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murphy PM, 2009, P NATL ACAD SCI USA, V106, P9215, DOI 10.1073/pnas.0811070106; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park HS, 2006, SCIENCE, V311, P535, DOI 10.1126/science.1118953; Pegg SCH, 2006, BIOCHEMISTRY-US, V45, P2545, DOI 10.1021/bi052101l; Raushel FM, 2011, NATURE, V469, P310, DOI 10.1038/469310a; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Schmidt DMZ, 2003, BIOCHEMISTRY-US, V42, P8387, DOI 10.1021/bi034769a; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Terao Y, 2006, CHEM COMMUN, P3600, DOI 10.1039/b607211a; Toscano MD, 2007, ANGEW CHEM INT EDIT, V46, P3212, DOI 10.1002/anie.200604205; Tsai PC, 2010, BIOCHEMISTRY-US, V49, P7978, DOI 10.1021/bi101056m; Wang ZM, 1998, BIOCHEMISTRY-US, V37, P8314, DOI 10.1021/bi980324o; Williams SD, 2000, BIOCHEMISTRY-US, V39, P10098, DOI 10.1021/bi0004652; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Xiang H, 1999, BIOCHEMISTRY-US, V38, P7638, DOI 10.1021/bi9901432; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106	37	168	172	2	121	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2012	8	3					294	300		10.1038/NCHEMBIO.777	http://dx.doi.org/10.1038/NCHEMBIO.777			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896VR	22306579	Green Accepted			2022-12-25	WOS:000300600000015
J	Mathieson, I; McVean, G				Mathieson, Iain; McVean, Gil			Differential confounding of rare and common variants in spatially structured populations	NATURE GENETICS			English	Article							GENOMIC CONTROL; GENETIC ASSOCIATION; HDL CHOLESTEROL; DISEASES; STRATIFICATION; SCALE; BIAS	Well-powered genome-wide association studies, now made possible through advances in technology and large-scale collaborative projects, promise to characterize the contribution of rare variants to complex traits and disease. However, while population structure is a known confounder of association studies, it remains unknown whether methods developed to control stratification are equally effective for rare variants. Here, we demonstrate that rare variants can show a stratification that is systematically different from, and typically stronger than, common variants, and this is not necessarily corrected by existing methods. We show that the same process leads to inflation for load-based tests and can obscure signals at truly associated variants. Furthermore, we show that populations can display spatial structure in rare variants, even when Wright's fixation index F-ST is low, but that allele frequency-dependent metrics of allele sharing can reveal localized stratification. These results underscore the importance of collecting and integrating spatial information in the genetic analysis of complex traits.	[Mathieson, Iain; McVean, Gil] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [McVean, Gil] Univ Oxford, Dept Stat, Oxford, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Mathieson, I (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	mathii@well.ox.ac.uk		McVean, Gil/0000-0002-5012-4162	Wellcome Trust [089250/Z/09/Z, 086084/Z/08/Z, 090532/Z/09/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	The authors thank M. Pirinen, C. Spencer, Z. Iqbal and C. Lindgren for discussion and M. Pirinen for providing software to fit the linear mixed models used in this analysis. This work was supported by grants from the Wellcome Trust (089250/Z/09/Z to I. M., 086084/Z/08/Z to G. M. and 090532/Z/09/Z to the Wellcome Trust Centre for Human Genetics).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Bustamante CD, 2011, NATURE, V475, P163, DOI 10.1038/475163a; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; COPELAND KT, 1977, AM J EPIDEMIOL, V105, P488, DOI 10.1093/oxfordjournals.aje.a112408; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Ionita-Laza I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001289; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Mukhopadhyay I, 2010, GENET EPIDEMIOL, V34, P213, DOI 10.1002/gepi.20451; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Wang J, 2000, ARTERIOSCL THROM VAS, V20, P1983, DOI 10.1161/01.ATV.20.8.1983	28	265	266	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2012	44	3					243	U29		10.1038/ng.1074	http://dx.doi.org/10.1038/ng.1074			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	899VC	22306651	Green Accepted			2022-12-25	WOS:000300843600005
J	Peng, ZY; Cheng, YB; Tan, BCM; Kang, L; Tian, ZJ; Zhu, YK; Zhang, WW; Liang, Y; Hu, XD; Tan, XM; Guo, J; Dong, ZR; Liang, Y; Bao, L; Wang, J				Peng, Zhiyu; Cheng, Yanbing; Tan, Bertrand Chin-Ming; Kang, Lin; Tian, Zhijian; Zhu, Yuankun; Zhang, Wenwei; Liang, Yu; Hu, Xueda; Tan, Xuemei; Guo, Jing; Dong, Zirui; Liang, Yan; Bao, Li; Wang, Jun			Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome	NATURE BIOTECHNOLOGY			English	Article							NONCODING RNA; GENOME SEQUENCE; WIDESPREAD RNA; ADENOSINE; IDENTIFICATION; EXPRESSION; DISCOVERY; SITES; TOOL	RNA editing is a post-transcriptional event that recodes hereditary information. Here we describe a comprehensive profile of the RNA editome of a male Han Chinese individual based on analysis of similar to 767 million sequencing reads from poly(A)(+), poly(A)(-) and small RNA samples. We developed a computational pipeline that carefully controls for false positives while calling RNA editing events from genome and whole-transcriptome data of the same individual. We identified 22,688 RNA editing events in noncoding genes and introns, untranslated regions and coding sequences of protein-coding genes. Most changes (similar to 93%) converted A to I(G), consistent with known editing mechanisms based on adenosine deaminase acting on RNA (ADAR). We also found evidence of other types of nucleotide changes; however, these were validated at lower rates. We found 44 editing sites in microRNAs (miRNAs), suggesting a potential link between RNA editing and miRNA-mediated regulation. Our approach facilitates large-scale studies to profile and compare editomes across a wide range of samples.	[Peng, Zhiyu; Cheng, Yanbing; Kang, Lin; Tian, Zhijian; Zhu, Yuankun; Zhang, Wenwei; Liang, Yu; Hu, Xueda; Tan, Xuemei; Guo, Jing; Dong, Zirui; Liang, Yan; Bao, Li; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Tan, Bertrand Chin-Ming] Chang Gung Univ, Coll Med, Dept Biomed Sci, Tao Yuan, Taiwan; [Tan, Bertrand Chin-Ming] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Beijing Genomics Institute (BGI); Chang Gung University; Chang Gung University; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen	Wang, J (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.	wangj@genomics.org.cn	Kang, Lin/AAA-2260-2019; DONG, Elvis/AAM-9274-2020; Peng, Zhiyu/GXV-5301-2022; Wang, Jun/A-7261-2013; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Kang, Lin/0000-0002-9186-9574; DONG, Elvis/0000-0002-3626-6500; Peng, Zhiyu/0000-0003-2349-750X; Tan, Bertrand/0000-0002-2218-7115; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931	National Basic Research Program of China (973 program) [2011CB809200, 2011CB809202, 2011CB809203]; National Natural Science Foundation of China [30725008, 30890032, 30811130531]; Chinese 863 program [2006AA02A302, 2009AA022707]; Shenzhen Municipal Government of China; Local Government of Yantian District of Shenzhen [JC200903190767A, JC200903190772A, ZYC200903240076A, CXB200903110066A, ZYC200903240077A, ZYC200903240080A]; Danish Natural Science Research Council	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 863 program(National High Technology Research and Development Program of China); Shenzhen Municipal Government of China; Local Government of Yantian District of Shenzhen; Danish Natural Science Research Council(Danish Natural Science Research Council)	This project was supported by a National Basic Research Program of China (973 program no. 2011CB809200, 2011CB809202 and 2011CB809203), the National Natural Science Foundation of China (30725008, 30890032 and 30811130531), the Chinese 863 program (2006AA02A302 and 2009AA022707), the Shenzhen Municipal Government of China and the Local Government of Yantian District of Shenzhen (grants JC200903190767A, JC200903190772A, ZYC200903240076A, CXB200903110066A, ZYC200903240077A and ZYC200903240080A) and the Ole Romer grant from the Danish Natural Science Research Council.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bahn JH, 2012, GENOME RES, V22, P142, DOI 10.1101/gr.124107.111; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Blow M, 2004, GENOME RES, V14, P2379, DOI 10.1101/gr.2951204; Borchert GM, 2009, HUM MOL GENET, V18, P4801, DOI 10.1093/hmg/ddp443; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Cirulli ET, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r57; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Eisenberg E, 2005, TRENDS GENET, V21, P77, DOI 10.1016/j.tig.2004.12.005; Eisenberg E, 2010, RNA BIOL, V7, P248, DOI 10.4161/rna.7.2.11565; Farajollahi S, 2010, TRENDS GENET, V26, P221, DOI 10.1016/j.tig.2010.02.001; He T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018129; Huang Songbo, 2011, Frontiers in Genetics, V2, P46, DOI 10.3389/fgene.2011.00046; Hundley HA, 2010, TRENDS BIOCHEM SCI, V35, P377, DOI 10.1016/j.tibs.2010.02.008; Jepson JEC, 2008, BBA-GENE REGUL MECH, V1779, P459, DOI 10.1016/j.bbagrm.2007.11.009; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Kiran A, 2010, BIOINFORMATICS, V26, P1772, DOI 10.1093/bioinformatics/btq285; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Maas S, 2011, BIOCHEM BIOPH RES CO, V412, P407, DOI 10.1016/j.bbrc.2011.07.075; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Osenberg S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011173; Paz-Yaacov N, 2010, P NATL ACAD SCI USA, V107, P12174, DOI 10.1073/pnas.1006183107; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Pullirsch D, 2010, RNA BIOL, V7, P205, DOI 10.4161/rna.7.2.11286; Reid JG, 2008, GENOME RES, V18, P1571, DOI 10.1101/gr.078246.108; Schrider DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025842; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Tian Z, 2011, GIGA SCI; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	50	379	394	6	109	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2012	30	3					253	+		10.1038/nbt.2122	http://dx.doi.org/10.1038/nbt.2122			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	905VI	22327324	Bronze			2022-12-25	WOS:000301303800021
J	Postel-Vinay, S; Veron, AS; Tirode, F; Pierron, G; Reynaud, S; Kovar, H; Oberlin, O; Lapouble, E; Ballet, S; Lucchesi, C; Kontny, U; Gonzalez-Neira, A; Picci, P; Alonso, J; Patino-Garcia, A; de Paillerets, BB; Laud, K; Dina, C; Froguel, P; Clavel-Chapelon, F; Doz, F; Michon, J; Chanock, SJ; Thomas, G; Cox, DG; Delattre, O				Postel-Vinay, Sophie; Veron, Amelie S.; Tirode, Franck; Pierron, Gaelle; Reynaud, Stephanie; Kovar, Heinrich; Oberlin, Odile; Lapouble, Eve; Ballet, Stelly; Lucchesi, Carlo; Kontny, Udo; Gonzalez-Neira, Anna; Picci, Piero; Alonso, Javier; Patino-Garcia, Ana; de Paillerets, Brigitte Bressac; Laud, Karine; Dina, Christian; Froguel, Philippe; Clavel-Chapelon, Francoise; Doz, Francois; Michon, Jean; Chanock, Stephen J.; Thomas, Gilles; Cox, David G.; Delattre, Olivier			Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TUMORS; RISK; DISEASE; CANCER; TRANSLOCATION; PATHOGENESIS; EXPRESSION; SIBLINGS; FUSION	Ewing sarcoma, a pediatric tumor characterized by EWSR1-ETS fusions, is predominantly observed in populations of European ancestry. We performed a genome-wide association study (GWAS) of 401 French individuals with Ewing sarcoma, 684 unaffected French individuals and 3,668 unaffected individuals of European descent and living in the United States. We identified candidate risk loci at 1p36.22, 10q21 and 15q15. We replicated these loci in two independent sets of cases and controls. Joint analysis identified associations with rs9430161 (P = 1.4 x 10(-20); odds ratio (OR) = 2.2) located 25 kb upstream of TARDBP, rs224278 (P = 4.0 x 10(-17); OR = 1.7) located 5 kb upstream of EGR2 and, to a lesser extent, rs4924410 at 15q15 (P = 6.6 x 10(-9); OR = 1.5). The major risk haplotypes were less prevalent in Africans, suggesting that these loci could contribute to geographical differences in Ewing sarcoma incidence. TARDBP shares structural similarities with EWSR1 and FUS, which encode RNA binding proteins, and EGR2 is a target gene of EWSR1-ETS. Variants at these loci were associated with expression levels of TARDBP, ADO (encoding cysteamine dioxygenase) and EGR2.	[Postel-Vinay, Sophie; Tirode, Franck; Lucchesi, Carlo; Laud, Karine; Delattre, Olivier] Inst Curie, INSERM, Genet & Biol Canc U830, Paris, France; [Postel-Vinay, Sophie; Tirode, Franck; Lucchesi, Carlo; Laud, Karine; Delattre, Olivier] Inst Curie, Ctr Rech, Paris, France; [Veron, Amelie S.; Thomas, Gilles; Cox, David G.] Canc Res Ctr Lyon, INSERM, U1052, Leon Berard Canc Ctr, Lyon, France; [Pierron, Gaelle; Reynaud, Stephanie; Lapouble, Eve; Ballet, Stelly; Delattre, Olivier] Ctr Hosp, Inst Curie, Unite Genet Somat, Paris, France; [Kovar, Heinrich] St Anna Childrens Hosp, Childrens Canc Res Inst, A-1090 Vienna, Austria; [Oberlin, Odile] Inst Gustave Roussy, Serv Pediat, Villejuif, France; [Kontny, Udo] Univ Freiburg Klinikum, Zentrum Kinder & Jugendmed, Freiburg, Germany; [Gonzalez-Neira, Anna] Spanish Natl Canc Res Ctr, Human Genotyping Unit CeGen, Human Canc Genet Programme, Madrid, Spain; [Picci, Piero] Ist Ortoped Rizzoli Bologna, Lab Oncol Sperimentale, Bologna, Italy; [Alonso, Javier] Inst Salud Carlos III, Unidad Tumores Solidos Infantiles, Majadahonda, Spain; [Patino-Garcia, Ana] Univ Navarra, Univ Clin, Lab Pediat, E-31080 Pamplona, Spain; [de Paillerets, Brigitte Bressac] Inst Gustave Roussy, Serv Genet, Villejuif, France; [Dina, Christian] IRI UN, INSERM, U915, Inst Thorax, Nantes, France; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Clavel-Chapelon, Francoise] Inst Gustave Roussy, Ctr Natl Rech Sci, Unite Mixtre Rech 1018, Villejuif, France; [Doz, Francois] Univ Paris 05, Paris, France; [Doz, Francois; Michon, Jean] Ctr Hosp, Dept Pediat, Inst Curie, Paris, France; [Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Thomas, Gilles] Synergie Lyon Canc, Lyon, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Saint Anna Children's Hospital; UNICANCER; Gustave Roussy; University of Freiburg; Centro Nacional de Investigaciones Oncologicas (CNIO); Instituto de Salud Carlos III; University of Navarra; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Imperial College London; Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Delattre, O (corresponding author), Inst Curie, INSERM, Genet & Biol Canc U830, Paris, France.	olivier.delattre@curie.fr	Dina, Christian R/D-3535-2015; Doz, Francois P/K-8616-2012; Patiño-Garcia, Ana/I-4299-2012; TIRODE, Franck/HHS-7070-2022; Cox, David G/A-2023-2009; Clavel-Chapelon, Francoise/G-6733-2014; Paillerets, Brigitte Bressac-de/D-8954-2018; Gonzalez-Neira, Anna/C-5791-2015; Cox, David/ABA-7454-2020; Alonso, Javier/B-6012-2013; FROGUEL, Philippe/O-6799-2017; Tirode, Franck/B-4586-2009; Picci, Piero/J-5979-2016	Dina, Christian R/0000-0002-7722-7348; Patiño-Garcia, Ana/0000-0002-4066-8203; Cox, David G/0000-0002-2152-9259; Paillerets, Brigitte Bressac-de/0000-0003-0245-8608; Gonzalez-Neira, Anna/0000-0002-5421-2020; Alonso, Javier/0000-0002-6287-8391; FROGUEL, Philippe/0000-0003-2972-0784; Lucchesi, Carlo/0000-0001-6657-2341; Kovar, Heinrich/0000-0001-6873-9109; Doz, Francois/0000-0001-9286-4831; Tirode, Franck/0000-0003-4731-7817; Picci, Piero/0000-0002-8519-4101; delattre, olivier/0000-0002-8730-2276; Cox, David/0000-0003-2047-4687	Institut Curie; Inserm; Ligue Nationale Contre le Cancer; Region Ile de France; Institut National du Cancer [2008-044, 0627, ZP09-027-EPI]; Synergie Lyon Cancer foundation; KCK; European Embryonal Tumor (EET) pipeline programs; Societe Francaise des Cancers de l'Enfant; Spanish Ministry of Science and Technology [SAF2009-10158]; Fundacion de la Asociacion Espanola Contra el Cancer; Fundacion Maria Francisca de Roviralta; Sociedad Espanola de Hematologia y Oncologia Pediatricas; Courir pour Mathieu; Dans les pas du Geant; Olivier Chape; Les Bagouzamanon; Enfants et Sante; les Amis de Claire; MRC [G1002084] Funding Source: UKRI; Medical Research Council [G1002084] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [ZIACP010201] Funding Source: NIH RePORTER	Institut Curie; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Region Ile de France(Region Ile-de-France); Institut National du Cancer(Institut National du Cancer (INCA) France); Synergie Lyon Cancer foundation; KCK; European Embryonal Tumor (EET) pipeline programs; Societe Francaise des Cancers de l'Enfant; Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion de la Asociacion Espanola Contra el Cancer; Fundacion Maria Francisca de Roviralta; Sociedad Espanola de Hematologia y Oncologia Pediatricas; Courir pour Mathieu; Dans les pas du Geant; Olivier Chape; Les Bagouzamanon; Enfants et Sante; les Amis de Claire; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank E. Thomas from Synergie Lyon Cancer for advice on statistical methods. We thank the staff from the Integragen Company for excellent service and V. Chene for outstanding assistance. We thank the following clinicians for providing samples used in this work: C. Alenda, F. Almazan, D. Ansoborlo, L. Aymerich, L. Benboukbher, C. Belendez, C. Berger, C. Bergeron, P. Biron, J. Y. Blay, E. Bompas, H. Bonnefoi, P. Boutard, B. Bui-Nguyen, D. Chauveaux, C. Calvo, A. Carbone, C. Clement, T. Contra, N. Corradini, A. S. Defachelles, V. Gendemer-Delignieres, A. Deville, A. Echevarria, J. Fayette, M. Fraga, D. Frappaz, J. L. Fuster, P. Garcia-Miguel, J. C. Gentet, P. Kerbrat, V. Laithier, V. Laurence, P. Leblond, O. Lejars, R. Lopez-Almaraz, B. Lopez-Ibor, P. Lutz, J. F. Mallet, L. Mansuy, P. Marec Berard, G. Margueritte, A. Marie Cardine, C. Melero, L. Mignot, F. Millot, O. Minckes, G. Margueritte, C. Mata, M. E. Mateos, M. Melo, C. Moscardo, M. Munzer, B. Narciso, A. Navajas, D. Orbach, C. Oudot, H. Pacquement, C. Paillard, Y. Perel, T. Philip, C. Piguet, M. I. Pintor, D. Plantaz, E. Plouvier, S. Ramirez-Del-Villar, I. Ray-Coquard, Y. Reguerre, M. Rios, P. Rohrlich, H. Rubie, A. Sastre, G. Schleiermacher, C. Schmitt, P. Schneider, L. Sierrasesumaga, C. Soler, N. Sirvent, S. Taque, E. Thebaud, A. Thyss, R. Tichit, J. J. Uriz, J. P. Vannier, F. Watelle-Pichon. We also thank the European Prospective Investigation into Cancer and Nutrition (EPIC) Steering Committee (E. Riboli, Principal Investigator) for access to genotype data from the EPIC cohorts and the Children's Cancer and Leukaemia Group (CCLG) Tissue Bank (funded by Cancer Research UK) for access to specimens. This work was supported by grants from the Institut Curie, the Inserm, the Ligue Nationale Contre le Cancer (Equipe labellisee, Carte d'Identite des Tumeurs program and Recherche Epidemiologique 2009 program), the Region Ile de France, the Institut National du Cancer (2008-044, 0627 and ZP09-027-EPI), the Synergie Lyon Cancer foundation, the KCK and European Embryonal Tumor (EET) pipeline programs, the Societe Francaise des Cancers de l'Enfant, the Spanish Ministry of Science and Technology (SAF2009-10158), the Fundacion de la Asociacion Espanola Contra el Cancer, the Fundacion Maria Francisca de Roviralta and the Sociedad Espanola de Hematologia y Oncologia Pediatricas and the following associations: Courir pour Mathieu, Dans les pas du Geant, Olivier Chape, Les Bagouzamanon, Enfants et Sante and les Amis de Claire.	AURIAS A, 1983, NEW ENGL J MED, V309, P496; Barmada SJ, 2010, REV NEUROSCIENCE, V21, P251; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berger P, 2006, GLIA, V54, P243, DOI 10.1002/glia.20386; Brisset S, 2001, CANCER GENET CYTOGEN, V130, P57, DOI 10.1016/S0165-4608(01)00454-X; Chiang PM, 2010, P NATL ACAD SCI USA, V107, P16320, DOI 10.1073/pnas.1002176107; Chung CC, 2011, HUM GENET, V130, P59, DOI 10.1007/s00439-011-1030-9; Clavel-Chapelon F, 1997, EUR J CANCER PREV, V6, P473, DOI 10.1097/00008469-199710000-00007; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Dominy J, 2007, J BIOL CHEM, V282, P25189, DOI 10.1074/jbc.M703089200; FRALEY C, 2006, 504 U WASH DEP STAT; Gabet Y, 2010, BLOOD, V116, P3964, DOI 10.1182/blood-2010-01-263830; Hancock JD, 2008, CELL CYCLE, V7, P250, DOI 10.4161/cc.7.2.5229; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; HUTTER RVP, 1964, AM J SURG, V107, P598, DOI 10.1016/0002-9610(64)90328-9; Jawad MU, 2009, CANCER-AM CANCER SOC, V115, P3526, DOI 10.1002/cncr.24388; Jensen R.D., 1970, LANCET, V295, P777; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; JOYCE MJ, 1984, CANCER, V53, P1959, DOI 10.1002/1097-0142(19840501)53:9<1959::AID-CNCR2820530926>3.0.CO;2-9; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Leclerc N, 2008, J CELL BIOCHEM, V103, P1938, DOI 10.1002/jcb.21587; Levi G, 1996, DEVELOPMENT, V122, P113; LI FP, 1980, LANCET, V1, P1255; Linden G., 1970, LANCET, V295, P1171; Maris JM, 2008, NEW ENGL J MED, V358, P2585, DOI 10.1056/NEJMoa0708698; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Savola S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-17; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Toomey EC, 2010, ONCOGENE, V29, P4504, DOI 10.1038/onc.2010.205; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Williamson D, 2010, J CLIN ONCOL, V28, P2151, DOI 10.1200/JCO.2009.26.3814; Worch J, 2011, CANCER EPIDEM BIOMAR, V20, P449, DOI 10.1158/1055-9965.EPI-10-1170; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	35	119	119	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2012	44	3					323	U133		10.1038/ng.1085	http://dx.doi.org/10.1038/ng.1085			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	899VC	22327514				2022-12-25	WOS:000300843600020
J	Vallee, RB; McKenney, RJ; Ori-McKenney, KM				Vallee, Richard B.; McKenney, Richard J.; Ori-McKenney, Kassandra M.			Multiple modes of cytoplasmic dynein regulation	NATURE CELL BIOLOGY			English	Review							NUCLEAR-ENVELOPE BREAKDOWN; MICROTUBULE-BINDING DOMAIN; BETA-III-SPECTRIN; NEURAL STEM-CELLS; AAA PLUS RING; DYNACTIN COMPLEX; ORGANELLE TRANSPORT; MOTOR DOMAIN; COILED-COIL; NEURONAL MIGRATION	In performing its multiple cellular functions, the cytoplasmic dynein motor is subject to complex regulation involving allosteric mechanisms within the dynein complex, as well as numerous extramolecular interactions controlling subcellular targeting and motor activity. Recent work has distinguished high- and low-load regulatory modes for cytoplasmic dynein, which, combined with a diversity of targeting mechanisms, accounts for a very broad range of functions.	[Vallee, Richard B.; McKenney, Richard J.; Ori-McKenney, Kassandra M.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA	Columbia University	Vallee, RB (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, 600 16th St,Mission Bay Campus, San Francisco, CA 94158 USA.	rv2025@columbia.edu			 [GM47434];  [HD40182]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047434, R01GM047434] Funding Source: NIH RePORTER	; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank P. Hook for contributions to the figures and S. Weil for helpful comments on the manuscript. Support granted by GM47434 and HD40182 to R.B.V.	Akhmanova A, 2010, CURR OPIN CELL BIOL, V22, P479, DOI 10.1016/j.ceb.2010.04.008; Bader JR, 2011, J BIOL CHEM, V286, P20769, DOI 10.1074/jbc.M111.226605; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Blangy A, 1997, J BIOL CHEM, V272, P19418, DOI 10.1074/jbc.272.31.19418; Bolhy S, 2011, J CELL BIOL, V192, P855, DOI 10.1083/jcb.201007118; Bremner KH, 2009, CELL HOST MICROBE, V6, P523, DOI 10.1016/j.chom.2009.11.006; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; Chen JL, 2005, J CELL BIOL, V169, P383, DOI 10.1083/jcb.200501157; Chen XJ, 2007, J NEUROSCI, V27, P14515, DOI 10.1523/JNEUROSCI.4338-07.2007; Cho C, 2008, J BIOL CHEM, V283, P25839, DOI 10.1074/jbc.M802951200; Culver-Hanlon TL, 2006, NAT CELL BIOL, V8, P264, DOI 10.1038/ncb1370; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; DeWitt MA, 2012, SCIENCE, V335, P221, DOI 10.1126/science.1215804; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Fridolfsson HN, 2010, J CELL BIOL, V191, P115, DOI 10.1083/jcb.201004118; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; GIBBONS IR, 1987, J BIOL CHEM, V262, P2780; Griffis ER, 2007, J CELL BIOL, V177, P1005, DOI 10.1083/jcb.200702062; Gross SP, 2002, J CELL BIOL, V156, P715, DOI 10.1083/jcb.200109047; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Haghnia M, 2007, MOL BIOL CELL, V18, P2081, DOI 10.1091/mbc.E06-08-0695; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; Hebbar S, 2008, J CELL BIOL, V182, P1063, DOI 10.1083/jcb.200803071; Holleran EA, 2001, J BIOL CHEM, V276, P36598, DOI 10.1074/jbc.M104838200; Holleran EA, 1996, J CELL BIOL, V135, P1815, DOI 10.1083/jcb.135.6.1815; HOLZBAUR ELF, 1991, NATURE, V351, P579, DOI 10.1038/351579a0; Hook P, 2005, J BIOL CHEM, V280, P33045, DOI 10.1074/jbc.M504693200; Hook P, 2009, BIOCHEMISTRY-US, V48, P2710, DOI 10.1021/bi900223x; Imai H, 2006, J MOL BIOL, V359, P833, DOI 10.1016/j.jmb.2006.03.071; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; Kim H, 2007, J CELL BIOL, V176, P641, DOI 10.1083/jcb.200608128; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; King SJ, 2002, PROTEIN SCI, V11, P1239, DOI 10.1110/ps.2520102; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Kon T, 2011, NAT STRUCT MOL BIOL, V18, P638, DOI 10.1038/nsmb.2074; Kon T, 2009, NAT STRUCT MOL BIOL, V16, P325, DOI 10.1038/nsmb.1555; Lam C, 2010, J CELL SCI, V123, P202, DOI 10.1242/jcs.059337; Liang Y, 2004, J CELL BIOL, V164, P557, DOI 10.1083/jcb.200308058; Liang Y, 2007, MOL BIOL CELL, V18, P2656, DOI 10.1091/mbc.E06-04-0345; Ligon LA, 2003, MOL BIOL CELL, V14, P1405, DOI 10.1091/mbc.E02-03-0155; Mao YH, 2010, CELL CYCLE, V9, P715, DOI 10.4161/cc.9.4.10763; Markus SM, 2011, DEV CELL, V20, P639, DOI 10.1016/j.devcel.2011.04.011; Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891; McKenney RJ, 2011, J BIOL CHEM, V286, P39615, DOI 10.1074/jbc.M111.289017; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Mesngon MT, 2006, J NEUROSCI, V26, P2132, DOI 10.1523/JNEUROSCI.5095-05.2006; Moore JK, 2009, P NATL ACAD SCI USA, V106, P5147, DOI 10.1073/pnas.0810828106; Mori D, 2009, NAT CELL BIOL, V11, P1057, DOI 10.1038/ncb1919; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Numata N, 2011, FEBS LETT, V585, P1185, DOI 10.1016/j.febslet.2011.03.036; Ori-McKenney KM, 2010, NAT CELL BIOL, V12, P1228, DOI 10.1038/ncb2127; Pandey JP, 2011, J NEUROSCI, V31, P17207, DOI 10.1523/JNEUROSCI.4108-11.2011; PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Qiu WH, 2012, NAT STRUCT MOL BIOL, V19, P193, DOI 10.1038/nsmb.2205; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Reck-Peterson SL, 2004, P NATL ACAD SCI USA, V101, P1491, DOI 10.1073/pnas.2637011100; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; Roghi C, 1999, J CELL SCI, V112, P4673; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; SCHAFER DA, 1994, J CELL BIOL, V126, P403, DOI 10.1083/jcb.126.2.403; Schlager MA, 2010, EMBO J, V29, P1637, DOI 10.1038/emboj.2010.51; Shen YD, 2008, DEV CELL, V14, P342, DOI 10.1016/j.devcel.2008.01.001; Short B, 2002, CURR BIOL, V12, P1792, DOI 10.1016/S0960-9822(02)01221-6; Soppina V, 2009, P NATL ACAD SCI USA, V106, P19381, DOI 10.1073/pnas.0906524106; Splinter D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000350; Stehman SA, 2007, J CELL BIOL, V178, P583, DOI 10.1083/jcb.200610112; Sun Y, 2007, MOL BIOL CELL, V18, P4129, DOI 10.1091/mbc.E07-01-0080; Tai CY, 2002, J CELL BIOL, V156, P959, DOI 10.1083/jcb.200109046; Tan SC, 2011, MOL BIOL CELL, V22, P467, DOI 10.1091/mbc.E10-02-0129; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai JW, 2010, NAT NEUROSCI, V13, P1463, DOI 10.1038/nn.2665; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Tynan SH, 2000, J BIOL CHEM, V275, P32763, DOI 10.1074/jbc.M001536200; Vallee RB, 2009, TRENDS CELL BIOL, V19, P347, DOI 10.1016/j.tcb.2009.03.009; Varma D, 2006, J CELL BIOL, V172, P655, DOI 10.1083/jcb.200510120; Vaughan KT, 1999, J CELL SCI, V112, P1437; Vaughan PS, 2002, J CELL BIOL, V158, P305, DOI 10.1083/jcb.200201029; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Wang SS, 2011, J BIOL CHEM, V286, P587, DOI 10.1074/jbc.M110.181578; Whyte J, 2008, J CELL BIOL, V183, P819, DOI 10.1083/jcb.200804114; Yamada M, 2008, EMBO J, V27, P2471, DOI 10.1038/emboj.2008.182; Yi JY, 2011, J CELL BIOL, V195, P193, DOI 10.1083/jcb.201104076; Zhang J, 2011, J CELL BIOL, V193, P1245, DOI 10.1083/jcb.201011022; Zhang QG, 2009, TRAFFIC, V10, P1337, DOI 10.1111/j.1600-0854.2009.00945.x; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018; Zuccolo M, 2007, EMBO J, V26, P1853, DOI 10.1038/sj.emboj.7601642; Zylkiewicz E, 2011, J CELL BIOL, V192, P433, DOI 10.1083/jcb.201011142	104	130	132	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2012	14	3					224	230		10.1038/ncb2420	http://dx.doi.org/10.1038/ncb2420			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	900ZE	22373868				2022-12-25	WOS:000300930400002
J	White, YAR; Woods, DC; Takai, Y; Ishihara, O; Seki, H; Tilly, JL				White, Yvonne A. R.; Woods, Dori C.; Takai, Yasushi; Ishihara, Osamu; Seki, Hiroyuki; Tilly, Jonathan L.			Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women	NATURE MEDICINE			English	Article							EMBRYONIC STEM-CELLS; ADULT MAMMALIAN OVARIES; FEMALE INFERTILITY; GENE-EXPRESSION; BONE-MARROW; TRANSPLANTATION; MOUSE; MICE; OOGENESIS; PROTEIN	Germline stem cells that produce oocytes in vitro and fertilization-competent eggs in vivo have been identified in and isolated from adult mouse ovaries. Here we describe and validate a fluorescence-activated cell sorting-based protocol that can be used with adult mouse ovaries and human ovarian cortical tissue to purify rare mitotically active cells that have a gene expression profile that is consistent with primitive germ cells. Once established in vitro, these cells can be expanded for months and can spontaneously generate 35- to 50-mu m oocytes, as determined by morphology, gene expression and haploid (1n) status. Injection of the human germline cells, engineered to stably express GFP, into human ovarian cortical biopsies leads to formation of follicles containing GFP-positive oocytes 1-2 weeks after xenotransplantation into immunodeficient female mice. Thus, ovaries of reproductive-age women, similar to adult mice, possess rare mitotically active germ cells that can be propagated in vitro as well as generate oocytes in vitro and in vivo.	[White, Yvonne A. R.; Woods, Dori C.; Tilly, Jonathan L.] Massachusetts Gen Hosp, Vincent Ctr Reprod Biol, Vincent Dept Obstet & Gynecol, Boston, MA 02114 USA; [White, Yvonne A. R.; Woods, Dori C.; Tilly, Jonathan L.] Harvard Univ, Sch Med, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; [Takai, Yasushi; Ishihara, Osamu; Seki, Hiroyuki] Saitama Med Univ, Saitama Med Ctr, Dept Obstet & Gynecol, Saitama, Japan	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Saitama Medical University	Tilly, JL (corresponding author), Massachusetts Gen Hosp, Vincent Ctr Reprod Biol, Vincent Dept Obstet & Gynecol, Boston, MA 02114 USA.	jtilly@partners.org			US National Institute on Aging [NIH R37-AG012279]; Henry and Vivian Rosenberg Philanthropic Fund; Sea Breeze Foundation; Vincent Memorial Hospital; NIH [F32-AG034809]; Grants-in-Aid for Scientific Research [22591833] Funding Source: KAKEN; NATIONAL INSTITUTE ON AGING [F32AG034809, R37AG012279] Funding Source: NIH RePORTER	US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Henry and Vivian Rosenberg Philanthropic Fund; Sea Breeze Foundation; Vincent Memorial Hospital; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank L. Prickett-Rice and K. Folz-Donahue of the Harvard Stem Cell Institute Flow Cytometry Core Facility and J. Groeneweg for expert technical assistance. We also thank J. R. Mann and K. J. MacLaughlin for the provision of TgOG2 transgenic mice. This work was supported by a Method to Extend Research in Time (MERIT) Award from the US National Institute on Aging (NIH R37-AG012279), the Henry and Vivian Rosenberg Philanthropic Fund, the Sea Breeze Foundation and Vincent Memorial Hospital Research Funds. This work was conducted while D. C. W. was supported in part by a Ruth L. Kirschstein National Research Service Award (NIH F32-AG034809).	Abban G, 2009, HUM REPROD, V24, P2974, DOI 10.1093/humrep/dep281; Brinster CJ, 2003, BIOL REPROD, V69, P412, DOI 10.1095/biolreprod.103.016519; Brinster RL, 2007, SCIENCE, V316, P404, DOI 10.1126/science.1137741; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Dolci S, 2002, J CELL SCI, V115, P1643; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1035, DOI 10.1210/me.13.6.1035; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; Gong SP, 2010, FERTIL STERIL, V93, P2594, DOI 10.1016/j.fertnstert.2009.12.053; Gu W, 1998, BIOL REPROD, V59, P1266, DOI 10.1095/biolreprod59.5.1266; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031; Kagawa N, 2009, REPROD BIOMED ONLINE, V18, P568, DOI 10.1016/S1472-6483(10)60136-8; Kagawa W, 2010, FEBS J, V277, P590, DOI 10.1111/j.1742-4658.2009.07503.x; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Ko K, 2006, SEMIN REPROD MED, V24, P322, DOI 10.1055/s-2006-952157; Lee HJ, 2007, J CLIN ONCOL, V25, P3198, DOI 10.1200/JCO.2006.10.3028; Massasa E, 2010, AGING-US, V2, P1; Matikainen T, 2001, NAT GENET, V28, P355, DOI 10.1038/ng575; Nicholas CR, 2009, HUM MOL GENET, V18, P4376, DOI 10.1093/hmg/ddp393; Nicholas CR, 2009, ENDOCR REV, V30, P264, DOI 10.1210/er.2008-0034; Niikura Y, 2010, AGING-US, V2, P999, DOI 10.18632/aging.100255; Niikura Y, 2009, AGING-US, V1, P971, DOI 10.18632/aging.100105; Noce T, 2001, CELL STRUCT FUNCT, V26, P131, DOI 10.1247/csf.26.131; Normile D, 2009, SCIENCE, V324, P320, DOI 10.1126/science.324.5925.320; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Oktay K, 2000, NEW ENGL J MED, V342, P1919, DOI 10.1056/NEJM200006223422516; Pacchiarotti J, 2010, DIFFERENTIATION, V79, P159, DOI 10.1016/j.diff.2010.01.001; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Pangas SA, 2006, P NATL ACAD SCI USA, V103, P8090, DOI 10.1073/pnas.0601083103; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Selesniemi K, 2011, P NATL ACAD SCI USA, V108, P12319, DOI 10.1073/pnas.1018793108; Sonmezer M, 2010, BEST PRACT RES CL OB, V24, P113, DOI 10.1016/j.bpobgyn.2009.09.002; Suzumori N, 2002, MECH DEVELOP, V111, P137, DOI 10.1016/S0925-4773(01)00620-7; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Tilly JL, 2009, MOL HUM REPROD, V15, P393, DOI 10.1093/molehr/gap036; Tilly JL, 2009, BIOL REPROD, V80, P2, DOI 10.1095/biolreprod.108.069088; Wang N, 2010, CELL CYCLE, V9, P339, DOI 10.4161/cc.9.2.10447; Weissman A, 1999, BIOL REPROD, V60, P1462, DOI 10.1095/biolreprod60.6.1462; West FD, 2011, STEM CELLS DEV, V20, P1079, DOI 10.1089/scd.2010.0255; Yang JX, 2005, P NATL ACAD SCI USA, V102, P5755, DOI 10.1073/pnas.0408718102; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; Zheng P, 2007, SEMIN REPROD MED, V25, P243, DOI 10.1055/s-2007-980218; Zou K, 2011, STEM CELLS DEV, V20, P2197, DOI 10.1089/scd.2011.0091; Zou K, 2009, NAT CELL BIOL, V11, P631, DOI 10.1038/ncb1869; ZUCKERMAN S, 1951, RECENT PROG HORM RES, V6, P63	50	462	492	3	132	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2012	18	3					413	U176		10.1038/nm.2669	http://dx.doi.org/10.1038/nm.2669			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22366948	Green Accepted			2022-12-25	WOS:000301264800043
J	Zhang, W; Trachootham, D; Liu, JY; Chen, G; Pelicano, H; Garcia-Prieto, C; Lu, WQ; Burger, JA; Croce, CM; Plunkett, W; Keating, MJ; Huang, P				Zhang, Wan; Trachootham, Dunyaporn; Liu, Jinyun; Chen, Gang; Pelicano, Helene; Garcia-Prieto, Celia; Lu, Weiqin; Burger, Jan A.; Croce, Carlo M.; Plunkett, William; Keating, Michael J.; Huang, Peng			Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia	NATURE CELL BIOLOGY			English	Article							GLUTAMATE TRANSPORTER SLC7A11; REGULATES BCL-2 EXPRESSION; B-CLL CELLS; GLUTATHIONE DEPLETION; MEDIATED MECHANISM; IN-VITRO; INDUCED APOPTOSIS; DRUG-RESISTANCE; FLUDARABINE; INHIBITION	Tissue stromal cells interact with leukaemia cells and profoundly affect their viability and drug sensitivity. Here we show a biochemical mechanism by which bone marrow stromal cells modulate the redox status of chronic lymphocytic leukaemia (CLL) cells and promote cellular survival and drug resistance. Primary CLL cells from patients exhibit a limited ability to transport cystine for glutathione (GSH) synthesis owing to a low expression level of Xc-transporter. In contrast, bone marrow stromal cells effectively import cystine and convert it to cysteine, which is then released into the microenvironment for uptake by CLL cells to promote GSH synthesis. The elevated level of GSH enhances leukaemia cell survival and protects them from drug-induced cytotoxicity. Furthermore, disabling this protective mechanism significantly sensitizes CLL cells to drug treatment in the stromal environment. This stromal leukaemia interaction is critical for CLL cell survival and represents a key biochemical pathway for effectively targeting leukaemia cells to overcome drug resistance in vivo.	[Zhang, Wan; Trachootham, Dunyaporn; Liu, Jinyun; Chen, Gang; Pelicano, Helene; Garcia-Prieto, Celia; Lu, Weiqin; Huang, Peng] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; [Zhang, Wan] Nanchang Univ, Affiliated Hosp 1, Nanchang 330006, Jiangxi, Peoples R China; [Trachootham, Dunyaporn] Thammasat Univ, Fac Dent, Pathum Thani 12121, Thailand; [Liu, Jinyun; Huang, Peng] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77030 USA; [Burger, Jan A.; Keating, Michael J.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Croce, Carlo M.] Ohio State Univ, Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Plunkett, William] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Nanchang University; Thammasat University; University of Texas System; UTMD Anderson Cancer Center; University System of Ohio; Ohio State University; University of Texas System; UTMD Anderson Cancer Center	Huang, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	phuang@mdanderson.org	Trachootham, Dunyaporn/ABE-8168-2020; Young, Richard A/F-6495-2012; Trachootham, Dunyaporn/GLR-2103-2022	Young, Richard A/0000-0001-8855-8647; Trachootham, Dunyaporn/0000-0002-6739-6295; Liu, Jinyun/0000-0002-4763-2684	National Institutes of Health [CA085563, CA100428]; CPRIT [PR110322]; CLL Global Research Foundation; NATIONAL CANCER INSTITUTE [R01CA085563, P01CA081534, R01CA100428, R01CA151319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; CLL Global Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank D. H. Hawke for expert assistance in LC-MS/MS analysis of cystine and cysteine, and B. A. Hayes, A. G. Melendez, M. A. Ogasawara, L. Feng and H. Zhang for technical assistance and helpful discussions. This work was supported in part by grants CA085563 and CA100428 from the National Institutes of Health, grant PR110322 from CPRIT and a grant for the CLL Global Research Foundation.	BANNAI S, 1984, BIOCHIM BIOPHYS ACTA, V779, P289, DOI 10.1016/0304-4157(84)90014-5; Bichi R, 2002, P NATL ACAD SCI USA, V99, P6955, DOI 10.1073/pnas.102181599; Burger JA, 2000, BLOOD, V96, P2655; BUSCHLE M, 1993, J EXP MED, V177, P213, DOI 10.1084/jem.177.1.213; Caligaris-Cappio F, 2000, Rev Clin Exp Hematol, V4, P5, DOI 10.1046/j.1468-0734.2000.00001.x; Campas C, 2003, LEUKEMIA, V17, P746, DOI 10.1038/sj.leu.2402860; Carew JS, 2003, LEUKEMIA, V17, P1437, DOI 10.1038/sj.leu.2403043; CHAWLA RK, 1984, GASTROENTEROLOGY, V87, P770; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; COLLINS RJ, 1989, BRIT J HAEMATOL, V71, P343; DANCESCU M, 1992, J EXP MED, V176, P1319, DOI 10.1084/jem.176.5.1319; Dang L, 2010, NATURE, V465, P966, DOI 10.1038/nature09132; DANHAUSER L, 1986, CANCER CHEMOTH PHARM, V18, P145; Endo T, 2007, BLOOD, V109, P703, DOI 10.1182/blood-2006-06-027755; Franco R, 2007, J BIOL CHEM, V282, P30452, DOI 10.1074/jbc.M703091200; Franco R, 2008, J BIOL CHEM, V283, P36071, DOI 10.1074/jbc.M807061200; Gout PW, 2001, LEUKEMIA, V15, P1633, DOI 10.1038/sj.leu.2402238; Graham MA, 2000, CLIN CANCER RES, V6, P1205; Grdisa M, 2003, LEUKEMIA RES, V27, P951, DOI 10.1016/S0145-2126(03)00028-6; Haslinger C, 2004, J CLIN ONCOL, V22, P3937, DOI 10.1200/JCO.2004.12.133; Hegde GV, 2008, MOL CANCER RES, V6, P1928, DOI 10.1158/1541-7786.MCR-08-0142; Hileman EO, 2004, CANCER CHEMOTH PHARM, V53, P209, DOI 10.1007/s00280-003-0726-5; Huang P, 2000, LEUKEMIA, V14, P1405, DOI 10.1038/sj.leu.2401845; Huang Y, 2005, CANCER RES, V65, P7446, DOI 10.1158/0008-5472.CAN-04-4267; Hyde R, 2003, BIOCHEM J, V373, P1, DOI 10.1042/BJ20030405; IGLEHART JD, 1977, J BIOL CHEM, V252, P7184; JEWELL AP, 1994, BRIT J HAEMATOL, V88, P268, DOI 10.1111/j.1365-2141.1994.tb05017.x; Jones DP, 2009, FREE RADICAL BIO MED, V47, P1329, DOI 10.1016/j.freeradbiomed.2009.08.021; Kawano Y, 2003, BLOOD, V101, P532, DOI 10.1182/blood-2002-04-1268; KEATING MJ, 2003, ASH ED BOOK, P153; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Konig A, 1997, LEUKEMIA, V11, P258, DOI 10.1038/sj.leu.2400556; Kurtova AV, 2009, BLOOD, V114, P4441, DOI 10.1182/blood-2009-07-233718; Lagneaux L, 1998, BLOOD, V91, P2387, DOI 10.1182/blood.V91.7.2387.2387_2387_2396; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Liu RQ, 2007, MOL PHARMACOL, V72, P1637, DOI 10.1124/mol.107.039644; Lo M, 2008, J CELL PHYSIOL, V215, P593, DOI 10.1002/jcp.21366; Lu SC, 2000, CURR TOP CELL REGUL, V36, P95; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Matsumoto S, 2005, BBA-GEN SUBJECTS, V1725, P57, DOI 10.1016/j.bbagen.2005.05.027; Moufarij MA, 2006, BLOOD, V108, P4187, DOI 10.1182/blood-2006-05-023259; Okuno S, 2003, BRIT J CANCER, V88, P951, DOI 10.1038/sj.bjc.6600786; Oltra AM, 2001, FREE RADICAL BIO MED, V30, P1286, DOI 10.1016/S0891-5849(01)00521-4; Pedersen IM, 2004, LEUKEMIA LYMPHOMA, V45, P2365, DOI 10.1080/10428190412331272703; Pelicano H, 2003, J BIOL CHEM, V278, P37832, DOI 10.1074/jbc.M301546200; Pepper C, 2001, BRIT J HAEMATOL, V114, P70, DOI 10.1046/j.1365-2141.2001.02895.x; Rai KR, 2003, NEW ENGL J MED, V348, P1797, DOI 10.1056/NEJMe030032; Reed JC, 1998, SEMIN ONCOL, V25, P11; ROECKLEIN BA, 1995, BLOOD, V85, P997, DOI 10.1182/blood.V85.4.997.bloodjournal854997; Sato H, 2005, J BIOL CHEM, V280, P37423, DOI 10.1074/jbc.M506439200; SILBER R, 1992, BLOOD, V80, P2038; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Tam CS, 2007, BEST PRACT RES CL HA, V20, P479, DOI 10.1016/j.beha.2007.02.004; TEW KD, 1994, CANCER RES, V54, P4313; Trachootham D, 2008, BLOOD, V112, P1912, DOI 10.1182/blood-2008-04-149815; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Turgut B, 2007, LEUKEMIA LYMPHOMA, V48, P311, DOI 10.1080/10428190601059829; UREN JR, 1979, CANCER TREAT REP, V63, P1073; WOODLOCK TJ, 1990, J CELL PHYSIOL, V145, P217, DOI 10.1002/jcp.1041450205; Zenz T, 2009, BLOOD, V114, P2589, DOI 10.1182/blood-2009-05-224071; Zhou Y, 2003, BLOOD, V101, P4098, DOI 10.1182/blood-2002-08-2512; Zwiebel JA, 1998, SEMIN ONCOL, V25, P42	62	236	245	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2012	14	3					276	+		10.1038/ncb2432	http://dx.doi.org/10.1038/ncb2432			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	900ZE	22344033	Green Accepted			2022-12-25	WOS:000300930400010
J	Chen, F; Liu, ZG; Wu, WH; Rozo, C; Bowdridge, S; Millman, A; Van Rooijen, N; Urban, JF; Wynn, TA; Gause, WC				Chen, Fei; Liu, Zhugong; Wu, Wenhui; Rozo, Cristina; Bowdridge, Scott; Millman, Ariel; Van Rooijen, Nico; Urban, Joseph F., Jr.; Wynn, Thomas A.; Gause, William C.			An essential role for T(H)2-type responses in limiting acute tissue damage during experimental helminth infection	NATURE MEDICINE			English	Article							ALTERNATIVELY ACTIVATED MACROPHAGES; INDUCED LUNG INJURY; T-CELLS; INFLAMMATORY CELLS; IMMUNE-RESPONSES; GENE-EXPRESSION; TYPE-2 IMMUNITY; WOUND REPAIR; IN-VIVO; IL-4	Helminths induce potent T helper 2 (T(H)2)-type immune responses that can mediate worm expulsion, but the role of this response in controlling the acute tissue damage caused by migrating multicellular parasites through vital tissues remains uncertain. We used a helminth infection model in which parasitic nematode larvae migrate transiently through the lung, resulting in hemorrhage and inflammation. We found that IL-17 initially contributed to inflammation and lung damage, whereas subsequent IL-4 receptor (IL-4R) signaling reduced elevations in IL-17 mRNA levels, enhanced the expression of insulin-like growth factor 1 (IGF-1) and IL-10 and stimulated the development of M2 macrophages, all of which contributed to the rapid resolution of tissue damage. These studies indicate an essential role for T(H)2-type immune responses in mediating acute wound healing during helminth infection.	[Chen, Fei; Liu, Zhugong; Wu, Wenhui; Rozo, Cristina; Bowdridge, Scott; Millman, Ariel; Gause, William C.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA; [Chen, Fei; Liu, Zhugong; Wu, Wenhui; Rozo, Cristina; Bowdridge, Scott; Millman, Ariel; Gause, William C.] Univ Med & Dent New Jersey, New Jersey Med Sch, Ctr Immun & Inflammat, Newark, NJ 07103 USA; [Van Rooijen, Nico] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol, Amsterdam, Netherlands; [Urban, Joseph F., Jr.] ARS, USDA, Beltsville Human Nutr Res Ctr, Diet Genom & Immunol Lab, Beltsville, MD USA; [Wynn, Thomas A.] NIAID, Parasit Dis Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Vrije Universiteit Amsterdam; United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Gause, WC (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA.	gausewc@umdnj.edu	Wynn, Thomas A/C-2797-2011; Wynn, Thomas A/AAO-3523-2021; Van Rooijen, Nico/Z-1578-2019	Wynn, Thomas A/0000-0002-7244-8731; Urban, Joseph/0000-0002-1590-8869	US National Institutes of Health [AI031678]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066188, ZIAAI000829, R01AI031678] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US National Institutes of Health grants AI031678.	Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Apewokin S, 2010, CYTOPATHOLOGY, V21, P345, DOI 10.1111/j.1365-2303.2010.00765.x; Asti C, 2000, PULM PHARMACOL THER, V13, P61, DOI 10.1006/pupt.2000.0231; Balic A, 2006, INT IMMUNOL, V18, P1421, DOI 10.1093/intimm/dxl075; Bliss SK, 2003, J IMMUNOL, V171, P3142, DOI 10.4049/jimmunol.171.6.3142; Brunet LR, 1997, J IMMUNOL, V159, P777; Brunet LR, 1998, PARASITOL TODAY, V14, P422, DOI 10.1016/S0169-4758(98)01317-9; Cailhier JF, 2005, J IMMUNOL, V174, P2336, DOI 10.4049/jimmunol.174.4.2336; Cooper AM, 2009, EUR J IMMUNOL, V39, P649, DOI 10.1002/eji.200839090; Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406; Edgerton C, 2009, CLIN IMMUNOL, V130, P313, DOI 10.1016/j.clim.2008.09.019; Enobe CS, 2006, PARASITE IMMUNOL, V28, P453, DOI 10.1111/j.1365-3024.2006.00892.x; Finkelman FD, 2010, J IMMUNOL, V184, P1663, DOI 10.4049/jimmunol.0902185; Gause WC, 2003, TRENDS IMMUNOL, V24, P269, DOI 10.1016/S1471-4906(03)00101-7; GILLERY P, 1992, J CELL PHYSIOL, V152, P389, DOI 10.1002/jcp.1041520221; Girod N, 2003, INT J PARASITOL, V33, P71, DOI 10.1016/S0020-7519(02)00248-5; Herbert DR, 2010, J IMMUNOL, V184, P6438, DOI 10.4049/jimmunol.0902009; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; HERBERT DR, 2009, J EXP MED, V206, P2947, DOI DOI 10.1084/jem.20091268; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; Kolosionek E, 2010, EXPERT REV ANTI-INFE, V8, P1467, DOI [10.1586/eri.10.124, 10.1586/ERI.10.124]; Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002; Krzyzaniak M, 2011, SHOCK, V36, P24, DOI 10.1097/SHK.0b013e318212276b; Laan M, 1999, J IMMUNOL, V162, P2347; Lee JJ, 2005, CLIN EXP ALLERGY, V35, P986, DOI 10.1111/j.1365-2222.2005.02302.x; Li B, 2011, J CELL PHYSIOL, V226, P2398, DOI 10.1002/jcp.22577; Liu Q, 2010, J IMMUNOL, V184, P5213, DOI 10.4049/jimmunol.0902879; Loke P, 2007, J IMMUNOL, V179, P3926, DOI 10.4049/jimmunol.179.6.3926; Marsland BJ, 2008, EUR J IMMUNOL, V38, P479, DOI 10.1002/eji.200737827; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; McNeil KS, 2002, PARASITE IMMUNOL, V24, P15, DOI 10.1046/j.0141-9838.2001.00428.x; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nembrini C, 2009, J ALLERGY CLIN IMMUN, V123, P986, DOI 10.1016/j.jaci.2009.03.033; Patel N, 2009, INT J PARASITOL, V39, P13, DOI 10.1016/j.ijpara.2008.08.003; Peranteau WH, 2008, J INVEST DERMATOL, V128, P1852, DOI 10.1038/sj.jid.5701232; Pesce JT, 2008, J IMMUNOL, V180, P464, DOI 10.4049/jimmunol.180.1.464; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Reece JJ, 2006, INFECT IMMUN, V74, P4970, DOI 10.1128/IAI.00687-06; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; ROM WN, 1988, J CLIN INVEST, V82, P1685, DOI 10.1172/JCI113781; Sakamoto T, 2005, PATHOL INT, V55, P497, DOI 10.1111/j.1440-1827.2005.01859.x; Sandler NG, 2003, J IMMUNOL, V171, P3655, DOI 10.4049/jimmunol.171.7.3655; Seno H, 2009, P NATL ACAD SCI USA, V106, P256, DOI 10.1073/pnas.0803343106; Shirey KA, 2010, MUCOSAL IMMUNOL, V3, P291, DOI 10.1038/mi.2010.6; SIMPSON DM, 1972, J CLIN INVEST, V51, P2009, DOI 10.1172/JCI107007; Steinman L, 2008, J EXP MED, V205, P1517, DOI 10.1084/jem.20072066; Toulon A, 2009, J EXP MED, V206, P743, DOI 10.1084/jem.20081787; Varin A, 2010, BLOOD, V115, P353, DOI 10.1182/blood-2009-08-236711; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Wynes MW, 2004, J LEUKOCYTE BIOL, V76, P1019, DOI 10.1189/jlb.0504288; Zhao AP, 2003, J IMMUNOL, V171, P948, DOI 10.4049/jimmunol.171.2.948	56	313	318	1	40	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					260	266		10.1038/nm.2628	http://dx.doi.org/10.1038/nm.2628			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22245779	Green Accepted			2022-12-25	WOS:000300140300040
J	Lee, JE; Silhavy, JL; Zaki, MS; Schroth, J; Bielas, SL; Marsh, SE; Olvera, J; Brancati, F; Iannicelli, M; Ikegami, K; Schlossman, AM; Merriman, B; Attie-Bitach, T; Logan, CV; Glass, IA; Cluckey, A; Louie, CM; Lee, JH; Raynes, HR; Rapin, I; Castroviejo, IP; Setou, M; Barbot, C; Boltshauser, E; Nelson, SF; Hildebrandt, F; Johnson, CA; Doherty, DA; Valente, EM; Gleeson, JG				Lee, Ji Eun; Silhavy, Jennifer L.; Zaki, Maha S.; Schroth, Jana; Bielas, Stephanie L.; Marsh, Sarah E.; Olvera, Jesus; Brancati, Francesco; Iannicelli, Miriam; Ikegami, Koji; Schlossman, Andrew M.; Merriman, Barry; Attie-Bitach, Tania; Logan, Clare V.; Glass, Ian A.; Cluckey, Andrew; Louie, Carrie M.; Lee, Jeong Ho; Raynes, Hilary R.; Rapin, Isabelle; Castroviejo, Ignacio P.; Setou, Mitsutoshi; Barbot, Clara; Boltshauser, Eugen; Nelson, Stanley F.; Hildebrandt, Friedhelm; Johnson, Colin A.; Doherty, Daniel A.; Valente, Enza Maria; Gleeson, Joseph G.			CEP41 is mutated in Joubert syndrome and is required for tubulin glutamylation at the cilium	NATURE GENETICS			English	Article							LEFT-RIGHT ASYMMETRY; PLANAR CELL POLARITY; POSTTRANSLATIONAL MODIFICATIONS; CILIARY MOTILITY; PROTEIN; POLYGLUTAMYLATION; ZEBRAFISH; CILIOGENESIS; POLYGLYCYLATION; CILIOPATHIES	Tubulin glutamylation is a post-translational modification that occurs predominantly in the ciliary axoneme and has been suggested to be important for ciliary function(1,2). However, its relationship to disorders of the primary cilium, termed ciliopathies, has not been explored. Here we mapped a new locus for Joubert syndrome (IBTS)(3), which we have designated as JBTS15, and identified causative mutations in CEP41, which encodes a 41-kDa centrosomal protein(4). We show that CEP41 is localized to the basal body and primary cilia, and regulates ciliary entry of TTLL6, an evolutionarily conserved polyglutamylase enzyme(5). Depletion of CEP41 causes ciliopathy-related phenotypes in zebrafish and mice and results in glutamylation defects in the ciliary axoneme. Our data identify CEP41 mutations as a cause of JBTS and implicate tubulin post-translational modification in the pathogenesis of human ciliary dysfunction.	[Lee, Ji Eun; Silhavy, Jennifer L.; Schroth, Jana; Bielas, Stephanie L.; Marsh, Sarah E.; Olvera, Jesus; Schlossman, Andrew M.; Louie, Carrie M.; Lee, Jeong Ho; Gleeson, Joseph G.] Univ Calif San Diego, Dept Neurosci, Howard Hughes Med Inst, San Diego, CA 92103 USA; [Lee, Ji Eun; Silhavy, Jennifer L.; Schroth, Jana; Bielas, Stephanie L.; Marsh, Sarah E.; Olvera, Jesus; Schlossman, Andrew M.; Louie, Carrie M.; Lee, Jeong Ho; Gleeson, Joseph G.] Univ Calif San Diego, Dept Pediat, Inst Genom Med, Neurogenet Lab, San Diego, CA 92103 USA; [Zaki, Maha S.] Natl Res Ctr, Human Genet & Genome Res Div, Dept Clin Genet, Dokki, Egypt; [Brancati, Francesco; Iannicelli, Miriam; Valente, Enza Maria] Casa Sollievo Sofferenza CSS Hosp, CSS Mendel Lab, San Giovanni Rotondo, Italy; [Brancati, Francesco] Tor Vergata Univ, Dept Biopathol & Diagnost Imaging, Med Genet Unit, Rome, Italy; [Ikegami, Koji; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Hamamatsu, Shizuoka 4313192, Japan; [Merriman, Barry; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet Pathol & Lab Med, Los Angeles, CA 90095 USA; [Attie-Bitach, Tania] Univ Paris 05, Hop Necker Enfants Malad, Dept Genet, INSERM,U781, Paris, France; [Logan, Clare V.; Johnson, Colin A.] St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds LS9 7TF, W Yorkshire, England; [Glass, Ian A.; Doherty, Daniel A.] Univ Washington, Dept Pediat, Div Dev Med, Seattle Childrens Hosp, Seattle, WA 98195 USA; [Glass, Ian A.; Doherty, Daniel A.] Univ Washington, Div Med Genet, Seattle Childrens Hosp, Seattle, WA 98195 USA; [Cluckey, Andrew; Hildebrandt, Friedhelm] Univ Michigan, Howard Hughes Med Inst, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Raynes, Hilary R.; Rapin, Isabelle] Albert Einstein Coll Med, Saul R Korey Dept Neurol, New York, NY USA; [Raynes, Hilary R.; Rapin, Isabelle] Albert Einstein Coll Med, Dept Pediat, New York, NY USA; [Raynes, Hilary R.; Rapin, Isabelle] Albert Einstein Coll Med, Rose F Kennedy Intellectual & Dev Disabil Res Ctr, New York, NY USA; [Castroviejo, Ignacio P.] Univ Hosp La Paz, Pediat Neurol Serv, Madrid, Spain; [Barbot, Clara] Hosp Criancas Maria Pia, Serv Neuropediat, Oporto, Portugal; [Boltshauser, Eugen] Univ Childrens Hosp Zurich, Dept Pediat Neurol, Zurich, Switzerland; [Valente, Enza Maria] Univ Messina, Dept Med & Surg Pediat Sci, Messina, Italy	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); IRCCS Casa Sollievo Della Sofferenza; University of Rome Tor Vergata; Hamamatsu University School of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Saint James's University Hospital; University of Leeds; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Yeshiva University; Yeshiva University; Yeshiva University; Hospital Universitario La Paz; University Children's Hospital Zurich; University of Messina	Gleeson, JG (corresponding author), Univ Calif San Diego, Dept Neurosci, Howard Hughes Med Inst, San Diego, CA 92103 USA.	jogleeson@ucsd.edu	ATTIE-BITACH, Tania/K-1453-2017; Brancati, Francesco/AAC-3778-2022; Lee, Jeong Ho/G-7361-2012; Nelson, Stanley F/D-4771-2009; Zaki, Maha S/B-9361-2013; Barbot, Clara/K-6378-2013; Valente, Enza Maria/G-2942-2017	ATTIE-BITACH, Tania/0000-0002-1155-3626; Brancati, Francesco/0000-0003-3624-2354; Nelson, Stanley F/0000-0002-2082-3114; Barbot, Clara/0000-0002-5597-107X; Valente, Enza Maria/0000-0002-0600-6820; Marsh, Sarah/0000-0003-4194-043X; Johnson, Colin/0000-0002-2979-8234; Bielas, Stephanie/0000-0003-0567-5632; Logan, Clare/0000-0003-4323-1602; Zaki, Maha/0000-0001-7840-0002	Marshfield Clinic Research Foundation; US National Institutes of Health; National Heart, Lung, and Blood Institute; US National Institutes of Health [R01NS048453, R01NS052455, R01DK068306, R01NS064077]; American Heart Association [09POST2250641]; Italian Ministry of Health; Telethon Foundation Italy [GGP08145]; Pierfranco and Luisa Mariani Foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science (JSPS) [23117517, 23570209]; Newlife Charity; Medical Research Council [G0700073]; Sir Jules Thorn Charitable Trust [09/JTA]; I'Agence National pour la Recherche (ANR) [07-MRAR]; Simons Foundation Autism Research Initiative; Howard Hughes Medical Institute; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052455, R01NS064077, R01NS048453, P30NS047101] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23570209] Funding Source: KAKEN; MRC [G0700073] Funding Source: UKRI	Marshfield Clinic Research Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Italian Ministry of Health(Ministry of Health, Italy); Telethon Foundation Italy(Fondazione Telethon); Pierfranco and Luisa Mariani Foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Newlife Charity; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sir Jules Thorn Charitable Trust; I'Agence National pour la Recherche (ANR)(French National Research Agency (ANR)); Simons Foundation Autism Research Initiative; Howard Hughes Medical Institute(Howard Hughes Medical Institute); The Sir Jules Thorn Charitable Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the Marshfield Clinic Research Foundation, Center for Inherited Disease Research (supported by the US National Institutes of Health and National Heart, Lung, and Blood Institute) for genotyping support. We thank the International JSRD Study Group, E. Bertini and the French Society of Foetal Pathology for subject referrals,). Meerloo at the UCSD Microscopy Core (P30NS047101), T Meerloo, Y. Jones, M. Farquhar and the Department of Cellular and Molecular Medicine (CMM) Electron Microscopy Core Facility at UCSD, S. Wirth and B. Willis for mutant mouse generation, C. Janke (Institute Curie Research Center) for GT335 antibody, TTLLs plasmids and technical advice, I. Drummond and N. Pathak (Massachusetts General Hospital) for ttll6 MO, M. Gorovsky (University of Rochester) for polyE and polyG antibodies, A.T. Look (Dana-Farber Cancer Institute) for the pCS2+ plasmid, S. Audollent for technical help, and B. Sotak, N. Akizu, A. Crawford, V. Cantagrel and E.-J. Choi for stimulating scientific discussion and comments. This work was supported by the US National Institutes of Health (R01NS048453 and R01NS052455 to J.G.G.; R01DK068306 to F.H.; and R01NS064077 to DAD.), the American Heart Association (09POST2250641 to J.E.L.), the Italian Ministry of Health (Ricerca Finalizzata Malattie Rare and Ricerca Corrente 2011), the Telethon Foundation Italy (GGP08145) and the Pierfranco and Luisa Mariani Foundation (to E.M.V.), Research was also supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and the Japan Society for the Promotion of Science (JSPS), (23117517 and 23570209 to K.I.), the Newlife Charity, the Medical Research Council (G0700073), the Sir Jules Thorn Charitable Trust (09/JTA to CA.).), I'Agence National pour la Recherche (ANR) (07-MRAR.-Fetalciliopathies to T.A.-B.), Simons Foundation Autism Research Initiative (to J.G.G.) and the Howard Hughes Medical Institute (to EH. and J.G.G.).	Amack JD, 2004, CURR BIOL, V14, P685, DOI 10.1016/j.cub.2004.04.002; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Bulinski JC, 2009, DEV CELL, V16, P773, DOI 10.1016/j.devcel.2009.06.003; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Colantonio JR, 2009, NATURE, V457, P205, DOI 10.1038/nature07520; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Gaertig J, 2008, CURR TOP DEV BIOL, V85, P83, DOI 10.1016/S0070-2153(08)00804-1; Gorden NT, 2008, AM J HUM GENET, V83, P559, DOI 10.1016/j.ajhg.2008.10.002; Hildebrandt F, 2007, J AM SOC NEPHROL, V18, P1855, DOI 10.1681/ASN.2006121344; Hoover AN, 2008, DEVELOPMENT, V135, P4049, DOI 10.1242/dev.029835; Ikegami K, 2010, P NATL ACAD SCI USA, V107, P10490, DOI 10.1073/pnas.1002128107; Jurczyk A, 2004, J CELL BIOL, V166, P637, DOI 10.1083/jcb.200405023; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Kim SK, 2010, SCIENCE, V329, P1337, DOI 10.1126/science.1191184; Kubo T, 2010, CURR BIOL, V20, P441, DOI 10.1016/j.cub.2009.12.058; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; McGrath J, 2003, CURR OPIN GENET DEV, V13, P385, DOI 10.1016/S0959-437X(03)00091-1; Million K, 1999, J CELL SCI, V112, P4357; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Parisi MA, 2009, AM J MED GENET C, V151C, P326, DOI 10.1002/ajmg.c.30229; Pathak N, 2007, MOL BIOL CELL, V18, P4353, DOI 10.1091/mbc.E07-06-0537; Pathak N, 2011, J BIOL CHEM, V286, P11685, DOI 10.1074/jbc.M110.209817; Rogowski K, 2009, CELL, V137, P1076, DOI 10.1016/j.cell.2009.05.020; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Suryavanshi S, 2010, CURR BIOL, V20, P435, DOI 10.1016/j.cub.2009.12.062; Valente EM, 2008, EUR J MED GENET, V51, P1, DOI 10.1016/j.ejmg.2007.11.003; van Dijk J, 2007, MOL CELL, V26, P437, DOI 10.1016/j.molcel.2007.04.012; Vogel P, 2010, VET PATHOL, V47, P703, DOI 10.1177/0300985810363485; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116; Wloga D, 2010, EUKARYOT CELL, V9, P184, DOI 10.1128/EC.00176-09; Wloga D, 2009, DEV CELL, V16, P867, DOI 10.1016/j.devcel.2009.04.008; Yamada T, 2002, GENE, V288, P57, DOI 10.1016/S0378-1119(02)00428-6; Zhao CT, 2007, MECH DEVELOP, V124, P605, DOI 10.1016/j.mod.2007.04.004	37	119	129	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2012	44	2					193	199		10.1038/ng.1078	http://dx.doi.org/10.1038/ng.1078			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	22246503	Green Accepted			2022-12-25	WOS:000299664400019
J	Ntziachristos, P; Tsirigos, A; Van Vlierberghe, P; Nedjic, J; Trimarchi, T; Flaherty, MS; Ferres-Marco, D; da Ros, V; Tang, ZJ; Siegle, J; Asp, P; Hadler, M; Rigo, I; De Keersmaecker, K; Patel, J; Huynh, T; Utro, F; Poglio, S; Samon, JB; Paietta, E; Racevskis, J; Rowe, JM; Rabadan, R; Levine, RL; Brown, S; Pflumio, F; Dominguez, M; Ferrando, A; Aifantis, I				Ntziachristos, Panagiotis; Tsirigos, Aristotelis; Van Vlierberghe, Pieter; Nedjic, Jelena; Trimarchi, Thomas; Flaherty, Maria Sol; Ferres-Marco, Dolors; da Ros, Vanina; Tang, Zuojian; Siegle, Jasmin; Asp, Patrik; Hadler, Michael; Rigo, Isaura; De Keersmaecker, Kim; Patel, Jay; Tien Huynh; Utro, Filippo; Poglio, Sandrine; Samon, Jeremy B.; Paietta, Elisabeth; Racevskis, Janis; Rowe, Jacob M.; Rabadan, Raul; Levine, Ross L.; Brown, Stuart; Pflumio, Francoise; Dominguez, Maria; Ferrando, Adolfo; Aifantis, Iannis			Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia	NATURE MEDICINE			English	Article							SOMATIC MUTATIONS; NOTCH1; PRC2; EZH2; CONTEXT	T cell acute lymphoblastic leukemia (T-ALL) is an immature hematopoietic malignancy driven mainly by oncogenic activation of NOTCH1 signaling(1). In this study we report the presence of loss-of-function mutations and deletions of the EZH2 and SUZ12 genes, which encode crucial components of the Polycomb repressive complex 2 (PRC2)(2,3), in 25% of T-ALLs. To further study the role of PRC2 in T-ALL, we used NOTCH1-dependent mouse models of the disease, as well as human T-ALL samples, and combined locus-specific and global analysis of NOTCH1-driven epigenetic changes. These studies demonstrated that activation of NOTCH1 specifically induces loss of the repressive mark Lys27 trimethylation of histone 3 (H3K27me3)(4) by antagonizing the activity of PRC2. These studies suggest a tumor suppressor role for PRC2 in human leukemia and suggest a hitherto unrecognized dynamic interplay between oncogenic NOTCH1 and PRC2 function for the regulation of gene expression and cell transformation.	[Ntziachristos, Panagiotis; Nedjic, Jelena; Trimarchi, Thomas; Siegle, Jasmin; Aifantis, Iannis] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10003 USA; [Ntziachristos, Panagiotis; Nedjic, Jelena; Trimarchi, Thomas; Siegle, Jasmin; Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY USA; [Ntziachristos, Panagiotis; Nedjic, Jelena; Trimarchi, Thomas; Siegle, Jasmin; Asp, Patrik; Aifantis, Iannis] NYU, Sch Med, Inst Canc, New York, NY USA; [Ntziachristos, Panagiotis; Nedjic, Jelena; Trimarchi, Thomas; Siegle, Jasmin; Asp, Patrik; Aifantis, Iannis] NYU, Sch Med, Helen L & Martin S Kimmel Ctr Stem Cell Biol, New York, NY USA; [Tsirigos, Aristotelis; Tien Huynh; Utro, Filippo] IBM Thomas J Watson Res Ctr, Computat Biol Ctr, Yorktown Hts, NY USA; [Van Vlierberghe, Pieter; Flaherty, Maria Sol; Hadler, Michael; Rigo, Isaura; Samon, Jeremy B.; Ferrando, Adolfo] Columbia Univ, Inst Canc Genet, Med Ctr, New York, NY USA; [Van Vlierberghe, Pieter; Samon, Jeremy B.; Ferrando, Adolfo] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA; [Van Vlierberghe, Pieter; Samon, Jeremy B.; Ferrando, Adolfo] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA; [Ferres-Marco, Dolors; da Ros, Vanina; Dominguez, Maria] Univ Miguel Hernandez, Inst Neurociencias Alicante, Consejo Super Invest Cient, Alicante, Spain; [Tang, Zuojian; Brown, Stuart] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Tang, Zuojian; Brown, Stuart] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY USA; [De Keersmaecker, Kim] Flanders Inst Biotechnol, Dept Mol & Dev Genet, Louvain, Belgium; [De Keersmaecker, Kim] Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium; [Patel, Jay; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Patel, Jay; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA; [Poglio, Sandrine; Pflumio, Francoise] Inst Radiobiol Cellulaire & Mol, CEA, Unite Mixte Rech 967, Fontenay Aux Roses, France; [Poglio, Sandrine; Pflumio, Francoise] INSERM, U967, Fontenay Aux Roses, France; [Poglio, Sandrine; Pflumio, Francoise] Univ Paris Diderot, UMR 967, Fontenay Aux Roses, France; [Poglio, Sandrine; Pflumio, Francoise] Univ Paris Sud, UMR 967, Fontenay Aux Roses, France; [Paietta, Elisabeth; Racevskis, Janis] Montefiore Med Ctr N, Bronx, NY USA; [Rowe, Jacob M.] Rambam Med Ctr, Haifa, Israel; [Rabadan, Raul] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY USA	Howard Hughes Medical Institute; New York University; New York University; New York University; New York University; International Business Machines (IBM); Columbia University; Columbia University; Columbia University; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); New York University; New York University; Flanders Institute for Biotechnology (VIB); Universite Catholique Louvain; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Montefiore Medical Center; Rambam Health Care Campus; Technion Israel Institute of Technology; Columbia University	Aifantis, I (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10003 USA.	atsirigo@us.ibm.com; af2196@columbia.edu; iannis.aifantis@nyumc.org	Dominguez, Maria/G-2171-2014; De Keersmaecker, Kim/W-9702-2018; Pflumio, Francoise/E-2074-2017; Van Vlierberghe, Pieter/G-8894-2013; levine, ross/AAE-7658-2019; Patel, Jay/HDM-6251-2022; Rabadan, Raul/AAZ-7367-2020	Dominguez, Maria/0000-0002-3329-7862; De Keersmaecker, Kim/0000-0002-7420-9531; Van Vlierberghe, Pieter/0000-0001-9063-7205; Poglio, Sandrine/0000-0001-8783-0709; Rabadan, Raul/0000-0001-7946-9255; Utro, Filippo/0000-0003-3226-7642; Da Ros, Vanina Gabriela/0000-0003-2367-0042; Pflumio, Francoise/0000-0001-8995-596X; Tsirigos, Aristotelis/0000-0002-7512-8477	US National Institutes of Health National Cancer Institute [P30 CA016087-30, 5 P30CA16087-31]; Damon Runyon Cancer Research Foundation; US National Institutes of Health [RO1CA133379, RO1CA105129, R21CA141399, RO1CA149655, RO1GM088847, R01CA120196, R01CA155743]; The Leukemia & Lymphoma Society; The V Foundation; American Cancer Society [RSG0806801]; Dana Foundation; Feinberg Lymphoma Pilot grant; Fund for Scientific Research of Flanders; US National Library of Medicine [1R01LM010140-01]; Eastern Cooperative Oncology Group tumor bank; Northeast Biodefense Center [U54-AI057158]; Stand Up To Cancer Innovative Research Award; Chemotherapy Foundation; Rally Across America Foundation; Swim Across America Foundation; Spanish Ministerio de Ciencia e Innovacion [BFU2009-09074, MEC-CONSOLIDER CSD2007-00023]; Generalitat Valenciana [PROMETEO2006/134]; EU [UE-HEALH-F2-2008-201666]; Institut du Cancer; Association Laurette Fugain; Ligue National Contre le Cancer; INSERM; CEA; StemPole; NATIONAL CANCER INSTITUTE [P30CA016087, R21CA141399, U24CA114737, R01CA120196, R01CA155743, R01CA133379, R01CA105129, R01CA149655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088847] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010140] Funding Source: NIH RePORTER	US National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Damon Runyon Cancer Research Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); The V Foundation; American Cancer Society(American Cancer Society); Dana Foundation; Feinberg Lymphoma Pilot grant; Fund for Scientific Research of Flanders(FWO); US National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Eastern Cooperative Oncology Group tumor bank; Northeast Biodefense Center; Stand Up To Cancer Innovative Research Award; Chemotherapy Foundation; Rally Across America Foundation; Swim Across America Foundation; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); EU(European Commission); Institut du Cancer(Institut National du Cancer (INCA) France); Association Laurette Fugain; Ligue National Contre le Cancer(Ligue nationale contre le cancer); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CEA(French Atomic Energy Commission); StemPole; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We would like to thank R. Bonasio and D. Reinberg (Howard Hughes Medical Institute and NYU School of Medicine) for critical reading of the manuscript and Ezh2-specific antibody; C. Siebel (Genentech) for technical advice; and P. Ballerini, C. Deswartes, T. Leblanc and A. Baruchel (Services d'Hematologie Pediatrique, Hopital Trousseau and Hopital Robert Debre Saint-Louis, respectively) for providing primary human T-ALL samples. We thank M. Gialitakis, L. Parida and G. Stolovitzky for comments on the manuscript and J. Zavadil, B. Berrin and the NYU Genome Technology Center (supported in part by US National Institutes of Health National Cancer Institute P30 CA016087-30 grant) for expert genomic assistance. The NYU Flow Cytometry facility (supported in part by US National Institutes of Health National Cancer Institute grant 5 P30CA16087-31) for expert cell sorting. We also thank the NYU Histology Core (5P30CA16087-31) and the Transgenic Mouse Core (NYU Cancer Institute Center Grant (5P30CA16087-31). J.N. was supported by the Damon Runyon Cancer Research Foundation. I.A. was supported by the US National Institutes of Health (RO1CA133379, RO1CA105129, R21CA141399, RO1CA149655 and RO1GM088847), The Leukemia & Lymphoma Society, The V Foundation, the American Cancer Society (RSG0806801) and the Dana Foundation. The Aifantis laboratory is also supported by a Feinberg Lymphoma Pilot grant. This study was also supported by the Fund for Scientific Research of Flanders (P.V.V. and K.D.K.); the US National Library of Medicine (1R01LM010140-01 to R.R.); the Eastern Cooperative Oncology Group tumor bank; a Northeast Biodefense Center American Recovery and Reinvestment Act award (U54-AI057158 to R.R.); the US National Institutes of Health (R01CA120196 and R01CA155743 to A.F.); the Stand Up To Cancer Innovative Research Award (A.F.), the Chemotherapy Foundation (I.A. and A.F.); the Rally Across America Foundation (A.F.) and the Swim Across America Foundation (A.F.). P.V.V. is an American Society of Hematology Scholar, and I.A. and A.F. are Leukemia & Lymphoma Society Scholars. M.D. is supported by grants from Spanish Ministerio de Ciencia e Innovacion (BFU2009-09074 and MEC-CONSOLIDER CSD2007-00023), Generalitat Valenciana (PROMETEO2006/134) and an EU Research Grant (UE-HEALH-F2-2008-201666). F.P. is supported by the Institut du Cancer, the Association Laurette Fugain, the Ligue National Contre le Cancer and also by INSERM, CEA and StemPole. S.P. is supported by a fellowship by the Institut du Cancer. I.A. is a Howard Hughes Medical Institute Early Career Scientist.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Buonamici S, 2009, NATURE, V459, P1000, DOI 10.1038/nature08020; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Carpenter AC, 2010, NAT IMMUNOL, V11, P666, DOI 10.1038/ni.1887; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Ferres-Marco D, 2006, NATURE, V439, P430, DOI 10.1038/nature04376; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Lopez J, 2009, BRIT J CANCER, V100, P571, DOI 10.1038/sj.bjc.6604930; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Natoli G, 2009, CURR OPIN DRUG DISC, V12, P607; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Paganin M, 2011, BLOOD REV, V25, P83, DOI 10.1016/j.blre.2010.09.004; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sulis ML, 2008, BLOOD, V112, P733, DOI 10.1182/blood-2007-12-130096; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Wendorff AA, 2010, IMMUNITY, V33, P671, DOI 10.1016/j.immuni.2010.11.014; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208	32	370	380	0	36	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					298	303		10.1038/nm.2651	http://dx.doi.org/10.1038/nm.2651			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22237151	Green Accepted			2022-12-25	WOS:000300140300046
J	Patel, SJ; Milwid, JM; King, KR; Bohr, S; Iracheta-Velle, A; Li, M; Vitalo, A; Parekkadan, B; Jindal, R; Yarmush, ML				Patel, Suraj J.; Milwid, Jack M.; King, Kevin R.; Bohr, Stefan; Iracheta-Velle, Arvin; Li, Matthew; Vitalo, Antonia; Parekkadan, Biju; Jindal, Rohit; Yarmush, Martin L.			Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure	NATURE BIOTECHNOLOGY			English	Article							HEPATOTOXICITY; SURVEILLANCE; MECHANISMS	Drug-induced liver injury (DILI) limits the development and application of many therapeutic compounds and presents major challenges to the pharmaceutical industry and clinical medicine(1,2). Acetaminophen-containing compounds are among the most frequently prescribed drugs and are also the most common cause of DILI3. Here we describe a pharmacological strategy that targets gap junction communication to prevent amplification of fulminant hepatic failure and acetaminophen-induced hepatotoxicity. We demonstrate that connexin 32 (Cx32), a key hepatic gap junction protein, is an essential mediator of DILI by showing that mice deficient in Cx32 are protected against liver damage, acute inflammation and death caused by liver-toxic drugs. We identify a small-molecule inhibitor of Cx32 that protects against liver failure and death in wild-type mice when co-administered with known hepatotoxic drugs. These findings indicate that gap junction inhibition could provide a pharmaceutical strategy to limit DILI and improve drug safety.	[Patel, Suraj J.; Milwid, Jack M.; King, Kevin R.; Bohr, Stefan; Iracheta-Velle, Arvin; Li, Matthew; Vitalo, Antonia; Parekkadan, Biju; Jindal, Rohit; Yarmush, Martin L.] Massachusetts Gen Hosp, Dept Surg, Ctr Engn Med, Boston, MA 02114 USA; [Patel, Suraj J.; Milwid, Jack M.; King, Kevin R.; Bohr, Stefan; Iracheta-Velle, Arvin; Li, Matthew; Vitalo, Antonia; Parekkadan, Biju; Jindal, Rohit; Yarmush, Martin L.] Shriners Burns Hosp, Boston, MA USA; [Patel, Suraj J.; Milwid, Jack M.; Yarmush, Martin L.] Harvard Univ, Sch Med, Harvard MIT Div Hlth Sci & Technol, MIT, Cambridge, MA 02138 USA; [Jindal, Rohit; Yarmush, Martin L.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Rutgers State University New Brunswick	Yarmush, ML (corresponding author), Massachusetts Gen Hosp, Dept Surg, Ctr Engn Med, Boston, MA 02114 USA.	ireis@sbi.org	; Iracheta-Vellve, Arvin/K-6140-2014	Parekkadan, Biju/0000-0002-3408-8085; Iracheta-Vellve, Arvin/0000-0002-6635-3904; Yarmush, Martin/0000-0003-4986-8444	Department of Defense; Shriners Hospitals for Children; US National Institutes of Health [DK059766, P41 EB-002503]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059766] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Shriners Hospitals for Children; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank K. Willecke (University of Bonn) and D. Paul (Harvard University) for the generous gift of Cx32<SUP>-/-</SUP> mice, K. Willecke (University of Bonn) for connexin expressing HeLa cells, H. Duffy (Harvard Medical School) for development of the tissue scrape-and-load assay, and M. Izamis (Harvard Medical School) for high-performance liquid chromatography assistance. S.J.P. was supported in part by a Department of Defense Congressionally Directed Medical Research Program Prostate Cancer Predoctoral Training Award and a Shriners Hospitals for Children Postdoctoral Fellowship Award. The work was supported by grants from the US National Institutes of Health (DK059766 and P41 EB-002503) and from the Shriners Hospitals for Children.	BARTOLONE JB, 1989, FUND APPL TOXICOL, V13, P859, DOI 10.1016/0272-0590(89)90339-4; BIRNBAUM J, 1985, AM J MED, V78, P3, DOI 10.1016/0002-9343(85)90097-X; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Chun LJ, 2009, J CLIN GASTROENTEROL, V43, P342, DOI 10.1097/MCG.0b013e31818a3854; Ferret PJ, 2001, HEPATOLOGY, V33, P1173, DOI 10.1053/jhep.2001.24267; Hutson S, 2010, NAT MED, V16, P10, DOI 10.1038/nm0110-10a; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166; Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750; Lee WM, 2007, HEPATOLOGY, V46, P966, DOI 10.1002/hep.21926; Lee WM, 2009, GASTROENTEROLOGY, V137, P856, DOI 10.1053/j.gastro.2009.06.006; Lee WM, 2003, NEW ENGL J MED, V349, P474, DOI 10.1056/NEJMra021844; Lindros KO, 1997, GEN PHARMACOL, V28, P191, DOI 10.1016/S0306-3623(96)00183-8; Liu ZX, 2006, HEPATOLOGY, V43, P1220, DOI 10.1002/hep.21175; Naiki-Ito A, 2010, TOXICOL PATHOL, V38, P280, DOI 10.1177/0192623309357951; Navarro VJ, 2006, NEW ENGL J MED, V354, P731, DOI 10.1056/NEJMra052270; Patel SJ, 2009, P NATL ACAD SCI USA, V106, P12867, DOI 10.1073/pnas.0809292106; Platt R, 2008, PHARMACOEPIDEM DR S, V17, P1175, DOI 10.1002/pds.1668; Rohr S, 2004, CARDIOVASC RES, V62, P309, DOI 10.1016/j.cardiores.2003.11.035; Roth RA, 2010, J PHARMACOL EXP THER, V332, P692, DOI 10.1124/jpet.109.162651; Segretain D, 2004, BBA-BIOMEMBRANES, V1662, P3, DOI 10.1016/j.bbamem.2004.01.007; Shenton JM, 2004, CHEM-BIOL INTERACT, V150, P53, DOI 10.1016/j.cbi.2004.09.001; Taha AS, 1996, NEW ENGL J MED, V334, P1435, DOI 10.1056/NEJM199605303342204; Tao L, 2007, MOL PHARMACOL, V71, P570, DOI 10.1124/mol.106.027508; Tujios S, 2011, NAT REV GASTRO HEPAT, V8, P202, DOI 10.1038/nrgastro.2011.22; Wit AL, 2008, AM J PHYSIOL-HEART C, V294, pH16, DOI 10.1152/ajpheart.01031.2007; Wysowski DK, 2005, ARCH INTERN MED, V165, P1363, DOI 10.1001/archinte.165.12.1363	27	90	99	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2012	30	2					179	183		10.1038/nbt.2089	http://dx.doi.org/10.1038/nbt.2089			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	892EI	22252509	Green Accepted			2022-12-25	WOS:000300269100021
J	Lam, HYK; Clark, MJ; Chen, R; Chen, R; Natsoulis, G; O'Huallachain, M; Dewey, FE; Habegger, L; Ashley, EA; Gerstein, MB; Butte, AJ; Ji, HP; Snyder, M				Lam, Hugo Y. K.; Clark, Michael J.; Chen, Rui; Chen, Rong; Natsoulis, Georges; O'Huallachain, Maeve; Dewey, Frederick E.; Habegger, Lukas; Ashley, Euan A.; Gerstein, Mark B.; Butte, Atul J.; Ji, Hanlee P.; Snyder, Michael			Performance comparison of whole-genome sequencing platforms	NATURE BIOTECHNOLOGY			English	Article							MACULAR DEGENERATION; STRUCTURAL VARIATION; PERSONAL GENOME; SHORT-READ; VARIANTS; GENE; ACCURATE; CFH	Whole-genome sequencing is becoming commonplace, but the accuracy and completeness of variant calling by the most widely used platforms from Illumina and Complete Genomics have not been reported. Here we sequenced the genome of an individual with both technologies to a high average coverage of similar to 76x, and compared their performance with respect to sequence coverage and calling of single-nucleotide variants (SNVs), insertions and deletions (indels). Although 88.1% of the similar to 3.7 million unique SNVs were concordant between platforms, there were tens of thousands of platform-specific calls located in genes and other genomic regions. In contrast, 26.5% of indels were concordant between platforms. Target enrichment validated 92.7% of the concordant SNVs, whereas validation by genotyping array revealed a sensitivity of 99.3%. The validation experiments also suggested that >60% of the platform-specific variants were indeed present in the genome. Our results have important implications for understanding the accuracy and completeness of the genome sequencing platforms.	[Lam, Hugo Y. K.; Clark, Michael J.; Chen, Rui; O'Huallachain, Maeve; Snyder, Michael] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Chen, Rong; Butte, Atul J.] Stanford Univ, Dept Pediat, Div Syst Med, Stanford, CA 94305 USA; [Natsoulis, Georges; Ji, Hanlee P.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Dewey, Frederick E.; Ashley, Euan A.] Stanford Univ, Ctr Inherited Cardiovasc Dis, Div Cardiovasc Med, Stanford, CA 94305 USA; [Habegger, Lukas; Gerstein, Mark B.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT USA; [Gerstein, Mark B.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [Gerstein, Mark B.] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA	Stanford University; Stanford University; Stanford University; Stanford University; Yale University; Yale University; Yale University	Snyder, M (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	mpsnyder@stanford.edu	O'Huallachain, Maeve/AAO-4312-2020	O'Huallachain, Maeve/0000-0002-0618-6032; Snyder, Michael/0000-0003-0784-7987	Stanford Department of Genetics; US National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002357, RC2HG005570, R01HG006137] Funding Source: NIH RePORTER	Stanford Department of Genetics; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work is supported by the Stanford Department of Genetics and the US National Institutes of Health.	Ajay SS, 2011, GENOME RES, V21, P1498, DOI 10.1101/gr.123638.111; Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Chen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013574; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Kaur I, 2008, INVEST OPHTH VIS SCI, V49, P1771, DOI 10.1167/iovs.07-0560; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Rios J, 2010, HUM MOL GENET, V19, P4313, DOI 10.1093/hmg/ddq352; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Snyder M, 2010, GENE DEV, V24, P423, DOI 10.1101/gad.1864110; Tam POS, 2008, INVEST OPHTH VIS SCI, V49, P2357, DOI 10.1167/iovs.07-1520; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980	23	207	214	1	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2012	30	1					78	U118		10.1038/nbt.2065	http://dx.doi.org/10.1038/nbt.2065			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	876MC	22178993	Green Accepted			2022-12-25	WOS:000299110600023
J	Reumers, J; De Rijk, P; Zhao, H; Liekens, A; Smeets, D; Cleary, J; Van Loo, P; Van Den Bossche, M; Catthoor, K; Sabbe, B; Despierre, E; Vergote, I; Hilbush, B; Lambrechts, D; Del-Favero, J				Reumers, Joke; De Rijk, Peter; Zhao, Hui; Liekens, Anthony; Smeets, Dominiek; Cleary, John; Van Loo, Peter; Van Den Bossche, Maarten; Catthoor, Kirsten; Sabbe, Bernard; Despierre, Evelyn; Vergote, Ignace; Hilbush, Brian; Lambrechts, Diether; Del-Favero, Jurgen			Optimized filtering reduces the error rate in detecting genomic variants by short-read sequencing	NATURE BIOTECHNOLOGY			English	Article							COMPUTATIONAL TOOL; MUTATIONS; FRAMEWORK; SPECTRUM; DATABASE; BROWSER; COMMON	Distinguishing single-nucleotide variants (SNVs) from errors in whole-genome sequences remains challenging. Here we describe a set of filters, together with a freely accessible software tool, that selectively reduce error rates and thereby facilitate variant detection in data from two short-read sequencing technologies, Complete Genomics and Illumina. By sequencing the nearly identical genomes from monozygotic twins and considering shared SNVs as 'true variants' and discordant SNVs as 'errors', we optimized thresholds for 12 individual filters and assessed which of the 1,048 filter combinations were effective in terms of sensitivity and specificity. Cumulative application of all effective filters reduced the error rate by 290-fold, facilitating the identification of genetic differences between monozygotic twins. We also applied an adapted, less stringent set of filters to reliably identify somatic mutations in a highly rearranged tumor and to identify variants in the NA19240 HapMap genome relative to a reference set of SNVs.	[Reumers, Joke; Zhao, Hui; Smeets, Dominiek; Lambrechts, Diether] VIB, Vesalius Res Ctr, Louvain, Belgium; [Reumers, Joke; Zhao, Hui; Smeets, Dominiek; Lambrechts, Diether] Univ Leuven, Vesalius Res Ctr, Louvain, Belgium; [De Rijk, Peter; Liekens, Anthony; Van Den Bossche, Maarten; Del-Favero, Jurgen] VIB, Appl Mol Genom Grp, Dept Mol Genet, Antwerp, Belgium; [De Rijk, Peter; Liekens, Anthony; Van Den Bossche, Maarten; Del-Favero, Jurgen] Univ Antwerp, Appl Mol Genom Grp, B-2020 Antwerp, Belgium; [Cleary, John; Hilbush, Brian] Real Time Genom, San Francisco, CA USA; [Van Loo, Peter] VIB, Dept Mol & Dev Genet, Louvain, Belgium; [Van Loo, Peter] Univ Leuven, Dept Human Genet, Louvain, Belgium; [Van Den Bossche, Maarten; Sabbe, Bernard] Univ Antwerp, CAPRI, Fac Med, B-2020 Antwerp, Belgium; [Van Den Bossche, Maarten; Sabbe, Bernard] PC Sint Norbertushuis, Duffel, Belgium; [Catthoor, Kirsten] ZNA Psychiat Hosp Stuivenberg, Antwerp, Belgium; [Despierre, Evelyn; Vergote, Ignace] Univ Hosp Gasthuisberg, Div Gynaecol Oncol, Dept Obstet & Gynaecol, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); University of Antwerp; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Antwerp; KU Leuven; University Hospital Leuven	Lambrechts, D (corresponding author), VIB, Vesalius Res Ctr, Louvain, Belgium.	diether.lambrechts@vib-kuleuven.be; jurgen.delfavero@molgen.vib-ua.be	De Rijk, Peter/GXH-9837-2022; Verdrengh, Evelien/H-4571-2012; Sabbe, Bernard/J-3598-2013; Van Loo, Peter/A-3287-2012; Lambrechts, Diether/AAJ-3167-2020	De Rijk, Peter/0000-0001-8558-9288; Sabbe, Bernard/0000-0002-1426-802X; Lambrechts, Diether/0000-0002-3429-302X; Reumers, Joke/0000-0001-5434-6515; Del Favero, jurgen/0000-0002-7427-7489; Van Loo, Peter/0000-0003-0292-1949; Van Den Bossche, Maarten/0000-0002-2989-6600	Fund for Scientific Research Flanders (FWO-F); Agency for Innovation by Science and Technology (IWT); Stichting tegen Kanker, FWO-F; KULeuven [KULPFV/10/016-SymBioSysII]	Fund for Scientific Research Flanders (FWO-F)(FWO); Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Stichting tegen Kanker, FWO-F; KULeuven(KU Leuven)	We appreciate the assistance of M. Veugelers and S. Plaisance (VIB Technology Watch). We acknowledge G. Peuteman, T. Van Brussel, S. Cammaerts, M. Strazisar and the Genetic Service Facility (http://www.vibgeneticservicefacility.be/) for technical assistance. We highly appreciate the helpful comments from the reviewers. The research was supported by the Fund for Scientific Research Flanders (FWO-F) to J.R. and P.V.L., the Agency for Innovation by Science and Technology (IWT) to M.V.D.B., the Stichting tegen Kanker, FWO-F and the KULeuven (KULPFV/10/016-SymBioSysII)) to D.L.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Baranzini SE, 2010, NATURE, V464, P1351, DOI 10.1038/nature08990; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; Fujimoto A, 2010, NAT GENET, V42, P931, DOI 10.1038/ng.691; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gorringe KL, 2009, MOL ONCOL, V3, P157, DOI 10.1016/j.molonc.2008.12.005; Griffith OL, 2008, NUCLEIC ACIDS RES, V36, pD107, DOI 10.1093/nar/gkm967; Haag-Liautard C, 2007, NATURE, V445, P82, DOI 10.1038/nature05388; Kaminker JS, 2007, NUCLEIC ACIDS RES, V35, pW595, DOI 10.1093/nar/gkm405; Karlsson H, 2001, P NATL ACAD SCI USA, V98, P4634, DOI 10.1073/pnas.061021998; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Leunen K, 2009, HUM MUTAT, V30, P1693, DOI 10.1002/humu.21135; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pelak K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001111; Penzkofer T, 2005, NUCLEIC ACIDS RES, V33, pD498, DOI 10.1093/nar/gki044; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Sheridan C, 2011, NAT BIOTECHNOL, V29, P463, DOI [10.1038/nbt0611-465, 10.1038/nbt.1901]; Siva Nayanah, 2008, Nat Biotechnol, V26, P256, DOI 10.1038/nbt0308-256b; Tong P, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r91; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Weckx S, 2005, GENOME RES, V15, P436, DOI 10.1101/gr.2754005; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316	49	164	165	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2012	30	1					61	U103		10.1038/nbt.2053	http://dx.doi.org/10.1038/nbt.2053			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	876MC	22178994	Bronze			2022-12-25	WOS:000299110600021
J	Toprak, E; Veres, A; Michel, JB; Chait, R; Hartl, DL; Kishony, R				Toprak, Erdal; Veres, Adrian; Michel, Jean-Baptiste; Chait, Remy; Hartl, Daniel L.; Kishony, Roy			Evolutionary paths to antibiotic resistance under dynamically sustained drug selection	NATURE GENETICS			English	Article							RIBOSOMAL-RNA GENE; ESCHERICHIA-COLI; DIHYDROFOLATE-REDUCTASE; CONTINUOUS-CULTURE; TETRACYCLINE RESISTANCE; PARALLEL EVOLUTION; MUTATIONS; EPIDEMIOLOGY; ARCHITECTURE; BACTERIA	Antibiotic resistance can evolve through the sequential accumulation of multiple mutations(1). To study such gradual evolution, we developed a selection device, the 'morbidostat', that continuously monitors bacterial growth and dynamically regulates drug concentrations, such that the evolving population is constantly challenged(2-5). We analyzed the evolution of resistance in Escherichia coli under selection with single drugs, including chloramphenicol, doxycycline and trimethoprim. Over a period of similar to 20 days, resistance levels increased dramatically, with parallel populations showing similar phenotypic trajectories. Whole-genome sequencing of the evolved strains identified mutations both specific to resistance to a particular drug and shared in resistance to multiple drugs. Chloramphenicol and doxycycline resistance evolved smoothly through diverse combinations of mutations in genes involved in translation, transcription and transport(3). In contrast, trimethoprim resistance evolved in a stepwise manner(1,6), through mutations restricted to the gene encoding the enzyme dihydrofolate reductase (DHFR)(7,8). Sequencing of DHFR over the time course of the experiment showed that parallel populations evolved similar mutations and acquired them in a similar order(9).	[Toprak, Erdal; Michel, Jean-Baptiste; Chait, Remy; Kishony, Roy] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02215 USA; [Veres, Adrian] Harvard Univ, Fac Arts & Sci, Cambridge, MA 02138 USA; [Michel, Jean-Baptiste] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Hartl, Daniel L.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Kishony, Roy] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard University; Harvard University	Kishony, R (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02215 USA.	roy_kishony@hms.harvard.edu	Toprak, Erdal/P-6340-2014; Michel, Jean-Baptiste/AAH-9336-2020	Veres, Adrian/0000-0002-3849-3475; Chait, Remy/0000-0003-0876-3187	US National Institutes of Health [GM081617, GM079536]; New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases [AI057159]; Foundational Questions in Evolutionary Biology Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079536, R01GM081617] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Foundational Questions in Evolutionary Biology Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank M. Baym, S. Bershtein, T. Bollenbach, M. Ernebjerg, Y. Gerardin, J. Horn, A. Kocabas, C. Kocabas, D. Landgraf, R. Milo, B. Okumus, A. Palmer, J. M. Pedraza, M. Shuman, I. Wapinski, R. Ward, P. Yeh and all members of the Kishony laboratory for technical help and discussions. This work was supported in part by grants from the US National Institutes of Health (GM081617 to R. K. and GM079536 to D. L. H.) and The New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (AI057159 to R. K.). J.-B.M. is supported by a Foundational Questions in Evolutionary Biology Fellowship.	Albert TJ, 2005, NAT METHODS, V2, P951, DOI 10.1038/NMETH805; Asako H, 1997, APPL ENVIRON MICROB, V63, P1428, DOI 10.1128/AEM.63.4.1428-1433.1997; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; BRYSON V, 1952, SCIENCE, V116, P45, DOI 10.1126/science.116.3003.45; Bull AT, 2010, J IND MICROBIOL BIOT, V37, P993, DOI 10.1007/s10295-010-0816-4; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Counago R, 2006, MOL CELL, V22, P441, DOI 10.1016/j.molcel.2006.04.012; Crandall KA, 1999, MOL BIOL EVOL, V16, P372, DOI 10.1093/oxfordjournals.molbev.a026118; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; de Crecy E, 2007, APPL MICROBIOL BIOT, V77, P489, DOI 10.1007/s00253-007-1168-5; de Visser JAGM, 2006, GENETICS, V172, P2093, DOI 10.1534/genetics.105.052373; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; DEMEREC M, 1945, P NATL ACAD SCI USA, V31, P16, DOI 10.1073/pnas.31.1.16; Drlica K, 2003, J ANTIMICROB CHEMOTH, V52, P11, DOI 10.1093/jac/dkg269; ETTAYEBI M, 1985, J BACTERIOL, V162, P551, DOI 10.1128/JB.162.2.551-557.1985; FLENSBURG J, 1987, EUR J BIOCHEM, V162, P473, DOI 10.1111/j.1432-1033.1987.tb10664.x; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; Gerrits MM, 2003, ANTIMICROB AGENTS CH, V47, P2984, DOI 10.1128/AAC.47.9.2984-2986.2003; Girgis HS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005629; HUOVINEN P, 1987, ANTIMICROB AGENTS CH, V31, P1451, DOI 10.1128/AAC.31.10.1451; Lane PG, 1999, BIOTECHNOL PROGR, V15, P1115, DOI 10.1021/bp990084j; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lipsitch M, 2000, P NATL ACAD SCI USA, V97, P1938, DOI 10.1073/pnas.97.4.1938; Lozovsky ER, 2009, P NATL ACAD SCI USA, V106, P12025, DOI 10.1073/pnas.0905922106; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P44, DOI 10.1111/j.1574-6976.2008.00142.x; Lunzer M, 2005, SCIENCE, V310, P499, DOI 10.1126/science.1115649; MANKIN AS, 1992, P NATL ACAD SCI USA, V89, P6535, DOI 10.1073/pnas.89.14.6535; MATTHEWS DA, 1977, SCIENCE, V197, P452, DOI 10.1126/science.17920; Michel JB, 2008, P NATL ACAD SCI USA, V105, P14918, DOI 10.1073/pnas.0800944105; Ohmae E, 2001, J BIOCHEM-TOKYO, V130, P439, DOI 10.1093/oxfordjournals.jbchem.a003004; Okusu H, 1996, J BACTERIOL, V178, P306, DOI 10.1128/JB.178.1.306-308.1996; Paalme T, 1997, ANTON LEEUW INT J G, V71, P217, DOI 10.1023/A:1000198404007; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Ross JI, 1998, ANTIMICROB AGENTS CH, V42, P1702, DOI 10.1128/AAC.42.7.1702; Ruiz J, 2003, J ANTIMICROB CHEMOTH, V51, P1109, DOI 10.1093/jac/dkg222; Schnell JR, 2004, ANNU REV BIOPH BIOM, V33, P119, DOI 10.1146/annurev.biophys.33.110502.133613; SMITH DR, 1982, MOL GEN GENET, V187, P72, DOI 10.1007/BF00384386; Taubes G, 2008, SCIENCE, V321, P356, DOI 10.1126/science.321.5887.356; Watson M, 2007, FEBS J, V274, P2661, DOI 10.1111/j.1742-4658.2007.05801.x; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422; Yee YC, 1996, J ANTIMICROB CHEMOTH, V38, P133, DOI 10.1093/jac/38.1.133; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755; Yeh PJ, 2009, NAT REV MICROBIOL, V7, P460, DOI 10.1038/nrmicro2133; Zhang QC, 2011, SCIENCE, V333, P1764, DOI 10.1126/science.1208747	48	445	467	1	201	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2012	44	1					101	U140		10.1038/ng.1034	http://dx.doi.org/10.1038/ng.1034			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	22179135	Green Accepted			2022-12-25	WOS:000298664000022
J	Ong, CK; Subimerb, C; Pairojkul, C; Wongkham, S; Cutcutache, I; Yu, W; McPherson, JR; Allen, GE; Ng, CCY; Wong, BH; Myint, SS; Rajasegaran, V; Heng, HL; Gan, A; Zang, ZJ; Wu, YT; Wu, J; Lee, MH; Huang, DC; Ong, P; Chan-on, W; Cao, Y; Qian, CN; Lim, KH; Ooi, A; Dykema, K; Furge, K; Kukongviriyapan, V; Sripa, B; Wongkham, C; Yongvanit, P; Futreal, PA; Bhudhisawasdi, V; Rozen, S; Tan, P; Teh, BT				Ong, Choon Kiat; Subimerb, Chutima; Pairojkul, Chawalit; Wongkham, Sopit; Cutcutache, Ioana; Yu, Willie; McPherson, John R.; Allen, George E.; Ng, Cedric Chuan Young; Wong, Bernice Huimin; Myint, Swe Swe; Rajasegaran, Vikneswari; Heng, Hong Lee; Gan, Anna; Zang, Zhi Jiang; Wu, Yingting; Wu, Jeanie; Lee, Ming Hui; Huang, DaChuan; Ong, Pauline; Chan-on, Waraporn; Cao, Yun; Qian, Chao-Nan; Lim, Kiat Hon; Ooi, Aikseng; Dykema, Karl; Furge, Kyle; Kukongviriyapan, Veerapol; Sripa, Banchob; Wongkham, Chaisiri; Yongvanit, Puangrat; Futreal, P. Andrew; Bhudhisawasdi, Vajarabhongsa; Rozen, Steve; Tan, Patrick; Teh, Bin Tean			Exome sequencing of liver fluke-associated cholangiocarcinoma	NATURE GENETICS			English	Article							BILIARY-TRACT; GENOMIC ANALYSES; COPY NUMBERS; CANCER; MUTATIONS; CARCINOMA; INSTABILITY; INDUCTION; GROWTH; CELLS	Opisthorchis viverrini-related cholangiocarcinoma (CCA), a fatal bile duct cancer, is a major public health concern in areas endemic for this parasite. We report here whole-exome sequencing of eight O. viverrini-related tumors and matched normal tissue. We identified and validated 206 somatic mutations in 187 genes using Sanger sequencing and selected 15 genes for mutation prevalence screening in an additional 46 individuals with CCA (cases). In addition to the known cancer-related genes TP53 (mutated in 44.4% of cases), KRAS (16.7%) and SMAD4 (16.7%), we identified somatic mutations in 10 newly implicated genes in 14.8-3.7% of cases. These included inactivating mutations in MLL3 (in 14.8% of cases), ROBO2 (9.3%), RNF43 (9.3%) and PEG3 (5.6%), and activating mutations in the GNAS oncogene (9.3%). These genes have functions that can be broadly grouped into three biological classes: (i) deactivation of histone modifiers, (ii) activation of G protein signaling and (iii) loss of genome stability. This study provides insight into the mutational landscape contributing to O. viverrini-related CCA.	[Subimerb, Chutima; Pairojkul, Chawalit; Wongkham, Sopit; Chan-on, Waraporn; Kukongviriyapan, Veerapol; Sripa, Banchob; Wongkham, Chaisiri; Yongvanit, Puangrat; Bhudhisawasdi, Vajarabhongsa] Khon Kaen Univ, Fac Med, Liver Fluke & Cholangiocarcinoma Res Ctr, Khon Kaen, Thailand; [Ong, Choon Kiat; Subimerb, Chutima; Yu, Willie; Allen, George E.; Ng, Cedric Chuan Young; Wong, Bernice Huimin; Myint, Swe Swe; Rajasegaran, Vikneswari; Heng, Hong Lee; Gan, Anna; Huang, DaChuan; Ong, Pauline; Chan-on, Waraporn; Teh, Bin Tean] Natl Canc Ctr, Div Med Sci, Nat Canc Ctr Singapore Van Andel Res Inst Transla, Singapore, Singapore; [Ong, Choon Kiat; Subimerb, Chutima; Yu, Willie; Allen, George E.; Ng, Cedric Chuan Young; Wong, Bernice Huimin; Myint, Swe Swe; Rajasegaran, Vikneswari; Heng, Hong Lee; Gan, Anna; Zang, Zhi Jiang; Wu, Jeanie; Lee, Ming Hui; Huang, DaChuan; Ong, Pauline; Chan-on, Waraporn; Tan, Patrick; Teh, Bin Tean] Duke Natl Univ Singapore NUS Grad Med Sch, Div Canc & Stem Cell Biol, Singapore, Singapore; [Cutcutache, Ioana; McPherson, John R.; Wu, Yingting; Rozen, Steve] Duke NUS Grad Med Sch, Div Neurosci & Behav Disorders, Singapore, Singapore; [Yu, Willie] NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore; [Zang, Zhi Jiang] Natl Canc Ctr, Div Cellular & Mol Res, Singapore, Singapore; [Wu, Yingting] Singapore MIT Alliance, Singapore, Singapore; [Cao, Yun; Qian, Chao-Nan] Sun Yat Sen Univ Canc Ctr, Guangzhou, Guangdong, Peoples R China; [Lim, Kiat Hon] Singapore Gen Hosp, Dept Pathol, Singapore 0316, Singapore; [Ooi, Aikseng; Dykema, Karl; Furge, Kyle] Van Andel Res Inst, Lab Computat Biol, Grand Rapids, MI USA; [Futreal, P. Andrew] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England; [Tan, Patrick] NUS, Canc Sci Inst Singapore, Singapore, Singapore; [Tan, Patrick] Genome Inst Singapore, Singapore, Singapore	Khon Kaen University; National Cancer Centre Singapore (NCCS); National University of Singapore; National University of Singapore; National Cancer Centre Singapore (NCCS); Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore-MIT Alliance for Research & Technology Centre (SMART); Sun Yat Sen University; Singapore General Hospital; Van Andel Institute; Wellcome Trust Sanger Institute; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Bhudhisawasdi, V (corresponding author), Khon Kaen Univ, Fac Med, Liver Fluke & Cholangiocarcinoma Res Ctr, Khon Kaen, Thailand.	joevajare@gmail.com; steve.rozen@duke-nus.edu.sg; gmstanp@duke-nus.edu.sg; teh.bin.tean@singhealth.com.sg	Wongkham, Sopit/ABB-6966-2021; Xiao, Yang/B-5668-2012; Ooi, Aikseng/B-8776-2012; Rozen, Steven G./J-5939-2013	Ooi, Aikseng/0000-0003-3853-7156; Rozen, Steven G./0000-0002-4288-0056; HUANG, DACHUAN/0000-0002-7518-4081; Wong, Bernice/0000-0001-8981-1376; Ong, Choon Kiat/0000-0001-6402-4288; Myint, Swe Swe/0000-0002-2430-088X; Teh, Bin Tean/0000-0003-1514-1124; Sripa, Banchob/0000-0001-8899-5919	Singapore National Medical Research Council [NMRC/STAR/0006/2009]; Singapore Millennium Foundation; Lee Foundation; Singapore National Cancer Centre; Duke-NUS Graduate Medical School; Cancer Science Institute, Singapore; Research Team Strengthening Grant; National Genetic Engineering and Biotechnology Center; National Science and Technology Development Agency, Thailand; NUS Graduate School for Integrative Sciences and Engineering, Singapore	Singapore National Medical Research Council(National Medical Research Council, Singapore); Singapore Millennium Foundation(Singapore Millennium Foundation); Lee Foundation; Singapore National Cancer Centre; Duke-NUS Graduate Medical School(National University of Singapore); Cancer Science Institute, Singapore; Research Team Strengthening Grant; National Genetic Engineering and Biotechnology Center; National Science and Technology Development Agency, Thailand; NUS Graduate School for Integrative Sciences and Engineering, Singapore(National University of Singapore)	We thank L. Farber for editing the manuscript. This work is supported in part by funding from the Singapore National Medical Research Council (NMRC/STAR/0006/2009), The Singapore Millennium Foundation, The Lee Foundation, the Singapore National Cancer Centre Research Fund, the Duke-NUS Graduate Medical School, the Cancer Science Institute, Singapore, the Research Team Strengthening Grant, the National Genetic Engineering and Biotechnology Center and the National Science and Technology Development Agency, Thailand. W.Y. is the recipient of the NUS Graduate School for Integrative Sciences and Engineering Scholarship, Singapore.	Aoki K, 2007, ONCOGENE, V26, P3511, DOI 10.1038/sj.onc.1210141; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bengtsson H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-245; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Cardinale Vincenzo, 2010, Italian Journal of Anatomy and Embryology, V115, P85; Deng YB, 2000, P NATL ACAD SCI USA, V97, P12050, DOI 10.1073/pnas.97.22.12050; Gilbert SF, 2000, DEV BIOL, P494; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Homayounfar K, 2009, HUM PATHOL, V40, P834, DOI 10.1016/j.humpath.2008.11.005; Idziaszczyk S, 2010, CANCER GENET CYTOGEN, V202, P67, DOI 10.1016/j.cancergencyto.2010.04.023; Jiang XL, 2010, J BIOL CHEM, V285, P8472, DOI 10.1074/jbc.M109.069450; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Low SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011824; McLean L, 2006, LIVER INT, V26, P1047, DOI 10.1111/j.1478-3231.2006.01350.x; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Nakanuma Y, 2010, PATHOL INT, V60, P419, DOI 10.1111/j.1440-1827.2010.02543.x; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Rashid A, 2002, CLIN CANCER RES, V8, P3156; Roskams T, 2006, ONCOGENE, V25, P3818, DOI 10.1038/sj.onc.1209558; Shinada K, 2011, BIOCHEM BIOPH RES CO, V404, P143, DOI 10.1016/j.bbrc.2010.11.082; Sripa B, 2007, PLOS MED, V4, P1148, DOI 10.1371/journal.pmed.0040201; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; van Oijen MGCT, 2000, CLIN CANCER RES, V6, P2138; VATANASAPT V, 1995, CANCER EPIDEM BIOMAR, V4, P475; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Wong N, 2002, J HEPATOL, V37, P633, DOI 10.1016/S0168-8278(02)00269-6; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Xu XL, 2006, J CLIN INVEST, V116, P1843, DOI 10.1172/JCI27282	31	355	365	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2012	44	6					690	U113		10.1038/ng.2273	http://dx.doi.org/10.1038/ng.2273			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	949BT	22561520				2022-12-25	WOS:000304551100017
J	Wang, SX; Zhang, C; Zhang, M; Liang, B; Zhu, HP; Lee, J; Viollet, B; Xia, LJ; Zhang, Y; Zou, MH				Wang, Shuangxi; Zhang, Cheng; Zhang, Miao; Liang, Bin; Zhu, Huaiping; Lee, Jiyeon; Viollet, Benoit; Xia, Lijun; Zhang, Yun; Zou, Ming-Hui			Activation of AMP-activated protein kinase alpha 2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo	NATURE MEDICINE			English	Article							SMOOTH-MUSCLE-CELLS; ENDOTHELIAL DYSFUNCTION; NITRIC-OXIDE; TGF-BETA; TRANSCRIPTION; PHOSPHORYLATION; DELETION; STRESS; IDENTIFICATION; PROTEOLYSIS	Smoking is the only modifiable risk factor that is associated with the development, expansion and rupture of abdominal aortic aneurysm (AAA). However, the causative link between cigarette smoke and AAA is unknown. Here we report a causative link between smoking and AAA in vivo. Acute infusion of angiotensin II (AngII) or nicotine, a major component of cigarette smoke, markedly increased the incidence of AAA in apolipoprotein E (apoE) knockout (Apoe(-/-)) mice and in mice deficient in both apoE and the AMP-activated kinase alpha 1 subunit (AMPK-alpha 1) (Apoe(-/-); Prkaa1(-/-) mice). In contrast, genetic deletion of AMPK-alpha 2 (Apoe(-/-); Prkaa2(-/-) mice) ablated nicotine-or AngII-triggered AAA in vivo. Mechanistically, we found that both nicotine and AngII activated AMPK-alpha 2 in cultured vascular smooth muscle cells (VSMCs), resulting in the phosphorylation of activator protein 2 alpha (AP-2 alpha) and consequent matrix metallopeptidase 2 (MMP2) gene expression. We conclude that smoking (through nicotine) instigates AAA through AMPK-alpha 2-mediated AP-2 alpha-dependent MMP2 expression in VSMCs.	[Wang, Shuangxi; Zhang, Cheng; Zhang, Miao; Liang, Bin; Zhu, Huaiping; Lee, Jiyeon; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Div Mol Med, Oklahoma City, OK 73104 USA; [Wang, Shuangxi; Zhang, Cheng; Zhang, Yun; Zou, Ming-Hui] Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Shandong, Peoples R China; [Wang, Shuangxi; Zhang, Cheng; Zhang, Yun; Zou, Ming-Hui] Shandong Univ, Qilu Hosp, Chinese Minist Hlth, Jinan 250100, Shandong, Peoples R China; [Viollet, Benoit] Univ Paris 05, CNRS, UMR 8104, Inst Cochin, Paris, France; [Xia, Lijun] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Shandong University; Shandong University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Oklahoma Medical Research Foundation	Zou, MH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Div Mol Med, Oklahoma City, OK 73104 USA.	ming-hui-zou@ouhsc.edu	Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224	US National Institutes of Health (NIH) [HL079584, HL074399, HL080499, HL089920, HL096032, HL105157, HL110488]; NIH [HL085607, RR018758]; National High-tech Research and Development Program of China [2012AA02A510]; National 973 Basic Research Program of China [2011CB503906]; National Natural Science Foundation of China for Innovative Research Group [81021001]; American Heart Association; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018758] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080499, R01HL105157, R01HL079584, R43HL110448, R01HL110488, R01HL096032, R01HL074399, P01HL085607, R01HL089920] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National High-tech Research and Development Program of China(National High Technology Research and Development Program of China); National 973 Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC)); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful for helpful discussions with J. Du, X.L. Wang and C. Yan. We also thank D. Wang and M. McDaniel for technical support. This work was supported by US National Institutes of Health (NIH) grants (HL079584, HL074399, HL080499, HL089920, HL096032, HL105157 and HL110488 to M.-H.Z.). L.X.'s lab is supported by NIH grants (HL085607 and RR018758). This work was also supported by the National High-tech Research and Development Program of China (No. 2012AA02A510) awarded to C.Z. and the National 973 Basic Research Program of China (number 2011CB503906) and the State Program of National Natural Science Foundation of China for Innovative Research Group (number 81021001) awarded to Y.Z. M.-H.Z. is a recipient of the National Established Investigator Award of the American Heart Association.	An ZB, 2007, J BIOL CHEM, V282, P26793, DOI 10.1074/jbc.M703701200; Aziz F, 2007, ANN VASC SURG, V21, P392, DOI 10.1016/j.avsg.2006.11.001; Benowitz NL, 2003, PROG CARDIOVASC DIS, V46, P91, DOI 10.1016/S0033-0620(03)00087-2; Browatzki M, 2005, J VASC RES, V42, P415, DOI 10.1159/000087451; Bungard D, 2010, SCIENCE, V329, P1201, DOI 10.1126/science.1191241; Choi HC, 2008, J BIOL CHEM, V283, P20186, DOI 10.1074/jbc.M803020200; Choi SL, 2001, BIOCHEM BIOPH RES CO, V287, P92, DOI 10.1006/bbrc.2001.5544; Dallas SL, 2002, J BIOL CHEM, V277, P21352, DOI 10.1074/jbc.M111663200; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; Daugherty A, 2010, CLIN SCI, V118, P681, DOI 10.1042/CS20090372; Dong YZ, 2010, CIRCULATION, V121, P792, DOI 10.1161/CIRCULATIONAHA.109.900928; Dua MM, 2010, SURGERY, V148, P429, DOI 10.1016/j.surg.2010.05.014; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Garcia MA, 1999, FEBS LETT, V444, P27, DOI 10.1016/S0014-5793(99)00021-6; Gavrila D, 2005, ARTERIOSCL THROM VAS, V25, P1671, DOI 10.1161/01.ATV.0000172631.50972.0f; Golledge J, 2008, EUR HEART J, V29, P665, DOI 10.1093/eurheartj/ehm557; Golledge J, 2006, ARTERIOSCL THROM VAS, V26, P2605, DOI 10.1161/01.ATV.0000245819.32762.cb; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Han YY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015420; HENNINGFIELD JE, 1993, DRUG ALCOHOL DEPEN, V33, P23, DOI 10.1016/0376-8716(93)90030-T; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Lu H, 2008, CURR HYPERTENS REP, V10, P99, DOI 10.1007/s11906-008-0020-3; Lukasova M, 2011, J CLIN INVEST, V121, P1163, DOI 10.1172/JCI41651; Maegdefessel L, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003441; Matute-Bello G, 2004, J IMMUNOL METHODS, V292, P25, DOI 10.1016/j.jim.2004.05.010; Miyama N, 2010, J VASC SURG, V52, P975, DOI 10.1016/j.jvs.2010.05.086; Moran CS, 2005, CIRCULATION, V111, P3119, DOI 10.1161/CIRCULATIONAHA.104.464727; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Nagata D, 2004, CIRCULATION, V110, P444, DOI 10.1161/01.CIR.0000136025.96811.76; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; Park MJ, 2007, J BIOL CHEM, V282, P30485, DOI 10.1074/jbc.M701081200; Pearce WH, 2006, ANN NY ACAD SCI, V1085, P117, DOI 10.1196/annals.1383.025; Pyo R, 2000, J CLIN INVEST, V105, P1641, DOI 10.1172/JCI8931; Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623; Rateri DL, 2011, CIRC RES, V108, P574, DOI 10.1161/CIRCRESAHA.110.222844; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Shah PK, 1997, CIRCULATION, V96, P2115; Song P, 2011, CIRC RES, V109, P1230, DOI 10.1161/CIRCRESAHA.111.250423; Sparks AR, 2002, AM FAM PHYSICIAN, V65, P1565; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Thomas M, 2006, CIRCULATION, V114, P404, DOI 10.1161/CIRCULATIONAHA.105.607168; Thompson RW, 2002, CURR PROB SURG, V39, P98; THOMPSON RW, 1995, J CLIN INVEST, V96, P318, DOI 10.1172/JCI118037; Tundulawessa Yongyuth, 2010, Journal of the Medical Association of Thailand, V93, P574; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Vorp DA, 2005, ARTERIOSCL THROM VAS, V25, P1558, DOI 10.1161/01.ATV.0000174129.77391.55; Wang SX, 2008, CARDIOVASC RES, V80, P255, DOI 10.1093/cvr/cvn179; Wang SX, 2008, HYPERTENSION, V52, P484, DOI 10.1161/HYPERTENSIONAHA.108.112094; Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530; Wang SX, 2009, DIABETES, V58, P1893, DOI 10.2337/db09-0267; Wang YX, 2005, CIRCULATION, V111, P2219, DOI 10.1161/01.CIR.0000163544.17221.BE; Xie ZL, 2009, MOL CELL BIOL, V29, P3582, DOI 10.1128/MCB.01417-08; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0; Zhang JH, 2008, J BIOL CHEM, V283, P27452, DOI 10.1074/jbc.M802578200; Zhang M, 2008, CIRC RES, V102, P328, DOI 10.1161/CIRCRESAHA.107.163253	58	184	192	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2012	18	6					902	+		10.1038/nm.2711	http://dx.doi.org/10.1038/nm.2711			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22561688	Green Accepted			2022-12-25	WOS:000305116600027
J	Villalobos, LIAC; Lee, S; De Oliveira, C; Ivetac, A; Brandt, W; Armitage, L; Sheard, LB; Tan, X; Parry, G; Mao, HB; Zheng, N; Napier, R; Kepinski, S; Estelle, M				Calderon Villalobos, Luz Irina A.; Lee, Sarah; De Oliveira, Cesar; Ivetac, Anthony; Brandt, Wolfgang; Armitage, Lynne; Sheard, Laura B.; Tan, Xu; Parry, Geraint; Mao, Haibin; Zheng, Ning; Napier, Richard; Kepinski, Stefan; Estelle, Mark			A combinatorial TIR1/AFB-Aux/IAA co-receptor system for differential sensing of auxin	NATURE CHEMICAL BIOLOGY			English	Article							FUNCTIONAL GENOMIC ANALYSIS; GENE FAMILY-MEMBERS; BOX PROTEIN TIR1; ARABIDOPSIS-THALIANA; AUX/IAA PROTEINS; DEGRADATION; RECEPTOR; MUTANTS; ACID; EMBRYOGENESIS	The plant hormone auxin regulates virtually every aspect of plant growth and development. Auxin acts by binding the F-box protein transport inhibitor response 1 (TIR1) and promotes the degradation of the AUXIN/INDOLE-3-ACETIC ACID (Aux/IAA) transcriptional repressors. Here we show that efficient auxin binding requires assembly of an auxin co-receptor complex consisting of TIR1 and an Aux/IAA protein. Heterologous experiments in yeast and quantitative IAA binding assays using purified proteins showed that different combinations of TIR1 and Aux/IAA proteins form co-receptor complexes with a wide range of auxin-binding affinities. Auxin affinity seems to be largely determined by the Aux/IAA. As there are 6 TIR1/AUXIN SIGNALING F-BOX proteins (AFBs) and 29 Aux/IAA proteins in Arabidopsis thaliana, combinatorial interactions may result in many co-receptors with distinct auxin-sensing properties. We also demonstrate that the AFB5-Aux/IAA co-receptor selectively binds the auxinic herbicide picloram. This co-receptor system broadens the effective concentration range of the hormone and may contribute to the complexity of auxin response.	[Calderon Villalobos, Luz Irina A.; Parry, Geraint; Estelle, Mark] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Calderon Villalobos, Luz Irina A.; Parry, Geraint; Estelle, Mark] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Lee, Sarah; Napier, Richard] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [De Oliveira, Cesar; Ivetac, Anthony] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Brandt, Wolfgang] IPB Leibniz Inst Plant Biochem, Dept Bioorgan Chem, Halle, Saale, Germany; [Armitage, Lynne; Kepinski, Stefan] Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England; [Sheard, Laura B.; Tan, Xu; Mao, Haibin; Zheng, Ning] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; [Sheard, Laura B.; Tan, Xu; Mao, Haibin; Zheng, Ning] Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Parry, Geraint] Univ Liverpool, Dept Plant Sci, Liverpool L69 3BX, Merseyside, England	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of Warwick; University of California System; University of California San Diego; Leibniz Institut fur Pflanzenbiochemie; University of Leeds; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Liverpool	Villalobos, LIAC (corresponding author), IPB Leibniz Inst Plant Biochem, Mol Signal Proc Dept, Halle, Saale, Germany.	mestelle@ucsd.edu	Villalobos, Luz Irina A Calderón/L-5876-2016; Tan, Xu/E-7170-2011; Estelle, Mark/ABD-6742-2021; de Oliveira, Cesar Augusto/C-4397-2011	Tan, Xu/0000-0003-4861-4573; Calderon Villalobos, Luz Irina A./0000-0002-6093-1478	US National Institutes of Health (NIH) [R01 CA107134, T32 GM07270]; HHMI; UK Biotechnology and Biological Sciences Research Council [BB/F013981/1, BB/F014651/1]; NIH; US National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA107134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043644, T32GM007270] Funding Source: NIH RePORTER; BBSRC [BB/F014651/1, BB/F007418/1, BB/F013981/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F014651/1, BB/F013981/1, BB/F007418/1] Funding Source: researchfish	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank E.J. Chapman for helpful discussions and comments to the manuscript and R. Shao and I. Kim for technical assistance. We also thank A. McCammon for hosting part of the computational analyses. We gratefully acknowledge financial support from the US National Institutes of Health (NIH) (R01 CA107134 to N.Z. and T32 GM07270 to L. B. S.), HHMI (M. E. and N.Z.) and the UK Biotechnology and Biological Sciences Research Council (BB/F013981/1 to S. K. and BB/F014651/1 to R.N.). The McCammon group, including A. I. and C.D.O., is supported by the NIH, US National Science Foundation and HHMI. We dedicate this work to the memory of L. B. Sheard, a talented young scientist who made key contributions at the early stage of this work. Her life was tragically cut short while this manuscript was under review.	Abel S, 1996, PLANT PHYSIOL, V111, P9, DOI 10.1104/pp.111.1.9; ABEL S, 1994, P NATL ACAD SCI USA, V91, P326, DOI 10.1073/pnas.91.1.326; Alonso JM, 2003, P NATL ACAD SCI USA, V100, P2992, DOI 10.1073/pnas.0438070100; [Anonymous], 2010, PRIM V 2 1; [Anonymous], 2009, MOL OP ENV 2008 10; Calderon-Villalobos LI, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005546; Chapman EJ, 2009, ANNU REV GENET, V43, P265, DOI 10.1146/annurev-genet-102108-134148; Dharmasiri N, 2003, CURR BIOL, V13, P1418, DOI 10.1016/S0960-9822(03)00536-0; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dreher KA, 2006, PLANT CELL, V18, P699, DOI 10.1105/tpc.105.039172; EVANS ML, 1994, PLANTA, V194, P215, DOI 10.1007/BF01101680; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Greenham K, 2011, CURR BIOL, V21, P520, DOI 10.1016/j.cub.2011.02.029; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Hao GF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010742; Hayashi K, 2008, P NATL ACAD SCI USA, V105, P5632, DOI 10.1073/pnas.0711146105; Holland JJ, 2009, J EXP BOT, V60, P1969, DOI 10.1093/jxb/erp113; Jenik PD, 2005, PLANT CELL, V17, P3362, DOI 10.1105/tpc.105.036889; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Korb O, 2010, J CHEM INF MODEL, V50, P1669, DOI 10.1021/ci1000218; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Long JA, 2006, SCIENCE, V312, P1520, DOI 10.1126/science.1123841; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Overvoorde P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001537; Overvoorde PJ, 2005, PLANT CELL, V17, P3282, DOI 10.1105/tpc.105.036723; Parry G, 2009, P NATL ACAD SCI USA, V106, P22540, DOI 10.1073/pnas.0911967106; Prigge MJ, 2010, CURR BIOL, V20, P1907, DOI 10.1016/j.cub.2010.08.050; Prusty R, 2004, P NATL ACAD SCI USA, V101, P4153, DOI 10.1073/pnas.0400659101; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Scarpella E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001511; SIPPL MJ, 1990, J MOL BIOL, V213, P859, DOI 10.1016/S0022-2836(05)80269-4; Sundberg E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001628; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; TIMPTE C, 1994, GENETICS, V138, P1239; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vernoux T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.39; Vernoux T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001487; Vidal EA, 2010, P NATL ACAD SCI USA, V107, P4477, DOI 10.1073/pnas.0909571107; Walsh TA, 2006, PLANT PHYSIOL, V142, P542, DOI 10.1104/pp.106.085969; Weijers D, 2006, DEV CELL, V10, P265, DOI 10.1016/j.devcel.2005.12.001; Weijers D, 2005, EMBO J, V24, P1874, DOI 10.1038/sj.emboj.7600659; Weijers D., 2011, AUXIN SIGNALING SYNT; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Worley CK, 2000, PLANT J, V21, P553, DOI 10.1046/j.1365-313x.2000.00703.x; Zhao YC, 2010, J PLANT PHYSIOL, V167, P879, DOI 10.1016/j.jplph.2010.01.012	50	360	371	12	205	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2012	8	5					477	485		10.1038/NCHEMBIO.926	http://dx.doi.org/10.1038/NCHEMBIO.926			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	928DY	22466420	Green Submitted, Green Accepted			2022-12-25	WOS:000302962500015
J	Vang, T; Liu, WH; Delacroix, L; Wu, SD; Vasile, S; Dahl, R; Yang, L; Musumeci, L; Francis, D; Landskron, J; Tasken, K; Tremblay, ML; Lie, BA; Page, R; Mustelin, T; Rahmouni, S; Rickert, RC; Tautz, L				Vang, Torkel; Liu, Wallace H.; Delacroix, Laurence; Wu, Shuangding; Vasile, Stefan; Dahl, Russell; Yang, Li; Musumeci, Lucia; Francis, Dana; Landskron, Johannes; Tasken, Kjetil; Tremblay, Michel L.; Lie, Benedicte A.; Page, Rebecca; Mustelin, Tomas; Rahmouni, Souad; Rickert, Robert C.; Tautz, Lutz			LYP inhibits T-cell activation when dissociated from CSK	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; KINASE P50(CSK); AUTOIMMUNE-DISEASE; PTP-PEST; RECEPTOR; VARIANT; CONFORMATION; ASSOCIATION; DOMAIN; PEP	Lymphoid tyrosine phosphatase (LYP) and C-terminal Src kinase (CSK) are negative regulators of signaling mediated through the T-cell antigen receptor (TCR) and are thought to act in a cooperative manner when forming a complex. Here we studied the spatiotemporal dynamics of the LYP-CSK complex in T cells. We demonstrate that dissociation of this complex is necessary for recruitment of LYP to the plasma membrane, where it downmodulates TCR signaling. Development of a potent and selective chemical probe of LYP confirmed that LYP inhibits T-cell activation when removed from CSK. Our findings may explain the reduced TCR-mediated signaling associated with a single-nucleotide polymorphism that confers increased risk for certain autoimmune diseases, including type 1 diabetes and rheumatoid arthritis, and results in expression of a mutant LYP that is unable to bind CSK. Our compound also represents a starting point for the development of a LYP-based treatment of autoimmunity.	[Vang, Torkel; Liu, Wallace H.; Wu, Shuangding; Mustelin, Tomas; Rickert, Robert C.; Tautz, Lutz] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA USA; [Vang, Torkel; Landskron, Johannes; Tasken, Kjetil] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway; [Delacroix, Laurence; Musumeci, Lucia; Rahmouni, Souad] Univ Liege, Grp Interdisciplinaire Genoprote Appl Signal Tran, Immunol & Infect Dis Unit, Liege, Belgium; [Vasile, Stefan; Dahl, Russell; Yang, Li] Sanford Burnham Med Res Inst, Conrad Prebys Ctr Chem Gen, La Jolla, CA USA; [Francis, Dana; Page, Rebecca] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Tremblay, Michel L.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada; [Lie, Benedicte A.] Univ Oslo, Dept Med Genet, Oslo, Norway; [Lie, Benedicte A.] Oslo Univ Hosp, Oslo, Norway	Sanford Burnham Prebys Medical Discovery Institute; University of Oslo; University of Liege; Sanford Burnham Prebys Medical Discovery Institute; Brown University; McGill University; University of Oslo; University of Oslo	Vang, T (corresponding author), Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA USA.	tautz@burnham.org	Tautz, Lutz/M-9989-2014	Tautz, Lutz/0000-0002-4075-6238; Dahl, Russell/0000-0002-2939-1004; Mustelin, Tomas/0000-0001-5912-8840; Tasken, Kjetil/0000-0003-2841-4697; Delacroix, Laurence/0000-0003-3440-5359	Exploratory Pharmacology Core at Sanford-Burnham Medical Research Institute; US National Institutes of Health [1R21CA132121]; Norwegian Cancer Society; American Cancer Society [RSG-08-067-01-LIB]; Oxnard Foundation; Belgian Research National Scientific Fund; Liege University; NATIONAL CANCER INSTITUTE [R21CA132121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041649] Funding Source: NIH RePORTER	Exploratory Pharmacology Core at Sanford-Burnham Medical Research Institute; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norwegian Cancer Society(Norwegian Cancer Society); American Cancer Society(American Cancer Society); Oxnard Foundation; Belgian Research National Scientific Fund(Fonds de la Recherche Scientifique - FNRS); Liege University(University of Liege); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Smith and the Exploratory Pharmacology Core at Sanford-Burnham Medical Research Institute for support and thoughtful discussions; S. Ormenese and the Groupe Interdisciplinaire de Genoproteomique Appliquee Imaging Core for their help with flow cytometry; and G. M. Tjorhom, S. T. Flam and J. Solheim for technical assistance. This work was supported by the US National Institutes of Health (grant 1R21CA132121 to L. T.), the Norwegian Cancer Society (T. V.), the American Cancer Society (research scholar grant RSG-08-067-01-LIB to R. P.), the Oxnard Foundation (research grant to T.M./R.C.R.), the Belgian Research National Scientific Fund (Mandat d'Impulsion Scientifique Young Investigator Starting Grant to S. R.) and the Liege University (startup grant to S.R.).	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Arechiga AF, 2009, J IMMUNOL, V182, P3343, DOI 10.4049/jimmunol.0713370; Arimura Y, 2008, MOL IMMUNOL, V45, P3074, DOI 10.1016/j.molimm.2008.03.019; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; CHOW LML, 1993, NATURE, V365, P156, DOI 10.1038/365156a0; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Cote JF, 2002, J BIOL CHEM, V277, P2973, DOI 10.1074/jbc.M106428200; Davidson D, 1997, J BIOL CHEM, V272, P23455, DOI 10.1074/jbc.272.37.23455; Fiorillo E, 2010, J BIOL CHEM, V285, P26506, DOI 10.1074/jbc.M110.111104; Ghose R, 2001, NAT STRUCT BIOL, V8, P998, DOI 10.1038/nsb1101-998; Gjorloff-Wingren A, 1999, EUR J IMMUNOL, V29, P3845, DOI 10.1002/(SICI)1521-4141(199912)29:12<3845::AID-IMMU3845>3.0.CO;2-U; Gregersen PK, 2009, ANNU REV IMMUNOL, V27, P363, DOI 10.1146/annurev.immunol.021908.132653; Gregorieff A, 1998, J BIOL CHEM, V273, P13217, DOI 10.1074/jbc.273.21.13217; Heinonen KM, 2009, P NATL ACAD SCI USA, V106, P9368, DOI 10.1073/pnas.0812109106; Liu SJ, 2008, J AM CHEM SOC, V130, P17075, DOI 10.1021/ja8068177; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Tautz L, 2006, EXPERT OPIN THER TAR, V10, P157, DOI 10.1517/14728222.10.1.157; Tautz L, 2005, J BIOL CHEM, V280, P9400, DOI 10.1074/jbc.M413122200; Tautz L, 2007, METHODS, V42, P250, DOI 10.1016/j.ymeth.2007.02.014; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Vang T, 2001, J EXP MED, V193, P497, DOI 10.1084/jem.193.4.497; Vang T, 2008, ANNU REV IMMUNOL, V26, P29, DOI 10.1146/annurev.immunol.26.021607.090418; Vang T, 2011, J MED CHEM, V54, P562, DOI 10.1021/jm101004d; Viken MK, 2007, TISSUE ANTIGENS, V70, P190, DOI 10.1111/j.1399-0039.2007.00871.x; Vintonyak VV, 2009, CURR OPIN CHEM BIOL, V13, P272, DOI 10.1016/j.cbpa.2009.03.021; Willett P, 2006, DRUG DISCOV TODAY, V11, P1046, DOI 10.1016/j.drudis.2006.10.005; Wu SD, 2009, CHEMMEDCHEM, V4, P440, DOI 10.1002/cmdc.200800375; Yu X, 2007, P NATL ACAD SCI USA, V104, P19767, DOI 10.1073/pnas.0706233104; Zhang JY, 2011, NAT GENET, V43, P902, DOI 10.1038/ng.904; Zhang X, 2010, J MED CHEM, V53, P2482, DOI 10.1021/jm901645u; Zikherman J, 2009, J IMMUNOL, V182, P4093, DOI 10.4049/jimmunol.0803317	37	105	107	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2012	8	5					437	446		10.1038/NCHEMBIO.916	http://dx.doi.org/10.1038/NCHEMBIO.916			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	928DY	22426112	Green Accepted			2022-12-25	WOS:000302962500010
J	Vega, NM; Allison, KR; Khalil, AS; Collins, JJ				Vega, Nicole M.; Allison, Kyle R.; Khalil, Ahmad S.; Collins, James J.			Signaling-mediated bacterial persister formation	NATURE CHEMICAL BIOLOGY			English	Article							GENERAL STRESS-RESPONSE; ESCHERICHIA-COLI; OXIDATIVE STRESS; INDOLE; RESISTANCE; CELLS; OPERON	Here we show that bacterial communication through indole signaling induces persistence, a phenomenon in which a subset of an isogenic bacterial population tolerates antibiotic treatment. We monitor indole-induced persister formation using microfluidics and identify the role of oxidative-stress and phage-shock pathways in this phenomenon. We propose a model in which indole signaling 'inoculates' a bacterial subpopulation against antibiotics by activating stress responses, leading to persister formation.	[Vega, Nicole M.; Allison, Kyle R.; Khalil, Ahmad S.; Collins, James J.] Boston Univ, Howard Hughes Med Inst, Boston, MA 02215 USA; [Vega, Nicole M.; Allison, Kyle R.; Khalil, Ahmad S.; Collins, James J.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Vega, Nicole M.; Allison, Kyle R.; Khalil, Ahmad S.; Collins, James J.] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA; [Collins, James J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Boston University; Howard Hughes Medical Institute; Boston University; Boston University; Boston University; Harvard University	Vega, NM (corresponding author), Boston Univ, Howard Hughes Med Inst, Boston, MA 02215 USA.	jcollins@bu.edu			US National Science Foundation; US National Institutes of Health; Howard Hughes Medical Institute; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank R. H. W. Lam for help with microfluidics. This work was supported by funding from the US National Science Foundation, the US National Institutes of Health Director's Pioneer Award Program and the Howard Hughes Medical Institute.	Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; CRAWFORD DR, 1994, ENVIRON HEALTH PERSP, V102, P25, DOI 10.2307/3432208; Di Martino P, 2003, CAN J MICROBIOL, V49, P443, DOI 10.1139/W03-056; Dukan S, 1999, J BIOL CHEM, V274, P26027, DOI 10.1074/jbc.274.37.26027; Garbe TR, 2000, ARCH MICROBIOL, V173, P78, DOI 10.1007/s002030050012; Gefen O, 2009, FEMS MICROBIOL REV, V33, P704, DOI 10.1111/j.1574-6976.2008.00156.x; Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Lee J, 2008, ISME J, V2, P1007, DOI 10.1038/ismej.2008.54; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Pinero-Fernandez S, 2011, J BACTERIOL, V193, P1793, DOI 10.1128/JB.01477-10; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Smith PA, 2007, NAT CHEM BIOL, V3, P549, DOI 10.1038/nchembio.2007.27; STORZ G, 1990, ANTON LEEUW INT J G, V58, P157, DOI 10.1007/BF00548927; Han TH, 2011, RES MICROBIOL, V162, P108, DOI 10.1016/j.resmic.2010.11.005; Wang DD, 2001, J BACTERIOL, V183, P4210, DOI 10.1128/JB.183.14.4210-4216.2001; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Wang XX, 2011, NAT CHEM BIOL, V7, P359, DOI [10.1038/NCHEMBIO.560, 10.1038/nchembio.560]; WEINER L, 1994, P NATL ACAD SCI USA, V91, P2191, DOI 10.1073/pnas.91.6.2191; YANOFSKY C, 1991, J BACTERIOL, V173, P6009, DOI 10.1128/jb.173.19.6009-6017.1991	25	291	303	9	150	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2012	8	5					431	433		10.1038/NCHEMBIO.915	http://dx.doi.org/10.1038/NCHEMBIO.915			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	928DY	22426114	Green Accepted			2022-12-25	WOS:000302962500008
J	Talchai, C; Xuan, SH; Kitamura, T; DePinho, RA; Accili, D				Talchai, Chutima; Xuan, Shouhong; Kitamura, Tadahiro; DePinho, Ronald A.; Accili, Domenico			Generation of functional insulin-producing cells in the gut by Foxo1 ablation	NATURE GENETICS			English	Article							GLUCAGON-LIKE PEPTIDE-1; STEM-CELLS; ENDOCRINE; DIFFERENTIATION; EXPRESSION; PROGENITORS; PANCREAS; LINEAGE; PROTEIN; GROWTH	Restoration of regulated insulin secretion is the ultimate goal of therapy for type 1 diabetes. Here, we show that, unexpectedly, somatic ablation of Foxo1 in Neurog3(+) enteroendocrine progenitor cells gives rise to gut insulin-positive (Ins(+)) cells that express markers of mature beta cells and secrete bioactive insulin as well as C-peptide in response to glucose and sulfonylureas. Lineage tracing experiments showed that gut Ins(+) cells arise cell autonomously from Foxo1-deficient cells. Inducible Foxo1 ablation in adult mice also resulted in the generation of gut Ins(+) cells. Following ablation by the beta-cell toxin streptozotocin, gut Ins(+) cells regenerate and produce insulin, reversing hyperglycemia in mice. The data indicate that Neurog3(+) enteroendocrine progenitors require active Foxo1 to prevent differentiation into Ins(+) cells. Foxo1 ablation in gut epithelium may provide an approach to restore insulin production in type 1 diabetes.	[Talchai, Chutima; Accili, Domenico] Columbia Univ, Med Ctr, Naomi Berrie Diabet Ctr, New York, NY 10027 USA; [Talchai, Chutima; Accili, Domenico] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Talchai, Chutima] Chulalongkorn Univ, Fac Med, King Chulalongkorn Mem Hosp, Bangkok 10330, Thailand; [Xuan, Shouhong] Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; [Kitamura, Tadahiro] Gunma Univ, Inst Mol & Cellular Regulat, Metabol Signal Res Ctr, Maebashi, Gunma 371, Japan; [DePinho, Ronald A.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	Columbia University; Columbia University; Chulalongkorn University; Columbia University; Gunma University; University of Texas System; UTMD Anderson Cancer Center	Accili, D (corresponding author), Columbia Univ, Med Ctr, Naomi Berrie Diabet Ctr, New York, NY 10027 USA.	da230@columbia.edu		DePinho, Ronald/0000-0002-5625-577X	US National Institutes of Health [DK58282, DK64819]; Columbia University Diabetes Research Center [DK63608]; New York Stem Cell Foundation; Brehm Coalition; Russell Berrie Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064819, R01DK058282, R01DK057539, R37DK058282, P30DK063608] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Columbia University Diabetes Research Center; New York Stem Cell Foundation; Brehm Coalition; Russell Berrie Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Efstratiadis (Biomedical Research Foundation, Academy of Athens, Athens, Greece) for Ins2-Gfp knock-in mice and A. Leiter (University of Massachusetts) for Neurog3-Cre mice. We thank L.S., J.Y.K.-M. and T.M. for advice and reagents and Q.X. for technical support. We also thank members of the Accili laboratory for insightful discussion and critical reading of the manuscript. This work was supported by grants from the US National Institutes of Health (DK58282 and DK64819), the Columbia University Diabetes Research Center (DK63608), the Druckenmiller Fellowship of the New York Stem Cell Foundation, the Brehm Coalition and the Russell Berrie Foundation.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Al-Masri M, 2010, DIABETOLOGIA, V53, P699, DOI 10.1007/s00125-009-1632-0; Bjerknes M, 2006, DEV BIOL, V300, P722, DOI 10.1016/j.ydbio.2006.07.040; Bonal C, 2008, INT J DEV BIOL, V52, P823, DOI 10.1387/ijdb.072444cb; Cheung AT, 2000, SCIENCE, V290, P1959, DOI 10.1126/science.290.5498.1959; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fujita Y, 2010, GASTROENTEROLOGY, V138, P1966, DOI 10.1053/j.gastro.2010.01.049; Fukuda A, 2006, J CLIN INVEST, V116, P1484, DOI 10.1172/JCI27704; Gao N, 2007, CELL METAB, V6, P267, DOI 10.1016/j.cmet.2007.08.015; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Golaz JL, 2007, IN VITRO CELL DEV-AN, V43, P176, DOI 10.1007/s11626-007-9034-4; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hoffman BG, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-81; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; HUNT RK, 1972, P NATL ACAD SCI USA, V69, P2860, DOI 10.1073/pnas.69.10.2860; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kageyama R, 2000, MOL CELLS, V10, P1, DOI 10.1007/s10059-000-0001-0; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kitamura T, 2009, MOL CELL BIOL, V29, P4417, DOI 10.1128/MCB.01622-08; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lee CS, 2002, GENE DEV, V16, P1488, DOI 10.1101/gad.985002; Lee JC, 2001, DIABETES, V50, P928, DOI 10.2337/diabetes.50.5.928; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Mundell NA, 2011, DEVELOPMENT, V138, P641, DOI 10.1242/dev.054718; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakamura T, 2007, J GASTROENTEROL, V42, P705, DOI 10.1007/s00535-007-2087-z; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Nielsen K, 1999, DIABETES, V48, P2324, DOI 10.2337/diabetes.48.12.2324; Nielsen LB, 2007, EUR J ENDOCRINOL, V156, P663, DOI 10.1530/EJE-06-0756; Okamoto H, 2004, J CLIN INVEST, V114, P214, DOI 10.1172/JCI200421645; Okamoto H, 2006, J CLIN INVEST, V116, P775, DOI 10.1172/JCI24967; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Schonhoff SE, 2004, ENDOCRINOLOGY, V145, P2639, DOI 10.1210/en.2004-0051; Schonhoff SE, 2004, DEV BIOL, V270, P443, DOI 10.1016/j.ydbio.2004.03.013; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Sewalt RGAB, 1999, MOL CELL BIOL, V19, P777; SHERMAN BM, 1971, J CLIN INVEST, V50, P849, DOI 10.1172/JCI106556; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Sonoshita M, 2011, CANCER CELL, V19, P125, DOI 10.1016/j.ccr.2010.11.008; Suzuki A, 2003, P NATL ACAD SCI USA, V100, P5034, DOI 10.1073/pnas.0936260100; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Wang S, 2009, P NATL ACAD SCI USA, V106, P9715, DOI 10.1073/pnas.0904247106; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zhou Q, 2008, COLD SH Q B, V73, P175, DOI 10.1101/sqb.2008.73.002	56	111	123	0	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2012	44	4					406	U213		10.1038/ng.2215	http://dx.doi.org/10.1038/ng.2215			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	916VF	22406641	Green Accepted			2022-12-25	WOS:000302130600014
J	Zeng, X; King, RW				Zeng, Xing; King, Randall W.			An APC/C inhibitor stabilizes cyclin B1 by prematurely terminating ubiquitination	NATURE CHEMICAL BIOLOGY			English	Article							ANAPHASE-PROMOTING COMPLEX; SPINDLE ASSEMBLY CHECKPOINT; SUBSTRATE-BINDING; DEGRADATION; CDC20; DRIVES; BOX; COMPLEX/CYCLOSOME; PROCESSIVITY; MAINTAINS	The anaphase-promoting complex/cyclosome (APC) is a ubiquitin ligase that is required for exit from mitosis. We previously showed that tosyl arginine methyl ester (TAME) inhibits APC-dependent proteolysis by competing with the C-terminal isoleucine-arginine tail of the APC activator cell division cycle 20 (Cdc20) for APC binding. Here we show that in the absence of APC substrates, TAME ejects Cdc20 from the APC by promoting Cdc20 autoubiquitination in its N-terminal region. Cyclin B1 antagonizes TAME's effect by promoting binding of free Cdc20 to the APC and by suppressing Cdc20 autoubiquitination. Nevertheless, TAME stabilizes cyclin B1 in Xenopus extracts by two mechanisms. First, it reduces the k(cat) of the APC-Cdc20-cyclin B1 complex without affecting the K-mr slowing the initial ubiquitination of unmodified cyclin B1. Second, as cyclin B1 becomes ubiquitinated, it loses its ability to promote Cdc20 binding to the APC in the presence of TAME. As a result, cyclin B1 ubiquitination terminates before reaching the threshold necessary for proteolysis.	[Zeng, Xing; King, Randall W.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Zeng, X (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	randy_king@hms.harvard.edu		King, Randall/0000-0001-7882-8180	US National Institutes of Health [GM66492]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM066492, R01GM066492] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Pines (University of Cambridge, UK) for providing the Cdc20<SUP>K-less</SUP> construct and J. W. Harper for critically reading the manuscript. This work was supported by US National Institutes of Health grant GM66492 to R.W.K.	Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Burton JL, 2005, MOL CELL, V18, P533, DOI 10.1016/j.molcel.2005.04.022; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Buschhorn BA, 2011, NAT STRUCT MOL BIOL, V18, P6, DOI 10.1038/nsmb.1979; da Fonseca PCA, 2011, NATURE, V470, P274, DOI 10.1038/nature09625; Dimova NV, 2012, NAT CELL BIOL, V14, P168, DOI 10.1038/ncb2425; Eytan E, 2006, P NATL ACAD SCI USA, V103, P2081, DOI 10.1073/pnas.0510695103; Foe IT, 2011, CURR BIOL, V21, P1870, DOI 10.1016/j.cub.2011.09.051; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Ge S, 2009, CELL CYCLE, V8, P167, DOI 10.4161/cc.8.1.7606; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; Hilioti Z, 2001, CURR BIOL, V11, P1347, DOI 10.1016/S0960-9822(01)00399-2; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kimata Y, 2008, MOL CELL, V32, P576, DOI 10.1016/j.molcel.2008.09.023; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Mansfeld J, 2011, NAT CELL BIOL, V13, P1234, DOI 10.1038/ncb2347; Matyskiela ME, 2009, MOL CELL, V34, P68, DOI 10.1016/j.molcel.2009.02.027; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Pan J, 2004, GENE DEV, V18, P1439, DOI 10.1101/gad.1184204; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Thornton BR, 2006, GENE DEV, V20, P449, DOI 10.1101/gad.1396906; Townsley FM, 1997, P NATL ACAD SCI USA, V94, P2362, DOI 10.1073/pnas.94.6.2362; Varetti G, 2011, MOL CELL, V44, P710, DOI 10.1016/j.molcel.2011.11.014; Verma R, 2004, SCIENCE, V306, P117, DOI 10.1126/science.1100946; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Wu T, 2010, P NATL ACAD SCI USA, V107, P1355, DOI 10.1073/pnas.0912802107; Zeng X, 2010, CANCER CELL, V18, P382, DOI 10.1016/j.ccr.2010.08.010	37	48	49	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2012	8	4					383	392		10.1038/NCHEMBIO.801	http://dx.doi.org/10.1038/NCHEMBIO.801			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	913PO	22366722	Green Submitted, Green Accepted			2022-12-25	WOS:000301890100013
J	Anderson, BH; Kasher, PR; Mayer, J; Szynkiewicz, M; Jenkinson, EM; Bhaskar, SS; Urquhart, JE; Daly, SB; Dickerson, JE; O'Sullivan, J; Leibundgut, EO; Muter, J; Abdel-Salem, GMH; Babul-Hirji, R; Baxter, P; Berger, A; Bonafe, L; Brunstom-Hernandez, JE; Buckard, JA; Chitayat, D; Chong, WK; Cordelli, DM; Ferreira, P; Fluss, J; Forrest, EH; Franzoni, E; Garone, C; Hammans, SR; Houge, G; Hughes, I; Jacquemont, S; Jeannet, PY; Jefferson, RJ; Kumar, R; Kutschke, G; Lundberg, S; Lourenco, CM; Mehta, R; Naidu, S; Nischal, KK; Nunes, L; Ounap, K; Philippart, M; Prabhakar, P; Risen, SR; Schiffmann, R; Soh, C; Stephenson, JBP; Stewart, H; Stone, J; Tolmie, JL; van der Knaap, MS; Vieira, JP; Vilain, CN; Wakeling, EL; Wermenbol, V; Whitney, A; Lovell, SC; Meyer, S; Livingston, JH; Baerlocher, GM; Black, GCM; Rice, GI; Crow, YJ				Anderson, Beverley H.; Kasher, Paul R.; Mayer, Josephine; Szynkiewicz, Marcin; Jenkinson, Emma M.; Bhaskar, Sanjeev S.; Urquhart, Jill E.; Daly, Sarah B.; Dickerson, Jonathan E.; O'Sullivan, James; Leibundgut, Elisabeth Oppliger; Muter, Joanne; Abdel-Salem, Ghada M. H.; Babul-Hirji, Riyana; Baxter, Peter; Berger, Andrea; Bonafe, Luisa; Brunstom-Hernandez, Janice E.; Buckard, Johannes A.; Chitayat, David; Chong, Wui K.; Cordelli, Duccio M.; Ferreira, Patrick; Fluss, Joel; Forrest, Ewan H.; Franzoni, Emilio; Garone, Caterina; Hammans, Simon R.; Houge, Gunnar; Hughes, Imelda; Jacquemont, Sebastien; Jeannet, Pierre-Yves; Jefferson, Rosalind J.; Kumar, Ram; Kutschke, Georg; Lundberg, Staffan; Lourenco, Charles M.; Mehta, Ramesh; Naidu, Sakkubai; Nischal, Ken K.; Nunes, Luis; Ounap, Katrin; Philippart, Michel; Prabhakar, Prab; Risen, Sarah R.; Schiffmann, Raphael; Soh, Calvin; Stephenson, John B. P.; Stewart, Helen; Stone, Jon; Tolmie, John L.; van der Knaap, Marjo S.; Vieira, Jose P.; Vilain, Catheline N.; Wakeling, Emma L.; Wermenbol, Vanessa; Whitney, Andrea; Lovell, Simon C.; Meyer, Stefan; Livingston, John H.; Baerlocher, Gabriela M.; Black, Graeme C. M.; Rice, Gillian I.; Crow, Yanick J.			Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus	NATURE GENETICS			English	Article							CEREBRORETINAL MICROANGIOPATHY; FAMILIAL SYNDROME; CALCIFICATIONS; PROTEIN; CYSTS; DNA; LEUKOENCEPHALOPATHY; DEFECTS; CST	Coats plus is a highly pleiotropic disorder particularly affecting the eye, brain, bone and gastrointestinal tract. Here, we show that Coats plus results from mutations in CTC1, encoding conserved telomere maintenance component 1, a member of the mammalian homolog of the yeast heterotrimeric CST telomeric capping complex. Consistent with the observation of shortened telomeres in an Arabidopsis CTC1 mutant and the phenotypic overlap of Coats plus with the telomeric maintenance disorders comprising dyskeratosis congenita, we observed shortened telomeres in three individuals with Coats plus and an increase in spontaneous gamma H2AX-positive cells in cell lines derived from two affected individuals. CTC1 is also a subunit of the alpha-accessory factor (AAF) complex, stimulating the activity of DNA polymerase-alpha primase, the only enzyme known to initiate DNA replication in eukaryotic cells. Thus, CTC1 may have a function in DNA metabolism that is necessary for but not specific to telomeric integrity.	[Anderson, Beverley H.; Kasher, Paul R.; Mayer, Josephine; Szynkiewicz, Marcin; Jenkinson, Emma M.; Bhaskar, Sanjeev S.; Urquhart, Jill E.; Daly, Sarah B.; Dickerson, Jonathan E.; O'Sullivan, James; Black, Graeme C. M.; Rice, Gillian I.; Crow, Yanick J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Leibundgut, Elisabeth Oppliger; Baerlocher, Gabriela M.] Univ Hosp Bern, Dept Clin Res, CH-3010 Bern, Switzerland; [Leibundgut, Elisabeth Oppliger; Baerlocher, Gabriela M.] Univ Bern, Bern, Switzerland; [Muter, Joanne; Meyer, Stefan] Univ Manchester, Stem Cell & Leukaemia Prote Lab, Manchester, Lancs, England; [Abdel-Salem, Ghada M. H.] Natl Res Ctr, Human Genet & Genome Res Div, Dept Clin Genet, Cairo, Egypt; [Babul-Hirji, Riyana; Chitayat, David] Univ Toronto, Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Baxter, Peter] Sheffield Childrens Natl Hlth Serv NHS Fdn Trust, Ryegate Ctr, Sheffield, S Yorkshire, England; [Berger, Andrea] Johannes Gutenberg Univ Mainz, Dept Pediat Neurol, Mainz, Germany; [Berger, Andrea] Childrens Hosp Harlaching, Dept Pediat Neurol, Munich, Germany; [Bonafe, Luisa] CHU Vaudois, Div Mol Pediat, CH-1011 Lausanne, Switzerland; [Brunstom-Hernandez, Janice E.] Washington Univ, Sch Med, Dept Neurol, St Louis Childrens Hosp, St Louis, MO 63110 USA; [Buckard, Johannes A.] Evangel Krankenhaus EVK Dusseldorf, Sozialpadiatr Zentrum, Dusseldorf, Germany; [Chitayat, David] Univ Toronto, Mt Sinai Hosp, Prenatal Diag & Med Genet Program, Dept Obstet & Gynecol, Toronto, ON M5G 1X5, Canada; [Chong, Wui K.] Great Ormond St Hosp Sick Children, Dept Radiol, London WC1N 3JH, England; [Cordelli, Duccio M.; Franzoni, Emilio; Garone, Caterina] Univ Bologna, S Orsola Malpighi Hosp, Child Neuropsychiat Unit, Bologna, Italy; [Ferreira, Patrick] Alberta Childrens Prov Gen Hosp, Div Med Genet, Calgary, AB, Canada; [Fluss, Joel] Geneva Childrens Hosp, Geneva, Switzerland; [Forrest, Ewan H.] Glasgow Royal Infirm, Glasgow G4 0SF, Lanark, Scotland; [Garone, Caterina] Columbia Univ, Med Ctr, Dept Neurol, New York, NY USA; [Hammans, Simon R.] Southampton Gen Hosp, Wessex Neurol Ctr, Southampton SO9 4XY, Hants, England; [Houge, Gunnar] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Hughes, Imelda] Cent Manchester Univ Hosp NHS Fdn Trust, Royal Manchester Childrens Hosp, Manchester, Lancs, England; [Jacquemont, Sebastien] CHU Vaudois, Serv Genet Med, CH-1011 Lausanne, Switzerland; [Jeannet, Pierre-Yves] CHU Vaudois, Dept Pediat, Pediat Neurol Unit, CH-1011 Lausanne, Switzerland; [Jefferson, Rosalind J.] Royal Berkshire Hosp, Dingley Specialist Childrens Ctr, Reading RG1 5AN, Berks, England; [Kumar, Ram] Alder Hey Childrens NHS Fdn Trust, Dept Neurol, Liverpool, Merseyside, England; [Kutschke, Georg] Univ Klinikum Saarlandes, Kliniken Kinder & Jugendmed, Klin Allgemeine Padiatrie & Neonatol, Homburg, Germany; [Lundberg, Staffan] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Lourenco, Charles M.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurosci, Neurogenet Unit, Sao Paulo, Brazil; [Mehta, Ramesh] Bedford Hosp NHS Trust, Bedford, England; [Naidu, Sakkubai] Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Neurogenet Unit,Hugo Moser Res Inst, Baltimore, MD USA; [Nischal, Ken K.] UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA USA; [Nischal, Ken K.] UPMC, Ctr Eye, Pittsburgh, PA USA; [Nunes, Luis] Univ Nova Lisboa, Fac Ciencias Med, Dept Med Genet, Hosp Dona Estefania,Ctr Hosp Lisboa Cent CHLC, P-1200 Lisbon, Portugal; [Ounap, Katrin] Tartu Univ Hosp, United Labs, Dept Genet, Tartu, Estonia; [Philippart, Michel] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA; [Prabhakar, Prab] Great Ormond St Hosp Sick Children, Dept Neurol, London WC1N 3JH, England; [Risen, Sarah R.] Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Dept Neurol & Dev Med, Baltimore, MD USA; [Schiffmann, Raphael] Baylor Res Inst, Inst Metab Dis, Dallas, TX USA; [Soh, Calvin] Salford Royal NHS Fdn Trust, Dept Neuroradiol, Salford, Lancs, England; [Stephenson, John B. P.] Royal Hosp Sick Children, Fraser Allander Neurosci Unit, Glasgow G3 8SJ, Lanark, Scotland; [Stewart, Helen] Oxford Radcliffe Hosp NHS Trust, Dept Clin Genet, Oxford, England; [Stone, Jon] Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland; [Tolmie, John L.] Royal Hosp Sick Children, Dept Clin Genet, Glasgow G3 8SJ, Lanark, Scotland; [van der Knaap, Marjo S.] Vrije Univ Amsterdam, Med Ctr, Dept Child Neurol, Amsterdam, Netherlands; [Vieira, Jose P.] Ctr Hosp Lisboa Cent, Hosp Dona Estefania, Dept Neurol, Lisbon, Portugal; [Vilain, Catheline N.] Univ Libre Bruxelles, Ctr Human Genet, Dept Med Genet, Brussels, Belgium; [Wakeling, Emma L.] NW London Hosp NHS Trust, NW Thames Reg Genet Serv, Harrow, Middx, England; [Wermenbol, Vanessa] Univ Libre Bruxelles, Hop Erasme, Dept Pediat Neurol, Brussels, Belgium; [Whitney, Andrea] Southampton Univ Hosp Fdn Trust, Southampton, Hants, England; [Lovell, Simon C.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Livingston, John H.] Leeds Gen Infirm, Dept Paediat Neurol, Leeds, W Yorkshire, England	University of Manchester; University of Bern; University Hospital of Bern; University of Bern; University of Manchester; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Johannes Gutenberg University of Mainz; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); St. Louis Children's Hospital; Washington University (WUSTL); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; Alberta Childrens Hospital; University of Calgary; University of Geneva; University of Glasgow; Columbia University; University of Southampton; University of Bergen; Haukeland University Hospital; Royal Manchester Children's Hospital; University of Manchester; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Royal Berkshire Hospital; Alder Hey Children's NHS Foundation Trust; Universitatsklinikum des Saarlandes; Uppsala University; Universidade de Sao Paulo; Johns Hopkins University; Kennedy Krieger Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centro Hospitalar de Lisboa Central, EPE; Universidade Nova de Lisboa; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Johns Hopkins University; Kennedy Krieger Institute; Baylor Scott & White Health; Baylor University Medical Center; Salford Royal NHS Foundation Trust; University of Glasgow; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Edinburgh; University of Glasgow; Vrije Universiteit Amsterdam; Centro Hospitalar de Lisboa Central, EPE; Universidade de Lisboa; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of Manchester; Leeds General Infirmary; University of Leeds	Crow, YJ (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.	yanickcrow@mac.com	Jacquemont, Sebastien/AAS-5060-2021; Garone, Caterina/AAB-8659-2019; Lourenço, Charles M/O-2731-2013; wei, wei/HHR-8613-2022; Ounap, Katrin/Q-1103-2016; Stone, Jon/C-3119-2014; Cordelli, Duccio Maria/Q-4983-2016; Oppliger Leibundgut, Elisabeth/AGG-5030-2022; Crow, Yanick J/N-6120-2014; Urquhart, Jill/G-2282-2015; Cordelli, Duccio Maria/N-4725-2019; vieira, jose pedro/AAT-4370-2020; Rice, Gillian I/G-3128-2015; Black, Graeme/K-7374-2015	Jacquemont, Sebastien/0000-0001-6838-8767; Garone, Caterina/0000-0003-4928-1037; Ounap, Katrin/0000-0002-4594-6364; Stone, Jon/0000-0001-9829-8092; Cordelli, Duccio Maria/0000-0002-1367-6419; Crow, Yanick J/0000-0001-7211-7564; Urquhart, Jill/0000-0002-5788-5511; Cordelli, Duccio Maria/0000-0002-1367-6419; vieira, jose pedro/0000-0002-2270-5314; Rice, Gillian I/0000-0002-4223-0571; Forrest, Ewan/0000-0002-7293-2574; Oppliger Leibundgut, Elisabeth/0000-0002-6652-4160; Wakeling, Emma/0000-0001-5712-0044; Prabhakar, Prab/0000-0002-1641-8714; Black, Graeme/0000-0001-8727-6592; van der Knaap, Marjo/0000-0001-8912-0954; Kasher, Paul/0000-0002-9213-502X; Lovell, Simon/0000-0002-4092-8458; FRANZONI, EMILIO/0000-0001-8913-3800; Chong, Kling/0000-0002-4335-3864	Great Ormond Street Hospital Children's Charity; Newlife Foundation; Great Ormond Street Hospital Childrens Charity [V1212] Funding Source: researchfish	Great Ormond Street Hospital Children's Charity; Newlife Foundation; Great Ormond Street Hospital Childrens Charity	We are very grateful to the affected families for their involvement in our research. Y. J. C. acknowledges the Manchester National Institute for Health Research (NIHR) Biomedical Research Centre. This work has received support from the Great Ormond Street Hospital Children's Charity and from the Newlife Foundation. We thank the NHLBI Grand Opportunity (GO) Exome Sequencing Project and acknowledge its ongoing studies that produced and provided exome variant calls for comparison, including the Lung GO Sequencing Project (HL-102923), the Women's Health Initiative (WHI) Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926) and the Heart GO Sequencing Project (HL-103010). We also thank G. Forte for organizing courier delivery of patient materials.	Baerlocher GM, 2006, NAT PROTOC, V1, P2365, DOI 10.1038/nprot.2006.263; Briggs TA, 2008, AM J MED GENET A, V146A, P182, DOI 10.1002/ajmg.a.32080; Briggs TA, 2010, MOL SYNDROMOL, V1, P159, DOI 10.1159/000321559; Casteel DE, 2009, J BIOL CHEM, V284, P5807, DOI 10.1074/jbc.M807593200; Crow YJ, 2004, NEUROPEDIATRICS, V35, P10, DOI 10.1055/s-2003-43552; Giraud-Panis MJ, 2010, MOL CELL, V39, P665, DOI 10.1016/j.molcel.2010.08.024; GOULIAN M, 1990, J BIOL CHEM, V265, P13231; Jain D, 2010, ANNU REV GENET, V44, P243, DOI 10.1146/annurev-genet-102108-134841; Labrune P, 1996, NEUROLOGY, V46, P1297, DOI 10.1212/WNL.46.5.1297; Linger BR, 2009, CRIT REV BIOCHEM MOL, V44, P434, DOI 10.3109/10409230903307329; Linnankivi T, 2006, NEUROLOGY, V67, P1437, DOI 10.1212/01.wnl.0000236999.63933.b0; Miyake Y, 2009, MOL CELL, V36, P193, DOI 10.1016/j.molcel.2009.08.009; Nagae-Poetscher LM, 2004, NEUROLOGY, V62, P1206, DOI 10.1212/01.WNL.0000119341.59445.CF; Nelson ND, 2012, MUTAT RES-FUND MOL M, V730, P43, DOI 10.1016/j.mrfmmm.2011.06.008; Price CM, 2010, CELL CYCLE, V9, P3157, DOI 10.4161/cc.9.16.12547; Savage SA, 2010, GENET MED, V12, P753, DOI 10.1097/GIM.0b013e3181f415b5; Surovtseva YV, 2009, MOL CELL, V36, P207, DOI 10.1016/j.molcel.2009.09.017; TOLMIE JL, 1988, EYE, V2, P297, DOI 10.1038/eye.1988.56	18	177	182	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2012	44	3					338	U1604		10.1038/ng.1084	http://dx.doi.org/10.1038/ng.1084			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	899VC	22267198	Green Published			2022-12-25	WOS:000300843600023
J	Tarrant, MK; Rho, HS; Xie, Z; Jiang, YL; Gross, C; Culhane, JC; Yan, G; Qian, J; Ichikawa, Y; Matsuoka, T; Zachara, N; Etzkorn, FA; Hart, GW; Jeong, JS; Blackshaw, S; Zhu, H; Cole, PA				Tarrant, Mary Katherine; Rho, Hee-Sool; Xie, Zhi; Jiang, Yu Lin; Gross, Christopher; Culhane, Jeffrey C.; Yan, Gai; Qian, Jiang; Ichikawa, Yoshitaka; Matsuoka, Tatsuji; Zachara, Natasha; Etzkorn, Felicia A.; Hart, Gerald W.; Jeong, Jun Seop; Blackshaw, Seth; Zhu, Heng; Cole, Philip A.			Regulation of CK2 by phosphorylation and O-GlcNAcylation revealed by semisynthesis	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-KINASE CK2; BETA-SUBUNIT; GLCNAC TRANSFERASE; CASEIN KINASE-2; CELL-CYCLE; PIN1; IDENTIFICATION; FLAVOPIRIDOL; ACTIVATION; EXPRESSION	Protein serine-threonine kinase casein kinase 3II (CK2) is involved in a myriad of cellular processes including cell growth and proliferation through its phosphorylation of hundreds of substrates, yet how CK2 function is regulated is poorly understood. Here we report that the CK2 catalytic subunit CK2 alpha is modified by O-linked beta-N-acetyl-glucosamine (O-GlcNAc) on Ser347, proximal to a cyclin-dependent kinase phosphorylation site (Thr344). We use protein semisynthesis to show that phosphorylation of Thr344 increases the cellular stability of CK2 alpha by strengthening its interaction with Pin1, whereas glycosylation of Ser347 seems to be antagonistic to Thr344 phosphorylation and permissive to proteasomal degradation. By performing kinase assays with site-specifically phospho- and glyco-modified CK2 alpha in combination with CK2 beta and Pin1 binding partners on human protein microarrays, we show that the kinase substrate selectivity of CK2 is modulated by these specific post-translational modifications. This study suggests how a promiscuous protein kinase can be regulated at multiple levels to achieve particular biological outputs.	[Tarrant, Mary Katherine; Rho, Hee-Sool; Jiang, Yu Lin; Gross, Christopher; Culhane, Jeffrey C.; Yan, Gai; Ichikawa, Yoshitaka; Jeong, Jun Seop; Zhu, Heng; Cole, Philip A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Rho, Hee-Sool; Jeong, Jun Seop; Blackshaw, Seth; Zhu, Heng] Johns Hopkins Univ, Sch Med, Ctr High Throughput Biol, Baltimore, MD USA; [Xie, Zhi; Qian, Jiang] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Xie, Zhi] US Natl Inst Hlth, Ctr Human Immunol, Bethesda, MD USA; [Jiang, Yu Lin] E Tennessee State Univ, Dept Chem, Johnson City, TN 37614 USA; [Matsuoka, Tatsuji; Zachara, Natasha; Hart, Gerald W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Matsuoka, Tatsuji] Daiichi Sankyo Co Ltd, Kasai R&D Ctr, Biol Res Labs, Tokyo, Japan; [Etzkorn, Felicia A.] Virginia Tech, Dept Chem, Blacksburg, VA USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; East Tennessee State University; Johns Hopkins University; Daiichi Sankyo Company Limited; Virginia Polytechnic Institute & State University; Johns Hopkins University	Tarrant, MK (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	pcole@jhmi.edu		Hart, Gerald/0000-0001-7812-4351; Xie, Zhi/0000-0002-5589-4836; Etzkorn, Felicia A./0000-0001-5850-3661; Matsuoka, Tatsuji/0000-0001-5982-4248	US National Institutes of Health [CA42486, GM62437, RR020839]; NATIONAL CANCER INSTITUTE [R29CA074305, R01CA042486] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062437, R01GM062437] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Schwarzer, L. Szewczuk, S. Taverna and Y. Zhang as well as the Johns Hopkins University School of Medicine Microscope Facility for advice and assistance and the US National Institutes of Health (CA42486, GM62437, RR020839) for support.	BOSC DG, 1995, J BIOL CHEM, V270, P25872, DOI 10.1074/jbc.270.43.25872; Bosc DG, 1999, MOL CELL BIOCHEM, V191, P213, DOI 10.1023/A:1006840329973; Canton DA, 2006, CELL SIGNAL, V18, P267, DOI 10.1016/j.cellsig.2005.07.008; Choudhary C, 2010, NAT REV MOL CELL BIO, V11, P427, DOI 10.1038/nrm2900; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Cory GOC, 2003, MOL CELL, V11, P1229, DOI 10.1016/S1097-2765(03)00172-2; Fischer PM, 2000, CURR MED CHEM, V7, P1213, DOI 10.2174/0929867003374048; Gussio R, 2000, ANTI-CANCER DRUG DES, V15, P53; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Homma MK, 2008, MOL CELL BIOCHEM, V316, P49, DOI 10.1007/s11010-008-9823-4; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; Huang R, 2010, J AM CHEM SOC, V132, P9986, DOI 10.1021/ja103954u; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; LITCHFIELD DW, 1992, J BIOL CHEM, V267, P13943; LIU QJ, 1994, J BIOL CHEM, V269, P9221; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Luo B, 2007, J BIOL CHEM, V282, P7172, DOI 10.1074/jbc.M607362200; Macauley MS, 2005, J AM CHEM SOC, V127, P17202, DOI 10.1021/ja0567687; Mahoney SJ, 2009, PROG MOL BIOL TRANSL, V90, P53, DOI 10.1016/S1877-1173(09)90002-3; MARIN O, 1994, BIOCHEM BIOPH RES CO, V198, P898, DOI 10.1006/bbrc.1994.1128; MARIN O, 1995, FEBS LETT, V363, P111, DOI 10.1016/0014-5793(95)00295-K; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MEGGIO F, 1992, EUR J BIOCHEM, V204, P293, DOI 10.1111/j.1432-1033.1992.tb16636.x; Messenger MM, 2002, J BIOL CHEM, V277, P23054, DOI 10.1074/jbc.M200111200; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Niefind K, 2001, EMBO J, V20, P5320, DOI 10.1093/emboj/20.19.5320; Ohnishi Y, 2000, BIOORG MED CHEM LETT, V10, P1289, DOI 10.1016/S0960-894X(00)00223-7; Pagano MA, 2006, BIOCHEM SOC T, V34, P1303, DOI 10.1042/BST0341303; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Piontek C, 2009, ANGEW CHEM INT EDIT, V48, P1936, DOI 10.1002/anie.200804734; Qiao YF, 2006, SCIENCE, V311, P1293, DOI 10.1126/science.1122224; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Salvi M, 2006, FEBS LETT, V580, P3948, DOI 10.1016/j.febslet.2006.06.031; Salvi M, 2009, BBA-MOL CELL RES, V1793, P847, DOI 10.1016/j.bbamcr.2009.01.013; Sarno S, 2000, BIOCHEMISTRY-US, V39, P12324, DOI 10.1021/bi0011431; Sarno S, 1998, FEBS LETT, V441, P29, DOI 10.1016/S0014-5793(98)01516-6; Sarno S, 1997, BIOCHEMISTRY-US, V36, P11717, DOI 10.1021/bi9705772; Senderowicz AM, 1999, INVEST NEW DRUG, V17, P313, DOI 10.1023/A:1006353008903; Shapiro GI, 1999, CLIN CANCER RES, V5, P2925; Shen HH, 2001, GENOMICS, V71, P21, DOI 10.1006/geno.2000.6397; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Siepe D, 2009, NAT CELL BIOL, V11, P967, DOI 10.1038/ncb1908; Tian G, 2009, J BIOL CHEM, V284, P18980, DOI 10.1074/jbc.M109.003160; Tiganis T, 1996, ARCH BIOCHEM BIOPHYS, V325, P289, DOI 10.1006/abbi.1996.0036; Vila-Perello M, 2010, CELL, V143, P191, DOI 10.1016/j.cell.2010.09.031; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678; Zheng WP, 2005, J BIOL CHEM, V280, P10462, DOI 10.1074/jbc.M412283200	50	116	118	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2012	8	3					262	269		10.1038/NCHEMBIO.771	http://dx.doi.org/10.1038/NCHEMBIO.771			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896VR	22267120	Green Accepted			2022-12-25	WOS:000300600000011
J	von Maltzahn, J; Bentzinger, CF; Rudnicki, MA				von Maltzahn, Julia; Bentzinger, C. Florian; Rudnicki, Michael A.			Wnt7a-Fzd7 signalling directly activates the Akt/mTOR anabolic growth pathway in skeletal muscle	NATURE CELL BIOLOGY			English	Article							TUMOR-NECROSIS-FACTOR; SATELLITE STEM-CELLS; MYOGENIC DIFFERENTIATION; INSULIN-RESISTANCE; CANCER CACHEXIA; FACTOR-I; KINASE; HYPERTROPHY; INHIBITION; MECHANISMS	Wnt7a signals through its receptor Fzd7 to activate the planar-cell-polarity pathway and drive the symmetric expansion of satellite stem cells resulting in enhanced repair of skeletal muscle. In differentiated myofibres, we observed that Wnt7a binding to Fzd7 directly activates the Akt/mTOR growth pathway, thereby inducing myofibre hypertrophy. Notably, the Fzd7 receptor complex was associated with G alpha(s) and PI(3)K and these components were required for Wnt7a to activate the Akt/mTOR growth pathway in myotubes. Wnt7a-Fzd7 activation of this pathway was completely independent of IGF-receptor activation. Together, these experiments demonstrate that Wnt7a-Fzd7 activates distinct pathways at different developmental stages during myogenic lineage progression, and identify a non-canonical anabolic signalling pathway for Wnt7a and its receptor Fzd7 in skeletal muscle.	[von Maltzahn, Julia; Bentzinger, C. Florian; Rudnicki, Michael A.] Ottawa Hosp Res Inst, Sprott Ctr Stem Cell Res, Ottawa, ON K1H 8L6, Canada; [Rudnicki, Michael A.] Univ Ottawa, Dept Med, Ottawa, ON K1H 8M5, Canada; [Rudnicki, Michael A.] Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON K1H 8L6, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Rudnicki, MA (corresponding author), Ottawa Hosp Res Inst, Sprott Ctr Stem Cell Res, Ottawa, ON K1H 8L6, Canada.	mrudnicki@ohri.ca	Bentzinger, C. Florian/A-1151-2015; von Maltzahn, Julia/A-6689-2017; von Maltzahn, Julia/AFP-2284-2022	Bentzinger, C. Florian/0000-0003-0422-9622; von Maltzahn, Julia/0000-0001-7674-1487; von Maltzahn, Julia/0000-0001-7674-1487; Rudnicki, Michael/0000-0002-3866-5249	Swiss National Science Foundation; Muscular Dystrophy Association; Canadian Institutes of Health Research; National Institutes of Health; Howard Hughes Medical Institute; Canada Research Chair; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044031] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Muscular Dystrophy Association(Muscular Dystrophy Association); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank F. Price and V. Soleimani for critical reading of the manuscript. M.A.R. holds the Canada Research Chair in Molecular Genetics and is an International Research Scholar of the Howard Hughes Medical Institute. C.F.B. is supported by the Swiss National Science Foundation. This work was financially supported by grants from the Muscular Dystrophy Association, Canadian Institutes of Health Research, National Institutes of Health, Howard Hughes Medical Institute and the Canada Research Chair Program.	Anakwe K, 2003, DEVELOPMENT, V130, P3503, DOI 10.1242/dev.00538; Borello U, 2006, DEVELOPMENT, V133, P3723, DOI 10.1242/dev.02517; Botfield C, 1997, BAILLIERE CLIN ENDOC, V11, P679, DOI 10.1016/S0950-351X(97)80958-5; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; COLLINS ARS, 1982, NUCLEIC ACIDS RES, V10, P1203, DOI 10.1093/nar/10.4.1203; Costelli P, 2006, AM J PHYSIOL-REG I, V291, pR674, DOI 10.1152/ajpregu.00104.2006; CRESCENZI M, 1994, J CELL BIOL, V125, P1137, DOI 10.1083/jcb.125.5.1137; de Alvaro C, 2004, J BIOL CHEM, V279, P17070, DOI 10.1074/jbc.M312021200; Del Aguila LF, 2000, AM J PHYSIOL-ENDOC M, V279, pE206, DOI 10.1152/ajpendo.2000.279.1.E206; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; Freissmuth M, 1996, MOL PHARMACOL, V49, P602; Frost RA, 2007, J APPL PHYSIOL, V103, P378, DOI 10.1152/japplphysiol.00089.2007; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Grounds MD, 2008, CLIN EXP PHARMACOL P, V35, P846, DOI 10.1111/j.1440-1681.2007.04868.x; Harwood AJ, 2001, CELL, V105, P821, DOI 10.1016/S0092-8674(01)00412-3; Kandarian SC, 2006, MUSCLE NERVE, V33, P155, DOI 10.1002/mus.20442; Kengaku M, 1998, SCIENCE, V280, P1274, DOI 10.1126/science.280.5367.1274; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lang CH, 2005, PEDIATR NEPHROL, V20, P306, DOI 10.1007/s00467-004-1607-9; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Miyazaki M, 2009, J APPL PHYSIOL, V106, P1367, DOI 10.1152/japplphysiol.91355.2008; Montcouquiol M, 2003, J NEUROSCI, V23, P9469; Parrizas M, 1997, ENDOCRINOLOGY, V138, P1427, DOI 10.1210/en.138.4.1427; Pietrangelo T, 2002, J MUSCLE RES CELL M, V23, P107, DOI 10.1023/A:1020288117082; Rochat A, 2004, MOL BIOL CELL, V15, P4544, DOI 10.1091/mbc.E03-11-0816; Sakuma Kunihiro, 2010, Curr Aging Sci, V3, P90; Schulte G, 2007, TRENDS PHARMACOL SCI, V28, P518, DOI 10.1016/j.tips.2007.09.001; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; Tanaka S, 1998, P NATL ACAD SCI USA, V95, P10164, DOI 10.1073/pnas.95.17.10164; Timmers S, 2008, PHYSIOL BEHAV, V94, P242, DOI 10.1016/j.physbeh.2007.12.002; Tisdale MJ, 2010, CURR OPIN GASTROEN, V26, P146, DOI 10.1097/MOG.0b013e3283347e77; van der Velden JLJ, 2006, AM J PHYSIOL-CELL PH, V290, pC453, DOI 10.1152/ajpcell.00068.2005; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59	35	149	156	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2012	14	2					186	191		10.1038/ncb2404	http://dx.doi.org/10.1038/ncb2404			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	893CF	22179044	Green Accepted			2022-12-25	WOS:000300332500013
J	Ratheesh, A; Gomez, GA; Priya, R; Verma, S; Kovacs, EM; Jiang, K; Brown, NH; Akhmanova, A; Stehbens, SJ; Yap, AS				Ratheesh, Aparna; Gomez, Guillermo A.; Priya, Rashmi; Verma, Suzie; Kovacs, Eva M.; Jiang, Kai; Brown, Nicholas H.; Akhmanova, Anna; Stehbens, Samantha J.; Yap, Alpha S.			Centralspindlin and alpha-catenin regulate Rho signalling at the epithelial zonula adherens	NATURE CELL BIOLOGY			English	Article							CELL-CELL ADHESION; E-CADHERIN; LOCAL CONCENTRATION; EXCHANGE FACTOR; PLUS-END; RAC; P190RHOGAP; COMPLEX; GTPASES; MICROTUBULES	The biological impact of Rho depends critically on the precise subcellular localization of its active, GTP-loaded form. This can potentially be determined by the balance between molecules that promote nucleotide exchange or GTP hydrolysis. However, how these activities may be coordinated is poorly understood. We now report a molecular pathway that achieves exactly this coordination at the epithelial zonula adherens. We identify an extramitotic activity of the centralspindlin complex, better understood as a cytokinetic regulator, which localizes to the interphase zonula adherens by interacting with the cadherin-associated protein, alpha-catenin. Centralspindlin recruits the RhoGEF, ECT2, to activate Rho and support junctional integrity through myosin IIA. Centralspindlin also inhibits the junctional localization of p190 B RhoGAP, which can inactivate Rho. Thus, a conserved molecular ensemble that governs Rho activation during cytokinesis is used in interphase cells to control the Rho GTPase cycle at the zonula adherens.	[Ratheesh, Aparna; Gomez, Guillermo A.; Priya, Rashmi; Verma, Suzie; Kovacs, Eva M.; Stehbens, Samantha J.; Yap, Alpha S.] Univ Queensland, Inst Mol Biosci, Div Mol Cell Biol, Brisbane, Qld 4072, Australia; [Jiang, Kai; Akhmanova, Anna] Univ Utrecht, Fac Sci, NL-3584 CH Utrecht, Netherlands; [Brown, Nicholas H.] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Brown, Nicholas H.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QN, England	University of Queensland; Utrecht University; University of Cambridge; University of Cambridge	Ratheesh, A (corresponding author), Univ Queensland, Inst Mol Biosci, Div Mol Cell Biol, Brisbane, Qld 4072, Australia.	aparnaratheesh@gmail.com; a.yap@uq.edu.au	Akhmanova, Anna S/B-8896-2011; Stehbens, Samantha/AAH-4145-2019; Kovacs, Eva/U-3526-2019; Yap, Alpha S./J-1554-2014; Stehbens, Samantha/D-3512-2019; Gomez, Guillermo/J-2993-2014	Akhmanova, Anna S/0000-0002-9048-8614; Stehbens, Samantha/0000-0002-8145-2708; Kovacs, Eva/0000-0002-7228-4028; Yap, Alpha S./0000-0002-1038-8956; Stehbens, Samantha/0000-0002-8145-2708; Gomez, Guillermo/0000-0002-0494-2404; Brown, Nicholas/0000-0002-8958-7017; Ratheesh, Aparna/0000-0001-7190-0776; Priya, Rashmi/0000-0002-0510-7515	Human Frontiers Science Program; National Health and Medical Research Council of Australia; Australian Research Council; Oncology Children's Foundation; Australian Cancer Research Foundation	Human Frontiers Science Program(Human Frontier Science Program); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Oncology Children's Foundation; Australian Cancer Research Foundation	We thank our laboratory colleagues for their support and advice, all our colleagues who provided gifts of reagents, and R. Saint who first suggested we think about ECT2. This work was financially supported by the Human Frontiers Science Program, the National Health and Medical Research Council of Australia, Australian Research Council, and the Oncology Children's Foundation. Confocal microscopy was performed at the IMB/ACRF Cancer Biology Imaging Facility, established with the generous support of the Australian Cancer Research Foundation.	Akhmanova A, 2009, TRAFFIC, V10, P268, DOI 10.1111/j.1600-0854.2008.00869.x; Bellett G, 2009, CELL MOTIL CYTOSKEL, V66, P893, DOI 10.1002/cm.20393; Bement WM, 2006, BIOESSAYS, V28, P983, DOI 10.1002/bies.20477; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Burbelo PD, 1995, J BIOL CHEM, V270, P30919, DOI 10.1074/jbc.270.52.30919; Bustos RI, 2008, CURR BIOL, V18, P1606, DOI 10.1016/j.cub.2008.09.019; Carramusa L, 2007, J CELL SCI, V120, P3870, DOI 10.1242/jcs.014365; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Hirose K, 2001, J BIOL CHEM, V276, P5821, DOI 10.1074/jbc.M007252200; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jordan MA, 1998, METHOD ENZYMOL, V298, P252, DOI 10.1016/S0076-6879(98)98024-7; Kametani Y, 2007, NAT CELL BIOL, V9, P92, DOI 10.1038/ncb1520; Kasza KE, 2011, CURR OPIN CELL BIOL, V23, P30, DOI 10.1016/j.ceb.2010.10.014; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Lien WH, 2006, CURR OPIN CELL BIOL, V18, P499, DOI 10.1016/j.ceb.2006.07.001; Liu XF, 2004, MOL CELL BIOL, V24, P6665, DOI 10.1128/mcb.24.15.6665-6675.2004; Magie Craig R., 2002, Development (Cambridge), V129, P3771; Manchinelly SAS, 2010, J BIOL CHEM, V285, P26923, DOI 10.1074/jbc.M110.103804; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Mikawa M, 2008, CELL CYCLE, V7, P2003, DOI 10.4161/cc.7.13.6128; Miller AL, 2009, NAT CELL BIOL, V11, P71, DOI 10.1038/ncb1814; Mishima M, 2002, DEV CELL, V2, P41, DOI 10.1016/S1534-5807(01)00110-1; Miyake Y, 2006, EXP CELL RES, V312, P1637, DOI 10.1016/j.yexcr.2006.01.031; Monier B, 2010, NAT CELL BIOL, V12, P60, DOI 10.1038/ncb2005; Noren NK, 2003, J BIOL CHEM, V278, P13615, DOI 10.1074/jbc.C200657200; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Saint R, 2003, J CELL SCI, V116, P4277, DOI 10.1242/jcs.00816; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; Scott JA, 2006, J CELL SCI, V119, P4599, DOI 10.1242/jcs.03267; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Smutny M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022458; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; Somers WG, 2003, DEV CELL, V4, P29, DOI 10.1016/S1534-5807(02)00402-1; Stehbens SJ, 2006, J CELL SCI, V119, P1801, DOI 10.1242/jcs.02903; Stehbens SJ, 2009, FRONT BIOSCI-LANDMRK, V14, P3159, DOI 10.2741/3442; Su L, 2009, EXP CELL RES, V315, P1347, DOI 10.1016/j.yexcr.2009.02.014; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Terry SJ, 2011, NAT CELL BIOL, V13, P159, DOI 10.1038/ncb2156; Verma S, 2004, J BIOL CHEM, V279, P34062, DOI 10.1074/jbc.M404814200; Vitriol EA, 2007, P NATL ACAD SCI USA, V104, P6702, DOI 10.1073/pnas.0701801104; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Wolfe BA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000110; Wolfe BA, 2009, GENE DEV, V23, P896, DOI 10.1101/gad.1801209; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yonemura S, 2004, EXP CELL RES, V295, P300, DOI 10.1016/j.yexcr.2004.01.005; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097	57	173	173	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2012	14	8					818	U101		10.1038/ncb2532	http://dx.doi.org/10.1038/ncb2532			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	983JP	22750944	Green Accepted			2022-12-25	WOS:000307115900011
J	Khmelinskii, A; Keller, PJ; Bartosik, A; Meurer, M; Barry, JD; Mardin, BR; Kaufmann, A; Trautmann, S; Wachsmuth, M; Pereira, G; Huber, W; Schiebel, E; Knop, M				Khmelinskii, Anton; Keller, Philipp J.; Bartosik, Anna; Meurer, Matthias; Barry, Joseph D.; Mardin, Balca R.; Kaufmann, Andreas; Trautmann, Susanne; Wachsmuth, Malte; Pereira, Gislene; Huber, Wolfgang; Schiebel, Elmar; Knop, Michael			Tandem fluorescent protein timers for in vivo analysis of protein dynamics	NATURE BIOTECHNOLOGY			English	Article							NUCLEAR-PORE COMPLEX; END RULE PATHWAY; SACCHAROMYCES-CEREVISIAE; MONOMERIC RED; UBIQUITIN LIGASES; PLASMA-MEMBRANE; CELL-CYCLE; HALF-LIFE; YEAST; DEGRADATION	The functional state of a cell is largely determined by the spatiotemporal organization of its proteome. Technologies exist for measuring particular aspects of protein turnover and localization, but comprehensive analysis of protein dynamics across different scales is possible only by combining several methods. Here we describe tandem fluorescent protein timers (tFTs), fusions of two single-color fluorescent proteins that mature with different kinetics, which we use to analyze protein turnover and mobility in living cells. We fuse tFTs to proteins in yeast to study the longevity, segregation and inheritance of cellular components and the mobility of proteins between subcellular compartments; to measure protein degradation kinetics without the need for time-course measurements; and to conduct high-throughput screens for regulators of protein turnover. Our experiments reveal the stable nature and asymmetric inheritance of nuclear pore complexes and identify regulators of N-end rule-mediated protein degradation.	[Khmelinskii, Anton; Bartosik, Anna; Meurer, Matthias; Mardin, Balca R.; Schiebel, Elmar; Knop, Michael] Univ Heidelberg ZMBH, Ctr Mol Biol, DKFZ ZMBH Alliance, Heidelberg, Germany; [Khmelinskii, Anton; Keller, Philipp J.; Bartosik, Anna; Meurer, Matthias; Kaufmann, Andreas; Trautmann, Susanne; Wachsmuth, Malte; Knop, Michael] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany; [Keller, Philipp J.] Howard Hughes Med Inst, Ashburn, VA USA; [Barry, Joseph D.; Huber, Wolfgang] European Mol Biol Lab, Genome Biol Unit, Heidelberg, Germany; [Trautmann, Susanne; Pereira, Gislene; Knop, Michael] German Canc Res Ctr, DKFZ ZMBH Alliance, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Howard Hughes Medical Institute; European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ)	Knop, M (corresponding author), Univ Heidelberg ZMBH, Ctr Mol Biol, DKFZ ZMBH Alliance, Heidelberg, Germany.	e.schiebel@zmbh.uni-heidelberg.de; m.knop@zmbh.uni-heidelberg.de	Pereira, Gislene/D-4024-2014; Khmelinskii, Anton/B-2830-2008	Huber, Wolfgang/0000-0002-0474-2218; Keller, Philipp/0000-0003-2896-4920; Barry, Joseph/0000-0002-1177-5771; Mardin, Balca R/0000-0002-3903-9354; Khmelinskii, Anton/0000-0002-0256-5190	Cell Networks cluster; German Research Foundation [SFB638]; Howard Hughes Medical Institute; European Molecular Biology Organization [EMBO ALTF 1124-2010]; EU-FP7 Network of Excellence in Systems Microscopy; Novartis Stiftung	Cell Networks cluster; German Research Foundation(German Research Foundation (DFG)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); EU-FP7 Network of Excellence in Systems Microscopy; Novartis Stiftung	We are grateful to Y. Belyaev, S. Terjung and the Advanced Light Microscopy Facility of EMBL for support with microscopy; A. Riddell, A. P. Gonzalez and the FACS Facility of EMBL for flow cytometry analyses; the Cell Networks cluster for funding to M.K., the German Research Foundation for funding to E.S. (SFB638), the Howard Hughes Medical Institute for funding to P.J.K., the European Molecular Biology Organization for funding to A.Kh. (EMBO ALTF 1124-2010), the EU-FP7 Network of Excellence in Systems Microscopy for funding to J.D.B. and W.H., and the Novartis Stiftung for funding to A.Ka. We thank P.I. Bastiaens, D. Gilmour and A. Kinkhabwala for discussions.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chen T, 2000, SCIENCE, V290, P1975, DOI 10.1126/science.290.5498.1975; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; Eden E, 2011, SCIENCE, V331, P764, DOI 10.1126/science.1199784; Gordon A, 2007, NAT METHODS, V4, P175, DOI 10.1038/nmeth1008; Hardy S, 2010, BIOL CELL, V102, P561, DOI 10.1042/BC20100038; Hwang CS, 2010, NAT CELL BIOL, V12, P1177, DOI 10.1038/ncb2121; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Khmelinskii A, 2010, NATURE, V466, DOI 10.1038/nature09255; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Makio T, 2009, J CELL BIOL, V185, P459, DOI 10.1083/jcb.200810029; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Newman RH, 2011, CHEM REV, V111, P3614, DOI 10.1021/cr100002u; Ouellet J, 2012, J CELL BIOL, V196, P305, DOI 10.1083/jcb.201102078; Pau G, 2010, BIOINFORMATICS, V26, P979, DOI 10.1093/bioinformatics/btq046; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pereira G, 2001, EMBO J, V20, P6359, DOI 10.1093/emboj/20.22.6359; Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200; Schoenheimer R., 1942, DYNAMIC STATE BODY C; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Steinkraus KA, 2008, ANNU REV CELL DEV BI, V24, P29, DOI 10.1146/annurev.cellbio.23.090506.123509; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Subach FV, 2009, NAT CHEM BIOL, V5, P118, DOI 10.1038/nchembio.138; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Terskikh A, 2000, SCIENCE, V290, P1585, DOI 10.1126/science.290.5496.1585; Tong AHY, 2007, METHOD MICROBIOL, V36, P369, DOI 10.1016/S0580-9517(06)36016-3; Tsuboi T, 2010, MOL BIOL CELL, V21, P87, DOI 10.1091/mbc.E09-08-0722; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Verzijlbergen KF, 2010, P NATL ACAD SCI USA, V107, P64, DOI 10.1073/pnas.0911164107; Winey M, 1997, MOL BIOL CELL, V8, P2119, DOI 10.1091/mbc.8.11.2119; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wu B, 2011, CURR OPIN CELL BIOL, V23, P310, DOI 10.1016/j.ceb.2010.12.004; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Yewdell JW, 2011, CELL BIOL INT, V35, P457, DOI 10.1042/CBI20110055; Zabel U, 1996, J CELL BIOL, V133, P1141, DOI 10.1083/jcb.133.6.1141; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang LJ, 2007, BIOTECHNIQUES, V42, P446, DOI 10.2144/000112453	53	160	164	2	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					708	+		10.1038/nbt.2281	http://dx.doi.org/10.1038/nbt.2281			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22729030				2022-12-25	WOS:000306293400030
J	Lin, ZW; Li, XR; Shannon, LM; Yeh, CT; Wang, ML; Bai, GH; Peng, Z; Li, JR; Trick, HN; Clemente, TE; Doebley, J; Schnable, PS; Tuinstra, MR; Tesso, TT; White, F; Yu, JM				Lin, Zhongwei; Li, Xianran; Shannon, Laura M.; Yeh, Cheng-Ting; Wang, Ming L.; Bai, Guihua; Peng, Zhao; Li, Jiarui; Trick, Harold N.; Clemente, Thomas E.; Doebley, John; Schnable, Patrick S.; Tuinstra, Mitchell R.; Tesso, Tesfaye T.; White, Frank; Yu, Jianming			Parallel domestication of the Shattering1 genes in cereals	NATURE GENETICS			English	Article							RICE ORYZA-SATIVA; SORGHUM-BICOLOR; WILD-RICE; GENOME; ASSOCIATION; DIVERSITY; EVOLUTION; MARKERS; ORIGIN; MAIZE	A key step during crop domestication is the loss of seed shattering. Here, we show that seed shattering in sorghum is controlled by a single gene, Shattering1 (Sh1), which encodes a YABBY transcription factor. Domesticated sorghums harbor three different mutations at the Sh1 locus. Variants at regulatory sites in the promoter and intronic regions lead to a low level of expression, a 2.2-kb deletion causes a truncated transcript that lacks exons 2 and 3, and a GT-to-GG splice-site variant in the intron 4 results in removal of the exon 4. The distributions of these non-shattering haplotypes among sorghum landraces suggest three independent origins. The function of the rice ortholog (OsSh1) was subsequently validated with a shattering-resistant mutant, and two maize orthologs (ZmSh1-1 and ZmSh1-5.1+ZmSh1-5.2) were verified with a large mapping population. Our results indicate that Sh1 genes for seed shattering were under parallel selection during sorghum, rice and maize domestication.	[Lin, Zhongwei; Li, Xianran; Bai, Guihua; Tesso, Tesfaye T.; Yu, Jianming] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [Shannon, Laura M.; Doebley, John] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Yeh, Cheng-Ting; Schnable, Patrick S.] Iowa State Univ, Ctr Plant Genom, Ames, IA USA; [Yeh, Cheng-Ting; Schnable, Patrick S.] Iowa State Univ, Dept Agron, Ames, IA USA; [Wang, Ming L.] ARS, USDA, Griffin, GA USA; [Bai, Guihua] ARS, USDA, Manhattan, KS USA; [Peng, Zhao; Li, Jiarui; Trick, Harold N.; White, Frank] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; [Clemente, Thomas E.] Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE USA; [Tuinstra, Mitchell R.] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA	Kansas State University; University of Wisconsin System; University of Wisconsin Madison; Iowa State University; Iowa State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Kansas State University; University of Nebraska System; University of Nebraska Lincoln; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Yu, JM (corresponding author), Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA.	jyu@ksu.edu	Peng, Zhao/B-2386-2018; Lin, Zhongwei/ABD-9297-2021; Li, Xianran/I-5651-2012; Yu, Jianming/Q-6722-2019; Li, Xianran/AAH-1070-2019; bai, guihua/L-6374-2019	Li, Xianran/0000-0002-4252-6911; Yu, Jianming/0000-0001-5326-3099; bai, guihua/0000-0002-1194-319X; Trick, Harold/0000-0001-5255-5575; Schnable, Patrick/0000-0001-9169-5204; Yeh, Cheng-Ting/0000-0002-1392-2018	Agriculture and Food Research Initiative from US Department of Agriculture (USDA) National Institute of Food and Agriculture [2011-03587]; National Science Foundation [DBI-0820610, DBI-0820619, DBI-1027527]; US Department of Energy [DE-SC0002259]; USDA-ARS; Kansas State University; Kansas State University Center for Sorghum Improvement; Direct For Biological Sciences [0820619] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007133] Funding Source: NIH RePORTER	Agriculture and Food Research Initiative from US Department of Agriculture (USDA) National Institute of Food and Agriculture; National Science Foundation(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Kansas State University; Kansas State University Center for Sorghum Improvement; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an Agriculture and Food Research Initiative Competitive Grant (2011-03587 to J.Y. and T. T. T.) from the US Department of Agriculture (USDA) National Institute of Food and Agriculture, the Plant Genome Research Program of the National Science Foundation (DBI-0820610 to J.Y., DBI-0820619 to J.D. and DBI-1027527 to P. S. S.), the Plant Feedstock Genomics Program of the US Department of Energy (DE-SC0002259 to J.Y.), the USDA-ARS (M. L. W. and G. B.), the Targeted Excellence Program of Kansas State University and the Kansas State University Center for Sorghum Improvement.	Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Casa AM, 2008, CROP SCI, V48, P30, DOI 10.2135/cropsci2007.02.0080; Cong B, 2008, NAT GENET, V40, P800, DOI 10.1038/ng.144; CUI YX, 1995, THEOR APPL GENET, V90, P787, DOI 10.1007/BF00222013; Devos KM, 2000, PLANT CELL, V12, P637, DOI 10.1105/tpc.12.5.637; DEWET JMJ, 1967, EVOLUTION, V21, P787, DOI 10.1111/j.1558-5646.1967.tb03434.x; DOEBLEY J, 1991, GENETICS, V129, P285; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Fukuta Y, 1998, BREEDING SCI, V48, P345; Gu XY, 2005, THEOR APPL GENET, V110, P1108, DOI 10.1007/s00122-005-1939-2; HARLAN JR, 1973, EVOLUTION, V27, P311, DOI [10.2307/2406971, 10.1111/j.1558-5646.1973.tb00676.x]; HARLAN JR, 1992, CROP MAN; He ZW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002100; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li CB, 2006, NEW PHYTOL, V170, P185, DOI 10.1111/j.1469-8137.2005.01647.x; Lin ZW, 2007, PLANTA, V226, P11, DOI 10.1007/s00425-006-0460-4; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Matsui K, 2004, GENOME, V47, P469, DOI [10.1139/g04-007, 10.1139/G04-007]; Murray SC, 2009, PLANT GENOME-US, V2, P48, DOI 10.3835/plantgenome2008.10.0011; Nalam VJ, 2006, THEOR APPL GENET, V112, P373, DOI 10.1007/s00122-005-0140-y; Onishi K, 2007, GENOME, V50, P757, DOI 10.1139/G07-051; Onishi K, 2007, BREEDING SCI, V57, P7, DOI 10.1270/jsbbs.57.7; PATERSON AH, 1995, SCIENCE, V269, P1714, DOI 10.1126/science.269.5231.1714; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Simons KJ, 2006, GENETICS, V172, P547, DOI 10.1534/genetics.105.044727; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050	30	278	305	4	156	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2012	44	6					720	U154		10.1038/ng.2281	http://dx.doi.org/10.1038/ng.2281			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	949BT	22581231	Green Submitted, Green Accepted			2022-12-25	WOS:000304551100023
J	Schadt, EE; Woo, S; Hao, K				Schadt, Eric E.; Woo, Sangsoon; Hao, Ke			Bayesian method to predict individual SNP genotypes from gene expression data	NATURE GENETICS			English	Article							HEPATOCELLULAR-CARCINOMA; LOCI; VALIDATION; PLATFORMS; ASSOCIATION; PROFILES; NETWORKS; PATHWAYS; IMPACTS; DISEASE	RNA profiling can be used to capture the expression patterns of many genes that are associated with expression quantitative trait loci (eQTLs). Employing published putative cis eQTLs, we developed a Bayesian approach to predict SNP genotypes that is based only on RNA expression data. We show that predicted genotypes can accurately and uniquely identify individuals in large populations. When inferring genotypes from an expression data set using eQTLs of the same tissue type (but from an independent cohort), we were able to resolve 99% of the identities of individuals in the cohort at P-adjusted <= 1 x 10(-5). When eQTLs derived from one tissue were used to predict genotypes using expression data from a different tissue, the identities of 90% of the study subjects could be resolved at P-adjusted <= 1 x 10(-5). We discuss the implications of deriving genotypic information from RNA data deposited in the public domain.	[Schadt, Eric E.; Hao, Ke] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Woo, Sangsoon] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Hao, Ke] Rosetta Inpharmat, Res Genet, Seattle, WA USA	Icahn School of Medicine at Mount Sinai; University of Washington; University of Washington Seattle; Merck & Company	Schadt, EE (corresponding author), Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA.	eric.schadt@mssm.edu; ke.hao@mssm.edu						Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Barnes M, 2005, NUCLEIC ACIDS RES, V33, P5914, DOI 10.1093/nar/gki890; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Baumbusch LO, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-379; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Couzin-Frankel J, 2010, SCIENCE, V328, P558, DOI 10.1126/science.328.5978.558; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Greenawalt DM, 2011, GENOME RES, V21, P1008, DOI 10.1101/gr.112821.110; Hao K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008695; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hertzberg L, 2007, GENE CHROMOSOME CANC, V46, P75, DOI 10.1002/gcc.20391; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Lamb JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020090; Lanktree MB, 2011, AM J HUM GENET, V88, P6, DOI 10.1016/j.ajhg.2010.11.007; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Wang SM, 2007, CLIN CANCER RES, V13, P6275, DOI 10.1158/1078-0432.CCR-06-2236; Yang X, 2010, GENOME RES, V20, P1020, DOI 10.1101/gr.103341.109; Yang X, 2009, NAT GENET, V41, P415, DOI 10.1038/ng.325; Zhong H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000932; Zhong H, 2010, AM J HUM GENET, V86, P581, DOI 10.1016/j.ajhg.2010.02.020	30	97	98	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2012	44	5					603	+		10.1038/ng.2248	http://dx.doi.org/10.1038/ng.2248			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	934BW	22484626				2022-12-25	WOS:000303416300024
J	Schwertman, P; Lagarou, A; Dekkers, DHW; Raams, A; van der Hoek, AC; Laffeber, C; Hoeijmakers, JHJ; Demmers, JAA; Fousteri, M; Vermeulen, W; Marteijn, JA				Schwertman, Petra; Lagarou, Anna; Dekkers, Dick H. W.; Raams, Anja; van der Hoek, Adriana C.; Laffeber, Charlie; Hoeijmakers, Jan H. J.; Demmers, Jeroen A. A.; Fousteri, Maria; Vermeulen, Wim; Marteijn, Jurgen A.			UV-sensitive syndrome protein UVSSA recruits USP7 to regulate transcription-coupled repair	NATURE GENETICS			English	Article							RNA-POLYMERASE-II; OXIDATIVE DNA LESIONS; COCKAYNE-SYNDROME; INDUCED UBIQUITYLATION; STATISTICAL-MODEL; MASS-SPECTROMETRY; IN-VIVO; DAMAGE; CELLS; DEGRADATION	Transcription-coupled nucleotide-excision repair (TC-NER) is a subpathway of NER that efficiently removes the highly toxic RNA polymerase II blocking lesions in DNA. Defective TC-NER gives rise to the human disorders Cockayne syndrome and UV-sensitive syndrome (UVSS)(1). NER initiating factors are known to be regulated by ubiquitination(2). Using a SILAC-based proteomic approach, we identified UVSSA (formerly known as KIAA1530) as part of a UV-induced ubiquitinated protein complex. Knockdown of UVSSA resulted in TC-NER deficiency. UVSSA was found to be the causative gene for UVSS, an unresolved NER deficiency disorder(3). The UVSSA protein interacts with elongating RNA polymerase II, localizes specifically to UV-induced lesions, resides in chromatin-associated TC-NER complexes and is implicated in stabilizing the TC-NER master organizing protein ERCC6 (also known as CSB) by delivering the deubiquitinating enzyme USP7 to TC-NER complexes. Together, these findings indicate that UVSSA-USP7-mediated stabilization of ERCC6 represents a critical regulatory mechanism of TC-NER in restoring gene expression.	[Schwertman, Petra; Raams, Anja; van der Hoek, Adriana C.; Laffeber, Charlie; Hoeijmakers, Jan H. J.; Vermeulen, Wim; Marteijn, Jurgen A.] Erasmus MC, Dept Genet, Ctr Biomed Genet, Rotterdam, Netherlands; [Schwertman, Petra; Raams, Anja; van der Hoek, Adriana C.; Laffeber, Charlie; Hoeijmakers, Jan H. J.; Vermeulen, Wim; Marteijn, Jurgen A.] Erasmus MC, Netherlands Prote Ctr, Ctr Biomed Genet, Rotterdam, Netherlands; [Lagarou, Anna; Fousteri, Maria] Biomed Sci Res Ctr Alexander Fleming, Inst Mol Biol & Genet, Athens, Greece; [Dekkers, Dick H. W.; Demmers, Jeroen A. A.] Erasmus Univ, Prote Ctr, Med Ctr, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Alexander Fleming Biomedical Sciences Research Center; Erasmus University Rotterdam; Erasmus MC	Vermeulen, W (corresponding author), Erasmus MC, Dept Genet, Ctr Biomed Genet, Rotterdam, Netherlands.	w.vermeulen@erasmusmc.nl; j.marteijn@erasmusmc.nl	Hoeijmakers, Jan/AAX-6972-2021; Fousteri, Maria/M-2312-2017; Vermeulen, Wim/W-8708-2019; Marteijn, Jurgen A/B-5696-2014; Schwertman, Petra/H-8924-2012; Demmers, Jeroen AA/F-4046-2016	Fousteri, Maria/0000-0003-1729-5899; Vermeulen, Wim/0000-0003-3616-734X; Marteijn, Jurgen A/0000-0001-9321-518X; Schwertman, Petra/0000-0002-3225-4430; Demmers, Jeroen AA/0000-0002-8757-9611	Netherlands Genomics Initiative NPCII [935.19.021, 935.11.042]; Dutch Organization for Scientific Research ZonMW [917.96.120]; TOP [912.08.031]; Association for International Cancer Research [10-594]; Cancer Genomics Centre; ERC;  [FP7-PIEF-GA-2009-253544]	Netherlands Genomics Initiative NPCII; Dutch Organization for Scientific Research ZonMW(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); TOP; Association for International Cancer Research; Cancer Genomics Centre; ERC(European Research Council (ERC)European Commission); 	We thank R. Bernards and M. Epping (Nederlands Kanker Instituut) for the Myc-tagged USP7 expression construct and P. Verrijzer and A. Reddy (Erasmus Medical Centre) for shUSP7-expressing lentivirus. We thank H. Slor (Tel Aviv University) for the TA-24sv40 cell line and N.G.J. Jaspers and H. Lans for discussions and critical reading of the manuscript. This work was funded by the Netherlands Genomics Initiative NPCII (to P. S.), 935.19.021 and 935.11.042 (to W. V., C. L. and J.A.M.), the Dutch Organization for Scientific Research ZonMW Veni Grant (917.96.120 to J.A.M.) and TOP grant (912.08.031 to W. V.), Marie Curie FP7-PIEF-GA-2009-253544 (to M. F.), the Association for International Cancer Research (10-594 to W.V.) and the Cancer Genomics Centre and ERC (advanced research grant to J.H.J.H.).	Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Bateman A, 2010, ACTA CRYSTALLOGR F, V66, P1148, DOI 10.1107/S1744309110001685; Beryink S, 2007, DNA REPAIR, V6, P1231, DOI 10.1016/j.dnarep.2007.01.012; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; D'Errico M, 2007, ONCOGENE, V26, P4336, DOI 10.1038/sj.onc.1210232; Dinant C, 2007, J CELL SCI, V120, P2731, DOI 10.1242/jcs.004523; Epping MT, 2011, NAT CELL BIOL, V13, P102, DOI 10.1038/ncb2142; Faustrup H, 2009, J CELL BIOL, V184, P13, DOI 10.1083/jcb.200807137; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; Gorgels TGMF, 2007, MOL CELL BIOL, V27, P1433, DOI 10.1128/MCB.01037-06; Groisman R, 2006, GENE DEV, V20, P1429, DOI 10.1101/gad.378206; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hendriks G, 2010, CURR BIOL, V20, P170, DOI 10.1016/j.cub.2009.11.061; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Horibata K, 2004, P NATL ACAD SCI USA, V101, P15410, DOI 10.1073/pnas.0404587101; Houtsmuller AB, 2001, HISTOCHEM CELL BIOL, V115, P13, DOI 10.1007/s004180000234; ITOH T, 1994, MUTAT RES, V314, P233, DOI 10.1016/0921-8777(94)90068-X; Jaspers NGJ, 2002, DNA REPAIR, V1, P1027, DOI 10.1016/S1568-7864(02)00166-0; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Khoronenkova SV, 2011, NUCLEIC ACIDS RES, V39, P2604, DOI 10.1093/nar/gkq1210; Kimura H, 2002, J CELL BIOL, V159, P777, DOI 10.1083/jcb.200206019; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Marteijn JA, 2009, J CELL BIOL, V186, P835, DOI 10.1083/jcb.200902150; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Mizuno E, 2003, MOL BIOL CELL, V14, P3675, DOI 10.1091/mbc.E02-12-0823; Nagase T, 2000, DNA RES, V7, P143, DOI 10.1093/dnares/7.2.143; Nakazawa Y., 2012, NAT GENET, DOI 10.1038ng.2229; Nakazawa Y, 2010, DNA REPAIR, V9, P506, DOI 10.1016/j.dnarep.2010.01.015; Nardo T, 2009, P NATL ACAD SCI USA, V106, P6209, DOI 10.1073/pnas.0902113106; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Newman JC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000031; Nicholson B, 2011, CELL BIOCHEM BIOPHYS, V60, P61, DOI 10.1007/s12013-011-9185-5; Rapic-Otrin V, 2002, NUCLEIC ACIDS RES, V30, P2588, DOI 10.1093/nar/30.11.2588; Spivak G, 2006, DNA REPAIR, V5, P13, DOI 10.1016/j.dnarep.2005.06.017; Spivak G, 2005, MUTAT RES-FUND MOL M, V577, P162, DOI 10.1016/j.mrfmmm.2005.03.017; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Sugaya K, 2000, J CELL SCI, V113, P2679; van den Boom V, 2004, J CELL BIOL, V166, P27, DOI 10.1083/jcb.200401056; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wei LZ, 2011, CANCER SCI, V102, P1840, DOI 10.1111/j.1349-7006.2011.02037.x; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Zhang X., 2012, NAT GENET, DOI 10.1038ng.2228	46	165	168	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2012	44	5					598	+		10.1038/ng.2230	http://dx.doi.org/10.1038/ng.2230			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	934BW	22466611				2022-12-25	WOS:000303416300023
J	Mitchison, HM; Schmidts, M; Loges, NT; Freshour, J; Dritsoula, A; Hirst, RA; O'Callaghan, C; Blau, H; Al Dabbagh, M; Olbrich, H; Beales, PL; Yagi, T; Mussaffi, H; Chung, EMK; Omran, H; Mitchell, DR				Mitchison, Hannah M.; Schmidts, Miriam; Loges, Niki T.; Freshour, Judy; Dritsoula, Athina; Hirst, Rob A.; O'Callaghan, Christopher; Blau, Hannah; Al Dabbagh, Maha; Olbrich, Heike; Beales, Philip L.; Yagi, Toshiki; Mussaffi, Huda; Chung, Eddie M. K.; Omran, Heymut; Mitchell, David R.			Mutations in axonemal dynein assembly factor DNAAF3 cause primary ciliary dyskinesia	NATURE GENETICS			English	Article							CONGENITAL HEART-DISEASE; OF-FUNCTION MUTATIONS; CHLAMYDOMONAS-FLAGELLA; REGULATORY COMPLEX; INTERMEDIATE CHAIN; SEQUENCE ALIGNMENT; PROXIMAL PORTION; ARM DYNEIN; OUTER ROW; PROTEIN	Primary ciliary dyskinesia most often arises from loss of the dynein motors that power ciliary beating. Here we show that DNAAF3 (also known as PF22), a previously uncharacterized protein, is essential for the preassembly of dyneins into complexes before their transport into cilia. We identified loss-of-function mutations in the human DNAAF3 gene in individuals from families with situs inversus and defects in the assembly of inner and outer dynein arms. Knockdown of dnaaf3 in zebrafish likewise disrupts dynein arm assembly and ciliary motility, causing primary ciliary dyskinesia phenotypes that include hydrocephalus and laterality malformations. Chlamydomonas reinhardtii PF22 is exclusively cytoplasmic, and a PF22-null mutant cannot assemble any outer and some inner dynein arms. Altered abundance of dynein subunits in mutant cytoplasm suggests that DNAAF3 (PF22) acts at a similar stage as other preassembly proteins, for example, DNAAF2 (also known as PF13 or KTU) and DNAAF1 (also known as ODA7 or LRRC50), in the dynein preassembly pathway. These results support the existence of a conserved, multistep pathway for the cytoplasmic formation of assembly competent ciliary dynein complexes.	[Freshour, Judy; Mitchell, David R.] SUNY Upstate Med Univ, Syracuse, NY USA; [Mitchison, Hannah M.; Schmidts, Miriam; Dritsoula, Athina; Beales, Philip L.] UCL, Inst Child Hlth, Mol Med Unit, London, England; [Loges, Niki T.; Olbrich, Heike; Omran, Heymut] Univ Hosp Muenster, Dept Pediat & Adolescent Med, Munster, Germany; [Hirst, Rob A.; O'Callaghan, Christopher] Univ Leicester, Dept Infect Immun & Inflammat, Leicester Royal Infirm, Leicester, Leics, England; [Blau, Hannah; Mussaffi, Huda] Tel Aviv Univ, Pulm Unit, Schneider Childrens Med Ctr Israel, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Al Dabbagh, Maha] King Fahd Armed Forces Hosp, Dept Pediat, Pulm Sect, Jeddah, Saudi Arabia; [Yagi, Toshiki] Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Tokyo, Japan; [Chung, Eddie M. K.] UCL, Gen & Adolescent Paediat Unit, Inst Child Hlth, London, England	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of London; University College London; University of Munster; University of Leicester; Tel Aviv University; Sackler Faculty of Medicine; King Fahd Armed Forces Hospital; University of Tokyo; University of London; University College London	Mitchell, DR (corresponding author), SUNY Upstate Med Univ, Syracuse, NY USA.	h.mitchison@ucl.ac.uk; mitcheld@upstate.edu	Schmidts, Miriam/A-3777-2012; Beales, Philip L/C-7367-2009; Hirst, Robert/AAD-1649-2022	Schmidts, Miriam/0000-0002-1714-6749; Mitchison, Hannah/0000-0002-3163-6293; Yagi, Toshiki/0000-0002-1379-460X; Dritsoula, Athina/0000-0003-4225-6605; Mitchell, David/0000-0003-2821-7511; Hirst, Robert Anthony/0000-0003-1989-1790; Omran, Heymut/0000-0003-0282-6765	Office of Science of the US Department of Energy [DE-AC02-05CH11231]; US National Institutes of Health [R01-GM044228]; PCD Family Support Group (UK); Fondation Milena Carvajal Pro-Kartagener; Medical Research Council UK; Wellcome Trust; Action Medical Research; Deutsche Forschungsgemeinschaft (DFG) [Om 6/4, GRK1104, BIOSS, SFB592]; Action Medical Research [1773] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044228] Funding Source: NIH RePORTER	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PCD Family Support Group (UK); Fondation Milena Carvajal Pro-Kartagener; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Action Medical Research; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Action Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the patients and their families for their participation and the physicians involved, particularly H. Simpson, J. Clarke and D. Spencer. We are grateful to M. Turmaine (University College London) for zebrafish electron microscopy. W. Sale (Emory University) and S. King ( University of Connecticut) provided antibodies to Chlamydomonas dynein subunits. We thank R.M. Gardiner, S. Spiden, M. Meeks, D. Antony and D. Osborn for advice and assistance. We also thank A. Heer, D. Nergenau, C. Reinhard, C. Kopp, K. Sutter, C. Tessmer, T. de Ledezma and S. Franz for excellent technical assistance. The work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under contract number DE-AC02-05CH11231. D.R.M. was supported by US National Institutes of Health grant R01-GM044228. H.M.M. received support from the PCD Family Support Group (UK) and funding from the Fondation Milena Carvajal Pro-Kartagener, the Medical Research Council UK, the Wellcome Trust and Action Medical Research. H. Omran was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (Om 6/4, GRK1104, BIOSS and SFB592).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmed NT, 2008, J CELL BIOL, V183, P313, DOI 10.1083/jcb.200802025; Ahmed NT, 2005, MOL BIOL CELL, V16, P5004, DOI 10.1091/mbc.E05-07-0627; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barbato A, 2009, EUR RESPIR J, V34, P1264, DOI 10.1183/09031936.00176608; BARTH KA, 1995, DEVELOPMENT, V121, P1755; Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; Boulon S, 2010, MOL CELL, V39, P912, DOI 10.1016/j.molcel.2010.08.023; Bush A, 1998, PEDIATR CARDIOL, V19, P191, DOI 10.1007/s002469900280; Bush A, 2009, CLIN PULM MED, V16, P219, DOI [10.1097/CPM.0b013e3181ad26eb, DOI 10.1097/CPM.0B013E3181AD26EB]; Castleman VH, 2009, AM J HUM GENET, V84, P197, DOI 10.1016/j.ajhg.2009.01.011; Colantonio JR, 2009, NATURE, V457, P205, DOI 10.1038/nature07520; Coren ME, 2002, ACTA PAEDIATR, V91, P667, DOI 10.1080/080352502760069089; Duquesnoy P, 2009, AM J HUM GENET, V85, P890, DOI 10.1016/j.ajhg.2009.11.008; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El Zein L, 2003, TRENDS GENET, V19, P162, DOI 10.1016/S0168-9525(03)00026-X; Ferrante MI, 2009, HUM MOL GENET, V18, P289, DOI 10.1093/hmg/ddn356; Fliegauf M, 2005, AM J RESP CRIT CARE, V171, P1343, DOI 10.1164/rccm.200411-1583OC; Fowkes M.E., 1999, THESIS STATE U NEW Y; Fowkes ME, 1998, MOL BIOL CELL, V9, P2337, DOI 10.1091/mbc.9.9.2337; Freshour J, 2007, J BIOL CHEM, V282, P5404, DOI 10.1074/jbc.M607509200; Gao CL, 2010, DEV DYNAM, V239, P2190, DOI 10.1002/dvdy.22355; Geremek M, 2011, HUM GENET, V129, P283, DOI 10.1007/s00439-010-0922-4; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Heuser T, 2009, J CELL BIOL, V187, P921, DOI 10.1083/jcb.200908067; Hom EFY, 2011, CYTOSKELETON, V68, P555, DOI 10.1002/cm.20533; Horejsi Z, 2010, MOL CELL, V39, P839, DOI 10.1016/j.molcel.2010.08.037; HUANG B, 1979, J BIOL CHEM, V254, P3091; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; KAMIYA R, 1988, J CELL BIOL, V107, P2253, DOI 10.1083/jcb.107.6.2253; Kamiya R, 2002, INT REV CYTOL, V219, P115; Kennedy MP, 2007, CIRCULATION, V115, P2814, DOI 10.1161/CIRCULATIONAHA.106.649038; KING SM, 1985, P NATL ACAD SCI USA, V82, P4717, DOI 10.1073/pnas.82.14.4717; Kosaki K, 2004, AM J MED GENET A, V129A, P308, DOI 10.1002/ajmg.a.30177; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Liu L, 2008, J BIOL CHEM, V283, P13185, DOI 10.1074/jbc.M800757200; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Loges NT, 2009, AM J HUM GENET, V85, P883, DOI 10.1016/j.ajhg.2009.10.018; Lunt SC, 2009, DEV DYNAM, V238, P1744, DOI 10.1002/dvdy.21999; Mazor M, 2011, AM J HUM GENET, V88, P599, DOI 10.1016/j.ajhg.2011.03.018; Meeks M, 2000, J MED GENET, V37, P241, DOI 10.1136/jmg.37.4.241; MITCHELL DR, 1986, CELL MOTIL CYTOSKEL, V6, P510, DOI 10.1002/cm.970060510; MITCHELL DR, 1994, J CELL SCI, V107, P635; MITCHELL DR, 1991, J CELL BIOL, V113, P835, DOI 10.1083/jcb.113.4.835; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Papon JF, 2010, EUR RESPIR J, V35, P1057, DOI 10.1183/09031936.00046209; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; PIPERNO G, 1991, J CELL BIOL, V112, P701, DOI 10.1083/jcb.112.4.701; PIPERNO G, 1992, J CELL BIOL, V118, P1455, DOI 10.1083/jcb.118.6.1455; Rashid S, 2006, MOL REPROD DEV, V73, P784, DOI 10.1002/mrd.20475; ROSENBAU.JL, 1969, J CELL BIOL, V41, P600, DOI 10.1083/jcb.41.2.600; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Rymarquis LA, 2005, PLANT PHYSIOL, V137, P557, DOI 10.1104/pp.104.054221; Sullivan-Brown J, 2008, DEV BIOL, V314, P261, DOI 10.1016/j.ydbio.2007.11.025; TAKADA S, 1994, J CELL BIOL, V126, P737, DOI 10.1083/jcb.126.3.737; Tan SY, 2007, J CLIN INVEST, V117, P3742, DOI 10.1172/JCI33284; van Rooijen E, 2008, J AM SOC NEPHROL, V19, P1128, DOI 10.1681/ASN.2007080917; WILKERSON CG, 1995, J CELL BIOL, V129, P169, DOI 10.1083/jcb.129.1.169; Yagi T, 2009, J CELL SCI, V122, P1306, DOI 10.1242/jcs.045096; Yamamoto R, 2010, J CELL BIOL, V190, P65, DOI 10.1083/jcb.201002081; Yang PF, 2006, J CELL SCI, V119, P1165, DOI 10.1242/jcs.02811; Yang PF, 1998, MOL BIOL CELL, V9, P3335, DOI 10.1091/mbc.9.12.3335; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	67	176	185	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2012	44	4					381	U186		10.1038/ng.1106	http://dx.doi.org/10.1038/ng.1106			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	916VF	22387996	Green Accepted			2022-12-25	WOS:000302130600011
J	Rubio-Texeira, M; Van Zeebroeck, G; Thevelein, JM				Rubio-Texeira, Marta; Van Zeebroeck, Griet; Thevelein, Johan M.			Peptides induce persistent signaling from endosomes by a nutrient transceptor	NATURE CHEMICAL BIOLOGY			English	Article							AMINO-ACID PERMEASE; YEAST SACCHAROMYCES-CEREVISIAE; INTRACELLULAR PH; PLASMA-MEMBRANE; NITROGEN-SOURCES; PROTEIN-KINASE; PATHWAY; TRAFFICKING; UBIQUITIN; ENDOCYTOSIS	The yeast Gap1 transceptor mediates amino acid activation of the protein kinase A pathway and undergoes endocytic internalization following amino acid transport. We identified three specific gamma-glutamyl dipeptides that cause persistent cyclic AMP-independent activation of protein kinase A, prevent Gap1 vacuolar sorting and cause Gap1 accumulation in endosomes. To our knowledge, these are the first examples of persistent agonists of a transceptor. In yeast mutants blocked in multivesicular body sorting, L-citrulline mimicked persistent signaling, further supporting that the internalized Gap1 transceptor keeps signaling. Unexpectedly, these dipeptides were transported by Gap1 and not by the regular dipeptide transporters. Their uptake was unusually sensitive to external pH and caused transient intracellular acidification. High external pH, NHA1 deletion or V-ATPase inhibition overcame the vacuolar sorting defect. Hence, this work has identified specific dipeptides that cause enhanced proton influx through the Gap1 symporter, resulting in its defective vacuolar sorting, and independently transform it into a persistently signaling transceptor.	[Rubio-Texeira, Marta; Van Zeebroeck, Griet; Thevelein, Johan M.] Katholieke Univ Leuven, Inst Bot & Microbiol, Mol Cell Biol Lab, Flanders, Belgium; [Rubio-Texeira, Marta; Van Zeebroeck, Griet; Thevelein, Johan M.] VIB, Dept Mol Microbiol, Flanders, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB)	Rubio-Texeira, M (corresponding author), Katholieke Univ Leuven, Inst Bot & Microbiol, Mol Cell Biol Lab, Flanders, Belgium.	johan.thevelein@mmbio.vib-kuleuven.be	Thevelein, Johan M./AAK-4203-2021; Rubio-Texeira, Marta/G-5383-2013; Thevelein, Johan M./A-7897-2013	Rubio-Texeira, Marta/0000-0002-8332-2245; Thevelein, Johan M./0000-0002-2626-0180	European Commission; Fonds Wetenschappelijk Onderzoek; Fund for Scientific Research-Flanders; Interuniversity Attraction Poles Network [P6/14]; KU Leuven (Concerted Research Actions); Hercules Foundation (Flanders)	European Commission(European CommissionEuropean Commission Joint Research Centre); Fonds Wetenschappelijk Onderzoek(FWO); Fund for Scientific Research-Flanders(FWO); Interuniversity Attraction Poles Network(Belgian Federal Science Policy Office); KU Leuven (Concerted Research Actions)(KU Leuven); Hercules Foundation (Flanders)	We would specially like to thank H. Sychrova and members of her laboratory, L. Maresova and O. Kinclova-Zimmermanova for their help and guidance in the intracellular pH measurements. We thank W. Verheyden and R. Wicik for technical help with the experiments, N. Vangoethem for help with preparation of the figures and V. Diaz for helping us with organochemistry calculations and concepts. We would also like to thank all researchers that have kindly provided us with strains, plasmids and antibodies from their laboratories (mentioned in Supplementary Tables 1 and 2). This work was supported by an European Commission-Marie Curie fellowship to M.R.-T., by Fonds Wetenschappelijk Onderzoek visiting and postdoctoral fellowships to M.R.-T. and G.V.Z. and by grants from the Fund for Scientific Research-Flanders, Interuniversity Attraction Poles Network P6/14, the Research Fund of the KU Leuven (Concerted Research Actions) and the Hercules Foundation (Flanders).	Arino J, 2010, MICROBIOL MOL BIOL R, V74, P95, DOI 10.1128/MMBR.00042-09; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Cai HJ, 2007, EUKARYOT CELL, V6, P1805, DOI 10.1128/EC.00257-06; Chen EJ, 2002, P NATL ACAD SCI USA, V99, P14837, DOI 10.1073/pnas.232591899; Colombo S, 1998, EMBO J, V17, P3326, DOI 10.1093/emboj/17.12.3326; DAVIS NG, 1993, J CELL BIOL, V122, P53, DOI 10.1083/jcb.122.1.53; Didion T, 1998, MOL MICROBIOL, V27, P643, DOI 10.1046/j.1365-2958.1998.00714.x; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; Dupre S, 2001, MOL CELL BIOL, V21, P4482, DOI 10.1128/MCB.21.14.4482-4494.2001; DURNEZ P, 1994, YEAST, V10, P1049, DOI 10.1002/yea.320100807; Forsberg H, 2001, CURR GENET, V40, P91, DOI 10.1007/s002940100244; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; GRENSON M, 1970, J BACTERIOL, V103, P770, DOI 10.1128/JB.103.3.770-777.1970; Hauser M, 2000, J BIOL CHEM, V275, P3037, DOI 10.1074/jbc.275.5.3037; Hauser M, 2001, MOL MEMBR BIOL, V18, P105, DOI 10.1080/713816114; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; HIRIMBUREGAMA K, 1992, J GEN MICROBIOL, V138, P2035, DOI 10.1099/00221287-138-10-2035; Holsbeeks I, 2004, TRENDS BIOCHEM SCI, V29, P556, DOI 10.1016/j.tibs.2004.08.010; HOPKINS P, 1992, YEAST, V8, P1053, DOI 10.1002/yea.320081208; JAUNIAUX JC, 1990, EUR J BIOCHEM, V190, P39, DOI 10.1111/j.1432-1033.1990.tb15542.x; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; Kriel J, 2011, BIOESSAYS, V33, P870, DOI 10.1002/bies.201100100; Lafourcade C, 2004, MOL CELL BIOL, V24, P3815, DOI 10.1128/MCB.24.9.3815-3826.2004; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Lundh F, 2009, BIOCHEMISTRY-US, V48, P4497, DOI 10.1021/bi9001198; Maresova L, 2010, YEAST, V27, P317, DOI 10.1002/yea.1755; Markgraf DF, 2009, MOL BIOL CELL, V20, P5276, DOI 10.1091/mbc.E09-06-0521; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nikko E, 2003, J BIOL CHEM, V278, P50732, DOI 10.1074/jbc.M306953200; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Proszynski TJ, 2005, P NATL ACAD SCI USA, V102, P17981, DOI 10.1073/pnas.0509107102; Rajagopalan S, 2010, TRAFFIC, V11, P1381, DOI 10.1111/j.1600-0854.2010.01112.x; Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469; Rubio-Texeira M, 2006, MOL BIOL CELL, V17, P3031, DOI 10.1091/mbc.E05-07-0669; Rubio-Texeira M, 2010, FEMS YEAST RES, V10, P134, DOI 10.1111/j.1567-1364.2009.00587.x; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Sychrova H, 1999, FEMS MICROBIOL LETT, V171, P167, DOI 10.1111/j.1574-6968.1999.tb13428.x; THEVELEIN JM, 1991, MOL MICROBIOL, V5, P1301, DOI 10.1111/j.1365-2958.1991.tb00776.x; THEVELEIN JM, 1987, J GEN MICROBIOL, V133, P2191; THEVELEIN JM, 1985, J GEN MICROBIOL, V131, P3199; TREVILLYAN JM, 1979, J BACTERIOL, V138, P397, DOI 10.1128/JB.138.2.397-403.1979; Van Zeebroeck G, 2009, NAT CHEM BIOL, V5, P45, DOI 10.1038/nchembio.132; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wiles AM, 2006, MICROBIOL-SGM, V152, P3133, DOI 10.1099/mic.0.29055-0	46	16	16	2	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2012	8	4					400	408		10.1038/NCHEMBIO.910	http://dx.doi.org/10.1038/NCHEMBIO.910			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	913PO	22388927				2022-12-25	WOS:000301890100015
J	Wong, VWY; Stange, DE; Page, ME; Buczacki, S; Wabik, A; Itami, S; van de Wetering, M; Poulsom, R; Wright, NA; Trotter, MWB; Watt, FM; Winton, DJ; Clevers, H; Jensen, KB				Wong, Vivian W. Y.; Stange, Daniel E.; Page, Mahalia E.; Buczacki, Simon; Wabik, Agnieszka; Itami, Satoshi; van de Wetering, Marc; Poulsom, Richard; Wright, Nicholas A.; Trotter, Matthew W. B.; Watt, Fiona M.; Winton, Doug J.; Clevers, Hans; Jensen, Kim B.			Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling	NATURE CELL BIOLOGY			English	Article							RECEPTOR TYROSINE KINASE; LGR5; POPULATION; PATTERN; MAINTENANCE; INHIBITION; ADENOMAS; NICHES; CRYPTS; LEVEL	Maintenance of adult tissues is carried out by stem cells and is sustained throughout life in a highly ordered manner(1,2). Homeostasis within the stem-cell compartment is governed by positive- and negative-feedback regulation of instructive extrinsic and intrinsic signals(3,4). ErbB signalling is a prerequisite for maintenance of the intestinal epithelium following injury and tumour formation(5,6). As ErbB-family ligands and receptors are highly expressed within the stem-cell niche(7), we hypothesize that strong endogenous regulators must control the pathway in the stem-cell compartment. Here we show that Lrig1, a negative-feedback regulator of the ErbB receptor family(8-10), is highly expressed by intestinal stem cells and controls the size of the intestinal stem-cell niche by regulating the amplitude of growth-factor signalling. Intestinal stem-cell maintenance has so far been attributed to a combination of Wnt and Notch activation and Bmpr inhibition(11-13). Our findings reveal ErbB activation as a strong inductive signal for stem-cell proliferation. This has implications for our understanding of ErbB signalling in tissue development and maintenance and the progression of malignant disease.	[Wong, Vivian W. Y.; Page, Mahalia E.; Trotter, Matthew W. B.; Jensen, Kim B.] Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge CB2 0SZ, England; [Wong, Vivian W. Y.; Page, Mahalia E.; Wabik, Agnieszka; Watt, Fiona M.; Jensen, Kim B.] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; [Wong, Vivian W. Y.; Page, Mahalia E.; Jensen, Kim B.] Univ Cambridge, Dept Oncol, Cambridge CB2 0QQ, England; [Stange, Daniel E.; van de Wetering, Marc; Clevers, Hans] KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Stange, Daniel E.; van de Wetering, Marc; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Buczacki, Simon; Watt, Fiona M.; Winton, Doug J.] Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge CB2 0RE, England; [Itami, Satoshi] Osaka Univ, Grad Sch Med, Dept Regenerat Dermatol, Suita, Osaka 5650871, Japan; [Poulsom, Richard; Wright, Nicholas A.] Canc Res UK London Res Inst, London WC2A 3LY, England; [Wright, Nicholas A.] Barts & London Queen Marys Sch Med & Dent, London E1 2AD, England; [Trotter, Matthew W. B.] Univ Cambridge, Dept Surg, Cambridge CB2 0QQ, England; [Trotter, Matthew W. B.] Celgene Inst Translat Res Europe, E-41092 Seville, Spain; [Watt, Fiona M.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	University of Cambridge; University of Cambridge; University of Cambridge; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Cancer Research UK; CRUK Cambridge Institute; Osaka University; Cancer Research UK; University of London; Queen Mary University London; University of Cambridge; University of Cambridge	Jensen, KB (corresponding author), Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge CB2 0SZ, England.	kbj22@cam.ac.uk	Parry, Lee/A-9623-2011; Jensen, Kim/F-5333-2014; Stange, Daniel E/O-1837-2015; Wright, Nicholas/HHY-7227-2022; Watt, Fiona/AHB-0226-2022	Parry, Lee/0000-0002-4467-9196; Stange, Daniel E/0000-0003-4246-2230; Watt, Fiona/0000-0001-9151-5154; Jensen, Kim/0000-0001-6569-1664; Wright, Nicholas/0000-0002-5525-3457; Trotter, Matthew/0000-0003-3702-915X; Buczacki, Simon/0000-0002-2975-416X	NIH [5R01 HL067395]; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research Training Grant at UCLA; UK Medical Research Council; Wellcome Trust; MRC [G0800784] Funding Source: UKRI; Cancer Research UK [17044] Funding Source: researchfish; Medical Research Council [G0800784B, 979886, G0800784] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research Training Grant at UCLA; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank E. Wagner, M. Frye, S. Yuspa, B. Otto, R. Walker, R. Jeffery, H. Begthel, M. McLeish, the WTCSCR Biofacility and Cambridge Genomics Services for reagents, technical assistance and advice, and R. Fordham and R. Williams for critical comments on the manuscript. We acknowledge support from the UK Medical Research Council and Wellcome Trust.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Biteau B, 2011, DEVELOPMENT, V138, P1045, DOI 10.1242/dev.056671; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Gur G, 2004, EMBO J, V23, P3270, DOI 10.1038/sj.emboj.7600342; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Iyer R, 2004, RADIOTHER ONCOL, V72, P283, DOI 10.1016/j.radonc.2004.07.012; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; Ledda F, 2008, J NEUROSCI, V28, P39, DOI 10.1523/JNEUROSCI.2196-07.2008; Lee D, 2009, J CLIN INVEST, V119, P2702, DOI 10.1172/JCI36435; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Roberts RB, 2002, P NATL ACAD SCI USA, V99, P1521, DOI 10.1073/pnas.032678499; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; SCHMIDT GH, 1988, DEVELOPMENT, V103, P785; Shattuck DL, 2007, MOL CELL BIOL, V27, P1934, DOI 10.1128/MCB.00757-06; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Suzuki Y, 2002, FEBS LETT, V521, P67, DOI 10.1016/S0014-5793(02)02824-7; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; von Furstenberg RJ, 2011, AM J PHYSIOL-GASTR L, V300, pG409, DOI 10.1152/ajpgi.00453.2010; Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011	40	296	299	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2012	14	4					401	+		10.1038/ncb2464	http://dx.doi.org/10.1038/ncb2464			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	921UM	22388892	Green Accepted			2022-12-25	WOS:000302503300013
J	Adamson, B; Smogorzewska, A; Sigoillot, FD; King, RW; Elledge, SJ				Adamson, Britt; Smogorzewska, Agata; Sigoillot, Frederic D.; King, Randall W.; Elledge, Stephen J.			A genome-wide homologous recombination screen identifies the RNA-binding protein RBMX as a component of the DNA-damage response	NATURE CELL BIOLOGY			English	Article							SPINDLE-CHECKPOINT; PROMOTES; TARGET; REPAIR; TAO1; EXPRESSION; PARALOG; ATM; P53	Repair of DNA double-strand breaks is critical to genomic stability and the prevention of developmental disorders and cancer. A central pathway for this repair is homologous recombination (HR). Most knowledge of HR is derived from work in prokaryotic and eukaryotic model organisms. We carried out a genome-wide siRNA-based screen in human cells. Among positive regulators of HR we identified networks of DNA-damage-response and pre-mRNA-processing proteins, and among negative regulators we identified a phosphatase network. Three candidate proteins localized to DNA lesions, including RBMX, a heterogeneous nuclear ribonucleoprotein that has a role in alternative splicing. RBMX accumulated at DNA lesions through multiple domains in a poly(ADP-ribose) polymerase 1-dependent manner and promoted HR by facilitating proper BRCA2 expression. Our screen also revealed that off-target depletion of RAD51 is a common source of RNAi false positives, raising a cautionary note for siRNA screens and RNAi-based studies of HR.	[Adamson, Britt; Smogorzewska, Agata; Elledge, Stephen J.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Howard Hughes Med Inst,Dept Genet,Div Genet, Boston, MA 02115 USA; [Smogorzewska, Agata] Rockefeller Univ, Lab Genome Maintenance, New York, NY 10065 USA; [Sigoillot, Frederic D.; King, Randall W.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Rockefeller University; Harvard University; Harvard Medical School	Elledge, SJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Howard Hughes Med Inst,Dept Genet,Div Genet, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu		Smogorzewska, Agata/0000-0001-6285-1562; King, Randall/0000-0001-7882-8180; Sigoillot, Frederic/0000-0002-8695-4838	National Institutes of Health; Burroughs Wellcome Fund Career Award for Medical Scientists; Rita Allen Foundation; Irma T. Hirschl scholar;  [T32CA09216]; NATIONAL CANCER INSTITUTE [T32CA009216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM044664, R01GM044664] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); Rita Allen Foundation; Irma T. Hirschl scholar; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Jasin (Memorial Sloan-Kettering Cancer Center, USA) for DR-U2OS cells, P. Ng and F. Graham (McMaster University, Canada) for the AdNGUS24i, P. D. Adams (Institute of Cancer Sciences, CR-UK Beatson Labs, UK) for antibodies, S. J. Boulton (DNA Damage Response Laboratory, London Research Institute, UK) for the PARP inhibitor and C. Cotta-Ramusino and members of the Elledge laboratory for advice and discussion. We thank the Institute of Chemistry and Cell Biology (ICCB) Longwood screening facility, including C. Shamu, S. Rudnicki, S. M. Johnston and T. Xie. This work was supported by a grant from the National Institutes of Health to S.J.E. A.S. was supported by T32CA09216 to the Pathology Department at the Massachusetts General Hospital and by Burroughs Wellcome Fund Career Award for Medical Scientists and is a Rita Allen Foundation and an Irma T. Hirschl scholar. S.J.E. is an investigator with the Howard Hughes Medical Institute.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bolderson E, 2010, NUCLEIC ACIDS RES, V38, P1821, DOI 10.1093/nar/gkp1164; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cotta-Ramusino C, 2011, SCIENCE, V332, P1313, DOI 10.1126/science.1203430; Draviam VM, 2007, NAT CELL BIOL, V9, P556, DOI 10.1038/ncb1569; Elliott DJ, 2004, INT J ANDROL, V27, P328, DOI 10.1111/j.1365-2605.2004.00496.x; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Heinrich B, 2009, J BIOL CHEM, V284, P14303, DOI 10.1074/jbc.M901026200; Hubner NC, 2010, CHROMOSOMA, V119, P149, DOI 10.1007/s00412-009-0244-2; Hurov KE, 2010, GENE DEV, V24, P1939, DOI 10.1101/gad.1934210; Janknecht R, 2010, AM J TRANSL RES, V2, P223; Kanhoush R, 2010, NUCLEUS-PHILA, V1, P109, DOI 10.4161/nucl.1.1.10857; Lingenfelter PA, 2001, MAMM GENOME, V12, P538, DOI 10.1007/s00335001-0003-z; Lorain S, 1998, MOL CELL BIOL, V18, P5546, DOI 10.1128/MCB.18.9.5546; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mazeyrat S, 1999, NAT GENET, V22, P224, DOI 10.1038/10282; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; Reinhardt HC, 2011, CELL CYCLE, V10, P23, DOI 10.4161/cc.10.1.14351; Reinhardt HC, 2010, MOL CELL, V40, P34, DOI 10.1016/j.molcel.2010.09.018; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Shin KH, 2007, DNA REPAIR, V6, P830, DOI 10.1016/j.dnarep.2007.01.013; Shin KH, 2006, CLIN CANCER RES, V12, P3222, DOI 10.1158/1078-0432.CCR-05-2656; Sigoillot F. D., NAT METHODS IN PRESS; Sigoillot FD, 2011, ACS CHEM BIOL, V6, P47, DOI 10.1021/cb100358f; Slabicki M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000408; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Westhorpe FG, 2010, CHROMOSOMA, V119, P371, DOI 10.1007/s00412-010-0261-1; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022	36	294	302	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2012	14	3					318	+		10.1038/ncb2426	http://dx.doi.org/10.1038/ncb2426			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	900ZE	22344029	Green Accepted			2022-12-25	WOS:000300930400015
J	Chandra, A; Grecco, HE; Pisupati, V; Perera, D; Cassidy, L; Skoulidis, F; Ismail, SA; Hedberg, C; Hanzal-Bayer, M; Venkitaraman, AR; Wittinghofer, A; Bastiaens, PIH				Chandra, Anchal; Grecco, Hernan E.; Pisupati, Venkat; Perera, David; Cassidy, Liam; Skoulidis, Ferdinandos; Ismail, Shehab A.; Hedberg, Christian; Hanzal-Bayer, Michael; Venkitaraman, Ashok R.; Wittinghofer, Alfred; Bastiaens, Philippe I. H.			The GDI-like solubilizing factor PDE delta sustains the spatial organization and signalling of Ras family proteins	NATURE CELL BIOLOGY			English	Article							K-RAS; PLASMA-MEMBRANE; H-RAS; FLUORESCENT PROTEIN; PANCREATIC-CANCER; SURFACE-CHARGE; RAP2 PROTEINS; SUBUNIT; PHOSPHODIESTERASE; LOCALIZATION	We identify a role for the GDI-like solubilizing factor (GSF) PDE delta in modulating signalling through Ras family G proteins by sustaining their dynamic distribution in cellular membranes. We show that the GDI-like pocket of PDE delta binds and solubilizes farnesylated Ras proteins, thereby enhancing their diffusion in the cytoplasm. This mechanism allows more effective trapping of depalmitoylated Ras proteins at the Golgi and polycationic Ras proteins at the plasma membrane to counter the entropic tendency to distribute these proteins over all intracellular membranes. Thus, PDE delta activity augments K/Hras signalling by enriching Ras at the plasma membrane; conversely, PDE delta down-modulation randomizes Ras distributions to all membranes in the cell and suppresses regulated signalling through wild-type Ras and also constitutive oncogenic Ras signalling in cancer cells. Our findings link the activity of PDE delta in determining Ras protein topography to Ras-dependent signalling.	[Chandra, Anchal; Grecco, Hernan E.; Bastiaens, Philippe I. H.] Max Planck Inst Mol Physiol, Dept Syst Cell Biol, D-44227 Dortmund, Germany; [Chandra, Anchal; Ismail, Shehab A.; Wittinghofer, Alfred] Max Planck Inst Mol Physiol, Dept Struct Biol, D-44227 Dortmund, Germany; [Hedberg, Christian] Max Planck Inst Mol Physiol, Dept Chem Biol, D-44227 Dortmund, Germany; [Hanzal-Bayer, Michael] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Bastiaens, Philippe I. H.] Tech Univ Dortmund, Fac Chem, D-44227 Dortmund, Germany; [Pisupati, Venkat; Perera, David; Cassidy, Liam; Skoulidis, Ferdinandos; Venkitaraman, Ashok R.] Hutchison MRC Res Ctr, Dept Oncol, Cambridge CB2 0XZ, England; [Pisupati, Venkat; Perera, David; Cassidy, Liam; Skoulidis, Ferdinandos; Venkitaraman, Ashok R.] Hutchison MRC Res Ctr, Canc Cell Unit, MRC, Cambridge CB2 0XZ, England	Max Planck Society; Max Planck Society; Max Planck Society; University of Queensland; Dortmund University of Technology	Bastiaens, PIH (corresponding author), Max Planck Inst Mol Physiol, Dept Syst Cell Biol, Otto Hahn Str 11, D-44227 Dortmund, Germany.	philippe.bastiaens@mpi-dortmund.mpg.de	Chandra, Anchal/AAT-5644-2021	Chandra, Anchal/0000-0003-4096-4771; Ismail, Shehab/0000-0002-4150-1077; Cassidy, Liam/0000-0002-9312-6256	Medical Research Council [G0600332, MC_U105359877, G1001521, G0700651] Funding Source: Medline; MRC [G0700651, G0600332, G1001521, MC_U105359877] Funding Source: UKRI; National Institute for Health Research [CL-2008-14-003] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))		Alexander M, 2009, CHEMBIOCHEM, V10, P98, DOI 10.1002/cbic.200800275; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Bhagatji P, 2010, BIOPHYS J, V99, P3327, DOI 10.1016/j.bpj.2010.10.001; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; CAMP LA, 1993, J BIOL CHEM, V268, P22566; Chen YX, 2010, ANGEW CHEM INT EDIT, V49, P6090, DOI 10.1002/anie.201001884; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Daleke DL, 2003, J LIPID RES, V44, P233, DOI 10.1194/jlr.R200019-JLR200; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Elad-Sfadia G, 2004, J BIOL CHEM, V279, P34922, DOI 10.1074/jbc.M312697200; FARRELL FX, 1993, BIOCHEM J, V289, P349, DOI 10.1042/bj2890349; Florio SK, 1996, J BIOL CHEM, V271, P24036, DOI 10.1074/jbc.271.39.24036; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Gosser YQ, 1997, NATURE, V387, P814, DOI 10.1038/42961; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; KIM JY, 1994, J BIOL CHEM, V269, P28214; Longenecker K, 1999, ACTA CRYSTALLOGR D, V55, P1503, DOI 10.1107/S090744499900801X; Lorentzen A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.20001370; Lorenz B, 1998, EUR J HUM GENET, V6, P283, DOI 10.1038/sj.ejhg.5200215; Marzesco AM, 1998, J BIOL CHEM, V273, P22340, DOI 10.1074/jbc.273.35.22340; Nancy V, 2002, J BIOL CHEM, V277, P15076, DOI 10.1074/jbc.M109983200; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Paz A, 2001, ONCOGENE, V20, P7486, DOI 10.1038/sj.onc.1204950; Peyker A, 2005, CHEMBIOCHEM, V6, P78, DOI 10.1002/cbic.200400280; RICHARDS CA, 1990, CANCER RES, V50, P1521; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Sang SLW, 2005, J PEPT RES, V66, P169, DOI 10.1111/j.1399-3011.2005.00285.x; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Skoulidis F, 2010, CANCER CELL, V18, P499, DOI 10.1016/j.ccr.2010.10.015; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; WILLIAMSON P, 1994, MOL MEMBR BIOL, V11, P199, DOI 10.3109/09687689409160430; Wilson SJ, 2006, J BIOL CHEM, V281, P11780, DOI 10.1074/jbc.M513110200; WINEGAR DA, 1991, J BIOL CHEM, V266, P4381; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Zhang H, 2007, P NATL ACAD SCI USA, V104, P8857, DOI 10.1073/pnas.0701681104; Zhang HB, 2004, J BIOL CHEM, V279, P407, DOI 10.1074/jbc.M306559200	52	223	230	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2012	14	2					148	158		10.1038/ncb2394	http://dx.doi.org/10.1038/ncb2394			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	893CF	22179043				2022-12-25	WOS:000300332500009
J	Rademakers, R; Baker, M; Nicholson, AM; Rutherford, NJ; Finch, N; Soto-Ortolaza, A; Lash, J; Wider, C; Wojtas, A; DeJesus-Hernandez, M; Adamson, J; Kouri, N; Sundal, C; Shuster, EA; Aasly, J; MacKenzie, J; Roeber, S; Kretzschmar, HA; Boeve, BF; Knopman, DS; Petersen, RC; Cairns, NJ; Ghetti, B; Spina, S; Garbern, J; Tselis, AC; Uitti, R; Das, P; Van Gerpen, JA; Meschia, JF; Levy, S; Broderick, DF; Graff-Radford, N; Ross, OA; Miller, BB; Swerdlow, RH; Dickson, DW; Wszolek, ZK				Rademakers, Rosa; Baker, Matt; Nicholson, Alexandra M.; Rutherford, Nicola J.; Finch, NiCole; Soto-Ortolaza, Alexandra; Lash, Jennifer; Wider, Christian; Wojtas, Aleksandra; DeJesus-Hernandez, Mariely; Adamson, Jennifer; Kouri, Naomi; Sundal, Christina; Shuster, Elizabeth A.; Aasly, Jan; MacKenzie, James; Roeber, Sigrun; Kretzschmar, Hans A.; Boeve, Bradley F.; Knopman, David S.; Petersen, Ronald C.; Cairns, Nigel J.; Ghetti, Bernardino; Spina, Salvatore; Garbern, James; Tselis, Alexandros C.; Uitti, Ryan; Das, Pritam; Van Gerpen, Jay A.; Meschia, James F.; Levy, Shawn; Broderick, Daniel F.; Graff-Radford, Neill; Ross, Owen A.; Miller, Bradley B.; Swerdlow, Russell H.; Dickson, Dennis W.; Wszolek, Zbigniew K.			Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids	NATURE GENETICS			English	Article							ADULT-ONSET LEUKODYSTROPHY; NASU-HAKOLA-DISEASE; NEUROAXONAL SPHEROIDS; PIGMENTED GLIA; MACROPHAGE; DEMENTIA; DAP12; EXPRESSION; MICROGLIA; SYSTEM	Hereditary diffuse leukoencephalopathy with spheroids (HDLS) is an autosomal-dominant central nervous system white-matter disease with variable clinical presentations, including personality and behavioral changes, dementia, depression, parkinsonism, seizures and other phenotypes(1,2). We combined genome-wide linkage analysis with exome sequencing and identified 14 different mutations affecting the tyrosine kinase domain of the colony stimulating factor 1 receptor (encoded by CSF1R) in 14 families with HDLS. In one kindred, we confirmed the de novo occurrence of the mutation. Followup sequencing identified an additional CSF1R mutation in an individual diagnosed with corticobasal syndrome. In vitro, CSF-1 stimulation resulted in rapid autophosphorylation of selected tyrosine residues in the kinase domain of wild-type but not mutant CSF1R, suggesting that HDLS may result from partial loss of CSF1R function. As CSF1R is a crucial mediator of microglial proliferation and differentiation in the brain, our findings suggest an important role for microglial dysfunction in HDLS pathogenesis.	[Rademakers, Rosa; Baker, Matt; Nicholson, Alexandra M.; Rutherford, Nicola J.; Finch, NiCole; Soto-Ortolaza, Alexandra; Wider, Christian; Wojtas, Aleksandra; DeJesus-Hernandez, Mariely; Adamson, Jennifer; Kouri, Naomi; Sundal, Christina; Das, Pritam; Ross, Owen A.; Dickson, Dennis W.] Mayo Clin Florida, Dept Neurosci, Jacksonville, FL USA; [Lash, Jennifer; Shuster, Elizabeth A.; Uitti, Ryan; Van Gerpen, Jay A.; Meschia, James F.; Graff-Radford, Neill; Wszolek, Zbigniew K.] Mayo Clin Florida, Dept Neurol, Jacksonville, FL USA; [Wider, Christian] Ctr Hosp Univ Vaudois CHUV UNIL, Dept Clin Neurosci, Lausanne, Switzerland; [Sundal, Christina] Gothenburg Univ, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, Sahlgrenska Acad, Gothenburg, Sweden; [Aasly, Jan] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [MacKenzie, James] Univ Aberdeen, Dept Pathol, Aberdeen, Scotland; [Roeber, Sigrun; Kretzschmar, Hans A.] Univ Munich, Ctr Neuropathol & Prion Res, Munich, Germany; [Boeve, Bradley F.; Knopman, David S.; Petersen, Ronald C.] Mayo Clin Minnesota, Dept Neurol, Rochester, MN USA; [Cairns, Nigel J.] Washington Univ, Sch Med, Dept Neurol, Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; [Ghetti, Bernardino; Spina, Salvatore] Indiana Univ Sch Med, Indiana Alzheimer Dis Ctr, Dept Pathol & Lab Med, Indianapolis, IN USA; [Garbern, James] Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA; [Tselis, Alexandros C.] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; [Levy, Shawn] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Broderick, Daniel F.] Mayo Clin Florida, Dept Radiol, Jacksonville, FL USA; [Miller, Bradley B.] Texas Tech Univ, Hlth Sci Ctr, Dept Pathol, Lubbock, TX 79430 USA; [Swerdlow, Russell H.] Univ Kansas, Sch Med, Dept Neurol, Kansas City, KS USA	Mayo Clinic; Mayo Clinic; University of Gothenburg; Norwegian University of Science & Technology (NTNU); University of Aberdeen; University of Munich; Washington University (WUSTL); Indiana University System; Indiana University Bloomington; University of Rochester; Wayne State University; HudsonAlpha Institute for Biotechnology; Mayo Clinic; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; University of Kansas; University of Kansas Medical Center	Rademakers, R (corresponding author), Mayo Clin Florida, Dept Neurosci, Jacksonville, FL USA.	rademakers.rosa@mayo.edu	Spina, Salvatore/M-4463-2019; Cairns, Nigel/AAB-9713-2020; Ross, Owen/D-7573-2013; Kouri, Naomi/G-6695-2013; Wszolek, Zbigniew K./AAB-1431-2019; Meschia, James/GPP-1636-2022	Cairns, Nigel/0000-0001-9858-3344; Meschia, James/0000-0002-4475-8142; Dickson, Dennis W/0000-0001-7189-7917; Levy, Shawn/0000-0002-1369-5740; Ross, Owen/0000-0003-4813-756X; Kouri, N/0000-0002-6841-9882	Mayo Benefactor and the Mayo Foundation; US National Institute of Neurological Disorders and Stroke [P50 NS072187]; US National Institutes of Health (NIH) [R01 NS057567, IRC2NS070276]; Mayo Clinic Florida CR [MCF 90052018, MCF 90052030]; Dystonia Medical Research Foundation; NIH [R01 NS065782, R01 AG026251, P50 AGO 16574, PHS P30 AG 10133, U24 AG 21886-0151]; Peebler PSP Research Foundation; American Heart Association; James & Esther King Biomedical Research Program; Florida Department of Health; Myron and Jane Hanley Award in Stroke research; Leenaards Foundation; Swiss Parkinson Foundation; Mayo Clinic Florida Cerebrovascular Diseases Registry [08-003878]; Mayo Foundation for Medical Education and Research; Sven and Dagmar Salens, Stiftelse, Sweden; Swedish and Gothenburg Societies for the Neurologically Disabled; Swedish Society of Medicine Gothenburg; Gothenburg Foundation for Neurological Research; Bjornsson Foundation, Gothenburg, Sweden; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057567, R01NS065782, RC2NS070276, P50NS072187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U24AG021886, R01AG026251, P50AG016574, P30AG010133] Funding Source: NIH RePORTER	Mayo Benefactor and the Mayo Foundation; US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Florida CR; Dystonia Medical Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peebler PSP Research Foundation; American Heart Association(American Heart Association); James & Esther King Biomedical Research Program; Florida Department of Health; Myron and Jane Hanley Award in Stroke research; Leenaards Foundation; Swiss Parkinson Foundation; Mayo Clinic Florida Cerebrovascular Diseases Registry; Mayo Foundation for Medical Education and Research; Sven and Dagmar Salens, Stiftelse, Sweden; Swedish and Gothenburg Societies for the Neurologically Disabled; Swedish Society of Medicine Gothenburg; Gothenburg Foundation for Neurological Research; Bjornsson Foundation, Gothenburg, Sweden; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank all family members who participated in this study, D. Gamble for help in coordinating sample and data collection from subjects with ischemic stroke, and R. Ossi for review of brain MRI scans from subjects with ischemic stroke. This work is funded by a Mayo Benefactor and the Mayo Foundation. Mayo Clinic Jacksonville is a Morris K. Udall Parkinson's Disease Research Center of Excellence supported by the US National Institute of Neurological Disorders and Stroke (P50 NS072187). Z.K.W. is partially funded by the US National Institutes of Health (NIH; R01 NS057567 and IRC2NS070276) and by Mayo Clinic Florida CR programs (MCF 90052018 and MCF 90052030). Z.K.W. is further supported by the family of Carl Edward Botch Jr. and Susan Bass Botch, and by Dystonia Medical Research Foundation. R.R. is funded by NIH grants R01 NS065782, R01 AG026251 and P50 AGO 16574 and by the Peebler PSP Research Foundation. OAR. is supported by the American Heart Association, the James & Esther King Biomedical Research Program, the Florida Department of Health and the Myron and Jane Hanley Award in Stroke research. C.W. is supported by the Leenaards Foundation and the Swiss Parkinson Foundation. The Mayo Clinic Florida Cerebrovascular Diseases Registry (IRB no. 08-003878; J.F.M., Principal Investigator) is supported by the Mayo Foundation for Medical Education and Research. C.S. is supported by grants from Sven and Dagmar Salens, Stiftelse, Sweden; the Swedish and Gothenburg Societies for the Neurologically Disabled; The Swedish Society of Medicine Gothenburg; the Gothenburg Foundation for Neurological Research; and the Bjornsson Foundation, Gothenburg, Sweden. This work is further funded by NIH PHS P30 AG 10133 (Indiana Alzheimer Disease Center, to B.G.) and NIH U24 AG 21886-0151 (National Cell Repository for Alzheimer's disease, to B.G.).	Akiguchi I, 1997, STROKE, V28, P1423, DOI 10.1161/01.STR.28.7.1423; AKIYAMA H, 1994, BRAIN RES, V639, P171, DOI 10.1016/0006-8993(94)91779-5; AXELSSON R, 1984, ACTA PSYCHIAT SCAND, V69, P1; Baba Y, 2006, ACTA NEUROPATHOL, V111, P300, DOI 10.1007/s00401-006-0046-z; Bianchin M.M., 2010, NAT REV NEUROL, V6, DOI [10.1038/nrneuro1.2010.17-cl, DOI 10.1038/NRNEUROL.2010.17-CL]; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Browne L, 2003, EUR NEUROL, V50, P85, DOI 10.1159/000072504; Chouery E, 2008, HUM MUTAT, V29, pE194, DOI 10.1002/humu.20836; Freeman SH, 2009, BRAIN PATHOL, V19, P39, DOI 10.1111/j.1750-3639.2008.00163.x; Hamilton JA, 1997, J LEUKOCYTE BIOL, V62, P145, DOI 10.1002/jlb.62.2.145; Hancock N, 2003, J NEUROL NEUROSUR PS, V74, P1345, DOI 10.1136/jnnp.74.9.1345; Itoh K, 2006, ACTA NEUROPATHOL, V111, P39, DOI 10.1007/s00401-005-1113-6; Keegan BM, 2008, NEUROLOGY, V70, P1128, DOI 10.1212/01.wnl.0000304045.99153.8f; Klunemann HH, 2005, NEUROLOGY, V64, P1502, DOI 10.1212/01.WNL.0000160304.00003.CA; Lassmann H, 2010, EXP NEUROL, V225, P2, DOI 10.1016/j.expneurol.2009.10.009; Levin N, 2008, ISR MED ASSOC J, V10, P386; Marotti JD, 2004, ACTA NEUROPATHOL, V107, P481, DOI 10.1007/s00401-004-0847-x; Mascalchi M, 2006, AM J NEURORADIOL, V27, P1037; Mateen FJ, 2010, J NEUROL NEUROSUR PS, V81, P619, DOI 10.1136/jnnp.2008.169243; Moro-de-Casillas ML, 2004, J NEUROL NEUROSUR PS, V75, P1070, DOI 10.1136/jnnp.2003.028431; Otero K, 2009, NAT IMMUNOL, V10, P734, DOI 10.1038/ni.1744; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Paloneva J, 2001, NEUROLOGY, V56, P1552, DOI 10.1212/WNL.56.11.1552; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Raivich G, 1998, J COMP NEUROL, V395, P342, DOI 10.1002/(SICI)1096-9861(19980808)395:3<342::AID-CNE6>3.0.CO;2-2; RIDGE SA, 1990, P NATL ACAD SCI USA, V87, P1377, DOI 10.1073/pnas.87.4.1377; Schiffmann R, 2009, NEUROLOGY, V72, P750, DOI 10.1212/01.wnl.0000343049.00540.c8; SENGUPTA A, 1988, P NATL ACAD SCI USA, V85, P8062, DOI 10.1073/pnas.85.21.8062; SMITH TW, 1990, J NEUROPATH EXP NEUR, V49, P357, DOI 10.1097/00005072-199007000-00001; Soares MJ, 2009, MODERN PATHOL, V22, P744, DOI 10.1038/modpathol.2009.43; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; Swerdlow RH, 2009, NEUROLOGY, V72, P260, DOI 10.1212/01.wnl.0000339484.61490.a4; Tanaka J, 2000, NEUROPATHOLOGY, V20, pS25; van der Knaap MS, 2000, NEUROLOGY, V54, P463, DOI 10.1212/WNL.54.2.463; Van Gerpen JA, 2008, NEUROLOGY, V71, P925, DOI 10.1212/01.wnl.0000325916.30701.21; Wang YQ, 1999, J NEUROSCI RES, V57, P616, DOI 10.1002/(SICI)1097-4547(19990901)57:5<616::AID-JNR4>3.0.CO;2-E; Wider C, 2009, NEUROLOGY, V72, P1953, DOI 10.1212/WNL.0b013e3181a826c0; Yamashita M, 2002, EUR NEUROL, V48, P20, DOI 10.1159/000064952; Yeung YG, 2003, MOL CELL PROTEOMICS, V2, P1143, DOI 10.1074/mcp.R300009-MCP200	40	349	361	3	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2012	44	2					200	205		10.1038/ng.1027	http://dx.doi.org/10.1038/ng.1027			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	22197934	Green Accepted			2022-12-25	WOS:000299664400020
J	Graubert, TA; Shen, D; Ding, L; Okeyo-Owuor, T; Lunn, CL; Shao, J; Krysiak, K; Harris, CC; Koboldt, DC; Larson, DE; McLellan, MD; Dooling, DJ; Abbott, RM; Fulton, RS; Schmidt, H; Kalicki-Veizer, J; O'Laughlin, M; Grillot, M; Baty, J; Heath, S; Frater, JL; Nasim, T; Link, DC; Tomasson, MH; Westervelt, P; DiPersio, JF; Mardis, ER; Ley, TJ; Wilson, RK; Walter, MJ				Graubert, Timothy A.; Shen, Dong; Ding, Li; Okeyo-Owuor, Theresa; Lunn, Cara L.; Shao, Jin; Krysiak, Kilannin; Harris, Christopher C.; Koboldt, Daniel C.; Larson, David E.; McLellan, Michael D.; Dooling, David J.; Abbott, Rachel M.; Fulton, Robert S.; Schmidt, Heather; Kalicki-Veizer, Joelle; O'Laughlin, Michelle; Grillot, Marcus; Baty, Jack; Heath, Sharon; Frater, John L.; Nasim, Talat; Link, Daniel C.; Tomasson, Michael H.; Westervelt, Peter; DiPersio, John F.; Mardis, Elaine R.; Ley, Timothy J.; Wilson, Richard K.; Walter, Matthew J.			Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; METHYLTRANSFERASE GENE EZH2; AU-RICH ELEMENT; MESSENGER-RNA; SMALL-SUBUNIT; DNMT3A MUTATIONS; RECOGNITION; IDENTIFICATION; TET2; SITE	Myelodysplastic syndromes (MDS) are hematopoietic stem cell disorders that often progress to chemotherapy-resistant secondary acute myeloid leukemia (sAML). We used whole-genome sequencing to perform an unbiased comprehensive screen to discover the somatic mutations in a sample from an individual with sAML and genotyped the loci containing these mutations in the matched MDS sample. Here we show that a missense mutation affecting the serine at codon 34 (Ser34) in U2AF1 was recurrently present in 13 out of 150 (8.7%) subjects with de novo MDS, and we found suggestive evidence of an increased risk of progression to sAML associated with this mutation. U2AF1 is a U2 auxiliary factor protein that recognizes the AG splice acceptor dinucleotide at the 3' end of introns, and the alterations in U2AF1 are located in highly conserved zinc fingers of this protein(1,2). Mutant U2AF1 promotes enhanced splicing and exon skipping in reporter assays in vitro. This previously unidentified, recurrent mutation in U2AF1 implicates altered pre-mRNA splicing as a potential mechanism for MDS pathogenesis.	[Graubert, Timothy A.; Okeyo-Owuor, Theresa; Lunn, Cara L.; Shao, Jin; Krysiak, Kilannin; Grillot, Marcus; Heath, Sharon; Link, Daniel C.; Tomasson, Michael H.; Westervelt, Peter; DiPersio, John F.; Walter, Matthew J.] Washington Univ, Dept Internal Med, Div Oncol, St Louis, MO 63130 USA; [Graubert, Timothy A.; Link, Daniel C.; Tomasson, Michael H.; Westervelt, Peter; DiPersio, John F.; Mardis, Elaine R.; Ley, Timothy J.; Wilson, Richard K.; Walter, Matthew J.] Washington Univ, Siteman Canc Ctr, St Louis, MO USA; [Graubert, Timothy A.; Frater, John L.] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA; [Shen, Dong; Ding, Li; Harris, Christopher C.; Koboldt, Daniel C.; Larson, David E.; McLellan, Michael D.; Dooling, David J.; Abbott, Rachel M.; Fulton, Robert S.; Schmidt, Heather; Kalicki-Veizer, Joelle; O'Laughlin, Michelle; Mardis, Elaine R.; Ley, Timothy J.; Wilson, Richard K.] Washington Univ, Genome Inst, St Louis, MO USA; [Ding, Li; Mardis, Elaine R.; Ley, Timothy J.; Wilson, Richard K.; Walter, Matthew J.] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Baty, Jack] Washington Univ, Div Biostat, St Louis, MO USA; [Nasim, Talat] Guys Hosp, Kings Coll, Dept Med & Mol Genet, London SE1 9RT, England; [Nasim, Talat] Guys & St Thomas Natl Hlth Serv NHS Fdn Trust, NIHR, Biomed Res Ctr, London, England; [Nasim, Talat] Kings Coll London, London WC2R 2LS, England	Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; University of London; King's College London	Walter, MJ (corresponding author), Washington Univ, Dept Internal Med, Div Oncol, St Louis, MO 63130 USA.	mjwalter@dom.wustl.edu	Walter, Matthew J/S-7758-2018; Wilson, Richard K./AAF-4139-2019; Mardis, Elaine/W-2202-2019	Wilson, Richard K./0000-0002-1992-1358; Nasim, Talat/0000-0003-1968-5663; Tomasson, Michael/0000-0003-4518-7123; Larson, David/0000-0001-7934-5906; MCLELLAN, MICHAEL/0000-0002-2703-8784; Krysiak, Kilannin/0000-0002-6299-9230; Graubert, Timothy/0000-0002-7710-1171	US National Institutes of Health [R01HL082973, RC2HL102927, U54HG003079, P01CA101937]; Howard Hughes Medical Institute; National Cancer Institute Cancer Center [P30CA91842]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by US National Institutes of Health grants R01HL082973 (T.A.G.), RC2HL102927 (T.A.G.), U54HG003079 (R.K.W.) and P01CA101937 (T.J.L.) and a Howard Hughes Medical Institute Physician-Scientist Early Career Award (M.J.W.). Technical assistance was provided by the Alvin J. Siteman Cancer Center High Speed Cell Sorting Core, the Molecular and Genomic Analysis Core, the Biomedical Informatics Core and the Tissue Procurement Core, which are all supported by the National Cancer Institute Cancer Center Support Grant P30CA91842. Additional technical assistance was provided by M. Izumi. We thank K. Ohno (Nagoya University Graduate School of Medicine, Japan) for minigene constructs. We thank K. Hall (Washington University School of Medicine) for helpful scientific discussions.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; BAUM LE, 1967, B AM MATH SOC, V73, P360, DOI 10.1090/S0002-9904-1967-11751-8; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Fortier JM, 2010, LEUKEMIA, V24, P950, DOI 10.1038/leu.2010.61; Fu Y, 2011, NUCLEIC ACIDS RES, V39, P4396, DOI 10.1093/nar/gkr026; Gelsi-Boyer V, 2009, BRIT J HAEMATOL, V145, P788, DOI 10.1111/j.1365-2141.2009.07697.x; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; Graubert TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004583; Grosso AR, 2008, EMBO REP, V9, P1087, DOI 10.1038/embor.2008.189; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kralovicova J, 2010, HUM GENET, V128, P383, DOI 10.1007/s00439-010-0860-1; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880; Link DC, 2011, JAMA-J AM MED ASSOC, V305, P1568, DOI 10.1001/jama.2011.473; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nasim MT, 2006, NAT PROTOC, V1, P1022, DOI 10.1038/nprot.2006.148; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Pacheco TR, 2006, MOL CELL BIOL, V26, P8183, DOI 10.1128/MCB.00350-06; Pacheco TR, 2006, MOL BIOL CELL, V17, P4187, DOI 10.1091/mbc.E06-01-0036; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Rudner DZ, 1996, P NATL ACAD SCI USA, V93, P10333, DOI 10.1073/pnas.93.19.10333; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Visconte V, 2012, LEUKEMIA, V26, P542, DOI 10.1038/leu.2011.232; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Webb CJ, 2004, MOL CELL BIOL, V24, P4229, DOI 10.1128/MCB.24.10.4229-4240.2004; Welch JS, 2011, JAMA-J AM MED ASSOC, V305, P1577, DOI 10.1001/jama.2011.497; Wu SP, 1999, NATURE, V402, P832, DOI 10.1038/45590; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zorio DAR, 1999, RNA, V5, P487, DOI 10.1017/S1355838299982225	46	401	424	4	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2012	44	1					53	U77		10.1038/ng.1031	http://dx.doi.org/10.1038/ng.1031			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	22158538	Green Accepted, Green Published			2022-12-25	WOS:000298664000013
J	Pasca, SP; Portmann, T; Voineagu, I; Yazawa, M; Shcheglovitov, A; Pasca, AM; Cord, B; Palmer, TD; Chikahisa, S; Nishino, S; Bernstein, JA; Hallmayer, J; Geschwind, DH; Dolmetsch, RE				Pasca, Sergiu P.; Portmann, Thomas; Voineagu, Irina; Yazawa, Masayuki; Shcheglovitov, Aleksandr; Pasca, Anca M.; Cord, Branden; Palmer, Theo D.; Chikahisa, Sachiko; Nishino, Seiji; Bernstein, Jonathan A.; Hallmayer, Joachim; Geschwind, Daniel H.; Dolmetsch, Ricardo E.			Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome	NATURE MEDICINE			English	Article							GATING MECHANISMS; SYNDROME MUTATION; GENE-EXPRESSION; CALCIUM-CHANNEL; DIFFERENTIATION; IDENTITY; ANTERIOR; REVEAL; SATB2; CELLS	Monogenic neurodevelopmental disorders provide key insights into the pathogenesis of disease and help us understand how specific genes control the development of the human brain. Timothy syndrome is caused by a missense mutation in the L-type calcium channel Ca(v)1.2 that is associated with developmental delay and autism(1). We generated cortical neuronal precursor cells and neurons from induced pluripotent stem cells derived from individuals with Timothy syndrome. Cells from these individuals have defects in calcium (Ca2+) signaling and activity-dependent gene expression. They also show abnormalities in differentiation, including decreased expression of genes that are expressed in lower cortical layers and in callosal projection neurons. In addition, neurons derived from individuals with Timothy syndrome show abnormal expression of tyrosine hydroxylase and increased production of norepinephrine and dopamine. This phenotype can be reversed by treatment with roscovitine, a cyclin-dependent kinase inhibitor and atypical L-type-channel blocker(2-4). These findings provide strong evidence that Ca(v)1.2 regulates the differentiation of cortical neurons in humans and offer new insights into the causes of autism in individuals with Timothy syndrome.	[Pasca, Sergiu P.; Portmann, Thomas; Yazawa, Masayuki; Shcheglovitov, Aleksandr; Pasca, Anca M.; Dolmetsch, Ricardo E.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Voineagu, Irina; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Voineagu, Irina; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Program Neurogenet, Los Angeles, CA 90095 USA; [Cord, Branden; Palmer, Theo D.] Stanford Sch Med, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA USA; [Cord, Branden; Palmer, Theo D.] Stanford Sch Med, Dept Neurosurg, Stanford, CA USA; [Chikahisa, Sachiko; Nishino, Seiji; Hallmayer, Joachim] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Chikahisa, Sachiko] Univ Tokushima, Grad Sch, Dept Integrat Physiol, Inst Hlth Biosci, Tokushima 770, Japan; [Bernstein, Jonathan A.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA	Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Stanford University; Stanford University; Stanford University; Tokushima University; Stanford University	Dolmetsch, RE (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	ricardo.dolmetsch@stanford.edu	Pasca, Sergiu/AAY-3949-2021; Palmer, Theo/GSI-6635-2022	Pasca, Sergiu/0000-0002-3216-3248; Voineagu, Irina/0000-0003-4162-3872; Palmer, Theo/0000-0002-6266-1862; Cord, Branden/0000-0002-9120-5989	US National Institutes of Health; US National Institute of Mental Health; California Institute for Regenerative Medicine; Simons Foundation for Autism Research; Tashia and John Morgridge Endowed Fellowship; Japan Society of the Promotion for Science; American Heart Association; Swiss National Science Foundation; Flora foundation; International Brain Research Organization; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH087898, R01MH094714, R21MH087898, DP1MH099904] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003889] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Simons Foundation for Autism Research; Tashia and John Morgridge Endowed Fellowship; Japan Society of the Promotion for Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); American Heart Association(American Heart Association); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Flora foundation; International Brain Research Organization; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank K. Timothy and the individuals with Timothy syndrome who participated in this study; E. Nigh for editing of the manuscript; U. Francke for karyotyping; A. Cherry and D. Bangs for help with fibroblast cultures; G. Panagiotakos and C. Young-Park for insightful discussions, and A. Krawisz, R. Schwemberger, D. Fu and R. Shu for help with data analysis. Antibodies to FORSE-1 were developed by P.H. Patterson and were obtained from the Developmental Studies Hybridoma Bank (University of Iowa). Financial support was provided by a US National Institutes of Health Director's Pioneer Award, and by grants to R.E.D. from the US National Institute of Mental Health, the California Institute for Regenerative Medicine and the Simons Foundation for Autism Research. S.P.P. was supported by awards from the International Brain Research Organization Outstanding Research Fellowship and the Tashia and John Morgridge Endowed Fellowship, M.Y. by a Japan Society of the Promotion for Science Postdoctoral Fellowship for Research Abroad and an American Heart Association Western States postdoctoral fellowship, T. P. by a Swiss National Science Foundation Postdoctoral Fellowship and A.S. by a California Institute for Regenerative Medicine Postdoctoral Fellowship. We are also grateful for funding from B. and F. Horowitz, M. McCafferey, B. and J. Packard, P. Kwan and K. Wang and the Flora foundation.	Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Barrett CF, 2008, P NATL ACAD SCI USA, V105, P2157, DOI 10.1073/pnas.0710501105; Barttfeld P, 2011, NEUROPSYCHOLOGIA, V49, P254, DOI 10.1016/j.neuropsychologia.2010.11.024; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Casanova MF, 2009, J AUTISM DEV DISORD, V39, P751, DOI 10.1007/s10803-008-0681-4; Coppola G, 2008, ANN NEUROL, V64, P92, DOI 10.1002/ana.21397; D'Souza A, 2009, BRAIN RES, V1247, P1, DOI 10.1016/j.brainres.2008.09.088; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dulcis D, 2008, NATURE, V456, P195, DOI 10.1038/nature07569; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Flatz L, 2011, P NATL ACAD SCI USA, V108, P5724, DOI 10.1073/pnas.1013084108; Garbelli R, 2009, NEUROLOGY, V73, P746, DOI 10.1212/WNL.0b013e3181af3397; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Ip BK, 2011, CEREB CORTEX, V21, P1395, DOI 10.1093/cercor/bhq219; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624; Moskvina V, 2009, MOL PSYCHIATR, V14, P252, DOI 10.1038/mp.2008.133; Nyegaard M, 2010, MOL PSYCHIATR, V15, P119, DOI 10.1038/mp.2009.69; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Raghanti MA, 2009, NEUROSCIENCE, V158, P1551, DOI 10.1016/j.neuroscience.2008.10.058; Romano G, 2005, J CELL PHYSIOL, V204, P666, DOI 10.1002/jcp.20319; Saito T, 2011, CEREB CORTEX, V21, P588, DOI 10.1093/cercor/bhq125; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TOLE S, 1995, J NEUROSCI, V15, P970; TORU M, 1982, J NEURAL TRANSM, V54, P181, DOI 10.1007/BF01254928; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Yarotskyy V, 2007, BRIT J PHARMACOL, V152, P386, DOI 10.1038/sj.bjp.0707414; Yarotskyy V, 2010, J BIOL CHEM, V285, P43, DOI 10.1074/jbc.M109.076448; Yarotskyy V, 2009, J PHYSIOL-LONDON, V587, P551, DOI 10.1113/jphysiol.2008.161737; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	37	405	425	3	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2011	17	12					1657	U176		10.1038/nm.2576	http://dx.doi.org/10.1038/nm.2576			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22120178	Green Submitted, Green Accepted			2022-12-25	WOS:000297978000039
J	Galic, M; Jeong, S; Tsai, FC; Joubert, LM; Wu, YI; Hahn, KM; Cui, Y; Meyer, T				Galic, Milos; Jeong, Sangmoo; Tsai, Feng-Chiao; Joubert, Lydia-Marie; Wu, Yi I.; Hahn, Klaus M.; Cui, Yi; Meyer, Tobias			External push and internal pull forces recruit curvature-sensing N-BAR domain proteins to the plasma membrane	NATURE CELL BIOLOGY			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; ACTIN CYTOSKELETON; MIGRATING CELLS; DYNAMIN; AMPHIPHYSIN; ADHESION; BINDING	Many of the more than 20 mammalian proteins with N-BAR domains(1,2) control cell architecture(3) and endocytosis(4,5) by associating with curved sections of the plasma membrane(6). It is not well understood whether N-BAR proteins are recruited directly by processes that mechanically curve the plasma membrane or indirectly by plasma-membrane-associated adaptor proteins that recruit proteins with N-BAR domains that then induce membrane curvature. Here, we show that externally induced inward deformation of the plasma membrane by cone-shaped nanostructures (nanocones) and internally induced inward deformation by contracting actin cables both trigger recruitment of isolated N-BAR domains to the curved plasma membrane. Markedly, live-cell imaging in adherent cells showed selective recruitment of full-length N-BAR proteins and isolated N-BAR domains to plasma membrane sub-regions above nano cone stripes. Electron microscopy confirmed that N-BAR domains are recruited to local membrane sites curved by nanocones.We further showed that N-BAR domains are periodically recruited to curved plasma membrane sites during local lamellipodia retraction in the front of migrating cells. Recruitment required myosin-II-generated force applied to plasma-membrane-connected actin cables. Together, our results show that N-BAR domains can be directly recruited to the plasma membrane by external push or internal pull forces that locally curve the plasma membrane.	[Galic, Milos; Tsai, Feng-Chiao; Meyer, Tobias] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Jeong, Sangmoo] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Joubert, Lydia-Marie] Stanford Univ, Sch Med, Cell Sci Imaging Facil, Stanford, CA 94305 USA; [Wu, Yi I.; Hahn, Klaus M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Cui, Yi] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; University of North Carolina; University of North Carolina Chapel Hill; Stanford University	Galic, M (corresponding author), Stanford Univ, Dept Chem & Syst Biol, 318 Campus Dr,Clark Bldg W200, Stanford, CA 94305 USA.	milos@stanford.edu; tobias1@stanford.edu	Cui, Yi/L-5804-2013	Cui, Yi/0000-0002-6103-6352; Joubert, Lydia-Marie/0000-0002-4709-007X; Meyer, Tobias/0000-0003-4339-3804; Hahn, Klaus/0000-0002-1970-7562; galic, milos/0000-0002-4493-2542; Tsai, Feng-Chiao/0000-0001-9615-6023	Swiss National Science Foundation [PBBSP3-123159]; Novartis Jubilaeumsstiftung; Stanford Deans Postdoctoral Fellowship; Korea Foundation for Advanced Studies graduate fellowship; DOE-EFRC [DE-SC0001060]; National Institutes of Health [MH064801, MH095087, GM063702]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030179, R01GM063702, R01GM090317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095087, R01MH064801] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Jubilaeumsstiftung(Novartis); Stanford Deans Postdoctoral Fellowship; Korea Foundation for Advanced Studies graduate fellowship; DOE-EFRC(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank the members of the Meyer laboratory for comments and discussion. M. G. was supported by the Swiss National Science Foundation (No. PBBSP3-123159), and a Novartis Jubilaeumsstiftung and Stanford Deans Postdoctoral Fellowship. S.J. was supported by a Korea Foundation for Advanced Studies graduate fellowship. Y.C. acknowledges the partial support from a DOE-EFRC at Stanford: Center on Nanostructuring for Efficient Energy Conversion (No. DE-SC0001060). T. M. acknowledges financial support from the National Institutes of Health, MH064801, MH095087 and GM063702.	ABERCROM.M, 1971, EXP CELL RES, V67, P359, DOI 10.1016/0014-4827(71)90420-4; Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Burnette DT, 2011, NAT CELL BIOL, V13, P371, DOI 10.1038/ncb2205; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Inoue T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003068; Jeong S, 2011, ACS NANO, V5, P5800, DOI 10.1021/nn2015216; Johnson H, 2009, EDN, V54, P20; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; Richnau N, 2001, J BIOL CHEM, V276, P35060, DOI 10.1074/jbc.M103540200; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Rocca DL, 2008, NAT CELL BIOL, V10, P259, DOI 10.1038/ncb1688; Rollason R, 2009, J CELL BIOL, V184, P721, DOI 10.1083/jcb.200804154; Salazar MA, 2003, J BIOL CHEM, V278, P49031, DOI 10.1074/jbc.M308104200; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Suetsugu S, 2010, SEMIN CELL DEV BIOL, V21, P340, DOI 10.1016/j.semcdb.2009.12.002; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Tsai FC, 2012, CURR BIOL, V22, P837, DOI 10.1016/j.cub.2012.03.037; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yamada H, 2009, J BIOL CHEM, V284, P34244, DOI 10.1074/jbc.M109.064204; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014	32	96	97	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2012	14	8					874	U212		10.1038/ncb2533	http://dx.doi.org/10.1038/ncb2533			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	983JP	22750946	Green Accepted, Green Submitted			2022-12-25	WOS:000307115900017
J	Cao, JL; Shen, YD; Zhu, L; Xu, YA; Zhou, YZ; Wu, ZL; Li, YP; Yan, XM; Zhu, XL				Cao, Jingli; Shen, Yidong; Zhu, Lei; Xu, Yanan; Zhou, Yizhuo; Wu, Zhili; Li, Yiping; Yan, Xiumin; Zhu, Xueliang			miR-129-3p controls cilia assembly by regulating CP110 and actin dynamics	NATURE CELL BIOLOGY			English	Article							ARP2/3 COMPLEX; MOLECULAR CHARACTERIZATION; EPITHELIAL-CELLS; KUPFFERS VESICLE; SIGNALING CENTER; MIGRATING CELLS; PROTEIN; CILIOGENESIS; ZEBRAFISH; MICRORNAS	Ciliogenesis requires the removal of CP110 from the mother centriole; actin dynamics also influence ciliation, at least partly by affecting the centrosomal accumulation of ciliogenic membrane vesicles. How these distinct processes are properly regulated remains unknown. Here we show that miR-129-3p, a microRNA conserved in vertebrates, controlled cilia biogenesis in cultured cells by concomitantly downregulating CP110 and repressing branched F.-actin formation. Blocking miR-129-3p inhibited serum-starvation-induced ciliogenesis, whereas its overexpression potently induced ciliation in proliferating cells and also promoted cilia elongation. Gene expression analysis further identified ARP2, TOCA1, ABLIM1 and ABLIM3 as its targets in ciliation-related actin dynamics. Moreover, miR-129-3p inhibition in zebrafish embryos suppressed ciliation in Kupffer's vesicle and the pronephros, and induced developmental abnormalities including a curved body, pericardial oedema and defective left right asymmetry. Therefore, our results reveal a mechanism that orchestrates both the centriole-to-basal body transition and subsequent cilia assembly through microRNA-mediated post-transcriptional regulation.	[Cao, Jingli; Shen, Yidong; Zhu, Lei; Xu, Yanan; Zhou, Yizhuo; Wu, Zhili; Li, Yiping; Yan, Xiumin; Zhu, Xueliang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Yan, XM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	yanx@sibs.ac.cn; xlzhu@sibs.ac.cn	Shen, Yi/GRS-3602-2022	Cao, Jingli/0000-0001-5938-6604; Yan, Xiumin/0000-0002-3260-1690	National Basic Research Program of China [2012CB945003, 2010CB912102]; National Science Foundation of China [30971430, 30830060, 31010103910]; Chinese Academy of Sciences [XDA01010107]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	The authors thank X. Yuan and D. Li for helpful suggestions, and Y. You, S. L. Brody (Washington University School of Medicine) and D. J. Davidson (University of Edinburgh) for tips on MTEC culture. We also thank H. Zhao, M. Yao, J. Sun and Y. Wang for technical assistance. This work was supported by the National Basic Research Program of China (2012CB945003 and 2010CB912102), the National Science Foundation of China (30971430, 30830060 and 31010103910) and the Chinese Academy of Sciences (XDA01010107).	Bachmann-Gagescu R, 2011, HUM MOL GENET, V20, P4041, DOI 10.1093/hmg/ddr332; Barrientos T, 2007, J BIOL CHEM, V282, P8393, DOI 10.1074/jbc.M607549200; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Deane JA, 2007, NEPHROLOGY, V12, P559, DOI 10.1111/j.1440-1797.2007.00869.x; Demarco RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001215; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Fuchs JL, 2004, CELL BIOL INT, V28, P111, DOI 10.1016/j.cellbi.2003.11.008; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang YW, 2009, CANCER RES, V69, P9038, DOI 10.1158/0008-5472.CAN-09-1499; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Kobayashi T, 2011, CELL, V145, P914, DOI 10.1016/j.cell.2011.04.028; Kobayashi T, 2011, J CELL BIOL, V193, P435, DOI 10.1083/jcb.201101005; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Ma M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030018; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Norris AD, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-38; Pitaval A, 2010, J CELL BIOL, V191, P303, DOI 10.1083/jcb.201004003; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Roof DJ, 1997, J CELL BIOL, V138, P575, DOI 10.1083/jcb.138.3.575; Rottner K, 2010, TRENDS CELL BIOL, V20, P650, DOI 10.1016/j.tcb.2010.08.014; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Sedmak T, 2011, BIOL CELL, V103, P449, DOI 10.1042/BC20110034; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shan YL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000116; Shen YD, 2008, DEV CELL, V14, P342, DOI 10.1016/j.devcel.2008.01.001; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Struckhoff EC, 2003, DEVELOPMENT, V130, P693, DOI 10.1242/dev.00300; Tramontin AD, 2003, CEREB CORTEX, V13, P580, DOI 10.1093/cercor/13.6.580; Tsang JS, 2010, MOL CELL, V38, P140, DOI 10.1016/j.molcel.2010.03.007; Tsang WY, 2008, DEV CELL, V15, P187, DOI 10.1016/j.devcel.2008.07.004; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; Wessely O, 2008, FRONT BIOSCI-LANDMRK, V13, P1866, DOI 10.2741/2806; Westlake CJ, 2011, P NATL ACAD SCI USA, V108, P2759, DOI 10.1073/pnas.1018823108; Wu JJ, 2010, CELL CYCLE, V9, P1809, DOI 10.4161/cc.9.9.11535; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002; Zaoui K, 2008, J CELL BIOL, V183, P401, DOI 10.1083/jcb.200805107; Zhang QH, 2004, PHYSIOLOGY, V19, P225, DOI 10.1152/physiol.00003.2004	56	113	117	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2012	14	7					697	706		10.1038/ncb2512	http://dx.doi.org/10.1038/ncb2512			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	967PV	22684256				2022-12-25	WOS:000305921200009
J	Gavathiotis, E; Reyna, DE; Bellairs, JA; Leshchiner, ES; Walensky, LD				Gavathiotis, Evripidis; Reyna, Denis E.; Bellairs, Joseph A.; Leshchiner, Elizaveta S.; Walensky, Loren D.			Direct and selective small-molecule activation of proapoptotic BAX	NATURE CHEMICAL BIOLOGY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; BCL-2 FAMILY; CYTOCHROME-C; CELL-DEATH; BH3 HELIX; MEMBRANE PERMEABILIZATION; MITOCHONDRIAL APOPTOSIS; PHASE-I; INHIBITOR; PROTEINS	BCL-2 family proteins are key regulators of the apoptotic pathway. Antiapoptotic members sequester the BCL-2 homology 3 (BH3) death domains of proapoptotic members such as BAX to maintain cell survival. The antiapoptotic BH3-binding groove has been successfully targeted to reactivate apoptosis in cancer. We recently identified a geographically distinct BH3-binding groove that mediates direct BAX activation, suggesting a new strategy for inducing apoptosis by flipping BAX's 'on switch'. Here we applied computational screening to identify a BAX activator molecule that directly and selectively activates BAX. We demonstrate by NMR and biochemical analyses that the molecule engages the BAX trigger site and promotes the functional oligomerization of BAX. The molecule does not interact with the BH3-binding pocket of antiapoptotic proteins or proapoptotic BAK and induces cell death in a BAX-dependent fashion. To our knowledge, we report the first gain-of-function molecular modulator of a BCL-2 family protein and demonstrate a new paradigm for pharmacologic induction of apoptosis.	[Gavathiotis, Evripidis; Reyna, Denis E.; Bellairs, Joseph A.; Leshchiner, Elizaveta S.; Walensky, Loren D.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Gavathiotis, Evripidis; Reyna, Denis E.; Bellairs, Joseph A.; Leshchiner, Elizaveta S.; Walensky, Loren D.] Dana Farber Canc Inst, Program Canc Chem Biol, Boston, MA 02115 USA; [Gavathiotis, Evripidis; Reyna, Denis E.; Bellairs, Joseph A.; Leshchiner, Elizaveta S.; Walensky, Loren D.] Childrens Hosp Boston, Div Hematol & Oncol, Boston, MA USA; [Gavathiotis, Evripidis; Reyna, Denis E.; Bellairs, Joseph A.; Leshchiner, Elizaveta S.; Walensky, Loren D.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Gavathiotis, Evripidis; Reyna, Denis E.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA; [Gavathiotis, Evripidis; Reyna, Denis E.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Gavathiotis, Evripidis; Reyna, Denis E.] Albert Einstein Coll Med, Wilf Family Cardiovasc Res Inst, Bronx, NY 10467 USA; [Gavathiotis, Evripidis; Reyna, Denis E.] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10467 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Gavathiotis, E (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.	evripidis.gavathiotis@einstein.yu.edu; loren_walensky@dfci.harvard.edu	Leshchiner, Elizaveta/F-3312-2010	Bellairs, Joseph/0000-0001-9031-6532; Gavathiotis, Evripidis/0000-0001-6319-8331	William Lawrence and Blanche Hughes Foundation; US National Institutes of Health (NIH) [4R00HL095929]; NIH [5R01CA050239]; Stand Up to Cancer Innovative Research Grant; NATIONAL CANCER INSTITUTE [R01CA050239] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL095929, R00HL095929] Funding Source: NIH RePORTER	William Lawrence and Blanche Hughes Foundation; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stand Up to Cancer Innovative Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank E. Smith for editorial and graphics assistance, M. Davis for help with establishing the competitive BAX binding assay, G. Bird for BIM SAHB production and characterization and CreaGen Biosciences for BAM7 resynthesis and characterization. This research program was supported by a grant from the William Lawrence and Blanche Hughes Foundation to L. D. W. Additional funding was provided by US National Institutes of Health (NIH) grant 4R00HL095929 to E. G. and NIH grant 5R01CA050239 and a Stand Up to Cancer Innovative Research Grant to L.D.W.	Bernal F, 2010, CANCER CELL, V18, P411, DOI 10.1016/j.ccr.2010.10.024; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gavathiotis E, 2010, MOL CELL, V40, P481, DOI 10.1016/j.molcel.2010.10.019; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; O'Brien SM, 2009, BLOOD, V113, P299, DOI 10.1182/blood-2008-02-137943; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pitter K, 2008, METHOD ENZYMOL, V446, P387, DOI 10.1016/S0076-6879(08)01623-6; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Roberts AW, 2012, J CLIN ONCOL, V30, P488, DOI 10.1200/JCO.2011.34.7898; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Stewart ML, 2010, NAT CHEM BIOL, V6, P595, DOI [10.1038/NCHEMBIO.391, 10.1038/nchembio.391]; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Takeuchi O, 2005, P NATL ACAD SCI USA, V102, P11272, DOI 10.1073/pnas.0504783102; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Walensky LD, 2012, J CLIN ONCOL, V30, P554, DOI 10.1200/JCO.2011.37.9339; Walensky LD, 2011, TRENDS BIOCHEM SCI, V36, P642, DOI 10.1016/j.tibs.2011.08.009; Wang GP, 2006, J MED CHEM, V49, P6139, DOI 10.1021/jm060460o; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI 10.1016/S1470-2045(10)70261-8; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	45	113	118	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2012	8	7					639	645		10.1038/NCHEMBIO.995	http://dx.doi.org/10.1038/NCHEMBIO.995			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961NJ	22634637	Green Accepted			2022-12-25	WOS:000305471400011
J	Raveh-Sadka, T; Levo, M; Shabi, U; Shany, B; Keren, L; Lotan-Pompan, M; Zeevi, D; Sharon, E; Weinberger, A; Segal, E				Raveh-Sadka, Tali; Levo, Michal; Shabi, Uri; Shany, Boaz; Keren, Leeat; Lotan-Pompan, Maya; Zeevi, Danny; Sharon, Eilon; Weinberger, Adina; Segal, Eran			Manipulating nucleosome disfavoring sequences allows fine-tune regulation of gene expression in yeast	NATURE GENETICS			English	Article							HISTONE-DNA INTERACTIONS; IN-VIVO; SACCHAROMYCES-CEREVISIAE; SATURATION MUTAGENESIS; PROTEIN EXPRESSION; TRANSCRIPTION; BINDING; PROMOTERS; MECHANISM; GENOME	Understanding how precise control of gene expression is specified within regulatory DNA sequences is a key challenge with far-reaching implications. Many studies have focused on the regulatory role of transcription factor-binding sites. Here, we explore the transcriptional effects of different elements, nucleosome-disfavoring sequences and, specifically, poly(dA:dT) tracts that are highly prevalent in eukaryotic promoters. By measuring promoter activity for a large-scale promoter library, designed with systematic manipulations to the properties and spatial arrangement of poly(dA:dT) tracts, we show that these tracts significantly and causally affect transcription. We show that manipulating these elements offers a general genetic mechanism, applicable to promoters regulated by different transcription factors, for tuning expression in a predictable manner, with resolution that can be even finer than that attained by altering transcription factor sites. Overall, our results advance the understanding of the regulatory code and suggest a potential mechanism by which promoters yielding prespecified expression patterns can be designed.	[Raveh-Sadka, Tali; Levo, Michal; Shany, Boaz; Keren, Leeat; Lotan-Pompan, Maya; Zeevi, Danny; Sharon, Eilon; Weinberger, Adina; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Raveh-Sadka, Tali; Levo, Michal; Shany, Boaz; Keren, Leeat; Lotan-Pompan, Maya; Zeevi, Danny; Sharon, Eilon; Weinberger, Adina; Segal, Eran] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Shabi, Uri] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Weinberger, A (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	adina.weinberger@weizmann.ac.il; eran.segal@weizmann.ac.il	Segal, Eran/AAF-4855-2019	Zeevi, Danny/0000-0002-6901-3737; Keren, Leeat/0000-0002-6799-6303; Segal, Eran/0000-0002-6859-1164; Sharon, Eilon/0000-0002-1262-350X	European Research Council (ERC); US National Institutes of Health (NIH); Azrieli Foundation	European Research Council (ERC)(European Research Council (ERC)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Azrieli Foundation	We wish to dedicate this paper to Jon Widom who inspired and assisted us greatly throughout this project. This work was supported by grants from the European Research Council (ERC) and the US National Institutes of Health (NIH) to E. Segal. E. Segal is the incumbent of the Soretta and Henry Shapiro career development chair. T.R.-S. and M.L. thank the Azrieli Foundation for the award of an Azrieli Fellowship. We thank G. Hornung for his help with the analysis of flow cytometry measurements and E. Mochly for his help with the preparation of Supplementary Figure 9.	Anderson JD, 2001, MOL CELL BIOL, V21, P3830, DOI 10.1128/MCB.21.11.3830-3839.2001; Bai L, 2010, DEV CELL, V18, P544, DOI 10.1016/j.devcel.2010.02.007; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Ben Yehezkel T, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn457; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; CHEN W, 1988, P NATL ACAD SCI USA, V85, P2691, DOI 10.1073/pnas.85.8.2691; Dechering KJ, 1998, NUCLEIC ACIDS RES, V26, P4056, DOI 10.1093/nar/26.17.4056; Ercan S, 2011, GENOME RES, V21, P237, DOI 10.1101/gr.115931.110; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Fordyce PM, 2010, NAT BIOTECHNOL, V28, P970, DOI 10.1038/nbt.1675; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Gietz RD, 2007, NAT PROTOC, V2, P5, DOI 10.1038/nprot.2007.16; HILL DE, 1986, SCIENCE, V234, P451, DOI 10.1126/science.3532321; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kim HD, 2008, NAT STRUCT MOL BIOL, V15, P1192, DOI 10.1038/nsmb.1500; Knutson BA, 2011, MOL CELL BIOL, V31, P818, DOI 10.1128/MCB.00687-10; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kuo MH, 2000, MOL CELL, V6, P1309, DOI 10.1016/S1097-2765(00)00129-5; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Linshiz G, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.26; Liu X, 2006, GENOME RES, V16, P1517, DOI 10.1101/gr.5655606; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Miller JA, 2003, MOL CELL BIOL, V23, P1623, DOI 10.1128/MCB.23.5.1623-1632.2003; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; PTASHNE M, 2002, GENES SIGNALS; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Raveh-Sadka T, 2009, GENOME RES, V19, P1480, DOI 10.1101/gr.088260.108; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Shabi Uri, 2010, Syst Synth Biol, V4, P227, DOI 10.1007/s11693-010-9059-y; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Wasson T, 2009, GENOME RES, V19, P2101, DOI 10.1101/gr.093450.109; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Yuan GC, 2008, PLOS COMPUT BIOL, V4, DOI [10.1371/journal.pcbi.0040013, 10.1371/journal.pcbi.0040013.eor]; Zeevi D, 2011, GENOME RES, V21, P2114, DOI 10.1101/gr.119669.110; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	43	136	136	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2012	44	7					743	U163		10.1038/ng.2305	http://dx.doi.org/10.1038/ng.2305			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967DP	22634752				2022-12-25	WOS:000305886900006
J	Sung, WK; Zheng, HC; Li, SY; Chen, RH; Liu, X; Li, YR; Lee, NP; Lee, WH; Ariyaratne, PN; Tennakoon, C; Mulawadi, FH; Wong, KF; Liu, AM; Poon, RT; Fan, ST; Chan, KL; Gong, ZL; Hu, YJ; Lin, Z; Wang, G; Zhang, QH; Barber, TD; Chou, WC; Aggarwal, A; Hao, K; Zhou, W; Zhang, CS; Hardwick, J; Buser, C; Xu, JC; Kan, ZY; Dai, HY; Mao, M; Reinhard, C; Wang, J; Luk, JM				Sung, Wing-Kin; Zheng, Hancheng; Li, Shuyu; Chen, Ronghua; Liu, Xiao; Li, Yingrui; Lee, Nikki P.; Lee, Wah H.; Ariyaratne, Pramila N.; Tennakoon, Chandana; Mulawadi, Fabianus H.; Wong, Kwong F.; Liu, Angela M.; Poon, Ronnie T.; Fan, Sheung Tat; Chan, Kwong L.; Gong, Zhuolin; Hu, Yujie; Lin, Zhao; Wang, Guan; Zhang, Qinghui; Barber, Thomas D.; Chou, Wen-Chi; Aggarwal, Amit; Hao, Ke; Zhou, Wei; Zhang, Chunsheng; Hardwick, James; Buser, Carolyn; Xu, Jiangchun; Kan, Zhengyan; Dai, Hongyue; Mao, Mao; Reinhard, Christoph; Wang, Jun; Luk, John M.			Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma	NATURE GENETICS			English	Article							B-VIRUS-DNA; CLINICAL-FEATURES; YOUNG-PATIENTS; CELL-LINE; RNA-SEQ; HEPATITIS; LIVER; GENE; IDENTIFICATION; MUTATIONS	To survey hepatitis B virus (HBV) integration in liver cancer genomes, we conducted massively parallel sequencing of 81 HBV-positive and 7 HBV-negative hepatocellular carcinomas (HCCs) and adjacent normal tissues. We found that HBV integration is observed more frequently in the tumors (86.4%) than in adjacent liver tissues (30.7%). Copy-number variations (CNVs) were significantly increased at HBV breakpoint locations where chromosomal instability was likely induced. Approximately 40% of HBV breakpoints within the HBV genome were located within a 1,800-bp region where the viral enhancer, X gene and core gene are located. We also identified recurrent HBV integration events (in >= 4 HCCs) that were validated by RNA sequencing (RNA-seq) and Sanger sequencing at the known and putative cancer-related TERT, MLL4 and CCNE1 genes, which showed upregulated gene expression in tumor versus normal tissue. We also report evidence that suggests that the number of HBV integrations is associated with patient survival.	[Li, Shuyu; Barber, Thomas D.; Chou, Wen-Chi; Aggarwal, Amit; Reinhard, Christoph] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Sung, Wing-Kin; Lee, Nikki P.; Wong, Kwong F.; Liu, Angela M.; Poon, Ronnie T.; Fan, Sheung Tat; Chan, Kwong L.; Luk, John M.] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Sung, Wing-Kin; Tennakoon, Chandana] Natl Univ Singapore, Sch Comp, Singapore 117548, Singapore; [Sung, Wing-Kin; Tennakoon, Chandana] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Sung, Wing-Kin; Lee, Wah H.; Ariyaratne, Pramila N.; Mulawadi, Fabianus H.] Genome Inst Singapore, Dept Computat & Syst Biol, Singapore, Singapore; [Zheng, Hancheng; Liu, Xiao; Li, Yingrui; Gong, Zhuolin; Hu, Yujie; Lin, Zhao; Wang, Guan; Zhang, Qinghui; Wang, Jun] Beijing Genom Inst, Shenzhen, Peoples R China; [Wong, Kwong F.; Liu, Angela M.; Luk, John M.] NUS, Canc Sci Inst, Singapore, Singapore; [Chen, Ronghua; Zhou, Wei; Zhang, Chunsheng; Hardwick, James; Xu, Jiangchun; Dai, Hongyue] Merck Res Labs, Boston, MA USA; [Wong, Kwong F.; Liu, Angela M.; Luk, John M.] NUS, Dept Pharmacol, Singapore, Singapore; [Wong, Kwong F.; Liu, Angela M.; Luk, John M.] NUS, Dept Surg, Singapore, Singapore; [Hardwick, James; Mao, Mao] Asian Canc Res Grp Inc, Wilmington, DE USA; [Xu, Jiangchun; Kan, Zhengyan; Dai, Hongyue] Pfizer Oncol, San Diego, CA USA; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark	Eli Lilly; University of Hong Kong; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Beijing Genomics Institute (BGI); National University of Singapore; Merck & Company; National University of Singapore; National University of Singapore; Pfizer; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen	Reinhard, C (corresponding author), Eli Lilly & Co, Indianapolis, IN 46285 USA.	reinhard_christoph@lilly.com; wangj@genomics.org.cn; john.luk@roche.com	Luk, John/A-4085-2008; Liu, Xiao/P-2732-2015; Li, Yingrui/K-1064-2015; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Luk, John/0000-0002-6323-7940; Liu, Xiao/0000-0002-8073-0534; Wang, Jun/0000-0002-8540-8931; Sung, Wing-Kin/0000-0001-7806-7086; Wang, Jun/0000-0002-2113-5874; Chou, Wen-Chi/0000-0001-8408-3533	Asian Cancer Research Group (ACRG); Eli Lilly; Merck; Pfizer	Asian Cancer Research Group (ACRG); Eli Lilly(Eli Lilly); Merck(Merck & Company); Pfizer(Pfizer)	We gratefully acknowledge Y.-K. Mak and the clinical team of the Division of Hepatobiliary and Pancreatic Surgery (HBP) at Queen Mary Hospital. This study was funded by the Asian Cancer Research Group (ACRG), a not-for-profit organization formed by Eli Lilly, Merck and Pfizer. We thank S. Friend and G. Jin for initiating the establishment of ACRG. We are grateful to former and present members of ACRG, especially K. Blanchard, Y. Turpaz, J. Sedgwick, G. Tucker-Kellogg, G. Gilliland, P. Shaw, N. Gibson and S. Adams.	BRECHOT C, 1980, NATURE, V286, P533, DOI 10.1038/286533a0; Brechot C, 2000, SEMIN CANCER BIOL, V10, P211, DOI 10.1006/scbi.2000.0321; But DYK, 2008, WORLD J GASTROENTERO, V14, P1652, DOI 10.3748/wjg.14.1652; Center MM, 2011, CANCER EPIDEM BIOMAR, V20, P2362, DOI 10.1158/1055-9965.EPI-11-0643; CHAKRABORTY PR, 1980, NATURE, V286, P531, DOI 10.1038/286531a0; Chen Y, 2003, J HEPATOL, V38, P84, DOI 10.1016/S0168-8278(02)00325-2; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Ferber MJ, 2003, ONCOGENE, V22, P3813, DOI 10.1038/sj.onc.1206528; FURUTA T, 1990, CANCER-AM CANCER SOC, V66, P2395, DOI 10.1002/1097-0142(19901201)66:11<2395::AID-CNCR2820661125>3.0.CO;2-T; Gehring AJ, 2009, GASTROENTEROLOGY, V137, P682, DOI 10.1053/j.gastro.2009.04.045; Gozuacik D, 2001, ONCOGENE, V20, P6233, DOI 10.1038/sj.onc.1204835; Guerrero RB, 2005, J HEPATOL, V42, P760, DOI 10.1016/j.jhep.2005.02.005; Hao K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-389; Ishikawa T, 2010, WORLD J GASTROENTERO, V16, P2463, DOI 10.3748/wjg.v16.i20.2463; Kim JH, 2006, J GASTROEN HEPATOL, V21, P588, DOI 10.1111/j.1440-1746.2005.04127.x; KOSHY R, 1983, CELL, V34, P215, DOI 10.1016/0092-8674(83)90152-6; Lamb JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020090; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murakami Y, 2005, GUT, V54, P1162, DOI 10.1136/gut.2004.054452; Neuveut C, 2010, J HEPATOL, V52, P594, DOI 10.1016/j.jhep.2009.10.033; Paterlini-Brechot P, 2003, ONCOGENE, V22, P3911, DOI 10.1038/sj.onc.1206492; Saigo K, 2008, HUM MUTAT, V29, P703, DOI 10.1002/humu.20701; SHAFRITZ DA, 1981, NEW ENGL J MED, V305, P1067, DOI 10.1056/NEJM198110293051807; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Zucnan-Rossi J, 2007, PHARMACOGENOMICS, V8, P997, DOI 10.2217/14622416.8.8.997	29	615	641	4	96	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2012	44	7					765	U188		10.1038/ng.2295	http://dx.doi.org/10.1038/ng.2295			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967DP	22634754				2022-12-25	WOS:000305886900009
J	Yeats, TH; Martin, LBB; Viart, HMF; Isaacson, T; He, YH; Zhao, LX; Matas, AJ; Buda, GJ; Domozych, DS; Clausen, MH; Rose, JKC				Yeats, Trevor H.; Martin, Laetitia B. B.; Viart, Helene M-F; Isaacson, Tal; He, Yonghua; Zhao, Lingxia; Matas, Antonio J.; Buda, Gregory J.; Domozych, David S.; Clausen, Mads H.; Rose, Jocelyn K. C.			The identification of cutin synthase: formation of the plant polyester cutin	NATURE CHEMICAL BIOLOGY			English	Article							FRUIT; ACYLTRANSFERASE; BIOSYNTHESIS; EXPRESSION; ESTERS; FAMILY; CELLS	A hydrophobic cuticle consisting of waxes and the polyester cutin covers the aerial epidermis of all land plants, providing essential protection from desiccation and other stresses. We have determined the enzymatic basis of cutin polymerization through characterization of a tomato extracellular acyltransferase, CD1, and its substrate, 2-mono(10,16-dihydroxyhexadecanoyl)glycerol. CD1 has in vitro polyester synthesis activity and is required for cutin accumulation in vivo, indicating that it is a cutin synthase.	[Yeats, Trevor H.; Martin, Laetitia B. B.; Isaacson, Tal; He, Yonghua; Matas, Antonio J.; Buda, Gregory J.; Rose, Jocelyn K. C.] Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA; [Viart, Helene M-F; Clausen, Mads H.] Tech Univ Denmark, Ctr Nanomed & Theranost, DK-2800 Lyngby, Denmark; [Viart, Helene M-F; Clausen, Mads H.] Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark; [Zhao, Lingxia] Shanghai Jiao Tong Univ, Sch Agr & Biol, Plant Biotechnol Res Ctr, Shanghai 200030, Peoples R China; [Domozych, David S.] Skidmore Coll, Dept Biol, Saratoga Springs, NY 12866 USA; [Domozych, David S.] Skidmore Coll, Skidmore Microscopy Imaging Ctr, Saratoga Springs, NY 12866 USA	Cornell University; Technical University of Denmark; Technical University of Denmark; Shanghai Jiao Tong University; Skidmore College; Skidmore College	Rose, JKC (corresponding author), Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA.	jr286@cornell.edu	Matas, Antonio J./A-9325-2008; Clausen, Mads H/A-9656-2015	Matas, Antonio J./0000-0003-4348-3930; Clausen, Mads H/0000-0001-9649-1729; Martin, Laetitia/0000-0002-6921-7246	US National Science Foundation [DBI-0606595]; United States-Israel Binational Agricultural Research and Development Fund [IS-4234-09]; US Department of Agriculture Cooperative State Research, Education and Extension Service [2011-04197]; Danish Council for Strategic Research [10-093465]; US National Institutes of Health [T32 GM008500]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008500] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); United States-Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation); US Department of Agriculture Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Lomonossoff (John Innes Centre) and Plant Bioscience Limited for the pEAQ vector, M. Toso for help with transmission electron microscopy, S. Zhang and B. Sherwood for assistance with MALDI-TOF MS and M. Pollard and K. Niklas for critical discussion. This work was supported by grants from the US National Science Foundation (Plant Genome Program; DBI-0606595), the United States-Israel Binational Agricultural Research and Development Fund (IS-4234-09); the US Department of Agriculture Cooperative State Research, Education and Extension Service (2011-04197); and the Danish Council for Strategic Research (10-093465). T.H.Y. was supported in part by a US National Institutes of Health Chemistry-Biology Interface Training Grant (T32 GM008500).	Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Baker E. A., 1982, PLANT CUTICLE, P33; CROTEAU R, 1974, BIOCHEMISTRY-US, V13, P3193, DOI 10.1021/bi00712a030; EDWARDS D, 1993, NEW PHYTOL, V125, P225, DOI 10.1111/j.1469-8137.1993.tb03879.x; Graca J, 2002, PHYTOCHEMISTRY, V61, P205, DOI 10.1016/S0031-9422(02)00212-1; Graca J, 2010, J AGR FOOD CHEM, V58, P9666, DOI 10.1021/jf1015297; Heredia A, 2009, BIOINTERPHASES, V4, pP1, DOI 10.1116/1.3063816; Irshad M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-94; Isaacson T, 2009, PLANT J, V60, P363, DOI 10.1111/j.1365-313X.2009.03969.x; Jetter R, 2006, ANNU PLANT REV, V23, P145; Jonas A, 2000, BBA-MOL CELL BIOL L, V1529, P245, DOI 10.1016/S1388-1981(00)00153-0; Li YH, 2007, PLANT PHYSIOL, V144, P1267, DOI 10.1104/pp.107.099432; Matas AJ, 2011, PLANT CELL, V23, P3893, DOI 10.1105/tpc.111.091173; Mintz-Oron S, 2008, PLANT PHYSIOL, V147, P823, DOI 10.1104/pp.108.116004; Nawrath C, 2006, CURR OPIN PLANT BIOL, V9, P281, DOI 10.1016/j.pbi.2006.03.001; Osman SF, 1999, J AGR FOOD CHEM, V47, P799, DOI 10.1021/jf980693r; Panikashvili D, 2009, PLANT PHYSIOL, V151, P1773, DOI 10.1104/pp.109.143388; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; Reina JJ, 2007, J EXP BOT, V58, P2717, DOI 10.1093/jxb/erm136; Shi JX, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001388; Volokita M, 2011, MOL BIOL EVOL, V28, P551, DOI 10.1093/molbev/msq226; Yang WL, 2010, P NATL ACAD SCI USA, V107, P12040, DOI 10.1073/pnas.0914149107; Yeats TH, 2010, J EXP BOT, V61, P3759, DOI 10.1093/jxb/erq194	23	138	151	2	120	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2012	8	7					609	611		10.1038/NCHEMBIO.960	http://dx.doi.org/10.1038/NCHEMBIO.960			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961NJ	22610035	Green Accepted			2022-12-25	WOS:000305471400006
J	Zhou, X; Stephens, M				Zhou, Xiang; Stephens, Matthew			Genome-wide efficient mixed-model analysis for association studies	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI	Linear mixed models have attracted considerable attention recently as a powerful and effective tool for accounting for population stratification and relatedness in genetic association tests. However, existing methods for exact computation of standard test statistics are computationally impractical for even moderate-sized genome-wide association studies. To address this issue, several approximate methods have been proposed. Here, we present an efficient exact method, which we refer to as genome-wide efficient mixed-model association (GEMMA), that makes approximations unnecessary in many contexts. This method is approximately n times faster than the widely used exact method known as efficient mixed-model association (EMMA), where n is the sample size, making exact genome-wide association analysis computationally practical for large numbers of individuals.	[Zhou, Xiang; Stephens, Matthew] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Zhou, X (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	xz7@uchicago.edu; mstephens@uchicago.edu			US National Institutes of Health (NIH) [HL092206, HG02585]; Wellcome Trust [085475]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092206] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002585] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research is supported in part by grants from the US National Institutes of Health (NIH) (HL092206 to Y. Gilad and HG02585 to M.S.). We thank A.J. Lusis for making the mouse genotype and phenotype data available. This study also makes use of data generated by the WTCCC<SUP>15</SUP>. A full list of the investigators who contributed to the generation of the data is available from the WTCCC website. Funding for the WTCCC project was provided by the Wellcome Trust (award 085475).	Abney M, 2002, AM J HUM GENET, V70, P920, DOI 10.1086/339705; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; Henderson C. R, 1984, APPL LINEAR MODELS A; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kang HM, 2008, GENETICS, V180, P1909, DOI 10.1534/genetics.108.094201; Knuth D. E., 1976, SIGACT News, V8, P18, DOI 10.1145/1008328.1008329; Lee SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000231; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; Listgarten J, 2010, P NATL ACAD SCI USA, V107, P16465, DOI 10.1073/pnas.1002425107; MEYER K, 1991, GENET SEL EVOL, V23, P67, DOI 10.1051/gse:19910106; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Searle S. R., 2006, VARIANCE COMPONENTS; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	20	1431	1459	21	203	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2012	44	7					821	U136		10.1038/ng.2310	http://dx.doi.org/10.1038/ng.2310			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967DP	22706312	Green Accepted			2022-12-25	WOS:000305886900020
J	Liddy, N; Bossi, G; Adams, KJ; Lissina, A; Mahon, TM; Hassan, NJ; Gavarret, J; Bianchi, FC; Pumphrey, NJ; Ladell, K; Gostick, E; Sewell, AK; Lissin, NM; Harwood, NE; Molloy, PE; Li, Y; Cameron, BJ; Sami, M; Baston, EE; Todorov, PT; Paston, SJ; Dennis, RE; Harper, JV; Dunn, SM; Ashfield, R; Johnson, A; McGrath, Y; Plesa, G; June, CH; Kalos, M; Price, DA; Vuidepot, A; Williams, DD; Sutton, DH; Jakobsen, BK				Liddy, Nathaniel; Bossi, Giovanna; Adams, Katherine J.; Lissina, Anna; Mahon, Tara M.; Hassan, Namir J.; Gavarret, Jessie; Bianchi, Frayne C.; Pumphrey, Nicholas J.; Ladell, Kristin; Gostick, Emma; Sewell, Andrew K.; Lissin, Nikolai M.; Harwood, Naomi E.; Molloy, Peter E.; Li, Yi; Cameron, Brian J.; Sami, Malkit; Baston, Emma E.; Todorov, Penio T.; Paston, Samantha J.; Dennis, Rebecca E.; Harper, Jane V.; Dunn, Steve M.; Ashfield, Rebecca; Johnson, Andy; McGrath, Yvonne; Plesa, Gabriela; June, Carl H.; Kalos, Michael; Price, David A.; Vuidepot, Annelise; Williams, Daniel D.; Sutton, Deborah H.; Jakobsen, Bent K.			Monoclonal TCR-redirected tumor cell killing	NATURE MEDICINE			English	Article							CYTOTOXIC T-LYMPHOCYTES; ANTIBODY THERAPY; HIGH-AFFINITY; DIRECTED EVOLUTION; PEPTIDE EPITOPES; PHAGE DISPLAY; CANCER; ANTIGEN; RECEPTOR; MELANOMA	T cell immunity can potentially eradicate malignant cells and lead to clinical remission in a minority of patients with cancer. In the majority of these individuals, however, there is a failure of the specific T cell receptor (TCR)-mediated immune recognition and activation process. Here we describe the engineering and characterization of new reagents termed immune-mobilizing monoclonal TCRs against cancer (ImmTACs). Four such ImmTACs, each comprising a distinct tumor-associated epitope-specific monoclonal TCR with picomolar affinity fused to a humanized cluster of differentiation 3 (CD3)-specific single-chain antibody fragment (scFv), effectively redirected T cells to kill cancer cells expressing extremely low surface epitope densities. Furthermore, these reagents potently suppressed tumor growth in vivo. Thus, ImmTACs overcome immune tolerance to cancer and represent a new approach to tumor immunotherapy.	[Liddy, Nathaniel; Bossi, Giovanna; Adams, Katherine J.; Mahon, Tara M.; Hassan, Namir J.; Gavarret, Jessie; Bianchi, Frayne C.; Pumphrey, Nicholas J.; Lissin, Nikolai M.; Harwood, Naomi E.; Molloy, Peter E.; Li, Yi; Cameron, Brian J.; Sami, Malkit; Baston, Emma E.; Todorov, Penio T.; Paston, Samantha J.; Dennis, Rebecca E.; Harper, Jane V.; Dunn, Steve M.; Ashfield, Rebecca; Johnson, Andy; McGrath, Yvonne; Vuidepot, Annelise; Williams, Daniel D.; Sutton, Deborah H.; Jakobsen, Bent K.] Immunocore Ltd, Abingdon, Oxon, England; [Lissina, Anna; Ladell, Kristin; Gostick, Emma; Sewell, Andrew K.; Price, David A.] Cardiff Univ, Sch Med, Cardiff, S Glam, Wales; [Plesa, Gabriela; June, Carl H.; Kalos, Michael] Univ Penn, Sch Med, Philadelphia, PA 19104 USA	Cardiff University; University of Pennsylvania	Jakobsen, BK (corresponding author), Immunocore Ltd, Abingdon, Oxon, England.	bent.jakobsen@immunocore.com	Ladell, Kristin/C-8301-2013; Price, David A/C-7876-2013; Ladell, Kristin/K-2475-2013; Sewell, Andrew/GPT-4220-2022	Ladell, Kristin/0000-0002-9856-2938; Price, David A/0000-0001-9416-2737; Sewell, Andrew/0000-0003-3194-3135; Molloy, Peter/0000-0002-0238-4744	Sanofi Pasteur; BBSRC [BB/H001085/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H001085/1] Funding Source: researchfish	Sanofi Pasteur; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We would like to thank Sanofi Pasteur for funding affinity maturation of the gp100 and MAGE-A3 mTCRs; C. Yee (Fred Hutchinson Cancer Research Centre, Seattle, Washington, USA), P. Coulie (University of Louvain, Brussels, Belgium) and V. Cerundolo (Weatherall Institute of Molecular Medicine, University of Oxford, UK) for providing T cell clones; Southern Research and Cellvax for conducting mouse xenograft experiments; Southern Research for immunohistochemistry staining; R. Liu for assistance with mouse imaging and tumor measurements; K. Haines (Translational and Correlative Studies Laboratory, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA) for technical support; and A. Secreto, C. Keefer and G. Danet-Desnoyers (Stem Cell and Xenograft Core, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA) for assistance with the established tumor xenograft studies.	ADEMA GJ, 1993, AM J PATHOL, V143, P1579; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Baeuerle PA, 2009, CURR OPIN MOL THER, V11, P22; Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; Benowitz S, 2008, J NATL CANCER I, V100, P237, DOI 10.1093/jnci/djn030; Bertozzi CC, 2006, IN VITRO CELL DEV-AN, V42, P58; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; CELIS E, 1994, P NATL ACAD SCI USA, V91, P2105, DOI 10.1073/pnas.91.6.2105; Chattopadhyay PK, 2009, J LEUKOCYTE BIOL, V85, P88, DOI 10.1189/jlb.0208107; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Chlewicki LK, 2005, J MOL BIOL, V346, P223, DOI 10.1016/j.jmb.2004.11.057; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; COX AL, 1994, SCIENCE, V264, P716, DOI 10.1126/science.7513441; Dunn SM, 2006, PROTEIN SCI, V15, P710, DOI 10.1110/ps.051936406; GAUGLER B, 1994, J EXP MED, V179, P921, DOI 10.1084/jem.179.3.921; Holler PD, 2000, P NATL ACAD SCI USA, V97, P5387, DOI 10.1073/pnas.080078297; ISAACS JD, 1992, LANCET, V340, P748, DOI 10.1016/0140-6736(92)92294-P; Jager E, 1998, J EXP MED, V187, P265, DOI 10.1084/jem.187.2.265; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; KAWAKAMI Y, 1994, J EXP MED, V180, P347, DOI 10.1084/jem.180.1.347; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P3515, DOI 10.1073/pnas.91.9.3515; Kiewe P, 2006, CLIN CANCER RES, V12, P3085, DOI 10.1158/1078-0432.CCR-05-2436; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kufer P, 2004, TRENDS BIOTECHNOL, V22, P238, DOI 10.1016/j.tibtech.2004.03.006; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Maynard J, 2000, ANNU REV BIOMED ENG, V2, P339, DOI 10.1146/annurev.bioeng.2.1.339; Moysey R, 2004, ANAL BIOCHEM, V326, P284, DOI 10.1016/j.ab.2003.12.011; Price DA, 1999, IMMUNOL TODAY, V20, P212, DOI 10.1016/S0167-5699(99)01447-4; Price DA, 2005, J EXP MED, V202, P1349, DOI 10.1084/jem.20051357; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Purbhoo MA, 2006, J IMMUNOL, V176, P7308, DOI 10.4049/jimmunol.176.12.7308; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Rosenberg SA, 2009, CURR OPIN IMMUNOL, V21, P233, DOI 10.1016/j.coi.2009.03.002; Schietinger A, 2010, J EXP MED, V207, P2469, DOI 10.1084/jem.20092450; Sebastian M, 2009, J IMMUNOTHER, V32, P195, DOI 10.1097/CJI.0b013e318195b5bb; von Mehren M, 2003, ANNU REV MED, V54, P343, DOI 10.1146/annurev.med.54.101601.152442; Withoff S, 2001, CURR OPIN MOL THER, V3, P53	40	195	237	2	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2012	18	6					980	+		10.1038/nm.2764	http://dx.doi.org/10.1038/nm.2764			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22561687				2022-12-25	WOS:000305116600038
J	Liu, H; Radisky, DC; Yang, D; Xu, R; Radisky, ES; Bissell, MJ; Bishop, JM				Liu, Hong; Radisky, Derek C.; Yang, Dun; Xu, Ren; Radisky, Evette S.; Bissell, Mina J.; Bishop, J. Michael			MYC suppresses cancer metastasis by direct transcriptional silencing of alpha(v) and beta(3) integrin subunits	NATURE CELL BIOLOGY			English	Article							C-MYC; TRANSGENIC MICE; BREAST-CANCER; CELL INVASION; EXPRESSION; ONCOGENE; MIGRATION; GENES; TRANSFORMATION; PROLIFERATION	Overexpression of MYC transforms cells in culture, elicits malignant tumours in experimental animals and is found in many human tumours. We now report the paradoxical finding that this powerful oncogene can also act as a suppressor of cell motility, invasiveness and metastasis. Overexpression of MYC stimulated proliferation of breast cancer cells both in culture and in vivo as expected, but inhibited motility and invasiveness in culture, and lung and liver metastases in xenografted tumours. We show further that MYC represses transcription of both subunits of alpha(v),beta(3) integrin, and that exogenous expression of beta(3) integrin in human breast cancer cells that do not express this integrin rescues invasiveness and migration when MYC is downregulated. These data uncover an unexpected function of MYC, provide an explanation for the hitherto puzzling literature on the relationship between MYC and metastasis, and reveal a variable that could influence the development of therapies that target MYC.	[Liu, Hong; Yang, Dun; Bishop, J. Michael] Univ Calif San Francisco, George Williams Hooper Fdn, San Francisco, CA 94143 USA; [Radisky, Derek C.; Radisky, Evette S.] Mayo Clin, Ctr Canc, Jacksonville, FL 32224 USA; [Xu, Ren; Bissell, Mina J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Life Sci Div, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; Mayo Clinic; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Radisky, DC (corresponding author), Univ Calif San Francisco, George Williams Hooper Fdn, San Francisco, CA 94143 USA.	radisky.derek@mayo.edu	Radisky, Derek/B-6569-2018; Radisky, Evette S/C-8526-2012	Radisky, Derek/0000-0002-1962-8784; Radisky, Evette S/0000-0003-3121-109X; Xu, Ren/0000-0002-3591-9522	George Williams Hooper Foundation; NIH [P50 CA091956]; DoD [PC094054, W81XWH0810736]; NCI [CA122086]; Susan B. Komen foundation [FA50703855]; Mayo Clinic Breast Cancer SPORE [CA116201]; NIH/NCI [R37CA064786, U01CA143233, U54CA143836, U54CA126552]; Department of Energy OBER [DE-AC02-05CH1123]; NATIONAL CANCER INSTITUTE [P50CA091956, U01CA143233, R01CA122086, P50CA116201, U54CA126552, R37CA064786, U54CA143836] Funding Source: NIH RePORTER	George Williams Hooper Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD(United States Department of Defense); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan B. Komen foundation(Susan G. Komen Breast Cancer Foundation); Mayo Clinic Breast Cancer SPORE; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Energy OBER(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Cheresh, F. G. Giancotti, A. Goga and D. Sheppard for providing DNA constructs and cell lines. We are grateful to C-Y. Chen, L. Prentice and B. Edenfeld for help with histology and imaging. We thank D. Khauv for work with the ChIP assay, E. Miller for work with the orthotopic animal assay, M. Cichon for cloning constructs and M. Stallings-Mann for work with analysis of experiments. We also thank members of the Bishop, Bissell and Radisky laboratories for their constructive discussion and help. This work was financially supported initially by the George Williams Hooper Foundation (J.M.B.). The founder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Further support came from NIH (P50 CA091956) and the DoD (PC094054) (to E.S.R.); NCI CA122086, Susan B. Komen foundation grant FA50703855 and the Mayo Clinic Breast Cancer SPORE grant CA116201 (to D.C.R.); the DoD (W81XWH0810736), NIH/NCI (R37CA064786, U01CA143233, U54CA143836 and U54CA126552) and the Department of Energy OBER Low Dose Radiation Program (contract no. DE-AC02-05CH1123) (to M.J.B.).	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; ALITALO K, 1986, ADV CANCER RES, V47, P235, DOI 10.1016/S0065-230X(08)60201-8; Arvanitis C, 2006, SEMIN CANCER BIOL, V16, P313, DOI 10.1016/j.semcancer.2006.07.012; Bauer K, 2007, INT J CANCER, V121, P1910, DOI 10.1002/ijc.22879; Boxer RB, 2004, CANCER CELL, V6, P577, DOI 10.1016/j.ccr.2004.10.013; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Dang CV, 1999, MOL CELL BIOL, V19, P1; de Nigris F, 2007, ONCOGENE, V26, P382, DOI 10.1038/sj.onc.1209804; Desgrosellier JS, 2009, NAT MED, V15, P1163, DOI 10.1038/nm.2009; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Felding-Habermann B, 2003, CLIN EXP METASTAS, V20, P203, DOI 10.1023/A:1022983000355; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Frye M, 2003, DEVELOPMENT, V130, P2793, DOI 10.1242/dev.00462; Gebhardt A, 2006, J CELL BIOL, V172, P139, DOI 10.1083/jcb.200506057; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Jamerson MH, 2004, J MAMMARY GLAND BIOL, V9, P27, DOI 10.1023/B:JOMG.0000023586.69263.0b; Kuttler F, 2006, GENOME DYN, V1, P171, DOI 10.1159/000092507; LEDER A, 1986, CELL, V45, P485, DOI 10.1016/0092-8674(86)90280-1; Liao DJ, 2000, ENDOCR-RELAT CANCER, V7, P143, DOI 10.1677/erc.0.0070143; Liapis H, 1996, DIAGN MOL PATHOL, V5, P127, DOI 10.1097/00019606-199606000-00008; Liu H, 2006, P NATL ACAD SCI USA, V103, P4134, DOI 10.1073/pnas.0511342103; Liu H, 2005, CELL CYCLE, V4, P646, DOI 10.4161/cc.4.5.1674; Liu H, 2004, J CELL BIOL, V164, P603, DOI 10.1083/jcb.200306090; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Mizejewski GJ, 1999, P SOC EXP BIOL MED, V222, P124, DOI 10.1046/j.1525-1373.1999.d01-122.x; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Pompetti F, 1996, J CELL BIOCHEM, V63, P37; Rapp UR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006029; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SHIU RP, 1993, CLIN CHEM, V39, P353; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; SMALL MB, 1987, MOL CELL BIOL, V7, P1638, DOI 10.1128/MCB.7.5.1638; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; van Golen CM, 2003, ONCOGENE, V22, P2664, DOI 10.1038/sj.onc.1206362; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Wanzel M, 2003, TRENDS CELL BIOL, V13, P146, DOI 10.1016/S0962-8924(03)00003-5; Welm AL, 2005, P NATL ACAD SCI USA, V102, P4324, DOI 10.1073/pnas.0500470102; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wolfer A, 2010, P NATL ACAD SCI USA, V107, P3698, DOI 10.1073/pnas.0914203107; Xiao JQ, 2003, J BIOL CHEM, V278, P49780, DOI 10.1074/jbc.M308542200	50	136	140	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2012	14	6					567	+		10.1038/ncb2491	http://dx.doi.org/10.1038/ncb2491			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	949TW	22581054	Green Accepted			2022-12-25	WOS:000304599900006
J	Provasi, E; Genovese, P; Lombardo, A; Magnani, Z; Liu, PQ; Reik, A; Chu, V; Paschon, DE; Zhang, L; Kuball, J; Camisa, B; Bondanza, A; Casorati, G; Ponzoni, M; Ciceri, F; Bordignon, C; Greenberg, PD; Holmes, MC; Gregory, PD; Naldini, L; Bonini, C				Provasi, Elena; Genovese, Pietro; Lombardo, Angelo; Magnani, Zulma; Liu, Pei-Qi; Reik, Andreas; Chu, Victoria; Paschon, David E.; Zhang, Lei; Kuball, Jurgen; Camisa, Barbara; Bondanza, Attilio; Casorati, Giulia; Ponzoni, Maurilio; Ciceri, Fabio; Bordignon, Claudio; Greenberg, Philip D.; Holmes, Michael C.; Gregory, Philip D.; Naldini, Luigi; Bonini, Chiara			Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer	NATURE MEDICINE			English	Article							VERSUS-HOST-DISEASE; ENHANCED ANTITUMOR-ACTIVITY; METASTATIC MELANOMA; RECEPTOR EXPRESSION; CANCER REGRESSION; TCR CHAINS; THERAPY; MEMORY; LYMPHOCYTES; DIFFERENTIATION	The transfer of high-avidity T cell receptor (TCR) genes isolated from rare tumor-specific lymphocytes into polyclonal T cells is an attractive cancer immunotherapy strategy. However, TCR gene transfer results in competition for surface expression and inappropriate pairing between the exogenous and endogenous TCR chains, resulting in suboptimal activity and potentially harmful unpredicted antigen specificities of the resultant TCRs. We designed zinc-finger nucleases (ZFNs) that promoted the disruption of endogenous TCR beta- and alpha-chain genes. Lymphocytes treated with ZFNs lacked surface expression of CD3-TCR and expanded with the addition of interleukin-7 (IL-7) and IL-15. After lentiviral transfer of a TCR specific for the Wilms tumor 1 (WT1) antigen, these TCR-edited cells expressed the new TCR at high levels, were easily expanded to near purity and were superior at specific antigen recognition compared to donor-matched, unedited TCR-transferred cells. In contrast to unedited TCR-transferred cells, the TCR-edited lymphocytes did not mediate off-target reactivity while maintaining their anti-tumor activity in vivo, thus showing that complete editing of T cell specificity generates tumor-specific lymphocytes with improved biosafety profiles.	[Provasi, Elena; Magnani, Zulma; Camisa, Barbara; Bondanza, Attilio; Ciceri, Fabio; Bonini, Chiara] Ist Sci San Raffaele, Leukemia Unit, Program Immunol Gene Therapy & Bioimmunotherapy C, Expt Hematol Unit,Div Regenerat Med Gene Therapy, I-20132 Milan, Italy; [Provasi, Elena; Genovese, Pietro; Bordignon, Claudio; Naldini, Luigi; Bonini, Chiara] Univ Vita Salute San Raffaele, Milan, Italy; [Genovese, Pietro; Lombardo, Angelo; Naldini, Luigi] Ist Sci San Raffaele, San Raffaele Telethon Inst Gene Therapy, I-20132 Milan, Italy; [Genovese, Pietro; Lombardo, Angelo; Naldini, Luigi] Ist Sci San Raffaele, Div Regenerat Med Gene Therapy & Stem Cells, I-20132 Milan, Italy; [Liu, Pei-Qi; Reik, Andreas; Chu, Victoria; Paschon, David E.; Zhang, Lei; Holmes, Michael C.; Gregory, Philip D.] Sangamo BioSci Inc, Richmond, CA USA; [Kuball, Jurgen; Greenberg, Philip D.] Univ Washington, Seattle, WA 98195 USA; [Kuball, Jurgen; Greenberg, Philip D.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Casorati, Giulia] Ist Sci San Raffaele, Expt Immunol Unit, Div Immunol Transplantat & Infect Dis, Program Immunol Gene Therapy & Bioimmunotherapy C, I-20132 Milan, Italy; [Ponzoni, Maurilio] Ist Sci San Raffaele, Leukemia Unit, Dept Pathol, I-20132 Milan, Italy; [Ciceri, Fabio; Bonini, Chiara] Ist Sci San Raffaele, Hematol Clin Unit, Div Regenerat Med Gene Therapy & Stem Cells, I-20132 Milan, Italy; [Bordignon, Claudio] MolMed SpA, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Sangamo Therapeutics, Inc.; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Bonini, C (corresponding author), Ist Sci San Raffaele, Leukemia Unit, Program Immunol Gene Therapy & Bioimmunotherapy C, Expt Hematol Unit,Div Regenerat Med Gene Therapy, I-20132 Milan, Italy.	naldini.luigi@hsr.it; bonini.chiara@hsr.it	Magnani, Zulma Irene/AAN-7588-2020; Naldini, Luigi/E-9083-2012; bonini, chiara/I-9202-2012; lombardo, angelo/J-6241-2016; camisa, barbara/AAN-1897-2020; Genovese, Pietro/H-3710-2018; Casorati, Giulia/J-7141-2018	Magnani, Zulma Irene/0000-0001-7612-6097; lombardo, angelo/0000-0001-8262-042X; camisa, barbara/0000-0002-3867-2457; Genovese, Pietro/0000-0001-9507-9003; BONINI, Maria Chiara/0000-0002-0772-1674; Gregory, Philip/0000-0001-9249-2468; Casorati, Giulia/0000-0002-5102-4112; NALDINI, Luigi/0000-0002-7835-527X	Italian Ministry of Health [GR07-5 BO, RO10/07-B-1]; Italian Ministry of Research and University (FIRB-IDEAS); Fondazione Cariplo; Italian Association for Cancer Research (AIRC); EU (ERC) [GA 222878, 249845]; AIRC; Italian Telethon [TELE11/12-D2]; NATIONAL CANCER INSTITUTE [P01CA018029] Funding Source: NIH RePORTER	Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of Research and University (FIRB-IDEAS); Fondazione Cariplo(Fondazione Cariplo); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); EU (ERC)(European Research Council (ERC)European Commission); AIRC(Fondazione AIRC per la ricerca sul cancro); Italian Telethon(Fondazione Telethon); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank E. Rebar, J. Miller, D. Guschin, E. Leung, X. Meng, S. Hinkley, S. Lam, A. Hassenberg, Z. Zhang, C. Flinders and A. Tam for help in the generation of the TCR-specific ZFNs and the off-target analysis using SELEX, L. Sergi for technical assistance in vector production, M. Bernardi, M.T. Lupo-Stanghellini, A. Forcina, C. Traversari and all of the individuals at the Naldini and Bonini laboratories for fruitful discussion, and C. Tresoldi and the San Raffaele Scientific Institute Leukemia Biobanking for assistance. E. P. and P. G. conducted this study as partial fulfillment of their PhD in molecular medicine at the Program in Immunology, San Raffaele University, Milan, Italy. This work was supported by the Italian Ministry of Health (GR07-5 BO and RO10/07-B-1), the Italian Ministry of Research and University (FIRB-IDEAS, linked to European Research Council (ERC) starting grants), Fondazione Cariplo and the Italian Association for Cancer Research (AIRC) to C. Bonini and by the EU (FP7: GA 222878, PERSIST and ERC advanced grant 249845 TARGETINGGENETHERAPY), AIRC, Italian Ministry of Health (Challenge in Oncology) and Italian Telethon (TELE11/12-D2) to L.	Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Appelbaum FR, 2001, NATURE, V411, P385, DOI 10.1038/35077251; Bendle GM, 2010, NAT MED, V16, P565, DOI 10.1038/nm.2128; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Bondanza A, 2006, BLOOD, V107, P1828, DOI 10.1182/blood-2005-09-3716; Bondanza A, 2011, BLOOD, V117, P6469, DOI 10.1182/blood-2010-11-320366; Cohen CJ, 2007, CANCER RES, V67, P3898, DOI 10.1158/0008-5472.CAN-06-3986; Cohen CJ, 2006, CANCER RES, V66, P8878, DOI 10.1158/0008-5472.CAN-06-1450; Cooke KR, 2001, J CLIN INVEST, V107, P1581, DOI 10.1172/JCI12156; Davis JL, 2010, CLIN CANCER RES, V16, P5852, DOI 10.1158/1078-0432.CCR-10-1280; Doyon Y, 2010, NAT METHODS, V7, P459, DOI [10.1038/NMETH.1456, 10.1038/nmeth.1456]; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Follenzi A, 2002, METHOD ENZYMOL, V346, P454; Heemskerk MHM, 2007, BLOOD, V109, P235, DOI 10.1182/blood-2006-03-013318; Heslop HE, 2010, BLOOD, V115, P925, DOI 10.1182/blood-2009-08-239186; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kaneko S, 2009, BLOOD, V113, P1006, DOI 10.1182/blood-2008-05-156059; Kessels HWHG, 2001, NAT IMMUNOL, V2, P957, DOI 10.1038/ni1001-957; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Kuball J, 2007, BLOOD, V109, P2331, DOI 10.1182/blood-2006-05-023069; Liu KB, 2002, P NATL ACAD SCI USA, V99, P6192, DOI 10.1073/pnas.092675799; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Nilsson M, 2004, J GENE MED, V6, P631, DOI 10.1002/jgm.543; Okamoto S, 2009, CANCER RES, V69, P9003, DOI 10.1158/0008-5472.CAN-09-1450; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; RIDDELL SR, 1990, J IMMUNOL METHODS, V128, P189, DOI 10.1016/0022-1759(90)90210-M; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Sacre K, 2005, J EXP MED, V201, P1999, DOI 10.1084/jem.20042408; Scholten KBJ, 2006, CLIN IMMUNOL, V119, P135, DOI 10.1016/j.clim.2005.12.009; Sollu C, 2010, NUCLEIC ACIDS RES, V38, P8269, DOI 10.1093/nar/gkq720; Thomas S, 2007, J IMMUNOL, V179, P5803, DOI 10.4049/jimmunol.179.9.5803; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; van Loenen MM, 2010, P NATL ACAD SCI USA, V107, P10972, DOI 10.1073/pnas.1005802107	37	325	369	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2012	18	5					807	U212		10.1038/nm.2700	http://dx.doi.org/10.1038/nm.2700			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22466705	Green Accepted			2022-12-25	WOS:000303763500049
J	Richter, L; de Graaf, C; Sieghart, W; Varagic, Z; Morzinger, M; de Esch, IJP; Ecker, GF; Ernst, M				Richter, Lars; de Graaf, Chris; Sieghart, Werner; Varagic, Zdravko; Moerzinger, Martina; de Esch, Iwan J. P.; Ecker, Gerhard F.; Ernst, Margot			Diazepam-bound GABA(A) receptor models identify new benzodiazepine binding-site ligands	NATURE CHEMICAL BIOLOGY			English	Article							AMINOBUTYRIC ACID(A) RECEPTORS; EMPIRICAL SCORING FUNCTIONS; A RECEPTOR; ALPHA-SUBUNIT; STRUCTURAL REQUIREMENTS; AMINO-ACID; DOCKING; AFFINITY; RECOGNITION; RESIDUES	Benzodiazepines exert their anxiolytic, anticonvulsant, muscle-relaxant and sedative-hypnotic properties by allosterically enhancing the action of GABA at GABA(A) receptors via their benzodiazepine-binding site. Although these drugs have been used clinically since 1960, the molecular basis of this interaction is still not known. By using multiple homology models and an unbiased docking protocol, we identified a binding hypothesis for the diazepam-bound structure of the benzodiazepine site, which was confirmed by experimental evidence. Moreover, two independent virtual screening approaches based on this structure identified known benzodiazepine-site ligands from different structural classes and predicted potential new ligands for this site. Receptor-binding assays and electrophysiological studies on recombinant receptors confirmed these predictions and thus identified new chemotypes for the benzodiazepine-binding site. Our results support the validity of the diazepam-bound structure of the benzodiazepine-binding pocket, demonstrate its suitability for drug discovery and pave the way for structure-based drug design.	[Richter, Lars; Ecker, Gerhard F.] Univ Vienna, Dept Med Chem, Vienna, Austria; [de Graaf, Chris; de Esch, Iwan J. P.] Vrije Univ Amsterdam, Fac Sci, Leiden Amsterdam Ctr Drug Res, Div Med Chem, Amsterdam, Netherlands; [Sieghart, Werner; Varagic, Zdravko; Moerzinger, Martina; Ernst, Margot] Med Univ Vienna, Ctr Brain Res, Dept Biochem & Mol Biol, Vienna, Austria	University of Vienna; Leiden University; Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Medical University of Vienna	Richter, L (corresponding author), Univ Vienna, Dept Med Chem, Vienna, Austria.	margot.ernst@meduniwien.ac.at	Sieghart, Werner/A-4877-2013; Richter, Lars/D-3426-2017; de Esch, Iwan/K-4909-2017; de Graaf, Chris/J-8549-2017	Sieghart, Werner/0000-0002-0443-0302; Richter, Lars/0000-0002-9417-9042; Ernst, Margot/0000-0002-9809-2649; Ecker, Gerhard/0000-0003-4209-6883; de Graaf, Chris/0000-0002-1226-2150	Austrian Academy of Science; Austrian Science Fund [P19653]; European Commission [HEALTH-F4-2008-202088]	Austrian Academy of Science; Austrian Science Fund(Austrian Science Fund (FWF)); European Commission(European CommissionEuropean Commission Joint Research Centre)	Financial support from the Doctoral Fellowship Programme of the Austrian Academy of Science (L. R.), the Austrian Science Fund grant P19653 (M. E.) and the European Commission Seventh Framework Programme grant HEALTH-F4-2008-202088 (W. S. and I.J.P.d.E.) is gratefully acknowledged. We also thank Inte:Ligand for providing us a free license for LigandScout 3.0 and Open Eye for an Omega license. We thank M. Mysinger and J. Irwin from the Shoichet laboratory for generating the focused 'benzodiazepine' decoy set. In addition we thank E. Sigel for helpful suggestions and discussions during generation of this work; M. Stojanovic for technical assistance in the binding assays; A. Chalikiopoulos and M. Verheij for assistance in fragment docking studies; and E. Urban, S. Haselmaier, J. Konig, H. Custers and A. van de Stolpe for providing HRMS and <SUP>1</SUP>H- and <SUP>13</SUP>C-NMR spectral data.	Amin J, 1997, MOL PHARMACOL, V51, P833, DOI 10.1124/mol.51.5.833; Berezhnoy D, 2004, J BIOL CHEM, V279, P3160, DOI 10.1074/jbc.M311371200; Berezhnoy D, 2009, MOL PHARMACOL, V76, P440, DOI 10.1124/mol.109.054650; Buhr A, 1997, MOL PHARMACOL, V52, P676, DOI 10.1124/mol.52.4.676; Buhr A, 1997, J BIOL CHEM, V272, P11799, DOI 10.1074/jbc.272.18.11799; Chema D, 2004, J COMPUT AID MOL DES, V18, P23, DOI 10.1023/B:JCAM.0000022561.76694.5b; Ci SQ, 2008, PROTEIN J, V27, P71, DOI 10.1007/s10930-007-9109-9; Claussen H, 2001, J MOL BIOL, V308, P377, DOI 10.1006/jmbi.2001.4551; Clayton T, 2007, CURR MED CHEM, V14, P2755, DOI 10.2174/092986707782360097; Davies M, 1998, J NEUROCHEM, V70, P2188; de Graaf C, 2008, J MED CHEM, V51, P4978, DOI 10.1021/jm800710x; Derry JMC, 2004, J NEUROCHEM, V88, P1431, DOI 10.1046/j.1471-4159.2003.02264.x; Duncalfe LL, 1996, J BIOL CHEM, V271, P9209, DOI 10.1074/jbc.271.16.9209; Evers A, 2003, J MOL BIOL, V334, P327, DOI 10.1016/j.jmb.2003.09.032; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Korb O, 2009, J CHEM INF MODEL, V49, P84, DOI 10.1021/ci800298z; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kucken AM, 2003, MOL PHARMACOL, V63, P289, DOI 10.1124/mol.63.2.289; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Marcou G, 2007, J CHEM INF MODEL, V47, P195, DOI 10.1021/ci600342e; Michino M, 2009, NAT REV DRUG DISCOV, V8, P455, DOI 10.1038/nrd2877; MIHIC SJ, 1994, J BIOL CHEM, V269, P32768; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Moitessier N, 2008, BRIT J PHARMACOL, V153, pS7, DOI 10.1038/sj.bjp.0707515; Mokrab Y, 2007, J MOL GRAPH MODEL, V26, P760, DOI 10.1016/j.jmgm.2007.04.012; Mysinger MM, 2010, J CHEM INF MODEL, V50, P1561, DOI 10.1021/ci100214a; POPP FD, 1980, J PHARM SCI, V69, P1235, DOI 10.1002/jps.2600691035; Ramerstorfer J, 2011, J NEUROSCI, V31, P870, DOI 10.1523/JNEUROSCI.5012-10.2011; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sancar F, 2007, MOL PHARMACOL, V71, P38, DOI 10.1124/mol.106.029595; Sawyer GW, 2002, J BIOL CHEM, V277, P50036, DOI 10.1074/jbc.M209281200; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; SIEGHART W, 1984, BIOCHEM PHARMACOL, V33, P4033, DOI 10.1016/0006-2952(84)90017-0; SIEGHART W, 1995, PHARMACOL REV, V47, P181; Sigel E, 1998, MOL PHARMACOL, V54, P1097, DOI 10.1124/mol.54.6.1097; Sigel Erwin, 2002, Current Topics in Medicinal Chemistry, V2, P833, DOI 10.2174/1568026023393444; Tan KR, 2007, J BIOL CHEM, V282, P26316, DOI 10.1074/jbc.M702153200; Tan KR, 2009, J NEUROCHEM, V111, P1264, DOI 10.1111/j.1471-4159.2009.06419.x; Venhorst J, 2008, J MED CHEM, V51, P3222, DOI 10.1021/jm8001058; Verheij MHP, 2011, BIOORG MED CHEM LETT, V21, P5460, DOI 10.1016/j.bmcl.2011.06.123; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Wei BQQ, 2002, J MOL BIOL, V322, P339, DOI 10.1016/S0022-2836(02)00777-5; WIELAND HA, 1992, J BIOL CHEM, V267, P1426; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Zhang W, 1995, Drug Des Discov, V12, P193	48	148	157	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2012	8	5					455	464		10.1038/NCHEMBIO.917	http://dx.doi.org/10.1038/NCHEMBIO.917			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	928DY	22446838	Green Accepted			2022-12-25	WOS:000302962500012
J	Roscioli, T; Kamsteeg, EJ; Buysse, K; Maystadt, I; van Reeuwijk, J; van den Elzen, C; van Beusekom, E; Riemersma, M; Pfundt, R; Vissers, LELM; Schraders, M; Altunoglu, U; Buckley, MF; Brunner, HG; Grisart, B; Zhou, HQ; Veltman, JA; Gilissen, C; Mancini, GMS; Delree, P; Willemsen, MA; Ramadza, DP; Chitayat, D; Bennett, C; Sheridan, E; Peeters, EAJ; Tan-Sindhunata, GMB; de Die-Smulders, CE; Devriendt, K; Kayserili, H; El-Hashash, OA; Stemple, DL; Lefeber, DJ; Lin, YY; van Bokhoven, H				Roscioli, Tony; Kamsteeg, Erik-Jan; Buysse, Karen; Maystadt, Isabelle; van Reeuwijk, Jeroen; van den Elzen, Christa; van Beusekom, Ellen; Riemersma, Moniek; Pfundt, Rolph; Vissers, Lisenka E. L. M.; Schraders, Margit; Altunoglu, Umut; Buckley, Michael F.; Brunner, Han G.; Grisart, Bernard; Zhou, Huiqing; Veltman, Joris A.; Gilissen, Christian; Mancini, Grazia M. S.; Delree, Paul; Willemsen, Michel A.; Ramadza, Danijela Petkovic; Chitayat, David; Bennett, Christopher; Sheridan, Eamonn; Peeters, Els A. J.; Tan-Sindhunata, Gita M. B.; de Die-Smulders, Christine E.; Devriendt, Koenraad; Kayserili, Hulya; El-Hashash, Osama Abd El-Fattah; Stemple, Derek L.; Lefeber, Dirk J.; Lin, Yung-Yao; van Bokhoven, Hans			Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of alpha-dystroglycan	NATURE GENETICS			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; ABNORMAL GLYCOSYLATION; MENTAL-RETARDATION; ZEBRAFISH EMBRYOS; GENE; FUKUTIN; FORM; HYPOGLYCOSYLATION; DISRUPTION; DEFICIENCY	Walker-Warburg syndrome (WWS) is an autosomal recessive multisystem disorder characterized by complex eye and brain abnormalities with congenital muscular dystrophy (CMD) and aberrant alpha-dystroglycan glycosylation. Here we report mutations in the ISPD gene (encoding isoprenoid synthase domain containing) as the second most common cause of WWS. Bacterial IspD is a nucleotidyl transferase belonging to a large glycosyltransferase family, but the role of the orthologous protein in chordates is obscure to date, as this phylum does not have the corresponding non-mevalonate isoprenoid biosynthesis pathway. Knockdown of ispd in zebrafish recapitulates the human WWS phenotype with hydrocephalus, reduced eye size, muscle degeneration and hypoglycosylated alpha-dystroglycan. These results implicate ISPD in alpha-dystroglycan glycosylation in maintaining sarcolemma integrity in vertebrates.	[Stemple, Derek L.; Lin, Yung-Yao] Wellcome Trust Sanger Inst, Cambridge, England; [Roscioli, Tony; Kamsteeg, Erik-Jan; Buysse, Karen; van Reeuwijk, Jeroen; van den Elzen, Christa; van Beusekom, Ellen; Riemersma, Moniek; Pfundt, Rolph; Vissers, Lisenka E. L. M.; Buckley, Michael F.; Brunner, Han G.; Zhou, Huiqing; Veltman, Joris A.; Gilissen, Christian; van Bokhoven, Hans] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Roscioli, Tony] Sydney Childrens Hosp, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Roscioli, Tony] Univ New S Wales, Sydney, NSW, Australia; [Maystadt, Isabelle; Grisart, Bernard; Delree, Paul] Inst Pathol & Genet, Ctr Genet Humaine, Gosselies, Belgium; [Riemersma, Moniek; Willemsen, Michel A.; Lefeber, Dirk J.] Radboud Univ Nijmegen, Dept Neurol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Schraders, Margit] Radboud Univ Nijmegen, Dept Otorhinolaryngol, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Altunoglu, Umut; Kayserili, Hulya] Istanbul Univ, Dept Med Genet, Istanbul Fac Med, Istanbul, Turkey; [Mancini, Grazia M. S.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Ramadza, Danijela Petkovic] Univ Hosp Ctr, Dept Pediat, Zagreb, Croatia; [Chitayat, David] Univ Toronto, Mt Sinai Hosp, Dept Obstet & Gynecol, Prenatal Diag & Med Genet Program, Toronto, ON M5G 1X5, Canada; [Chitayat, David] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Bennett, Christopher; Sheridan, Eamonn] St James Univ Hosp, Dept Clin Genet, Leeds, W Yorkshire, England; [Peeters, Els A. J.] Med Ctr Haaglanden, The Hague, Netherlands; [Tan-Sindhunata, Gita M. B.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [de Die-Smulders, Christine E.] Maastricht Univ, Med Ctr, Dept Clin Genet, Maastricht, Netherlands; [Devriendt, Koenraad] Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium; [El-Hashash, Osama Abd El-Fattah] Farwaniya Hosp, Dept Pediat, Farwaniya, Kuwait; [El-Hashash, Osama Abd El-Fattah] Minist Hlth Cairo, Cairo, Egypt; [Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Lab Genet Endocrine & Metab Dis, NL-6525 ED Nijmegen, Netherlands	Wellcome Trust Sanger Institute; Radboud University Nijmegen; University of Sydney; University of New South Wales Sydney; Radboud University Nijmegen; Radboud University Nijmegen; Istanbul University; Erasmus University Rotterdam; Erasmus MC; University of Zagreb; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Saint James's University Hospital; Haaglanden Medical Center; Vrije Universiteit Amsterdam; Maastricht University; Universite Catholique Louvain; Egyptian Knowledge Bank (EKB); Ministry of Health & Population - Egypt; Radboud University Nijmegen	Lin, YY (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	yyl@sanger.ac.uk; h.vanbokhoven@gen.numcn.nl	Kayserili, Hülya/AAA-5593-2021; Gilissen, Christian/E-5246-2012; Kamsteeg, Erik-Jan/L-4421-2015; Maystadt, Isabelle/AAH-1483-2021; Veltman, Joris A/F-5128-2010; Vissers, Lisenka ELM/A-2598-2015; lefeber, dirk/G-5063-2012; Pfundt, Rolph/L-4576-2015; Schraders, Margit/A-1607-2016; Ramadža, Danijela Petković/AAQ-7287-2021; van Bokhoven, Hans/D-8764-2012; Lefeber, Dirk DJ/A-2146-2014; Willemsen, Michel A.A.P./H-8119-2014; van Reeuwijk, Jeroen/P-8665-2015; van Beusekom, Ellen/AAF-2687-2019; Brunner, Han/C-9928-2013; Bokhoven, J.H.L.M. van van/H-8015-2014; Zhou, Huiqing/B-1721-2013	Kayserili, Hülya/0000-0003-0376-499X; Gilissen, Christian/0000-0003-1693-9699; Veltman, Joris A/0000-0002-3218-8250; Vissers, Lisenka ELM/0000-0001-6470-5497; van Reeuwijk, Jeroen/0000-0002-0658-4399; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Zhou, Huiqing/0000-0002-2434-3986; Lin, Yung-Yao/0000-0002-0435-7694; buckley, michael/0000-0002-8298-8758; Altunoglu, Umut/0000-0002-3172-5368	Large-Scale Integrating Project GENCODYS-Genetic and Epigenetic Networks in COgnitive DYSfunction [241995]; European Union; Australian National Health and Medical Research Council (NHMRC); Prinses Beatrix Fund [W.OR09-15]; Hersenstichting Nederland; European Molecular Biology Organization (EMBO) [ALTF 805-2009]; Wellcome Trust [WT 077047/Z/05/Z, WT 077037/Z/05/Z]; Department of Human Genetics at Nijmegen; Netherlands Organisation for Health Research and Development (ZonMW) [916-86-016]	Large-Scale Integrating Project GENCODYS-Genetic and Epigenetic Networks in COgnitive DYSfunction; European Union(European Commission); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Prinses Beatrix Fund; Hersenstichting Nederland; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Wellcome Trust(Wellcome TrustEuropean Commission); Department of Human Genetics at Nijmegen; Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	We thank all family members who participated in this study. We would also like to thank A. Charon for referring an affected individual, G. Powell and S. Gerety for critical comments on the manuscript and R. Schot for study of the deletion in family WWS-161. This project was supported by the Large-Scale Integrating Project GENCODYS-Genetic and Epigenetic Networks in COgnitive DYSfunction (241995), which is funded by the European Union Framework Programme 7 (FP7) Health program (to H. v. B.), the Australian National Health and Medical Research Council (NHMRC) with an overseas postdoctoral fellowship (to T. R.), The Prinses Beatrix Fund (grant W.OR09-15 to D. L. and H. v. B.), the Hersenstichting Nederland (to H. v. B.) and a European Molecular Biology Organization (EMBO) Long-Term Fellowship (ALTF 805-2009 to K. B.). All zebrafish work was sponsored by the Wellcome Trust (grant WT 077047/Z/05/Z and WT 077037/Z/05/Z). Next-generation sequencing experiments were financially supported by the Department of Human Genetics at Nijmegen, as well as by the Netherlands Organisation for Health Research and Development (ZonMW; grant 916-86-016 to L.E.L.M.V.).	Bassett DI, 2003, DEVELOPMENT, V130, P5851, DOI 10.1242/dev.00799; Baur S, 2009, J BACTERIOL, V191, P1200, DOI 10.1128/JB.01120-08; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Bleckmann C, 2009, BIOL CHEM, V390, P627, DOI 10.1515/BC.2009.044; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; de Bernabe DBV, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013870; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Godfrey C, 2007, BRAIN, V130, P2725, DOI 10.1093/brain/awm212; Hall TE, 2007, P NATL ACAD SCI USA, V104, P7092, DOI 10.1073/pnas.0700942104; Hara Y, 2011, NEW ENGL J MED, V364, P939, DOI 10.1056/NEJMoa1006939; Jimenez-Mallebrera C, 2009, BRAIN PATHOL, V19, P596, DOI 10.1111/j.1750-3639.2008.00198.x; Kemp LE, 2003, ACTA CRYSTALLOGR D, V59, P607, DOI 10.1107/S090744490202365X; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Lefeber DJ, 2009, AM J HUM GENET, V85, P76, DOI 10.1016/j.ajhg.2009.06.006; Lin YY, 2011, HUM MOL GENET, V20, P1763, DOI 10.1093/hmg/ddr059; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Liu J, 2003, PROTEIN SCI, V12, P1418, DOI 10.1110/ps.0302103; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; MacLeod H, 2007, NEUROMUSCULAR DISORD, V17, P285, DOI 10.1016/j.nmd.2007.01.005; McMullan DJ, 2009, HUM MUTAT, V30, P1082, DOI 10.1002/humu.21015; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Parsons MJ, 2002, DEVELOPMENT, V129, P3505; Parsons MJ, 2002, DEVELOPMENT, V129, P3137; Richard SB, 2004, BIOCHEMISTRY-US, V43, P12189, DOI 10.1021/bi0487241; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Silan F, 2003, ANN NEUROL, V53, P392, DOI 10.1002/ana.10491; Snow CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000219; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; van Reeuwijk J, 2005, CLIN GENET, V67, P281, DOI 10.1111/j.1399-0004.2004.00368.x; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; van Reeuwijk J, 2007, HUM GENET, V121, P685, DOI 10.1007/s00439-007-0362-y; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Wood AJ, 2011, HUM MOL GENET, V20, P4879, DOI 10.1093/hmg/ddr426; Woods CG, 2006, AM J HUM GENET, V78, P889, DOI 10.1086/503875; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Zhang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019080	37	148	156	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2012	44	5					581	+		10.1038/ng.2253	http://dx.doi.org/10.1038/ng.2253			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	934BW	22522421	Green Submitted, Green Accepted			2022-12-25	WOS:000303416300020
J	Valderrama-Rincon, JD; Fisher, AC; Merritt, JH; Fan, YY; Reading, CA; Chhiba, K; Heiss, C; Azadi, P; Aebi, M; DeLisa, MP				Valderrama-Rincon, Juan D.; Fisher, Adam C.; Merritt, Judith H.; Fan, Yao-Yun; Reading, Craig A.; Chhiba, Krishan; Heiss, Christian; Azadi, Parastoo; Aebi, Markus; DeLisa, Matthew P.			An engineered eukaryotic protein glycosylation pathway in Escherichia coli	NATURE CHEMICAL BIOLOGY			English	Article							N-LINKED GLYCOSYLATION; DISPLAY; SPECIFICITY; DISTINCT; SYSTEM; ALG11	We performed bottom-up engineering of a synthetic pathway in Escherichia coli for the production of eukaryotic trimannosyl chitobiose glycans and the transfer of these glycans to specific asparagine residues in target proteins. The glycan biosynthesis was enabled by four eukaryotic glycosyltransferases, including the yeast uridine diphosphate-N-acetylglucosamine transferases Alg13 and Alg14 and the mannosyltransferases Alg1 and Alg2. By including the bacterial oligosaccharyltransferase PglB from Campylobacter jejuni, we successfully transferred glycans to eukaryotic proteins.	[Valderrama-Rincon, Juan D.; DeLisa, Matthew P.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA; [Fisher, Adam C.; Merritt, Judith H.; Reading, Craig A.] Glycobia Inc, Ithaca, NY USA; [Fan, Yao-Yun; Aebi, Markus] ETH, Inst Microbiol, Dept Biol, CH-8092 Zurich, Switzerland; [Chhiba, Krishan] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA; [Heiss, Christian; Azadi, Parastoo] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Cornell University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Cornell University; University System of Georgia; University of Georgia	Valderrama-Rincon, JD (corresponding author), Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.	md255@cornell.edu	Heiss, Christian/GPX-7678-2022; DeLisa, Matthew/AAE-7361-2019; Fan, YaoYun/AAS-5920-2020	Heiss, Christian/0000-0003-1118-8953; DeLisa, Matthew/0000-0003-3226-1566	National Science Foundation [CBET-0449080]; New York State Office of Science; National Institutes of Health [R43 GM087766, R43 GM086965]; National Institutes of Health National Center for Research Resources [1 P41 RR018502-01]; LASPAU; Universidad Antonio Narino; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM087766, R43GM086965] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); New York State Office of Science; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); LASPAU; Universidad Antonio Narino; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Imperiali (Massachusetts Institute of Technology) for plasmid pBAD(ALG2)-DEST49, G. O'Toole (Dartmouth College) for plasmid pMQ70, T. Mansell for helpful discussions regarding RNaseA glycosylation, C. Hong for helpful discussions regarding glycan synthesis and individuals from the Functional Genomic Center Zurich for input and instrument support. This work was supported by the National Science Foundation Career Award CBET-0449080 (to M. P. D.), the New York State Office of Science, Technology and Academic Research Distinguished Faculty Award (to M. P. D.), the National Institutes of Health Small Business Innovation Research grants R43 GM087766 and R43 GM086965 (to A. C. F.), the National Institutes of Health National Center for Research Resources grant 1 P41 RR018502-01 (to the Complex Carbohydrate Research Center) and a graduate fellowship from LASPAU and the Universidad Antonio Narino (to J.D.V.-R.).	Alaimo C, 2006, EMBO J, V25, P967, DOI 10.1038/sj.emboj.7601024; Celik E, 2010, PROTEIN SCI, V19, P2006, DOI 10.1002/pro.472; Cipollo JF, 2001, J BIOL CHEM, V276, P21828, DOI 10.1074/jbc.M010896200; COUTO JR, 1984, J BIOL CHEM, V259, P378; Durr C, 2010, GLYCOBIOLOGY, V20, P1366, DOI 10.1093/glycob/cwq102; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; Fisher AC, 2011, APPL ENVIRON MICROB, V77, P871, DOI 10.1128/AEM.01901-10; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Ielmini MV, 2011, GLYCOBIOLOGY, V21, P734, DOI 10.1093/glycob/cwq192; Ihssen J, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-61; Ilg K, 2010, GLYCOBIOLOGY, V20, P1289, DOI 10.1093/glycob/cwq091; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Liu X, 2006, ANAL CHEM, V78, P6081, DOI 10.1021/ac060516m; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Nasab FP, 2008, MOL BIOL CELL, V19, P3758, DOI 10.1091/mbc.E08-05-0467; O'Reilly MK, 2006, BIOCHEMISTRY-US, V45, P9593, DOI 10.1021/bi060878o; Pandhal J, 2010, BIOTECHNOL LETT, V32, P1189, DOI 10.1007/s10529-010-0289-6; Schwarz F, 2011, GLYCOBIOLOGY, V21, P45, DOI 10.1093/glycob/cwq130; Schwarz F, 2010, NAT CHEM BIOL, V6, P264, DOI [10.1038/NCHEMBIO.314, 10.1038/nchembio.314]; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; Van Patten SM, 2007, GLYCOBIOLOGY, V17, P467, DOI 10.1093/glycob/cwm008; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Wang X, 2008, STRUCTURE, V16, P965, DOI 10.1016/j.str.2008.03.010; Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099	25	165	176	3	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2012	8	5					434	436		10.1038/NCHEMBIO.921	http://dx.doi.org/10.1038/NCHEMBIO.921			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	928DY	22446837	Green Accepted			2022-12-25	WOS:000302962500009
J	Cole, F; Kauppi, L; Lange, J; Roig, I; Wang, R; Keeney, S; Jasin, M				Cole, Francesca; Kauppi, Liisa; Lange, Julian; Roig, Ignasi; Wang, Raymond; Keeney, Scott; Jasin, Maria			Homeostatic control of recombination is implemented progressively in mouse meiosis	NATURE CELL BIOLOGY			English	Article							MEIOTIC CROSSING-OVER; DOUBLE-STRAND BREAKS; HUMAN ANEUPLOIDY; MLH1 FOCI; INTERFERENCE; MICE; SPERMATOCYTES; CROSSOVERS; PROPHASE	Humans suffer from high rates of fetal aneuploidy, often arising from the absence of meiotic crossover recombination between homologous chromosomes(1). Meiotic recombination is initiated by double-strand breaks (DSBs) generated by the SPO11 transesterase(2). In yeast and worms, at least one buffering mechanism, crossover homeostasis, maintains crossover numbers despite variation in DSB numbers(3-8). We show here that mammals exhibit progressive homeostatic control of recombination. In wild-type mouse spermatocytes, focus numbers for early recombination proteins (RAD51, DMC1) were highly variable from cell to cell, whereas foci of the crossover marker MLH1 showed little variability. Furthermore, mice with greater or fewer copies of the Spo11 gene-with correspondingly greater or fewer numbers of early recombination foci-exhibited relatively invariant crossover numbers. Homeostatic control is enforced during at least two stages, after the formation of early recombination intermediates and later while these intermediates mature towards crossovers. Thus, variability within the mammalian meiotic program is robustly managed by homeostatic mechanisms to control crossover formation, probably to suppress aneuploidy. Meiotic recombination exemplifies how order can be progressively implemented in a self-organizing system despite natural cell-to-cell disparities in the underlying biochemical processes.	[Kauppi, Liisa; Lange, Julian; Roig, Ignasi; Keeney, Scott] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Cole, Francesca; Wang, Raymond; Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Roig, Ignasi] Univ Autonoma Barcelona, Cytol & Histol Unit, Dept Cell Biol Physiol & Immunol, E-08193 Barcelona, Spain; [Keeney, Scott] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Autonomous University of Barcelona; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Keeney, S (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA.	s-keeney@ski.mskcc.org; m-jasin@ski.mskcc.org	Roig, Ignasi/A-9697-2012; Keeney, Scott/GVR-8515-2022; Kauppi, Liisa/H-5845-2012	Roig, Ignasi/0000-0003-0313-3581; Cole, Francesca/0000-0001-6391-2363; Kauppi, Liisa/0000-0002-6759-8997; Keeney, Scott/0000-0002-1283-6417	Ruth L. Kirschstein NRSA [F32HD51392]; NIH [HD040916]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040916, F32HD051392] Funding Source: NIH RePORTER	Ruth L. Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank present and past members of the Jasin and Keeney laboratories for helpful discussions. F.C. was supported by a Ruth L. Kirschstein NRSA (F32HD51392). S.K. is an Investigator of the Howard Hughes Medical Institute. This work was supported by NIH grant HD040916 (to M.J. and S.K.).	Anderson LK, 1999, GENETICS, V151, P1569; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Barchi M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000076; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Bellani MA, 2010, MOL CELL BIOL, V30, P4391, DOI 10.1128/MCB.00002-10; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Cohen PE, 2006, ENDOCR REV, V27, P398, DOI 10.1210/er.2005-0017; Cole F, 2010, MOL CELL, V39, P700, DOI 10.1016/j.molcel.2010.08.017; Cole F, 2010, GENE DEV, V24, P1201, DOI 10.1101/gad.1944710; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; de Boer E, 2007, J CELL SCI, V120, P731, DOI 10.1242/jcs.003186; de Boer E, 2006, P NATL ACAD SCI USA, V103, P9607, DOI 10.1073/pnas.0600418103; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Dray E, 2011, P NATL ACAD SCI USA, V108, P3560, DOI 10.1073/pnas.1016454108; Ferguson KA, 2009, HUM REPROD, V24, P1313, DOI 10.1093/humrep/dep021; Goldfarb T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000520; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; HEYTING C, 1991, METHOD CELL BIOL, V35, P177; Hillers KJ, 2003, CURR BIOL, V13, P1641, DOI 10.1016/j.cub.2003.08.026; Holloway JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000186; Jones GH, 2006, CELL, V126, P246, DOI 10.1016/j.cell.2006.07.010; Kauppi L, 2011, SCIENCE, V331, P916, DOI 10.1126/science.1195774; Keeney Scott, 2008, V2, P81, DOI 10.1007/7050_2007_026; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; Koehler KE, 2006, CURR BIOL, V16, pR579, DOI 10.1016/j.cub.2006.07.018; Lange J, 2011, NATURE, V479, P237, DOI 10.1038/nature10508; LaRocque JR, 2010, MOL CELL BIOL, V30, P1887, DOI 10.1128/MCB.01553-09; Lenzi ML, 2005, AM J HUM GENET, V76, P112, DOI 10.1086/427268; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Mets DG, 2009, CELL, V139, P73, DOI 10.1016/j.cell.2009.07.035; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Roig I, 2008, DEV CELL, V15, P331, DOI 10.1016/j.devcel.2008.08.009; Roig I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001062; Rosu S, 2011, SCIENCE, V334, P1286, DOI 10.1126/science.1212424; Stahl FW, 2010, GENETICS, V186, P515, DOI 10.1534/genetics.110.121194; Youds JL, 2010, SCIENCE, V327, P1254, DOI 10.1126/science.1183112; Zhang LR, 2011, P NATL ACAD SCI USA, V108, P20036, DOI 10.1073/pnas.1117937108	40	154	157	0	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2012	14	4					424	+		10.1038/ncb2451	http://dx.doi.org/10.1038/ncb2451			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	921UM	22388890	Green Accepted			2022-12-25	WOS:000302503300016
J	Munns, R; James, RA; Xu, B; Athman, A; Conn, SJ; Jordans, C; Byrt, CS; Hare, RA; Tyerman, SD; Tester, M; Plett, D; Gilliham, M				Munns, Rana; James, Richard A.; Xu, Bo; Athman, Asmini; Conn, Simon J.; Jordans, Charlotte; Byrt, Caitlin S.; Hare, Ray A.; Tyerman, Stephen D.; Tester, Mark; Plett, Darren; Gilliham, Matthew			Wheat grain yield on saline soils is improved by an ancestral Na+ transporter gene	NATURE BIOTECHNOLOGY			English	Article							SALT TOLERANCE; DURUM-WHEAT; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; POTASSIUM-TRANSPORT; EXCLUSION; SODIUM; RICE; LOCUS; NAX2	The ability of wheat to maintain a low sodium concentration ([Na+]) in leaves correlates with improved growth under saline conditions(1,2). This trait, termed Na+ exclusion, contributes to the greater salt tolerance of bread wheat relative to durum wheat(3,4). To improve the salt tolerance of durum wheat, we explored natural diversity in shoot Na+ exclusion within ancestral wheat germplasm. Previously, we showed that crossing of Nax2, a gene locus in the wheat relative Triticum monococcum into a commercial durum wheat (Triticum turgidum ssp. durum var. Tamaroi) reduced its leaf [Na+] (ref. 5). Here we show that a gene in the Nax2 locus, TmHKT1; 5-A, encodes a Na+-selective transporter located on the plasma membrane of root cells surrounding xylem vessels, which is therefore ideally localized to withdraw Na+ from the xylem and reduce transport of Na+ to leaves. Field trials on saline soils demonstrate that the presence of TmHKT1; 5-A significantly reduces leaf [Na+] and increases durum wheat grain yield by 25% compared to near-isogenic lines without the Nax2 locus.	[Xu, Bo; Athman, Asmini; Conn, Simon J.; Jordans, Charlotte; Byrt, Caitlin S.; Tyerman, Stephen D.; Tester, Mark; Plett, Darren; Gilliham, Matthew] Univ Adelaide, Sch Agr Food & Wine, Glen Osmond, SA, Australia; [Xu, Bo; Byrt, Caitlin S.; Tester, Mark; Plett, Darren] Univ Adelaide, Waite Res Inst, Australian Ctr Plant Funct Genom, Glen Osmond, SA, Australia; [Munns, Rana; James, Richard A.; Byrt, Caitlin S.] CSIRO Plant Ind, Canberra, ACT, Australia; [Munns, Rana] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia; [Xu, Bo; Athman, Asmini; Tyerman, Stephen D.; Gilliham, Matthew] Univ Adelaide, Waite Res Inst, Australian Res Council, Ctr Excellence Plant Energy Biol, Glen Osmond, SA, Australia; [Byrt, Caitlin S.] Univ Adelaide, Waite Res Inst, Australian Res Council, Ctr Excellence Plant Cell Walls, Glen Osmond, SA, Australia; [Hare, Ray A.] NSW Dept Primary Ind, Tamworth, NSW, Australia	University of Adelaide; University of Adelaide; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia; University of Adelaide; University of Adelaide; NSW Department of Primary Industries	Gilliham, M (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Glen Osmond, SA, Australia.	matthew.gilliham@adelaide.edu.au	Xu, Bo/AAB-6603-2019; Xu, Bo/GWQ-7260-2022; Conn, Simon/G-1191-2012; Byrt, Caitlin/I-9785-2018; Gilliham, Matthew/Y-4403-2019; Tester, Mark/J-2368-2017; Munns, Rana E/B-4237-2013; James, Richard A/G-3279-2018; Tyerman, Steve D/F-9056-2010; James, Richard A/J-7667-2015; Gilliham, Matthew/C-1998-2013	Xu, Bo/0000-0002-7583-2384; Byrt, Caitlin/0000-0001-8549-2873; Gilliham, Matthew/0000-0003-0666-3078; Tester, Mark/0000-0002-5085-8801; Munns, Rana E/0000-0002-7519-2698; James, Richard A/0000-0002-4881-2572; Tyerman, Steve D/0000-0003-2455-1643; Gilliham, Matthew/0000-0003-0666-3078; Conn, Simon/0000-0002-1376-4515; Plett, Darren/0000-0002-9551-8755	Grains Research and Development Corporation (GRDC) of Australia; Australian Research Council (ARC)	Grains Research and Development Corporation (GRDC) of Australia(Grains R&D Corp); Australian Research Council (ARC)(Australian Research Council)	The authors thank grain growers A. and J. Crowe for hosting our field trials on their property at Moree. We acknowledge the assistance of C. Blake (CSIRO), B. Collard, D. Gulliford (NSW DPI) and A. Smart (PCT); J. Dubcovsky, University of California, Davis, for kindly providing the BAC sequence used to design cslinkNax2; D. Cooper, T. Rathjen, A. Webster and J. Able for additional field data on Nax2. We thank S. Ramesh for extracting Xenopus oocytes, Adelaide Microscopy for facilities and training, G. Mayo for assistance with in situ PCR, S. Roy for assistance with confocal microscopy and flame photometry and O. Cotsaftis for the clone of OsHKT1;5. This research was supported by the Grains Research and Development Corporation (GRDC) of Australia and the Australian Research Council (ARC).	Byrt CS, 2007, PLANT PHYSIOL, V143, P1918, DOI 10.1104/pp.106.093476; Conn SJ, 2011, NEW PHYTOL, V190, P583, DOI 10.1111/j.1469-8137.2010.03619.x; Davenport R, 2005, PLANT PHYSIOL, V137, P807, DOI 10.1104/pp.104.057307; Davenport RJ, 2007, PLANT CELL ENVIRON, V30, P497, DOI 10.1111/j.1365-3040.2007.01637.x; DICK DAT, 1969, J PHYSIOL-LONDON, V205, P61, DOI 10.1113/jphysiol.1969.sp008951; Dubcovsky J, 1996, THEOR APPL GENET, V92, P448, DOI 10.1007/BF00223692; DVORAK J, 1994, THEOR APPL GENET, V87, P872, DOI 10.1007/BF00221141; Gassmann W, 1996, PLANT J, V10, P869, DOI 10.1046/j.1365-313X.1996.10050869.x; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gilliham M, 2011, PLANT SIGNAL BEHAV, V6, P1656, DOI 10.4161/psb.6.11.17797; Horie T, 2009, TRENDS PLANT SCI, V14, P660, DOI 10.1016/j.tplants.2009.08.009; Huang S, 2008, J EXP BOT, V59, P927, DOI 10.1093/jxb/ern033; Jabnoune M, 2009, PLANT PHYSIOL, V150, P1955, DOI 10.1104/pp.109.138008; James RA, 2006, PLANT PHYSIOL, V142, P1537, DOI 10.1104/pp.106.086538; James RA, 2006, PLANT CELL ENVIRON, V29, P2185, DOI 10.1111/j.1365-3040.2006.01592.x; James RA, 2011, J EXP BOT, V62, P2939, DOI 10.1093/jxb/err003; Koltai H, 2000, PLANT PHYSIOL, V123, P1203, DOI 10.1104/pp.123.4.1203; Lauchli A, 2008, PLANT CELL ENVIRON, V31, P1565, DOI 10.1111/j.1365-3040.2008.01864.x; Maser P, 2002, FEBS LETT, V531, P157, DOI 10.1016/S0014-5793(02)03488-9; Molendijk AJ, 2008, PLANT J, V53, P909, DOI 10.1111/j.1365-313X.2007.03384.x; Moller IS, 2009, PLANT CELL, V21, P2163, DOI 10.1105/tpc.108.064568; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; Munns R, 2003, PLANT SOIL, V253, P201, DOI 10.1023/A:1024553303144; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Plett D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012571; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Rengasamy P, 2010, FUNCT PLANT BIOL, V37, P613, DOI 10.1071/FP09249; RICHARDS RA, 1983, EUPHYTICA, V32, P431, DOI 10.1007/BF00021452; RODRIGUEZNAVARRO A, 1984, J BACTERIOL, V159, P940; Roy SJ, 2008, PLANT CELL ENVIRON, V31, P861, DOI 10.1111/j.1365-3040.2008.01801.x; SCHACHTMAN DP, 1991, CROP SCI, V31, P992, DOI 10.2135/cropsci1991.0011183X003100040030x; SCHACHTMAN DP, 1994, NATURE, V370, P655, DOI 10.1038/370655a0; Sunarpi, 2005, PLANT J, V44, P928, DOI 10.1111/j.1365-313X.2005.02595.x; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Uozumi N, 2000, PLANT PHYSIOL, V122, P1249, DOI 10.1104/pp.122.4.1249; Yao X, 2010, PLANT PHYSIOL, V152, P341, DOI 10.1104/pp.109.145722; YEO AR, 1986, AUST J PLANT PHYSIOL, V13, P161, DOI 10.1071/PP9860161	38	475	515	15	335	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2012	30	4					360	U173		10.1038/nbt.2120	http://dx.doi.org/10.1038/nbt.2120			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	925TR	22407351				2022-12-25	WOS:000302785000025
J	Zhang, FZ; Carothers, JM; Keasling, JD				Zhang, Fuzhong; Carothers, James M.; Keasling, Jay D.			Design of a dynamic sensor-regulator system for production of chemicals and fuels derived from fatty acids	NATURE BIOTECHNOLOGY			English	Article							ESCHERICHIA-COLI; ACYL-COENZYME; TRANSCRIPTIONAL REGULATION; FADR; PROTEINS; BINDING; METABOLISM; EXPRESSION; PATHWAYS; PROMOTER	Microbial production of chemicals is now an attractive alternative to chemical synthesis. Current efforts focus mainly on constructing pathways to produce different types of molecules(1-3). However, there are few strategies for engineering regulatory components to improve product titers and conversion yields of heterologous pathways(4). Here we developed a dynamic sensor-regulator system (DSRS) to produce fatty acid-based products in Escherichia coli, and demonstrated its use for biodiesel production. The DSRS uses a transcription factor that senses a key intermediate and dynamically regulates the expression of genes involved in biodiesel production. This DSRS substantially improved the stability of biodiesel-producing strains and increased the titer to 1.5 g/l and the yield threefold to 28% of the theoretical maximum. Given the large number of natural sensors available, this DSRS strategy can be extended to many other biosynthetic pathways to balance metabolism, thereby increasing product titers and conversion yields and stabilizing production hosts.	[Zhang, Fuzhong; Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA USA; [Zhang, Fuzhong; Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Zhang, Fuzhong; Keasling, Jay D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Carothers, James M.; Keasling, Jay D.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Synthet Biol Engn Res Ctr, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Keasling, JD (corresponding author), Joint BioEnergy Inst, Emeryville, CA USA.	keasling@berkeley.edu	Keasling, Jay D/J-9162-2012	Keasling, Jay D/0000-0003-4170-6088; Zhang, Fuzhong/0000-0001-6979-7909; Carothers, James/0000-0001-6728-7833	Synthetic Biology Engineering Research Center; National Science Foundation [0540879]; US Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; Natural Sciences and Engineering Research Council of Canada	Synthetic Biology Engineering Research Center; National Science Foundation(National Science Foundation (NSF)); US Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The authors would like to thank W. Holtz, E. Steen and N. Hillson for discussion and critical reading of the manuscript. This work was supported in part by the Synthetic Biology Engineering Research Center, which is funded by National Science Foundation award no. 0540879, and by the Joint BioEnergy Institute, which is funded by the US Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231. F.Z. is supported by the Postdoctoral Fellowships Program of the Natural Sciences and Engineering Research Council of Canada.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Carothers JM, 2011, SCIENCE, V334, P1716, DOI 10.1126/science.1212209; Corchero JL, 1998, BIOTECHNOL BIOENG, V58, P625, DOI 10.1002/(SICI)1097-0290(19980620)58:6<625::AID-BIT8>3.3.CO;2-1; Cronan JE, 1997, J BACTERIOL, V179, P1819, DOI 10.1128/jb.179.5.1819-1823.1997; De Mey M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-34; DIRUSSO CC, 1992, J BIOL CHEM, V267, P8685; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Farmer WR, 2000, NAT BIOTECHNOL, V18, P533, DOI 10.1038/75398; Friehs K, 2004, ADV BIOCHEM ENG BIOT, V86, P47; Fujita Y, 2007, MOL MICROBIOL, V66, P829, DOI 10.1111/j.1365-2958.2007.05947.x; Hajimorad M, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-3; Harcum SW, 1999, APPL BIOCHEM BIOTECH, V80, P23, DOI 10.1385/ABAB:80:1:23; HENRY MF, 1992, CELL, V70, P671, DOI 10.1016/0092-8674(92)90435-F; Holtz WJ, 2010, CELL, V140, P19, DOI 10.1016/j.cell.2009.12.029; Iram SH, 2005, J BIOL CHEM, V280, P32148, DOI 10.1074/jbc.M504054200; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; LANZER M, 1988, P NATL ACAD SCI USA, V85, P8973, DOI 10.1073/pnas.85.23.8973; Lee TS, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-12; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Ramsey Stephen, 2005, Journal of Bioinformatics and Computational Biology, V3, P415, DOI 10.1142/S0219720005001132; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; SPENCER AK, 1978, J BIOL CHEM, V253, P5922; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; van Aalten DMF, 2001, EMBO J, V20, P2041, DOI 10.1093/emboj/20.8.2041; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Zhang FZ, 2011, CURR OPIN BIOTECH, V22, P775, DOI 10.1016/j.copbio.2011.04.024; Zhang FZ, 2011, TRENDS MICROBIOL, V19, P323, DOI 10.1016/j.tim.2011.05.003	29	560	603	11	338	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2012	30	4					354	U166		10.1038/nbt.2149	http://dx.doi.org/10.1038/nbt.2149			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	925TR	22446695				2022-12-25	WOS:000302785000024
J	Giddings, LV; Potrykus, I; Ammann, K; Fedoroff, NV				Giddings, L. Val; Potrykus, Ingo; Ammann, Klaus; Fedoroff, Nina V.			Confronting the Gordian knot	NATURE BIOTECHNOLOGY			English	News Item									[Giddings, L. Val] ITIF, Washington, DC USA; [Potrykus, Ingo] Golden Rice Board & Network, Zurich, Switzerland; [Potrykus, Ingo] Swiss Inst Plant Sci, Zurich, Switzerland; [Ammann, Klaus] Univ Bern, Neuchatel, Switzerland; [Fedoroff, Nina V.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Fedoroff, Nina V.] King Abdullah Univ Sci & Technol, Thuwal, Saudi Arabia	University of Bern; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; King Abdullah University of Science & Technology	Giddings, LV (corresponding author), ITIF, Washington, DC USA.							Arber W, 2010, NEW BIOTECHNOL, V27, P517, DOI 10.1016/j.nbt.2010.05.007; Brookes G, 2011, GM CROPS GLOBAL SOCI; Carson Rachel, 1994, SILENT SPRING; Diamond J, 1998, GUNS GERMS STEEL; James C., 2011, ISAAA BRIEF, V43; Lusser M, 2012, NAT BIOTECHNOL, V30, P231, DOI 10.1038/nbt.2142; Paarlberg R., 2008, STARVED SCI BIOTECHN; Potrykus I, 2010, NEW BIOTECHNOL, V27, P447, DOI [10.1016/j.nbt.2010.07.004, 10.1016/j.nbt.2010.09.013]; Potrykus I, 2010, NATURE, V466, P561, DOI 10.1038/466561a; Ricroch AE, 2011, PLANT PHYSIOL, V155, P1752, DOI 10.1104/pp.111.173609; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0	11	15	16	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2012	30	3					208	209		10.1038/nbt.2145	http://dx.doi.org/10.1038/nbt.2145			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	905VI	22398608				2022-12-25	WOS:000301303800007
J	Russell, AJ; Hartman, JJ; Hinken, AC; Muci, AR; Kawas, R; Driscoll, L; Godinez, G; Lee, KH; Marquez, D; Browne, WF; Chen, MM; Clarke, D; Collibee, SE; Garard, M; Hansen, R; Jia, ZH; Lu, PP; Rodriguez, H; Saikali, KG; Schaletzky, J; Vijayakumar, V; Albertus, DL; Claflin, DR; Morgans, DJ; Morgan, BP; Malik, FI				Russell, Alan J.; Hartman, James J.; Hinken, Aaron C.; Muci, Alexander R.; Kawas, Raja; Driscoll, Lena; Godinez, Guillermo; Lee, Kenneth H.; Marquez, David; Browne, William F.; Chen, Michael M.; Clarke, David; Collibee, Scott E.; Garard, Marc; Hansen, Richard; Jia, Zhiheng; Lu, Pu-Ping; Rodriguez, Hector; Saikali, Khalil G.; Schaletzky, Julia; Vijayakumar, Vipin; Albertus, Daniel L.; Claflin, Dennis R.; Morgans, David J.; Morgan, Bradley P.; Malik, Fady I.			Activation of fast skeletal muscle troponin as a potential therapeutic approach for treating neuromuscular diseases	NATURE MEDICINE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MYASTHENIA-GRAVIS; MOTOR-UNIT; MYOSIN; FIBERS; PURIFICATION; CONTRACTION; TROPOMYOSIN; MYOFIBRILS; FATIGUE	Limited neural input results in muscle weakness in neuromuscular disease because of a reduction in the density of muscle innervation, the rate of neuromuscular junction activation or the efficiency of synaptic transmission(1). We developed a small-molecule fast-skeletal-troponin activator, CK-2017357, as a means to increase muscle strength by amplifying the response of muscle when neural input is otherwise diminished secondary to neuromuscular disease. Binding selectively to the fast-skeletal-troponin complex, CK-2017357 slows the rate of calcium release from troponin C and sensitizes muscle to calcium. As a consequence, the force-calcium relationship of muscle fibers shifts leftwards, as does the force-frequency relationship of a nerve-muscle pair, so that CK-2017357 increases the production of muscle force in situ at sub-maximal nerve stimulation rates. Notably, we show that sensitization of the fast-skeletal-troponin complex to calcium improves muscle force and grip strength immediately after administration of single doses of CK-2017357 in a model of the neuromuscular disease myasthenia gravis. Troponin activation may provide a new therapeutic approach to improve physical activity in diseases where neuromuscular function is compromised.	[Russell, Alan J.; Hartman, James J.; Hinken, Aaron C.; Muci, Alexander R.; Kawas, Raja; Driscoll, Lena; Godinez, Guillermo; Lee, Kenneth H.; Marquez, David; Browne, William F.; Clarke, David; Collibee, Scott E.; Garard, Marc; Hansen, Richard; Jia, Zhiheng; Lu, Pu-Ping; Rodriguez, Hector; Schaletzky, Julia; Vijayakumar, Vipin; Morgans, David J.; Morgan, Bradley P.; Malik, Fady I.] Preclin Res & Dev, San Francisco, CA USA; [Chen, Michael M.; Saikali, Khalil G.] Cytokinet Inc, Biometr, San Francisco, CA USA; [Albertus, Daniel L.; Claflin, Dennis R.] Univ Michigan, Dept Surg, Sect Plast Surg, Ann Arbor, MI 48109 USA; [Albertus, Daniel L.; Claflin, Dennis R.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Malik, FI (corresponding author), Preclin Res & Dev, San Francisco, CA USA.	fmalik@cytokinetics.com		Claflin, Dennis/0000-0001-8044-0142; Russell, Alan/0000-0001-7545-5008	Cytokinetics, Inc.; National Institute of Neurological Disorders and Stroke [1RC3NS070670-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC3NS070670] Funding Source: NIH RePORTER	Cytokinetics, Inc.; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The project described was supported by Cytokinetics, Inc. and by award number 1RC3NS070670-01 (F. I. M.) from the National Institute of Neurological Disorders and Stroke. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the US National Institutes of Health.	Bloemink MJ, 2007, J MOL BIOL, V373, P1184, DOI 10.1016/j.jmb.2007.08.050; BROOKS SV, 1990, AM J PHYSIOL, V258, pC436, DOI 10.1152/ajpcell.1990.258.3.C436; Claflin DR, 2011, J APPL PHYSIOL, V111, P1021, DOI 10.1152/japplphysiol.01119.2010; Conti-Fine BM, 2006, J CLIN INVEST, V116, P2843, DOI 10.1172/JCI29894; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; DRACHMAN DB, 1994, NEW ENGL J MED, V330, P1797, DOI 10.1056/NEJM199406233302507; EBASHI S, 1967, J BIOCHEM-TOKYO, V62, P137, DOI 10.1093/oxfordjournals.jbchem.a128628; Erim Z, 1999, J NEUROPHYSIOL, V82, P2081, DOI 10.1152/jn.1999.82.5.2081; FREUND HJ, 1983, PHYSIOL REV, V63, P387, DOI 10.1152/physrev.1983.63.2.387; HERRMANN C, 1993, BIOCHEMISTRY-US, V32, P7255, DOI 10.1021/bi00079a023; JASMIN BJ, 1987, J APPL PHYSIOL, V63, P713, DOI 10.1152/jappl.1987.63.2.713; Jimenez-Moreno R, 2008, BIOPHYS J, V94, P3178, DOI 10.1529/biophysj.107.118786; Kent-Braun JA, 2000, MUSCLE NERVE, V23, P909, DOI 10.1002/(SICI)1097-4598(200006)23:6<909::AID-MUS10>3.0.CO;2-V; LINDSTROM JM, 1976, J EXP MED, V144, P739, DOI 10.1084/jem.144.3.739; Ling SM, 2009, ARCH PHYS MED REHAB, V90, P1237, DOI 10.1016/j.apmr.2008.09.565; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Patzko A, 2011, CURR NEUROL NEUROSCI, V11, P78, DOI 10.1007/s11910-010-0158-7; Pollard T. D., 2008, CELL BIOL; Poole KJV, 2006, J STRUCT BIOL, V155, P273, DOI 10.1016/j.jsb.2006.02.020; POTTER JD, 1982, METHOD ENZYMOL, V85, P241; Research Group in Neuromuscular Diseases, 1968, LANCET, V291, P1020; ROSENFELD SS, 1985, J BIOL CHEM, V260, P252; ROSENFELD SS, 1985, J BIOL CHEM, V260, P242; Sharma KR, 1996, MUSCLE NERVE, V19, P1391, DOI 10.1002/(SICI)1097-4598(199611)19:11<1391::AID-MUS3>3.3.CO;2-A; SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234; SOLARO RJ, 1971, BIOCHIM BIOPHYS ACTA, V245, P259, DOI 10.1016/0005-2728(71)90033-8; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; TALMADGE RJ, 1993, J APPL PHYSIOL, V75, P2337, DOI 10.1152/jappl.1993.75.5.2337; YOUNG OA, 1981, BIOCHEM J, V195, P317, DOI 10.1042/bj1950317	32	95	100	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2012	18	3					452	U216		10.1038/nm.2618	http://dx.doi.org/10.1038/nm.2618			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22344294	Green Accepted			2022-12-25	WOS:000301264800049
J	Bonn, S; Zinzen, RP; Girardot, C; Gustafson, EH; Perez-Gonzalez, A; Delhomme, N; Ghavi-Helm, Y; Wilczynski, B; Riddell, A; Furlong, EEM				Bonn, Stefan; Zinzen, Robert P.; Girardot, Charles; Gustafson, E. Hilary; Perez-Gonzalez, Alexis; Delhomme, Nicolas; Ghavi-Helm, Yad; Wilczynski, Bartek; Riddell, Andrew; Furlong, Eileen E. M.			Tissue-specific analysis of chromatin state identifies temporal signatures of enhancer activity during embryonic development	NATURE GENETICS			English	Article							GENE-EXPRESSION; DROSOPHILA-MELANOGASTER; HUMAN GENOME; TRANSCRIPTIONAL NETWORK; HISTONE MODIFICATIONS; MUSCLE DEVELOPMENT; CELL-TYPES; PROMOTERS; MAP; METHYLATIONS	Chromatin modifications are associated with many aspects of gene expression, yet their role in cellular transitions during development remains elusive. Here, we use a new approach to obtain cell type specific information on chromatin state and RNA polymerase II (Pol II) occupancy within the multicellular Drosophila melanogaster embryo. We directly assessed the relationship between chromatin modifications and the spatio-temporal activity of enhancers. Rather than having a unique chromatin state, active developmental enhancers show heterogeneous histone modifications and Pol II occupancy. Despite this complexity, combined chromatin signatures and Pol II presence are sufficient to predict enhancer activity de novo. Pol II recruitment is highly predictive of the timing of enhancer activity and seems dependent on the timing and location of transcription factor binding. Chromatin modifications typically demarcate large regulatory regions encompassing multiple enhancers, whereas local changes in nucleosome positioning and Pol II occupancy delineate single active enhancers. This cell type specific view identifies dynamic enhancer usage, an essential step in deciphering developmental networks.	[Bonn, Stefan; Zinzen, Robert P.; Girardot, Charles; Gustafson, E. Hilary; Perez-Gonzalez, Alexis; Delhomme, Nicolas; Ghavi-Helm, Yad; Wilczynski, Bartek; Riddell, Andrew; Furlong, Eileen E. M.] EMBL, Genome Biol Unit, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Furlong, EEM (corresponding author), EMBL, Genome Biol Unit, Heidelberg, Germany.	eileen.furlong@embl.de	Zinzen, Robert P/A-3130-2015; Gonzalez, Alexis/O-9802-2016; Wilczynski, Bartek/A-5710-2009; Girardot, Charles/AAF-2417-2020; Zinzen, Robert/AAG-2784-2020; Delhomme, Nicolas/B-9187-2015	Zinzen, Robert P/0000-0002-8638-5102; Gonzalez, Alexis/0000-0002-8674-2034; Wilczynski, Bartek/0000-0002-8134-0589; Girardot, Charles/0000-0003-4301-3920; Delhomme, Nicolas/0000-0002-3053-0796; Ghavi-Helm, Yad/0000-0003-2397-9576; Bonn, Stefan/0000-0003-4366-5662; Gustafson, Eleanor Hilary/0000-0003-3978-8088; Furlong, Eileen/0000-0002-9544-8339	ERASysBio (Mod Heart); Human Frontiers Science Program Organization; International Human Frontiers Science Program Organization; EMBL	ERASysBio (Mod Heart); Human Frontiers Science Program Organization(Human Frontier Science Program); International Human Frontiers Science Program Organization(Human Frontier Science Program); EMBL	This work was technically supported by the EMBL Genomics Core facility for Solexa sequencing and by the IT service unit. We thank S. Muller for performing Drosophila injections and all members of the Furlong laboratory for discussions and comments on the manuscript. We thank J. Lis (Cornell University) for the Rpb3 (Pol II) antibody. This work was supported by grants to E.E.M.F. from ERASysBio (Mod Heart) and the Human Frontiers Science Program Organization and by a long-term fellowship to R.P.Z. from the International Human Frontiers Science Program Organization. S.B. was funded by the EMBL Interdisciplinary Postdoc (EIPOD) programme.	Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]; Akkers RC, 2009, DEV CELL, V17, P425, DOI 10.1016/j.devcel.2009.08.005; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Cheung I, 2010, P NATL ACAD SCI USA, V107, P8824, DOI 10.1073/pnas.1001702107; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Cunha PMF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001014; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Deal RB, 2010, DEV CELL, V18, P1030, DOI 10.1016/j.devcel.2010.05.013; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hoffman BG, 2010, GENOME RES, V20, P1037, DOI 10.1101/gr.104356.109; Jakobsen JS, 2007, GENE DEV, V21, P2448, DOI 10.1101/gad.437607; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Koch F, 2011, NAT STRUCT MOL BIOL, V18, P956, DOI 10.1038/nsmb.2085; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Liu YH, 2009, DEV CELL, V16, P280, DOI 10.1016/j.devcel.2009.01.006; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Riddle NC, 2011, GENOME RES, V21, P147, DOI 10.1101/gr.110098.110; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Sandmann T, 2006, NAT PROTOC, V1, P2839, DOI 10.1038/nprot.2006.383; Sandmann T, 2007, GENE DEV, V21, P436, DOI 10.1101/gad.1509007; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shankaranarayanan P, 2011, NAT METHODS, V8, P565, DOI [10.1038/NMETH.1626, 10.1038/nmeth.1626]; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Tomancak P, 2002, GENOME BIOL, V3, P88, DOI 10.1186/gb-2002-3-12-research0088; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wardle FC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r71; Wilczynski B, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.35; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	48	340	348	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2012	44	2					148	156		10.1038/ng.1064	http://dx.doi.org/10.1038/ng.1064			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	22231485				2022-12-25	WOS:000299664400011
J	Cheung, C; Bernardo, AS; Trotter, MWB; Pedersen, RA; Sinha, S				Cheung, Christine; Bernardo, Andreia S.; Trotter, Matthew W. B.; Pedersen, Roger A.; Sinha, Sanjay			Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility	NATURE BIOTECHNOLOGY			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTOR-B; CARDIAC NEURAL CREST; AORTIC-ANEURYSMS; MOLECULAR REGULATION; DIFFERENTIATION; MUTATIONS; MESODERM; FATE; ATHEROSCLEROSIS	Heterogeneity of embryological origins is a hallmark of vascular smooth muscle cells (SMCs) and may influence the development of vascular disease. Differentiation of human pluripotent stem cells (hPSCs) into developmental origin specific SMC subtypes remains elusive. Here we describe a chemically defined protocol in which hPSCs were initially induced to form neuroectoderm, lateral plate mesoderm or paraxial mesoderm. These intermediate populations were further differentiated toward SMCs (>80% MYH11(+) and ACTA2(+)), which displayed contractile ability in response to vasoconstrictors and invested perivascular regions in vivo. Derived SMC subtypes recapitulated the unique proliferative and secretory responses to cytokines previously documented in studies using aortic SMCs of distinct origins. Notably, this system predicted increased extracellular matrix degradation by SMCs derived from lateral plate mesoderm, which was confirmed using rat aortic SMCs from corresponding origins. This differentiation approach will have broad applications in modeling origin-dependent disease susceptibility and in developing bioengineered vascular grafts for regenerative medicine.	[Cheung, Christine; Bernardo, Andreia S.; Trotter, Matthew W. B.; Pedersen, Roger A.; Sinha, Sanjay] Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge, England; [Cheung, Christine; Sinha, Sanjay] Univ Cambridge, Addenbrookes Hosp, Div Cardiovasc Med, Cambridge CB2 2QQ, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Sinha, S (corresponding author), Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge, England.	ss661@cam.ac.uk	Sinha, Sanjay/AAF-1692-2021; Cheung, Christine/J-9721-2017	Sinha, Sanjay/0000-0001-5900-1209; Cheung, Christine/0000-0001-7127-9107; Trotter, Matthew/0000-0003-3702-915X; Bernardo, Andreia Sofia/0000-0002-5355-6657	Wellcome Trust; Cambridge National Institute for Health Research Comprehensive Biomedical Research Centre; Agency for Science, Technology and Research (Singapore); Medical Research Council centre; Leukemia and Lymphoma Society; MRC [G0800784, G0600275] Funding Source: UKRI; British Heart Foundation [FS/10/022/28262] Funding Source: researchfish; Medical Research Council [G0600275, G0800784B, G0800784] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Cambridge National Institute for Health Research Comprehensive Biomedical Research Centre; Agency for Science, Technology and Research (Singapore)(Agency for Science Technology & Research (A*STAR)); Medical Research Council centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank L. Vallier and S.T. Rashid for supplying us the wild-type human iPSCs; K. Jensen for the human fetal gut RNA; N. Figg and M. Ackers-Johnson for help rendered in Matrigel sectioning and the harvesting of rat aortic SMCs, respectively. We also thank T. Faial and D. Ortmann for validation of the mesoderm protocols. This work was supported by a Wellcome Trust Intermediate Clinical Fellowship for S.S. and the Cambridge National Institute for Health Research Comprehensive Biomedical Research Centre. C. Cheung was sponsored by a National Science Scholarship (PhD) from the Agency for Science, Technology and Research (Singapore). R.A.P. and M.W.B.T. were supported by a Medical Research Council centre grant and A.S.B. was supported by a Leukemia and Lymphoma Society grant.	Ailawadi G, 2009, J THORAC CARDIOV SUR, V138, P1392, DOI 10.1016/j.jtcvs.2009.07.075; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Cheung C, 2011, J MOL CELL CARDIOL, V51, P651, DOI 10.1016/j.yjmcc.2011.07.014; DEBAKEY ME, 1985, ANN SURG, V201, P115; Dosch R, 1997, DEVELOPMENT, V124, P2325; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Gadson PF, 1997, EXP CELL RES, V230, P169, DOI 10.1006/excr.1996.3398; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Gittenberger-De Groot AC, 2005, PEDIATR RES, V57, P169, DOI 10.1203/01.PDR.0000148710.69159.61; Goldman DC, 2009, BLOOD, V114, P4393, DOI 10.1182/blood-2009-02-206433; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; HAIMOVICI H, 1964, ARCH SURG-CHICAGO, V89, P961; Huang X, 2004, DEV BIOL, V275, P1, DOI 10.1016/j.ydbio.2004.07.033; Isoda K, 2003, CIRCULATION, V108, P516, DOI 10.1161/01.CIR.0000085567.18648.21; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kalimo H, 2002, BRAIN PATHOL, V12, P371; Kramer J, 2001, J VASC RES, V38, P120, DOI 10.1159/000051039; Leroux-Berger M, 2011, J BONE MINER RES, V26, P1543, DOI 10.1002/jbmr.382; Li J, 2005, P NATL ACAD SCI USA, V102, P8916, DOI 10.1073/pnas.0503741102; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lindsay ME, 2011, NATURE, V473, P308, DOI 10.1038/nature10145; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; Milewicz DM, 2005, CIRCULATION, V111, pE150, DOI 10.1161/01.CIR.0000155243.70456.F4; Oh JY, 2005, P NATL ACAD SCI USA, V102, P15122, DOI 10.1073/pnas.0507346102; Owens AP, 2010, CIRC RES, V106, P611, DOI 10.1161/CIRCRESAHA.109.212837; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Peeters MPFMV, 1999, ANAT EMBRYOL, V199, P367, DOI 10.1007/s004290050235; Pouget C, 2008, DEV BIOL, V315, P437, DOI 10.1016/j.ydbio.2007.12.045; Ruddy JM, 2008, J THORAC CARDIOV SUR, V136, P1123, DOI 10.1016/j.jtcvs.2008.06.027; Schneider MD, 2003, CYTOKINE GROWTH F R, V14, P1, DOI 10.1016/S1359-6101(02)00053-9; Topouzis S, 1996, DEV BIOL, V178, P430, DOI 10.1006/dbio.1996.0229; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744; Waldo KL, 2005, DEV BIOL, V281, P78, DOI 10.1016/j.ydbio.2005.02.012; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wasteson P, 2008, DEVELOPMENT, V135, P1823, DOI 10.1242/dev.020958; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	45	242	251	2	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2012	30	2					165	173		10.1038/nbt.2107	http://dx.doi.org/10.1038/nbt.2107			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	892EI	22252507	Green Accepted, Green Submitted			2022-12-25	WOS:000300269100019
J	Duckert, H; Pries, V; Khedkar, V; Menninger, S; Bruss, H; Bird, AW; Maliga, Z; Brockmeyer, A; Janning, P; Hyman, A; Grimme, S; Schurmann, M; Preut, H; Hubel, K; Ziegler, S; Kumar, K; Waldmann, H				Dueckert, Heiko; Pries, Verena; Khedkar, Vivek; Menninger, Sascha; Bruss, Hanna; Bird, Alexander W.; Maliga, Zoltan; Brockmeyer, Andreas; Janning, Petra; Hyman, Anthony; Grimme, Stefan; Schuermann, Markus; Preut, Hans; Huebel, Katja; Ziegler, Slava; Kumar, Kamal; Waldmann, Herbert			Natural product-inspired cascade synthesis yields modulators of centrosome integrity	NATURE CHEMICAL BIOLOGY			English	Article							BIOLOGY-ORIENTED SYNTHESIS; NUCLEOPHOSMIN; INHIBITOR; DRUGS; EFFICIENT; COMPLEX; CANCER	In biology-oriented synthesis, the scaffolds of biologically relevant compound classes inspire the synthesis of focused compound collections enriched in bioactivity. This criterion is, in particular, met by the scaffolds of natural products selected in evolution. The synthesis of natural product-inspired compound collections calls for efficient reaction sequences that preferably combine multiple individual transformations in one operation. Here we report the development of a one-pot, twelve-step cascade reaction sequence that includes nine different reactions and two opposing kinds of organocatalysis. The cascade sequence proceeds within 10-30 min and transforms readily available substrates into complex indoloquinolizines that resemble the core tetracyclic scaffold of numerous polycyclic indole alkaloids. Biological investigation of a corresponding focused compound collection revealed modulators of centrosome integrity, termed centrocountins, which caused fragmented and supernumerary centrosomes, chromosome congression defects, multipolar mitotic spindles, acentrosomal spindle poles and multipolar cell division by targeting the centrosome-associated proteins nucleophosmin and Crm1.	[Dueckert, Heiko; Pries, Verena; Khedkar, Vivek; Menninger, Sascha; Bruss, Hanna; Brockmeyer, Andreas; Janning, Petra; Huebel, Katja; Ziegler, Slava; Kumar, Kamal; Waldmann, Herbert] Max Planck Inst Mol Physiol, Abt Chem Biol, D-44139 Dortmund, Germany; [Dueckert, Heiko; Pries, Verena; Menninger, Sascha; Bruss, Hanna; Schuermann, Markus; Preut, Hans; Kumar, Kamal; Waldmann, Herbert] Tech Univ Dortmund, Fak Chem, Dortmund, Germany; [Bird, Alexander W.; Maliga, Zoltan; Hyman, Anthony] Max Planck Inst Mol Zellbiol & Genet, Dresden, Germany; [Grimme, Stefan] Univ Munster, Inst Chem, Munster, Germany	Max Planck Society; Dortmund University of Technology; Max Planck Society; University of Munster	Kumar, K (corresponding author), Max Planck Inst Mol Physiol, Abt Chem Biol, Rheinlanddamm 201, D-44139 Dortmund, Germany.	kamal.kumar@mpi-dortmund.mpg.de; herbert.waldmann@mpi-dortmund.mpg.de	Waldmann, Herbert/B-7406-2017; Kumar, Kamal/M-7623-2018; Hyman, Tony/F-1923-2011	Waldmann, Herbert/0000-0002-9606-7247; Kumar, Kamal/0000-0003-3593-8421; Ziegler, Slava/0000-0003-4398-7741; Bird, Alexander/0000-0002-1061-0799	European Research Council under the European Union [268309]; Max Planck Gesellschaft	European Research Council under the European Union(European Research Council (ERC)); Max Planck Gesellschaft(Max Planck Society)	We would like to thank T. U. Mayer (Universitat Konstanz) for helpful discussions, S. Muller and T. Klussendorf (Max-Planck-Institut Dortmund) for assistance with the fluorescence lifetime imaging microscopy measurements, C. Nowak for technical assistance, S.J. Martin (Smurfit Institute of Genetics, Trinity College Dublin) for the pET19b-NPM plasmid, A. Wittinghofer (Max-Planck-Institut Dortmund) for the pET3a-Crm1 vector and the Dortmund Protein Facility for cloning NPM-citrine. This work was supported by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no. 268309 to H. W.) and by the Max Planck Gesellschaft.	Amin MA, 2008, FEBS LETT, V582, P3839, DOI 10.1016/j.febslet.2008.10.023; Antonchick AP, 2010, NAT CHEM, V2, P735, DOI 10.1038/nchem.730; Bon RS, 2010, ACCOUNTS CHEM RES, V43, P1103, DOI 10.1021/ar100014h; Carlson EE, 2010, ACS CHEM BIOL, V5, P639, DOI 10.1021/cb100105c; Duflos Alain, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P55, DOI 10.2174/1568011023354452; Elders N, 2009, ANGEW CHEM INT EDIT, V48, P5856, DOI 10.1002/anie.200902683; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hung DT, 1996, CHEM BIOL, V3, P623, DOI 10.1016/S1074-5521(96)90129-5; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Ishikura M, 2010, NAT PROD REP, V27, P1630, DOI 10.1039/c005345g; Islam K, 2010, ANGEW CHEM INT EDIT, V49, P8484, DOI 10.1002/anie.201004026; Khedkar V, 2010, SYNLETT, P1576; Khedkar V, 2010, SYNLETT, P403, DOI 10.1055/s-0029-1219176; Kumar K, 2009, ANGEW CHEM INT EDIT, V48, P3224, DOI 10.1002/anie.200803437; LAVILLA R, 1992, TETRAHEDRON, V48, P6445, DOI 10.1016/S0040-4020(01)88234-X; Lim MJ, 2006, CANCER DETECT PREV, V30, P481, DOI 10.1016/j.cdp.2006.10.008; Liu QY, 2009, BIOCHEM BIOPH RES CO, V384, P383, DOI 10.1016/j.bbrc.2009.04.154; Liu W, 2011, ANGEW CHEM INT EDIT, V50, P6900, DOI 10.1002/anie.201102440; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Nicolaou KC, 2009, CHEM SOC REV, V38, P2993, DOI 10.1039/b903290h; Noren-Muller A, 2006, P NATL ACAD SCI USA, V103, P10606, DOI 10.1073/pnas.0601490103; Orosz F, 2006, MINI-REV MED CHEM, V6, P1145, DOI 10.2174/138955706778560094; Peterson JR, 2002, CHEM BIOL, V9, P1275, DOI 10.1016/S1074-5521(02)00284-3; Plafker K, 2000, MOL CELL BIOL, V20, P3510, DOI 10.1128/MCB.20.10.3510-3521.2000; ROBERTS BJ, 1986, CANCER CHEMOTH PHARM, V16, P95; Tietze LF, 1996, CHEM REV, V96, P115, DOI 10.1021/cr950027e; Waldmann H, 2008, ANGEW CHEM INT EDIT, V47, P6869, DOI 10.1002/anie.200802413; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; WENKERT E, 1976, J AM CHEM SOC, V98, P3645, DOI 10.1021/ja00428a044; Wetzel S, 2011, ANGEW CHEM INT EDIT, V50, P10800, DOI 10.1002/anie.201007004; Wulff JE, 2007, J AM CHEM SOC, V129, P14444, DOI 10.1021/ja075327f; Yashiroda Y, 2003, CURR MED CHEM, V10, P741, DOI 10.2174/0929867033457791	33	97	97	0	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2012	8	2					179	184		10.1038/nchembio.758	http://dx.doi.org/10.1038/nchembio.758			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879IP	22198731				2022-12-25	WOS:000299323200010
J	Samaco, RC; Mandel-Brehm, C; McGraw, CM; Shaw, CA; McGill, BE; Zoghbi, HY				Samaco, Rodney C.; Mandel-Brehm, Caleigh; McGraw, Christopher M.; Shaw, Chad A.; McGill, Bryan E.; Zoghbi, Huda Y.			Crh and Oprm1 mediate anxiety-related behavior and social approach in a mouse model of MECP2 duplication syndrome	NATURE GENETICS			English	Article							CORTICOTROPIN-RELEASING-FACTOR; OPIOID RECEPTOR GENE; RETT-SYNDROME; MENTAL-RETARDATION; NEUROLOGICAL SYMPTOMS; TRANSGENIC MICE; COPY-NUMBER; MUTATION; STRESS; REGION	Genomic duplications spanning Xq28 are associated with a spectrum of phenotypes, including anxiety and autism. The minimal region shared among affected individuals includes MECP2 and IRAK1, although it is unclear which gene when overexpressed causes anxiety and social behavior deficits. We report that doubling MECP2 levels causes heightened anxiety and autism-like features in mice and alters the expression of genes that influence anxiety and social behavior, such as Crh and Oprm1. To test the hypothesis that alterations in these two genes contribute to heightened anxiety and social behavior deficits, we analyzed MECP2 duplication mice (MECP2-TG1) that have reduced Crh and Oprm1 expression. In MECP2-TG1 animals, reducing the levels of Crh or its receptor, Crhr1, suppressed anxiety-like behavior; in contrast, reducing Oprm1 expression improved abnormal social behavior. These data indicate that increased MeCP2 levels affect molecular pathways underlying anxiety and social behavior and provide new insight into potential therapies for MECP2-related disorders.	[Samaco, Rodney C.; Mandel-Brehm, Caleigh; Shaw, Chad A.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Samaco, Rodney C.; McGraw, Christopher M.; Zoghbi, Huda Y.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [McGraw, Christopher M.; Zoghbi, Huda Y.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [McGill, Bryan E.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Neurol Sect, Dept Pediat, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	hzoghbi@bcm.edu		Shaw, Chad/0000-0001-7267-5398; Samaco, Rodney/0000-0001-5636-5314; Zoghbi, Huda/0000-0002-0700-3349; mandel-brehm, caleigh/0000-0001-7764-6529	US National Institutes of Health [NS043124, NS073317, NS057819, HD24064]; Autism Speaks; Carl C. Anderson, Sr. and Marie Jo Anderson Charitable Foundation; Simons Foundation; Rett Syndrome Research Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS073317, R01NS057819, T32NS043124] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Speaks; Carl C. Anderson, Sr. and Marie Jo Anderson Charitable Foundation; Simons Foundation; Rett Syndrome Research Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Ramocki and J. Neul for critical reading of the manuscript, C. Spencer, R. Paylor and P. Moretti for advice on neurobehavioral tasks, the Baylor College of Medicine (BCM) Microarray core and the BCM Intellectual and Developmental Disabilities Research Center (IDDRC) RNA In Situ and Mouse Neurobehavior cores for use of their facilities. This work was funded by grants from the US National Institutes of Health (NS043124 to R.C.S.; NS073317 to C.M.M.; NS057819 to H.Y.Z.; and HD24064 to H.Y.Z. and the BCM IDDRC), the Autism Speaks (Predoctoral Fellowship to R.C.S.), the Carl C. Anderson, Sr. and Marie Jo Anderson Charitable Foundation, the Simons Foundation and the Rett Syndrome Research Trust (to H.Y.Z.). H.Y.Z. is a Howard Hughes Medical Institute investigator.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ben-Shachar S, 2009, HUM MOL GENET, V18, P2431, DOI 10.1093/hmg/ddp181; Carney RM, 2003, PEDIATR NEUROL, V28, P205, DOI 10.1016/S0887-8994(02)00624-0; Carvalho CMB, 2009, HUM MOL GENET, V18, P2188, DOI 10.1093/hmg/ddp151; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Cook MN, 2001, BEHAV NEUROSCI, V115, P468, DOI 10.1037/0735-7044.115.2.468; del Gaudio D, 2006, GENET MED, V8, P784, DOI 10.1097/01.gim.0000250502.28516.3c; Filliol D, 2000, NAT GENET, V25, P195, DOI 10.1038/76061; Friez MJ, 2006, PEDIATRICS, V118, pE1687, DOI 10.1542/peds.2006-0395; Griebel G, 2002, J PHARMACOL EXP THER, V301, P333, DOI 10.1124/jpet.301.1.333; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Habib KE, 2000, P NATL ACAD SCI USA, V97, P6079, DOI 10.1073/pnas.97.11.6079; Hwang CK, 2007, MOL CELL BIOL, V27, P4720, DOI 10.1128/MCB.00073-07; Hwang CK, 2010, MOL PHARMACOL, V78, P58, DOI 10.1124/mol.110.064311; Hwang CK, 2009, J CELL MOL MED, V13, P3591, DOI 10.1111/j.1582-4934.2008.00535.x; Keck ME, 2004, ANN NY ACAD SCI, V1018, P445, DOI 10.1196/annals.1296.055; Klauck SM, 2002, AM J HUM GENET, V70, P1034, DOI 10.1086/339553; Lam C W, 2000, J Med Genet, V37, pE41, DOI 10.1136/jmg.37.12.e41; Landgraf R, 2007, NEUROSCI BIOBEHAV R, V31, P89, DOI 10.1016/j.neubiorev.2006.07.003; Li HD, 2011, NAT NEUROSCI, V14, P1001, DOI 10.1038/nn.2866; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; McGill BE, 2006, P NATL ACAD SCI USA, V103, P18267, DOI 10.1073/pnas.0608702103; Meins M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.023804; Milani D, 2005, PEDIATR NEUROL, V32, P355, DOI 10.1016/j.pediatrneurol.2004.12.012; Moles A, 2004, SCIENCE, V304, P1983, DOI 10.1126/science.1095943; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; MUGLIA L, 1995, NATURE, V373, P427, DOI 10.1038/373427a0; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Pelka GJ, 2006, BRAIN, V129, P887, DOI 10.1093/brain/awl022; Prescott TE, 2009, CLIN DYSMORPHOL, V18, P78, DOI 10.1097/MCD.0b013e32831e19cd; Ramocki MB, 2009, ANN NEUROL, V66, P771, DOI 10.1002/ana.21715; Samaco RC, 2008, HUM MOL GENET, V17, P1718, DOI 10.1093/hmg/ddn062; Samaco RC, 2009, P NATL ACAD SCI USA, V106, P21966, DOI 10.1073/pnas.0912257106; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Silva AJ, 1997, NEURON, V19, P755, DOI 10.1016/S0896-6273(00)80958-7; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; STENZELPOORE MP, 1994, J NEUROSCI, V14, P2579; Tao JF, 2009, P NATL ACAD SCI USA, V106, P4882, DOI 10.1073/pnas.0811648106; Trezza V, 2011, J NEUROSCI, V31, P6362, DOI 10.1523/JNEUROSCI.5492-10.2011; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; van Gaalen MM, 2002, EUR J NEUROSCI, V15, P2007, DOI 10.1046/j.1460-9568.2002.02040.x; Velinov M, 2009, CLIN DYSMORPHOL, V18, P9, DOI 10.1097/MCD.0b013e3283157cad; Watson P, 2001, J MED GENET, V38, P224, DOI 10.1136/jmg.38.4.224; Wolfer DP, 2000, EXP PHYSIOL, V85, P627, DOI 10.1017/S0958067000020959; Yilmazer-Hanke DM, 2008, BEHAV PHARMACOL, V19, P403, DOI 10.1097/FBP.0b013e32830dc0de	49	110	117	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2012	44	2					206	211		10.1038/ng.1066	http://dx.doi.org/10.1038/ng.1066			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	22231481	Green Accepted			2022-12-25	WOS:000299664400021
J	Austgen, K; Johnson, ET; Park, TJ; Curran, T; Oakes, SA				Austgen, Kathryn; Johnson, Emily T.; Park, Tae-Ju; Curran, Tom; Oakes, Scott A.			The adaptor protein CRK is a pro-apoptotic transducer of endoplasmic reticulum stress	NATURE CELL BIOLOGY			English	Article							XENOPUS EGG EXTRACTS; CYTOCHROME-C; MITOCHONDRIAL APOPTOSIS; BH3-ONLY PROTEINS; BCL-2 FAMILY; DEATH; ACTIVATION; CLEAVAGE; PATHWAY; BAK	Excessive demands on the protein-folding capacity of the endoplasmic reticulum (ER) cause irremediable ER stress and contribute to cell loss in a number of cell degenerative diseases, including type 2 diabetes and neurodegeneration(1,2). The signals communicating catastrophic ER damage to the mitochondrial apoptotic machinery remain poorly under stood(3-6). We used a biochemical approach to purify a cytosolic activity induced by ER stress that causes release of cytochrome c from isolated mitochondria. We discovered that the principal component of the purified pro-apoptotic activity is the proto-oncoprotein CRK (CT10-regulated kinase), an adaptor protein with no known catalytic activity(7). Crk(-/-) cells are strongly resistant to ER-stress-induced a poptosis. More over, CRK is cleaved inresponse to ER stress to generate an amino-terminal M(r)similar to 14 K fragment with greatly enhanced cytotoxic potential. We identified aputative BH3 (BCL2 homology 3) domain within this N-terminal CRK fragment, which sensitizes isolated mitochondria to cytochrome c release and when mutated significantly reduces the apoptotic activity of CRK in vivo. Together these results identify CRK as a pro-apoptotic protein that signals irremediable ER stress to the mitochondrial execution machinery	[Austgen, Kathryn; Johnson, Emily T.; Oakes, Scott A.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Park, Tae-Ju; Curran, Tom] Childrens Hosp Philadelphia Res Inst, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Oakes, SA (corresponding author), Univ Calif San Francisco, Dept Pathol, 513 Parnassus Ave,HSW 517,Box 0511, San Francisco, CA 94143 USA.	scott.oakes@ucsf.edu	Curran, Thomas/AAE-7631-2019; Curran, Tom/C-1164-2008; Curran, Tom/D-7515-2011; Curran, Tom/F-5234-2018	Curran, Thomas/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551; Park, Taeju/0000-0003-3897-3994	NIH [K08 AI054650, RO1 CA136577]; HHMI; Steward Trust Foundation; Sandler Program in Basic Sciences; Pennsylvania Department of Health Cure Formulary [4100047628]; NATIONAL CANCER INSTITUTE [R01CA136577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI054650] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Steward Trust Foundation; Sandler Program in Basic Sciences; Pennsylvania Department of Health Cure Formulary; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Ganem, F. Papa and W. Greene for scientific advice and encouragement throughout this project. We thank C. Lin for help in preparing figures for the manuscript. We thank C. Crane for quantitative PCR assistance. We thank D. Winant at the Stanford PAN facility and N. Krogan and G. Cagney, UCSF, for mass spectrometry analysis of purified samples. This work was supported by NIH grants K08 AI054650 and RO1 CA136577 (S.A.O.); an HHMI Physician-Scientist Early Career Award (S.A.O.); the Steward Trust Foundation (S.A.O.); and the Sandler Program in Basic Sciences (S.A.O.). This work was also supported by a Pennsylvania Department of Health Cure Formulary grant (SAP#4100047628 to T.C.).	Chipuk JE, 2009, CELL CYCLE, V8, P2692, DOI 10.4161/cc.8.17.9412; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Evans EK, 1997, EMBO J, V16, P230, DOI 10.1093/emboj/16.2.230; Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; Glimcher LH, 2010, ANN RHEUM DIS, V69, P67, DOI 10.1136/ard.2009.119388; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Kar B, 2007, BIOCHEMISTRY-US, V46, P10828, DOI 10.1021/bi700537e; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; MATSUDA M, 1992, MOL CELL BIOL, V12, P3482, DOI 10.1128/MCB.12.8.3482; MAYER BJ, 1988, COLD SPRING HARB SYM, V53, P907, DOI 10.1101/SQB.1988.053.01.104; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; Miller CT, 2003, ONCOGENE, V22, P7950, DOI 10.1038/sj.onc.1206529; Oakes SA, 2006, CURR MOL MED, V6, P99, DOI 10.2174/156652406775574587; Park TJ, 2006, MOL CELL BIOL, V26, P6272, DOI 10.1128/MCB.00472-06; Parrizas M, 1997, BIOCHEM BIOPH RES CO, V234, P616, DOI 10.1006/bbrc.1997.6641; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; Smith JJ, 2002, MOL CELL BIOL, V22, P1412, DOI 10.1128/MCB.22.5.1412-1423.2002; Smith JJ, 2000, J CELL BIOL, V151, P1391, DOI 10.1083/jcb.151.7.1391; Sriram Ganapathy, 2010, Genes Cancer, V1, P1132, DOI 10.1177/1947601910397188; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tosello-Trampont AC, 2007, CELL DEATH DIFFER, V14, P963, DOI 10.1038/sj.cdd.4402094; Tosello-Trampont AC, 2001, J BIOL CHEM, V276, P13797, DOI 10.1074/jbc.M011238200; Upton JP, 2008, MOL CELL BIOL, V28, P3943, DOI 10.1128/MCB.00013-08; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060	40	25	25	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2012	14	1					87	U206		10.1038/ncb2395	http://dx.doi.org/10.1038/ncb2395			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	866YC	22179045	Green Accepted, Green Submitted			2022-12-25	WOS:000298421100014
J	Tiwari, VK; Stadler, MB; Wirbelauer, C; Paro, R; Schubeler, D; Beisel, C				Tiwari, Vijay K.; Stadler, Michael B.; Wirbelauer, Christiane; Paro, Renato; Schuebeler, Dirk; Beisel, Christian			A chromatin-modifying function of JNK during stem cell differentiation	NATURE GENETICS			English	Article							SIGNAL-TRANSDUCTION PATHWAY; ACTIVATED PROTEIN-KINASE; N-TERMINAL KINASE; HISTONE H3; TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; MAP KINASES; PHOSPHORYLATION; LINEAGE; DNA	Signaling mediates cellular responses to extracellular stimuli. The c-Jun NH2-terminal kinase (JNK) pathway exemplifies one subgroup of the mitogen-activated protein (MAP) kinases, which, besides having established functions in stress response, also contribute to development by an unknown mechanism(1-4). We show by genome-wide location analysis that JNK binds to a large set of active promoters during the differentiation of stem cells into neurons. JNK-bound promoters are enriched with binding motifs for the transcription factor NF-Y but not for AP-1. NF-Y occupies these predicted sites, and overexpression of dominant-negative NF-YA reduces the JNK presence on chromatin. We find that histone H3 Ser10 (H3S10) is a substrate for JNK, and JNK-bound promoters are enriched for H3S10 phosphorylation. Inhibition of JNK signaling in post-mitotic neurons reduces phosphorylation at H3S10 and the expression of target genes. These results establish MAP kinase binding and function on chromatin at a novel class of target genes during stem cell differentiation.	[Tiwari, Vijay K.; Stadler, Michael B.; Wirbelauer, Christiane; Schuebeler, Dirk] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Stadler, Michael B.] Swiss Inst Bioinformat, Basel, Switzerland; [Paro, Renato; Beisel, Christian] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [Paro, Renato; Schuebeler, Dirk] Univ Basel, Fac Sci, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Swiss Institute of Bioinformatics; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel	Schubeler, D (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	michael.stadler@fmi.ch; dirk@fmi.ch		Tiwari, Vijay/0000-0003-0292-6635; Beisel, Christian/0000-0001-5360-2193	Marie Curie International Incoming fellowship; EMBO; Deutsche Forschungsgemeinschaft (DFG); European Union Epigenome Network of Excellence (EU-NoE) Epigenesys; Novartis; ETH Zurich; Novartis Research Foundation; European Union ((EU-NoE) Epigenesys, Blueprint)); European Research Council [ERC-204264]; SystemsX.ch (Cell Plasticity)	Marie Curie International Incoming fellowship(European Commission); EMBO(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union Epigenome Network of Excellence (EU-NoE) Epigenesys; Novartis(Novartis); ETH Zurich(ETH Zurich); Novartis Research Foundation; European Union ((EU-NoE) Epigenesys, Blueprint)); European Research Council(European Research Council (ERC)European Commission); SystemsX.ch (Cell Plasticity)	We thank L. Hoerner, M. Seimiya and I. Nissen for technical assistance, N. Tiwari for help with reagents and critical suggestions, G. Christofori, M. Bentires-Alj and members of the Schubeler laboratory for comments to the manuscript, R. Davis (University of Massachusetts Medical School, Worcester, Massachusetts, USA) for providing wild-type NIH3T3 cells and those lacking JNK1 and JNK2, and R. Mantovani (University of Milan, Milan, Italy) for the wild-type and dominant-negative NF-Y constructs. We thank the facilities at the Friedrich Miescher Institute, especially T. Roloff. Illumina sequencing was carried out at the Quantitative Genomics Facility of the Department of Biosystems Science and Engineering (D-BSSE), ETH Zurich. V. K. T. is supported by a Marie Curie International Incoming fellowship and an EMBO long-term postdoctoral fellowship. Research in the laboratory of R. P. is supported by the Deutsche Forschungsgemeinschaft (DFG), the European Union Epigenome Network of Excellence (EU-NoE) Epigenesys, Novartis and the ETH Zurich. Research in the laboratory of D. S. is supported by the Novartis Research Foundation, the European Union ((EU-NoE) Epigenesys, Blueprint)), the European Research Council (ERC-204264) and SystemsX.ch (Cell Plasticity).	Alabert C, 2006, ONCOGENE, V25, P3387, DOI 10.1038/sj.onc.1209385; Amura CR, 2005, MOL CELL BIOL, V25, P10791, DOI 10.1128/MCB.25.24.10791-10802.2005; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Aplin AE, 2002, J CELL SCI, V115, P2781; Baek SH, 2011, MOL CELL, V42, P274, DOI 10.1016/j.molcel.2011.03.022; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Binetruy B, 2007, STEM CELLS, V25, P1090, DOI 10.1634/stemcells.2006-0612; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Bungard D, 2010, SCIENCE, V329, P1201, DOI 10.1126/science.1191241; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Cerutti H, 2009, EPIGENETICS-US, V4, P71, DOI 10.4161/epi.4.2.7781; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Dolfini D, 2009, CELL CYCLE, V8, P4127, DOI 10.4161/cc.8.24.10240; Dyson MH, 2005, J CELL SCI, V118, P2247, DOI 10.1242/jcs.02373; Edmunds JW, 2004, J CELL SCI, V117, P3715, DOI 10.1242/jcs.01346; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Gehani SS, 2010, MOL CELL, V39, P886, DOI 10.1016/j.molcel.2010.08.020; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; Karin M, 2005, IUBMB LIFE, V57, P283, DOI 10.1080/15216540500097111; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lawrence MC, 2008, CELL RES, V18, P436, DOI 10.1038/cr.2008.37; Lecona E, 2008, MOL CELL BIOL, V28, P4665, DOI 10.1128/MCB.00650-07; MANTOVANI R, 1994, J BIOL CHEM, V269, P20340; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Oliva AA, 2006, J NEUROSCI, V26, P9462, DOI 10.1523/JNEUROSCI.2625-06.2006; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Perez-Cadahia B, 2009, BIOCHEM CELL BIOL, V87, P695, DOI 10.1139/O09-053; Plachta N, 2004, DEVELOPMENT, V131, P5449, DOI 10.1242/dev.01420; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Wood JL, 2001, J BIOL CHEM, V276, P21262, DOI 10.1074/jbc.M007520200; Xu P, 2003, J BIOL CHEM, V278, P48422, DOI 10.1074/jbc.M307888200; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yoshioka Y, 2008, GENES CELLS, V13, P117, DOI 10.1111/j.1365-2443.2007.01155.x; Zhang WG, 2006, DEVELOPMENT, V133, P229, DOI 10.1242/dev.02199; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	54	92	94	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2012	44	1					94	U134		10.1038/ng.1036	http://dx.doi.org/10.1038/ng.1036			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	22179133				2022-12-25	WOS:000298664000021
J	Geiger, H; Pawar, SA; Kerschen, EJ; Nattamai, KJ; Hernandez, I; Liang, HPH; Fernandez, JA; Cancelas, JA; Ryan, MA; Kustikova, O; Schambach, A; Fu, Q; Wang, JR; Fink, LM; Petersen, KU; Zhou, DH; Griffin, JH; Baum, C; Weiler, H; Hauer-Jensen, M				Geiger, Hartmut; Pawar, Snehalata A.; Kerschen, Edward J.; Nattamai, Kalpana J.; Hernandez, Irene; Liang, Hai Po H.; Fernandez, Jose A.; Cancelas, Jose A.; Ryan, Marnie A.; Kustikova, Olga; Schambach, Axel; Fu, Qiang; Wang, Junru; Fink, Louis M.; Petersen, Karl-Uwe; Zhou, Daohong; Griffin, John H.; Baum, Christopher; Weiler, Hartmut; Hauer-Jensen, Martin			Pharmacological targeting of the thrombomodulin-activated protein C pathway mitigates radiation toxicity	NATURE MEDICINE			English	Article							HEMATOPOIETIC STEM-CELLS; SOLUBLE HUMAN THROMBOMODULIN; VASCULAR ENDOTHELIUM; EXTRACELLULAR HISTONES; IONIZING-RADIATION; THROMBIN RECEPTOR; DENDRITIC CELLS; RAT MODEL; MICE; APOPTOSIS	Tissue damage induced by ionizing radiation in the hematopoietic and gastrointestinal systems is the major cause of lethality in radiological emergency scenarios and underlies some deleterious side effects in patients undergoing radiation therapy(1,2). The identification of target-specific interventions that confer radiomitigating activity is an unmet challenge. Here we identify the thrombomodulin (Thbd)-activated protein C (aPC) pathway as a new mechanism for the mitigation of total body irradiation (TBI)-induced mortality. Although the effects of the endogenous Thbd-aPC pathway were largely confined to the local microenvironment of Thbd-expressing cells, systemic administration of soluble Thbd or aPC could reproduce and augment the radioprotective effect of the endogenous Thbd-aPC pathway. Therapeutic administration of recombinant, soluble Thbd or aPC to lethally irradiated wild-type mice resulted in an accelerated recovery of hematopoietic progenitor activity in bone marrow and a mitigation of lethal TBI. Starting infusion of aPC as late as 24 h after exposure to radiation was sufficient to mitigate radiation-induced mortality in these mice. These findings suggest that pharmacologic augmentation of the activity of the Thbd-aPC pathway by recombinant Thbd or aPC might offer a rational approach to the mitigation of tissue injury and lethality caused by ionizing radiation.	[Geiger, Hartmut; Nattamai, Kalpana J.; Cancelas, Jose A.; Ryan, Marnie A.] Univ Cincinnati, Div Expt Hematol & Canc Biol, Canc & Blood Dis Inst, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45221 USA; [Geiger, Hartmut] Univ Ulm, Dept Dermatol & Allerg Dis, Ulm, Germany; [Pawar, Snehalata A.; Fu, Qiang; Wang, Junru; Zhou, Daohong; Hauer-Jensen, Martin] Univ Arkansas Med Sci, Coll Pharm, Div Radiat Hlth, Little Rock, AR 72205 USA; [Kerschen, Edward J.; Hernandez, Irene; Liang, Hai Po H.; Weiler, Hartmut] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Kerschen, Edward J.; Hernandez, Irene; Liang, Hai Po H.; Weiler, Hartmut] Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI USA; [Fernandez, Jose A.; Griffin, John H.] Scripps Res Inst, La Jolla, CA USA; [Kustikova, Olga; Schambach, Axel; Baum, Christopher] Hannover Med Sch, Dept Expt Hematol, D-3000 Hannover, Germany; [Fink, Louis M.] Desert Res Inst, Las Vegas, NV USA; [Petersen, Karl-Uwe] PAION Deutschland GmbH, Aachen, Germany; [Hauer-Jensen, Martin] Cent Arkansas Vet Healthcare Syst, Surg Serv, Little Rock, AR USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Ulm University; University of Arkansas System; University of Arkansas Medical Sciences; Medical College of Wisconsin; Versiti Blood Center of Wisconsin; Scripps Research Institute; Hannover Medical School; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Geiger, H (corresponding author), Univ Cincinnati, Div Expt Hematol & Canc Biol, Canc & Blood Dis Inst, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45221 USA.	hartmut.geiger@cchmc.org	Schambach, Axel/C-5491-2011; Cancelas, Jose/AAR-9324-2020; Fernandez, Jose A/A-3211-2008; Pawar, Snehalata/ABD-4557-2020	Fernandez, Jose A/0000-0002-0804-1865; Pawar, Snehalata/0000-0003-3992-2494; Griffin, John/0000-0002-4302-2547	US National Institutes of Health [CA71382, AI67798, AI080557, HL31950, HL052246, HL44612, CA122023, AI080421]; Edward P. Evans Foundation; Ziegler Family Chair for Research; Veterans Administration; Comprehensive Mouse and Cancer Core at Cincinnati Children's Hospital Medical Center (CCHMC); NATIONAL CANCER INSTITUTE [R01CA122023, R37CA071382, R01CA071382] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044612, R01HL052246, P01HL031950, R37HL052246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798, R21AI080557, R33AI080557, R01AI080421] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward P. Evans Foundation; Ziegler Family Chair for Research; Veterans Administration(US Department of Veterans Affairs); Comprehensive Mouse and Cancer Core at Cincinnati Children's Hospital Medical Center (CCHMC); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the US National Institutes of Health (grants CA71382 and AI67798 to M.H.-J., AI080557 to H.W., J.A.F. and H.G., HL31950 and HL052246 to J.H.G., HL44612 to H.W. and CA122023 and AI080421 to D.Z.), the Edward P. Evans Foundation (M.H.-J., D.Z. and H.G.), the Ziegler Family Chair for Research (H.W.) and the Veterans Administration. We thank J. Bailey and V. Summey from the Comprehensive Mouse and Cancer Core at Cincinnati Children's Hospital Medical Center (CCHMC) for their support and services. We are grateful to M. Monestier (Temple University School of Medicine, Philadelphia, Pennsylvania, USA) for the BWA3 antibody, S.J. Kennel (University of Tennessee Graduate School of Medicine, Knoxville, Tennessee, USA) for the antibodies to Thbd (273-34A and 411-201B) and D. Gailani and A. Gruber (Vanderbilt University, Nashville, Tennessee, USA) for providing the 14E11 antibody.	BADDELEY AJ, 1986, J MICROSC-OXFORD, V142, P259, DOI 10.1111/j.1365-2818.1986.tb04282.x; Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; CONWAY EM, 1992, BLOOD, V80, P1254; Darrow AL, 1996, THROMB HAEMOSTASIS, V76, P860; ESMON CT, 1982, J BIOL CHEM, V257, P7944; ESMON NL, 1982, J BIOL CHEM, V257, P859; Foley JH, 2012, BLOOD, V119, P3622, DOI 10.1182/blood-2011-11-392308; GLASER CB, 1992, J CLIN INVEST, V90, P2565, DOI 10.1172/JCI116151; Gupta PK, 2011, ANAL METHODS-UK, V3, P1759, DOI 10.1039/c1ay05213f; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; Ismail JA, 2003, CARDIOVASC PATHOL, V12, P82, DOI 10.1016/S1054-8807(02)00166-7; Iwaki T, 2005, BLOOD, V105, P2364, DOI 10.1182/blood-2004-06-2456; Iwasaki H, 2010, BLOOD, V116, P544, DOI 10.1182/blood-2009-08-240903; Johnson SM, 2010, J CLIN INVEST, V120, P2528, DOI 10.1172/JCI41402; Kanzawa T, 2006, ONCOGENE, V25, P3638, DOI 10.1038/sj.onc.1209414; KENNEL SJ, 1988, LAB INVEST, V59, P692; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kerschen E, 2010, J CLIN INVEST, V120, P3167, DOI 10.1172/JCI42629; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Kirsch DG, 2010, SCIENCE, V327, P593, DOI 10.1126/science.1166202; Kodell RL, 2010, BIOMETRICS, V66, P239, DOI 10.1111/j.1541-0420.2009.01236.x; Kustikova OS, 2007, BLOOD, V109, P1897, DOI 10.1182/blood-2006-08-044156; Kustikova OS, 2009, MOL THER, V17, P1537, DOI 10.1038/mt.2009.134; Langberg CW, 1996, RADIOTHER ONCOL, V41, P249, DOI 10.1016/S0167-8140(96)01809-9; Luo DY, 2012, INFECT IMMUN, V80, P91, DOI 10.1128/IAI.05568-11; MAUCH P, 1995, INT J RADIAT ONCOL, V31, P1319, DOI 10.1016/0360-3016(94)00430-S; Modlich U, 2006, BLOOD, V108, P2545, DOI 10.1182/blood-2005-08-024976; Mosnier LO, 2007, J BIOL CHEM, V282, P33022, DOI 10.1074/jbc.M705824200; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Mosnier LO, 2009, BLOOD, V113, P5970, DOI 10.1182/blood-2008-10-183327; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Ross CC, 2008, RADIAT RES, V169, P408, DOI 10.1667/RR1148.1; Rotolo JA, 2010, CANCER RES, V70, P957, DOI 10.1158/0008-5472.CAN-09-1562; Schuller BW, 2006, P NATL ACAD SCI USA, V103, P3787, DOI 10.1073/pnas.0600133103; SOLIS MM, 1994, THROMB RES, V73, P385, DOI 10.1016/0049-3848(94)90040-X; Su EJ, 2011, J THROMB HAEMOST, V9, P1174, DOI 10.1111/j.1538-7836.2011.04269.x; Tanaka KA, 2006, BRIT J HAEMATOL, V132, P197, DOI 10.1111/j.1365-2141.2005.05855.x; van Iersel T, 2011, THROMB HAEMOSTASIS, V105, P302, DOI 10.1160/TH10-05-0287; Wang W, 2000, J BIOL CHEM, V275, P22942, DOI 10.1074/jbc.M001760200; Weiler H, 2003, J THROMB HAEMOST, V1, P1515, DOI 10.1046/j.1538-7836.2003.00306.x; Weiler H, 2001, ARTERIOSCL THROM VAS, V21, P1531, DOI 10.1161/hq0901.094496; Weiler H, 2004, THROMB HAEMOSTASIS, V92, P467, DOI 10.1160/TH04-05-0307; Weiler H, 2010, CRIT CARE MED, V38, pS18, DOI 10.1097/CCM.0b013e3181c9cbb5; Weiler-Guettler H, 1998, J CLIN INVEST, V101, P1983, DOI 10.1172/JCI2006; WeilerGuettler H, 1996, CIRC RES, V78, P180, DOI 10.1161/01.RES.78.2.180; Weisel JW, 1996, J BIOL CHEM, V271, P31485, DOI 10.1074/jbc.271.49.31485; Xu J, 2011, J IMMUNOL, V187, P2626, DOI 10.4049/jimmunol.1003930; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Yerkovich ST, 2009, J ALLERGY CLIN IMMUN, V123, P209, DOI 10.1016/j.jaci.2008.09.009; Yu H, 2010, BLOOD, V115, P3472, DOI 10.1182/blood-2009-10-248278	53	81	84	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2012	18	7					1123	+		10.1038/nm.2813	http://dx.doi.org/10.1038/nm.2813			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22729286	Green Accepted			2022-12-25	WOS:000306121600043
J	Miyazaki, Y; Adachi, H; Katsuno, M; Minamiyama, M; Jiang, YM; Huang, Z; Doi, H; Matsumoto, S; Kondo, N; Iida, M; Tohnai, G; Tanaka, F; Muramatsu, S; Sobue, G				Miyazaki, Yu; Adachi, Hiroaki; Katsuno, Masahisa; Minamiyama, Makoto; Jiang, Yue-Mei; Huang, Zhe; Doi, Hideki; Matsumoto, Shinjiro; Kondo, Naohide; Iida, Madoka; Tohnai, Genki; Tanaka, Fumiaki; Muramatsu, Shin-ichi; Sobue, Gen			Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2	NATURE MEDICINE			English	Article							BULBAR MUSCULAR-ATROPHY; TRANSGENIC MOUSE MODEL; MOTOR-NEURON DEGENERATION; ANDROGEN RECEPTOR PROTEIN; NEURODEGENERATION; MICRORNAS; MICE; OVEREXPRESSION; PROGRESSION; SEQUENCE	Spinal and bulbar muscular atrophy (SBMA) is an inherited neurodegenerative disorder caused by the expansion of the polyglutamine (polyQ) tract of the androgen receptor (AR-polyQ)(1,2). Characteristics of SBMA include proximal muscular atrophy, weakness, contraction fasciculation and bulbar involvement(3). MicroRNAs (miRNAs) are a diverse class of highly conserved small RNA molecules that function as crucial regulators of gene expression in animals and plants(4). Recent functional studies have shown the potent activity of specific miRNAs as disease modifiers both in vitro and in vivo(5-8). Thus, potential therapeutic approaches that target the miRNA processing pathway have recently attracted attention(9,10). Here we describe a novel therapeutic approach using the adeno-associated virus (AAV) vector-mediated delivery of a specific miRNA for SBMA. We found that miR-196a enhanced the decay of the AR mRNA by silencing CUGBP, Elav-like family member 2 (CELF2). CELF2 directly acted on AR mRNA and enhanced the stability of AR mRNA. Furthermore, we found that the early intervention of miR-196a delivered by an AAV vector ameliorated the SBMA phenotypes in a mouse model. Our results establish the proof of principle that disease-specific miRNA delivery could be useful in neurodegenerative diseases.	[Miyazaki, Yu; Adachi, Hiroaki; Katsuno, Masahisa; Minamiyama, Makoto; Jiang, Yue-Mei; Huang, Zhe; Doi, Hideki; Matsumoto, Shinjiro; Kondo, Naohide; Iida, Madoka; Tohnai, Genki; Tanaka, Fumiaki; Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4648601, Japan; [Muramatsu, Shin-ichi] Jichi Med Univ, Dept Med, Div Neurol, Shimotsuke, Tochigi, Japan	Nagoya University; Jichi Medical University	Sobue, G (corresponding author), Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4648601, Japan.	sobueg@med.nagoya-u.ac.jp	Adachi, Hiroaki/I-2669-2012; iida, madoka/AAB-7707-2020; Adachi, Hiroaki/AAM-7812-2020; Muramatsu, Shin-ichi/K-9420-2013; KATSUNO, MASAHISA/I-7502-2014; Muramatsu, Shinichi/ABC-6093-2021	Adachi, Hiroaki/0000-0002-9302-4663; Adachi, Hiroaki/0000-0002-9302-4663; Muramatsu, Shin-ichi/0000-0002-3185-7790; KATSUNO, MASAHISA/0000-0001-9453-9311; Muramatsu, Shinichi/0000-0002-3185-7790	Ministry of Health, Labor and Welfare; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Center-of-Excellence (COE) grant; Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research [23390231] Funding Source: KAKEN	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Center-of-Excellence (COE) grant; Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to T. Cooper (Department of Pathology and Immunology, Baylor College of Medicine) for kindly providing the plasmid expressing human CELF2. We also thank N. Takino, H. Miyauchi and K. Ayabe (Division of Neurology, Department of Medicine, Jichi Medical University) for their help with the production of the AAV vectors and Y. Kondo and K. Shinjo (Division of Molecular Oncology, Aichi Cancer Center Research Institute) for expert technical support and helpful discussions. This work was supported by grants from the Ministry of Health, Labor and Welfare; grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; a Center-of-Excellence (COE) grant; a Grant-in-Aid for Scientific Research on Innovated Areas "Foundations of Synapse and Neurocircuit Pathology"; and the Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST).	Adachi H, 2003, J NEUROSCI, V23, P2203; Bilen J, 2006, MOL CELL, V24, P157, DOI 10.1016/j.molcel.2006.07.030; Boudreau RL, 2011, HUM MOL GENET, V20, pR21, DOI 10.1093/hmg/ddr137; Dhaenens CM, 2011, BBA-MOL BASIS DIS, V1812, P732, DOI 10.1016/j.bbadis.2011.03.010; Dominguez E, 2011, HUM MOL GENET, V20, P681, DOI 10.1093/hmg/ddq514; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; Fu HY, 2011, MOL THER, V19, P1025, DOI 10.1038/mt.2011.34; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Hui ABY, 2009, LAB INVEST, V89, P597, DOI 10.1038/labinvest.2009.12; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Katsuno M, 2010, J NEUROSCI, V30, P5702, DOI 10.1523/JNEUROSCI.0388-10.2010; Kennedy WR, 1998, NEUROLOGY, V50, P583, DOI 10.1212/WNL.50.3.583; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kobayashi Y, 2000, J BIOL CHEM, V275, P8772, DOI 10.1074/jbc.275.12.8772; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lee Y, 2008, NAT NEUROSCI, V11, P1137, DOI 10.1038/nn.2183; Li XG, 2006, MOL THER, V13, P160, DOI 10.1016/j.ymthe.2005.08.009; Maru DM, 2009, AM J PATHOL, V174, P1940, DOI 10.2353/ajpath.2009.080718; Natarajan G, 2008, AM J PHYSIOL-GASTR L, V294, pG1235, DOI 10.1152/ajpgi.00037.2008; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Petrs-Silva H, 2011, MOL THER, V19, P293, DOI 10.1038/mt.2010.234; Roshan R, 2009, DRUG DISCOV TODAY, V14, P1123, DOI 10.1016/j.drudis.2009.09.009; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; SOBUE G, 1989, BRAIN, V112, P209, DOI 10.1093/brain/112.1.209; Subramaniam D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016958; Tokui K, 2009, HUM MOL GENET, V18, P898, DOI 10.1093/hmg/ddn419; Towne C, 2010, GENE THER, V17, P141, DOI 10.1038/gt.2009.119; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	35	115	120	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2012	18	7					1136	+		10.1038/nm.2791	http://dx.doi.org/10.1038/nm.2791			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22660636				2022-12-25	WOS:000306121600045
J	Guichard, C; Amaddeo, G; Imbeaud, S; Ladeiro, Y; Pelletier, L; Ben Maad, I; Calderaro, J; Bioulac-Sage, P; Letexier, M; Degos, F; Clement, B; Balabaud, C; Chevet, E; Laurent, A; Couchy, G; Letouze, E; Calvo, F; Zucman-Rossi, J				Guichard, Cecile; Amaddeo, Giuliana; Imbeaud, Sandrine; Ladeiro, Yannick; Pelletier, Laura; Ben Maad, Ichrafe; Calderaro, Julien; Bioulac-Sage, Paulette; Letexier, Melanie; Degos, Francoise; Clement, Bruno; Balabaud, Charles; Chevet, Eric; Laurent, Alexis; Couchy, Gabrielle; Letouze, Eric; Calvo, Fabien; Zucman-Rossi, Jessica			Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma	NATURE GENETICS			English	Article							P53 GENE; ARID1A; CANCER; INACTIVATION; RECOGNITION; PATTERNS	Hepatocellular carcinoma (HCC) is the most common primary liver malignancy. Here, we performed high-resolution copy-number analysis on 125 HCC tumors and whole-exome sequencing on 24 of these tumors. We identified 135 homozygous deletions and 994 somatic mutations of genes with predicted functional consequences. We found new recurrent alterations in four genes (ARID1A, RPS6KA3, NFE2L2 and IRF2) not previously described in HCC. Functional analyses showed tumor suppressor properties for IRF2, whose inactivation, exclusively found in hepatitis B virus (HBV)-related tumors, led to impaired TP53 function. In contrast, inactivation of chromatin remodelers was frequent and predominant in alcohol-related tumors. Moreover, association of mutations in specific genes (RPS6KA3-AXIN1 and NFE2L2-CTNNB1) suggested that Wnt/beta-catenin signaling might cooperate in liver carcinogenesis with both oxidative stress metabolism and Ras/mitogen-activated protein kinase (MAPK) pathways. This study provides insight into the somatic mutational landscape in HCC and identifies interactions between mutations in oncogene and tumor suppressor gene mutations related to specific risk factors.	[Guichard, Cecile; Amaddeo, Giuliana; Imbeaud, Sandrine; Ladeiro, Yannick; Pelletier, Laura; Ben Maad, Ichrafe; Calderaro, Julien; Couchy, Gabrielle; Zucman-Rossi, Jessica] Inst Univ Hematol IUH, Unite Mixte Rech UMR 674, Inst Natl Sante & Rech Med INSERM, Paris, France; [Guichard, Cecile; Amaddeo, Giuliana; Imbeaud, Sandrine; Ladeiro, Yannick; Pelletier, Laura; Ben Maad, Ichrafe; Calderaro, Julien; Couchy, Gabrielle; Zucman-Rossi, Jessica] Univ Paris 05, Fac Med, Paris, France; [Calderaro, Julien] Ctr Hosp Univ CHU Henri Mondor, AP HP, Dept Pathol, Creteil, France; [Bioulac-Sage, Paulette; Balabaud, Charles; Chevet, Eric] Univ Bordeaux 2, INSERM, UMR 1053, F-33076 Bordeaux, France; [Bioulac-Sage, Paulette; Balabaud, Charles] Pellegrin Hosp, CHU Bordeaux, Dept Pathol, Bordeaux, France; [Letexier, Melanie] IntegraGen, Evry, France; [Degos, Francoise] Univ Paris Diderot, Beaujon Hosp, AP HP, Dept Hepatol, Clichy, France; [Clement, Bruno] Univ Rennes 1, INSERM, UMR 991, Rennes, France; [Laurent, Alexis] CHU Henri Mondor, AP HP, F-94010 Creteil, France; [Laurent, Alexis] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France; [Letouze, Eric] Programme Cartes Identite Tumeurs, Paris, France; [Calvo, Fabien] Inst Natl Canc INCa, Boulogne, France; [Zucman-Rossi, Jessica] Hop Europeen Georges Pompidou, AP HP, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National du Cancer (INCA) France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Zucman-Rossi, J (corresponding author), Inst Univ Hematol IUH, Unite Mixte Rech UMR 674, Inst Natl Sante & Rech Med INSERM, Paris, France.	zucman@cephb.fr	zucman-rossi, Jessica/B-5098-2009; Clement, Bruno/E-5546-2016; j, zucman-rossi/AAV-3594-2021; Letouzé, Eric/AAP-9924-2020; chevet, eric/E-4992-2016; Imbeaud, Sandrine/P-8780-2017; Laurent, Alexis/O-3657-2016	zucman-rossi, Jessica/0000-0002-5687-0334; Clement, Bruno/0000-0001-8827-146X; j, zucman-rossi/0000-0002-5687-0334; Letouzé, Eric/0000-0002-6369-2839; chevet, eric/0000-0001-5855-4522; Ladeiro, Yannick/0000-0001-9986-3276; Pelletier, Laura/0000-0002-9668-718X; calvo, fabien/0000-0002-0298-7633; Imbeaud, Sandrine/0000-0001-8439-6732; Laurent, Alexis/0000-0003-1372-0843	INCa; ICGC; Ligue Nationale Contre le Cancer; PAIR-CHC; Association pour la Recherche Contre le Cancer, ARC; Reseau National Centre de Recherches Biocosmetiques (CRB) Foie; HEPTROMIC; BioIntelligence (OSEO); Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS)	INCa(Institut National du Cancer (INCA) France); ICGC; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); PAIR-CHC; Association pour la Recherche Contre le Cancer, ARC(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Reseau National Centre de Recherches Biocosmetiques (CRB) Foie; HEPTROMIC; BioIntelligence (OSEO); Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS)(ANRSFrench National Research Agency (ANR))	We warmly thank T. Burguiere, G. Thomas, R. Fahraeus and C. Mlynarczyk for their helpful participation in this work. We also thank J. Saric, C. Laurent, B. Le Bail, A. Rullier, A. Sa Cunha, J. T. Van Nhieu, D. Cherqui and D. Azoulay for contributing to tissue collection. This work was supported by INCa with the ICGC project, the Ligue Nationale Contre le Cancer (Cartes d'Identite des Tumeurs program), the PAIR-CHC project NoFLIC (funded by INCa and the Association pour la Recherche Contre le Cancer, ARC), the Reseau National Centre de Recherches Biocosmetiques (CRB) Foie, HEPTROMIC (Framework Programme 7, FP7) and BioIntelligence (OSEO). G. A. is supported by a fellowship from the Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Antonov AV, 2010, NUCLEIC ACIDS RES, V38, pW78, DOI 10.1093/nar/gkq482; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bluteau O, 2002, NAT GENET, V32, P312, DOI 10.1038/ng1001; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; BRESSAC B, 1991, NATURE, V350, P429, DOI 10.1038/350429a0; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Denissenko MF, 1998, ONCOGENE, V16, P1241, DOI 10.1038/sj.onc.1201647; Douville E, 1997, ONCOGENE, V15, P373, DOI 10.1038/sj.onc.1201214; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Hainaut P, 2001, CARCINOGENESIS, V22, P367, DOI 10.1093/carcin/22.3.367; Han KJ, 2008, BIOCHEM BIOPH RES CO, V372, P772, DOI 10.1016/j.bbrc.2008.05.103; HSU IC, 1991, NATURE, V350, P427, DOI 10.1038/350427a0; Jones S, 2012, HUM MUTAT, V33, P100, DOI 10.1002/humu.21633; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kim YR, 2010, J PATHOL, V220, P446, DOI 10.1002/path.2653; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nault JC, 2011, SEMIN LIVER DIS, V31, P173, DOI 10.1055/s-0031-1276646; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Pettersson S, 2009, BIOCHEM J, V418, P575, DOI 10.1042/BJ20082087; Popova T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r128; Rebouissou S, 2007, J BIOL CHEM, V282, P14437, DOI 10.1074/jbc.M610725200; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040; Schneider A, 2011, J NEUROCHEM, V119, P447, DOI 10.1111/j.1471-4159.2011.07423.x; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Staaf J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-409; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tao Y, 2011, P NATL ACAD SCI USA, V108, P12042, DOI 10.1073/pnas.1108715108; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068	40	979	1018	5	163	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2012	44	6					694	U120		10.1038/ng.2256	http://dx.doi.org/10.1038/ng.2256			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	949BT	22561517	Green Submitted, Green Accepted			2022-12-25	WOS:000304551100018
J	Jaeger, E; Leedham, S; Lewis, A; Segditsas, S; Becker, M; Cuadrado, PR; Davis, H; Kaur, K; Heinimann, K; Howarth, K; East, J; Taylor, J; Thomas, H; Tomlinson, I				Jaeger, Emma; Leedham, Simon; Lewis, Annabelle; Segditsas, Stefania; Becker, Martin; Cuadrado, Pedro Rodenas; Davis, Hayley; Kaur, Kulvinder; Heinimann, Karl; Howarth, Kimberley; East, James; Taylor, Jenny; Thomas, Huw; Tomlinson, Ian			Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1	NATURE GENETICS			English	Article							PROTEIN-RECEPTOR 1A; COLORECTAL-CANCER; GENE-EXPRESSION; JUVENILE POLYPOSIS; MUTATIONS; ADENOMAS; VARIANTS; COMMON; LOCUS; COLON	Hereditary mixed polyposis syndrome (HMPS) is characterized by apparent autosomal dominant inheritance of multiple types of colorectal polyp, with colorectal carcinoma occurring in a high proportion of affected individuals. Here, we use genetic mapping, copy-number analysis, exclusion of mutations by high-throughput sequencing, gene expression analysis and functional assays to show that HMPS is caused by a duplication spanning the 3' end of the SCG5 gene and a region upstream of the GREM1 locus. This unusual mutation is associated with increased allele-specific GREM1 expression. Whereas GREM1 is expressed in intestinal subepithelial myofibroblasts in controls, GREM1 is predominantly expressed in the epithelium of the large bowel in individuals with HMPS. The HMPS duplication contains predicted enhancer elements; some of these interact with the GREM1 promoter and can drive gene expression in vitro. Increased GREM1 expression is predicted to cause reduced bone morphogenetic protein (BMP) pathway activity, a mechanism that also underlies tumorigenesis in juvenile polyposis of the large bowel.	[Jaeger, Emma; Leedham, Simon; Lewis, Annabelle; Segditsas, Stefania; Becker, Martin; Cuadrado, Pedro Rodenas; Davis, Hayley; Heinimann, Karl; Howarth, Kimberley; Tomlinson, Ian] Univ Oxford, Wellcome Trust Ctr Human Genet, Mol & Populat Genet Lab, Oxford, England; [Leedham, Simon; East, James] John Radcliffe Hosp, Translat Gastroenterol Unit, Oxford OX3 9DU, England; [Kaur, Kulvinder; Taylor, Jenny; Tomlinson, Ian] Univ Oxford, Wellcome Trust Ctr Human Genet, Natl Inst Hlth Res NIHR Comprehens Biomed Res Ctr, Oxford, England; [Heinimann, Karl] Univ Kinderspital Beider Basel, Abt Med Genet, Basel, Switzerland; [Thomas, Huw] St Marks Hosp, Imperial Coll Sch Med, Family Canc Clin, Harrow, Middx, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Basel; Imperial College London	Tomlinson, I (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Mol & Populat Genet Lab, Oxford, England.	iant@well.ox.ac.uk	Becker, Martin/AAK-9307-2020; Becker, Martin/ABA-5555-2020; wei, wei/HHR-8613-2022	Becker, Martin/0000-0001-8442-4246; Becker, Martin/0000-0001-8442-4246; Taylor, Jenny/0000-0003-3602-5704; Lewis, Annabelle/0000-0003-1876-1927	Ashkenazi Bowel Cancer study committee; Cancer Research UK; Wellcome Trust [090532/Z/09/Z]	Ashkenazi Bowel Cancer study committee; Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)	We are grateful to all the study subjects and their relatives from the families with HMPS and to those who have provided their medical care. We are particularly grateful to those who have provided samples from endoscopy or operation. We acknowledge the invaluable roles of all colleagues who have worked on HMPS in the nearly 50 years since it was first described. The following institutions and/or individuals have generously provided samples or resources for this project over the years, and are therefore regarded as part of the broad HMPS Consortium: Maggie Stevens, Carole Cummings and colleagues (St Mark's Hospital Family Cancer Clinic); members of St Mark's Hospital Polyposis Registry; members of St Mark's Hospital Endoscopy Unit; Ian Talbot, Thomas Guenther and colleagues (St Mark's Hospital Histopathology Department); Ghislaine Davies (Wycombe General Hospital Endoscopy Department); Maggie Gorman and colleagues (Molecular and Population Genetics Laboratory, University of Oxford); Peter Zauber (St Barnabas, New Jersey); Carrie Melvin Drovdlic and Charis Eng (Ohio State University); Melissa Southey (University of Melbourne); Paul Rozen (Tel Aviv Medical Center); Rosemary Jeffery, Richard Poulsom and colleagues (Cancer Research UK London Research Institute In Situ Hybridisation Service); and Sally Cottrell, Andrew Rowan, Walter Bodmer and colleagues (ICRF Cancer Genetics Laboratory). We also gratefully acknowledge the support of the Ashkenazi Bowel Cancer study committee. This work was principally funded by Cancer Research UK. We also acknowledge core funding to the Wellcome Trust Centre for Human Genetics from the Wellcome Trust (090532/Z/09/Z).	Cheah PY, 2009, AM J GASTROENTEROL, V104, P3027, DOI 10.1038/ajg.2009.542; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; East JE, 2008, GASTROENTEROL CLIN N, V37, P25, DOI 10.1016/j.gtc.2007.12.014; Hobert JA, 2009, GENET MED, V11, P687, DOI 10.1097/GIM.0b013e3181ac9aea; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Jaeger EEM, 2003, AM J HUM GENET, V72, P1261, DOI 10.1086/375144; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Miele A, 2006, CURR PROTOC MOL BIOL; Papaemmanuil E, 2008, EUR J HUM GENET, V16, P1477, DOI 10.1038/ejhg.2008.129; Poulsom R, 1998, EUR J HISTOCHEM, V42, P121; Segditsas S, 2008, HUM MOL GENET, V17, P3864, DOI 10.1093/hmg/ddn286; Tian Q, 2005, CELL CYCLE, V4, P215; Tomlinson I, 1999, GASTROENTEROLOGY, V116, P789, DOI 10.1016/S0016-5085(99)70061-2; Tomlinson IPM, 2010, BRIT J CANCER, V102, P447, DOI 10.1038/sj.bjc.6605338; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Venkatachalam R, 2011, INT J CANCER, V129, P1635, DOI 10.1002/ijc.25821; Whitelaw SC, 1997, GASTROENTEROLOGY, V112, P327, DOI 10.1053/gast.1997.v112.pm9024286; Zuniga AE, 2004, GENE DEV, V18, P1553, DOI 10.1101/gad.299904	21	153	156	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2012	44	6					699	U127		10.1038/ng.2263	http://dx.doi.org/10.1038/ng.2263			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	949BT	22561515	Green Published, Green Accepted			2022-12-25	WOS:000304551100019
J	Fu, J; Bian, XY; Hu, SB; Wang, HL; Huang, F; Seibert, PM; Plaza, A; Xia, LQ; Muller, R; Stewart, AF; Zhang, YM				Fu, Jun; Bian, Xiaoying; Hu, Shengbaio; Wang, Hailong; Huang, Fan; Seibert, Philipp M.; Plaza, Alberto; Xia, Liqiu; Mueller, Rolf; Stewart, A. Francis; Zhang, Youming			Full-length RecE enhances linear-linear homologous recombination and facilitates direct cloning for bioprospecting	NATURE BIOTECHNOLOGY			English	Article							BACTERIUM PHOTORHABDUS-LUMINESCENS; NONRIBOSOMAL PEPTIDE SYNTHETASES; ESCHERICHIA-COLI; POLYKETIDE SYNTHASES; RECOMBINEERING PIPELINE; ARTIFICIAL CHROMOSOMES; FUNCTIONAL GENOMICS; ANNEALING PROTEINS; CRYSTAL-STRUCTURE; AFFINITY CAPTURE	Functional analysis of genome sequences requires methods for cloning DNA of interest. However, existing methods, such as library cloning and screening, are too demanding or inefficient for high-throughput application to the wealth of genomic data being delivered by massively parallel sequencing. Here we describe direct DNA cloning based on the discovery that the full-length Rac prophage protein RecE and its partner RecT mediate highly efficient linear-linear homologous recombination mechanistically distinct from conventional recombineering mediated by Red alpha beta from lambda phage or truncated versions of RecET. We directly cloned all ten megasynthetase gene clusters (each 10-52 kb in length) from Photorhabdus luminescens into expression vectors and expressed two of them in a heterologous host to identify the metabolites luminmycin A and luminmide A/B. We also directly cloned cDNAs and exactly defined segments from bacterial artificial chromosomes. Direct cloning with full-length RecE expands the DNA engineering toolbox and will facilitate bioprospecting for natural products.	[Fu, Jun; Hu, Shengbaio; Wang, Hailong; Huang, Fan; Seibert, Philipp M.; Stewart, A. Francis] Tech Univ Dresden, BioInnovat Zentrum, D-01062 Dresden, Germany; [Bian, Xiaoying; Plaza, Alberto; Mueller, Rolf] Helmholtz Zentrum Infekt Forsch, Helmholtz Inst Pharmazeut Forsch, Saarbrucken, Germany; [Bian, Xiaoying; Plaza, Alberto; Mueller, Rolf] Univ Saarland, Dept Pharmaceut Biotechnol, Saarbrucken, Germany; [Hu, Shengbaio; Wang, Hailong; Huang, Fan; Xia, Liqiu] Hunan Normal Univ, Coll Life Sci, Key Lab Microbial Mol Biol Hunan Prov, Changsha, Hunan, Peoples R China; [Zhang, Youming] Gene Bridges, Saarbrucken, Germany	Technische Universitat Dresden; Helmholtz Association; Helmholtz-Center for Infection Research; Saarland University; Hunan Normal University	Stewart, AF (corresponding author), Tech Univ Dresden, BioInnovat Zentrum, D-01062 Dresden, Germany.	rom@mx.uni-saarland.de; stewart@biotec.tu-dresden.de; youming.zhang@genebridges.com	Stewart, A. Francis/E-7789-2010; Bian, Xiaoying/G-1405-2013; Bian, Xiaoying/A-7007-2015; Müller, Rolf/B-1559-2008; Fu, Jun/C-9133-2011	Bian, Xiaoying/0000-0002-1356-3211; Müller, Rolf/0000-0002-1042-5665; 	Bundesministerium fur Bildung und Forschung (MiPro); EU; Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung und Forschung; China Scholarship Council	Bundesministerium fur Bildung und Forschung (MiPro)(Federal Ministry of Education & Research (BMBF)); EU(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); China Scholarship Council(China Scholarship Council)	Research work in R&D in Gene Bridges (Y.Z.) was partially funded by the Bundesministerium fur Bildung und Forschung (MiPro). This work was supported by funding to A.F.S. from the EU 6th and 7th Framework projects, EUCOMM and EUCOMMTOOLS. Research in the laboratory of R.M. was funded by the Deutsche Forschungsgemeinschaft and the Bundesministerium fur Bildung und Forschung. X.B. is supported by China Scholarship Council. The authors thank J. Herrmann in the laboratory of R.M. for cytotoxic activity assay.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amrein H, 2004, MOL PLANT MICROBE IN, V17, P90, DOI 10.1094/MPMI.2004.17.1.90; Ansari MZ, 2004, NUCLEIC ACIDS RES, V32, pW405, DOI 10.1093/nar/gkh359; Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Banik JJ, 2010, CURR OPIN MICROBIOL, V13, P603, DOI 10.1016/j.mib.2010.08.012; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bode HB, 2005, ANGEW CHEM INT EDIT, V44, P6828, DOI 10.1002/anie.200501080; Bowen D, 1998, SCIENCE, V280, P2129, DOI 10.1126/science.280.5372.2129; CHU CC, 1989, J BACTERIOL, V171, P2101, DOI 10.1128/jb.171.4.2101-2109.1989; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Court DL, 2002, ANNU REV GENET, V36, P361, DOI 10.1146/annurev.genet.36.061102.093104; Court R, 2007, J MOL BIOL, V371, P25, DOI 10.1016/j.jmb.2007.05.037; Craig JW, 2010, APPL ENVIRON MICROB, V76, P1633, DOI 10.1128/AEM.02169-09; Del Vecchio F, 2003, J IND MICROBIOL BIOT, V30, P489, DOI 10.1007/s10295-003-0062-0; Demidov VV, 2002, P NATL ACAD SCI USA, V99, P5953, DOI 10.1073/pnas.092127999; Donadio S, 2007, NAT PROD REP, V24, P1073, DOI 10.1039/b514050c; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Erler A, 2009, J MOL BIOL, V391, P586, DOI 10.1016/j.jmb.2009.06.030; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Fu J, 2010, METHOD ENZYMOL, V477, P125, DOI 10.1016/S0076-6879(10)77008-7; Fu J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn499; Gaitatzis N, 2001, J BIOCHEM, V129, P119, DOI 10.1093/oxfordjournals.jbchem.a002821; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Homburg S, 2007, FEMS MICROBIOL LETT, V275, P255, DOI 10.1111/j.1574-6968.2007.00889.x; ITO T, 1992, P NATL ACAD SCI USA, V89, P495, DOI 10.1073/pnas.89.2.495; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-8; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Kouprina N, 2008, NAT PROTOC, V3, P371, DOI 10.1038/nprot.2008.5; Kovall R, 1997, SCIENCE, V277, P1824, DOI 10.1126/science.277.5333.1824; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Lagesen K, 2010, MICROBIOL-SGM, V156, P603, DOI 10.1099/mic.0.038257-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maresca M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-54; Mosberg JA, 2010, GENETICS, V186, P791, DOI 10.1534/genetics.110.120782; Murphy KC, 2007, J MOL BIOL, V371, P19, DOI 10.1016/j.jmb.2007.05.085; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Muyrers JPP, 2000, GENE DEV, V14, P1971; OKA M, 1988, J ANTIBIOT, V41, P1338, DOI 10.7164/antibiotics.41.1338; Poteete AR, 2008, MOL MICROBIOL, V68, P66, DOI 10.1111/j.1365-2958.2008.06133.x; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Sarov M, 2006, NAT METHODS, V3, P839, DOI 10.1038/nmeth933; Schellenberg B, 2007, ENVIRON MICROBIOL, V9, P1640, DOI 10.1111/j.1462-2920.2007.01278.x; Simon C, 2011, APPL ENVIRON MICROB, V77, P1153, DOI 10.1128/AEM.02345-10; Swingle B, 2010, MOL MICROBIOL, V75, P138, DOI 10.1111/j.1365-2958.2009.06976.x; Testa G, 2003, NAT BIOTECHNOL, V21, P443, DOI 10.1038/nbt804; Wang JP, 2006, MOL BIOTECHNOL, V32, P43, DOI 10.1385/MB:32:1:043; Waterfield NR, 2008, P NATL ACAD SCI USA, V105, P15967, DOI 10.1073/pnas.0711114105; Wenzel SC, 2005, CHEM BIOL, V12, P349, DOI 10.1016/j.chembiol.2004.12.012; YAMAMOTO T, 1992, GENETICS, V131, P811; Yonemura I, 2007, GENE, V391, P171, DOI 10.1016/j.gene.2006.12.029; Zhang JJ, 2009, STRUCTURE, V17, P690, DOI 10.1016/j.str.2009.03.008; Zhang Y, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-42; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449; Zhumabayeva B, 1999, BIOTECHNIQUES, V27, P834, DOI 10.2144/99274rr06	56	282	326	6	183	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2012	30	5					440	+		10.1038/nbt.2183	http://dx.doi.org/10.1038/nbt.2183			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	939IP	22544021				2022-12-25	WOS:000303803200024
J	Di Niro, R; Mesin, L; Zheng, NY; Stamnaes, J; Morrissey, M; Lee, JH; Huang, M; Iversen, R; du Pre, MF; Qiao, SW; Lundin, KEA; Wilson, PC; Sollid, LM				Di Niro, Roberto; Mesin, Luka; Zheng, Nai-Ying; Stamnaes, Jorunn; Morrissey, Michael; Lee, Jane-Hwei; Huang, Min; Iversen, Rasmus; du Pre, M. Fleur; Qiao, Shuo-Wang; Lundin, Knut E. A.; Wilson, Patrick C.; Sollid, Ludvig M.			High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions	NATURE MEDICINE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; MEMORY B-CELLS; TISSUE TRANSGLUTAMINASE; IMMUNE-RESPONSES; GERMINAL-CENTER; RAPID GENERATION; AFFINITY; ANTIGEN; ASSOCIATION; PEPTIDES	Celiac disease is an immune-mediated disorder in which mucosal autoantibodies to the enzyme transglutaminase 2 (TG2)(1) are generated in response to the exogenous antigen gluten(2) in individuals who express human leukocyte antigen HLA-DQ2 or HLA-DQ8 (ref. 3). We assessed in a comprehensive and nonbiased manner the IgA anti-TG2 response by expression cloning of the antibody repertoire of ex vivo-isolated intestinal antibody-secreting cells (ASCs). We found that TG2-specific plasma cells are markedly expanded within the duodenal mucosa in individuals with active celiac disease. TG2-specific antibodies were of high affinity yet showed little adaptation by somatic mutations. Unlike infection-induced peripheral blood plasmablasts4, the TG2-specific ASCs had not recently proliferated and were not short-lived ex vivo. Altogether, these observations demonstrate that there is a germline repertoire with high affinity for TG2 that may favor massive generation of autoreactive B cells. TG2-specific antibodies did not block enzymatic activity and served as substrates for TG2-mediated crosslinking when expressed as IgD or IgM but not as IgA1 or IgG1. This could result in preferential recruitment of plasma cells from naive IgD- and IgM-expressing B cells, thus possibly explaining why the antibody response to TG2 bears signs of a primary immune response despite the disease chronicity.	[Di Niro, Roberto; Mesin, Luka; Stamnaes, Jorunn; Iversen, Rasmus; du Pre, M. Fleur; Qiao, Shuo-Wang; Lundin, Knut E. A.; Sollid, Ludvig M.] Univ Oslo, Ctr Immune Regulat, Oslo, Norway; [Di Niro, Roberto; Mesin, Luka; Stamnaes, Jorunn; Iversen, Rasmus; du Pre, M. Fleur; Qiao, Shuo-Wang; Lundin, Knut E. A.; Sollid, Ludvig M.] Univ Oslo, Dept Immunol, Oslo, Norway; [Lundin, Knut E. A.] Univ Oslo, Rikshosp, Oslo Univ Hospital, Dept Med, N-0027 Oslo, Norway; [Zheng, Nai-Ying; Morrissey, Michael; Lee, Jane-Hwei; Huang, Min; Wilson, Patrick C.] Univ Chicago, Gwenn Knapp Ctr Lupus & Immunol Res, Chicago, IL 60637 USA; [Wilson, Patrick C.] Univ Chicago, Dept Med, Rheumatol Sect, Chicago, IL 60637 USA; [Wilson, Patrick C.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Chicago; University of Chicago; University of Chicago	Sollid, LM (corresponding author), Univ Oslo, Ctr Immune Regulat, Oslo, Norway.	wilsonp@uchicago.edu; l.m.sollid@medisin.uio.no	Lundin, Knut E. A./AAW-9519-2021; Wilson, Patrick/HGC-3157-2022; Sollid, Ludvig/N-9691-2015; Qiao, Shuo-Wang/ABE-8148-2020	Lundin, Knut E. A./0000-0003-1713-5545; Sollid, Ludvig/0000-0001-8860-704X; Qiao, Shuo-Wang/0000-0002-0935-8397; Iversen, Rasmus/0000-0002-3292-1766; Stamnaes, Jorunn/0000-0002-0257-2112; du Pre, M. Fleur/0000-0001-9231-643X	Marie Curie Research and Training Network (European Commission) [MRTN-CT-2006-036032]; European Research Council; Research Council of Norway; US National Institutes of Health National Institute of Allergy and Infectious Disease [U19 AI082724-01, R01 AI76585-03, HHSN266200500026C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082724, R01AI076585, N01AI050026, U19AI057266] Funding Source: NIH RePORTER	Marie Curie Research and Training Network (European Commission)(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission); Research Council of Norway(Research Council of Norway); US National Institutes of Health National Institute of Allergy and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Mummert (Phadia) for providing recombinant human TG2 produced in Sf9 insect cells, C. Khosla (Stanford University) and L. Fesus (University of Debrecen) for providing plasmids encoding His-tagged recombinant TG2 for expression in Escherichia coli, M. Raki for help in sample collection and immunofluorescence analysis, J. Jahnsen for providing biopsy samples from two subjects, and the staffs at the LIIPAT laboratory and the flow cytometry core facility (both at Oslo University Hospital-Rikshospitalet) for technical assistance. This work was supported by the Marie Curie Research and Training Network (European Commission) contract MRTN-CT-2006-036032, the European Research Council and grants from the Research Council of Norway to L. M. S., and US National Institutes of Health National Institute of Allergy and Infectious Disease grants U19 AI082724-01, R01 AI76585-03 and HHSN266200500026C to P. C. W. We thank M. Shlomchik and B. Jabri for discussion and critical reading of the manuscript.	Anderson SM, 2009, J IMMUNOL, V183, P7314, DOI 10.4049/jimmunol.0902452; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Benckert J, 2011, J CLIN INVEST, V121, P1946, DOI 10.1172/JCI44447; Bjorck S, 2010, J PEDIATR GASTR NUTR, V50, P49, DOI 10.1097/MPG.0b013e3181b477a6; Borrelli M, 2010, CLIN EXP IMMUNOL, V160, P199, DOI 10.1111/j.1365-2249.2009.04077.x; Boursier L, 1999, IMMUNOLOGY, V97, P558; Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690; Di Niro R, 2010, J IMMUNOL, V185, P5377, DOI 10.4049/jimmunol.1001587; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Duty JA, 2009, J EXP MED, V206, P139, DOI 10.1084/jem.20080611; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Green PHR, 2005, GASTROENTEROLOGY, V128, pS74, DOI 10.1053/j.gastro.2005.02.016; HALSTENSEN TS, 1992, GASTROENTEROLOGY, V102, P751, DOI 10.1016/0016-5085(92)90155-R; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; KROESE FGM, 1989, IMMUNOL INVEST, V18, P47, DOI 10.3109/08820138909112226; Kurppa K, 2010, J PEDIATR-US, V157, P373, DOI 10.1016/j.jpeds.2010.02.070; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Marzari R, 2001, J IMMUNOL, V166, P4170, DOI 10.4049/jimmunol.166.6.4170; Meffre E, 2008, CURR OPIN IMMUNOL, V20, P632, DOI 10.1016/j.coi.2008.09.001; Mei HE, 2009, BLOOD, V113, P2461, DOI 10.1182/blood-2008-04-153544; Mesin L, 2011, J IMMUNOL, V187, P2867, DOI 10.4049/jimmunol.1003181; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Qiao SW, 2011, J IMMUNOL, V187, P3064, DOI 10.4049/jimmunol.1101526; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Rostom A, 2005, GASTROENTEROLOGY, V128, pS38, DOI 10.1053/j.gastro.2005.02.028; Salmi TT, 2006, GUT, V55, P1746, DOI 10.1136/gut.2005.071514; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; SITIA R, 1990, CELL, V60, P781, DOI 10.1016/0092-8674(90)90092-S; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Sollid LM, 1997, GUT, V41, P851, DOI 10.1136/gut.41.6.851; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Stamnaes J, 2008, BBA-PROTEINS PROTEOM, V1784, P1804, DOI 10.1016/j.bbapap.2008.08.011; Sulkanen S, 1998, GASTROENTEROLOGY, V115, P1322, DOI 10.1016/S0016-5085(98)70008-3; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Toellner KM, 2002, J EXP MED, V195, P383, DOI 10.1084/jem.20011112; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890	40	139	140	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2012	18	3					441	U204		10.1038/nm.2656	http://dx.doi.org/10.1038/nm.2656			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22366952	Green Accepted			2022-12-25	WOS:000301264800047
J	Golubchik, T; Brueggemann, AB; Street, T; Gertz, RE; Spencer, CCA; Ho, T; Giannoulatou, E; Link-Gelles, R; Harding, RM; Beall, B; Peto, TEA; Moore, MR; Donnelly, P; Crook, DW; Bowden, R				Golubchik, Tanya; Brueggemann, Angela B.; Street, Teresa; Gertz, Robert E., Jr.; Spencer, Chris C. A.; Ho, Thien; Giannoulatou, Eleni; Link-Gelles, Ruth; Harding, Rosalind M.; Beall, Bernard; Peto, Tim E. A.; Moore, Matthew R.; Donnelly, Peter; Crook, Derrick W.; Bowden, Rory			Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event	NATURE GENETICS			English	Article							PNEUMONIAE SEROTYPE 19A; STREPTOCOCCUS-PNEUMONIAE; UNITED-STATES; HAEMOPHILUS-INFLUENZAE; CONJUGATE VACCINE; DISEASE; CHILDREN; TRANSFORMATION; REPLACEMENT; PREVENTION	Streptococcus pneumoniae ('pneumococcus') causes an estimated 14.5 million cases of serious disease and 826,000 deaths annually in children under 5 years of age(1). The highly effective introduction of the PCV7 pneumococcal vaccine in 2000 in the United States(2,3) provided an unprecedented opportunity to investigate the response of an important pathogen to widespread, vaccine-induced selective pressure. Here, we use array-based sequencing of 62 isolates from a US national monitoring program to study five independent instances of vaccine escape recombination(4), showing the simultaneous transfer of multiple and often large (up to at least 44 kb) DNA fragments. We show that one such new strain quickly became established, spreading from east to west across the United States. These observations clarify the roles of recombination and selection in the population genomics of pneumococcus and provide proof of principle of the considerable value of combining genomic and epidemiological information in the surveillance and enhanced understanding of infectious diseases.	[Golubchik, Tanya; Street, Teresa; Ho, Thien; Donnelly, Peter; Bowden, Rory] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Brueggemann, Angela B.; Harding, Rosalind M.] Univ Oxford, Dept Zool, Oxford OX1 3TG, England; [Gertz, Robert E., Jr.; Link-Gelles, Ruth; Beall, Bernard; Moore, Matthew R.] Ctr Dis Control & Prevent CDC, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Spencer, Chris C. A.; Giannoulatou, Eleni; Donnelly, Peter; Bowden, Rory] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 3TG, England; [Peto, Tim E. A.; Crook, Derrick W.; Bowden, Rory] Univ Oxford, Nuffield Dept Med, Oxford Biomed Res Ctr, Oxford OX1 3TG, England	University of Oxford; University of Oxford; Centers for Disease Control & Prevention - USA; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Donnelly, P (corresponding author), Univ Oxford, Dept Stat, Oxford OX1 3TG, England.	peter.donnelly@well.ox.ac.uk	Ho, Thien X/A-7209-2012; Golubchik, Tanya/B-4226-2018	Ho, Thien X/0000-0003-0914-306X; Golubchik, Tanya/0000-0003-2765-9828; Donnelly, Peter/0000-0001-9495-3408; peto, tim/0000-0003-3477-8307; Giannoulatou, Eleni/0000-0002-7084-6736; Brueggemann, Angela/0000-0002-2329-1934	Wellcome Trust [079126/Z/06/Z, 090532/Z/09/Z]; UK National Health Service (NHS) National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; NIHR; Wolfson Royal Society; NHS NIHR Oxford Biomedical Research Centre; UK Clinical Research Collaboration (UKCRC) (MRC UK) [G0800778]; UK Clinical Research Collaboration (UKCRC) (Wellcome Trust) [087646/2/08/Z]; MRC [G0800778] Funding Source: UKRI; Medical Research Council [G0800778] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); UK National Health Service (NHS) National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; NIHR(National Institute for Health Research (NIHR)); Wolfson Royal Society(Royal Society of London); NHS NIHR Oxford Biomedical Research Centre; UK Clinical Research Collaboration (UKCRC) (MRC UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Clinical Research Collaboration (UKCRC) (Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors gratefully acknowledge the clinicians, microbiologists and investigators of the ABCs program of the Emerging Infections Program Network. We thank X. Didelot for contributions to the analysis of Illumina genomic data. This work was funded by the Wellcome Trust (079126/Z/06/Z). T. E. A. P. and D. W. C. are funded by the UK National Health Service (NHS) National Institute for Health Research (NIHR) Oxford Biomedical Research Centre and NIHR Senior Investigator Awards. P. D. is funded by a Wellcome Trust Core Award Grant (090532/Z/09/Z) and is supported, in part, by a Wolfson Royal Society Merit Award. R. B. is supported by the NHS NIHR Oxford Biomedical Research Centre and the UK Clinical Research Collaboration (UKCRC) (MRC UK G0800778 and Wellcome Trust 087646/2/08/Z). A. B. B. is a Wellcome Trust Career Development Fellow (083511/Z/07/Z). Genetic and epidemiological data are available from the authors.	Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Beall B, 2006, J CLIN MICROBIOL, V44, P999, DOI 10.1128/JCM.44.3.999-1017.2006; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Campbell H, 2009, VACCINE, V27, pB20, DOI 10.1016/j.vaccine.2009.04.067; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; ESKOLA J, 1990, NEW ENGL J MED, V323, P1381, DOI 10.1056/NEJM199011153232004; Feil EJ, 2000, GENETICS, V154, P1439; Griffith F, 1928, J HYG-CAMBRIDGE, V27, P113, DOI 10.1017/S0022172400031879; Hiller NL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001108; LACKS S, 1960, BIOCHIM BIOPHYS ACTA, V39, P508, DOI 10.1016/0006-3002(60)90205-5; Lipsitch M, 1999, EMERG INFECT DIS, V5, P336, DOI 10.3201/eid0503.990304; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; Perkins BA, 2000, JAMA-J AM MED ASSOC, V283, P2842, DOI 10.1001/jama.283.21.2842; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; R Development Core Team, 2007, R LANG ENV STAT COMP; Spratt BG, 2000, LANCET, V356, P1210, DOI 10.1016/S0140-6736(00)02779-3; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Trzcinski K, 2004, J BACTERIOL, V186, P3447, DOI 10.1128/JB.186.11.3447-3452.2004; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zwick ME, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r10	27	80	81	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2012	44	3					352	U168		10.1038/ng.1072	http://dx.doi.org/10.1038/ng.1072			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	899VC	22286217	Green Accepted, Green Submitted			2022-12-25	WOS:000300843600026
J	Keller, TL; Zocco, D; Sundrud, MS; Hendrick, M; Edenius, M; Yum, J; Kim, YJ; Lee, HK; Cortese, JF; Wirth, DF; Dignam, JD; Rao, A; Yeo, CY; Mazitschek, R; Whitman, M				Keller, Tracy L.; Zocco, Davide; Sundrud, Mark S.; Hendrick, Margaret; Edenius, Maja; Yum, Jinah; Kim, Yeon-Jin; Lee, Hak-Kyo; Cortese, Joseph F.; Wirth, Dyann F.; Dignam, John David; Rao, Anjana; Yeo, Chang-Yeol; Mazitschek, Ralph; Whitman, Malcolm			Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase	NATURE CHEMICAL BIOLOGY			English	Article							AMINO-ACID-METABOLISM; GENE-EXPRESSION; CELL-DIFFERENTIATION; MAMMALIAN-CELLS; DENDRITIC CELLS; STRESS-RESPONSE; INFLAMMATION; SPECIFICITY; DEPRIVATION; LIMITATION	Febrifugine, the bioactive constituent of one of the SO fundamental herbs of traditional Chinese medicine, has been characterized for its therapeutic activity, though its molecular target has remained unknown. Febrifugine derivatives have been used to treat malaria, cancer, fibrosis and inflammatory disease. We recently demonstrated that halofuginone (HF), a widely studied derivative of febrifugine, inhibits the development of T(H)17-driven autoimmunity in a mouse model of multiple sclerosis by activating the amino acid response (AAR) pathway. Here we show that HF binds glutamyl-prolyl-tRNA synthetase (EPRS), inhibiting prolyl-tRNA synthetase activity; this inhibition is reversed by the addition of exogenous proline or EPRS. We further show that inhibition of EPRS underlies the broad bioactivities of this family of natural product derivatives. This work both explains the molecular mechanism of a promising family of therapeutics and highlights the AAR pathway as an important drug target for promoting inflammatory resolution.	[Keller, Tracy L.; Zocco, Davide; Hendrick, Margaret; Edenius, Maja; Yeo, Chang-Yeol; Whitman, Malcolm] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; [Sundrud, Mark S.; Rao, Anjana] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Sundrud, Mark S.; Rao, Anjana] Childrens Hosp, Immune Dis Inst, Boston, MA 02115 USA; [Yum, Jinah; Kim, Yeon-Jin; Yeo, Chang-Yeol] Ewha Womans Univ, Div Life & Pharmaceut Sci, Dept Life Sci, Seoul, South Korea; [Lee, Hak-Kyo] Hankyong Natl Univ, Genom Informat Ctr, Ansung, Kyongi Do, South Korea; [Cortese, Joseph F.; Wirth, Dyann F.; Mazitschek, Ralph] Broad Inst Harvard & MIT, Infect Dis Initiat, Cambridge, MA USA; [Wirth, Dyann F.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Dignam, John David] Univ Toledo, Coll Med, Dept Biochem & Canc Biol, Toledo, OH 43606 USA; [Mazitschek, Ralph] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA	Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Ewha Womans University; Hankyong National University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; University System of Ohio; University of Toledo; Harvard University; Massachusetts General Hospital	Keller, TL (corresponding author), Harvard Univ, Sch Dent Med, Dept Dev Biol, 188 Longwood Ave, Boston, MA 02115 USA.	tkeller@hms.harvard.edu; cyeo@ewha.ac.kr; rmazitschek@mgh.harvard.edu; mwhitman@hms.harvard.edu	Mazitschek, Ralph/E-3741-2013	Mazitschek, Ralph/0000-0002-1105-689X; Yeo, Chang-Yeol/0000-0002-4440-1215	US National Institutes of Health (NIH) [GM089885]; Harvard Technology Accelerator Award; Rural Development Administration, Republic of Korea [PJ00812701, PJ008196]; NIH [AI40127, AI48213]; Juvenile Diabetes Research Foundation [17-2010-421]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048213, R01AI040127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089885] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Technology Accelerator Award; Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank R. Copeland (Epizyme) for advice on the execution of tight-binding analysis, W Kilo Harvard Catalyst Laboratory for Innovative Translational Technologies for assistance with the establishment of qPCR assays, and C. Walsh (Harvard), T. Roberts (Dana-Farber Cancer Institute) anti S. Thomas (National Institute of Environmental Health Science, USA) for their valuable comments on the manuscript. This work was supported by US National Institutes of Health (NIH) grant GM089885 and a Harvard Technology Accelerator Award (to MW); by grants PJ00812701 and PJ008196 from The Next Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea (to C.Y.Y. and H.K.L.); and by NIH grants AI40127 and AI48213 and Juvenile Diabetes Research Foundation 17-2010-421 (to A.R.).	Anderson RM, 2010, TRENDS ENDOCRIN MET, V21, P134, DOI 10.1016/j.tem.2009.11.005; Boye K, 2010, AM J PATHOL, V176, P528, DOI 10.2353/ajpath.2010.090526; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Caro P, 2009, BIOGERONTOLOGY, V10, P579, DOI 10.1007/s10522-008-9200-4; Clardy J, 2004, NATURE, V432, P829, DOI 10.1038/nature03194; Coatney G. R., 1950, Journal of the National Malaria Society, V9, P183; Cobbold SP, 2009, P NATL ACAD SCI USA, V106, P12055, DOI 10.1073/pnas.0903919106; Copeland Robert A, 2005, Methods Biochem Anal, V46, P1; Deval C, 2009, FEBS J, V276, P707, DOI 10.1111/j.1742-4658.2008.06818.x; Elkin M, 1999, CANCER RES, V59, P4111; Esposito M, 2010, J NEUROIMMUNOL, V220, P52, DOI 10.1016/j.jneuroim.2010.01.001; Finlay D, 2011, NAT REV IMMUNOL, V11, P109, DOI 10.1038/nri2888; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Grohmann U, 2010, IMMUNOL REV, V236, P243, DOI 10.1111/j.1600-065X.2010.00915.x; Haigis MC, 2010, MOL CELL, V40, P333, DOI 10.1016/j.molcel.2010.10.002; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Heacock D, 1996, BIOORG CHEM, V24, P273, DOI 10.1006/bioo.1996.0025; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Howitz KT, 2008, CELL, V133, P387, DOI 10.1016/j.cell.2008.04.019; Huang L, 2010, INT REV IMMUNOL, V29, P133, DOI 10.3109/08830180903349669; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JAHN MJ, 1991, NUCLEIC ACIDS RES, V19, P2786, DOI 10.1093/nar/19.10.2786; Kamberov Yana G, 2011, BMC Res Notes, V4, P381, DOI 10.1186/1756-0500-4-381; Kikuchi H, 2002, J MED CHEM, V45, P2563, DOI 10.1021/jm010448q; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; Kobayashi S, 1999, J ORG CHEM, V64, P6833, DOI 10.1021/jo990877k; Koon HB, 2011, JAIDS-J ACQ IMM DEF, V56, P64, DOI 10.1097/QAI.0b013e3181fc0141; McGaha T, 2002, AUTOIMMUNITY, V35, P277, DOI 10.1080/0891693021000001235; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Nath N, 2009, J IMMUNOL, V182, P8005, DOI 10.4049/jimmunol.0803563; Oslejskova L, 2009, RHEUMATOLOGY, V48, P1590, DOI 10.1093/rheumatology/kep316; Palii SS, 2009, AMINO ACIDS, V37, P79, DOI 10.1007/s00726-008-0199-2; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Pines A, 2003, BIOL BLOOD MARROW TR, V9, P417, DOI 10.1016/S1083-8791(03)00151-4; Pines M, 1998, GEN PHARMACOL, V30, P445, DOI 10.1016/S0306-3623(97)00307-8; Pleiss JA, 2007, MOL CELL, V27, P928, DOI 10.1016/j.molcel.2007.07.018; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; Powell JD, 2010, IMMUNITY, V33, P301, DOI 10.1016/j.immuni.2010.09.002; Ruan BF, 2005, J BIOL CHEM, V280, P571, DOI 10.1074/jbc.M411039200; Ryley J F, 1973, Adv Pharmacol Chemother, V11, P221, DOI 10.1016/S1054-3589(08)60459-7; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Splan KE, 2008, J BIOL CHEM, V283, P7128, DOI 10.1074/jbc.M709902200; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; TING SM, 1992, J BIOL CHEM, V267, P17701; von Bubnoff D, 2011, J AM ACAD DERMATOL, V65, P819, DOI 10.1016/j.jaad.2010.07.050; Xiao F, 2011, DIABETES; Yaremchuk A, 2001, J MOL BIOL, V309, P989, DOI 10.1006/jmbi.2001.4712; Zelante T, 2007, EUR J IMMUNOL, V37, P2695, DOI 10.1002/eji.200737409; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	50	229	245	8	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2012	8	3					311	317		10.1038/NCHEMBIO.790	http://dx.doi.org/10.1038/NCHEMBIO.790			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896VR	22327401	Green Accepted			2022-12-25	WOS:000300600000017
J	Foxler, DE; Bridge, KS; James, V; Webb, TM; Mee, M; Wong, SCK; Feng, YF; Constantin-Teodosiu, D; Petursdottir, TE; Bjornsson, J; Ingvarsson, S; Ratcliffe, PJ; Longmore, GD; Sharp, TV				Foxler, Daniel E.; Bridge, Katherine S.; James, Victoria; Webb, Thomas M.; Mee, Maureen; Wong, Sybil C. K.; Feng, Yunfeng; Constantin-Teodosiu, Dumitru; Petursdottir, Thorgunnur Eyfjord; Bjornsson, Johannes; Ingvarsson, Sigurdur; Ratcliffe, Peter J.; Longmore, Gregory D.; Sharp, Tyson V.			The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity	NATURE CELL BIOLOGY			English	Article							HYPOXIA-INDUCIBLE FACTOR; HIPPEL-LINDAU GENE; TUMOR-SUPPRESSOR; TRANSCRIPTIONAL ACTIVITY; PROLINE HYDROXYLATION; FACTOR 1-ALPHA; FACTOR-I; HIF-1-ALPHA; DOMAIN; ALPHA	There are three prolyl hydroxylases (PHD1, 2 and 3) that regulate the hypoxia-inducible factors (HIFs), the master transcriptional regulators that respond to changes in intracellular O-2 tension(1,2). In high O-2 tension (normoxia) the PHDs hydroxylate two conserved proline residues on HIF-1 alpha, which leads to binding of the von Hippel-Lindau (VHL) tumour suppressor, the recognition component of a ubiquiti-ligase complex, initiating HIF-1 alpha ubiquitylation and degradation(3-6). However, it is not known whether PHDs and VHL act separately to exert their enzymatic activities on HIF-1 alpha or as a multiprotein complex. Here we show that the tumour suppressor protein LIMD1 (LIM domain-containing protein) acts as a molecular scaffold, simultaneously binding the PHDs and VHL, thereby assembling a PHD-LIMD1-VHL protein complex and creating an enzymatic niche that enables efficient degradation of HIF-1 alpha. Depletion of endogenous LIMD1 increases HIF-1 alpha levels and transcriptional activity in both normoxia and hypoxia. Conversely, LIMD1 expression downregulates HIF-1 transcriptional activity in a manner depending on PHD and 26S proteasome activities. LIMD1 family member proteins Ajuba and WTIP also bind to VHL and PHDs 1 and 3, indicating that these LIM domain-containing proteins represent a previously unrecognized group of hypoxic regulators.	[Webb, Thomas M.] GSK, Discovery R&D, BDU, Stevenage SG1 2NY, Herts, England; [Feng, Yunfeng; Longmore, Gregory D.] Washington Univ, BRIGHT Inst, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Feng, Yunfeng; Longmore, Gregory D.] Washington Univ, BRIGHT Inst, Dept Med, St Louis, MO 63110 USA; [Petursdottir, Thorgunnur Eyfjord; Bjornsson, Johannes] Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland; [Ingvarsson, Sigurdur] Univ Iceland Keldur, Fac Med, Reykjavik, Iceland; [Ingvarsson, Sigurdur] Univ Iceland Keldur, Inst Expt Pathol, Reykjavik, Iceland; [Ratcliffe, Peter J.] Univ Oxford, Oxford OX3 7BN, England; [Foxler, Daniel E.; Bridge, Katherine S.; James, Victoria; Mee, Maureen; Wong, Sybil C. K.; Constantin-Teodosiu, Dumitru; Sharp, Tyson V.] Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Nottingham NG7 2UH, England	GlaxoSmithKline; Washington University (WUSTL); Washington University (WUSTL); Landspitali National University Hospital; University of Iceland; University of Iceland; University of Oxford; University of Nottingham	Sharp, TV (corresponding author), Queen Mary Univ London, Barts Canc Inst, London EC1M 6BQ, England.	t.sharp@qmul.ac.uk	Bridge, Katherine S./GWM-4251-2022; Sharp, Tyson/AAD-6190-2020; Ingvarsson, Sigurdur/E-7448-2011	Bridge, Katherine S./0000-0003-1516-1459; Sharp, Tyson/0000-0003-1861-7984; Ingvarsson, Sigurdur/0000-0003-4125-1714; Foxler, Daniel/0000-0003-3753-0278; James, Victoria/0000-0002-9926-2953; Ratcliffe, Peter/0000-0002-2853-806X; Feng, Yunfeng/0000-0001-9150-7795; Constantin-Teodosiu, Dumitru/0000-0002-8448-5564; Wong, Sybil/0000-0001-5238-2109	Biotechnology and Biological Sciences Research Council [BB/F006470/1, BB/I007571/1]; BBSRC [BB/I007571/1, BB/I007571/2, BB/F006470/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I007571/2] Funding Source: researchfish; Cancer Research UK [12733] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	We thank R. Layfield, T. Hagen, M. Cockman and S. Kristjansdottir for reagents and technical advice/assistance. K.S.B. is supported by a Biotechnology and Biological Sciences Research Council Doctorate Training Award. V.J. and D.E.F. were supported by funding from the Biotechnology and Biological Sciences Research Council (BB/F006470/1 and BB/I007571/1) awarded to T.V.S.	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; Barth S, 2009, J BIOL CHEM, V284, P23046, DOI 10.1074/jbc.M109.032631; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Berra E, 2000, BIOCHEM PHARMACOL, V60, P1171, DOI 10.1016/S0006-2952(00)00423-8; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Feng YF, 2005, MOL CELL BIOL, V25, P4010, DOI 10.1128/MCB.25.10.4010-4022.2005; Feng Yunfeng, 2010, Genomics Proteomics & Bioinformatics, V8, P238, DOI 10.1016/S1672-0229(10)60025-3; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Hubbi ME, 2011, MOL CELL, V42, P700, DOI 10.1016/j.molcel.2011.03.029; Huggins CJ, 2008, CANCER LETT, V267, P55, DOI 10.1016/j.canlet.2008.03.015; Iliopoulos O, 1998, P NATL ACAD SCI USA, V95, P11661, DOI 10.1073/pnas.95.20.11661; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Liu W, 2011, ONCOGENE, V30, P21, DOI 10.1038/onc.2010.395; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Minet E, 2001, FREE RADICAL BIO MED, V31, P847, DOI 10.1016/S0891-5849(01)00657-8; Nakayama K, 2004, CELL CYCLE, V3, P1345, DOI 10.4161/cc.3.11.1207; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Schoenfeld A, 1998, P NATL ACAD SCI USA, V95, P8817, DOI 10.1073/pnas.95.15.8817; Sharp TV, 2004, P NATL ACAD SCI USA, V101, P16531, DOI 10.1073/pnas.0407123101; Sharp TV, 2008, P NATL ACAD SCI USA, V105, P19932, DOI 10.1073/pnas.0805003105; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Tan M, 2008, ONCOGENE, V27, P1404, DOI 10.1038/sj.onc.1210780; WANG GL, 1993, J BIOL CHEM, V268, P21513; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	35	65	77	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2012	14	2					201	208		10.1038/ncb2424	http://dx.doi.org/10.1038/ncb2424			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	893CF	22286099	Green Published			2022-12-25	WOS:000300332500015
J	Mallam, AL; Jackson, SE				Mallam, Anna L.; Jackson, Sophie E.			Knot formation in newly translated proteins is spontaneous and accelerated by chaperonins	NATURE CHEMICAL BIOLOGY			English	Article							SINGLE-DOMAIN PROTEINS; PULSE PROTEOLYSIS; IN-VIVO; STABILITY; FOLD; METHYLTRANSFERASE; SPACES; CHAIN; STATE; YIBK	Topological knots are found in a considerable number of protein structures, but it is not clear how they knot and fold within the cellular environment. We investigated the behavior of knotted protein molecules as they are first synthesized by the ribosome using a cell-free translation system. We found that newly translated knotted proteins can spontaneously self-tie and do not require the assistance of molecular chaperones to fold correctly to their trefoil-knotted structures. This process is slow but efficient, and we found no evidence of misfolded species. A kinetic analysis indicates that the knotting process is rate limiting, occurs post-translationally, and is specifically and significantly (P < 0.001) accelerated by the GroEL-GroES chaperonin complex. This demonstrates a new active mechanism for this molecular chaperone and suggests that chaperonin-catalyzed knotting probably dominates in vivo. These results explain how knotted protein structures have withstood evolutionary pressures despite their topological complexity.	[Mallam, Anna L.; Jackson, Sophie E.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge	Jackson, SE (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	sej13@cam.ac.uk		Jackson, Sophie/0000-0002-7470-9800	St. John's College, University of Cambridge, UK	St. John's College, University of Cambridge, UK	We thank E. O'Brien, D. Hsu, F. Andersson, G. Blaser and E. Werrell for helpful discussions. This research was supported by a fellowship and a grant from St. John's College, University of Cambridge, UK (to A.L.M.).	Baker D, 2000, NATURE, V405, P39, DOI 10.1038/35011000; Baumketner A, 2003, J MOL BIOL, V332, P701, DOI 10.1016/S0022-2836(03)00929-X; Bolinger D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000731; Cabrita LD, 2010, CURR OPIN STRUC BIOL, V20, P33, DOI 10.1016/j.sbi.2010.01.005; Chakraborty K, 2010, CELL, V142, P112, DOI 10.1016/j.cell.2010.05.027; Cheung MS, 2006, J MOL BIOL, V357, P632, DOI 10.1016/j.jmb.2005.12.048; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Friel CT, 2009, NAT STRUCT MOL BIOL, V16, P318, DOI 10.1038/nsmb.1562; Fujiwara K, 2010, EMBO J, V29, P1552, DOI 10.1038/emboj.2010.52; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hsu STD, 2009, CHEM SOC REV, V38, P2951, DOI 10.1039/b908170b; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kim MS, 2009, PROTEIN SCI, V18, P1051, DOI 10.1002/pro.115; King NP, 2010, P NATL ACAD SCI USA, V107, P20732, DOI 10.1073/pnas.1007602107; Lim K, 2003, PROTEINS, V51, P56, DOI 10.1002/prot.10323; Maisnier-Patin S, 2005, NAT GENET, V37, P1376, DOI 10.1038/ng1676; Mallam AL, 2005, J MOL BIOL, V346, P1409, DOI 10.1016/j.jmb.2004.12.055; Mallam AL, 2008, MOL CELL, V30, P642, DOI 10.1016/j.molcel.2008.03.019; Mallam AL, 2007, J MOL BIOL, V366, P650, DOI 10.1016/j.jmb.2006.11.014; Mallam AL, 2007, STRUCTURE, V15, P111, DOI 10.1016/j.str.2006.11.007; Mallam AL, 2006, J MOL BIOL, V359, P1420, DOI 10.1016/j.jmb.2006.04.032; Mallam AL, 2010, P NATL ACAD SCI USA, V107, P8189, DOI 10.1073/pnas.0912161107; Mallam AL, 2009, FEBS J, V276, P365, DOI 10.1111/j.1742-4658.2008.06801.x; Mallam AL, 2008, P NATL ACAD SCI USA, V105, P18740, DOI 10.1073/pnas.0806697105; Micheletti C, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2162886; Micheletti C, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2210476; Noel JK, 2010, P NATL ACAD SCI USA, V107, P15403, DOI 10.1073/pnas.1009522107; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Park CW, 2005, NAT METHODS, V2, P207, DOI 10.1038/NMETH740; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Prentiss MC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000835; Purta E, 2008, RNA, V14, P2234, DOI 10.1261/rna.1198108; Schlebach JP, 2011, J MOL BIOL, V406, P545, DOI 10.1016/j.jmb.2010.12.018; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Shimizu Y, 2005, METHODS, V36, P299, DOI 10.1016/j.ymeth.2005.04.006; Sulkowska JI, 2010, J AM CHEM SOC, V132, P13954, DOI 10.1021/ja102441z; Sulkowska JI, 2009, P NATL ACAD SCI USA, V106, P3119, DOI 10.1073/pnas.0811147106; Taylor WR, 2007, COMPUT BIOL CHEM, V31, P151, DOI 10.1016/j.compbiolchem.2007.03.002; Virnau P, 2005, J AM CHEM SOC, V127, P15102, DOI 10.1021/ja052438a; Virnau P, 2006, PLOS COMPUT BIOL, V2, P1074, DOI 10.1371/journal.pcbi.0020122; Virnau P, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/3/033101; Wallin S, 2007, J MOL BIOL, V368, P884, DOI 10.1016/j.jmb.2007.02.035; Watters AL, 2007, CELL, V128, P613, DOI 10.1016/j.cell.2006.12.042; Ying BW, 2004, BIOCHEM BIOPH RES CO, V320, P1359, DOI 10.1016/j.bbrc.2004.06.095	47	110	110	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2012	8	2					147	153		10.1038/nchembio.742	http://dx.doi.org/10.1038/nchembio.742			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879IP	22179065				2022-12-25	WOS:000299323200006
J	Stark, MS; Woods, SL; Gartside, MG; Bonazzi, VF; Dutton-Regester, K; Aoude, LG; Chow, D; Sereduk, C; Niemi, NM; Tang, NY; Ellis, JJ; Reid, J; Zismann, V; Tyagi, S; Muzny, D; Newsham, I; Wu, YQ; Palmer, JM; Pollak, T; Youngkin, D; Brooks, BR; Lanagan, C; Schmidt, CW; Kobe, B; MacKeigan, JP; Yin, HW; Brown, KM; Gibbs, R; Trent, J; Hayward, NK				Stark, Mitchell S.; Woods, Susan L.; Gartside, Michael G.; Bonazzi, Vanessa F.; Dutton-Regester, Ken; Aoude, Lauren G.; Chow, Donald; Sereduk, Chris; Niemi, Natalie M.; Tang, Nanyun; Ellis, Jonathan J.; Reid, Jeffrey; Zismann, Victoria; Tyagi, Sonika; Muzny, Donna; Newsham, Irene; Wu, YuanQing; Palmer, Jane M.; Pollak, Thomas; Youngkin, David; Brooks, Bradford R.; Lanagan, Catherine; Schmidt, Christopher W.; Kobe, Bostjan; MacKeigan, Jeffrey P.; Yin, Hongwei; Brown, Kevin M.; Gibbs, Richard; Trent, Jeffrey; Hayward, Nicholas K.			Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing	NATURE GENETICS			English	Article							MALIGNANT-MELANOMA; HUMAN CANCER; APOPTOSIS; KINASE-1; TEMOZOLOMIDE; INHIBITION; ACTIVATION; GENES; BRAF	We sequenced eight melanoma exomes to identify new somatic mutations in metastatic melanoma. Focusing on the mitogen-activated protein (MAP) kinase kinase kinase (MAP3K) family, we found that 24% of melanoma cell lines have mutations in the protein-coding regions of either MAP3K5 or MAP3K9. Structural modeling predicted that mutations in the kinase domain may affect the activity and regulation of these protein kinases. The position of the mutations and the loss of heterozygosity of MAP3K5 and MAP3K9 in 85% and 67% of melanoma samples, respectively, together suggest that the mutations are likely to be inactivating. In in vitro kinase assays, MAP3K5 1780F and MAP3K9 W333* variants had reduced kinase activity. Overexpression of MAP3K5 or MAP3K9 mutants in HEK293T cells reduced the phosphorylation of downstream MAP kinases. Attenuation of MAP3K9 function in melanoma cells using siRNA led to increased cell viability after temozolomide treatment, suggesting that decreased MAP3K pathway activity can lead to chemoresistance in melanoma.	[Stark, Mitchell S.; Woods, Susan L.; Gartside, Michael G.; Bonazzi, Vanessa F.; Dutton-Regester, Ken; Aoude, Lauren G.; Tyagi, Sonika; Palmer, Jane M.; Pollak, Thomas; Lanagan, Catherine; Schmidt, Christopher W.; Hayward, Nicholas K.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Dutton-Regester, Ken] Queensland Univ Technol, Brisbane, Qld 4001, Australia; [Aoude, Lauren G.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Chow, Donald; Sereduk, Chris; Ellis, Jonathan J.; Zismann, Victoria; Youngkin, David; Yin, Hongwei; Brown, Kevin M.; Trent, Jeffrey] Translat Genom Res Inst, Phoenix, AZ USA; [Niemi, Natalie M.; Brooks, Bradford R.; MacKeigan, Jeffrey P.; Trent, Jeffrey] Van Andel Res Inst, Grand Rapids, MI USA; [Ellis, Jonathan J.; Kobe, Bostjan] Univ Queensland, Sch Chem & Mol Biosci, Inst Mol Biosci, Brisbane, Qld, Australia; [Ellis, Jonathan J.; Kobe, Bostjan] Univ Queensland, Ctr Infect Dis Res, Brisbane, Qld, Australia; [Reid, Jeffrey; Muzny, Donna; Newsham, Irene; Wu, YuanQing; Gibbs, Richard] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Brown, Kevin M.] NCI, Adv Technol Ctr, Gaithersburg, MD USA	QIMR Berghofer Medical Research Institute; Queensland University of Technology (QUT); University of Queensland; Translational Genomics Research Institute; Van Andel Institute; University of Queensland; University of Queensland; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hayward, NK (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.	nick.hayward@qimr.edu.au	Yin, Hong/AAC-5784-2020; Ellis, Jonathan J/F-2920-2010; Tyagi, Sonika/L-2256-2019; Kobe, Bostjan/D-1292-2009; Bonazzi, Vanessa F/R-1676-2018; Stark, Mitchell/K-3874-2019; Stark, Mitchell S/E-3542-2010; hayward, nicholas k/C-1367-2015; Stark, Mitchell/K-6794-2019; Aoude, Lauren/C-7484-2014; hayward, nick/AAV-8802-2020; Niemi, Natalie/AAH-6963-2021; Schmidt, Christopher/A-4353-2009	Ellis, Jonathan J/0000-0003-0410-5064; Tyagi, Sonika/0000-0003-0181-6258; Kobe, Bostjan/0000-0001-9413-9166; Bonazzi, Vanessa F/0000-0002-2574-0334; Stark, Mitchell S/0000-0002-4510-2161; hayward, nicholas k/0000-0003-4760-1033; Stark, Mitchell/0000-0002-4510-2161; Aoude, Lauren/0000-0003-1448-3923; Niemi, Natalie/0000-0002-5174-4005; Ellis, Jonathan/0000-0003-0218-546X; MacKeigan, Jeffrey/0000-0002-0198-5679; Dutton-Regester, Ken/0000-0002-8884-6355; Schmidt, Christopher/0000-0002-3955-5076; Woods, Susan/0000-0002-8955-2017	National Health and Medical Research Council of Australia; Australian Centre for Vaccine Development; US National Cancer Institute [5U01CA129447]; US National Cancer Institute, Division of Cancer Epidemiology and Genetics; NATIONAL CANCER INSTITUTE [ZIACP010201, U01CA129447, R01CA129447] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Centre for Vaccine Development; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Cancer Institute, Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors would like to acknowledge M. Aziz for data processing, M. Kassner for technical support and J.-C. Deza for graphics support. This work was funded through grants from the National Health and Medical Research Council of Australia, the Australian Centre for Vaccine Development, the US National Cancer Institute (5U01CA129447 to J.T.), the US National Cancer Institute, Division of Cancer Epidemiology and Genetics (to K.M.B.), and a charitable donation by Francis Najafi (to K.M.B. and IT.).	Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Berger AH, 2011, J PATHOL, V223, P137, DOI 10.1002/path.2800; Bisson N, 2008, CELL CYCLE, V7, P909, DOI 10.4161/cc.7.7.5610; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Durkin JT, 2004, BIOCHEMISTRY-US, V43, P16348, DOI 10.1021/bi049866y; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Iriyama T, 2009, EMBO J, V28, P843, DOI 10.1038/emboj.2009.32; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Middleton MR, 2000, J CLIN ONCOL, V18, P158, DOI 10.1200/JCO.2000.18.1.158; Naumann SC, 2009, BRIT J CANCER, V100, P322, DOI 10.1038/sj.bjc.6604856; Paige AJW, 2003, CELL MOL LIFE SCI, V60, P2147, DOI 10.1007/s00018-003-3027-6; Prickett TD, 2011, NAT GENET, V43, P1119, DOI 10.1038/ng.950; Prickett TD, 2009, NAT GENET, V41, P1127, DOI 10.1038/ng.438; She QB, 2002, CANCER RES, V62, P1343; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solomon DA, 2008, CANCER RES, V68, P10300, DOI 10.1158/0008-5472.CAN-08-3272; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; Takeda K, 2008, ANNU REV PHARMACOL, V48, P199, DOI 10.1146/annurev.pharmtox.48.113006.094606; Wei XM, 2011, HUM MUTAT, V32, pE2148, DOI 10.1002/humu.21477; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Wei XM, 2010, MOL CANCER RES, V8, P1513, DOI 10.1158/1541-7786.MCR-10-0262; Xu ZH, 2001, MOL CELL BIOL, V21, P4713, DOI 10.1128/MCB.21.14.4713-4724.2001	24	143	147	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2012	44	2					165	169		10.1038/ng.1041	http://dx.doi.org/10.1038/ng.1041			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	22197930	Green Accepted, Green Submitted			2022-12-25	WOS:000299664400013
J	Tost, H; Meyer-Lindenberg, A				Tost, Heike; Meyer-Lindenberg, Andreas			Schizophrenia, social environment and the brain	NATURE MEDICINE			English	Editorial Material							URBANICITY		[Tost, Heike; Meyer-Lindenberg, Andreas] Heidelberg Univ, Cent Inst Mental Hlth, Med Fac Mannheim, D-6800 Mannheim, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Tost, H (corresponding author), Heidelberg Univ, Cent Inst Mental Hlth, Med Fac Mannheim, D-6800 Mannheim, Germany.	a.meyer-lindenberg@zi-mannheim.de	Tost, med. Dr. phil. Heike/AAX-8305-2020; Meyer-Lindenberg, Andreas/H-1076-2011	Meyer-Lindenberg, Andreas/0000-0001-5619-1123				Borgwardt SJ, 2008, NEUROIMAGE, V39, P553, DOI 10.1016/j.neuroimage.2007.08.047; Bourque F, 2011, PSYCHOL MED, V41, P897, DOI 10.1017/S0033291710001406; Brunelin J., 2010, J PSYCHIATR RES, V181, P130; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Erk S, 2010, ARCH GEN PSYCHIAT, V67, P803, DOI 10.1001/archgenpsychiatry.2010.94; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Krabbendam L, 2005, SCHIZOPHRENIA BULL, V31, P795, DOI 10.1093/schbul/sbi060; Kuhn, 1962, STRUCTURE SCI REVOLU, P148; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Meyer-Lindenberg A, 2010, NATURE, V468, P194, DOI 10.1038/nature09569; Pedersen CB, 2001, ARCH GEN PSYCHIAT, V58, P1039, DOI 10.1001/archpsyc.58.11.1039; van Os J, 2008, SCHIZOPHRENIA BULL, V34, P1066, DOI 10.1093/schbul/sbn117; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Zammit S, 2010, ARCH GEN PSYCHIAT, V67, P914, DOI 10.1001/archgenpsychiatry.2010.101; Zink CF, 2008, NEURON, V58, P273, DOI 10.1016/j.neuron.2008.01.025	15	38	38	1	34	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					211	213		10.1038/nm.2671	http://dx.doi.org/10.1038/nm.2671			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22310688				2022-12-25	WOS:000300140300032
J	Erturk, A; Mauch, CP; Hellal, F; Forstner, F; Keck, T; Becker, K; Jahrling, N; Steffens, H; Richter, M; Hubener, M; Kramer, E; Kirchhoff, F; Dodt, HU; Bradke, F				Ertuerk, Ali; Mauch, Christoph P.; Hellal, Farida; Foerstner, Friedrich; Keck, Tara; Becker, Klaus; Jaehrling, Nina; Steffens, Heinz; Richter, Melanie; Huebener, Mark; Kramer, Edgar; Kirchhoff, Frank; Dodt, Hans Ulrich; Bradke, Frank			Three-dimensional imaging of the unsectioned adult spinal cord to assess axon regeneration and glial responses after injury	NATURE MEDICINE			English	Article							NOGO-A; FUNCTIONAL RECOVERY; TRANSGENIC MICE; ANTIBODY IN-1; ASTROCYTES; PROTEIN; LESION; BRAIN; DEGENERATION; FIBERS	Studying regeneration in the central nervous system (CNS) is hampered by current histological and imaging techniques because they provide only partial information about axonal and glial reactions. Here we developed a tetrahydrofuranbased clearing procedure that renders fixed and unsectioned adult CNS tissue transparent and fully penetrable for optical imaging. In large spinal cord segments, we imaged fluorescently labeled cells by `ultramicroscopy' and two-photon microscopy without the need for histological sectioning. We found that more than a year after injury growth-competent axons regenerated abundantly through the injury site. A few growth-incompetent axons could also regenerate when they bypassed the lesion. Moreover, we accurately determined quantitative changes of glial cells after spinal cord injury. Thus, clearing CNS tissue enables an unambiguous evaluation of axon regeneration and glial reactions. Our clearing procedure also renders other organs transparent, which makes this approach useful for a large number of preclinical paradigms.	[Ertuerk, Ali; Hellal, Farida; Bradke, Frank] Max Planck Inst Neurobiol Axonal Growth & Regener, Martinsried, Germany; [Ertuerk, Ali] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; [Mauch, Christoph P.] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Hellal, Farida; Bradke, Frank] Deutsch Zentrum Neurodegenerat Erkrankungen Axona, Bonn, Germany; [Foerstner, Friedrich] Max Planck Inst Neurobiol Syst & Computat Neurobi, Martinsried, Germany; [Keck, Tara; Huebener, Mark] Max Planck Inst Neurobiol Cellular & Syst Neurobi, Martinsried, Germany; [Keck, Tara] Kings Coll London, Med Res Council Ctr Dev Neurobiol, London WC2R 2LS, England; [Becker, Klaus; Jaehrling, Nina; Dodt, Hans Ulrich] Vienna Univ Technol, Inst Solid State Elect, Dept Bioelect, A-1060 Vienna, Austria; [Becker, Klaus; Jaehrling, Nina; Dodt, Hans Ulrich] Med Univ Vienna, Sect Bioelect, Ctr Brain Res, Vienna, Austria; [Jaehrling, Nina] Carl von Ossietzky Univ Oldenburg, Dept Neurobiol, D-2900 Oldenburg, Germany; [Steffens, Heinz; Kirchhoff, Frank] Max Planck Inst Expt Med, Dept Neurogenet, Glial Physiol & Imaging, D-3400 Gottingen, Germany; [Richter, Melanie; Kramer, Edgar] Univ Hamburg, Ctr Mol Neurobiol, D-2000 Hamburg, Germany; [Kirchhoff, Frank] Univ Saarland, Inst Physiol, D-6650 Homburg, Germany	Max Planck Society; Roche Holding; Genentech; Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Max Planck Society; Max Planck Society; University of London; King's College London; Technische Universitat Wien; Medical University of Vienna; Carl von Ossietzky Universitat Oldenburg; Max Planck Society; University of Hamburg; Saarland University	Bradke, F (corresponding author), Max Planck Inst Neurobiol Axonal Growth & Regener, Martinsried, Germany.	frank.bradke@dzne.de	Kramer, Edgar/A-9288-2012; Hellal, Farida/E-8533-2013; Hellal, Farida/AHC-2588-2022; Hellal, Farida/D-1834-2015; Kirchhoff, Frank/B-9335-2008	Kramer, Edgar/0000-0002-4882-4143; Hellal, Farida/0000-0002-9344-1846; Hellal, Farida/0000-0002-9344-1846; Kirchhoff, Frank/0000-0002-2324-2761; Bradke, Frank/0000-0002-0345-3772; Keck, Tara/0000-0001-6623-1037; Becker, Klaus/0000-0002-2406-0476; Richter, Melanie/0000-0003-0575-9625	Marie Curie Association (European Union) [WEN MRTN-CT-2, WEN MRTN-CT-003-504, WEN MRTN-CT-636]; Hertie Stiftung; Theodor Korner Fonds; Human Frontier Science Program; Max Planck Society; Deutsche Forschungsgemeinschaft; Austrian Science Fund (FWF) [P 23102] Funding Source: researchfish; Medical Research Council [G0900499] Funding Source: researchfish; MRC [G0900499] Funding Source: UKRI	Marie Curie Association (European Union)(European Commission); Hertie Stiftung(Austrian Science Fund (FWF)); Theodor Korner Fonds; Human Frontier Science Program(Human Frontier Science Program); Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank K. Dornmair, J. Enes, C. Hojer, A. Kania, D. Neukirchen, K. Olsen, M. Stiess and S. Tahirovic for critically reading the manuscript, V. Duc Ha for technical assistance and R. Brand for his help with Amira. We are indebted to A. Borst and M. Sheng for their support and to J. Sanes (Harvard University) for the GFP-M mice. A.E. was supported by the Marie Curie Association (European Union; WEN MRTN-CT-2,003-504,636). C.P.M. was supported by the Hertie Stiftung. N.J. was supported by the Theodor Korner Fonds. F.B. is a recipient of a Career Development Award from the Human Frontier Science Program. This work was supported by the Max Planck Society, the International Foundation for Research in Paraplegia and additional grants from the Deutsche Forschungsgemeinschaft and the Hertie Stiftung.	Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Callaway EM, 2008, CURR OPIN NEUROBIOL, V18, P617, DOI 10.1016/j.conb.2009.03.007; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; DIAZ RS, 1992, J NEUROSCI RES, V31, P136, DOI 10.1002/jnr.490310119; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Enes J, 2010, CURR BIOL, V20, P1154, DOI 10.1016/j.cub.2010.05.055; Erturk A, 2007, J NEUROSCI, V27, P9169, DOI 10.1523/JNEUROSCI.0612-07.2007; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fouad K, 2004, EUR J NEUROSCI, V20, P2479, DOI 10.1111/j.1460-9568.2004.03716.x; Freund P, 2006, NAT MED, V12, P790, DOI 10.1038/nm1436; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Labombarda F, 2000, J STEROID BIOCHEM, V73, P159, DOI 10.1016/S0960-0760(00)00064-9; Lichtman JW, 2008, CURR OPIN NEUROBIOL, V18, P346, DOI 10.1016/j.conb.2008.08.010; Neher R, 2004, J MICROSC-OXFORD, V213, P46, DOI 10.1111/j.1365-2818.2004.01262.x; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Nolte C, 2001, GLIA, V33, P72; Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Spalteholz W., 1914, DURCHSICHTIGMACHEN M; STARR RMH, 1943, ORG SYNTH, V2, P566; Steward O, 2003, J COMP NEUROL, V459, P1, DOI 10.1002/cne.10593; STUART DA, 1995, J NEUROSCI METH, V61, P5, DOI 10.1016/0165-0270(95)00017-O; Wang L, 2009, NEUROPATHOLOGY, V29, P230, DOI 10.1111/j.1440-1789.2008.00969.x; Ylera B, 2009, CURR BIOL, V19, P930, DOI 10.1016/j.cub.2009.04.017; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	28	247	266	5	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					166	171		10.1038/nm.2600	http://dx.doi.org/10.1038/nm.2600			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22198277				2022-12-25	WOS:000299018600044
J	Rosenthal, AZ; Elowitz, MB				Rosenthal, Adam Z.; Elowitz, Michael B.			Following evolution of bacterial antibiotic resistance in real time	NATURE GENETICS			English	Editorial Material							ESCHERICHIA-COLI; POPULATION		[Rosenthal, Adam Z.; Elowitz, Michael B.] CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Rosenthal, AZ (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA.	melowitz@caltech.edu						Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; BRYSON V, 1952, SCIENCE, V116, P45, DOI 10.1126/science.116.3003.45; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Gould S. J., 1989, WONDERFUL LIFE BURGE; Hermsen R, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.248104; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Toprak E, 2012, NAT GENET, V44, P101, DOI 10.1038/ng.1034; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914; Zhang QC, 2011, SCIENCE, V333, P1764, DOI 10.1126/science.1208747	11	5	5	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2012	44	1					11	13		10.1038/ng.1048	http://dx.doi.org/10.1038/ng.1048			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	22200772				2022-12-25	WOS:000298664000005
J	Steinberg, KM; Antonacci, F; Sudmant, PH; Kidd, JM; Campbell, CD; Vives, L; Malig, M; Scheinfeldt, L; Beggs, W; Ibrahim, M; Lema, G; Nyambo, TB; Omar, SA; Bodo, JM; Froment, A; Donnelly, MP; Kidd, KK; Tishkoff, SA; Eichler, EE				Steinberg, Karyn Meltz; Antonacci, Francesca; Sudmant, Peter H.; Kidd, Jeffrey M.; Campbell, Catarina D.; Vives, Laura; Malig, Maika; Scheinfeldt, Laura; Beggs, William; Ibrahim, Muntaser; Lema, Godfrey; Nyambo, Thomas B.; Omar, Sabah A.; Bodo, Jean-Marie; Froment, Alain; Donnelly, Michael P.; Kidd, Kenneth K.; Tishkoff, Sarah A.; Eichler, Evan E.			Structural diversity and African origin of the 17q21.31 inversion polymorphism	NATURE GENETICS			English	Article							COPY NUMBER VARIATION; ADULT DEPRESSION; SEGMENTAL DUPLICATIONS; PARKINSON-DISEASE; COMMON INVERSION; KANSL1 CAUSE; HAPLOTYPE; MAPT; GENE; ASSOCIATION	The 17q21.31 inversion polymorphism exists either as direct (H1) or inverted (H2) haplotypes with differential predispositions to disease and selection. We investigated its genetic diversity in 2,700 individuals, with an emphasis on African populations. We characterize eight structural haplotypes due to complex rearrangements that vary in size from 1.08-1.49 Mb and provide evidence for a 30-kb H1-H2 double recombination event. We show that recurrent partial duplications of the KANSL1 gene have occurred on both the H1 and H2 haplotypes and have risen to high frequency in European populations. We identify a likely ancestral H2 haplotype (H2') lacking these duplications that is enriched among African hunter-gatherer groups yet essentially absent from West African populations. Whereas H1 and H2 segmental duplications arose independently and before human migration out of Africa, they have reached high frequencies recently among Europeans, either because of extraordinary genetic drift or selective sweeps.	[Steinberg, Karyn Meltz; Antonacci, Francesca; Sudmant, Peter H.; Kidd, Jeffrey M.; Campbell, Catarina D.; Vives, Laura; Malig, Maika; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Scheinfeldt, Laura; Beggs, William; Tishkoff, Sarah A.] Univ Penn, Dept Genet & Biol, Philadelphia, PA 19104 USA; [Ibrahim, Muntaser] Univ Khartoum, Inst Endem Dis, Dept Mol Biol, Khartoum, Sudan; [Lema, Godfrey; Nyambo, Thomas B.] Muhimbili Univ Hlth & Allied Sci, Dept Biochem, Dar Es Salaam, Tanzania; [Omar, Sabah A.] Ctr Biotechnol Res & Dev, Kenya Med Res Inst, Nairobi, Kenya; [Bodo, Jean-Marie] Musee Homme Paris, MNHN, IRD, Unite Mixte Rech UMR 208, Paris, France; [Froment, Alain] Minist Rech Sci & Innovat, Yaounde, Cameroon; [Donnelly, Michael P.; Kidd, Kenneth K.] Yale Univ, Dept Genet, New Haven, CT USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Pennsylvania; University of Khartoum; Muhimbili University of Health & Allied Sciences; Kenya Medical Research Institute; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Yale University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Antonacci, Francesca/F-5457-2013	Antonacci, Francesca/0000-0002-5833-6186; Kidd, Jeffrey/0000-0002-9631-1465; Sudmant, Peter/0000-0002-9573-8248; Meltz Steinberg, Karyn/0000-0002-8676-3337; Scheinfeldt, Laura/0000-0001-6529-6701	Ruth L. Kirschstein National Research Service Award (NRSA) training grant to the University of Washington [T32HG00035]; individual NRSA Fellowship [F32GM097807, F32HG006070]; Natural Sciences and Engineering Research Council of Canada Fellowship; Ruth L. Kirschstein NRSA training grant to Stanford University [T32HG000044]; US National Institutes of Health [HG002385, HG004120]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002385, T32HG000044, F32HG006070, T32HG000035, P01HG004120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [DP1ES022577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM097807] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award (NRSA) training grant to the University of Washington(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); individual NRSA Fellowship; Natural Sciences and Engineering Research Council of Canada Fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ruth L. Kirschstein NRSA training grant to Stanford University; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Akey, M. Dennis and B. Dumont for helpful discussions and C. Alkan for computational assistance. We thank Z. Jiang for his initial work on the H1-H2 alignments. We are grateful to T. Brown for assistance with manuscript preparation, to C. Lee for technical assistance and to the anonymous reviewers of this paper who provided insightful comments. We thank the 1000 Genomes Project Consortium for access to unpublished sequence data for the 17q21.31 locus. K.M.S. was supported by a Ruth L. Kirschstein National Research Service Award (NRSA) training grant to the University of Washington (T32HG00035) and an individual NRSA Fellowship (F32GM097807). C.D.C. was supported by an individual NRSA Fellowship (F32HG006070). P.H.S. was supported by a Natural Sciences and Engineering Research Council of Canada Fellowship. J.M.K. was supported by a Ruth L. Kirschstein NRSA training grant to Stanford University (T32HG000044). This work was supported by the US National Institutes of Health (grants HG002385 and HG004120 to E.E.E.). E.E.E. is an Investigator of the Howard Hughes Medical Institute.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Antonacci F, 2010, NAT GENET, V42, P745, DOI 10.1038/ng.643; Antonacci F, 2009, HUM MOL GENET, V18, P2555, DOI 10.1093/hmg/ddp187; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Boettger LM, 2012, NAT GENET, V44, P881, DOI 10.1038/ng.2334; Bradley RG, 2008, ARCH GEN PSYCHIAT, V65, P190, DOI 10.1001/archgenpsychiatry.2007.26; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Campbell CD, 2011, AM J HUM GENET, V88, P317, DOI 10.1016/j.ajhg.2011.02.004; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Dawkins R, 1999, IMMUNOL REV, V167, P275, DOI 10.1111/j.1600-065X.1999.tb01399.x; Dobzhansky T, 1938, GENETICS, V23, P28; DOBZHANSKY T, 1950, GENETICS, V35, P288; Donnelly MP, 2010, AM J HUM GENET, V86, P161, DOI 10.1016/j.ajhg.2010.01.007; Dubourg C, 2011, EUR J MED GENET, V54, P144, DOI 10.1016/j.ejmg.2010.11.003; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fledel-Alon A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020321; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Heim C, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.041.2009; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Hoglinger GU, 2011, NAT GENET, V43, P699, DOI 10.1038/ng.859; Igartua C, 2010, CURR PROTOC HUM GENE, V18; Jiang Z, 2007, NAT GENET, V39, P1361, DOI 10.1038/ng.2007.9; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kidd JM, 2008, GENOME RES, V18, P2016, DOI 10.1101/gr.081786.108; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Koolen DA, 2008, J MED GENET, V45, P710, DOI 10.1136/jmg.2008.058701; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Koolen DA, 2012, NAT GENET, V44, P639, DOI 10.1038/ng.2262; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu ZC, 2007, NEUROSCI LETT, V414, P155, DOI 10.1016/j.neulet.2006.12.013; Liu ZC, 2006, NEUROSCI LETT, V404, P358, DOI 10.1016/j.neulet.2006.06.016; Lowry DB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000500; Lupski JR, 2006, NAT GENET, V38, P974, DOI 10.1038/ng0906-974; Mefford HC, 2009, GENOME RES, V19, P1579, DOI 10.1101/gr.094987.109; Myers AJ, 2007, NEUROBIOL DIS, V25, P561, DOI 10.1016/j.nbd.2006.10.018; Pittman AM, 2004, HUM MOL GENET, V13, P1267, DOI 10.1093/hmg/ddh138; Polanczyk G, 2009, ARCH GEN PSYCHIAT, V66, P978, DOI 10.1001/archgenpsychiatry.2009.114; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rao PN, 2010, CYTOGENET GENOME RES, V129, P275, DOI 10.1159/000315901; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Seto-Salvia N, 2011, ARCH NEUROL-CHICAGO, V68, P359, DOI 10.1001/archneurol.2011.17; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Sharp AJ, 2009, HUM MUTAT, V30, P135, DOI 10.1002/humu.20843; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Skipper L, 2004, AM J HUM GENET, V75, P669, DOI 10.1086/424492; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Tobin JE, 2008, NEUROLOGY, V71, P28, DOI 10.1212/01.wnl.0000304051.01650.23; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Zody MC, 2008, NAT GENET, V40, P1076, DOI 10.1038/ng.193; Zollino M, 2012, NAT GENET, V44, P636, DOI 10.1038/ng.2257	60	87	87	0	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2012	44	8					872	+		10.1038/ng.2335	http://dx.doi.org/10.1038/ng.2335			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	979WV	22751100	Green Accepted, Green Submitted			2022-12-25	WOS:000306854700010
J	Astuti, D; Morris, MR; Cooper, WN; Staals, RHJ; Wake, NC; Fews, GA; Gill, H; Gentle, D; Shuib, S; Ricketts, CJ; Cole, T; van Essen, AJ; van Lingen, RA; Neri, G; Opitz, JM; Rump, P; Stolte-Dijkstra, I; Muller, F; Pruijn, GJM; Latif, F; Maher, ER				Astuti, Dewi; Morris, Mark R.; Cooper, Wendy N.; Staals, Raymond H. J.; Wake, Naomi C.; Fews, Graham A.; Gill, Harmeet; Gentle, Dean; Shuib, Salwati; Ricketts, Christopher J.; Cole, Trevor; van Essen, Anthonie J.; van Lingen, Richard A.; Neri, Giovanni; Opitz, John M.; Rump, Patrick; Stolte-Dijkstra, Irene; Mueller, Ferenc; Pruijn, Ger J. M.; Latif, Farida; Maher, Eamonn R.			Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility	NATURE GENETICS			English	Article							SISTER-CHROMATID SEPARATION; FAMILIAL RENAL DYSPLASIA; FETAL GIGANTISM; RNA DEGRADATION; RIBOSOMAL-RNA; NEPHROBLASTOMATOSIS; HAMARTOMAS; 2Q37; EXORIBONUCLEASE; OVEREXPRESSION	Perlman syndrome is a congenital overgrowth syndrome inherited in an autosomal recessive manner that is associated with Wilms tumor susceptibility. We mapped a previously unknown susceptibility locus to 2q37.1 and identified germline mutations in DIS3L2, a homolog of the Schizosaccharomyces pombe dis3 gene, in individuals with Perlman syndrome. Yeast dis3 mutant strains have mitotic abnormalities. Yeast Dis3 and its human homologs, DIS3 and DIS3L1, have exoribonuclease activity and bind to the core RNA exosome complex. DIS3L2 has a different intracellular localization and lacks the PIN domain found in DIS3 and DIS3L1; nevertheless, we show that DIS3L2 has exonuclease activity. DIS3L2 inactivation was associated with mitotic abnormalities and altered expression of mitotic checkpoint proteins. DIS3L2 overexpression suppressed the growth of human cancer cell lines, and knockdown enhanced the growth of these cells. We also detected evidence of DIS3L2 mutations in sporadic Wilms tumor. These observations suggest that DIS3L2 has a critical role in RNA metabolism and is essential for the regulation of cell growth and division.	[Astuti, Dewi; Morris, Mark R.; Cooper, Wendy N.; Wake, Naomi C.; Gill, Harmeet; Gentle, Dean; Shuib, Salwati; Ricketts, Christopher J.; Mueller, Ferenc; Latif, Farida; Maher, Eamonn R.] Univ Birmingham, Ctr Rare Dis & Personalised Med, Sch Clin & Expt Med, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Morris, Mark R.] Wolverhampton Univ, Sch Appl Sci, Wolverhampton WV1 1DJ, W Midlands, England; [Staals, Raymond H. J.; Pruijn, Ger J. M.] Radboud Univ Nijmegen, Dept Biomol Chem, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Staals, Raymond H. J.; Pruijn, Ger J. M.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 ED Nijmegen, Netherlands; [Fews, Graham A.; Cole, Trevor; Maher, Eamonn R.] Birmingham Womens Hosp, W Midlands Reg Genet Serv, Birmingham, W Midlands, England; [van Essen, Anthonie J.; Rump, Patrick; Stolte-Dijkstra, Irene] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [van Lingen, Richard A.] Isala Clin, Dept Pediat, Zwolle, Netherlands; [Neri, Giovanni] Univ Cattolica Sacro Cuore, Ist Genet Med, Rome, Italy; [Opitz, John M.] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Opitz, John M.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Opitz, John M.] Univ Utah, Dept Obstet, Salt Lake City, UT USA; [Opitz, John M.] Univ Utah, Dept Gynecol, Salt Lake City, UT USA	University of Birmingham; University of Wolverhampton; Radboud University Nijmegen; Radboud University Nijmegen; Birmingham Women's Hospital; University of Groningen; Isala Clinics; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Maher, ER (corresponding author), Univ Birmingham, Ctr Rare Dis & Personalised Med, Sch Clin & Expt Med, Coll Med & Dent Sci, Birmingham, W Midlands, England.	e.r.maher@bham.ac.uk	Pruijn, Ger/D-6664-2012; MAHER, EAMONN R/A-9507-2008; Muller, Ferenc/C-6426-2009; Ricketts, Christopher/AAV-9580-2020; Morris, Mark/C-6413-2008; Staals, Raymond/AAD-6871-2020	MAHER, EAMONN R/0000-0002-6226-6918; Staals, Raymond/0000-0002-5741-9457; mueller, ferenc/0000-0002-0996-774X; Morris, Mark/0000-0002-0700-355X; Astuti, Dewi/0000-0003-4205-6160	Association of International Cancer Research [07-0503]; Cancer Research UK [C485/A5441]	Association of International Cancer Research; Cancer Research UK(Cancer Research UK)	We thank J. Arrand for processing the Affymetrix 50k SNP chip. We thank the Association of International Cancer Research (07-0503) and Cancer Research UK (C485/A5441) for financial support.	Alessandri JL, 2008, AM J MED GENET A, V146A, P2532, DOI 10.1002/ajmg.a.32391; Baujat G, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-36; Bocciardi R, 2007, HUM MUTAT, V28, P724, DOI 10.1002/humu.20511; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Coleman ML, 2003, EMBO J, V22, P2036, DOI 10.1093/emboj/cdg189; CONRAD B, 1995, CLIN GENET, V48, P134; Drake KM, 2009, CLIN CANCER RES, V15, P5985, DOI 10.1158/1078-0432.CCR-09-1065; Drummond IA, 2010, METHOD CELL BIOL, V100, P233, DOI 10.1016/B978-0-12-384892-5.00009-8; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; Frio TR, 2010, NEW ENGL J MED, V363, P2628, DOI 10.1056/NEJMoa1006565; GREENBERG F, 1988, AM J MED GENET, V29, P773, DOI 10.1002/ajmg.1320290406; GREENBERG F, 1986, AM J MED GENET, V24, P101, DOI 10.1002/ajmg.1320240112; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Henneveld HT, 1999, AM J MED GENET, V86, P439, DOI 10.1002/(SICI)1096-8628(19991029)86:5<439::AID-AJMG9>3.3.CO;2-W; Kelly AE, 2009, CURR OPIN CELL BIOL, V21, P51, DOI 10.1016/j.ceb.2009.01.004; Kiss DL, 2010, RNA, V16, P781, DOI 10.1261/rna.1906710; Lanktree MB, 2011, AM J HUM GENET, V88, P6, DOI 10.1016/j.ajhg.2010.11.007; Lapunzina P, 2005, AM J MED GENET C, V137C, P53, DOI 10.1002/ajmg.c.30064; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; LIBAN E, 1970, CANCER, V25, P885, DOI 10.1002/1097-0142(197004)25:4<885::AID-CNCR2820250420>3.0.CO;2-#; Lim DHK, 2010, ADV GENET, V70, P145, DOI [10.1016/B978-0-12-380866-0.60006-X, 10.1016/S0065-2660(10)70006-7]; Moncla A, 2007, HUM MUTAT, V28, P1183, DOI 10.1002/humu.20611; NERI G, 1984, AM J MED GENET, V19, P195, DOI 10.1002/ajmg.1320190120; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Noguchi E, 1996, EMBO J, V15, P5595, DOI 10.1002/j.1460-2075.1996.tb00944.x; OHKURA H, 1988, EMBO J, V7, P1465, DOI 10.1002/j.1460-2075.1988.tb02964.x; PERLMAN M, 1986, AM J MED GENET, V25, P793, DOI 10.1002/ajmg.1320250418; PERLMAN M, 1975, CANCER, V35, P1212, DOI 10.1002/1097-0142(197504)35:4<1212::AID-CNCR2820350427>3.0.CO;2-2; PERLMAN M, 1973, J PEDIATR-US, V83, P414, DOI 10.1016/S0022-3476(73)80264-1; Rozen S, 2000, Methods Mol Biol, V132, P365; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schilders G, 2005, NUCLEIC ACIDS RES, V33, P6795, DOI 10.1093/nar/gki982; Schneider C, 2007, MOL CELL, V27, P324, DOI 10.1016/j.molcel.2007.06.006; Schulte-Merker S., 2005, ZEBRAFISH PRACTICAL, P39; Shiomi T, 1998, J BIOCHEM-TOKYO, V123, P883; Slanchev K, 2011, HUM MOL GENET, V20, P3119, DOI 10.1093/hmg/ddr214; Staals RHJ, 2010, EMBO J, V29, P2358, DOI 10.1038/emboj.2010.122; Suzuki N, 2001, GENETICS, V158, P613; Tomecki R, 2010, EMBO J, V29, P2342, DOI 10.1038/emboj.2010.121; Tomecki R, 2010, CHEMBIOCHEM, V11, P938, DOI 10.1002/cbic.201000025; Viot-Szoboszlai G, 1998, CLIN GENET, V53, P278; Wang SW, 2008, MOL CELL BIOL, V28, P656, DOI 10.1128/MCB.01531-07; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	44	159	167	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2012	44	3					277	U75		10.1038/ng.1071	http://dx.doi.org/10.1038/ng.1071			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	899VC	22306653				2022-12-25	WOS:000300843600012
J	Bonnefond, A; Clement, N; Fawcett, K; Yengo, L; Vaillant, E; Guillaume, JL; Dechaume, A; Payne, F; Roussel, R; Czernichow, S; Hercberg, S; Hadjadj, S; Balkau, B; Marre, M; Lantieri, O; Langenberg, C; Bouatia-Naji, N; Charpentier, G; Vaxillaire, M; Rocheleau, G; Wareham, NJ; Sladek, R; McCarthy, MI; Dina, C; Barroso, I; Jockers, R; Froguel, P				Bonnefond, Amelie; Clement, Nathalie; Fawcett, Katherine; Yengo, Loic; Vaillant, Emmanuel; Guillaume, Jean-Luc; Dechaume, Aurelie; Payne, Felicity; Roussel, Ronan; Czernichow, Sebastien; Hercberg, Serge; Hadjadj, Samy; Balkau, Beverley; Marre, Michel; Lantieri, Olivier; Langenberg, Claudia; Bouatia-Naji, Nabila; Charpentier, Guillaume; Vaxillaire, Martine; Rocheleau, Ghislain; Wareham, Nicholas J.; Sladek, Robert; McCarthy, Mark I.; Dina, Christian; Barroso, Ines; Jockers, Ralf; Froguel, Philippe		Meta-Anal Glucose Insulin-Related	Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; FASTING PLASMA-GLUCOSE; GENERAL-POPULATION; RISK; DISEASES; EXCESS; LOCI	Genome-wide association studies have revealed that common noncoding variants in MTNR1B (encoding melatonin receptor 1B, also known as MT2) increase type 2 diabetes (T2D) risk(1,2). Although the strongest association signal was highly significant (P < 1 x 10(-20)), its contribution to T2D risk was modest (odds ratio (OR) of similar to 1.10-1.15)(1-3). We performed large-scale exon resequencing in 7,632 Europeans, including 2,186 individuals with T2D, and identified 40 nonsynonymous variants, including 36 very rare variants (minor allele frequency (MAF) < 0.1%), associated with T2D (OR = 3.31, 95% confidence interval (CI) = 1.78-6.18; P = 1.64 x 10(-4)). A four-tiered functional investigation of all 40 mutants revealed that 14 were nonfunctional and rare (MAF < 1%), and 4 were very rare with complete loss of melatonin binding and signaling capabilities. Among the very rare variants, the partial-or total-loss-of-function variants but not the neutral ones contributed to T2D (OR = 5.67, CI = 2.17-14.82; P = 4.09 x 10(-4)). Genotyping the four complete loss-of-function variants in 11,854 additional individuals revealed their association with T2D risk (8,153 individuals with T2D and 10,100 controls; OR = 3.88, CI = 1.49-10.07; P = 5.37 x 10(-3)). This study establishes a firm functional link between MTNR1B and T2D risk.	[Bonnefond, Amelie; Yengo, Loic; Vaillant, Emmanuel; Dechaume, Aurelie; Bouatia-Naji, Nabila; Vaxillaire, Martine; Froguel, Philippe] Lille Pasteur Inst, CNRS, Unite Mixte Rech UMR 8199, Lille, France; [Bonnefond, Amelie; Yengo, Loic; Vaillant, Emmanuel; Dechaume, Aurelie; Bouatia-Naji, Nabila; Vaxillaire, Martine; Froguel, Philippe] Lille Nord France Univ, Ecole Doctorale Biol Sante, Lille, France; [Guillaume, Jean-Luc; Jockers, Ralf] Inst Cochin, INSERM, U1016, Paris, France; [Clement, Nathalie; Guillaume, Jean-Luc; Jockers, Ralf] CNRS, UMR 8104, Paris, France; [Clement, Nathalie; Guillaume, Jean-Luc; Jockers, Ralf] Paris Descartes Univ, Dept Med, Paris, France; [Fawcett, Katherine; Payne, Felicity; Barroso, Ines] Wellcome Trust Sanger Inst, Cambridge, England; [Roussel, Ronan; Marre, Michel] Bichat Claude Bernard Univ Hosp, AP HP, Dept Endocrinol Diabetol & Nutr, Paris, France; [Roussel, Ronan; Marre, Michel] Univ Paris 07, INSERM, U695, Paris, France; [Czernichow, Sebastien] Ambroise Pare Hosp, AP HP, Dept Nutr, Boulogne, France; [Czernichow, Sebastien] Univ Versailles Saint Quentin, Unite Format & Rech UFR Sci Sante, Boulogne, France; [Hercberg, Serge] Univ Paris 13, Ctr Rech Nutr Humaine, Inst Natl Rech Agron, INSERM,U557,U1125, Bobigny, France; [Hercberg, Serge] Avicenne Hosp, AP HP, Dept Publ Hlth, Bobigny, France; [Hadjadj, Samy] Ctr Hosp Univ Poitiers, Dept Endocrinol & Diabetol, Poitiers, France; [Hadjadj, Samy] Clin Invest Ctr Poitiers Biotheque CIC0802, INSERM, U927, Poitiers, France; [Balkau, Beverley] Ctr Res Epidemiol & Populat Hlth, INSERM, U780, Villejuif, France; [Balkau, Beverley] Univ Paris 11, Orsay, France; [Lantieri, Olivier] Inst Interreg Sante IRSA, La Riche, France; [Langenberg, Claudia] Univ Cambridge, MRC, Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Charpentier, Guillaume] Corbeil Essonnes Hosp, Dept Endocrinol & Diabetol, Essonnes, France; [Rocheleau, Ghislain] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada; [Rocheleau, Ghislain] Prognomix, Montreal, PQ, Canada; [Sladek, Robert] McGill Univ, Fac Med, Dept Human Genet, Montreal, PQ, Canada; [Sladek, Robert] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Dina, Christian] Inst Thorax, INSERM, U915, Nantes, France; [Dina, Christian] CNRS, Equipe Rech Labellisee 3147, Nantes, France; [Dina, Christian] Univ Nantes, Dept Biol Med & Hlth, Nantes, France; [Barroso, Ines] Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 2QQ, England; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Dept Genom Common Dis, Sch Publ Hlth, Hammersmith Hosp, London, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Sanofi-Aventis; Sanofi France; UDICE-French Research Universities; Universite Paris Cite; Wellcome Trust Sanger Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; CHU Poitiers; Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Cambridge; Centre Hospitalier Sud Francilien; Universite de Montreal; McGill University; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); Nantes Universite; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Imperial College London	Froguel, P (corresponding author), Lille Pasteur Inst, CNRS, Unite Mixte Rech UMR 8199, Lille, France.	ralf.jockers@inserm.fr; p.froguel@imperial.ac.uk	Serge, Hercberg/F-3038-2017; Bouatia-Naji, Nabila/AGF-1400-2022; Jockers, Ralf/Q-2100-2019; Yengo, Loic/D-2692-2017; HERCBERG, Serge/B-4429-2008; FROGUEL, Philippe/O-6799-2017; BOUATIA-NAJI, NABILA/D-5863-2013; Payne, Felicity/GKF-2573-2022; Langenberg, Claudia/ABG-9067-2021; Sladek, Robert/R-2391-2019; Dina, Christian R/D-3535-2015; Jockers, Ralf/P-2272-2017; Bonnefond, Amélie/O-2784-2017; McCarthy, Mark/M-3763-2015	Serge, Hercberg/0000-0002-3168-1350; Bouatia-Naji, Nabila/0000-0001-5424-2134; Jockers, Ralf/0000-0002-4354-1750; Yengo, Loic/0000-0002-4272-9305; HERCBERG, Serge/0000-0002-3168-1350; FROGUEL, Philippe/0000-0003-2972-0784; Payne, Felicity/0000-0003-4228-581X; Langenberg, Claudia/0000-0002-5017-7344; Sladek, Robert/0000-0002-2730-1204; Dina, Christian R/0000-0002-7722-7348; Jockers, Ralf/0000-0002-4354-1750; Bonnefond, Amélie/0000-0001-9976-3005; Marre, Michel/0000-0002-3071-1837; Fawcett, Katherine/0000-0002-6675-2112; McCarthy, Mark/0000-0002-4393-0510; Barroso, Ines/0000-0001-5800-4520	French Agence Nationale de la Recherche [ANR-08-GENOPAT, ANR-11-blanc 'MLT2D', ANR-11-META 'MELA-BETES']; Contrat de Projects Etat-Region Nord-Pas-De-Calais (CPER); Societe Francophone du Diabete; Fondation Recherche Medicale; Inserm; CNRS; Wellcome Trust [077016/Z/05/Z]; UK National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre; MRC Centre for Obesity and Related Metabolic Diseases; Medical Research Council [MC_U106179471, G0600717B] Funding Source: researchfish	French Agence Nationale de la Recherche(French National Research Agency (ANR)); Contrat de Projects Etat-Region Nord-Pas-De-Calais (CPER)(Region Hauts-de-France); Societe Francophone du Diabete; Fondation Recherche Medicale; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Wellcome Trust(Wellcome Trust); UK National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre; MRC Centre for Obesity and Related Metabolic Diseases(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are sincerely indebted to all participants in the genetic study. We thank M. Deweirder and F. Allegaert for their technical assistance and their invaluable management of DNA samples and B. Gardiola-Lemaitre for her invaluable advice. This study was supported by the French Agence Nationale de la Recherche (ANR-08-GENOPAT to P. F. and ANR-11-blanc 'MLT2D' and ANR-11-META 'MELA-BETES' to R. J. and P. F.), the Contrat de Projects Etat-Region Nord-Pas-De-Calais (CPER 2007-2013 'Axe Cardio-Diabete' to P. F.), the Societe Francophone du Diabete (to A. B.), the Fondation Recherche Medicale ('Equipe FRM' to R. J.), Inserm and CNRS. I. B. acknowledges funding from the Wellcome Trust (077016/Z/05/Z) and from the UK National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre and the MRC Centre for Obesity and Related Metabolic Diseases.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; Andersson EA, 2010, DIABETES, V59, P1539, DOI 10.2337/db09-1757; Ayoub MA, 2002, J BIOL CHEM, V277, P21522, DOI 10.1074/jbc.M200729200; Balkau B, 1996, REV EPIDEMIOL SANTE, V44, P373; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Downes K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012646; Dubocovich ML, 2010, PHARMACOL REV, V62, P343, DOI 10.1124/pr.110.002832; Dubovsky SL, 2009, EXPERT OPIN INV DRUG, V18, P1533, DOI 10.1517/13543780903292634; Hadjadj S, 2008, DIABETES CARE, V31, P1847, DOI 10.2337/dc07-2079; Hercberg S, 1998, CONTROL CLIN TRIALS, V19, P336, DOI 10.1016/S0197-2456(98)00015-4; Jockers R, 2008, BRIT J PHARMACOL, V154, P1182, DOI 10.1038/bjp.2008.184; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Meyre D, 2004, DIABETES, V53, P803, DOI 10.2337/diabetes.53.3.803; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Peschke E, 2010, BEST PRACT RES CL EN, V24, P829, DOI 10.1016/j.beem.2010.09.001; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Syddall HE, 2005, INT J EPIDEMIOL, V34, P1234, DOI 10.1093/ije/dyi127; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; WILLIAMS DRR, 1995, DIABETIC MED, V12, P30, DOI 10.1111/j.1464-5491.1995.tb02058.x	29	266	269	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2012	44	3					297	U98		10.1038/ng.1053	http://dx.doi.org/10.1038/ng.1053			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	899VC	22286214	Green Accepted			2022-12-25	WOS:000300843600015
J	Hergenreider, E; Heydt, S; Treguer, K; Boettger, T; Horrevoets, AJG; Zeiher, AM; Scheffer, MP; Frangakis, AS; Yin, XK; Mayr, M; Braun, T; Urbich, C; Boon, RA; Dimmeler, S				Hergenreider, Eduard; Heydt, Susanne; Treguer, Karine; Boettger, Thomas; Horrevoets, Anton J. G.; Zeiher, Andreas M.; Scheffer, Margot P.; Frangakis, Achilleas S.; Yin, Xiaoke; Mayr, Manuel; Braun, Thomas; Urbich, Carmen; Boon, Reinier A.; Dimmeler, Stefanie			Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs	NATURE CELL BIOLOGY			English	Article							TRANSCRIPTION FACTOR; MICRORNAS; EXPRESSION; MECHANISM; KLF2; FLOW; MICROPARTICLES; INTEGRATION; REGULATOR; PHENOTYPE	The shear-responsive transcription factor Kruppel-like factor 2 (KLF2) is a critical regulator of endothelial gene expression patterns induced by atheroprotective flow. As microRNAs (miRNAs) post-transcriptionally control gene expression in many pathogenic and physiological processes, we investigated the regulation of miRNAs by KLF2 in endothelial cells. KLF2 binds to the promoter and induces a significant upregulation of the miR-143/145 cluster. Interestingly, miR-143/145 has been shown to control smooth muscle cell (SMC) phenotypes; therefore, we investigated the possibility of transport of these miRNAs between endothelial cells and SMCs. Indeed, extracellular vesicles secreted by KLF2-transduced or shear-stress-stimulated HUVECs are enriched in miR-143/145 and control target gene expression in co-cultured SMCs. Extracellular vesicles derived from KLF2-expressing endothelial cells also reduced atherosclerotic lesion formation in the aorta of ApoE(-/-) mice. Combined, our results show that atheroprotective stimuli induce communication between endothelial cells and SMCs through an miRNA- and extracellular-vesicle-mediated mechanism and that this may comprise a promising strategy to combat atherosclerosis.	[Hergenreider, Eduard; Heydt, Susanne; Treguer, Karine; Urbich, Carmen; Boon, Reinier A.; Dimmeler, Stefanie] Goethe Univ Hosp, Ctr Mol Med, Inst Cardiovasc Regenerat, D-60590 Frankfurt, Germany; [Boettger, Thomas; Braun, Thomas] Max Planck Inst Heart & Lung Res, D-61231 Bad Nauheim, Germany; [Horrevoets, Anton J. G.] Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, NL-1007 MB Amsterdam, Netherlands; [Zeiher, Andreas M.] Goethe Univ Hosp, Dept Internal Med 3, D-60590 Frankfurt, Germany; [Scheffer, Margot P.; Frangakis, Achilleas S.] Goethe Univ Frankfurt, Inst Biophys, D-60438 Frankfurt, Germany; [Yin, Xiaoke; Mayr, Manuel] Kings Coll London, Div Cardiovasc, London SE5 9NU, England	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Max Planck Society; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; University of London; King's College London	Dimmeler, S (corresponding author), Goethe Univ Hosp, Ctr Mol Med, Inst Cardiovasc Regenerat, D-60590 Frankfurt, Germany.	dimmeler@em.uni-frankfurt.de	Boon, Reinier A/E-8423-2011; Boettger, Thomas/E-3406-2012; Braun, Thomas/B-2310-2008; Yin, Xiaoke/AAZ-2658-2020	Boon, Reinier A/0000-0001-7944-9748; Boettger, Thomas/0000-0003-4280-8449; Yin, Xiaoke/0000-0002-5172-0935; Frangakis, Achilleas/0000-0002-8067-6611; Braun, Thomas/0000-0002-6165-4804; Mayr, Manuel/0000-0002-0597-829X; Dimmeler, Stefanie/0000-0002-1045-2436; Scheffer, Margot/0000-0001-7067-8958	Deutsche Forschungsgemeinschaft [SFB834, SFB902]; Excellence Cluster Cardiopulmonary System [Exc 147-1]; European Research Council; British Heart Foundation [FS/08/002/24537, SP/12/5/29574] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Cluster Cardiopulmonary System(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); British Heart Foundation(British Heart Foundation)	We thank M. Muhly-Reinholz, A. Fischer and N. Reinfeld for technical assistance. This study was supported by the Deutsche Forschungsgemeinschaft (SFB834 and SFB902), the Excellence Cluster Cardiopulmonary System (Exc 147-1) and the European Research Council (Advanced grant 'Angiomirs').	Aliotta JM, 2010, EXP HEMATOL, V38, P233, DOI 10.1016/j.exphem.2010.01.002; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Boon RA, 2009, HAMOSTASEOLOGIE, V29, P39, DOI 10.1055/s-0037-1616937; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Chan LS, 2009, EUR J PHARM SCI, V38, P370, DOI 10.1016/j.ejps.2009.08.008; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Davies PF, 1999, TRENDS BIOTECHNOL, V17, P347, DOI 10.1016/S0167-7799(99)01348-7; Dekker RJ, 2006, BLOOD, V107, P4354, DOI 10.1182/blood-2005-08-3465; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Fang Y, 2010, P NATL ACAD SCI USA, V107, P13450, DOI 10.1073/pnas.1002120107; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Kazenwadel J, 2010, BLOOD, V116, P2395, DOI 10.1182/blood-2009-12-256297; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; Li L, 2010, SCAND J IMMUNOL, V71, P227, DOI 10.1111/j.1365-3083.2010.02383.x; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mayr M, 2009, CIRC-CARDIOVASC GENE, V2, P379, DOI 10.1161/CIRCGENETICS.108.842849; Montgomery RL, 2010, CURR DRUG TARGETS, V11, P936; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Prokopi M, 2009, BLOOD, V114, P723, DOI 10.1182/blood-2009-02-205930; Qin XM, 2010, P NATL ACAD SCI USA, V107, P3240, DOI 10.1073/pnas.0914882107; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang KC, 2010, P NATL ACAD SCI USA, V107, P3234, DOI 10.1073/pnas.0914825107; Wu JH, 2008, J BIOL CHEM, V283, P3942, DOI 10.1074/jbc.M707882200; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhang CX, 2009, CIRCULATION, V120, pS584; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zhu N, 2011, ATHEROSCLEROSIS, V215, P286, DOI 10.1016/j.atherosclerosis.2010.12.024	44	972	1045	7	262	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2012	14	3					249	+		10.1038/ncb2441	http://dx.doi.org/10.1038/ncb2441			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	900ZE	22327366				2022-12-25	WOS:000300930400007
J	Iqbal, Z; Caccamo, M; Turner, I; Flicek, P; McVean, G				Iqbal, Zamin; Caccamo, Mario; Turner, Isaac; Flicek, Paul; McVean, Gil			De novo assembly and genotyping of variants using colored de Bruijn graphs	NATURE GENETICS			English	Article							DIPLOID GENOME SEQUENCE; COPY-NUMBER VARIATION; HIGH-RESOLUTION HLA; STRUCTURAL VARIATION; POPULATION-SCALE; POLYMORPHIC GENOMES; CIONA-SAVIGNYI; HAPLOTYPE MAP; STRING GRAPH; GENE	Detecting genetic variants that are highly divergent from a reference sequence remains a major challenge in genome sequencing. We introduce de novo assembly algorithms using colored de Bruijn graphs for detecting and genotyping simple and complex genetic variants in an individual or population. We provide an efficient software implementation, Cortex, the first de novo assembler capable of assembling multiple eukaryotic genomes simultaneously. Four applications of Cortex are presented. First, we detect and validate both simple and complex structural variations in a high-coverage human genome. Second, we identify more than 3 Mb of sequence absent from the human reference genome, in pooled low-coverage population sequence data from the 1000 Genomes Project. Third, we show how population information from ten chimpanzees enables accurate variant calls without a reference sequence. Last, we estimate classical human leukocyte antigen (HLA) genotypes at HLA-B, the most variable gene in the human genome.	[Iqbal, Zamin; Turner, Isaac; McVean, Gil] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Iqbal, Zamin; Flicek, Paul] European Bioinformat Inst, Hinxton, England; [Caccamo, Mario] Genome Anal Ctr, Norwich, Norfolk, England; [McVean, Gil] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of Oxford; Wellcome Centre for Human Genetics; European Molecular Biology Laboratory (EMBL); The Genome Analysis Centre (TGAC); University of Oxford	McVean, G (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	mcvean@well.ox.ac.uk	Turner, Isaac/T-1092-2019	Turner, Isaac/0000-0002-2378-4886; McVean, Gil/0000-0002-5012-4162; Iqbal, Zamin/0000-0001-8466-7547; Flicek, Paul/0000-0002-3897-7955	Wellcome Trust [WT086084/Z/08/Z, 090532/Z/09/Z]; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193] Funding Source: researchfish; BBSRC [BBS/E/T/000PR6193] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We would like to thank the members of the 1000 Genomes Project Consortium for discussion, suggestions and sequencing data. We thank B. Ahiska, A. Auton, E. Birney, R. Durbin, G. Lunter, J. Woolf and D. Zerbino for discussion, two anonymous reviewers for their comments and members of the PanMap Project and the Genomics Core at the Wellcome Trust Centre for Human Genetics for access to sequence data. Z.I. is funded by a grant from the Wellcome Trust (WT086084/Z/08/Z to G.M.). The sequencing of NA12878 was performed by the Wellcome Trust Sequencing Core at Oxford, under a grant from the Wellcome Trust (090532/Z/09/Z).	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; ALLSOPP CEM, 1991, HUM IMMUNOL, V30, P105, DOI 10.1016/0198-8859(91)90078-N; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chaisson MJ, 2009, GENOME RES, V19, P336, DOI 10.1101/gr.079053.108; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Ding L, 2010, HUM MOL GENET, V19, pR188, DOI 10.1093/hmg/ddq391; Donmez N, 2011, LECT N BIOINFORMAT, V6577, P38, DOI 10.1007/978-3-642-20036-6_5; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Ge F, 2005, PLOS BIOL, V3, P1709, DOI 10.1371/journal.pbio.0030316; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Hajirasouliha I, 2010, BIOINFORMATICS, V26, P1277, DOI 10.1093/bioinformatics/btq152; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Holcomb CL, 2011, TISSUE ANTIGENS, V77, P206, DOI 10.1111/j.1399-0039.2010.01606.x; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Idury R M, 1995, J Comput Biol, V2, P291, DOI 10.1089/cmb.1995.2.291; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r116; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kidd JM, 2010, CELL, V143, P837, DOI 10.1016/j.cell.2010.10.027; Kim JH, 2007, GENOME RES, V17, P1101, DOI 10.1101/gr.5894107; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Korbel JO, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r23; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee S, 2009, NAT METHODS, V6, P473, DOI 10.1038/nmeth.f.256; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Myers E W, 1995, J Comput Biol, V2, P275, DOI 10.1089/cmb.1995.2.275; Myers EW, 2005, BIOINFORMATICS, V21, P79, DOI 10.1093/bioinformatics/bti1114; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Peterlongo P, 2010, LECT NOTES COMPUT SC, V6393, P147, DOI 10.1007/978-3-642-16321-0_14; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Ratan A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-130; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Simpson JT, 2010, BIOINFORMATICS, V26, pi367, DOI 10.1093/bioinformatics/btq217; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Vinson JP, 2005, GENOME RES, V15, P1127, DOI 10.1101/gr.3722605; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zerbino DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008407	52	360	386	2	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2012	44	2					226	232		10.1038/ng.1028	http://dx.doi.org/10.1038/ng.1028			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	22231483	Green Accepted			2022-12-25	WOS:000299664400025
J	Jaumann, M; Dettling, J; Gubelt, M; Zimmermann, U; Gerling, A; Paquet-Durand, F; Feil, S; Wolpert, S; Franz, C; Varakina, K; Xiong, H; Brandt, N; Kuhn, S; Geisler, HS; Rohbock, K; Ruth, P; Schlossmann, J; Hutter, J; Sandner, P; Feil, R; Engel, J; Knipper, M; Ruttiger, L				Jaumann, Mirko; Dettling, Juliane; Gubelt, Martin; Zimmermann, Ulrike; Gerling, Andrea; Paquet-Durand, Francois; Feil, Susanne; Wolpert, Stephan; Franz, Christoph; Varakina, Ksenya; Xiong, Hao; Brandt, Niels; Kuhn, Stephanie; Geisler, Hyun-Soon; Rohbock, Karin; Ruth, Peter; Schlossmann, Jens; Huetter, Joachim; Sandner, Peter; Feil, Robert; Engel, Jutta; Knipper, Marlies; Ruettiger, Lukas			cGMP-Prkg1 signaling and Pde5 inhibition shelter cochlear hair cells and hearing function	NATURE MEDICINE			English	Article							GUINEA-PIG COCHLEA; DEPENDENT PROTEIN-KINASE; P2X(2) RECEPTOR SUBUNIT; NITRIC-OXIDE SYNTHASE; CYCLIC-GMP; STEREOCILIA DAMAGE; POTASSIUM CURRENT; INNER-EAR; CGMP; PHOSPHODIESTERASE	Noise-induced hearing loss (NIHL) is a global health hazard with considerable pathophysiological and social consequences that has no effective treatment. In the heart, lung and other organs, cyclic guanosine monophosphate (cGMP) facilitates protective processes in response to traumatic events. We therefore analyzed NIHL in mice with a genetic deletion of the gene encoding cGMP-dependent protein kinase type 1 (Prkg1) and found a greater vulnerability to and markedly less recovery from NIHL in these mice as compared to mice without the deletion. Prkg1 was expressed in the sensory cells and neurons of the inner ear of wild-type mice, and its expression partly overlapped with the expression profile of cGMP-hydrolyzing phosphodiesterase 5 (Pde5). Treatment of rats and wild-type mice with the Pde5 inhibitor vardenafil almost completely prevented NIHL and caused a Prkg1-dependent upregulation of poly (ADP-ribose) in hair cells and the spiral ganglion, suggesting an endogenous protective cGMP-Prkg1 signaling pathway that culminates in the activation of poly (ADP-ribose) polymerase. These data suggest vardenafil or related drugs as possible candidates for the treatment of NIHL.	[Jaumann, Mirko; Dettling, Juliane; Gubelt, Martin; Zimmermann, Ulrike; Wolpert, Stephan; Franz, Christoph; Varakina, Ksenya; Xiong, Hao; Geisler, Hyun-Soon; Rohbock, Karin; Knipper, Marlies; Ruettiger, Lukas] Univ Tubingen, Dept Otolaryngol, THRC, Tubingen, Germany; [Gerling, Andrea; Feil, Susanne; Feil, Robert] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Paquet-Durand, Francois] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Div Expt Ophthalmol, Tubingen, Germany; [Brandt, Niels; Kuhn, Stephanie; Engel, Jutta] Univ Tubingen, Inst Physiol 2, D-7400 Tubingen, Germany; [Brandt, Niels; Engel, Jutta] Univ Saarland, Dept Biophys, Fac Med, D-6650 Homburg, Germany; [Ruth, Peter] Univ Tubingen, Inst Pharm, Dept Pharmacol & Toxicol, Tubingen, Germany; [Schlossmann, Jens] Univ Regensburg, Dept Pharmacol & Toxicol, Regensburg, Germany; [Huetter, Joachim; Sandner, Peter] Bayer Hlth Care Pharmaceut, Global Drug Discovery Common Mech Res, Pharma Res Ctr Wuppertal, Wuppertal, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Saarland University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Regensburg; Bayer AG	Ruttiger, L (corresponding author), Univ Tubingen, Dept Otolaryngol, THRC, Tubingen, Germany.	lukas.ruettiger@uni-tuebingen.de	Paquet-Durand, Francois/G-6709-2015; Feil, Susanne/AAF-7032-2019; Feil, Robert/B-8918-2014; Schlossmann, Jens/I-7743-2016	Paquet-Durand, Francois/0000-0001-7355-5742; Feil, Robert/0000-0002-7335-4841; Schlossmann, Jens/0000-0002-2550-6839; , Stephanie/0000-0001-6633-9478	Marie Curie Research Training Network CavNET [MRTN-CT-2006-035367]; Royal National Institute for Deaf People (RNID) [G54_Ruttiger]; Hahn Stiftung (Index AG); University of Tubingen; Landesgraduiertenforderung Baden-Wurttemberg, Germany; Kerstan Stiftung; Deutsche Forschungsgemeinschaft (DFG) [PA1751/1-1, DFG Fe 438/2]	Marie Curie Research Training Network CavNET(European Commission); Royal National Institute for Deaf People (RNID); Hahn Stiftung (Index AG); University of Tubingen; Landesgraduiertenforderung Baden-Wurttemberg, Germany; Kerstan Stiftung; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We thank S. Kasperek for excellent technical assistance and R. Panford-Walsh for proofreading the manuscript. This work was supported by the Marie Curie Research Training Network CavNET MRTN-CT-2006-035367, the Royal National Institute for Deaf People (RNID) G54_Ruttiger, the Hahn Stiftung (Index AG), the Graduate Program of the University of Tubingen, the Landesgraduiertenforderung Baden-Wurttemberg, Germany, the Kerstan Stiftung and Deutsche Forschungsgemeinschaft (DFG) PA1751/1-1 and DFG Fe 438/2.	Beneke S, 2007, NUCLEIC ACIDS RES, V35, P7456, DOI 10.1093/nar/gkm735; Chen YS, 2003, ORL-J OTO-RHIN-LARYN, V65, P266, DOI 10.1159/000075224; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Engel J, 2006, NEUROSCIENCE, V143, P837, DOI 10.1016/j.neuroscience.2006.08.060; Feil R, 2006, EMBO REP, V7, P149, DOI 10.1038/sj.embor.7400627; Fiscus RR, 2002, NEUROSIGNALS, V11, P175, DOI 10.1159/000065431; Fuchs PA, 2005, J PHYSIOL-LONDON, V566, P7, DOI 10.1113/jphysiol.2004.082214; Gale JE, 2004, CURR BIOL, V14, P526, DOI 10.1016/j.cub.2004.03.002; Giuliano F, 2010, INT J CLIN PRACT, V64, P240, DOI 10.1111/j.1742-1241.2009.02254.x; Hibino H, 1999, AM J PHYSIOL-CELL PH, V277, pC638, DOI 10.1152/ajpcell.1999.277.4.C638; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Hong BN, 2008, BIOL PHARM BULL, V31, P1981, DOI 10.1248/bpb.31.1981; Housley GD, 1999, J NEUROSCI, V19, P8377; Johnson SL, 2011, NAT NEUROSCI, V14, P711, DOI 10.1038/nn.2803; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Kim YM, 1999, J NEUROSCI, V19, P6740, DOI 10.1523/JNEUROSCI.19-16-06740.1999; Komalavilas P, 1999, J BIOL CHEM, V274, P34301, DOI 10.1074/jbc.274.48.34301; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; LIBERMAN MC, 1984, HEARING RES, V16, P43, DOI 10.1016/0378-5955(84)90024-8; LIBERMAN MC, 1990, HEARING RES, V49, P209, DOI 10.1016/0378-5955(90)90105-X; LIBERMAN MC, 1984, HEARING RES, V16, P55, DOI 10.1016/0378-5955(84)90025-X; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Maddox PT, 2009, LARYNGOSCOPE, V119, P1586, DOI 10.1002/lary.20511; Marcotti W, 1999, J PHYSIOL-LONDON, V520, P653, DOI 10.1111/j.1469-7793.1999.00653.x; McGwin G, 2010, ARCH OTOLARYNGOL, V136, P488, DOI 10.1001/archoto.2010.51; Meltser I, 2009, J NEUROTRAUM, V26, P1835, DOI 10.1089/neu.2008.0874; Murai N, 2008, J NEUROTRAUM, V25, P72, DOI 10.1089/neu.2007.0346; Paquet-Durand F, 2007, J NEUROSCI, V27, P10311, DOI 10.1523/JNEUROSCI.1514-07.2007; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; Porst H, 2011, EUR UROL, V60, P1105, DOI 10.1016/j.eururo.2011.08.005; Ruben RJ, 1967, ACTA OTO LARYNGOLOGI, V220, P221; Ruttiger L, 2004, P NATL ACAD SCI USA, V101, P12922, DOI 10.1073/pnas.0402660101; Sahaboglu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015495; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Shen J, 2006, BRAIN RES, V1081, P101, DOI 10.1016/j.brainres.2005.12.129; Shen J, 2005, EUR J NEUROSCI, V21, P2912, DOI 10.1111/j.1460-9568.2005.04135.x; Shen J, 2003, NEUROSCI LETT, V337, P135, DOI 10.1016/S0304-3940(02)01320-4; Sugasawa M, 1996, J PHYSIOL-LONDON, V491, P707, DOI 10.1113/jphysiol.1996.sp021251; Szabo C, 2006, NITRIC OXIDE-BIOL CH, V14, P169, DOI 10.1016/j.niox.2005.06.008; Takeda-Nakazawa H, 2007, HEARING RES, V227, P59, DOI 10.1016/j.heares.2006.09.007; THOMAS MK, 1990, J BIOL CHEM, V265, P14971; Tian F, 1999, HEARING RES, V131, P63, DOI 10.1016/S0378-5955(99)00015-5; Uemaetomari I, 2009, TOHOKU J EXP MED, V218, P41, DOI 10.1620/tjem.218.41; Vaandrager AB, 2005, FRONT BIOSCI-LANDMRK, V10, P2150, DOI 10.2741/1687; Valtcheva N, 2009, J BIOL CHEM, V284, P556, DOI 10.1074/jbc.M806161200; van Wijk E, 2006, HUM MOL GENET, V15, P751, DOI 10.1093/hmg/ddi490; Wang HL, 2009, J MOL CELL CARDIOL, V47, P304, DOI 10.1016/j.yjmcc.2009.03.021; Wang JCC, 2003, NEUROREPORT, V14, P817, DOI 10.1097/00001756-200305060-00008; Yu ZY, 2006, J BIOL CHEM, V281, P9101, DOI 10.1074/jbc.M511049200	50	63	69	1	14	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					252	259		10.1038/nm.2634	http://dx.doi.org/10.1038/nm.2634			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22270721				2022-12-25	WOS:000300140300039
J	Riedelsheimer, C; Czedik-Eysenberg, A; Grieder, C; Lisec, J; Technow, F; Sulpice, R; Altmann, T; Stitt, M; Willmitzer, L; Melchinger, AE				Riedelsheimer, Christian; Czedik-Eysenberg, Angelika; Grieder, Christoph; Lisec, Jan; Technow, Frank; Sulpice, Ronan; Altmann, Thomas; Stitt, Mark; Willmitzer, Lothar; Melchinger, Albrecht E.			Genomic and metabolic prediction of complex heterotic traits in hybrid maize	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; QUANTITATIVE RESISTANCE; GENETIC-VARIATION; WIDE ASSOCIATION; LEAF-BLIGHT; SELECTION; DIVERSITY; LINES	Maize is both an exciting model organism in plant genetics and also the most important crop worldwide for food, animal feed and bioenergy production. Recent genome-wide association and metabolic profiling studies aimed to resolve quantitative traits to their causal genetic loci and key metabolic regulators. Here we present a complementary approach that exploits large-scale genomic and metabolic information to predict complex, highly polygenic traits in hybrid testcrosses. We crossed 285 diverse Dent inbred lines from worldwide sources with two testers and predicted their combining abilities for seven biomass- and bioenergy-related traits using 56,110 SNPs and 130 metabolites. Whole-genome and metabolic prediction models were built by fitting effects for all SNPs or metabolites. Prediction accuracies ranged from 0.72 to 0.81 for SNPs and from 0.60 to 0.80 for metabolites, allowing a reliable screening of large collections of diverse inbred lines for their potential to create superior hybrids.	[Riedelsheimer, Christian; Grieder, Christoph; Technow, Frank; Melchinger, Albrecht E.] Univ Hohenheim, Inst Plant Breeding Seed Sci & Populat Genet, D-7000 Stuttgart, Germany; [Czedik-Eysenberg, Angelika; Lisec, Jan; Sulpice, Ronan; Stitt, Mark; Willmitzer, Lothar] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Altmann, Thomas] Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Mol Genet, Gatersleben, Germany; [Willmitzer, Lothar] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia	University Hohenheim; Max Planck Society; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; King Abdulaziz University	Melchinger, AE (corresponding author), Univ Hohenheim, Inst Plant Breeding Seed Sci & Populat Genet, D-7000 Stuttgart, Germany.	melchinger@uni-hohenheim.de	Willmitzer, Lothar/F-7377-2011; Technow, Frank/AAC-4994-2019; Stitt, Mark/GVT-1242-2022; Sulpice, Ronan/I-2738-2013	Technow, Frank/0000-0002-2497-3136; Sulpice, Ronan/0000-0002-6113-9570; Melchinger, Albrecht E./0000-0002-8346-7786; Altmann, Thomas/0000-0002-3759-360X; Lisec, Jan/0000-0003-1220-2286; Stitt, Mark/0000-0002-4900-1763	Max-Planck Society; German Federal Ministry of Education and Research (BMBF) [FKZ: 0315045, FKZ: 0315528D]	Max-Planck Society(Max Planck SocietyFoundation CELLEX); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	We thank the staff of the experimental research stations of the University of Hohenheim for assistance in conducting the field experiments. This research was funded by the Max-Planck Society and the German Federal Ministry of Education and Research (BMBF) within the project GABI-Energy (FKZ: 0315045) and the AgroClustEr 'Synbreed-Synergistic plant and animal breeding' (FKZ: 0315528D).	Albrecht T, 2011, THEOR APPL GENET, V123, P339, DOI 10.1007/s00122-011-1587-7; Bernardo R, 2008, CROP SCI, V48, P1649, DOI 10.2135/cropsci2008.03.0131; Ching A, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-19; Clark SA, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-18; de los Campos G, 2010, NAT REV GENET, V11, P880, DOI 10.1038/nrg2898; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; Duvick D. N., 2004, Plant Breeding Reviews, V24, P109; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Eyre-Walker A, 1998, P NATL ACAD SCI USA, V95, P4441, DOI 10.1073/pnas.95.8.4441; Fernie AR, 2009, TRENDS GENET, V25, P39, DOI 10.1016/j.tig.2008.10.010; Fischer S, 2008, PLANT BREEDING, V127, P446, DOI 10.1111/j.1439-0523.2007.01475.x; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Hallauer AR, 2010, HANDB PLANT BREED, V6, P33, DOI 10.1007/978-1-4419-0766-0_2; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Hoisington D, 1999, P NATL ACAD SCI USA, V96, P5937, DOI 10.1073/pnas.96.11.5937; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Keurentjes JJB, 2006, NAT GENET, V38, P842, DOI 10.1038/ng1815; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Lorenzana RE, 2009, THEOR APPL GENET, V120, P151, DOI 10.1007/s00122-009-1166-3; Melchinger AE, 1998, THEOR APPL GENET, V96, P503, DOI 10.1007/s001220050767; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen Theo, 2010, Genetics, V185, P623, DOI 10.1534/genetics.110.116590; Meyer RC, 2007, P NATL ACAD SCI USA, V104, P4759, DOI 10.1073/pnas.0609709104; Montes JM, 2011, FIELD CROP RES, V121, P268, DOI 10.1016/j.fcr.2010.12.017; Montes JM, 2007, TRENDS PLANT SCI, V12, P433, DOI 10.1016/j.tplants.2007.08.006; Nelson PT, 2008, CROP SCI, V48, P1673, DOI 10.2135/cropsci2008.02.0092; Piepho HP, 2009, CROP SCI, V49, P1165, DOI 10.2135/cropsci2008.10.0595; Poland JA, 2011, P NATL ACAD SCI USA, V108, P6893, DOI 10.1073/pnas.1010894108; Saito K, 2010, ANNU REV PLANT BIOL, V61, P463, DOI 10.1146/annurev.arplant.043008.092035; Schauer N, 2006, NAT BIOTECHNOL, V24, P447, DOI 10.1038/nbt1192; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Smith JSC, 2008, MOL BREEDING, V22, P51, DOI 10.1007/s11032-007-9155-1; Steinfath M, 2010, PLANT BIOTECHNOL J, V8, P900, DOI 10.1111/j.1467-7652.2010.00516.x; Stitt M, 2010, PLANT PHYSIOL, V152, P428, DOI 10.1104/pp.109.150821; Sulpice R, 2009, P NATL ACAD SCI USA, V106, P10348, DOI 10.1073/pnas.0903478106; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Van Inghelandt D, 2011, THEOR APPL GENET, V123, P11, DOI 10.1007/s00122-011-1562-3; Xu YB, 2008, CROP SCI, V48, P391, DOI 10.2135/cropsci2007.04.0191; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702	47	382	410	2	198	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2012	44	2					217	220		10.1038/ng.1033	http://dx.doi.org/10.1038/ng.1033			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	22246502				2022-12-25	WOS:000299664400023
J	Blumberg, RS; Dittel, B; Hailer, D; von Herrath, M; Nestle, FO				Blumberg, Richard S.; Dittel, Bonnie; Hailer, David; von Herrath, Matthias; Nestle, Frank O.			Unraveling the autoimmune translational research process layer by layer	NATURE MEDICINE			English	Article							CLINICAL-RESEARCH; NIH BUDGET; RECEPTOR; HEALTH; ANTIBODIES; INNOVATION; DISCOVERY; MEDICINE; THERAPY; TRENDS	Autoimmune diseases have a complex etiology and despite great progress having been made in our comprehension of these disorders, there has been limited success in the development of approved medications based on these insights. Development of drugs and strategies for application in translational research and medicine are hampered by an inadequate molecular definition of the human autoimmune phenotype and the organizational models that are necessary to clarify this definition.	[Blumberg, Richard S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol & Hepatol,Dept Med, Boston, MA 02115 USA; [Hailer, David] Yale Univ, Dept Neurol & Immunobiol, New Haven, CT USA; [von Herrath, Matthias] La Jolla Inst Allergy & Immunol, La Jolla, CA USA; [Nestle, Frank O.] Kings Coll London, St Johns Inst Dermatol, London WC2R 2LS, England; [Nestle, Frank O.] Guys & St Thomas Hosp, Biomed Res Ctr, Natl Inst Hlth Res, London SE1 9RT, England	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Yale University; La Jolla Institute for Immunology; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Blumberg, RS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol & Hepatol,Dept Med, Boston, MA 02115 USA.	rblumberg@partners.org			US National Institutes of Health [DK44319, DK53056, DK51362, DK88199]; Harvard Digestive Diseases Center [DK34854]; National Institutes of Health Research; Wellcome Trust [GR078173MA]; Medical Research Council UK [G0601387]; UK Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre; King's College London; MRC [G0601387] Funding Source: UKRI; Medical Research Council [MR/J006742/1, G0601387] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044319, R01DK044319, P30DK034854, R01DK053056, R01DK051362, R01DK088199] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center; National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre; King's College London; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank T Rath, C. Pola and L. Paradiso for assistance in assembling data related to recent approvals of therapeutic agents in autoimmunity and assembling the manuscript. R.S.B. was supported by US National Institutes of Health grants DK44319, DK53056, DK51362, DK88199 and the Harvard Digestive Diseases Center (grant DK34854). F.O.N. is supported by a Senior Investigator award of the National Institutes of Health Research, Wellcome Trust Programme grant GR078173MA, Medical Research Council UK Programme grant G0601387 and the UK Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's & St. Thomas' National Health Service Foundation Trust in partnership with King's College London.	[Anonymous], NHE FACT SHEET; [Anonymous], 2006, C US C BUDG OFF OCT; [Anonymous], 2011, NAT I HLTH RES PORTF; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; Azarova AM, 2011, SEMIN CANCER BIOL, V21, P267, DOI 10.1016/j.semcancer.2011.09.005; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Benson JM, 2011, NAT BIOTECHNOL, V29, P615, DOI 10.1038/nbt.1903; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Califf RM, 2010, ACAD MED, V85, P457, DOI 10.1097/ACM.0b013e3181ccb74d; Cech TR, 2005, JAMA-J AM MED ASSOC, V294, P1390, DOI 10.1001/jama.294.11.1390; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Collins FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002747; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Couzin-Frankel J, 2011, SCIENCE, V333, P819, DOI 10.1126/science.333.6044.819; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; DiMasi JA, 2010, CLIN PHARMACOL THER, V87, P272, DOI 10.1038/clpt.2009.295; DiMasi JA, 2007, MANAG DECIS ECON, V28, P469, DOI 10.1002/mde.1360; Disis ML, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000421; Finkbeiner S, 2010, NAT MED, V16, P1227, DOI 10.1038/nm.2222; Goldman M, 2011, NAT REV DRUG DISCOV, V10, P321, DOI 10.1038/nrd3434; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; Hla T, 2011, NEUROLOGY, V76, pS3, DOI 10.1212/WNL.0b013e31820d5ec1; Honey K, 2011, J CLIN INVEST, V121, P3778, DOI 10.1172/JCI60890; Horig H, 2005, NAT MED, V11, P705, DOI 10.1038/nm0705-705; Hughes B, 2008, NAT REV DRUG DISCOV, V7; Hughes B, 2010, NAT REV DRUG DISCOV, V9, P89, DOI 10.1038/nrd3101; Hughes B, 2009, NAT REV DRUG DISCOV, V8, P93, DOI 10.1038/nrd2813; Ioannidis JP, 2004, J TRANSL MED, V2, P5, DOI DOI 10.1186/1479-5876-2-5; Ji Z., 2011, TRENDS MOL MED, DOI [10.1016/j.mol-med.2011.08.001, DOI 10.1016/J.MOL-MED.2011.08.001]; Kaitin KI, 2011, CLIN PHARMACOL THER, V89, P183, DOI 10.1038/clpt.2010.286; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaser A, 2011, GUT, V60, P430, DOI 10.1136/gut.2010.229138; Kelly RJ, 2010, J CLIN ONCOL, V28, pE507, DOI 10.1200/JCO.2010.29.3126; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Korn D, 2002, SCIENCE, V296, P1401, DOI 10.1126/science.1072486; Lettre G, 2008, HUM MOL GENET, V17, pR116, DOI 10.1093/hmg/ddn246; Littman BH, 2007, CLIN SCI, V112, P217, DOI 10.1042/CS20060108; LoRusso PM, 2009, J CLIN ONCOL, V27, P2586, DOI 10.1200/JCO.2008.21.5798; Loscalzo J, 2006, NEW ENGL J MED, V354, P1665, DOI 10.1056/NEJMp068050; Maecker HT, 2010, NAT IMMUNOL, V11, P975, DOI 10.1038/ni1110-975; Mankoff Stacey P, 2004, J Transl Med, V2, P14, DOI 10.1186/1479-5876-2-14; Mannon PJ, 2011, GUT, V60, P449, DOI 10.1136/gut.2010.226860; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; MINTZBERG H, 1981, HARVARD BUS REV, V59, P103; Mullard A, 2011, NAT REV DRUG DISCOV, V10, P82, DOI 10.1038/nrd3370; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Notarangelo LD, 2009, J ALLERGY CLIN IMMUN, V124, P1161, DOI 10.1016/j.jaci.2009.10.013; Nussenblatt RB, 2010, ANN NY ACAD SCI, V1200, pE1, DOI 10.1111/j.1749-6632.2010.05682.x; Owens J, 2007, NAT REV DRUG DISCOV, V6, P99, DOI 10.1038/nrd2247; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Philipson L, 2005, JAMA-J AM MED ASSOC, V294, P1394, DOI 10.1001/jama.294.11.1394; Porter M, 1996, HARVARD BUSINESS NOV, P61; Pyne S, 2009, P NATL ACAD SCI USA, V106, P8519, DOI 10.1073/pnas.0903028106; Ratner M, 2011, NAT BIOTECHNOL, V29, P3, DOI 10.1038/nbt0111-3; Reichert JM, 2008, CURR PHARM BIOTECHNO, V9, P423, DOI 10.2174/138920108786786358; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Sandborn WJ, 2005, NEW ENGL J MED, V353, P1912, DOI 10.1056/NEJMoa043335; Snape K, 2008, QJM-INT J MED, V101, P901, DOI 10.1093/qjmed/hcn100; Soderquest K, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001129; Spear BB, 2001, TRENDS MOL MED, V7, P201, DOI 10.1016/S1471-4914(01)01986-4; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278; Tanaka T, 2011, FEBS LETT, V585, P3699, DOI 10.1016/j.febslet.2011.03.023; Tigue CC, 2007, TARGET ONCOL, V2, P113, DOI 10.1007/s11523-007-0043-8; von Herrath M, 2009, J CLIN INVEST, V119, P1061, DOI 10.1172/JCI37593; von Herrath MG, 2005, J EXP MED, V202, P1159, DOI 10.1084/jem.20051224; Webb Craig P, 2004, J Transl Med, V2, P35, DOI 10.1186/1479-5876-2-35; Westfall JM, 2007, JAMA-J AM MED ASSOC, V297, P403, DOI 10.1001/jama.297.4.403; Woodcock J, 2008, ANNU REV MED, V59, P1, DOI 10.1146/annurev.med.59.090506.155819; Woolley M, 2005, JAMA-J AM MED ASSOC, V294, P1380, DOI 10.1001/jama.294.11.1380; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867	75	35	39	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					35	41		10.1038/nm.2632	http://dx.doi.org/10.1038/nm.2632			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22227670	Green Accepted			2022-12-25	WOS:000299018600025
J	Le Goff, C; Mahaut, C; Abhyankar, A; Le Goff, W; Serre, V; Afenjar, A; Destree, A; di Rocco, M; Heron, D; Jacquemont, S; Marlin, S; Simon, M; Tolmie, J; Verloes, A; Casanova, JL; Munnich, A; Cormier-Daire, V				Le Goff, Carine; Mahaut, Clementine; Abhyankar, Avinash; Le Goff, Wilfried; Serre, Valerie; Afenjar, Alexandra; Destree, Anne; di Rocco, Maja; Heron, Delphine; Jacquemont, Sebastien; Marlin, Sandrine; Simon, Marleen; Tolmie, John; Verloes, Alain; Casanova, Jean-Laurent; Munnich, Arnold; Cormier-Daire, Valerie			Mutations at a single codon in Mad homology 2 domain of SMAD4 cause Myhre syndrome	NATURE GENETICS			English	Article							WEILL-MARCHESANI-SYNDROME; TUMOR-SUPPRESSOR GENE; GELEOPHYSIC DYSPLASIA; HETEROGENEITY; DEFICIENCY; DPC4	Myhre syndrome (MIM 139210) is a developmental disorder characterized by short stature, short hands and feet, facial dysmorphism, muscular hypertrophy, deafness and cognitive delay. Using exome sequencing of individuals with Myhre syndrome, we identified SMAD4 as a candidate gene that contributes to this syndrome on the basis of its pivotal role in the bone morphogenetic pathway (BMP) and transforming growth factor (TGF)-beta signaling. We identified three distinct heterozygous missense SMAD4 mutations affecting the codon for Ile500 in 11 individuals with Myhre syndrome. All three mutations are located in the region of SMAD4 encoding the Mad homology 2 (MH2) domain near the site of monoubiquitination at Lys519, and we found a defect in SMAD4 ubiquitination in fibroblasts from affected individuals. We also observed decreased expression of downstream TGF-beta target genes, supporting the idea of impaired TGF-beta-mediated transcriptional control in individuals with Myhre syndrome.	[Le Goff, Carine; Mahaut, Clementine; Serre, Valerie; Munnich, Arnold; Cormier-Daire, Valerie] Univ Paris 05, Hop Necker Enfants Malad, Unite INSERM U781, Dept Genet, Paris, France; [Abhyankar, Avinash; Casanova, Jean-Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, New York, NY 10021 USA; [Le Goff, Wilfried] Univ Paris 06, INSERM, Unite Mixte Rech UMR S939, Paris, France; [Afenjar, Alexandra] Hop Armand Trousseau, Serv Neuropediat, Ctr Reference Anomalies Dev, Paris, France; [Destree, Anne] IPG, Inst Genet Humaine, Charleroi, Belgium; [di Rocco, Maja] Gaslini Inst, Dept Pediat, Unit Rare Dis, Genoa, Italy; [Heron, Delphine] Hop La Pitie Salpetriere, Unite Genet Clin, Paris, France; [Jacquemont, Sebastien] CHU Vaudois, Serv Genet Med, Lausanne, Switzerland; [Marlin, Sandrine] Hop Armand Trousseau, Unite Genet Clin, Paris, France; [Simon, Marleen] Erasmus MC Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [Tolmie, John] Yorkhill Hosp, Ferguson Smith Ctr, Dept Med Genet, Glasgow, Lanark, Scotland; [Verloes, Alain] Hop Robert Debre, INSERM U676, Dept Genet, F-75019 Paris, France; [Casanova, Jean-Laurent] Univ Paris 05, Lab Human Genet Infect Dis, Paris, France; [Casanova, Jean-Laurent] Necker Med Sch, INSERM U980, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Rockefeller University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Genoa; IRCCS Istituto Giannina Gaslini; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Erasmus University Rotterdam; Erasmus MC; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Cormier-Daire, V (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, Unite INSERM U781, Dept Genet, Paris, France.	valerie.cormier-daire@inserm.fr	Casanova, Jean-Laurent/I-3418-2017; Jacquemont, Sebastien/AAS-5060-2021; Le Goff, Carine/N-9940-2017; Le Goff, Wilfried/N-6326-2017; Le Goff, Wilfried/N-7593-2019; LE GOFF, Carine/AAG-2390-2020; /AAK-8500-2021; cormier-daire, valerie/H-6520-2017; VERLOES, Alain/E-7287-2014	Jacquemont, Sebastien/0000-0001-6838-8767; Le Goff, Wilfried/0000-0002-7611-9644; Le Goff, Wilfried/0000-0002-7611-9644; LE GOFF, Carine/0000-0002-7788-708X; cormier-daire, valerie/0000-0002-2839-9856; VERLOES, Alain/0000-0003-4819-0264; Casanova, Jean-Laurent/0000-0002-7782-4169; marlin, sandrine/0000-0002-4115-9806	French National Research Agency (ANR) [R09183KS]	French National Research Agency (ANR)(French National Research Agency (ANR))	We are grateful to the individuals with Myhre syndrome and their families for their participation in this study. We also thank the following physicians for the management of the affected individuals: D. Doummar, R. McGowan, P. Picco and M. Whiteford. This research was supported by the French National Research Agency (ANR; R09183KS to V.C.-D.).	Allali S, 2011, J MED GENET, V48, P417, DOI 10.1136/jmg.2010.087544; Burglen L, 2003, J MED GENET, V40, P546, DOI 10.1136/jmg.40.7.546; Byun M, 2010, J EXP MED, V207, P2307, DOI 10.1084/jem.20101597; Dagoneau N, 2004, AM J HUM GENET, V75, P801, DOI 10.1086/425231; Faivre L, 2003, AM J MED GENET A, V123A, P204, DOI 10.1002/ajmg.a.20289; Faivre L, 2003, J MED GENET, V40, P34, DOI 10.1136/jmg.40.1.34; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; Larrede S, 2009, ARTERIOSCL THROM VAS, V29, P1930, DOI 10.1161/ATVBAHA.109.194548; Le Goff C, 2008, NAT GENET, V40, P1119, DOI 10.1038/ng.199; Le Goff C, 2011, AM J HUM GENET, V89, P7, DOI 10.1016/j.ajhg.2011.05.012; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loeys BL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000488; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MYHRE SA, 1981, CLIN GENET, V20, P1; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Schutte M, 1996, CANCER RES, V56, P2527; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Sunamura Makoto, 2002, J Hepatobiliary Pancreat Surg, V9, P32, DOI 10.1007/s005340200002; Tan XH, 2007, J CELL SCI, V120, P2162, DOI 10.1242/jcs.03466; Xu J, 2000, P NATL ACAD SCI USA, V97, P4820, DOI 10.1073/pnas.97.9.4820; Yang SM, 2009, DEV DYNAM, V238, P1897, DOI 10.1002/dvdy.22014; Zhang JH, 2005, DEV BIOL, V284, P311, DOI 10.1016/j.ydbio.2005.05.036	26	110	111	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2012	44	1					85	U118		10.1038/ng.1016	http://dx.doi.org/10.1038/ng.1016			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	22158539				2022-12-25	WOS:000298664000019
J	Mak, HC				Mak, H. Craig			Drug pipeline: Q411	NATURE BIOTECHNOLOGY			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2012	30	1					15	15		10.1038/nbt.2090	http://dx.doi.org/10.1038/nbt.2090			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	876MC	22231084				2022-12-25	WOS:000299110600007
J	Wong, VW; Rustad, KC; Akaishi, S; Sorkin, M; Glotzbach, JP; Januszyk, M; Nelson, ER; Levi, K; Paterno, J; Vial, IN; Kuang, AA; Longaker, MT; Gurtner, GC				Wong, Victor W.; Rustad, Kristine C.; Akaishi, Satoshi; Sorkin, Michael; Glotzbach, Jason P.; Januszyk, Michael; Nelson, Emily R.; Levi, Kemal; Paterno, Josemaria; Vial, Ivan N.; Kuang, Anna A.; Longaker, Michael T.; Gurtner, Geoffrey C.			Focal adhesion kinase links mechanical force to skin fibrosis via inflammatory signaling	NATURE MEDICINE			English	Article							HYPERTROPHIC SCAR FORMATION; MEDIATED MECHANOTRANSDUCTION; WOUND REPAIR; FIBROBLASTS; FAK; CELLS; REGENERATION; DEFICIENCY; EXPRESSION; DELETION	Exuberant fibroproliferation is a common complication after injury for reasons that are not well understoodl. One key component of wound repair that is often overlooked is mechanical force, which regulates cell-matrix interactions through intracellular focal adhesion components, including focal adhesion kinase (FAK)(1,2). Here we report that FAK is activated after cutaneous injury and that this process is potentiated by mechanical loading. Fibroblast-specific FAK knockout mice have substantially less inflammation and fibrosis than control mice in a model of hypertrophic scar formation. We show that FAK acts through extracellular-related kinase (ERK) to mechanically trigger the secretion of monocyte chemoattractant protein-1 (MCP-1, also known as CCL2), a potent chemokine that is linked to human fibrotic disorders3-5. Similarly, MCP-1 knockout mice form minimal scars, indicating that inflammatory chemokine pathways are a major mechanism by which FAK mechanotransduction induces fibrosis. Smallmolecule inhibition of FAK blocks these effects in human cells and reduces scar formation in vivo through attenuated MCP-1 signaling and inflammatory cell recruitment. These findings collectively indicate that physical force regulates fibrosis through inflammatory FAK-ER K-MCP-1 pathways and that molecular strategies targeting FAK can effectively uncouple mechanical force from pathologic scar formation.	[Wong, Victor W.; Rustad, Kristine C.; Akaishi, Satoshi; Sorkin, Michael; Glotzbach, Jason P.; Januszyk, Michael; Nelson, Emily R.; Levi, Kemal; Paterno, Josemaria; Vial, Ivan N.; Longaker, Michael T.; Gurtner, Geoffrey C.] Stanford Univ, Dept Surg, Stanford, CA 94305 USA; [Kuang, Anna A.] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA	Stanford University; Oregon Health & Science University	Gurtner, GC (corresponding author), Stanford Univ, Dept Surg, Stanford, CA 94305 USA.	ggurtner@stanford.edu	Glotzbach, Jason P./O-4394-2019	Glotzbach, Jason P./0000-0002-8002-9422; Levi, Kemal/0000-0001-9760-166X	Oak Foundation; Hagey Family Endowed Fund in Stem Cell Research and Regenerative Medicine; United States Armed Forces Institute of Regenerative Medicine [W81XWH-08-2-0033]; NATIONAL INSTITUTE ON AGING [R01AG025016] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	Oak Foundation; Hagey Family Endowed Fund in Stem Cell Research and Regenerative Medicine; United States Armed Forces Institute of Regenerative Medicine; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank B. de Crombrugghe (The University of Texas MD Anderson Cancer Center, Houston, Texas) for providing the procollagen-alpha 2(I)-Cre transgenic mice, J. Rajadas for experimental insight, F. You for harvesting human fibroblasts and Y. Park for histologic processing. This work was supported by the Oak Foundation, the Hagey Family Endowed Fund in Stem Cell Research and Regenerative Medicine and a United States Armed Forces Institute of Regenerative Medicine grant (DOD #W81XWH-08-2-0033).	Aarabi S, 2007, FASEB J, V21, P3250, DOI 10.1096/fj.07-8218com; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; CHANTARASAK ND, 1989, BRIT J PLAST SURG, V42, P687, DOI 10.1016/0007-1226(89)90082-9; Dun ZN, 2010, WORLD J GASTROENTERO, V16, P4100, DOI 10.3748/wjg.v16.i32.4100; Durkaya S, 2005, TEX HEART I J, V32, P544; Ehrlich HP, 2003, METH MOLEC MED, V78, P277; ELLIOT D, 1989, BRIT J PLAST SURG, V42, P74, DOI 10.1016/S0007-1226(89)90117-3; Essayem S, 2006, ONCOGENE, V25, P1081, DOI 10.1038/sj.onc.1209130; Ferreira AM, 2006, J INVEST DERMATOL, V126, P1900, DOI 10.1038/sj.jid.5700302; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Gurtner GC, 2011, ANN SURG, V254, P217, DOI 10.1097/SLA.0b013e318220b159; Hayashida T, 2007, J CELL SCI, V120, P4230, DOI 10.1242/jcs.03492; Ingber DE, 2003, ANN MED, V35, P564, DOI 10.1080/07853890310016333; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; LANGER K, 1978, BRIT J PLAST SURG, V31, P3, DOI 10.1016/0007-1226(78)90003-6; Leucht P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000390; McLean GW, 2004, GENE DEV, V18, P2998, DOI 10.1101/gad.316304; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Paterno J, 2011, WOUND REPAIR REGEN, V19, P49, DOI 10.1111/j.1524-475X.2010.00643.x; Shibusawa Y, 2008, RHEUMATOLOGY, V47, P454, DOI 10.1093/rheumatology/ken058; Stramer BM, 2007, J INVEST DERMATOL, V127, P1009, DOI 10.1038/sj.jid.5700811; Wang JHC, 2007, GENE, V391, P1, DOI 10.1016/j.gene.2007.01.014; Wang JF, 2011, J CELL PHYSIOL, V226, P1265, DOI 10.1002/jcp.22454; Wang Z, 2006, J CELL PHYSIOL, V206, P510, DOI 10.1002/jcp.20486; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yamamoto T, 2008, FRONT BIOSCI-LANDMRK, V13, P2686, DOI 10.2741/2875; Zheng B, 2002, AM J PATHOL, V160, P1609, DOI 10.1016/S0002-9440(10)61108-X	29	311	337	8	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2012	18	1					148	152		10.1038/nm.2574	http://dx.doi.org/10.1038/nm.2574			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22157678	Green Accepted			2022-12-25	WOS:000299018600041
J	Boettger, LM; Handsaker, RE; Zody, MC; McCarroll, SA				Boettger, Linda M.; Handsaker, Robert E.; Zody, Michael C.; McCarroll, Steven A.			Structural haplotypes and recent evolution of the human 17q21.31 region	NATURE GENETICS			English	Article							COPY-NUMBER VARIATION; GENOME-WIDE ASSOCIATION; GENOTYPE IMPUTATION; POPULATION-SCALE; PHASE INFERENCE; DISEASE; POLYMORPHISM; DROSOPHILA; INVERSION; COMPLEX	Structurally complex genomic regions are not yet well understood. One such locus, human chromosome 17q21.31, contains a megabase-long inversion polymorphism(1), many uncharacterized copy-number variations (CNVs) and markers that associate with female fertility(1), female meiotic recombination(1-3) and neurological disease(4,5). Additionally, the inverted H2 form of 17q21.31 seems to be positively selected in Europeans(1). We developed a population genetics approach to analyze complex genome structures and identified nine segregating structural forms of 17q21.31. Both the H1 and H2 forms of the 17q21.31 inversion polymorphism contain independently derived, partial duplications of the KANSL1 gene; these duplications, which produce novel KANSL1 transcripts, have both recently risen to high allele frequencies (26% and 19%) in Europeans. An older H2 form lacking such a duplication is present at low frequency in European and central African hunter-gatherer populations. We further show that complex genome structures can be analyzed by imputation from SNPs.	[Boettger, Linda M.; Handsaker, Robert E.; Zody, Michael C.; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Boettger, Linda M.; Handsaker, Robert E.; Zody, Michael C.; McCarroll, Steven A.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Boettger, Linda M.] Harvard Univ, Sch Med, Program Genet & Genom, Grad Program Biol & Biomed Sci, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	McCarroll, SA (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	mccarroll@genetics.med.harvard.edu	Handsaker, Bob/AAX-9095-2021	Handsaker, Bob/0000-0002-3128-3547; McCarroll, Steven/0000-0002-6954-8184	Smith Family Award for Excellence in Biomedical Research; National Human Genome Research Institute [U01HG005208]; Harvard Medical School Department of Genetics; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG005208] Funding Source: NIH RePORTER	Smith Family Award for Excellence in Biomedical Research; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Harvard Medical School Department of Genetics; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	J. Korn provided an early version of software for visualizing haplotype diversity. N. Rohland and T. Mullen contributed expertise on laboratory experiments. We thank N. Patterson, D. Reich, D. Altshuler, E. Lander, B. Browning, J. Korn, J. Gray, C. Patil, G. Genovese, A. Sekar and S. Grossman for helpful conversations and/or comments on the manuscript. This work was supported by a Smith Family Award for Excellence in Biomedical Research to S.A.M., by the National Human Genome Research Institute (U01HG005208) and by startup resources from the Harvard Medical School Department of Genetics.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2008, HUM GENET, V124, P439, DOI 10.1007/s00439-008-0568-7; Chowdhury R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000648; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Fledel-Alon A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020321; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Li XZ, 2009, MOL CELL, V36, P290, DOI 10.1016/j.molcel.2009.07.031; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McCarroll SA, 2008, NAT GENET, V40, P5, DOI 10.1038/ng0108-5; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Quinlan AR, 2012, TRENDS GENET, V28, P43, DOI 10.1016/j.tig.2011.10.002; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Skipper L, 2004, AM J HUM GENET, V75, P669, DOI 10.1086/424492; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Steinberg KM, 2012, NAT GENET, V44, P872, DOI 10.1038/ng.2335; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yu L, 2010, GENESIS, V48, P161, DOI 10.1002/dvg.20600; Zody MC, 2008, NAT GENET, V40, P1076, DOI 10.1038/ng.193	31	84	89	2	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2012	44	8					881	+		10.1038/ng.2334	http://dx.doi.org/10.1038/ng.2334			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	979WV	22751096	Green Accepted			2022-12-25	WOS:000306854700011
J	Shakhova, O; Zingg, D; Schaefer, SM; Hari, L; Civenni, G; Blunschi, J; Claudinot, S; Okoniewski, M; Beermann, F; Mihic-Probst, D; Moch, H; Wegner, M; Dummer, R; Barrandon, Y; Cinelli, P; Sommer, L				Shakhova, Olga; Zingg, Daniel; Schaefer, Simon M.; Hari, Lisette; Civenni, Gianluca; Blunschi, Jacqueline; Claudinot, Stephanie; Okoniewski, Michal; Beermann, Friedrich; Mihic-Probst, Daniela; Moch, Holger; Wegner, Michael; Dummer, Reinhard; Barrandon, Yann; Cinelli, Paolo; Sommer, Lukas			Sox 10 promotes the formation and maintenance of giant congenital naevi and melanoma	NATURE CELL BIOLOGY			English	Article							TRANSCRIPTION FACTOR SOX10; NEURAL CREST CELLS; HIRSCHSPRUNG-DISEASE; MOUSE MODEL; STEM-CELLS; EXPRESSION; MUTATIONS; GENE; DIFFERENTIATION; LOCUS	Giant congenital naevi are pigmented childhood lesions that frequently lead to melanoma, the most aggressive skin cancer. The mechanisms underlying this malignancy are largely unknown, and there are no effective therapies. Here we describe a mouse model forgiant congenital naevi and show that naevi and melanoma prominently express Sox 10, a transcription factor crucial for the formation of melanocytes from the neural crest. Strikingly, Sox 10 haploinsufficiency counteracts Nras(Q61K)-driven congenital naevus and melanoma formation without affecting the physiological functions of neural crest derivatives in the skin. Moreover, Sox 10 is also crucial for the maintenance of neoplastic cells in vivo. In human patients, virtually all congenital naevi and melanomas are SOX 10 positive. Furthermore, SOX 10 silencing in human melanoma cells suppresses neural crest stem cell properties, counteracts proliferation and cells urvival, and completely abolishes in vivo tumour formation. Thus, SOX 10 represents a promising target for the treatment of congenital naevi and melanoma in human patient.	[Shakhova, Olga; Zingg, Daniel; Schaefer, Simon M.; Hari, Lisette; Civenni, Gianluca; Blunschi, Jacqueline; Sommer, Lukas] Univ Zurich, Inst Anat, CH-8057 Zurich, Switzerland; [Claudinot, Stephanie; Barrandon, Yann] Ecole Polytech Fed Lausanne, Sch Life Sci, Lab Stem Cell Dynam, CH-1015 Lausanne, Switzerland; [Okoniewski, Michal] Funct Genom Ctr Zurich, CH-8057 Zurich, Switzerland; [Beermann, Friedrich] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res ISREC, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Mihic-Probst, Daniela; Moch, Holger] Univ Zurich Hosp, Inst Surg Pathol, Dept Pathol, CH-8091 Zurich, Switzerland; [Wegner, Michael] Univ Erlangen Nurnberg, Inst Biochem, Emil Fischer Ctr, D-91054 Erlangen, Germany; [Dummer, Reinhard] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland; [Cinelli, Paolo] Univ Zurich, Inst Lab Anim Sci, CH-8057 Zurich, Switzerland; [Cinelli, Paolo] Univ Zurich, Ctr Appl Biotechnol & Mol Med, CH-8057 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; University of Zurich; University Zurich Hospital; University of Erlangen Nuremberg; University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich	Shakhova, O (corresponding author), Univ Zurich, Inst Anat, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	olga.shakhova@anatom.uzh.ch; lukas.sommer@anatom.uzh.ch	Mihic-Probst, Daniela/AAB-6374-2021	Sommer, Lukas/0000-0002-1143-7908; Cinelli, Paolo/0000-0002-0163-9055; Wegner, Michael/0000-0002-4586-3294; Zingg, Daniel/0000-0001-6450-2534; Civenni, Gianluca/0000-0003-1921-161X	Swiss Cancer League; Swiss National Science Foundation; National Research Program (NRP63); UBS Wealth Manageme	Swiss Cancer League; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Research Program (NRP63); UBS Wealth Manageme	We thank the FACS facility and the Functional Genomic Center Zurich (FGCZ) of the University of Zurich for technical assistance, S. Behnke and C. Burger for assistance in histology, and M.Serrano and L.Chin for providing mouse lines.This work was supported by the Swiss Cancer League (including a grant supporting a Collaborative Cancer Research Project (CCRP) by D.M.P., R.D. and L.S.), the Swiss National Science Foundation, the National Research Program (NRP63) 'Stem Cells and Regenerative Medicine' and a stipend from the UBS Wealth Management.	Ackermann J, 2005, CANCER RES, V65, P4005, DOI 10.1158/0008-5472.CAN-04-2970; Agnarsdottir M, 2010, MELANOMA RES, V20, P468, DOI 10.1097/CMR.0b013e3283403ccd; Arnheiter H, 2010, PIGM CELL MELANOMA R, V23, P729, DOI 10.1111/j.1755-148X.2010.00759.x; Bakos RM, 2010, EXP DERMATOL, V19, pE89, DOI 10.1111/j.1600-0625.2009.00991.x; Bauer J, 2007, J INVEST DERMATOL, V127, P179, DOI 10.1038/sj.jid.5700490; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bondurand N, 2006, DEVELOPMENT, V133, P2075, DOI 10.1242/dev.02375; Bondurand N, 1999, HUM MOL GENET, V8, P1785, DOI 10.1093/hmg/8.9.1785; Bosenberg M, 2006, GENESIS, V44, P262, DOI 10.1002/dvg.20205; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Civenni G, 2011, CANCER RES, V71, P3098, DOI 10.1158/0008-5472.CAN-10-3997; Finzsch M, 2010, J CELL BIOL, V189, P701, DOI 10.1083/jcb.200912142; Flammiger A, 2009, J INVEST DERMATOL, V129, P945, DOI 10.1038/jid.2008.316; Ghosh Papia, 2009, Expert Rev Dermatol, V4, P131, DOI 10.1586/edm.09.2; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Ichii-Nakato N, 2006, J INVEST DERMATOL, V126, P2111, DOI 10.1038/sj.jid.5700366; John N, 2011, STEM CELLS, V29, P689, DOI 10.1002/stem.607; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kuhlbrodt K, 1998, J BIOL CHEM, V273, P23033, DOI 10.1074/jbc.273.36.23033; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Mihic-Probst D, 2007, INT J CANCER, V121, P1764, DOI 10.1002/ijc.22891; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Nonaka D, 2008, AM J SURG PATHOL, V32, P1291, DOI 10.1097/PAS.0b013e3181658c14; Paratore C, 2002, HUM MOL GENET, V11, P3075, DOI 10.1093/hmg/11.24.3075; Paratore C, 2001, DEVELOPMENT, V128, P3949; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Rabbani P, 2011, CELL, V145, P941, DOI 10.1016/j.cell.2011.05.004; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sommer L, 2011, PIGM CELL MELANOMA R, V24, P411, DOI 10.1111/j.1755-148X.2011.00834.x; Southard-Smith EM, 1999, GENOME RES, V9, P215; Stolt CC, 2008, NUCLEIC ACIDS RES, V36, P5427, DOI 10.1093/nar/gkn527; Wong CE, 2006, J CELL BIOL, V175, P1005, DOI 10.1083/jcb.200606062	33	174	183	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2012	14	8					882	U228		10.1038/ncb2535	http://dx.doi.org/10.1038/ncb2535			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	983JP	22772081				2022-12-25	WOS:000307115900018
J	Baietti, MF; Zhang, Z; Mortier, E; Melchior, A; Degeest, G; Geeraerts, A; Ivarsson, Y; Depoortere, F; Coomans, C; Vermeiren, E; Zimmermann, P; David, G				Baietti, Maria Francesca; Zhang, Zhe; Mortier, Eva; Melchior, Aurelie; Degeest, Gisele; Geeraerts, Annelies; Ivarsson, Ylva; Depoortere, Fabienne; Coomans, Christien; Vermeiren, Elke; Zimmermann, Pascale; David, Guido			Syndecan-syntenin-ALIX regulates the biogenesis of exosomes	NATURE CELL BIOLOGY			English	Article							MULTIVESICULAR BODY BIOGENESIS; HEPARAN-SULFATE PROTEOGLYCANS; ESCRT MACHINERY; PLASMA-MEMBRANE; DOMAIN BINDING; CELL-ADHESION; PDZ PROTEIN; MECHANISM; ENDOSOMES; VESICLES	The biogenesis of exosomes, small secreted vesicles involved in signalling processes, remains incompletely understood. Here, we report evidence that the syndecan heparan sulphate proteoglycans and their cytoplasmic adaptor syntenin control the formation of exosomes. Syntenin interacts directly with ALIX through LYPX(n)L motifs, similarly to retroviral proteins, and supports the intraluminal budding of endosomal membranes. Syntenin exosomes depend on the availability of heparan sulphate, syndecans, ALIX and ESCRTs, and impact on the trafficking and confinement of FGF signals. This study identifies a key role for syndecan syntenin ALIX in membrane transport and signalling processes.	[Baietti, Maria Francesca; Mortier, Eva; Geeraerts, Annelies; Ivarsson, Ylva; Depoortere, Fabienne; Vermeiren, Elke; Zimmermann, Pascale] KULeuven, Dept Human Genet, Lab Signal Integrat Cell Fate Decis, B-3000 Louvain, Belgium; [Baietti, Maria Francesca; Zhang, Zhe; Melchior, Aurelie; Degeest, Gisele; Coomans, Christien; David, Guido] KULeuven, Dept Human Genet, Lab Glycobiol & Dev Genet, B-3000 Louvain, Belgium; [Baietti, Maria Francesca; Zhang, Zhe; Melchior, Aurelie; Degeest, Gisele; Coomans, Christien; David, Guido] VIB, Ctr Biol Dis, B-3000 Louvain, Belgium; [Geeraerts, Annelies] KULeuven, Dept Chem, Lab Biomol Dynam, B-3001 Heverlee, Belgium	KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven	Zimmermann, P (corresponding author), KULeuven, Dept Human Genet, Lab Signal Integrat Cell Fate Decis, Campus Gasthuisberg,Herestr 49, B-3000 Louvain, Belgium.	pascale.zimmermann@med.kuleuven.be; guido.david@cme.vib-kuleuven.be	Zimmermann, Pascale/P-4190-2017; Baietti, Maria Francesca/AAA-6749-2019; Ivarsson, Ylva/HGE-0283-2022	Baietti, Maria Francesca/0000-0002-1495-226X; Ivarsson, Ylva/0000-0002-7081-3846	Fund for Scientific Research-Flanders (FWO); Concerted Actions Program of K.U. Leuven; VIB; Belgian Federation against Cancer (STK); Interuniversity Attraction Poles of the Prime Ministers Services (IUAP); EU; EMBO; Agency for Innovation by Science and Technology (IWT), Flanders	Fund for Scientific Research-Flanders (FWO)(FWO); Concerted Actions Program of K.U. Leuven; VIB; Belgian Federation against Cancer (STK); Interuniversity Attraction Poles of the Prime Ministers Services (IUAP); EU(European Commission); EMBO(European Molecular Biology Organization (EMBO)); Agency for Innovation by Science and Technology (IWT), Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	We are grateful to H. Ceulemans, G. Reekmans and J. Grootjans for technical support, and to P. Baatsen for access to the electron microscopy facility at the Department for Human Genetics, VIB-KULeuven. We thank C. Dotti and P. Courtoy for critical feedback on the manuscript. This work was supported by the Fund for Scientific Research-Flanders (FWO), the Concerted Actions Program of the K.U. Leuven, the VIB, the Belgian Federation against Cancer (STK), the Interuniversity Attraction Poles of the Prime Ministers Services (IUAP) and the EMBO young investigator programme (P.Z.). A.M. was supported by a Marie Curie postdoctoral fellowship of the EU (FP7); Y.I. by an EMBO-long term postdoctoral fellowship; and A.G. by a PhD-student fellowship of the Agency for Innovation by Science and Technology (IWT), Flanders.	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Babst M, 2011, CURR OPIN CELL BIOL, V23, P452, DOI 10.1016/j.ceb.2011.04.008; Beekman JM, 2008, J CELL SCI, V121, P1349, DOI 10.1242/jcs.026401; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Couzin J, 2005, SCIENCE, V308, P1862, DOI 10.1126/science.308.5730.1862; Doyotte A, 2005, J CELL SCI, V118, P3003, DOI 10.1242/jcs.02421; Fang Y, 2007, PLOS BIOL, V5, P1267, DOI 10.1371/journal.pbio.0050158; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Fujii K, 2007, NAT REV MICROBIOL, V5, P912, DOI 10.1038/nrmicro1790; Gottlinger H, 2007, NAT STRUCT MOL BIOL, V14, P254, DOI 10.1038/nsmb0407-254; Grootjans JJ, 2000, J BIOL CHEM, V275, P19933, DOI 10.1074/jbc.M002459200; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Jouvenet N, 2011, NAT CELL BIOL, V13, P394, DOI 10.1038/ncb2207; Lambaerts K, 2009, CURR OPIN CELL BIOL, V21, P662, DOI 10.1016/j.ceb.2009.05.002; Latysheva N, 2006, MOL CELL BIOL, V26, P7707, DOI 10.1128/MCB.00849-06; Lee S, 2007, NAT STRUCT MOL BIOL, V14, P194, DOI 10.1038/nsmb1203; Liegeois S, 2006, J CELL BIOL, V173, P949, DOI 10.1083/jcb.200511072; Luyten A, 2008, MOL BIOL CELL, V19, P1594, DOI 10.1091/mbc.E07-08-0832; Martin-Serrano J, 2011, NAT REV MICROBIOL, V9, P519, DOI 10.1038/nrmicro2596; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; McClelland AC, 2009, P NATL ACAD SCI USA, V106, P20487, DOI 10.1073/pnas.0811862106; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Morita E, 2011, CELL HOST MICROBE, V9, P235, DOI 10.1016/j.chom.2011.02.004; Nabhan JF, 2012, P NATL ACAD SCI USA, V109, P4146, DOI 10.1073/pnas.1200448109; Odorizzi G, 2006, J CELL SCI, V119, P3025, DOI 10.1242/jcs.03072; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Razi M, 2006, MOL BIOL CELL, V17, P3469, DOI 10.1091/mbc.E05-11-1054; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Schulz JG, 2003, J BIOL CHEM, V278, P48651, DOI 10.1074/jbc.M308424200; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stuffers S, 2009, TRAFFIC, V10, P925, DOI 10.1111/j.1600-0854.2009.00920.x; Theos AC, 2006, DEV CELL, V10, P343, DOI 10.1016/j.devcel.2006.01.012; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Tkachenko E, 2002, J BIOL CHEM, V277, P19946, DOI 10.1074/jbc.M200841200; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Wehman AM, 2011, CURR BIOL, V21, P1951, DOI 10.1016/j.cub.2011.10.040; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Xu NJ, 2011, NAT NEUROSCI, V14, P1421, DOI 10.1038/nn.2931; Zhai Q, 2008, NAT STRUCT MOL BIOL, V15, P43, DOI 10.1038/nsmb1319; Zhou X, 2010, BIOCHEM J, V432, P525, DOI 10.1042/BJ20100862; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011; Zimmermann P, 2002, MOL CELL, V9, P1215, DOI 10.1016/S1097-2765(02)00549-X; Zimmermann P, 2001, MOL BIOL CELL, V12, P339, DOI 10.1091/mbc.12.2.339	55	1055	1106	8	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2012	14	7					677	685		10.1038/ncb2502	http://dx.doi.org/10.1038/ncb2502			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	967PV	22660413				2022-12-25	WOS:000305921200007
J	Hufford, MB; Xu, X; van Heerwaarden, J; Pyhajarvi, T; Chia, JM; Cartwright, RA; Elshire, RJ; Glaubitz, JC; Guill, KE; Kaeppler, SM; Lai, JS; Morrell, PL; Shannon, LM; Song, C; Springer, NM; Swanson-Wagner, RA; Tiffin, P; Wang, J; Zhang, GY; Doebley, J; McMullen, MD; Ware, D; Buckler, ES; Yang, S; Ross-Ibarra, J				Hufford, Matthew B.; Xu, Xun; van Heerwaarden, Joost; Pyhaejaervi, Tanja; Chia, Jer-Ming; Cartwright, Reed A.; Elshire, Robert J.; Glaubitz, Jeffrey C.; Guill, Kate E.; Kaeppler, Shawn M.; Lai, Jinsheng; Morrell, Peter L.; Shannon, Laura M.; Song, Chi; Springer, Nathan M.; Swanson-Wagner, Ruth A.; Tiffin, Peter; Wang, Jun; Zhang, Gengyun; Doebley, John; McMullen, Michael D.; Ware, Doreen; Buckler, Edward S.; Yang, Shuang; Ross-Ibarra, Jeffrey			Comparative population genomics of maize domestication and improvement	NATURE GENETICS			English	Article							PATTERNS; DIVERSITY; SELECTION; ORIGIN; GENE; POLYMORPHISM; EXPRESSION; EVOLUTION; TEOSINTE; RICE	Domestication and plant breeding are ongoing 10,000-year-old evolutionary experiments that have radically altered wild species to meet human needs. Maize has undergone a particularly striking transformation. Researchers have sought for decades to identify the genes underlying maize evolution(1,2), but these efforts have been limited in scope. Here, we report a comprehensive assessment of the evolution of modern maize based on the genome-wide resequencing of 75 wild, landrace and improved maize lines(3). We find evidence of recovery of diversity after domestication, likely introgression from wild relatives, and evidence for stronger selection during domestication than improvement. We identify a number of genes with stronger signals of selection than those previously shown to underlie major morphological changes(4,5). Finally, through transcriptome-wide analysis of gene expression, we find evidence both consistent with removal of cis-acting variation during maize domestication and improvement and suggestive of modern breeding having increased dominance in expression while targeting highly expressed genes.	[Hufford, Matthew B.; van Heerwaarden, Joost; Pyhaejaervi, Tanja; Ross-Ibarra, Jeffrey] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Xu, Xun; Song, Chi; Wang, Jun; Zhang, Gengyun; Yang, Shuang] BGI Shenzhen, Shenzhen, Peoples R China; [Chia, Jer-Ming; Ware, Doreen] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Cartwright, Reed A.] Arizona State Univ, Ctr Evolutionary Med & Informat, Biodesign Inst, Tempe, AZ USA; [Cartwright, Reed A.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Elshire, Robert J.; Glaubitz, Jeffrey C.; Buckler, Edward S.] Cornell Univ, Inst Genom Div, Ithaca, NY USA; [Guill, Kate E.; McMullen, Michael D.] Univ Missouri, Div Plant Sci, Columbia, MO USA; [Kaeppler, Shawn M.] Univ Wisconsin, Dept Energy DOE, Great Lakes Bioenergy Res Ctr, Madison, WI USA; [Kaeppler, Shawn M.] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA; [Lai, Jinsheng] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Morrell, Peter L.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA; [Shannon, Laura M.; Doebley, John] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Springer, Nathan M.; Swanson-Wagner, Ruth A.; Tiffin, Peter] Univ Minnesota, Dept Plant Biol, St Paul, MN USA; [Ross-Ibarra, Jeffrey] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Ross-Ibarra, Jeffrey] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	University of California System; University of California Davis; Beijing Genomics Institute (BGI); Cold Spring Harbor Laboratory; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Cornell University; University of Missouri System; University of Missouri Columbia; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; China Agricultural University; University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Davis; University of California System; University of California Davis	Ross-Ibarra, J (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	esb33@cornell.edu; yangsh@genomics.org.cn; rossibarra@ucdavis.edu	Morrell, Peter/E-2059-2011; Ross-Ibarra, Jeffrey/D-7782-2011; Buckler, Edward/L-7651-2019; Buckler, Edward/GPS-4932-2022; van Heerwaarden, Joost/A-1424-2014; Springer, Nathan/F-2680-2013; Hufford, Matthew/E-7810-2012; Pyhäjärvi, Tanja/ABD-4161-2021; Wang, Jun/A-7261-2013; Xu, Xun/AAI-6763-2020; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Morrell, Peter/0000-0001-6282-1582; Ross-Ibarra, Jeffrey/0000-0003-1656-4954; Buckler, Edward/0000-0002-3100-371X; van Heerwaarden, Joost/0000-0002-4959-3914; Springer, Nathan/0000-0002-7301-4759; Hufford, Matthew/0000-0003-3945-1143; Xu, Xun/0000-0002-5338-5173; Tiffin, Peter/0000-0003-1975-610X; Pyhajarvi, Tanja/0000-0001-6958-5172; Wang, Jun/0000-0002-8540-8931; Elshire, Robert/0000-0003-1753-6920; Wang, Jun/0000-0002-2113-5874; Kaeppler, Shawn/0000-0002-5964-1668	US National Science Foundation (NSF) [IOS-0820619, IOS-0922703]; USDA-ARS; USDA; Chinese 973 program [2007CB815701]; Chinese Ministry of Agriculture [2010-Z13]; Shenzhen Municipal Government; US DOE Great Lakes Bioenergy Research Center (DOE Office of Science) [BER DE-FC02-07ER64494]; Office of Science of the US DOE [DE-AC02-05CH11231]; USDA-National Institute of Food and Agriculture [2009-01864]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007133] Funding Source: NIH RePORTER; Direct For Biological Sciences [0922703, 0820619] Funding Source: National Science Foundation	US National Science Foundation (NSF)(National Science Foundation (NSF)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA(United States Department of Agriculture (USDA)); Chinese 973 program(National Basic Research Program of China); Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs); Shenzhen Municipal Government; US DOE Great Lakes Bioenergy Research Center (DOE Office of Science)(United States Department of Energy (DOE)); Office of Science of the US DOE(United States Department of Energy (DOE)); USDA-National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors would like to thank T. Kono, S. Watson and M. Watson for photographs of inflorescences, P. Brown for help with QTL delineation, B.S. Gaut, A.M. Gonzales and two anonymous reviewers for comments on an earlier version of the manuscript and M. Grote for statistical advice. This work was supported by funding to the maize diversity project from the US National Science Foundation (NSF; IOS-0820619 to E.S.B., J.D. and M.D.M.) and USDA-ARS (to E.S.B., M.D.M. and D.W.), as well as from USDA Hatch Funds (to P.T. and N.M.S.), the Chinese 973 program (2007CB815701 to J.W.), the Chinese Ministry of Agriculture 984 program (2010-Z13 to G.Z.), the Shenzhen Municipal Government Basic Research Program (to J.W.), the US DOE Great Lakes Bioenergy Research Center (DOE Office of Science; BER DE-FC02-07ER64494), the Office of Science of the US DOE (contract DE-AC02-05CH11231 to the US DOE Joint Genome Institute) and by grants from the US NSF (IOS-0922703 to J.R.-I.) and the USDA-National Institute of Food and Agriculture (2009-01864 to J.R.-I.).	Beadle GW, 1939, J HERED, V30, P245, DOI 10.1093/oxfordjournals.jhered.a104728; Briggs WH, 2007, GENETICS, V177, P1915, DOI 10.1534/genetics.107.076497; Brown PJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002383; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Camus-Kulandaivelu L, 2006, GENETICS, V172, P2449, DOI 10.1534/genetics.105.048603; Chen H, 2010, GENOME RES, V20, P393, DOI 10.1101/gr.100545.109; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Davison AC, 1997, BOOTSTRAP METHODS TH; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Eastmond PJ, 2006, PLANT CELL, V18, P665, DOI 10.1105/tpc.105.040543; Fang Z, 2012, GENETICS, V191, P883, DOI 10.1534/genetics.112.138578; Gallais A, 2004, J EXP BOT, V55, P295, DOI 10.1093/jxb/erh006; Gualberti G, 2002, PLANT CELL, V14, P1253, DOI 10.1105/tpc.010491; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Hudson RR, 2001, GENETICS, V159, P1805; Hufford KM, 2007, PLANT PHYSIOL, V144, P1642, DOI 10.1104/pp.107.098988; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jackson D, 1999, DEVELOPMENT, V126, P315; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lawrence CJ, 2004, NUCLEIC ACIDS RES, V32, pD393, DOI 10.1093/nar/gkh011; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lo SF, 2008, PLANT CELL, V20, P2603, DOI 10.1105/tpc.108.060913; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Olsen KM, 2006, GENETICS, V173, P975, DOI 10.1534/genetics.106.056473; Palaisa K, 2004, P NATL ACAD SCI USA, V101, P9885, DOI 10.1073/pnas.0307839101; Piperno DR, 2009, P NATL ACAD SCI USA, V106, P5019, DOI 10.1073/pnas.0812525106; Purugganan MD, 2011, EVOLUTION, V65, P171, DOI 10.1111/j.1558-5646.2010.01093.x; Ryu CH, 2009, PLANT CELL ENVIRON, V32, P1412, DOI 10.1111/j.1365-3040.2009.02008.x; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Springer N. M., 2010, PLOS GENET, V5; Stupar RM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-33; Swanson-Wagner RA, 2010, GENOME RES, V20, P1689, DOI 10.1101/gr.109165.110; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; van Heerwaarden J, 2011, P NATL ACAD SCI USA, V108, P1088, DOI 10.1073/pnas.1013011108; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wang Y, 2005, PLANT J, V43, P413, DOI 10.1111/j.1365-313X.2005.02463.x; Wilkes H.G., 1967, TEOSINTE CLOSEST REL; Wolfgruber TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000743; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891	43	557	576	16	404	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2012	44	7					808	U118		10.1038/ng.2309	http://dx.doi.org/10.1038/ng.2309			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967DP	22660546	Green Accepted			2022-12-25	WOS:000305886900017
J	Kua, HY; Liu, HJ; Leong, WF; Li, LL; Jia, DY; Ma, G; Hu, YY; Wang, XY; Chau, JFL; Chen, YG; Mishina, Y; Boast, S; Yeh, J; Xia, L; Chen, GQ; He, L; Goff, SP; Li, BJ				Kua, Hui-Yi; Liu, Huijuan; Leong, Wai Fook; Li, Lili; Jia, Deyong; Ma, Gang; Hu, Yuanyu; Wang, Xueying; Chau, Jenny F. L.; Chen, Ye-Guang; Mishina, Yuji; Boast, Sharon; Yeh, James; Xia, Li; Chen, Guo-Qiang; He, Lin; Goff, Stephen P.; Li, Baojie			c-Abl promotes osteoblast expansion by differentially regulating canonical and non-canonical BMP pathways and p16(INK4a) expression	NATURE CELL BIOLOGY			English	Article							TYROSINE KINASE; CELLULAR SENESCENCE; DISTINCT ROLES; BONE-FORMATION; ID PROTEINS; B-CELL; APOPTOSIS; FAMILY; MECHANISMS; MURINE	Defects in stem cell renewal or progenitor cell expansion underlie ageing-related diseases such as osteoporosis. Yet much remains unclear about the mechanisms regulating progenitor expansion. Here we show that the tyrosine kinase c-Abl plays an important role in osteoprogenitor expansion. c-Abl interacts with and phosphorylates BMPRIA and the phosphorylation differentially influences the interaction of BMPRIA with BMPRII and the Tab1-Tak1 complex, leading to uneven activation of Smad1/5/8 and Erk1/2, the canonical and non-canonical BMP pathways that direct the expression of p(16INK4a). c-Abl deficiency shunts BMP signalling from Smad1/5/8 to Erk1/2, leading to p(16INK4a) upregulation and osteoblast senescence. Mouse genetic studies revealed that p16(INK4a) controls mesenchymal stem cell maintenance and osteoblast expansion and mediates the effects of c-Abl deficiency on osteoblast expansion and bone formation. These findings identify c-Abl as a regulator of BMP signalling pathways and uncover a role for c-Abl in p16(INK4a) expression and osteoprogenitor expansion.	[Kua, Hui-Yi; Liu, Huijuan; Li, Lili; Jia, Deyong; Ma, Gang; Yeh, James; He, Lin; Li, Baojie] Shanghai Jiao Tong Univ, Minist Educ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200240, Peoples R China; [Kua, Hui-Yi; Leong, Wai Fook; Hu, Yuanyu; Chau, Jenny F. L.; Li, Baojie] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Wang, Xueying] Canc Sci Inst Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore; [Chen, Ye-Guang] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China; [Mishina, Yuji] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Boast, Sharon; Goff, Stephen P.] Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY USA; [Xia, Li; Chen, Guo-Qiang] Shanghai Jiao Tong Univ, Sch Med, Dept Pathophysiol, Key Lab Cell Differentiat & Apoptosis, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Tsinghua University; University of Michigan System; University of Michigan; Columbia University; Howard Hughes Medical Institute; Shanghai Jiao Tong University	Li, BJ (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200240, Peoples R China.	libj@sjtu.edu.cn	Leong, Wai Fook Peter/GXG-9911-2022; xia, li/B-2790-2014; Goff, Stephen P/K-6337-2014; Jia, Deyong/GSJ-0327-2022; Jia, Deyong/GQP-9611-2022; Chen, Ye-Guang/L-6998-2019	Leong, Wai Fook Peter/0000-0002-2438-2715; Goff, Stephen P/0000-0003-0693-5547; Jia, Deyong/0000-0003-2034-0363; Hu, Yuanyu/0000-0001-5457-4331	Ministry of Science and Technology of China [2012CB966901]; National Natural Science Foundation of China [81130039, 31071229, 81121001]; Shanghai Pujiang Program [10PJ1405000]; Ministry of Education; Agency for Science, Technology and Research of Singapore	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Ministry of Education; Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR))	We would like to thank A. Nur-E-Kamal, Y. Wan and X-H. Sun for helpful discussions, I. H. In, D. Cai, G. C. Hong, L. Soh, J. Lin and T. Cheng for technical assistance, and Novartis, J. Campisi (Buck Institute for Research on Aging, USA), J. Wang (UCSD, USA), A. Koleske (Yale University, USA), X-H. Sun (Oklahoma Medical Research Foundation, USA), C. Cepko (Harvard Medical School, USA), D. Bulavin (IMCB, Singapore) and R. DePinho (University of Texas, MD Anderson Cancer Center, USA) for reagents and mice. S.P.G. is an investigator of Howard Hughes Medical Institute. The work was supported by grants from the Ministry of Science and Technology of China (The National Key Scientific Program (2012CB966901, to B.L.)), the National Natural Science Foundation of China (81130039, 31071229 and 81121001), Shanghai Pujiang Program (10PJ1405000), Changjiang Scholars Program of the Ministry of Education and the Agency for Science, Technology and Research of Singapore.	Alani RM, 2001, P NATL ACAD SCI USA, V98, P7812, DOI 10.1073/pnas.141235398; Beausejour CM, 2006, NATURE, V443, P404, DOI 10.1038/nature05221; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Huang YP, 2008, BLOOD, V112, P111, DOI 10.1182/blood-2007-10-118232; Huot TJ, 2002, MOL CELL BIOL, V22, P8135, DOI 10.1128/MCB.22.23.8135-8143.2002; Ivanov A, 2011, NAT CELL BIOL, V13, P193, DOI 10.1038/ncb0311-193; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kamiya N, 2008, DEVELOPMENT, V135, P3801, DOI 10.1242/dev.025825; Kamiya N, 2008, J BONE MINER RES, V23, P2007, DOI 10.1359/JBMR.080809; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Ko HS, 2010, P NATL ACAD SCI USA, V107, P16691, DOI 10.1073/pnas.1006083107; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Li BJ, 2004, GENE DEV, V18, P1824, DOI 10.1101/gad.1223504; Li BJ, 2000, NAT GENET, V24, P304, DOI 10.1038/73542; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Michael M, 2010, CURR BIOL, V20, P783, DOI 10.1016/j.cub.2010.03.048; Mishina Y, 2004, J BIOL CHEM, V279, P27560, DOI 10.1074/jbc.M404222200; Miyazono Kohei, 2002, Sci STKE, V2002, ppe40, DOI 10.1126/stke.2002.151.pe40; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; ONeill AJ, 1997, J PATHOL, V183, P325, DOI 10.1002/(SICI)1096-9896(199711)183:3<325::AID-PATH941>3.0.CO;2-A; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; de Arce KP, 2010, J NEUROSCI, V30, P3728, DOI 10.1523/JNEUROSCI.2024-09.2010; Randle DH, 2001, P NATL ACAD SCI USA, V98, P9654, DOI 10.1073/pnas.171217498; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Schlatterer SD, 2011, J MOL NEUROSCI, V45, P445, DOI 10.1007/s12031-011-9588-1; Schmitt CA, 2003, NAT REV CANCER, V3, P286, DOI 10.1038/nrc1044; SCHWARTZBERG PL, 1991, CELL, V65, P1165, DOI 10.1016/0092-8674(91)90012-N; Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Silberman I, 2008, CELL CYCLE, V7, P3847, DOI 10.4161/cc.7.24.7267; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Tzeng SJ, 2005, J BIOL CHEM, V280, P35247, DOI 10.1074/jbc.M505308200; Usui M, 2008, J BONE MINER RES, V23, P314, DOI 10.1359/JBMR.071025; Van Etten RA, 1999, TRENDS CELL BIOL, V9, P179, DOI 10.1016/S0962-8924(99)01549-4; van Riggelen J, 2010, NAT CELL BIOL, V12, P7, DOI 10.1038/ncb0110-7; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; von Kriegsheim A, 2009, NAT CELL BIOL, V11, P1458, DOI 10.1038/ncb1994; Wang JYJ, 2004, NAT CELL BIOL, V6, P3, DOI 10.1038/ncb0104-3; Wang X, 2011, CELL DEATH DIFFER, V18, P5, DOI 10.1038/cdd.2010.106; Whang YE, 2000, P NATL ACAD SCI USA, V97, P5486, DOI 10.1073/pnas.97.10.5486; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Woodring PJ, 2002, J CELL BIOL, V156, P879, DOI 10.1083/jcb.200110014; Yamaguchi K, 1999, EMBO J, V18, P179, DOI 10.1093/emboj/18.1.179; Zebedee Z, 2001, ONCOGENE, V20, P8317, DOI 10.1038/sj.onc.1205092; Zhang Y, 1999, TRENDS CELL BIOL, V9, P274, DOI 10.1016/S0962-8924(99)01579-2; Zhao M, 2002, J CELL BIOL, V157, P1049, DOI 10.1083/jcb.200109012; Zipfel PA, 2004, CURR BIOL, V14, P1222, DOI 10.1016/j.cub.2004.07.021; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	66	45	48	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2012	14	7					727	737		10.1038/ncb2528	http://dx.doi.org/10.1038/ncb2528			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	967PV	22729085	Green Accepted			2022-12-25	WOS:000305921200012
J	Wu, W; Allen, RA; Wang, YD				Wu, Wei; Allen, Robert A.; Wang, Yadong			Fast-degrading elastomer enables rapid remodeling of a cell-free synthetic graft into a neoartery	NATURE MEDICINE			English	Article							SMALL-INTESTINAL SUBMUCOSA; ENGINEERED BLOOD-VESSELS; SMALL-DIAMETER; VASCULAR GRAFTS; SAPHENOUS-VEIN; CAROTID-ARTERY; SURFACE; REGENERATION; COLLAGEN; INJURY	Host remodeling is important for the success of medical implants, including vascular substitutes. Synthetic and tissue-engineered grafts have yet to show clinical effectiveness in arteries smaller than 5 mm in diameter. We designed cell-free biodegradable elastomeric grafts that degrade rapidly to yield neoarteries nearly free of foreign materials 3 months after interposition grafting in rat abdominal aorta. This design focuses on enabling rapid host remodeling. Three months after implantation, the neoarteries resembled native arteries in the following aspects: regular, strong and synchronous pulsation; a confluent endothelium and contractile smooth muscle layers; expression of elastin, collagen and glycosaminoglycan; and tough and compliant mechanical properties. Therefore, future studies employing large animal models more representative of human vascular regeneration are warranted before clinical translation. This cell-free approach represents a philosophical shift from the prevailing focus on cells in vascular tissue engineering and may have an impact on regenerative medicine in general.	[Wu, Wei; Allen, Robert A.; Wang, Yadong] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Wu, Wei] Fourth Mil Med Univ, Qindu Hosp, Dept Maxillofacial Surg, Xian 710032, Peoples R China; [Wang, Yadong] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Wang, Yadong] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Air Force Military Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, YD (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.	yaw20@pitt.edu	Wang, Yadong/AAC-3381-2020	Wang, Yadong/0000-0003-2067-382X; Allen, Robert/0000-0003-2885-1758	US National Institutes of Health (NIH) grant [HL089658]; American Heart Association award [0730031N]; US NIH training grant [2T32HL076124]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076124, R01HL089658] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association award(American Heart Association); US NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research is supported by US National Institutes of Health (NIH) grant HL089658, American Heart Association award 0730031N and US NIH training grant 2T32HL076124. We thank S. Shroff for insightful discussions on mechanical testing of arteries, W. Wagner for access to the laser Doppler ultrasound and K. Kim for assistance with ultrasound imaging. We greatly appreciate R. Wagner and D. Rossi for performing angiography, M. Witt for DNA quantification, and D. Stolz, M. Sun and D. Clay for performing transmission electron microscopy.	Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bezuidenhout D, 2010, J BIOMATER APPL, V24, P401, DOI 10.1177/0885328208097565; Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040; BULL DA, 1995, J SURG RES, V58, P58, DOI 10.1006/jsre.1995.1010; Dahl SLM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001426; DAMUS PS, 1973, NATURE, V246, P355, DOI 10.1038/246355a0; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Hashi CK, 2010, ARTERIOSCL THROM VAS, V30, P1621, DOI 10.1161/ATVBAHA.110.208348; He W, 2010, BIOMATERIALS, V31, P8235, DOI 10.1016/j.biomaterials.2010.07.034; Hibino N, 2011, FASEB J, V25, P4253, DOI 10.1096/fj.11-186585; Huynh T, 1999, NAT BIOTECHNOL, V17, P1083, DOI 10.1038/15062; Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84; Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035; L'Heureux N, 1998, FASEB J, V12, P47, DOI 10.1096/fasebj.12.1.47; L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364; L'Heureux N, 2007, NEW ENGL J MED, V357, P1451, DOI 10.1056/NEJMc071536; Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351; Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X; Lee KW, 2011, P NATL ACAD SCI USA, V108, P2705, DOI 10.1073/pnas.1017834108; Li L, 2008, KIDNEY INT, V74, P1247, DOI 10.1038/ki.2008.318; Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Neff LP, 2011, J VASC SURG, V53, P426, DOI 10.1016/j.jvs.2010.07.054; Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489; Pavcnik D, 2009, CARDIOVASC INTER RAD, V32, P106, DOI 10.1007/s00270-008-9449-7; PREVEL CD, 1994, MICROSURG, V15, P586, DOI 10.1002/micr.1920150812; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107; SANDUSKY GE, 1995, J SURG RES, V58, P415, DOI 10.1006/jsre.1995.1064; SANDUSKY GE, 1992, AM J PATHOL, V140, P317; Soletti L, 2011, J BIOMED MATER RES A, V96A, P436, DOI 10.1002/jbm.a.32997; Torikai K, 2008, J THORAC CARDIOV SUR, V136, P37, DOI 10.1016/j.jtcvs.2007.06.039; Turner NA, 2007, ATHEROSCLEROSIS, V193, P36, DOI 10.1016/j.atherosclerosis.2006.08.017; VEITH FJ, 1986, J VASC SURG, V3, P104; Verrier ED, 1996, ANN THORAC SURG, V62, P915; Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534; WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816; Yokota T, 2008, J THORAC CARDIOV SUR, V136, P900, DOI 10.1016/j.jtcvs.2008.02.058; Zhu CH, 2008, BIOMATERIALS, V29, P2628, DOI 10.1016/j.biomaterials.2008.03.005; Zilla P, 2007, BIOMATERIALS, V28, P5009, DOI 10.1016/j.biomaterials.2007.07.017	40	298	307	4	162	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2012	18	7					1148	+		10.1038/nm.2821	http://dx.doi.org/10.1038/nm.2821			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22729285	Green Accepted			2022-12-25	WOS:000306121600047
J	Barbieri, CE; Baca, SC; Lawrence, MS; Demichelis, F; Blattner, M; Theurillat, JP; White, TA; Stojanov, P; Van Allen, E; Stransky, N; Nickerson, E; Chae, SS; Boysen, G; Auclair, D; Onofrio, RC; Park, K; Kitabayashi, N; MacDonald, TY; Sheikh, K; Vuong, T; Guiducci, C; Cibulskis, K; Sivachenko, A; Carter, SL; Saksena, G; Voet, D; Hussain, WM; Ramos, AH; Winckler, W; Redman, MC; Ardlie, K; Tewari, AK; Mosquera, JM; Rupp, N; Wild, PJ; Moch, H; Morrissey, C; Nelson, PS; Kantoff, PW; Gabriel, SB; Golub, TR; Meyerson, M; Lander, ES; Getz, G; Rubin, MA; Garraway, LA				Barbieri, Christopher E.; Baca, Sylvan C.; Lawrence, Michael S.; Demichelis, Francesca; Blattner, Mirjam; Theurillat, Jean-Philippe; White, Thomas A.; Stojanov, Petar; Van Allen, Eliezer; Stransky, Nicolas; Nickerson, Elizabeth; Chae, Sung-Suk; Boysen, Gunther; Auclair, Daniel; Onofrio, Robert C.; Park, Kyung; Kitabayashi, Naoki; MacDonald, Theresa Y.; Sheikh, Karen; Vuong, Terry; Guiducci, Candace; Cibulskis, Kristian; Sivachenko, Andrey; Carter, Scott L.; Saksena, Gordon; Voet, Douglas; Hussain, Wasay M.; Ramos, Alex H.; Winckler, Wendy; Redman, Michelle C.; Ardlie, Kristin; Tewari, Ashutosh K.; Mosquera, Juan Miguel; Rupp, Niels; Wild, Peter J.; Moch, Holger; Morrissey, Colm; Nelson, Peter S.; Kantoff, Philip W.; Gabriel, Stacey B.; Golub, Todd R.; Meyerson, Matthew; Lander, Eric S.; Getz, Gad; Rubin, Mark A.; Garraway, Levi A.			Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer	NATURE GENETICS			English	Article							ETS GENE FUSIONS; FORKHEAD BOX A1; ANDROGEN RECEPTOR; SUPPRESSOR; PROTEIN; DATABASE; TMPRSS2; NKX3.1; HEAD	Prostate cancer is the second most common cancer in men worldwide and causes over 250,000 deaths each year(1). Overtreatment of indolent disease also results in significant morbidity(2). Common genetic alterations in prostate cancer include losses of NKX3.1 (8p21)(3,4) and PTEN (10q23)(5,6), gains of AR (the androgen receptor gene) 7,8 and fusion of ETS family transcription factor genes with androgen-responsive promoters(9-11). Recurrent somatic base-pair substitutions are believed to be less contributory in prostate tumorigenesis(12,13) but have not been systematically analyzed in large cohorts. Here, we sequenced the exomes of 112 prostate tumor and normal tissue pairs. New recurrent mutations were identified in multiple genes, including MED12 and FOXA1. SPOP was the most frequently mutated gene, with mutations involving the SPOP substrate-binding cleft in 6-15% of tumors across multiple independent cohorts. Prostate cancers with mutant SPOP lacked ETS family gene rearrangements and showed a distinct pattern of genomic alterations. Thus, SPOP mutations may define a new molecular subtype of prostate cancer.	[Barbieri, Christopher E.; Blattner, Mirjam; Chae, Sung-Suk; Boysen, Gunther; Park, Kyung; Kitabayashi, Naoki; MacDonald, Theresa Y.; Sheikh, Karen; Vuong, Terry; Hussain, Wasay M.; Mosquera, Juan Miguel; Rubin, Mark A.] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA; [Barbieri, Christopher E.; Tewari, Ashutosh K.; Rubin, Mark A.] Weill Cornell Med Coll, Dept Urol, New York, NY USA; [Baca, Sylvan C.; Lawrence, Michael S.; Theurillat, Jean-Philippe; Stojanov, Petar; Van Allen, Eliezer; Stransky, Nicolas; Nickerson, Elizabeth; Auclair, Daniel; Onofrio, Robert C.; Guiducci, Candace; Cibulskis, Kristian; Sivachenko, Andrey; Carter, Scott L.; Saksena, Gordon; Voet, Douglas; Ramos, Alex H.; Winckler, Wendy; Redman, Michelle C.; Ardlie, Kristin; Gabriel, Stacey B.; Golub, Todd R.; Meyerson, Matthew; Lander, Eric S.; Getz, Gad; Garraway, Levi A.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA; [Baca, Sylvan C.; Ramos, Alex H.; Kantoff, Philip W.; Meyerson, Matthew; Lander, Eric S.; Garraway, Levi A.] Harvard Univ, Sch Med, Boston, MA USA; [Baca, Sylvan C.; Van Allen, Eliezer; Kantoff, Philip W.; Meyerson, Matthew; Lander, Eric S.; Garraway, Levi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Demichelis, Francesca; Hussain, Wasay M.] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY USA; [Demichelis, Francesca] Univ Trento, Ctr Integrat Biol, Trento, Italy; [White, Thomas A.; Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA; [Rupp, Niels; Wild, Peter J.; Moch, Holger] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Morrissey, Colm; Nelson, Peter S.] Univ Washington, Dept Med, Seattle, WA USA; [Morrissey, Colm; Nelson, Peter S.] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Golub, Todd R.; Meyerson, Matthew; Garraway, Levi A.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA USA	Cornell University; Cornell University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Cornell University; University of Trento; Fred Hutchinson Cancer Center; University of Zurich; University Zurich Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT)	Rubin, MA (corresponding author), Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA.	rubinma@med.cornell.edu; levi_garraway@dfci.harvard.edu	Cibulskis, Kristian/AAC-7380-2019; Lawrence, Michael/AAC-8202-2020; Stojanov, Petar/GQI-4462-2022; Meyerson, Matthew L/E-7123-2012; Demichelis, Francesca/J-9829-2016	Stojanov, Petar/0000-0001-7815-776X; Demichelis, Francesca/0000-0002-8266-8631; Barbieri, Christopher/0000-0002-0381-1947; Cibulskis, Kristian/0000-0003-1343-1582; Kantoff, Philip/0000-0001-7275-0597; White, Thomas/0000-0002-5013-9129; Wild, Peter Johannes/0000-0002-1017-3744; Boysen, Gunther/0000-0002-7610-6085; Meyerson, Matthew/0000-0002-9133-8108; Rubin, Mark/0000-0002-8321-9950; Van Allen, Eliezer/0000-0002-0201-4444	US National Human Genome Research Institute (NHGRI) [U54 HG003067]; Kohlberg Foundation; Starr Cancer Consortium; Prostate Cancer Foundation; US Department of Defense [PC101020, PC093372]; Dana-Farber/Harvard Cancer Center Prostate Cancer SPORE (US National Institutes of Health (NIH)) [P50 CA090381]; New Investigator Award [PC094516]; US National Cancer Institute, Early Detection Research Network [U01CA111275, NCI EDRN]; US National Cancer Institute [R01 CA125612]; Pacific Northwest Prostate Cancer SPORE [P50CA097186]; Swiss Science Foundation [PASMP3_134379/1]; US NIH [DP2OD002750]; NATIONAL CANCER INSTITUTE [T32CA080416, P50CA090381, R01CA125612, U01CA111275, P50CA097186] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002750] Funding Source: NIH RePORTER	US National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Kohlberg Foundation; Starr Cancer Consortium; Prostate Cancer Foundation; US Department of Defense(United States Department of Defense); Dana-Farber/Harvard Cancer Center Prostate Cancer SPORE (US National Institutes of Health (NIH))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Investigator Award; US National Cancer Institute, Early Detection Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pacific Northwest Prostate Cancer SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swiss Science Foundation(Swiss National Science Foundation (SNSF)); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful for the assistance of members of the Broad Institute Biological Samples Platform, Genetic Analysis Platform and Genome Sequencing Platform. We thank S. Banerjee for computational assistance, R. Kim and R. Leung for their critical contributions to the Weill Cornell Prostate Cancer Tumor Bank, P. Schraml, S. Dettwiler and M. Storz for assistance with the University Hospital Zurich cohort and biobank and the members of the University of Washington Rapid Autopsy Program. We thank the University of Michigan Prostate Cancer Special Program of Research Excellence (SPORE) (K. Pienta) for sample contribution to this study. We are also grateful to the individuals with prostate cancer and the families who contributed to these studies. This work was supported by the US National Human Genome Research Institute (NHGRI) Large Scale Sequencing Program (U54 HG003067 to the Broad Institute, E. S. L.), the Kohlberg Foundation (L. A. G.), the Starr Cancer Consortium (M. A. R., F. D. and L. A. G), the Prostate Cancer Foundation (M. A. R.), US Department of Defense Synergy Awards (PC101020 to F. D., L. A. G. and M. A. R. and PC093372 to T. W. and P.S.N.), the Dana-Farber/Harvard Cancer Center Prostate Cancer SPORE (US National Institutes of Health (NIH) P50 CA090381), a New Investigator Award (PC094516 to F. D.), the US National Cancer Institute, Early Detection Research Network (U01CA111275 and NCI EDRN to F. D. and M. A. R.), the US National Cancer Institute (R01 CA125612 to F. D. and M. A. R.), the Pacific Northwest Prostate Cancer SPORE (P50CA097186 to C. M. and P.S.N.), the Swiss Science Foundation (PASMP3_134379/1 to J.-P.T.) and a US NIH Director's New Innovator Award (DP2OD002750 to L. A. G.). S. C. B. is supported by a Medical Scientist Training Program (MSTP) grant from the US NIH. C. E. B. is supported by a Prostate Cancer Foundation Young Investigator Award.	Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Cairns P, 1997, CANCER RES, V57, P4997; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Cibulskis K, 2011, BIOINFORMATICS, V27, P2601, DOI 10.1093/bioinformatics/btr446; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Daskivich TJ, 2011, CANCER-AM CANCER SOC, V117, P2058, DOI 10.1002/cncr.25751; Demichelis F, 2009, GENE CHROMOSOME CANC, V48, P366, DOI 10.1002/gcc.20647; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gao N, 2005, DEVELOPMENT, V132, P3431, DOI 10.1242/dev.01917; Gao N, 2003, MOL ENDOCRINOL, V17, P1484, DOI 10.1210/me.2003-0020; Griffith OL, 2008, NUCLEIC ACIDS RES, V36, pD107, DOI 10.1093/nar/gkm967; He WW, 1997, GENOMICS, V43, P69, DOI 10.1006/geno.1997.4715; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kibel AS, 2003, CANCER RES, V63, P2033; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kumar A, 2011, P NATL ACAD SCI USA, V108, P17087, DOI 10.1073/pnas.1108745108; Lapointe J, 2007, CANCER RES, V67, P8504, DOI 10.1158/0008-5472.CAN-07-0673; Li C, 2011, ONCOGENE, V30, P4350, DOI 10.1038/onc.2011.151; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Linja MJ, 2004, J STEROID BIOCHEM, V92, P255, DOI 10.1016/j.jsbmb.2004.10.012; Liu J, 2009, SCIENCE, V323, P1218, DOI 10.1126/science.1157669; Majumder PK, 2008, CANCER CELL, V14, P146, DOI 10.1016/j.ccr.2008.06.002; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Mandelbaum J, 2010, CANCER CELL, V18, P568, DOI 10.1016/j.ccr.2010.10.030; Mosquera JM, 2009, CLIN CANCER RES, V15, P4706, DOI 10.1158/1078-0432.CCR-08-2927; Nagai Y, 1997, FEBS LETT, V418, P23, DOI 10.1016/S0014-5793(97)01340-9; Park K, 2010, NEOPLASIA, V12, P590, DOI 10.1593/neo.10726; Perner S, 2006, CANCER RES, V66, P8337, DOI 10.1158/0008-5472.CAN-06-1482; Pflueger D, 2011, GENOME RES, V21, P56, DOI 10.1101/gr.110684.110; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Svensson MA, 2011, LAB INVEST, V91, P404, DOI 10.1038/labinvest.2010.179; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wang CB, 2010, DEVELOPMENT, V137, P2001, DOI 10.1242/dev.052126; Wang QB, 2002, J BIOL CHEM, V277, P42852, DOI 10.1074/jbc.M206061200; Williamson EA, 2006, ONCOGENE, V25, P1391, DOI 10.1038/sj.onc.1209170; Yang JY, 2009, CLIN CANCER RES, V15, P752, DOI 10.1158/1078-0432.CCR-08-0124; Zhang CP, 2011, CANCER RES, V71, P6738, DOI 10.1158/0008-5472.CAN-11-1882; Zhou RJ, 2002, NUCLEIC ACIDS RES, V30, P3245, DOI 10.1093/nar/gkf443; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022	54	1062	1105	6	127	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2012	44	6					685	U107		10.1038/ng.2279	http://dx.doi.org/10.1038/ng.2279			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	949BT	22610119	Green Submitted, Green Accepted			2022-12-25	WOS:000304551100016
J	Sajish, M; Zhou, QS; Kishi, S; Valdez, DM; Kapoor, M; Guo, M; Lee, S; Kim, S; Yang, XL; Schimmel, P				Sajish, Mathew; Zhou, Quansheng; Kishi, Shuji; Valdez, Delgado M., Jr.; Kapoor, Mili; Guo, Min; Lee, Sunhee; Kim, Sunghoon; Yang, Xiang-Lei; Schimmel, Paul			Trp-tRNA synthetase bridges DNA-PKcs to PARP-1 to link IFN-gamma and p53 signaling	NATURE CHEMICAL BIOLOGY			English	Article							DEPENDENT PROTEIN-KINASE; INTERFERON-GAMMA; IN-VIVO; POLY(ADP-RIBOSE) POLYMERASE; INDOLEAMINE 2,3-DIOXYGENASE; CRYSTAL-STRUCTURE; RELEASE FACTOR; ACTIVE-SITE; ANGIOGENESIS; INHIBITION	Interferon-gamma (IFN-gamma) engenders strong antiproliferative responses, in part through activation of p53. However, the long-known IFN-gamma-dependent upregulation of human Trp-tRNA synthetase (TrpRS), a cytoplasmic enzyme that activates tryptophan to form Trp-AMP in the first step of protein synthesis, is unexplained. Here we report a nuclear complex of TrpRS with the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) and with poly(ADP-ribose) polymerase 1 (PARP-1), the major PARP in human cells. The IFN-gamma-dependent poly(ADP-ribosyl) ation of DNA-PKcs (which activates its kinase function) and concomitant activation of the tumor suppressor p53 were specifically prevented by Trp-SA, an analog of Trp-AMP that disrupted the TrpRS-DNA-PKcs-PARP-1 complex. The connection of TrpRS to p53 signaling in vivo was confirmed in a vertebrate system. These and further results suggest an unexpected evolutionary expansion of the protein synthesis apparatus to a nuclear role that links major signaling pathways.	[Sajish, Mathew; Zhou, Quansheng; Kapoor, Mili; Lee, Sunhee; Yang, Xiang-Lei; Schimmel, Paul] Scripps Res Inst, Dept Mol Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Kishi, Shuji; Valdez, Delgado M., Jr.; Guo, Min] Scripps Res Inst, Jupiter, FL USA; [Lee, Sunhee; Kim, Sunghoon] Seoul Natl Univ, World Class Univ, Dept Mol Med & Biopharmaceut Sci, Med Bioconvergence Res Ctr, Seoul, South Korea	Scripps Research Institute; Scripps Research Institute; Seoul National University (SNU)	Sajish, M (corresponding author), Scripps Res Inst, Dept Mol Biol, Skaggs Inst Chem Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schimmel@scripps.edu	Kim, Sunghoon/AAE-8314-2020; Yang, Xiang-Lei/AAR-7107-2020; Thekkel, Sajish Mathew/AAM-3548-2021	Thekkel, Sajish Mathew/0000-0001-6715-5953; kim, sunghoon/0000-0002-1570-3230; Zhou, Quansheng/0000-0003-4712-0731; Yang, Xiang-Lei/0000-0003-2554-084X	US National Institutes of Health [GM15539, GM23562, GM088278]; National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088278, R37GM015539, R01GM023562, R01GM015539] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Chen (University of Texas Southwestern Medical School) for the DNA-PKcs clone and P. Chang (Massachusetts Institute of Technology) for the ZZ-PARP-1 clone. This work was supported by grants GM15539 and GM23562 (to P.S.) and GM088278 (to X.-L.Y.) from the US National Institutes of Health and by a fellowship from the National Foundation for Cancer Research.	Aggad D, 2010, J IMMUNOL, V185, P6774, DOI 10.4049/jimmunol.1000549; ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; Ariumi Y, 1999, ONCOGENE, V18, P4616, DOI 10.1038/sj.onc.1202823; BANGE FC, 1992, FEBS LETT, V300, P162, DOI 10.1016/0014-5793(92)80187-L; Beckert S, 2006, BIOCHEM BIOPH RES CO, V341, P67, DOI 10.1016/j.bbrc.2005.12.148; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Cao L, 2003, GENE DEV, V17, P201, DOI 10.1101/gad.1050003; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; FLECKNER J, 1991, P NATL ACAD SCI USA, V88, P11520, DOI 10.1073/pnas.88.24.11520; Grueneberg DA, 2008, P NATL ACAD SCI USA, V105, P16490, DOI 10.1073/pnas.0806578105; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Jin SF, 1997, J BIOL CHEM, V272, P24763, DOI 10.1074/jbc.272.40.24763; Kapoor M, 2008, J BIOL CHEM, V283, P2070, DOI 10.1074/jbc.M706028200; Kim KS, 2009, MECH AGEING DEV, V130, P179, DOI 10.1016/j.mad.2008.11.004; Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; Lindner Daniel J, 2002, Curr Oncol Rep, V4, P510, DOI 10.1007/s11912-002-0065-4; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Liu JM, 2004, NUCLEIC ACIDS RES, V32, P719, DOI 10.1093/nar/gkh240; POPENKO V I, 1989, Molekulyarnaya Biologiya (Moscow), V23, P1669; POPENKO VI, 1993, EUR J CELL BIOL, V62, P248; RUBIN BY, 1991, J BIOL CHEM, V266, P24245; Ruscetti T, 1998, J BIOL CHEM, V273, P14461, DOI 10.1074/jbc.273.23.14461; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Seburn KL, 2006, NEURON, V51, P715, DOI 10.1016/j.neuron.2006.08.027; Sgadari C, 1997, BLOOD, V89, P2635, DOI 10.1182/blood.V89.8.2635; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Sidi S, 2008, CELL, V133, P864, DOI 10.1016/j.cell.2008.03.037; Sieger D, 2009, DIS MODEL MECH, V2, P571, DOI 10.1242/dmm.003509; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Teodoro JG, 2006, SCIENCE, V313, P968, DOI 10.1126/science.1126391; Wakasugi K, 2002, P NATL ACAD SCI USA, V99, P173, DOI 10.1073/pnas.012602099; Weterings E, 2007, J CELL BIOL, V179, P183, DOI 10.1083/jcb.200705106; Woo RA, 1998, NATURE, V394, P700, DOI 10.1038/29343; Yang G, 2007, ONCOGENE, V26, P594, DOI 10.1038/sj.onc.1209807; Yang XL, 2007, STRUCTURE, V15, P793, DOI 10.1016/j.str.2007.05.009; Yang XL, 2006, EMBO J, V25, P2919, DOI 10.1038/sj.emboj.7601154; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019; YOSHIDA R, 1979, P NATL ACAD SCI USA, V76, P4084, DOI 10.1073/pnas.76.8.4084; YOSHIDA R, 1981, P NATL ACAD SCI-BIOL, V78, P129, DOI 10.1073/pnas.78.1.129; Zhao Y, 2006, CANCER RES, V66, P5354, DOI 10.1158/0008-5472.CAN-05-4275; Zhou QS, 2010, NAT STRUCT MOL BIOL, V17, P57, DOI 10.1038/nsmb.1706	44	63	67	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2012	8	6					547	554		10.1038/NCHEMBIO.937	http://dx.doi.org/10.1038/NCHEMBIO.937			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	945ET	22504299	Green Accepted			2022-12-25	WOS:000304256300010
J	Whitehead, TA; Chevalier, A; Song, YF; Dreyfus, C; Fleishman, SJ; De Mattos, C; Myers, CA; Kamisetty, H; Blair, P; Wilson, IA; Baker, D				Whitehead, Timothy A.; Chevalier, Aaron; Song, Yifan; Dreyfus, Cyrille; Fleishman, Sarel J.; De Mattos, Cecilia; Myers, Chris A.; Kamisetty, Hetunandan; Blair, Patrick; Wilson, Ian A.; Baker, David			Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing	NATURE BIOTECHNOLOGY			English	Article							PROTEIN; ANTIBODIES	We show that comprehensive sequence-function maps obtained by deep sequencing can be used to reprogram interaction specificity and to leapfrog over bottlenecks in affinity maturation by combining many individually small contributions not detectable in conventional approaches. We use this approach to optimize two computationally designed inhibitors against H1N1 influenza hemagglutinin and, in both cases, obtain variants with subnanomolar binding affinity. The most potent of these, a 51-residue protein, is broadly cross-reactive against all influenza group 1 hemagglutinins, including human H2, and neutralizes H1N1 viruses with a potency that rivals that of several human monoclonal antibodies, demonstrating that computational design followed by comprehensive energy landscape mapping can generate proteins with potential therapeutic utility.	[Whitehead, Timothy A.; Chevalier, Aaron; Song, Yifan; Fleishman, Sarel J.; Kamisetty, Hetunandan; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Dreyfus, Cyrille; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Dreyfus, Cyrille; Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [De Mattos, Cecilia; Myers, Chris A.; Blair, Patrick] USN, Hlth Res Ctr, San Diego, CA 92152 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Scripps Research Institute; Scripps Research Institute; United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Fleishman, Sarel/0000-0003-3177-7560	Defense Advanced Research Projects Agency (DARPA); Defense Threat Reduction Agency (DTRA); US National Institutes of Health, National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences [Y1-GM-1104]; National Cancer Institute [Y1-CO-1020]; US Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); US National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank D. Fowler and S. Fields for helpful discussions and use of their in-house software to process sequencing data, C. Lee, J. Shendure and M. Dunham for experimental expertise in DNA prep and sequencing, C. Sitz and C. Santiago for technical help and the Joint Center for Structural Genomics for crystallization using the JCSG/IAVI/TSRI Rigaku Crystalmation system. This work was funded by Defense Advanced Research Projects Agency (DARPA) and the Defense Threat Reduction Agency (DTRA), and US National Institutes of Health, National Institute of Allergy and Infectious Diseases and National Institute of General Medical Sciences. The GM/CA CAT 23-ID-B beamline has been funded in whole or in part with federal funds from National Cancer Institute (Y1-CO-1020) and NIGMS (Y1-GM-1104). Use of the Advanced Photon Source (APS) was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIGMS or the NIH.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], PYMOL MOL GRAPH SYST; Araya CL, 2011, TRENDS BIOTECHNOL, V29, P435, DOI 10.1016/j.tibtech.2011.04.003; Balakrishnan S, 2011, PROTEINS, V79, P1061, DOI 10.1002/prot.22934; Benatuil L, 2010, PROTEIN ENG DES SEL, V23, P155, DOI 10.1093/protein/gzq002; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; Chao G, 2004, J MOL BIOL, V342, P539, DOI 10.1016/j.jmb.2004.07.053; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Dutta S, 2010, J MOL BIOL, V398, P747, DOI 10.1016/j.jmb.2010.03.058; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Hietpas RT, 2011, P NATL ACAD SCI USA, V108, P7896, DOI 10.1073/pnas.1016024108; Joughin BA, 2005, PROTEIN SCI, V14, P1363, DOI 10.1110/ps.041283105; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Marshall SA, 2005, PROTEIN SCI, V14, P1293, DOI 10.1110/ps.041259105; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Nguyen JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009332; Nguyen JT, 2009, ANTIMICROB AGENTS CH, V53, P4115, DOI 10.1128/AAC.00476-09; Pal G, 2006, J BIOL CHEM, V281, P22378, DOI 10.1074/jbc.M603826200; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Pitt JN, 2010, SCIENCE, V330, P376, DOI 10.1126/science.1192001; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0; Shultzaberger RK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001042; Sitkoff D, 1996, J PHYS CHEM-US, V100, P2744, DOI 10.1021/jp952986i; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Smee DF, 2001, ANTIMICROB AGENTS CH, V45, P743, DOI 10.1128/AAC.45.3.743-748.2001; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532	44	259	278	3	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2012	30	6					543	+		10.1038/nbt.2214	http://dx.doi.org/10.1038/nbt.2214			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	957JV	22634563	Green Accepted			2022-12-25	WOS:000305158600024
J	Nelson, KS; Khan, Z; Molnar, I; Mihaly, J; Kaschube, M; Beitel, GJ				Nelson, Kevin S.; Khan, Zia; Molnar, Imre; Mihaly, Jozsef; Kaschube, Matthias; Beitel, Greg J.			Drosophila Src regulates anisotropic apical surface growth to control epithelial tube size	NATURE CELL BIOLOGY			English	Article							SEPTATE JUNCTION ORGANIZATION; CHITIN; CUTICLE; PHOSPHORYLATION; MORPHOGENESIS; LOCALIZATION; ALGORITHM; PROTEINS; DISTINCT; MATRIX	Networks of epithelial and endothelial tubes are essential for the function of organs such as the lung, kidney and vascular system. The sizes and shapes of these tubes are highly regulated to match their individual functions. Defects in tube size can cause debilitating diseases such as polycystic kidney disease and ischaemia(1,2). It is therefore critical to understand how tube dimensions are regulated. Here we identify the tyrosine kinase Src as an instructive regulator of epithelial-tube length in the Drosophila tracheal system. Loss-of-function Src42 mutations shorten tracheal tubes, whereas Src42 overexpression elongates them. Surprisingly, Src42 acts distinctly from known tube-size pathways and regulates both the amount of apical surface growth and, with the conserved formin dDaam, the direction of growth. Quantitative three-dimensional image analysis reveals that Src42- and dDaam-mutant tracheal cells expand more in the circumferential than the axial dimension, resulting in tubes that are shorter in length-but larger in diameter-than wild-type tubes. Thus, Src42 and dDaam control tube dimensions by regulating the direction of anisotropic growth, a mechanism that has not previously been described.	[Nelson, Kevin S.; Beitel, Greg J.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Nelson, Kevin S.; Beitel, Greg J.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA; [Khan, Zia; Kaschube, Matthias] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Khan, Zia] Princeton Univ, Dept Comp Sci, Princeton, NJ 08540 USA; [Molnar, Imre; Mihaly, Jozsef] Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6726 Szeged, Hungary; [Kaschube, Matthias] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA	Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Princeton University; Princeton University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Princeton University	Beitel, GJ (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	beitel@northwestern.edu		Mihaly, Jozsef/0000-0003-3399-2424; Khan, Zia/0000-0002-7859-3489	National Institutes of Health (NIH) [T32 GM008061, P50 GM 071508]; Malkin Scholar Award; Achievement Rewards for College Scientists (ARCS) Award; Northwestern University Alumni Association; Hungarian Scientific Research Fund (OTKA) [K 82039]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061, P50GM071508] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Malkin Scholar Award; Achievement Rewards for College Scientists (ARCS) Award; Northwestern University Alumni Association; Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Zeeb and E. Lammert for sharing unpublished results and comments on the manuscript, R. Carthew, S. Hilgenfeldt and A. Dudley for discussions, Bill Russin and the Northwestern Biological Imaging Facility for imaging support, S. Hayashi, A. O'Reilly, T. Xu, the Bloomington Stock Center and the Developmental Studies Hybridoma Bank for fly stocks and reagents, M. Singh for technical advice and R. Robbins, T. Helenius and T. Krupinski for comments on the manuscript. This work was supported by a predoctoral fellowship from the National Institutes of Health (NIH) Cellular and Molecular Basis of Disease training grant (T32 GM008061 to K.S.N.), a Malkin Scholar Award (to K.S.N.), an Achievement Rewards for College Scientists (ARCS) Award (to K.S.N.), a grant from the Northwestern University Alumni Association (to G.J.B.), NIH grant P50 GM 071508, principal investigator D. Botstein (Z.K. and M.K.), and Hungarian Scientific Research Fund (OTKA) grant K 82039 (to J.M.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ang SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013064; Araujo SJ, 2005, DEV BIOL, V288, P179, DOI 10.1016/j.ydbio.2005.09.031; Aspenstrom P, 2006, EXP CELL RES, V312, P2180, DOI 10.1016/j.yexcr.2006.03.013; Behr M, 2003, DEV CELL, V5, P611, DOI 10.1016/S1534-5807(03)00275-2; Beitel GJ, 2000, DEVELOPMENT, V127, P3271; Chung S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000746; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; KAPLAN KB, 1995, GENE DEV, V9, P1505, DOI 10.1101/gad.9.12.1505; Laprise P, 2010, CURR BIOL, V20, P55, DOI 10.1016/j.cub.2009.11.017; LeClaire LL, 2008, J CELL BIOL, V182, P647, DOI 10.1083/jcb.200802145; Lorensen WE, 1987, SIGGRAPH 87 P 14 ANN; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Marx M, 2001, EXP MOL PATHOL, V70, P201, DOI 10.1006/exmp.2001.2358; Matusek T, 2006, DEVELOPMENT, V133, P957, DOI 10.1242/dev.02266; Matusek T, 2008, J NEUROSCI, V28, P13310, DOI 10.1523/JNEUROSCI.2727-08.2008; Maurer CR, 2003, IEEE T PATTERN ANAL, V25, P265, DOI 10.1109/TPAMI.2003.1177156; Moussian B, 2006, DEVELOPMENT, V133, P163, DOI 10.1242/dev.02177; Nelson KS, 2010, GENETICS, V185, P831, DOI 10.1534/genetics.110.114959; O'Reilly AM, 2006, DEVELOPMENT, V133, P2627, DOI 10.1242/dev.02423; Padash-Barmchi M, 2010, J CELL SCI, V123, P4052, DOI 10.1242/jcs.066605; Paul SM, 2007, DEVELOPMENT, V134, P147, DOI 10.1242/dev.02710; Paul SM, 2003, DEVELOPMENT, V130, P4963, DOI 10.1242/dev.00691; Pedraza LG, 2004, ONCOGENE, V23, P4754, DOI 10.1038/sj.onc.1207635; Requena L, 1997, J AM ACAD DERMATOL, V37, P523, DOI 10.1016/S0190-9622(97)70169-5; Samakovlis C, 1996, DEVELOPMENT, V122, P1395; Schwartzberg PL, 1997, GENE DEV, V11, P2835, DOI 10.1101/gad.11.21.2835; Segalen M, 2009, SEMIN CELL DEV BIOL, V20, P972, DOI 10.1016/j.semcdb.2009.03.018; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; Shindo M, 2008, DEVELOPMENT, V135, P1355, DOI 10.1242/dev.015982; Sweeney WE, 2008, J AM SOC NEPHROL, V19, P1331, DOI 10.1681/ASN.2007060665; Takahashi M, 2005, DEVELOPMENT, V132, P2547, DOI 10.1242/dev.01850; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Ward RE, 1998, J CELL BIOL, V140, P1463, DOI 10.1083/jcb.140.6.1463; Wu VM, 2004, J CELL BIOL, V164, P313, DOI 10.1083/jcb.200309134; Young KG, 2010, BBA-MOL CELL RES, V1803, P183, DOI 10.1016/j.bbamcr.2008.09.017	40	48	48	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2012	14	5					518	U150		10.1038/ncb2467	http://dx.doi.org/10.1038/ncb2467			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	936NW	22446737	Green Accepted			2022-12-25	WOS:000303598300012
J	Potowski, M; Schurmann, M; Preut, H; Antonchick, AP; Waldmann, H				Potowski, Marco; Schuermann, Markus; Preut, Hans; Antonchick, Andrey P.; Waldmann, Herbert			Programmable enantioselective one-pot synthesis of molecules with eight stereocenters	NATURE CHEMICAL BIOLOGY			English	Article							DIELS-ALDER REACTIONS; AZOMETHINE YLIDES; 1,3-DIPOLAR CYCLOADDITIONS; NATURAL-PRODUCTS; CONSTRUCTION; CATALYSIS	We developed an enantioselectively catalyzed tandem synthesis of structurally and stereochemically complex molecules that forms four carbon-carbon bonds and sets eight stereocenters with high regio-, diastereo- and enantioselectivity. It can be programmed to yield different stereoisomers by varying only the order of combination of a common set of reagents and catalysts. We report what is to our knowledge the first synthesis of both enantiomers of a chiral compound using the same chiral catalyst.	[Potowski, Marco; Antonchick, Andrey P.; Waldmann, Herbert] Max Planck Inst Mol Physiol, Abt Chem Biol, D-44139 Dortmund, Germany; [Potowski, Marco; Schuermann, Markus; Preut, Hans; Waldmann, Herbert] Tech Univ Dortmund, Fak Chem, Dortmund, Germany	Max Planck Society; Dortmund University of Technology	Potowski, M (corresponding author), Max Planck Inst Mol Physiol, Abt Chem Biol, Rheinlanddamm 201, D-44139 Dortmund, Germany.	andrey.antonchick@mpi-dortmund.mpg.de; herbert.waldmann@mpi-dortmund.mpg.de	Antonchick, Andrey/P-1529-2016; Waldmann, Herbert/B-7406-2017	Antonchick, Andrey/0000-0003-0435-9443; Waldmann, Herbert/0000-0002-9606-7247	Fonds der Chemischen Industrie; European Research Council (ERC) under the European Union; ERC [268309]	Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); European Research Council (ERC) under the European Union(European Research Council (ERC)); ERC(European Research Council (ERC)European Commission)	M.P. thanks the Fonds der Chemischen Industrie for a fellowship. The research leading to these results has received funding from the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013) and ERC grant agreement no. 268309.	Adrio J, 2011, CHEM COMMUN, V47, P6784, DOI 10.1039/c1cc10779h; Antonchick AP, 2010, NAT CHEM, V2, P735, DOI 10.1038/nchem.730; Bertelsen S, 2008, CHEM COMMUN, P3016, DOI 10.1039/b806418k; BRECKNELL DJ, 1989, AUST J CHEM, V42, P511, DOI 10.1071/CH9890511; BURNELL DJ, 1987, CAN J CHEM, V65, P154, DOI 10.1139/v87-024; Cabrera S, 2006, PURE APPL CHEM, V78, P257, DOI 10.1351/pac200678020257; Cabrera S, 2005, J AM CHEM SOC, V127, P16394, DOI 10.1021/ja0552186; Cabrera S, 2007, TETRAHEDRON, V63, P6587, DOI 10.1016/j.tet.2007.03.130; Enders D, 2006, NATURE, V441, P861, DOI 10.1038/nature04820; GARRATT PJ, 1986, TETRAHEDRON LETT, V27, P2761, DOI 10.1016/S0040-4039(00)84637-7; Koch MA, 2005, P NATL ACAD SCI USA, V102, P17272, DOI 10.1073/pnas.0503647102; Morton D, 2009, ANGEW CHEM INT EDIT, V48, P104, DOI 10.1002/anie.200804486; Pandey G, 2006, CHEM REV, V106, P4484, DOI 10.1021/cr050011g; Pellissier H, 2007, TETRAHEDRON, V63, P3235, DOI 10.1016/j.tet.2007.01.009; Rainbolt JE, 2007, J ORG CHEM, V72, P3020, DOI 10.1021/jo062675b; Rendler S, 2010, J AM CHEM SOC, V132, P5027, DOI 10.1021/ja100185p; Stanley LM, 2008, CHEM REV, V108, P2887, DOI 10.1021/cr078371m; Valiulin RA, 2010, ORG LETT, V12, P3398, DOI 10.1021/ol101297b; Yu J, 2011, ACCOUNTS CHEM RES, V44, P1156, DOI 10.1021/ar2000343	19	66	66	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2012	8	5					428	430		10.1038/NCHEMBIO.901	http://dx.doi.org/10.1038/NCHEMBIO.901			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	928DY	22426113				2022-12-25	WOS:000302962500007
J	Lu, MJ; Wan, M; Leavens, KF; Chu, QW; Monks, BR; Fernandez, S; Ahima, RS; Ueki, K; Kahn, CR; Birnbaum, MJ				Lu, Mingjian; Wan, Min; Leavens, Karla F.; Chu, Qingwei; Monks, Bobby R.; Fernandez, Sully; Ahima, Rexford S.; Ueki, Kohjiro; Kahn, C. Ronald; Birnbaum, Morris J.			Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1	NATURE MEDICINE			English	Article							TRANSCRIPTION FACTOR FOXO1; PROTEIN-KINASE-B; FORKHEAD TRANSCRIPTION; GLUCOSE-HOMEOSTASIS; MICE LACKING; PHOSPHORYLATION; GROWTH; LIPOGENESIS; RESISTANCE; INHIBITION	Considerable data support the idea that forkhead box O1 (Foxo1) drives the liver transcriptional program during fasting and is then inhibited by thymoma viral proto-oncogene 1 (Akt) after feeding. Here we show that mice with hepatic deletion of Akt1 and Akt2 were glucose intolerant, insulin resistant and defective in their transcriptional response to feeding in the liver. These defects were normalized with concomitant liver-specific deletion of Foxo1. Notably, in the absence of both Akt and Foxo1, mice adapted appropriately to both the fasted and fed state, and insulin suppressed hepatic glucose production normally. A gene expression analysis revealed that deletion of Akt in liver led to the constitutive activation of Foxo1-dependent gene expression, but again, concomitant ablation of Foxo1 restored postprandial regulation, preventing the inhibition of the metabolic response to nutrient intake caused by deletion of Akt. These results are inconsistent with the canonical model of hepatic metabolism in which Akt is an obligate intermediate for proper insulin signaling. Rather, they show that a major role of hepatic Akt is to restrain the activity of Foxo1 and that in the absence of Foxo1, Akt is largely dispensable for insulin-and nutrient-mediated hepatic metabolic regulation in vivo.	[Lu, Mingjian; Wan, Min; Leavens, Karla F.; Chu, Qingwei; Monks, Bobby R.; Fernandez, Sully; Ahima, Rexford S.; Birnbaum, Morris J.] Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ueki, Kohjiro] Univ Tokyo, Dept Diabet & Metab Dis, Grad Sch Med, Tokyo, Japan; [Kahn, C. Ronald] Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02115 USA	University of Pennsylvania; Pennsylvania Medicine; University of Tokyo; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Birnbaum, MJ (corresponding author), Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA.	birnbaum@mail.med.upenn.edu	Kahn, Ronald/AAY-2435-2021; Fernandez, Sully/E-9812-2013; Ahima, Rexford/W-1394-2019; Lu, Mingjian/AAO-6179-2021; Lu, Mingjian/AGK-0751-2022	Kahn, Ronald/0000-0002-7583-9228; Lu, Mingjian/0000-0001-9328-4935; Birnbaum, Morris/0000-0001-9972-8680	NIH [P30 DK19525]; US National Institutes of Health [RO1 DK56886]; diabetes training grant [T32 DK007314]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525, R01DK056886, T32DK007314, R01DK033201] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); diabetes training grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank M. Magnuson (Vanderbilt University) for providing the antibody to Gck and D. Accili (Columbia University) for sharing the Foxo1<SUP>loxP/loxP</SUP> mice. We are grateful to J. Schug, who helped with the microarray data analysis and generated the heat map and the density plot. The Functional Genomics Core and the Transgenic, Knockout, Mouse Phenotyping and Biomarker Cores of the University of Pennsylvania Diabetes and Endocrinology Research Center (NIH grant P30 DK19525) were instrumental in this work. This work was supported by the US National Institutes of Health grant RO1 DK56886 (M. J. B.) and the diabetes training grant T32 DK007314 (M.L.).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chakrabarti P, 2010, DIABETES, V59, P775, DOI 10.2337/db09-1602; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cheng ZY, 2011, ANTIOXID REDOX SIGN, V14, P649, DOI 10.1089/ars.2010.3370; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Gelling RW, 2006, CELL METAB, V3, P67, DOI 10.1016/j.cmet.2005.11.013; Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851; Hill JW, 2010, CELL METAB, V11, P286, DOI 10.1016/j.cmet.2010.03.002; Hirota K, 2008, J BIOL CHEM, V283, P32432, DOI 10.1074/jbc.M806179200; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoue H, 2006, CELL METAB, V3, P267, DOI 10.1016/j.cmet.2006.02.009; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kim KH, 2004, J BIOL CHEM, V279, P51999, DOI 10.1074/jbc.M405522200; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Laplante M, 2010, P NATL ACAD SCI USA, V107, P3281, DOI 10.1073/pnas.1000323107; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Miller RA, 2011, J CLIN INVEST, V121, P2518, DOI 10.1172/JCI45942; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; O'Brien RM, 2001, BIOCHEM SOC T, V29, P552, DOI 10.1042/BST0290552; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Okamoto H, 2005, J CLIN INVEST, V115, P1314, DOI 10.1172/JCI200523096; Partridge L, 2008, ONCOGENE, V27, P2351, DOI 10.1038/onc.2008.28; Perrot V, 2005, MOL ENDOCRINOL, V19, P2283, DOI 10.1210/me.2004-0292; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Rintelen F, 2001, P NATL ACAD SCI USA, V98, P15020, DOI 10.1073/pnas.011318098; Sakoda H, 2003, J BIOL CHEM, V278, P25802, DOI 10.1074/jbc.M301127200; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Samuel VT, 2006, DIABETES, V55, P2042, DOI 10.2337/db05-0705; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Slack C, 2011, AGING CELL, V10, P735, DOI 10.1111/j.1474-9726.2011.00707.x; Summers SA, 1999, J BIOL CHEM, V274, P23858, DOI 10.1074/jbc.274.34.23858; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; van der Vos KE, 2011, ANTIOXID REDOX SIGN, V14, P579, DOI 10.1089/ars.2010.3419; Wan M, 2012, MOL CELL BIOL, V32, P96, DOI 10.1128/MCB.05806-11; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhou YJ, 2011, NAT MED, V17, P356, DOI 10.1038/nm.2293	59	259	271	0	53	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2012	18	3					388	U254		10.1038/nm.2686	http://dx.doi.org/10.1038/nm.2686			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22344295	Green Submitted, Green Accepted			2022-12-25	WOS:000301264800040
J	Maeda, K; Kobayashi, Y; Udagawa, N; Uehara, S; Ishihara, A; Mizoguchi, T; Kikuchi, Y; Takada, I; Kato, S; Kani, S; Nishita, M; Marumo, K; Martin, TJ; Minami, Y; Takahashi, N				Maeda, Kazuhiro; Kobayashi, Yasuhiro; Udagawa, Nobuyuki; Uehara, Shunsuke; Ishihara, Akihiro; Mizoguchi, Toshihide; Kikuchi, Yuichiro; Takada, Ichiro; Kato, Shigeaki; Kani, Shuichi; Nishita, Michiru; Marumo, Keishi; Martin, T. John; Minami, Yasuhiro; Takahashi, Naoyuki			Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis	NATURE MEDICINE			English	Article							RECEPTOR TYROSINE KINASE; BONE-FORMATION; WNT; DIFFERENTIATION; ROR2; PATHWAY; OSTEOPROTEGERIN; EXPRESSION; LIGAND; PROTEIN	The signaling molecule Wnt regulates bone homeostasis through beta-catenin-dependent canonical and beta-catenin-independent noncanonical pathways. Impairment of canonical Wnt signaling causes bone loss in arthritis and osteoporosis; however, it is unclear how noncanonical Wnt signaling regulates bone resorption. Wnt5a activates noncanonical Wnt signaling through receptor tyrosine kinase-like orphan receptor (Ror) proteins. We showed that Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhanced osteoclastogenesis. Osteoblast-lineage cells expressed Wnt5a, whereas osteoclast precursors expressed Ror2. Mice deficient in either Wnt5a or Ror2, and those with either osteoclast precursor-specific Ror2 deficiency or osteoblast-lineage cell-specific Wnt5a deficiency showed impaired osteoclastogenesis. Wnt5a-Ror2 signals enhanced receptor activator of nuclear factor-kappa B (RANK) expression in osteoclast precursors by activating JNK and recruiting c-Jun on the promoter of the gene encoding RANK, thereby enhancing RANK ligand (RANKL)-induced osteoclastogenesis. A soluble form of Ror2 acted as a decoy receptor of Wnt5a and abrogated bone destruction in mouse arthritis models. Our results suggest that the Wnt5a-Ror2 pathway is crucial for osteoclastogenesis in physiological and pathological environments and represents a therapeutic target for bone diseases, including arthritis.	[Maeda, Kazuhiro; Kobayashi, Yasuhiro; Mizoguchi, Toshihide; Takahashi, Naoyuki] Matsumoto Dent Univ, Inst Oral Sci, Nagano, Japan; [Maeda, Kazuhiro; Marumo, Keishi] Jikei Univ, Dept Orthoped Surg, Sch Med, Tokyo, Japan; [Udagawa, Nobuyuki; Uehara, Shunsuke] Matsumoto Dent Univ, Dept Biochem, Nagano, Japan; [Ishihara, Akihiro] Matsumoto Dent Univ, Dept Periodontol, Nagano, Japan; [Kikuchi, Yuichiro] Matsumoto Dent Univ, Dept Microbiol, Nagano, Japan; [Takada, Ichiro] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan; [Kato, Shigeaki] Univ Tokyo, Lab Nucl Signaling, Inst Mol & Cellular Biosci, Tokyo, Japan; [Kani, Shuichi; Nishita, Michiru; Minami, Yasuhiro] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Kobe, Hyogo, Japan; [Martin, T. John] St Vincent Inst Med Res, Melbourne, Vic, Australia	Matsumoto Dental University; Jikei University; Matsumoto Dental University; Matsumoto Dental University; Matsumoto Dental University; Keio University; University of Tokyo; Kobe University; St. Vincent's Institute of Medical Research	Takahashi, N (corresponding author), Matsumoto Dent Univ, Inst Oral Sci, Nagano, Japan.	ykoba@po.mdu.ac.jp; takahashinao@po.mdu.ac.jp	KOBAYASHI, YASUHIRO/AAU-4931-2021; Maeda, Kazuhiro/ABD-5762-2020	KIKUCHI, YUICHIRO/0000-0001-7232-837X; Kobayashi, Yasuhiro/0000-0002-0903-3226	Ministry of Education, Culture, Sports, Science and Technology of Japan [18390495, 22390351, 18390557, 21390551, 19390476, 21390498]; Naito Foundation; Grants-in-Aid for Scientific Research [23791668, 22790291, 21390080, 22021039, 23593054] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T. Kitamura (Tokyo University) for pMX-IRES-GFP vectors and Plat-E cells; M. Sakoda, S. Kinugawa, Y. Nakamichi and T. Yamashita for technical assistance; A. Yamaguchi, H. Takayanagi and T. Nakashima for thoughtful discussion; and T. Nishizawa, Y. Ueno and M. Saito for discussions about mice models. This work was supported by a Grant-in-Aid for Scientific Research (18390495, 22390351 (N.T.); 18390557, 21390551 (Y. Kobayashi); 19390476, 21390498 (N.U.)) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by a grant from the Naito Foundation (Y. Kobayashi).	Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Baron R, 2007, ENDOCRINOLOGY, V148, P2635, DOI 10.1210/en.2007-0270; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Billiard J, 2005, MOL ENDOCRINOL, V19, P90, DOI 10.1210/me.2004-0153; Binder NB, 2009, NAT MED, V15, P417, DOI 10.1038/nm.1945; Blaine SA, 2001, J BIOL CHEM, V276, P42737, DOI 10.1074/jbc.M107773200; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; DeChiara TM, 2000, NAT GENET, V24, P271, DOI 10.1038/73488; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Goldring SR, 2000, CURR OPIN RHEUMATOL, V12, P195, DOI 10.1097/00002281-200005000-00006; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Kardassis D, 1999, J BIOL CHEM, V274, P29572, DOI 10.1074/jbc.274.41.29572; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kubota A, 2004, J RHEUMATOL, V31, P426; Kwon OH, 2005, BIOCHEM BIOPH RES CO, V335, P437, DOI 10.1016/j.bbrc.2005.07.092; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Li XF, 2005, NAT GENET, V37, P945, DOI 10.1038/ng1614; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; Liu Y, 2007, MOL ENDOCRINOL, V21, P376, DOI 10.1210/me.2006-0342; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mizoguchi T, 2009, J CELL BIOL, V184, P541, DOI 10.1083/jcb.200806139; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nomi M, 2001, MOL CELL BIOL, V21, P8329, DOI 10.1128/MCB.21.24.8329-8335.2001; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Pettit AR, 2006, RHEUMATOLOGY, V45, P1068, DOI 10.1093/rheumatology/kel045; Pettit AR, 2001, AM J PATHOL, V159, P1689, DOI 10.1016/S0002-9440(10)63016-7; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Schett G, 2008, NAT CLIN PRACT RHEUM, V4, P473, DOI 10.1038/ncprheum0881; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Spellman PT, 2002, GENOME BIOL, V3; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Takeuchi S, 2000, GENES CELLS, V5, P71, DOI 10.1046/j.1365-2443.2000.00300.x; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; TRENTHAM DE, 1977, J EXP MED, V146, P857, DOI 10.1084/jem.146.3.857; van Bokhoven H, 2000, NAT GENET, V25, P423, DOI 10.1038/78113; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yamane T, 2001, J IMMUNOL, V167, P765, DOI 10.4049/jimmunol.167.2.765; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhou H, 2008, J BIOL CHEM, V283, P1936, DOI 10.1074/jbc.M702687200	60	328	354	3	60	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2012	18	3					405	U166		10.1038/nm.2653	http://dx.doi.org/10.1038/nm.2653			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22344299				2022-12-25	WOS:000301264800042
J	Takeuchi, K; Soda, M; Togashi, Y; Suzuki, R; Sakata, S; Hatano, S; Asaka, R; Hamanaka, W; Ninomiya, H; Uehara, H; Choi, YL; Satoh, Y; Okumura, S; Nakagawa, K; Mano, H; Ishikawa, Y				Takeuchi, Kengo; Soda, Manabu; Togashi, Yuki; Suzuki, Ritsuro; Sakata, Seiji; Hatano, Satoko; Asaka, Reimi; Hamanaka, Wakako; Ninomiya, Hironori; Uehara, Hirofumi; Choi, Young Lim; Satoh, Yukitoshi; Okumura, Sakae; Nakagawa, Ken; Mano, Hiroyuki; Ishikawa, Yuichi			RET, ROS1 and ALK fusions in lung cancer	NATURE MEDICINE			English	Article							EML4-ALK FUSION; TRANSFORMING GENE; IDENTIFICATION; IMMUNOHISTOCHEMISTRY; REARRANGEMENTS; RADIATION; ONCOGENE	Through an integrated molecular-and histopathology-based screening system, we performed a screening for fusions of anaplastic lymphoma kinase (ALK) and c-ros oncogene 1, receptor tyrosine kinase (ROS1) in 1,529 lung cancers and identified 44 ALK-fusion-positive and 13 ROS1-fusion-positive adenocarcinomas, including for unidentified fusion partners for ROS1. In addition, we discovered previously unidentified kinase fusions that may be promising for molecular-targeted therapy, kinesin family member 5B (KIF5B)-ret proto-oncogene (RET) and coiled-coil domain containing 6 (CCDC6)-RET, in 14 adenocarcinomas. A multivariate analysis of 1,116 adenocarcinomas containing these 71 kinase-fusion-positive adenocarcinomas identified four independent factors that are indicators of poor prognosis: age >= 50 years, male sex, high pathological stage and negative kinase-fusion status.	[Takeuchi, Kengo; Togashi, Yuki; Sakata, Seiji; Hatano, Satoko; Asaka, Reimi] Japanese Fdn Canc Res, Inst Canc, Pathol Project Mol Targets, Tokyo 170, Japan; [Takeuchi, Kengo; Togashi, Yuki; Asaka, Reimi; Hamanaka, Wakako; Ninomiya, Hironori; Ishikawa, Yuichi] Japanese Fdn Canc Res, Inst Canc, Div Pathol, Tokyo 170, Japan; [Suzuki, Ritsuro] Nagoya Univ, Grad Sch Med, Dept Hematopoiet Stem Cell Transplantat Data Mana, Nagoya, Aichi 4648601, Japan; [Uehara, Hirofumi; Satoh, Yukitoshi; Okumura, Sakae; Nakagawa, Ken] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Thorac Surg Oncol, Thorac Ctr, Tokyo 170, Japan; [Choi, Young Lim; Mano, Hiroyuki] Univ Tokyo, Dept Med Genom, Grad Sch Med, Tokyo, Japan	Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Nagoya University; Japanese Foundation for Cancer Research; University of Tokyo	Takeuchi, K (corresponding author), Japanese Fdn Canc Res, Inst Canc, Pathol Project Mol Targets, Tokyo 170, Japan.	kentakeuchi-tky@umin.net	Gotoh, Osamu/B-4704-2012; Takeuchi, Kengo/C-3614-2008	Takeuchi, Kengo/0000-0002-1599-5800; Suzuki, Ritsuro/0000-0002-5974-7614	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Ministry of Health, Labor and Welfare of Japan; Vehicle Racing Commemorative Foundation of Japan; Princess Takamatsu Cancer Research Fund; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [22300326] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Vehicle Racing Commemorative Foundation of Japan; Princess Takamatsu Cancer Research Fund; Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Iwakoshi, K. Shiozawa, T. Kakita, H. Nagano and K. Nomura for their technical assistance and S. Sengoku for providing administrative assistance. This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, as well as by grants from the Japan Society for the Promotion of Science; the Ministry of Health, Labor and Welfare of Japan; the Vehicle Racing Commemorative Foundation of Japan; the Princess Takamatsu Cancer Research Fund; and the Uehara Memorial Foundation.	Bounacer A, 1997, ONCOGENE, V15, P1263, DOI 10.1038/sj.onc.1200206; Choi YL, 2008, CANCER RES, V68, P4971, DOI 10.1158/0008-5472.CAN-07-6158; Flanigan J, 2010, BIOL-TARGETS THER, V4, P237, DOI 10.2147/BTT.S7223; GRIECO M, 1990, CELL, V60, P557, DOI 10.1016/0092-8674(90)90659-3; Hamatani K, 2008, CANCER RES, V68, P7176, DOI 10.1158/0008-5472.CAN-08-0293; Han B, 2008, CANCER RES, V68, P7629, DOI 10.1158/0008-5472.CAN-08-2014; Inamura K, 2008, J THORAC ONCOL, V3, P13, DOI 10.1097/JTO.0b013e31815e8b60; ITO T, 1994, LANCET, V344, P259; Jokoji R, 2010, J CLIN PATHOL, V63, P1066, DOI 10.1136/jcp.2010.081166; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sugawara E, 2012, CANCER-AM CANCER SOC, V118, P4427, DOI 10.1002/cncr.27391; TAKAHASHI M, 1985, CELL, V42, P581, DOI 10.1016/0092-8674(85)90115-1; Takeuchi K., 2010, PATHOL CLIN MED, V28, P139; Takeuchi K, 2008, CLIN CANCER RES, V14, P6618, DOI 10.1158/1078-0432.CCR-08-1018; Takeuchi K, 2011, CLIN CANCER RES, V17, P3341, DOI 10.1158/1078-0432.CCR-11-0063; Takeuchi K, 2011, HAEMATOL-HEMATOL J, V96, P464, DOI 10.3324/haematol.2010.033514; Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0	20	925	1024	11	116	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2012	18	3					378	381		10.1038/nm.2658	http://dx.doi.org/10.1038/nm.2658			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22327623				2022-12-25	WOS:000301264800037
J	Lawrence, R; Brown, JR; Al-Mafraji, K; Lamanna, WC; Beitel, JR; Boons, GJ; Esko, JD; Crawford, BE				Lawrence, Roger; Brown, Jillian R.; Al-Mafraji, Kanar; Lamanna, William C.; Beitel, James R.; Boons, Geert-Jan; Esko, Jeffrey D.; Crawford, Brett E.			Disease-specific non-reducing end carbohydrate biomarkers for mucopolysaccharidoses	NATURE CHEMICAL BIOLOGY			English	Article							TANDEM MASS-SPECTROMETRY; DRIED BLOOD SPOTS; HEPARAN-SULFATE; DERMATAN SULFATE; DISACCHARIDES; DEFICIENCY; PLASMA; ASSAY; OLIGOSACCHARIDES; ACCUMULATION	A considerable need exists for improved biomarkers for differential diagnosis, prognosis and monitoring of therapeutic interventions for mucopolysaccharidoses (MPS), inherited metabolic disorders that involve lysosomal storage of glycosaminoglycans. Here we report a simple, reliable method based on the detection of abundant nonreducing ends of the glycosaminoglycans that accumulate in cells, blood and urine of individuals with MPS. In this method, glycosaminoglycans are enzymatically depolymerized, releasing unique mono-, di- or trisaccharides from the nonreducing ends of the chains. The composition of the released mono-and oligosaccharides depends on the nature of the lysosomal enzyme deficiency, and therefore they serve as diagnostic biomarkers. Analysis by LC/MS allowed qualitative and quantitative assessment of the biomarkers in biological samples. We provide a simple conceptual scheme for diagnosing MPS in uncharacterized samples and a method to monitor efficacy of enzyme replacement therapy or other forms of treatment.	[Brown, Jillian R.; Beitel, James R.; Crawford, Brett E.] Zacharon Pharmaceut Inc, San Diego, CA USA; [Lawrence, Roger; Lamanna, William C.; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Al-Mafraji, Kanar; Boons, Geert-Jan] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	BioMarin Pharmaceutical Inc.; Zacharon Pharmaceuticals Inc.; University of California System; University of California San Diego; University System of Georgia; University of Georgia	Crawford, BE (corresponding author), Zacharon Pharmaceut Inc, San Diego, CA USA.	jesko@ucsd.edu; bcrawford@zacharon.com	Boons, Geert-Jan P H/J-3211-2016	Boons, Geert-Jan P H/0000-0003-3111-5954	US National Institutes of Health [R01 GM077471, P41 RR005351]; Kirschstein National Research Service Award [DK085905]; National MPS Society; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK085905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390, R01GM077471] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National MPS Society; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by US National Institutes of Health grants R01 GM077471 to J.D.E. and P41 RR005351 to G.J.B. for synthesis of disaccharide standards, a Kirschstein National Research Service Award DK085905 to W.C L. and grants from the National MPS Society to J.D.E. and B.E.C.	Beck M, 2010, IUBMB LIFE, V62, P33, DOI 10.1002/iub.284; Bhaumik M, 1999, GLYCOBIOLOGY, V9, P1389, DOI 10.1093/glycob/9.12.1389; Blanchard S, 2008, CLIN CHEM, V54, P2067, DOI 10.1373/clinchem.2008.115410; Byers S, 1998, MOL GENET METAB, V65, P282, DOI 10.1006/mgme.1998.2761; Camelier MV, 2011, CLIN CHIM ACTA, V412, P1805, DOI 10.1016/j.cca.2011.06.001; Clarke Lorne A., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000550; Dean CJ, 2006, CLIN CHEM, V52, P643, DOI 10.1373/clinchem.2005.061838; Duffey TA, 2010, CLIN CHEM, V56, P1854, DOI 10.1373/clinchem.2010.152009; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Freeze H. H., 2009, ESSENTIALS GLYCOBIOL; Fuller M, 2006, GLYCOBIOLOGY, V16, P318, DOI 10.1093/glycob/cwj072; Fuller M, 2004, GLYCOBIOLOGY, V14, P443, DOI 10.1093/glycob/cwh049; Fuller M, 2011, J MED GENET, V48, P422, DOI 10.1136/jmg.2010.088096; HE W, 1993, J INHERIT METAB DIS, V16, P935, DOI 10.1007/BF00711508; Holley RJ, 2011, J BIOL CHEM, V286, P37515, DOI 10.1074/jbc.M111.287474; Kaneiwa T, 2010, GLYCOBIOLOGY, V20, P300, DOI 10.1093/glycob/cwp174; KIMURA A, 1982, TOHOKU J EXP MED, V136, P61, DOI 10.1620/tjem.136.61; KIMURA A, 1980, TOHOKU J EXP MED, V131, P241, DOI 10.1620/tjem.131.241; KIMURA A, 1984, TOHOKU J EXP MED, V144, P227, DOI 10.1620/tjem.144.227; King B, 2006, MOL GENET METAB, V87, P107, DOI 10.1016/j.ymgme.2005.09.026; Komosinska-Vassev KB, 2008, CLIN CHEM LAB MED, V46, P219, DOI 10.1515/CCLM.2008.048; KRESSE H, 1980, P NATL ACAD SCI-BIOL, V77, P6822, DOI 10.1073/pnas.77.11.6822; Lamanna WC, 2011, J BIOL CHEM, V286, P6955, DOI 10.1074/jbc.M110.192062; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; Linhardt R.J, 2001, CURR PROTOC MOL BIOL, V48; Mason KE, 2006, ANAL CHEM, V78, P4534, DOI 10.1021/ac052083d; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Nielsen TC, 2010, ANAL BIOCHEM, V402, P113, DOI 10.1016/j.ab.2010.04.002; OBRIEN JF, 1974, BIOCHEM BIOPH RES CO, V60, P1170, DOI 10.1016/0006-291X(74)90435-5; Oguma T, 2007, ANAL BIOCHEM, V368, P79, DOI 10.1016/j.ab.2007.05.016; Peterson SB, 2010, J BIOL CHEM, V285, P14504, DOI 10.1074/jbc.M110.104166; Ramsay SL, 2003, MOL GENET METAB, V78, P193, DOI 10.1016/S1096-7192(03)00018-0; Shi XF, 2009, J BIOL CHEM, V284, P11806, DOI 10.1074/jbc.M809637200; SJOBERG I, 1973, BIOCHEM BIOPH RES CO, V54, P1125, DOI 10.1016/0006-291X(73)90809-7; Toma L, 1996, LAB INVEST, V75, P771; Tomatsu S, 2005, J INHERIT METAB DIS, V28, P743, DOI 10.1007/s10545-005-0069-y; Tomatsu S, 2010, J INHERIT METAB DIS, V33, P141, DOI 10.1007/s10545-009-9036-3; Varki A, 2009, PROTEOMICS, V9, P5398, DOI 10.1002/pmic.200900708; Wei W, 2011, ANAL CHEM, V83, P3703, DOI 10.1021/ac2001077; Wolfe BJ, 2011, ANAL CHEM, V83, P1152, DOI 10.1021/ac102777s; Xia BY, 2009, ANAL BIOCHEM, V387, P162, DOI 10.1016/j.ab.2009.01.028; Zhou H, 2011, J PEDIATR-US, V159, P7, DOI 10.1016/j.jpeds.2011.02.026	43	100	103	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2012	8	2					197	204		10.1038/nchembio.766	http://dx.doi.org/10.1038/nchembio.766			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879IP	22231271	Green Accepted			2022-12-25	WOS:000299323200012
J	Hahn, CN; Scott, HS				Hahn, Christopher N.; Scott, Hamish S.			Spliceosome mutations in hematopoietic malignancies	NATURE GENETICS			English	Editorial Material									[Hahn, Christopher N.; Scott, Hamish S.] SA Pathol Adelaide, Ctr Canc Biol, Dept Mol Pathol, Adelaide, SA, Australia	Centre for Cancer Biology; SA Pathology	Hahn, CN (corresponding author), SA Pathol Adelaide, Ctr Canc Biol, Dept Mol Pathol, Adelaide, SA, Australia.	chris.hahn@health.sa.gov.au; hamish.scott@health.sa.gov.au	Hahn, Christopher/C-1369-2009; HAHN, CHRISTOPHER/D-8427-2018; Scott, Hamish/B-2122-2009	Hahn, Christopher/0000-0001-5105-2554; Scott, Hamish/0000-0002-5813-631X				Damm F, 2012, LEUKEMIA, V26, P1137, DOI 10.1038/leu.2011.321; Graubert TA, 2012, NAT GENET, V44, P53, DOI 10.1038/ng.1031; Kikushige Y, 2011, CANCER CELL, V20, P246, DOI 10.1016/j.ccr.2011.06.029; Lasho TL, 2012, LEUKEMIA, V26, P1135, DOI 10.1038/leu.2011.320; Levine A, 2001, NUCLEIC ACIDS RES, V29, P4006, DOI 10.1093/nar/29.19.4006; Malcovati L, 2011, BLOOD, V118, P6239, DOI 10.1182/blood-2011-09-377275; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Patnaik MM, 2012, BLOOD, V119, P569, DOI 10.1182/blood-2011-09-377994; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Rossi D, 2011, BLOOD, V118, P6904, DOI 10.1182/blood-2011-08-373159; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Visconte V, 2012, LEUKEMIA, V26, P542, DOI 10.1038/leu.2011.232; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496	13	44	47	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2012	44	1					9	10		10.1038/ng.1045	http://dx.doi.org/10.1038/ng.1045			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	22200771				2022-12-25	WOS:000298664000004
J	Lin, ZM; Bei, JX; Shen, MX; Li, QX; Liao, ZT; Zhang, YL; Lv, Q; Wei, QJ; Low, HQ; Guo, YM; Cao, SY; Yang, MC; Hu, ZY; Xu, ML; Wang, XW; Wei, YL; Li, L; Li, C; Li, TW; Huang, JL; Pan, YF; Jin, O; Wu, YQ; Wu, J; Guo, ZS; He, PG; Hu, SX; Wu, HS; Song, H; Zhan, F; Liu, SY; Gao, GM; Liu, ZS; Li, YN; Xiao, CH; Li, J; Ye, ZZ; He, WZ; Liu, DZ; Shen, LX; Huang, AB; Wu, HL; Tao, Y; Pan, XP; Yu, BY; Tai, ES; Zeng, YX; Ren, EC; Shen, Y; Liu, JJ; Gu, JR				Lin, Zhiming; Bei, Jin-Xin; Shen, Meixin; Li, Qiuxia; Liao, Zetao; Zhang, Yanli; Lv, Qing; Wei, Qiujing; Low, Hui-Qi; Guo, Yun-Miao; Cao, Shuangyan; Yang, Mingcan; Hu, Zaiying; Xu, Manlong; Wang, Xinwei; Wei, Yanlin; Li, Li; Li, Chao; Li, Tianwang; Huang, Jianlin; Pan, Yunfeng; Jin, Ou; Wu, Yuqiong; Wu, Jing; Guo, Zishi; He, Peigen; Hu, Shaoxian; Wu, Husheng; Song, Hui; Zhan, Feng; Liu, Shengyun; Gao, Guanmin; Liu, Zhangsuo; Li, Yinong; Xiao, Changhong; Li, Juan; Ye, Zhizhong; He, Weizhen; Liu, Dongzhou; Shen, Lingxun; Huang, Anbin; Wu, Henglian; Tao, Yi; Pan, Xieping; Yu, Buyun; Tai, E. Shyong; Zeng, Yi-Xin; Ren, Ee Chee; Shen, Yan; Liu, Jianjun; Gu, Jieruo			A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitis	NATURE GENETICS			English	Article							HLA-B27; POPULATION; MATURATION; VARIANTS; SUBTYPES; PROTEIN; ERAP1	To identify susceptibility loci for ankylosing spondylitis, we performed a two-stage genome-wide association study in Han Chinese. In the discovery stage, we analyzed 1,356,350 autosomal SNPs in 1,837 individuals with ankylosing spondylitis and 4,231 controls; in the validation stage, we analyzed 30 suggestive SNPs in an additional 2,100 affected individuals and 3,496 controls. We identified two new susceptibility loci between EDIL3 and HAPLN1 at 5q14.3 (rs4552569; P = 8.77 x 10(-10)) and within ANO6 at 12q12 (rs17095830; P = 1.63 x 10(-8)). We also confirmed previously reported associations in Europeans within the major histocompatibility complex (MHC) region (top SNP, rs13202464; P < 5 x 10(-324)) and at 2p15 (rs10865331; P = 1.98 x 10(-8)). We show that rs13202464 within the MHC region mainly represents the risk effect of HLA-B*27 variants (including HLA-B*2704, HLA-B*2705 and HLA-B*2715) in Chinese. The two newly discovered loci implicate genes related to bone formation and cartilage development, suggesting their potential involvement in the etiology of ankylosing spondylitis.	[Lin, Zhiming; Li, Qiuxia; Liao, Zetao; Zhang, Yanli; Lv, Qing; Wei, Qiujing; Cao, Shuangyan; Yang, Mingcan; Hu, Zaiying; Xu, Manlong; Wang, Xinwei; Wei, Yanlin; Li, Li; Li, Chao; Li, Tianwang; Huang, Jianlin; Pan, Yunfeng; Jin, Ou; Wu, Yuqiong; Wu, Jing; Guo, Zishi; Yu, Buyun; Gu, Jieruo] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Rheumatol, Guangzhou 510275, Guangdong, Peoples R China; [Bei, Jin-Xin; Guo, Yun-Miao; Zeng, Yi-Xin] Sun Yat Sen Univ, State Key Lab Oncol S China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Shen, Meixin] Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore; [Low, Hui-Qi; Liu, Jianjun] ASTAR, Agcy Sci, Genome Inst Singapore, Singapore, Singapore; [He, Peigen; Hu, Shaoxian] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol & Rheumatol, Tongji Hosp, Wuhan, Hubei, Peoples R China; [Wu, Husheng; Song, Hui] Beijing Jishuitan Hosp, Dept Rheumatol & Immunol, Beijing, Peoples R China; [Zhan, Feng] Hainan Prov Peoples Hosp, Dept Rheumatol, Hainan, Peoples R China; [Liu, Shengyun; Gao, Guanmin; Liu, Zhangsuo] Zhengzhou Univ, Affiliated Hosp 1, Dept Urol & Rheumatol, Zhengzhou, Henan, Peoples R China; [Li, Yinong] Fuzhou Gen Hosp Nanjing Mil Command, Dept Rheumatol, Fuzhou, Peoples R China; [Xiao, Changhong] Hosp Integrated Tradit Chinese Med, Dept Rheumatol & Immunol, Guangzhou, Guangdong, Peoples R China; [Xiao, Changhong] Western Med So Med Univ, Guangzhou, Guangdong, Peoples R China; [Li, Juan] So Med Univ, Nanfang Hosp, Dept Rheumatol, Guangzhou, Guangdong, Peoples R China; [Ye, Zhizhong; He, Weizhen] Guangdong Med Coll, Shenzhen Rheumatol Inst, Peoples Hosp Shenzhen 4, Xiangmihu Rheumatol Branch, Shenzhen, Peoples R China; [Liu, Dongzhou] Jinan Univ, Clin Med Coll 2, Dept Rheumatol & Immunol, Shenzhen Peoples Hosp, Shenzhen, Peoples R China; [Shen, Lingxun; Huang, Anbin] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Immunol & Rheumatol, Wuhan, Hubei, Peoples R China; [Tao, Yi] Guangzhou Med Univ, Affiliated Hosp 2, Dept Rheumatol & Immunol, Guangzhou, Guangdong, Peoples R China; [Pan, Xieping] Soochow Univ, Affiliated Hosp 3, Peoples Hosp Changzhou 1, Dept Rheumatol & Immunol, Suzhou, Jiangsu, Peoples R China; [Tai, E. Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Epidemiol & Publ Hlth, Singapore 117595, Singapore; [Ren, Ee Chee] ASTAR, Singapore Immunol Network, Singapore, Singapore; [Ren, Ee Chee] Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore; [Shen, Yan] Tsinghua Univ, Peking Union Med Coll, Beijing 100084, Peoples R China; [Shen, Yan] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China; [Liu, Jianjun] Anhui Med Univ, Sch Life Sci, Hefei, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Huazhong University of Science & Technology; Zhengzhou University; Southern Medical University - China; Guangdong Medical University; Jinan University; Huazhong University of Science & Technology; Guangzhou Medical University; Soochow University - China; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tsinghua University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Anhui Medical University	Gu, JR (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Rheumatol, Guangzhou 510275, Guangdong, Peoples R China.	liuj3@gis.a-star.edu.sg; gujieruo@163.com	Bei, Jin-Xin/AAO-1259-2020; Liu, Jianjun/AAK-4989-2020; gao, guanmin/S-6403-2019; Tai, E Shyong/J-9831-2013	Liu, Jianjun/0000-0002-3255-3019; gao, guanmin/0000-0001-7458-8378; Li, Tian-wang/0000-0001-6438-2691; gu, jieruo/0000-0002-8785-0600; Tai, E Shyong/0000-0003-2929-8966; Shen, Meixin/0000-0003-1757-2753	China National Funds for Distinguished Young Scientists [30325019]; National Natural Science Foundation of China [30571735]; Clinical Subject of the Ministry of Public Health of China; Foundation of Guangdong Province of China [2005A30801005, 2009B080701086]; Foundation of Guangzhou of China [2006Z2-E0221]; Sun Yat-sen University; Agency of Science, Technology and Research (A<SUP>star</SUP>STAR) of Singapore	China National Funds for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Clinical Subject of the Ministry of Public Health of China; Foundation of Guangdong Province of China; Foundation of Guangzhou of China; Sun Yat-sen University; Agency of Science, Technology and Research (A<SUP>star</SUP>STAR) of Singapore	We thank all participants recruited for this study. We also thank Y. Xie, X. Guo, Q. Li, L. Zhao, S. Zhang, Z. Huang and Z. Guo for providing suggestions and for their help in the recruitment of subjects. This work was funded by China National Funds for Distinguished Young Scientists (30325019), The National Natural Science Foundation of China (30571735), Clinical Subject of the Ministry of Public Health of China (2007, 2010), the Foundation of Guangdong Province of China (2005A30801005, 2009B080701086), the Foundation of Guangzhou of China (2006Z2-E0221), 5010 Subject of Sun Yat-sen University (2009-2010) and the Agency of Science, Technology and Research (A<SUP>star</SUP>STAR) of Singapore.	Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Boonen A, 2006, NAT CLIN PRACT RHEUM, V2, P546, DOI 10.1038/ncprheum0297; Braun J, 1998, ARTHRITIS RHEUM-US, V41, P58, DOI 10.1002/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; Chen C, 2012, RHEUMATOL INT, V32, P15, DOI 10.1007/s00296-010-1566-3; Cheng S, 2007, SEMIN ARTHRITIS RHEU, V37, P39, DOI 10.1016/j.semarthrit.2007.01.003; Danoy P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001195; Davidson SI, 2011, ANN RHEUM DIS, V70, P289, DOI 10.1136/ard.2010.133322; Davidson SI, 2009, ARTHRITIS RHEUM-US, V60, P3263, DOI 10.1002/art.24933; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Glantschnig H, 2010, J BIOL CHEM, V285, P40135, DOI 10.1074/jbc.M110.166892; GonzalezRoces S, 1997, TISSUE ANTIGENS, V49, P116, DOI 10.1111/j.1399-0039.1997.tb02724.x; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005; Hou TY, 2007, INTERN MED J, V37, P749, DOI 10.1111/j.1445-5994.2007.01450.x; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kou I, 2004, J BIOL CHEM, V279, P50942, DOI 10.1074/jbc.M406786200; Liu X, 2010, RHEUMATOL INT, V30, P587, DOI 10.1007/s00296-009-1018-0; Liu Y, 2010, TISSUE ANTIGENS, V75, P61, DOI 10.1111/j.1399-0039.2009.01379.x; Montserrat V, 2006, J IMMUNOL, V177, P7015, DOI 10.4049/jimmunol.177.10.7015; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Pozzi S, 1999, TISSUE ANTIGENS, V53, P275, DOI 10.1034/j.1399-0039.1999.530308.x; Price AL, 2008, AM J HUM GENET, V83, P132, DOI 10.1016/j.ajhg.2008.06.005; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Saleki K, 2006, ANTIOXID REDOX SIGN, V8, P292, DOI 10.1089/ars.2006.8.292; Sieper J, 2008, ARTHRITIS RHEUM-US, V58, P649, DOI 10.1002/art.23260; Sim X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001363; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Takai A, 2010, DEVELOPMENT, V137, P3293, DOI 10.1242/dev.051136; Tew SR, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2311; Uderhardt S, 2010, ANN RHEUM DIS, V69, P592, DOI 10.1136/ard.2008.102046; Urano T, 2011, EUR SPINE J, V20, P572, DOI 10.1007/s00586-010-1598-0; van der Heijde D, 2008, ARTHRITIS RHEUM-US, V58, P3063, DOI 10.1002/art.23901; Watanabe H, 1999, NAT GENET, V21, P225, DOI 10.1038/6016; Wilson R, 2010, MOL CELL PROTEOMICS, V9, P1296, DOI 10.1074/mcp.M000014-MCP201; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310	39	124	131	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2012	44	1					73	U104		10.1038/ng.1005	http://dx.doi.org/10.1038/ng.1005			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	22138694				2022-12-25	WOS:000298664000017
J	Marimuthu, G; Kumari, S; Kandasamy, M; Raghunathan, S; Saberwal, G				Marimuthu, Ganesan; Kumari, Sangita; Kandasamy, Muthukrishnakumar; Raghunathan, Srivatsan; Saberwal, Gayatri			Maintaining patents protecting biologics or small-molecule drugs	NATURE BIOTECHNOLOGY			English	Editorial Material									[Marimuthu, Ganesan; Kumari, Sangita; Kandasamy, Muthukrishnakumar; Raghunathan, Srivatsan; Saberwal, Gayatri] Inst Bioinformat & Appl Biotechnol, Bangalore, Karnataka, India		Marimuthu, G (corresponding author), Inst Bioinformat & Appl Biotechnol, Bangalore, Karnataka, India.	gayatri@ibab.ac.in						Cukier KN, 2006, NAT BIOTECHNOL, V24, P249, DOI 10.1038/nbt0306-249; Johnson L.A., 2011, ASS PRESS       0725; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Lemley MA, 2001, NORTHWEST U LAW REV, V95, P1495; Ouellette Lisa Larrimore, 2010, MICH TELECOMM TECH L, V17, P300; Parida DK, 2008, NAT BIOTECHNOL, V26, P763, DOI 10.1038/nbt0708-763; Putnam J., 1996, 5741 NBER; Quinn G., 2011, IP WATCHDOG     0128; Walsh G, 2006, NAT BIOTECHNOL, V24, P769, DOI 10.1038/nbt0706-769	9	1	1	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2012	30	1					50	53		10.1038/nbt.2082	http://dx.doi.org/10.1038/nbt.2082			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	876MC	22231094				2022-12-25	WOS:000299110600017
J	Schneider, A; Thiel, C; Rindermann, J; DeRossi, C; Popovici, D; Hoffmann, GF; Grone, HJ; Korner, C				Schneider, Anette; Thiel, Christian; Rindermann, Jan; DeRossi, Charles; Popovici, Diana; Hoffmann, Georg F.; Groene, Hermann-Josef; Koerner, Christian			Successful prenatal mannose treatment for congenital disorder of glycosylation-Ia in mice	NATURE MEDICINE			English	Article							SYNDROME TYPE 1A; SUPPLEMENTATION; DISEASE; PMM2; GENE	Congenital disorder of glycosylation-Ia (CDG-Ia, also known as PMM2-CDG) is caused by mutations in the gene that encodes phosphomannomutase 2 (PMM2, EC 5.4.2.8) leading to a multisystemic disease with severe psychomotor and mental retardation. In a hypomorphic Pmm2 mouse model, we were able to overcome embryonic lethality by feeding mannose to pregnant dams. The results underline the essential role of glycosylation in embryonic development and may open new treatment options for this disease.	[Schneider, Anette; Thiel, Christian; DeRossi, Charles; Popovici, Diana; Hoffmann, Georg F.; Koerner, Christian] Ctr Child & Adolescent Med, Heidelberg, Germany; [Schneider, Anette; Thiel, Christian; DeRossi, Charles; Popovici, Diana; Hoffmann, Georg F.; Koerner, Christian] Ctr Metab Dis Heidelberg, Dept Kinderheilkunde 1, Heidelberg, Germany; [Rindermann, Jan] Inst Biochem II, Gottingen, Germany; [Groene, Hermann-Josef] German Canc Res Ctr Heidelberg, Div Cellular & Mol Pathol, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Korner, C (corresponding author), Ctr Child & Adolescent Med, Heidelberg, Germany.	christian.koerner@med.uni-heidelberg.de		Thiel, Christian/0000-0001-6419-8747	Deutsche Forschungsgemeinschaft [KO 2152/3-2, TH1461/2-1]; Fritz Thyssen Stiftung; US National Institutes of Health [R21 HD062914]; Rocket Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD062914] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fritz Thyssen Stiftung; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rocket Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The work of C.K. and C.T. was supported by grants of the Deutsche Forschungsgemeinschaft (KO 2152/3-2 and TH1461/2-1) and the Fritz Thyssen Stiftung. The work of C.D. was supported by a US National Institutes of Health grant (R21 HD062914) and The Rocket Fund.	Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Grunewald S, 2009, BBA-MOL BASIS DIS, V1792, P827, DOI 10.1016/j.bbadis.2009.01.003; Kjaergaard S, 1998, ACTA PAEDIATR, V87, P884, DOI 10.1080/080352598750013680; Kjaergaard S, 1999, EUR J HUM GENET, V7, P884, DOI 10.1038/sj.ejhg.5200398; Korner C, 1998, GLYCOCONJUGATE J, V15, P499, DOI 10.1023/A:1006939104442; Matthijs G, 1998, AM J HUM GENET, V62, P542, DOI 10.1086/301763; Matthijs G, 1997, NAT GENET, V16, P88, DOI 10.1038/ng0597-88; Mayatepek E, 1998, EUR J PEDIATR, V157, P605, DOI 10.1007/s004310050889; Mayatepek E, 1997, ACTA PAEDIATR, V86, P1138, DOI 10.1111/j.1651-2227.1997.tb14825.x; Panneerselvam K, 1996, J CLIN INVEST, V97, P1478, DOI 10.1172/JCI118570; Silvaggi NR, 2006, J BIOL CHEM, V281, P14918, DOI 10.1074/jbc.M601505200; Thiel C, 2006, MOL CELL BIOL, V26, P5615, DOI 10.1128/MCB.02391-05	12	56	60	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2012	18	1					71	73		10.1038/nm.2548	http://dx.doi.org/10.1038/nm.2548			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22157680				2022-12-25	WOS:000299018600031
J	Patou, G				Patou, Gary			In vogue with venture	NATURE BIOTECHNOLOGY			English	Editorial Material									MPM Capital, San Francisco, CA 94080 USA		Patou, G (corresponding author), MPM Capital, San Francisco, CA 94080 USA.	gpatou@mpmcapital.com							0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2011	29	11					967	969						3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	845CT	22175076				2022-12-25	WOS:000296801300010
J	Zhang, XM; Mak, S; Li, L; Parra, A; Denlinger, B; Belmonte, C; McNaughton, PA				Zhang, Xuming; Mak, Stephanie; Li, Lin; Parra, Andres; Denlinger, Bristol; Belmonte, Carlos; McNaughton, Peter A.			Direct inhibition of the cold-activated TRPM8 ion channel by G alpha(q)	NATURE CELL BIOLOGY			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PHOSPHOLIPASE-C; G-PROTEINS; RECEPTOR; MEMBRANE; IDENTIFICATION; NEURONS; TRPV1; GQ; PHOSPHORYLATION	Activation of the TRPM8 ion channel in sensory nerve endings produces a sensation of pleasant coolness. Here we show that inflammatory mediators such as bradykinin and histamine inhibit TRPM8 in intact sensory nerves, but do not do so through conventional signalling pathways. The G-protein subunit G alpha(q) instead binds to TRPM8 and when activated by a Gq-coupled receptor directly inhibits ion channel activity. Deletion of G alpha(q) largely abolished inhibition of TRPM8, and inhibition was rescued by a G alpha(q) chimaera whose ability to activate downstream signalling pathways was completely ablated. Activated G alpha(q) protein, but not G beta gamma, potently inhibits TRPM8 in excised patches. We conclude that G alpha(q) pre-forms a complex with TRPM8 and inhibits activation of TRPM8, following activation of G-protein-coupled receptors, by a direct action. This signalling mechanism may underlie the abnormal cold sensation caused by inflammation.	[Zhang, Xuming; Mak, Stephanie; Li, Lin; McNaughton, Peter A.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Parra, Andres; Denlinger, Bristol; Belmonte, Carlos] Univ Miguel Hernandez, Consejo Super Invest Cient, Inst Neurociencias Alicante, Alacant 03550, Spain	University of Cambridge; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Zhang, XM (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	xz213@cam.ac.uk; pam42@cam.ac.uk		parra martin, andres/0000-0003-3389-5288; Zhang, Xuming/0000-0002-5331-8675; McNaughton, Peter/0000-0003-1946-9610	MRC [G0801387]; BBSRC [BB/F003072/1]; Fundacion BBVA; Biotechnology and Biological Sciences Research Council [BB/F003072/1] Funding Source: researchfish; Medical Research Council [G0801387] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Fundacion BBVA(BBVA Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank S. Offermanns (Max Planck Institute for Heart and Lung Research, Germany) for providing MEF cells, G. Hammond (Department of Pharmacology, University of Cambridge, UK) for Tubby-R332H-cYFP and PLC delta-PH-EGFP cDNA and for help with imaging analysis, O. Opaleye (Department of Biochemistry, University of Cambridge, UK) for help with protein purification, R. Hardie (Department of Physiology, Development and Neuroscience, University of Cambridge, UK) and S.B. Hladky (Department of Pharmacology, University of Cambridge, UK) for help with single channel recording, and R. Hardie for critical reading of an earlier version of the manuscript. This work was supported by an MRC new investigator research grant (G0801387 to X.Z.), a BBSRC research grant (BB/F003072/1 to P.A.M.) and a grant from the Fundacion BBVA (to P.A.M., to support a BBVA visiting professorship at the Instituto de Neurociencias, Alicante, Spain).	Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Brown DA, 2007, J PHYSIOL-LONDON, V582, P917, DOI 10.1113/jphysiol.2007.132498; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Cesare P, 1999, NEURON, V23, P617, DOI 10.1016/S0896-6273(00)80813-2; Chen XD, 2006, P NATL ACAD SCI USA, V103, P3422, DOI 10.1073/pnas.0507710103; Chung MK, 2007, NEURON, V54, P345, DOI 10.1016/j.neuron.2007.04.025; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Daniels RL, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-23; Dascal N, 2001, TRENDS ENDOCRIN MET, V12, P391, DOI 10.1016/S1043-2760(01)00475-1; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Dowal L, 2006, J BIOL CHEM, V281, P23999, DOI 10.1074/jbc.M512330200; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Grubb DR, 2008, FASEB J, V22, P2768, DOI 10.1096/fj.07-102558; Huang JJ, 2006, SEMIN CELL DEV BIOL, V17, P638, DOI 10.1016/j.semcdb.2006.11.002; Klasen K, 2012, PFLUG ARCH EUR J PHY, V463, P779, DOI 10.1007/s00424-012-1098-7; Koike-Tani M, 2005, J PHYSIOL-LONDON, V564, P489, DOI 10.1113/jphysiol.2004.079285; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Linte RM, 2007, EXP BRAIN RES, V178, P89, DOI 10.1007/s00221-006-0712-3; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Nilius B, 2008, EMBO J, V27, P2809, DOI 10.1038/emboj.2008.217; Numazaki M, 2002, J BIOL CHEM, V277, P13375, DOI 10.1074/jbc.C200104200; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Parra A, 2010, NAT MED, V16, P1396, DOI 10.1038/nm.2264; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Premkumar LS, 2005, J NEUROSCI, V25, P11322, DOI 10.1523/JNEUROSCI.3006-05.2005; Proudfoot CJ, 2006, CURR BIOL, V16, P1591, DOI 10.1016/j.cub.2006.07.061; Quinn KV, 2008, J PHYSIOL-LONDON, V586, P2855, DOI 10.1113/jphysiol.2008.153791; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Studer M, 2010, J PHYSIOL-LONDON, V588, P3743, DOI 10.1113/jphysiol.2010.190611; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Venkatakrishnan G, 1996, J BIOL CHEM, V271, P5066; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; WU DQ, 1992, J BIOL CHEM, V267, P1811; Xing H, 2007, J NEUROSCI, V27, P13680, DOI 10.1523/JNEUROSCI.2203-07.2007; Yao XQ, 2005, NEUROSIGNALS, V14, P273, DOI 10.1159/000093042; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhang XM, 2008, NEURON, V59, P450, DOI 10.1016/j.neuron.2008.05.015	42	110	112	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2012	14	8					850	U168		10.1038/ncb2529	http://dx.doi.org/10.1038/ncb2529			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	983JP	22750945	Green Accepted			2022-12-25	WOS:000307115900014
J	Wortmann, SB; Vaz, FM; Gardeitchik, T; Vissers, LELM; Renkema, GH; Schuurs-Hoeijmakers, JHM; Kulik, W; Lammens, M; Christin, C; Kluijtmans, LAJ; Rodenburg, RJ; Nijtmans, LGJ; Grunewald, A; Klein, C; Gerhold, JM; Kozicz, T; van Hasselt, PM; Harakalova, M; Kloosterman, W; Baric, I; Pronicka, E; Ucar, SK; Naess, K; Singhal, KK; Krumina, Z; Gilissen, C; van Bokhoven, H; Veltman, JA; Smeitink, JAM; Lefeber, DJ; Spelbrink, JN; Wevers, RA; Morava, E; Arjan, PMB				Wortmann, Saskia B.; Vaz, Frederic M.; Gardeitchik, Thatjana; Vissers, Lisenka E. L. M.; Renkema, G. Herma; Schuurs-Hoeijmakers, Janneke H. M.; Kulik, Wim; Lammens, Martin; Christin, Christin; Kluijtmans, Leo A. J.; Rodenburg, Richard J.; Nijtmans, Leo G. J.; Gruenewald, Anne; Klein, Christine; Gerhold, Joachim M.; Kozicz, Tamas; van Hasselt, Peter M.; Harakalova, Magdalena; Kloosterman, Wigard; Baric, Ivo; Pronicka, Ewa; Ucar, Sema Kalkan; Naess, Karin; Singhal, Kapil K.; Krumina, Zita; Gilissen, Christian; van Bokhoven, Hans; Veltman, Joris A.; Smeitink, Jan A. M.; Lefeber, Dirk J.; Spelbrink, Johannes N.; Wevers, Ron A.; Morava, Eva; de Brouwer, Arjan P. M.			Mutations in the phospholipid remodeling gene SERAC1 impair mitochondrial function and intracellular cholesterol trafficking and cause dystonia and deafness	NATURE GENETICS			English	Article							3-METHYLGLUTACONIC ACIDURIA; BARTH SYNDROME; BIOSYNTHESIS; CARDIOLIPIN; ASSOCIATION; INTERFACE; FRACTION	Using exome sequencing, we identify SERAC1 mutations as the cause of MEGDEL syndrome, a recessive disorder of dystonia and deafness with Leigh-like syndrome, impaired oxidative phosphorylation and 3-methylglutaconic aciduria. We localized SERAC1 at the interface between the mitochondria and the endoplasmic reticulum in the mitochondria-associated membrane fraction that is essential for phospholipid exchange. A phospholipid analysis in patient fibroblasts showed elevated concentrations of phosphatidylglycerol-34:1 (where the species nomenclature denotes the number of carbon atoms in the two acyl chains: number of double bonds in the two acyl groups) and decreased concentrations of phosphatidylglycerol-36:1 species, resulting in an altered cardiolipin subspecies composition. We also detected low concentrations of bis(monoacyl-glycerol)-phosphate, leading to the accumulation of free cholesterol, as shown by abnormal filipin staining. Complementation of patient fibroblasts with wild-type human SERAC1 by lentiviral infection led to a decrease and partial normalization of the mean ratio of phosphatidylglycerol-34:1 to phosphatidylglycerol-36:1. Our data identify SERAC1 as a key player in the phosphatidylglycerol remodeling that is essential for both mitochondrial function and intracellular cholesterol trafficking.	[Wortmann, Saskia B.; Gardeitchik, Thatjana; Vissers, Lisenka E. L. M.; Renkema, G. Herma; Rodenburg, Richard J.; Nijtmans, Leo G. J.; Gerhold, Joachim M.; Smeitink, Jan A. M.; Lefeber, Dirk J.; Spelbrink, Johannes N.; Wevers, Ron A.; Morava, Eva] RUNMC, IGMD, Nijmegen, Netherlands; [Wortmann, Saskia B.; Gardeitchik, Thatjana; Renkema, G. Herma; Rodenburg, Richard J.; Nijtmans, Leo G. J.; Gerhold, Joachim M.; Smeitink, Jan A. M.; Spelbrink, Johannes N.; Morava, Eva] RUNMC, Dept Pediat, Nijmegen, Netherlands; [Vaz, Frederic M.; Kulik, Wim] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem & Pediat, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Gardeitchik, Thatjana; Kluijtmans, Leo A. J.; Rodenburg, Richard J.; Lefeber, Dirk J.; Wevers, Ron A.] RUNMC, Dept Lab Med, Lab Genet Endocrine & Metab Dis LGEM, Nijmegen, Netherlands; [Vissers, Lisenka E. L. M.; Schuurs-Hoeijmakers, Janneke H. M.; Gilissen, Christian; van Bokhoven, Hans; Veltman, Joris A.; de Brouwer, Arjan P. M.] RUNMC, Dept Human Genet, Nijmegen, Netherlands; [Vissers, Lisenka E. L. M.; van Bokhoven, Hans] RUNMC, Nijmegen Ctr Mol Life Sci, Nijmegen, Netherlands; [Renkema, G. Herma] RUNMC, Ctr Syst Biol & Bioenerget, Nijmegen, Netherlands; [Lammens, Martin] RUNMC, Dept Pathol, Nijmegen, Netherlands; [Christin, Christin] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinform, Bioinformat Lab, NL-1105 AZ Amsterdam, Netherlands; [Gruenewald, Anne; Klein, Christine] Med Univ Lubeck, Dept Neurol, Sect Clin & Mol Neurogenet, D-23538 Lubeck, Germany; [Kozicz, Tamas; van Bokhoven, Hans] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Kozicz, Tamas] Radboud Univ Nijmegen, Dept Anim Physiol, NL-6525 ED Nijmegen, Netherlands; [van Hasselt, Peter M.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp Utrecht, Dept Metab Dis, Utrecht, Netherlands; [Harakalova, Magdalena; Kloosterman, Wigard] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Baric, Ivo] Univ Hosp Ctr Zagreb, Dept Pediat, Zagreb, Croatia; [Baric, Ivo] Univ Zagreb, Sch Med, Zagreb 41001, Croatia; [Pronicka, Ewa] Childrens Mem Hlth Inst, Dept Metab Dis, Warsaw, Poland; [Ucar, Sema Kalkan] Ege Univ Fac Med, Dept Pediat, Izmir, Turkey; [Naess, Karin] Karolinska Univ Hosp, Dept Pediat Neurol, Stockholm, Sweden; [Singhal, Kapil K.] All India Inst Med Sci, Dept Neurol, Delhi, India; [Krumina, Zita] Childrens Univ Hosp, Med Genet Clin, Riga, Latvia; [Lefeber, Dirk J.] RUNMC, Dept Neurol, Nijmegen, Netherlands; [Spelbrink, Johannes N.] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Spelbrink, Johannes N.] Univ Tampere, Tampere Univ Hosp, FIN-33101 Tampere, Finland	Radboud University Nijmegen; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; University of Lubeck; Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Zagreb; University of Zagreb; Children's Memorial Health Institute; Ege University; Karolinska Institutet; Karolinska University Hospital; All India Institute of Medical Sciences (AIIMS) New Delhi; Radboud University Nijmegen; Tampere University; Tampere University; Tampere University Hospital	Wevers, RA (corresponding author), RUNMC, IGMD, Nijmegen, Netherlands.	s.wortmann@cukz.umcn.nl; r.wevers@labgk.umcn.nl	Lefeber, Dirk DJ/A-2146-2014; Nijtmans, L.G.J./L-4549-2015; Gerhold, Joachim/N-3033-2019; lefeber, dirk/G-5063-2012; Lammens, Martin/AAI-9343-2021; van Bokhoven, Hans/D-8764-2012; Rodenburg, Richard/N-3579-2014; Kozicz, Tamas/G-3161-2012; Wortmann, Saskia/E-6125-2010; Wevers, Ron A./H-8116-2014; Morava, E./L-4529-2015; Gerhold, Joachim M/B-7276-2012; Uçar, Sema Kalkan/AAO-4465-2020; Bokhoven, J.H.L.M. van van/H-8015-2014; Spelbrink, Johannes N/L-4661-2015; Lammens, Martin/H-1503-2011; Vissers, Lisenka ELM/A-2598-2015; Gilissen, Christian/E-5246-2012; Renkema, Herma/L-1489-2015; Grünewald, Anne/ABD-1255-2021; Kluijtmans, Leo A/L-4437-2015; Klein, Christine/AGK-8003-2022; de Brouwer, Arjan PM/P-5949-2015; Kozicz, Tamas/N-5154-2014; Smeitink, Jan/C-1351-2013; Veltman, Joris A/F-5128-2010	Gerhold, Joachim/0000-0002-4972-1947; Rodenburg, Richard/0000-0001-5227-3527; Kozicz, Tamas/0000-0001-6915-4364; Wevers, Ron A./0000-0003-2278-9746; Gerhold, Joachim M/0000-0002-4972-1947; Uçar, Sema Kalkan/0000-0001-9574-7841; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Spelbrink, Johannes N/0000-0002-9756-2602; Lammens, Martin/0000-0002-3881-6692; Vissers, Lisenka ELM/0000-0001-6470-5497; Gilissen, Christian/0000-0003-1693-9699; Renkema, Herma/0000-0002-8174-6538; Grünewald, Anne/0000-0002-4179-2994; Kozicz, Tamas/0000-0001-6915-4364; Veltman, Joris A/0000-0002-3218-8250; Klein, Christine/0000-0003-2102-3431; Vaz, Frederic/0000-0002-9048-1041; Naess, Karin/0000-0003-4310-7927; Pronicka, Ewa/0000-0002-5705-4814	Dutch Brain Foundation [2010(1)-30, 2011(1)-101]; EU [241995]; Netherlands Organisation for Health Research and Development (ZonMW) [916.86.016, 917.66.363]; Ministry of Science, Education and Sports of the Republic of Croatia [108-1081870-1885]; Stichting Energy4all; IGMD junior scientist grant; EMBO; Marie Curie Actions EMBO [1066_2011, MCA-EMBOCOFUND2010, GA-2010-267146]; Academy of Finland; Tampere University Hospital Medical Research Fund [9J119, 9K126, 9L097]; Netherlands Organization for Scientific Research (NWO: VICI) [865.10.004]	Dutch Brain Foundation; EU(European Commission); Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Ministry of Science, Education and Sports of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Stichting Energy4all; IGMD junior scientist grant; EMBO(European Molecular Biology Organization (EMBO)); Marie Curie Actions EMBO; Academy of Finland(Academy of Finland); Tampere University Hospital Medical Research Fund; Netherlands Organization for Scientific Research (NWO: VICI)(Netherlands Organization for Scientific Research (NWO))	We thank the patients and their parents for participating in this study. The study was financially supported by the Dutch Brain Foundation (2010(1)-30 to A.P.M.d.B. and 2011(1)-101 to E.M.), the EU 7th framework programme (grant 241995 (GENCODYS) to H.v.B.), the Netherlands Organisation for Health Research and Development (ZonMW 916.86.016 to L.E.L.M.V. and ZonMW 917.66.363 to J.A.V.) and the Ministry of Science, Education and Sports of the Republic of Croatia (108-1081870-1885 to I.B.). S.B.W. is supported by the 'Stichting Energy4all'. T.G. is a recipient of the 'IGMD junior scientist grant 2010'. J.M.G. is a recipient of an EMBO long-term fellowship cofunded by Marie Curie Actions EMBO long-term fellowship 1066_2011 (including MCA-EMBOCOFUND2010 and GA-2010-267146). J.N.S. is supported by the Academy of Finland (Centre of Excellence funding), the Tampere University Hospital Medical Research Fund (9J119, 9K126 and 9L097) and the Netherlands Organization for Scientific Research (NWO: VICI grant 865.10.004). We are grateful to B. van den Ende, M. Seders and S. van de Velde-Vissers (Department of Human Genetics, RUNMC, Nijmegen), as well as to K. Janssen and A. van Heck-Kappen (Department of Laboratory Medicine, RUNMC, Nijmegen), A. Leenders (Department of Pediatrics, RUNMC, Nijmegen), the colleagues of the tissue culture lab of the LGEM (Department of Laboratory Medicine, RUNMC, Nijmegen) and F.S. Stet (University of Amsterdam) for excellent technical assistance. For technical assistance, data analysis, critical discussion and exome sequencing, we are grateful to the Genomic Disorders groups of the Department of Human Genetics, RUNMC, Nijmegen (headed by H. Brunner) and the Department of Medical Genetics, University Medical Center, Utrecht (headed by E. Cuppen). We also thank F.A.J. Muskiet, F. Preijers, A. van Kampen and J. van Dam for useful discussions.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Chevallier J, 2008, J BIOL CHEM, V283, P27871, DOI 10.1074/jbc.M801463200; DEREWENDA ZS, 1993, TRENDS BIOCHEM SCI, V18, P20, DOI 10.1016/0968-0004(93)90082-X; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Houtkooper RH, 2009, BBA-BIOMEMBRANES, V1788, P2003, DOI 10.1016/j.bbamem.2009.07.009; Houtkooper RH, 2009, ANAL BIOCHEM, V387, P230, DOI 10.1016/j.ab.2009.01.032; Hullin-Matsuda F, 2007, J LIPID RES, V48, P1997, DOI 10.1194/jlr.M700154-JLR200; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Ledvinova J, 1993, Sb Lek, V94, P137; LEWIS JA, 1973, J CELL SCI, V13, P447; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reiners JJ, 2011, FREE RADICAL BIO MED, V50, P281, DOI 10.1016/j.freeradbiomed.2010.11.006; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Wortmann S, 2006, MOL GENET METAB, V88, P47, DOI 10.1016/j.ymgme.2006.01.013; Wortmann SB, 2012, J INHERIT METAB DIS, V35, P13, DOI 10.1007/s10545-010-9210-7; Wortmann SB, 2009, BRAIN, V132, P136, DOI 10.1093/brain/awn296	24	137	144	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2012	44	7					797	U231		10.1038/ng.2325	http://dx.doi.org/10.1038/ng.2325			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967DP	22683713				2022-12-25	WOS:000305886900015
J	Blau, HM				Blau, Helen M.			Redefining differentiation: Reshaping our ends	NATURE CELL BIOLOGY			English	Editorial Material									Stanford Univ, Baxter Lab Stem Cell Biol, Sch Med, Stanford, CA 94305 USA	Stanford University	Blau, HM (corresponding author), Stanford Univ, Baxter Lab Stem Cell Biol, Sch Med, CCSR Room 4215,269 Campus Dr, Stanford, CA 94305 USA.	hblau2@stanford.edu			NHLBI NIH HHS [U01 HL099997, R01 HL096113] Funding Source: Medline; NIAMS NIH HHS [R01 AR063963] Funding Source: Medline; NIA NIH HHS [R01 AG024987, R01 AG009521] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096113, U01HL099997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024987, R01AG009521, R01AG020961] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))			0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2012	14	6					558	558		10.1038/ncb2506	http://dx.doi.org/10.1038/ncb2506			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	949TW	22643873	Bronze			2022-12-25	WOS:000304599900002
J	Chio, IIC; Sasaki, M; Ghazarian, D; Moreno, J; Done, S; Ueda, T; Inoue, S; Chang, YL; Chen, NJ; Mak, TW				Chio, Iok In Christine; Sasaki, Masato; Ghazarian, Danny; Moreno, Juan; Done, Susan; Ueda, Takeshi; Inoue, Satoshi; Chang, Yu-Ling; Chen, Nien Jung; Mak, Tak Wah			TRADD contributes to tumour suppression by regulating ULF-dependent p19(Arf) ubiquitylation	NATURE CELL BIOLOGY			English	Article							NECROSIS-FACTOR-ALPHA; TNF-ALPHA; FACTOR RECEPTOR; ALLELIC LOSS; CANCER; MICE; SENESCENCE; EXPRESSION; DEFICIENT; GENE	Tumour necrosis factor receptor (TNFR)-associated death domain (TRADD) protein is a central adaptor in the TNFR1 signalling complex that mediates both cell death and inflammatory signals. Here, we report that Tradd deficiency in mice accelerated tumour formation in a chemical-induced carcinogenesis model independently of TNFR1 signalling. In vitro, primary cells lacking TRADD were less susceptible to HRas-induced senescence and showed a reduced level of accumulation of the p19(Arf) tumour suppressor protein. Our data indicate that TRADD shuttles dynamically from the cytoplasm into the nucleus to modulate the interaction between p19(Arf) and its E3 ubiquitin ligase ULF, thereby promoting p19(Arf) protein stability and tumour suppression. These results reveal a previously unknown tumour-suppressive role for nuclear TRADD, augmenting its long-established cytoplasmic functions in inflammatoiy and immune signalling cascades. Our findings also make an important contribution to the rapidly expanding field of p19(Arf) post-translational regulation.	[Chio, Iok In Christine; Sasaki, Masato; Moreno, Juan; Done, Susan; Inoue, Satoshi; Mak, Tak Wah] Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2M9, Canada; [Chio, Iok In Christine; Mak, Tak Wah] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; [Ghazarian, Danny; Done, Susan] Univ Toronto, Univ Hlth Network, Dept Lab Med & Pathobiol, Toronto, ON M5G 2M9, Canada; [Ueda, Takeshi] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Dis Model, Hiroshima 7348553, Japan; [Chang, Yu-Ling; Chen, Nien Jung] Natl Yang Ming Univ, Sch Life Sci, Inst Microbiol & Immunol, Taipei 112, Taiwan	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Hiroshima University; National Yang Ming Chiao Tung University	Mak, TW (corresponding author), Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Breast Canc Res, 620 Univ Ave,Suite 706, Toronto, ON M5G 2M9, Canada.	tmak@uhnres.utoronto.ca		Chang, Yu-Ling/0000-0002-0789-4989; Ueda, Takeshi/0000-0001-9823-6764; Done, Susan/0000-0002-1770-988X; Ghazarian, Danny/0000-0002-3531-1074	Canadian Institutes of Health Research; University of Toronto; Ontario Graduate Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Toronto(University of Toronto); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	We are deeply grateful to K. Yamamoto, Z. Y. Hao and W. J. Lin for their helpful discussions during the initiation of this investigation; to M. Saunders for scientific editing; and to S. McCracken and I. N.g for administrative assistance. This work was supported by grants to T.W.M. from the Canadian Institutes of Health Research. I.I.C.C. is financially supported by the University of Toronto through the Connaught Scholarship and the Ontario Graduate Scholarship.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aliouat-Denis CM, 2005, MOL CANCER RES, V3, P627, DOI 10.1158/1541-7786.MCR-05-0121; Arnott CH, 2004, ONCOGENE, V23, P1902, DOI 10.1038/sj.onc.1207317; Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; BOS JL, 1989, CANCER RES, V49, P4682; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cao XM, 2011, FASEB J, V25, P1353, DOI 10.1096/fj.10-170480; Chen DL, 2010, NATURE, V464, P624, DOI 10.1038/nature08820; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Chen NJ, 2008, P NATL ACAD SCI USA, V105, P12429, DOI 10.1073/pnas.0806585105; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dechant MJ, 2008, PEDIATR BLOOD CANCER, V51, P616, DOI 10.1002/pbc.21672; Ermolaeva MA, 2008, NAT IMMUNOL, V9, P1037, DOI 10.1038/ni.1638; Filippova GN, 1998, GENE CHROMOSOME CANC, V22, P26, DOI 10.1002/(SICI)1098-2264(199805)22:1<26::AID-GCC4>3.0.CO;2-9; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; HAINSWORTH PJ, 1991, CANCER GENET CYTOGEN, V53, P205, DOI 10.1016/0165-4608(91)90097-E; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He ZM, 2000, CANCER RES, V60, P1845; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Kamijo T, 1999, CANCER RES, V59, P2217; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kelly-Spratt KS, 2004, PLOS BIOL, V2, P1138, DOI 10.1371/journal.pbio.0020242; KENNARD MD, 1995, MOL CARCINOGEN, V12, P14, DOI 10.1002/mc.2940120104; Kihana T, 1996, JPN J CANCER RES, V87, P1184, DOI 10.1111/j.1349-7006.1996.tb03130.x; Kim NR, 2009, J NEURO-ONCOL, V94, P425, DOI 10.1007/s11060-009-9879-3; Knuutila S, 1999, AM J PATHOL, V155, P683, DOI 10.1016/S0002-9440(10)65166-8; Kulbe H, 2007, CANCER RES, V67, P585, DOI 10.1158/0008-5472.CAN-06-2941; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Mahler JF, 1996, TOXICOL PATHOL, V24, P710, DOI 10.1177/019262339602400606; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Morgan M, 2002, J CELL BIOL, V157, P975, DOI 10.1083/jcb.200204039; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Park A, 1996, J BIOL CHEM, V271, P9858, DOI 10.1074/jbc.271.16.9858; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Pobezinskaya YL, 2008, NAT IMMUNOL, V9, P1047, DOI 10.1038/ni.1639; Pollice A, 2008, FEBS LETT, V582, P3257, DOI 10.1016/j.febslet.2008.09.026; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; ROTHE J, 1994, CIRC SHOCK, V44, P51; SAKAI K, 1992, J GASTROEN HEPATOL, V7, P288, DOI 10.1111/j.1440-1746.1992.tb00982.x; Scheuerpflug CG, 2001, CYTOGENET CELL GENET, V92, P347, DOI 10.1159/000056927; Scott KA, 2003, MOL CANCER THER, V2, P445; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Oskarsson T, 2006, GENE DEV, V20, P2024, DOI 10.1101/gad.381206; Suganuma M, 1999, CANCER RES, V59, P4516; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Wang DP, 2009, CANCER RES, V69, P9448, DOI 10.1158/0008-5472.CAN-09-1903; Wang G, 2000, CELL RES, V10, P311, DOI 10.1038/sj.cr.7290058; Wesemann DR, 2004, NAT IMMUNOL, V5, P199, DOI 10.1038/ni1025; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Woodworth CD, 2004, CARCINOGENESIS, V25, P1771, DOI 10.1093/carcin/bgh170	58	24	26	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2012	14	6					625	+		10.1038/ncb2496	http://dx.doi.org/10.1038/ncb2496			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	949TW	22561347				2022-12-25	WOS:000304599900012
J	Downing, JR; Wilson, RK; Zhang, JH; Mardis, ER; Pui, CH; Ding, L; Ley, TJ; Evans, WE				Downing, James R.; Wilson, Richard K.; Zhang, Jinghui; Mardis, Elaine R.; Pui, Ching-Hon; Ding, Li; Ley, Timothy J.; Evans, William E.			The Pediatric Cancer Genome Project	NATURE GENETICS			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; STRUCTURAL VARIATION; SOMATIC MUTATIONS; PANCREATIC-CANCER; GLIOBLASTOMA; EVOLUTION; GENES		[Downing, James R.; Zhang, Jinghui; Pui, Ching-Hon; Evans, William E.] Washington Univ, Pediat Canc Genome Project, St Jude Childrens Res Hosp, Memphis, TN USA; [Downing, James R.; Pui, Ching-Hon] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Wilson, Richard K.; Mardis, Elaine R.; Ding, Li; Ley, Timothy J.] Washington Univ, Pediat Canc Genome Project, St Jude Childrens Res Hosp, St Louis, MO USA; [Wilson, Richard K.; Mardis, Elaine R.; Ding, Li; Ley, Timothy J.] Washington Univ, Genome Inst, St Louis, MO USA; [Zhang, Jinghui] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Pui, Ching-Hon] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Evans, William E.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Washington University (WUSTL); Washington University (WUSTL); St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Downing, JR (corresponding author), Washington Univ, Pediat Canc Genome Project, St Jude Childrens Res Hosp, Memphis, TN USA.	james.downing@stjude.org; william.evans@stjude.org	Mardis, Elaine/W-2202-2019; Pui, Ching-Hon/N-8076-2018; Zhang, Jing/GWZ-7332-2022; Wilson, Richard K./AAF-4139-2019; Downing, James R./N-8102-2018; Evans, William E./C-2069-2012	Pui, Ching-Hon/0000-0003-0303-5658; Wilson, Richard K./0000-0002-1992-1358; Evans, William E./0000-0002-9333-5322	St. Jude Children's Research Hospital-Washington University; American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital; NCI Cancer Center [P30 CA021765]; US National Institutes of Health (NIH) [U01 GM 92666, R37 CA36401]; Washington University in St. Louis; NHGRI [U54 HG003079]; NATIONAL CANCER INSTITUTE [P30CA021765, R37CA036401] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092666] Funding Source: NIH RePORTER	St. Jude Children's Research Hospital-Washington University; American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University in St. Louis; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Inaba, C. Mullighan, K. Roberts, S. Ramondi, S.-C. Chen, D. Pei and J. Groff for their extensive contributions to and diligence in preparing Figure 1, and we thank X. Chen for contributions to Figure 2. We would also like to thank M. Rusch and P. Nagahawatte for their contributions to data submission to EBI and dbGaP. This work was funded by The St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project, American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital, an NCI Cancer Center support grant (P30 CA021765), the US National Institutes of Health (NIH; U01 GM 92666 and R37 CA36401 to St. Jude Children's Research Hospital), grants to R. K. W. from Washington University in St. Louis and a grant from the NHGRI (U54 HG003079 to Washington University in St. Louis).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], 2010, NATURE, V463, P407; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cheung NKV, 2012, JAMA-J AM MED ASSOC, V307, P1062, DOI 10.1001/jama.2012.228; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Hudson MM, 2012, PEDIATR BLOOD CANCER, V58, P334, DOI 10.1002/pbc.23385; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pui CH, 2011, NAT REV CLIN ONCOL, V8, P540, DOI 10.1038/nrclinonc.2011.95; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/nmeth.1628, 10.1038/NMETH.1628]; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	21	222	224	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2012	44	6					619	622		10.1038/ng.2287	http://dx.doi.org/10.1038/ng.2287			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	949BT	22641210	Green Accepted			2022-12-25	WOS:000304551100005
J	Sharon, E; Kalma, Y; Sharp, A; Raveh-Sadka, T; Levo, M; Zeevi, D; Keren, L; Yakhini, Z; Weinberger, A; Segal, E				Sharon, Eilon; Kalma, Yael; Sharp, Ayala; Raveh-Sadka, Tali; Levo, Michal; Zeevi, Danny; Keren, Leeat; Yakhini, Zohar; Weinberger, Adina; Segal, Eran			Inferring gene regulatory logic from high-throughput measurements of thousands of systematically designed promoters	NATURE BIOTECHNOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTORS; DNA-BINDING; NUCLEOSOME ORGANIZATION; GLOBAL ANALYSIS; IN-VIVO; YEAST; EXPRESSION; GENOME; LIBRARIES	Despite extensive research, our understanding of the rules according to which cis-regulatory sequences are converted into gene expression is limited. We devised a method for obtaining parallel, highly accurate gene expression measurements from thousands of designed promoters and applied it to measure the effect of systematic changes in the location, number, orientation, affinity and organization of transcription-factor binding sites and nucleosome-disfavoring sequences. Our analyses reveal a clear relationship between expression and binding-site multiplicity, as well as dependencies of expression on the distance between transcription-factor binding sites and gene starts which are transcription-factor specific, including a striking similar to 10-bp periodic relationship between gene expression and binding-site location. We show how this approach can measure transcription-factor sequence specificities and the sensitivity of transcription-factor sites to the surrounding sequence context, and compare the activity of 75 yeast transcription factors. Our method can be used to study both cis and trans effects of genotype on transcriptional, post-transcriptional and translational control.	[Sharon, Eilon; Kalma, Yael; Raveh-Sadka, Tali; Levo, Michal; Zeevi, Danny; Keren, Leeat; Weinberger, Adina; Segal, Eran] Weizmann Inst Sci, Dept Appl Math & Comp Sci, IL-76100 Rehovot, Israel; [Sharon, Eilon; Kalma, Yael; Sharp, Ayala; Zeevi, Danny; Keren, Leeat; Weinberger, Adina; Segal, Eran] Weizmann Inst Sci, Dept Mol & Cell Biol, IL-76100 Rehovot, Israel; [Yakhini, Zohar] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel; [Yakhini, Zohar] Agilent Labs, Santa Clara, CA USA	Weizmann Institute of Science; Weizmann Institute of Science; Technion Israel Institute of Technology; Agilent Technologies	Segal, E (corresponding author), Weizmann Inst Sci, Dept Appl Math & Comp Sci, IL-76100 Rehovot, Israel.	adina.weinberger@weizmann.ac.il; eran.segal@weizmann.ac.il	Segal, Eran/AAF-4855-2019	Yakhini, Zohar/0000-0002-0420-5412; Segal, Eran/0000-0002-6859-1164; Zeevi, Danny/0000-0002-6901-3737; Sharon, Eilon/0000-0002-1262-350X; Keren, Leeat/0000-0002-6799-6303	European Research Council; US National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA119176] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Widom for assistance and inspiration throughout this project. This work was supported by grants from the European Research Council and the US National Institutes of Health to E. Segal. E. Segal is the incumbent of the Soretta and Henry Shapiro career development chair. We thank S. Lubliner for help with computational analyses. We thank C. Boone (University of Toronto) for kindly giving us the Y8205 strain.	Akache B, 2001, NUCLEIC ACIDS RES, V29, P2181, DOI 10.1093/nar/29.10.2181; Anderson JD, 2001, MOL CELL BIOL, V21, P3830, DOI 10.1128/MCB.21.11.3830-3839.2001; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Baliga Nitin S., 2001, Biological Procedures Online, V3, P64, DOI 10.1251/bpo24; Blaiseau PL, 2001, J BIOL CHEM, V276, P34221, DOI 10.1074/jbc.M104987200; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Bulyk ML, 1999, NAT BIOTECHNOL, V17, P573, DOI 10.1038/9878; Canizares JV, 2002, ARCH MICROBIOL, V177, P352, DOI 10.1007/s00203-002-0400-z; Chiang DY, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-16; Cleary MA, 2004, NAT METHODS, V1, P241, DOI 10.1038/nmeth724; Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187; Fazekas AJ, 2010, BIOTECHNIQUES, V48, P277, DOI 10.2144/000113369; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GINIGER E, 1988, P NATL ACAD SCI USA, V85, P382, DOI 10.1073/pnas.85.2.382; Hanlon SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019060; Hoaglin D.C., 1983, UNDERSTANDING ROBUST; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kim JH, 2003, MOL CELL BIOL, V23, P5208, DOI 10.1128/MCB.23.15.5208-5216.2003; Kinkhabwala A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002030; Kinney JB, 2010, P NATL ACAD SCI USA, V107, P9158, DOI 10.1073/pnas.1004290107; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Lamb TM, 2003, MOL CELL BIOL, V23, P677, DOI 10.1128/MCB.23.2.677-686.2003; LeProust EM, 2010, NUCLEIC ACIDS RES, V38, P2522, DOI 10.1093/nar/gkq163; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Ligr M, 2006, GENETICS, V172, P2113, DOI 10.1534/genetics.105.052688; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Murphy KF, 2007, P NATL ACAD SCI USA, V104, P12726, DOI 10.1073/pnas.0608451104; Nutiu R, 2011, NAT BIOTECHNOL, V29, P659, DOI 10.1038/nbt.1882; Otsuka C, 2002, MUTAT RES-FUND MOL M, V502, P53, DOI 10.1016/S0027-5107(02)00023-4; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Raveh-Sadka T., NAT GENET IN PRESS; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; WOUDT LP, 1986, EMBO J, V5, P1037, DOI 10.1002/j.1460-2075.1986.tb04319.x; Zeevi D, 2011, GENOME RES, V21, P2114, DOI 10.1101/gr.119669.110; Zhao Y, 2006, MOL CELL BIOL, V26, P4853, DOI 10.1128/MCB.02367-05; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	43	289	294	4	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2012	30	6					521	+		10.1038/nbt.2205	http://dx.doi.org/10.1038/nbt.2205			13	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	957JV	22609971	Green Accepted			2022-12-25	WOS:000305158600022
J	Serafimova, IM; Pufall, MA; Krishnan, S; Duda, K; Cohen, MS; Maglathlin, RL; McFarland, JM; Miller, RM; Frodin, M; Taunton, J				Serafimova, Iana M.; Pufall, Miles A.; Krishnan, Shyam; Duda, Katarzyna; Cohen, Michael S.; Maglathlin, Rebecca L.; McFarland, Jesse M.; Miller, Rand M.; Frodin, Morten; Taunton, Jack			Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles	NATURE CHEMICAL BIOLOGY			English	Article							GROWTH-FACTOR RECEPTOR; KINASE; INHIBITOR; RSK; ACTIVATION; DESIGN; EGFR	Targeting noncatalytic cysteine residues with irreversible acrylamide-based inhibitors is a powerful approach for enhancing pharmacological potency and selectivity. Nevertheless, concerns about off-target modification motivate the development of reversible cysteine-targeting strategies. Here we show that electron-deficient olefins, including acrylamides, can be tuned to react with cysteine thiols in a rapidly reversible manner. Installation of a nitrile group increased the olefins' intrinsic reactivity, but, paradoxically, eliminated the formation of irreversible adducts. Incorporation of these electrophiles into a noncovalent kinase-recognition scaffold produced slowly dissociating, covalent inhibitors of the p90 ribosomal protein S6 kinase RSK2. A cocrystal structure revealed specific noncovalent interactions that stabilize the complex by positioning the electrophilic carbon near the targeted cysteine. Disruption of these interactions by protein unfolding or proteolysis promoted instantaneous cleavage of the covalent bond. Our results establish a chemistry-based framework for engineering sustained covalent inhibition without accumulating permanently modified proteins and peptides.	[Serafimova, Iana M.; Cohen, Michael S.; Maglathlin, Rebecca L.; Miller, Rand M.; Taunton, Jack] Univ Calif San Francisco, Grad Program Chem & Chem Biol, San Francisco, CA 94143 USA; [Serafimova, Iana M.; Pufall, Miles A.; Krishnan, Shyam; Cohen, Michael S.; Maglathlin, Rebecca L.; McFarland, Jesse M.; Miller, Rand M.; Taunton, Jack] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Pufall, Miles A.] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Duda, Katarzyna; Frodin, Morten] Univ Copenhagen, Biotech Res & Innovat Ctr, DK-1168 Copenhagen, Denmark; [Duda, Katarzyna; Frodin, Morten] Univ Copenhagen, Ctr Epigenet, DK-1168 Copenhagen, Denmark; [Cohen, Michael S.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Taunton, Jack] Howard Hughes Med Inst, Chevy Chase, MD USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Iowa; University of Copenhagen; University of Copenhagen; Cornell University; Howard Hughes Medical Institute	Serafimova, IM (corresponding author), Univ Calif San Francisco, Grad Program Chem & Chem Biol, San Francisco, CA 94143 USA.	taunton@cmp.ucsf.edu		Frodin, Morten/0000-0003-3691-9820; Pufall, Miles/0000-0002-7022-6916	US National Institutes of Health (NIH) [GM071434, CA020535, K99CA149088, F32GM087052]; Leukemia and Lymphoma Society [5416-7]; California Tobacco Related Disease Research Program [19FT-0091]; NIH [P41RR001614]; Novo Nordisk Fonden [NNF11OC1015111] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA020535, R37CA020535, K99CA149088] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM087052, R01GM071434] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); California Tobacco Related Disease Research Program(University of California System); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. King (Howard Hughes Medical Institute Mass Spectrometry Laboratory) for protein mass spectrometry expertise, members of the Taunton laboratory for insight, and the staff of Advanced Light Source (ALS) Beamline 8.3.1 for help with data collection. This work was supported by grants from the US National Institutes of Health (NIH) (GM071434 to J.T., CA020535 and K99CA149088 to M. A. P., F32GM087052 to J.M.M.), the Leukemia and Lymphoma Society (5416-7 to M. A. P.), and the California Tobacco Related Disease Research Program (19FT-0091 to S. K.). We acknowledge the University of California San Francisco (UCSF) Mass Spectrometry Facility (supported by NIH grant P41RR001614).	Cohen MS, 2007, NAT CHEM BIOL, V3, P156, DOI 10.1038/nchembio859; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Doehn U, 2009, MOL CELL, V35, P511, DOI 10.1016/j.molcel.2009.08.002; Evans DC, 2004, CHEM RES TOXICOL, V17, P3, DOI 10.1021/tx034170b; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Fry DW, 1998, P NATL ACAD SCI USA, V95, P12022, DOI 10.1073/pnas.95.20.12022; Hagel M, 2011, NAT CHEM BIOL, V7, P22, DOI 10.1038/NCHEMBIO.492; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Kang SM, 2010, J CLIN INVEST, V120, P1165, DOI 10.1172/JCI40582; Lee G, 2006, J MOL BIOL, V357, P1051, DOI 10.1016/j.jmb.2006.01.032; Leproult E, 2011, J MED CHEM, V54, P1347, DOI 10.1021/jm101396q; Malakhova M, 2008, NAT STRUCT MOL BIOL, V15, P112, DOI 10.1038/nsmb1347; Park BK, 2011, NAT REV DRUG DISCOV, V10, P292, DOI 10.1038/nrd3408; Patch RJ, 2011, J MED CHEM, V54, P788, DOI 10.1021/jm101063h; PEARSON RG, 1953, J AM CHEM SOC, V75, P2439, DOI 10.1021/ja01106a048; Potashman MH, 2009, J MED CHEM, V52, P1231, DOI 10.1021/jm8008597; PRITCHARD RB, 1968, CAN J CHEMISTRY, V46, P775, DOI 10.1139/v68-128; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Smith AJT, 2009, J MED CHEM, V52, P225, DOI 10.1021/jm800498e; Smolen GA, 2010, GENE DEV, V24, P2654, DOI 10.1101/gad.1989110; Uetrecht J, 2008, CHEM RES TOXICOL, V21, P84, DOI 10.1021/tx700186p; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Wissner A, 2003, J MED CHEM, V46, P49, DOI 10.1021/jm020241c; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhou WJ, 2010, CHEM BIOL, V17, P285, DOI 10.1016/j.chembiol.2010.02.007; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	28	321	339	11	177	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2012	8	5					471	476		10.1038/NCHEMBIO.925	http://dx.doi.org/10.1038/NCHEMBIO.925			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	928DY	22466421	Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000302962500014
J	Hill, DA; Siracusa, MC; Abt, MC; Kim, BS; Kobuley, D; Kubo, M; Kambayashi, T; LaRosa, DF; Renner, ED; Orange, JS; Bushman, FD; Artis, D				Hill, David A.; Siracusa, Mark C.; Abt, Michael C.; Kim, Brian S.; Kobuley, Dmytro; Kubo, Masato; Kambayashi, Taku; LaRosa, David F.; Renner, Ellen D.; Orange, Jordan S.; Bushman, Frederic D.; Artis, David			Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation	NATURE MEDICINE			English	Article							FUNGAL MICROBIOTA; IGE PRODUCTION; MAST-CELLS; IN-VIVO; ASTHMA; IL-4; SUSCEPTIBILITY; ACTIVATION; ANTIGEN; ANTIBIOTICS	Commensal bacteria that colonize mammalian barrier surfaces are reported to influence T helper type 2 (T(H)2) cytokine-dependent inflammation and susceptibility to allergic disease, although the mechanisms that underlie these observations are poorly understood. In this report, we find that deliberate alteration of commensal bacterial populations via oral antibiotic treatment resulted in elevated serum IgE concentrations, increased steady-state circulating basophil populations and exaggerated basophil-mediated T(H)2 cell responses and allergic inflammation. Elevated serum IgE levels correlated with increased circulating basophil populations in mice and subjects with hyperimmunoglobulinemia E syndrome. Furthermore, B cell-intrinsic expression of myeloid differentiation factor 88 (MyD88) was required to limit serum IgE concentrations and circulating basophil populations in mice. Commensal-derived signals were found to influence basophil development by limiting proliferation of bone marrow-resident precursor populations. Collectively, these results identify a previously unrecognized pathway through which commensal-derived signals influence basophil hematopoiesis and susceptibility to T(H)2 cytokine-dependent inflammation and allergic disease.	[Hill, David A.; Siracusa, Mark C.; Abt, Michael C.; Kim, Brian S.; Kobuley, Dmytro; Bushman, Frederic D.; Artis, David] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hill, David A.; Siracusa, Mark C.; Abt, Michael C.; Kim, Brian S.; Kobuley, Dmytro; Artis, David] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hill, David A.; Siracusa, Mark C.; Abt, Michael C.; Kim, Brian S.; Kobuley, Dmytro; Artis, David] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Kubo, Masato] RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Lab Signal Network, Yokohama, Kanagawa, Japan; [Kubo, Masato] Tokyo Univ Sci, Res Inst Biol Sci, Div Mol Pathol, Chiba, Japan; [Kambayashi, Taku] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [LaRosa, David F.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Renner, Ellen D.] Univ Munich, Dr von Haunersches Kinderspital, Univ Childrens Hosp, D-80337 Munich, Germany; [Orange, Jordan S.] Childrens Hosp Philadelphia, Dept Pediat, Div Immunol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; RIKEN; Tokyo University of Science; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Artis, D (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	dartis@mail.med.upenn.edu	Kim, Brian/GZK-6649-2022; Renner, Ellen/R-7168-2016; Kubo, Masato/A-5918-2016	Kim, Brian/0000-0002-8100-7161; Renner, Ellen/0000-0001-9816-8538; Artis, David/0000-0002-1753-4100; Bushman, Frederic/0000-0003-4740-4056; Abt, Michael/0000-0002-7351-2061; Hill, David/0000-0001-9286-4268; orange, jordan/0000-0001-7117-7725	National Institute of Diabetes and Digestive and Kidney Disease Center for the Molecular Studies in Digestive and Liver Disease Molecular Pathology and Imaging Core [DK50306]; Abramson Cancer Center Flow Cytometry; Cell Sorting Resource Laboratory; US National Cancer Institute Comprehensive Cancer Center Support [2-P30 CA016520]; US National Institutes of Health [AI061570, AI087990, AI074878, AI095608, AI083480, AI095466, T32-AI060516, F32-AI085828, T32-AI05528]; Burroughs Wellcome Fund; Penn Genome Frontiers Institute; University of Pennsylvania Veterinary Center of Infectious Diseases;  [HL107589];  [HL111501];  [AI067946];  [UH2DK083981]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107589, R01HL111501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061570, R21AI083480, T32AI060516, R56AI067946, F32AI085828, R01AI095466, U01AI095608, R01AI067946, R01AI074878, R21AI087990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UH2DK083981, P30DK050306] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22021041] Funding Source: KAKEN	National Institute of Diabetes and Digestive and Kidney Disease Center for the Molecular Studies in Digestive and Liver Disease Molecular Pathology and Imaging Core; Abramson Cancer Center Flow Cytometry; Cell Sorting Resource Laboratory; US National Cancer Institute Comprehensive Cancer Center Support; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Penn Genome Frontiers Institute; University of Pennsylvania Veterinary Center of Infectious Diseases; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank members of the Artis lab for helpful discussions; M. R. Comeau (Tslp<SUP>-/-</SUP> mice, Amgen), H. Oettgen (Igh-7<SUP>-/-</SUP> mice, Harvard University) and J. Weiser (Nod1<SUP>-/-</SUP> mice, University of Pennsylvania) for providing access to mice; L. Shawver, R. Sinha and R. Custers-Allen for assistance with data; J. Sawalle-Belohradsky and B. Hagl for performing DOCK8 sequencing; A. Jansson, G. Notheis, B.H. Belohradsky, M. Albert and the referring physicians for patient care; the Matthew J. Ryan Veterinary Hospital Pathology Lab; the National Institute of Diabetes and Digestive and Kidney Disease Center for the Molecular Studies in Digestive and Liver Disease Molecular Pathology and Imaging Core (DK50306); the Abramson Cancer Center Flow Cytometry and Cell Sorting Resource Laboratory (supported by US National Cancer Institute Comprehensive Cancer Center Support grant (2-P30 CA016520) for technical advice and support; and the University of Pennsylvania Gnotobiotic Mouse Facility for germ-free mice. Research in the Artis lab is supported by the US National Institutes of Health (AI061570, AI087990, AI074878, AI095608, AI083480 and AI095466 to D.A.; T32-AI060516 to D.A.H.; F32-AI085828 to M.C.S.; T32-AI05528 to M.C.A.) the Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award (D.A.), the Penn Genome Frontiers Institute (D.A. and F.D.B.), and pilot grants from the University of Pennsylvania Veterinary Center of Infectious Diseases (D.A.). Additional National Institutes of Health support provided by HL107589 and HL111501 to T.K., AI067946 to J.S.O. and UH2DK083981 to F.D.B.	Bahadori Katayoun, 2009, BMC Pulm Med, V9, P24, DOI 10.1186/1471-2466-9-24; Bashir MEH, 2004, J IMMUNOL, V172, P6978, DOI 10.4049/jimmunol.172.11.6978; Chen ML, 2008, J IMMUNOL, V180, P7327, DOI 10.4049/jimmunol.180.11.7327; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; DELPHIN S, 1995, J EXP MED, V181, P181, DOI 10.1084/jem.181.1.181; Eckburg PB, 2003, INFECT IMMUN, V71, P591, DOI 10.1128/IAI.71.2.591-596.2003; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Engelhardt KR, 2009, J ALLERGY CLIN IMMUN, V124, P1289, DOI 10.1016/j.jaci.2009.10.038; Fink LN, 2012, AM J PHYSIOL-GASTR L, V302, pG55, DOI 10.1152/ajpgi.00428.2010; Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063; Gilliland FD, 2009, PEDIATRICS, V123, pS168, DOI 10.1542/peds.2008-2233G; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Herbst T, 2011, AM J RESP CRIT CARE, V184, P198, DOI 10.1164/rccm.201010-1574OC; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Holgate S, 2009, RESP MED, V103, P1098, DOI 10.1016/j.rmed.2009.03.008; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Kalliomaki M, 2001, J ALLERGY CLIN IMMUN, V107, P129, DOI 10.1067/mai.2001.111237; Kim BS, 2010, P NATL ACAD SCI USA, V107, P8742, DOI 10.1073/pnas.0911756107; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Kummeling I, 2007, PEDIATRICS, V119, pE225, DOI 10.1542/peds.2006-0896; Layland LE, 2005, EUR J IMMUNOL, V35, P3248, DOI 10.1002/eji.200526273; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lin H, 2004, J ALLERGY CLIN IMMUN, V113, P297, DOI 10.1016/j.jaci.2003.11.044; Liu NS, 2003, NAT IMMUNOL, V4, P687, DOI 10.1038/ni941; Marra F, 2009, PEDIATRICS, V123, P1003, DOI 10.1542/peds.2008-1146; McCoy KD, 2006, IMMUNITY, V24, P329, DOI 10.1016/j.immuni.2006.01.013; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Mowen KA, 2004, IMMUNOL REV, V202, P203, DOI 10.1111/j.0105-2896.2004.00209.x; Noverr MC, 2005, INFECT IMMUN, V73, P30, DOI 10.1128/IAI.73.1.30-38.2005; Noverr MC, 2004, INFECT IMMUN, V72, P6206, DOI 10.1128/IAI.72.11.6206-6210.2004; NOVEY HS, 1979, J ALLERGY CLIN IMMUN, V63, P98, DOI 10.1016/0091-6749(79)90198-2; Ohmori K, 2009, J IMMUNOL, V182, P2835, DOI 10.4049/jimmunol.0802870; Pace E, 2011, J ASTHMA, V48, P387, DOI 10.3109/02770903.2011.561512; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Phythian-Adams AT, 2010, J EXP MED, V207, P2089, DOI 10.1084/jem.20100734; Redhu NS, 2011, J ALLERGY CLIN IMMUN, V128, P892, DOI 10.1016/j.jaci.2011.06.045; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Shiratori I, 2005, J IMMUNOL, V175, P4441, DOI 10.4049/jimmunol.175.7.4441; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Siracusa MC, 2010, IMMUNOL CELL BIOL, V88, P275, DOI 10.1038/icb.2010.1; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Sudo N, 1997, J IMMUNOL, V159, P1739; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Xiang Z, 2006, ALLERGY, V61, P1040, DOI 10.1111/j.1398-9995.2006.01024.x; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Zeiger RS, 2003, PEDIATRICS, V111, P1662; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506	56	312	327	1	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2012	18	4					538	546		10.1038/nm.2657	http://dx.doi.org/10.1038/nm.2657			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22447074	Green Accepted			2022-12-25	WOS:000302617800030
J	Van Houdt, JKJ; Nowakowska, BA; Sousa, SB; van Schaik, BDC; Seuntjens, E; Avonce, N; Sifrim, A; Abdul-Rahman, OA; van den Boogaard, MJH; Bottani, A; Castori, M; Cormier-Daire, V; Deardorff, MA; Filges, I; Fryer, A; Fryns, JP; Gana, S; Garavelli, L; Gillessen-Kaesbach, G; Hall, BD; Horn, D; Huylebroeck, D; Klapecki, J; Krajewska-Walasek, M; Kuechler, A; Lines, MA; Maas, S; MacDermot, KD; McKee, S; Magee, A; de Man, SA; Moreau, Y; Morice-Picard, F; Obersztyn, E; Pilch, J; Rosser, E; Shannon, N; Stolte-Dijkstra, I; Van Dijck, P; Vilain, C; Vogels, A; Wakeling, E; Wieczorek, D; Wilson, L; Zuffardi, O; van Kampen, AHC; Devriendt, K; Hennekam, R; Vermeesch, JR				Van Houdt, Jeroen K. J.; Nowakowska, Beata Anna; Sousa, Sergio B.; van Schaik, Barbera D. C.; Seuntjens, Eve; Avonce, Nelson; Sifrim, Alejandro; Abdul-Rahman, Omar A.; van den Boogaard, Marie-Jose H.; Bottani, Armand; Castori, Marco; Cormier-Daire, Valerie; Deardorff, Matthew A.; Filges, Isabel; Fryer, Alan; Fryns, Jean-Pierre; Gana, Simone; Garavelli, Livia; Gillessen-Kaesbach, Gabriele; Hall, Bryan D.; Horn, Denise; Huylebroeck, Danny; Klapecki, Jakub; Krajewska-Walasek, Malgorzata; Kuechler, Alma; Lines, Matthew A.; Maas, Saskia; MacDermot, Kay D.; McKee, Shane; Magee, Alex; de Man, Stella A.; Moreau, Yves; Morice-Picard, Fanny; Obersztyn, Ewa; Pilch, Jacek; Rosser, Elizabeth; Shannon, Nora; Stolte-Dijkstra, Irene; Van Dijck, Patrick; Vilain, Catheline; Vogels, Annick; Wakeling, Emma; Wieczorek, Dagmar; Wilson, Louise; Zuffardi, Orsetta; van Kampen, Antoine H. C.; Devriendt, Koenraad; Hennekam, Raoul; Vermeesch, Joris Robert			Heterozygous missense mutations in SMARCA2 cause Nicolaides-Baraitser syndrome	NATURE GENETICS			English	Article							SEQUENCING DATA; FAMILY; DELINEATION; EXPRESSION; COMPLEXES; VARIANTS; HELICASE; MOTIFS; CANCER; DOMAIN	Nicolaides-Baraitser syndrome (NBS) is characterized by sparse hair, distinctive facial morphology, distal-limb anomalies and intellectual disability. We sequenced the exomes of ten individuals with NBS and identified heterozygous variants in SMARCA2 in eight of them. Extended molecular screening identified nonsynonymous SMARCA2 mutations in 36 of 44 individuals with NBS; these mutations were confirmed to be de novo when parental samples were available. SMARCA2 encodes the core catalytic unit of the SWI/SNF ATP-dependent chromatin remodeling complex that is involved in the regulation of gene transcription. The mutations cluster within sequences that encode ultra-conserved motifs in the catalytic ATPase region of the protein. These alterations likely do not impair SWI/SNF complex assembly but may be associated with disrupted ATPase activity. The identification of SMARCA2 mutations in humans provides insight into the function of the Snf2 helicase family.	[Maas, Saskia; Hennekam, Raoul] Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; [Van Houdt, Jeroen K. J.; Nowakowska, Beata Anna; Fryns, Jean-Pierre; Vogels, Annick; Devriendt, Koenraad; Vermeesch, Joris Robert] Catholic Univ Louvain, Ctr Human Genet, Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium; [Nowakowska, Beata Anna; Klapecki, Jakub; Obersztyn, Ewa] Inst Mother & Child Hlth, Dept Med Genet, Warsaw, Poland; [Sousa, Sergio B.] Inst Child Hlth, Clin & Mol Genet Unit, London, England; [Sousa, Sergio B.] Hosp Pediat Coimbra, Serv Genet Med, Coimbra, Portugal; [van Schaik, Barbera D. C.; van Kampen, Antoine H. C.] Univ Amsterdam, Acad Med Ctr, Bioinformat Lab, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Seuntjens, Eve; Huylebroeck, Danny] Catholic Univ Louvain, Ctr Human Genet, Lab Mol Biol Celgen, B-3000 Louvain, Belgium; [Seuntjens, Eve; Huylebroeck, Danny] Flanders Inst Biotechnol, Dept Mol & Dev Genet, Louvain, Belgium; [Avonce, Nelson; Van Dijck, Patrick] Flanders Inst Biotechnol, Dept Mol Microbiol, Louvain, Belgium; [Avonce, Nelson; Van Dijck, Patrick] Catholic Univ Louvain, Mol Cell Biol Lab, B-3000 Louvain, Belgium; [Sifrim, Alejandro; Moreau, Yves] Catholic Univ Louvain, Dept Elect Engn ESAT, B-3000 Louvain, Belgium; [Abdul-Rahman, Omar A.] Univ Mississippi, Med Ctr, Dept Pediat, Div Med Genet, Jackson, MS 39216 USA; [van den Boogaard, Marie-Jose H.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Bottani, Armand] Univ Hosp Geneva, Dept Genet & Lab Med, Geneva, Switzerland; [Castori, Marco] Sapienza Univ, Dept Mol Med, San Camillo Forlanini Hosp, Rome, Italy; [Cormier-Daire, Valerie] Univ Paris 05, Dept Genet, INSERM, U781,Hop Necker Enfants Malad, Paris, France; [Deardorff, Matthew A.] Childrens Hosp Philadelphia, Div Genet, Philadelphia, PA 19104 USA; [Filges, Isabel] Univ Childrens Hosp, Dept Biomed, Div Med Genet, Basel, Switzerland; [Fryer, Alan] Alder Hey Childrens Hosp, Dept Clin Genet, Liverpool L12 2AP, Merseyside, England; [Fryer, Alan] Liverpool Womens Hosp, Liverpool, Merseyside, England; [Zuffardi, Orsetta] Univ Pavia, IRCCS, Neurol Inst C Mondino, I-27100 Pavia, Italy; [Garavelli, Livia] Santa Maria Nuova Hosp, IRCCS, Clin Genet Unit, Dept Obstet & Pediat, Reggio Emilia, Italy; [Gillessen-Kaesbach, Gabriele] Univ Lubeck, Inst Human Genet, Lubeck, Germany; [Hall, Bryan D.] Univ Kentucky, Dept Pediat, Lexington, KY USA; [Horn, Denise] Humboldt Univ, Inst Med Genet, D-10099 Berlin, Germany; [Krajewska-Walasek, Malgorzata] Childrens Mem Hlth Inst, Dept Med Genet, Warsaw, Poland; [Kuechler, Alma; Wieczorek, Dagmar] Univ Klinikum Essen, Inst Humangenet, Essen, Germany; [Lines, Matthew A.] Childrens Hosp Eastern Ontario, Dept Genet, Ottawa, ON K1H 8L1, Canada; [MacDermot, Kay D.; Wakeling, Emma] Kennedy Galton Ctr, N W Thames Reg Genet Serv, London, England; [McKee, Shane; Magee, Alex] Belfast City Hosp, No Ireland Reg Genet Serv, Belfast BT9 7AD, Antrim, North Ireland; [de Man, Stella A.] Amphia Hosp, Dept Pediat, Breda, Netherlands; [de Man, Stella A.] Erasmus Univ, Dept Clin Genet, Sch Med, Rotterdam, Netherlands; [Morice-Picard, Fanny] Ctr Hosp Univ CHU Bordeaux, Serv Genet Med, Lab Malad Rares Genet & Metab, EA 4576, Bordeaux, France; [Pilch, Jacek] Med Univ Silesia, Dept Child Neurol, Katowice, Poland; [Rosser, Elizabeth; Wilson, Louise] Hosp Children, Dept Clin Genet, London, England; [Shannon, Nora] City Hosp, Clin Genet Serv, Nottingham NG5 1PB, England; [Stolte-Dijkstra, Irene] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Vilain, Catheline] Univ Libre Bruxelles, Ctr Human Genet, Dept Clin Genet, Brussels, Belgium	University of Amsterdam; Academic Medical Center Amsterdam; KU Leuven; University Hospital Leuven; Universite Catholique Louvain; University of London; University College London; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); University of Amsterdam; Academic Medical Center Amsterdam; Universite Catholique Louvain; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); Universite Catholique Louvain; Universite Catholique Louvain; University of Mississippi; University of Mississippi Medical Center; Utrecht University; Utrecht University Medical Center; University of Geneva; Azienda Ospedaliera San Camillo-Forlanini; Sapienza University Rome; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Liverpool; IRCCS Fondazione Casimiro Mondino; University of Pavia; IRCCS Arcispedale S. Maria Nuova; University of Lubeck; University of Kentucky; Humboldt University of Berlin; Children's Memorial Health Institute; University of Duisburg Essen; University of Ottawa; Children's Hospital of Eastern Ontario; Belfast City Hospital; Amphia Hospital; Erasmus University Rotterdam; CHU Bordeaux; Medical University Silesia; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Nottingham; University of Groningen; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles	Hennekam, R (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands.	r.c.hennekam@amc.uva.nl; joris.vermeesch@uzleuven.be	Sifrim, Alejandro/AAY-2019-2021; Garavelli, Livia/AAA-8132-2021; Castori, Marco/K-1099-2016; Gana, Simone/AAH-5562-2019; Lines, Matthew/M-4540-2018; Seuntjens, Eve/AAM-2478-2021; Avonce, Nelson/M-3507-2014; Wieczorek, Dagmar/AAU-6008-2021; MORICE-PICARD, Fanny/M-5125-2014; cormier-daire, valerie/H-6520-2017	Sifrim, Alejandro/0000-0001-8247-4020; Garavelli, Livia/0000-0002-7684-3982; Castori, Marco/0000-0002-6069-0993; Wieczorek, Dagmar/0000-0003-2812-6492; Seuntjens, Eve/0000-0002-0126-461X; Gana, Simone/0000-0001-6544-7135; Avonce, Nelson/0000-0003-2747-4065; Moreau, Yves/0000-0002-4647-6560; zuffardi, orsetta/0000-0002-1466-4559; Krajewska-Walasek, Malgorzata/0000-0001-8721-210X; Vermeesch, Joris/0000-0002-3071-1191; Obersztyn, Ewa/0000-0002-3044-9517; Huylebroeck, Danny/0000-0003-4862-1079; de Man, Stella/0000-0002-3895-4649; Klapecki, Jakub/0000-0003-2236-6903; cormier-daire, valerie/0000-0002-2839-9856; van Schaik, Barbera/0000-0002-5568-8127; Wakeling, Emma/0000-0001-5712-0044	Agency for Innovation by Science and Technology (IWT) [SBO-60848]; Catholic University of Leuven [PFV/10/016 SymBioSys, GOA/12/015]; Queen Elisabeth Medical Foundation [GSKE 1113]; Flanders Hercules Foundation; Foundation for Polish Science; Fundacao Para a Ciencia e Tecnologia [SFRH/BD/46778/2008]	Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Catholic University of Leuven(KU Leuven); Queen Elisabeth Medical Foundation; Flanders Hercules Foundation; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Fundacao Para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	We thank the Genome of the Netherlands Project (GoNL) for providing their variant data. GoNL is one of the rainbow projects of the Dutch hub of the Biobanking and Biomolecular Research Infrastructure (BBMRI-NL). We thank S. Olabarriaga and M. Santcroos for their support in using the Dutch Grid for data analysis. We thank T.J.L. de Ravel and P. Brady for critical reading of the manuscript and G. Peeters for technical support. We are grateful to the subjects and their families for participating in this study. This work was made possible by grants from the Agency for Innovation by Science and Technology (IWT; SBO-60848), the Catholic University of Leuven (PFV/10/016 SymBioSys and GOA/12/015 to J.R.V., Y.M. and K.D.), the Queen Elisabeth Medical Foundation (GSKE 1113 to D. Hu and E.S.) and the type 3 large-infrastructure support InfraMouse by the Flanders Hercules Foundation (to D. Hu). B.A.N. is supported by a KOLUMB fellowship from the Foundation for Polish Science. S.B.S. was supported by the Fundacao Para a Ciencia e Tecnologia (SFRH/BD/46778/2008).	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Boerkoel CF, 2002, NAT GENET, V30, P215, DOI 10.1038/ng821; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Christ LA, 1999, AM J HUM GENET, V65, P1387, DOI 10.1086/302606; De la Serna IL, 2000, MOL CELL BIOL, V20, P2839, DOI 10.1128/MCB.20.8.2839-2851.2000; Durr H, 2006, NUCLEIC ACIDS RES, V34, P4160, DOI 10.1093/nar/gkl540; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Hall MC, 1999, MOL MICROBIOL, V34, P867, DOI 10.1046/j.1365-2958.1999.01659.x; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu G, 2011, ONCOGENE, V30, P3295, DOI 10.1038/onc.2011.81; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Magnani L, 2009, REPRODUCTION, V137, P23, DOI 10.1530/REP-08-0335; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nicolaides P, 1993, Clin Dysmorphol, V2, P232; Olabarriaga SD, 2010, IEEE T INF TECHNOL B, V14, P979, DOI 10.1109/TITB.2010.2046742; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Richmond E, 1996, NUCLEIC ACIDS RES, V24, P3685, DOI 10.1093/nar/24.19.3685; Sousa SB, 2009, AM J MED GENET A, V149A, P1628, DOI 10.1002/ajmg.a.32956; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	25	174	177	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2012	44	4					445	U261		10.1038/ng.1105	http://dx.doi.org/10.1038/ng.1105			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	916VF	22366787				2022-12-25	WOS:000302130600021
J	Daboussi, L; Costaguta, G; Payne, GS				Daboussi, Lydia; Costaguta, Giancarlo; Payne, Gregory S.			Phosphoinositide-mediated clathrin adaptor progression at the trans-Golgi network	NATURE CELL BIOLOGY			English	Article							ADP-RIBOSYLATION FACTOR; EPSIN-RELATED PROTEINS; SACCHAROMYCES-CEREVISIAE; GAMMA-ADAPTIN; YEAST GOLGI; PHOSPHATIDYLINOSITOL-4-OH KINASE; MULTIVESICULAR BODY; ENDOSOME TRANSPORT; DISTINCT ROLES; DOMAINS	Clathrin-coated vesicles mediate endocytosis and transport between the trans-Golgi network (TGN) and endosomes in eukaryotic cells. Clathrin adaptors play central roles in coat assembly, interacting with clathrin, cargo and membranes. Two main types of clathrin adaptor act in TGN endosome traffic: GGA proteins and the AP-1 complex. Here we characterize the relationship between GGA proteins, AP-1 and other TGN clathrin adaptors using live-cell and super-resolution microscopy in yeast. We present evidence that GGA proteins and AP-1 are recruited sequentially in two waves of coat assembly at the TGN. Mutations that decrease phosphatidylinositol 4-phosphate (PtdIns(4)P) levels at the TGN slow or uncouple AP-1 coat assembly from GGA coat assembly. Conversely, enhanced PtdIns(4)P synthesis shortens the time between adaptor waves. Gga2p binds directly to the TGN PtdIns(4)-kinase Piklp and contributes to Piklp recruitment. These results identify a PtdIns(4)P-based mechanism for regulating progressive assembly of adaptor-specific clathrin coats at the TGN.	[Daboussi, Lydia; Costaguta, Giancarlo; Payne, Gregory S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Payne, Gregory S.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Payne, GS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	gpayne@mednet.ucla.edu			NIH NRSA [T32 GM-007104]; UCLA; NIH [GM39040]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039040, T32GM007104] Funding Source: NIH RePORTER	NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA(University of California System); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J.Thorner, S. Emr and T. Levine for plasmids and strains, J. Atkins for help with SIM, and members of the laboratory for helpful discussions. We are especially grateful to K. Kilborn for advice and assistance with confocal microscopy and K. Martin, G. Weinmaster and A. van der Bliek for comments on the manuscript. This work was supported by NIH NRSA T32 GM-007104 and a UCLA Dissertation Year Fellowship to L.D. and NIH GM39040 to G.P.	Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Black MW, 2000, J CELL BIOL, V151, P587, DOI 10.1083/jcb.151.3.587; Boman AL, 2002, MOL BIOL CELL, V13, P3078, DOI 10.1091/mbc.E02-02-0078; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Chidambaram S, 2004, J BIOL CHEM, V279, P4175, DOI 10.1074/jbc.M308667200; Chidambaram S, 2008, J CELL SCI, V121, P329, DOI 10.1242/jcs.012708; Costaguta G, 2001, MOL BIOL CELL, V12, P1885, DOI 10.1091/mbc.12.6.1885; Costaguta G, 2006, MOL BIOL CELL, V17, P3907, DOI 10.1091/mbc.E06-05-0410; Dean N, 1999, BBA-GEN SUBJECTS, V1426, P309, DOI 10.1016/S0304-4165(98)00132-9; Demmel L, 2008, MOL BIOL CELL, V19, P1991, DOI 10.1091/mbc.E06-10-0937; Doray B, 2002, SCIENCE, V297, P1700, DOI 10.1126/science.1075327; Duncan MC, 2003, TRENDS CELL BIOL, V13, P211, DOI 10.1016/S0962-8924(03)00076-X; Duncan MC, 2003, NAT CELL BIOL, V5, P77, DOI 10.1038/ncb901; Eugster A, 2004, MOL BIOL CELL, V15, P3031, DOI 10.1091/mbc.e03-11-0793; Fernandez GE, 2006, MOL BIOL CELL, V17, P3304, DOI 10.1091/mbc.E06-02-0096; FRANZUSOFF A, 1991, J CELL BIOL, V112, P27, DOI 10.1083/jcb.112.1.27; Friant S, 2003, DEV CELL, V5, P499, DOI 10.1016/S1534-5807(03)00238-7; FULLER RS, 1988, ANNU REV PHYSIOL, V50, P345, DOI 10.1146/annurev.ph.50.030188.002021; Gaynor EC, 1998, MOL BIOL CELL, V9, P653, DOI 10.1091/mbc.9.3.653; Graham T. R., 1994, J CELL BIOL, V127, P667; Graham TR, 2011, TRENDS CELL BIOL, V21, P113, DOI 10.1016/j.tcb.2010.10.002; Ha SA, 2003, MOL BIOL CELL, V14, P1319, DOI 10.1091/mbc.E02-10-0686; Hendricks KB, 1999, NAT CELL BIOL, V1, P234, DOI 10.1038/12058; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Narayan K, 2006, METHODS, V39, P122, DOI 10.1016/j.ymeth.2006.05.006; Newpher TM, 2005, DEV CELL, V9, P87, DOI 10.1016/j.devcel.2005.04.014; PAYNE GS, 1989, SCIENCE, V245, P1358, DOI 10.1126/science.2675311; PHAN HL, 1994, EMBO J, V13, P1706, DOI 10.1002/j.1460-2075.1994.tb06435.x; Poussu A, 2000, J BIOL CHEM, V275, P7176, DOI 10.1074/jbc.275.10.7176; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Rossanese OW, 2001, J CELL BIOL, V153, P47, DOI 10.1083/jcb.153.1.47; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; SIKORSKI RS, 1989, GENETICS, V122, P19; Singer-Kruger B, 2008, EMBO J, V27, P1423, DOI 10.1038/emboj.2008.75; STEARNS T, 1990, MOL CELL BIOL, V10, P6690, DOI 10.1128/MCB.10.12.6690; Strahl T, 2005, J CELL BIOL, V171, P967, DOI 10.1083/jcb.200504104; Traub LM, 2005, BBA-MOL CELL RES, V1744, P415, DOI 10.1016/j.bbamcr.2005.04.005; Vowels JJ, 1998, MOL BIOL CELL, V9, P1351, DOI 10.1091/mbc.9.6.1351; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; Wang J, 2007, MOL BIOL CELL, V18, P2646, DOI 10.1091/mbc.E06-10-0897; Wang J, 2011, P NATL ACAD SCI USA, V108, P12277, DOI 10.1073/pnas.1013101108; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Yeung BG, 1999, MOL BIOL CELL, V10, P3643, DOI 10.1091/mbc.10.11.3643; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	50	96	97	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2012	14	3					239	+		10.1038/ncb2427	http://dx.doi.org/10.1038/ncb2427			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	900ZE	22344030	Green Submitted, Green Accepted			2022-12-25	WOS:000300930400006
J	Holman, CM				Holman, Christopher M.			Debunking the myth that whole-genome sequencing infringes thousands of gene patents	NATURE BIOTECHNOLOGY			English	Editorial Material									Univ Missouri, Kansas City Sch Law, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City	Holman, CM (corresponding author), Univ Missouri, Kansas City Sch Law, Kansas City, MO 64110 USA.	holmancm@umkc.edu						[Anonymous], US PATENTS ARE FREEL; [Anonymous], 2009, SINGLE MOL REAL TIME; [Anonymous], MORE SPECIFICALLY TH; [Anonymous], QUERY EMPLOYED JENSE; Cook-Deegan R., COMMUNICATION; Cook-Deegan R, 2010, ANNU REV GENOM HUM G, V11, P383, DOI 10.1146/annurev-genom-082509-141811; Davies Kevin, 2010, 1000 GENOME REVOLUTI; Holman C., 2011, HOLMANS BIOTECH 0724; Holman C. M., 2011, IP THEORY, V2, P4; Holman CM, 2008, SCIENCE, V322, P198, DOI 10.1126/science.1160687; Holman CM, 2011, NEW DIRECT PATENT, P260; Huys I, 2009, NAT BIOTECHNOL, V27, P903, DOI 10.1038/nbt1009-903; Jensen K, 2005, SCIENCE, V310, P239, DOI 10.1126/science.1120014; Kepler TB, 2010, GENOMICS, V95, P312, DOI 10.1016/j.ygeno.2010.03.003; Moran N, 2012, NAT BIOTECHNOL, V30, P3, DOI 10.1038/nbt0112-3; Price W. N. II, 2012, CARDOZO L REV, V33; Secretary's Advisory Committee for Genetics Health and Society, 2010, GEN PAT LIC PRACT TH; 2001, FED REG         0105, V66, P1092	18	22	23	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2012	30	3					240	244		10.1038/nbt.2146	http://dx.doi.org/10.1038/nbt.2146			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	905VI	22398617				2022-12-25	WOS:000301303800016
J	Sugimoto, H; LeBleu, VS; Bosukonda, D; Keck, P; Taduri, G; Bechtel, W; Okada, H; William, C; Bey, P; Rusckowski, M; Tampe, B; Tampe, D; Kanasaki, K; Zeisberg, M; Kalluri, R				Sugimoto, Hikaru; LeBleu, Valerie S.; Bosukonda, Dattatreyamurty; Keck, Peter; Taduri, Gangadhar; Bechtel, Wibke; Okada, Hirokazu; Carlson, William, Jr.; Bey, Philippe; Rusckowski, Mary; Tampe, Bjoern; Tampe, Desiree; Kanasaki, Keizo; Zeisberg, Michael; Kalluri, Raghu			Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis	NATURE MEDICINE			English	Article							BONE MORPHOGENETIC PROTEIN-7; TO-MESENCHYMAL TRANSITION; GROWTH-FACTOR-BETA; CRYSTAL-STRUCTURE; RENAL FIBROSIS; EXPRESSION; PROGRESSION; BMP-7; FIBROBLASTS; RECEPTORS	Molecules associated with the transforming growth factor beta (TGF-beta) superfamily, such as bone morphogenic proteins (BMPs) and TGF-beta, are key regulators of inflammation, apoptosis and cellular transitions. Here we show that the BMP receptor activin-like kinase 3 (Alk3) is elevated early in diseased kidneys after injury. We also found that its deletion in the tubular epithelium leads to enhanced TGF-beta 1-Smad family member 3 (Smad3) signaling, epithelial damage and fibrosis, suggesting a protective role for Alk3-mediated signaling in the kidney. A structure-function analysis of the BMP-Alk3-BMP receptor, type 2 (BMPR2) ligand-receptor complex, along with synthetic organic chemistry, led us to construct a library of small peptide agonists of BMP signaling that function through the Alk3 receptor. One such peptide agonist, THR-123, suppressed inflammation, apoptosis and the epithelial-to-mesenchymal transition program and reversed established fibrosis in five mouse models of acute and chronic renal injury. THR-123 acts specifically through Alk3 signaling, as mice with a targeted deletion for Alk3 in their tubular epithelium did not respond to therapy with THR-123. Combining THR-123 and the angiotensin-converting enzyme inhibitor captopril had an additive therapeutic benefit in controlling renal fibrosis. Our studies show that BMP signaling agonists constitute a new line of therapeutic agents with potential utility in the clinic to induce regeneration, repair and reverse established fibrosis.	[Sugimoto, Hikaru; LeBleu, Valerie S.; Taduri, Gangadhar; Bechtel, Wibke; Okada, Hirokazu; Kanasaki, Keizo; Zeisberg, Michael; Kalluri, Raghu] Beth Israel Deaconess Med Ctr, Dept Med, Div Matrix Biol, Boston, MA 02215 USA; [Bosukonda, Dattatreyamurty; Keck, Peter; Carlson, William, Jr.] Thrasos Innovat Inc, Montreal, PQ, Canada; [Carlson, William, Jr.; Bey, Philippe] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol,Dept Med, Boston, MA USA; [Rusckowski, Mary] Univ Massachusetts, Div Nucl Med, Dept Radiol, Coll Med, Worcester, MA 01605 USA; [Tampe, Bjoern; Tampe, Desiree; Zeisberg, Michael; Kalluri, Raghu] Univ Gottingen, Goettingen Univ Med Ctr, Dept Nephrol & Rheumatol, D-3400 Gottingen, Germany; [Kalluri, Raghu] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Boston, MA USA; [Kalluri, Raghu] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester; University of Gottingen; Harvard University; Harvard University; Harvard Medical School	Kalluri, R (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Matrix Biol, Boston, MA 02215 USA.	rkalluri@bidmc.harvard.edu	Tampe, Björn/ABA-6091-2021; LeBleu, Valerie/E-2991-2015; Kalluri, Raghu/E-2677-2015	Tampe, Björn/0000-0002-4357-9863; Tampe, Desiree/0000-0002-8724-4803; Bechtel-Walz, Wibke/0000-0001-6032-3627; Kalluri, Raghu/0000-0002-2190-547X	US National Institutes of Health [DK55001, DK061688, DK081576, DK074558, CA155370 CA163191, CA125550, CA151925]; Else Kroner-Memorial-Stipend [P58/05//EKMS 05/59]; Research Training Grant in Gastroenterology [2T32DK007760-11]; Research Training Grant in Cardiovascular Biology [5T32HL007374-30]; NATIONAL CANCER INSTITUTE [U01CA151925, R01CA155370, U54CA163191, R01CA125550] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061688, R01DK081576, K08DK074558, T32DK007760] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Else Kroner-Memorial-Stipend; Research Training Grant in Gastroenterology; Research Training Grant in Cardiovascular Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by US National Institutes of Health grants DK55001, DK061688, DK081576, DK074558, CA155370 CA163191, CA125550, CA151925 and the Else Kroner-Memorial-Stipend P58/05//EKMS 05/59 (M.Z.). V. S. L. is funded from the Research Training Grant in Gastroenterology (2T32DK007760-11). H. S. is funded by the Research Training Grant in Cardiovascular Biology (5T32HL007374-30). Mice with the Alk3<SUP>flox/flox</SUP> allele (Alk3<SUP>f/f</SUP>) were kindly provided by Y. Mishina, US National Institutes of Health under a material transfer agreement. gamma GT-Cre mice, NP-1 cells and the polyclonal antibody to FSP1 were provided by E. Neilson, Vanderbilt University Medical Center. We thank S. McGoohan for his technical assistance.	Archdeacon P, 2008, ADV CHRONIC KIDNEY D, V15, P314, DOI 10.1053/j.ackd.2008.04.011; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Bosukonda D, 2000, KIDNEY INT, V58, P1902, DOI 10.1046/j.1523-1755.2000.00362.x; DAOPIN S, 1992, SCIENCE, V257, P369, DOI 10.1126/science.1631557; Gould SE, 2002, KIDNEY INT, V61, P51, DOI 10.1046/j.1523-1755.2002.00103.x; Griffith DL, 1996, P NATL ACAD SCI USA, V93, P878, DOI 10.1073/pnas.93.2.878; Haaijman A, 2000, GROWTH FACTORS, V17, P177, DOI 10.3109/08977190009001067; Hojo H, 2010, J BONE MINER METAB, V28, P489, DOI 10.1007/s00774-010-0199-7; Ide H, 1997, CANCER RES, V57, P5022; ISHIDOU Y, 1995, J BONE MINER RES, V10, P1651; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kashtan CE, 1999, MEDICINE, V78, P338, DOI 10.1097/00005792-199909000-00005; Keck P.C., 2002, United States Patent Office, Patent No. [WO/2002/037313, 2002037313]; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Lloyd GM, 1997, J EXP MED, V185, P1371, DOI 10.1084/jem.185.7.1371; MACKENSENHAEN S, 1981, CLIN NEPHROL, V15, P167; Mishina Y, 2002, GENESIS, V32, P69, DOI 10.1002/gene.10038; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; PARVING HH, 1989, BMJ-BRIT MED J, V299, P533, DOI 10.1136/bmj.299.6698.533; RISDON RA, 1968, LANCET, V2, P363; Rodriguez-Iturbe B, 2010, NEPHRON CLIN PRACT, V116, pC81, DOI 10.1159/000314656; Schainuck L I, 1970, Hum Pathol, V1, P631, DOI 10.1016/S0046-8177(70)80061-2; SCHLUNEGGER MP, 1992, NATURE, V358, P430, DOI 10.1038/358430a0; Simic P, 2005, CYTOKINE GROWTH F R, V16, P299, DOI 10.1016/j.cytogfr.2005.02.010; Simic P, 2007, EMBO REP, V8, P327, DOI 10.1038/sj.embor.7400943; Simon N, 1999, AM J PHYSIOL-RENAL, V276, pF382, DOI 10.1152/ajprenal.1999.276.3.F382; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952; Striker G E, 1970, Hum Pathol, V1, P615, DOI 10.1016/S0046-8177(70)80060-0; Sugimoto H, 2007, DIABETES, V56, P1825, DOI 10.2337/db06-1226; Tuglular S, 2004, TRANSPL P, V36, P131, DOI 10.1016/j.transproceed.2003.11.018; Vukicevic S, 1998, J CLIN INVEST, V102, P202, DOI 10.1172/JCI2237; Wang SN, 2001, J AM SOC NEPHROL, V12, P2392, DOI 10.1681/ASN.V12112392; Wetzel P, 2006, KIDNEY INT, V70, P717, DOI 10.1038/sj.ki.5001653; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9; Zeisberg M, 2005, J BIOL CHEM, V280, P8094, DOI 10.1074/jbc.M413102200; Zeisberg M, 2003, AM J PHYSIOL-RENAL, V285, pF1060, DOI 10.1152/ajprenal.00191.2002; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	40	168	180	0	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2012	18	3					396	U264		10.1038/nm.2629	http://dx.doi.org/10.1038/nm.2629			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22306733	Green Submitted, Green Accepted			2022-12-25	WOS:000301264800041
J	Eiben, CB; Siegel, JB; Bale, JB; Cooper, S; Khatib, F; Shen, BW; Players, F; Stoddard, BL; Popovic, Z; Baker, D				Eiben, Christopher B.; Siegel, Justin B.; Bale, Jacob B.; Cooper, Seth; Khatib, Firas; Shen, Betty W.; Players, Foldit; Stoddard, Barry L.; Popovic, Zoran; Baker, David			Increased Diels-Alderase activity through backbone remodeling guided by Foldit players	NATURE BIOTECHNOLOGY			English	Article							COMPUTATIONAL DESIGN; ENZYME; EVOLUTION; MOTIF; LOOP; GAME	Computational enzyme design holds promise for the production of renewable fuels, drugs and chemicals. De novo enzyme design has generated catalysts for several reactions, but with lower catalytic efficiencies than naturally occurring enzymes(1-4). Here we report the use of game-driven crowdsourcing to enhance the activity of a computationally designed enzyme through the functional remodeling of its structure. Players of the online game Foldit(5,6) were challenged to remodel the backbone of a computationally designed bimolecular Diels-Alderase(3) to enable additional interactions with substrates. Several iterations of design and characterization generated a 24-residue helix-turn-helix motif, including a 13-residue insertion, that increased enzyme activity >18-fold. X-ray crystallography showed that the large insertion adopts a helix-turn-helix structure positioned as in the Foldit model. These results demonstrate that human creativity can extend beyond the macroscopic challenges encountered in everyday life to molecular-scale design problems.	[Eiben, Christopher B.; Siegel, Justin B.; Bale, Jacob B.; Khatib, Firas; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Bale, Jacob B.] Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Cooper, Seth; Popovic, Zoran] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Shen, Betty W.; Stoddard, Barry L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Kovanecz, Istvan/H-7386-2014; Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Eiben, Christopher/0000-0002-2816-2277; Bale, Jacob/0000-0003-2444-5875; Kovanecz, Istvan/0000-0002-3514-2338	Center for Game Science at the University of Washington; US Defense Advanced Research Projects Agency (DARPA) [N00173-08-1-G025]; DARPA PDP; Howard Hughes Medical Institute; National Science Foundation [DGE-0718124, 0906026]; Direct For Biological Sciences [0906026] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049857] Funding Source: NIH RePORTER	Center for Game Science at the University of Washington; US Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); DARPA PDP; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to acknowledge the members of the Foldit team for their help designing and developing the game and all the Foldit players who volunteered to make this work possible. We would also like to thank J. Thompson for useful scripts, as well as B. Siegel and M. Eiben for helpful comments on the manuscript. This work was supported by the Center for Game Science at the University of Washington, US Defense Advanced Research Projects Agency (DARPA) grant N00173-08-1-G025, the DARPA PDP program, the Howard Hughes Medical Institute (D.B.), a National Science Foundation graduate research fellowship to J.B.B. (grant no. DGE-0718124), and a National Science Foundation grant for F.K. (grant no. 0906026).	[Anonymous], PYMOL MOL GRAPH SYST; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Havranek JJ, 2009, PROTEIN SCI, V18, P1293, DOI 10.1002/pro.142; Hu XZ, 2007, P NATL ACAD SCI USA, V104, P17668, DOI 10.1073/pnas.0707977104; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Khatib F, 2011, NAT STRUCT MOL BIOL, V18, P1175, DOI 10.1038/nsmb.2119; Murphy PM, 2009, P NATL ACAD SCI USA, V106, P9215, DOI 10.1073/pnas.0811070106; Park HS, 2006, SCIENCE, V311, P535, DOI 10.1126/science.1118953; Religa TL, 2007, P NATL ACAD SCI USA, V104, P9272, DOI 10.1073/pnas.0703434104; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Sterner R, 2005, CHEM REV, V105, P4038, DOI 10.1021/cr030191z	14	183	191	2	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2012	30	2					190	192		10.1038/nbt.2109	http://dx.doi.org/10.1038/nbt.2109			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	892EI	22267011	Green Accepted			2022-12-25	WOS:000300269100023
J	Gu, SG; Pak, J; Guang, SH; Maniar, JM; Kennedy, S; Fire, A				Gu, Sam Guoping; Pak, Julia; Guang, Shouhong; Maniar, Jay M.; Kennedy, Scott; Fire, Andrew			Amplification of siRNA in Caenorhabditis elegans generates a transgenerational sequence-targeted histone H3 lysine 9 methylation footprint	NATURE GENETICS			English	Article							DOUBLE-STRANDED-RNA; MEDIATED GENETIC INTERFERENCE; C-ELEGANS; POLYMERASE; HETEROCHROMATIN; HP1; DROSOPHILA; HELICASE; INTERACT; PROTEIN	Exogenous double-stranded RNA (dsRNA) has been shown to exert homology-dependent effects at the level of both target mRNA stability and chromatin structure. Using C. elegans undergoing RNAi as an animal model, we have investigated the generality, scope and longevity of dsRNA-targeted chromatin effects and their dependence on components of the RNAi machinery. Using high-resolution genome-wide chromatin profiling, we found that a diverse set of genes can be induced to acquire locus-specific enrichment of histone H3 lysine 9 trimethylation (H3K9me3), with modification footprints extending several kilobases from the site of dsRNA homology and with locus specificity sufficient to distinguish the targeted locus from the other 20,000 genes in the C. elegans genome. Genetic analysis of the response indicated that factors responsible for secondary siRNA production during RNAi were required for effective targeting of chromatin. Temporal analysis revealed that H3K9me3, once triggered by dsRNA, can be maintained in the absence of dsRNA for at least two generations before being lost. These results implicate dsRNA-triggered chromatin modification in C. elegans as a programmable and locus-specific response defining a metastable state that can persist through generational boundaries.	[Gu, Sam Guoping; Pak, Julia; Fire, Andrew] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Guang, Shouhong; Kennedy, Scott] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; [Maniar, Jay M.; Fire, Andrew] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	Stanford University; University of Wisconsin System; University of Wisconsin Madison; Stanford University	Fire, A (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	afire@stanford.edu		Kennedy, Scott/0000-0002-7974-8155; Fire, Andrew/0000-0001-6217-8312	US National Institutes of Health [R01-GM37706]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088289, R01GM037706] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Z. Weng, P. Lacroute, A. Sidow, H. Zhang, J. Merker, D. Wu, K. Artiles, L. Gracey, A. Lamm, C. Mello, M. Stadler, R. Alcazar and). Ni for help, suggestions and support. Funding for this study was provided by a grant from the US National Institutes of Health (R01-GM37706).	Alcazar RM, 2008, GENETICS, V180, P1275, DOI 10.1534/genetics.108.089433; Aronica L, 2008, GENE DEV, V22, P2228, DOI 10.1101/gad.481908; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; BRENNER S, 1974, GENETICS, V77, P71; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Deshpande G, 2005, GENE DEV, V19, P1680, DOI 10.1101/gad.1316805; Dufourcq P, 1999, GENETICS, V152, P221; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gent JI, 2010, MOL CELL, V37, P679, DOI 10.1016/j.molcel.2010.01.012; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Grishok A, 2005, GENE DEV, V19, P683, DOI 10.1101/gad.1247705; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Guoping S, 2010, CHROMOSOMA, V119, P73, DOI 10.1007/s00412-009-0235-3; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Herr AJ, 2004, COLD SPRING HARB SYM, V69, P363, DOI 10.1101/sqb.2004.69.363; HODGKIN J, 1989, GENETICS, V123, P301; Iida T, 2008, MOL CELL, V31, P178, DOI 10.1016/j.molcel.2008.07.003; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kawasaki H, 2006, NATURE, V441, P1176, DOI 10.1038/nature04952; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Malone CD, 2005, MOL CELL BIOL, V25, P9151, DOI 10.1128/MCB.25.20.9151-9164.2005; Maniar JM, 2011, CURR BIOL, V21, P449, DOI 10.1016/j.cub.2011.02.019; MATZKE MA, 1989, EMBO J, V8, P643, DOI 10.1002/j.1460-2075.1989.tb03421.x; Mellone BG, 2003, CURR BIOL, V13, P1748, DOI 10.1016/j.cub.2003.09.031; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Nowacki M, 2008, NATURE, V451, P153, DOI 10.1038/nature06452; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Saito K, 2010, DEV CELL, V19, P687, DOI 10.1016/j.devcel.2010.10.011; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Simmer F, 2010, EMBO REP, V11, P112, DOI 10.1038/embor.2009.273; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Snowden AW, 2002, CURR BIOL, V12, P2159, DOI 10.1016/S0960-9822(02)01391-X; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 1998, SCIENCE, V282, P430, DOI 10.1126/science.282.5388.430; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wassenegger M, 2000, PLANT MOL BIOL, V43, P203, DOI 10.1023/A:1006479327881; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Weinberg MS, 2007, NUCLEIC ACIDS RES, V35, P7303, DOI 10.1093/nar/gkm847; Weinberg MS, 2006, RNA, V12, P256, DOI 10.1261/rna.2235106; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033	63	176	186	1	47	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2012	44	2					157	164		10.1038/ng.1039	http://dx.doi.org/10.1038/ng.1039			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	22231482	Green Accepted			2022-12-25	WOS:000299664400012
J	Hu, ZB; Xia, YK; Guo, XJ; Dai, JC; Li, HG; Hu, HL; Jiang, Y; Lu, F; Wu, YB; Yang, XY; Li, HZ; Yao, B; Lu, CC; Xiong, CL; Li, Z; Gui, YT; Liu, JY; Zhou, ZM; Shen, HB; Wang, XR; Sha, JH				Hu, Zhibin; Xia, Yankai; Guo, Xuejiang; Dai, Juncheng; Li, HongGang; Hu, Hongliang; Jiang, Yue; Lu, Feng; Wu, Yibo; Yang, Xiaoyu; Li, Huizhang; Yao, Bing; Lu, Chuncheng; Xiong, Chenliang; Li, Zheng; Gui, Yaoting; Liu, Jiayin; Zhou, Zuomin; Shen, Hongbing; Wang, Xinru; Sha, Jiahao			A genome-wide association study in Chinese men identifies three risk loci for non-obstructive azoospermia	NATURE GENETICS			English	Article							DNA-POLYMERASE-BETA; BASE-EXCISION-REPAIR; MALE-INFERTILITY; SEVERE OLIGOZOOSPERMIA; ARGININE METHYLATION; GERM-CELLS; EXPRESSION; PROTEIN; METHYLTRANSFERASE; SPERMATOGENESIS	Non-obstructive azoospermia (NOA) is one of the most severe forms of male infertility. Its pathophysiology is largely unknown, and few genetic influences have been defined. To identify common variants contributing to NOA in Han Chinese men, we performed a three-stage genome-wide association study of 2,927 individuals with NOA and 5,734 controls. The combined analyses identified significant (P < 5.0 x 10(-8)) associations between NOA risk and common variants near PRMT6 (rs12097821 at 1p13.3: odds ratio (OR) = 1.25, P = 5.7 x 10(-10)), PEX10 (rs2477686 at 1p36.32: OR = 1.39, P = 5.7 x 10(-12)) and SOX5 (rs10842262 at 12p12.1: OR = 1.23, P = 2.3 x 10(-9)). These findings implicate genetic variants at 1p13.3, 1p36.32 and 12p12.1 in the etiology of NOA in Han Chinese men.	[Hu, Zhibin; Xia, Yankai; Guo, Xuejiang; Wu, Yibo; Yang, Xiaoyu; Liu, Jiayin; Zhou, Zuomin; Shen, Hongbing; Wang, Xinru; Sha, Jiahao] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Hu, Zhibin; Dai, Juncheng; Jiang, Yue; Lu, Feng; Li, Huizhang; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Hu, Zhibin; Dai, Juncheng; Jiang, Yue; Lu, Feng; Li, Huizhang; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Xia, Yankai; Lu, Chuncheng; Wang, Xinru] Nanjing Med Univ, Sch Publ Hlth, Dept Toxicol, Nanjing, Jiangsu, Peoples R China; [Xia, Yankai; Lu, Chuncheng; Wang, Xinru] Nanjing Med Univ, Sch Publ Hlth, Key Lab Modern Toxicol, Minist Educ, Nanjing, Jiangsu, Peoples R China; [Guo, Xuejiang; Wu, Yibo; Zhou, Zuomin; Sha, Jiahao] Nanjing Med Univ, Dept Histol & Embryol, Nanjing, Jiangsu, Peoples R China; [Li, HongGang; Xiong, Chenliang] Huazhong Univ Sci & Technol, Tongji Med Coll, Ctr Reprod Med, Family Planning Res Inst, Wuhan 430074, Peoples R China; [Hu, Hongliang; Li, Zheng] Shanghai Jiao Tong Univ, Sperm Dev & Genet Lab, Shanghai Human Sperm Bank, Shanghai Inst Androl,Sch Med, Shanghai 200030, Peoples R China; [Hu, Hongliang; Li, Zheng] Shanghai Jiao Tong Univ, Dept Urol, Renji Hosp, Sch Med, Shanghai 200030, Peoples R China; [Yang, Xiaoyu; Liu, Jiayin] Nanjing Med Univ, Affiliated Hosp 1, Ctr Clin Reprod Med, Nanjing, Jiangsu, Peoples R China; [Yao, Bing] Nanjing Jinling Hosp, Dept Androl, Nanjing, Jiangsu, Peoples R China; [Gui, Yaoting] Peking Univ, Shenzhen Hosp, Guangdong Key Lab Male Reprod Med & Genet, Shenzhen, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Huazhong University of Science & Technology; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Nanjing Medical University; Peking University	Sha, JH (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	hbshen@njmu.edu.cn; xrwang@njmu.edu.cn; shajh@njmu.edu.cn	Wang, Xin/AAN-8435-2021; 杨, 玉/W-7221-2019; Pillay, Nischalan/F-9536-2012; Guo, Xuejiang/J-9600-2014; gui, yaoting/GLT-3684-2022	Wang, Xin/0000-0002-4457-7376; Guo, Xuejiang/0000-0002-0475-5705; Shen, Hongbing/0000-0002-2581-5906	National Key Basic Research Program Grant [2011CB944304]; China National High-Tech Research and Development Program Grant [2009AA022705]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Key Basic Research Program Grant(National Basic Research Program of China); China National High-Tech Research and Development Program Grant; Priority Academic Program Development of Jiangsu Higher Education Institutions	The authors wish to thank all the study participants, research staff and students who participated in this work. We thank Q. Wei (MD Anderson Cancer Center) for editing the manuscript. This work was funded by the National Key Basic Research Program Grant (2011CB944304) and the China National High-Tech Research and Development Program Grant (2009AA022705) and partly by a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Anne J, 2007, DEVELOPMENT, V134, P137, DOI 10.1242/dev.02687; Aston KI, 2010, HUM REPROD, V25, P1383, DOI 10.1093/humrep/deq081; Aston KI, 2009, J ANDROL, V30, P711, DOI 10.2164/jandrol.109.007971; Bashamboo A, 2010, AM J HUM GENET, V87, P505, DOI 10.1016/j.ajhg.2010.09.009; BHASIN S, 1994, J CLIN ENDOCR METAB, V79, P1525, DOI 10.1210/jc.79.6.1525; Budde LM, 2002, MOL BIOL CELL, V13, P4179, DOI 10.1091/mbc.01-07-0373; Carpentier M, 2004, MOL CELL BIOL, V24, P4428, DOI 10.1128/MCB.24.10.4428-4437.2004; Chen HY, 2010, HUM MOL GENET, V19, P494, DOI 10.1093/hmg/ddp518; Chen W, 2009, FISH PHYSIOL BIOCHEM, V35, P325, DOI 10.1007/s10695-008-9233-2; DENNY P, 1992, EMBO J, V11, P3705, DOI 10.1002/j.1460-2075.1992.tb05455.x; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dohle GR, 2002, HUM REPROD, V17, P13, DOI 10.1093/humrep/17.1.13; El-Andaloussi N, 2006, MOL CELL, V22, P51, DOI 10.1016/j.molcel.2006.02.013; Ferlin A, 2007, REPROD BIOMED ONLINE, V14, P734, DOI 10.1016/S1472-6483(10)60677-3; Frojdman K, 2000, HISTOCHEM CELL BIOL, V113, P31, DOI 10.1007/s004180050004; Gonsalvez GB, 2006, CURR BIOL, V16, P1077, DOI 10.1016/j.cub.2006.04.037; Hirsh A, 2003, BMJ-BRIT MED J, V327, P669, DOI 10.1136/bmj.327.7416.669; Huynh T, 2002, HUM REPROD UPDATE, V8, P183, DOI 10.1093/humupd/8.2.183; Lu CC, 2009, HUM MOL GENET, V18, P1122, DOI 10.1093/hmg/ddn427; Maduro MR, 2002, J UROLOGY, V168, P2197, DOI 10.1016/S0022-5347(05)64355-8; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; O'Brien KLO, 2010, FERTIL STERIL, V93, P1, DOI 10.1016/j.fertnstert.2009.10.045; O'Bryan MK, 2008, DEV BIOL, V316, P359, DOI 10.1016/j.ydbio.2008.01.042; Okada H, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040026; Olsen AK, 2001, NUCLEIC ACIDS RES, V29, P1781, DOI 10.1093/nar/29.8.1781; Plug AW, 1997, P NATL ACAD SCI USA, V94, P1327, DOI 10.1073/pnas.94.4.1327; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Wu B, 2007, HUM REPROD, V22, P1107, DOI 10.1093/humrep/del499; Wunderle VM, 1996, GENOMICS, V36, P354, DOI 10.1006/geno.1996.0474; Zafarana G, 2002, CANCER RES, V62, P1822	32	117	137	2	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2012	44	2					183	186		10.1038/ng.1040	http://dx.doi.org/10.1038/ng.1040			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	22197933				2022-12-25	WOS:000299664400017
J	Kusch, J; Thon, S; Schulz, E; Biskup, C; Nache, V; Zimmer, T; Seifert, R; Schwede, F; Benndorf, K				Kusch, Jana; Thon, Susanne; Schulz, Eckhard; Biskup, Christoph; Nache, Vasilica; Zimmer, Thomas; Seifert, Reinhard; Schwede, Frank; Benndorf, Klaus			How subunits cooperate in cAMP-induced activation of homotetrameric HCN2 channels	NATURE CHEMICAL BIOLOGY			English	Article							NUCLEOTIDE-GATED CHANNELS; PATCH-CLAMP FLUOROMETRY; CURRENT I-H; PACEMAKER CHANNELS; CATION CHANNELS; LIGAND-BINDING; MOLECULAR-MECHANISM; VOLTAGE SENSOR; ION CHANNELS; CYCLIC-AMP	Hyperpolarization-activated cyclic nucleotide-modulated (HCN) channels are tetrameric membrane proteins that generate electrical rhythmicity in specialized neurons and cardiomyocytes. The channels are primarily activated by voltage but are receptors as well, binding the intracellular ligand cyclic AMP. The molecular mechanism of channel activation is still unknown. Here we analyze the complex activation mechanism of homotetrameric HCN2 channels by confocal patch-clamp fluorometry and kinetically quantify all ligand binding steps and closed-open isomerizations of the intermediate states. For the binding affinity of the second, third and fourth ligand, our results suggest pronounced cooperativity in the sequence positive, negative and positive, respectively. This complex interaction of the subunits leads to a preferential stabilization of states with zero, two or four ligands and suggests a dimeric organization of the activation process: within the dimers the cooperativity is positive, whereas it is negative between the dimers.	[Kusch, Jana; Thon, Susanne; Biskup, Christoph; Nache, Vasilica; Zimmer, Thomas; Benndorf, Klaus] Univ Jena, Inst Physiol 2, Univ Klinikum Jena, Jena, Germany; [Schulz, Eckhard] Fachhsch Schmalkalden, Fak Elektrotech, Blechhammer, Schmalkalden, Germany; [Biskup, Christoph] Univ Jena, Arbeitsgrp Biomol Photon, Univ Klinikum Jena, Jena, Germany; [Seifert, Reinhard] Ctr Adv European Studies & Res, Abt Mol Neurosensor, Bonn, Germany; [Schwede, Frank] BIOLOG Life Sci Inst, Bremen, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Center of Advanced European Studies & Research (CAESAR)	Benndorf, K (corresponding author), Univ Jena, Inst Physiol 2, Univ Klinikum Jena, Jena, Germany.	Klaus.Benndorf@mti.uni-jena.de	Kusch, Jana/ABC-9738-2020	Kusch, Jana/0000-0001-7206-8133; Benndorf, Klaus/0000-0002-0707-4083	Deutsche Forschungsgemeinschaft; Friedrich-Schiller-University; Bremen Innovation Agency	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Schiller-University; Bremen Innovation Agency	We are indebted to U.B. Kaupp for providing the cDNA and to F. Lehmann (Dyomics GmbH, Jena, Germany) for providing the dyes. We would also like to thank G. Ditze, G. Sammler, F. Horn, M. Handel, K. Schoknecht, S. Bernhardt, A. Kolchmeier and B. Tietsch for excellent technical assistance. This work was supported by grants from the Deutsche Forschungsgemeinschaft (to K.B.) and from the Friedrich-Schiller-University (to J.K.). F.S. acknowledges support from the Bremen Innovation Agency.	Altomare C, 2001, J GEN PHYSIOL, V117, P519, DOI 10.1085/jgp.117.6.519; BANKS MI, 1993, J NEUROPHYSIOL, V70, P1420, DOI 10.1152/jn.1993.70.4.1420; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Biskup C, 2007, NATURE, V446, P440, DOI 10.1038/nature05596; BROWN HF, 1979, NATURE, V280, P235, DOI 10.1038/280235a0; Bruening-Wright A, 2007, J GEN PHYSIOL, V130, P71, DOI 10.1085/jgp.200709769; Burzomato V, 2004, J NEUROSCI, V24, P10924, DOI 10.1523/JNEUROSCI.3424-04.2004; Chan CS, 2004, J NEUROSCI, V24, P9921, DOI 10.1523/JNEUROSCI.2162-04.2004; Chen S, 2007, J GEN PHYSIOL, V129, P175, DOI 10.1085/jgp.200609585; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Cuttle MF, 2001, J PHYSIOL-LONDON, V534, P733, DOI 10.1111/j.1469-7793.2001.00733.x; DiFrancesco D, 1999, J PHYSIOL-LONDON, V515, P367, DOI 10.1111/j.1469-7793.1999.367ac.x; DIFRANCESCO D, 1986, NATURE, V324, P470, DOI 10.1038/324470a0; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Elinder F, 2006, J PHYSIOL-LONDON, V575, P417, DOI 10.1113/jphysiol.2006.110437; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Gauss R, 2000, CHRONOBIOL INT, V17, P453, DOI 10.1081/CBI-100101057; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; Ingram SL, 1996, J PHYSIOL-LONDON, V492, P97, DOI 10.1113/jphysiol.1996.sp021292; Jonas Peter, 1995, P231; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; Kusch J, 2010, NEURON, V67, P75, DOI 10.1016/j.neuron.2010.05.022; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; Mannikko R, 2005, J GEN PHYSIOL, V125, P305, DOI 10.1085/jgp.200409130; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Moosmang S, 1999, BIOL CHEM, V380, P975, DOI 10.1515/BC.1999.121; Nache V, 2005, J PHYSIOL-LONDON, V569, P91, DOI 10.1113/jphysiol.2005.092304; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Saitow F, 2000, J NEUROPHYSIOL, V84, P2026, DOI 10.1152/jn.2000.84.4.2026; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Shin KS, 2004, NEURON, V41, P737, DOI 10.1016/S0896-6273(04)00083-2; Ulens C, 2003, NEURON, V40, P959, DOI 10.1016/S0896-6273(03)00753-0; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Wu SJ, 2011, BIOPHYS J, V100, P1226, DOI 10.1016/j.bpj.2011.01.034; Yifrach O, 2004, BIOPHYS J, V87, P822, DOI 10.1529/biophysj.104.040410; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zheng J, 2000, NEURON, V28, P369, DOI 10.1016/S0896-6273(00)00117-3; ZHENG J, 2003, SCI STKE, pPL7	48	59	59	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2012	8	2					162	169		10.1038/nchembio.747	http://dx.doi.org/10.1038/nchembio.747			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879IP	22179066				2022-12-25	WOS:000299323200008
J	Sandilands, E; Serrels, B; McEwan, DG; Morton, JP; Macagno, JP; McLeod, K; Stevens, C; Brunton, VG; Langdon, WY; Vidal, M; Sansom, OJ; Dikic, I; Wilkinson, S; Frame, MC				Sandilands, Emma; Serrels, Bryan; McEwan, David G.; Morton, Jennifer P.; Macagno, Juan Pablo; McLeod, Kenneth; Stevens, Craig; Brunton, Valerie G.; Langdon, Wallace Y.; Vidal, Marcos; Sansom, Owen J.; Dikic, Ivan; Wilkinson, Simon; Frame, Margaret C.			Autophagic targeting of Src promotes cancer cell survival following reduced FAK signallin	NATURE CELL BIOLOGY			English	Article							TYROSINE PHOSPHORYLATION; MONITORING AUTOPHAGY; PROTEIN; KINASE; ACTIVATION; DEGRADATION; DYNAMICS; ACTIN	Here we describe a mechanism that cancer cells use to survive when flux through the Src/FAK pathway is severely perturbed. Depletion of FAK, detachment of FAK-proficient cells or expression of non-phosphorylatable FAK proteins causes sequestration of active Src away from focal adhesions into intracellular puncta that co-stain with several autophagy regulators. Inhibition of autophagy results in restoration of active Src at peripheral adhesions, and this leads to cancer cell death. Autophagic targeting of active Src is associated with a Src-LC3B complex, and is mediated by c-Cbl. However, this is independent of c-Cbl E3 ligase activity, but is mediated by an LC3-interacting region. Thus, c-Cbl-mediated autophagic targeting of active Src can occur in cancer cells to maintain viability when flux through the integrin/Src/FAK pathway is disrupted. This exposes a previously unrecognized cancer cell vulnerability that may provide a new therapeutic opportunity.	[Sandilands, Emma; Serrels, Bryan; McLeod, Kenneth; Stevens, Craig; Brunton, Valerie G.; Wilkinson, Simon; Frame, Margaret C.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Edinburgh Canc Res UK Ctr, Edinburgh FH4 2XR, Midlothian, Scotland; [McEwan, David G.; Dikic, Ivan] Goethe Univ Frankfurt, Frankfurt Inst Mol Life Sci, D-60590 Frankfurt, Germany; [Morton, Jennifer P.; Macagno, Juan Pablo; Vidal, Marcos; Sansom, Owen J.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Langdon, Wallace Y.] Univ Western Australia, Sch Pathol & Lab Med, Crawley, WA 6009, Australia	University of Edinburgh; Goethe University Frankfurt; Beatson Institute; University of Western Australia	Wilkinson, S (corresponding author), Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Edinburgh Canc Res UK Ctr, Crewe Rd S, Edinburgh FH4 2XR, Midlothian, Scotland.	s.wilkinson@ed.ac.uk; m.frame@ed.ac.uk	McEwan, David/AAY-6264-2020; Morton, Jennifer/AAJ-5113-2021; Dikic, Ivan/O-4650-2015; Morton, Jennifer P/E-1633-2011; McEwan, David/A-3754-2015	Morton, Jennifer/0000-0001-5766-9141; Dikic, Ivan/0000-0001-8156-9511; Morton, Jennifer P/0000-0001-5766-9141; McEwan, David/0000-0003-0353-6532; Sansom, Owen J./0000-0001-9540-3010; Wilkinson, Simon/0000-0003-1082-8218; Frame, Margaret/0000-0001-5882-1942; Sandilands, Emma/0000-0001-6829-0911; Vidal, Marcos/0000-0001-5042-3480	Cancer Research UK [C157/A11473]; Beatson Institute; Timpson (Beatson Institute, UK); Cancer Research UK [12481] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Beatson Institute; Timpson (Beatson Institute, UK); Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK (Program Grant to M.C.F. number: C157/A11473), a CR-UK Career Development Fellowship to S.W. and Beatson Institute core grants to O.J.S. and M.V. We thank P. Timpson (Beatson Institute, UK) for reagents.	ANDONIOU CE, 1994, EMBO J, V13, P4515, DOI 10.1002/j.1460-2075.1994.tb06773.x; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; CARTWRIGHT CA, 1990, P NATL ACAD SCI USA, V87, P558, DOI 10.1073/pnas.87.2.558; CARTWRIGHT CA, 1989, J CLIN INVEST, V83, P2025, DOI 10.1172/JCI114113; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kimura S, 2009, METHOD ENZYMOL, V452, P1, DOI 10.1016/S0076-6879(08)03601-X; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; McLean GW, 2004, GENE DEV, V18, P2998, DOI 10.1101/gad.316304; Morton JP, 2010, GASTROENTEROLOGY, V139, P292, DOI 10.1053/j.gastro.2010.03.034; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Timpson P, 2001, CURR BIOL, V11, P1836, DOI 10.1016/S0960-9822(01)00583-8; Verbeek BS, 1996, J PATHOL, V180, P383, DOI 10.1002/(SICI)1096-9896(199612)180:4<383::AID-PATH686>3.0.CO;2-N; Westhoff MA, 2004, MOL CELL BIOL, V24, P8113, DOI 10.1128/MCB.24.18.8113-8133.2004; Yokouchi M, 2001, J BIOL CHEM, V276, P35185, DOI 10.1074/jbc.M102219200	22	130	136	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2012	14	1					51	U76		10.1038/ncb2386	http://dx.doi.org/10.1038/ncb2386			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	866YC	22138575				2022-12-25	WOS:000298421100010
J	Ebrahimkhani, MR; Oakley, F; Murphy, LB; Mann, J; Moles, A; Perugorria, MJ; Ellis, E; Lakey, AF; Burt, AD; Douglass, A; Wright, MC; White, SA; Jaffre, F; Maroteaux, L; Mann, DA				Ebrahimkhani, Mohammad R.; Oakley, Fiona; Murphy, Lindsay B.; Mann, Jelena; Moles, Anna; Perugorria, Maria J.; Ellis, Elizabeth; Lakey, Anne F.; Burt, Alastair D.; Douglass, Angela; Wright, Matthew C.; White, Steven A.; Jaffre, Fabrice; Maroteaux, Luc; Mann, Derek A.			Stimulating healthy tissue regeneration by targeting the 5-HT2B receptor in chronic liver disease	NATURE MEDICINE			English	Article							HEPATIC STELLATE CELLS; BILE-DUCT LIGATION; FIBROSIS; RAT; GROWTH; INJURY; JUND; PROLIFERATION; TRANSCRIPTION; ANTAGONIST	Tissue homeostasis requires an effective, limited wound-healing response to injury. In chronic disease, failure to regenerate parenchymal tissue leads to the replacement of lost cellular mass with a fibrotic matrix. The mechanisms that dictate the balance of cell regeneration and fibrogenesis are not well understood(1). Here we report that fibrogenic hepatic stellate cells (HSCs) in the liver are negative regulators of hepatocyte regeneration. This negative regulatory function requires stimulation of the 5-hydroxytryptamine 2B receptor (5-HT2B) on HSCs by serotonin, which activates expression of transforming growth factor beta 1 (TGF-beta 1), a powerful suppressor of hepatocyte proliferation, through signaling by mitogen-activated protein kinase 1 (ERK) and the transcription factor JunD. Selective antagonism of 5-HT2B enhanced hepatocyte growth in models of acute and chronic liver injury. We also observed similar effects in mice lacking 5-HT2B or JunD or upon selective depletion of HSCs in wild-type mice. Antagonism of 5-HT2B attenuated fibrogenesis and improved liver function in disease models in which fibrosis was pre-established and progressive. Pharmacological targeting of 5-HT2B is clinically safe in humans and may be therapeutic in chronic liver disease.	[Ebrahimkhani, Mohammad R.; Oakley, Fiona; Murphy, Lindsay B.; Mann, Jelena; Moles, Anna; Perugorria, Maria J.; Ellis, Elizabeth; Lakey, Anne F.; Burt, Alastair D.; Douglass, Angela; Wright, Matthew C.; White, Steven A.; Mann, Derek A.] Newcastle Univ, Fibrosis Lab, Liver Grp, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Ebrahimkhani, Mohammad R.] MIT, Ctr Environm Hlth Sci, Dept Biol Engn, Dept Biol, Cambridge, MA 02139 USA; [Jaffre, Fabrice; Maroteaux, Luc] INSERM, Unite Mixte Rech S 839, Paris, France; [Jaffre, Fabrice; Maroteaux, Luc] Univ Paris 06, Paris, France; [Jaffre, Fabrice; Maroteaux, Luc] Inst Fer Moulin, Paris, France	Newcastle University - UK; Massachusetts Institute of Technology (MIT); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Mann, DA (corresponding author), Newcastle Univ, Fibrosis Lab, Liver Grp, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	derek.mann@ncl.ac.uk	Burt, Alastair D/D-3634-2013; Maroteaux, Luc/H-4585-2019; Moles, Ana/A-5889-2017; Mann, Derek/E-4765-2011	Burt, Alastair D/0000-0002-3011-7774; Maroteaux, Luc/0000-0002-9499-8603; Moles, Ana/0000-0002-3915-0060; Ebrahimkhani, Mo R./0000-0001-5753-6779; Oakley, Fiona/0000-0001-8692-1836; Mann, Derek/0000-0003-0950-243X; Jaffre, Fabrice/0000-0002-4858-1954; Wright, Matthew/0000-0003-3167-6743	UK Medical Research Council [G0700890, G0900535]; Wellcome Trust [WT084961MA, WT086755MA]; European Commission (EC) [223151]; European Association for Study of the Liver (EASL); Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Universite Pierre et Marie Curie; Fondation de France; Fondation pour la Recherche Medicale; French ministry of research (Agence Nationale pour la Recherche); European Commission (DEVANX); MRC [G0700890, G0900535] Funding Source: UKRI; Medical Research Council [G0700890, G0900535] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Commission (EC)(European CommissionEuropean Commission Joint Research Centre); European Association for Study of the Liver (EASL); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie; Fondation de France(Fondation de France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); French ministry of research (Agence Nationale pour la Recherche)(French National Research Agency (ANR)Ministry of Research, France); European Commission (DEVANX)(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by grants from the UK Medical Research Council (grant G0700890 to D.A.M., M.C.W. and F.O. and G0900535 to F.O.), the Wellcome Trust (grant WT084961MA to F.O., D. A. M. and M.C.W. and WT086755MA to M.C.W., A.D.B. and D.A.M.). Work in D.A.M.'s lab is also funded by a European Commission FP7 program grant 'INFLA-CARE' (EC Contract No. 223151; http://inflacare.imbb.forth.gr/). M.R.E. was supported by a European Association for Study of the Liver (EASL) Sheila Sherlock fellowship. L.M.'s work was supported by the Centre National de la Recherche Scientifique, the Institut National de la Sante et de la Recherche Medicale, the Universite Pierre et Marie Curie and by grants from the Fondation de France, the Fondation pour la Recherche Medicale, the French ministry of research (Agence Nationale pour la Recherche) and the European Commission (DEVANX).	ARTHUR MJP, 1989, J CLIN INVEST, V84, P1076, DOI 10.1172/JCI114270; Cassiman D, 2002, J HEPATOL, V36, P200, DOI 10.1016/S0168-8278(01)00260-4; Douglass A, 2008, J HEPATOL, V49, P88, DOI 10.1016/j.jhep.2008.01.032; Elrick LJ, 2005, J HEPATOL, V42, P888, DOI 10.1016/j.jhep.2005.01.028; FAUSTO N, 1991, DIGEST DIS SCI, V36, P653, DOI 10.1007/BF01297034; FORBES IT, 1995, J MED CHEM, V38, P855, DOI 10.1021/jm00006a001; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gieling RG, 2010, HEPATOLOGY, V51, P922, DOI 10.1002/hep.23385; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Higgins GM, 1931, ARCH PATHOL, V12, P186; Kalinichenko VV, 2003, HEPATOLOGY, V37, P107, DOI 10.1053/jhep.2003.50005; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; Malik R, 2002, SEMIN CELL DEV BIOL, V13, P425, DOI 10.1016/S1084952102001301; Marshall A, 2005, GASTROENTEROLOGY, V128, P33, DOI 10.1053/j.gastro.2004.09.076; Nebigil CG, 2000, P NATL ACAD SCI USA, V97, P9508, DOI 10.1073/pnas.97.17.9508; Omenetti A, 2007, LAB INVEST, V87, P499, DOI 10.1038/labinvest.3700537; Omenetti A, 2011, AM J PHYSIOL-GASTR L, V300, pG303, DOI 10.1152/ajpgi.00368.2010; Palmer MJ, 2009, EXPERT OPIN THER PAT, V19, P575, DOI 10.1517/13543770902877725; Passino MA, 2007, SCIENCE, V315, P1853, DOI 10.1126/science.1137603; Pillebout E, 2003, J CLIN INVEST, V112, P843, DOI 10.1172/JCI200317647; POLIMENO L, 1995, HEPATOLOGY, V21, P1070, DOI 10.1016/0270-9139(95)90257-0; Roskams T, 2006, ONCOGENE, V25, P3818, DOI 10.1038/sj.onc.1209558; Ruddell RG, 2006, AM J PATHOL, V169, P861, DOI 10.2353/ajpath.2006.050767; SCOBIE BA, 1965, AM J DIG DIS, V10, P135, DOI 10.1007/BF02236664; Smart DE, 2006, HEPATOLOGY, V44, P1432, DOI 10.1002/hep.21436; Smart DE, 2001, J BIOL CHEM, V276, P24414, DOI 10.1074/jbc.M101840200; Varty GB, 1995, EUR J PHARMACOL, V287, P201, DOI 10.1016/0014-2999(95)00660-5; Wallace K, 2008, BIOCHEM J, V411, P1, DOI 10.1042/BJ20071570; Wright MC, 2001, GASTROENTEROLOGY, V121, P685, DOI 10.1053/gast.2001.27188; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144	31	139	155	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2011	17	12					1668	U189		10.1038/nm.2490	http://dx.doi.org/10.1038/nm.2490			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22120177	Green Submitted, Green Accepted			2022-12-25	WOS:000297978000041
J	Kim, K; Zhao, R; Doi, A; Ng, K; Unternaehrer, J; Cahan, P; Huo, HG; Loh, YH; Aryee, MJ; Lensch, MW; Li, H; Collins, JJ; Feinberg, AP; Daley, GQ				Kim, Kitai; Zhao, Rui; Doi, Akiko; Ng, Kitwa; Unternaehrer, Juli; Cahan, Patrick; Huo Hongguang; Loh, Yuin-Han; Aryee, Martin J.; Lensch, M. William; Li, Hu; Collins, James J.; Feinberg, Andrew P.; Daley, George Q.			Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							METHYLATION; MEMORY	We compared bona fide human induced pluripotent stem cells (iPSCs) derived from umbilical cord blood (CB) cells and neonatal keratinocytes (K). As a consequence of both incomplete erasure of tissue-specific methylation and aberrant de novo methylation, CB-iPSCs and K-iPSCs were distinct in genome-wide DNA methylation profiles and differentiation potential. Extended passage of some iPSC clones in culture did not improve their epigenetic resemblance to embryonic stem cells, implying that some human iPSCs retain a residual 'epigenetic memory' of their tissue of origin.	[Kim, Kitai; Zhao, Rui; Ng, Kitwa; Unternaehrer, Juli; Cahan, Patrick; Huo Hongguang; Loh, Yuin-Han; Lensch, M. William; Daley, George Q.] Childrens Hosp, Howard Hughes Med Inst, Stem Cell Transplantat Program, Div Pediat Hematol Oncol,Manton Ctr Orphan Dis Re, Boston, MA 02115 USA; [Kim, Kitai; Zhao, Rui; Ng, Kitwa; Unternaehrer, Juli; Cahan, Patrick; Huo Hongguang; Loh, Yuin-Han; Lensch, M. William; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Kim, Kitai; Zhao, Rui; Unternaehrer, Juli; Cahan, Patrick; Loh, Yuin-Han; Lensch, M. William; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kim, Kitai; Zhao, Rui; Ng, Kitwa; Unternaehrer, Juli; Cahan, Patrick; Huo Hongguang; Loh, Yuin-Han; Lensch, M. William; Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA USA; [Doi, Akiko; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD USA; [Doi, Akiko; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Aryee, Martin J.] Johns Hopkins Univ, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Li, Hu; Collins, James J.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Li, Hu; Collins, James J.] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Boston University; Boston University; Harvard University; Harvard University; Brigham & Women's Hospital	Daley, GQ (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Stem Cell Transplantat Program, Div Pediat Hematol Oncol,Manton Ctr Orphan Dis Re, Boston, MA 02115 USA.	afeinberg@jhu.edu; george.daley@childrens.harvard.edu	Feinberg, Andrew/AAY-7666-2020; Loh, Yuin-Han/E-1096-2014; Aryee, Martin/AAC-8113-2020	Loh, Yuin-Han/0000-0002-4715-6454; Feinberg, Andrew/0000-0002-8364-1991; Unternaehrer-Hamm, Julia/0000-0001-5864-4704; Cahan, Patrick/0000-0003-3652-2540	US National Institutes of Health (NIH) [DK70055, DK59279, RC2-HL102815, K99HL093212-01, R37CA054358, P50HG003233]; Leukemia and Lymphoma Society [3567-07]; Cooley's Anemia Foundation; NATIONAL CANCER INSTITUTE [R37CA054358, R01CA054358] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100001, RC2HL102815, K99HL093212] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070055, R01DK059279] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Cooley's Anemia Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	G.Q.D. was funded by US National Institutes of Health (NIH) grants DK70055 and DK59279, special funds received by the NIH under the American Recovery and Reinvestment Act (RC2-HL102815). K. K. was supported by NIH (K99HL093212-01), Leukemia and Lymphoma Society (3567-07), and Cooley's Anemia Foundation. A. P. F. was funded by NIH grants R37CA054358 and P50HG003233.	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bhattacharya B, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-22; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Metallo CM, 2010, METHODS MOL BIOL, V585, P83, DOI 10.1007/978-1-60761-380-0_7; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Soshnikova N, 2010, DEV CELL, V19, P819, DOI 10.1016/j.devcel.2010.11.009; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017	13	416	437	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2011	29	12					1117	1119		10.1038/nbt.2052	http://dx.doi.org/10.1038/nbt.2052			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	861SE	22119740	Green Accepted			2022-12-25	WOS:000298038700022
J	Lee, JH; Huynh, M; Silhavy, JL; Kim, S; Dixon-Salazar, T; Heiberg, A; Scott, E; Bafna, V; Hill, KJ; Collazo, A; Funari, V; Russ, C; Gabriel, SB; Mathern, GW; Gleeson, JG				Lee, Jeong Ho; My Huynh; Silhavy, Jennifer L.; Kim, Sangwoo; Dixon-Salazar, Tracy; Heiberg, Andrew; Scott, Eric; Bafna, Vineet; Hill, Kiley J.; Collazo, Adrienne; Funari, Vincent; Russ, Carsten; Gabriel, Stacey B.; Mathern, Gary W.; Gleeson, Joseph G.			De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly	NATURE GENETICS			English	Article							TUBEROUS SCLEROSIS COMPLEX; KINASE-B-GAMMA; HUMAN CANCER; CELL-GROWTH; MITOTIC RECOMBINATION; CORTICAL DYSPLASIAS; PROTEUS SYNDROME; AKT3 MUTATION; GENE; CLASSIFICATION	De novo somatic mutations in focal areas are well documented in diseases such as neoplasia but are rarely reported in malformation of the developing brain. Hemimegalencephaly (HME) is characterized by overgrowth of either one of the two cerebral hemispheres. The molecular etiology of HME remains a mystery. The intractable epilepsy that is associated with HME can be relieved by the surgical treatment hemispherectomy, allowing sampling of diseased tissue. Exome sequencing and mass spectrometry analysis in paired brain-blood samples from individuals with HME (n = 20 cases) identified de novo somatic mutations in 30% of affected individuals in the PIK3CA, AKT3 and MTOR genes. A recurrent PIK3CA c.1633G > A mutation was found in four separate cases. Identified mutations were present in 8-40% of sequenced alleles in various brain regions and were associated with increased neuronal S6 protein phosphorylation in the brains of affected individuals, indicating aberrant activation of mammalian target of rapamycin (mTOR) signaling. Thus HME is probably a genetically mosaic disease caused by gain of function in phosphatidylinositol 3-kinase (PI3K)-AKT3-mTOR signaling.	[Lee, Jeong Ho; Silhavy, Jennifer L.; Dixon-Salazar, Tracy; Heiberg, Andrew; Scott, Eric; Hill, Kiley J.; Collazo, Adrienne; Gleeson, Joseph G.] Univ Calif San Diego, Rady Childrens Hosp, Inst Genom Med, La Jolla, CA 92093 USA; [Lee, Jeong Ho; Silhavy, Jennifer L.; Dixon-Salazar, Tracy; Heiberg, Andrew; Scott, Eric; Hill, Kiley J.; Collazo, Adrienne; Gleeson, Joseph G.] Howard Hughes Med Inst, Chevy Chase, MD USA; [My Huynh; Mathern, Gary W.] Univ Calif Los Angeles, David Geffen Sch Med, Mattel Childrens Hosp, Dept Neurosurg, Los Angeles, CA 90095 USA; [My Huynh; Mathern, Gary W.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Mattel Childrens Hosp, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Kim, Sangwoo; Bafna, Vineet] Univ Calif San Diego, Sch Engn, Dept Comp Sci, La Jolla, CA 92093 USA; [Funari, Vincent] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Funari, Vincent] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Russ, Carsten; Gabriel, Stacey B.] Broad Inst MIT & Harvard, Cambridge, MA USA	Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Diego; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Gleeson, JG (corresponding author), Univ Calif San Diego, Rady Childrens Hosp, Inst Genom Med, La Jolla, CA 92093 USA.	gmathern@ucla.edu; jogleeson@ucsd.edu	Lee, Jeong Ho/G-7361-2012; Mathern, Gary W./J-2483-2016; Bafna, Vineet/AAY-8111-2020	Bafna, Vineet/0000-0002-5810-6241; Kim, Sangwoo/0000-0001-5356-0827	US National Institute of Neurological Disorders and Stroke [P30NS047101]; Genomics Core at Cedars-Sinai Medical Center; Broad Institute; US National Human Genome Research Institute [U54HG003067]; Daland Fellowship from the American Philosophical Society; US National Institutes of Health [R01 NS038992, R01 NS048453, R01 NS052455, R01 NS041537, P01 HD070494]; Simons Foundation Autism Research Initiative; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052455, P30NS047101, R01NS038992, R01NS041537, R01NS083823, R01NS048453] Funding Source: NIH RePORTER	US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Genomics Core at Cedars-Sinai Medical Center; Broad Institute; US National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Daland Fellowship from the American Philosophical Society; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation Autism Research Initiative; Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Meerloo at the UCSD Neurosciences Core for microscopy services (supported by the US National Institute of Neurological Disorders and Stroke; P30NS047101), the Genomics Core at Cedars-Sinai Medical Center, the Broad Institute (supported by the US National Human Genome Research Institute; U54HG003067 to E. Lander) for sequencing support and analysis, D. Neelam (Sequenom) for technical support and W.B. Dobyns and M.L. Warman for sharing unpublished results. This work was supported by grants from the Daland Fellowship from the American Philosophical Society (to J.H.L.), the US National Institutes of Health (R01 NS038992 to G.W.M. and R01 NS048453, R01 NS052455, R01 NS041537 and P01 HD070494), the Simons Foundation Autism Research Initiative and the Howard Hughes Medical Institute (to J.G.G.).	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Auriemma A, 2000, Eur J Ultrasound, V12, P61, DOI 10.1016/S0929-8266(00)00099-9; Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Boer K, 2007, NEUROPATH APPL NEURO, V33, P455, DOI 10.1111/j.1365-2990.2006.00818.x; Broderick DK, 2004, CANCER RES, V64, P5048, DOI 10.1158/0008-5472.CAN-04-1170; Chapman K, 2008, SEMIN PEDIATR NEUROL, V15, P190, DOI 10.1016/j.spen.2008.10.010; Choate KA, 2010, SCIENCE, V330, P94, DOI 10.1126/science.1192280; Crino PB, 2011, TRENDS MOL MED, V17, P734, DOI 10.1016/j.molmed.2011.07.008; Davies MA, 2008, BRIT J CANCER, V99, P1265, DOI 10.1038/sj.bjc.6604637; Di Rocco C, 2006, CHILD NERV SYST, V22, P852, DOI 10.1007/s00381-006-0149-9; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; GRIFFITHS PD, 1994, NEUROPEDIATRICS, V25, P140, DOI 10.1055/s-2008-1073012; Hardt M, 2011, GENES CELLS, V16, P141, DOI 10.1111/j.1365-2443.2010.01482.x; Hemb M, 2010, NEUROLOGY, V74, P1768, DOI 10.1212/WNL.0b013e3181e0f17a; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; Jonas R, 2004, NEUROLOGY, V62, P1712, DOI 10.1212/01.WNL.0000127109.14569.C3; Jongmans MCJ, 2012, AM J HUM GENET, V90, P426, DOI 10.1016/j.ajhg.2012.01.004; Jonkman MF, 2009, NEW ENGL J MED, V360, P1680, DOI 10.1056/NEJMc0809896; Jozwiak J, 2005, HISTOL HISTOPATHOL, V20, P1321, DOI 10.14670/HH-20.1321; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Mefford HC, 2011, ANN NEUROL, V70, P974, DOI 10.1002/ana.22645; Merks JHM, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.10.e111; Oeth P, 2009, METHODS MOL BIOL, V578, P307, DOI 10.1007/978-1-60327-411-1_20; Palmini A, 2004, NEUROLOGY, V62, pS2, DOI 10.1212/01.WNL.0000114507.30388.7E; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Roth A, 2012, BIOINFORMATICS, V28, P907, DOI 10.1093/bioinformatics/bts053; Salamon N, 2006, BRAIN, V129, P352, DOI 10.1093/brain/awh681; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Sharma Suvasini, 2009, Dermatol Online J, V15, P12; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tokuda S, 2011, HUM MOL GENET, V20, P988, DOI 10.1093/hmg/ddq544; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Yu J, 2005, BRAIN PATHOL, V15, P179	42	449	461	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2012	44	8					941	+		10.1038/ng.2329	http://dx.doi.org/10.1038/ng.2329			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	979WV	22729223	Green Accepted			2022-12-25	WOS:000306854700022
J	Hatlestad, GJ; Sunnadeniya, RM; Akhavan, NA; Gonzalez, A; Goldman, IL; McGrath, JM; Lloyd, AM				Hatlestad, Gregory J.; Sunnadeniya, Rasika M.; Akhavan, Neda A.; Gonzalez, Antonio; Goldman, Irwin L.; McGrath, J. Mitchell; Lloyd, Alan M.			The beet R locus encodes a new cytochrome P450 required for red betalain production	NATURE GENETICS			English	Article							TABLE BEET; EXPRESSION; BIOSYNTHESIS; CLONING; 5-O-GLUCOSYLTRANSFERASE; IDENTIFICATION; METABOLISM; VECTORS; PLANTS; L.	Anthocyanins are red and violet pigments that color flowers, fruits and epidermal tissues in virtually all flowering plants. A single order, Caryophyllales, contains families in which an unrelated family of pigments, the betalains, color tissues normally pigmented by anthocyanins(1). Here we show that CYP76AD1 encoding a novel cytochrome P450 is required to produce the red betacyanin pigments in beets. Gene silencing of CYP76AD1 results in loss of red pigment and production of only yellow betaxanthin pigment. Yellow betalain mutants are complemented by transgenic expression of CYP76AD1, and an insertion in CYP76AD1 maps to the R locus(2,3) that is responsible for yellow versus red pigmentation. Finally, expression of CYP76AD1 in yeast verifies its position in the betalain biosynthetic pathway. Thus, this cytochrome P450 performs the biosynthetic step that provides the cyclo-DOPA moiety of all red betacyanins. This discovery will contribute to our ability to engineer this simple, nutritionally valuable pathway(4) into heterologous species.	[Hatlestad, Gregory J.; Sunnadeniya, Rasika M.; Akhavan, Neda A.; Gonzalez, Antonio; Lloyd, Alan M.] Univ Texas Austin, Inst Cell & Mol Biol, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA; [Goldman, Irwin L.] Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; [McGrath, J. Mitchell] ARS, Sugarbeet & Bean Res Unit, USDA, E Lansing, MI USA; [McGrath, J. Mitchell] Michigan State Univ, Dept Crop & Soil Sci, E Lansing, MI 48824 USA	University of Texas System; University of Texas Austin; University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); Michigan State University	Lloyd, AM (corresponding author), Univ Texas Austin, Inst Cell & Mol Biol, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA.	lloyd@uts.cc.utexas.edu	McGrath, Mitch/S-7397-2019		USDA [2008-01111]; US National Science Foundation (NSF) [MCB-1122179]; Div Of Molecular and Cellular Bioscience [1122179] Funding Source: National Science Foundation	USDA(United States Department of Agriculture (USDA)); US National Science Foundation (NSF)(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors dedicate this manuscript to Tom Mabry and thank him for inspiration. The authors thank K. Keller for help with pigment analysis. This work was supported by USDA grant 2008-01111 and US National Science Foundation (NSF) grant MCB-1122179.	BILYK A, 1981, J FOOD SCI, V46, P298, DOI 10.1111/j.1365-2621.1981.tb14588.x; Christinet L, 2004, PLANT PHYSIOL, V134, P265, DOI 10.1104/pp.103.031914; Clement JS, 1996, BOT ACTA, V109, P360, DOI 10.1111/j.1438-8677.1996.tb00584.x; Goldman IL, 1996, HORTSCIENCE, V31, P880, DOI 10.21273/HORTSCI.31.5.880; Goldman IL, 2000, THEOR APPL GENET, V100, P337, DOI 10.1007/s001220050044; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Keller W, 1936, J AGRIC RES, V52, P0027; Kim JH, 1998, CARCINOGENESIS, V19, P1847, DOI 10.1093/carcin/19.10.1847; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Kugler F, 2004, J AGR FOOD CHEM, V52, P2975, DOI 10.1021/jf035491w; Lewellen RT, 2004, CROP SCI, V44, P357, DOI 10.2135/cropsci2004.0357; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; QUANDT HJ, 1993, MOL PLANT MICROBE IN, V6, P699, DOI 10.1094/MPMI-6-699; Sasaki N, 2004, FEBS LETT, V568, P159, DOI 10.1016/j.febslet.2004.04.097; Schliemann W, 1999, PLANT PHYSIOL, V119, P1217, DOI 10.1104/pp.119.4.1217; Steiner U, 1999, PLANTA, V208, P114, DOI 10.1007/s004250050541; Stintzing FC, 2004, TRENDS FOOD SCI TECH, V15, P19, DOI 10.1016/j.tifs.2003.07.004; Urban P, 1997, J BIOL CHEM, V272, P19176, DOI 10.1074/jbc.272.31.19176; Van Mullem V, 2003, YEAST, V20, P739, DOI 10.1002/yea.999; Vogt T, 1999, PLANT J, V19, P509, DOI 10.1046/j.1365-313X.1999.00540.x; Zhao M, 2008, DEVELOPMENT, V135, P1991, DOI 10.1242/dev.016873	22	133	150	4	136	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2012	44	7					816	U130		10.1038/ng.2297	http://dx.doi.org/10.1038/ng.2297			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967DP	22660548				2022-12-25	WOS:000305886900019
J	Jimenez-Mateos, EM; Engel, T; Merino-Serrais, P; McKiernan, RC; Tanaka, K; Mouri, G; Sano, T; O'Tuathaigh, C; Waddington, JL; Prenter, S; Delanty, N; Farrell, MA; O'Brien, DF; Conroy, RM; Stallings, RL; DeFelipe, J; Henshall, DC				Jimenez-Mateos, Eva M.; Engel, Tobias; Merino-Serrais, Paula; McKiernan, Ross C.; Tanaka, Katsuhiro; Mouri, Genshin; Sano, Takanori; O'Tuathaigh, Colm; Waddington, John L.; Prenter, Suzanne; Delanty, Norman; Farrell, Michael A.; O'Brien, Donncha F.; Conroy, Ronan M.; Stallings, Raymond L.; DeFelipe, Javier; Henshall, David C.			Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects	NATURE MEDICINE			English	Article							TEMPORAL-LOBE EPILEPSY; LONG-TERM POTENTIATION; STATUS-EPILEPTICUS; DENDRITIC SPINES; IN-VIVO; SYNAPTIC REORGANIZATION; ELECTROGRAPHIC SEIZURES; BRAIN-DAMAGE; KAINIC ACID; CELL-DEATH	Temporal lobe epilepsy is a common, chronic neurological disorder characterized by recurrent spontaneous seizures. MicroRNAs (miRNAs) are small, noncoding RNAs that regulate post-transcriptional expression of protein-coding mRNAs, which may have key roles in the pathogenesis of neurological disorders. In experimental models of prolonged, injurious seizures (status epilepticus) and in human epilepsy, we found upregulation of miR-134, a brain-specific, activity-regulated miRNA that has been implicated in the control of dendritic spine morphology. Silencing of miR-134 expression in vivo using antagomirs reduced hippocampal CA3 pyramidal neuron dendrite spine density by 21% and rendered mice refractory to seizures and hippocampal injury caused by status epilepticus. Depletion of miR-134 after status epilepticus in mice reduced the later occurrence of spontaneous seizures by over 90% and mitigated the attendant pathological features of temporal lobe epilepsy. Thus, silencing miR-134 exerts prolonged seizure-suppressant and neuroprotective actions; determining whether these are anticonvulsant effects or are truly antiepileptogenic effects requires additional experimentation.	[Jimenez-Mateos, Eva M.; Engel, Tobias; McKiernan, Ross C.; Tanaka, Katsuhiro; Mouri, Genshin; Sano, Takanori; Henshall, David C.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Jimenez-Mateos, Eva M.; Engel, Tobias; McKiernan, Ross C.; Tanaka, Katsuhiro; Mouri, Genshin; Sano, Takanori; Henshall, David C.] Royal Coll Surgeons Ireland, Ctr Study Neurol Disorders, Dublin 2, Ireland; [Merino-Serrais, Paula; DeFelipe, Javier] Univ Politecn Madrid, Inst Cajal CSIC, Madrid, Spain; [Merino-Serrais, Paula; DeFelipe, Javier] Univ Politecn Madrid, Ctr Tecnol Biomed, Lab Cajal Circuitos Corticales, Madrid, Spain; [Delanty, Norman] Beaumont Hosp, Dept Neurol, Dublin 9, Ireland; [Farrell, Michael A.] Beaumont Hosp, Dept Pathol, Dublin 9, Ireland; [O'Brien, Donncha F.] Beaumont Hosp, Dept Neurol Surg, Dublin 9, Ireland; [Conroy, Ronan M.] Royal Coll Surgeons Ireland, Div Populat Hlth Sci, Dublin 2, Ireland; [Stallings, Raymond L.] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB); Royal College of Surgeons - Ireland; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin	Henshall, DC (corresponding author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland.	dhenshall@rcsi.ie	Merino-Serrais, Paula/X-5970-2019; Conroy, Ronan/C-6416-2008; Jimenez-Mateos, Eva/AAG-8072-2019; DEFELIPE, JAVIER/D-1195-2014; Stallings, Raymond/A-7213-2008	Conroy, Ronan/0000-0001-5983-8682; DEFELIPE, JAVIER/0000-0001-5484-0660; Delaney, Norman/0000-0002-3953-9842; Engel, Tobias/0000-0001-9137-0637; Henshall, David/0000-0001-6237-9632; Merino-Serrais, Paula/0000-0002-1842-9476; Jimenez-Mateos, Eva/0000-0001-6417-6580; O'Tuathaigh, Colm/0000-0003-1365-1606	NINDS NIH HHS [R56 NS073714] Funding Source: Medline; PHS HHS [R56 073714] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS073714] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Araki T, 2002, J NEUROSCI RES, V69, P614, DOI 10.1002/jnr.10356; Aronica E, 2010, EUR J NEUROSCI, V31, P1100, DOI 10.1111/j.1460-9568.2010.07122.x; Ballesteros-Yanez I, 2010, P NATL ACAD SCI USA, V107, P11567, DOI 10.1073/pnas.1006269107; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Brandt C, 2003, NEUROSCIENCE, V118, P727, DOI 10.1016/S0306-4522(03)00027-7; CAVAZOS JE, 1991, J NEUROSCI, V11, P2795; Christensen M, 2010, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.016.2009; DeFelipe J, 1999, BRAIN, V122, P1807, DOI 10.1093/brain/122.10.1807; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Engel T, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.55; Engel T, 2010, FASEB J, V24, P853, DOI 10.1096/fj.09-145870; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Halpain S, 1998, J NEUROSCI, V18, P9835; Hu K, 2011, NEUROSCI LETT, V488, P252, DOI 10.1016/j.neulet.2010.11.040; Jimenez-Mateos EM, 2010, NEUROSCIENCE, V171, P556, DOI 10.1016/j.neuroscience.2010.09.003; Jimenez-Mateos EM, 2011, AM J PATHOL, V179, P2519, DOI 10.1016/j.ajpath.2011.07.036; Jimenez-Mateos EM, 2008, NEUROBIOL DIS, V32, P442, DOI 10.1016/j.nbd.2008.08.008; Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104; Kim CH, 1999, J NEUROSCI, V19, P4314; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzfeldt J, 2007, NUCLEIC ACIDS RES, V35, P2885, DOI 10.1093/nar/gkm024; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee B, 2009, J NEUROCHEM, V108, P1251, DOI 10.1111/j.1471-4159.2008.05864.x; Mathern G.W., 1997, EPILEPSY COMPREHENSI, P133; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MCNAMARA JO, 2006, SCI STKE, pRE12, DOI DOI 10.1126/STKE.3562006RE12; Meller R, 2008, J NEUROSCI, V28, P50, DOI 10.1523/JNEUROSCI.3474-07.2008; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Merino-Serrais P, 2011, HIPPOCAMPUS, V21, P1037, DOI 10.1002/hipo.20861; Mouri G, 2008, BRAIN RES, V1213, P140, DOI 10.1016/j.brainres.2008.03.061; MULLER M, 1993, P NATL ACAD SCI USA, V90, P257, DOI 10.1073/pnas.90.1.257; Murphy BM, 2010, CELL DEATH DIFFER, V17, P459, DOI 10.1038/cdd.2009.134; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nairismagi J, 2004, EPILEPSIA, V45, P1024, DOI 10.1111/j.0013-9580.2004.08904.x; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; O'Tuathaigh CMP, 2007, NEUROSCIENCE, V147, P18, DOI 10.1016/j.neuroscience.2007.03.051; Pavlowsky A, 2010, CURR BIOL, V20, P103, DOI 10.1016/j.cub.2009.12.030; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Pitkanen A, 2005, EPILEPSY RES, V63, P27, DOI 10.1016/j.eplepsyres.2004.10.003; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Rensing N, 2005, ANN NEUROL, V58, P888, DOI 10.1002/ana.20658; Saneyoshi T, 2010, CURR OPIN NEUROBIOL, V20, P108, DOI 10.1016/j.conb.2009.09.013; Saugstad JA, 2010, J CEREBR BLOOD F MET, V30, P1564, DOI 10.1038/jcbfm.2010.101; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Segal M, 2010, EUR J NEUROSCI, V31, P2178, DOI 10.1111/j.1460-9568.2010.07270.x; Shinoda S, 2004, J NEUROSCI RES, V76, P121, DOI 10.1002/jnr.20064; Sierra-Paredes G, 2006, J MOL NEUROSCI, V28, P151, DOI 10.1385/JMN:28:2:151; Song YJ, 2011, BRAIN RES, V1387, P134, DOI 10.1016/j.brainres.2011.02.073; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Tao JF, 2011, J NEUROSCI, V31, P8306, DOI 10.1523/JNEUROSCI.0567-11.2011; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Wermeling DP, 2009, NEUROTHERAPEUTICS, V6, P352, DOI 10.1016/j.nurt.2009.01.002; Wetherington J, 2008, NEURON, V58, P168, DOI 10.1016/j.neuron.2008.04.002; Zeng LH, 2007, J NEUROSCI, V27, P11604, DOI 10.1523/JNEUROSCI.0983-07.2007; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	60	338	357	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2012	18	7					1087	+		10.1038/nm.2834	http://dx.doi.org/10.1038/nm.2834			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22683779	Green Accepted			2022-12-25	WOS:000306121600038
J	Saher, G; Rudolphi, F; Corthals, K; Ruhwedel, T; Schmidt, KF; Lowel, S; Dibaj, P; Barrette, B; Mobius, W; Nave, KA				Saher, Gesine; Rudolphi, Fabian; Corthals, Kristina; Ruhwedel, Torben; Schmidt, Karl-Friedrich; Loewel, Siegrid; Dibaj, Payam; Barrette, Benoit; Moebius, Wiebke; Nave, Klaus-Armin			Therapy of Pelizaeus-Merzbacher disease in mice by feeding a cholesterol-enriched diet	NATURE MEDICINE			English	Article							TRANSGENIC MOUSE MODEL; BLOOD-BRAIN-BARRIER; PROTEOLIPID PROTEIN; PERFRINGOLYSIN-O; MYELIN; ACCUMULATION; DYSFUNCTION; NEURODEGENERATION; OVEREXPRESSION; TRAFFICKING	Duplication of PLP1 (proteolipid protein gene 1) and the subsequent overexpression of the myelin protein PLP (also known as DM20) in oligodendrocytes is the most frequent cause of Pelizaeus-Merzbacher disease (PMD), a fatal leukodystrophy(1) without therapeutic options(2,3). PLP binds cholesterol and is contained within membrane lipid raft microdomains(4). Cholesterol availability is the rate-limiting factor of central nervous system myelin synthesis(5). Transgenic mice with extra copies of the Plp1 gene(6) are accurate models of PMD. Dysmyelination(6-8) followed by demyelination(9,10), secondary inflammation and axon damage contribute to the severe motor impairment in these mice(9,10). The finding that in Plp1-transgenic oligodendrocytes, PLP and cholesterol accumulate in late endosomes and lysosomes (endo/lysosomes)(9,11-13), prompted us to further investigate the role of cholesterol in PMD. Here we show that cholesterol itself promotes normal PLP trafficking and that dietary cholesterol influences PMD pathology. In a preclinical trial, PMD mice were fed a cholesterol-enriched diet. This restored oligodendrocyte numbers and ameliorated intracellular PLP accumulation. Moreover, myelin content increased, inflammation and gliosis were reduced and motor defects improved. Even after onset of clinical symptoms, cholesterol treatment prevented disease progression. Dietary cholesterol did not reduce Plp1 overexpression but facilitated incorporation of PLP into myelin membranes. These findings may have implications for therapeutic interventions in patients with PMD.	[Saher, Gesine; Rudolphi, Fabian; Corthals, Kristina; Ruhwedel, Torben; Dibaj, Payam; Barrette, Benoit; Moebius, Wiebke; Nave, Klaus-Armin] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Schmidt, Karl-Friedrich; Loewel, Siegrid] Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, Gottingen, Germany	Max Planck Society; University of Gottingen	Saher, G (corresponding author), Max Planck Inst Expt Med, Dept Neurogenet, Hermann Rein Str 3, D-37075 Gottingen, Germany.	saher@em.mpg.de; nave@em.mpg.de	Dibaj, Payam/AAS-5479-2021; Saher, Gesine/AAH-1826-2021; Dibaj, Payam/GQH-9423-2022	Saher, Gesine/0000-0003-3507-9604; Dibaj, Payam/0000-0003-1585-6330; /0000-0002-2902-7165; Ruhwedel, Torben/0000-0002-9535-9395	PMD foundation; Deutsche Forschungsgemeinschaft [SA2114/1-1]; EU-FP7; Bundesministerium fur Bildung und Forschung (BMBF); European Research Council (ERC) Advanced Grant; BMBF [01GQ0810]	PMD foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU-FP7(European Commission); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); European Research Council (ERC) Advanced Grant(European Research Council (ERC)); BMBF(Federal Ministry of Education & Research (BMBF))	We dedicate this work to the memory of Jim Garbern for his support of PMD research. We are grateful to A. Fahrenholz, T. Freerck, M. Schildmann, M. Matthes and A. Kanbach for technical support and thank J. Edgar for helpful comments on the manuscript. We thank M. Grebe (Umea University) for providing the BC theta expression construct and Pfizer for the generous gift of the squalestatin CP-340868. This work was funded by the PMD foundation and the Deutsche Forschungsgemeinschaft (SA2114/1-1) to G.S.K.-A.N. is supported by the EU-FP7 (Leukotreat, Ngidd), the Bundesministerium fur Bildung und Forschung (BMBF; Leukonet) and a European Research Council (ERC) Advanced Grant. Support of the BMBF to S.L. and K.-F.S. is gratefully acknowledged (01GQ0810).	Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794; Anderson TJ, 1998, J COMP NEUROL, V394, P506, DOI 10.1002/(SICI)1096-9861(19980518)394:4<506::AID-CNE8>3.0.CO;2-5; Anderson TJ, 1999, ANN NY ACAD SCI, V883, P234, DOI 10.1111/j.1749-6632.1999.tb08585.x; Bauer NG, 2009, GLIA, V57, P1691, DOI 10.1002/glia.20885; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Edgar JM, 2010, EMBO MOL MED, V2, P42, DOI 10.1002/emmm.200900057; Garbern JY, 2007, CELL MOL LIFE SCI, V64, P50, DOI 10.1007/s00018-006-6182-8; Goetze B, 2010, NEUROIMAGE, V49, P1622, DOI 10.1016/j.neuroimage.2009.10.019; Hawes CM, 2010, J NEUROCHEM, V114, P311, DOI 10.1111/j.1471-4159.2010.06768.x; Holtta-Vuori M, 2008, TRAFFIC, V9, P1839, DOI 10.1111/j.1600-0854.2008.00801.x; Ip CW, 2008, MOL CELL NEUROSCI, V38, P489, DOI 10.1016/j.mcn.2008.04.009; Jung M, 1996, J NEUROSCI, V16, P7920; Karim SA, 2007, GLIA, V55, P341, DOI 10.1002/glia.20465; Karim SA, 2010, GLIA, V58, P1727, DOI 10.1002/glia.21043; Karten B, 2009, BBA-MOL CELL BIOL L, V1791, P659, DOI 10.1016/j.bbalip.2009.01.025; Kramer EM, 2001, MICROSC RES TECHNIQ, V52, P656, DOI 10.1002/jemt.1050; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Mobius W, 2002, J HISTOCHEM CYTOCHEM, V50, P43; Otomo T, 2011, J BIOL CHEM, V286, P35283, DOI 10.1074/jbc.M111.267930; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Qin CB, 2006, ARTERIOSCL THROM VAS, V26, P372, DOI 10.1161/01.ATV.0000197848.67999.e1; READHEAD C, 1994, NEURON, V12, P583, DOI 10.1016/0896-6273(94)90214-3; Saher G, 2005, NAT NEUROSCI, V8, P468, DOI 10.1038/nn1426; Saher G, 2009, J NEUROSCI, V29, P6094, DOI 10.1523/JNEUROSCI.0686-09.2009; SEITELBERGER F, 1995, BRAIN PATHOL, V5, P267, DOI 10.1111/j.1750-3639.1995.tb00603.x; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Simons M, 2002, J CELL BIOL, V157, P327, DOI 10.1083/jcb.200110138; Simons M, 2000, J CELL BIOL, V151, P143, DOI 10.1083/jcb.151.1.143; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; Stolp HB, 2009, NEUROPATH APPL NEURO, V35, P132, DOI 10.1111/j.1365-2990.2008.01005.x; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Tang YY, 2009, J VIROL, V83, P7982, DOI 10.1128/JVI.00259-09; Waheed AA, 2001, P NATL ACAD SCI USA, V98, P4926, DOI 10.1073/pnas.091090798; Woodward Karen J., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000677; Xie CL, 2003, J LIPID RES, V44, P1780, DOI 10.1194/jlr.M300164-JLR200	36	78	78	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2012	18	7					1130	+		10.1038/nm.2833	http://dx.doi.org/10.1038/nm.2833			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22706386				2022-12-25	WOS:000306121600044
J	Bierhaus, A; Fleming, T; Stoyanov, S; Leffler, A; Babes, A; Neacsu, C; Sauer, SK; Eberhardt, M; Schnolzer, M; Lasischka, F; Neuhuber, WL; Kichko, TI; Konrade, I; Elvert, R; Mier, W; Pirags, V; Lukic, IK; Morcos, M; Dehmer, T; Rabbani, N; Thornalley, PJ; Edelstein, D; Nau, C; Forbes, J; Humpert, PM; Schwaninger, M; Ziegler, D; Stern, DM; Cooper, ME; Haberkorn, U; Brownlee, M; Reeh, PW; Nawroth, PP				Bierhaus, Angelika; Fleming, Thomas; Stoyanov, Stoyan; Leffler, Andreas; Babes, Alexandru; Neacsu, Cristian; Sauer, Susanne K.; Eberhardt, Mirjam; Schnoelzer, Martina; Lasischka, Felix; Neuhuber, Winfried L.; Kichko, Tatjana I.; Konrade, Ilze; Elvert, Ralf; Mier, Walter; Pirags, Valdis; Lukic, Ivan K.; Morcos, Michael; Dehmer, Thomas; Rabbani, Naila; Thornalley, Paul J.; Edelstein, Diane; Nau, Carla; Forbes, Josephine; Humpert, Per M.; Schwaninger, Markus; Ziegler, Dan; Stern, David M.; Cooper, Mark E.; Haberkorn, Uwe; Brownlee, Michael; Reeh, Peter W.; Nawroth, Peter P.			Methylglyoxal modification of Na(v)1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy	NATURE MEDICINE			English	Article							ROOT GANGLION NEURONS; RESISTANT SODIUM-CHANNELS; GLYOXALASE-I; PERIPHERAL NEUROPATHY; SENSITIVE METHOD; BLOOD-FLOW; RAT; ACTIVATION; EXPRESSION; FOREBRAIN	This study establishes a mechanism for metabolic hyperalgesia based on the glycolytic metabolite methylglyoxal. We found that concentrations of plasma methylglyoxal above 600 nM discriminate between diabetes-affected individuals with pain and those without pain. Methylglyoxal depolarizes sensory neurons and induces post-translational modifications of the voltage-gated sodium channel Na(v)1.8, which are associated with increased electrical excitability and facilitated firing of nociceptive neurons, whereas it promotes the slow inactivation of Na(v)1.7. In mice, treatment with methylglyoxal reduces nerve conduction velocity, facilitates neurosecretion of calcitonin gene-related peptide, increases cyclooxygenase-2 (COX-2) expression and evokes thermal and mechanical hyperalgesia. This hyperalgesia is reflected by increased blood flow in brain regions that are involved in pain processing. We also found similar changes in streptozotocin-induced and genetic mouse models of diabetes but not in Na(v)1.8 knockout (Scn10(-/-)) mice. Several strategies that include a methylglyoxal scavenger are effective in reducing methylglyoxal-and diabetes-induced hyperalgesia. This previously undescribed concept of metabolically driven hyperalgesia provides a new basis for the design of therapeutic interventions for painful diabetic neuropathy.	[Bierhaus, Angelika; Fleming, Thomas; Stoyanov, Stoyan; Konrade, Ilze; Lukic, Ivan K.; Morcos, Michael; Humpert, Per M.; Nawroth, Peter P.] Univ Heidelberg Hosp, Dept Med & Clin Chem 1, Heidelberg, Germany; [Leffler, Andreas] Hannover Med Sch, Dept Anesthesiol & Intens Care, D-3000 Hannover, Germany; [Leffler, Andreas; Nau, Carla] Univ Erlangen Nurnberg, Dept Anesthesiol, D-91054 Erlangen, Germany; [Babes, Alexandru; Sauer, Susanne K.; Eberhardt, Mirjam; Neuhuber, Winfried L.; Kichko, Tatjana I.; Reeh, Peter W.] Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, D-91054 Erlangen, Germany; [Babes, Alexandru; Neacsu, Cristian] Univ Bucharest, Fac Biol, Dept Physiol & Biophys, Bucharest, Romania; [Schnoelzer, Martina] German Canc Res Ctr, Core Facil Prot Anal W120, D-6900 Heidelberg, Germany; [Lasischka, Felix] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany; [Konrade, Ilze] Stradins Univ, Riga Eastern Clin Univ Hosp, Riga, Latvia; [Elvert, Ralf] Sanofi Aventis Deutschland, Frankfurt, Germany; [Mier, Walter; Haberkorn, Uwe] Univ Heidelberg Hosp, Dept Nucl Med, Heidelberg, Germany; [Pirags, Valdis] Latvian State Univ, Pauls Stradins Clin Univ Hosp, LV-1063 Riga, Latvia; [Lukic, Ivan K.] Biosistemi Doo, Zagreb, Croatia; [Dehmer, Thomas] Zentrum Psychiat Sudwurttemberg, Zwiefalten, Germany; [Rabbani, Naila; Thornalley, Paul J.] Univ Warwick, Univ Hosp, Clin Sci Res Inst, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Edelstein, Diane; Brownlee, Michael] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Forbes, Josephine; Cooper, Mark E.] Baker Int Diabet Inst, Heart & Diabet Inst, Melbourne, Vic, Australia; [Schwaninger, Markus] Univ Lubeck, Inst Expt & Clin Pharmacol & Toxicol, Lubeck, Germany; [Ziegler, Dan] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, D-40225 Dusseldorf, Germany; [Stern, David M.] Univ Tennessee, Coll Med, Memphis, TN USA	Ruprecht Karls University Heidelberg; Hannover Medical School; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Bucharest; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Riga East University Hospital; Riga Stradins University; Sanofi-Aventis; Ruprecht Karls University Heidelberg; Pauls Stradins Clinical University Hospital; University of Latvia; University of Warwick; Yeshiva University; Albert Einstein College of Medicine; Baker Heart and Diabetes Institute; University of Lubeck; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; University of Tennessee System; University of Tennessee Health Science Center	Nawroth, PP (corresponding author), Univ Heidelberg Hosp, Dept Med & Clin Chem 1, Heidelberg, Germany.	peter.nawroth@med.uni-heidelberg.de	Babes, Alexandru/A-6212-2010; Pirags, Valdis/AAQ-5492-2020; Cooper, Mark/AAC-5326-2020; Reeh, Peter W./J-8981-2012; Babes, Alexandru/ABB-9128-2021; Forbes, Josephine M/A-4569-2012; Sauer, Susanne/K-1145-2012; Leffler, Andreas/K-1191-2012	Pirags, Valdis/0000-0002-3650-7394; Reeh, Peter W./0000-0002-4367-094X; Babes, Alexandru/0000-0002-7110-6908; Forbes, Josephine M/0000-0002-5595-8174; Leffler, Andreas/0000-0003-1121-6387; Schwaninger, Markus/0000-0002-4510-9718; Sauer, Susanne Katharina/0000-0002-9734-885X; Rabbani, Naila/0000-0002-5819-2506; Thornalley, Paul/0000-0001-7659-443X	Juvenile Diabetes Research Foundation (JDRF); Deutsche Forschungsgemeinschaft [BI-1281/3-1, LU728/3-1, NA-350/3-2 in KFO 130]; US National Institutes of Health [2R56DK33861-21]; European Foundation for the Study of Diabetes (EFSD); German Diabetes Association (DDG); Manfred-Lautenschlager-Stiftung for Diabetes (LSD); Dietmar-Hopp-Stiftung; Network Aging Research (NAR); Romanian Research Council (CNCSIS) [PN2 164/2007]; Alexander von Humboldt Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK033861] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Foundation for the Study of Diabetes (EFSD); German Diabetes Association (DDG); Manfred-Lautenschlager-Stiftung for Diabetes (LSD); Dietmar-Hopp-Stiftung; Network Aging Research (NAR); Romanian Research Council (CNCSIS)(Consiliul National al Cercetarii Stiintifice (CNCS)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank S. Kaymak for immunohistochemistry, A. Buhl and K. Leotta for assistance in the cerebral blood flow experiments, L. Werner for support with bregma gradings and X. Du and A. Erhardt for the daily care of the mice. A. Bierhaus, J.F., M. E. C., M. B. and P.P.N. were supported by a Centre grant from the Juvenile Diabetes Research Foundation (JDRF). This work was also supported in part by grants from the Deutsche Forschungsgemeinschaft (BI-1281/3-1 to A. Bierhaus; LU728/3-1 and NA-350/3-2 in KFO 130 to P. W. R., C. Nau and A. L.), the US National Institutes of Health (2R56DK33861-21 to M. B.), the European Foundation for the Study of Diabetes (EFSD/Lilly-Programme, to A. Bierhaus), the German Diabetes Association (DDG, Christian-Hagedorn-Award to A. Bierhaus), the Manfred-Lautenschlager-Stiftung for Diabetes (LSD, to P.P.N.), the Dietmar-Hopp-Stiftung (to A. Bierhaus, P. M. H. and P.P.N.) and the Network Aging Research (NAR, to A. Bierhaus). A. Babes and C.N. were supported by grant PN2 164/2007 from the Romanian Research Council (CNCSIS). A. Babes also received support from the Alexander von Humboldt Foundation.	Ahmed N, 2005, J BIOL CHEM, V280, P5724, DOI 10.1074/jbc.M410973200; Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792; Bierhaus A, 2004, J CLIN INVEST, V114, P1741, DOI 10.1172/JCI200418058; Bierhaus A, 2009, DIABETOLOGIA, V52, P2251, DOI 10.1007/s00125-009-1458-9; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Calcutt NA, 2002, INT REV NEUROBIOL, V50, P205; Craner MJ, 2002, ANN NEUROL, V52, P786, DOI 10.1002/ana.10364; El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188; ERICKSON BR, 1957, P SOC EXP BIOL MED, V94, P1, DOI 10.3181/00379727-94-22840; Fuchs D, 2010, PAIN, V151, P496, DOI 10.1016/j.pain.2010.08.010; GRAFE P, 1994, J PHYSIOL-LONDON, V480, P297, DOI 10.1113/jphysiol.1994.sp020360; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hirade M, 1999, NEUROSCIENCE, V90, P933, DOI 10.1016/S0306-4522(98)00486-2; Hong SS, 2008, J NEUROCHEM, V105, P1212, DOI 10.1111/j.1471-4159.2008.05220.x; Hong SS, 2004, J BIOL CHEM, V279, P29341, DOI 10.1074/jbc.M404167200; Humpert PM, 2009, PAIN MED, V10, P413, DOI 10.1111/j.1526-4637.2008.00557.x; Jack MM, 2011, DIABETOLOGIA, V54, P2174, DOI 10.1007/s00125-011-2196-3; Karachalias N, 2003, BIOCHEM SOC T, V31, P1423; Kellogg AP, 2008, CURR DRUG TARGETS, V9, P68; Konrade I., 2007, DIABETOL STOFFWECHS, V2, pP98; Lampert A, 2010, PFLUG ARCH EUR J PHY, V460, P249, DOI 10.1007/s00424-009-0779-3; Menendez L, 2002, J NEUROSCI METH, V113, P91, DOI 10.1016/S0165-0270(01)00483-6; Misawa S, 2005, CLIN NEUROPHYSIOL, V116, P1181, DOI 10.1016/j.clinph.2004.12.019; MIYOSHI T, 1973, ELECTROEN CLIN NEURO, V35, P125, DOI 10.1016/0013-4694(73)90168-5; Morcos M, 2008, AGING CELL, V7, P260, DOI 10.1111/j.1474-9726.2008.00371.x; Morrow TJ, 1998, PAIN, V75, P355, DOI 10.1016/S0304-3959(98)00016-5; Morrow TJ, 2000, EXP NEUROL, V161, P220, DOI 10.1006/exnr.1999.7246; Nawroth PP, 2010, EXP CLIN ENDOCR DIAB, V118, P1, DOI 10.1055/s-0029-1246117; Obrosova IG, 2009, NEUROTHERAPEUTICS, V6, P638, DOI 10.1016/j.nurt.2009.07.004; Paulson PE, 2007, EXP NEUROL, V208, P305, DOI 10.1016/j.expneurol.2007.09.001; Quasthoff S, 1998, MUSCLE NERVE, V21, P1246, DOI 10.1002/(SICI)1097-4598(199810)21:10<1246::AID-MUS2>3.0.CO;2-B; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Rush AM, 2007, J PHYSIOL-LONDON, V579, P1, DOI 10.1113/jphysiol.2006.121483; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Shah BS, 2001, NEUROSCI LETT, V309, P1, DOI 10.1016/S0304-3940(01)01976-0; Silos-Santiago I, 2008, CURR OPIN INVEST DR, V9, P83; Stucky CL, 1999, J NEUROSCI, V19, P6497; Sullivan KA, 2007, NEUROBIOL DIS, V28, P276, DOI 10.1016/j.nbd.2007.07.022; Suzuki Y, 2002, NEUROSCI RES, V43, P171, DOI 10.1016/S0168-0102(02)00033-0; Tavee J, 2009, CLEV CLIN J MED, V76, P297, DOI 10.3949/ccjm.76a.08070; Thornalley PJ, 1996, BIOCHEM PHARMACOL, V51, P1365, DOI 10.1016/0006-2952(96)00059-7; Thornalley PJ, 2005, ANN NY ACAD SCI, V1043, P111, DOI 10.1196/annals.1333.014; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Vareniuk I, 2008, DIABETOLOGIA, V51, P2126, DOI 10.1007/s00125-008-1136-3; Zhang YM, 1996, J CLIN INVEST, V97, P2213, DOI 10.1172/JCI118662	46	332	342	7	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2012	18	6					926	+		10.1038/nm.2750	http://dx.doi.org/10.1038/nm.2750			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22581285				2022-12-25	WOS:000305116600030
J	Breen, DM; Rasmussen, BA; Kokorovic, A; Wang, RNA; Cheung, GWC; Lam, TKT				Breen, Danna M.; Rasmussen, Brittany A.; Kokorovic, Andrea; Wang, Rennian; Cheung, Grace W. C.; Lam, Tony K. T.			Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes	NATURE MEDICINE			English	Article							GASTRIC BYPASS; FATTY-ACIDS; FOOD-INTAKE; CHOLECYSTOKININ; GUT; HOMEOSTASIS; MECHANISMS; EXCLUSION; SATIETY; DELTA	Gastrointestinal bypass surgeries restore metabolic homeostasis in patients with type 2 diabetes and obesity(1), but the underlying mechanisms remain elusive. Duodenal-jejunal bypass surgery (DJB), an experimental surgical technique that excludes the duodenum and proximal jejunum from nutrient transit(1,2), lowers glucose concentrations in nonobese type 2 diabetic rats(2-5). Given that DJB redirects and enhances nutrient flow into the jejunum and that jejunal nutrient sensing affects feeding(6,7), the repositioned jejunum after DJB represents a junction at which nutrients could regulate glucose homeostasis. Here we found that intrajejunal nutrient administration lowered endogenous glucose production in normal rats through a gut-brain-liver network in the presence of basal plasma insulin concentrations. Inhibition of jejunal glucose uptake or formation of long chain fatty acyl-coA negated the metabolic effects of glucose or lipid, respectively, in normal rats, and altered the rapid (2 d) glucose-lowering effect induced by DJB in streptozotocin (STZ)-induced uncontrolled diabetic rats during refeeding. Lastly, in insulin-deficient autoimmune type 1 diabetic rats and STZ-induced diabetic rats, DJB lowered glucose concentrations in 2 d independently of changes in plasma insulin concentrations, food intake and body weight. These data unveil a glucoregulatory role of jejunal nutrient sensing and its relevance in the early improvement of glycemic control after DJB in rat models of uncontrolled diabetes.	[Breen, Danna M.; Rasmussen, Brittany A.; Kokorovic, Andrea; Cheung, Grace W. C.; Lam, Tony K. T.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Breen, Danna M.; Lam, Tony K. T.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Rasmussen, Brittany A.; Kokorovic, Andrea; Cheung, Grace W. C.; Lam, Tony K. T.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Wang, Rennian] Univ Western Ontario, Dept Physiol, London, ON, Canada; [Wang, Rennian] Univ Western Ontario, Dept Pharmacol, London, ON, Canada; [Lam, Tony K. T.] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5G 1L5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto	Lam, TKT (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada.	tony.lam@uhnres.utoronto.ca	Wang, Rennian/N-3879-2015	Breen, Danna/0000-0002-6460-8555	Canadian Institutes of Health Research [MOP-82701]; University Health Network; Banting and Best Diabetes Centre (BBDC), University of Toronto; BBDC; John Kitson McIvor Endowed Chair in Diabetes Research; Toronto General Research Institute and the University of Toronto	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University Health Network; Banting and Best Diabetes Centre (BBDC), University of Toronto(University of Toronto); BBDC; John Kitson McIvor Endowed Chair in Diabetes Research; Toronto General Research Institute and the University of Toronto	We are extremely grateful to P.Y.T. Wang for excellent technical assistance. This work was supported by a research grant to T. K. T. L. from the Canadian Institutes of Health Research (MOP-82701). D. M. B. is supported by a post-doctoral fellowship from the University Health Network and the Banting and Best Diabetes Centre (BBDC), University of Toronto. B. A. R. is supported by a BBDC graduate scholarship. A. K. and G. W. C. C. were supported by Canadian Institutes of Health Research and BBDC graduate scholarships. T. K. T. L. holds the John Kitson McIvor (1915-1942) Endowed Chair in Diabetes Research and the Canada Research Chair in Obesity at the Toronto General Research Institute and the University of Toronto.	Badman MK, 2005, SCIENCE, V307, P1909, DOI 10.1126/science.1109951; Breen DM, 2011, DIABETES, V60, P3148, DOI 10.2337/db11-0852; Chambers AP, 2011, GASTROENTEROLOGY, V141, P950, DOI 10.1053/j.gastro.2011.05.050; Cheung GWC, 2009, CELL METAB, V10, P99, DOI 10.1016/j.cmet.2009.07.005; Cohen Ricardo, 2006, Surg Obes Relat Dis, V2, P401, DOI 10.1016/j.soard.2006.02.011; Cohen R, 2012, SURG OBES RELAT DIS, V8, P375, DOI 10.1016/j.soard.2012.01.017; Cohen RV, 2007, SURG OBES RELAT DIS, V3, P195, DOI 10.1016/j.soard.2007.01.009; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Cox JE, 2004, PHYSIOL BEHAV, V81, P29, DOI 10.1016/j.physbeh.2003.12.012; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; DREWE J, 1992, GASTROENTEROLOGY, V102, P1654, DOI 10.1016/0016-5085(92)91726-K; Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532; GREENBERG D, 1990, AM J PHYSIOL, V259, pR110, DOI 10.1152/ajpregu.1990.259.1.R110; Kim Z, 2011, WORLD J SURG, V35, P631, DOI 10.1007/s00268-010-0909-2; Kindel TL, 2009, J GASTROINTEST SURG, V13, P1762, DOI 10.1007/s11605-009-0912-9; Kokorovic A, 2011, GASTROENTEROLOGY, V141, P1720, DOI 10.1053/j.gastro.2011.06.042; Lal S, 2001, AM J PHYSIOL-GASTR L, V281, pG907, DOI 10.1152/ajpgi.2001.281.4.G907; Lam TKT, 2010, NAT MED, V16, P392, DOI 10.1038/nm0410-392; Matzinger D, 2000, GUT, V46, P688, DOI 10.1136/gut.46.5.689; Mordes JP, 2004, ILAR J, V45, P278, DOI 10.1093/ilar.45.3.278; Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484; Ogawa N, 2008, NEUROSCI LETT, V433, P38, DOI 10.1016/j.neulet.2007.12.036; Pacheco D, 2007, AM J SURG, V194, P221, DOI 10.1016/j.amjsurg.2006.11.015; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Randich A, 2004, AM J PHYSIOL-REG I, V286, pR166, DOI 10.1152/ajpregu.00431.2003; Rubino FA, 2004, ANN SURG, V239, P1, DOI 10.1097/01.sla.0000102989.54824.fc; Rubino F, 2008, DIABETES CARE, V31, pS290, DOI 10.2337/dc08-s271; Rubino F, 2010, ANNU REV MED, V61, P393, DOI 10.1146/annurev.med.051308.105148; Thaler JP, 2009, ENDOCRINOLOGY, V150, P2518, DOI 10.1210/en.2009-0367; Troy S, 2008, CELL METAB, V8, P201, DOI 10.1016/j.cmet.2008.08.008; Wang PYT, 2008, NATURE, V452, P1012, DOI 10.1038/nature06852; Wang TT, 2008, ANN SURG, V247, P968, DOI 10.1097/SLA.0b013e318172504d; WATKINS JB, 1987, DRUG METAB DISPOS, V15, P177	33	151	158	1	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2012	18	6					950	+		10.1038/nm.2745	http://dx.doi.org/10.1038/nm.2745			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22610279				2022-12-25	WOS:000305116600033
J	Dunbar, KL; Melby, JO; Mitchell, DA				Dunbar, Kyle L.; Melby, Joel O.; Mitchell, Douglas A.			YcaO domains use ATP to activate amide backbones during peptide cyclodehydrations	NATURE CHEMICAL BIOLOGY			English	Article							AMINOIMIDAZOLE RIBONUCLEOTIDE SYNTHETASE; INHIBITOR MICROCIN B17; ESCHERICHIA-COLI; BIOSYNTHESIS; HETEROCYCLIZATION; PATHWAY; AUTOPROTEOLYSIS; SUBSTITUTION; PHOSPHATE; COMPLEX	Thiazole/oxazole-modified microcins (TOMMs) encompass a recently defined class of ribosomally synthesized natural products with a diverse set of biological activities. Although TOMM biosynthesis has been investigated for over a decade, the mechanism of heterocycle formation by the synthetase enzymes remains poorly understood. Using substrate analogs and isotopic labeling, we demonstrate that ATP is used to directly phosphorylate the peptide amide backbone during TOMM heterocycle formation. Moreover, we present what is to our knowledge the first experimental evidence that the D-protein component of the heterocycle-forming synthetase (YcaO/domain of unknown function 181 family member), formerly annotated as a docking protein involved in complex formation and regulation, is able to perform the ATP-dependent cyclodehydration reaction in the absence of the other TOMM biosynthetic proteins. Together, these data reveal the role of ATP in the biosynthesis of azole and azoline heterocycles in ribosomal natural products and prompt a reclassification of the enzymes involved in their installation.	[Dunbar, Kyle L.; Melby, Joel O.; Mitchell, Douglas A.] Univ Illinois, Dept Chem, Urbana, IL USA; [Dunbar, Kyle L.; Melby, Joel O.; Mitchell, Douglas A.] Univ Illinois, Inst Genom Biol, Urbana, IL USA; [Mitchell, Douglas A.] Univ Illinois, Dept Microbiol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Dunbar, KL (corresponding author), Univ Illinois, Dept Chem, Urbana, IL USA.	douglasm@illinois.edu	Mitchell, Doug/B-6349-2012; Mitchell, Douglas/C-4400-2011	Mitchell, Doug/0000-0002-9564-0953; Dunbar, Kyle L./0000-0002-7410-5169	University of Illinois; US National Institutes of Health (NIH) [1R01 GM097142]; NIH [DP2 OD008463, 2T32 GM070421]; University of Illinois Department of Chemistry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070421, R01GM097142] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008463] Funding Source: NIH RePORTER	University of Illinois; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois Department of Chemistry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to W. van der Donk for technical advice and for suggestions in the preparation of the manuscript. We thank members of the Mitchell lab and M. Marletta for critical review of this manuscript. This work was supported in part by the institutional funds provided by the University of Illinois and the US National Institutes of Health (NIH) (1R01 GM097142 to D.A.M). D.A.M. is also the recipient of the NIH Director's New Innovator Award (DP2 OD008463). K.L.D. was supported by the NIH Training Program in the Chemistry-Biology Interface (2T32 GM070421). J.O.M. was supported by the University of Illinois Department of Chemistry Chinoree T. Kimiyo Enta Fellowship.	BALDWIN JE, 1976, J CHEM SOC CHEM COMM, P734, DOI 10.1039/c39760000734; Bowers AA, 2010, J AM CHEM SOC, V132, P7519, DOI 10.1021/ja102339q; Brown LCW, 2009, P NATL ACAD SCI USA, V106, P2549, DOI [10.1073/pnas.0900008105, 10.1073/pnas.0900008106]; Chong SR, 1996, J BIOL CHEM, V271, P22159, DOI 10.1074/jbc.271.36.22159; COHN M, 1978, P NATL ACAD SCI USA, V75, P200, DOI 10.1073/pnas.75.1.200; Ghilarov D, 2011, J BIOL CHEM, V286, P26308, DOI 10.1074/jbc.M111.241315; Kelleher NL, 1999, BIOCHEMISTRY-US, V38, P15623, DOI 10.1021/bi9913698; Kelly WL, 2009, J AM CHEM SOC, V131, P4327, DOI 10.1021/ja807890a; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Lee SW, 2008, P NATL ACAD SCI USA, V105, P5879, DOI 10.1073/pnas.0801338105; Li CL, 1999, STRUCTURE, V7, P1155, DOI 10.1016/S0969-2126(99)80182-8; Li YM, 1996, SCIENCE, V274, P1188, DOI 10.1126/science.274.5290.1188; Liao RJ, 2009, CHEM BIOL, V16, P141, DOI 10.1016/j.chembiol.2009.01.007; Ludwig C, 2008, J BIOL CHEM, V283, P25264, DOI 10.1074/jbc.M802972200; McIntosh JA, 2010, CHEMBIOCHEM, V11, P1413, DOI 10.1002/cbic.201000196; McIntosh JA, 2010, J AM CHEM SOC, V132, P4089, DOI 10.1021/ja9107116; Melby JO, 2012, J AM CHEM SOC, V134, P5309, DOI 10.1021/ja211675n; Melby JO, 2011, CURR OPIN CHEM BIOL, V15, P369, DOI 10.1016/j.cbpa.2011.02.027; Milne JC, 1998, BIOCHEMISTRY-US, V37, P13250, DOI 10.1021/bi980996e; Milne JC, 1999, BIOCHEMISTRY-US, V38, P4768, DOI 10.1021/bi982975q; Molohon KJ, 2011, ACS CHEM BIOL, V6, P1307, DOI 10.1021/cb200339d; Morar M, 2006, BIOCHEMISTRY-US, V45, P14880, DOI 10.1021/bi061591u; Morris RP, 2009, J AM CHEM SOC, V131, P5946, DOI 10.1021/ja900488a; Myers CL, 2010, BIOORGAN MED CHEM, V18, P4231, DOI 10.1016/j.bmc.2010.04.098; Perler FB, 1997, CURR OPIN CHEM BIOL, V1, P292, DOI 10.1016/S1367-5931(97)80065-8; Roush RF, 2008, J AM CHEM SOC, V130, P3603, DOI 10.1021/ja7101949; Roy RS, 1998, BIOCHEMISTRY-US, V37, P4125, DOI 10.1021/bi9728250; SCHENDEL FJ, 1989, BIOCHEMISTRY-US, V28, P2459, DOI 10.1021/bi00432a017; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; SCHRIMSHER JL, 1986, BIOCHEMISTRY-US, V25, P4366, DOI 10.1021/bi00363a028; Strader MB, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005199; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Yu Y, 2009, ACS CHEM BIOL, V4, P855, DOI 10.1021/cb900133x; Zamble DB, 2000, BIOCHEMISTRY-US, V39, P16190, DOI 10.1021/bi001398e; Zhang Y, 2008, CELL MOL LIFE SCI, V65, P3699, DOI 10.1007/s00018-008-8295-8	35	97	96	1	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2012	8	6					569	575		10.1038/NCHEMBIO.944	http://dx.doi.org/10.1038/NCHEMBIO.944			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	945ET	22522320	Green Accepted			2022-12-25	WOS:000304256300013
J	Sheng, L; Zhou, YJ; Chen, Z; Ren, DC; Cho, KW; Jiang, L; Shen, H; Sasaki, Y; Rui, LY				Sheng, Liang; Zhou, Yingjiang; Chen, Zheng; Ren, Decheng; Cho, Kae Won; Jiang, Lin; Shen, Hong; Sasaki, Yoshiteru; Rui, Liangyou			NF-kappa B-inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action	NATURE MEDICINE			English	Article							INDUCED INSULIN-RESISTANCE; CREB-BINDING-PROTEIN; HEPATIC GLUCONEOGENESIS; IKK-BETA; COACTIVATOR PGC-1; PHOSPHORYLATION; INFLAMMATION; ACTIVATION; DISRUPTION; METABOLISM	The canonical inhibitor of nuclear factor kappa B kinase subunit beta (IKK-beta)-nuclear factor of kappa light polypeptide gene enhancer in B cells 1 (NF-kappa B1) pathway has been well documented to promote insulin resistance; however, the noncanonical NF-kappa B-inducing kinase (NIK)-NF-kappa B2 pathway is not well understood in obesity. Additionally, the contribution of counter-regulatory hormones, particularly glucagon, to hyperglycemia in obesity is unclear. Here we show that NIK promotes glucagon responses in obesity. Hepatic NIK was abnormally activated in mice with dietary or genetic obesity. Systemic deletion of Map3k14, encoding NIK, resulted in reduced glucagon responses and hepatic glucose production (HGP). Obesity is associated with high glucagon responses, and liver-specific inhibition of NIK led to lower glucagon responses and HGP and protected against hyperglycemia and glucose intolerance in obese mice. Conversely, hepatocyte-specific overexpression of NIK resulted in higher glucagon responses and HGP. In isolated mouse livers and primary hepatocytes, NIK also promoted glucagon action and glucose production, at least in part by increasing cAMP response element-binding (CREB) stability. Therefore, overactivation of liver NIK in obesity promotes hyperglycemia and glucose intolerance by increasing the hyperglycemic response to glucagon and other factors that activate CREB.	[Sheng, Liang; Zhou, Yingjiang; Chen, Zheng; Ren, Decheng; Cho, Kae Won; Jiang, Lin; Shen, Hong; Rui, Liangyou] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Sasaki, Yoshiteru] RIKEN, Ctr Dev Biol, Lab Stem Cell Biol, Kobe, Hyogo, Japan	University of Michigan System; University of Michigan; RIKEN	Rui, LY (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	ruily@umich.edu	shen, hong/I-6179-2016; chen, zheng/J-4600-2014; Jiang, Lin/E-7468-2012	chen, zheng/0000-0003-2161-6106; , zheng/0000-0001-7129-6644; SHEN, HONG/0000-0002-1559-3633	US National Institutes of Health (NIH) [DK 065122, DK073601]; American Diabetes Association [1-09-RA-156]; Michigan Diabetes Research and Training Center; NIH [5P60 DK20572, 5 P30 CA46592, P30AG013283, DK34933]; University of Michigan's Cancer Center; University of Michigan Nathan Shock Center; University of Michigan Gut Peptide Research Center; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933, R01DK091591, R01DK073601, P60DK020572, R01DK065122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Michigan Diabetes Research and Training Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan's Cancer Center(University of Michigan System); University of Michigan Nathan Shock Center; University of Michigan Gut Peptide Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank H. Su, Z. Li, C. Duan, D. Morris and S. Wang for assistance and discussion. We thank R. Schreiber (Washington University School of Medicine, St. Louis, Missouri) for providing NIK knockout mice and K. Rajewsky (Immune Disease Institute, Harvard Medical School, Boston, Massachusetts) for providing STOP-NIK mice. Generation of the NIK knockout mice was supported by Amgen Inc., Thousand Oaks, California. This study was supported by grants DK 065122 and DK073601 from the US National Institutes of Health (NIH) and by research award 1-09-RA-156 from the American Diabetes Association. This work used the cores supported by the Michigan Diabetes Research and Training Center (funded by NIH 5P60 DK20572), the University of Michigan's Cancer Center (funded by NIH 5 P30 CA46592), the University of Michigan Nathan Shock Center (funded by NIH P30AG013283) and the University of Michigan Gut Peptide Research Center (funded by NIH DK34933).	Aoki K, 1999, DIABETES, V48, P1579, DOI 10.2337/diabetes.48.8.1579; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cho KW, 2011, MOL CELL BIOL, V31, P450, DOI 10.1128/MCB.00459-10; Cummings BP, 2011, P NATL ACAD SCI USA, V108, P14670, DOI 10.1073/pnas.1107163108; Denroche HC, 2011, DIABETES, V60, P1414, DOI 10.2337/db10-0958; Duan CJ, 2004, MOL CELL BIOL, V24, P7435, DOI 10.1128/MCB.24.17.7435-7443.2004; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang W, 2004, J BIOL CHEM, V279, P21695, DOI 10.1074/jbc.M401546200; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lee Y, 2011, DIABETES, V60, P391, DOI 10.2337/db10-0426; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; MARUYAMA H, 1984, J CLIN INVEST, V74, P2296, DOI 10.1172/JCI111658; Murray SE, 2011, J CLIN INVEST, V121, P4775, DOI 10.1172/JCI44943; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Ren DC, 2007, J CLIN INVEST, V117, P397, DOI 10.1172/JCI29417; Sasaki Y, 2008, P NATL ACAD SCI USA, V105, P10883, DOI 10.1073/pnas.0805186105; Sheng L, 2011, J BIOL CHEM, V286, P38128, DOI 10.1074/jbc.M111.256677; Shoelson SE, 2009, NAT MED, V15, P373, DOI 10.1038/nm0409-373; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Thu YM, 2010, CYTOKINE GROWTH F R, V21, P213, DOI 10.1016/j.cytogfr.2010.06.002; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Xiao GT, 2004, J BIOL CHEM, V279, P30099, DOI 10.1074/jbc.M401428200; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yu X, 2008, P NATL ACAD SCI USA, V105, P14070, DOI 10.1073/pnas.0806993105; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhou XY, 2004, NAT MED, V10, P633, DOI 10.1038/nm1050; Zhou YJ, 2009, J BIOL CHEM, V284, P11152, DOI 10.1074/jbc.M900754200	37	75	78	2	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2012	18	6					943	+		10.1038/nm.2756	http://dx.doi.org/10.1038/nm.2756			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22581287	Green Accepted			2022-12-25	WOS:000305116600032
J	Chanet, S; Schweisguth, F				Chanet, Soline; Schweisguth, Francois			Regulation of epithelial polarity by the E3 ubiquitin ligase Neuralized and the Bearded inhibitors in Drosophila	NATURE CELL BIOLOGY			English	Article							ADHERENS JUNCTIONS; APICAL CONSTRICTION; SIGNALING ACTIVITY; VENTRAL FURROW; SPLIT COMPLEX; PAR PROTEINS; NOTCH; DELTA; MIGRATION; CELLS	Understanding how epithelial polarity is established and regulated during tissue morphogenesis is a major issue. Here, we identify a regulatory mechanism important for mesoderm invagination, germ-band extension and transepithelial migration in the Drosophila melanogaster embryo. This mechanism involves the inhibition of the conserved E3 ubiquitin ligase Neuralized by proteins of the Bearded family. First, Bearded mutant embryos exhibited a loss of epithelial polarity associated with an early loss of the apical domain. Bearded regulated epithelial polarity by antagonizing neuralized. Second, repression of Bearded gene expression by Snail was required for the Snail-dependent disassembly of adherens junctions in the mesoderm. Third, neuralized was strictly required to promote the downregulation of the apical domain in the midgut epithelium and to facilitate the transepithelial migration of primordial germ cells across this epithelium. This function of Neuralized was independent of its known role in Notch signalling. Thus, Neuralized has two distinct functions in epithelial cell polarity and Notch signalling.	[Chanet, Soline; Schweisguth, Francois] Inst Pasteur, Dept Dev Biol, F-75015 Paris, France; [Chanet, Soline; Schweisguth, Francois] CNRS, URA2578, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Schweisguth, F (corresponding author), Inst Pasteur, Dept Dev Biol, F-75015 Paris, France.	fschweis@pasteur.fr		/0000-0001-9434-0628; chanet, soline/0000-0002-4065-9411	CNRS; Institut Pasteur; ANR [08-BLAN-0235]; FRM [DEQ20100318284]; MENRT; ARC	CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur(European Commission); ANR(French National Research Agency (ANR)); FRM(Fondation pour la Recherche Medicale); MENRT; ARC(Australian Research Council)	We thank M. Biggin (Lawrence Berkeley National Laboratory, Berkeley, USA), P. Bryant (University of California Irvine, Irvine, California, USA), K. Choi (Baylor College of Medicine, Houston, Texas, USA), Y-N. Jan (University of California San Francisco, San Francisco, California, USA), D. Kiehart (Duke University, Durham, North Carolina, USA), J. Knoblich (Institute of Molecular Biotechnology, Austria, Vienna), P. Lasko (McGill University, Montreal, Quebec, Canada), M. Leptin (University of Koln, Koln, Germany), A. Martinez-Arias (University of Cambridge, Cambridge, UK), N. Perrimon (Harvard University, Boston, USA), A. Preiss (University of Hohenheim, Hohenheim, Germany), M. Rand, (University of Vermont, Burlington, Vermont, USA), J. Skeath (Washington University, Saint Louis, Missouri, USA), U. Tepass (University of Toronto, Toronto, Canada), E. Wieschaus (Princeton University, Princeton, New Jersey, USA) and A. Wodarz (University of Gottingen, Gottingen, Germany) the Bloomington Drosophila Stock Center, the Developmental Studies Hybridoma Bank and Flybase for flies, antibodies and other resources. We thank S. Guadagnini for the scanning electron microscopy. We are very grateful to L. Couturier for her help in the analysis of midgut polarity. We thank V. Mayau for technical help and A. Bardin, T. Lecuit, M. Leptin and all laboratory members for discussion and critical reading. This work was financially supported by the CNRS, Institut Pasteur, ANR (08-BLAN-0235) and FRM (DEQ20100318284). S.C. received fellowships from the MENRT and the ARC.	Bardin AJ, 2006, DEV CELL, V10, P245, DOI 10.1016/j.devcel.2005.12.017; Benhra N, 2010, MOL BIOL CELL, V21, P2078, DOI 10.1091/mbc.E09-11-0926; Brodland GW, 2010, P NATL ACAD SCI USA, V107, P22111, DOI 10.1073/pnas.1006591107; Campbell K, 2011, DEV CELL, V21, P1051, DOI 10.1016/j.devcel.2011.10.005; Campbell K, 2009, J CELL SCI, V122, P2604, DOI 10.1242/jcs.047183; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Chanet S, 2009, GENETICS, V182, P1101, DOI 10.1534/genetics.109.105023; Choi EY, 2009, FRONT BIOSCI-LANDMRK, V14, P1596, DOI 10.2741/3327; Dawes-Hoang RE, 2005, DEVELOPMENT, V132, P4165, DOI 10.1242/dev.01938; De Renzis S, 2006, DEV CELL, V10, P257, DOI 10.1016/j.devcel.2006.01.011; Fontana JR, 2009, DEV BIOL, V333, P373, DOI 10.1016/j.ydbio.2009.06.039; Grawe F, 1996, DEVELOPMENT, V122, P951; Harris KP, 2008, J CELL BIOL, V183, P1129, DOI 10.1083/jcb.200807020; Harris TJC, 2005, J CELL BIOL, V170, P813, DOI 10.1083/jcb.200505127; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Ishiuchi T, 2011, NAT CELL BIOL, V13, P860, DOI 10.1038/ncb2274; JAGLARZ MK, 1995, DEVELOPMENT, V121, P3495; JAGLARZ MK, 1994, DEVELOPMENT, V120, P83; Kolsch V, 2007, SCIENCE, V315, P384, DOI 10.1126/science.1134833; Koo BK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001221; Kunwar PS, 2008, J CELL BIOL, V183, P157, DOI 10.1083/jcb.200807049; Kunwar PS, 2006, ANNU REV CELL DEV BI, V22, P237, DOI 10.1146/annurev.cellbio.22.010305.103337; Lai EC, 2000, DEVELOPMENT, V127, P291; Lai EC, 2000, DEVELOPMENT, V127, P3441; Laprise P, 2011, TRENDS CELL BIOL, V21, P401, DOI 10.1016/j.tcb.2011.03.005; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Lecuit T, 2004, J CELL SCI, V117, P3427, DOI 10.1242/jcs.01312; Lee JY, 2010, CURR BIOL, V20, P253, DOI 10.1016/j.cub.2009.12.021; LEPTIN M, 1990, DEVELOPMENT, V110, P73; Leviten MW, 1997, DEVELOPMENT, V124, P4039; Lopez-Schier H, 2001, GENE DEV, V15, P1393, DOI 10.1101/gad.200901; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Mavrakis M, 2009, DEV CELL, V16, P93, DOI 10.1016/j.devcel.2008.11.003; McGill MA, 2009, J CELL BIOL, V185, P787, DOI 10.1083/jcb.200812146; Morais-de-Sa E, 2010, CELL, V141, P509, DOI 10.1016/j.cell.2010.02.040; Morel V, 2000, GENE DEV, V14, P377; Morel V, 2003, DEV GENES EVOL, V213, P65, DOI 10.1007/s00427-003-0296-x; Nance J, 2011, DEVELOPMENT, V138, P799, DOI 10.1242/dev.053538; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Nikolaidou KK, 2004, CURR BIOL, V14, P1822, DOI 10.1016/j.cub.2004.09.080; Roeth JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007634; Samarin SN, 2007, MOL BIOL CELL, V18, P3429, DOI 10.1091/mbc.E07-04-0315; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; SWEETON D, 1991, DEVELOPMENT, V112, P775; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; Weinmaster G, 2011, DEV CELL, V21, P134, DOI 10.1016/j.devcel.2011.06.006; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049	48	29	29	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2012	14	5					467	U61		10.1038/ncb2481	http://dx.doi.org/10.1038/ncb2481			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	936NW	22504274				2022-12-25	WOS:000303598300007
J	Fairfax, BP; Makino, S; Radhakrishnan, J; Plant, K; Leslie, S; Dilthey, A; Ellis, P; Langford, C; Vannberg, FO; Knight, JC				Fairfax, Benjamin P.; Makino, Seiko; Radhakrishnan, Jayachandran; Plant, Katharine; Leslie, Stephen; Dilthey, Alexander; Ellis, Peter; Langford, Cordelia; Vannberg, Fredrik O.; Knight, Julian C.			Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; DETERMINANTS; PSORIASIS; SNP; VISUALIZATION; APOPTOSIS; COMPLEX	Trans-acting genetic variants have a substantial, albeit poorly characterized, role in the heritable determination of gene expression. Using paired purified primary monocytes and B cells, we identify new predominantly cell type-specific cis and trans expression quantitative trait loci (eQTLs), including multi-locus trans associations to LYZ and KLF4 in monocytes and B cells, respectively. Additionally, we observe a B cell-specific trans association of rs11171739 at 12q13.2, a known autoimmune disease locus, with IP6K2 (P = 5.8 x 10(-15)), PRIC285 (P = 3.0 x 10(-10)) and an upstream region of CDKN1A (P = 2 x 10(-52)), suggesting roles for cell cycle regulation and peroxisome proliferator-activated receptor gamma (PPAR gamma) signaling in autoimmune pathogenesis. We also find that specific human leukocyte antigen (HLA) alleles form trans associations with the expression of AOAH and ARHGAP24 in monocytes but not in B cells. In summary, we show that mapping gene expression in defined primary cell populations identifies new cell type-specific trans-regulated networks and provides insights into the genetic basis of disease susceptibility.	[Fairfax, Benjamin P.; Makino, Seiko; Radhakrishnan, Jayachandran; Plant, Katharine; Vannberg, Fredrik O.; Knight, Julian C.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Leslie, Stephen] Univ Oxford, Dept Oncol, Oxford, England; [Dilthey, Alexander] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Ellis, Peter; Langford, Cordelia] Univ Cambridge, Wellcome Trust Sanger Inst, Cambridge, England; [Vannberg, Fredrik O.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; University of Cambridge; Wellcome Trust Sanger Institute; University System of Georgia; Georgia Institute of Technology	Fairfax, BP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	bfairfax@well.ox.ac.uk; julian@well.ox.ac.uk	Knight, Julian Charles/W-2399-2019; Knight, Julian/C-7242-2009	Knight, Julian Charles/0000-0002-0377-5536; Knight, Julian/0000-0002-0377-5536; Radhakrishnan, Jayachandran/0000-0001-6009-1862; Fairfax, Benjamin/0000-0001-7413-5002	Wellcome Trust [074318, 088891, 075491/Z/04]; European Research Council under the European Union [FP7/2007-2013, 281824]; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; National Institute for Health Research [ACF-2008-13-017] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council under the European Union(European Research Council (ERC)); National Institute for Health Research (NIHR) Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	We are very grateful to all the volunteers who participated in this study, together with members of the Knight laboratory and A. Hill for their support. We thank A. Auton for his assistance in the identification of probes containing SNPs with European MAF of >0.01% using the 1000 Genomes Project data set and to J. Broxholme for bioinformatic support and mapping of all probes to the reference sequence. We thank G. Gibson, A. Hill and colleagues for critical reading of the manuscript and helpful suggestions. This work was supported by the Wellcome Trust (074318 to J. C. K., 088891 to B. P. F. and 075491/Z/04 to the core facilities at the Wellcome Trust Centre for Human Genetics), the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013) (281824 to J. C. K.) and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre.	Akino K, 2007, CANCER SCI, V98, P88, DOI 10.1111/j.1349-7006.2006.00351.x; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andres AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001157; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Benson V, 2010, INT IMMUNOL, V22, P167, DOI 10.1093/intimm/dxp123; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Elstak ED, 2011, BLOOD, V118, P1570, DOI 10.1182/blood-2011-02-339523; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fischer U, 1997, HUM MOL GENET, V6, P1817, DOI 10.1093/hmg/6.11.1817; Gerrits A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000692; Gray M, 2007, P NATL ACAD SCI USA, V104, P14080, DOI 10.1073/pnas.0700326104; HAGEN FS, 1991, BIOCHEMISTRY-US, V30, P8415, DOI 10.1021/bi00098a020; Hakonarson H, 2008, DIABETES, V57, P1143, DOI 10.2337/db07-1305; Ho PYPC, 2008, ANN RHEUM DIS, V67, P677, DOI 10.1136/ard.2007.071399; Hotfilder M, 1999, BRIT J HAEMATOL, V106, P335, DOI 10.1046/j.1365-2141.1999.01551.x; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Idaghdour Y, 2010, NAT GENET, V42, P62, DOI 10.1038/ng.495; Kim K, 2009, GENES IMMUN, V10, P482, DOI 10.1038/gene.2009.5; KNOWLES RW, 1986, J IMMUNOL, V137, P2618; Koldobskiy MA, 2010, P NATL ACAD SCI USA, V107, P20947, DOI 10.1073/pnas.1015671107; Kwan T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000608; Landers JE, 2009, P NATL ACAD SCI USA, V106, P9004, DOI 10.1073/pnas.0812937106; Lavelin I, 2005, J BIOL CHEM, V280, P7178, DOI 10.1074/jbc.M411990200; Lawson BR, 2004, J EXP MED, V199, P547, DOI 10.1084/jem.20031685; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Lyons PA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-64; MUKAI R, 1984, J IMMUNOL, V133, P3211; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Neznanov N, 2005, DNA CELL BIOL, V24, P777, DOI 10.1089/dna.2005.24.777; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Plagnol V, 2009, BIOSTATISTICS, V10, P327, DOI 10.1093/biostatistics/kxn039; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; Ruland J, 2008, ANN NY ACAD SCI, V1143, P35, DOI 10.1196/annals.1443.024; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; TEDDER TF, 1989, J IMMUNOL, V143, P712; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tomaru T, 2006, ENDOCRINOLOGY, V147, P377, DOI 10.1210/en.2005-0450; Van Laer L, 1998, NAT GENET, V20, P194; Vandiedonck C, 2011, GENOME RES, V21, P1042, DOI 10.1101/gr.116681.110; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xu HP, 2008, BLOOD, V112, P1166, DOI 10.1182/blood-2007-06-098327; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	67	335	338	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2012	44	5					502	+		10.1038/ng.2205	http://dx.doi.org/10.1038/ng.2205			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	934BW	22446964	Green Accepted			2022-12-25	WOS:000303416300008
J	Aceto, N; Sausgruber, N; Brinkhaus, H; Gaidatzis, D; Martiny-Baron, G; Mazzarol, G; Confalonieri, S; Quarto, M; Hu, G; Balwierz, PJ; Pachkov, M; Elledge, SJ; van Nimwegen, E; Stadler, MB; Bentires-Alj, M				Aceto, Nicola; Sausgruber, Nina; Brinkhaus, Heike; Gaidatzis, Dimos; Martiny-Baron, Georg; Mazzarol, Giovanni; Confalonieri, Stefano; Quarto, Micaela; Hu, Guang; Balwierz, Piotr J.; Pachkov, Mikhail; Elledge, Stephen J.; van Nimwegen, Erik; Stadler, Michael B.; Bentires-Alj, Mohamed			Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop	NATURE MEDICINE			English	Article							IN-VITRO PROPAGATION; STEM-CELL; MYELOID-LEUKEMIA; DUCTAL CARCINOMA; NOONAN-SYNDROME; PROTEIN; GENE; DIFFERENTIATION; METASTASIS; MUTATIONS	New cancer therapies are likely to arise from an in-depth understanding of the signaling networks influencing tumor initiation, progression and metastasis. We show a fundamental role for Src-homology 2 domain-containing phosphatase 2 (SHP2) in these processes in human epidermal growth factor receptor 2 (HER2)-positive and triple-negative breast cancers. Knockdown of SHP2 eradicated breast tumor-initiating cells in xenograft models, and SHP2 depletion also prevented invasion in three-dimensional cultures and in a transductal invasion assay in vivo. Notably, SHP2 knockdown in established breast tumors blocked their growth and reduced metastasis. Mechanistically, SHP2 activated stemness-associated transcription factors, including v-myc myelocytomatosis viral oncogene homolog (c-Myc) and zinc finger E-box binding homeobox 1 (ZEB1), which resulted in the repression of let-7 microRNA and the expression of a set of 'SHP2 signature' genes. We found these genes to be simultaneously activated in a large subset of human primary breast tumors that are associated with invasive behavior and poor prognosis. These results provide new insights into the signaling cascades influencing tumor-initiating cells as well as a rationale for targeting SHP2 in breast cancer.	[Aceto, Nicola; Sausgruber, Nina; Brinkhaus, Heike; Gaidatzis, Dimos; Stadler, Michael B.; Bentires-Alj, Mohamed] Friedrich Miescher Inst Biomed Res FMI, Basel, Switzerland; [Martiny-Baron, Georg] Novartis Inst Biomed Res, Basel, Switzerland; [Mazzarol, Giovanni; Confalonieri, Stefano; Quarto, Micaela] Fdn Ist FIRC Oncol Mol IFOM, Milan, Italy; [Mazzarol, Giovanni; Confalonieri, Stefano; Quarto, Micaela] IEO, Milan, Italy; [Hu, Guang; Elledge, Stephen J.] Harvard Univ, Brigham & Womens Hosp, Howard Hughes Med Inst, Div Genet,Med Sch, Boston, MA 02115 USA; [Hu, Guang; Elledge, Stephen J.] Harvard Univ, Brigham & Womens Hosp, Dept Genet, Div Genet,Med Sch, Boston, MA 02115 USA; [Balwierz, Piotr J.; Pachkov, Mikhail; van Nimwegen, Erik] Univ Basel, Biozentrum, Basel, Switzerland; [Balwierz, Piotr J.; Pachkov, Mikhail; van Nimwegen, Erik] Swiss Inst Bioinformat, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Novartis; IFOM - FIRC Institute of Molecular Oncology; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS European Institute of Oncology (IEO); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Basel; Swiss Institute of Bioinformatics	Bentires-Alj, M (corresponding author), Friedrich Miescher Inst Biomed Res FMI, Basel, Switzerland.	bentires@fmi.ch	Hu, Guang/E-7474-2016; Mohamed, Bentires-Alj/F-4484-2015; Balwierz, Piotr J/AAG-4187-2020; van Nimwegen, Erik/ABF-1085-2021; Confalonieri, Stefano/AAQ-6786-2020; Hu, Guang/B-2909-2012; Aceto, Nicola/O-2484-2014	Hu, Guang/0000-0003-0437-4723; Mohamed, Bentires-Alj/0000-0001-6344-1127; Balwierz, Piotr J/0000-0002-1548-4605; van Nimwegen, Erik/0000-0001-6338-1312; Confalonieri, Stefano/0000-0001-6886-9851; Hu, Guang/0000-0002-8754-1541; Aceto, Nicola/0000-0001-9579-6918	Novartis Research Foundation; European Research Council (ERC) [243211-PTPsBDC]; Swiss Cancer League; Krebsliga Beider Basel; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102745] Funding Source: NIH RePORTER	Novartis Research Foundation; European Research Council (ERC)(European Research Council (ERC)); Swiss Cancer League; Krebsliga Beider Basel; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank N. Hynes (FMI) and G. Christofori (University of Basel) for helpful comments on the manuscript, S. Gasser, W. Filipowicz, H. Grosshans, J. Krol (FMI) and R.B. Clarke (Manchester University) for helpful discussions, W. Xian (in the lab of J. Brugge, Harvard Medical School) and D. Medina (Baylor College of Medicine) for help with the intraductal protocol, T. Westbrook (Baylor College of Medicine) for providing the dox-inducible lentiviral vector, C. Kuperwasser (Tufts University) for providing the SUM159 and SUM1315 cells, V. Reddy (GNF) for providing the primary breast tumor, and A. Terrier (Novartis Institutes for Biomedical Research) for excellent technical assistance, as well as additional members of the Bentires-Alj lab for advice and discussions and various colleagues for reagents. We also thank the International Genomics Consortium and expO (http://www.intgen.org/expo/) for offering free access to clinically annotated tumor data. Research in the lab of M.B.-A. is supported by the Novartis Research Foundation, the European Research Council (ERC starting grant 243211-PTPsBDC), the Swiss Cancer League and the Krebsliga Beider Basel.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Behbod F, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2358; Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Bocanegra M, 2010, ONCOGENE, V29, P774, DOI 10.1038/onc.2009.364; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Feng GS, 2007, CELL RES, V17, P37, DOI 10.1038/sj.cr.7310140; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Grossmann KS, 2010, ADV CANCER RES, V106, P53, DOI 10.1016/S0065-230X(10)06002-1; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Muggerud AA, 2010, MOL ONCOL, V4, P357, DOI 10.1016/j.molonc.2010.06.007; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Pawson T, 2009, CURR OPIN CELL BIOL, V21, P147, DOI 10.1016/j.ceb.2009.02.005; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Schuetz CS, 2006, CANCER RES, V66, P5278, DOI 10.1158/0008-5472.CAN-05-4610; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shi ZQ, 2000, MOL CELL BIOL, V20, P1526, DOI 10.1128/MCB.20.5.1526-1536.2000; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tripathi A, 2008, INT J CANCER, V122, P1557, DOI 10.1002/ijc.23267; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Voena C, 2007, CANCER RES, V67, P4278, DOI 10.1158/0008-5472.CAN-06-4350; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045; Zhan Y, 2009, EXP CELL RES, V315, P2343, DOI 10.1016/j.yexcr.2009.05.001; Zhou X, 2008, HISTOPATHOLOGY, V53, P389, DOI 10.1111/j.1365-2559.2008.03103.x	51	196	217	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2012	18	4					529	537		10.1038/nm.2645	http://dx.doi.org/10.1038/nm.2645			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22388088				2022-12-25	WOS:000302617800029
J	Harris, SR; Clarke, IN; Seth-Smith, HMB; Solomon, AW; Cutcliffe, LT; Marsh, P; Skilton, RJ; Holland, MJ; Mabey, D; Peeling, RW; Lewis, DA; Spratt, BG; Unemo, M; Persson, K; Bjartling, C; Brunham, R; de Vries, HJC; Morre, SA; Speksnijder, A; Bebear, CM; Clerc, M; de Barbeyrac, B; Parkhill, J; Thomson, NR				Harris, Simon R.; Clarke, Ian N.; Seth-Smith, Helena M. B.; Solomon, Anthony W.; Cutcliffe, Lesley T.; Marsh, Peter; Skilton, Rachel J.; Holland, Martin J.; Mabey, David; Peeling, Rosanna W.; Lewis, David A.; Spratt, Brian G.; Unemo, Magnus; Persson, Kenneth; Bjartling, Carina; Brunham, Robert; de Vries, Henry J. C.; Morre, Servaas A.; Speksnijder, Arjen; Bebear, Cecile M.; Clerc, Maite; de Barbeyrac, Bertille; Parkhill, Julian; Thomson, Nicholas R.			Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing	NATURE GENETICS			English	Article							OUTER-MEMBRANE PROTEIN; HIGH-RISK WOMEN; LYMPHOGRANULOMA-VENEREUM; SEQUENCE-ANALYSIS; SEROVAR DISTRIBUTION; MAXIMUM-LIKELIHOOD; OMPA GENE; RECOMBINATION; INFECTIONS; GENOTYPES	Chlamydia trachomatis is responsible for both trachoma and sexually transmitted infections, causing substantial morbidity and economic cost globally. Despite this, our knowledge of its population and evolutionary genetics is limited. Here we present a detailed phylogeny based on whole-genome sequencing of representative strains of C. trachomatis from both trachoma and lymphogranuloma venereum (LGV) biovars from temporally and geographically diverse sources. Our analysis shows that predicting phylogenetic structure using ompA, which is traditionally used to classify Chlamydia, is misleading because extensive recombination in this region masks any true relationships present. We show that in many instances, ompA is a chimera that can be exchanged in part or as a whole both within and between biovars. We also provide evidence for exchange of, and recombination within, the cryptic plasmid, which is another key diagnostic target. We used our phylogenetic framework to show how genetic exchange has manifested itself in ocular, urogenital and LGV C. trachomatis strains, including the epidemic LGV serotype L2b.	[Harris, Simon R.; Seth-Smith, Helena M. B.; Parkhill, Julian; Thomson, Nicholas R.] Wellcome Trust Sanger Inst, Cambridge, England; [Clarke, Ian N.; Cutcliffe, Lesley T.; Skilton, Rachel J.] Southampton Gen Hosp, Mol Microbiol Grp, Univ Med Sch, Southampton SO9 4XY, Hants, England; [Solomon, Anthony W.; Holland, Martin J.; Mabey, David; Peeling, Rosanna W.; Lewis, David A.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England; [Marsh, Peter] Southampton Gen Hosp, Publ Hlth Lab Southampton, Hlth Protect Agcy, Southampton SO9 4XY, Hants, England; [Lewis, David A.] Natl Hlth Lab Serv, Sexually Transmitted Infect Reference Ctr, Natl Inst Communicable Dis, Johannesburg, South Africa; [Lewis, David A.] Univ Witwatersrand, Dept Internal Med, Fac Hlth Sci, Johannesburg, South Africa; [Spratt, Brian G.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Unemo, Magnus] Orebro Univ Hosp, Dept Lab Med & Clin Microbiol, Natl Reference Lab Pathogen Neisseria, Orebro, Sweden; [Persson, Kenneth] Malmo Univ Hosp, Dept Lab Med, Malmo, Sweden; [Bjartling, Carina] Malmo Univ Hosp, Inst Clin Sci, Dept Obstet & Gynecol, Malmo, Sweden; [Brunham, Robert] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [de Vries, Henry J. C.] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands; [de Vries, Henry J. C.] Publ Hlth Serv Amsterdam, Sexually Transmitted Infect Outpatient Clin, Amsterdam, Netherlands; [de Vries, Henry J. C.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [Morre, Servaas A.] Vrije Univ Amsterdam, Immunogenet Lab, Dept Med Microbiol Infect Prevent, Med Ctr, Amsterdam, Netherlands; [Morre, Servaas A.] Univ Maastricht, Inst Publ Hlth Genom, Sch Publ Hlth & Primary Care, Fac Hlth Med & Life Sci,Dept Genet & Cell Biol, Maastricht, Netherlands; [Morre, Servaas A.] Univ Maastricht, Sch Oncol & Dev Biol, Fac Hlth Med & Life Sci, Maastricht, Netherlands; [Speksnijder, Arjen] Hlth Serv Amsterdam, GGD, Amsterdam, Netherlands; [Bebear, Cecile M.; Clerc, Maite; de Barbeyrac, Bertille] Univ Bordeaux, Unite Contrat USC Mycoplasmal & Chlamydial Infect, French Natl Reference Ctr Chlamydial Infect, Bordeaux, France; [Bebear, Cecile M.; Clerc, Maite; de Barbeyrac, Bertille] French Natl Reference Ctr Chlamydial Infect, Inst Natl Rech Agron, USC Mycoplasmal & Chlamydial Infect Humans, Bordeaux, France	Wellcome Trust Sanger Institute; University of Southampton; University of London; London School of Hygiene & Tropical Medicine; Health Protection Agency; University of Southampton; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; Imperial College London; Orebro University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Maastricht University; Maastricht University; UDICE-French Research Universities; Universite de Bordeaux; INRAE	Harris, SR (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	sh16@sanger.ac.uk	Bébéar, Cécile/A-6596-2016; Speksnijder, Arjen/M-3406-2017; Holland, Martin J/K-6502-2012; Harris, Simon R/K-1318-2013; Parkhill, Julian/G-4703-2011; Unemo, Magnus/ABD-6653-2021; de Vries, Henry/K-5963-2012; Thomson, Nicholas/P-5988-2014	Speksnijder, Arjen/0000-0002-1966-7265; Holland, Martin J/0000-0002-5828-6318; Harris, Simon R/0000-0003-1512-6194; Parkhill, Julian/0000-0002-7069-5958; de Vries, Henry/0000-0001-9784-547X; Clarke, Ian/0000-0002-4938-1620; Solomon, Anthony/0000-0001-7101-6649; Bebear, Cecile/0000-0001-6065-2332; Thomson, Nicholas/0000-0002-4432-8505; Mabey, David/0000-0002-0031-8276	Wellcome Trust [098051, 080348]; National Institute for Health Research [CL-2009-20-001, NF-SI-0507-10336] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank the core informatics, library-making and sequencing teams at the Wellcome Trust Sanger Institute. S.R.H. is grateful for the opportunity to discuss this project at the Permafrost conference. This work was funded by the Wellcome Trust grant numbers 098051 and 080348. B.G.S. was funded by the Wellcome Trust.	BARNES RC, 1985, J INFECT DIS, V152, P985, DOI 10.1093/infdis/152.5.985; BATTEIGER BE, 1989, J INFECT DIS, V160, P332, DOI 10.1093/infdis/160.2.332; Behets FMT, 1999, J INFECT DIS, V180, P1382, DOI 10.1086/315005; Binet R, 2005, ANTIMICROB AGENTS CH, V49, P4455, DOI 10.1128/AAC.49.11.4455-4464.2005; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Brunelle BW, 2006, INFECT IMMUN, V74, P578, DOI 10.1128/IAI.74.1.578-585.2006; BRUNHAM R, 1994, J CLIN INVEST, V94, P458, DOI 10.1172/JCI117347; BURGOYNE RA, 1990, PRIMARY CARE, V17, P153; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Clarke IN, 2011, ANN NY ACAD SCI, V1230, pE11, DOI 10.1111/j.1749-6632.2011.06194.x; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; DEAN D, 1994, J CLIN MICROBIOL, V32, P1506, DOI 10.1128/JCM.32.6.1506-1510.1994; Dean D, 2009, EMERG INFECT DIS, V15, P1385, DOI 10.3201/eid1509.090272; Fredlund H, 2004, APMIS, V112, P771, DOI 10.1111/j.1600-0463.2004.apm11211-1205.x; Gao X, 2007, J CLIN MICROBIOL, V45, P1185, DOI 10.1128/JCM.02076-06; Gaydos CA, 2005, INFECT DIS CLIN N AM, V19, P367, DOI 10.1016/j.idc.2005.03.006; Geisler WM, 2003, SEX TRANSM DIS, V30, P160, DOI 10.1097/00007435-200302000-00013; Gomes JP, 2007, GENOME RES, V17, P50, DOI 10.1101/gr.5674706; Gomes JP, 2004, J BACTERIOL, V186, P4295, DOI 10.1128/JB.186.13.4295-4306.2004; HANNA L, 1959, SCIENCE, V130, P1339, DOI 10.1126/science.130.3385.1339; HAYES LJ, 1994, INFECT IMMUN, V62, P5659, DOI 10.1128/IAI.62.12.5659-5663.1994; Ikryannikova LN, 2010, FEMS IMMUNOL MED MIC, V59, P188, DOI 10.1111/j.1574-695X.2010.00678.x; Jakobsen IB, 1996, COMPUT APPL BIOSCI, V12, P291; Jeffrey BM, 2010, INFECT IMMUN, V78, P2544, DOI 10.1128/IAI.01324-09; JONES RB, 1990, J INFECT DIS, V162, P1309, DOI 10.1093/infdis/162.6.1309; Joseph SJ, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-28; Jurstrand M, 2001, J CLIN MICROBIOL, V39, P3915, DOI 10.1128/JCM.39.11.3915-3919.2001; Klint M, 2007, J CLIN MICROBIOL, V45, P1410, DOI 10.1128/JCM.02301-06; KUO CC, 1974, J IMMUNOL, V113, P591; Kurtz S, 1999, BIOINFORMATICS, V15, P426, DOI 10.1093/bioinformatics/15.5.426; Lefevre JC, 1997, PATHOL BIOL, V45, P376; LEQUESNE WJ, 1969, SYST ZOOL, V18, P201; Lysen M, 2004, J CLIN MICROBIOL, V42, P1641, DOI 10.1128/JCM.42.4.1641-1647.2004; Mabey D, 2002, SEX TRANSM INFECT, V78, P90, DOI 10.1136/sti.78.2.90; Machado ACS, 2011, J MED MICROBIOL, V60, P472, DOI 10.1099/jmm.0.026476-0; Mariotti SP, 2009, BRIT J OPHTHALMOL, V93, P563, DOI 10.1136/bjo.2008.148494; Millman K, 2004, J BACTERIOL, V186, P2457, DOI 10.1128/JB.186.8.2457-2465.2004; Millman KL, 2001, J BACTERIOL, V183, P5997, DOI 10.1128/JB.183.20.5997-6008.2001; Misyurina OY, 2004, ANTIMICROB AGENTS CH, V48, P1347, DOI 10.1128/AAC.48.4.1347-1349.2004; MONCAN T, 1990, RES MICROBIOL, V141, P695, DOI 10.1016/0923-2508(90)90063-V; Nieuwenhuis RF, 2003, SEX TRANSM INFECT, V79, P453, DOI 10.1136/sti.79.6.453; Nunes A, 2009, J BACTERIOL, V191, P7182, DOI 10.1128/JB.00895-09; Otto TD, 2010, BIOINFORMATICS, V26, P1704, DOI 10.1093/bioinformatics/btq269; Pannekoek Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-42; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; PERSSON K, 1993, EUR J CLIN MICROBIOL, V12, P195, DOI 10.1007/BF01967111; Pudjiatmoko, 1997, INT J SYST BACTERIOL, V47, P425; Seth-Smith HMB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-239; SMITH JM, 1992, J MOL EVOL, V34, P126; Somani Jyoti, 2000, Journal of Infectious Diseases, V181, P1421, DOI 10.1086/315372; Spaargaren J, 2004, SEX TRANSM INFECT, V80, P151, DOI 10.1136/sti.2003.006395; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Stephens S, 2002, P 10 INT S HUM CHLAM, V6, P3; Sturm-Ramirez K, 2000, J CLIN MICROBIOL, V38, P138; Suchland RJ, 2003, SEX TRANSM DIS, V30, P357, DOI 10.1097/00007435-200304000-00016; Thomson NR, 2008, GENOME RES, V18, P161, DOI 10.1101/gr.7020108; Unemo M, 2011, CURR OPIN INFECT DIS, V24, P62, DOI 10.1097/QCO.0b013e32834204d5; Unemo M, 2010, MICROBIOL-SGM, V156, P1394, DOI 10.1099/mic.0.036830-0; van Duynhoven YTHP, 1998, CLIN INFECT DIS, V26, P314, DOI 10.1086/516291; vandeLaar JW, 1996, GENITOURIN MED, V72, P261; Viravan C, 1996, CLIN INFECT DIS, V22, P233, DOI 10.1093/clinids/22.2.233; WAGENVOORT JHT, 1988, GENITOURIN MED, V64, P159; World Health Organization Department of Reproductive Health and Research, 2011, PREV INC SEL SEX TRA; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	67	227	233	2	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2012	44	4					413	U221		10.1038/ng.2214	http://dx.doi.org/10.1038/ng.2214			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	916VF	22406642	Green Accepted, Green Submitted			2022-12-25	WOS:000302130600015
J	Schenk, T; Chen, WC; Gollner, S; Howell, L; Jin, LQ; Hebestreit, K; Klein, HU; Popescu, AC; Burnett, A; Mills, K; Casero, RA; Marton, L; Woster, P; Minden, MD; Dugas, M; Wang, JCY; Dick, JE; Muller-Tidow, C; Petrie, K; Zelent, A				Schenk, Tino; Chen, Weihsu Claire; Goellner, Stefanie; Howell, Louise; Jin, Liqing; Hebestreit, Katja; Klein, Hans-Ulrich; Popescu, Andreea C.; Burnett, Alan; Mills, Ken; Casero, Robert A., Jr.; Marton, Laurence; Woster, Patrick; Minden, Mark D.; Dugas, Martin; Wang, Jean C. Y.; Dick, John E.; Mueller-Tidow, Carsten; Petrie, Kevin; Zelent, Arthur			Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia	NATURE MEDICINE			English	Article							STEM-CELLS; EXPRESSION; ANALOGS; TARGET; REEXPRESSION; INDUCTION; HIERARCHY; DEATH; RARA; MAP	Acute promyelocytic leukemia (APL), a cytogenetically distinct subtype of acute myeloid leukemia (AML), characterized by the t(15; 17)-associated PML-RARA fusion, has been successfully treated with therapy utilizing all-trans-retinoic acid (ATRA) to differentiate leukemic blasts. However, among patients with non-APL AML, ATRA-based treatment has not been effective. Here we show that, through epigenetic reprogramming, inhibitors of lysine-specific demethylase 1 (LSD1, also called KDM1A), including tranylcypromine (TCP), unlocked the ATRA-driven therapeutic response in non-APL AML. LSD1 inhibition did not lead to a large-scale increase in histone 3 Lys4 dimethylation (H3K4(me2)) across the genome, but it did increase H3K4(me2) and expression of myeloid-differentiation-associated genes. Notably, treatment with ATRA plus TCP markedly diminished the engraftment of primary human AML cells in vivo in nonobese diabetic (NOD)-severe combined immunodeficient (SCID) mice, suggesting that ATRA in combination with TCP may target leukemia-initiating cells. Furthermore, initiation of ATRA plus TCP treatment 15 d after engraftment of human AML cells in NOD-SCID gamma (with interleukin-2 (IL-2) receptor gamma chain deficiency) mice also revealed the ATRA plus TCP drug combination to have a potent anti-leukemic effect that was superior to treatment with either drug alone. These data identify LSD1 as a therapeutic target and strongly suggest that it may contribute to AML pathogenesis by inhibiting the normal pro-differentiative function of ATRA, paving the way for new combinatorial therapies for AML.	[Schenk, Tino; Howell, Louise; Petrie, Kevin; Zelent, Arthur] Inst Canc Res, Div Mol Pathol, Sutton, Surrey, England; [Chen, Weihsu Claire; Jin, Liqing; Popescu, Andreea C.; Wang, Jean C. Y.; Dick, John E.] Univ Hlth Network, Princess Margaret Hosp, Toronto, ON, Canada; [Chen, Weihsu Claire; Jin, Liqing; Popescu, Andreea C.; Wang, Jean C. Y.; Dick, John E.] Ontario Canc Inst, Campbell Family Canc Res Inst, Div Stem Cell & Dev Biol, Toronto, ON M4X 1K9, Canada; [Goellner, Stefanie; Mueller-Tidow, Carsten] Univ Munster, Dept Med Hematol & Oncol, Munster, Germany; [Goellner, Stefanie; Mueller-Tidow, Carsten] Univ Munster, Interdisciplinary Ctr Clin Res IZKF, Munster, Germany; [Hebestreit, Katja; Klein, Hans-Ulrich; Dugas, Martin] Univ Munster, Inst Med Informat, Munster, Germany; [Burnett, Alan] Cardiff Univ, Sch Med, Cardiff, S Glam, Wales; [Mills, Ken] Queens Univ, Sch Med Dent & Biomed Sci, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Casero, Robert A., Jr.] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA; [Marton, Laurence] Progen Pharmaceut Inc, Palo Alto, CA USA; [Woster, Patrick] Med Univ S Carolina, Dept Pharmaceut & Biomed Sci, Charleston, SC 29425 USA; [Minden, Mark D.; Wang, Jean C. Y.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of London; Institute of Cancer Research - UK; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Munster; University of Munster; University of Munster; Cardiff University; Queens University Belfast; Johns Hopkins University; Medical University of South Carolina; University of Toronto; University of Toronto	Zelent, A (corresponding author), Inst Canc Res, Div Mol Pathol, Sutton, Surrey, England.	arthur.zelent@icr.ac.uk	Klein, Hans-Ulrich/O-5118-2019; Müller-Tidow, Carsten CMT/B-5257-2014; Hebestreit, Katja/A-7906-2013; Petrie, Kevin/I-7115-2015; Dugas, Martin/F-5454-2011; Klein, Hans-Ulrich/A-7801-2013; Zelent, Arthur/B-3532-2009; Göllner, Stefanie/AAX-3901-2020; Woster, Patrick M/A-5604-2010; Müller-Tidow, Carsten/O-7207-2018; Schenk, Tino/P-4381-2019; Mills, Ken/A-8556-2012	Klein, Hans-Ulrich/0000-0002-6382-9428; Petrie, Kevin/0000-0002-9805-9152; Klein, Hans-Ulrich/0000-0002-6382-9428; Woster, Patrick M/0000-0002-9471-1916; Müller-Tidow, Carsten/0000-0002-7166-5232; Schenk, Tino/0000-0003-3430-5876; Zelent, Arthur/0000-0002-7968-9888; Casero, Robert/0000-0001-5653-3306; Dick, John/0000-0002-9527-8317; Mills, Ken/0000-0002-6362-4481; Wang, Jean/0000-0001-7543-3917	Leukaemia and Lymphoma Research; Samuel Waxman Cancer Research Foundation; Interdisziplinares Zentrum fur Klinische Forschung (IZKF); Deutsche Forschungsgemeinschaft [1328/6-1, 8-1, 9-1]; Cancer Stem Cell Consortium; Government of Canada; Ontario Genomics Institute through the Canadian Institute of Health Research [OGI-047, CSC-105367]; Canadian Institutes for Health Research (CIHR); Canadian Cancer Society Research Institute; Terry Fox Foundation; province of Ontario; Canada Research Chair; Ontario Ministry of Health and Long Term Care (OMOHLTC); National Cancer Institute [CA51085]; NATIONAL CANCER INSTITUTE [R01CA149095, R01CA051085] Funding Source: NIH RePORTER	Leukaemia and Lymphoma Research; Samuel Waxman Cancer Research Foundation; Interdisziplinares Zentrum fur Klinische Forschung (IZKF); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cancer Stem Cell Consortium; Government of Canada(CGIAR); Ontario Genomics Institute through the Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Terry Fox Foundation; province of Ontario; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	T.S., L.H., K.P. and A.Z. were supported by a Specialist Programme Grant from Leukaemia and Lymphoma Research. T. S., L. H., K. P. and A.Z. were also supported in part by the Samuel Waxman Cancer Research Foundation. S.G. and C.M.-T. were supported by the Interdisziplinares Zentrum fur Klinische Forschung (IZKF) and the Deutsche Forschungsgemeinschaft (1328/6-1, 8-1 and 9-1). W.C.C., L.J., J.C.Y.W. and J.E.D. were supported by the Cancer Stem Cell Consortium with funding from the Government of Canada through Genome Canada and the Ontario Genomics Institute (OGI-047) and through the Canadian Institute of Health Research (CSC-105367), as well as with funding from Canadian Institutes for Health Research (CIHR), the Canadian Cancer Society Research Institute, the Terry Fox Foundation; Genome Canada through the Ontario Genomics Institute; Ontario Institute for Cancer Research with funds from the province of Ontario; and a Canada Research Chair. W.C.C., L.J., J.C.Y.W. and J.E.D. were also funded in part by the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed here do not necessarily reflect those of the OMOHLTC. R.A.C. Jr. was supported by a National Cancer Institute Grant (CA51085). The authors would like to thank D. Leongamornlert, L. Jasnos and S. Bashir for valuable discussions on the interpretation of the ChIP-Seq data and the statistical analyses. The authors would also like to thank M. Greaves for support and critical reading of the manuscript.	Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; Altucci L, 2001, NAT MED, V7, P680, DOI 10.1038/89050; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Binda C, 2010, J AM CHEM SOC, V132, P6827, DOI 10.1021/ja101557k; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Culhane JC, 2010, J AM CHEM SOC, V132, P3164, DOI 10.1021/ja909996p; DALTON WT, 1988, BLOOD, V71, P242; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Florean C, 2011, EPIGENOMICS-UK, V3, P581, DOI [10.2217/EPI.11.73, 10.2217/epi.11.73]; Glasow A, 2005, BLOOD, V105, P341, DOI 10.1182/blood-2004-03-1074; Glasow A, 2008, BLOOD, V111, P2374, DOI 10.1182/blood-2007-05-088344; Hayami S, 2011, INT J CANCER, V128, P574, DOI 10.1002/ijc.25349; HOWELL AL, 1990, BLOOD, V75, P721; Huang Y, 2007, P NATL ACAD SCI USA, V104, P8023, DOI 10.1073/pnas.0700720104; Huang Y, 2009, CLIN CANCER RES, V15, P7217, DOI 10.1158/1078-0432.CCR-09-1293; Krug U, 2010, LANCET, V376, P2000, DOI 10.1016/S0140-6736(10)62105-8; LAPIDOT T, 1992, SCIENCE, V255, P1137, DOI 10.1126/science.1372131; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; McDermott SP, 2012, BLOOD, V119, P1200, DOI 10.1182/blood-2011-01-330019; McKenzie JL, 2007, EXP HEMATOL, V35, P1429, DOI 10.1016/j.exphem.2007.05.017; McKenzie JL, 2006, NAT IMMUNOL, V7, P1225, DOI 10.1038/ni1393; Milojkovic D, 2004, J IMMUNOL, V173, P6745, DOI 10.4049/jimmunol.173.11.6745; Petrie K, 2009, CURR OPIN HEMATOL, V16, P84, DOI 10.1097/MOH.0b013e3283257aee; Pollyea DA, 2011, BRIT J HAEMATOL, V152, P524, DOI 10.1111/j.1365-2141.2010.08470.x; Sharma SK, 2010, J MED CHEM, V53, P5197, DOI 10.1021/jm100217a; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Ueda R, 2009, J AM CHEM SOC, V131, P17536, DOI 10.1021/ja907055q; Wang H, 2000, BLOOD, V96, P3529; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Warner JK, 2005, LEUKEMIA, V19, P1794, DOI 10.1038/sj.leu.2403917; Whyte I.M, 2003, MED TOXICOL, P823; WOLF D, 1985, P NATL ACAD SCI USA, V82, P790, DOI 10.1073/pnas.82.3.790; Yin B, 2009, BLOOD, V113, P1075, DOI 10.1182/blood-2008-03-144436; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	36	486	531	5	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2012	18	4					605	611		10.1038/nm.2661	http://dx.doi.org/10.1038/nm.2661			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22406747	Green Accepted			2022-12-25	WOS:000302617800039
J	Simmons, DP; Wickham, ME				Simmons, David P.; Wickham, Mark E.			Gene patents in Australia: where do we stand?	NATURE BIOTECHNOLOGY			English	Editorial Material								The provision of a patent system that protects innovators and researchers while ensuring reasonable access to emerging technologies and medical treatments are the key objectives of the Australian government's response to three important reports concerning Australia's patent system and gene patents.	[Simmons, David P.; Wickham, Mark E.] Phillips Ormonde Fitzpatrick, Melbourne, Vic, Australia		Simmons, DP (corresponding author), Phillips Ormonde Fitzpatrick, Melbourne, Vic, Australia.	david.simmons@pof.com.au; mark.wickham@pof.com.au	Wickham, Mark/A-1396-2009; Wickham, Mark E/HCI-4959-2022	Wickham, Mark/0000-0002-3473-7196; Wickham, Mark E/0000-0002-3473-7196				*AUSTR LAW REF COM, 2004, GEN ING GEN PAT HUM; Australian Law Reform Commission, 2010, ADV COUNC INT PROP R; Australian Law Reform Commission, 2009, ALRC SEN STAND UNPUB; Myriad Genetics Inc, 1995, AUSTR GOVT RESPONSE, Patent No. 686004; Myriad Genetics Inc, 1995, [No title captured], Patent No. 686004	5	4	4	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2012	30	4					323	324		10.1038/nbt.2173	http://dx.doi.org/10.1038/nbt.2173			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	925TR	22491279				2022-12-25	WOS:000302785000014
J	Tsurusaki, Y; Okamoto, N; Ohashi, H; Kosho, T; Imai, Y; Hibi-Ko, Y; Kaname, T; Naritomi, K; Kawame, H; Wakui, K; Fukushima, Y; Homma, T; Kato, M; Hiraki, Y; Yamagata, T; Yano, S; Mizuno, S; Sakazume, S; Ishii, T; Nagai, T; Shiina, M; Ogata, K; Ohta, T; Niikawa, N; Miyatake, S; Okada, I; Mizuguchi, T; Doi, H; Saitsu, H; Miyake, N; Matsumoto, N				Tsurusaki, Yoshinori; Okamoto, Nobuhiko; Ohashi, Hirofumi; Kosho, Tomoki; Imai, Yoko; Hibi-Ko, Yumiko; Kaname, Tadashi; Naritomi, Kenji; Kawame, Hiroshi; Wakui, Keiko; Fukushima, Yoshimitsu; Homma, Tomomi; Kato, Mitsuhiro; Hiraki, Yoko; Yamagata, Takanori; Yano, Shoji; Mizuno, Seiji; Sakazume, Satoru; Ishii, Takuma; Nagai, Toshiro; Shiina, Masaaki; Ogata, Kazuhiro; Ohta, Tohru; Niikawa, Norio; Miyatake, Satoko; Okada, Ippei; Mizuguchi, Takeshi; Doi, Hiroshi; Saitsu, Hirotomo; Miyake, Noriko; Matsumoto, Naomichi			Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome	NATURE GENETICS			English	Article							GENE; SCHWANNOMATOSIS; SMARCB1; CANCER	By exome sequencing, we found de novo SMARCB1 mutations in two of five individuals with typical Coffin-Siris syndrome (CSS), a rare autosomal dominant anomaly syndrome. As SMARCB1 encodes a subunit of the SWItch/Sucrose NonFermenting (SWI/SNF) complex, we screened 15 other genes encoding subunits of this complex in 23 individuals with CSS. Twenty affected individuals (87%) each had a germline mutation in one of six SWI/SNF subunit genes, including SMARCB1, SMARCA4, SMARCA2, SMARCE1, ARID1A and ARID1B.	[Tsurusaki, Yoshinori; Miyatake, Satoko; Okada, Ippei; Mizuguchi, Takeshi; Doi, Hiroshi; Saitsu, Hirotomo; Miyake, Noriko; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 232, Japan; [Okamoto, Nobuhiko] Osaka Med Ctr, Div Med Genet, Izumi, Japan; [Okamoto, Nobuhiko] Res Inst Maternal & Child Hlth, Izumi, Japan; [Ohashi, Hirofumi] Saitama Childrens Med Ctr, Div Med Genet, Iwatsuki, Saitama, Japan; [Kosho, Tomoki; Wakui, Keiko; Fukushima, Yoshimitsu] Shinshu Univ, Sch Med, Dept Med Genet, Matsumoto, Nagano, Japan; [Imai, Yoko; Hibi-Ko, Yumiko] Japanese Red Cross Med Ctr, Div Pediat, Tokyo, Japan; [Kaname, Tadashi; Naritomi, Kenji] Univ Ryukyus, Fac Med, Dept Med Genet, Okinawa, Japan; [Kawame, Hiroshi] Ochanomizu Univ, Grad Sch Humanities & Sci, Dept Genet Counseling, Tokyo 112, Japan; [Kawame, Hiroshi] Nagano Childrens Hosp, Div Med Genet, Azumino, Japan; [Homma, Tomomi] Nihonkai Gen Hosp, Yamagata Prefectural & Sakata Municipal Hosp Org, Div Pediat, Sakata, Yamagata, Japan; [Kato, Mitsuhiro] Yamagata Univ, Fac Med, Dept Pediat, Yamagata 990, Japan; [Hiraki, Yoko] Hiroshima Municipal Ctr Child Hlth & Dev, Hiroshima, Japan; [Yamagata, Takanori] Jichi Med Univ, Dept Pediat, Shimotsuke, Tochigi, Japan; [Yano, Shoji] Univ So Calif, Dept Pediat, Div Genet, Los Angeles Cty & Univ So Calif Med Ctr,Keck Sch, Los Angeles, CA 90089 USA; [Mizuno, Seiji] Cent Hosp Kasugai, Aichi Human Serv Ctr, Dept Pediat, Kasugai, Aichi, Japan; [Sakazume, Satoru; Ishii, Takuma; Nagai, Toshiro] Dokkyo Univ, Koshigaya Hosp, Dept Pediat, Sch Med, Koshigaya, Japan; [Ishii, Takuma] Hosp Disabled, Saitama, Japan; [Shiina, Masaaki; Ogata, Kazuhiro] Yokohama City Univ, Grad Sch Med, Dept Biochem, Yokohama, Kanagawa 232, Japan; [Ohta, Tohru; Niikawa, Norio] Hlth Sci Univ Hokkaido, Res Inst Personalized Hlth Sci, Ishikari, Hokkaido 06102, Japan	Yokohama City University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Saitama Children's Medical Center; Shinshu University; Japanese Red Cross Medical Center; University of Tokyo; University of the Ryukyus; Ochanomizu University; Yamagata University; Jichi Medical University; University of Southern California; Dokkyo Medical University; Yokohama City University; Health Sciences University of Hokkaido	Matsumoto, N (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 232, Japan.	nmiyake@yokohama-cu.ac.jp; naomat@yokohama-cu.ac.jp	Yano, Shoji/AAG-2771-2021; Saitsu, Hirotomo/AAM-7131-2021	Yano, Shoji/0000-0001-5565-9572; Saitsu, Hirotomo/0000-0003-0723-0960; Tsurusaki, Yoshinori/0000-0002-7240-6355; Kato, Mitsuhiro/0000-0003-1485-8553	Ministry of Health, Labour and Welfare; Japan Science and Technology Agency; Strategic Research Program for Brain Sciences; Japan Epilepsy Research Foundation; Takeda Science Foundation; (Foundation of Synapse and Neurocircuit Pathology) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Yokohama City University; Grants-in-Aid for Scientific Research [21390104, 22790823] Funding Source: KAKEN	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Strategic Research Program for Brain Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Epilepsy Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); (Foundation of Synapse and Neurocircuit Pathology) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Yokohama City University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank all the family members for participating in this study. This work was supported by research grants from the Ministry of Health, Labour and Welfare (to N. Miyake, H.S. and N. Matsumoto), the Japan Science and Technology Agency (to N. Matsumoto), the Strategic Research Program for Brain Sciences (to N. Matsumoto), the Japan Epilepsy Research Foundation (to H.S.) and the Takeda Science Foundation (to N. Matsumoto and N. Miyake). This study was also funded by a Grant-in-Aid for Scientific Research on Innovative Areas (Foundation of Synapse and Neurocircuit Pathology) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to N. Matsumoto), a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (to N. Matsumoto), a Grant-in-Aid for Young Scientists from the Japan Society for the Promotion of Science (to N. Miyake and H.S.) and a Grant for 2011 Strategic Research Promotion of Yokohama City University (to N. Matsumoto). This study was performed at the Advanced Medical Research Center at Yokohama City University. Informed consent was obtained from all the families of affected individuals. The Institutional Review Board of Yokohama City University approved this study.	Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Boyd C, 2008, CLIN GENET, V74, P358, DOI 10.1111/j.1399-0004.2008.01060.x; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; COFFIN GS, 1970, AM J DIS CHILD, V119, P433, DOI 10.1001/archpedi.1970.02100050435009; Hadfield KD, 2008, J MED GENET, V45, P332, DOI 10.1136/jmg.2007.056499; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Schneppenheim R, 2010, AM J HUM GENET, V86, P279, DOI 10.1016/j.ajhg.2010.01.013; Taylor MD, 2000, AM J HUM GENET, V66, P1403, DOI 10.1086/302833; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Xue YT, 2000, P NATL ACAD SCI USA, V97, P13015, DOI 10.1073/pnas.240208597	14	356	376	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2012	44	4					376	378		10.1038/ng.2219	http://dx.doi.org/10.1038/ng.2219			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	916VF	22426308				2022-12-25	WOS:000302130600009
J	Delgado-Olguin, P; Huang, Y; Li, X; Christodoulou, D; Seidman, CE; Seidman, JG; Tarakhovsky, A; Bruneau, BG				Delgado-Olguin, Paul; Huang, Yu; Li, Xue; Christodoulou, Danos; Seidman, Christine E.; Seidman, J. G.; Tarakhovsky, Alexander; Bruneau, Benoit G.			Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis	NATURE GENETICS			English	Article							TRANSCRIPTION FACTORS; SELF-RENEWAL; 6 FAMILY; CHROMATIN; METHYLATION; IDENTITY; PRC2	Adult-onset diseases can be associated with in utero events, but mechanisms for this remain unknown(1,2). The Polycomb histone methyltransferase Ezh2 stabilizes transcription by depositing repressive marks during development that persist into adulthood(3-9), but its function in postnatal organ homeostasis is unknown. We show that Ezh2 stabilizes cardiac gene expression and prevents cardiac pathology by repressing the homeodomain transcription factor gene Six1, which functions in cardiac progenitor cells but is stably silenced upon cardiac differentiation(10). Deletion of Ezh2 in cardiac progenitors caused postnatal myocardial pathology and destabilized cardiac gene expression with activation of Six1-dependent skeletal muscle genes. Six1 induced cardiomyocyte hypertrophy and skeletal muscle gene expression. Furthermore, genetically reducing Six1 levels rescued the pathology of Ezh2-deficient hearts. Thus, Ezh2-mediated repression of Six1 in differentiating cardiac progenitors is essential for stable gene expression and homeostasis in the postnatal heart. Our results suggest that epigenetic dysregulation in embryonic progenitor cells is a predisposing factor for adult disease and dysregulated stress responses.	[Delgado-Olguin, Paul; Huang, Yu; Bruneau, Benoit G.] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Li, Xue] Childrens Hosp Boston, Urol Dis Res Ctr, Boston, MA USA; [Li, Xue] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Li, Xue] Harvard Stem Cell Inst, Cambridge, MA USA; [Christodoulou, Danos; Seidman, Christine E.; Seidman, J. G.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Seidman, Christine E.] Brigham & Womens Hosp, Howard Hughes Med Inst, Div Cardiovasc Med, Boston, MA 02115 USA; [Tarakhovsky, Alexander] Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10021 USA; [Bruneau, Benoit G.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Bruneau, Benoit G.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Bruneau, Benoit G.] Univ Calif San Francisco, Inst Regenerat Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Rockefeller University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bruneau, BG (corresponding author), Gladstone Inst Cardiovasc Dis, San Francisco, CA USA.	bbruneau@gladstone.ucsf.edu	Olguin, Paul Delgado/H-9293-2019	Olguin, Paul Delgado/0000-0002-5355-247X; Bruneau, Benoit/0000-0002-0804-7597	California Institute for Regenerative Medicine; US National Institutes of Health [U01HL098179, U01HL098166]; Lawrence J. and Florence A. DeGeorge Charitable Trust/American Heart Association; US National Institutes of Health/National Center for Research Resources [C06 RR018928]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098166, U01HL098179] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lawrence J. and Florence A. DeGeorge Charitable Trust/American Heart Association(American Heart Association); US National Institutes of Health/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank A. Blais for Six1 antiserum, T. Sukonnik for in situ hybridization, J. Wythe for mT/mG embryos, J. Wylie for technical assistance, D. Miguel-Perez for animal husbandry, A. Holloway and A. Williams (Gladstone Bioinformatics Core) for RNA-seq and microarray data analysis, L. Ta (Gladstone Genomics Core) for microarray experiments, J. Zhang (Gladstone Transgenic Core) for oocyte injection, C. Miller (Gladstone Histology Core) for histology, Bruneau lab members for helpful discussions and G. Howard for editorial assistance. This work was supported by a fellowship from the California Institute for Regenerative Medicine (P.D.-O.), US National Institutes of Health grants U01HL098179 (B. G. B.) and U01HL098166 (C. E. S. and J. G. S.), by the Lawrence J. and Florence A. DeGeorge Charitable Trust/American Heart Association Established Investigator Award (B. G. B.) and by William H. Younger, Jr. (B. G. B.). Animal work was supported by a US National Institutes of Health/National Center for Research Resources grant (C06 RR018928) to the J. David Gladstone Institutes.	Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Christodoulou D. C., 2011, CURR PROTOC MOL BIOL, V94, P4121, DOI DOI 10.1002/0471142727.MB0412S94; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Guo CS, 2011, J CLIN INVEST, V121, P1585, DOI 10.1172/JCI44630; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Houweling AC, 2005, CARDIOVASC RES, V67, P583, DOI 10.1016/j.cardiores.2005.06.013; Juan AH, 2011, GENE DEV, V25, P789, DOI 10.1101/gad.2027911; Kumar JP, 2009, CELL MOL LIFE SCI, V66, P565, DOI 10.1007/s00018-008-8335-4; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Liu YB, 2010, NUCLEIC ACIDS RES, V38, P6857, DOI 10.1093/nar/gkq585; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; McFadden DG, 2000, DEVELOPMENT, V127, P5331; Pereira JD, 2010, P NATL ACAD SCI USA, V107, P15957, DOI 10.1073/pnas.1002530107; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Schonberger J, 2005, NAT GENET, V37, P418, DOI 10.1038/ng1527; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Swynghedauw B, 2006, J EXP BIOL, V209, P2320, DOI 10.1242/jeb.02084; Takeuchi JK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1187; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; Weiford BC, 2004, CIRCULATION, V109, P2965, DOI 10.1161/01.CIR.0000132478.60674.D0; Xu CR, 2011, SCIENCE, V332, P963, DOI 10.1126/science.1202845	26	192	197	3	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2012	44	3					343	U158		10.1038/ng.1068	http://dx.doi.org/10.1038/ng.1068			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	899VC	22267199	Green Accepted			2022-12-25	WOS:000300843600024
J	Wang, C; Li, YL; Shi, L; Ren, J; Patti, M; Wang, T; de Oliveira, JRM; Sobrido, MJ; Quintans, B; Baquero, M; Cui, XN; Zhang, XY; Wang, LQ; Xu, HB; Wang, JH; Yao, J; Dai, XH; Liu, J; Zhang, L; Ma, HY; Gao, Y; Ma, XX; Feng, SL; Liu, MG; Wang, QK; Forster, IC; Zhang, X; Liu, JY				Wang, Cheng; Li, Yulei; Shi, Lei; Ren, Jie; Patti, Monica; Wang, Tao; de Oliveira, Joao R. M.; Sobrido, Maria-Jesus; Quintans, Beatriz; Baquero, Miguel; Cui, Xiaoniu; Zhang, Xiang-Yang; Wang, Lianqing; Xu, Haibo; Wang, Junhan; Yao, Jing; Dai, Xiaohua; Liu, Juan; Zhang, Lu; Ma, Hongying; Gao, Yong; Ma, Xixiang; Feng, Shenglei; Liu, Mugen; Wang, Qing K.; Forster, Ian C.; Zhang, Xue; Liu, Jing-Yu			Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis	NATURE GENETICS			English	Article							TRANSPORT; DISEASE; IDENTIFICATION; BRAIN	Familial idiopathic basal ganglia calcification (IBGC) is a genetic condition with a wide spectrum of neuropsychiatric symptoms, including parkinsonism and dementia. Here, we identified mutations in SLC20A2, encoding the type III sodium-dependent phosphate transporter 2 (PiT2), in IBGC-affected families of varied ancestry, and we observed significantly impaired phosphate transport activity for all assayed PiT2 mutants in Xenopus laevis oocytes. Our results implicate altered phosphate homeostasis in the etiology of IBGC.	[Wang, Cheng; Li, Yulei; Ren, Jie; Cui, Xiaoniu; Zhang, Xiang-Yang; Yao, Jing; Dai, Xiaohua; Liu, Juan; Zhang, Lu; Ma, Hongying; Gao, Yong; Ma, Xixiang; Feng, Shenglei; Liu, Mugen; Wang, Qing K.; Liu, Jing-Yu] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Peoples R China; [Wang, Cheng; Li, Yulei; Ren, Jie; Cui, Xiaoniu; Zhang, Xiang-Yang; Yao, Jing; Dai, Xiaohua; Liu, Juan; Zhang, Lu; Ma, Hongying; Gao, Yong; Ma, Xixiang; Feng, Shenglei; Liu, Mugen; Wang, Qing K.; Liu, Jing-Yu] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan 430074, Peoples R China; [Shi, Lei; Wang, Lianqing; Zhang, Xue] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, McKusick Zhang Ctr Genet Med, Beijing 100730, Peoples R China; [Shi, Lei; Wang, Lianqing; Zhang, Xue] Peking Union Med Coll, Beijing 100021, Peoples R China; [Patti, Monica; Forster, Ian C.] Univ Zurich, Inst Physiol, Zurich Ctr Integrated Human Physiol, Zurich, Switzerland; [de Oliveira, Joao R. M.] Univ Fed Pernambuco, Keizo Asami Lab, Dept Neuropsychiat, Recife, PE, Brazil; [Wang, Tao] Union Hosp HUST, Dept Neurol, Wuhan, Peoples R China; [Sobrido, Maria-Jesus; Quintans, Beatriz] Clin Hosp Santiago de Compostela, Fdn Publ Galega Med Xenom, Serv Galego Saude SERGAS, Santiago De Compostela, Spain; [Sobrido, Maria-Jesus; Quintans, Beatriz] Inst Hlth Carlos III, Ctr Network Res Rare Dis CIBERER, Barcelona, Spain; [Baquero, Miguel] Univ Valencia, Hosp Univ & Politecn La Fe, Serv Neurol, Dept Med, Valencia, Spain; [Xu, Haibo] Union Hosp HUST, Dept Radiol, Wuhan, Peoples R China; [Wang, Junhan] Hosp HUST, Dept Clin Lab, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Universidade Federal de Pernambuco; Huazhong University of Science & Technology; Complexo Hospitalario Universitario de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitari i Politecnic La Fe; University of Valencia; Huazhong University of Science & Technology	Liu, JY (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Peoples R China.	xuezhang@pumc.edu.cn; liujy@mail.hust.edu.cn	Wang, Lianqing/AAX-5278-2020; Oliveira, João/GXN-3304-2022; de Oliveira, João/GWV-0126-2022	Wang, Lianqing/0000-0002-7161-4718; Wang, Cheng/0000-0002-7822-259X; Yao, Jing/0000-0003-1844-3988; Forster, Ian/0000-0003-3087-9952	National Natural Science Foundation of China [30670736, 30972655, 30730097, 31021091, 30871386]; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT1006]; Swiss National Science Foundation; John Simon Guggenheim Memorial Foundation; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Institute of Health Carlos III; FEDER funds	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); John Simon Guggenheim Memorial Foundation; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Institute of Health Carlos III(Instituto de Salud Carlos III); FEDER funds(European Commission)	We would like to thank all the family members for their enthusiastic participation in the study. X. Z. would like to thank K. Hong, Q. Liu, Z. Wu, W. Xia, C. Zhang and L. Zou for clinical support. J. R. M. d. O. would like to thank R. Lemos and D. Oliveira for technical support. This study was mainly supported by the National Natural Science Foundation of China (30670736 and 30972655 to J.-Y. L. and 30730097 and 31021091 to X. Z.) and by the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT; IRT1006 to X. Z.). I. C. F. is supported by the Swiss National Science Foundation. M. L. is supported by the National Natural Science Foundation of China (30871386). J. R. M. d. O. is supported by the John Simon Guggenheim Memorial Foundation and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico M.-J. S. and B. Q. are supported by research contracts from the Institute of Health Carlos III and by FEDER funds. The study was approved by the ethics committees of HUST and Peking Union Medical College. Written informed consent was obtained from all participants or their legal guardians.	Bottger P, 2002, J BIOL CHEM, V277, P42741, DOI 10.1074/jbc.M207096200; Dai XH, 2010, AM J MED GENET B, V153B, P1305, DOI 10.1002/ajmg.b.31102; Giachelli CM, 2009, KIDNEY INT, V75, P890, DOI 10.1038/ki.2008.644; Kavanaugh MP, 1996, KIDNEY INT, V49, P959, DOI 10.1038/ki.1996.135; Kendrick J, 2011, ADV CHRONIC KIDNEY D, V18, P113, DOI 10.1053/j.ackd.2010.12.003; Lagrue E, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-91; Manyam BV, 2005, PARKINSONISM RELAT D, V11, P73, DOI 10.1016/j.parkreldis.2004.12.001; Miklossy J, 2005, ACTA NEUROPATHOL, V109, P643, DOI 10.1007/s00401-005-1007-7; Oliveira JRM, 2004, NEUROLOGY, V63, P2165, DOI 10.1212/01.WNL.0000145601.88274.88; Prie D, 2010, NEW ENGL J MED, V362, P2399, DOI 10.1056/NEJMra0904186; Ravera S, 2007, AM J PHYSIOL-CELL PH, V293, pC606, DOI 10.1152/ajpcell.00064.2007; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; St Hilaire C, 2011, NEW ENGL J MED, V364, P432, DOI [10.1056/NEJMoa0912923, 10.1056/NEJMc1102515]; Villa-Bellosta R, 2009, AM J PHYSIOL-RENAL, V296, pF691, DOI 10.1152/ajprenal.90623.2008; Wider C, 2009, J NEUROL, V256, P839, DOI 10.1007/s00415-009-5025-6	15	280	296	1	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2012	44	3					254	256		10.1038/ng.1077	http://dx.doi.org/10.1038/ng.1077			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	899VC	22327515				2022-12-25	WOS:000300843600008
J	Montagut, C; Dalmases, A; Bellosillo, B; Crespo, M; Pairet, S; Iglesias, M; Salido, M; Gallen, M; Marsters, S; Tsai, SP; Minoche, A; Somasekar, S; Serrano, S; Himmelbauer, H; Bellmunt, J; Rovira, A; Settleman, J; Bosch, F; Albanell, J				Montagut, Clara; Dalmases, Alba; Bellosillo, Beatriz; Crespo, Marta; Pairet, Silvia; Iglesias, Mar; Salido, Marta; Gallen, Manuel; Marsters, Scot; Tsai, Siao Ping; Minoche, Andre; Somasekar, Seshagiri; Serrano, Sergi; Himmelbauer, Heinz; Bellmunt, Joaquim; Rovira, Ana; Settleman, Jeff; Bosch, Francesc; Albanell, Joan			Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer	NATURE MEDICINE			English	Article							1ST-LINE TREATMENT; PHASE-III; PANITUMUMAB; FLUOROURACIL; LEUCOVORIN; OXALIPLATIN; EFFICACY	Antibodies against epidermal growth factor receptor (EGFR)-cetuximab and panitumumab-are widely used to treat colorectal cancer. Unfortunately, patients eventually develop resistance to these agents. We describe an acquired EGFR ectodomain mutation (S492R) that prevents cetuximab binding and confers resistance to cetuximab. Cells with this mutation, however, retain binding to and are growth inhibited by panitumumab. Two of ten subjects studied here with disease progression after cetuximab treatment acquired this mutation. A subject with cetuximab resistance harboring the S492R mutation responded to treatment with panitumumab.	[Montagut, Clara; Dalmases, Alba; Gallen, Manuel; Bellmunt, Joaquim; Rovira, Ana; Albanell, Joan] Hosp del Mar, Dept Med Oncol, Barcelona, Spain; [Montagut, Clara; Dalmases, Alba; Bellosillo, Beatriz; Pairet, Silvia; Gallen, Manuel; Serrano, Sergi; Bellmunt, Joaquim; Rovira, Ana; Albanell, Joan] Hosp del Mar, Canc Res Program, IMIM, Res Inst, Barcelona, Spain; [Bellosillo, Beatriz; Pairet, Silvia; Iglesias, Mar; Salido, Marta; Serrano, Sergi] Hosp del Mar, Dept Pathol, Barcelona, Spain; [Crespo, Marta; Bosch, Francesc] Vall dHebron Univ Hosp, Dept Hematol, Barcelona, Spain; [Iglesias, Mar; Serrano, Sergi; Albanell, Joan] Univ Autonoma Barcelona, Dept Med, Bellaterra, Spain; [Marsters, Scot; Tsai, Siao Ping; Somasekar, Seshagiri; Settleman, Jeff] Genentech Inc, Discovery Oncol, San Francisco, CA 94080 USA; [Minoche, Andre; Himmelbauer, Heinz] Ctr Genom Regulat, Barcelona, Spain; [Bellmunt, Joaquim] UPF, Sch Med, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Roche Holding; Genentech; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University	Montagut, C (corresponding author), Hosp del Mar, Dept Med Oncol, Barcelona, Spain.	cmontagut@hospitaldelmar.cat; jalbanell@hospitaldelmar.cat	Bellmunt, Joaquim/B-8151-2019; Albanell, Joan/R-9470-2019; Bosch, Francesc/AAE-7052-2019; Rovira, Ana/ABH-5661-2020	Bellmunt, Joaquim/0000-0003-2328-3421; Bosch, Francesc/0000-0001-9241-2886; Crespo, Marta/0000-0002-7732-7808; Rovira, Ana/0000-0003-1301-2599; Himmelbauer, Heinz/0000-0001-8897-2928	Institut de Salud Carlos III (ISCIII) -Subdireccion General de Evaluacion y Fomento de la Investigacion [PS09/01491, PI08/0211, PI09/1285]; Plan Nacional (PN) de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+I), iniciativa Ingenio, programa Consolider; ISCIII/FEDER [RD06/0020/0109]; PN de I+D+I [2008-20011]; DIUE Generalitat de Catalunya [2009 SGR 321]; FEDER [RD09/0076/00036]; Xarxa de Bancs de Tumors de Catalunya; PDO (XBTC)	Institut de Salud Carlos III (ISCIII) -Subdireccion General de Evaluacion y Fomento de la Investigacion; Plan Nacional (PN) de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+I), iniciativa Ingenio, programa Consolider; ISCIII/FEDER; PN de I+D+I; DIUE Generalitat de Catalunya(Generalitat de Catalunya); FEDER(European Commission); Xarxa de Bancs de Tumors de Catalunya; PDO (XBTC)	This work was supported by Institut de Salud Carlos III (ISCIII) -Subdireccion General de Evaluacion y Fomento de la Investigacion (PS09/01491, PI08/0211 and PI09/1285) and Plan Nacional (PN) de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+I), iniciativa Ingenio 2010, programa Consolider and ISCIII/FEDER (RD06/0020/0109); PN de I+D+I 2008-20011 and DIUE Generalitat de Catalunya (2009 SGR 321) grants. We thank the Fundacio Privada Cellex (Barcelona) for a generous donation to the Medical Oncology Service, Hospital del Mar. We thank the Tumor Bank of Pathology of Hospital del Mar (MARBiobanc), which is supported by FEDER (RD09/0076/00036), and Xarxa de Bancs de Tumors de Catalunya, which is sponsored by PDO (XBTC). We thank L. Roth and R. Cook for assistance with the EGFR binding studies, J. Guillory and J. Stinson for DNA sequencing, and J. Yelamos for key discussions.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Peeters M, 2010, J CLIN ONCOL, V28, P4706, DOI 10.1200/JCO.2009.27.6055; Saif MW, 2010, CLIN COLORECTAL CANC, V9, P315, DOI 10.3816/CCC.2010.n.046; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019	7	356	375	1	28	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					221	223		10.1038/nm.2609	http://dx.doi.org/10.1038/nm.2609			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22270724				2022-12-25	WOS:000300140300034
J	Wang, WS; Lv, N; Zhang, SS; Shui, GH; Qian, H; Zhang, JF; Chen, YY; Ye, J; Xie, YS; Shen, YM; Wenk, MR; Li, P				Wang, Wenshan; Lv, Na; Zhang, Shasha; Shui, Guanghou; Qian, Hui; Zhang, Jingfeng; Chen, Yuanying; Ye, Jing; Xie, Yuansheng; Shen, Yuemao; Wenk, Markus R.; Li, Peng			Cidea is an essential transcriptional coactivator regulating mammary gland secretion of milk lipids	NATURE MEDICINE			English	Article							BINDING-PROTEIN-BETA; XANTHINE-OXIDOREDUCTASE; DEFICIENT MICE; DUCTAL MORPHOGENESIS; INSULIN SENSITIVITY; SOCS-3 GENE; C/EBP-BETA; EXPRESSION; OBESITY; DROPLETS	Adequate lipid secretion by mammary glands during lactation is essential for the survival of mammalian offspring. However, the mechanism governing this process is poorly understood. Here we show that Cidea is expressed at high levels in lactating mammary glands and its deficiency leads to premature pup death as a result of severely reduced milk lipids. Furthermore, the expression of xanthine oxidoreductase (XOR), an essential factor for milk lipid secretion, is markedly lower in Cidea-deficient mammary glands. Conversely, ectopic Cidea expression induces the expression of XOR and enhances lipid secretion in vivo. Unexpectedly, as Cidea has heretofore been thought of as a cytoplasmic protein, we detected it in the nucleus and found it to physically interact with transcription factor CCAAT/enhancer-binding protein beta (C/EBP beta) in mammary epithelial cells. We also observed that Cidea induces XOR expression by promoting the association of C/EBP beta onto, and the dissociation of HDAC1 from, the promoter of the Xdh gene encoding XOR. Finally, we found that Fsp27, another CIDE family protein, is detected in the nucleus and interacts with C/EBP beta to regulate expression of a subset of C/EBP beta downstream genes in adipocytes. Thus, Cidea acts as a previously unknown transcriptional coactivator of C/EBP beta in mammary glands to control lipid secretion and pup survival.	[Wang, Wenshan; Lv, Na; Zhang, Shasha; Qian, Hui; Zhang, Jingfeng; Chen, Yuanying; Li, Peng] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China; [Shui, Guanghou; Wenk, Markus R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Shui, Guanghou; Wenk, Markus R.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Ye, Jing] Fourth Mil Med Univ, Dept Pathol, Xian 710032, Shaanxi, Peoples R China; [Xie, Yuansheng] Chinese Peoples Liberat Army Gen Hosp, State Key Lab Kidney Dis, Inst Nephrol, Beijing, Peoples R China; [Shen, Yuemao] Shandong Univ, Sch Pharmaceut Sci, Jinan 250100, Shandong, Peoples R China	Tsinghua University; National University of Singapore; National University of Singapore; Air Force Military Medical University; Chinese People's Liberation Army General Hospital; Shandong University	Li, P (corresponding author), Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China.	li-peng@mail.tsinghua.edu.cn	Wenk, Markus Rene/D-1441-2014	Shui, Guanghou/0000-0002-1621-9643	Ministry of Science and Technology of China [2007CB914404, 2011CB910800]; National Natural Science Foundation of China [30925017, 31030038, 90913024]; National University of Singapore; Singapore National Research Foundation under CRP [2007-04]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National University of Singapore(National University of Singapore); Singapore National Research Foundation under CRP(National Research Foundation, Singapore)	We thank L. Yu, L. Huang, Y. Hong and Y. Zhou for helpful discussions, and B. Groner (Georg-Speyer-Haus Institute for Biomedical Research) for providing HC11 cells. This work was supported by grants from the National Basic Research Program (2007CB914404, 2011CB910800) from the Ministry of Science and Technology of China and the National Natural Science Foundation of China (30925017 and 31030038 to PL., 90913024 to Y.S.), and from the National University of Singapore and the Singapore National Research Foundation under CRP award no. 2007-04 to M.R.W.	Amir-Zilberstein L, 2007, MOL CELL BIOL, V27, P5246, DOI 10.1128/MCB.00586-07; Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Borland G, 2009, J BIOL CHEM, V284, P17391, DOI 10.1074/jbc.M109.015370; Boxer RB, 2006, CELL METAB, V4, P475, DOI 10.1016/j.cmet.2006.10.011; Cheung KJ, 2007, CELL METAB, V5, P115, DOI 10.1016/j.cmet.2007.01.005; Cui TX, 2011, MOL ENDOCRINOL, V25, P681, DOI 10.1210/me.2010-0232; Dahlman I, 2005, DIABETES, V54, P3032, DOI 10.2337/diabetes.54.10.3032; Dong J, 2006, J BIOL CHEM, V281, P18825, DOI 10.1074/jbc.M512826200; Drost J, 2010, NAT CELL BIOL, V12, P380, DOI 10.1038/ncb2038; Goldhar AS, 2011, MOL CELL ENDOCRINOL, V335, P148, DOI 10.1016/j.mce.2011.01.004; Gomes NP, 2010, GENE DEV, V24, P1022, DOI 10.1101/gad.1881010; Jeong J, 2009, J BIOL CHEM, V284, P22444, DOI 10.1074/jbc.M109.020446; Karaya K, 2005, NUCLEIC ACIDS RES, V33, P1924, DOI 10.1093/nar/gki339; Kleinberg DL, 2000, J MAMMARY GLAND BIOL, V5, P7, DOI 10.1023/A:1009507030633; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kulyte A, 2011, FEBS LETT, V585, P744, DOI 10.1016/j.febslet.2011.02.004; Lee S, 2010, J BIOL CHEM, V285, P21399, DOI 10.1074/jbc.M110.128413; Li JZ, 2007, DIABETES, V56, P2523, DOI 10.2337/db07-0040; LINZELL JL, 1971, PHYSIOL REV, V51, P564, DOI 10.1152/physrev.1971.51.3.564; Mather IH, 1998, J MAMMARY GLAND BIOL, V3, P259, DOI 10.1023/A:1018711410270; McCarthy TL, 2007, MOL ENDOCRINOL, V21, P2713, DOI 10.1210/me.2007-0210; McManaman JL, 2002, J PHYSIOL-LONDON, V545, P567, DOI 10.1113/jphysiol.2002.027185; McManaman JL, 2004, ADV EXP MED BIOL, V554, P263; Mori S, 2000, EMBO J, V19, P5772, DOI 10.1093/emboj/19.21.5772; Neifert MR, 2001, PEDIATR CLIN N AM, V48, P273, DOI 10.1016/S0031-3955(08)70026-9; Neville MC, 1997, ANNU REV NUTR, V17, P159, DOI 10.1146/annurev.nutr.17.1.159; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Ogg SL, 2004, P NATL ACAD SCI USA, V101, P10084, DOI 10.1073/pnas.0402930101; Paz-Priel I, 2011, BLOOD, V117, P4085, DOI 10.1182/blood-2010-07-294470; Pettersson AT, 2008, INT J OBESITY, V32, P1380, DOI 10.1038/ijo.2008.101; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Robenek H, 2006, P NATL ACAD SCI USA, V103, P10385, DOI 10.1073/pnas.0600795103; Sahay B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000687; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Seymour KJ, 2006, J BIOL CHEM, V281, P8545, DOI 10.1074/jbc.M507349200; Shekar PC, 2006, P NATL ACAD SCI USA, V103, P8000, DOI 10.1073/pnas.0601611103; Smith S, 1975, Adv Lipid Res, V13, P195; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Vorbach C, 2002, GENE DEV, V16, P3223, DOI 10.1101/gad.1032702; Wessells J, 2004, MOL CELL BIOL, V24, P3238, DOI 10.1128/MCB.24.8.3238-3250.2004; Wiper-Bergeron N, 2003, EMBO J, V22, P2135, DOI 10.1093/emboj/cdg218; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5; Yarwood SJ, 2008, J BIOL CHEM, V283, P6843, DOI 10.1074/jbc.M710342200; Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	47	72	79	0	43	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					235	243		10.1038/nm.2614	http://dx.doi.org/10.1038/nm.2614			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22245780				2022-12-25	WOS:000300140300037
J	Allen, HL; Flanagan, SE; Shaw-Smith, C; De Franco, E; Akerman, I; Caswell, R; Ferrer, J; Hattersley, AT; Ellard, S				Allen, Hana Lango; Flanagan, Sarah E.; Shaw-Smith, Charles; De Franco, Elisa; Akerman, Ildem; Caswell, Richard; Ferrer, Jorge; Hattersley, Andrew T.; Ellard, Sian		Int Pancreatic Agenesis Consortium	GATA6 haploinsufficiency causes pancreatic agenesis in humans	NATURE GENETICS			English	Article							IN-VIVO; MUTATIONS; ENDODERM; SEQUENCE; DEFECTS; CELLS	Understanding the regulation of pancreatic development is key for efforts to develop new regenerative therapeutic approaches for diabetes. Rare mutations in PDX1 and PTF1A can cause pancreatic agenesis, however, most instances of this disorder are of unknown origin. We report de novo heterozygous inactivating mutations in GATA6 in 15/27 (56%) individuals with pancreatic agenesis. These findings define the most common cause of human pancreatic agenesis and establish a key role for the transcription factor GATA6 in human pancreatic development.	[Allen, Hana Lango; Flanagan, Sarah E.; Shaw-Smith, Charles; De Franco, Elisa; Caswell, Richard; Hattersley, Andrew T.; Ellard, Sian] Univ Exeter, Peninsula Coll Med & Dent, Inst Biomed & Clin Sci, Exeter, Devon, England; [Akerman, Ildem; Ferrer, Jorge] Inst Invest August Pi & Sunyer IDIBAPS, Genom Programming Beta Cells Lab, Barcelona, Spain; [Akerman, Ildem; Ferrer, Jorge] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain; [Akerman, Ildem; Ferrer, Jorge] Hosp Clin Barcelona, Dept Endocrinol & Nutr, Barcelona, Spain	University of Exeter; University of Plymouth; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; Hospital Clinic de Barcelona	Hattersley, AT (corresponding author), Univ Exeter, Peninsula Coll Med & Dent, Inst Biomed & Clin Sci, Exeter, Devon, England.	andrew.hattersley@pms.ac.uk	Noordam, Cees/AAL-9015-2021; Noordam, C./H-8077-2014; Allen, Hana Lango/G-9026-2012; Shield, Julian PH/D-6297-2014; Ferrer, Jorge/A-3176-2012	Noordam, Cees/0000-0001-9735-5921; Noordam, C./0000-0001-9735-5921; Allen, Hana Lango/0000-0002-7803-8688; Shield, Julian PH/0000-0003-2601-7575; Ferrer, Jorge/0000-0002-5959-5729; Ellard, Sian/0000-0002-7620-5526; Akerman, Ildem/0000-0002-9875-1421; Hattersley, Andrew/0000-0001-5620-473X; Flanagan, Sarah/0000-0002-8670-6340; Aanstoot, Henk-Jan/0000-0002-5534-1633; Caswell, Richard/0000-0003-0713-4602	Diabetes UK; Wellcome Research Leave Award for Clinical Academics [067463/Z/2/Z]; European Community [223211, FP7-PEOPLE-ITN-2008]; Diabetes UK [11/0004193] Funding Source: researchfish	Diabetes UK(Diabetes UK); Wellcome Research Leave Award for Clinical Academics; European Community(European Commission); Diabetes UK(Diabetes UK)	The authors thank the families who participated in this study. We are grateful to A. Damhuis, A. Moorhouse and K. Paszkiewicz for their expert technical assistance. We thank H. Yamagishi (Keio University, Japan) for providing the GATA6 plasmid. S. E. F. was the Sir Graham Wilkins, Peninsula Medical School Research Fellow. S. E. and A. T. H. are employed as core members of staff within the National Institute for Health Research-funded Peninsula Clinical Research Facility. The research leading to these results received funding from Diabetes UK, the Wellcome Research Leave Award for Clinical Academics (ref 067463/Z/2/Z) and the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 223211 (Collaborative European Effort to Develop Diabetes Diagnostics, CEED3) and grant agreement number FP7-PEOPLE-ITN-2008 (Marie Curie Initial Training Networks, Biology of Liver and Pancreatic Development and Disease).	Balasubramanian M, 2010, AM J MED GENET A, V152A, P340, DOI 10.1002/ajmg.a.33194; Decker K, 2006, DEV BIOL, V298, P415, DOI 10.1016/j.ydbio.2006.06.046; Kodo K, 2009, P NATL ACAD SCI USA, V106, P13933, DOI 10.1073/pnas.0904744106; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lin XP, 2010, J HUM GENET, V55, P662, DOI 10.1038/jhg.2010.84; Maitra M, 2010, PEDIATR RES, V68, P281, DOI 10.1203/00006450-201011001-00549; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Rubio-Cabezas O, 2011, DIABETES, V60, P1349, DOI 10.2337/db10-1008; Rubio-Cabezas O, 2010, DIABETES, V59, P2326, DOI 10.2337/db10-0011; Sellick GS, 2004, NAT GENET, V36, P1301, DOI 10.1038/ng1475; Servitja JM, 2004, DIABETOLOGIA, V47, P597, DOI 10.1007/s00125-004-1368-9; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Thomas IH, 2009, PEDIATR DIABETES, V10, P492, DOI 10.1111/j.1399-5448.2009.00526.x; Watt AJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-37; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	15	175	177	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2012	44	1					20	22		10.1038/ng.1035	http://dx.doi.org/10.1038/ng.1035			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	22158542	Green Accepted			2022-12-25	WOS:000298664000008
J	Comas, I; Borrell, S; Roetzer, A; Rose, G; Malla, B; Kato-Maeda, M; Galagan, J; Niemann, S; Gagneux, S				Comas, Inaki; Borrell, Sonia; Roetzer, Andreas; Rose, Graham; Malla, Bijaya; Kato-Maeda, Midori; Galagan, James; Niemann, Stefan; Gagneux, Sebastien			Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes	NATURE GENETICS			English	Article							ANTIBIOTIC-RESISTANCE; BIOLOGICAL COST; BEIJING GENOTYPE; EVOLUTION; FITNESS; PHYLOGEOGRAPHY; PROTEINS; GENETICS	Epidemics of drug-resistant bacteria emerge worldwide, even as resistant strains frequently have reduced fitness compared to their drug-susceptible counterparts(1). Data from model systems suggest that the fitness cost of antimicrobial resistance can be reduced by compensatory mutations(2); however, there is limited evidence that compensatory evolution has any significant role in the success of drug-resistant bacteria in human populations(3-6). Here we describe a set of compensatory mutations in the RNA polymerase genes of rifampicin-resistant M. tuberculosis, the etiologic agent of human tuberculosis (TB). M. tuberculosis strains harboring these compensatory mutations showed a high competitive fitness in vitro. Moreover, these mutations were associated with high fitness in vivo, as determined by examining their relative clinical frequency across patient populations. Of note, in countries with the world's highest incidence of multidrug-resistant (MDR) TB7, more than 30% of MDR clinical isolates had this form of mutation. Our findings support a role for compensatory evolution in the global epidemics of MDR TB8.	[Borrell, Sonia; Malla, Bijaya; Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland; [Comas, Inaki; Rose, Graham] Natl Inst Med Res, Med Res Council, Div Mycobacterial Res, London NW7 1AA, England; [Borrell, Sonia; Malla, Bijaya; Gagneux, Sebastien] Univ Basel, Basel, Switzerland; [Roetzer, Andreas; Niemann, Stefan] Res Ctr Borstel, Borstel, Germany; [Kato-Maeda, Midori] Univ Calif San Francisco, Dept Med, San Francisco Gen Hosp, San Francisco, CA USA; [Galagan, James] MIT, Broad Inst, Cambridge, MA 02139 USA; [Galagan, James] Harvard Univ, Cambridge, MA 02138 USA; [Galagan, James] Boston Univ, Dept Microbiol, Boston, MA 02215 USA	University of Basel; Swiss Tropical & Public Health Institute; MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Basel; Forschungszentrum Borstel; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston University	Gagneux, S (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland.	sebastien.gagneux@unibas.ch	Niemann, Stefan/C-9327-2011; Comas, Iñaki/AAA-1155-2019; Comas, Iñaki/F-1185-2011; Gagneux, Sebastien/ABE-7909-2020	Comas, Iñaki/0000-0001-5504-9408; Comas, Iñaki/0000-0001-5504-9408; Rose, Graham/0000-0002-5097-5426; Niemann, Stefan/0000-0002-6604-0684; Galagan, James/0000-0003-0542-3291; Gagneux, Sebastien/0000-0001-7783-9048	US National Institute of Allergy and Infectious Disease, US National Institutes of Health; US Department of Health and Human Services [HHSN266200400001C, AI090928, AI034238]; Medical Research Council, UK [MRC_U117588500]; Swiss National Science Foundation [PP00A-119205]; European Community [QLK-CT-2002-01612, FP7-223681]; Medical Research Council [MC_U117581288] Funding Source: researchfish; MRC [MC_U117581288] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090928, R01AI034238] Funding Source: NIH RePORTER	US National Institute of Allergy and Infectious Disease, US National Institutes of Health; US Department of Health and Human Services; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Community(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Small and C. Davis Long for stimulating discussions at the onset of this project, D. Young and M. Coscolla for reviewing the manuscript, A. Candel for advice in the interpretation of the RNA polymerase molecular structure and T. Van for technical support. We acknowledge the Wellcome Trust Sanger Institute for making available unpublished DNA sequence data (see URLs). We would like to thank T. Ubben, I. Razio and the other members of the German National Reference Center for Mycobateria for technical assistance and all partners that have contributed to previous studies in regions of high MDR TB incidence and collected some of the strains analyzed here. This project was funded wholly or in part by the US National Institute of Allergy and Infectious Disease, US National Institutes of Health and US Department of Health and Human Services (contract HHSN266200400001C, grants AI090928 and AI034238). This work was also supported by the Medical Research Council, UK (MRC_U117588500), the Swiss National Science Foundation (PP00A-119205) and the European Community LONG-DRUG (QLK-CT-2002-01612) and TB PAN-NET (FP7-223681) projects.	Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Andersson DI, 1999, CURR OPIN MICROBIOL, V2, P489, DOI 10.1016/S1369-5274(99)00005-3; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Bjorkholm B, 2001, P NATL ACAD SCI USA, V98, P14607, DOI 10.1073/pnas.241517298; Blower SM, 2004, NAT MED, V10, P1111, DOI 10.1038/nm1102; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456; Bottger EC, 1998, NAT MED, V4, P1343, DOI 10.1038/3906; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Cox HS, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-134; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hazbon MH, 2008, ANTIMICROB AGENTS CH, V52, P3369, DOI 10.1128/AAC.00309-08; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Kubica T, 2005, INT J TUBERC LUNG D, V9, P646; Levin BR, 2000, GENETICS, V154, P985; Mariam DH, 2004, ANTIMICROB AGENTS CH, V48, P1289, DOI 10.1128/AAC.48.4.1289-1294.2004; Nagaev I, 2001, MOL MICROBIOL, V40, P433, DOI 10.1046/j.1365-2958.2001.02389.x; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Opalka N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000483; Pardini M, 2009, TUBERCULOSIS, V89, P317, DOI 10.1016/j.tube.2009.04.002; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Reynolds MG, 2000, GENETICS, V156, P1471; Sander P, 2002, ANTIMICROB AGENTS CH, V46, P1204, DOI 10.1128/AAC.46.5.1204-1211.2002; Shcherbakov D, 2010, MOL MICROBIOL, V77, P830, DOI 10.1111/j.1365-2958.2010.07218.x; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Supply P, 2003, MOL MICROBIOL, V47, P529, DOI 10.1046/j.1365-2958.2003.03315.x; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; World Health Organization, 2010, GLOB TUB CONTR SURV	39	359	372	1	81	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2012	44	1					106	U147		10.1038/ng.1038	http://dx.doi.org/10.1038/ng.1038			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	22179134	Green Accepted			2022-12-25	WOS:000298664000023
J	Elia, J; Glessner, JT; Wang, K; Takahashi, N; Shtir, CJ; Hadley, D; Sleiman, PMA; Zhang, HT; Kim, CE; Robison, R; Lyon, GJ; Flory, JH; Bradfield, JP; Imielinski, M; Hou, CP; Frackelton, EC; Chiavacci, RM; Sakurai, T; Rabin, C; Middleton, FA; Thomas, KA; Garris, M; Mentch, F; Freitag, CM; Steinhausen, HC; Todorov, AA; Reif, A; Rothenberger, A; Franke, B; Mick, EO; Roeyers, H; Buitelaar, J; Lesch, KP; Banaschewski, T; Ebstein, RP; Mulas, F; Oades, RD; Sergeant, J; Sonuga-Barke, EJS; Renner, TJ; Romanos, M; Romanos, J; Warnke, A; Walitza, S; Meyer, J; Palmason, H; Seitz, C; Loo, SK; Smalley, SL; Biederman, J; Kent, L; Asherson, P; Anney, RJL; Gaynor, JW; Shaw, P; Devoto, M; White, PS; Grant, SFA; Buxbaum, JD; Rapoport, JL; Williams, NM; Nelson, SF; Faraone, SV; Hakonarson, H				Elia, Josephine; Glessner, Joseph T.; Wang, Kai; Takahashi, Nagahide; Shtir, Corina J.; Hadley, Dexter; Sleiman, Patrick M. A.; Zhang, Haitao; Kim, Cecilia E.; Robison, Reid; Lyon, Gholson J.; Flory, James H.; Bradfield, Jonathan P.; Imielinski, Marcin; Hou, Cuiping; Frackelton, Edward C.; Chiavacci, Rosetta M.; Sakurai, Takeshi; Rabin, Cara; Middleton, Frank A.; Thomas, Kelly A.; Garris, Maria; Mentch, Frank; Freitag, Christine M.; Steinhausen, Hans-Christoph; Todorov, Alexandre A.; Reif, Andreas; Rothenberger, Aribert; Franke, Barbara; Mick, Eric O.; Roeyers, Herbert; Buitelaar, Jan; Lesch, Klaus-Peter; Banaschewski, Tobias; Ebstein, Richard P.; Mulas, Fernando; Oades, Robert D.; Sergeant, Joseph; Sonuga-Barke, Edmund J. S.; Renner, Tobias J.; Romanos, Marcel; Romanos, Jasmin; Warnke, Andreas; Walitza, Susanne; Meyer, Jobst; Palmason, Haukur; Seitz, Christiane; Loo, Sandra K.; Smalley, Susan L.; Biederman, Joseph; Kent, Lindsey; Asherson, Philip; Anney, Richard J. L.; Gaynor, J. William; Shaw, Philip; Devoto, Marcella; White, Peter S.; Grant, Struan F. A.; Buxbaum, Joseph D.; Rapoport, Judith L.; Williams, Nigel M.; Nelson, Stanley F.; Faraone, Stephen V.; Hakonarson, Hakon			Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder	NATURE GENETICS			English	Article							HIDDEN-MARKOV MODEL; MICE LACKING; CHILDREN; ADHD; EXPRESSION; REPLICATION; DOPAMINE; CORTEX; SCAN	Attention deficit hyperactivity disorder (ADHD) is a common, heritable neuropsychiatric disorder of unknown etiology. We performed a whole-genome copy number variation (CNV) study on 1,013 cases with ADHD and 4,105 healthy children of European ancestry using 550,000 SNPs. We evaluated statistically significant findings in multiple independent cohorts, with a total of 2,493 cases with ADHD and 9,222 controls of European ancestry, using matched platforms. CNVs affecting metabotropic glutamate receptor genes were enriched across all cohorts (P = 2.1 x 10(-9)). We saw GRM5 (encoding glutamate receptor, metabotropic 5) deletions in ten cases and one control (P = 1.36 x 10(-6)). We saw GRM7 deletions in six cases, and we saw GRM8 deletions in eight cases and no controls. GRM1 was duplicated in eight cases. We experimentally validated the observed variants using quantitative RT-PCR. A gene network analysis showed that genes interacting with the genes in the GRM family are enriched for CNVs in similar to 10% of the cases (P = 4.38 x 10(-10)) after correction for occurrence in the controls. We identified rare recurrent CNVs affecting glutamatergic neurotransmission genes that were overrepresented in multiple ADHD cohorts.	[Glessner, Joseph T.; Wang, Kai; Hadley, Dexter; Sleiman, Patrick M. A.; Zhang, Haitao; Kim, Cecilia E.; Flory, James H.; Bradfield, Jonathan P.; Imielinski, Marcin; Hou, Cuiping; Frackelton, Edward C.; Chiavacci, Rosetta M.; Thomas, Kelly A.; Garris, Maria; Mentch, Frank] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Elia, Josephine] Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Elia, Josephine] Childrens Hosp Philadelphia, Dept Child & Adolescent Psychiat, Philadelphia, PA 19104 USA; [Takahashi, Nagahide; Sakurai, Takeshi; Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, Lab Mol Neuropsychiat, New York, NY USA; [Shtir, Corina J.] Univ Calif Los Angeles, Dept Human Genet & Psychiat, Los Angeles, CA USA; [Robison, Reid; Lyon, Gholson J.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Rabin, Cara; Shaw, Philip] NIMH, Child Psychiat Branch, Bethesda, MD 20892 USA; [Middleton, Frank A.; Faraone, Stephen V.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY USA; [Freitag, Christine M.] Goethe Univ Frankfurt, Dept Child & Adolescent Psychiat Psychosom & psyc, Frankfurt, Germany; [Steinhausen, Hans-Christoph; Asherson, Philip] Univ Zurich, Dept Child & Adolescent Psychiat, Zurich, Switzerland; [Steinhausen, Hans-Christoph] Aarhus Univ Hosp, Aalborg Psychiat Hosp, DK-8000 Aarhus, Denmark; [Steinhausen, Hans-Christoph] Univ Basel, Inst Psychol, Basel, Switzerland; [Todorov, Alexandre A.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Reif, Andreas; Lesch, Klaus-Peter] Univ Wurzburg, Attent Deficit Hyperact Disorder Clin Res Network, Unit Mol Psychiat, Dept Psychiat Psychosomat & Psychotherapy, D-97070 Wurzburg, Germany; [Rothenberger, Aribert] Univ Gottingen, Gottingen, Germany; [Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, Donders Inst Brain Cognit & Behav,Ctr Neurosci, NL-6525 ED Nijmegen, Netherlands; [Mick, Eric O.; Biederman, Joseph] Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Roeyers, Herbert] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium; [Buitelaar, Jan] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands; [Banaschewski, Tobias] Heidelberg Univ, Dept Child & Adolescent Psychiat & Psychotherapy, Cent Inst Mental Hlth, D-6800 Mannheim, Germany; [Ebstein, Richard P.] Natl Univ Singapore, Dept Psychol, Queenstown, Singapore; [Mulas, Fernando] La Fe Univ Hosp, Fac Med, Dept Neuropaediat, Valencia, Spain; [Oades, Robert D.] Univ Duisburg Essen, Clin Child & Adolescent Psychiat, Essen, Germany; [Sergeant, Joseph] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Sonuga-Barke, Edmund J. S.] Univ Southampton, Sch Psychol, Inst Disorder Impulse & Attent, Southampton, Hants, England; [Sonuga-Barke, Edmund J. S.] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium; [Sonuga-Barke, Edmund J. S.] NYU, Ctr Child Study, New York, NY USA; [Renner, Tobias J.; Romanos, Marcel; Romanos, Jasmin; Warnke, Andreas; Walitza, Susanne] Univ Wurzburg, Dept Child & Adolescent Psychiat Psychosomat & Ps, Wurzburg, Germany; [Romanos, Marcel] Univ Hosp Munich, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munich, Germany; [Meyer, Jobst; Palmason, Haukur] Univ Trier, Dept Neurobehav Genet, Inst Psychobiol, Trier, Germany; [Seitz, Christiane] Univ Saarland, Dept Child & Adolescent Psychiat, D-6650 Homburg, Germany; [Loo, Sandra K.; Smalley, Susan L.] Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Kent, Lindsey] Bute Med Sch, St Andrews, Fife, Scotland; [Anney, Richard J. L.] St James Hosp, Dept Psychiat, Trinity Ctr Hlth Sci, Dublin 8, Ireland; [Gaynor, J. William; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Cardiothorac Surg, Philadelphia, PA 19104 USA; [Devoto, Marcella; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Genet, Philadelphia, PA 19104 USA; [Devoto, Marcella; Grant, Struan F. A.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Devoto, Marcella] Univ Roma La Sapienza, Dipartimento Med Sperimentale, Rome, Italy; [Devoto, Marcella] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [White, Peter S.] Childrens Hosp Philadelphia, Ctr Biomed Informat, Philadelphia, PA 19104 USA; [White, Peter S.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Williams, Nigel M.] Cardiff Univ, Sch Med, Dept Psychol Med, Cardiff, S Glam, Wales; [Faraone, Stephen V.] SUNY Upstate Med Univ, Dept Psychiat, Syracuse, NY USA; [Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Pulm Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Icahn School of Medicine at Mount Sinai; University of California System; University of California Los Angeles; Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Goethe University Frankfurt; University of Zurich; Aarhus University; University of Basel; Washington University (WUSTL); University of Wurzburg; University of Gottingen; Radboud University Nijmegen; Radboud University Nijmegen; Harvard University; Harvard Medical School; Massachusetts General Hospital; Ghent University; Radboud University Nijmegen; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; National University of Singapore; University of Duisburg Essen; Vrije Universiteit Amsterdam; University of Southampton; Ghent University; New York University; University of Wurzburg; University of Munich; Universitat Trier; Saarland University; University of California System; University of California Los Angeles; University of St Andrews; Trinity College Dublin; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Sapienza University Rome; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Cardiff University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Hakonarson, H (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.	hakonarson@email.chop.edu	Buxbaum, Joseph D/G-6001-2010; Lyon, Gholson/D-2765-2014; Takahashi, Nagahide/AAR-6268-2020; Lesch, Klaus-Peter/J-4906-2013; Buitelaar, J.K./AAY-7522-2020; Franke, Barbara/D-4836-2009; Shaw, Philip/A-1129-2008; Sonuga-Barke, Edmund j/D-9137-2011; Romanos, Marcel/D-7695-2017; Faraone, Stephen/AAE-7334-2019; Devoto, Marcella/AAP-7595-2021; Buitelaar, Jan K/E-4584-2012; Nelson, Stanley F/D-4771-2009; Hadley, Dexter/ABB-7568-2021; Banaschewski, Tobias/ABE-5985-2020; Renner, Tobias J/I-2120-2013; Walitza, Susanne/AAF-5616-2019; Roeyers, Herbert M/A-5557-2018; Walitza, Susanne/HHS-0438-2022; Faraone, Stephen V/O-7239-2018	Lyon, Gholson/0000-0002-5869-0716; Takahashi, Nagahide/0000-0002-7711-0297; Lesch, Klaus-Peter/0000-0001-8348-153X; Franke, Barbara/0000-0003-4375-6572; Shaw, Philip/0000-0002-1313-2526; Romanos, Marcel/0000-0001-7628-8299; Faraone, Stephen/0000-0002-9217-3982; Buitelaar, Jan K/0000-0001-8288-7757; Nelson, Stanley F/0000-0002-2082-3114; Hadley, Dexter/0000-0003-0990-4674; Banaschewski, Tobias/0000-0003-4595-1144; Walitza, Susanne/0000-0002-8161-8683; Roeyers, Herbert M/0000-0002-4895-583X; Walitza, Susanne/0000-0002-8161-8683; Faraone, Stephen V/0000-0002-9217-3982; Grant, Struan/0000-0003-2025-5302; Ebstein, Richard/0000-0002-3626-541X; Glessner, Joseph/0000-0001-5131-2811; Asherson, Philip/0000-0003-2667-2254; Connolly, John/0000-0003-4396-1226; Freitag, Christine Margarete/0000-0001-9676-4782; DEVOTO, MARCELLA/0000-0002-4431-5114; Buxbaum, Joseph/0000-0001-8898-8313; Mick, Eric/0000-0001-8505-8145; Middleton, Frank/0000-0002-3107-7188; Sonuga-Barke, Edmund/0000-0002-6996-3935; Kent, Lindsey/0000-0002-5315-3399; Newton-Bishop, Julia/0000-0001-9147-6802; Anney, Richard/0000-0002-6083-407X	US National Institutes of Health (NIH) [R01MH62873]; NIH [K23MH066275]; Pfizer; CHOP; University of Pennsylvania National Center for Research Resources [UL1-RR-024134]; Cotswold Foundation; US Department of Health and Human Services [1RC2MH089924]; Seaver Foundation; NIMH [P50MH066392]; Deutsche Forschungsgemeinschaft [KFO 125, SFB 581, SFB TRR 58, ME 1923/5-1, ME 1923/5-3]; Bundesministerium fur Bildung und Forschung (BMBF) [01GV0605]; Medical Research Council [G9817803B, G0801418B] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC2MH089924, P50MH066392, R01MH083823, R01MH062873, K23MH066275] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); CHOP; University of Pennsylvania National Center for Research Resources; Cotswold Foundation; US Department of Health and Human Services; Seaver Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the IMAGE, IMAGE II and PUWMa consortium investigators and the NIMH for making the genotype data available. Funding support for International Multi-Center ADHD Genetics (IMAGE) and IMAGE II Projects was provided by US National Institutes of Health (NIH) grant R01MH62873 to S. V. F., and the genotyping of samples was provided through the Genetic Association Information Network (GAIN). The dataset used for the IMAGE analyses described in this manuscript were obtained from the database of Genotype and Phenotype (dbGaP), which is found at http://www.ncbi.nlm.nih.gov/gap, through dbGaP accession numbers phs000016.v2.p2 (ADHD IMAGE), phs000020.v2.p1 (depression) and phs000019.v1.p1 (psoriasis). Samples and associated phenotype data for the GAIN Major Depression: Stage 1 Genome-wide Association In Population Based Samples Study (principal investigator, P. F. Sullivan, University of North Carolina) were provided by D. I. Boomsma and E. de Geus, Vrije Universiteit Amsterdam (principal investigators, Netherlands Twin Register); B. W. Penninx, Vrije Universiteit Medical Center Amsterdam; F. Zitman, Leiden University Medical Center, Leiden; and W. Nolen, University Medical Center Groningen (principal investigators and site principal investigators, Netherlands Study of Depression and Anxiety). Samples and associated phenotype data for the Collaborative Association Study of Psoriasis were provided by J.T. Elder (University of Michigan, Ann Arbor, Michigan), G. G. Krueger (University of Utah, Salt Lake City, Utah), A. Bowcock (Washington University, St. Louis, Missouri) and G. R. Abecasis (University of Michigan, Ann Arbor, Michigan). Samples and associated phenotype data for the International Multi-Center ADHD Genetics Project were provided by the following investigators: S. V. F. (principal investigator), R.J.L.A., P. A., J.S., R. P. E., B. F., M. Gill, A. Miranda, F. Mulas, R. D. O., H. R., A. Rothenberger, T. B., J. Buitelaar, E. Sonuga-Barke and H.-C. S. (site principal investigators), M. Daly, C. Lange, N. Laird, J. Su and B. Neale (statistical analysis team). Samples and associated phenotype data were accessed through an authorized data access request by H. H. and S. F. A. G. Data collection for the PUWMa sample was supported by NIH grants to S. V. F., J. Biederman, S. Smalley, R. Todd and A. A. T. GWAS genotyping of the PUWMa samples was completed by Genizon and was provided through a grant for genotyping services to S. V. F. The PUWMa consortium represents a Pfizer-funded collaboration among the University of California Los Angeles, Washington University and Massachussetts General Hospital. We thank M. C. O'Donovan, M. Gill, M. J. Owen, P. A. Holmans, A. Thapar, B. M. Neale and A. Miranda for contributing DNA samples and phenotypes to the study and for editing the manuscript. We thank G. DePalma, T. Topner, A. Guiney and H. Zhang for providing samples for the qRT-PCR CNV validation.; The study was supported by an Institutional Development Award to the Center for Applied Genomics from CHOP (H. H.), which funded all of the discovery genome-wide genotyping for this study. This work was additionally supported in part by NIH grant K23MH066275 (J. E.), University of Pennsylvania National Center for Research Resources Clinical and Translational Science Awards grant UL1-RR-024134 (J. E.), by a Research Development Award from the Cotswold Foundation (H. H. and S. F. A. G.) and by US Department of Health and Human Services grant 1RC2MH089924 (H. H.). N. T., T. S. and J. D. B. received support from the Seaver Foundation and a Conte Center for Neuroscience of Mental Disorders grant from the NIMH (P50MH066392).; Sample and phenotype data collection of parts of the IMAGE II cohort was supported by the Deutsche Forschungsgemeinschaft (KFO 125, SFB 581 and SFB TRR 58 to K.-P.L. and A. Reif, ME 1923/5-1 and ME 1923/5-3 to C.M.F. and J.M.) and the Bundesministerium fur Bildung und Forschung (BMBF 01GV0605 to K.-P.L.).	Berthele A, 1999, NEUROREPORT, V10, P3861, DOI 10.1097/00001756-199912160-00026; Carrey N, 2003, CLIN NEUROPHARMACOL, V26, P218, DOI 10.1097/00002826-200307000-00013; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Courvoisie H, 2004, J NEUROPSYCH CLIN N, V16, P63, DOI 10.1176/appi.neuropsych.16.1.63; Cronin S, 2009, EUR J HUM GENET, V17, P213, DOI 10.1038/ejhg.2008.194; Cryan JF, 2003, EUR J NEUROSCI, V17, P2409, DOI 10.1046/j.1460-9568.2003.02667.x; DasBanerjee T, 2008, AM J MED GENET B, V147B, P1554, DOI 10.1002/ajmg.b.30877; de Lanerolle NC, 2010, CURR PSYCHIATRY REV, V6, P135, DOI 10.2174/157340010791196448; Del Bo R, 2008, J NEUROL NEUROSUR PS, V79, P1085, DOI 10.1136/jnnp.2008.149146; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Derks EM, 2008, BEHAV GENET, V38, P11, DOI 10.1007/s10519-007-9178-8; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Dorval KM, 2007, GENES BRAIN BEHAV, V6, P444, DOI 10.1111/j.1601-183X.2006.00273.x; Elia J, 2010, MOL PSYCHIATR, V15, P637, DOI 10.1038/mp.2009.57; Elia J, 2011, LANCET, V377, P377, DOI 10.1016/S0140-6736(11)60120-7; Elia J, 2009, PSYCHIAT GENET, V19, P134, DOI 10.1097/YPG.0b013e32832a5043; Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Gainetdinov RR, 2001, P NATL ACAD SCI USA, V98, P11047, DOI 10.1073/pnas.191353298; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Haberstick BC, 2008, PSYCHOL MED, V38, P1057, DOI 10.1017/S0033291707001584; Jin Z, 2001, NEUROSCI LETT, V315, P45, DOI 10.1016/S0304-3940(01)02315-1; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kessler RC, 2005, BIOL PSYCHIAT, V57, P1442, DOI 10.1016/j.biopsych.2005.04.001; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; Lasky-Su J, 2008, AM J MED GENET B, V147B, P1345, DOI 10.1002/ajmg.b.30867; Lesch KP, 2011, MOL PSYCHIATR, V16, P491, DOI 10.1038/mp.2010.29; Lesch KP, 2008, J NEURAL TRANSM, V115, P1573, DOI 10.1007/s00702-008-0119-3; MacMaster FP, 2003, BIOL PSYCHIAT, V53, P184, DOI 10.1016/S0006-3223(02)01401-4; Makoff A, 1996, MOL BRAIN RES, V40, P165, DOI 10.1016/0169-328X(96)00110-6; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Masuo Y, 2002, NEUROSCI LETT, V335, P124, DOI 10.1016/S0304-3940(02)01167-9; Mick E, 2008, CHILD ADOL PSYCH CL, V17, P261, DOI 10.1016/j.chc.2007.11.011; Mick E, 2008, AM J MED GENET B, V147B, P1412, DOI 10.1002/ajmg.b.30865; Miyamoto K, 2001, BRAIN RES, V901, P252, DOI 10.1016/S0006-8993(01)02281-8; Murias M, 2007, CEREB CORTEX, V17, P1788, DOI 10.1093/cercor/bhl089; Neale BM, 2008, AM J MED GENET B, V147B, P1337, DOI 10.1002/ajmg.b.30866; Oades RD, 1998, PSYCHIAT RES, V80, P177, DOI 10.1016/S0165-1781(98)00064-X; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P96, DOI 10.1093/schbul/sbn155; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Russell V, 2000, BEHAV BRAIN RES, V117, P69, DOI 10.1016/S0166-4328(00)00291-6; Russell VA, 2003, NEUROSCI BIOBEHAV R, V27, P671, DOI 10.1016/j.neubiorev.2003.08.010; Sagvolden T, 2009, NEUROPHARMACOLOGY, V57, P619, DOI 10.1016/j.neuropharm.2009.08.004; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Taniura H, 2006, J BIOL CHEM, V281, P12336, DOI 10.1074/jbc.M512723200; Turic D, 2005, BIOL PSYCHIAT, V57, P1461, DOI 10.1016/j.biopsych.2005.03.025; Turic D, 2004, MOL PSYCHIATR, V9, P169, DOI 10.1038/sj.mp.4001387; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wang L, 2009, HUM BRAIN MAPP, V30, P638, DOI 10.1002/hbm.20530; Wang XK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-360; Williams NM, 2010, LANCET, V376, P1401, DOI 10.1016/S0140-6736(10)61109-9; Wood AC, 2008, BEHAV GENET, V38, P266, DOI 10.1007/s10519-008-9196-1; Zhou KX, 2008, AM J MED GENET B, V147B, P1392, DOI 10.1002/ajmg.b.30878	58	239	250	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2012	44	1					78	U113		10.1038/ng.1013	http://dx.doi.org/10.1038/ng.1013			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	22138692	Green Published, Green Accepted			2022-12-25	WOS:000298664000018
J	Xu, M; Pavone, ME; Woodruff, T				Xu, Min; Pavone, Mary Ellen; Woodruff, Teresa			Fruitful progress to fertility Preserving oocytes from chemodestruction	NATURE MEDICINE			English	Editorial Material							FOLLICLE-STIMULATING-HORMONE; BREAST-CANCER; CHEMOTHERAPY; PRESERVATION; MENOPAUSE; OVARY; WOMEN	Chemotherapy can save the lives of many individuals with cancer. Unfortunately, it usually causes infertility after treatment, posing a concern for these people who will face a lifetime condition that considerably limits the quality of their lives. Advances in the field of oncofertility have brought hope to cancer survivors who long to plan a family; however, standard approaches only rely on cryopreservation of sperms and eggs before treatment and do not prevent infertility. In 'Bedside to Bench', Min Xu, Mary Ellen Pavone and Teresa Woodruff examine a study where individuals treated with gonadotropin-releasing hormone (GnRH) agonists before cancer therapy showed a decreased risk of infertility. How these agonists work to suppress and protect ovarian function and increase fertility in women after treatment is still unclear and begs further investigation at the bench. In 'Bench to Bedside', Amander Clark, Bart Phillips and Kyle Orwig discuss potential experimental options to preserve and restore male fertility after chemotherapy. These approaches will shed light into mechanisms of male fertility and spermatogenesis and may be the alternative to sperm freezing, which is not suitable for prepubertal boys and men unable to make sperm.	[Xu, Min; Pavone, Mary Ellen; Woodruff, Teresa] Northwestern Univ, Dept Obstet & Gynecol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Xu, M (corresponding author), Northwestern Univ, Dept Obstet & Gynecol, Feinberg Sch Med, Chicago, IL 60611 USA.	tkw@northwestern.edu		Woodruff, Teresa/0000-0002-1197-3399; Pavone, Mary Ellen/0000-0001-9682-6381				Badawy A, 2009, FERTIL STERIL, V91, P694, DOI 10.1016/j.fertnstert.2007.12.044; BAUERDANTOIN AC, 1995, ENDOCRINOLOGY, V136, P4432, DOI 10.1210/en.136.10.4432; Broer SL, 2011, HUM REPROD UPDATE, V17, P46, DOI 10.1093/humupd/dmq034; Danforth DR, 2005, FERTIL STERIL, V83, P1333, DOI 10.1016/j.fertnstert.2004.12.030; Del Mastro L, 2011, JAMA-J AM MED ASSOC, V306, P269, DOI 10.1001/jama.2011.991; Del Mastro L, 2011, EXPERT OPIN PHARMACO, V12, P387, DOI 10.1517/14656566.2011.522568; Dierich A, 1998, P NATL ACAD SCI USA, V95, P13612, DOI 10.1073/pnas.95.23.13612; Gerber B, 2011, J CLIN ONCOL, V29, P2334, DOI 10.1200/JCO.2010.32.5704; Hansen KR, 2008, HUM REPROD, V23, P699, DOI 10.1093/humrep/dem408; Jeruss JS, 2009, NEW ENGL J MED, V360, P902, DOI 10.1056/NEJMra0801454; Kang SK, 2003, ENDOCR-RELAT CANCER, V10, P169, DOI 10.1677/erc.0.0100169; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; MAIANI E, 2011, PHARMACOLOGY, V82, P1269; Meirow D, 2004, HUM REPROD, V19, P1294, DOI 10.1093/humrep/deh257; Partridge AH, 2004, J CLIN ONCOL, V22, P4174, DOI 10.1200/jco.2004.01.159; Sverrisdottir A, 2009, BREAST CANCER RES TR, V117, P561, DOI 10.1007/s10549-009-0313-5	16	12	13	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2011	17	12					1562	1563		10.1038/nm.2595	http://dx.doi.org/10.1038/nm.2595			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22146461				2022-12-25	WOS:000297978000024
J	Freilinger, T; Anttila, V; de Vries, B; Malik, R; Kallela, M; Terwindt, GM; Pozo-Rosich, P; Winsvold, B; Nyholt, DR; van Oosterhout, WPJ; Artto, V; Todt, U; Hamalainen, E; Fernandez-Morales, J; Louter, MA; Kaunisto, MA; Schoenen, J; Raitakari, O; Lehtimaki, T; Vila-Pueyo, M; Gobel, H; Wichmann, E; Sintas, C; Uitterlinden, AG; Hofman, A; Rivadeneira, F; Heinze, A; Tronvik, E; van Duijn, CM; Kaprio, J; Cormand, B; Wessman, M; Frants, RR; Meitinger, T; Muller-Myhsok, B; Zwart, JA; Farkkila, M; Macaya, A; Ferrari, MD; Kubisch, C; Palotie, A; Dichgans, M; van den Maagdenberg, AMJM				Freilinger, Tobias; Anttila, Verneri; de Vries, Boukje; Malik, Rainer; Kallela, Mikko; Terwindt, Gisela M.; Pozo-Rosich, Patricia; Winsvold, Bendik; Nyholt, Dale R.; van Oosterhout, Willebrordus P. J.; Artto, Ville; Todt, Unda; Hamalainen, Eija; Fernandez-Morales, Jessica; Louter, Mark A.; Kaunisto, Mari A.; Schoenen, Jean; Raitakari, Olli; Lehtimaki, Terho; Vila-Pueyo, Marta; Goebel, Hartmut; Wichmann, Erich; Sintas, Celia; Uitterlinden, Andre G.; Hofman, Albert; Rivadeneira, Fernando; Heinze, Axel; Tronvik, Erling; van Duijn, Cornelia M.; Kaprio, Jaakko; Cormand, Bru; Wessman, Maija; Frants, Rune R.; Meitinger, Thomas; Mueller-Myhsok, Bertram; Zwart, John-Anker; Farkkila, Markus; Macaya, Alfons; Ferrari, Michel D.; Kubisch, Christian; Palotie, Aarno; Dichgans, Martin; van den Maagdenberg, Arn M. J. M.		Int Headache Genetics Consortium	Genome-wide association analysis identifies susceptibility loci for migraine without aura	NATURE GENETICS			English	Article							GENERAL-POPULATION; NEUROPATHIC PAIN; RECEPTOR; METAANALYSIS; EXPRESSION; COMMON; MEF2; HEADACHE; PROTEIN; FAMILY	Migraine without aura is the most common form of migraine, characterized by recurrent disabling headache and associated autonomic symptoms. To identify common genetic variants associated with this migraine type, we analyzed genome-wide association data of 2,326 clinic-based German and Dutch individuals with migraine without aura and 4,580 population-matched controls. We selected SNPs from 12 loci with 2 or more SNPs associated with P values of <1 x 10(-5) for replication testing in 2,508 individuals with migraine without aura and 2,652 controls. SNPs at two of these loci showed convincing replication: at 1q22 (in MEF2D; replication P = 4.9 x 10(-4); combined P = 7.06 x 10(-11)) and at 3p24 (near TGFBR2; replication P = 1.0 x 10(-4); combined P = 1.17 x 10(-9)). In addition, SNPs at the PHACTR1 and ASTN2 loci showed suggestive evidence of replication (P = 0.01; combined P = 3.20 x 10(-8) and P = 0.02; combined P = 3.86 x 10(-8), respectively). We also replicated associations at two previously reported migraine loci in or near TRPM8 and LRP1. This study identifies the first susceptibility loci for migraine without aura, thereby expanding our knowledge of this debilitating neurological disorder.	[Anttila, Verneri; Winsvold, Bendik; Hamalainen, Eija; Fernandez-Morales, Jessica; Palotie, Aarno] Wellcome Trust Sanger Inst, Cambridge, England; [Freilinger, Tobias; Malik, Rainer; Dichgans, Martin] Klinikum Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany; [Freilinger, Tobias] Klinikum Univ Munchen, Dept Neurol, Munich, Germany; [Anttila, Verneri; Hamalainen, Eija; Kaunisto, Mari A.; Kaprio, Jaakko; Wessman, Maija; Palotie, Aarno] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [de Vries, Boukje; Frants, Rune R.; van den Maagdenberg, Arn M. J. M.] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands; [Kallela, Mikko; Artto, Ville; Farkkila, Markus] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland; [Terwindt, Gisela M.; van Oosterhout, Willebrordus P. J.; Louter, Mark A.; Ferrari, Michel D.; van den Maagdenberg, Arn M. J. M.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [Pozo-Rosich, Patricia] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Neurol, E-08193 Barcelona, Spain; [Pozo-Rosich, Patricia; Fernandez-Morales, Jessica] Univ Autonoma Barcelona, Vall dHebron Res Inst, Headache Res Grp, E-08193 Barcelona, Spain; [Winsvold, Bendik; Zwart, John-Anker] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Winsvold, Bendik; Zwart, John-Anker] Univ Oslo, Oslo, Norway; [Nyholt, Dale R.] Queensland Inst Med Res, Neurogenet Lab, Brisbane, Qld 4006, Australia; [Todt, Unda; Kubisch, Christian] Univ Ulm, Inst Human Genet, Ulm, Germany; [Louter, Mark A.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Kaunisto, Mari A.; Wessman, Maija] Folkhalsan Res Ctr, Helsinki, Finland; [Schoenen, Jean] Univ Liege, Headache Res Unit, Dept Neurol, Liege, Belgium; [Schoenen, Jean] Univ Liege, Headache Res Unit, Grp Interdisciplinaire Genoprote Appl GIGA Neuros, Liege, Belgium; [Raitakari, Olli] Univ Turku, Dept Clin Psychol, Turku, Finland; [Raitakari, Olli] Turku Univ, Cent Hosp, Turku, Finland; [Lehtimaki, Terho] Tampere Univ Hosp, Dept Clin Chem, Tampere, Finland; [Lehtimaki, Terho] Univ Tampere, FIN-33101 Tampere, Finland; [Vila-Pueyo, Marta; Macaya, Alfons] Univ Autonoma Barcelona, Vall dHebron Res Inst, Pediat Neurol Res Grp, E-08193 Barcelona, Spain; [Goebel, Hartmut; Heinze, Axel] Kiel Pain & Headache Ctr, Kiel, Germany; [Wichmann, Erich] Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Sintas, Celia] Univ Barcelona, Dept Genet, Barcelona, Spain; [Sintas, Celia; Cormand, Bru] Biomed Network Res Ctr Rare Dis CIBERER, Barcelona, Spain; [Uitterlinden, Andre G.; Rivadeneira, Fernando] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Hofman, Albert; Rivadeneira, Fernando; van Duijn, Cornelia M.] Erasmus Univ, Dept Epidemiol, Med Ctr, Rotterdam, Netherlands; [Tronvik, Erling] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Kaprio, Jaakko] Natl Inst Hlth & Welf, Dept Mental Hlth & Alcohol Res, Helsinki, Finland; [Cormand, Bru] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Meitinger, Thomas] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-80804 Munich, Germany; [Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Palotie, Aarno] Broad Inst MIT & Harvard, Boston, MA USA; [Palotie, Aarno] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Palotie, Aarno] Univ Helsinki, Cent Hosp, Dept Med Genet, Helsinki, Finland	Wellcome Trust Sanger Institute; University of Munich; University of Munich; University of Helsinki; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Helsinki; Helsinki University Central Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; University of Oslo; University of Oslo; QIMR Berghofer Medical Research Institute; Ulm University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Folkhalsan Research Center; University of Liege; University of Liege; University of Turku; University of Turku; Tampere University; Tampere University Hospital; Autonomous University of Barcelona; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Norwegian University of Science & Technology (NTNU); University of Helsinki; Finland National Institute for Health & Welfare; University of Barcelona; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Max Planck Society; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Palotie, A (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	ap8@sanger.ac.uk; maagdenberg@lumc.nl	Kaprio, Jaakko/A-1820-2008; Göbel, Hartmut/AAE-4719-2020; Kubisch, Christian/F-1893-2011; Rivadeneira, Fernando/O-5385-2015; van den Maagdenberg, Arn M.J.M./AAE-9052-2019; Meitinger, Thomas/O-1318-2015; Lehtimäki, Terho/AAD-1094-2022; Palta, Priit/W-2477-2019; Gormley, Padhraig/L-1949-2018; Müller-Myhsok, Bertram/A-3289-2013; Cormand, Bru/H-5338-2015; Ferrari, Michel D./ABE-3758-2021; Nyholt, Dale Robert/J-3174-2017; Dichgans, Martin/HCH-3247-2022; Raitakari, Olli/AAQ-7389-2021; Winsvold, Bendik/ABF-7839-2021; Vila-Pueyo, Marta/M-2530-2019; Vila-Pueyo, Marta/C-8415-2018	Kaprio, Jaakko/0000-0002-3716-2455; Kubisch, Christian/0000-0003-4220-0978; Rivadeneira, Fernando/0000-0001-9435-9441; Lehtimäki, Terho/0000-0002-2555-4427; Palta, Priit/0000-0001-9320-7008; Gormley, Padhraig/0000-0002-8908-6968; Cormand, Bru/0000-0001-5318-4382; Ferrari, Michel D./0000-0001-9691-9449; Nyholt, Dale Robert/0000-0001-7159-3040; Dichgans, Martin/0000-0002-0654-387X; Winsvold, Bendik/0000-0003-4171-8919; Vila-Pueyo, Marta/0000-0003-0652-2988; Pozo-Rosich, Patricia/0000-0003-0796-4702; Selmer, Kaja Kristine/0000-0003-4871-112X; Macaya Ruiz, Alfons/0000-0001-7998-4185; Kaunisto, Mari/0000-0002-6946-9195; Anttila, Verneri/0000-0002-0073-4675; Palotie, Aarno/0000-0002-2527-5874; Van Duijn, Cornelia/0000-0002-2374-9204; Malik, Rainer/0000-0001-9212-2520; Stefansson, Hreinn/0000-0002-9331-6666; Meitinger, Thomas/0000-0002-8838-8403	German Federal Ministry of Education and Research (BMBF) [01GS08121]; Spanish Ministry of Science and Innovation [SAF2009-13182-C03]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) [2009SGR78, 2009SGR971]; Vascular Dementia Research Foundation; Netherlands Organization for Health Research and Development (ZonMw) [90700217]; VIDI (ZonMw) [91711319]; Netherlands Organisation for Scientific Research (NWO) VICI [918.56.602]; Netherlands Organisation for Scientific Research (NWO) Spinoza; Center for Medical Systems Biology (CMSB) established in the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NGI/NWO) [050-060-409, 050-060-810]; Erasmus Medical Center, Erasmus University Rotterdam [175.010.2005.011, 911-03-012]; Ministries of Education, Culture and Science, Health, Welfare and Sports; NGI; Research Institute for Diseases in the Elderly [014-93-015, RIDE2]; German Federal Ministry of Education and Research (BMBF) within the framework of the National Genome Research Network (NGFN-Plus) [01GS08120, 01GS1103]; German Federal Ministry of Education and Research; State of Bavaria within the Munich Center of Health Sciences (MC Health); National Health and Medical Research Council (NHMRC) [613674]; Australian Research Council (ARC) [FT0991022]; Wellcome Trust [098051]; Academy of Finland [251704, 139795]; Academy of Finland, Center of Excellence in Complex Disease Genetics [213506, 129680]; South-Eastern Norway Regional Health Authority [2010075, 2011083]; Unger-Vetlesen Medical Fund; Ullevaal fund; European Community; ENGAGE Consortium [HEALTH-F4-2007-201413]; EU/SYNSYS-Synaptic Systems [242167]; Sigrid Juselius Foundation, Finland; Folkhalsan Research Foundation, Helsinki; Helsinki University Central Hospital	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Vascular Dementia Research Foundation; Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); VIDI (ZonMw); Netherlands Organisation for Scientific Research (NWO) VICI(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Scientific Research (NWO) Spinoza(Netherlands Organization for Scientific Research (NWO)); Center for Medical Systems Biology (CMSB) established in the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NGI/NWO); Erasmus Medical Center, Erasmus University Rotterdam; Ministries of Education, Culture and Science, Health, Welfare and Sports; NGI; Research Institute for Diseases in the Elderly; German Federal Ministry of Education and Research (BMBF) within the framework of the National Genome Research Network (NGFN-Plus)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); State of Bavaria within the Munich Center of Health Sciences (MC Health); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Wellcome Trust(Wellcome Trust); Academy of Finland(Academy of Finland); Academy of Finland, Center of Excellence in Complex Disease Genetics(Academy of Finland); South-Eastern Norway Regional Health Authority; Unger-Vetlesen Medical Fund; Ullevaal fund; European Community(European Commission); ENGAGE Consortium; EU/SYNSYS-Synaptic Systems; Sigrid Juselius Foundation, Finland(Sigrid Juselius Foundation); Folkhalsan Research Foundation, Helsinki; Helsinki University Central Hospital	We wish to thank all individuals in the respective cohorts for their generous participation. This work was supported by the German Federal Ministry of Education and Research (BMBF) (grant 01GS08121 to M.D., along with support to E.W. in the context of the German National Genome Research Network, (NGFN-2 and NGFN-plus) for the Heinz Nixdorf Recall Study); the Spanish Ministry of Science and Innovation (grant SAF2009-13182-C03 to A.M. and B.C.); the Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) (grants 2009SGR78 and 2009SGR971 to A.M. and B.C., respectively); an unrestricted grant of the Vascular Dementia Research Foundation (to M.D.); the Netherlands Organization for Health Research and Development (ZonMw) (90700217) and VIDI (ZonMw) (91711319 to G.M.T.); the Netherlands Organisation for Scientific Research (NWO) VICI (918.56.602) and Spinoza (2009) grants (to M.D.F.); the Center for Medical Systems Biology (CMSB) established in the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NGI/NWO) (project 050-060-409 to C.M.v.D., R.R.F., M.D.F. and A.M.J.M.v.d.M. and 050-060-810 to C.M.v.D.) and the generation and management of GWAS genotype data for the Rotterdam Study (175.010.2005.011 and 911-03-012) (funded by the Erasmus Medical Center, Erasmus University Rotterdam and the Ministries of Education, Culture and Science, Health, Welfare and Sports), as well as the NGI-sponsored Netherlands Consortium for Healthy Aging (NCHA) and the Research Institute for Diseases in the Elderly (014-93-015; RIDE2); the German Federal Ministry of Education and Research (BMBF) within the framework of the National Genome Research Network (NGFN-Plus; grants 01GS08120 and 01GS1103 to C.K.); the German Federal Ministry of Education and Research and the State of Bavaria, supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ) for the KORA research platform, which was initiated by the Helmholtz Center Munich, German Research Center for Environmental Health; the National Health and Medical Research Council (NHMRC) Research Fellowship (613674) and the Australian Research Council (ARC) Future Fellowship (FT0991022) schemes (to D.R.N.); the Wellcome Trust (grant 098051 to A.P.); the Academy of Finland (grant 251704 to A.P. and 139795 to M.W.); the Academy of Finland, Center of Excellence in Complex Disease Genetics (grants 213506 and 129680 to A.P. and J.K.); the South-Eastern Norway Regional Health Authority (2010075 and 2011083 to B.W. and J.-A.Z.), the Unger-Vetlesen Medical Fund (to B.W.) and the Ullevaal fund (to B.W.); the European Community's Seventh Framework Programme (FP7/2007-2013), the ENGAGE Consortium, (grant agreement HEALTH-F4-2007-201413); EU/SYNSYS-Synaptic Systems (grant 242167 to A.P.); the Sigrid Juselius Foundation, Finland (to A.P.); the Folkhalsan Research Foundation, Helsinki (to M.W.); and the Helsinki University Central Hospital (to M.K., V. Artto and M.F.).	Allen PB, 2004, P NATL ACAD SCI USA, V101, P7187, DOI 10.1073/pnas.0401673101; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Anttila V, 2010, NAT GENET, V42, P869, DOI 10.1038/ng.652; Aurora SK, 2007, CEPHALALGIA, V27, P1442, DOI 10.1111/j.1468-2982.2007.01502.x; Caspani O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007383; Chasman DI, 2011, NAT GENET, V43, P695, DOI 10.1038/ng.856; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; d'Agostino VC, 2010, NEUROL SCI, V31, P159, DOI 10.1007/s10072-010-0316-3; DaSilva AFM, 2007, NEUROLOGY, V69, P1990, DOI 10.1212/01.wnl.0000291618.32247.2d; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; FERRARI MD, 1990, NEUROLOGY, V40, P1582, DOI 10.1212/WNL.40.10.1582; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Goadsby PJ, 2002, NEW ENGL J MED, V346, P257, DOI 10.1056/NEJMra010917; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Jarray R, 2011, BIOCHIMIE, V93, P1668, DOI 10.1016/j.biochi.2011.07.010; Kallela M, 2001, EUR J NEUROL, V8, P441, DOI 10.1046/j.1468-1331.2001.00260.x; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kruit MC, 2004, JAMA-J AM MED ASSOC, V291, P427, DOI 10.1001/jama.291.4.427; Launer LJ, 1999, NEUROLOGY, V53, P537, DOI 10.1212/WNL.53.3.537; Law C, 2006, J MED GENET, V43, P908, DOI 10.1136/jmg.2006.042176; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; Lin X, 1996, MOL BRAIN RES, V42, P307, DOI 10.1016/S0169-328X(96)00135-0; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; Markovics A, 2012, NEUROBIOL DIS, V45, P633, DOI 10.1016/j.nbd.2011.10.010; MARTINEZ F, 1993, CEPHALALGIA, V13, P89, DOI 10.1046/j.1468-2982.1993.1302089.x; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Olesen J, 2007, CEPHALALGIA, V27, P995, DOI 10.1111/j.1468-2982.2007.01397.x; Pfeiffer BE, 2010, NEURON, V66, P191, DOI 10.1016/j.neuron.2010.03.017; Proudfoot CJ, 2006, CURR BIOL, V16, P1591, DOI 10.1016/j.cub.2006.07.061; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rist PM, 2011, CEPHALALGIA, V31, P886, DOI 10.1177/0333102411401634; Russell MB, 1996, CEPHALALGIA, V16, P239, DOI 10.1046/j.1468-2982.1996.1604239.x; Schytz HW, 2009, BRAIN, V132, P16, DOI 10.1093/brain/awn307; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Stovner LJ, 2006, EUR J NEUROL, V13, P333, DOI 10.1111/j.1468-1331.2006.01184.x; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Tietjen GE, 2009, CEPHALALGIA, V29, P989, DOI 10.1111/j.1468-2982.2009.01937.x; Tottene A, 2009, NEURON, V61, P762, DOI 10.1016/j.neuron.2009.01.027; Wilson PM, 2010, J NEUROSCI, V30, P8529, DOI 10.1523/JNEUROSCI.0032-10.2010	49	232	234	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2012	44	7					777	U205		10.1038/ng.2307	http://dx.doi.org/10.1038/ng.2307			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967DP	22683712	Green Accepted, Green Submitted			2022-12-25	WOS:000305886900011
J	Zeissig, S; Murata, K; Sweet, L; Publicover, J; Hu, ZY; Kaser, A; Bosse, E; Iqbal, J; Hussain, MM; Balschun, K; Rocken, C; Arlt, A; Gunther, R; Hampe, J; Schreiber, S; Baron, JL; Moody, DB; Liang, TJ; Blumberg, RS				Zeissig, Sebastian; Murata, Kazumoto; Sweet, Lindsay; Publicover, Jean; Hu, Zongyi; Kaser, Arthur; Bosse, Esther; Iqbal, Jahangir; Hussain, M. Mahmood; Balschun, Katharina; Roecken, Christoph; Arlt, Alexander; Guenther, Rainer; Hampe, Jochen; Schreiber, Stefan; Baron, Jody L.; Moody, D. Branch; Liang, T. Jake; Blumberg, Richard S.			Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity	NATURE MEDICINE			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; NKT CELLS; IN-VIVO; ANTIGEN PRESENTATION; PHOSPHOLIPASE A(2); MICROBIAL INFECTION; VIRAL CLEARANCE; SURFACE-ANTIGEN; MOUSE MODEL; INNATE	In most adult humans, hepatitis B is a self-limiting disease leading to life-long protective immunity, which is the consequence of a robust adaptive immune response occurring weeks after hepatitis B virus (HBV) infection. Notably, HBV-specific T cells can be detected shortly after infection, but the mechanisms underlying this early immune priming and its consequences for subsequent control of viral replication are poorly understood. Using primary human and mouse hepatocytes and mouse models of transgenic and adenoviral HBV expression, we show that HBV-expressing hepatocytes produce endoplasmic reticulum (ER)-associated endogenous antigenic lipids including lysophospholipids that are generated by HBV-induced secretory phospholipases and that lead to activation of natural killer T (NKT) cells. The absence of NKT cells or CD1d or a defect in ER-associated transfer of lipids onto CD1d results in diminished HBV-specific T and B cell responses and delayed viral control in mice. NKT cells may therefore contribute to control of HBV infection through sensing of HBV-induced modified self-lipids.	[Zeissig, Sebastian; Kaser, Arthur; Blumberg, Richard S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA; [Zeissig, Sebastian; Bosse, Esther; Arlt, Alexander; Guenther, Rainer; Hampe, Jochen; Schreiber, Stefan] Univ Kiel, Univ Med Ctr Schleswig Holstein, Dept Internal Med 1, Kiel, Germany; [Murata, Kazumoto; Hu, Zongyi; Liang, T. Jake] NIDDK, Liver Dis Branch, US Natl Inst Hlth, Bethesda, MD USA; [Sweet, Lindsay; Moody, D. Branch] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Publicover, Jean; Baron, Jody L.] Univ Calif San Francisco, Ctr Liver, Dept Med, San Francisco, CA 94143 USA; [Iqbal, Jahangir; Hussain, M. Mahmood] SUNY Hlth Sci Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Hussain, M. Mahmood] SUNY Hlth Sci Ctr, Dept Pediat, Brooklyn, NY 11203 USA; [Balschun, Katharina; Roecken, Christoph] Univ Kiel, Univ Med Ctr Schleswig Holstein, Dept Pathol, Kiel, Germany	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Kiel; Schleswig Holstein University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Harvard University; Brigham & Women's Hospital; University of California System; University of California San Francisco; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Kiel; Schleswig Holstein University Hospital	Blumberg, RS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA.	jliang@nih.gov; rblumberg@partners.org	Hampe, Jochen/A-2555-2010; Zeissig, Sebastian/B-6297-2012; Arlt, Alexander/G-7308-2019; Röcken, Christoph/A-9239-2010; Iqbal, Jahangir/B-3903-2014	Hampe, Jochen/0000-0002-2421-6127; Zeissig, Sebastian/0000-0001-5124-0897; Arlt, Alexander/0000-0002-6160-1059; Röcken, Christoph/0000-0002-6989-8002; Iqbal, Jahangir/0000-0002-9021-2271	US National Institutes of Health (NIH) [DK51362, DK44319, DK53056, DK88199]; Harvard Digestive Diseases Center [DK034854]; Deutsche Forschungsgemeinschaft [Ze 814/1-1, Ze 814/4-1]; Marie Curie International Reintegration Grant within the 7th European Community Framework Programme [256363]; Crohn's and Colitis Foundation of America; Austrian Science Fund; Max Kade Foundation; NIH [AR048632, AI049313]; Burroughs Wellcome Fund for Translational Research; NIH Intramural Research Program; Burroughs Wellcome Fund [AI068090, DK026743]; A.P. Gianinni Foundation;  [DK46900]; Austrian Science Fund (FWF) [P 21530] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049313, R01AI068090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, R29DK046900, P30DK026743, R01DK093646, ZIADK054500, R01DK044319, R37DK044319, R56DK046900, R01DK051362, R01DK046900, R01DK053056, R01DK088199] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Marie Curie International Reintegration Grant within the 7th European Community Framework Programme(European Commission); Crohn's and Colitis Foundation of America; Austrian Science Fund(Austrian Science Fund (FWF)); Max Kade Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund for Translational Research(Burroughs Wellcome Fund); NIH Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); A.P. Gianinni Foundation; ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by US National Institutes of Health (NIH) grants DK51362, DK44319, DK53056, DK88199, the Harvard Digestive Diseases Center DK034854 (to R.S.B.); the Deutsche Forschungsgemeinschaft (Ze 814/1-1, Ze 814/4-1), a Marie Curie International Reintegration Grant within the 7th European Community Framework Programme (256363) and the Crohn's and Colitis Foundation of America (to S.Z.); the Crohn's and Colitis Foundation of America, Austrian Science Fund, and Max Kade Foundation (to A.K.); NIH AR048632, AI049313 and the Burroughs Wellcome Fund for Translational Research (to D.B.M.); DK46900 (to M.M.H.); the NIH Intramural Research Program (K.M., Z.H. and T.J.L.); NIH grants AI068090, DK026743 and the Burroughs Wellcome Fund (to J.L.B.); and the A.P. Gianinni Foundation (to J.P.). We thank D.E. Cohen, E. Scapa and S.K. Dougan for insightful discussions.	Arrenberg P, 2010, P NATL ACAD SCI USA, V107, P10984, DOI 10.1073/pnas.1000576107; Baron JL, 2002, IMMUNITY, V16, P583, DOI 10.1016/S1074-7613(02)00305-9; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2011, J EXP MED, V208, P1163, DOI 10.1084/jem.20102555; Brozovic S, 2004, NAT MED, V10, P535, DOI 10.1038/nm1043; Calabrese LH, 2006, ANN RHEUM DIS, V65, P983, DOI 10.1136/ard.2005.043257; CHISARI FV, 1987, P NATL ACAD SCI USA, V84, P6909, DOI 10.1073/pnas.84.19.6909; Cox D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005325; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Dougan SK, 2005, J EXP MED, V202, P529, DOI 10.1084/jem.20050183; Dougan SK, 2007, J EXP MED, V204, P533, DOI 10.1084/jem.20062006; ERNSTER L, 1962, J CELL BIOL, V15, P541, DOI 10.1083/jcb.15.3.541; Esteve M, 2004, GUT, V53, P1363, DOI 10.1136/gut.2004.040675; Fisicaro P, 2009, GUT, V58, P974, DOI 10.1136/gut.2008.163600; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fox LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000228; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Fujii SI, 2004, J EXP MED, V199, P1607, DOI 10.1084/jem.20040317; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Guy CS, 2008, J VIROL, V82, P8579, DOI 10.1128/JVI.01022-08; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Isogawa M, 2005, VIROLOGY, V333, P293, DOI 10.1016/j.virol.2005.01.004; Ito M, 2004, J GASTROEN HEPATOL, V19, P1140, DOI 10.1111/j.1440-1746.2004.03435.x; Kakimi K, 2000, J EXP MED, V192, P921, DOI 10.1084/jem.192.7.921; Kaser A, 2008, EUR J IMMUNOL, V38, P2351, DOI 10.1002/eji.200738102; Khatun I, 2012, HEPATOLOGY, V55, P1356, DOI 10.1002/hep.25504; Kuwata H, 2004, BBA-MOL CELL BIOL L, V1686, P15, DOI 10.1016/j.bbalip.2004.07.002; Masuda S, 2005, BBA-MOL CELL BIOL L, V1736, P200, DOI 10.1016/j.bbalip.2005.08.014; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Nagarajan NA, 2007, J IMMUNOL, V178, P2706, DOI 10.4049/jimmunol.178.5.2706; Ni Z, 2006, J BIOL CHEM, V281, P16245, DOI 10.1074/jbc.M513874200; Patient R, 2009, CELL MICROBIOL, V11, P1561, DOI 10.1111/j.1462-5822.2009.01363.x; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Publicover J, 2011, J CLIN INVEST, V121, P1154, DOI 10.1172/JCI44198; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; SATOH O, 1990, J LIPID RES, V31, P1293; Scapa EF, 2008, FASEB J, V22, P2579, DOI 10.1096/fj.07-105395; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; Sprinzl MF, 2001, J VIROL, V75, P5108, DOI 10.1128/JVI.75.11.5108-5118.2001; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Thimme R, 2003, J VIROL, V77, P68, DOI 10.1128/JVI.77.1.68-76.2003; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Tischfield JA, 1996, GENOMICS, V32, P328, DOI 10.1006/geno.1996.0126; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Vilarinho S, 2007, P NATL ACAD SCI USA, V104, P18187, DOI 10.1073/pnas.0708968104; von Freyend MJ, 2011, J VIRAL HEPATITIS, V18, P216, DOI 10.1111/j.1365-2893.2010.01302.x; Webster GJM, 2000, HEPATOLOGY, V32, P1117, DOI 10.1053/jhep.2000.19324; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101; Yeo WN, 2009, J CLIN ONCOL, V27, P605, DOI 10.1200/JCO.2008.18.0182; Zeissig S, 2010, J CLIN INVEST, V120, P2889, DOI 10.1172/JCI42703	55	167	178	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2012	18	7					1060	+		10.1038/nm.2811	http://dx.doi.org/10.1038/nm.2811			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22706385	Green Accepted			2022-12-25	WOS:000306121600035
J	Hopkins, MM; Hogarth, S				Hopkins, Michael M.; Hogarth, Stuart			Biomarker patents for diagnostics: problem or solution?	NATURE BIOTECHNOLOGY			English	Editorial Material							PHARMACOGENETICS; GENE		[Hopkins, Michael M.] Univ Sussex, SPRU Sci & Technol Policy Res, Brighton, E Sussex, England; [Hogarth, Stuart] Kings Coll London, Dept Social Sci Hlth & Med, London WC2R 2LS, England	University of Sussex; University of London; King's College London	Hopkins, MM (corresponding author), Univ Sussex, SPRU Sci & Technol Policy Res, Brighton, E Sussex, England.	m.m.hopkins@sussex.ac.uk; stuart.hogarth@kcl.ac.uk		Hogarth, Stuart/0000-0001-6796-8815	Economic and Social Research Council [ES/J012521/1] Funding Source: researchfish; ESRC [ES/J012521/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		*ASS U TECHN MAN, 2007, PUBL INT 9 POINTS CO; Baker M, 2006, NAT BIOTECHNOL, V24, P931, DOI 10.1038/nbt0806-931; Carbone J, 2010, NAT BIOTECHNOL, V28, P784, DOI 10.1038/nbt0810-784; Cho MK, 2003, J MOL DIAGN, V5, P3, DOI 10.1016/S1525-1578(10)60444-8; Cornish W.R., 2003, INTELLECTUAL PROPERT; Digene Corp, 2003, ANN REP DIG CORP; Gaisser S, 2009, NATURE, V458, P407, DOI 10.1038/458407a; Garrison LP, 2006, HEALTH AFFAIR, V25, P1281, DOI 10.1377/hlthaff.25.5.1281; Hogarth S, 2012, SOCIOL HEALTH ILL, V34, P234, DOI 10.1111/j.1467-9566.2011.01411.x; Hopkins MM, 2006, NAT BIOTECHNOL, V24, P403, DOI 10.1038/nbt0406-403; Human Genetics Commission, 2011, INT PROP DNA DIAGN; Huys I, 2011, EUR J HUM GENET, V19, P1104, DOI 10.1038/ejhg.2011.76; Huys I, 2009, NAT BIOTECHNOL, V27, P903, DOI 10.1038/nbt1009-903; Liddell K, 2008, INTELLECTUAL PROPERT, V3, P286; Malik NN, 2011, NAT BIOTECHNOL, V29, P390, DOI 10.1038/nbt.1869; Matthijs G, 2004, BRIT MED J, V329, P1358, DOI 10.1136/bmj.329.7479.1358; NASS SJ, 2007, CANC BIOMARKERS PROM; National Endowment for Science Technology and the Arts, 2006, INN GAP, P24; *NUFF COUNC BIOETH, 2002, ETH PAT DNA; Organisation for Economic Cooperation and Development, 2006, GUID LIC GEN INV; Secretary's Advisory Committee for Genetics Health and Society, 2010, GEN PAT LIC PRACT TH; Stiglitz JE, 2006, BMJ-BRIT MED J, V333, P1279, DOI 10.1136/bmj.39048.428380.80; Thompson M, 2011, BRIT MED J, V342, pd2973	23	12	12	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2012	30	6					498	501		10.1038/nbt.2257	http://dx.doi.org/10.1038/nbt.2257			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	957JV	22678384	Bronze			2022-12-25	WOS:000305158600016
J	Jankowski, W; Saleh, T; Pai, MT; Sriram, G; Birge, RB; Kalodimos, CG				Jankowski, Wojciech; Saleh, Tamjeed; Pai, Ming-Tao; Sriram, Ganapathy; Birge, Raymond B.; Kalodimos, Charalampos G.			Domain organization differences explain Bcr-Abl's preference for CrkL over CrkII	NATURE CHEMICAL BIOLOGY			English	Article							TERMINAL SH3 DOMAIN; ADAPTER PROTEIN; STRUCTURAL BASIS; C-CRK; SIGNAL-TRANSDUCTION; CANCER; CELLS; PHOSPHORYLATION; IDENTIFICATION; LEUKEMIA	CrkL is a key signaling protein that mediates the leukemogenic activity of Bcr-Abl. CrkL is thought to adopt a structure that is similar to that of its CrkII homolog. The two proteins share high sequence identity and indistinguishable ligand binding preferences, yet they have distinct physiological roles. Here we show that the structures of CrkL and phosphorylated CrkL are markedly different than the corresponding structures of CrkII. As a result, the binding activities of the Src homology 2 and Src homology 3 domains in the two proteins are regulated in a distinct manner and to a different extent. The different structural architecture of CrkL and CrkII may account for their distinct functional roles. The data show that CrkL forms a constitutive complex with Abl, thus explaining the strong preference of Bcr-Abl for CrkL. The results also highlight how the structural organization of the modular domains in adaptor proteins can control signaling outcome.	[Jankowski, Wojciech; Saleh, Tamjeed; Pai, Ming-Tao; Kalodimos, Charalampos G.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Sriram, Ganapathy; Birge, Raymond B.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Jankowski, W (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA.	babis@rutgers.edu	Kalodimos, Charalampos/Q-9846-2018; Saleh, Tamjeed/M-8698-2016	Kalodimos, Charalampos/0000-0001-6354-2796; Saleh, Tamjeed/0000-0002-7539-7300	US Department of Defense; US National Institutes of Health [GM80308]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080308] Funding Source: NIH RePORTER	US Department of Defense(United States Department of Defense); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Karamanou for performing the MALLS experiments and D. Duffield for collecting the mass spectrometry data. This work was supported by the US Department of Defense (R.B.B.) and the US National Institutes of Health (GM80308 to C.G.K.).	Antoku S, 2009, J CELL SCI, V122, P4228, DOI 10.1242/jcs.054627; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; Cheerathodi M, 2011, J PROTEOME RES, V10, P4453, DOI 10.1021/pr200229a; Cho JH, 2011, NAT STRUCT MOL BIOL, V18, P550, DOI 10.1038/nsmb.2039; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; deJong R, 1997, ONCOGENE, V14, P507, DOI 10.1038/sj.onc.1200885; Donaldson LW, 2002, P NATL ACAD SCI USA, V99, P14053, DOI 10.1073/pnas.212518799; FELLER SM, 1994, EMBO J, V13, P2341, DOI 10.1002/j.1460-2075.1994.tb06518.x; Feng RH, 2010, CANCER LETT, V298, P50, DOI 10.1016/j.canlet.2010.06.004; Guris DL, 2001, NAT GENET, V27, P293, DOI 10.1038/85855; Harkiolaki M, 2006, STRUCTURE, V14, P1741, DOI 10.1016/j.str.2006.09.013; Huang XD, 2008, J CELL BIOL, V183, P711, DOI 10.1083/jcb.200801192; Isakov N, 2008, TRENDS IMMUNOL, V29, P388, DOI 10.1016/j.it.2008.04.006; Kardinal C, 2000, FASEB J, V14, P1529, DOI 10.1096/fj.14.11.1529; Kim YH, 2010, ONCOGENE, V29, P1421, DOI 10.1038/onc.2009.437; Kobashigawa Y, 2007, NAT STRUCT MOL BIOL, V14, P503, DOI 10.1038/nsmb1241; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Lucas CM, 2010, BRIT J HAEMATOL, V149, P458, DOI 10.1111/j.1365-2141.2009.08066.x; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; MATSUDA M, 1992, MOL CELL BIOL, V12, P3482, DOI 10.1128/MCB.12.8.3482; Mihrshahi R, 2010, J IMMUNOL, V185, P7216, DOI 10.4049/jimmunol.1002858; Mintz PJ, 2009, P NATL ACAD SCI USA, V106, P2182, DOI 10.1073/pnas.0807543105; Mittermaier AK, 2009, TRENDS BIOCHEM SCI, V34, P601, DOI 10.1016/j.tibs.2009.07.004; Muralidharan V, 2006, BIOCHEMISTRY-US, V45, P8874, DOI 10.1021/bi060590z; NICHOLS GL, 1994, BLOOD, V84, P2912; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Pawson T, 2007, CURR OPIN CELL BIOL, V19, P112, DOI 10.1016/j.ceb.2007.02.013; REN RB, 1994, GENE DEV, V8, P783, DOI 10.1101/gad.8.7.783; ROSEN MK, 1995, NATURE, V374, P477, DOI 10.1038/374477a0; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Sarkar P, 2007, MOL CELL, V25, P413, DOI 10.1016/j.molcel.2007.01.004; Sarkar P, 2011, NAT CHEM BIOL, V7, P51, DOI 10.1038/NCHEMBIO.494; Sattler M, 1998, LEUKEMIA, V12, P637, DOI 10.1038/sj.leu.2401010; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Senechal K, 1998, MOL CELL BIOL, V18, P5082, DOI 10.1128/MCB.18.9.5082; Senechal K, 1996, J BIOL CHEM, V271, P23255, DOI 10.1074/jbc.271.38.23255; Seo JH, 2010, CANCER RES, V70, P7325, DOI 10.1158/0008-5472.CAN-10-0607; Seo JH, 2009, MOL CELL BIOL, V29, P3076, DOI 10.1128/MCB.01686-08; Severin A, 2009, J MOL BIOL, V387, P726, DOI 10.1016/j.jmb.2009.02.012; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sriram G, 2011, ONCOGENE, V30, P4645, DOI 10.1038/onc.2011.170; TENHOEVE J, 1994, BLOOD, V84, P1731; TENHOEVE J, 1993, ONCOGENE, V8, P2469; Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020; Wang H, 2010, TUMOR BIOL, V31, P59, DOI 10.1007/s13277-009-0009-9; Wang J, 2011, MOL CARCINOGEN, V50, P506, DOI 10.1002/mc.20745; WU XD, 1995, STRUCTURE, V3, P215, DOI 10.1016/S0969-2126(01)00151-4; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	50	38	39	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2012	8	6					590	596		10.1038/NCHEMBIO.954	http://dx.doi.org/10.1038/NCHEMBIO.954			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	945ET	22581121	Green Accepted, Green Submitted			2022-12-25	WOS:000304256300016
J	Rabinowitz, JD; Vastag, L				Rabinowitz, Joshua D.; Vastag, Livia			Teaching the design principles of metabolism	NATURE CHEMICAL BIOLOGY			English	Article							PYRUVATE-KINASE; METABOLOMICS; PLATFORM; CYCLE; M2		[Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ USA; [Vastag, Livia] Castleton Coll, Dept Chem, Castleton, VT USA	Princeton University; Princeton University	Rabinowitz, JD (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	joshr@princeton.edu	Rabinowitz, Joshua/GPP-4019-2022	Rabinowitz, Joshua/0000-0002-1247-4727	NATIONAL CANCER INSTITUTE [RC1CA147961] Funding Source: NIH RePORTER; NCI NIH HHS [RC1 CA147961] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BERG JM, 2007, BIOCHEMISTRY; Chen M, 2012, NAT STRUCT MOL BIOL, V19, P346, DOI 10.1038/nsmb.2219; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Dellomonaco C, 2011, NATURE, V476, P355, DOI 10.1038/nature10333; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Garrett R., 2010, BIOCHEMISTRY; Goyal S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000802; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Lehninger A., 2005, LEHNINGER PRINCIPLES; Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a; MELENDEZHEVIA E, 1990, BIOMED BIOCHIM ACTA, V49, P903; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Noor E, 2010, MOL CELL, V39, P809, DOI 10.1016/j.molcel.2010.08.031; Patti GJ, 2012, NAT CHEM BIOL, V8, P232, DOI [10.1038/nchembio.767, 10.1038/NCHEMBIO.767]; RILEY M, 1993, MICROBIOL REV, V57, P862, DOI 10.1128/MMBR.57.4.862-952.1993; Vazquez A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000195; Voet D., 2010, BIOCHEMISTRY; Wargacki AJ, 2012, SCIENCE, V335, P308, DOI 10.1126/science.1214547	25	19	20	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2012	8	6					497	501		10.1038/nchembio.969	http://dx.doi.org/10.1038/nchembio.969			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	945ET	22596190	Green Accepted			2022-12-25	WOS:000304256300002
J	Schleiffer, A; Maier, M; Litos, G; Lampert, F; Hornung, P; Mechtler, K; Westermann, S				Schleiffer, Alexandre; Maier, Michael; Litos, Gabriele; Lampert, Fabienne; Hornung, Peter; Mechtler, Karl; Westermann, Stefan			CENP-T proteins are conserved centromere receptors of the Ndc80 complex	NATURE CELL BIOLOGY			English	Article							BUDDING YEAST KINETOCHORE; OUTER KINETOCHORE; MOLECULAR ARCHITECTURE; CHROMOSOME SEGREGATION; STRUCTURE PREDICTION; A NUCLEOSOMES; HISTONE-FOLD; DNA; ALIGNMENT; TENSION	Centromeres direct the assembly of kinetochores, microtubule-attachment sites that allow chromosome segregation on the mitotic spindle. Fundamental differences in size and organization between evolutionarily distant eukaryotic centromeres have in many cases obscured general principles of their function. Here we demonstrate that centromere-binding proteins are highly conserved between budding yeast and humans. We identify the histone-fold protein Cnn1(CENP-T) as a direct centromere receptor of the microtubule-binding Ndc80 complex. The amino terminus of Cnn1 contains a conserved peptide motif that mediates stoichiometric binding to the Spc24-25 domain of the Ndc80 complex. Consistent with the critical role of this interaction, artificial tethering of the Ndc80 complex through Cnn1 allows mini-chromosomes to segregate in the absence of a natural centromere. Our results reveal the molecular function of CENP-T proteins and demonstrate how the Ndc80 complex is anchored to centromeres in a manner that couples chromosome movement to spindle dynamics.	[Schleiffer, Alexandre; Westermann, Stefan] Res Inst Mol Pathol IMP, IMP IMBA Bioinformat Core Facil, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Westermann, S (corresponding author), Res Inst Mol Pathol IMP, IMP IMBA Bioinformat Core Facil, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	westermann@imp.ac.at	Mechtler, Karl/AAF-2717-2019; Maier, Michael/O-8088-2015	Mechtler, Karl/0000-0002-3392-9946; Maier, Michael/0000-0001-8841-5283; Westermann, Stefan/0000-0001-6921-9113; Schleiffer, Alexander/0000-0001-6251-2747	European Research Council under the European Community [203499]; Austrian Science Fund FWF [SFB F34-B03]	European Research Council under the European Community(European Research Council (ERC)); Austrian Science Fund FWF(Austrian Science Fund (FWF))	O. Hudecz for help with presentation of the mass spectrometry results and M. Madalinski for peptide synthesis. We thank P. De Wulf (European Institute of Oncology, Milan, Italy) for the Cnn1-3GFP strain and communicating results before publication. Research in the Westermann laboratory receives funding from the European Research Council under the European Community's Seventh Framework Programme (S.W.. FP7/2007-2013)/ERC grant agreement no. 203499, and from the Austrian Science Fund FWF (S.W., SFB F34-B03).	Akiyoshi B, 2010, NATURE, V468, P576, DOI 10.1038/nature09594; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alushin GM, 2010, NATURE, V467, P805, DOI 10.1038/nature09423; Amano M, 2009, J CELL BIOL, V186, P173, DOI 10.1083/jcb.200903100; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bock L.J, 2012, NAT CELL BIOL; Burley SK, 1997, CURR OPIN STRUC BIOL, V7, P94, DOI 10.1016/S0959-440X(97)80012-7; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Gascoigne KE, 2011, CELL, V145, P410, DOI 10.1016/j.cell.2011.03.031; Guse A, 2011, NATURE, V477, P354, DOI 10.1038/nature10379; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hori T, 2008, MOL BIOL CELL, V19, P843, DOI 10.1091/mbc.E07-06-0556; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Hornung P, 2011, J MOL BIOL, V405, P548, DOI 10.1016/j.jmb.2010.11.012; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kiermaier E, 2009, NAT CELL BIOL, V11, P1109, DOI 10.1038/ncb1924; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Lacefield S, 2009, NAT CELL BIOL, V11, P1116, DOI 10.1038/ncb1925; Lampert F, 2011, NAT REV MOL CELL BIO, V12, P407, DOI 10.1038/nrm3133; Lampert F, 2010, J CELL BIOL, V189, P641, DOI 10.1083/jcb.200912021; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Liu XK, 2005, EMBO J, V24, P2919, DOI 10.1038/sj.emboj.7600762; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Malik HS, 2009, CELL, V138, P1067, DOI 10.1016/j.cell.2009.08.036; Maskell DP, 2010, J CELL BIOL, V190, P823, DOI 10.1083/jcb.201002059; McAinsh AD, 2011, SEMIN CELL DEV BIOL, V22, P946, DOI 10.1016/j.semcdb.2011.09.016; Mendoza MA, 2009, METHODS MOL BIOL, V557, P267, DOI 10.1007/978-1-59745-527-5_17; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nishino T, 2012, CELL, V148, P487, DOI 10.1016/j.cell.2011.11.061; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Petrovic A, 2010, J CELL BIOL, V190, P835, DOI 10.1083/jcb.201002070; Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Rodal AA, 2003, CURR BIOL, V13, P1000, DOI 10.1016/S0960-9822(03)00383-X; Sandman K, 2006, CURR OPIN MICROBIOL, V9, P520, DOI 10.1016/j.mib.2006.08.003; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Screpanti E, 2011, CURR BIOL, V21, P391, DOI 10.1016/j.cub.2010.12.039; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Suzuki A, 2011, J CELL BIOL, V193, P125, DOI 10.1083/jcb.201012050; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Tanaka K, 2009, DEV CELL, V17, P334, DOI 10.1016/j.devcel.2009.08.004; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409; Westermann S, 2003, J CELL BIOL, V163, P215, DOI 10.1083/jcb.200305100; Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; Yan ZJ, 2010, MOL CELL, V37, P865, DOI 10.1016/j.molcel.2010.01.039	63	131	141	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2012	14	6					604	+		10.1038/ncb2493	http://dx.doi.org/10.1038/ncb2493			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	949TW	22561346				2022-12-25	WOS:000304599900010
J	Carter, SL; Cibulskis, K; Helman, E; McKenna, A; Shen, H; Zack, T; Laird, PW; Onofrio, RC; Winckler, W; Weir, BA; Beroukhim, R; Pellman, D; Levine, DA; Lander, ES; Meyerson, M; Getz, G				Carter, Scott L.; Cibulskis, Kristian; Helman, Elena; McKenna, Aaron; Shen, Hui; Zack, Travis; Laird, Peter W.; Onofrio, Robert C.; Winckler, Wendy; Weir, Barbara A.; Beroukhim, Rameen; Pellman, David; Levine, Douglas A.; Lander, Eric S.; Meyerson, Matthew; Getz, Gad			Absolute quantification of somatic DNA alterations in human cancer	NATURE BIOTECHNOLOGY			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; COPY-NUMBER ALTERATION; NUCLEOTIDE POLYMORPHISM ARRAYS; HIGH-RESOLUTION ANALYSIS; ACUTE MYELOID-LEUKEMIA; CHROMOSOMAL INSTABILITY; GENETIC EVOLUTION; PROSTATE-CANCER; TUMOR SAMPLES; SOLID TUMORS	We describe a computational method that infers tumor purity and malignant cell ploidy directly from analysis of somatic DNA alterations. The method, named ABSOLUTE, can detect subclonal heterogeneity and somatic homozygosity, and it can calculate statistical sensitivity for detection of specific aberrations. We used ABSOLUTE to analyze exome sequencing data from 214 ovarian carcinoma tumor-normal pairs. This analysis identified both pervasive subclonal somatic point-mutations and a small subset of predominantly clonal and homozygous mutations, which were overrepresented in the tumor suppressor genes TP53 and NF1 and in a candidate tumor suppressor gene CDK12. We also used ABSOLUTE to infer absolute allelic copy-number profiles from 3,155 diverse cancer specimens, revealing that genome-doubling events are common in human cancer, likely occur in cells that are already aneuploid, and influence pathways of tumor progression (for example, with recessive inactivation of NF1 being less common after genome doubling). ABSOLUTE will facilitate the design of clinical sequencing studies and studies of cancer genome evolution and intra-tumor heterogeneity.	[Carter, Scott L.; Cibulskis, Kristian; Helman, Elena; McKenna, Aaron; Onofrio, Robert C.; Winckler, Wendy; Weir, Barbara A.; Beroukhim, Rameen; Lander, Eric S.; Meyerson, Matthew; Getz, Gad] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Carter, Scott L.; Helman, Elena] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Shen, Hui; Laird, Peter W.] Univ So Calif, Keck Sch Med, USC Epigenome Ctr, Los Angeles, CA 90033 USA; [Zack, Travis] Harvard Univ, Biophys Program, Cambridge, MA 02138 USA; [Zack, Travis; Beroukhim, Rameen; Meyerson, Matthew] Dana Farber Canc Inst, Div Med Oncol, Boston, MA 02115 USA; [Zack, Travis; Beroukhim, Rameen; Meyerson, Matthew] Dana Farber Canc Inst, Div Canc Biol, Boston, MA 02115 USA; [Zack, Travis; Beroukhim, Rameen; Meyerson, Matthew] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Beroukhim, Rameen] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Pellman, David] Harvard Univ, Childrens Hosp, Dana Farber Canc Inst,Dept Cell Biol, Howard Hughes Med Inst,Dept Pediat Oncol,Sch Med, Boston, MA 02115 USA; [Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of Southern California; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Getz, G (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	gadgetz@broadinstitute.org	Meyerson, Matthew L/E-7123-2012; Cibulskis, Kristian/AAC-7380-2019; Shen, Hui/AAO-4387-2020; Laird, Peter W/G-8683-2012	Laird, Peter W/0000-0001-9117-3641; Meyerson, Matthew/0000-0002-9133-8108; Cibulskis, Kristian/0000-0003-1343-1582; Shen, Hui/0000-0001-9767-4084; Levine, Douglas/0000-0003-1038-8232	National Cancer Institute [U24CA126546, U24CA143867, U24CA143845]; National Human Genome Research Institute [T32 HG002295]; US National Institutes of Health (NIH) [5R01 GM083299-14]; Department of Defense [W81XWH-10-1-0222]; NIH/National Institute of General Medical Sciences [5 T32 GM008313]; NIH [K08CA122833, U54CA14379]; National Research Service Award [F32CA113126]; NATIONAL CANCER INSTITUTE [U54CA143798, U24CA143867, K08CA122833, F32CA113126, U24CA143845, U24CA143882, U24CA126546] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313, R01GM083299] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NIH/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Cancer Institute as part of The Cancer Genome Atlas project: U24CA126546 (M.M.), U24CA143867 (M.M.), and U24CA143845 (G.G.). S.L.C. and E.H. were supported by training grant T32 HG002295 from the National Human Genome Research Institute. In addition, D.P. was supported by the US National Institutes of Health (NIH) - 5R01 GM083299-14; D.A.L. by Department of Defense W81XWH-10-1-0222; T.Z. by NIH/National Institute of General Medical Sciences 5 T32 GM008313; R.B. by NIH K08CA122833 and U54CA143798. B.A.W. was supported by National Research Service Award grant F32CA113126.	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Attiyeh EF, 2009, GENOME RES, V19, P276, DOI 10.1101/gr.075671.107; Barrett MT, 1999, NAT GENET, V22, P106, DOI 10.1038/8816; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Bazeley PS, 2011, CELL PROLIFERAT, V44, P212, DOI 10.1111/j.1365-2184.2011.00746.x; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2004, GENOME RES, V14, P287, DOI 10.1101/gr.2012304; Browning BL, 2009, AM J HUM GENET, V85, P847, DOI 10.1016/j.ajhg.2009.11.004; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Carter S.L, 2011, ACCURATE ESTIMATION; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Davoli T, 2010, CELL, V141, P81, DOI 10.1016/j.cell.2010.01.031; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; DUTRILLAUX B, 1991, BREAST CANCER RES TR, V19, P245, DOI 10.1007/BF01961161; Fudenberg G, 2011, NAT BIOTECHNOL, V29, P1109, DOI 10.1038/nbt.2049; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Galipeau PC, 1996, P NATL ACAD SCI USA, V93, P7081, DOI 10.1073/pnas.93.14.7081; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Harris H, 2008, J CELL SCI, V121, P3, DOI 10.1242/jcs.025742; Hicks J, 2005, COLD SH Q B, V70, P51, DOI 10.1101/sqb.2005.70.055; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Levanon K, 2008, J CLIN ONCOL, V26, P5284, DOI 10.1200/JCO.2008.18.1107; Li A, 2011, NUCLEIC ACIDS RES, V39, P4928, DOI 10.1093/nar/gkr014; Lindblad-Toh K, 2000, NAT BIOTECHNOL, V18, P1001, DOI 10.1038/79269; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Lyng H, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r86; Mei R, 2000, GENOME RES, V10, P1126, DOI 10.1101/gr.10.8.1126; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mitelman F, 2000, MUTAT RES-REV MUTAT, V462, P247, DOI 10.1016/S1383-5742(00)00006-5; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Popova T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r128; Roschke AV, 2003, CANCER RES, V63, P8634; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Storchova Z, 2008, J CELL SCI, V121, P3859, DOI 10.1242/jcs.039537; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yau C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r92; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308	60	1206	1239	4	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2012	30	5					413	+		10.1038/nbt.2203	http://dx.doi.org/10.1038/nbt.2203			14	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	939IP	22544022	Green Submitted, Green Accepted, Bronze			2022-12-25	WOS:000303803200021
J	Larder, R; O'Rahilly, S				Larder, Rachel; O'Rahilly, Stephen			Guts over glory-why diets fail	NATURE MEDICINE			English	Editorial Material							LONG-TERM PERSISTENCE; WEIGHT-LOSS		[Larder, Rachel; O'Rahilly, Stephen] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Larder, R (corresponding author), Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 2QQ, England.	so104@medschl.cam.ac.uk	O'Rahilly, Stephen/ABF-6509-2020	O'Rahilly, Stephen/0000-0003-2199-4449; Larder, Rachel/0000-0003-1697-9455	Medical Research Council [G0900554] Funding Source: Medline; MRC [G0900554] Funding Source: UKRI; Medical Research Council [G0600717B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Anderson JW, 2001, AM J CLIN NUTR, V74, P579; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Chandarana K, 2011, DIABETES, V60, P810, DOI 10.2337/db10-0566; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Karra E, 2010, TRENDS ENDOCRIN MET, V21, P337, DOI 10.1016/j.tem.2010.01.006; Kindel TL, 2009, J GASTROINTEST SURG, V13, P1762, DOI 10.1007/s11605-009-0912-9; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Meguid MM, 2008, NUTRITION, V24, P832, DOI 10.1016/j.nut.2008.06.027; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Powell AG, 2011, CLIN PHARMACOL THER, V90, P40, DOI 10.1038/clpt.2011.82; Rosenbaum M, 2008, AM J CLIN NUTR, V88, P906, DOI 10.1093/ajcn/88.4.906; Scherer T, 2011, REV ENDOCR METAB DIS, V12, P235, DOI 10.1007/s11154-011-9190-4; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816	14	15	16	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					666	667		10.1038/nm.2747	http://dx.doi.org/10.1038/nm.2747			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22561823				2022-12-25	WOS:000303763500033
J	Shestopalov, IA; Pitt, CLW; Chen, JK				Shestopalov, Ilya A.; Pitt, Cameron L. W.; Chen, James K.			Spatiotemporal resolution of the Ntla transcriptome in axial mesoderm development	NATURE CHEMICAL BIOLOGY			English	Article							T-BOX GENES; IN-SITU HYBRIDIZATION; NO-TAIL; ZEBRAFISH NOTOCHORD; FLOOR PLATE; EXPRESSION; EMBRYOS; MOUSE; PROTEIN; INHIBITION	Transcription factors have diverse roles during embryonic development, combinatorially controlling cellular states in a spatially and temporally defined manner. Resolving the dynamic transcriptional profiles that underlie these patterning processes is essential for understanding embryogenesis at the molecular level. Here we show how temporal, tissue-specific changes in embryonic transcription factor function can be discerned by integrating caged morpholino oligonucleotides with photoactivatable fluorophores, fluorescence-activated cell sorting and microarray technologies. As a proof of principle, we have dynamically profiled No tail a (Ntla)-dependent genes at different stages of axial mesoderm development in zebrafish, discovering discrete sets of transcripts that are coincident with either notochord cell fate commitment or differentiation. Our studies reveal new regulators of notochord development and the sequential activation of distinct transcriptomes within a cell lineage by a single transcriptional factor and demonstrate how optically controlled chemical tools can dissect developmental processes with spatiotemporal precision.	[Shestopalov, Ilya A.; Pitt, Cameron L. W.; Chen, James K.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University	Shestopalov, IA (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	jameschen@stanford.edu	Chen, James/G-9972-2011	Chen, James/0000-0002-9220-8436	US National Institutes of Health [R01 GM072600, R01 GM087292, DP1 OD003792]; March of Dimes Foundation [1-FY-08-433]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD075622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072600, R01GM087292] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003792] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Amacher and A. Garnett for helpful discussions, M. Halpern (Carnegie Institution) for providing ntla and flh cDNA, W Talbot (Stanford University) for pax2a cDNA, J. Mich and X. Ouyang (both from Stanford University) for sharing in situ hybridization probes and C. Crumpton for technical assistance with FACS. This work was supported by funding from the US National Institutes of Health (R01 GM072600, R01 GM087292 and DP1 OD003792) and the March of Dimes Foundation (1-FY-08-433).	Amacher SL, 2002, DEVELOPMENT, V129, P3311; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Brand Michael, 2002, P7; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chesley P, 1935, J EXP ZOOL, V70, P429, DOI 10.1002/jez.1400700306; Conlon FL, 1996, DEVELOPMENT, V122, P2427; Currie PD, 1996, NATURE, V382, P452, DOI 10.1038/382452a0; Deiters A, 2010, J AM CHEM SOC, V132, P15644, DOI 10.1021/ja1053863; Draper BW, 2003, DEVELOPMENT, V130, P4639, DOI 10.1242/dev.00671; Franchi-Gazzola R, 2006, ACTA PHYSIOL, V187, P273, DOI 10.1111/j.1748-1716.2006.01552.x; Gajewski M, 2003, DEVELOPMENT, V130, P4269, DOI 10.1242/dev.00627; Gansner JM, 2008, DEV DYNAM, V237, P3715, DOI 10.1002/dvdy.21779; Garnett AT, 2009, DEVELOPMENT, V136, P749, DOI 10.1242/dev.024703; Glickman NS, 2003, DEVELOPMENT, V130, P873, DOI 10.1242/dev.00314; Goering LM, 2003, P NATL ACAD SCI USA, V100, P9410, DOI 10.1073/pnas.1633548100; HALPERN ME, 1993, CELL, V75, P99, DOI 10.1016/0092-8674(93)90682-G; Halpern ME, 1997, DEV BIOL, V187, P154, DOI 10.1006/dbio.1997.8605; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Jowett T, 2001, METHODS, V23, P345, DOI 10.1006/meth.2000.1147; Melby AE, 1996, DEVELOPMENT, V122, P2225; Melby AE, 1997, DEV DYNAM, V209, P156; Morley RH, 2009, P NATL ACAD SCI USA, V106, P3829, DOI 10.1073/pnas.0808382106; Moulton J.D., 2008, CURR PROTOC MOL BIOL, V83, P2681; Nixon SJ, 2005, HUM MOL GENET, V14, P1727, DOI 10.1093/hmg/ddi179; Nixon SJ, 2007, J CELL SCI, V120, P2151, DOI 10.1242/jcs.003830; Ochi H, 2008, J BIOL CHEM, V283, P3529, DOI 10.1074/jbc.M708594200; Ouyang XH, 2010, CHEM BIOL, V17, P590, DOI 10.1016/j.chembiol.2010.04.013; Ouyang XH, 2009, J AM CHEM SOC, V131, P13255, DOI 10.1021/ja809933h; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; Shestopalov IA, 2007, NAT CHEM BIOL, V3, P650, DOI 10.1038/nchembio.2007.30; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Stemple DL, 1996, DEVELOPMENT, V123, P117; TALBOT WS, 1995, NATURE, V378, P150, DOI 10.1038/378150a0; Tang XJ, 2007, J AM CHEM SOC, V129, P11000, DOI 10.1021/ja073723s; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tomasini AJ, 2009, GENESIS, V47, P736, DOI 10.1002/dvg.20554; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0	38	31	31	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2012	8	3					270	276		10.1038/NCHEMBIO.772	http://dx.doi.org/10.1038/NCHEMBIO.772			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896VR	22286130	Green Accepted			2022-12-25	WOS:000300600000012
J	Derry, JMJ; Mangravite, LM; Suver, C; Furia, MD; Henderson, D; Schildwachter, X; Bot, B; Izant, J; Sieberts, SK; Kellen, MR; Friend, SH				Derry, Jonathan M. J.; Mangravite, Lara M.; Suver, Christine; Furia, Matthew D.; Henderson, David; Schildwachter, Xavier; Bot, Brian; Izant, Jonathan; Sieberts, Solveig K.; Kellen, Michael R.; Friend, Stephen H.			Developing predictive molecular maps of human disease through community-based modeling	NATURE GENETICS			English	Article									[Derry, Jonathan M. J.; Mangravite, Lara M.; Suver, Christine; Furia, Matthew D.; Henderson, David; Schildwachter, Xavier; Bot, Brian; Izant, Jonathan; Sieberts, Solveig K.; Kellen, Michael R.; Friend, Stephen H.] Sage Bionetworks, Seattle, WA USA		Derry, JMJ (corresponding author), Sage Bionetworks, Seattle, WA USA.	derry@sagebase.org; friend@sagebase.org		Bot, Brian/0000-0002-2412-6826; Suver, Christine/0000-0002-2986-385X	Washington Life Sciences Discovery fund [3104672]; National Cancer Institute [U54CA149237]; Stanford Center for Biomedical Ontology [U54 HG004028]; NATIONAL CANCER INSTITUTE [U54CA149237] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004028] Funding Source: NIH RePORTER	Washington Life Sciences Discovery fund; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stanford Center for Biomedical Ontology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This project is supported by program grant 3104672 from the Washington Life Sciences Discovery fund, grant U54CA149237 from the Integrative Cancer Biology Program of the National Cancer Institute and a grant to the Stanford Center for Biomedical Ontology (U54 HG004028).	Anderson N., 2010, P 2010 WORKSH GOV TE, P15; [Anonymous], 2009, NATURE, V461, P145, DOI 10.1038/461145a; [Anonymous], 2011, SCIENCE, V331, P692, DOI DOI 10.1126/SCIENCE.331.6018.692; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Field D, 2009, SCIENCE, V326, P234, DOI 10.1126/science.1180598; Friend SH, 2010, CLIN PHARMACOL THER, V87, P536, DOI 10.1038/clpt.2010.40; Friend SH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001280; Gentleman R, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1034; Giardine B, 2011, NAT GENET, V43, P295, DOI 10.1038/ng.785; Guttmacher AE, 2009, P NATL ACAD SCI USA, V106, P16894, DOI 10.1073/pnas.0910378106; Hrynaszkiewicz Iain, 2011, Serials, V24, P31, DOI 10.1629/2431; Knoppers BM, 2011, GENOME MED, V3, DOI 10.1186/gm262; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Mesirov JP, 2010, SCIENCE, V327, P415, DOI 10.1126/science.1179653; Musen M.A., 2011, J AM MED INFORM ASSN, DOI [10.1136/amiajnI-2011-000523, DOI 10.1136/AMIAJNI-2011-000523]; Rocca-Serra P, 2010, BIOINFORMATICS, V26, P2354, DOI 10.1093/bioinformatics/btq415; Schadt EE, 2009, NAT REV DRUG DISCOV, V8, P286, DOI 10.1038/nrd2826; Schofield PN, 2009, NATURE, V461, P171, DOI 10.1038/461171a; Shelton RH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002037; Tegner JN, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-56; Walport M, 2011, LANCET, V377, P537, DOI 10.1016/S0140-6736(10)62234-9	21	38	38	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2012	44	2					127	130		10.1038/ng.1089	http://dx.doi.org/10.1038/ng.1089			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	22281773	Green Accepted, hybrid			2022-12-25	WOS:000299664400007
J	Maeda, A; Golczak, M; Chen, Y; Okano, K; Kohno, H; Shiose, S; Ishikawa, K; Harte, W; Palczewska, G; Maeda, T; Palczewski, K				Maeda, Akiko; Golczak, Marcin; Chen, Yu; Okano, Kiichiro; Kohno, Hideo; Shiose, Satomi; Ishikawa, Kaede; Harte, William; Palczewska, Grazyna; Maeda, Tadao; Palczewski, Krzysztof			Primary amines protect against retinal degeneration in mouse models of retinopathies	NATURE CHEMICAL BIOLOGY			English	Article							RECESSIVE RETINITIS-PIGMENTOSA; STARGARDT MACULAR DYSTROPHY; LIGHT-INDUCED DAMAGE; ALL-TRANS-RETINOL; DISEASE GENE ABCR; VISUAL CYCLE; EPITHELIAL-CELLS; LIPOFUSCIN FLUOROPHORE; COUPLED RECEPTOR; OUTER SEGMENTS	Vertebrate vision is initiated by photoisomerization of the visual pigment chromophore 11-cis-retinal and is maintained by continuous regeneration of this retinoid through a series of reactions termed the retinoid cycle. However, toxic side reaction products, especially those involving reactive aldehyde groups of the photoisomerized product, all-trans-retinal, can cause severe retinal pathology. Here we lowered peak concentrations of free all-trans-retinal with primary amine-containing Food and Drug Administration (FDA)-approved drugs that did not inhibit chromophore regeneration in mouse models of retinal degeneration. Schiff base adducts between all-trans-retinal and these amines were identified by MS. Adducts were observed in mouse eyes only when an experimental drug protected the retina from degeneration in both short-term and long-term treatment experiments. This study demonstrates a molecular basis of all-trans-retinal-induced retinal pathology and identifies an assemblage of FDA-approved compounds with protective effects against this pathology in a mouse model that shows features of Stargardt's disease and age-related retinal degeneration.	[Maeda, Akiko; Golczak, Marcin; Chen, Yu; Okano, Kiichiro; Kohno, Hideo; Shiose, Satomi; Ishikawa, Kaede; Maeda, Tadao; Palczewski, Krzysztof] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Maeda, Akiko; Maeda, Tadao] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Harte, William] Polgenix Inc, Cleveland, OH USA; [Palczewska, Grazyna] Visum Inc, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.	kxp65@case.edu			US National Institutes of Health [EY009339, EY021126, EY019031, EY019880, P30 EY11373]; State of Ohio Department of Development [TECH 09-004]; Third Frontier Commission; Research to Prevent Blindness; Ohio Lion Eye Research Foundation; Foundation Fighting Blindness; Fight for Sight; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY011373, R01EY009339, K08EY019880, K08EY019031, R24EY021126] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Ohio Department of Development; Third Frontier Commission; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Ohio Lion Eye Research Foundation; Foundation Fighting Blindness(European Commission); Fight for Sight; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We would like to thank Z. Dong for expert handling of mice, S. Roos for block preparation and plastic sectioning, J. Zhang for NMR analyses, and M. Matosky for retinoid analyses. We also thank L. Webster Jr, J. Saari, M. E. Maguire and members of the Palczewski laboratory for critical comments on the manuscript. This research was supported in part by grants EY009339, EY021126, EY019031, EY019880 and P30 EY11373 from the US National Institutes of Health; TECH 09-004 from the State of Ohio Department of Development; the Third Frontier Commission; Research to Prevent Blindness; Ohio Lion Eye Research Foundation; Foundation Fighting Blindness; and Fight for Sight.	Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; Dean DM, 2002, P NATL ACAD SCI USA, V99, P8372, DOI 10.1073/pnas.122681899; Ellis EM, 2007, PHARMACOL THERAPEUT, V115, P13, DOI 10.1016/j.pharmthera.2007.03.015; Field MJ, 2001, BRIT J PHARMACOL, V132, P1, DOI 10.1038/sj.bjp.0703794; Fishkin N, 2005, BIOORGAN MED CHEM, V13, P5189, DOI 10.1016/j.bmc.2005.05.001; Golczak M, 2005, J BIOL CHEM, V280, P42263, DOI 10.1074/jbc.M509351200; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Golczak M, 2008, J BIOL CHEM, V283, P9543, DOI 10.1074/jbc.M708982200; Holz FG, 2007, AM J OPHTHALMOL, V143, P463, DOI 10.1016/j.ajo.2006.11.041; Imanishi Y, 2004, J CELL BIOL, V164, P373, DOI 10.1083/jcb.200311079; Kalia J, 2008, ANGEW CHEM INT EDIT, V47, P7523, DOI 10.1002/anie.200802651; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Kim YK, 2008, J BIOL CHEM, V283, P5611, DOI 10.1074/jbc.M708885200; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2007, P NATL ACAD SCI USA, V104, P19565, DOI 10.1073/pnas.0707477104; Maeda A, 2006, MOL PHARMACOL, V70, P1220, DOI 10.1124/mol.106.026823; Maeda A, 2006, J BIOL CHEM, V281, P37697, DOI 10.1074/jbc.M608375200; Maeda A, 2010, P NATL ACAD SCI USA, V107, P8428, DOI 10.1073/pnas.1000640107; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Martinez-Mir A, 1998, NAT GENET, V18, P11, DOI 10.1038/ng0198-11; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; Mata NL, 2001, INVEST OPHTH VIS SCI, V42, P1685; Molday RS, 2010, PROG LIPID RES, V49, P476, DOI 10.1016/j.plipres.2010.07.002; Molday RS, 2006, ADV EXP MED BIOL, V572, P465; Murdaugh LS, 2010, J MASS SPECTROM, V45, P1139, DOI 10.1002/jms.1795; Negre-Salvayre A, 2008, BRIT J PHARMACOL, V153, P6, DOI 10.1038/sj.bjp.0707395; Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; Rozanowska M, 2005, PHOTOCHEM PHOTOBIOL, V81, P1305, DOI 10.1562/2004-11-13-IR-371; Sparrow JR, 2010, J LIPID RES, V51, P247, DOI 10.1194/jlr.R000687; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Stecher H, 2000, METHOD ENZYMOL, V316, P330; Stecher H, 1999, J BIOL CHEM, V274, P8577, DOI 10.1074/jbc.274.13.8577; Sun H, 2001, J BIOL CHEM, V276, P11766, DOI 10.1074/jbc.M010152200; TAYLOR CP, 1993, EPILEPSY RES, V14, P11, DOI 10.1016/0920-1211(93)90070-N; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Tsybovsky Y, 2010, ADV EXP MED BIOL, V703, P105, DOI 10.1007/978-1-4419-5635-4_8; Vollmer-Snarr HR, 2006, ADV EXP MED BIOL, V572, P69; von Lintig J, 2010, TRENDS BIOCHEM SCI, V35, P400, DOI 10.1016/j.tibs.2010.01.005; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Yannuzzi LA, 2004, AM J OPHTHALMOL, V137, P511, DOI 10.1016/j.ajo.2003.12.035; Zhang QJ, 2005, HUM GENET, V118, P356, DOI 10.1007/s00439-005-0054-4; Zhong M, 2009, J BIOL CHEM, V284, P3640, DOI 10.1074/jbc.M806580200	49	104	118	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2012	8	2					170	178		10.1038/nchembio.759	http://dx.doi.org/10.1038/nchembio.759			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879IP	22198730	Green Accepted			2022-12-25	WOS:000299323200009
J	Shamu, CE; Wiemann, S; Boutros, M				Shamu, Caroline E.; Wiemann, Stefan; Boutros, Michael			On target: A public repository for large-scale RNAi experiments	NATURE CELL BIOLOGY			English	Editorial Material								Many RNA interference (RNAi) screens are now performed to functionally annotate the mammalian genome. Implementing a public repository based on common data standards is essential to realize the full value of large-scale RNAi data sets.	[Shamu, Caroline E.] Harvard Univ, Sch Med, ICCB Longwood Screening Facil, Boston, MA 02115 USA; [Wiemann, Stefan] German Canc Res Ctr, Div Mol Genome Anal & Genom, D-69120 Heidelberg, Germany; [Wiemann, Stefan] German Canc Res Ctr, Prote Core Facil, D-69120 Heidelberg, Germany; [Boutros, Michael] Univ Heidelberg, Fac Med, Dept Cell & Mol Biol, D-69120 Heidelberg, Germany; [Boutros, Michael] Univ Heidelberg, Fac Med, German Canc Res Ctr DKFZ, Div Signaling & Funct Genom, D-69120 Heidelberg, Germany	Harvard University; Harvard Medical School; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Shamu, CE (corresponding author), Harvard Univ, Sch Med, ICCB Longwood Screening Facil, 250 Longwood Ave, Boston, MA 02115 USA.	caroline_shamu@hms.harvard.edu; s.wiemann@dkfz.de; m.boutros@dkfz.de	Wiemann, Stefan/E-4424-2013; Boutros, Michael/C-3566-2008	Wiemann, Stefan/0000-0003-4683-3174; Boutros, Michael/0000-0002-9458-817X					0	6	6	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2012	14	2					115	115		10.1038/ncb2435	http://dx.doi.org/10.1038/ncb2435			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	893CF	22298037	Bronze			2022-12-25	WOS:000300332500001
J	Gopalakrishnan, J; Chim, YCF; Ha, A; Basiri, ML; Lerit, DA; Rusan, NM; Avidor-Reiss, T				Gopalakrishnan, Jayachandran; Chim, Yiu-Cheung Frederick; Ha, Andrew; Basiri, Marcus L.; Lerit, Dorothy A.; Rusan, Nasser M.; Avidor-Reiss, Tomer			Tubulin nucleotide status controls Sas-4-dependent pericentriolar material recruitment	NATURE CELL BIOLOGY			English	Article							CELL-CYCLE; MICROTUBULE NUCLEATION; DROSOPHILA NEUROBLASTS; CENTRIOLE DUPLICATION; CENTROSOME SIZE; C-ELEGANS; PROTEIN; SAS-4; CPAP; POLYMERIZATION	Regulated centrosome biogenesis is required for accurate cell division and for maintaining genome integrity(1). Centrosomes consist of a centriole pair surrounded by protein network known as pericentriolar material(1) (PCM). PCM assembly is a tightly regulated, critical step that determines the size and capability of centrosomes(2-4). Here, we report a role for tubulin in regulating PCM recruitment through the conserved centrosomal protein Sas-4. Tubulin directly binds to Sas-4; together they are components of cytoplasmic complexes of centrosomal proteins(5,6). A Sas-4 mutant, which cannot bind tubulin, enhances centrosomal protein complex formation and has abnormally large centrosomes with excessive activity. These results suggest that tubulin negatively regulates PCM recruitment. Whereas tubulin-GTP prevents Sas-4 from forming protein complexes, tubulin-GDP promotes it. Thus, the regulation of PCM recruitment by tubulin depends on its GTP/GDP-bound state. These results identify a role for tubulin in regulating PCM recruitment independent of its well-known role as a building block of microtubules(7). On the basis of its guanine-bound state, tubulin can act as a molecular switch in PCM recruitment.	[Gopalakrishnan, Jayachandran; Chim, Yiu-Cheung Frederick; Ha, Andrew; Basiri, Marcus L.; Avidor-Reiss, Tomer] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Lerit, Dorothy A.; Rusan, Nasser M.] NHLBI, Cell Biol & Physiol Ctr, NIH, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Avidor-Reiss, T (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	tomer_avidor-reiss@hms.harvard.edu	Avidor-Reiss, Tomer/AAK-6153-2020; Rusan, Nasser/P-3511-2016; Rusan, Nasser/U-2513-2017	Avidor-Reiss, Tomer/0000-0003-0918-526X; 	National Institute of General Medical Sciences [R01GM098394]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098394] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank J. Iwasa for scientific illustrations; T. Mitchision A. Johnson, I. Cheeseman and J. Malicki for scientific discussions; T. Kaufman, J. Raff, B. Raynaud-Messina and T. K. Tang (Institute of Biomedical Sciences, Taipei, Taiwan) for reagents; R. Reed laboratory (Harvard Medical School, USA), F. Eric, A. Hari, R. Rodriguez for technical help with biophysical experiments; E. Koundakjian for scientific editing and discussions; and electron microscopy facility staff at HMS for help with electron microscopy analyses. This work was supported by a grant (R01GM098394) from the National Institute of General Medical Sciences.	Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Blachon S, 2009, GENETICS, V182, P133, DOI 10.1534/genetics.109.101709; Blachon S, 2008, GENETICS, V180, P2081, DOI 10.1534/genetics.108.095141; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Choi YK, 2010, J CELL BIOL, V191, P1089, DOI 10.1083/jcb.201007030; Conduit PT, 2010, CURR BIOL, V20, P2178, DOI 10.1016/j.cub.2010.11.011; Cormier A, 2009, J BIOL CHEM, V284, P6909, DOI 10.1074/jbc.M808249200; Dammermann A, 2008, J CELL BIOL, V180, P771, DOI 10.1083/jcb.200709102; DAVIDPFEUTY T, 1979, J BIOL CHEM, V254, P1696; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Giansanti MG, 2001, DEVELOPMENT, V128, P1137; Gopalakrishnan J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1367; Gopalakrishnan J, 2010, J BIOL CHEM, V285, P8759, DOI 10.1074/jbc.M109.092627; HILLER G, 1978, CELL, V14, P795, DOI 10.1016/0092-8674(78)90335-5; Hsu WB, 2008, EXP CELL RES, V314, P2591, DOI 10.1016/j.yexcr.2008.05.012; Hung LY, 2000, MOL CELL BIOL, V20, P7813, DOI 10.1128/MCB.20.20.7813-7825.2000; Hung LY, 2004, MOL BIOL CELL, V15, P2697, DOI 10.1091/mbc.E04-02-0121; Janulevicius A, 2006, BIOPHYS J, V90, P788, DOI 10.1529/biophysj.105.059410; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; Kobayashi T, 2011, J CELL BIOL, V193, P435, DOI 10.1083/jcb.201101005; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; Leidel S, 2003, DEV CELL, V4, P431, DOI 10.1016/S1534-5807(03)00062-5; Li KJ, 1998, J CELL BIOL, V141, P455, DOI 10.1083/jcb.141.2.455; MELKI R, 1989, BIOCHEMISTRY-US, V28, P9143, DOI 10.1021/bi00449a028; MORITZ M, 1995, J CELL BIOL, V130, P1149, DOI 10.1083/jcb.130.5.1149; Mozziconacci J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003821; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Piehl M, 2004, P NATL ACAD SCI USA, V101, P1584, DOI 10.1073/pnas.0308205100; Rogers GC, 2008, MOL BIOL CELL, V19, P3163, DOI 10.1091/mbc.E07-10-1069; Rusan NM, 2007, J CELL BIOL, V177, P13, DOI 10.1083/jcb.200612140; SANDOVAL IV, 1978, P NATL ACAD SCI USA, V75, P3178, DOI 10.1073/pnas.75.7.3178; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Zhai Y, 1996, J CELL BIOL, V135, P201, DOI 10.1083/jcb.135.1.201; Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244	40	34	35	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2012	14	8					865	U197		10.1038/ncb2527	http://dx.doi.org/10.1038/ncb2527			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	983JP	22729084	Green Submitted, Green Accepted			2022-12-25	WOS:000307115900016
J	Peil, L; Starosta, AL; Virumae, K; Atkinson, GC; Tenson, T; Remme, J; Wilson, DN				Peil, Lauri; Starosta, Agata L.; Virumaee, Kai; Atkinson, Gemma C.; Tenson, Tanel; Remme, Jaanus; Wilson, Daniel N.			Lys34 of translation elongation factor EF-P is hydroxylated by YfcM	NATURE CHEMICAL BIOLOGY			English	Article							PEPTIDE-BOND SYNTHESIS; SALMONELLA-ENTERICA; POSTTRANSLATIONAL MODIFICATION; PROTEIN-SYNTHESIS; POXA; IDENTIFICATION; VIRULENCE; RIBOSOME; PARALOG; GENE	Lys34 of the conserved translation elongation factor P (EF-P) is post-translationally lysinylated by YjeK and YjeA-a modification that is critical for bacterial virulence. Here we show that the currently accepted Escherichia coli EF-P modification pathway is incomplete and lacks a final hydroxylation step mediated by YfcM, an enzyme distinct from deoxyhypusine hydroxylase that catalyzes the final maturation step of eukaryotic initiation factor 5A, the eukaryotic EF-P homolog.	[Virumaee, Kai; Remme, Jaanus] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Peil, Lauri; Atkinson, Gemma C.; Tenson, Tanel] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia; [Starosta, Agata L.; Wilson, Daniel N.] Univ Munich, Gene Ctr, Munich, Germany; [Starosta, Agata L.; Wilson, Daniel N.] Univ Munich, Dept Biochem, Ctr Integrated Prot Sci Munich, Munich, Germany	University of Tartu; University of Tartu; University of Munich; University of Munich	Remme, J (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Ulikooli 18, EE-50090 Tartu, Estonia.	jremme@ebc.ee; wilson@lmb.uni-muenchen.de	Remme, Jaanus/A-4614-2011; Remme, Jaanus/L-1830-2019; Starosta, Agata/D-9535-2017; Wilson, Daniel/AAE-8504-2019; Atkinson, Gemma/L-9655-2019; Peil, Lauri/G-9944-2012; Tenson, Tanel/I-6431-2015	Remme, Jaanus/0000-0002-4011-6580; Remme, Jaanus/0000-0002-4011-6580; Starosta, Agata/0000-0003-3915-5723; Wilson, Daniel/0000-0003-3816-3828; Atkinson, Gemma/0000-0002-4861-4584; Peil, Lauri/0000-0001-6906-7113; Tenson, Tanel/0000-0002-0260-3601	Deutsche Forschungsgemeinschaft [WI3285/1-1]; Human Frontiers of Science Foundation [RGY88/2008]; European Molecular Biology Organization young investigator program; Estonian Science Foundation [9289]; European Social Fund program Mobilitas [MJD144, MJD99]; European Regional Development Fund through the Center of Excellence in Chemical Biology (Institute of Technology, University of Tartu)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Human Frontiers of Science Foundation; European Molecular Biology Organization young investigator program; Estonian Science Foundation; European Social Fund program Mobilitas; European Regional Development Fund through the Center of Excellence in Chemical Biology (Institute of Technology, University of Tartu)	We thank N. Morrice and J. Rappsilber for invaluable help and advice on amino acid analyses and L. Arike and T. Tammsalu for help with MS analyses. This research was supported by grants from the Deutsche Forschungsgemeinschaft WI3285/1-1, the Human Frontiers of Science Foundation (RGY88/2008), the European Molecular Biology Organization young investigator program (to D. N. W.) and the Estonian Science Foundation grant no. 9289 (to J. R.). L. P. and G. C. A. are supported by the European Social Fund program Mobilitas grants MJD144 and MJD99, respectively. MS analyses were, in part, supported by the European Regional Development Fund through the Center of Excellence in Chemical Biology (Institute of Technology, University of Tartu).	Aoki H, 2008, FEBS J, V275, P671, DOI 10.1111/j.1742-4658.2007.06228.x; Bailly M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-3; Bearson SMD, 2011, FOODBORNE PATHOG DIS, V8, P725, DOI 10.1089/fpd.2010.0796; Bearson SMD, 2006, APPL ENVIRON MICROB, V72, P2829, DOI 10.1128/AEM.72.4.2829-2836.2006; Behshad E, 2006, BIOCHEMISTRY-US, V45, P12639, DOI 10.1021/bi061328t; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; de Crecy E, 2007, APPL MICROBIOL BIOT, V77, P489, DOI 10.1007/s00253-007-1168-5; Ganoza MC, 2000, BIOL CHEM, V381, P553, DOI 10.1515/BC.2000.071; GLICK BR, 1979, EUR J BIOCHEM, V97, P23, DOI 10.1111/j.1432-1033.1979.tb13081.x; GLICK BR, 1975, P NATL ACAD SCI USA, V72, P4257, DOI 10.1073/pnas.72.11.4257; Kaniga K, 1998, INFECT IMMUN, V66, P5599, DOI 10.1128/IAI.66.12.5599-5606.1998; Kyrpides NC, 1998, P NATL ACAD SCI USA, V95, P224, DOI 10.1073/pnas.95.1.224; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Park JH, 2012, J BIOL CHEM, V287, P2579, DOI 10.1074/jbc.M111.309633; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Peng WT, 2001, J BACTERIOL, V183, P36, DOI 10.1128/JB.183.1.36-45.2001; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; Swaney S, 2006, J BIOMOL SCREEN, V11, P736, DOI 10.1177/1087057106291634; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889	19	61	68	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2012	8	8					695	697		10.1038/NCHEMBIO.1001	http://dx.doi.org/10.1038/NCHEMBIO.1001			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975RC	22706199				2022-12-25	WOS:000306527600007
J	Bashir, A; Klammer, AA; Robins, WP; Chin, CS; Webster, D; Paxinos, E; Hsu, D; Ashby, M; Wang, S; Peluso, P; Sebra, R; Sorenson, J; Bullard, J; Yen, J; Valdovino, M; Mollova, E; Luong, K; Lin, S; Lamay, B; Joshi, A; Rowe, L; Frace, M; Tarr, CL; Turnsek, M; Davis, BM; Kasarskis, A; Mekalanos, JJ; Waldor, MK; Schadt, EE				Bashir, Ali; Klammer, Aaron A.; Robins, William P.; Chin, Chen-Shan; Webster, Dale; Paxinos, Ellen; Hsu, David; Ashby, Meredith; Wang, Susana; Peluso, Paul; Sebra, Robert; Sorenson, Jon; Bullard, James; Yen, Jackie; Valdovino, Marie; Mollova, Emilia; Luong, Khai; Lin, Steven; Lamay, Brianna; Joshi, Amruta; Rowe, Lori; Frace, Michael; Tarr, Cheryl L.; Turnsek, Maryann; Davis, Brigid M.; Kasarskis, Andrew; Mekalanos, John J.; Waldor, Matthew K.; Schadt, Eric E.			A hybrid approach for the automated finishing of bacterial genomes	NATURE BIOTECHNOLOGY			English	Article							READ SEQUENCE DATA; VIBRIO-CHOLERAE; STRUCTURAL VARIATION; ORIGIN; GENERATION; INTEGRONS; ASSEMBLER; OUTBREAK; STRAIN; HAITI	Advances in DNA sequencing technology have improved our ability to characterize most genomic diversity. However, accurate resolution of large structural events is challenging because of the short read lengths of second-generation technologies. Third-generation sequencing technologies, which can yield longer multikilobase reads, have the potential to address limitations associated with genome assembly. Here we combine sequencing data from second- and third-generation DNA sequencing technologies to assemble the two-chromosome genome of a recent Haitian cholera outbreak strain into two nearly finished contigs at >99.9% accuracy. Complex regions with clinically relevant structure were completely resolved. In separate control assemblies on experimental and simulated data for the canonical N16961 cholera reference strain, we obtained 14 scaffolds of greater than 1 kb for the experimental data and 8 scaffolds of greater than 1 kb for the simulated data, which allowed us to correct several errors in contigs assembled from the short-read data alone. This work provides a blueprint for the next generation of rapid microbial identification and full-genome assembly.	[Bashir, Ali; Klammer, Aaron A.; Chin, Chen-Shan; Webster, Dale; Paxinos, Ellen; Hsu, David; Ashby, Meredith; Wang, Susana; Peluso, Paul; Sebra, Robert; Sorenson, Jon; Bullard, James; Yen, Jackie; Valdovino, Marie; Mollova, Emilia; Luong, Khai; Lin, Steven; Lamay, Brianna; Joshi, Amruta; Kasarskis, Andrew; Schadt, Eric E.] Pacific Biosci, Menlo Pk, CA USA; [Bashir, Ali; Schadt, Eric E.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Robins, William P.; Mekalanos, John J.; Waldor, Matthew K.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Rowe, Lori; Frace, Michael; Tarr, Cheryl L.; Turnsek, Maryann] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Davis, Brigid M.; Waldor, Matthew K.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Davis, Brigid M.; Waldor, Matthew K.] Howard Hughes Med Inst, Boston, MA 02115 USA	Icahn School of Medicine at Mount Sinai; Harvard University; Harvard Medical School; Centers for Disease Control & Prevention - USA; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Schadt, EE (corresponding author), Pacific Biosci, Menlo Pk, CA USA.	eschadt@pacificbiosciences.com	Paxinos, Ellen/AAG-2907-2019	Paxinos, Ellen/0000-0002-1710-8064; Sorenson, Jon/0000-0002-5301-8306; Ashby, Meredith/0000-0002-4385-9486; Waldor, Matthew/0000-0003-1843-7000; Bashir, Ali/0000-0002-5240-9604	US National Institutes of Health National Institute of General Medical Sciences [R01GM068851]; NIH [R37 AI-42347]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042347, T32AI007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068851] Funding Source: NIH RePORTER	US National Institutes of Health National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by the US National Institutes of Health National Institute of General Medical Sciences grant R01GM068851 (J.J.M. and W.P.R.), NIH R37 AI-42347 (B.M.D. and M.K.W.) and the Howard Hughes Medical Institute (B.M.D. and M.K.W.).	Ali A, 2011, EMERG INFECT DIS, V17, P699, DOI 10.3201/eid1704.101973; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Chaisson M, 2004, BIOINFORMATICS, V20, P2067, DOI 10.1093/bioinformatics/bth205; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Davis BM, 2000, P NATL ACAD SCI USA, V97, P8572, DOI 10.1073/pnas.140109997; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Frerichs RR, 2012, CLIN MICROBIOL INFEC, V18, pE158, DOI 10.1111/j.1469-0691.2012.03841.x; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Grim CJ, 2010, J BACTERIOL, V192, P3524, DOI 10.1128/JB.00040-10; Hassan F, 2010, NATURE, V467, P982, DOI 10.1038/nature09469; Hendriksen RS, 2011, MBIO, V2, DOI [10.1128/mBio.00157-11, 10.1128/mBio.00305-11]; Kingsford C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-21; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li YR, 2011, NAT BIOTECHNOL, V29, P723, DOI 10.1038/nbt.1904; Liolios K, 2010, NUCLEIC ACIDS RES, V38, pD346, DOI 10.1093/nar/gkp848; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Margulies M, 2006, NATURE, V441, P120, DOI 10.1038/nature04726; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mazel D, 1998, SCIENCE, V280, P605, DOI 10.1126/science.280.5363.605; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; Medvedev P, 2009, J COMPUT BIOL, V16, P1101, DOI 10.1089/cmb.2009.0047; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Myers EW, 2005, BIOINFORMATICS, V21, P79, DOI 10.1093/bioinformatics/bti1114; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Pop M, 2004, GENOME RES, V14, P149; Pop M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/bib/bbp026; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Reimer AR, 2011, EMERG INFECT DIS, V17, P2113, DOI 10.3201/eid1711.110794; Reinhardt JA, 2009, GENOME RES, V19, P294, DOI 10.1101/gr.083311.108; Ritz A, 2010, BIOINFORMATICS, V26, P1291, DOI 10.1093/bioinformatics/btq153; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Rowe-Magnus DA, 1999, RES MICROBIOL, V150, P641, DOI 10.1016/S0923-2508(99)00127-8; Rubin EJ, 1998, MOL MICROBIOL, V28, P1247, DOI 10.1046/j.1365-2958.1998.00889.x; Schadt EE, 2011, HUM MOL GENET, V20, P853, DOI 10.1093/hmg/ddq481; Schadt EE, 2010, HUM MOL GENET, V19, pR227, DOI 10.1093/hmg/ddq416; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	49	130	134	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					701	+		10.1038/nbt.2288	http://dx.doi.org/10.1038/nbt.2288			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22750883	Green Accepted			2022-12-25	WOS:000306293400029
J	Chia, JM; Song, C; Bradbury, PJ; Costich, D; de Leon, N; Doebley, J; Elshire, RJ; Gaut, B; Geller, L; Glaubitz, JC; Gore, M; Guill, KE; Holland, J; Hufford, MB; Lai, JS; Li, M; Liu, X; Lu, YL; McCombie, R; Nelson, R; Poland, J; Prasanna, BM; Pyhajarvi, T; Rong, TZ; Sekhon, RS; Sun, Q; Tenaillon, MI; Tian, F; Wang, J; Xu, X; Zhang, ZW; Kaeppler, SM; Ross-Ibarra, J; McMullen, MD; Buckler, ES; Zhang, GY; Xu, YB; Ware, D				Chia, Jer-Ming; Song, Chi; Bradbury, Peter J.; Costich, Denise; de Leon, Natalia; Doebley, John; Elshire, Robert J.; Gaut, Brandon; Geller, Laura; Glaubitz, Jeffrey C.; Gore, Michael; Guill, Kate E.; Holland, Jim; Hufford, Matthew B.; Lai, Jinsheng; Li, Meng; Liu, Xin; Lu, Yanli; McCombie, Richard; Nelson, Rebecca; Poland, Jesse; Prasanna, Boddupalli M.; Pyhaejaervi, Tanja; Rong, Tingzhao; Sekhon, Rajandeep S.; Sun, Qi; Tenaillon, Maud I.; Tian, Feng; Wang, Jun; Xu, Xun; Zhang, Zhiwu; Kaeppler, Shawn M.; Ross-Ibarra, Jeffrey; McMullen, Michael D.; Buckler, Edward S.; Zhang, Gengyun; Xu, Yunbi; Ware, Doreen			Maize HapMap2 identifies extant variation from a genome in flux	NATURE GENETICS			English	Article							QUANTITATIVE RESISTANCE; WIDE ASSOCIATION; LEAF-BLIGHT; DIVERSITY; EVOLUTION; ALIGNMENT; ZEA; BIOCONDUCTOR; ULTRAFAST; PATTERNS	Whereas breeders have exploited diversity in maize for yield improvements, there has been limited progress in using beneficial alleles in undomesticated varieties. Characterizing standing variation in this complex genome has been challenging, with only a small fraction of it described to date. Using a population genetics scoring model, we identified 55 million SNPs in 103 lines across pre-domestication and domesticated Zea mays varieties, including a representative from the sister genus Tripsacum. We find that structural variations are pervasive in the Z. mays genome and are enriched at loci associated with important traits. By investigating the drivers of genome size variation, we find that the larger Tripsacum genome can be explained by transposable element abundance rather than an allopolyploid origin. In contrast, intraspecies genome size variation seems to be controlled by chromosomal knob content. There is tremendous overlap in key gene content in maize and Tripsacum, suggesting that adaptations from Tripsacum (for example, perennialism and frost and drought tolerance) can likely be integrated into maize.	[Bradbury, Peter J.; Costich, Denise; Elshire, Robert J.; Glaubitz, Jeffrey C.; Li, Meng; Sun, Qi; Tian, Feng; Zhang, Zhiwu; Buckler, Edward S.] Cornell Univ, Inst Genom Div, Ithaca, NY USA; [Chia, Jer-Ming; Geller, Laura; McCombie, Richard; Ware, Doreen] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Song, Chi; Liu, Xin; Wang, Jun; Xu, Xun; Zhang, Gengyun] BGI Shenzhen, Shenzhen, Peoples R China; [de Leon, Natalia; Sekhon, Rajandeep S.; Kaeppler, Shawn M.] Univ Wisconsin, US Dept Energy DOE, Great Lakes Bioenergy Res Ctr, Madison, WI USA; [de Leon, Natalia; Sekhon, Rajandeep S.; Kaeppler, Shawn M.] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA; [Doebley, John] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Gaut, Brandon; Tenaillon, Maud I.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Gore, Michael] US Arid Land Agr Res Ctr, Maricopa, AZ USA; [Guill, Kate E.; McMullen, Michael D.] Univ Missouri, Div Plant Sci, Columbia, MO USA; [Holland, Jim] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Hufford, Matthew B.; Pyhaejaervi, Tanja; Ross-Ibarra, Jeffrey] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Lai, Jinsheng] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Lai, Jinsheng] China Agr Univ, Natl Maize Improvement Ctr, Beijing 100094, Peoples R China; [Lai, Jinsheng] China Agr Univ, Dept Plant Genet & Breeding, Beijing 100094, Peoples R China; [Lu, Yanli; Rong, Tingzhao] Sichuan Agr Univ, Maize Res Inst, Chengdu, Peoples R China; [Nelson, Rebecca] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY USA; [Prasanna, Boddupalli M.] Int Maize & Wheat Improvement Ctr CIMMYT, Nairobi, Kenya; [Poland, Jesse] Kansas State Univ, Manhattan, KS 66506 USA; [Tenaillon, Maud I.] Univ Paris 11, CNRS, INRA, Unite Mixte Rech UMR Genet Vegetale,AgroParisTech, Gif Sur Yvette, France; [Ross-Ibarra, Jeffrey] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Xu, Yunbi] Chinese Acad Agr Sci, Natl Key Facil Crop Genet Resources & Improvement, Inst Crop Sci, Beijing 100193, Peoples R China; [Xu, Yunbi] CIMMYT, Texcoco, Mexico	Cornell University; Cold Spring Harbor Laboratory; Beijing Genomics Institute (BGI); United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Irvine; University of Missouri System; University of Missouri Columbia; University of North Carolina; North Carolina State University; University of California System; University of California Davis; China Agricultural University; China Agricultural University; China Agricultural University; Sichuan Agricultural University; Cornell University; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Kansas State University; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California Davis; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Buckler, ES (corresponding author), Cornell Univ, Inst Genom Div, Ithaca, NY USA.	mcmullenm@missouri.edu; esb33@cornell.edu; zhanggengyun@genomics.org.cn; y.xu@cgiar.org; ware@cshl.edu	Buckler, Edward/GPS-4932-2022; Pyhäjärvi, Tanja/ABD-4161-2021; Zhang, zs/GXN-3521-2022; Zhang, Zhiwu/P-6156-2016; Hufford, Matthew/E-7810-2012; Xu, Xun/AAI-6763-2020; Buckler, Edward/L-7651-2019; Ross-Ibarra, Jeffrey/D-7782-2011; Wang, Jun/A-7261-2013; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Zhang, Zhiwu/0000-0002-5784-9684; Hufford, Matthew/0000-0003-3945-1143; Xu, Xun/0000-0002-5338-5173; Buckler, Edward/0000-0002-3100-371X; Ross-Ibarra, Jeffrey/0000-0003-1656-4954; McCombie, W. Richard/0000-0003-1899-0682; Wang, Jun/0000-0002-2113-5874; Poland, Jesse/0000-0002-7856-1399; Pyhajarvi, Tanja/0000-0001-6958-5172; Wang, Jun/0000-0002-8540-8931; Tenaillon, Maud/0000-0002-0867-3678; Gore, Michael/0000-0001-6896-8024; Elshire, Robert/0000-0003-1753-6920; Kaeppler, Shawn/0000-0002-5964-1668; Holland, James/0000-0002-4341-9675; Boddupalli, Prasanna/0000-0002-5761-2273; Liu, Xin/0000-0003-3256-2940	US National Science Foundation [DBI-0820619, 0321467, 0703908, 0638566, IOS-092270]; USDA-ARS; USDA-National Institute of Food and Agriculture (NIFA) [2009-01864]; US DOE (BER) [DE-FC02-07ER44494, DE-AC02-03CH11211]; Rockefeller Foundation; Bill and Melinda Gates Foundation; Generation Challenge Program; Chinese 971 program [2007CB813701, 2007CB813703]; National Natural Science Foundation of China (NSFC) [10723008]; Chinese Ministry of Agriculture [2010-Z11]; National High Technology Research and Development Program of China [2009AA10AA03-2]; National Basic Research Program of China [2007CB108900]; Direct For Biological Sciences [0922703] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA-National Institute of Food and Agriculture (NIFA); US DOE (BER)(United States Department of Energy (DOE)); Rockefeller Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Generation Challenge Program; Chinese 971 program; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the US National Science Foundation (DBI-0820619, 0321467, 0703908, 0638566 and IOS-092270), the USDA-ARS, the USDA-National Institute of Food and Agriculture (NIFA) (2009-01864), the US DOE (BER DE-FC02-07ER44494 and DE-AC02-03CH11211), The Rockefeller Foundation, the Bill and Melinda Gates Foundation, the Generation Challenge Program, the Chinese 971 program (2007CB813701, 2007CB813701 and 2007CB813703), the National Natural Science Foundation of China (NSFC) to Young Scientists (10723008), Guangdong Innovation Team Funding, the Chinese Ministry of Agriculture 984 program (2010-Z11), the National High Technology Research and Development Program of China (2009AA10AA03-2) and the National Basic Research Program of China (2007CB108900).	Albert PS, 2010, CYTOGENET GENOME RES, V129, P6, DOI 10.1159/000314342; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson Edgar, 1944, ANN MISSOURI BOT GARD, V31, P317, DOI 10.2307/2394366; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P229, DOI [10.1007/BF02672073, DOI 10.1007/BF02672073]; Baucom RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000732; Brunner S, 2005, PLANT CELL, V17, P343, DOI 10.1105/tpc.104.025627; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Fu HH, 2002, P NATL ACAD SCI USA, V99, P9573, DOI 10.1073/pnas.132259199; Gaut BS, 2000, P NATL ACAD SCI USA, V97, P7008, DOI 10.1073/pnas.97.13.7008; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LAURIE DA, 1985, HEREDITY, V55, P307, DOI 10.1038/hdy.1985.112; Le Rouzic A, 2007, P NATL ACAD SCI USA, V104, P19375, DOI 10.1073/pnas.0705238104; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Meyers BC, 2001, GENOME RES, V11, P1660, DOI 10.1101/gr.188201; Morgante M, 2007, CURR OPIN PLANT BIOL, V10, P149, DOI 10.1016/j.pbi.2007.02.001; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Piegu B, 2006, GENOME RES, V16, P1262, DOI 10.1101/gr.5290206; Poggio L, 1998, ANN BOT-LONDON, V82, P107, DOI 10.1006/anbo.1998.0757; Poland JA, 2011, P NATL ACAD SCI USA, V108, P6893, DOI 10.1073/pnas.1010894108; Rizzon C, 2006, PLOS COMPUT BIOL, V2, P989, DOI 10.1371/journal.pcbi.0020115; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Swanson-Wagner RA, 2010, GENOME RES, V20, P1689, DOI 10.1101/gr.109165.110; Tenaillon MI, 2011, GENOME BIOL EVOL, V3, P219, DOI 10.1093/gbe/evr008; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	40	415	436	3	197	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2012	44	7					803	U238		10.1038/ng.2313	http://dx.doi.org/10.1038/ng.2313			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967DP	22660545				2022-12-25	WOS:000305886900016
J	Yamagishi, Y; Yang, CH; Tanno, Y; Watanabe, Y				Yamagishi, Yuya; Yang, Ching-Hui; Tanno, Yuji; Watanabe, Yoshinori			MPS1/Mph1 phosphorylates the kinetochore protein KNL1/Spc7 to recruit SAC components	NATURE CELL BIOLOGY			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; BUDDING YEAST; BUB1; MPS1; LOCALIZATION; MAD2; ACTIVATION; CENTROMERE; INHIBITOR; COMPLEXES	The genomic stability of all organisms depends on the precise partition of chromosomes to daughter cells. The spindle assembly checkpoint (SAC) senses unattached kinetochores and prevents premature entry to anaphase, thus ensuring that all chromosomes attach to opposite spindle poles (bi-orientation) during mitosis(1). MPS1 is an evolutionarily conserved protein kinase required for the SAC and chromosome bi-orientation(2-4). Yet, its primary cellular substrate has remained elusive. We show that fission yeast Mph1 (MPS1 homologue) phosphorylates the kinetochore protein Spc7 (KNL1/Blinkin homologue) at the MELT repeat sequences. This phosphorylation promotes the-in vitro binding to the Bub1-Bub3 complex, which is required for kinetochore-based SAC activation (Mad1-Mad2-Mad3 localization) and chromosome alignment. Accordingly, a non-phosphorylatable spc7-12A mutation abolishes kinetochore targeting of Bub1-Bub3, whereas a phospho-mimetic spc7-12E mutation forces them to localize at kinetochores throughout the entire cell cycle, even in the absence of Mph1. Thus, MPS1/Mph1 kinase locating at the unattached kinetochores initially creates a mark, which is crucial for SAC activation and chromosome bi-orientation. This mechanism seems to be conserved in human cells.	[Yamagishi, Yuya; Yang, Ching-Hui; Tanno, Yuji; Watanabe, Yoshinori] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Yayoi, Tokyo 1130032, Japan	University of Tokyo	Watanabe, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Yayoi, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp		Watanabe, Yoshinori/0000-0002-5488-4812	JSPS; Global COE Program from Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [23870005, 21000010] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global COE Program from Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Hauf for critical reading of the manuscript and for yeast strains, and all of the members of our laboratory for their valuable support and discussion. This work was supported in part by JSPS Research Fellowships and Grant-in-Aid for Research Activity Start-up (to Y.Y.), the Global COE Program and a Grant-in-Aid for Specially Promoted Research (to Y.W.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Araki Y, 2010, J CELL BIOL, V189, P41, DOI 10.1083/jcb.200910027; Bernard P, 1998, J CELL BIOL, V143, P1775, DOI 10.1083/jcb.143.7.1775; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; HIRAOKA Y, 1984, CELL, V39, P349, DOI 10.1016/0092-8674(84)90013-8; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Ito D, 2012, P NATL ACAD SCI USA, V109, P209, DOI 10.1073/pnas.1114647109; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Kemmler S, 2009, EMBO J, V28, P1099, DOI 10.1038/emboj.2009.62; Kerres A, 2007, MOL BIOL CELL, V18, P2441, DOI 10.1091/mbc.E06-08-0738; Kiyomitsu T, 2011, MOL CELL BIOL, V31, P998, DOI 10.1128/MCB.00815-10; Krenn V, 2012, J CELL BIOL, V196, P451, DOI 10.1083/jcb.201110013; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Lau DTC, 2012, CURR BIOL, V22, P180, DOI 10.1016/j.cub.2011.12.029; London N, 2012, CURR BIOL, V22, P900, DOI 10.1016/j.cub.2012.03.052; Maciejowski J, 2010, J CELL BIOL, V190, P89, DOI 10.1083/jcb.201001050; Maldonado M, 2011, NAT CELL BIOL, V13, P475, DOI 10.1038/ncb2223; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Maure JF, 2007, CURR BIOL, V17, P2175, DOI 10.1016/j.cub.2007.11.032; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Rischitor PE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001342; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Shah JV, 2004, CURR BIOL, V14, P942, DOI 10.1016/j.cub.2004.05.046; Sharp-Baker H, 2001, J CELL BIOL, V153, P1239, DOI 10.1083/jcb.153.6.1239; Shepperd LA, 2012, CURR BIOL, V22, P891, DOI 10.1016/j.cub.2012.03.051; Shimogawa MM, 2006, CURR BIOL, V16, P1489, DOI 10.1016/j.cub.2006.06.063; Sliedrecht T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010251; Tange Y, 2008, GENETICS, V179, P785, DOI 10.1534/genetics.107.081695; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Taylor SS, 1998, J CELL BIOL, V142, P1, DOI 10.1083/jcb.142.1.1; Tooley J, 2011, CHROMOSOME RES, V19, P377, DOI 10.1007/s10577-010-9180-5; Vanoosthuyse V, 2004, MOL CELL BIOL, V24, P9786, DOI 10.1128/MCB.24.22.9786-9801.2004; Vanoosthuyse V, 2009, MOL BIOL CELL, V20, P5096, DOI 10.1091/mbc.E09-09-0762; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; Williams GL, 2007, CELL CYCLE, V6, P1699, DOI 10.4161/cc.6.14.4493; Windecker H, 2009, EMBO REP, V10, P1022, DOI 10.1038/embor.2009.183; Winey M, 2002, ONCOGENE, V21, P6161, DOI 10.1038/sj.onc.1205712; Zich J, 2012, CURR BIOL, V22, P296, DOI 10.1016/j.cub.2011.12.049	41	224	227	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2012	14	7					746	752		10.1038/ncb2515	http://dx.doi.org/10.1038/ncb2515			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	967PV	22660415				2022-12-25	WOS:000305921200014
J	Perciavalle, RM; Stewart, DP; Koss, B; Lynch, J; Milasta, S; Bathina, M; Temirov, J; Cleland, MM; Pelletier, S; Schuetz, JD; Youle, RJ; Green, DR; Opferman, JT				Perciavalle, Rhonda M.; Stewart, Daniel P.; Koss, Brian; Lynch, John; Milasta, Sandra; Bathina, Madhavi; Temirov, Jamshid; Cleland, Megan M.; Pelletier, Stephane; Schuetz, John D.; Youle, Richard J.; Green, Douglas R.; Opferman, Joseph T.			Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration	NATURE CELL BIOLOGY			English	Article							CYTOCHROME-C-OXIDASE; COMPLEX-I; SUPRAMOLECULAR ORGANIZATION; SKELETAL-MUSCLE; PROTEIN IMPORT; ATP SYNTHASE; CELL-DEATH; SURVIVAL; BCL-2; FAMILY	MCL-1, an anti-apoptotic BCL-2 family member that is essential for the survival of multiple cell lineages, is also among the most highly amplified genes in cancer. Although MCL-1 is known to oppose cell death, precisely how it functions to promote survival of normal and malignant cells is poorly understood. Here, we report that different forms of MCL-1 reside in distinct mitochondrial locations and exhibit separable functions. On the outer mitochondrial membrane, an MCL-1 isoform acts like other anti-apoptotic BCL-2 molecules to antagonize apoptosis, whereas an amino-terminally truncated isoform of MCL-1 that is imported into the mitochondrial matrix is necessary to facilitate normal mitochondrial fusion, ATP production, membrane potential, respiration, cristae ultrastructure and maintenance of oligomeric ATP synthase. Our results provide insight into how the surprisingly diverse salutary functions of MCL-1 may control the survival of both normal and cancer cells.	[Perciavalle, Rhonda M.; Stewart, Daniel P.; Koss, Brian; Bathina, Madhavi; Pelletier, Stephane; Opferman, Joseph T.] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; [Perciavalle, Rhonda M.] Univ Tennessee, Ctr Hlth Sci, Integrated Program Biomed Sci, Memphis, TN 38163 USA; [Temirov, Jamshid] St Jude Childrens Res Hosp, Cell & Tissue Imaging Facil, Memphis, TN 38105 USA; [Cleland, Megan M.; Youle, Richard J.] Natl Inst Neurol Disorders & Stroke, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Opferman, JT (corresponding author), St Jude Childrens Res Hosp, Dept Biochem, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	Joseph.Opferman@stjude.org	qiao, zhixin/I-3408-2012; BATHINA, MADHAVI/G-3200-2012; Opferman, Joseph T/M-5331-2018; Green, Douglas R/N-8083-2018	Opferman, Joseph T/0000-0002-1147-5621; Green, Douglas R/0000-0002-7332-1417; Harwig, Megan/0000-0003-2140-5739; Koss, Brian/0000-0003-0155-4809; Pelletier, Stephane/0000-0002-1127-0212	Pew Scholars Program in the Biomedical Sciences; National Institutes of Health [HL-102175]; American Cancer Society [RSG-10-255-01-LIB]; Cancer Center [P30CA021765]; American Lebanese Syrian Associated Charities of St Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003127, ZIANS003123] Funding Source: NIH RePORTER	Pew Scholars Program in the Biomedical Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Cancer Center; American Lebanese Syrian Associated Charities of St Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the St Jude Cell and Tissue Imaging Facility for assistance with live-cell imaging and S. Erase for assistance with electron micrographs; the W. M. Keck Foundation Biotechnology Resource Laboratory at Yale University for Edman sequencing; B. Xia, E. Parganas and D. Gable for technical assistance; C. Shaner for animal husbandry; and members of the St Jude Biochemistry Department, S. Oakes, J. Ihle and C. Sherr for helpful discussions. J.T.O. is supported by the Pew Scholars Program in the Biomedical Sciences; the National Institutes of Health HL-102175; the American Cancer Society RSG-10-255-01-LIB; a Cancer Center Support Grant P30CA021765; and the American Lebanese Syrian Associated Charities of St Jude Children's Research Hospital.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Arbour N, 2008, J NEUROSCI, V28, P6068, DOI 10.1523/JNEUROSCI.4940-07.2008; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Bornhovd C, 2006, J BIOL CHEM, V281, P13990, DOI 10.1074/jbc.M512334200; Chan DC, 2007, NEW ENGL J MED, V356, P1707, DOI 10.1056/NEJMp078040; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; De Biasio A, 2007, J BIOL CHEM, V282, P23919, DOI 10.1074/jbc.M700938200; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Dzhagalov I, 2008, J IMMUNOL, V181, P521, DOI 10.4049/jimmunol.181.1.521; Dzhagalov I, 2007, BLOOD, V109, P1620, DOI 10.1182/blood-2006-03-013771; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; Frost MT, 2005, AM J PHYSIOL-REG I, V288, pR394, DOI 10.1152/ajpregu.00504.2004; Genova ML, 2008, BBA-BIOENERGETICS, V1777, P740, DOI 10.1016/j.bbabio.2008.04.007; Gilkerson RW, 2003, FEBS LETT, V546, P355, DOI 10.1016/S0014-5793(03)00633-1; Giraud MF, 2002, BBA-BIOENERGETICS, V1555, P174, DOI 10.1016/S0005-2728(02)00274-8; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; HINMAN LM, 1981, J BIOL CHEM, V256, P6583; Huang CR, 2010, FEBS LETT, V584, P3323, DOI 10.1016/j.febslet.2010.07.013; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Kojima S, 2010, BIOCHEM BIOPH RES CO, V391, P492, DOI 10.1016/j.bbrc.2009.11.086; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, pC1440, DOI 10.1152/ajpcell.00607.2004; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; KRAJEWSKI S, 1995, AM J PATHOL, V146, P1309; Krause F, 2005, BIOCHEM BIOPH RES CO, V329, P583, DOI 10.1016/j.bbrc.2005.02.010; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Miro O, 1998, J NEUROSCI METH, V80, P107, DOI 10.1016/S0165-0270(97)00204-5; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100; Morel C, 2009, MOL CELL BIOL, V29, P3845, DOI 10.1128/MCB.00279-09; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Peters PJ, 2006, CURR PROTOC CELL BIO; PFANNER N, 1987, EMBO J, V6, P3449, DOI 10.1002/j.1460-2075.1987.tb02668.x; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Rinkenberger JL, 2000, GENE DEV, V14, P23; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Steimer DA, 2009, BLOOD, V113, P2805, DOI 10.1182/blood-2008-05-159145; Stewart DP, 2010, MOL CELL BIOL, V30, P3099, DOI 10.1128/MCB.01266-09; Thomas D, 2008, BIOL CELL, V100, P591, DOI 10.1042/BC20080022; Velours J, 2009, INT J BIOCHEM CELL B, V41, P1783, DOI 10.1016/j.biocel.2009.01.011; Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Warr MR, 2008, CURR MOL MED, V8, P138; Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wuilleme-Toumi S, 2005, LEUKEMIA, V19, P1248, DOI 10.1038/sj.leu.2403784; YANG T, 1995, J CELL BIOL, V128, P1173, DOI 10.1083/jcb.128.6.1173; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	62	277	286	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2012	14	6					575	+		10.1038/ncb2488	http://dx.doi.org/10.1038/ncb2488			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	949TW	22544066	Green Accepted			2022-12-25	WOS:000304599900007
J	Shichita, T; Hasegawa, E; Kimura, A; Morita, R; Sakaguchi, R; Takada, I; Sekiya, T; Ooboshi, H; Kitazono, T; Yanagawa, T; Ishii, T; Takahashi, H; Mori, S; Nishibori, M; Kuroda, K; Akira, S; Miyake, K; Yoshimura, A				Shichita, Takashi; Hasegawa, Eiichi; Kimura, Akihiro; Morita, Rimpei; Sakaguchi, Ryota; Takada, Ichiro; Sekiya, Takashi; Ooboshi, Hiroaki; Kitazono, Takanari; Yanagawa, Toru; Ishii, Tetsuro; Takahashi, Hideo; Mori, Shuji; Nishibori, Masahiro; Kuroda, Kazumichi; Akira, Shizuo; Miyake, Kensuke; Yoshimura, Akihiko			Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain	NATURE MEDICINE			English	Article							INNATE IMMUNE-RESPONSES; CRYSTAL-STRUCTURE; MAMMALIAN PEROXIREDOXIN; ANGSTROM RESOLUTION; PIVOTAL ROLE; RECEPTOR 4; ISCHEMIA; INJURY; STROKE; CELLS	Post-ischemic inflammation is an essential step in the progression of brain ischemia-reperfusion injury. However, the mechanism that activates infiltrating macrophages in the ischemic brain remains to be clarified. Here we demonstrate that peroxiredoxin (Prx) family proteins released extracellularly from necrotic brain cells induce expression of inflammatory cytokines including interleukin-23 in macrophages through activation of Toll-like receptor 2 (TLR2) and TLR4, thereby promoting neural cell death, even though intracellular Prxs have been shown to be neuroprotective. The extracellular release of Prxs in the ischemic core occurred 12 h after stroke onset, and neutralization of extracellular Prxs with antibodies suppressed inflammatory cytokine expression and infarct volume growth. In contrast, high mobility group box 1 (HMGB1), a well-known damage-associated molecular pattern molecule, was released before Prx and had a limited role in post-ischemic macrophage activation. We thus propose that extracellular Prxs are previously unknown danger signals in the ischemic brain and that its blocking agents are potent neuroprotective tools.	[Shichita, Takashi; Hasegawa, Eiichi; Kimura, Akihiro; Morita, Rimpei; Sakaguchi, Ryota; Takada, Ichiro; Sekiya, Takashi; Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan; [Shichita, Takashi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Tokyo, Japan; [Shichita, Takashi; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan; [Ooboshi, Hiroaki] Fukuoka Dent Coll Med & Dent Hosp, Dept Internal Med, Fukuoka, Japan; [Yanagawa, Toru; Ishii, Tetsuro] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan; [Takahashi, Hideo; Mori, Shuji; Nishibori, Masahiro] Okayama Univ, Grad Sch Med, Dept Pharmacol, Okayama 7008530, Japan; [Kuroda, Kazumichi] Nihon Univ, Sch Med, Div Microbiol, Tokyo, Japan; [Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Host Def Lab, Osaka, Japan; [Miyake, Kensuke] Univ Tokyo, Inst Med Sci, Div Infect Genet, Tokyo, Japan; [Yoshimura, Akihiko] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Keio University; Japan Science & Technology Agency (JST); Kyushu University; Fukuoka Dental College (FDC); University of Tsukuba; Okayama University; Nihon University; Osaka University; University of Tokyo; Japan Science & Technology Agency (JST)	Yoshimura, A (corresponding author), Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan.	yoshimura@a6.keio.jp	Yoshimura, Akihiko/K-5515-2013; Akira, Shizuo/C-3134-2009; Yanagawa, Toru/GYU-6448-2022	Yanagawa, Toru/0000-0003-0868-2563; Kimura, Akihiro/0000-0001-5614-8547; Takahashi, Hideo/0000-0001-9444-9746	Ministry of Education, Culture, Sports, Science and Technology of Japan; PRESTO from the Japan Science and Technology Agency; CREST from the Japan Science and Technology Agency; National Center of Neurology and Psychiatry (NCNP) [22-4]; SENSHIN Research Foundation; Takeda Science Foundation; Uehara Memorial Foundation; Mochida Memorial Foundation; Ministry of Health, Labor and Welfare of Japan [09156274]; National Institute of Biomedical Innovation; Grants-in-Aid for Scientific Research [24390061] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PRESTO from the Japan Science and Technology Agency; CREST from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); National Center of Neurology and Psychiatry (NCNP); SENSHIN Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Mochida Memorial Foundation; Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank N. Saito, N. Shiino and M. Asakawa for technical assistance. This work was supported by special grants-in-aid (A) and open research for young academics and specialists from the Ministry of Education, Culture, Sports, Science and Technology of Japan, PRESTO and CREST from the Japan Science and Technology Agency, an Intramural Research Grant (22-4) for Neurological and Psychiatric Disorders of the National Center of Neurology and Psychiatry (NCNP), the SENSHIN Research Foundation, the Takeda Science Foundation, the Uehara Memorial Foundation, the Mochida Memorial Foundation, the Scientific Research Fund from the Ministry of Health, Labor and Welfare of Japan (09156274) and the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation.	Akashi-Takamura S, 2008, CURR OPIN IMMUNOL, V20, P420, DOI 10.1016/j.coi.2008.07.001; Brea D, 2011, J CEREBR BLOOD F MET, V31, P1424, DOI 10.1038/jcbfm.2010.231; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chesterman ES, 2001, DEV DYNAM, V222, P459, DOI 10.1002/dvdy.1198; Choi HJ, 1998, NAT STRUCT BIOL, V5, P400, DOI 10.1038/nsb0598-400; Chou JLJ, 2011, PROTEOMICS, V11, P239, DOI 10.1002/pmic.201000438; Dayon L, 2011, J PROTEOME RES, V10, P1043, DOI 10.1021/pr101123t; Declercq JP, 2001, J MOL BIOL, V311, P751, DOI 10.1006/jmbi.2001.4853; Eismann T, 2009, AM J PHYSIOL-GASTR L, V296, pG266, DOI 10.1152/ajpgi.90583.2008; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Hayakawa K, 2010, ANN NY ACAD SCI, V1207, P50, DOI 10.1111/j.1749-6632.2010.05728.x; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Hu XM, 2011, J NEUROSCI, V31, P247, DOI 10.1523/JNEUROSCI.4589-10.2011; Hurn PD, 2007, J CEREBR BLOOD F MET, V27, P1798, DOI 10.1038/sj.jcbfm.9600482; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Jin MH, 2005, NEUROSCI LETT, V381, P252, DOI 10.1016/j.neulet.2005.02.048; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Konoeda F, 2010, BIOCHEM BIOPH RES CO, V402, P500, DOI 10.1016/j.bbrc.2010.10.058; Liesz A, 2011, BRAIN, V134, P704, DOI 10.1093/brain/awr008; Liu K, 2007, FASEB J, V21, P3904, DOI 10.1096/fj.07-8770com; Lo EH, 2010, NAT MED, V16, P1205, DOI 10.1038/nm.2226; Macrez R, 2011, LANCET NEUROL, V10, P471, DOI 10.1016/S1474-4422(11)70066-7; Marsh BJ, 2009, NEUROSCIENCE, V158, P1007, DOI 10.1016/j.neuroscience.2008.07.067; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Ooboshi H, 2005, CIRCULATION, V111, P913, DOI 10.1161/01.CIR.0000155622.68580.DC; Patenaude A, 2005, CELL MOL LIFE SCI, V62, P1063, DOI 10.1007/s00018-005-4541-5; Qiu J, 2008, J CEREBR BLOOD F MET, V28, P927, DOI 10.1038/sj.jcbfm.9600582; Rashidian J, 2009, J NEUROSCI, V29, P12497, DOI 10.1523/JNEUROSCI.3892-09.2009; Ren XF, 2011, J NEUROSCI, V31, P8556, DOI 10.1523/JNEUROSCI.1623-11.2011; Riddell JR, 2010, J IMMUNOL, V184, P1022, DOI 10.4049/jimmunol.0901945; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Sugimori H, 2004, BRAIN RES PROTOC, V13, P189, DOI 10.1016/j.brainresprot.2004.06.001; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; TOOHEY JI, 1975, P NATL ACAD SCI USA, V72, P73, DOI 10.1073/pnas.72.1.73; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang QW, 2011, J CEREBR BLOOD F MET, V31, P593, DOI 10.1038/jcbfm.2010.129; Yi HF, 2009, BLOOD, V113, P5819, DOI 10.1182/blood-2008-11-190033; Yilmaz G, 2006, CIRCULATION, V113, P2105, DOI 10.1161/CIRCULATIONAHA.105.593046; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zhang JY, 2011, STROKE, V42, P1420, DOI 10.1161/STROKEAHA.110.598334; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	47	287	301	2	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2012	18	6					911	+		10.1038/nm.2749	http://dx.doi.org/10.1038/nm.2749			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22610280				2022-12-25	WOS:000305116600028
J	Liao, GY; An, JJ; Gharami, K; Waterhouse, EG; Vanevski, F; Jones, KR; Xu, BJ				Liao, Guey-Ying; An, Juan Ji; Gharami, Kusumika; Waterhouse, Emily G.; Vanevski, Filip; Jones, Kevin R.; Xu, Baoji			Dendritically targeted Bdnf mRNA is essential for energy balance and response to leptin	NATURE MEDICINE			English	Article							LOCAL PROTEIN-SYNTHESIS; NEUROTROPHIC FACTOR; FOOD-INTAKE; BODY-WEIGHT; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; SEVERE OBESITY; BRAIN; MICE; EXPRESSION	Mutations in the Bdnf gene, which produces transcripts with either short or long 3' untranslated regions (3' UTRs), cause human obesity; however, the precise role of brain-derived neurotrophic factor (BDNF) in the regulation of energy balance is unknown. Here we show the relationship between Bdnf mRNA with a long 3' UTR (long 3' UTR Bdnf mRNA), leptin, neuronal activation and body weight. We found that long 3' UTR Bdnf mRNA was enriched in the dendrites of hypothalamic neurons and that insulin and leptin could stimulate its translation in dendrites. Furthermore, mice harboring a truncated long Bdnf 3' UTR developed severe hyperphagic obesity, which was completely reversed by viral expression of long 3' UTR Bdnf mRNA in the hypothalamus. In these mice, the ability of leptin to activate hypothalamic neurons and inhibit food intake was compromised despite normal activation of leptin receptors. These results reveal a novel mechanism linking leptin action to BDNF expression during hypothalamic-mediated regulation of body weight, while also implicating dendritic protein synthesis in this process.	[Liao, Guey-Ying; An, Juan Ji; Gharami, Kusumika; Waterhouse, Emily G.; Vanevski, Filip; Xu, Baoji] Georgetown Univ Med Ctr, Dept Physiol & Pharmacol, Washington, DC USA; [Jones, Kevin R.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Georgetown University; University of Colorado System; University of Colorado Boulder	Xu, BJ (corresponding author), Georgetown Univ Med Ctr, Dept Physiol & Pharmacol, Washington, DC USA.	bx3@georgetown.edu		JONES, KEVIN/0000-0002-3802-7562	US National Institutes of Health [R01 DK089237, R21 DK081008, R01 NS050596, F30 DK084717, F31 NS060453]; American Diabetes Association [7-07-RA-183]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK081008, F30DK084717, R01DK089237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS050596, R01NS050596, F31NS060453] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the grants from the US National Institutes of Health to B.X. (R01 DK089237, R21 DK081008 and R01 NS050596), E.G.W. (F30 DK084717) and F.V. (F31 NS060453) and from the American Diabetes Association to B.X. (7-07-RA-183).	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Cao L, 2009, NAT MED, V15, P447, DOI 10.1038/nm.1933; Chua SC, 1996, SCIENCE, V271, P994, DOI 10.1126/science.271.5251.994; Coppola V, 2004, NEUROREPORT, V15, P2665, DOI 10.1097/00001756-200412030-00022; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Gharami K, 2008, J NEUROCHEM, V105, P369, DOI 10.1111/j.1471-4159.2007.05137.x; Gorski JA, 2003, J NEUROSCI, V23, P6856; Gray J, 2006, DIABETES, V55, P3366, DOI 10.2337/db06-0550; Han JC, 2008, NEW ENGL J MED, V359, P918, DOI 10.1056/NEJMoa0801119; He W, 2006, NAT NEUROSCI, V9, P227, DOI 10.1038/nn1626; Horvath TL, 2001, ENDOCRINOLOGY, V142, P4163, DOI 10.1210/en.142.10.4163; Hotta K, 2009, J HUM GENET, V54, P727, DOI 10.1038/jhg.2009.106; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Hubschle T, 2001, J NEUROSCI, V21, P2413, DOI 10.1523/JNEUROSCI.21-07-02413.2001; Joseph-Bravo P, 2002, BRAIN RES PROTOC, V9, P93, DOI 10.1016/S1385-299X(01)00140-4; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; LIN CR, 1987, P NATL ACAD SCI USA, V84, P5962, DOI 10.1073/pnas.84.16.5962; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Pocai A, 2006, J CLIN INVEST, V116, P1081, DOI 10.1172/JCI26640; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Scott MM, 2009, J COMP NEUROL, V514, P518, DOI 10.1002/cne.22025; Shintani M, 2001, DIABETES, V50, P227, DOI 10.2337/diabetes.50.2.227; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; TangChristensen M, 1996, AM J PHYSIOL-REG I, V271, pR848, DOI 10.1152/ajpregu.1996.271.4.R848; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Wynne K, 2005, J ENDOCRINOL, V184, P291, DOI 10.1677/joe.1.05866; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	51	126	130	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2012	18	4					564	571		10.1038/nm.2687	http://dx.doi.org/10.1038/nm.2687			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22426422	Green Accepted			2022-12-25	WOS:000302617800033
J	Prysyazhna, O; Rudyk, O; Eaton, P				Prysyazhna, Oleksandra; Rudyk, Olena; Eaton, Philip			Single atom substitution in mouse protein kinase G eliminates oxidant sensing to cause hypertension	NATURE MEDICINE			English	Article							SMOOTH-MUSCLE HYPERPOLARIZATION; HYDROGEN-PEROXIDE; IN-VIVO; MICE; RELAXATION; DISEASE; ARTERY	Blood pressure regulation is crucial for the maintenance of health, and hypertension is a risk factor for myocardial infarction, heart failure, stroke and renal disease. Nitric oxide (NO) and prostacyclin trigger well-defined vasodilator pathways; however, substantial vasorelaxation in response to agents such as acetylcholine persists when the synthesis of these molecules is prevented. This remaining vasorelaxation activity, termed endothelium-derived hyperpolarizing factor (EDHF), is more prevalent in resistance than in conduit blood vessels and is considered a major mechanism for blood pressure control(1-4). Hydrogen peroxide (H2O2) has been shown to be a major component of EDHF in several vascular beds in multiple species, including in humans(5-10). H2O2 causes the formation of a disulfide bond between the two a subunits of protein kinase G I-alpha (PKGI-alpha), which activates the kinase independently of the NO-cyclic guanosine monophosphate (cGMP) pathway and is coupled to vasodilation(11). To test the importance of PKGI-alpha oxidation in the EDHF mechanism and blood pressure control in vivo, we generated a knock-in mouse expressing only a C42S 'redox-dead' version of PKGI-alpha. This amino acid substitution, a single-atom change (an oxygen atom replacing a sulfur atom), blocked the vasodilatory action of H2O2 on resistance vessels and resulted in hypertension in vivo.	[Prysyazhna, Oleksandra; Rudyk, Olena; Eaton, Philip] Kings Coll London, Cardiovasc Div, British Heart Fdn Ctr Excellence, Rayne Inst,St Thomas Hosp, London WC2R 2LS, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Eaton, P (corresponding author), Kings Coll London, Cardiovasc Div, British Heart Fdn Ctr Excellence, Rayne Inst,St Thomas Hosp, London WC2R 2LS, England.	philip.eaton@kcl.ac.uk	Rudyk, Olena/AAY-3789-2020; Eaton, Philip/I-5444-2015	Eaton, Philip/0000-0003-0748-2367; Rudyk, Olena/0000-0001-9422-9233; Prysyazhna, Oleksandra/0000-0002-0394-7000	Medical Research Council; British Heart Foundation; Leducq Foundation; UK Department of Health through the National Institute for Health Research comprehensive Biomedical Research Centre; British Heart Foundation [PG/10/98/28655] Funding Source: researchfish; Medical Research Council [G1000458, G0700320, G0600785] Funding Source: researchfish; MRC [G1000458, G0600785, G0700320] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Leducq Foundation(Leducq Foundation); UK Department of Health through the National Institute for Health Research comprehensive Biomedical Research Centre; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge support from the Medical Research Council, the British Heart Foundation, the Leducq Foundation and the UK Department of Health through the National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's & St Thomas' National Health Service Foundation Trust.	Burgoyne J.R., 2008, THESIS KINGS COLL LO; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Busse R, 2002, TRENDS PHARMACOL SCI, V23, P374, DOI 10.1016/S0165-6147(02)02050-3; Dalsgaard T, 2010, EXPERT OPIN THER TAR, V14, P825, DOI 10.1517/14728222.2010.500616; Dora KA, 2001, AM J PHYSIOL-HEART C, V280, pH2424, DOI 10.1152/ajpheart.2001.280.6.H2424; Eaton P, 2006, FREE RADICAL BIO MED, V40, P1889, DOI 10.1016/j.freeradbiomed.2005.12.037; Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1; Feletou M, 2007, ANN MED, V39, P495, DOI 10.1080/07853890701491000; Garland CJ, 2011, BRIT J PHARMACOL, V164, P839, DOI 10.1111/j.1476-5381.2010.01148.x; Griffith TM, 2004, BRIT J PHARMACOL, V141, P881, DOI 10.1038/sj.bjp.0705698; Leung HS, 2006, VASC PHARMACOL, V44, P299, DOI 10.1016/j.vph.2006.01.010; Matoba T, 2002, BIOCHEM BIOPH RES CO, V290, P909, DOI 10.1006/bbrc.2001.6278; Matoba T, 2000, J CLIN INVEST, V106, P1521, DOI 10.1172/JCI10506; Miura H, 2003, CIRC RES, V92, pE31, DOI 10.1161/01.RES.0000054200.44505.AB; Shimokawa H, 2005, J MOL CELL CARDIOL, V39, P725, DOI 10.1016/j.yjmcc.2005.07.007; Shimokawa H, 2010, PFLUG ARCH EUR J PHY, V459, P915, DOI 10.1007/s00424-010-0790-8; Suvorava T, 2005, CIRCULATION, V112, P2487, DOI 10.1161/CIRCULATIONAHA.105.543157; Takaki A, 2008, J CARDIOVASC PHARM, V52, P510, DOI 10.1097/FJC.0b013e318190358b; Tataki A., 2008, J EXP MED, V205, P2053; Yada T, 2006, AM J PHYSIOL-HEART C, V291, pH1138, DOI 10.1152/ajpheart.00187.2006; Yang H, 2003, AM J HYPERTENS, V16, P1, DOI 10.1016/S0895-7061(02)03086-8; Yi L, 2010, J BIOL CHEM, V285, P20117, DOI 10.1074/jbc.M110.116483	22	127	128	0	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					286	290		10.1038/nm.2603	http://dx.doi.org/10.1038/nm.2603			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22245782	Green Accepted			2022-12-25	WOS:000300140300044
J	Shen, BQ; Xu, KY; Liu, LN; Raab, H; Bhakta, S; Kenrick, M; Parsons-Reponte, KL; Tien, J; Yu, SF; Mai, E; Li, DW; Tibbitts, J; Baudys, J; Saadi, OM; Scales, SJ; McDonald, PJ; Hass, PE; Eigenbrot, C; Nguyen, T; Solis, WA; Fuji, RN; Flagella, KM; Patel, D; Spencer, SD; Khawlil, LA; Ebens, A; Wong, WL; Vandlen, R; Kaur, S; Sliwkowski, MX; Scheller, RH; Polakis, P; Junutula, JR				Shen, Ben-Quan; Xu, Keyang; Liu, Luna; Raab, Helga; Bhakta, Sunil; Kenrick, Margaret; Parsons-Reponte, Kathryn L.; Tien, Janet; Yu, Shang-Fan; Mai, Elaine; Li, Dongwei; Tibbitts, Jay; Baudys, Jakub; Saadi, Ola M.; Scales, Suzie J.; McDonald, Paul J.; Hass, Philip E.; Eigenbrot, Charles; Trung Nguyen; Solis, Willy A.; Fuji, Reina N.; Flagella, Kelly M.; Patel, Darshana; Spencer, Susan D.; Khawlil, Leslie A.; Ebens, Allen; Wong, Wai Lee; Vandlen, Richard; Kaur, Surinder; Sliwkowski, Mark X.; Scheller, Richard H.; Polakis, Paul; Junutula, Jagath R.			Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates	NATURE BIOTECHNOLOGY			English	Article							TARGETED CANCER-THERAPY; ARMING ANTIBODIES; CYTOTOXIC DRUG; BREAST-CANCER; HYDROLYSIS; MALEIMIDE; ADDUCTS; INDEX	The reactive thiol in cysteine is used for coupling maleimide linkers in the generation of antibody conjugates. To assess the impact of the conjugation site, we engineered cysteines into a therapeutic HER2/neu antibody at three sites differing in solvent accessibility and local charge. The highly solvent-accessible site rapidly lost conjugated thiol-reactive linkers in plasma owing to maleimide exchange with reactive thiols in albumin, free cysteine or glutathione. In contrast, a partially accessible site with a positively charged environment promoted hydrolysis of the succinimide ring in the linker, thereby preventing this exchange reaction. The site with partial solvent-accessibility and neutral charge displayed both properties. In a mouse mammary tumor model, the stability and therapeutic activity of the antibody conjugate were affected positively by succinimide ring hydrolysis and negatively by maleimide exchange with thiol-reactive constituents in plasma. Thus, the chemical and structural dynamics of the conjugation site can influence antibody conjugate performance by modulating the stability of the antibody-linker interface.	[Shen, Ben-Quan; Xu, Keyang; Liu, Luna; Raab, Helga; Bhakta, Sunil; Kenrick, Margaret; Parsons-Reponte, Kathryn L.; Tien, Janet; Yu, Shang-Fan; Mai, Elaine; Li, Dongwei; Tibbitts, Jay; Baudys, Jakub; Saadi, Ola M.; Scales, Suzie J.; McDonald, Paul J.; Hass, Philip E.; Eigenbrot, Charles; Trung Nguyen; Solis, Willy A.; Fuji, Reina N.; Flagella, Kelly M.; Patel, Darshana; Spencer, Susan D.; Khawlil, Leslie A.; Ebens, Allen; Wong, Wai Lee; Vandlen, Richard; Kaur, Surinder; Sliwkowski, Mark X.; Scheller, Richard H.; Polakis, Paul; Junutula, Jagath R.] Genentech Inc, San Francisco, CA 94080 USA	Roche Holding; Genentech	Junutula, JR (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	jagath@gene.com	Junutula, Jagath Reddy/ABD-4753-2020; Scales, Suzie J./H-4507-2019	Junutula, Jagath Reddy/0000-0002-5942-4428; Scales, Suzie J./0000-0003-2544-0283; BHAKTA, SUNIL/0000-0002-1554-7098; Saad, Ola/0000-0002-2607-8901				Alley SC, 2008, BIOCONJUGATE CHEM, V19, P759, DOI 10.1021/bc7004329; Carter PJ, 2008, CANCER J, V14, P154, DOI 10.1097/PPO.0b013e318172d704; Chapman AP, 1999, NAT BIOTECHNOL, V17, P780, DOI 10.1038/11717; Chari RVJ, 2008, ACCOUNTS CHEM RES, V41, P98, DOI 10.1021/ar700108g; Doronina SO, 2003, NAT BIOTECHNOL, V21, P778, DOI 10.1038/nbt832; Hamblett KJ, 2004, CLIN CANCER RES, V10, P7063, DOI 10.1158/1078-0432.CCR-04-0789; Junutula JR, 2008, NAT BIOTECHNOL, V26, P925, DOI 10.1038/nbt.1480; Junutula JR, 2010, CLIN CANCER RES, V16, P4769, DOI 10.1158/1078-0432.CCR-10-0987; Kalia J, 2007, BIOORG MED CHEM LETT, V17, P6286, DOI 10.1016/j.bmcl.2007.09.002; KHAN MN, 1984, J PHARM SCI, V73, P1767, DOI 10.1002/jps.2600731227; KNIGHT P, 1979, BIOCHEM J, V179, P191, DOI 10.1042/bj1790191; Kreitman RJ, 1998, ADV DRUG DELIVER REV, V31, P53, DOI 10.1016/S0169-409X(97)00094-X; Lin D, 2008, CHEM RES TOXICOL, V21, P2361, DOI 10.1021/tx800248x; Marik J, 2011, CURR DRUG DELIV, V8, P70, DOI 10.2174/156720111793663589; McCarron PA, 2005, MOL INTERV, V5, P368, DOI 10.1124/mi.5.6.9; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; Phillips GDL, 2008, CANCER RES, V68, P9280, DOI 10.1158/0008-5472.CAN-08-1776; Polakis P, 2005, CURR OPIN PHARMACOL, V5, P382, DOI 10.1016/j.coph.2005.04.008; Polson AG, 2009, CANCER RES, V69, P2358, DOI 10.1158/0008-5472.CAN-08-2250; Ryan SM, 2008, EXPERT OPIN DRUG DEL, V5, P371, DOI [10.1517/17425247.5.4.371, 10.1517/17425247.5.4.371 ]; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Xu K, 2011, ANAL BIOCHEM, V412, P56, DOI 10.1016/j.ab.2011.01.004	22	672	757	23	348	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2012	30	2					184	189		10.1038/nbt.2108	http://dx.doi.org/10.1038/nbt.2108			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	892EI	22267010				2022-12-25	WOS:000300269100022
J	Zhang, G; Guo, BS; Wu, H; Tang, T; Zhang, BT; Zheng, LZ; He, YX; Yang, ZJ; Pan, XH; Chow, H; To, K; Li, YP; Li, DH; Wang, XL; Wang, YX; Lee, K; Hou, ZB; Dong, N; Li, G; Leung, K; Hung, L; He, FC; Zhang, LQ; Qin, L				Zhang, Ge; Guo, Baosheng; Wu, Heng; Tang, Tao; Zhang, Bao-Ting; Zheng, Lizhen; He, Yixin; Yang, Zhijun; Pan, Xiaohua; Chow, Heelum; To, Kinwah; Li, Yaping; Li, Dahu; Wang, Xinluan; Wang, Yixiang; Lee, Kwongman; Hou, Zhibo; Dong, Nan; Li, Gang; Leung, Kwoksui; Hung, Leungkim; He, Fuchu; Zhang, Lingqiang; Qin, Ling			A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy	NATURE MEDICINE			English	Article							PARATHYROID-HORMONE; POSTMENOPAUSAL WOMEN; COMBINATION; ALENDRONATE; DEPOSITION; FRACTURES; DOMAINS	Metabolic skeletal disorders associated with impaired bone formation are a major clinical challenge. One approach to treat these defects is to silence bone-formation-inhibitory genes by small interference RNAs (siRNAs) in osteogenic-lineage cells that occupy the niche surrounding the bone-formation surfaces. We developed a targeting system involving dioleoyl trimethylammonium propane (DOTAP)-based cationic liposomes attached to six repetitive sequences of aspartate, serine, serine ((AspSerSer)(6)) for delivering siRNAs specifically to bone-formation surfaces. Using this system, we encapsulated an osteogenic siRNA that targets casein kinase-2 interacting protein-1 (encoded by Plekho1, also known as Plekho1). In vivo systemic delivery of Plekho1 siRNA in rats using our system resulted in the selective enrichment of the siRNAs in osteogenic cells and the subsequent depletion of Plekho1. A bioimaging analysis further showed that this approach markedly promoted bone formation, enhanced the bone micro-architecture and increased the bone mass in both healthy and osteoporotic rats. These results indicate (AspSerSer)(6)-liposome as a promising targeted delivery system for RNA interference- based bone anabolic therapy.	[Zhang, Ge; Guo, Baosheng; Wu, Heng; Tang, Tao; Zhang, Bao-Ting; Zheng, Lizhen; He, Yixin; Wang, Xinluan; Li, Gang; Leung, Kwoksui; Hung, Leungkim; Qin, Ling] Chinese Univ Hong Kong, Musculoskeletal Res Lab, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China; [Zhang, Bao-Ting] Chinese Univ Hong Kong, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Yang, Zhijun] Hong Kong Baptist Univ, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Pan, Xiaohua] Ji Nan Univ, Dept Orthoped, Hosp Med Coll 2, Shenzhen Peoples Hosp, Shenzhen, Peoples R China; [Chow, Heelum; To, Kinwah] Chinese Univ Hong Kong, Sch Pharm, Hong Kong, Hong Kong, Peoples R China; [Li, Yaping] Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Drug Delivery Syst, Shanghai 200031, Peoples R China; [Li, Dahu; He, Fuchu; Zhang, Lingqiang] Beijing Inst Radiat Med, State Key Lab Prote, Beijing Proteome Res Ctr, Beijing, Peoples R China; [Wang, Yixiang] Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Hong Kong, Hong Kong, Peoples R China; [Lee, Kwongman] Chinese Univ Hong Kong, Lee Hysan Clin Res Lab, Hong Kong, Hong Kong, Peoples R China; [Hou, Zhibo] Jinan Univ, Biomed Res & Dev Ctr, Guangdong Prov Key Lab Bioengn Med, Natl Engn Res Ctr Genet Med, Guangzhou, Guangdong, Peoples R China; [Dong, Nan] Nankai Univ, Inst Mol Biol, Tianjin, Peoples R China; [Qin, Ling] Shenzhen Inst Adv Technol, Translat Med Res & Dev Ctr, Inst Biomed & Hlth Engn, Shenzhen, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Hong Kong Baptist University; Jinan University; Chinese University of Hong Kong; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Academy of Military Medical Sciences - China; Chinese University of Hong Kong; Chinese University of Hong Kong; Jinan University; Nankai University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Qin, L (corresponding author), Chinese Univ Hong Kong, Musculoskeletal Res Lab, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.	zhangge@ort.cuhk.edu.hk; zhanglq@nic.bmi.ac.cn; lingqin@cuhk.edu.hk	Li, Gang/J-7830-2018; To, Kenneth K W/M-4500-2013; Zhang, Baoting/B-6273-2015; Zhang, Ge/N-4150-2013; Zhang, Ge/K-9118-2019; Guo, Baosheng/ABD-4800-2021; Qin, Ling/J-9047-2018; Zheng, Lizhen/C-6550-2014; GUO, Baosheng/M-6023-2013; Wang, Yi Xiang/I-5952-2016	Li, Gang/0000-0002-3981-2239; To, Kenneth K W/0000-0003-2755-0283; Zhang, Ge/0000-0002-7807-7695; Zhang, Ge/0000-0002-7807-7695; Guo, Baosheng/0000-0002-4510-5418; Qin, Ling/0000-0001-6173-6167; Wang, Yi Xiang/0000-0001-5697-0717; Zhang, Lingqiang/0000-0002-9795-2141; Zhang, Bao-Ting/0000-0003-1421-0212; Yang, Zhijun/0000-0002-6094-0438	Chinese National Basic Research Programs [2011CB910602]; Hong Kong Competitive Earmarked Research Grant [CUHK479111, 473011]; Faculty of Medicine of the Chinese University of Hong Kong [2041478, 2041525]; Hong Kong Baptist University [31-08-089]; Chinese National Natural Science Foundation [30830029]; National Key Technologies Research and Development Program for New Drugs [2009ZX09503-002]	Chinese National Basic Research Programs(National Basic Research Program of China); Hong Kong Competitive Earmarked Research Grant; Faculty of Medicine of the Chinese University of Hong Kong; Hong Kong Baptist University; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Technologies Research and Development Program for New Drugs	We thank X.-H. Yang for technical support with the confocal imaging, H. Yang for technical support with the flow cytometry and F.C. Chun-Wan for assistance with the bone histomorphometry. This study was supported by the Chinese National Basic Research Programs (2011CB910602), the Hong Kong Competitive Earmarked Research Grant (CUHK479111 and 473011), the Direct Grant of Faculty of Medicine of the Chinese University of Hong Kong (2041478 and 2041525), the Faculty Research Grant of Hong Kong Baptist University (31-08-089), the Chinese National Natural Science Foundation Project (30830029) and the National Key Technologies Research and Development Program for New Drugs (2009ZX09503-002).	Aubin J., 2002, PEDIAT BONE, P43; Black DM, 2003, NEW ENGL J MED, V349, P1207, DOI 10.1056/NEJMoa031975; Cosman F, 2005, NEW ENGL J MED, V353, P566, DOI 10.1056/NEJMoa050157; CULLIS P R, 1989, Advanced Drug Delivery Reviews, V3, P267, DOI 10.1016/0169-409X(89)90024-0; Federman N, 2010, PEDIATR RES, V67, P514, DOI 10.1203/PDR.0b013e3181d601c5; Gronthos S, 1999, J BONE MINER RES, V14, P47, DOI 10.1359/jbmr.1999.14.1.47; Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079; Hodsman AB, 2005, ENDOCR REV, V26, P688, DOI 10.1210/er.2004-0006; Ishikawa S, 2004, INT IMMUNOL, V16, P1019, DOI 10.1093/intimm/dxh103; Itaka K, 2007, MOL THER, V15, P1655, DOI 10.1038/sj.mt.6300218; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Lindsay R, 1997, LANCET, V350, P550, DOI 10.1016/S0140-6736(97)02342-8; Lopez-Fraga M, 2009, BIODRUGS, V23, P305, DOI 10.2165/11318190-000000000-00000; Lu KF, 2008, NAT CELL BIOL, V10, P994, DOI 10.1038/ncb1760; Midura RJ, 2004, J BIOL CHEM, V279, P25464, DOI 10.1074/jbc.M312409200; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; POSNER AS, 1975, ACCOUNTS CHEM RES, V8, P273, DOI 10.1021/ar50092a003; Steitz SA, 2002, AM J PATHOL, V161, P2035, DOI 10.1016/S0002-9440(10)64482-3; STUART AJ, 1992, AVIAN DIS, V36, P447, DOI 10.2307/1591527; Takahashi-Nishioka Tatsuo, 2008, Curr Drug Discov Technol, V5, P39; Vegni FE, 2004, NEW ENGL J MED, V350, P189; Wang D, 2005, ADV DRUG DELIVER REV, V57, P1049, DOI 10.1016/j.addr.2004.12.011; Wang D, 2003, BIOCONJUGATE CHEM, V14, P853, DOI 10.1021/bc034090j; Wang D, 2007, BIOCONJUGATE CHEM, V18, P1375, DOI 10.1021/bc7002132; Wang GL, 2010, J DRUG TARGET, V18, P611, DOI 10.3109/10611861003622560; Yarbrough DK, 2010, CALCIFIED TISSUE INT, V86, P58, DOI 10.1007/s00223-009-9312-0; Zhang LQ, 2007, CELL SIGNAL, V19, P932, DOI 10.1016/j.cellsig.2006.11.002	28	285	301	5	198	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					307	314		10.1038/nm.2617	http://dx.doi.org/10.1038/nm.2617			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22286306				2022-12-25	WOS:000300140300048
J	Challen, GA; Sun, DQ; Jeong, M; Luo, M; Jelinek, J; Berg, JS; Bock, C; Vasanthakumar, A; Gu, HC; Xi, YX; Liang, SD; Lu, Y; Darlington, GJ; Meissner, A; Issa, JPJ; Godley, LA; Li, W; Goodell, MA				Challen, Grant A.; Sun, Deqiang; Jeong, Mira; Luo, Min; Jelinek, Jaroslav; Berg, Jonathan S.; Bock, Christoph; Vasanthakumar, Aparna; Gu, Hongcang; Xi, Yuanxin; Liang, Shoudan; Lu, Yue; Darlington, Gretchen J.; Meissner, Alexander; Issa, Jean-Pierre J.; Godley, Lucy A.; Li, Wei; Goodell, Margaret A.			Dnmt3a is essential for hematopoietic stem cell differentiation	NATURE GENETICS			English	Article							NOVO DNA METHYLTRANSFERASE; MAMMALIAN DNA; SELF-RENEWAL; METHYLATION; GENE; HYPERMETHYLATION; TRANSCRIPTION; HYPOMETHYLATION; MUTATIONS; EXPRESSION	Loss of the de novo DNA methyltransferases Dnmt3a and Dnmt3b in embryonic stem cells obstructs differentiation; however, the role of these enzymes in somatic stem cells is largely unknown. Using conditional ablation, we show that Dnmt3a loss progressively impairs hematopoietic stem cell (HSC) differentiation over serial transplantation, while simultaneously expanding HSC numbers in the bone marrow. Dnmt3a-null HSCs show both increased and decreased methylation at distinct loci, including substantial CpG island hypermethylation. Dnmt3a-null HSCs upregulate HSC multipotency genes and downregulate differentiation factors, and their progeny exhibit global hypomethylation and incomplete repression of HSC-specific genes. These data establish Dnmt3a as a critical participant in the epigenetic silencing of HSC regulatory genes, thereby enabling efficient differentiation.	[Challen, Grant A.; Jeong, Mira; Goodell, Margaret A.] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA; [Challen, Grant A.; Jeong, Mira; Goodell, Margaret A.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Challen, Grant A.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Sun, Deqiang; Xi, Yuanxin; Li, Wei] Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA; [Sun, Deqiang; Xi, Yuanxin; Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Luo, Min; Darlington, Gretchen J.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Jelinek, Jaroslav; Gu, Hongcang; Issa, Jean-Pierre J.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Berg, Jonathan S.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Berg, Jonathan S.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Bock, Christoph; Meissner, Alexander] Harvard Univ, Broad Inst, Cambridge, MA 02138 USA; [Bock, Christoph; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Vasanthakumar, Aparna; Godley, Lucy A.] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Liang, Shoudan] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Goodell, Margaret A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; University of Chicago; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Goodell, MA (corresponding author), Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA.	WL1@bcm.edu; goodell@bcm.edu	Bock, Christoph/AAE-7618-2019; Jelinek, Jaroslav/O-6876-2019	Bock, Christoph/0000-0001-6091-3088; Goodell, Margaret A./0000-0003-1111-2932; Berg, Jonathan/0000-0003-2360-2664; Li, Wei/0000-0001-9931-5990; sun, deqiang/0000-0002-5806-7289; Issa, Jean-Pierre/0000-0003-2258-5030; Gu, Hongcang/0000-0002-1439-7606; Lu, Yue/0000-0002-5479-9095; luo, min/0000-0003-4883-4189	US National Institutes of Health [NIH K99 DK084259-01A1]; NIH [AG036562, HL086223, CA100632, CA129831, P50CA126752, DK092883, CA125123, DK58192]; Ellison foundation; American Heart Association (CPRIT) [RP110028]; Functional Genomics Core [P30 DK056338]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison foundation(Lawrence Ellison Foundation); American Heart Association (CPRIT)(American Heart Association); Functional Genomics Core	The authors would like to thank all members of the Goodell laboratory for scientific advice, A. Rosen, Y. Zheng and L. Yang for mouse management and technical support, C. Threeton for flow cytometry, L. White (microarray core) and A. Gnirke for assistance with the RRBS technique. G. A. C. was supported by a grant from the US National Institutes of Health (NIH K99 DK084259-01A1) and is an American Society of Hematology Scholar. This work was also supported by NIH grants (AG036562, HL086223, CA100632, CA129831, P50CA126752, DK092883, CA125123 and DK58192), the Ellison foundation, the American Heart Association (CPRIT grant RP110028) and the Functional Genomics Core (P30 DK056338).	Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Challen GA, 2010, EXP HEMATOL, V38, P403, DOI 10.1016/j.exphem.2010.02.011; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chen D, 2001, EXP HEMATOL, V29, P971, DOI 10.1016/S0301-472X(01)00670-1; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cho YH, 2010, ANTICANCER RES, V30, P2489; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Ehrlich M, 2002, ONCOGENE, V21, P6694, DOI 10.1038/sj.onc.1205890; Fahrner JA, 2002, CANCER RES, V62, P7213; Feng CG, 2008, CELL STEM CELL, V2, P83, DOI 10.1016/j.stem.2007.10.007; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; Frigola J, 2005, HUM MOL GENET, V14, P319, DOI 10.1093/hmg/ddi028; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; Jelinek J, 2009, BLOOD, V114, P567; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kroeger H, 2008, BLOOD, V112, P1366, DOI 10.1182/blood-2007-11-126227; Lei H, 1996, DEVELOPMENT, V122, P3195; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Sirin O, 2010, NAT CELL BIOL, V12, P1213, DOI 10.1038/ncb2125; Smith ZD, 2009, METHODS, V48, P226, DOI 10.1016/j.ymeth.2009.05.003; Song LG, 2005, ANAL CHEM, V77, P504, DOI 10.1021/ac0489420; Stehling-Sun S, 2009, NAT IMMUNOL, V10, P289, DOI 10.1038/ni.1694; Tadokoro Y, 2007, J EXP MED, V204, P715, DOI 10.1084/jem.20060750; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Trowbridge JJ, 2009, CELL STEM CELL, V5, P442, DOI 10.1016/j.stem.2009.08.016; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Yamashita Y, 2010, ONCOGENE, V29, P3723, DOI 10.1038/onc.2010.117; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788	49	739	768	4	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2012	44	1					23	U43		10.1038/ng.1009	http://dx.doi.org/10.1038/ng.1009			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	22138693	Green Accepted, Green Published			2022-12-25	WOS:000298664000009
J	Shkreli, M; Sarin, KY; Pech, MF; Papeta, N; Chang, W; Brockman, SA; Cheung, P; Lee, E; Kuhnert, F; Olson, JL; Kuo, CJ; Gharavi, AG; D'Agati, VD; Artandi, SE				Shkreli, Marina; Sarin, Kavita Y.; Pech, Matthew F.; Papeta, Natalia; Chang, Woody; Brockman, Stephanie A.; Cheung, Peggie; Lee, Eunice; Kuhnert, Frank; Olson, Jean L.; Kuo, Calvin J.; Gharavi, Ali G.; D'Agati, Vivette D.; Artandi, Steven E.			Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling	NATURE MEDICINE			English	Article							UP-REGULATION; PROLIFERATION; DIFFERENTIATION; PROTEINS; DICKKOPF-1; INDUCTION; BIOLOGY; REPAIR; MOUSE; LEADS	Mechanisms of epithelial cell renewal remain poorly understood in the mammalian kidney, particularly in the glomerulus, a site of cellular damage in chronic kidney disease. Within the glomerulus, podocytes-differentiated epithelial cells crucial for filtration are thought to lack substantial capacity for regeneration. Here we show that podocytes rapidly lose differentiation markers and enter the cell cycle in adult mice in which the telomerase protein component TERT is conditionally expressed. Transgenic TERT expression in mice induces marked upregulation of Wnt signaling and disrupts glomerular structure, resulting in a collapsing glomerulopathy resembling those in human disease, including HIV-associated nephropathy (HIVAN). Human and mouse HIVAN kidneys show increased expression of TERT and activation of Wnt signaling, indicating that these are general features of collapsing glomerulopathies. Silencing transgenic TERT expression or inhibiting Wnt signaling through systemic expression of the Wnt inhibitor Dkk1 in either TERT transgenic mice or in a mouse model of HIVAN results in marked normalization of podocytes, including rapid cell-cycle exit, re-expression of differentiation markers and improved filtration barrier function. These data reveal an unexpected capacity of podocytes to reversibly enter the cell cycle, suggest that podocyte renewal may contribute to glomerular homeostasis and implicate the telomerase and Wnt-beta-catenin pathways in podocyte proliferation and disease.	[Pech, Matthew F.; Kuo, Calvin J.; Artandi, Steven E.] Stanford Sch Med, Program Canc Biol, Stanford, CA USA; [Papeta, Natalia; Gharavi, Ali G.] Columbia Univ, Dept Med, New York, NY USA; [Olson, Jean L.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [D'Agati, Vivette D.] Columbia Univ, Dept Pathol, New York, NY USA; [Artandi, Steven E.] Stanford Univ, Sch Med, Glenn Labs Biol Aging, Stanford, CA 94305 USA; [Shkreli, Marina; Sarin, Kavita Y.; Pech, Matthew F.; Chang, Woody; Brockman, Stephanie A.; Cheung, Peggie; Lee, Eunice; Kuhnert, Frank; Kuo, Calvin J.; Artandi, Steven E.] Stanford Sch Med, Dept Med, Stanford, CA USA	Stanford University; Columbia University; University of California System; University of California San Francisco; Columbia University; Stanford University; Stanford University	Artandi, SE (corresponding author), Univ Nice, Lab Biol & Pathol Genomes, Nice, France.	sartandi@stanford.edu		Shkreli, Marina/0000-0002-8615-1891; Kuo, Calvin/0000-0002-7427-5985; Sarin, Kavita/0000-0001-5363-3053	Stanford School of Medicine; Stanford Center on Longevity; US National Institutes of Health [DK085527, DK085720, DK087626, CA111691, CA125453, AG033747, AG036695]; NATIONAL CANCER INSTITUTE [T32CA009302, R01CA125453, R01CA111691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087626, U01DK085527, R01DK085720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG036695, R56AG033747, R01AG033747] Funding Source: NIH RePORTER	Stanford School of Medicine; Stanford Center on Longevity; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank P. Chu in the Stanford Comparative Medicine Histology Research Core Laboratory, S. Busque for guidance with nephrectomy, and R. Nusse, Stanford University, for Axin2<SUP>LacZ/+</SUP> mice. M.S. was supported by the Stanford School of Medicine Dean's postdoctoral fellowship and the Stanford Center on Longevity postdoctoral fellowship. This work was supported by US National Institutes of Health grants DK085527 and DK085720 to C.J.K., DK087626 to A.G.G. and CA111691, CA125453, AG033747 and AG036695 to S.E.A.	Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Appel D, 2009, J AM SOC NEPHROL, V20, P333, DOI 10.1681/ASN.2008070795; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Barisoni L, 1999, J AM SOC NEPHROL, V10, P51; Barisoni L, 2000, KIDNEY INT, V58, P137, DOI 10.1046/j.1523-1755.2000.00149.x; Batista LFZ, 2011, NATURE, V474, P399, DOI 10.1038/nature10084; Bruggeman LA, 2000, J AM SOC NEPHROL, V11, P2079, DOI 10.1681/ASN.V11112079; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; D'Agati V, 2003, SEMIN NEPHROL, V23, P117, DOI 10.1053/snep.2003.50012; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; DICKIE P, 1991, VIROLOGY, V185, P109, DOI 10.1016/0042-6822(91)90759-5; Ding M, 2006, NAT MED, V12, P1081, DOI 10.1038/nm1460; He WC, 2011, J AM SOC NEPHROL, V22, P90, DOI 10.1681/ASN.2009121236; Heikkila E, 2007, MOL CELL BIOCHEM, V305, P9, DOI 10.1007/s11010-007-9522-6; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Husain M, 2005, AIDS, V19, P1975, DOI 10.1097/01.aids.0000191918.42110.27; Iglesias DM, 2007, AM J PHYSIOL-RENAL, V293, pF494, DOI 10.1152/ajprenal.00416.2006; Imai E, 1999, EXP NEPHROL, V7, P63; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kato H, 2011, J BIOL CHEM, V286, P26003, DOI 10.1074/jbc.M111.223164; Korgaonkar SN, 2008, J AM SOC NEPHROL, V19, P877, DOI 10.1681/ASN.2007050629; Kriz W, 1996, NEPHROL DIAL TRANSPL, V11, P1738, DOI 10.1093/oxfordjournals.ndt.a027660; Kriz W, 2002, MICROSC RES TECHNIQ, V57, P189, DOI 10.1002/jemt.10072; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Lancaster MA, 2009, NAT MED, V15, P1046, DOI 10.1038/nm.2010; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Marshall CB, 2007, NEPHRON EXP NEPHROL, V106, pE51, DOI 10.1159/000101793; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Mundel P, 1997, J AM SOC NEPHROL, V8, P697; NADASDY T, 1994, J AM SOC NEPHROL, V4, P2032; Nagata M, 1998, AM J PATHOL, V153, P1511, DOI 10.1016/S0002-9440(10)65739-2; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Pavenstadt H, 2000, AM J PHYSIOL-RENAL, V278, pF173, DOI 10.1152/ajprenal.2000.278.2.F173; Reiser J, 2000, J AM SOC NEPHROL, V11, P1, DOI 10.1681/ASN.V1111; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709; Rosenstiel P, 2009, J AM SOC NEPHROL, V20, P2296, DOI 10.1681/ASN.2008121230; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Shankland SJ, 2000, AM J PHYSIOL-RENAL, V278, pF515, DOI 10.1152/ajprenal.2000.278.4.F515; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Welsh GI, 2010, CELL METAB, V12, P329, DOI 10.1016/j.cmet.2010.08.015; Zuo YQ, 2006, J AM SOC NEPHROL, V17, P2832, DOI 10.1681/ASN.2005080878	50	79	83	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					111	119		10.1038/nm.2550	http://dx.doi.org/10.1038/nm.2550			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22138751	Green Accepted			2022-12-25	WOS:000299018600036
J	Fujimoto, A; Totoki, Y; Abe, T; Boroevich, KA; Hosoda, F; Nguyen, HH; Aoki, M; Hosono, N; Kubo, M; Miya, F; Arai, Y; Takahashi, H; Shirakihara, T; Nagasaki, M; Shibuya, T; Nakano, K; Watanabe-Makino, K; Tanaka, H; Nakamura, H; Kusuda, J; Ojima, H; Shimada, K; Okusaka, T; Ueno, M; Shigekawa, Y; Kawakami, Y; Arihiro, K; Ohdan, H; Gotoh, K; Ishikawa, O; Ariizumi, S; Yamamoto, M; Yamada, T; Chayama, K; Kosuge, T; Yamaue, H; Kamatani, N; Miyano, S; Nakagama, H; Nakamura, Y; Tsunoda, T; Shibata, T; Nakagawa, H				Fujimoto, Akihiro; Totoki, Yasushi; Abe, Tetsuo; Boroevich, Keith A.; Hosoda, Fumie; Nguyen, Ha Hai; Aoki, Masayuki; Hosono, Naoya; Kubo, Michiaki; Miya, Fuyuki; Arai, Yasuhito; Takahashi, Hiroyuki; Shirakihara, Takuya; Nagasaki, Masao; Shibuya, Tetsuo; Nakano, Kaoru; Watanabe-Makino, Kumiko; Tanaka, Hiroko; Nakamura, Hiromi; Kusuda, Jun; Ojima, Hidenori; Shimada, Kazuaki; Okusaka, Takuji; Ueno, Masaki; Shigekawa, Yoshinobu; Kawakami, Yoshiiku; Arihiro, Koji; Ohdan, Hideki; Gotoh, Kunihito; Ishikawa, Osamu; Ariizumi, Shun-ichi; Yamamoto, Masakazu; Yamada, Terumasa; Chayama, Kazuaki; Kosuge, Tomoo; Yamaue, Hiroki; Kamatani, Naoyuki; Miyano, Satoru; Nakagama, Hitoshi; Nakamura, Yusuke; Tsunoda, Tatsuhiko; Shibata, Tatsuhiro; Nakagawa, Hidewaki			Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators	NATURE GENETICS			English	Article							B VIRUS-DNA; HEPATOCELLULAR-CARCINOMA; NEGATIVE REGULATOR; SOMATIC MUTATIONS; INTEGRATION; ALIGNMENT; COMPLEX; TARGETS	Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide. We sequenced and analyzed the whole genomes of 27 HCCs, 25 of which were associated with hepatitis B or C virus infections, including two sets of multicentric tumors. Although no common somatic mutations were identified in the multicentric tumor pairs, their whole-genome substitution patterns were similar, suggesting that these tumors developed from independent mutations, although their shared etiological backgrounds may have strongly influenced their somatic mutation patterns. Statistical and functional analyses yielded a list of recurrently mutated genes. Multiple chromatin regulators, including ARID1A, ARID1B, ARID2, MLL and MLL3, were mutated in similar to 50% of the tumors. Hepatitis B virus genome integration in the TERT locus was frequently observed in a high clonal proportion. Our whole-genome sequencing analysis of HCCs identified the influence of etiological background on somatic mutation patterns and subsequent carcinogenesis, as well as recurrent mutations in chromatin regulators in HCCs.	[Fujimoto, Akihiro; Abe, Tetsuo; Boroevich, Keith A.; Nguyen, Ha Hai; Aoki, Masayuki; Hosono, Naoya; Kubo, Michiaki; Miya, Fuyuki; Nakano, Kaoru; Watanabe-Makino, Kumiko; Chayama, Kazuaki; Kamatani, Naoyuki; Nakamura, Yusuke; Tsunoda, Tatsuhiko; Nakagawa, Hidewaki] RIKEN, Ctr Genom Med, Yokohama, Kanagawa, Japan; [Totoki, Yasushi; Hosoda, Fumie; Arai, Yasuhito; Takahashi, Hiroyuki; Shirakihara, Takuya; Nakamura, Hiromi] Natl Canc Ctr, Res Inst, Tokyo 104, Japan; [Nagasaki, Masao; Shibuya, Tetsuo; Tanaka, Hiroko; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab DNA Informat Anal, Tokyo, Japan; [Kusuda, Jun] Natl Inst Biomed Innovat, Ibaraki, Osaka, Japan; [Ojima, Hidenori; Nakagama, Hitoshi] Natl Canc Ctr, Res Inst, Div Mol Pathol, Tokyo 104, Japan; [Shimada, Kazuaki; Kosuge, Tomoo] Natl Canc Ctr, Hepatobiliary & Pancreat Surg Div, Tokyo, Japan; [Okusaka, Takuji] Natl Canc Ctr, Hepatobiliary & Pancreat Oncol Div, Tokyo, Japan; [Ueno, Masaki; Shigekawa, Yoshinobu; Yamaue, Hiroki] Wakayama Med Univ, Dept Surg Gastroenterol, Wakayama, Japan; [Kawakami, Yoshiiku; Chayama, Kazuaki] Hiroshima Univ, Sch Med, Dept Med & Mol Sci, Hiroshima, Japan; [Arihiro, Koji] Hiroshima Univ, Sch Med, Dept Surg Gastroenterol, Hiroshima, Japan; [Ohdan, Hideki] Hiroshima Univ, Sch Med, Dept Pathol Anat, Hiroshima, Japan; [Gotoh, Kunihito; Ishikawa, Osamu; Yamada, Terumasa] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka, Japan; [Ariizumi, Shun-ichi; Yamamoto, Masakazu] Tokyo Womens Med Univ, Dept Surg Gastroenterol, Tokyo, Japan; [Nakagama, Hitoshi] Natl Canc Ctr, Res Inst, Div Canc Dev Syst, Tokyo 104, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan	RIKEN; National Cancer Center - Japan; University of Tokyo; National Institute of Health Sciences - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Wakayama Medical University; Hiroshima University; Hiroshima University; Hiroshima University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Tokyo Women's Medical University; National Cancer Center - Japan; University of Tokyo	Nakagawa, H (corresponding author), RIKEN, Ctr Genom Med, Yokohama, Kanagawa, Japan.	tashibat@ncc.go.jp; hidewaki@ims.u-tokyo.ac.jp	Kubo, Michiaki/N-7947-2015; Ohdan, Hideki/G-4719-2019; Shibata, Tatsuhiro/ABA-8234-2020; nguyễn, Hà/V-6993-2019; Shibata, Tatsuhiro/AAO-1278-2021; Tsunoda, Tatsuhiko/K-2061-2014	Ohdan, Hideki/0000-0002-9066-1288; nguyễn, Hà/0000-0002-5431-5935; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Shirakihara, Takuya/0000-0002-6222-0143; Miya, Fuyuki/0000-0001-6758-2015; Arai, Yasuhito/0000-0001-6306-9409; Nagasaki, Masao/0000-0002-4292-8785; Boroevich, Keith/0000-0001-7095-7332; Chayama, Kazuaki/0000-0002-5530-5341; Miyano, Satoru/0000-0002-1753-6616	National Institute of Biomedical Innovation (NIBIO); National Cancer Center [23-A-8]; RIKEN; Grants-in-Aid for Scientific Research [24659368] Funding Source: KAKEN	National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); National Cancer Center; RIKEN; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The supercomputing resource SHIROKANE was provided by the Human Genome Center at The University of Tokyo. The authors thank T. Urushidate, S. Ohashi, N. Okada, A. Kokubu and H. Shimizu at the National Cancer Center Research Institute and C. Inai, R. Ooishi, and R. Kitada at the RIKEN Center for Genomic Medicine for their technical assistances. This work was supported partially by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), the National Cancer Center Research and Development Fund (23-A-8) and the RIKEN Strategic Research Program for R&D of President's Fund 2011.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson R, 2008, BIOINFORMATICS, V24, P751, DOI 10.1093/bioinformatics/btn003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Ferby I, 2006, NAT MED, V12, P568, DOI 10.1038/nm1401; Fujimoto A, 2010, NAT GENET, V42, P931, DOI 10.1038/ng.691; Gozuacik D, 2001, ONCOGENE, V20, P6233, DOI 10.1038/sj.onc.1204835; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jiang ZS, 2012, GENOME RES, V22, P593, DOI 10.1101/gr.133926.111; Jones S, 2012, HUM MUTAT, V33, P100, DOI 10.1002/humu.21633; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Laurent-Puig P, 2006, ONCOGENE, V25, P3778, DOI 10.1038/sj.onc.1209547; Lee J, 2009, P NATL ACAD SCI USA, V106, P8513, DOI 10.1073/pnas.0902873106; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2009, ONCOGENE, V28, P2948, DOI 10.1038/onc.2009.162; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Paterlini-Brechot P, 2003, ONCOGENE, V22, P3911, DOI 10.1038/sj.onc.1206492; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Qin J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn518; Reschke M, 2010, HEPATOLOGY, V51, P1383, DOI 10.1002/hep.23428; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; SHAFRITZ DA, 1981, NEW ENGL J MED, V305, P1067, DOI 10.1056/NEJM198110293051807; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; ZHOU YZ, 1987, J NATL CANCER I, V79, P223	30	649	670	3	107	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2012	44	7					760	U182		10.1038/ng.2291	http://dx.doi.org/10.1038/ng.2291			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967DP	22634756				2022-12-25	WOS:000305886900008
J	Groesser, L; Herschberger, E; Ruetten, A; Ruivenkamp, C; Lopriore, E; Zutt, M; Langmann, T; Singer, S; Klingseisen, L; Schneider-Brachert, W; Toll, A; Real, FX; Landthaler, M; Hafner, C				Groesser, Leopold; Herschberger, Eva; Ruetten, Arno; Ruivenkamp, Claudia; Lopriore, Enrico; Zutt, Markus; Langmann, Thomas; Singer, Sebastian; Klingseisen, Laura; Schneider-Brachert, Wulf; Toll, Agusti; Real, Francisco X.; Landthaler, Michael; Hafner, Christian			Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome	NATURE GENETICS			English	Article							FEUERSTEIN-MIMS-SYNDROME; EPIDERMAL NEVUS; COSTELLO-SYNDROME; SEBORRHEIC KERATOSES; GERMLINE MUTATIONS; SOMATIC MOSAICISM; MAFFUCCI SYNDROME; FGFR3 MUTATIONS; OLLIER DISEASE; HUMAN SKIN	Nevus sebaceous is a common congenital cutaneous malformation. Affected individuals may develop benign and malignant secondary tumors in the nevi during life. Schimmelpenning syndrome is characterized by the association of nevus sebaceous with extracutaneous abnormalities. We report that of 65 sebaceous nevi studied, 62 (95%) had mutations in the HRAS gene and 3 (5%) had mutations in the KRAS gene. The HRAS c.37G>C mutation, which results in a p.Gly13Arg substitution, was present in 91% of lesions. Nonlesional tissues from 18 individuals had a wild-type sequence, confirming genetic mosaicism. The HRAS c.37G>C mutation was also found in 8 of 8 associated secondary tumors. Mosaicism for HRAS c.37G>C and KRAS c.35G>A mutations was found in two individuals with Schimmelpenning syndrome. Functional analysis of HRAS c.37G>C mutant cells showed constitutive activation of the MAPK and PI3K-Akt signaling pathways. Our results indicate that nevus sebaceous and Schimmelpenning syndrome are caused by postzygotic HRAS and KRAS mutations. These mutations may predispose individuals to the development of secondary tumors in nevus sebaceous.	[Groesser, Leopold; Herschberger, Eva; Singer, Sebastian; Landthaler, Michael; Hafner, Christian] Univ Regensburg, Dept Dermatol, Regensburg, Germany; [Ruetten, Arno] Dermatopathol Friedrichshafen, Friedrichshafen, Germany; [Ruivenkamp, Claudia] Leiden Univ, Lab Diagnost Genome Anal, Med Ctr, Leiden, Netherlands; [Lopriore, Enrico] Leiden Univ, Med Ctr, Dept Pediat, Div Neonatol, Leiden, Netherlands; [Zutt, Markus] Univ Gottingen, Dept Dermatol, Gottingen, Germany; [Langmann, Thomas] Univ Regensburg, Inst Human Genet, Regensburg, Germany; [Langmann, Thomas] Univ Cologne, Ctr Ophthalmol, Dept Expt Immunol Eye, D-50931 Cologne, Germany; [Klingseisen, Laura; Schneider-Brachert, Wulf] Univ Regensburg, Inst Med Microbiol & Hyg, Regensburg, Germany; [Toll, Agusti] Univ Autonoma Barcelona, Hosp Mar, Serv Dermatol, E-08193 Barcelona, Spain; [Real, Francisco X.] Ctr Nacl Invest Oncol, Programa Patol Mol, Grp Carcinogenesis Epitelial, Madrid, Spain; [Real, Francisco X.] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain	University of Regensburg; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Gottingen; University of Regensburg; University of Cologne; University of Regensburg; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University	Hafner, C (corresponding author), Univ Regensburg, Dept Dermatol, Regensburg, Germany.	christian.hafner@ukr.de	Lopriore, Enrico/ABE-3576-2021; Langmann, Thomas/HHZ-9814-2022; Arribas, Francisco X Real/H-5275-2015	Lopriore, Enrico/0000-0002-3513-5066; Langmann, Thomas/0000-0001-6826-529X; Arribas, Francisco X Real/0000-0001-9501-498X; Toll, Agustin/0000-0003-2656-0076	Deutsche Forschungsgemeinschaft [HA 5531/1-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the research grant HA 5531/1-2 from the Deutsche Forschungsgemeinschaft to C.H. We thank all subjects who participated in this study and A. Groesser and H. Hafner for their valuable support.	Amary MF, 2011, NAT GENET, V43, P1262, DOI 10.1038/ng.994; Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Ball EAM, 2005, CLIN EXP DERMATOL, V30, P259, DOI 10.1111/j.1365-2230.2005.01744.x; Bourdeaut F, 2010, J MED GENET, V47, P859, DOI 10.1136/jmg.2009.075374; Chou CY, 2011, J CLIN ONCOL, V29, pE719, DOI 10.1200/JCO.2011.35.8093; Davies Derek, 2002, Australas J Dermatol, V43, P20, DOI 10.1046/j.1440-0960.2002.00546.x; Gripp KW, 2006, AM J MED GENET A, V140A, P2163, DOI 10.1002/ajmg.a.31456; Gripp KW, 2012, GENET MED, V14, P285, DOI [10.1038/GIM.0b013e31822dd91f, 10.1038/gim.0b013e31822dd91f]; Hafner C, 2007, P NATL ACAD SCI USA, V104, P13450, DOI 10.1073/pnas.0705218104; Hafner C, 2006, J INVEST DERMATOL, V126, P2404, DOI 10.1038/sj.jid.5700422; Hafner C, 2006, J CLIN INVEST, V116, P2201, DOI 10.1172/JCI28163; Hafner C, 2011, NEW ENGL J MED, V365, P1940, DOI 10.1056/NEJMc1109381; Hafner C, 2010, P NATL ACAD SCI USA, V107, P20780, DOI 10.1073/pnas.1008365107; HAPPLE R, 1987, J AM ACAD DERMATOL, V16, P899, DOI 10.1016/S0190-9622(87)80249-9; HAPPLE R, 1993, ARCH DERMATOL, V129, P1460, DOI 10.1001/archderm.129.11.1460; Happle R, 2010, J AM ACAD DERMATOL, V63, P1, DOI 10.1016/j.jaad.2010.01.017; Hurst Carolyn D, 2009, BMC Res Notes, V2, P66, DOI 10.1186/1756-0500-2-66; Izumi M, 2008, J DERMATOL, V35, P704, DOI 10.1111/j.1346-8138.2008.00550.x; Kompier LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013821; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Moody MN, 2012, PEDIATR DERMATOL, V29, P15, DOI 10.1111/j.1525-1470.2011.01562.x; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; Pansuriya TC, 2011, NAT GENET, V43, P1256, DOI 10.1038/ng.1004; Rijntjes-Jacobs EGJ, 2010, AM J MED GENET A, V152A, P2816, DOI 10.1002/ajmg.a.33635; ROGERS M, 1992, PEDIATR DERMATOL, V9, P342, DOI 10.1111/j.1525-1470.1992.tb00623.x; Schimmelpenning GW, 1957, ROFO FORTSCHR RONTG, V87, P716; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Schubbert S, 2007, MOL CELL BIOL, V27, P7765, DOI 10.1128/MCB.00965-07; Sol-Church K, 2009, AM J MED GENET A, V149A, P315, DOI 10.1002/ajmg.a.32639; Sugarman JL, 2007, SEMIN CUTAN MED SURG, V26, P221, DOI 10.1016/j.sder.2008.03.006; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Zutt M, 2003, DERMATOLOGY, V207, P72, DOI 10.1159/000070948	33	193	199	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2012	44	7					783	U211		10.1038/ng.2316	http://dx.doi.org/10.1038/ng.2316			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967DP	22683711				2022-12-25	WOS:000305886900012
J	Berchtold, D; Piccolis, M; Chiaruttini, N; Riezman, I; Riezman, H; Roux, A; Walther, TC; Loewith, R				Berchtold, Doris; Piccolis, Manuele; Chiaruttini, Nicolas; Riezman, Isabelle; Riezman, Howard; Roux, Aurelien; Walther, Tobias C.; Loewith, Robbie			Plasma membrane stress induces relocalization of Slm proteins and activation of TORC2 to promote sphingolipid synthesis	NATURE CELL BIOLOGY			English	Article							YEAST; CAVEOLIN-1; PHOSPHORYLATION; HOMEOSTASIS; SCREEN; TARGET; GENES; CELLS; ORM2	The plasma membrane delimits the cell, and its integrity is essential for cell survival. Lipids and proteins form domains of distinct composition within the plasma membrane. How changes in plasma membrane composition are perceived, and how the abundance of lipids in the plasma membrane is regulated to balance changing needs remains largely unknown. Here, we show that the Slm1/2 paralogues and the target of rapamycin kinase complex 2 (TORC2) play a central role in this regulation. Membrane stress, induced by either inhibition of sphingolipid metabolism or by mechanically stretching the plasma membrane, redistributes Slm proteins between distinct plasma membrane domains. This increases Slm protein association with and activation of TORC2, which is restricted to the domain known as the membrane compartment containing TORC2 (MCT; ref. 1). As TORC2 regulates sphingolipid metabolism(2), our discoveries reveal a homeostasis mechanism in which TORC2 responds to plasma membrane stress to mediate compensatory changes in cellular lipid synthesis and hence modulates the composition of the plasma membrane. The components of this pathway and their involvement in signalling after membrane stretch are evolutionarily conserved.	[Berchtold, Doris; Walther, Tobias C.] Max Planck Inst Biochem Organelle Architecture &, D-82152 Martinsried, Germany; [Piccolis, Manuele; Loewith, Robbie] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Chiaruttini, Nicolas; Riezman, Isabelle; Riezman, Howard; Roux, Aurelien] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland; [Riezman, Howard; Roux, Aurelien; Loewith, Robbie] Swiss Natl Ctr Competence Res, Programme Chem Biol, CH-1211 Geneva, Switzerland; [Walther, Tobias C.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Loewith, Robbie] Swiss Natl Ctr Competence Res, Programme Frontiers Genet, CH-1211 Geneva, Switzerland	Max Planck Society; University of Geneva; University of Geneva; Yale University	Walther, TC (corresponding author), Max Planck Inst Biochem Organelle Architecture &, D-82152 Martinsried, Germany.	tobias.walther@yale.edu; robbie.loewith@unige.ch	Roux, Aurelien/AAU-1262-2021; Roux, Aurelien R/G-9541-2013; Loewith, Robbie J/S-6289-2016	Roux, Aurelien R/0000-0002-6088-0711; Loewith, Robbie J/0000-0002-2482-603X; Walther, Tobias/0000-0003-1442-1327; Riezman, Howard/0000-0003-4680-9422	German Research Council (DFG); Minna-James-Heineman Foundation; SystemsX.ch; Human Frontier Science Program; National Centre for Competence in Research (NCCR) Frontiers in Genetics; European Research Council; Swiss National Science Foundation; NCCR Chemical Biology; Canton of Geneva	German Research Council (DFG)(German Research Foundation (DFG)); Minna-James-Heineman Foundation; SystemsX.ch; Human Frontier Science Program(Human Frontier Science Program); National Centre for Competence in Research (NCCR) Frontiers in Genetics(Swiss National Science Foundation (SNSF)); European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR Chemical Biology(Swiss National Science Foundation (SNSF)); Canton of Geneva	The authors are grateful to R. Wedlich-Soldner for helping with TIRF microscopy, to P. deCamilli, R. V. Farese Jr, T. Halazonetis, J. Paszkowski, M. Gonzalez-Gaitan and members of the Walther and Loewith laboratories for comments on the manuscript and to A. Huber, Y. Kamada, J. Urban, G. Tevzadze and S. Emr for the ypk1<SUP>L424G</SUP>, YPK2<SUP>D239A</SUP> GTR1/gtr1<SUP>S20L</SUP> constructs and tor2<SUP>W2469A,</SUP> <SUP>W2473A</SUP> and slm<SUP>ts</SUP> strains, respectively. T.C.W. acknowledges support from the German Research Council (DFG) and the Minna-James-Heineman Foundation. H.R. and A.R. acknowledge support from SystemsX.ch and the Human Frontier Science Program, respectively. R.L. acknowledges support from the National Centre for Competence in Research (NCCR) Frontiers in Genetics, and the European Research Council. H.R., A.R. and R.L. acknowledge support from the Swiss National Science Foundation, the NCCR Chemical Biology and the Canton of Geneva.	Aronova S, 2008, CELL METAB, V7, P148, DOI 10.1016/j.cmet.2007.11.015; Berchtold D, 2009, MOL BIOL CELL, V20, P1565, DOI 10.1091/mbc.E08-10-1001; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Bultynck G, 2006, MOL CELL BIOL, V26, P4729, DOI 10.1128/MCB.01973-05; Daquinag A, 2007, MOL CELL BIOL, V27, P633, DOI 10.1128/MCB.00461-06; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Fadri M, 2005, MOL BIOL CELL, V16, P1883, DOI 10.1091/mbc.e04-07-0564; Frohlich F, 2009, J CELL BIOL, V185, P1227, DOI 10.1083/jcb.200811081; Gallego O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.87; Grossmann G, 2008, J CELL BIOL, V183, P1075, DOI 10.1083/jcb.200806035; Guan XL, 2009, MOL BIOL CELL, V20, P2083, DOI 10.1091/mbc.E08-11-1126; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Haruki H, 2008, MOL CELL, V31, P925, DOI 10.1016/j.molcel.2008.07.020; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005; Kippenberger S, 2005, J BIOL CHEM, V280, P3060, DOI 10.1074/jbc.M409590200; Lempiainen H, 2009, MOL CELL, V33, P704, DOI 10.1016/j.molcel.2009.01.034; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Ramstedt B, 2002, FEBS LETT, V531, P33, DOI 10.1016/S0014-5793(02)03406-3; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Roelants FM, 2010, P NATL ACAD SCI USA, V107, P34, DOI 10.1073/pnas.0912497106; Sedding DG, 2005, CIRC RES, V96, P635, DOI 10.1161/01.RES.0000160610.61306.0f; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Tabuchi M, 2006, MOL CELL BIOL, V26, P5861, DOI 10.1128/MCB.02403-05; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Walther TC, 2006, NATURE, V439, P998, DOI 10.1038/nature04472; Wanke V, 2008, MOL MICROBIOL, V69, P277, DOI 10.1111/j.1365-2958.2008.06292.x; Yu J, 2006, J CLIN INVEST, V116, P1284, DOI 10.1172/JCI27100; Zhang BF, 2007, CELL SIGNAL, V19, P1690, DOI 10.1016/j.cellsig.2007.03.005	32	227	231	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2012	14	5					542	U200		10.1038/ncb2480	http://dx.doi.org/10.1038/ncb2480			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	936NW	22504275				2022-12-25	WOS:000303598300015
J	Schodel, J; Bardella, C; Sciesielski, LK; Brown, JM; Pugh, CW; Buckle, V; Tomlinson, IP; Ratcliffe, PJ; Mole, DR				Schoedel, Johannes; Bardella, Chiara; Sciesielski, Lina K.; Brown, Jill M.; Pugh, Chris W.; Buckle, Veronica; Tomlinson, Ian P.; Ratcliffe, Peter J.; Mole, David R.			Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression	NATURE GENETICS			English	Article							HYPOXIA-INDUCIBLE FACTORS; TUMOR-SUPPRESSOR PROTEIN; GENOME-WIDE ASSOCIATION; CELL CARCINOMA; TARGET GENE; CHROMOSOME CONFORMATION; DNA-BINDING; ALPHA; MUTATION; IDENTIFICATION	Although genome-wide association studies (GWAS) have identified the existence of numerous population-based cancer susceptibility loci, mechanistic insights remain limited, particularly for intergenic polymorphisms. Here, we show that polymorphism at a remote intergenic region on chromosome 11q13.3, recently identified as a susceptibility locus for renal cell carcinoma(1), modulates the binding and function of hypoxia-inducible factor (HIF) at a previously unrecognized transcriptional enhancer of CCND1 (encoding cyclin D1) that is specific for renal cancers characterized by inactivation of the von Hippel-Lindau tumor suppressor (pVHL). The protective haplotype impairs binding of HIF-2, resulting in an allelic imbalance in cyclin D1 expression, thus affecting a link between hypoxia pathways and cell cycle control.	[Bardella, Chiara; Tomlinson, Ian P.; Ratcliffe, Peter J.] Univ Oxford, Mol & Populat Genet Lab, Wellcome Trust Ctr Human Genet, Oxford, England; [Brown, Jill M.; Buckle, Veronica] John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Tomlinson, Ian P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Comprehens Biomed Res Ctr, Oxford Natl Inst Hlth Res NIHR, Oxford, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics	Ratcliffe, PJ (corresponding author), Univ Oxford, Mol & Populat Genet Lab, Wellcome Trust Ctr Human Genet, Henry Wellcome Bldg Mol Physiol, Oxford, England.	schoedel@well.ox.ac.uk; pjr@well.ox.ac.uk; drmole@well.ox.ac.uk	bardella, chiara/AAG-6272-2021; Sciesielski, Lina/G-3716-2017	Sciesielski, Lina/0000-0003-3458-0309; Mole, David/0000-0002-0984-300X; Pugh, Chris/0000-0002-5170-1662; Ratcliffe, Peter/0000-0002-2853-806X; Bardella, Chiara/0000-0002-7780-2541; Schodel, Johannes/0000-0002-3587-8839	Wellcome Trust [088182/Z/09/Z, 078333/Z/05/Z, WT091857MA]; Higher Education Funding Council for England; German Research Foundation [SC 132/2-1]; Urology Cancer Research and Education (UCARE); MRC [MC_UU_12009/1] Funding Source: UKRI; Medical Research Council [MC_UU_12009/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); German Research Foundation(German Research Foundation (DFG)); Urology Cancer Research and Education (UCARE); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Samples of renal tumors were a gift from A.L. Harris through the Oxford Radcliffe Biobank, Oxford Biomedical Research Centre. HKC-8 cells were provided by L. Racusen (Johns Hopkins University), 786-O cells re-expressing pVHL were a gift from W.G. Kaelin Jr. (Harvard Medical School), RCC4 cells were a gift from C.H. Buys (University of Groningen), and all other RCC cells were from M. Lerman (National Institutes of Health). This work was funded by the Wellcome Trust (088182/Z/09/Z, 078333/Z/05/Z and WT091857MA to J.S.), the Higher Education Funding Council for England, the German Research Foundation (SC 132/2-1 to L.K.S.) and by Urology Cancer Research and Education (UCARE).	Baba M, 2003, ONCOGENE, V22, P2728, DOI 10.1038/sj.onc.1206373; Bindra RS, 2002, CANCER RES, V62, P3014; Brown J, 2001, NAT MED, V7, P497, DOI 10.1038/86581; Brown JM, 2006, J CELL BIOL, V172, P177, DOI 10.1083/jcb.200507073; Cao Q, 2012, MUTAGENESIS, V27, P345, DOI 10.1093/mutage/ger085; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Gumz ML, 2007, CLIN CANCER RES, V13, P4740, DOI 10.1158/1078-0432.CCR-07-0143; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2009, CANCER-AM CANCER SOC, V115, P2262, DOI 10.1002/cncr.24232; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Krieg AJ, 2010, MOL CELL BIOL, V30, P344, DOI 10.1128/MCB.00444-09; Lau KW, 2007, BRIT J CANCER, V96, P1284, DOI 10.1038/sj.bjc.6603675; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Morris MR, 2009, ANTICANCER RES, V29, P4337; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ramachandrareddy H, 2010, P NATL ACAD SCI USA, V107, P11930, DOI 10.1073/pnas.1004962107; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wu XF, 2012, HUM MOL GENET, V21, P456, DOI 10.1093/hmg/ddr479; Wykoff CC, 2004, BRIT J CANCER, V90, P1235, DOI 10.1038/sj.bjc.6601657; Xia XB, 2009, P NATL ACAD SCI USA, V106, P4260, DOI 10.1073/pnas.0810067106; Yan Q, 2007, MOL CELL BIOL, V27, P2092, DOI 10.1128/MCB.01514-06; Zatyka M, 2002, CANCER RES, V62, P3803	43	111	114	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2012	44	4					420	U229		10.1038/ng.2204	http://dx.doi.org/10.1038/ng.2204			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	916VF	22406644	Green Accepted			2022-12-25	WOS:000302130600016
J	Couturier, L; Vodovar, N; Schweisguth, F				Couturier, Lydie; Vodovar, Nicolas; Schweisguth, Francois			Endocytosis by Numb breaks Notch symmetry at cytokinesis	NATURE CELL BIOLOGY			English	Article							ASYMMETRIC CELL-DIVISION; LETHAL-GIANT-LARVAE; MEMBRANE LOCALIZATION; ALPHA-ADAPTIN; DROSOPHILA; SANPODO; PROTEIN; DELTA; ACTIVATION; FATES	Cell-fate diversity can be generated by the unequal segregation of the Notch regulator Numb at mitosis in both vertebrates and invertebrates. Whereas the mechanisms underlying unequal inheritance of Numb are understood, how Numb antagonizes Notch has remained unsolved. Live imaging of Notch in sensory organ precursor cells revealed that nuclear Notch is detected at cytokinesis in the daughter cell that does not inherit Numb. Numb and Sanpodo act together to regulate Notch trafficking and establish directional Notch signalling at cytokinesis. We propose that unequal segregation of Numb results in increased endocytosis in one daughter cell, hence asymmetry of Notch at the cytokinetic furrow, directional signalling and binary fate choice.	[Couturier, Lydie; Vodovar, Nicolas; Schweisguth, Francois] Inst Pasteur, Dept Dev Biol, F-75015 Paris, France; [Couturier, Lydie; Vodovar, Nicolas; Schweisguth, Francois] CNRS, URA2578, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Schweisguth, F (corresponding author), Inst Pasteur, Dept Dev Biol, F-75015 Paris, France.	fschweis@pasteur.fr	Vodovar, Nicolas/S-2947-2019	Vodovar, Nicolas/0000-0001-8087-387X	Centre National de la Recherche Scientifique, Institut Pasteur, the National Agency for Research [BLAN-05-0277]; Fondation pour la Recherche Medicale [DEQ20100318284]	Centre National de la Recherche Scientifique, Institut Pasteur, the National Agency for Research; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We thank O. Baudouin, K. Basler, H. Bellen, R. Bodmer, P. Bryant, S. Eaton, M. Gonzalez-Gaitan, Y. Hong, J. Knoblich, R. be Borgne, T. Lecuit, Y. Hong, N. Perrimon, F. Roegiers, J. Skeath, R. Ueda, A. Wodarz, W. Zhong, the Bloomington Drosophila Stock Center, the Developmental Studies Hybridoma Bank, the Drosophila Genomics Resource Center and Flybase for flies, antibodies, DNA and other resources. We are very grateful to H. Rouault for the custom design of a temperature-controlled stage. We thank R. be Borgne, A. Martinez-Arias, O. Pourquie, C. Saleh and laboratory members for discussions and critical reading. This work was funded by the Centre National de la Recherche Scientifique, Institut Pasteur, the National Agency for Research (BLAN-05-0277) and the Fondation pour la Recherche Medicale (DEQ20100318284).	Babaoglan AB, 2009, DEVELOPMENT, V136, P4089, DOI 10.1242/dev.040386; Benhra N, 2011, CURR BIOL, V21, P87, DOI 10.1016/j.cub.2010.12.010; Benhra N, 2010, MOL BIOL CELL, V21, P2078, DOI 10.1091/mbc.E09-11-0926; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Coumailleau F, 2009, NATURE, V458, P1051, DOI 10.1038/nature07854; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Gulino A, 2010, EXP CELL RES, V316, P900, DOI 10.1016/j.yexcr.2009.11.017; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Hutterer A, 2005, EMBO REP, V6, P836, DOI 10.1038/sj.embor.7400500; Jory A, 2009, STEM CELLS, V27, P2769, DOI 10.1002/stem.220; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Langevin J, 2005, CURR BIOL, V15, P955, DOI 10.1016/j.cub.2005.04.054; Lecourtois M, 1998, CURR BIOL, V8, P771, DOI 10.1016/S0960-9822(98)70300-8; O'Connor-Giles KM, 2003, DEV CELL, V5, P231, DOI 10.1016/S1534-5807(03)00226-0; RAMOS RGP, 1989, GENETICS, V123, P337; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Roegiers F, 2005, MOL BIOL CELL, V16, P3480, DOI 10.1091/mbc.E05-03-0177; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Shen Q, 2002, DEVELOPMENT, V129, P4843; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Tong X, 2010, MOL BIOL CELL, V21, P802, DOI 10.1091/mbc.E09-09-0831; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049	28	96	96	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2012	14	2					131	139		10.1038/ncb2419	http://dx.doi.org/10.1038/ncb2419			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	893CF	22267085				2022-12-25	WOS:000300332500007
J	Jeong, H; Cohen, DE; Cui, LB; Supinski, A; Savas, JN; Mazzulli, JR; Yates, JR; Bordone, L; Guarente, L; Krainc, D				Jeong, Hyunkyung; Cohen, Dena E.; Cui, Libin; Supinski, Andrea; Savas, Jeffrey N.; Mazzulli, Joseph R.; Yates, John R., III; Bordone, Laura; Guarente, Leonard; Krainc, Dimitri			Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway	NATURE MEDICINE			English	Article							GENE-TRANSCRIPTION; PGC-1-ALPHA; EXPRESSION; REPEAT	Sirt1, a NAD-dependent protein deacetylase, has emerged as a key regulator of mammalian transcription in response to cellular metabolic status and stressl. Here we show that Sirt1 has a neuroprotective role in models of Huntington's disease, an inherited neurodegenerative disorder caused by a glutamine repeat expansion in huntingtin protein (HIT)2. Brain-specific knockout of Sirt1 results in exacerbation of brain pathology in a mouse model of Huntington's disease, whereas overexpression of Sirt1 improves survival, neuropathology and the expression of brain-derived neurotrophic factor (BDNF) in Huntington's disease mice. We show that Sirt1 deacetylase activity directly targets neurons to mediate neuroprotection from mutant HTT. The neuroprotective effect of Sirt1 requires the presence of CREB-regulated transcription coactivator 1 (TORC1), a brain-specific modulator of CREB activity3. We show that under normal conditions, Sirt1 deacetylates and activates TORC1 by promoting its dephosphorylation and its interaction with CREB. We identified BDNF as a key target of Sirt1 and TORC1 transcriptional activity in both normal and Huntington's disease neurons. Mutant HTT interferes with the TORC1-CREB interaction to repress BDNF transcription, and Sirt1 rescues this defect in vitro and in vivo. These studies suggest a key role for Sirt1 in transcriptional networks in both the normal and Huntington's disease brain and offer an opportunity for therapeutic development.	[Jeong, Hyunkyung; Cui, Libin; Mazzulli, Joseph R.; Krainc, Dimitri] Harvard Univ, MassGen Inst Neurodegenerat Dis, Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; [Cohen, Dena E.; Supinski, Andrea; Guarente, Leonard] MIT, Dept Biol, Paul F Glenn Lab, Cambridge, MA USA; [Savas, Jeffrey N.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Bordone, Laura] Novartis Inst BioMed Res, Cardiovasc & Metab Dis Area, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Scripps Research Institute; Novartis	Krainc, D (corresponding author), Harvard Univ, MassGen Inst Neurodegenerat Dis, Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA.	leng@mit.edu; krainc@helix.mgh.harvard.edu	Mazzulli, joseph/AAS-4480-2020		US National Institutes of Health [R01NS051303, R01MH067880-08, P41RR011823-15]; Cure Huntington's Disease Initiative (CHDI); Hereditary Disease Foundation (FIDE); Glenn Foundation for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051303] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Huntington's Disease Initiative (CHDI); Hereditary Disease Foundation (FIDE); Glenn Foundation for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Montminy (Peptide Biology Laboratories (PBL), Salk Institute) for the Flag-CREB, Flag-TORC1 and Flag-TORC1 S151A plasmids and for antibody to TORC1 (#6937, PBL, Salk Institute) and helpful discussions; M.E. Greenberg (Harvard Medical School) for the pIII(170)Luc plasmid 15; T. Kouzarides (University of Cambridge) for Sirt1 and Sift1 HY plasmids; Z. Wu (Novartis Institutes for Biomedical Research) for the TORC1 plasmid; M. Difiglia (Massachusetts General Hospital) for antibody to HTT (Ab1); E. Regulier (Novartis Institutes for Biomedical Research) for lentiviral vectors expressing HTTEx1-25Q, HTTEx1-72Q and Sirt1; and J.M. Park (Massachusetts General Hospital) for the lentiviral vector used for CREB knockdown. We also acknowledge C. Whitaker (Massachusetts Institute of Technology) for analysis of the microarray data. This work was supported by grant R01NS051303 from the US National Institutes of Health (D.K.); the Cure Huntington's Disease Initiative (CHDI), Hereditary Disease Foundation (FIDE) (D.E.C.); US National Institutes of Health, Glenn Foundation for Medical Research (L.G.) and grants R01MH067880-08 and P41RR011823-15 from the US National Institutes of Health (J.R.Y.).	Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866; Beal M Flint, 2007, Novartis Found Symp, V287, P183; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Li SA, 2009, J NEUROSCI, V29, P2334, DOI 10.1523/JNEUROSCI.2296-08.2009; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Pallos J, 2008, HUM MOL GENET, V17, P3767, DOI 10.1093/hmg/ddn273; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Stack EC, 2005, J COMP NEUROL, V490, P354, DOI 10.1002/cne.20680; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Wang J, 2010, BBA-PROTEINS PROTEOM, V1804, P1690, DOI 10.1016/j.bbapap.2009.11.015; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; Zala D, 2005, NEUROBIOL DIS, V20, P785, DOI 10.1016/j.nbd.2005.05.017; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102; Zhao W, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-51; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	31	261	268	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					159	165		10.1038/nm.2559	http://dx.doi.org/10.1038/nm.2559			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22179316	Green Submitted, Green Accepted			2022-12-25	WOS:000299018600043
J	Xue, Y; Lim, S; Yang, YL; Wang, ZW; Jensen, LDE; Hedlund, EM; Andersson, P; Sasahara, M; Larsson, O; Galter, D; Gao, RH; Hosaka, K; Cao, YH				Xue, Yuan; Lim, Sharon; Yang, Yunlong; Wang, Zongwei; Jensen, Lasse Dahl Ejby; Hedlund, Eva-Maria; Andersson, Patrik; Sasahara, Masakiyo; Larsson, Ola; Galter, Dagmar; Gao, Renhai; Hosaka, Kayoko; Cao, Yihai			PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells	NATURE MEDICINE			English	Article							GROWTH FACTOR-A; VASCULAR STABILITY; BETA-RECEPTOR; CANCER; MICE; THERAPY; STRESS; COMBINATION; PROGENITORS; FIBROBLASTS	The platelet-derived growth factor (PDGF) signaling system contributes to tumor angiogenesis and vascular remodeling. Here we show in mouse tumor models that PDGF-BB induces erythropoietin (EPO) mRNA and protein expression by targeting stromal and perivascular cells that express PDGF receptor-beta (PDGFR-beta). Tumor-derived PDGF-BB promoted tumor growth, angiogenesis and extramedullary hematopoiesis at least in part through modulation of EPO expression. Moreover, adenoviral delivery of PDGF-BB to tumor-free mice increased both EPO production and erythropoiesis, as well as protecting from irradiation-induced anemia. At the molecular level, we show that the PDGF-BB PDGFR-beta signaling system activates the EPO promoter, acting in part through transcriptional regulation by the transcription factor Atf3, possibly through its association with two additional transcription factors, c-Jun and Sp1. Our findings suggest that PDGF-BB-induced EPO promotes tumor growth through two mechanisms: first, paracrine stimulation of tumor angiogenesis by direct induction of endothelial cell proliferation, migration, sprouting and tube formation, and second, endocrine stimulation of extramedullary hematopoiesis leading to increased oxygen perfusion and protection against tumor-associated anemia.	[Xue, Yuan; Lim, Sharon; Yang, Yunlong; Wang, Zongwei; Jensen, Lasse Dahl Ejby; Hedlund, Eva-Maria; Andersson, Patrik; Gao, Renhai; Hosaka, Kayoko; Cao, Yihai] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Sasahara, Masakiyo] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pathol, Toyama 930, Japan; [Larsson, Ola] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Galter, Dagmar] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Cao, Yihai] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden	Karolinska Institutet; University of Toyama; Karolinska Institutet; Karolinska Institutet; Linkoping University	Cao, YH (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	yihai.cao@ki.se	Andersson, Patrik/AAJ-6994-2020; Larsson, Ola/F-8151-2013; Xue, Yuan/D-3030-2012; Galter, Dagmar/C-4826-2011	Andersson, Patrik/0000-0002-8454-3963; Galter, Dagmar/0000-0001-6485-6244; Jensen, Lasse/0000-0003-2338-357X; Yang, Yunlong/0000-0003-1551-9828; Larsson, Ola/0000-0003-1412-1308; Hedlund, Eva-Maria/0000-0002-5452-2547	Swedish Research Council; Swedish Cancer Foundation; Karolinska Institute Foundation; Karolinska Institute; ImClone; European Union of Metoxia [222741]; European Research Council [250021]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Karolinska Institute Foundation(Karolinska Institutet); Karolinska Institute(Karolinska Institutet); ImClone; European Union of Metoxia; European Research Council(European Research Council (ERC)European Commission)	We thank J. Nissen and Z. Peng for their technical support. We thank Z. Zhu at ImClone for providing us the antibodies specific to mouse PDGFR-a and PDGFR-beta. The MS-5 and S17 cell lines were provided by A. Berardi (Ospedale Bambin Gesu, Italy) and K. Dorshkind (University of California, Los Angeles, California, USA), and the adenoviruses were provided by S. Yla-Herttuala (University of Kuopio, Kuopio, Finland). This work was supported by the laboratory of Y.C. through research grants from the Swedish Research Council, the Swedish Cancer Foundation, the Karolinska Institute Foundation, the Karolinska Institute distinguished professor award Torsten och Ragnar Soderbergs Stiftelser, a grant from ImClone, the European Union Integrated Project of Metoxia (project number 222741) and the European Research Council advanced grant ANGIOFAT (project number 250021).	Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549; Ameri K, 2007, ONCOGENE, V26, P284, DOI 10.1038/sj.onc.1209781; BACCARANI M, 1978, B I SIEROTER MILAN, V57, P257; Bahlmann FH, 2004, BLOOD, V103, P921, DOI 10.1182/blood-2003-04-1284; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bhowmick NA, 2005, CURR OPIN GENET DEV, V15, P97, DOI 10.1016/j.gde.2004.12.003; Cao RH, 2002, FASEB J, V16, P1575, DOI 10.1096/fj.02-0319com; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Cao Y, 2008, ADV CANCER RES, V100, P113, DOI 10.1016/S0065-230X(08)00004-3; Cao YH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.259re1; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chen J, 2008, J CLIN INVEST, V118, P526, DOI [10.1172/JC133813, 10.1172/JCI33813]; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Grimm C, 2002, NAT MED, V8, P718, DOI 10.1038/nm723; Harandi OF, 2010, J CLIN INVEST, V120, P4507, DOI 10.1172/JCI41291; Hardee ME, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000549; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kirschner KM, 2003, MOL CANCER RES, V1, P970; Kiryu-Seo S, 2008, J BIOL CHEM, V283, P6988, DOI 10.1074/jbc.M707514200; Korpisalo P, 2008, CIRC RES, V103, P1092, DOI 10.1161/CIRCRESAHA.108.182287; Kuhnert F, 2008, P NATL ACAD SCI USA, V105, P10185, DOI 10.1073/pnas.0803194105; Kurimoto M, 1995, ACTA NEUROCHIR, V137, P182, DOI 10.1007/BF02187191; KUSHNER JP, 1971, MEDICINE, V50, P139, DOI 10.1097/00005792-197105000-00001; LEITZEL K, 1991, CANCER RES, V51, P4149; Lenox LE, 2009, EXP HEMATOL, V37, P549, DOI 10.1016/j.exphem.2009.01.004; Lindahl P, 1998, DEVELOPMENT, V125, P3313; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Millot S, 2010, BLOOD, V116, P6072, DOI 10.1182/blood-2010-04-281840; Moritz KM, 1997, AM J PHYSIOL-REG I, V273, pR1829, DOI 10.1152/ajpregu.1997.273.6.R1829; Nakayama T, 2007, J NATL CANCER I, V99, P223, DOI 10.1093/jnci/djk031; Nisancioglu MH, 2010, CANCER RES, V70, P5109, DOI 10.1158/0008-5472.CAN-09-4245; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; Pietras K, 2003, CANCER CELL, V3, P439, DOI 10.1016/S1535-6108(03)00089-8; Ribatti D, 2003, EUR J CLIN INVEST, V33, P891, DOI 10.1046/j.1365-2362.2003.01245.x; Saintigny P, 2007, CLIN CANCER RES, V13, P4825, DOI 10.1158/1078-0432.CCR-06-3061; Sasaki R, 2003, INTERNAL MED, V42, P142, DOI 10.2169/internalmedicine.42.142; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; SOUTTER AD, 1993, CANCER RES, V53, P5297; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Tokunaga A, 2008, J BONE MINER RES, V23, P1519, DOI 10.1359/JBMR.080409; Wang SB, 2010, J BIOL CHEM, V285, P19976, DOI 10.1074/jbc.M110.102467; WESTERMARK B, 1985, NEUROL CLIN, V3, P785, DOI 10.1016/S0733-8619(18)31009-0; WESTERMARK B, 1987, ACTA MED SCAND, P19; Xue Y, 2008, P NATL ACAD SCI USA, V105, P18513, DOI 10.1073/pnas.0807967105; Yamaguchi T, 1996, PEDIATR RADIOL, V26, P312, DOI 10.1007/BF01395704; Zhang JH, 2009, FASEB J, V23, P153, DOI 10.1096/fj.08-113860	51	148	152	2	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2012	18	1					100	110		10.1038/nm.2575	http://dx.doi.org/10.1038/nm.2575			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22138754				2022-12-25	WOS:000299018600035
J	Amanna, IJ; Raue, HP; Slifka, MK				Amanna, Ian J.; Raue, Hans-Peter; Slifka, Mark K.			Development of a new hydrogen peroxide-based vaccine platform	NATURE MEDICINE			English	Article							SYNCYTIAL VIRUS-DISEASE; T-CELL RESPONSES; ENCEPHALITIS-VIRUS; BETA-PROPIOLACTONE; MONKEYPOX VIRUS; IMMUNITY; MEMORY; IMMUNOGENICITY; PROTECTION; ANTIBODIES	Safe and effective vaccines are crucial for maintaining public health and reducing the global burden of infectious disease. Here we introduce a new vaccine platform that uses hydrogen peroxide (H2O2) to inactivate viruses for vaccine production. H2O2 rapidly inactivates both RNA and DNA viruses with minimal damage to antigenic structure or immunogenicity and is a highly effective method when compared with conventional vaccine inactivation approaches such as formaldehyde or beta-propiolactone. Mice immunized with H2O2-inactivated lymphocytic choriomeningitis virus (LCMV) generated cytolytic, multifunctional virus-specific CD8(+) T cells that conferred protection against chronic LCMV infection. Likewise, mice vaccinated with H2O2-inactivated vaccinia virus or H2O2-inactivated West Nile virus showed high virus-specific neutralizing antibody titers and were fully protected against lethal challenge. Together, these studies demonstrate that H2O2-based vaccines are highly immunogenic, provide protection against a range of viral pathogens in mice and represent a promising new approach to future vaccine development.	[Raue, Hans-Peter; Slifka, Mark K.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Amanna, Ian J.] Najit Technol, Beaverton, OR USA	Oregon Health & Science University; Oregon National Primate Research Center	Slifka, MK (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA.	slifkam@ohsu.edu		Amanna, Ian/0000-0001-7545-4013	US National Institutes of Health [R56 AI076506, UO1 AI082196, R43 AI079898]; Oregon National Primate Research Center [8P51 OD011092-53]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI076506, R43AI079898, R44AI079898, U01AI082196] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon National Primate Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank E. Poore and M. Dubois for the growth of YFV and E. Hammarlund for the growth of monkeypox virus. This work was supported by US National Institutes of Health grants R56 AI076506 (to M. K. S.), UO1 AI082196 (to M. K. S.) and R43 AI079898 (to I.J.A. and M. K. S.) and Oregon National Primate Research Center grant 8P51 OD011092-53 (to M.K.S.).	Amanna IJ, 2008, HUM VACCINES, V4, P316, DOI 10.4161/hv.4.4.5751; Amanna IJ, 2009, ANTIVIR RES, V84, P119, DOI 10.1016/j.antiviral.2009.08.008; ANNUNZIATO D, 1982, PEDIATRICS, V70, P203; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; BROWN F, 1993, DEV BIOL STAND, V81, P103; CHANNON JY, 1985, PARASITOLOGY, V91, P197, DOI 10.1017/S0031182000057309; DeQueiroz GA, 2008, LETT APPL MICROBIOL, V46, P176, DOI 10.1111/j.1472-765X.2007.02283.x; Eckels Kenneth H, 2003, Adv Virus Res, V61, P395, DOI 10.1016/S0065-3527(03)61010-9; Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261; Fiore AE, 2008, VACCINES; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; Giannini SL, 2006, VACCINE, V24, P5937, DOI 10.1016/j.vaccine.2006.06.005; Guenter T.E, 1988, ENCY CHEM PROCESSING, V27, P27; Gujral IB, 2007, EMERG INFECT DIS, V13, P419, DOI 10.3201/eid1303.060941; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hammarlund E, 2008, P NATL ACAD SCI USA, V105, P14567, DOI 10.1073/pnas.0800589105; Hassett DE, 2000, J VIROL, V74, P8286, DOI 10.1128/JVI.74.18.8286-8291.2000; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; LOGRIPPO GA, 1955, J IMMUNOL, V75, P123; Monath TP, 2011, NEW ENGL J MED, V364, P1326, DOI 10.1056/NEJMoa1009303; Monath TP, 2010, VACCINE, V28, P3827, DOI 10.1016/j.vaccine.2010.03.023; NEIGHBOR NK, 1994, POULTRY SCI, V73, P1511, DOI 10.3382/ps.0731511; Ng T., 2003, VVolume 114, P221; Plotkin S, 2008, VACCINES; Plotkin S., 2008, VACCINES, P1; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Raue HP, 2007, J LEUKOCYTE BIOL, V81, P1165, DOI 10.1189/jlb.0806535; REED L. J., 1938, AMER JOUR HYG, V27, P493; Robinson HL, 2005, NAT MED, V11, pS25, DOI 10.1038/nm1212; Schwarz K, 2005, EUR J IMMUNOL, V35, P816, DOI 10.1002/eji.200425755; Shrestha B, 2008, VACCINE, V26, P2020, DOI 10.1016/j.vaccine.2008.02.009; SIBER GR, 1991, VACCINE, V9, P735, DOI 10.1016/0264-410X(91)90289-I; Slifka MK, 1996, J VIROL, V70, P2902, DOI 10.1128/JVI.70.5.2902-2910.1996; Srivastava AK, 2001, VACCINE, V19, P4557, DOI 10.1016/S0264-410X(01)00208-0; Stauffer Fausto, 2006, Recent Pat Antiinfect Drug Discov, V1, P291, DOI 10.2174/157489106778777673; SWANSON MC, 1987, J INFECT DIS, V155, P909, DOI 10.1093/infdis/155.5.909; Sykes G, 1965, DISINFECTION STERILI; Termini J, 2000, MUTAT RES-FUND MOL M, V450, P107, DOI 10.1016/S0027-5107(00)00019-1; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001	40	79	86	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2012	18	6					974	+		10.1038/nm.2763	http://dx.doi.org/10.1038/nm.2763			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22635006	Bronze, Green Accepted			2022-12-25	WOS:000305116600037
J	Bergamini, G; Bell, K; Shimamura, S; Werner, T; Cansfield, A; Muller, K; Perrin, J; Rau, C; Ellard, K; Hopf, C; Doce, C; Leggate, D; Mangano, R; Mathieson, T; O'Mahony, A; Plavec, I; Rharbaoui, F; Reinhard, F; Savitski, MM; Ramsden, N; Hirsch, E; Drewes, G; Rausch, O; Bantscheff, M; Neubauer, G				Bergamini, Giovanna; Bell, Kathryn; Shimamura, Satoko; Werner, Thilo; Cansfield, Andrew; Mueller, Katrin; Perrin, Jessica; Rau, Christina; Ellard, Katie; Hopf, Carsten; Doce, Carola; Leggate, Daniel; Mangano, Raffaella; Mathieson, Toby; O'Mahony, Alison; Plavec, Ivan; Rharbaoui, Faiza; Reinhard, Friedrich; Savitski, Mikhail M.; Ramsden, Nigel; Hirsch, Emilio; Drewes, Gerard; Rausch, Oliver; Bantscheff, Marcus; Neubauer, Gitte			A selective inhibitor reveals PI3K gamma dependence of T(H)17 cell differentiation	NATURE CHEMICAL BIOLOGY			English	Article							RHEUMATOID-ARTHRITIS; KINASE INHIBITORS; INDUCED INFLAMMATION; JOINT INFLAMMATION; INSULIN-RESISTANCE; CLASS-IB; KEY ROLE; PI3K; CHEMOPROTEOMICS; IDENTIFICATION	We devised a high-throughput chemoproteomics method that enabled multiplexed screening of 16,000 compounds against native protein and lipid kinases in cell extracts. Optimization of one chemical series resulted in CZC24832, which is to our knowledge the first selective inhibitor of phosphoinositide 3-kinase gamma (PI3K gamma) with efficacy in in vitro and in vivo models of inflammation. Extensive target- and cell-based profiling of CZC24832 revealed regulation of interleukin-17-producing T helper cell (T(H)17) differentiation by PI3K gamma, thus reinforcing selective inhibition of PI3K gamma as a potential treatment for inflammatory and autoimmune diseases.	[Bergamini, Giovanna; Shimamura, Satoko; Werner, Thilo; Mueller, Katrin; Perrin, Jessica; Rau, Christina; Hopf, Carsten; Doce, Carola; Mathieson, Toby; Rharbaoui, Faiza; Reinhard, Friedrich; Savitski, Mikhail M.; Drewes, Gerard; Bantscheff, Marcus; Neubauer, Gitte] Cellzome AG, Heidelberg, Germany; [Bell, Kathryn; Cansfield, Andrew; Ellard, Katie; Leggate, Daniel; Mangano, Raffaella; Ramsden, Nigel; Rausch, Oliver] Cellzome Ltd, Cambridge, England; [O'Mahony, Alison; Plavec, Ivan] BioSeek LLC, San Francisco, CA USA; [Hirsch, Emilio] Univ Turin, Ctr Mol Biotechnol, Dept Genet Biol & Biochem, Turin, Italy	GlaxoSmithKline; Cellzome GmbH; GlaxoSmithKline; Cellzome GmbH; University of Turin	Bergamini, G (corresponding author), Cellzome AG, Heidelberg, Germany.	marcus.bantscheff@cellzome.com; gitte.neubauer@cellzome.com	Bantscheff, Marcus/AAQ-2903-2021; Hirsch, Emilio/F-4848-2013; Hopf, Carsten/A-3275-2015	Bantscheff, Marcus/0000-0002-8343-8977; Hirsch, Emilio/0000-0002-9073-6024; Hopf, Carsten/0000-0003-0802-6451; Drewes, Gerard/0000-0003-0575-6766; Mathieson, Toby/0000-0002-6153-3113; Bergamini, Giovanna/0000-0002-9662-9502				Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Becattini B, 2011, P NATL ACAD SCI USA, V108, pE854, DOI 10.1073/pnas.1106698108; Berg EL, 2010, J PHARMACOL TOX MET, V61, P3, DOI 10.1016/j.vascn.2009.10.001; Bilancio A, 2006, BLOOD, V107, P642, DOI 10.1182/blood-2005-07-3041; Bohnacker T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000259; Brachmann SM, 2009, P NATL ACAD SCI USA, V106, P22299, DOI 10.1073/pnas.0905152106; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Cansfield A., 2011, European patent EP, Patent No. 2245181; Ciraolo E, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1161577; Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944; Fadden P, 2010, CHEM BIOL, V17, P686, DOI 10.1016/j.chembiol.2010.04.015; Fougerat A, 2008, CIRCULATION, V117, P1310, DOI 10.1161/CIRCULATIONAHA.107.720466; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Ghigo A, 2010, BIOESSAYS, V32, P185, DOI 10.1002/bies.200900150; Graves PR, 2002, MOL PHARMACOL, V62, P1364, DOI 10.1124/mol.62.6.1364; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Haylock-Jacobs S, 2011, J AUTOIMMUN, V36, P278, DOI 10.1016/j.jaut.2011.02.006; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Ji H, 2007, BLOOD, V110, P2940, DOI 10.1182/blood-2007-04-086751; Jones GE, 2003, EXP CELL RES, V290, P120, DOI 10.1016/S0014-4827(03)00318-5; Kageyama Y, 2009, MOD RHEUMATOL, V19, P657, DOI 10.1007/s10165-009-0217-6; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kobayashi N, 2011, P NATL ACAD SCI USA, V108, P5753, DOI 10.1073/pnas.1016430108; Konrad S, 2008, J BIOL CHEM, V283, P33296, DOI 10.1074/jbc.M804617200; Konstantinidou G, 2009, CANCER RES, V69, P7644, DOI 10.1158/0008-5472.CAN-09-0823; Kruse U, 2011, LEUKEMIA, V25, P89, DOI 10.1038/leu.2010.233; Kunkel EJ, 2004, ASSAY DRUG DEV TECHN, V2, P431, DOI 10.1089/1540658041850607; Kunkel EJ, 2004, FASEB J, V18, P1279, DOI 10.1096/fj.04-1538fje; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Martin D, 2011, CANCER CELL, V19, P805, DOI 10.1016/j.ccr.2011.05.005; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Savitski MM, 2011, ANAL CHEM, V83, P8959, DOI 10.1021/ac201760x; Savitski MM, 2010, ANAL CHEM, V82, P9843, DOI 10.1021/ac102083q; Savitski MM, 2010, J AM SOC MASS SPECTR, V21, P1668, DOI 10.1016/j.jasms.2010.01.012; Schmid MC, 2011, CANCER CELL, V19, P715, DOI 10.1016/j.ccr.2011.04.016; Sharma K, 2009, NAT METHODS, V6, P741, DOI [10.1038/NMETH.1373, 10.1038/nmeth.1373]; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Vecchione C, 2005, J EXP MED, V201, P1217, DOI 10.1084/jem.20040995; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Williams O, 2010, CHEM BIOL, V17, P123, DOI 10.1016/j.chembiol.2010.01.010; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	49	107	119	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2012	8	6					576	582		10.1038/NCHEMBIO.957	http://dx.doi.org/10.1038/NCHEMBIO.957			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	945ET	22544264				2022-12-25	WOS:000304256300014
J	Dion, V; Kalck, V; Horigome, C; Towbin, BD; Gasser, SM				Dion, Vincent; Kalck, Veronique; Horigome, Chihiro; Towbin, Benjamin D.; Gasser, Susan M.			Increased mobility of double-strand breaks requires Mec1, Rad9 and the homologous recombination machinery	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE RESPONSE; SACCHAROMYCES-CEREVISIAE; POSITIONAL STABILITY; CHROMOSOME DYNAMICS; YEAST CHROMOSOMES; MAMMALIAN-CELLS; REPAIR; CHECKPOINT; PROTEIN; KINASE	Chromatin mobility is thought to facilitate homology search during homologous recombination and to shift damage either towards or away from specialized repair compartments. However, unconstrained mobility of double-strand breaks could also promote deleterious chromosomal translocations. Here we use live time-lapse fluorescence microscopy to track the mobility of damaged DNA in budding yeast. We found that a Rad52-YFP focus formed at an irreparable double-strand break moves in a larger subnuclear volume than the undamaged locus. In contrast, Rad52-YFP bound at damage arising from a protein DNA adduct shows no increase in movement. Mutant analysis shows that enhanced double-strand-break mobility requires Rad51, the ATPase activity of Rad54, the AIR homologue Mec1 and the DNA-damage-response mediator Rad9. Consistent with a role for movement in the homology-search step of homologous recombination, we show that recombination intermediates take longer to form in cells lacking Rad9.	[Dion, Vincent; Kalck, Veronique; Horigome, Chihiro; Towbin, Benjamin D.; Gasser, Susan M.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Towbin, Benjamin D.; Gasser, Susan M.] Univ Basel, Fac Sci, CH-4056 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Basel	Gasser, SM (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	susan.gasser@fmi.ch	Towbin, Benjamin D/C-8545-2018; Towbin, Benjamin D/AAO-8064-2021; Horigome, Chihiro/AAH-5989-2021	Towbin, Benjamin D/0000-0001-7046-1257; Dion, Vincent/0000-0003-4953-7637; Gasser, Susan/0000-0003-3610-9123	Terry Fox Foundation [19759]; Novartis Research Foundation; Swiss National Science Foundation National Centre of Competence in Research	Terry Fox Foundation; Novartis Research Foundation; Swiss National Science Foundation National Centre of Competence in Research(Swiss National Science Foundation (SNSF))	We thank R. Schmid for imaging assistance, H. van Attikum for cloning assistance and L. Bjergbaek for the Flp-nick strain and sharing unpublished data. We thank W. Heyer for the Rad54 mutant construct, J. E. Haber for JKM154 and R. Rothstein and J. Mine-Hattab for sharing unpublished reagents and results. We thank B. Pike, K. Shimada, A. Gonzalez, N. Hustedt, M. Oppikofer, A. Seeber and F. Hamaratoglu for reading the manuscript and the Friedrich Miescher Institute Facility for Advanced Imaging and Microscopy for technical help. V.D. is supported in part by a postdoctoral award from the Terry Fox Foundation (award no. 19759) and work in S.M.G.'s laboratory is supported by the Novartis Research Foundation and the Swiss National Science Foundation National Centre of Competence in Research 'Frontiers in genetics' programme.	Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Barlow JH, 2009, EMBO J, V28, P1121, DOI 10.1038/emboj.2009.43; BENNETT CB, 1993, P NATL ACAD SCI USA, V90, P5613, DOI 10.1073/pnas.90.12.5613; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Clever B, 1999, YEAST, V15, P721, DOI 10.1002/(SICI)1097-0061(19990630)15:9<721::AID-YEA414>3.0.CO;2-W; Conde F, 2009, GENETICS, V182, P437, DOI 10.1534/genetics.109.101899; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Dubrana K, 2007, J CELL SCI, V120, P4209, DOI 10.1242/jcs.018366; Frank-Vaillant M, 2002, MOL CELL, V10, P1189, DOI 10.1016/S1097-2765(02)00705-0; Gartenberg MR, 2004, CELL, V119, P955, DOI 10.1016/j.cell.2004.11.008; Gehlen LR, 2011, PROG THEOR PHYS SUPP, P20; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; Jakob B, 2009, RADIAT RES, V171, P405, DOI 10.1667/RR1520.1; Jakob B, 2009, P NATL ACAD SCI USA, V106, P3172, DOI 10.1073/pnas.0810987106; Kim YH, 2006, NUCLEIC ACIDS RES, V34, P2914, DOI 10.1093/nar/gkl293; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Mazin AV, 2010, DNA REPAIR, V9, P286, DOI 10.1016/j.dnarep.2009.12.006; Meister P, 2010, METHOD ENZYMOL, V470, P535, DOI 10.1016/S0076-6879(10)70021-5; Mine-Hattab J, 2012, NAT CELL BIOL; Mochan TA, 2004, DNA REPAIR, V3, P945, DOI 10.1016/j.dnarep.2004.03.017; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; Neumann FR, 2012, GENE DEV, V26, P369, DOI 10.1101/gad.176156.111; Nielsen I, 2009, NAT METHODS, V6, P753, DOI [10.1038/NMETH.1372, 10.1038/nmeth.1372]; Noon AT, 2011, DNA REPAIR, V10, P1071, DOI 10.1016/j.dnarep.2011.07.012; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; Ponti A., 2007, IMAGING MICROSC, V9, P57, DOI [10.1002/imic.200790154, DOI 10.1002/IMIC.200790154]; Povirk LF, 1996, MUTAT RES-FUND MOL M, V355, P71, DOI 10.1016/0027-5107(96)00023-1; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; Savage JRK, 1996, MUTAT RES-REV GENET, V366, P81, DOI 10.1016/S0165-1110(96)90030-5; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Stuck M, 2004, DNA REPAIR, V3, P953, DOI 10.1016/j.dnarep.2004.03.007; Sweeney FD, 2005, CURR BIOL, V15, P1364, DOI 10.1016/j.cub.2005.06.063; Torres-Rosell J, 2007, NAT CELL BIOL, V9, P923, DOI 10.1038/ncb1619; Usui T, 2009, MOL CELL, V33, P147, DOI 10.1016/j.molcel.2008.12.022; Vialard JE, 1998, EMBO J, V17, P5679, DOI 10.1093/emboj/17.19.5679; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	43	210	214	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2012	14	5					502	U221		10.1038/ncb2465	http://dx.doi.org/10.1038/ncb2465			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	936NW	22484486				2022-12-25	WOS:000303598300010
J	Islam, MN; Das, SR; Emin, MT; Wei, M; Sun, L; Westphalen, K; Rowlands, DJ; Quadri, SK; Bhattacharya, S; Bhattacharya, J				Islam, Mohammad Naimul; Das, Shonit R.; Emin, Memet T.; Wei, Michelle; Sun, Li; Westphalen, Kristin; Rowlands, David J.; Quadri, Sadiqa K.; Bhattacharya, Sunita; Bhattacharya, Jahar			Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury	NATURE MEDICINE			English	Article							MESENCHYMAL STEM-CELLS; DYSFUNCTION; ENGRAFTMENT; EXOCYTOSIS; SURFACTANT; SEVERITY; CONNEXIN; THERAPY; SEPSIS; ROS	Bone marrow-derived stromal cells (BMSCs) protect against acute lung injury (ALI). To determine the role of BMSC mitochondria in this protection, we airway-instilled mice first with lipopolysaccharide (LPS) and then with either mouse BMSCs (mBMSCs) or human BMSCs (hBMSCs). Live optical studies revealed that the mBMSCs formed connexin 43 (Cx43)-containing gap junctional channels (GJCs) with the alveolar epithelia in these mice, releasing mitochondria-containing microvesicles that the epithelia engulfed. The presence of BMSC-derived mitochondria in the epithelia was evident optically, as well as by the presence of human mitochondrial DNA in mouse lungs instilled with hBMSCs. The mitochondrial transfer resulted in increased alveolar ATP concentrations. LPS-induced ALI, as indicated by alveolar leukocytosis and protein leak, inhibition of surfactant secretion and high mortality, was markedly abrogated by the instillation of wild-type mBMSCs but not of mutant, GJC-incompetent mBMSCs or mBMSCs with dysfunctional mitochondria. This is the first evidence, to our knowledge, that BMSCs protect against ALI by restituting alveolar bioenergetics through Cx43-dependent alveolar attachment and mitochondrial transfer.	[Islam, Mohammad Naimul; Das, Shonit R.; Emin, Memet T.; Wei, Michelle; Sun, Li; Westphalen, Kristin; Rowlands, David J.; Quadri, Sadiqa K.; Bhattacharya, Sunita; Bhattacharya, Jahar] Columbia Univ Coll Phys & Surg, Dept Med, Div Pulm Allergy & Crit Care Med, Lung Biol Lab, New York, NY 10032 USA	Columbia University	Bhattacharya, J (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, Div Pulm Allergy & Crit Care Med, Lung Biol Lab, New York, NY 10032 USA.	jb39@columbia.edu		Islam, Mohammad Naimul/0000-0001-7929-9444	US National Institutes of Health [HL64896, HL36024, HL57556]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057556, R01HL036024, R01HL064896, R37HL036024] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by US National Institutes of Health grants HL64896, HL36024 and HL57556 to J.B. The authors thank G. Yellen (Harvard University) for the Perceval plasmid.	Ashino Y, 2000, AM J PHYSIOL-LUNG C, V279, pL5, DOI 10.1152/ajplung.2000.279.1.L5; Beahm DL, 2006, J BIOL CHEM, V281, P7994, DOI 10.1074/jbc.M506533200; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Chang JC, 2005, AM J RESP CELL MOL, V33, P335, DOI 10.1165/rcmb.2005-0129OC; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Curley GF, 2012, THORAX, V67, P496, DOI 10.1136/thoraxjnl-2011-201059; Dada LA, 2011, J CLIN INVEST, V121, P1683, DOI 10.1172/JCI57748; Das Sarma J, 2001, J CELL SCI, V114, P4013; Dietl P, 2005, ANNU REV PHYSIOL, V67, P595, DOI 10.1146/annurev.physiol.67.040403.102553; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Harrois A, 2009, CURR OPIN ANESTHESIO, V22, P143, DOI 10.1097/ACO.0b013e328328d1cc; Hawat G, 2010, PFLUG ARCH EUR J PHY, V460, P583, DOI 10.1007/s00424-010-0849-6; Heller AR, 2007, EUR J ANAESTH, V24, P258, DOI 10.1017/S026502150600144X; Kao SJ, 2007, J CARDIOVASC PHARM, V50, P333, DOI 10.1097/FJC.0b013e3180cbd18a; Kotton DN, 2005, AM J RESP CELL MOL, V33, P328, DOI 10.1165/rcmb.2005-0175RC; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Lee JW, 2009, P NATL ACAD SCI USA, V106, P16357, DOI 10.1073/pnas.0907996106; Lindert J, 2007, AM J RESP CELL MOL, V36, P688, DOI 10.1165/rcmb.2006-0347OC; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Matthay MA, 2010, CRIT CARE MED, V38, pS569, DOI 10.1097/CCM.0b013e3181f1ff1d; Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Otsu K, 2009, BLOOD, V113, P4197, DOI 10.1182/blood-2008-09-176198; Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309; Parthasarathi K, 2006, J CLIN INVEST, V116, P2193, DOI 10.1172/JCI26605; Plotnikov EY, 2008, J CELL MOL MED, V12, P1622, DOI 10.1111/j.1582-4934.2007.00205.x; Prockop DJ, 2010, J CELL MOL MED, V14, P2190, DOI 10.1111/j.1582-4934.2010.01151.x; Rowlands DJ, 2011, J CLIN INVEST, V121, P1986, DOI 10.1172/JCI43839; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103; Wang PM, 2001, AM J PHYSIOL-LUNG C, V281, pL1327, DOI 10.1152/ajplung.2001.281.6.L1327; Weiss Daniel J, 2008, Proc Am Thorac Soc, V5, P637, DOI 10.1513/pats.200804-037DW; Whitsett JA, 2010, ANNU REV MED, V61, P105, DOI 10.1146/annurev.med.60.041807.123500; Xu J, 2008, J PATHOL, V214, P472, DOI 10.1002/path.2302	40	879	913	19	211	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					759	U153		10.1038/nm.2736	http://dx.doi.org/10.1038/nm.2736			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22504485	Green Accepted			2022-12-25	WOS:000303763500043
J	Petersen, BC; Budelsky, AL; Baptist, AP; Schaller, MA; Lukacs, NW				Petersen, Bryan C.; Budelsky, Alison L.; Baptist, Alan P.; Schaller, Matthew A.; Lukacs, Nicholas W.			Interleukin-25 induces type 2 cytokine production in a steroid-resistant interleukin-17RB(+) myeloid population that exacerbates asthmatic pathology	NATURE MEDICINE			English	Article							INDUCED AIRWAY HYPERREACTIVITY; RESPIRATORY VIRAL-INFECTION; ALLERGIC INFLAMMATION; IMMUNE-RESPONSES; CELL-POPULATION; IL-25 RECEPTOR; EXPRESSION; PROMOTES; EOSINOPHILS; IL-17RB	Interleukin-25 (IL-25) is a cytokine associated with allergy and asthma that functions to promote type 2 immune responses at mucosal epithelial surfaces and serves to protect against helminth parasitic infections in the intestinal tract. This study identifies the IL-25 receptor, IL-17RB, as a key mediator of both innate and adaptive pulmonary type 2 immune responses. Allergen exposure upregulated IL-25 and induced type 2 cytokine production in a previously undescribed granulocytic population, termed type 2 myeloid (T2M) cells. Il17rb(-/-) mice showed reduced lung pathology after chronic allergen exposure and decreased type 2 cytokine production in T2M cells and CD4(+) T lymphocytes. Airway instillation of IL-25 induced IL-4 and IL-13 production in T2M cells, demonstrating their importance in eliciting T cell-independent inflammation. The adoptive transfer of T2M cells reconstituted IL-25-mediated responses in Il17rb(-/-) mice. High-dose dexamethasone treatment did not reduce the IL-25-induced T2M pulmonary response. Finally, a similar IL-4- and IL-13-producing granulocytic population was identified in peripheral blood of human subjects with asthma. These data establish IL-25 and its receptor IL-17RB as targets for innate and adaptive immune responses in chronic allergic airway disease and identify T2M cells as a new steroid-resistant cell population.	[Petersen, Bryan C.; Schaller, Matthew A.; Lukacs, Nicholas W.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Budelsky, Alison L.] Amgen Inc, Dept Inflammat, Seattle, WA USA; [Baptist, Alan P.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Amgen; University of Michigan System; University of Michigan	Lukacs, NW (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	nlukacs@umich.edu	Lukacs, Nicholas W/ABH-5583-2020; Schaller, Matthew/AAL-7640-2020		US National Institutes of Health [R01 HL05178, R01 HL036302]; National Institute of General Medical Studies [3T32GM007863-31S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Studies(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Connett for comments on the manuscript, K. Augusztiny for valuable insight and perspective, members of the Lukacs, Kunkel and Hogaboam labs for many helpful discussions, and the University of Michigan Flow Cytometry and DNA Sequencing Cores for technical assistance. This work was supported by US National Institutes of Health grants R01 HL05178 and R01 HL036302 (to N.W.L.) and National Institute of General Medical Studies grant 3T32GM007863-31S1 (to the University of Michigan Medical Scientist Training Program and B.C.P.). Il17rb<SUP>-/-</SUP> mice were provided by A.L. Budelsky (Amgen).	Adcock IM, 2008, CURR ALLERGY ASTHM R, V8, P171, DOI 10.1007/s11882-008-0028-4; Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Ballantyne SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1324, DOI 10.1016/j.jaci.2007.07.051; Bandeira-Melo C, 2002, J IMMUNOL, V168, P4756, DOI 10.4049/jimmunol.168.9.4756; Berlin AA, 2006, LAB INVEST, V86, P557, DOI 10.1038/labinvest.3700419; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Campbell E, 1999, AM J PATHOL, V154, P1259, DOI 10.1016/S0002-9440(10)65377-1; Campbell EM, 1998, J IMMUNOL, V161, P7047; Claudio E, 2009, J IMMUNOL, V182, P1617, DOI 10.4049/jimmunol.182.3.1617; Corrigan CJ, 2011, J ALLERGY CLIN IMMUN, V128, P116, DOI 10.1016/j.jaci.2011.03.043; Dolgachev V, 2009, J IMMUNOL, V183, P5705, DOI 10.4049/jimmunol.0901666; Drews AC, 2009, ALLERGY, V64, P1597, DOI 10.1111/j.1398-9995.2009.02057.x; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Fukakusa M, 2005, J ALLERGY CLIN IMMUN, V115, P280, DOI 10.1016/j.jaci.2004.10.036; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Garley A, 2009, NEOPLASMA, V56, P96, DOI 10.4149/neo_2009_02_96; Hansbro PM, 2011, BRIT J PHARMACOL, V163, P81, DOI 10.1111/j.1476-5381.2011.01219.x; Holtzman MJ, 2009, ADV IMMUNOL, V102, P245, DOI 10.1016/S0065-2776(09)01205-X; Jatakanon A, 1999, AM J RESP CRIT CARE, V160, P1532, DOI 10.1164/ajrccm.160.5.9806170; Jung JS, 2009, CHEST, V135, P1173, DOI 10.1378/chest.08-1595; Kaiko GE, 2010, J IMMUNOL, V185, P4681, DOI 10.4049/jimmunol.1001758; Kallal LE, 2010, J IMMUNOL, V185, P4137, DOI 10.4049/jimmunol.1000677; Kikuchi S, 2005, INT ARCH ALLERGY IMM, V137, P7, DOI 10.1159/000085425; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Lee J, 2001, J BIOL CHEM, V276, P1660, DOI 10.1074/jbc.M008289200; Linden A, 2000, EUR RESPIR J, V15, P973, DOI 10.1034/j.1399-3003.2000.15e28.x; Lukacs NW, 2010, J IMMUNOL, V185, P2231, DOI 10.4049/jimmunol.1000733; Maezawa Y, 2006, J IMMUNOL, V176, P1013, DOI 10.4049/jimmunol.176.2.1013; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Ogawa Y, 2010, CURR OPIN PULM MED, V16, P48, DOI 10.1097/MCP.0b013e3283357d15; PAUL WE, 1991, SKIN PHARMACOL, V4, P8; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; SEDER RA, 1991, INT ARCH ALLER A IMM, V94, P137, DOI 10.1159/000235345; Sharkhuu T, 2006, CLIN EXP ALLERGY, V36, P1575, DOI 10.1111/j.1365-2222.2006.02595.x; Smit JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001720; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Stock P, 2009, J IMMUNOL, V182, P5116, DOI 10.4049/jimmunol.0804213; Swaidani S, 2009, J IMMUNOL, V182, P1631, DOI 10.4049/jimmunol.182.3.1631; Tamachi T, 2006, J ALLERGY CLIN IMMUN, V118, P606, DOI 10.1016/j.jaci.2006.04.051; Terrier B, 2010, BLOOD, V116, P4523, DOI 10.1182/blood-2010-02-267542; Torrero MN, 2010, J IMMUNOL, V185, P7426, DOI 10.4049/jimmunol.0903864; van Panhuys N, 2011, J IMMUNOL, V186, P2719, DOI 10.4049/jimmunol.1000940; Vazquez-Tello A, 2010, CLIN EXP ALLERGY, V40, P1312, DOI 10.1111/j.1365-2222.2010.03544.x; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Wang H, 2010, CLIN EXP ALLERGY, V40, P1194, DOI 10.1111/j.1365-2222.2010.03542.x; Wang HB, 2007, J IMMUNOL, V179, P7585, DOI 10.4049/jimmunol.179.11.7585; Wang W, 2010, CURR DRUG TARGETS, V11, P957, DOI 10.2174/138945010791591412; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Wong CK, 2007, IMMUNOL LETT, V112, P82, DOI 10.1016/j.imlet.2007.07.002; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737	57	75	77	0	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					751	U145		10.1038/nm.2735	http://dx.doi.org/10.1038/nm.2735			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22543263	Green Accepted			2022-12-25	WOS:000303763500042
J	Stahl, EA; Wegmann, D; Trynka, G; Gutierrez-Achury, J; Do, R; Voight, BF; Kraft, P; Chen, R; Kallberg, HJ; Kurreeman, FAS; Kathiresan, S; Wijmenga, C; Gregersen, PK; Alfredsson, L; Siminovitch, KA; Worthington, J; de Bakker, PIW; Raychaudhuri, S; Plenge, RM				Stahl, Eli A.; Wegmann, Daniel; Trynka, Gosia; Gutierrez-Achury, Javier; Do, Ron; Voight, Benjamin F.; Kraft, Peter; Chen, Robert; Kallberg, Henrik J.; Kurreeman, Fina A. S.; Kathiresan, Sekar; Wijmenga, Cisca; Gregersen, Peter K.; Alfredsson, Lars; Siminovitch, Katherine A.; Worthington, Jane; de Bakker, Paul I. W.; Raychaudhuri, Soumya; Plenge, Robert M.		Diabet Genetics Replication Metaan; Myocardial Infarction Genetics Con	Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; CELIAC-DISEASE; GENETIC SUSCEPTIBILITY; MISSING HERITABILITY; HEART-DISEASE; HUMAN HEIGHT; COMMON SNPS; RISK LOCI; VARIANTS	The genetic architectures of common, complex diseases are largely uncharacterized. We modeled the genetic architecture underlying genome-wide association study (GWAS) data for rheumatoid arthritis and developed a new method using polygenic risk-score analyses to infer the total liability-scale variance explained by associated GWAS SNPs. Using this method, we estimated that, together, thousands of SNPs from rheumatoid arthritis GWAS explain an additional 20% of disease risk (excluding known associated loci). We further tested this method on datasets for three additional diseases and obtained comparable estimates for celiac disease (43% excluding the major histocompatibility complex), myocardial infarction and coronary artery disease (48%) and type 2 diabetes (49%). Our results are consistent with simulated genetic models in which hundreds of associated loci harbor common causal variants and a smaller number of loci harbor multiple rare causal variants. These analyses suggest that GWAS will continue to be highly productive for the discovery of additional susceptibility loci for common diseases.	[Stahl, Eli A.; Chen, Robert; Kurreeman, Fina A. S.; Raychaudhuri, Soumya; Plenge, Robert M.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Stahl, Eli A.; Do, Ron; Chen, Robert; Kurreeman, Fina A. S.; Kathiresan, Sekar; de Bakker, Paul I. W.; Raychaudhuri, Soumya; Plenge, Robert M.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Stahl, Eli A.; Chen, Robert; Kurreeman, Fina A. S.; de Bakker, Paul I. W.; Raychaudhuri, Soumya; Plenge, Robert M.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Wegmann, Daniel] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Trynka, Gosia; Gutierrez-Achury, Javier; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Trynka, Gosia; Gutierrez-Achury, Javier; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Do, Ron; Kathiresan, Sekar] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA USA; [Do, Ron; Kathiresan, Sekar] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, Boston, MA USA; [Voight, Benjamin F.] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Kallberg, Henrik J.; Alfredsson, Lars] Karolinska Inst Hosp Solna, Inst Environm Med, Stockholm, Sweden; [Gregersen, Peter K.] N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA; [Siminovitch, Katherine A.] Univ Toronto, Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Siminovitch, Katherine A.] Univ Hlth Network, Toronto, ON, Canada; [Worthington, Jane] Univ Manchester, Arthrit Res UK Epidemiol Unit, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Epidemiol, Utrecht, Netherlands	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; University of California System; University of California Los Angeles; University of Groningen; University of Groningen; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Harvard T.H. Chan School of Public Health; Karolinska Institutet; Northwell Health; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Manchester; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Stahl, EA (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.	estahl@rics.bwh.harvard.edu; rplenge@partners.org	Langenberg, Claudia/ABG-9067-2021; Wegmann, Daniel/K-2199-2012; Hide, Winston/R-3815-2019; Ramos, Rafel/D-9627-2016; Wijmenga, Cisca/D-2173-2009; Meitinger, Thomas/O-1318-2015; Benediktsson, Rafn/R-2457-2018; Boehm, Bernhard Otto/F-8750-2015; Siminovitch, Katherine/K-1475-2013; Walters, G. Bragi/L-4215-2013; Duga, Stefano/F-8173-2014; Hide, Winston Hide/C-7217-2009; Roden, Michael/AAD-3843-2019; Ramos, Rafel/P-2083-2019; Rudan, Igor/I-1467-2012; Wijmenga, Cisca/AAE-7719-2019; Elliott, Amanda/G-5120-2012; Worthington, Jane/M-9770-2014; de Bakker, Paul IW/B-8730-2009; FROGUEL, Philippe/O-6799-2017; Alfredsson, Lars/AAC-9007-2019; Hide, Winston A/V-2727-2017; Aulchenko, Yurii/M-8270-2013; Asselta, Rosanna/AAC-2367-2019	Langenberg, Claudia/0000-0002-5017-7344; Wegmann, Daniel/0000-0003-2866-6739; Hide, Winston/0000-0002-8621-3271; Ramos, Rafel/0000-0001-7970-5537; Benediktsson, Rafn/0000-0002-2954-9801; Walters, G. Bragi/0000-0002-5415-6487; Duga, Stefano/0000-0003-3457-1410; Hide, Winston Hide/0000-0002-8621-3271; Ramos, Rafel/0000-0001-7970-5537; Rudan, Igor/0000-0001-6993-6884; Wijmenga, Cisca/0000-0002-5635-1614; Worthington, Jane/0000-0003-0544-042X; de Bakker, Paul IW/0000-0001-7735-7858; FROGUEL, Philippe/0000-0003-2972-0784; Alfredsson, Lars/0000-0003-1688-6697; Hide, Winston A/0000-0002-8621-3271; Berzuini, Carlo/0000-0001-6056-0489; Lindgren, Cecilia/0000-0002-4903-9374; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153; Gloyn, Anna/0000-0003-1205-1844; Raychaudhuri, Soumya/0000-0002-1901-8265; Jorgensen, Torben/0000-0001-9453-2830; Weedon, Michael/0000-0002-6174-6135; Meitinger, Thomas/0000-0002-8838-8403; Aulchenko, Yurii/0000-0002-7899-1575; Voight, Benjamin/0000-0002-6205-9994; Trynka, Gosia/0000-0002-6955-9529; Gutierrez-Achury, Javier/0000-0002-4971-1474; Dina, Christian/0000-0002-7722-7348; Marrugat, Jaume/0000-0003-3320-554X; Asselta, Rosanna/0000-0001-5351-0619; Van Duijn, Cornelia/0000-0002-2374-9204; Melander, Olle/0000-0002-2581-484X; Hattersley, Andrew/0000-0001-5620-473X; Zeggini, Eleftheria/0000-0003-4238-659X	US National Institutes of Health (NIH) [R01-AR057108, R01-AR056768, U01-GM092691, R01-AR059648]; NIH [K08AR055688-01A1, NO1-AR-2-2263, RO1-AR44422]; Crescendo and Biogen-Idec; National Institute of Arthritis, Musculoskeletal and Skin Diseases of the NIH; Canada Research Chair; Canadian Institutes for Health Research [MOP79321, IIN-84042]; Ontario Research Fund [RE01061]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044422, K08AR055688, N01AR022263, R01AR056768, R01AR059648, R01AR057108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092691] Funding Source: NIH RePORTER; Medical Research Council [MC_U106179471] Funding Source: researchfish	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crescendo and Biogen-Idec; National Institute of Arthritis, Musculoskeletal and Skin Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	R.M.P. is supported by grants from the US National Institutes of Health (NIH) (R01-AR057108, R01-AR056768, U01-GM092691 and R01-AR059648) and holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. S. R. is supported by an NIH Career Development Award (K08AR055688-01A1). The Brigham Rheumatoid Arthritis Sequential Study Registry is supported by a grant from Crescendo and Biogen-Idec. The North American Rheumatoid Arthritis Consortium is supported by the NIH (NO1-AR-2-2263 and RO1-AR44422). This research was also supported in part by the Intramural Research Program of the National Institute of Arthritis, Musculoskeletal and Skin Diseases of the NIH and by a Canada Research Chair and grants to K. A. S. from the Canadian Institutes for Health Research (MOP79321 and IIN-84042) and the Ontario Research Fund (RE01061). We acknowledge S. Purcell, A. Price and N. Zaitlen for help with the design and implementation of the study and analysis.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Almgren P, 2011, DIABETOLOGIA, V54, P2811, DOI 10.1007/s00125-011-2267-5; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Bush WS, 2010, AM J HUM GENET, V86, P621, DOI 10.1016/j.ajhg.2010.02.027; Chen R, 2011, GENES IMMUN, V12, P314, DOI 10.1038/gene.2011.8; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Eijgelsheim M, 2010, HUM MOL GENET, V19, P3885, DOI 10.1093/hmg/ddq303; Eleftherohorinou H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008068; Falconer D. S, 1996, INTRO QUANTITATIVE G; Fisher R. A., 1918, PHILOS T ROYAL SOC E, V52, DOI DOI 10.1017/S0080456800012163; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Freudenberg J, 2010, HUM MOL GENET, V19, P3863, DOI 10.1093/hmg/ddq304; Hu XL, 2011, AM J HUM GENET, V89, P496, DOI 10.1016/j.ajhg.2011.09.002; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Leuenberger C, 2010, GENETICS, V184, P243, DOI 10.1534/genetics.109.109058; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Myocardial Infarction Genetics Consortium, 2009, NAT GENET, V41, P762; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nistico L, 2006, GUT, V55, P803, DOI 10.1136/gut.2005.083964; NORA JJ, 1980, CIRCULATION, V61, P503, DOI 10.1161/01.CIR.61.3.503; NORTON B, 1976, NOTES REC ROY SOC, V31, P151, DOI 10.1098/rsnr.1976.0005; Orozco G, 2010, HUM MOL GENET, V19, pR137, DOI 10.1093/hmg/ddq368; Painter JN, 2011, NAT GENET, V43, P51, DOI 10.1038/ng.731; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Park L, 2010, GENETICA, V138, P1147, DOI 10.1007/s10709-010-9505-5; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Pritchard JK, 2010, NAT REV GENET, V11, P665, DOI 10.1038/nrg2880; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Raychaudhuri S, 2010, CURR OPIN RHEUMATOL, V22, P109, DOI 10.1097/BOR.0b013e328336474d; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Spencer C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001337; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; van der Woude D, 2009, ARTHRITIS RHEUM-US, V60, P916, DOI 10.1002/art.24385; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang K, 2010, AM J HUM GENET, V86, P730, DOI 10.1016/j.ajhg.2010.04.003; Wegmann D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-116; Wei Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000678; Wheeler E, 2011, BRIEF FUNCT GENOMICS, V10, P52, DOI 10.1093/bfgp/elr008; Wray NR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000579; Xue W, 2011, NATURE, V473, P544, DOI 10.1038/nature09909; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	59	297	301	0	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2012	44	5					483	+		10.1038/ng.2232	http://dx.doi.org/10.1038/ng.2232			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	934BW	22446960	Green Accepted			2022-12-25	WOS:000303416300006
J	Willer, T; Lee, H; Lommel, M; Yoshida-Moriguchi, T; de Bernabe, DBV; Venzke, D; Cirak, S; Schachter, H; Vajsar, J; Voit, T; Muntoni, F; Loder, AS; Dobyns, WB; Winder, TL; Strahl, S; Mathews, KD; Nelson, SF; Moore, SA; Campbell, KP				Willer, Tobias; Lee, Hane; Lommel, Mark; Yoshida-Moriguchi, Takako; de Bernabe, Daniel Beltran Valero; Venzke, David; Cirak, Sebahattin; Schachter, Harry; Vajsar, Jiri; Voit, Thomas; Muntoni, Francesco; Loder, Andrea S.; Dobyns, William B.; Winder, Thomas L.; Strahl, Sabine; Mathews, Katherine D.; Nelson, Stanley F.; Moore, Steven A.; Campbell, Kevin P.			ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome	NATURE GENETICS			English	Article							CONGENITAL MUSCULAR-DYSTROPHIES; DNA-SEQUENCING DATA; ALPHA-DYSTROGLYCAN; POLYETHYLENE-GLYCOL; GENETIC-ANALYSIS; BIOSYNTHESIS; MEVALONATE; RECEPTOR; IDENTIFICATION; GLYCOSYLATION	Walker-Warburg syndrome (WWS) is clinically defined as congenital muscular dystrophy that is accompanied by a variety of brain and eye malformations. It represents the most severe clinical phenotype in a spectrum of diseases associated with abnormal post-translational processing of a-dystroglycan that share a defect in laminin-binding glycan synthesis(1). Although mutations in six genes have been identified as causes of WWS, only half of all individuals with the disease can currently be diagnosed on this basis(2). A cell fusion complementation assay in fibroblasts from undiagnosed individuals with WWS was used to identify five new complementation groups. Further evaluation of one group by linkage analysis and targeted sequencing identified recessive mutations in the ISPD gene (encoding isoprenoid synthase domain containing). The pathogenicity of the identified ISPD mutations was shown by complementation of fibroblasts with wild-type ISPD. Finally, we show that recessive mutations in ISPD abolish the initial step in laminin-binding glycan synthesis by disrupting dystroglycan O-mannosylation. This establishes a new mechanism for WWS pathophysiology.	[Willer, Tobias; Yoshida-Moriguchi, Takako; de Bernabe, Daniel Beltran Valero; Venzke, David; Campbell, Kevin P.] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Willer, Tobias; Yoshida-Moriguchi, Takako; de Bernabe, Daniel Beltran Valero; Venzke, David; Mathews, Katherine D.; Campbell, Kevin P.] Univ Iowa, Dept Neurol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Willer, Tobias; Yoshida-Moriguchi, Takako; de Bernabe, Daniel Beltran Valero; Venzke, David; Campbell, Kevin P.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Willer, Tobias; Yoshida-Moriguchi, Takako; de Bernabe, Daniel Beltran Valero; Venzke, David; Campbell, Kevin P.] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Lee, Hane; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Lee, Hane; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Lommel, Mark; Strahl, Sabine] Univ Heidelberg, Dept Cell Chem, Ctr Organismal Studies, Heidelberg, Germany; [Cirak, Sebahattin; Muntoni, Francesco] Inst Child Hlth, Dubowitz Neuromuscular Ctr, Div Neurosci, London, England; [Cirak, Sebahattin; Muntoni, Francesco] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Vajsar, Jiri] Hosp Sick Children, Div Neurol, Toronto, ON M5G 1X8, Canada; [Voit, Thomas] Univ Paris 06, INSERM U974, CNRS UMR 7215, AP HP,Inst Myol,UM 76, Paris, France; [Loder, Andrea S.] White Wilson Med Ctr, Ft Walton Beach, FL USA; [Dobyns, William B.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Winder, Thomas L.] PreventionGenetics, Marshfield, WI USA; [Mathews, Katherine D.] Univ Iowa, Dept Pediat, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Moore, Steven A.] Univ Iowa, Dept Pathol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Ruprecht Karls University Heidelberg; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Assistance Publique Hopitaux Paris (APHP); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Chicago; University of Iowa; University of Iowa	Campbell, KP (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	kevin-campbell@uiowa.edu	Lommel, Mark/E-3836-2014; Cirak, Sebahattin/AAX-9593-2020; Nelson, Stanley F/D-4771-2009; Cirak, Sebahattin/AAZ-6829-2020; Dobyns, William/AAI-2768-2020; Dobyns, William Brian/ABC-6525-2021	Nelson, Stanley F/0000-0002-2082-3114; Dobyns, William/0000-0002-7681-2844; Campbell, Kevin/0000-0003-2066-5889; Venzke, David/0000-0001-8180-9562; Lommel, Mark/0000-0001-6954-3714; mathews, katherine/0000-0003-4160-0435; Moore, Steven/0000-0002-6353-7900	US National Institutes of Health (NIH); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [P30 DK 54759]; Center for Duchenne Muscular Dystrophy; UCLA Muscular Dystrophy Core Center from NIH [5P30AR05723]; National Commission for Human Development (NICHD); Paul D. Wellstone Muscular Dystrophy Cooperative Research Center [1U54NS053672]; American Recovery and Reinvestment Act (ARRA) [1 RC2 NS069521-01]; NMD-Chip; Bio-NMD; Great Ormond Street Hospital Children's Charity; Rosetrees Trust [M145] Funding Source: researchfish; Muscular Dystrophy UK [RA4/0924, RA4/924] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS069521, U54NS053672] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for Duchenne Muscular Dystrophy; UCLA Muscular Dystrophy Core Center from NIH; National Commission for Human Development (NICHD); Paul D. Wellstone Muscular Dystrophy Cooperative Research Center; American Recovery and Reinvestment Act (ARRA); NMD-Chip; Bio-NMD; Great Ormond Street Hospital Children's Charity; Rosetrees Trust(Rosetrees Trust); Muscular Dystrophy UK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Gene Transfer Vector Core (University of Iowa, supported by the US National Institutes of Health (NIH) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (P30 DK 54759) for generating adenoviruses, T. Toy at the UCLA Clinical Genomics Center (see URLs) for assisting with construction of the sequencing libraries, S. Feng at the UCLA Broad Stem Cell Research Center (BSCRC) for assisting in running HiSeq2000 and B. Harry at the UCLA Clinical Genomics Center for maintaining the data analysis pipeline. Sequencing and sequence analysis were supported by the Center for Duchenne Muscular Dystrophy and the UCLA Muscular Dystrophy Core Center grant from the NIH (5P30AR05723). This study used fibroblast samples from the National Institute of Neurological Disorders and Stroke (NINDS) Cell Line Repository (see URLs) and the Miami Brain and Tissue Bank for Developmental Disorders, funded by the National Commission for Human Development (NICHD). We thank members of the Campbell laboratory and C. A. Campbell for fruitful discussions, A. Dietz, A. Crimmins, G. Morgensen, J. Eskuri, P. Guicheney and H. v. Bokhoven for technical support and C. Blaumueller for critical reading of the manuscript. This work was supported in part by a Paul D. Wellstone Muscular Dystrophy Cooperative Research Center Grant (1U54NS053672 to K. P. C., K. D. M., S. A. M. and T. W.) and an American Recovery and Reinvestment Act (ARRA) Go Grant (1 RC2 NS069521-01 to K. P. C. and T. W.). The Muscular Dystrophy Campaign Grant to F. M. is also gratefully acknowledged. S. C. and F. M. are investigators of and are supported by the European Framework Programme 7 (FP7) NMD-Chip and Bio-NMD projects. F. M. is supported by the Great Ormond Street Hospital Children's Charity. K. P. C. is an investigator of the Howard Hughes Medical Institute.	Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Clarke NF, 2011, EUR J HUM GENET, V19, P452, DOI 10.1038/ejhg.2010.212; DAVIDSON RL, 1976, SOMAT CELL GENET, V2, P165, DOI 10.1007/BF01542629; de Bernabe DBV, 2009, J BIOL CHEM, V284, P11279, DOI 10.1074/jbc.C900007200; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Kanoff RJ, 1998, PEDIATR NEUROL, V18, P76, DOI 10.1016/S0887-8994(97)00137-9; Kunz S, 2001, J CELL BIOL, V155, P301, DOI 10.1083/jcb.200104103; Kuzuyama T, 2002, BIOSCI BIOTECH BIOCH, V66, P1619, DOI 10.1271/bbb.66.1619; Lee H, 2008, HEADACHE, V48, P1460, DOI 10.1111/j.1526-4610.2007.01002.x; Lee H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-646; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lommel M, 2010, NEUROLOGY, V74, P157, DOI 10.1212/WNL.0b013e3181c919d6; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; MASSELOT M, 1975, MOL GEN GENET, V139, P121, DOI 10.1007/BF00264692; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Miziorko HM, 2011, ARCH BIOCHEM BIOPHYS, V505, P131, DOI 10.1016/j.abb.2010.09.028; PONTECORVO G, 1977, NATURE, V265, P257, DOI 10.1038/265257a0; Richard SB, 2001, NAT STRUCT BIOL, V8, P641, DOI 10.1038/89691; Satz JS, 2008, J NEUROSCI, V28, P10567, DOI 10.1523/JNEUROSCI.2457-08.2008; SHARP AH, 1989, J BIOL CHEM, V264, P2816; Skorupinska-Tudek K, 2008, J BIOL CHEM, V283, P21024, DOI 10.1074/jbc.M706069200; STANLEY P, 1985, MOL CELL BIOL, V5, P923, DOI 10.1128/MCB.5.5.923; Surmacz L, 2011, BIOCHEM BIOPH RES CO, V407, P627, DOI 10.1016/j.bbrc.2011.03.059; Vajsar J, 2000, PEDIATR NEUROL, V22, P139, DOI 10.1016/S0887-8994(99)00129-0; Vajsar J, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-29; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	33	163	166	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2012	44	5					575	+		10.1038/ng.2252	http://dx.doi.org/10.1038/ng.2252			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	934BW	22522420	Green Accepted			2022-12-25	WOS:000303416300019
J	Chiang, C; Jacobsen, JC; Ernst, C; Hanscom, C; Heilbut, A; Blumenthal, I; Mills, RE; Kirby, A; Lindgren, AM; Rudiger, SR; McLaughlan, CJ; Bawden, CS; Reid, SJ; Faull, RLM; Snell, RG; Hall, IM; Shen, YP; Ohsumi, TK; Borowsky, ML; Daly, MJ; Lee, C; Morton, CC; MacDonald, ME; Gusella, JF; Talkowski, ME				Chiang, Colby; Jacobsen, Jessie C.; Ernst, Carl; Hanscom, Carrie; Heilbut, Adrian; Blumenthal, Ian; Mills, Ryan E.; Kirby, Andrew; Lindgren, Amelia M.; Rudiger, Skye R.; McLaughlan, Clive J.; Bawden, C. Simon; Reid, Suzanne J.; Faull, Richard L. M.; Snell, Russell G.; Hall, Ira M.; Shen, Yiping; Ohsumi, Toshiro K.; Borowsky, Mark L.; Daly, Mark J.; Lee, Charles; Morton, Cynthia C.; MacDonald, Marcy E.; Gusella, James F.; Talkowski, Michael E.			Complex reorganization and predominant non-homologous repair following chromosomal breakage in karyotypically balanced germline rearrangements and transgenic integration	NATURE GENETICS			English	Article							B DNA CONFORMATIONS; HUMAN GENOME; STRUCTURAL VARIATION; CANCER; MECHANISMS; DISEASE; CHROMOTHRIPSIS; MUTAGENESIS	We defined the genetic landscape of balanced chromosomal rearrangements at nucleotide resolution by sequencing 141 breakpoints from cytogenetically interpreted translocations and inversions. We confirm that the recently described phenomenon of 'chromothripsis' (massive chromosomal shattering and reorganization) is not unique to cancer cells but also occurs in the germline, where it can resolve to a relatively balanced state with frequent inversions. We detected a high incidence of complex rearrangements (19.2%) and substantially less reliance on microhomology (31%) than previously observed in benign copy-number variants (CNVs). We compared these results to experimentally generated DNA breakage-repair by sequencing seven transgenic animals, revealing extensive rearrangement of the transgene and host genome with similar complexity to human germline alterations. Inversion was the most common rearrangement, suggesting that a combined mechanism involving template switching and non-homologous repair mediates the formation of balanced complex rearrangements that are viable, stably replicated and transmitted unaltered to subsequent generations.	[Chiang, Colby; Jacobsen, Jessie C.; Ernst, Carl; Hanscom, Carrie; Heilbut, Adrian; Blumenthal, Ian; Kirby, Andrew; Shen, Yiping; Daly, Mark J.; MacDonald, Marcy E.; Gusella, James F.; Talkowski, Michael E.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Jacobsen, Jessie C.; Ernst, Carl; MacDonald, Marcy E.; Gusella, James F.; Talkowski, Michael E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Jacobsen, Jessie C.; Ernst, Carl; MacDonald, Marcy E.; Gusella, James F.; Talkowski, Michael E.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Mills, Ryan E.; Lindgren, Amelia M.; Lee, Charles; Morton, Cynthia C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Kirby, Andrew; Daly, Mark J.; Morton, Cynthia C.; MacDonald, Marcy E.; Gusella, James F.; Talkowski, Michael E.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Rudiger, Skye R.; McLaughlan, Clive J.; Bawden, C. Simon] S Australian Res & Dev Inst, Livestock & Farming Syst Div, Mol Biol Lab, Roseworthy, SA, Australia; [Rudiger, Skye R.; McLaughlan, Clive J.; Bawden, C. Simon] S Australian Res & Dev Inst, Livestock & Farming Syst Div, Reprod Technol Lab, Roseworthy, SA, Australia; [Reid, Suzanne J.; Faull, Richard L. M.; Snell, Russell G.] Univ Auckland, Ctr Brain Res, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Reid, Suzanne J.; Snell, Russell G.] Univ Auckland, Fac Sci, Sch Biol Sci, Auckland 1, New Zealand; [Faull, Richard L. M.] Univ Auckland, Dept Anat Radiol, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Hall, Ira M.] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Shen, Yiping] Childrens Hosp Boston, Dept Lab Med, Boston, MA USA; [Ohsumi, Toshiro K.; Borowsky, Mark L.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Morton, Cynthia C.] Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Auckland; University of Auckland; University of Auckland; University of Virginia; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Talkowski, ME (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	talkowski@chgr.mgh.harvard.edu	Heilbut, Adrian M/J-9427-2012; Mills, Ryan/F-4225-2010; Reid, Suzanne/H-7082-2012; Daly, Mark J/B-2453-2017	Heilbut, Adrian M/0000-0002-8169-7967; Mills, Ryan/0000-0003-3425-6998; Daly, Mark J/0000-0002-0949-8752; Chiang, Colby/0000-0002-4113-6065; Snell, Russell/0000-0002-8166-4014; Talkowski, Michael/0000-0003-2889-0992; Faull, Richard/0000-0003-3385-9498; Reid, Suzanne/0000-0002-8068-6529	US National Institutes of Health [GM061354, HD065286, MH087123, NS32765, NS16367]; Simons Foundation Autism Research Initiative; Autism Speaks; CHDI Foundation; Neurological Foundation of New Zealand; Canadian Institute for Health Research (CIHR); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD065286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH087123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS016367, R01NS032765, P01NS016367] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation Autism Research Initiative; Autism Speaks; CHDI Foundation; Neurological Foundation of New Zealand; Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all study participants, their families and the referring clinicians for their invaluable contributions. We thank T. Gillis, M.A. Anderson, W. Varney, J. Ruliera, T. Henderson, C. Zhang, L. Griffin, The Genomics Core of the Massachusetts General Hospital Center for Human Genetic Research, the Genome Sequencing Platform at the Broad Institute and the Partners Center for Personalized Genomic Medicine for technical assistance. We thank M. Sun for performing the multiplex ligation-dependent probe amplification (MLPA) experiments. We also thank the Partners Research Computing at Massachusetts General Hospital. This work was funded by grants from the US National Institutes of Health (GM061354, HD065286, MH087123, NS32765 and NS16367), the Simons Foundation Autism Research Initiative, Autism Speaks and the CHDI Foundation. J.C.J. was the recipient of the Philip Wrightson Fellowship of the Neurological Foundation of New Zealand, C.E. received a Bisby Fellowship from the Canadian Institute for Health Research (CIHR).	Arlt MF, 2011, GENETICS, V187, P675, DOI 10.1534/genetics.110.124776; Astbury C, 2004, HUM GENET, V114, P448, DOI 10.1007/s00439-003-1079-1; Bacolla A, 2009, MOL CARCINOGEN, V48, P273, DOI 10.1002/mc.20507; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Conrad DF, 2010, NAT GENET, V42, P385, DOI 10.1038/ng.564; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; De Gregori M, 2007, J MED GENET, V44, P750, DOI 10.1136/jmg.2007.052787; Giardino D, 2009, PRENATAL DIAG, V29, P257, DOI 10.1002/pd.2215; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Higgins AW, 2008, AM J HUM GENET, V82, P712, DOI 10.1016/j.ajhg.2008.01.011; Iliakis G, 2004, CYTOGENET GENOME RES, V104, P14, DOI 10.1159/000077461; Jacobsen JC, 2010, HUM MOL GENET, V19, P1873, DOI 10.1093/hmg/ddq063; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kidd JM, 2010, CELL, V143, P837, DOI 10.1016/j.cell.2010.10.027; Kloosterman WP, 2011, HUM MOL GENET, V20, P1916, DOI 10.1093/hmg/ddr073; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lam HYK, 2010, NAT BIOTECHNOL, V28, P47, DOI 10.1038/nbt.1600; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Magrangeas F, 2011, BLOOD, V118, P675, DOI 10.1182/blood-2011-03-344069; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Ou Z, 2011, GENOME RES, V21, P33, DOI 10.1101/gr.111609.110; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Talkowski ME, 2011, AM J HUM GENET, V89, P551, DOI 10.1016/j.ajhg.2011.09.011; Talkowski ME, 2011, AM J HUM GENET, V88, P469, DOI 10.1016/j.ajhg.2011.03.013; Vanneste E, 2009, HUM REPROD, V24, P2679, DOI 10.1093/humrep/dep266; Wells RD, 2007, TRENDS BIOCHEM SCI, V32, P271, DOI 10.1016/j.tibs.2007.04.003; Wurtele H, 2003, GENE THER, V10, P1791, DOI 10.1038/sj.gt.3302074; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang F, 2009, TRENDS GENET, V25, P298, DOI 10.1016/j.tig.2009.05.005	41	173	173	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2012	44	4					390	U195		10.1038/ng.2202	http://dx.doi.org/10.1038/ng.2202			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	916VF	22388000	Green Accepted, Green Submitted			2022-12-25	WOS:000302130600012
J	Zhou, H; Gao, ZZ; Qiao, KJ; Wang, JJ; Vederas, JC; Tang, Y				Zhou, Hui; Gao, Zhizeng; Qiao, Kangjian; Wang, Jingjing; Vederas, John C.; Tang, Yi			A fungal ketoreductase domain that displays substrate-dependent stereospecificity	NATURE CHEMICAL BIOLOGY			English	Article							MODULAR POLYKETIDE SYNTHASES; SHORT-CHAIN DEHYDROGENASES/REDUCTASES; FATTY-ACID; CATALYSIS; BIOSYNTHESIS; STEREOCHEMISTRY; HYPOTHEMYCIN; MUTAGENESIS; RESIDUES; GENES	Iterative highly reducing polyketide synthases from filamentous fungi are the most complex and enigmatic type of polyketide synthase discovered to date. Here we uncover an unusual degree of programming by the hypothemycin highly reducing polyketide synthase, in which a single ketoreductase domain shows stereospecificity that is controlled by substrate length. Mapping of the structural domains responsible for this feature allowed for the biosynthesis of an unnatural diastereomer of the natural product dehydrozearalenol.	[Zhou, Hui; Qiao, Kangjian; Wang, Jingjing; Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90024 USA; [Gao, Zhizeng; Vederas, John C.] Univ Alberta, Dept Chem, Edmonton, AB, Canada; [Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of Alberta; University of California System; University of California Los Angeles	Zhou, H (corresponding author), Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90024 USA.	john.vederas@ualberta.ca; yitang@ucla.edu	wang, jing/GRS-7509-2022; Gao, Zhizeng/E-2963-2019	Vederas, John/0000-0002-2996-0326; Gao, Zhizeng/0000-0002-8176-0727	US National Institutes of Health [1R01GM085128]; Natural Sciences and Engineering Research Council of Canada; Canada Research Chair in Bioorganic and Medicinal Chemistry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085128] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair in Bioorganic and Medicinal Chemistry(Canada Research Chairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health grant 1R01GM085128 to Y.T., the Natural Sciences and Engineering Research Council of Canada and the Canada Research Chair in Bioorganic and Medicinal Chemistry to J.C.V. We thank C. Reeves (Amyris Inc.) for the hpm genes.	Baerga-Ortiz A, 2006, CHEM BIOL, V13, P277, DOI 10.1016/j.chembiol.2006.01.004; Caffrey P, 2003, CHEMBIOCHEM, V4, P654, DOI 10.1002/cbic.200300581; Castonguay R, 2008, J AM CHEM SOC, V130, P11598, DOI 10.1021/ja804453p; Castonguay R, 2007, J AM CHEM SOC, V129, P13758, DOI 10.1021/ja0753290; CELMER WD, 1965, J AM CHEM SOC, V87, P1801, DOI 10.1021/ja01086a038; Cox RJ, 2007, ORG BIOMOL CHEM, V5, P2010, DOI 10.1039/b704420h; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Fisch KM, 2011, J AM CHEM SOC, V133, P16635, DOI 10.1021/ja206914q; HAGLER WM, 1979, APPL ENVIRON MICROB, V37, P849, DOI 10.1128/AEM.37.5.849-853.1979; Keatinge-Clay AT, 2007, CHEM BIOL, V14, P898, DOI 10.1016/j.chembiol.2007.07.009; Keatinge-Clay AT, 2006, STRUCTURE, V14, P737, DOI 10.1016/j.str.2006.01.009; Ma SM, 2009, SCIENCE, V326, P589, DOI 10.1126/science.1175602; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Meier JL, 2009, CHEM SOC REV, V38, P2012, DOI 10.1039/b805115c; O'Hare HM, 2006, CHEM BIOL, V13, P287, DOI 10.1016/j.chembiol.2006.01.003; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Reeves CD, 2008, APPL ENVIRON MICROB, V74, P5121, DOI 10.1128/AEM.00478-08; Reid R, 2003, BIOCHEMISTRY-US, V42, P72, DOI 10.1021/bi0268706; ROSSMANN MG, 1981, ANNU REV BIOCHEM, V50, P497, DOI 10.1146/annurev.bi.50.070181.002433; Siskos AP, 2005, CHEM BIOL, V12, P1145, DOI 10.1016/j.chembiol.2005.08.017; Smith S, 2007, NAT PROD REP, V24, P1041, DOI 10.1039/b603600g; Valenzano CR, 2009, J AM CHEM SOC, V131, P18501, DOI 10.1021/ja908296m; Weissman KJ, 2005, NAT REV MICROBIOL, V3, P925, DOI 10.1038/nrmicro1287; Zheng JT, 2010, STRUCTURE, V18, P913, DOI 10.1016/j.str.2010.04.015; Zhou H, 2010, J AM CHEM SOC, V132, P4530, DOI 10.1021/ja100060k	25	61	64	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2012	8	4					331	333		10.1038/NCHEMBIO.912	http://dx.doi.org/10.1038/NCHEMBIO.912			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	913PO	22406519	Green Accepted			2022-12-25	WOS:000301890100006
J	Lassar, A				Lassar, Andrew			Finding MyoD with a little help from my friends	NATURE CELL BIOLOGY			English	Editorial Material									Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Lassar, A (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	andrew_lassar@hms.harvard.edu							0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2012	14	2					116	116		10.1038/ncb2421	http://dx.doi.org/10.1038/ncb2421			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	893CF	22298038	Bronze			2022-12-25	WOS:000300332500002
J	Schonhoft, JD; Stivers, JT				Schonhoft, Joseph D.; Stivers, James T.			Timing facilitated site transfer of an enzyme on DNA	NATURE CHEMICAL BIOLOGY			English	Article							ONE-DIMENSIONAL DIFFUSION; DAMAGED DNA; REPAIR; GLYCOSYLASE; PROTEIN; SEARCH; URACIL; RECOGNITION; BINDING; TRANSLOCATION	Many enzymes that react with specific sites in DNA have the property of facilitated diffusion, in which the DNA chain is used as a conduit to accelerate site location. Despite the importance of such mechanisms in gene regulation and DNA repair, there have been few viable approaches to elucidate the microscopic process of facilitated diffusion. Here we describe a new method in which a small-molecule trap (uracil) is used to clock a DNA repair enzyme as it hops and slides between damaged sites in DNA. The 'molecular clock' provides unprecedented information: the mean length for DNA sliding, the one-dimensional diffusion constant, the maximum hopping radius and the time frame for DNA hopping events. In addition, the data establish that the DNA phosphate backbone is a sufficient requirement for DNA sliding.	[Schonhoft, Joseph D.; Stivers, James T.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Johns Hopkins University	Stivers, JT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	jstivers@jhmi.edu	Schonhoft, Joseph/C-1797-2013	Schonhoft, Joseph/0000-0002-5860-5040	US National Institutes of Health [GM056834]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056834] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Parker (Harvard Medical School) for purified hUNG used in this study. This work was supported by US National Institutes of Health grant GM056834.	AMYES TL, 1989, J AM CHEM SOC, V111, P7888, DOI 10.1021/ja00202a033; Bagchi B, 2008, J PHYS CHEM B, V112, P6282, DOI 10.1021/jp077568f; Belotserkovskii BP, 2004, J THEOR BIOL, V226, P195, DOI 10.1016/j.jtbi.2003.08.013; Berg, 2018, RANDOM WALKS BIOL; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Blainey PC, 2009, NAT STRUCT MOL BIOL, V16, P1224, DOI 10.1038/nsmb.1716; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Cao CY, 2004, NAT STRUCT MOL BIOL, V11, P1230, DOI 10.1038/nsmb864; DOWD DR, 1989, BIOCHEMISTRY-US, V28, P8699, DOI 10.1021/bi00448a005; Dunn AR, 2011, NUCLEIC ACIDS RES, V39, P7487, DOI 10.1093/nar/gkr459; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; FISHBEIN JC, 1988, J AM CHEM SOC, V110, P5075, DOI 10.1021/ja00223a028; Friedman JI, 2009, NUCLEIC ACIDS RES, V37, P3493, DOI 10.1093/nar/gkp161; Gorman J, 2007, MOL CELL, V28, P359, DOI 10.1016/j.molcel.2007.09.008; Gorman J, 2010, NAT STRUCT MOL BIOL, V17, P932, DOI 10.1038/nsmb.1858; Gowers DM, 2005, P NATL ACAD SCI USA, V102, P15883, DOI 10.1073/pnas.0505378102; GRILLER D, 1980, ACCOUNTS CHEM RES, V13, P317, DOI 10.1021/ar50153a004; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Hedglin M, 2008, BIOCHEMISTRY-US, V47, P11434, DOI 10.1021/bi801046y; Hedglin M, 2010, ACS CHEM BIOL, V5, P427, DOI 10.1021/cb1000185; Jiang YL, 2005, J AM CHEM SOC, V127, P17412, DOI 10.1021/ja055846n; Kad NM, 2010, MOL CELL, V37, P702, DOI 10.1016/j.molcel.2010.02.003; Kampmann M, 2004, J BIOL CHEM, V279, P38715, DOI 10.1074/jbc.M404504200; Komazin-Meredith G, 2008, P NATL ACAD SCI USA, V105, P10721, DOI 10.1073/pnas.0802676105; Krosky DJ, 2005, BIOCHEMISTRY-US, V44, P5949, DOI 10.1021/bi050084u; Kuznetsov NA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P118, DOI 10.1134/S0006297911010123; Kuznetsov NA, 2007, J BIOL CHEM, V282, P1029, DOI 10.1074/jbc.M605788200; Maul RW, 2010, ADV IMMUNOL, V105, P159, DOI 10.1016/S0065-2776(10)05006-6; NISHIDA K, 1983, COLLOID POLYM SCI, V261, P70, DOI 10.1007/BF01411520; Parker JB, 2007, NATURE, V449, P433, DOI 10.1038/nature06131; Parker JB, 2011, BIOCHEMISTRY-US, V50, P612, DOI 10.1021/bi101536k; Porecha RH, 2008, P NATL ACAD SCI USA, V105, P10791, DOI 10.1073/pnas.0801612105; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; SCHURR JM, 1979, BIOPHYS CHEM, V9, P413, DOI 10.1016/0301-4622(75)80057-3; Sidorenko VS, 2008, BIOCHEMISTRY-US, V47, P8970, DOI 10.1021/bi800569e; Stanford NP, 2000, EMBO J, V19, P6546, DOI 10.1093/emboj/19.23.6546; Tafvizi A, 2011, P NATL ACAD SCI USA, V108, P563, DOI 10.1073/pnas.1016020107; TERRY BJ, 1985, J BIOL CHEM, V260, P3130; Wang YM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.048302; Wang YM, 2011, BIOL MED PHYS BIOMED, P9, DOI 10.1007/978-0-387-92808-1_2; Xiao GY, 1999, PROTEINS, V35, P13; Young MA, 1997, BIOPHYS J, V73, P2313, DOI 10.1016/S0006-3495(97)78263-8; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	44	62	63	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2012	8	2					205	210		10.1038/nchembio.764	http://dx.doi.org/10.1038/nchembio.764			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879IP	22231272	Green Accepted, Green Submitted			2022-12-25	WOS:000299323200013
J	Hoetzenecker, W; Echtenacher, B; Guenova, E; Hoetzenecker, K; Woelbing, F; Bruck, J; Teske, A; Valtcheva, N; Fuchs, K; Kneilling, M; Park, JH; Kim, KH; Kim, KW; Hoffmann, P; Krenn, C; Hai, T; Ghoreschi, K; Biederman, T; Rocken, M				Hoetzenecker, Wolfram; Echtenacher, Bernd; Guenova, Emmanuella; Hoetzenecker, Konrad; Woelbing, Florian; Brueck, Juergen; Teske, Anna; Valtcheva, Nadejda; Fuchs, Kerstin; Kneilling, Manfred; Park, Ji-Hyeon; Kim, Kyu-Han; Kim, Kyu-Won; Hoffmann, Petra; Krenn, Claus; Hai, Tsonwin; Ghoreschi, Kamran; Biederman, Tilo; Roecken, Martin			ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression	NATURE MEDICINE			English	Article							ACTIVATING TRANSCRIPTION FACTOR-3; OXIDATIVE STRESS; MONOCLONAL-ANTIBODY; NEGATIVE REGULATOR; GENETIC-CONTROL; PROTECTS MICE; SEPTIC SHOCK; DOUBLE-BLIND; GLUTATHIONE; INFLAMMATION	Sepsis, sepsis-induced hyperinflammation and subsequent sepsis-associated immunosuppression (SAIS) are important causes of death. Here we show in humans that the loss of the major reactive oxygen species (ROS) scavenger, glutathione (GSH), during SAIS directly correlates with an increase in the expression of activating transcription factor 3 (ATF3). In endotoxin-stimulated monocytes, ROS stress strongly superinduced NF-E2-related factor 2 (NRF2)-dependent ATF3. In vivo, this ROS-mediated superinduction of ATF3 protected against endotoxic shock by inhibiting innate cytokines, as Atf3(-/-) mice remained susceptible to endotoxic shock even under conditions of ROS stress. Although it protected against endotoxic shock, this ROS-mediated superinduction of ATF3 caused high susceptibility to bacterial and fungal infections through the suppression of interleukin 6 (IL-6). As a result, Atf3(-/-) mice were protected against bacterial and fungal infections, even under conditions of ROS stress, whereas Atf3(-/-)ll6(-/-) mice were highly susceptible to these infections. Moreover, in a model of SAIS, secondary infections caused considerably less mortality in Atf3(-/-) mice than in wild-type mice, indicating that ROS-induced ATF3 crucially determines susceptibility to secondary infections during SAIS.	[Hoetzenecker, Wolfram; Guenova, Emmanuella; Woelbing, Florian; Brueck, Juergen; Teske, Anna; Fuchs, Kerstin; Kneilling, Manfred; Ghoreschi, Kamran; Biederman, Tilo; Roecken, Martin] Univ Tubingen, Univ Med Ctr, Dept Dermatol, Tubingen, Germany; [Echtenacher, Bernd] Univ Regensburg, Inst Immunol, Regensburg, Germany; [Hoetzenecker, Konrad] Med Univ Vienna, Dept Surg, Vienna, Austria; [Valtcheva, Nadejda] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland; [Fuchs, Kerstin; Kneilling, Manfred] Univ Tubingen, Univ Med Ctr, Dept Preclin Imaging & Radiopharm, Lab Preclin Imaging & Imaging Technol,Werner Siem, Tubingen, Germany; [Park, Ji-Hyeon; Kim, Kyu-Han; Kim, Kyu-Won] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea; [Park, Ji-Hyeon; Kim, Kyu-Han; Kim, Kyu-Won] Seoul Natl Univ, NeuroVasc Coordinat Res Ctr, Coll Pharm, Seoul, South Korea; [Kim, Kyu-Won] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Hoffmann, Petra] Univ Hosp Regensburg, Dept Haematol & Oncol, Regensburg, Germany; [Krenn, Claus] Med Univ Vienna, Dept Anaesthesia & Gen Intens Care, Vienna, Austria; [Hai, Tsonwin] Ohio State Univ, Neurobiotechnol Ctr, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Regensburg; Medical University of Vienna; Swiss Federal Institutes of Technology Domain; ETH Zurich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); University of Regensburg; Medical University of Vienna; University System of Ohio; Ohio State University	Rocken, M (corresponding author), Univ Tubingen, Univ Med Ctr, Dept Dermatol, Tubingen, Germany.	tilo.biedermann@med.uni-tuebingen.de; mrocken@med.uni-tuebingen.de	Hai, Tsonwin/E-3185-2011; Textoris, Julien/H-3317-2019; Kim, Kyu Won/AAJ-7213-2020; Friggeri, Arnaud/AAE-7644-2020; Guenova, Emmanuella/G-7441-2017	Hai, Tsonwin/0000-0003-4510-0315; Textoris, Julien/0000-0002-3821-9337; Friggeri, Arnaud/0000-0003-4687-2173; Guenova, Emmanuella/0000-0001-5478-8735; Hoetzenecker, Konrad/0000-0001-6775-7460; Ghoreschi, Kamran/0000-0002-5526-7517; Rocken, Martin/0000-0003-3795-7001; Biedermann, Tilo/0000-0002-5352-5105	Sander Stiftung [2005.043.2, 2005.043.3]; Deutsche Krebshilfe [109037]; Deutsche Forschungsgemeinschaft [SFB 685 A6, SFB 685 C1, Bi 696/3-3, Bi 696/5-1]; German Federal Ministry of Education and Research [BMBF FKZ 0315079, DLR 01GN0970]; University of Tuebingen [f-33654-87, f-1803-0-0]; European Union [FP7-HEALTH-2007-2.4.4-1 200515]; German Dermatologic Society/Arbeitsgemeinschaft Dermatologische Forschung; National Research Foundation of Korea; Ministry of Education, Science and Technology through the Creative Research Initiative [R16-2004-001010010]; World Class University [R31-2008-000-10103-0]; NATIONAL CANCER INSTITUTE [R01CA118306] Funding Source: NIH RePORTER	Sander Stiftung; Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); University of Tuebingen; European Union(European Commission); German Dermatologic Society/Arbeitsgemeinschaft Dermatologische Forschung; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology through the Creative Research Initiative; World Class University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank B. Pichler, N. Suttorp, T. Welte, S. Werner and P. Dotto for helpful discussions, and for reviewing the manuscript, and M. Haberbosch and S. Hemberger for technical assistance. S. Werner (Eidgenossische Technische Hochschule Zurich) provided the Nrf2<SUP>-/-</SUP> (Nfe2l2<SUP>tm1Ywk</SUP>) mice<SUP>25</SUP> with the permission of J.A. Johnson (University of California, San Francisco). This work has been supported by grants from the Sander Stiftung (2005.043.2 and 2005.043.3), Deutsche Krebshilfe (no. 109037), Deutsche Forschungsgemeinschaft (SFB 685 A6 and C1, Bi 696/3-3, Bi 696/5-1), German Federal Ministry of Education and Research (BMBF FKZ 0315079 to KG., DLR 01GN0970 to M.R.), University of Tuebingen (W.H., f-33654-87; E.G., f-1803-0-0; K.G. and M.R., IZKF-Tuebingen, collaborative research program), European Union FP7-HEALTH-2007-2.4.4-1 200515 (M.R.), The German Dermatologic Society/Arbeitsgemeinschaft Dermatologische Forschung (W.H.), a National Research Foundation of Korea grant that was funded by the Ministry of Education, Science and Technology through the Creative Research Initiative Program (grant R16-2004-001010010,2010) and a World Class University grant (no. R31-2008-000-10103-0).	ABRAHAM E, 1995, JAMA-J AM MED ASSOC, V273, P934, DOI 10.1001/jama.273.12.934; Akram A, 2010, AM J RESP CRIT CARE, V182, P489, DOI 10.1164/rccm.200906-0925OC; Alves JC, 2010, NAT MED, V16, P708, DOI 10.1038/nm.2156; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; [Anonymous], 2009, CHEST; Benjamim CF, 2003, AM J PATHOL, V163, P2605, DOI 10.1016/S0002-9440(10)63615-2; Benjamin CF, 2004, J LEUKOCYTE BIOL, V75, P408, DOI 10.1189/jlb.0503214; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; Biolo G, 2007, CRIT CARE MED, V35, pS591, DOI 10.1097/01.CCM.0000278913.19123.13; BONE RC, 1987, NEW ENGL J MED, V317, P653, DOI 10.1056/NEJM198709103171101; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Deng JC, 2006, J CLIN INVEST, V116, P2532, DOI 10.1172/JCI28054; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; FATTORI E, 1994, J EXP MED, V180, P1243, DOI 10.1084/jem.180.4.1243; Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603; FISHER CJ, 1994, CRIT CARE MED, V22, P12, DOI 10.1097/00003246-199401000-00008; Flaring UB, 2009, CLIN SCI, V117, P313, DOI 10.1042/CS20080462; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gilchrist M, 2008, J EXP MED, V205, P2349, DOI 10.1084/jem.20072254; Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006; Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214; Hai T, 1999, GENE EXPRESSION, V7, P321; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Hoogerwerf JJ, 2011, AM J RESP CRIT CARE, V183, P932, DOI 10.1164/rccm.201006-0934OC; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kim KH, 2010, NUCLEIC ACIDS RES, V38, P48, DOI 10.1093/nar/gkp865; Kneilling M, 2007, ARTHRITIS RHEUM, V56, P1806, DOI 10.1002/art.22602; Kobold ACM, 2000, INTENS CARE MED, V26, P883, DOI 10.1007/s001340051277; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Li HF, 2010, J AM SOC NEPHROL, V21, P1003, DOI 10.1681/ASN.2009070690; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; OBRIEN AD, 1980, J IMMUNOL, V124, P20; Ortolani O, 2000, AM J RESP CRIT CARE, V161, P1907, DOI 10.1164/ajrccm.161.6.9903043; Osuchowski MF, 2006, J IMMUNOL, V177, P1967, DOI 10.4049/jimmunol.177.3.1967; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Rosenberger CM, 2008, P NATL ACAD SCI USA, V105, P2544, DOI 10.1073/pnas.0712182105; Steinhauser ME, 1999, J IMMUNOL, V162, P392; SULTZER BM, 1968, NATURE, V219, P1253, DOI 10.1038/2191253a0; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Villa P, 2002, J INFECT DIS, V185, P1115, DOI 10.1086/340042; Vincent JL, 2003, INTENS CARE MED, V29, pS74; Ward NS, 2008, CLIN CHEST MED, V29, P617, DOI 10.1016/j.ccm.2008.06.010; Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622; ZIEGLER EJ, 1991, NEW ENGL J MED, V324, P429, DOI 10.1056/NEJM199102143240701	51	135	136	2	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					128	134		10.1038/nm.2557	http://dx.doi.org/10.1038/nm.2557			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22179317	Green Accepted			2022-12-25	WOS:000299018600038
J	Chaturvedi, KS; Hung, CS; Crowley, JR; Stapleton, AE; Henderson, JP				Chaturvedi, Kaveri S.; Hung, Chia S.; Crowley, Jan R.; Stapleton, Ann E.; Henderson, Jeffrey P.			The siderophore yersiniabactin binds copper to protect pathogens during infection	NATURE CHEMICAL BIOLOGY			English	Article							URINARY-TRACT-INFECTION; ESCHERICHIA-COLI; IRON ACQUISITION; PSEUDOMONAS-AERUGINOSA; ESCHETICHIA-COLI; METHANOBACTIN; VIRULENCE; MECHANISMS; TOXICITY; RESISTANCE	Bacterial pathogens secrete chemically diverse iron chelators called siderophores, which may exert additional distinctive functions in vivo. Among these, uropathogenic Escherichia coli often coexpress the virulence-associated siderophore yersiniabactin (Ybt) with catecholate siderophores. Here we used a new MS screening approach to reveal that Ybt is also a physiologically favorable Cu(II) ligand. Direct MS detection of the resulting Cu(II)-Ybt complex in mice and humans with E. coli urinary tract infections demonstrates copper binding to be a physiologically relevant in vivo interaction during infection. Ybt expression corresponded to higher copper resistance among human urinary tract isolates, suggesting a protective role for this interaction. Chemical and genetic characterization showed that Ybt helps bacteria resist copper toxicity by sequestering host-derived Cu(II) and preventing its catechol-mediated reduction to Cu(I). Together, these studies reveal a new virulence-associated function for Ybt that is distinct from iron binding.	[Chaturvedi, Kaveri S.; Hung, Chia S.; Henderson, Jeffrey P.] Washington Univ, Sch Med, Ctr Womens Infect Dis Res, St Louis, MO 63130 USA; [Chaturvedi, Kaveri S.; Hung, Chia S.; Henderson, Jeffrey P.] Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA; [Chaturvedi, Kaveri S.; Hung, Chia S.; Crowley, Jan R.; Henderson, Jeffrey P.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Stapleton, Ann E.] Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle	Henderson, JP (corresponding author), Washington Univ, Sch Med, Ctr Womens Infect Dis Res, St Louis, MO 63130 USA.	jhenderson@dom.wustl.edu	Stapleton, Ann E/N-2428-2015; Henderson, Jeffrey P/D-3337-2015; Hung, Chia-Suei/G-6167-2010	Stapleton, Ann E/0000-0003-0130-8659; Hung, Chia-Suei/0000-0001-9844-9954	Burroughs-Wellcome Fund; US National Institutes of Health [K12 HD001459-09, AI 07172-24, P30 HL101263-01, P50 DK64540, U01 DK082315, UL1 RR024992];  [P41-RR00954];  [8-P41 GM103422-35];  [P60-DK20579];  [P30-DK56341]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001459] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954, UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P30HL101263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088830, U01DK082315, P60DK020579, R01DK070906, P50DK064540, P30DK056341, P01DK053369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER	Burroughs-Wellcome Fund(Burroughs Wellcome Fund); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank M. Gross, H. Rohrs and Y. Zhang for high-resolution MS analysis and J. Pinker for assistance with small-molecule purification. We are grateful to S. Hultgren, G. Marshall and B. Ford for helpful discussions. J. P. H. holds a Career Award for Medical Scientists from the Burroughs-Wellcome Fund. We additionally acknowledge US National Institutes of Health grants K12 HD001459-09, AI 07172-24, P30 HL101263-01, P50 DK64540, U01 DK082315 and UL1 RR024992. MS was supported by P41-RR00954, 8-P41 GM103422-35 (NCRR), P60-DK20579 and P30-DK56341.	ARCENEAUX JEL, 1984, ANTIMICROB AGENTS CH, V25, P650, DOI 10.1128/AAC.25.5.650; Bachman MA, 2011, INFECT IMMUN, V79, P3309, DOI 10.1128/IAI.05114-11; Baker J, 2011, ENVIRON MICROBIOL, V13, P2495, DOI 10.1111/j.1462-2920.2011.02522.x; Balasubramanian R, 2008, CURR OPIN CHEM BIOL, V12, P245, DOI 10.1016/j.cbpa.2008.01.043; Behling LA, 2008, J AM CHEM SOC, V130, P12604, DOI 10.1021/ja804747d; BESWICK PH, 1976, CHEM-BIOL INTERACT, V14, P347, DOI 10.1016/0009-2797(76)90113-7; Braud A, 2009, J BACTERIOL, V191, P3517, DOI 10.1128/JB.00010-09; Brickman TJ, 2011, J BACTERIOL, V193, P4798, DOI 10.1128/JB.05136-11; Caza M, 2008, INFECT IMMUN, V76, P3539, DOI 10.1128/IAI.00455-08; Caza M, 2011, MOL MICROBIOL, V80, P266, DOI 10.1111/j.1365-2958.2011.07570.x; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Clark H W, 1905, Public Health Pap Rep, V31, P175; CLARKE SE, 1987, APPL ENVIRON MICROB, V53, P917, DOI 10.1128/AEM.53.5.917-922.1987; Crouch MLV, 2008, MOL MICROBIOL, V67, P971, DOI 10.1111/j.1365-2958.2007.06089.x; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Grass G, 2004, J BACTERIOL, V186, P5826, DOI 10.1128/JB.186.17.5826-5833.2004; Hakemian AS, 2007, ANNU REV BIOCHEM, V76, P223, DOI 10.1146/annurev.biochem.76.061505.175355; Hammer ND, 2011, ANNU REV MICROBIOL, V65, P129, DOI 10.1146/annurev-micro-090110-102851; Hellman NE, 2002, J BIOL CHEM, V277, P46632, DOI 10.1074/jbc.M206246200; Henderson JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000305; Hung CS, 2009, NAT PROTOC, V4, P1230, DOI 10.1038/nprot.2009.116; Kenney GE, 2012, ACS CHEM BIOL, V7, pA, DOI 10.1021/cb2003913; Kim HJ, 2004, SCIENCE, V305, P1612, DOI 10.1126/science.1098322; Kim HJ, 2005, BIOCHEMISTRY-US, V44, P5140, DOI 10.1021/bi047367r; Kurz T, 2006, FEBS J, V273, P3106, DOI 10.1111/j.1742-4658.2006.05321.x; Leary SC, 2007, EMBO REP, V8, P224, DOI 10.1038/sj.embor.7400915; Lide D.R., 1991, CRC HDB CHEM PHYS, P44; Luo MK, 2005, NAT CHEM BIOL, V1, P149, DOI 10.1038/nchembio717; Mabbett AN, 2009, INT J MED MICROBIOL, V299, P53, DOI 10.1016/j.ijmm.2008.06.003; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; MCKNIGHT DM, 1980, LIMNOL OCEANOGR, V25, P62, DOI 10.4319/lo.1980.25.1.0062; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Mokracka J, 2004, FEMS IMMUNOL MED MIC, V40, P51, DOI 10.1016/S0928-8244(03)00276-1; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Nandakumar R, 2011, BIOMETALS, V24, P429, DOI 10.1007/s10534-011-9434-5; Nataro J.P., 2011, MANUAL CLIN MICROBIO; Ogawa S, 2009, ANAL CHEM, V81, P9199, DOI 10.1021/ac901782d; Paauw A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008240; Prentice AM, 2007, J NUTR, V137, P1334, DOI 10.1093/jn/137.5.1334; Reigstad CS, 2007, J BIOL CHEM, V282, P21259, DOI 10.1074/jbc.M611502200; Seifert M, 2008, IMMUNOBIOLOGY, V213, P767, DOI 10.1016/j.imbio.2008.07.010; Shafeeq S, 2011, MOL MICROBIOL, V81, P1255, DOI 10.1111/j.1365-2958.2011.07758.x; Snyder JA, 2004, INFECT IMMUN, V72, P6373, DOI 10.1128/IAI.72.11.6373-6381.2004; Thiele DJ, 2008, NAT CHEM BIOL, V4, P145, DOI 10.1038/nchembio0308-145; VISCA P, 1992, APPL ENVIRON MICROB, V58, P2886, DOI 10.1128/AEM.58.9.2886-2893.1992; Wagner P, 1997, ARTERIOSCL THROM VAS, V17, P3338, DOI 10.1161/01.ATV.17.11.3338; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; Wolschendorf F, 2011, P NATL ACAD SCI USA, V108, P1621, DOI 10.1073/pnas.1009261108	49	191	193	5	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2012	8	8					731	736		10.1038/NCHEMBIO.1020	http://dx.doi.org/10.1038/NCHEMBIO.1020			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975RC	22772152	Green Accepted			2022-12-25	WOS:000306527600013
J	Balko, JM; Cook, RS; Vaught, DB; Kuba, MG; Miller, TW; Bhola, NE; Sanders, ME; Granja-Ingram, NM; Smith, JJ; Meszoely, IM; Salter, J; Dowsett, M; Stemke-Hale, K; Gonzalez-Angulo, AM; Mills, GB; Pinto, JA; Gomez, HL; Arteaga, CL				Balko, Justin M.; Cook, Rebecca S.; Vaught, David B.; Kuba, Maria G.; Miller, Todd W.; Bhola, Neil E.; Sanders, Melinda E.; Granja-Ingram, Nara M.; Smith, J. Joshua; Meszoely, Ingrid M.; Salter, Janine; Dowsett, Mitch; Stemke-Hale, Katherine; Gonzalez-Angulo, Ana M.; Mills, Gordon B.; Pinto, Joseph A.; Gomez, Henry L.; Arteaga, Carlos L.			Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance	NATURE MEDICINE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION; STEM-CELLS; KINASE; RECURRENCE; KI67; MEK; METASTASIS; INHIBITION; PREDICTOR	Neoadjuvant chemotherapy (NAC) induces a pathological complete response (pCR) in similar to 30% of patients with breast cancer. However, many patients have residual cancer after chemotherapy, which correlates with a higher risk of metastatic recurrence and poorer outcome than those who achieve a pCR. We hypothesized that molecular profiling of tumors after NAC would identify genes associated with drug resistance. Digital transcript counting was used to profile surgically resected breast cancers after NAC. Low concentrations of dual specificity protein phosphatase 4 (DUSP4), an ERK phosphatase, correlated with high post-NAC tumor cell proliferation and with basal-like breast cancer (BLBC) status. BLBC had higher DUSP4 promoter methylation and gene expression patterns of Ras-ERK pathway activation relative to other breast cancer subtypes. DUSP4 overexpression increased chemotherapy-induced apoptosis, whereas DUSP4 depletion dampened the response to chemotherapy. Reduced DUSP4 expression in primary tumors after NAC was associated with treatment-refractory high Ki-67 scores and shorter recurrence-free survival. Finally, inhibition of mitogen-activated protein kinase kinase (MEK) synergized with docetaxel treatment in BLBC xenografts. Thus, DUSP4 downregulation activates the Ras-ERK pathway in BLBC, resulting in an attenuated response to anti-cancer chemotherapy.	[Balko, Justin M.; Bhola, Neil E.; Arteaga, Carlos L.] Vanderbilt Univ, Dept Med, Vanderbilt Ingram Comprehens Canc Ctr, Nashville, TN 37235 USA; [Cook, Rebecca S.; Vaught, David B.; Miller, Todd W.; Arteaga, Carlos L.] Vanderbilt Univ, Dept Canc Biol, Vanderbilt Ingram Comprehens Canc Ctr, Nashville, TN USA; [Cook, Rebecca S.; Miller, Todd W.; Sanders, Melinda E.; Meszoely, Ingrid M.; Arteaga, Carlos L.] Vanderbilt Univ, Vanderbilt Ingram Comprehens Canc Ctr, Breast Canc Res Program, Nashville, TN USA; Vanderbilt Univ, Dept Pathol, Vanderbilt Ingram Comprehens Canc Ctr, Nashville, TN USA; [Smith, J. Joshua; Meszoely, Ingrid M.] Vanderbilt Univ, Dept Surg, Vanderbilt Ingram Comprehens Canc Ctr, Nashville, TN 37240 USA; [Salter, Janine; Dowsett, Mitch] Royal Marsden Hosp, Inst Canc Res, Breakthrough Breast Canc Ctr, London SW3 6JJ, England; [Salter, Janine; Dowsett, Mitch] Royal Marsden Hosp, Acad Dept Biochem, London SW3 6JJ, England; [Stemke-Hale, Katherine; Gonzalez-Angulo, Ana M.; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Gonzalez-Angulo, Ana M.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Pinto, Joseph A.] Oncosalud, Div Invest, Lima, Peru; [Gomez, Henry L.] Inst Nacl Enfermedades Neoplas, Lima, Peru	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Instituto Nacional de Enfermedades Neoplasicas	Arteaga, CL (corresponding author), Vanderbilt Univ, Dept Med, Vanderbilt Ingram Comprehens Canc Ctr, Nashville, TN 37235 USA.	carlos.arteaga@vanderbilt.edu	Smith, Jesse Joshua/AAN-5440-2020; Pinto, Joseph/AAA-5379-2022; Stemke-Hale, Katherine/K-9113-2013	Smith, Jesse Joshua/0000-0003-2538-5456; Stemke-Hale, Katherine/0000-0002-1231-4192; Pinto, Joseph/0000-0002-7744-1635; Gomez, Henry/0000-0003-2660-1843; Vaught, David/0000-0002-3346-6769	Breast Cancer Specialized Program of Research Excellence (SPORE) grant [P50CA98131]; Vanderbilt-Ingram Cancer Center Support grant [P30CA68485]; Breast Cancer Research Foundation; American Cancer Society Clinical Research Professorship grant [CRP-07-234]; Lee Jeans Translational Breast Cancer Research Program; SU2C Dream Team award [PO1CA099031]; Komen Promise grant [KG 081694]; Breakthrough Breast Cancer; Royal Marsden National Institutes of Health Research Biomedical Research Centre; NATIONAL CANCER INSTITUTE [K99CA142899, P50CA098258, R01CA143126, P50CA098131, R00CA142899, P30CA016672, P01CA099031, P30CA068485] Funding Source: NIH RePORTER	Breast Cancer Specialized Program of Research Excellence (SPORE) grant; Vanderbilt-Ingram Cancer Center Support grant; Breast Cancer Research Foundation; American Cancer Society Clinical Research Professorship grant(American Cancer Society); Lee Jeans Translational Breast Cancer Research Program; SU2C Dream Team award; Komen Promise grant(Susan G. Komen Breast Cancer Foundation); Breakthrough Breast Cancer; Royal Marsden National Institutes of Health Research Biomedical Research Centre; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank E. Penni Black (University of Kentucky), who provided the AdMEK1ca adenoviral construct. The authors would also like to thank P.D. Smith and AstraZeneca for supplying selumetinib utilized in the in vivo experiments. This work was supported by Breast Cancer Specialized Program of Research Excellence (SPORE) grant P50CA98131, Vanderbilt-Ingram Cancer Center Support grant P30CA68485, a grant from the Breast Cancer Research Foundation, the American Cancer Society Clinical Research Professorship grant CRP-07-234 and the Lee Jeans Translational Breast Cancer Research Program (to C.L.A.). G.B.M. was supported by the SU2C Dream Team award, PO1CA099031 and the Komen Promise grant KG 081694. J.S. and M.D. were funded by the Breakthrough Breast Cancer and the Royal Marsden National Institutes of Health Research Biomedical Research Centre.	Armes JE, 2004, ONCOGENE, V23, P5697, DOI 10.1038/sj.onc.1207740; Balko JM, 2009, CANCER BIOL THER, V8, P522, DOI 10.4161/cbt.8.6.7690; Bediaga NG, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2721; Boersma BJ, 2008, INT J CANCER, V122, P1324, DOI 10.1002/ijc.23237; Britson JS, 2009, BIOCHEM BIOPH RES CO, V390, P849, DOI 10.1016/j.bbrc.2009.10.061; Brumby AM, 2011, GENETICS, V188, P105, DOI 10.1534/genetics.111.127910; Cadalbert L, 2005, CELL SIGNAL, V17, P1254, DOI 10.1016/j.cellsig.2005.01.003; Cadalbert LC, 2010, CELL SIGNAL, V22, P357, DOI 10.1016/j.cellsig.2009.10.002; Calcagno AM, 2010, JNCI-J NATL CANCER I, V102, P1637, DOI 10.1093/jnci/djq361; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Chiaradonna F, 2006, ONCOGENE, V25, P5391, DOI 10.1038/sj.onc.1209528; Chitale D, 2009, ONCOGENE, V28, P2773, DOI 10.1038/onc.2009.135; Creighton CJ, 2010, J MAMMARY GLAND BIOL, V15, P253, DOI 10.1007/s10911-010-9173-1; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Dowsett M, 2005, CLIN CANCER RES, V11, p951S; Dowsett M, 2007, JNCI-J NATL CANCER I, V99, P167, DOI 10.1093/jnci/djk020; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Guarneri V, 2009, ANN ONCOL, V20, P1193, DOI 10.1093/annonc/mdn761; Haibe-Kains B, 2009, GENEFU R PACKAGE REL; Hennessy BT, 2007, CLIN CANCER RES, V13, P7421, DOI 10.1158/1078-0432.CCR-07-0760; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Holm K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2590; Hu J, 2007, BIOINFORMATICS, V23, P1986, DOI 10.1093/bioinformatics/btm283; Jones RL, 2009, BREAST CANCER RES TR, V116, P53, DOI 10.1007/s10549-008-0081-7; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Korde LA, 2010, BREAST CANCER RES TR, V119, P685, DOI 10.1007/s10549-009-0651-3; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Miller WR, 2009, J CLIN ONCOL, V27, P1382, DOI 10.1200/JCO.2008.16.8849; Mirzoeva OK, 2009, CANCER RES, V69, P565, DOI 10.1158/0008-5472.CAN-08-3389; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Popovici V, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2468; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Pusztai L, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2430; Sanchez-Munoz A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-136; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Stickeler E, 2011, ONCOL REP, V26, P1037, DOI 10.3892/or.2011.1392; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Waha A, 2010, CANCER RES, V70, P1689, DOI 10.1158/0008-5472.CAN-09-3218; Wang JH, 2010, MOL CANCER RES, V8, P266, DOI 10.1158/1541-7786.MCR-09-0221; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Yacoub A, 2003, CANCER BIOL THER, V2, P670; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]	50	188	194	2	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2012	18	7					1052	+		10.1038/nm.2795	http://dx.doi.org/10.1038/nm.2795			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22683778	Green Accepted			2022-12-25	WOS:000306121600034
J	Guo, W; Schafer, S; Greaser, ML; Radke, MH; Liss, M; Govindarajan, T; Maatz, H; Schulz, H; Li, SJ; Parrish, AM; Dauksaite, V; Vakeel, P; Klaassen, S; Gerull, B; Thierfelder, L; Regitz-Zagrosek, V; Hacker, TA; Saupe, KW; Dec, GW; Ellinor, PT; MacRae, CA; Spallek, B; Fischer, R; Perrot, A; Ozcelik, C; Saar, K; Hubner, N; Gotthardt, M				Guo, Wei; Schafer, Sebastian; Greaser, Marion L.; Radke, Michael H.; Liss, Martin; Govindarajan, Thirupugal; Maatz, Henrike; Schulz, Herbert; Li, Shijun; Parrish, Amanda M.; Dauksaite, Vita; Vakeel, Padmanabhan; Klaassen, Sabine; Gerull, Brenda; Thierfelder, Ludwig; Regitz-Zagrosek, Vera; Hacker, Timothy A.; Saupe, Kurt W.; Dec, G. William; Ellinor, Patrick T.; MacRae, Calum A.; Spallek, Bastian; Fischer, Robert; Perrot, Andreas; Oezcelik, Cemil; Saar, Kathrin; Hubner, Norbert; Gotthardt, Michael			RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing	NATURE MEDICINE			English	Article							FAMILIAL DILATED CARDIOMYOPATHY; RNA-BINDING PROTEINS; ISOFORM EXPRESSION; PASSIVE STIFFNESS; HEART-FAILURE; SR PROTEINS; DISEASE; MUTATIONS; RAT; MYOCARDIUM	Alternative splicing has a major role in cardiac adaptive responses, as exemplified by the isoform switch of the sarcomeric protein titin, which adjusts ventricular filling. By positional cloning using a previously characterized rat strain with altered titin mRNA splicing, we identified a loss-of-function mutation in the gene encoding RNA binding motif protein 20 (Rbm20) as the underlying cause of pathological titin isoform expression. The phenotype of Rbm20-deficient rats resembled the pathology seen in individuals with dilated cardiomyopathy caused by RBM20 mutations. Deep sequencing of the human and rat cardiac transcriptome revealed an RBM20-dependent regulation of alternative splicing. In addition to titin (TTN), we identified a set of 30 genes with conserved splicing regulation between humans and rats. This network is enriched for genes that have previously been linked to cardiomyopathy, ion homeostasis and sarcomere biology. Our studies emphasize the key role of post-transcriptional regulation in cardiac function and provide mechanistic insights into the pathogenesis of human heart failure.	[Schafer, Sebastian; Radke, Michael H.; Liss, Martin; Govindarajan, Thirupugal; Maatz, Henrike; Schulz, Herbert; Dauksaite, Vita; Vakeel, Padmanabhan; Klaassen, Sabine; Gerull, Brenda; Thierfelder, Ludwig; Saar, Kathrin; Hubner, Norbert; Gotthardt, Michael] Max Delbruck Ctr Mol Med, Berlin, Germany; [Guo, Wei; Greaser, Marion L.; Li, Shijun; Parrish, Amanda M.] Univ Wisconsin, Muscle Biol Lab, Madison, WI 53706 USA; [Regitz-Zagrosek, Vera] Univ Med Berlin, Charite, Cardiovasc Res Ctr, Berlin, Germany; [Regitz-Zagrosek, Vera] Univ Med Berlin, Charite, Inst Gender Med, Berlin, Germany; [Hacker, Timothy A.; Saupe, Kurt W.] Univ Wisconsin, Dept Med, Madison, WI USA; [Dec, G. William; Ellinor, Patrick T.; MacRae, Calum A.] Massachusetts Gen Hosp, Div Cardiol, Charlestown, MA USA; [Spallek, Bastian; Fischer, Robert] Univ Med Berlin, Charite, Univ Kilikum Benjamin Franklin, Berlin, Germany; [Perrot, Andreas; Oezcelik, Cemil] Charite, Campus Virchow Klinikum, Dept Cardiol, D-13353 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Wisconsin System; University of Wisconsin Madison; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Massachusetts General Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Gotthardt, M (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	gotthardt@mdc-berlin.de	Govindarajan, Thirupugal/A-8758-2015; Govindarajan, Thirupugal/ABF-9464-2020; Gotthardt, Michael/ABE-8274-2021; Greaser, Marion L/C-6147-2012	Govindarajan, Thirupugal/0000-0003-2660-9730; Govindarajan, Thirupugal/0000-0003-2660-9730; Gotthardt, Michael/0000-0003-1788-3172; Greaser, Marion L/0000-0002-6583-9566; Ellinor, Patrick/0000-0002-2067-0533; Liss, Martin/0000-0002-0585-7850; Schafer, Sebastian/0000-0002-6909-8275; Regitz-Zagrosek, Vera/0000-0002-3566-3467; Perrot, Andreas/0000-0002-8800-342X; Saar, Kathrin/0000-0002-4483-1557; Radke, Michael/0000-0003-0112-9917; Govindarajan, Thirupugal/0000-0003-1714-1267; Klaassen, Sabine/0000-0001-5925-9912	US National Institutes of Health [HL77196, HL075431]; Deutsche Forschungsgemeinschaft, Bonn, Germany; European Research Council [StG282078]; German Ministry of Science and Education (Nationales Genomforschungsnetz, NGFN-Plus Heart Failure Network) and EURATRANS [HEALTH-F4-2010-241504]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075431, R01HL077196] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); German Ministry of Science and Education (Nationales Genomforschungsnetz, NGFN-Plus Heart Failure Network) and EURATRANS; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to B. Goldbrich, O. Hummel, S. Lubitz, S. Makino, G. Patone, S. Blachut, R. Plehm, S. Probst, S. Schmidt and M. Wehle for expert technical assistance. R. Hetzer (Deutsches Herzzentrum Berlin) generously provided human cardiac tissue. Mammalian expression vectors for PTBP1 and HuD were gifts from R. Darnell, The Rockefeller University. This work was supported by the US National Institutes of Health grants HL77196 (M.L.G.) and HL075431 (C.A.M.), the Deutsche Forschungsgemeinschaft, Bonn, Germany and the European Research Council grant StG282078 (M.G.), the German Ministry of Science and Education (Nationales Genomforschungsnetz, NGFN-Plus Heart Failure Network) and EURATRANS (HEALTH-F4-2010-241504) (N.H.) and the American Heart Association (P.T.E.).	Arimura T, 2004, J BIOL CHEM, V279, P6746, DOI 10.1074/jbc.M311849200; Arimura T, 2009, CARDIOVASC RES, V83, P80, DOI 10.1093/cvr/cvp119; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brauch KM, 2009, J AM COLL CARDIOL, V54, P930, DOI 10.1016/j.jacc.2009.05.038; Cazorla O, 2000, CIRC RES, V86, P59, DOI 10.1161/01.RES.86.1.59; Chaturvedi RR, 2010, CIRCULATION, V121, P979, DOI 10.1161/CIRCULATIONAHA.109.850677; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Cheng HQ, 2011, HUM MOL GENET, V20, P1751, DOI 10.1093/hmg/ddr050; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Ding JH, 2004, EMBO J, V23, P885, DOI 10.1038/sj.emboj.7600054; Feng Y, 2009, DEV CELL, V16, P528, DOI 10.1016/j.devcel.2009.02.009; GamaCarvalho M, 1997, J CELL BIOL, V137, P975, DOI 10.1083/jcb.137.5.975; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Greaser ML, 2008, J MOL CELL CARDIOL, V44, P983, DOI 10.1016/j.yjmcc.2008.02.272; Greaser ML, 2005, J MUSCLE RES CELL M, V26, P325, DOI 10.1007/s10974-005-9039-0; Hardenbol P, 2005, GENOME RES, V15, P269, DOI 10.1101/gr.3185605; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Itoh-Satoh M, 2002, BIOCHEM BIOPH RES CO, V291, P385, DOI 10.1006/bbrc.2002.6448; Kruger M, 2008, CIRC RES, V102, P439, DOI 10.1161/CIRCRESAHA.107.162719; Kruger M, 2010, J MOL CELL CARDIOL, V48, P910, DOI 10.1016/j.yjmcc.2010.02.012; Lahmers S, 2004, CIRC RES, V94, P505, DOI 10.1161/01.RES.0000115522.52554.86; Li DX, 2010, CTS-CLIN TRANSL SCI, V3, P90, DOI 10.1111/j.1752-8062.2010.00198.x; Liew CC, 2004, NAT REV GENET, V5, P811, DOI 10.1038/nrg1470; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; Lin SR, 2005, MOL CELL, V20, P413, DOI 10.1016/j.molcel.2005.09.015; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Mahon NG, 2005, ANN INTERN MED, V143, P108, DOI 10.7326/0003-4819-143-2-200507190-00009; Makarenko I, 2004, CIRC RES, V95, P708, DOI 10.1161/01.RES.0000143901.37063.2f; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Neagoe C, 2002, CIRCULATION, V106, P1333, DOI 10.1161/01.CIR.0000029803.93022.93; Okano HJ, 1997, J NEUROSCI, V17, P3024; Opitz CA, 2004, CIRC RES, V94, P967, DOI 10.1161/01.RES.0000124301.48193.E1; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Saar K, 2008, NAT GENET, V40, P560, DOI 10.1038/ng.124; Tacke R, 1999, CURR OPIN CELL BIOL, V11, P358, DOI 10.1016/S0955-0674(99)80050-7; Tang ZZ, 2011, J BIOL CHEM, V286, P10007, DOI 10.1074/jbc.M110.208116; Toko H, 2010, CIRCULATION, V122, P891, DOI 10.1161/CIRCULATIONAHA.109.935296; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; Wagner S, 2006, J CLIN INVEST, V116, P3127, DOI 10.1172/JCI26620; Wang D, 2006, PHARMACOGENET GENOM, V16, P735, DOI 10.1097/01.fpc.0000230119.34205.8a; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Warren CM, 2004, MECH DEVELOP, V121, P1301, DOI 10.1016/j.mod.2004.07.003; Williams L, 2009, CLIN SCI, V117, P237, DOI 10.1042/CS20080248; Wu YM, 2007, J MOL CELL CARDIOL, V42, P186, DOI 10.1016/j.yjmcc.2006.09.017; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Yamasaki R, 2002, CIRC RES, V90, P1181, DOI 10.1161/01.RES.0000021115.24712.99; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; Zhong XY, 2009, GENE DEV, V23, P482, DOI 10.1101/gad.1752109	51	326	339	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2012	18	5					766	U162		10.1038/nm.2693	http://dx.doi.org/10.1038/nm.2693			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22466703	Green Accepted			2022-12-25	WOS:000303763500044
J	Liang, GY; He, J; Zhang, Y				Liang, Gaoyang; He, Jin; Zhang, Yi			Kdm2b promotes induced pluripotent stem cell generation by facilitating gene activation early in reprogramming	NATURE CELL BIOLOGY			English	Article							MOUSE EMBRYONIC FIBROBLASTS; SMALL-MOLECULE COMPOUNDS; E-CADHERIN; INDUCTION; DEMETHYLASE; PATHWAY; DOMAIN; LOCUS; STATE; OCT4	Transcription-factor-directed reprogramming from somatic cells to induced pluripotent stem cells (iPSCs) is by nature an epigenetic process of cell fate change. Previous studies have demonstrated that this inefficient process can be facilitated by the inclusion of additional factors. To gain insight into the reprogramming mechanism, we aimed to identify epigenetic enzymes capable of promoting iPSC generation. Here we show that Kdm2b, a histone H3 Lys 36 dimethyl (H3K36me2)-specific demethylase, has the capacity to promote iPSC generation. This capacity depends on its demethylase and DNA-binding activities, but is largely independent of its role in antagonizing senescence. Kdm2b functions at the beginning of the reprogramming process and enhances activation of early responsive genes in reprogramming. Kdm2b contributes to gene activation by binding to and demethylating the gene promoters. Our studies not only identify an important epigenetic factor for iPSC generation, but also reveal the molecular mechanism underlying how Kdm2b contributes to reprogramming.	[Liang, Gaoyang; He, Jin; Zhang, Yi] Univ N Carolina, Lineberger Comprehens Canc Ctr, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; [Liang, Gaoyang; He, Jin; Zhang, Yi] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zhang, Y (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu	Liang, Gaoyang/L-2087-2013	Liang, Gaoyang/0000-0002-2157-974X; He, Jin/0000-0001-8283-7952; Zhang, Yi/0000-0002-2789-0811	NIH [U01DK089565]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089565] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank UNC Animal Models Core for chimaera generation and UNC Functional Genomic Core for microarray analysis. We thank S. Yamaguchi and K-H. Hong for helpful discussions. This work is supported by U01DK089565 from the NIH. Y.Z. is an Investigator of the Howard Hughes Medical Institute.	Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Chen TT, 2010, STEM CELLS, V28, P1315, DOI 10.1002/stem.456; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Farkas LM, 2008, NEURON, V60, P40, DOI 10.1016/j.neuron.2008.09.020; Gierl MS, 2006, GENE DEV, V20, P2465, DOI 10.1101/gad.381806; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Liang GY, 2010, J BIOL CHEM, V285, P25516, DOI 10.1074/jbc.M110.142059; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Mellitzer G, 2006, EMBO J, V25, P1344, DOI 10.1038/sj.emboj.7601011; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Pfau R, 2008, P NATL ACAD SCI USA, V105, P1907, DOI 10.1073/pnas.0711865105; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Redmer T, 2011, EMBO REP, V12, P720, DOI 10.1038/embor.2011.88; Richardson RJ, 2009, HUM MOL GENET, V18, P2632, DOI 10.1093/hmg/ddp201; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomason HA, 2010, J CLIN INVEST, V120, P1561, DOI 10.1172/JCI40266; Tsukada Y, 2006, NATURE, V439, P811; Tzatsos A, 2009, P NATL ACAD SCI USA, V106, P2641, DOI 10.1073/pnas.0813139106; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Voo KS, 2000, MOL CELL BIOL, V20, P2108; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005	40	127	133	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2012	14	5					457	U45		10.1038/ncb2483	http://dx.doi.org/10.1038/ncb2483			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	936NW	22522173	Green Published, Green Accepted			2022-12-25	WOS:000303598300006
J	Niola, F; Zhao, XD; Singh, D; Castano, A; Sullivan, R; Lauria, M; Nam, HS; Zhuang, Y; Benezra, R; Di Bernardo, D; Iavarone, A; Lasorella, A				Niola, Francesco; Zhao, Xudong; Singh, Devendra; Castano, Angelica; Sullivan, Ryan; Lauria, Mario; Nam, Hyung-song; Zhuang, Yuan; Benezra, Robert; Di Bernardo, Diego; Iavarone, Antonio; Lasorella, Anna			Id proteins synchronize sternness and anchorage to the niche of neural stern cells	NATURE CELL BIOLOGY			English	Article							UBIQUITIN LIGASE HUWE1; BETA-GAMMA-SUBUNITS; SELF-RENEWAL; CEREBRAL-CORTEX; VASCULAR NICHE; IN-VIVO; PROLIFERATION; NEUROGENESIS; ADHESION; BRAIN	Stem-cell functions require activation of stem-cell-intrinsic transcriptional programs and extracellular interaction with a niche microenvironment. How the transcriptional machinery controls residency of stem cells in the niche is unknown. Here we show that Id proteins coordinate stem-cell activities with anchorage of neural stem cells (NSCs) to the niche. Conditional inactivation of three Id genes in NSCs triggered detachment of embryonic and postnatal NSCs from the ventricular and vascular niche, respectively. The interrogation of the gene modules directly targeted by Id deletion in NSCs revealed that Id proteins repress bHLH-mediated activation of Rap1GAP, thus serving to maintain the GTPase activity of RAP1, a key mediator of cell adhesion. Preventing the elevation of the Rap1GAP level countered the consequences of Id loss on NSC niche interaction and stem-cell identity. Thus, by preserving anchorage of NSCs to the extracellular environment, Id activity synchronizes NSC functions to residency in the specialized niche.	[Niola, Francesco; Zhao, Xudong; Singh, Devendra; Castano, Angelica; Sullivan, Ryan; Iavarone, Antonio; Lasorella, Anna] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA; [Lauria, Mario; Di Bernardo, Diego] Telethon Inst Genet & Med TIGEM, I-80131 Naples, Italy; [Nam, Hyung-song; Benezra, Robert] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Zhuang, Yuan] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Iavarone, Antonio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA; [Iavarone, Antonio; Lasorella, Anna] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; [Lasorella, Anna] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA	Columbia University; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Memorial Sloan Kettering Cancer Center; Duke University; Columbia University; Columbia University; Columbia University	Iavarone, A (corresponding author), Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA.	ai2102@columbia.edu; al2179@columbia.edu	di Bernardo, Diego/AAF-5881-2021; di Bernardo, Diego/I-9440-2012; Lauria, Mario/G-6796-2012	di Bernardo, Diego/0000-0002-1911-7407; di Bernardo, Diego/0000-0002-1911-7407; Lauria, Mario/0000-0001-5983-7292; zhuang, yuan/0000-0002-2964-3654; zhao, zhao xu dong/0000-0001-9126-7365; Iavarone, Antonio/0000-0002-0683-4634; , namhyeongsong/0000-0002-0429-5446	National Cancer Institute [R01CA101644, R01CA131126, R01CA085628, R01CA127643]; National Institute of Neurological Disorders and Stroke [R01NS061776]; Italian Ministry of Welfare/Provincia di Benevento; Fondazione Telethon Funding Source: Custom; NATIONAL CANCER INSTITUTE [R01CA085628, R01CA101644, R01CA127643, R01CA131126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061776] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Italian Ministry of Welfare/Provincia di Benevento; Fondazione Telethon(Fondazione Telethon); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Cancer Institute grants R01CA101644 and R01CA131126 (A.L.), R01CA085628 and R01CA127643 (A.I.) and National Institute of Neurological Disorders and Stroke R01NS061776 (A.I.). F.N. is supported by a fellowship from the Italian Ministry of Welfare/Provincia di Benevento. We thank S. Angers for the Venus-Radil expression plasmid.	Ahmed SM, 2010, J BIOL CHEM, V285, P6538, DOI 10.1074/jbc.M109.069948; Angelini C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-415; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Bos JL, 2003, BIOCHEM SOC T, V31, P83, DOI 10.1042/bst0310083; Boutin C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001883; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Caron E, 2003, J CELL SCI, V116, P435, DOI 10.1242/jcs.00238; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Currle DS, 2008, CELL STEM CELL, V3, P234, DOI 10.1016/j.stem.2008.08.011; Della Gatta G, 2008, GENOME RES, V18, P939, DOI 10.1101/gr.073601.107; Ellis SJ, 2010, CELL TISSUE RES, V339, P121, DOI 10.1007/s00441-009-0828-4; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; Fortunel NO, 2003, SCIENCE, V302, P393; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Guo ZL, 2011, IMMUNOL LETT, V135, P34, DOI 10.1016/j.imlet.2010.09.009; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Heng JIT, 2008, NATURE, V455, P114, DOI 10.1038/nature07198; Jankovic V, 2007, P NATL ACAD SCI USA, V104, P1260, DOI 10.1073/pnas.0607894104; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Loulier K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000176; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Marthiens V, 2010, J CELL SCI, V123, P1613, DOI 10.1242/jcs.054312; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Pagliuca A, 1998, J BIOL CHEM, V273, P7668, DOI 10.1074/jbc.273.13.7668; Pan LH, 1999, MOL CELL BIOL, V19, P5969; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Raymond K, 2009, CURR OPIN CELL BIOL, V21, P623, DOI 10.1016/j.ceb.2009.05.004; Rothschild G, 2006, MOL CELL BIOL, V26, P4351, DOI 10.1128/MCB.01743-05; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Shen Q, 2002, DEVELOPMENT, V129, P4843; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Smolen GA, 2007, GENE DEV, V21, P2131, DOI 10.1101/gad.1561507; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wang H, 2006, DEV CELL, V10, P117, DOI 10.1016/j.devcel.2005.11.004; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zhao X, 2009, DEV CELL, V17, P210, DOI 10.1016/j.devcel.2009.07.009	46	94	98	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2012	14	5					477	U80		10.1038/ncb2490	http://dx.doi.org/10.1038/ncb2490			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	936NW	22522171	Green Accepted			2022-12-25	WOS:000303598300008
J	Gulbransen, BD; Bashashati, M; Hirota, SA; Gui, XY; Roberts, JA; MacDonald, JA; Muruve, DA; Mckay, DM; Beck, PL; Mawe, GM; Thompson, RJ; Sharkey, KA				Gulbransen, Brian D.; Bashashati, Mohammad; Hirota, Simon A.; Gui, Xianyong; Roberts, Jane A.; MacDonald, Justin A.; Muruve, Daniel A.; Mckay, Derek M.; Beck, Paul L.; Mawe, Gary M.; Thompson, Roger J.; Sharkey, Keith A.			Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis	NATURE MEDICINE			English	Article							MYENTERIC NEURONS; P2X(7) RECEPTORS; ATP; RELEASE; GLIA; INNERVATION; STIMULATION; INHIBITION; RECOVERY; MOTILITY	Inflammatory bowel diseases (IBDs) are chronic relapsing and remitting conditions associated with long-term gut dysfunction resulting from alterations to the enteric nervous system and a loss of enteric neurons(1,2). The mechanisms underlying inflammation-induced enteric neuron death are unknown. Here using in vivo models of experimental colitis we report that inflammation causes enteric neuron death by activating a neuronal signaling complex composed of P2X7 receptors (P2X7Rs), pannexin-1 (Panx1) channels, the Asc adaptor protein and caspases. Inhibition of P2X7R, Panx1, Asc or caspase activity prevented inflammation-induced neuron cell death. Preservation of enteric neurons by inhibiting Panx1 in vivo prevented the onset of inflammation-induced colonic motor dysfunction. Panx1 expression was reduced in Crohn's disease but not ulcerative colitis. We conclude that activation of neuronal Panx1 underlies neuron death and the subsequent development of abnormal gut motility in IBD. Targeting Panx1 represents a new neuroprotective strategy to ameliorate the progression of IBD-associated dysmotility.	[Gulbransen, Brian D.; Bashashati, Mohammad; Thompson, Roger J.; Sharkey, Keith A.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Gulbransen, Brian D.; Bashashati, Mohammad; Mckay, Derek M.; Sharkey, Keith A.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Gulbransen, Brian D.; Bashashati, Mohammad; Hirota, Simon A.; MacDonald, Justin A.; Muruve, Daniel A.; Mckay, Derek M.; Beck, Paul L.; Sharkey, Keith A.] Univ Calgary, Snyder Inst Infect Immun & Inflammat, Calgary, AB, Canada; [Hirota, Simon A.; Muruve, Daniel A.; Beck, Paul L.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Hirota, Simon A.; MacDonald, Justin A.] Univ Calgary, Libin Cardiovasc Inst, Calgary, AB, Canada; [Hirota, Simon A.; MacDonald, Justin A.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Gui, Xianyong] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Roberts, Jane A.; Mawe, Gary M.] Univ Vermont Coll Med, Dept Anat & Neurobiol, Burlington, VT USA; [Thompson, Roger J.] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Calgary; University of Calgary; University of Vermont; University of Calgary	Gulbransen, BD (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.	bgulbran@ucalgary.ca; ksharkey@ucalgary.ca	McKay, Derek/HCH-3240-2022; Thompson, Roger/L-3930-2016	Thompson, Roger/0000-0002-7019-7246; Sharkey, Keith/0000-0001-9560-1711; MacDonald, Justin/0000-0002-9238-8473; Gulbransen, Brian/0000-0003-1145-3227	Canadian Institutes of Health Research (CIHR); Crohn's & Colitis Foundation of Canada (CCFC); US National Institutes of Health [DK62267]; Canadian Foundation for Innovation; Alberta Science and Research Authority; Canadian Association of Gastroenterology/CIHR; Alberta Innovates-Health Solutions (AI-HS)/CCFC; AI-HS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062267] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Crohn's & Colitis Foundation of Canada (CCFC); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Foundation for Innovation(Canada Foundation for Innovation); Alberta Science and Research Authority; Canadian Association of Gastroenterology/CIHR(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions (AI-HS)/CCFC; AI-HS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Canadian Institutes of Health Research (CIHR, to K.A.S., R.J.T. and D.M.M.), the Crohn's & Colitis Foundation of Canada (CCFC to D.M.M.) and US National Institutes of Health grant DK62267 (to G.M.M.). Some of the equipment used in the study was provided by funds from the Canadian Foundation for Innovation and the Alberta Science and Research Authority. B.D.G. holds fellowships from the Canadian Association of Gastroenterology/CIHR and Alberta Innovates-Health Solutions (AI-HS)/CCFC. K.A.S. is an AI-HS Medical Scientist and holds the CCFC Chair in IBD Research at the University of Calgary. R.J.T. is an AI-HS Scholar. P.L.B. is supported by AI-HS, CIHR and CCFC. J.A.M. is an AI-HS Senior Scholar and Canada Research Chair. D.M.M. is an AI-HS Scientist and holds a Canada Research Chair (Tier 1). S.A.H. holds fellowships from CIHR and AI-HS. We thank C. MacNaughton, W. Ho and A. Wang for technical support, D.M. McCafferty (University of Calgary) for providing Il10<SUP>-/-</SUP> mice, V. Dixit (Genentech) and J. Tschopp (University of Lausanne) for providing male Pycard<SUP>-/-</SUP> and Nlrp3<SUP>-/-</SUP> mice, respectively, N. Hyman (University of Vermont), O. Bathe (University of Calgary) and the IBD Tissue Bank for providing human tissue samples and J. Bains for reviewing and commenting on the manuscript.	Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Bossone C, 2001, AM J PHYSIOL-GASTR L, V280, pG949, DOI 10.1152/ajpgi.2001.280.5.G949; Cavaliere F, 2004, J CEREBR BLOOD F MET, V24, P392, DOI 10.1097/00004647-200404000-00004; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Collins SM, 1996, GASTROENTEROLOGY, V111, P1683, DOI 10.1016/S0016-5085(96)70034-3; De Giorgio R, 2004, GASTROENTEROLOGY, V126, P1872, DOI 10.1053/j.gastro.2004.02.024; Depoortere I, 2002, BRIT J PHARMACOL, V135, P2011, DOI 10.1038/sj.bjp.0704648; Ferrari D, 1997, J IMMUNOL, V159, P1451; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; Friedman DJ, 2009, P NATL ACAD SCI USA, V106, P16788, DOI 10.1073/pnas.0902869106; Gomes P, 2009, NEUROGASTROENT MOTIL, V21, P870, DOI 10.1111/j.1365-2982.2009.01302.x; Gulbransen BD, 2010, J NEUROSCI, V30, P6801, DOI 10.1523/JNEUROSCI.0603-10.2010; Gulbransen BD, 2009, GASTROENTEROLOGY, V136, P1349, DOI 10.1053/j.gastro.2008.12.058; Guzman J, 2006, INFLAMM BOWEL DIS, V12, P766, DOI 10.1097/00054725-200608000-00014; Hu HL, 2010, EXP EYE RES, V91, P425, DOI 10.1016/j.exer.2010.06.017; Krauter EM, 2007, NEUROGASTROENT MOTIL, V19, P990, DOI 10.1111/j.1365-2982.2007.00986.x; Lazarowski ER, 2000, J BIOL CHEM, V275, P31061, DOI 10.1074/jbc.M003255200; Linden DR, 2005, NEUROGASTROENT MOTIL, V17, P751, DOI 10.1111/j.1365-2982.2005.00703.x; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Lomax AE, 2005, J PHYSIOL-LONDON, V564, P863, DOI 10.1113/jphysiol.2005.084285; Mawe GM, 2009, NEUROGASTROENT MOTIL, V21, P481, DOI 10.1111/j.1365-2982.2009.01291.x; McCafferty DM, 2000, AM J PHYSIOL-GASTR L, V279, pG90, DOI 10.1152/ajpgi.2000.279.1.G90; Mizuta Y, 2000, GASTROENTEROLOGY, V118, P714, DOI 10.1016/S0016-5085(00)70141-7; Nasser Y, 2006, AM J PHYSIOL-GASTR L, V291, pG912, DOI 10.1152/ajpgi.00067.2006; Rybaczyk L, 2009, INFLAMM BOWEL DIS, V15, P971, DOI 10.1002/ibd.20893; Seminario-Vidal L, 2011, J BIOL CHEM, V286, P26277, DOI 10.1074/jbc.M111.260562; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Storr MA, 2009, INFLAMM BOWEL DIS, V15, P1678, DOI 10.1002/ibd.20960; Strong DS, 2010, J PHYSIOL-LONDON, V588, P847, DOI 10.1113/jphysiol.2009.185082; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Vasina V, 2006, AUTON NEUROSCI-BASIC, V126, P264, DOI 10.1016/j.autneu.2006.02.025; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wynn G, 2004, AM J PHYSIOL-GASTR L, V287, pG647, DOI 10.1152/ajpgi.00020.2004; Yiangou Y, 2001, NEUROGASTROENT MOTIL, V13, P365, DOI 10.1046/j.1365-2982.2001.00276.x; Zhang XL, 2005, INVEST OPHTH VIS SCI, V46, P2183, DOI 10.1167/iovs.05-0052	38	288	298	3	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2012	18	4					600	604		10.1038/nm.2679	http://dx.doi.org/10.1038/nm.2679			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22426419	Green Accepted			2022-12-25	WOS:000302617800038
J	Pierron, G; Tirode, F; Lucchesi, C; Reynaud, S; Ballet, S; Cohen-Gogo, S; Perrin, V; Coindre, JM; Delattre, O				Pierron, Gaelle; Tirode, Franck; Lucchesi, Carlo; Reynaud, Stephanie; Ballet, Stelly; Cohen-Gogo, Sarah; Perrin, Virginie; Coindre, Jean-Michel; Delattre, Olivier			A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion	NATURE GENETICS			English	Article							EWING SARCOMA; EXPRESSION; BCOR; TRANSLOCATION; FAMILY; MUTATIONS; CYCLIN; TUMORS	The identification of subtype-specific translocations has revolutionized the diagnostics of sarcoma and has provided new insight into oncogenesis. We used RNA-seq to investigate samples from individuals diagnosed with small round cell tumors of bone, possibly Ewing sarcoma, but which lacked the canonical EWSR1-ETS translocation. A new fusion was observed between BCOR (encoding the BCL6 co-repressor) and CCNB3 (encoding the testis-specific cyclin B3) on the X chromosome. RNA-seq results were confirmed by RT-PCR and through cloning of the tumor-specific genomic translocation breakpoints. In total, 24 BCOR-CCNB3-positive tumors were identified among a series of 594 sarcoma cases. Gene profiling experiments indicated that BCOR-CCNB3-positive cases are biologically distinct from other sarcomas, particularly Ewing sarcoma. Finally, we show that CCNB3 immunohistochemistry is a powerful diagnostic marker for this subgroup of sarcoma and that overexpression of BCOR-CCNB3 or of truncated CCNB3 activates S phase in NIH3T3 cells. Thus, the intrachromosomal X-chromosome fusion described here represents a new subtype of bone sarcoma caused by a newly identified gene fusion mechanism.	[Pierron, Gaelle; Reynaud, Stephanie; Ballet, Stelly; Delattre, Olivier] Ctr Hosp, Inst Curie, Unite Genet Somat, Paris, France; [Tirode, Franck; Lucchesi, Carlo; Cohen-Gogo, Sarah; Perrin, Virginie; Delattre, Olivier] Ctr Rech, Inst Curie, INSERM, U830, Paris, France; [Coindre, Jean-Michel] Inst Bergonie, Bordeaux, France	Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UNICANCER; Institut Bergonie	Delattre, O (corresponding author), Ctr Hosp, Inst Curie, Unite Genet Somat, Paris, France.	olivier.delattre@curie.fr	Cohen-Gogo, Sarah/AAM-4700-2021; TIRODE, Franck/HHS-7070-2022; Tirode, Franck/B-4586-2009	Cohen-Gogo, Sarah/0000-0002-8852-1104; Lucchesi, Carlo/0000-0001-6657-2341; delattre, olivier/0000-0002-8730-2276; Tirode, Franck/0000-0003-4731-7817	Ligue Nationale Contre le Cancer; Region Ile de France; Institut National du Cancer (INCa) [2008-044, 0627, ZP09-027-EPI]; European Union (European Embryonal Tumors pipeline); Courir pour Mathieu; Dans les Pas du Geant; Olivier Chape; Les Bagouzamanon; Les Amis de Claire	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Region Ile de France(Region Ile-de-France); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); European Union (European Embryonal Tumors pipeline); Courir pour Mathieu; Dans les Pas du Geant; Olivier Chape; Les Bagouzamanon; Les Amis de Claire	We thank S. Chanock for fruitful discussions and critical reading of the manuscript. We are indebted to V. Raynal, P. Legoix-Ne, A. Nicolas, D. Gentien, S. Lair, A. Lermine and E. Barillot for critical technical help. We thank the following individuals for contributing cases and paraffin blocks or for supplying clinical information: J. Champigneulle, A. Croue, P. Dechelotte, J.M. Guinebretiere, C. Jeanne-Pasquier, A. Moreau, J.M. Picquenot, D. Ranchere-Vince, X. Sastre-Garau, P. Terrier, M.C. Vacher-Lavenue, V. Verkaere and L. Guillou. We thank E. Louis, S. Thoraval and T. Scarcez from the Life Science Company for help in applying SOLiD technology. We also thank N. Bretschneider, C. Gugenmus, M. Scherf and M. Seifert from the Genomatix company for the analysis of data. This work was supported by grants from the Ligue Nationale Contre le Cancer (Equipe Labellisee and Carte d'Identite des Tumeurs program), the Region Ile de France, the Institut National du Cancer (INCa; 2008-044, 0627 and ZP09-027-EPI), the European Union (European Embryonal Tumors pipeline) and the following associations: Courir pour Mathieu, Dans les Pas du Geant, Olivier Chape, Les Bagouzamanon and Les Amis de Claire.	Armengol G, 1997, BRIT J CANCER, V75, P1403, DOI 10.1038/bjc.1997.242; Broadhead Matthew L., 2011, Sarcoma, V2011, P959248, DOI 10.1155/2011/959248; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Dauphinot L, 2001, ONCOGENE, V20, P3258, DOI 10.1038/sj.onc.1204437; DELATTRE O, 1994, NEW ENGL J MED, V331, P294, DOI 10.1056/NEJM199408043310503; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Fan ZP, 2009, NAT CELL BIOL, V11, P1002, DOI 10.1038/ncb1913; GALLANT P, 1994, EMBO J, V13, P595, DOI 10.1002/j.1460-2075.1994.tb06297.x; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Grossmann V, 2011, BLOOD, V118, P6153, DOI 10.1182/blood-2011-07-365320; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huynh KD, 2000, GENE DEV, V14, P1810; Kawamura-Saito M, 2006, HUM MOL GENET, V15, P2125, DOI 10.1093/hmg/ddl136; Maher CA, 2009, P NATL ACAD SCI USA, V106, P12353, DOI 10.1073/pnas.0904720106; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ng D, 2004, NAT GENET, V36, P411, DOI 10.1038/ng1321; Ng TL, 2007, J MOL DIAGN, V9, P459, DOI 10.2353/jmoldx.2007.070009; Nguyen TB, 2002, J BIOL CHEM, V277, P41960, DOI 10.1074/jbc.M203951200; Peter M, 2001, LAB INVEST, V81, P905, DOI 10.1038/labinvest.3780299; Sboner A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r104; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szuhai K, 2009, CLIN CANCER RES, V15, P2259, DOI 10.1158/1078-0432.CCR-08-2184; Toomey EC, 2010, ONCOGENE, V29, P4504, DOI 10.1038/onc.2010.205; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Venables W.N., 2005, R LANGUAGE ENV STAT; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Yamamoto Y, 2010, BLOOD, V116, P4274, DOI 10.1182/blood-2010-01-264432	27	281	299	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2012	44	4					461	U151		10.1038/ng.1107	http://dx.doi.org/10.1038/ng.1107			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	916VF	22387997	Green Submitted			2022-12-25	WOS:000302130600024
J	Riviere, JB; van Bon, BWM; Hoischen, A; Kholmanskikh, SS; O'Roak, BJ; Gilissen, C; Gijsen, S; Sullivan, CT; Christian, SL; Abdul-Rahman, OA; Atkin, JF; Chassaing, N; Drouin-Garraud, V; Fry, AE; Fryns, JP; Gripp, KW; Kempers, M; Kleefstra, T; Mancini, GMS; Nowaczyk, MJM; van Ravenswaaij-Arts, CMA; Roscioli, T; Marble, M; Rosenfeld, JA; Siu, VM; de Vries, BBA; Shendure, J; Verloes, A; Veltman, JA; Brunner, HG; Ross, ME; Pilz, DT; Dobyns, WB				Riviere, Jean-Baptiste; van Bon, Bregje W. M.; Hoischen, Alexander; Kholmanskikh, Stanislav S.; O'Roak, Brian J.; Gilissen, Christian; Gijsen, Sabine; Sullivan, Christopher T.; Christian, Susan L.; Abdul-Rahman, Omar A.; Atkin, Joan F.; Chassaing, Nicolas; Drouin-Garraud, Valerie; Fry, Andrew E.; Fryns, Jean-Pierre; Gripp, Karen W.; Kempers, Marlies; Kleefstra, Tjitske; Mancini, Grazia M. S.; Nowaczyk, Malgorzata J. M.; van Ravenswaaij-Arts, Conny M. A.; Roscioli, Tony; Marble, Michael; Rosenfeld, Jill A.; Siu, Victoria M.; de Vries, Bert B. A.; Shendure, Jay; Verloes, Alain; Veltman, Joris A.; Brunner, Han G.; Ross, M. Elizabeth; Pilz, Daniela T.; Dobyns, William B.			De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome	NATURE GENETICS			English	Article							DNA-SEQUENCING DATA; BETA-ACTIN; MENTAL-RETARDATION; NOONAN-SYNDROME; IRIS COLOBOMA; GAMMA-ACTIN; MALFORMATIONS; IDENTIFICATION; PTOSIS; GROWTH	Brain malformations are individually rare but collectively common causes of developmental disabilities(1-3). Many forms of malformation occur sporadically and are associated with reduced reproductive fitness, pointing to a causative role for de novo mutations(4,5). Here, we report a study of Baraitser-Winter syndrome, a well-defined disorder characterized by distinct craniofacial features, ocular colobomata and neuronal migration defect(6,7). Using whole-exome sequencing of three proband-parent trios, we identified de novo missense changes in the cytoplasmic actin-encoding genes ACTB and ACTG1 in one and two probands, respectively. Sequencing of both genes in 15 additional affected individuals identified disease-causing mutations in all probands, including two recurrent de novo alterations (ACTB, encoding p. Arg196His, and ACTG1, encoding p. Ser155Phe). Our results confirm that trio-based exome sequencing is a powerful approach to discover genes causing sporadic developmental disorders, emphasize the overlapping roles of cytoplasmic actin proteins in development and suggest that Baraitser-Winter syndrome is the predominant phenotype associated with mutation of these two genes.	[Fry, Andrew E.; Pilz, Daniela T.] Univ Wales Hosp, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales; [Riviere, Jean-Baptiste; Sullivan, Christopher T.; Christian, Susan L.; Dobyns, William B.] Seattle Childrens Hosp, Ctr Integrat Brain Res, Seattle, WA USA; [van Bon, Bregje W. M.; Hoischen, Alexander; Gilissen, Christian; Gijsen, Sabine; Kempers, Marlies; Kleefstra, Tjitske; Roscioli, Tony; de Vries, Bert B. A.; Veltman, Joris A.; Brunner, Han G.] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Kholmanskikh, Stanislav S.; Ross, M. Elizabeth] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA; [O'Roak, Brian J.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Abdul-Rahman, Omar A.] Univ Mississippi, Med Ctr, Dept Pediat, Jackson, MS 39216 USA; [Atkin, Joan F.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Chassaing, Nicolas] Toulouse Univ Hosp, Dept Med Genet, Toulouse, France; [Chassaing, Nicolas] Univ Toulouse 3, F-31062 Toulouse, France; [Drouin-Garraud, Valerie] Univ Hosp, Dept Genet, Rouen, France; [Fryns, Jean-Pierre] Univ Hosp Leuven, Dept Menselijke Erfelijkheid, Ctr Human Genet, Louvain, Belgium; [Gripp, Karen W.] Alfred I duPont Hosp Children, Div Med Genet, Wilmington, DE USA; [Mancini, Grazia M. S.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Nowaczyk, Malgorzata J. M.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [van Ravenswaaij-Arts, Conny M. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Marble, Michael] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA USA; [Marble, Michael] Childrens Hosp New Orleans, New Orleans, LA USA; [Rosenfeld, Jill A.] PerkinElmer, Signature Genom Labs, Spokane, WA USA; [Siu, Victoria M.] Univ Western Ontario, Dept Pediat, London, ON N6A 3K7, Canada; [Verloes, Alain] Hop Robert Debre, Dept Genet, F-75019 Paris, France; [Dobyns, William B.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Dobyns, William B.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA	Cardiff University; Seattle Children's Hospital; Radboud University Nijmegen; Cornell University; University of Washington; University of Washington Seattle; University of Mississippi; University of Mississippi Medical Center; University System of Ohio; Ohio State University; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Rouen; KU Leuven; University Hospital Leuven; Nemours Alfred I. duPont Hospital for Children; Erasmus University Rotterdam; Erasmus MC; McMaster University; University of Groningen; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Children's Hospital of New Orleans; Western University (University of Western Ontario); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Pilz, DT (corresponding author), Univ Wales Hosp, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales.	daniela.pilz@wales.nhs.uk; wbd@uw.edu	Fry, Andrew/AAN-2730-2020; Fry, Andrew/AFK-7448-2022; van Bon, Bregje/D-3720-2013; Hoischen, Alexander/D-1282-2013; Gilissen, Christian/E-5246-2012; Kleefstra, Tjitske/G-2619-2012; Brunner, Han/C-9928-2013; Dobyns, William/AAI-2768-2020; Veltman, Joris A/F-5128-2010; /AAK-8500-2021; Shendure, Jay/AAU-3684-2021; van Bon, Bregje/Q-2445-2015; Hoischen, Alexander/AGF-7293-2022; Dobyns, William Brian/ABC-6525-2021; VERLOES, Alain/E-7287-2014	Fry, Andrew/0000-0001-9778-6924; Fry, Andrew/0000-0001-9778-6924; Hoischen, Alexander/0000-0002-8072-4476; Gilissen, Christian/0000-0003-1693-9699; Dobyns, William/0000-0002-7681-2844; Veltman, Joris A/0000-0002-3218-8250; van Bon, Bregje/0000-0003-2234-0105; Hoischen, Alexander/0000-0002-8072-4476; O'Roak, Brian/0000-0002-4141-0095; VERLOES, Alain/0000-0003-4819-0264; Shendure, Jay/0000-0002-1516-1865	US National Institutes of Health [NS058721, NS048120]; Netherlands Organization for Health Research and Development (ZonMW) [917-66-363, 911-08-025]; European Union (EU) [Health-F5-2009-223143]; AnEUploidy project [LSHG-CT-2006-37627]; Canadian Institutes of Health Research; Australian National Health and Medical Research Council (NHMRC); Simons Foundation Autism Research Initiative (SFARI) [191889]; National Institute of Environmental Health Services (NIEHS) [HHSN273200800010C]; NHLBI GO Exome Sequencing Project; Lung GO Sequencing Project [HL-102923]; Women's Health Initiative (WHI) [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UC2HL103010, UC2HL102926, RC2HL102926, UC2HL102923, RC2HL102923, RC2HL102924, RC2HL103010, UC2HL102925, UC2HL102924, RC2HL102925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058721, P01NS048120] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); European Union (EU)(CGIAREuropean Commission); AnEUploidy project; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Simons Foundation Autism Research Initiative (SFARI); National Institute of Environmental Health Services (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI GO Exome Sequencing Project; Lung GO Sequencing Project; Women's Health Initiative (WHI); Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the families for their contribution to this study. We thank all members of the Northwest Genomics Center and Genomic Disorders Group Nijmegen, as well as personnel from the Microarray Facility and Sequencing Facility Nijmegen, for excellent technical assistance. This work was supported by grants from the US National Institutes of Health (NS058721 to W.B.D. and NS048120 to M.E.R.), the Netherlands Organization for Health Research and Development (ZonMW; 917-66-363 and 911-08-025 to J.A.V.), the European Union (EU)-funded TECHGENE project (Health-F5-2009-223143 to J.A.V.) and the AnEUploidy project (LSHG-CT-2006-37627 to A.H., B.W.M.v.B., H.G.B. and J.A.V.). J.-B.R. is supported by a Banting Postdoctoral Fellowship from the Canadian Institutes of Health Research. T.R. is supported by an Australian National Health and Medical Research Council (NHMRC) postdoctoral fellowship. We thank the Simons Foundation Autism Research Initiative (SFARI) that provided control exome data (191889), the National Institute of Environmental Health Services (NIEHS) Environmental Genome Project for providing support for this project (HHSN273200800010C) and the NHLBI GO Exome Sequencing Project and its ongoing studies that produced and provided exome variant calls for comparison, including the Lung GO Sequencing Project (HL-102923), the Women's Health Initiative (WHI) Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926) and the Heart GO Sequencing Project (HL-103010).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; BARAITSER M, 1988, J MED GENET, V25, P41, DOI 10.1136/jmg.25.1.41; Belyantseva IA, 2009, P NATL ACAD SCI USA, V106, P9703, DOI 10.1073/pnas.0900221106; Buetow KH, 1999, NAT GENET, V21, P323, DOI 10.1038/6851; Bunnell TM, 2010, CYTOSKELETON, V67, P564, DOI 10.1002/cm.20467; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dugina V, 2009, J CELL SCI, V122, P2980, DOI 10.1242/jcs.041970; Fryns JP, 2000, J MED GENET, V37, P460, DOI 10.1136/jmg.37.6.460; GARRELS JI, 1976, CELL, V9, P793, DOI 10.1016/0092-8674(76)90142-2; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Glinianaia SV, 2011, ARCH DIS CHILD, V96, P180, DOI 10.1136/adc.2010.183939; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; GUPTON SL, 2007, SCI STKE, pRE5, DOI DOI 10.1126/STKE.4002007RE5; Harborth J, 2001, J CELL SCI, V114, P4557; Hofer D, 1997, J CELL SCI, V110, P765; Hoischen A, 2011, NAT GENET, V43, P729, DOI 10.1038/ng.868; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Ibrahimi OA, 2004, HUM MOL GENET, V13, P69, DOI 10.1093/hmg/ddh011; Kholmanskikh SS, 2006, NAT NEUROSCI, V9, P50, DOI 10.1038/nn1619; Kholmanskikh SS, 2003, J NEUROSCI, V23, P8673; Lambrechts A, 2004, INT J BIOCHEM CELL B, V36, P1890, DOI 10.1016/j.biocel.2004.01.024; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Nunoi H, 1999, P NATL ACAD SCI USA, V96, P8693, DOI 10.1073/pnas.96.15.8693; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Procaccio V, 2006, AM J HUM GENET, V78, P947, DOI 10.1086/504271; RAMER JC, 1995, AM J MED GENET, V57, P403, DOI 10.1002/ajmg.1320570308; Rankin J, 2010, DEV MED CHILD NEUROL, V52, P345, DOI 10.1111/j.1469-8749.2009.03415.x; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rossi M, 2003, NEUROPEDIATRICS, V34, P287; SCARANO E, 1967, P NATL ACAD SCI USA, V57, P1394, DOI 10.1073/pnas.57.5.1394; Shawlot W, 1998, TRANSGENIC RES, V7, P95, DOI 10.1023/A:1008816308171; Tartaglia M, 2005, ANNU REV GENOM HUM G, V6, P45, DOI 10.1146/annurev.genom.6.080604.162305; VANDEKERCKHOVE J, 1978, J MOL BIOL, V126, P783, DOI 10.1016/0022-2836(78)90020-7; VERLOES A, 1993, J MED GENET, V30, P425, DOI 10.1136/jmg.30.5.425; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; VONWENDT L, 1986, CHILD NERV SYST, V2, P80, DOI 10.1007/BF00286225; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yarmola EG, 2000, J BIOL CHEM, V275, P28120; Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286	50	176	184	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2012	44	4					440	U255		10.1038/ng.1091	http://dx.doi.org/10.1038/ng.1091			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	916VF	22366783	Green Submitted, Green Accepted			2022-12-25	WOS:000302130600020
J	Shim, J; Mukherjee, T; Banerjee, U				Shim, Jiwon; Mukherjee, Tina; Banerjee, Utpal			Direct sensing of systemic and nutritional signals by haematopoietic progenitors in Drosophila	NATURE CELL BIOLOGY			English	Article							INSULIN-LIKE PEPTIDES; STEM-CELLS; GROWTH; PROTEIN; INFLAMMATION; MAINTENANCE; ACTIVATION; EXPRESSION; HOMOLOG; GENES	The Drosophila lymph gland is a haematopoietic organ in which progenitor cells, which are most akin to the common myeloid progenitor in mammals, proliferate and differentiate into three types of mature cell-plasmatocytes, crystal cells and lamellocytes-the functions of which are reminiscent of mammalian myeloid cells'. During the first and early second instars of larval development, the lymph gland contains only progenitors, whereas in the third instar, a medial region of the primary lobe of the lymph gland called the medullary zone contains these progenitors(2), and maturing blood cells are found juxtaposed in a peripheral region designated the cortical zone(2). A third group of cells referred to as the posterior signalling centre functions as a haematopoietic niche(3,4). Similarly to mammalian myeloid cells, Drosophila blood cells respond to multiple stresses including hypoxia, infection and oxidative stress(5-7). However, how systemic signals are sensed by myeloid progenitors to regulate cell-fate determination has not been well described. Here, we show that the haematopoietic progenitors of Drosophila are direct targets of systemic (insulin) and nutritional (essential amino acid) signals, and that these systemic signals maintain the progenitors by promoting Wingless (WNT in mammals) signalling. We expect that this study will promote investigation of such possible direct signal sensing mechanisms by mammalian myeloid progenitors.	[Shim, Jiwon; Mukherjee, Tina; Banerjee, Utpal] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Banerjee, U (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	banerjee@mbi.ucla.edu	Shim, Jiwon/AAQ-4501-2021	Shim, Jiwon/0000-0003-2409-1130	NIH [5R01 HL067395]; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research Training Grant at UCLA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067395] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research Training Grant at UCLA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank C. J. Evans, K. T. Jones, other members of the Banerjee laboratory and J. A. Martinez-Agosto for helpful comments and discussions. We thank R. Erdmann for help with the amino-acid supplementation assay and S. Pham for confirming experiments with anti-Hml in different genetic backgrounds. We acknowledge P. Leopold, E. Hafen, E. Rulifs on, L. Pick, T. P. Neufeld, R. A. Schulz, A. Courey, J-M. Reichhart, the VDRC Stock Center and the Bloomington Stock Center for fly stocks, the Developmental Studies Hybridoma Bank (University of Iowa), the Drosophila Genomics Resource Center and J. Fessler for reagents. We also thank M. Cr ozatiers' group for providing the in situ hybridization protocol. This work was supported by an NIH grant (5R01 HL067395) to U.B. and the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research Training Grant at UCLA to J.S.	Becker T, 2010, NATURE, V463, P369, DOI 10.1038/nature08698; Bidla G, 2007, J CELL SCI, V120, P1209, DOI 10.1242/jcs.03420; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Chell JM, 2010, CELL, V143, P1161, DOI 10.1016/j.cell.2010.12.007; Choi NH, 2011, P NATL ACAD SCI USA, V108, P18702, DOI 10.1073/pnas.1109348108; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Flores-Saaib RD, 2001, DEVELOPMENT, V128, P1869; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Goto A, 2001, BIOCHEM J, V359, P99, DOI 10.1042/0264-6021:3590099; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hennig KM, 2006, J CELL BIOL, V173, P963, DOI 10.1083/jcb.200511140; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hsu HJ, 2009, P NATL ACAD SCI USA, V106, P1117, DOI 10.1073/pnas.0809144106; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Lee JY, 2010, CELL STEM CELL, V7, P593, DOI 10.1016/j.stem.2010.09.015; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Mandal L, 2007, NATURE, V446, P320, DOI 10.1038/nature05585; McLeod CJ, 2010, CURR BIOL, V20, P2100, DOI 10.1016/j.cub.2010.10.038; Meister M, 2004, CURR OPIN IMMUNOL, V16, P10, DOI 10.1016/j.coi.2003.11.002; Mukherjee T, 2011, SCIENCE, V332, P1210, DOI 10.1126/science.1199643; NELSON RE, 1994, EMBO J, V13, P3438, DOI 10.1002/j.1460-2075.1994.tb06649.x; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Rutter Guy A., 2001, Molecular Aspects of Medicine, V22, P247, DOI 10.1016/S0098-2997(01)00013-9; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Sinenko SA, 2009, DEV CELL, V16, P756, DOI 10.1016/j.devcel.2009.03.003; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Sousa-Nunes R, 2011, NATURE, V471, P508, DOI 10.1038/nature09867; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhang H, 2009, P NATL ACAD SCI USA, V106, P19617, DOI 10.1073/pnas.0905083106	39	98	98	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2012	14	4					394	+		10.1038/ncb2453	http://dx.doi.org/10.1038/ncb2453			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	921UM	22407365	Green Accepted, Green Submitted			2022-12-25	WOS:000302503300012
J	Yui, SR; Nakamura, T; Sato, T; Nemoto, Y; Mizutani, T; Zheng, X; Ichinose, S; Nagaishi, T; Okamoto, R; Tsuchiya, K; Clevers, H; Watanabe, M				Yui, Shiro; Nakamura, Tetsuya; Sato, Toshiro; Nemoto, Yasuhiro; Mizutani, Tomohiro; Zheng, Xiu; Ichinose, Shizuko; Nagaishi, Takashi; Okamoto, Ryuichi; Tsuchiya, Kiichiro; Clevers, Hans; Watanabe, Mamoru			Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5(+) stem cell	NATURE MEDICINE			English	Article							INTESTINAL EPITHELIUM; SELF-RENEWAL; R-SPONDIN1; GROWTH; REGENERATION; INHIBITION; RECEPTORS; SIGNALS; LRP6; MICE	Adult stem-cell therapy holds promise for the treatment of gastrointestinal diseases. Here we describe methods for long-term expansion of colonic stem cells positive for leucine-rich repeat containing G protein-coupled receptor 5 (Lgr5(+) cells) in culture. To test the transplantability of these cells, we reintroduced cultured GFP(+) colon organoids into superficially damaged mouse colon. The transplanted donor cells readily integrated into the mouse colon, covering the area that lacked epithelium as a result of the introduced damage in recipient mice. At 4 weeks after transplantation, the donor-derived cells constituted a single-layered epithelium, which formed self-renewing crypts that were functionally and histologically normal. Moreover, we observed long-term (>6 months) engraftment with transplantation of organoids derived from a single Lgr5(+) colon stem cell after extensive in vitro expansion. These data show the feasibility of colon stem-cell therapy based on the in vitro expansion of a single adult colonic stem cell.	[Sato, Toshiro; Clevers, Hans] Hubrecht Inst, Utrecht, Netherlands; [Sato, Toshiro; Clevers, Hans] Univ Med Ctr, Utrecht, Netherlands; [Yui, Shiro; Nemoto, Yasuhiro; Mizutani, Tomohiro; Zheng, Xiu; Nagaishi, Takashi; Tsuchiya, Kiichiro; Watanabe, Mamoru] Tokyo Med & Dent Univ, Dept Gastroenterol & Hepatol, Grad Sch, Bunkyo Ku, Tokyo, Japan; [Nakamura, Tetsuya; Okamoto, Ryuichi] Tokyo Med & Dent Univ, Dept Adv Therapeut Gastrointestinal Dis, Bunkyo Ku, Tokyo, Japan; [Ichinose, Shizuko] Tokyo Med & Dent Univ, Res Ctr Med & Dent Sci, Bunkyo Ku, Tokyo, Japan	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Clevers, H (corresponding author), Hubrecht Inst, Utrecht, Netherlands.	h.clevers@hubrecht.eu; mamoru.gast@tmd.ac.jp	Mizutani, Tomohiro/AAX-5650-2021; Tsuchiya, Kiichiro/AAB-1769-2020; Sato, Toshiro/J-3522-2014; Watanabe, Mamoru/AHE-0489-2022; Okamoto, Ryuichi/I-1130-2019	Mizutani, Tomohiro/0000-0002-8373-7969; Tsuchiya, Kiichiro/0000-0002-1977-8707; Sato, Toshiro/0000-0001-8353-8137; Okamoto, Ryuichi/0000-0002-7047-571X; Yui, Shiro/0000-0003-4268-647X	Japanese Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare of Japan; European Research Council; Dutch Cancer Foundation; Grants-in-Aid for Scientific Research [22590696, 24390186, 21590806, 24112508, 21590803] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); European Research Council(European Research Council (ERC)European Commission); Dutch Cancer Foundation(KWF Kankerbestrijding); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Okabe (Osaka University) for EGFP transgenic mice and Y. Kato, J. Inazawa, I. Sekiya (TMDU), H. Snippert and R. Vries (Hubrecht Institute) for technical assistance. This study was supported by Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology, by the Health and Labour Sciences Research Grants for Research on Intractable Diseases from Ministry of Health, Labour and Welfare of Japan, and by a grant from the European Research Council and from the Dutch Cancer Foundation.	Avansino JR, 2006, J SURG RES, V132, P74, DOI 10.1016/j.jss.2005.09.009; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Bjerknes M, 2006, METHOD ENZYMOL, V419, P337, DOI 10.1016/S0076-6879(06)19014-X; Booth C, 1995, EPITHELIAL CELL BIOL, V4, P76; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Gerbe F, 2011, J CELL BIOL, V192, P767, DOI 10.1083/jcb.201010127; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Kanayama M, 2007, AM J PHYSIOL-GASTR L, V293, pG230, DOI 10.1152/ajpgi.00068.2007; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Okamoto R, 2009, AM J PHYSIOL-GASTR L, V296, pG23, DOI 10.1152/ajpgi.90225.2008; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Tahara Y, 2003, J PHARMACOL EXP THER, V307, P146, DOI 10.1124/jpet.103.054106; TAIT IS, 1994, AM J SURG, V167, P67, DOI 10.1016/0002-9610(94)90055-8; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; van Es JH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1017; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Whitehead RH, 1999, GASTROENTEROLOGY, V117, P858, DOI 10.1016/S0016-5085(99)70344-6; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200	34	495	532	2	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2012	18	4					618	623		10.1038/nm.2695	http://dx.doi.org/10.1038/nm.2695			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22406745				2022-12-25	WOS:000302617800041
J	Benhamed, M; Herbig, U; Ye, T; Dejean, A; Bischof, O				Benhamed, Moussa; Herbig, Utz; Ye, Tao; Dejean, Anne; Bischof, Oliver			Senescence is an endogenous trigger for microRNA-directed transcriptional gene silencing in human cells	NATURE CELL BIOLOGY			English	Article							CELLULAR SENESCENCE; HISTONE DEACETYLASE; TUMOR-CELLS; RB; CHROMATIN; EXPRESSION; BINDING; PROTEIN; METHYLATION; INHIBITION	Cellular senescence is a tumour-suppressor mechanism that is triggered by cancer-initiating or promoting events in mammalian cells. The molecular underpinnings for this stable arrest involve transcriptional repression of proliferation-promoting genes regulated by the retinoblastoma (RB1)/E2F repressor complex. Here, we demonstrate that AGO2, RB1 and microRNAs (miRNAs), as exemplified here by let-7, physically and functionally interact to repress RB1/E2F-target genes in senescence, a process that we call senescence-associated transcriptional gene silencing (SA-TGS). Herein, AGO2 acts as the effector protein for let-7-directed implementation of silent-state chromatin modifications at target promoters, and inhibition of the let-7/AGO2 effector complex perturbs the timely execution of senescence. Thus, we identify cellular senescence as the an endogenous signal of miRNA/AGO2-mediated TGS in human cells. Our results suggest that miRNA/AGO2-mediated SA-TGS may contribute to tumour suppression by stably repressing proliferation-promoting genes in premalignant cancer cells.	[Benhamed, Moussa; Dejean, Anne; Bischof, Oliver] Inst Pasteur, Nucl Org & Oncogenesis Unit, Dept Cell Biol & Infect, F-75015 Paris, France; [Benhamed, Moussa; Dejean, Anne; Bischof, Oliver] INSERM, U993, F-75015 Paris, France; [Herbig, Utz] Univ Med & Dent New Jersey, New Jersey Med Sch, Univ Hosp Canc Ctr, Newark, NJ 07103 USA; [Herbig, Utz] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ 07103 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Bischof, O (corresponding author), Inst Pasteur, Nucl Org & Oncogenesis Unit, Dept Cell Biol & Infect, F-75015 Paris, France.	anne.dejean@pasteur.fr; Oliver.bischof@pasteur.fr	Dejean, Anne/L-5145-2018; Bischof, Oliver/K-1548-2019		Ligue Nationale Contre le Cancer (Equipe labellisee); Association for International Cancer Research; Agence Nationale de la Recherche; Association pour la Recherche sur le Cancer (ARC); OdysseyRe; New Jersey Commission on Cancer Research [09-1124-CCR-EO]; NATIONAL CANCER INSTITUTE [R01CA136533] Funding Source: NIH RePORTER	Ligue Nationale Contre le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); Association for International Cancer Research; Agence Nationale de la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); OdysseyRe; New Jersey Commission on Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank A. Verdel and M. Yaniv for discussions and critical reading of the manuscript. We are grateful to P. Adams for providing the anti-macroH2A antibody to U.H. and N. Mirani for technical help with histopathology as well as S. Volinia and C. Croce for miRNA profiling and J. Doudement (GenomeQuest, France) for bioinformatics analysis. This work was supported by grants from Ligue Nationale Contre le Cancer (Equipe labellisee), Association for International Cancer Research, Agence Nationale de la Recherche, Association pour la Recherche sur le Cancer (ARC), OdysseyRe and the New Jersey Commission on Cancer Research 09-1124-CCR-EO to U.H. O.B. is a CNRS (Centre National de la Recherche Scientifique) fellow, A.D. Institut National de la Sante et de la Recherche Medicate (INSERM)/Institut Pasteur and M.B. was supported by ARC.	Adams PD, 2007, AGING CELL, V6, P425, DOI 10.1111/j.1474-9726.2007.00313.x; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Bischof O, 2005, MOL CELL BIOL, V25, P1013, DOI 10.1128/MCB.25.3.1013-1024.2005; Bischof O, 2006, MOL CELL, V22, P783, DOI 10.1016/j.molcel.2006.05.016; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Chang BD, 1999, CANCER RES, V59, P3761; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; DALTON S, 1992, EMBO J, V11, P1797, DOI 10.1002/j.1460-2075.1992.tb05231.x; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283; Han J, 2007, P NATL ACAD SCI USA, V104, P12422, DOI 10.1073/pnas.0701635104; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Ji P, 2004, MOL CELL, V16, P47, DOI 10.1016/j.molcel.2004.09.029; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kim MS, 2010, J PATHOL, V221, P139, DOI 10.1002/path.2683; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Li L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-38; Liu CG, 2008, METHODS, V44, P22, DOI 10.1016/j.ymeth.2007.10.010; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Meng L, 2003, PLANT MOL BIOL, V53, P327, DOI 10.1023/B:PLAN.0000006942.00464.e3; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Morris KV, 2008, CURR TOP MICROBIOL, V320, P211; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Rabinovich A, 2008, GENOME RES, V18, P1763, DOI 10.1101/gr.080622.108; Ricke RM, 2005, BIOL PROCED ONLINE, V7, P60, DOI 10.1251/bpo106; Ro S, 2007, RNA, V13, P1693, DOI 10.1261/rna.640307; Ross JF, 2001, GENE DEV, V15, P392, DOI 10.1101/gad.858501; Rudel S, 2008, RNA, V14, P1244, DOI 10.1261/rna.973808; Sporn JC, 2009, ONCOGENE, V28, P3423, DOI 10.1038/onc.2009.26; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; Zhou YM, 2010, P NATL ACAD SCI USA, V107, P7904, DOI 10.1073/pnas.0908441107	39	179	181	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2012	14	3					266	+		10.1038/ncb2443	http://dx.doi.org/10.1038/ncb2443			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	900ZE	22366686	Green Accepted			2022-12-25	WOS:000300930400009
J	Rexach, JE; Clark, PM; Mason, DE; Neve, RL; Peters, EC; Hsieh-Wilson, LC				Rexach, Jessica E.; Clark, Peter M.; Mason, Daniel E.; Neve, Rachael L.; Peters, Eric C.; Hsieh-Wilson, Linda C.			Dynamic O-GlcNAc modification regulates CREB-mediated gene expression and memory formation	NATURE CHEMICAL BIOLOGY			English	Article							ELEMENT-BINDING PROTEIN; LONG-TERM-MEMORY; SYNAPTIC PLASTICITY; DEPENDENT TRANSCRIPTION; N-ACETYLGLUCOSAMINE; PHOSPHORYLATION; GLYCOSYLATION; NEURONS; KINASE; CONSOLIDATION	The transcription factor cyclic AMP-response element binding protein (CREB) is a key regulator of many neuronal processes, including brain development, circadian rhythm and long-term memory. Studies of CREB have focused on its phosphorylation, although the diversity of CREB functions in the brain suggests additional forms of regulation. Here we expand on a chemoenzymatic strategy for quantifying glycosylation stoichiometries to characterize the functional roles of CREB glycosylation in neurons. We show that CREB is dynamically modified with an O-linked beta-N-acetyl-D-glucosamine sugar in response to neuronal activity and that glycosylation represses CREB-dependent transcription by impairing its association with CREB-regulated transcription coactivator (CRTC; also known as transducer of regulated CREB activity). Blocking glycosylation of CREB alters cellular function and behavioral plasticity, enhancing both axonal and dendritic growth and long-term memory consolidation. Our findings demonstrate a new role for O-glycosylation in memory formation and provide a mechanistic understanding of how glycosylation contributes to critical neuronal functions. Moreover, we identify a previously unknown mechanism for the regulation of activity-dependent gene expression, neural development and memory.	[Rexach, Jessica E.; Clark, Peter M.; Hsieh-Wilson, Linda C.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Rexach, Jessica E.; Clark, Peter M.; Hsieh-Wilson, Linda C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Mason, Daniel E.; Peters, Eric C.] Novartis Res Fdn, Genom Inst, San Diego, CA USA; [Neve, Rachael L.] MIT, Picower Inst, Cambridge, MA 02139 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Novartis; Massachusetts Institute of Technology (MIT)	Rexach, JE (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	lhw@caltech.edu	Peters, Eric/W-2739-2019		US National Institutes of Health [R01 GM084724, F31 NS056525, 5T32 GM07737]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084724, T32GM007737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS056525] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Antoniou (King's College London School of Medicine) for the pA2UCOE-EGFP construct, M. Greenberg (Harvard University) for the pLEMPRA-GOI and pLLX-shRNA constructs, G. Hart (The John Hopkins University School of Medicine) for the OGT-specific antibody, S. Josselyn (University of Toronto) for the p1005-CREB construct, R. Lansford (California Institute of Technology) for the pLenti PGK-H2B-mCherry construct, R. Malenka (Stanford University) and X. Yu (Shanghai Institutes for Biological Sciences) for the pcDNA3-Dkk-1-Flag and Ncad(intra) constructs, P. Qasba (US National Cancer Institute) for the Y289L GalT construct and L. Wells (University of Georgia) for the pDEST-HA-OGA construct. We thank S.-H. Yu (California Institute of Technology) for synthesizing the UDP-ketogalactose substrate and D. Anderson (California Institute of Technology) for providing the fear conditioning apparatus. We thank A. Silva for a critical reading of the manuscript. This work was supported by grants from the US National Institutes of Health (R01 GM084724 to L.C.H.-W, F31 NS056525 to J.E.R. and National Research Service Award Training Grant 5T32 GM07737 to P.M.C.).	Aguado F, 2009, J NEUROSCI, V29, P328, DOI 10.1523/JNEUROSCI.5252-08.2009; Barco A, 2008, TRANSCRIPTIONAL REGULATION BY NEURONAL ACTIVITY, P127, DOI 10.1007/978-0-387-73609-9_7; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Deisseroth K, 2002, NEURON, V34, P179, DOI 10.1016/S0896-6273(02)00664-5; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Francisco H, 2009, DEV NEUROBIOL, V69, P162, DOI 10.1002/dneu.20695; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gau D, 2002, NEURON, V34, P245, DOI 10.1016/S0896-6273(02)00656-6; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Khidekel N, 2004, P NATL ACAD SCI USA, V101, P13132, DOI 10.1073/pnas.0403471101; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Lamarre-Vincent N, 2003, J AM CHEM SOC, V125, P6612, DOI 10.1021/ja028200t; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Lu Q, 2003, J BIOL CHEM, V278, P15727, DOI 10.1074/jbc.M300546200; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Rengifo J, 2007, J NEUROSCI, V27, P13813, DOI 10.1523/JNEUROSCI.2069-07.2007; Rexach JE, 2008, NAT CHEM BIOL, V4, P97, DOI 10.1038/nchembio.68; Rexach JE, 2010, NAT CHEM BIOL, V6, P645, DOI [10.1038/NCHEMBIO.412, 10.1038/nchembio.412]; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Tallent MK, 2009, J BIOL CHEM, V284, P174, DOI 10.1074/jbc.M807431200; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Viosca J, 2009, LEARN MEMORY, V16, P193, DOI 10.1101/lm.1254209; Vosseller K, 2006, MOL CELL PROTEOMICS, V5, P923, DOI 10.1074/mcp.T500040-MCP200; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Wearne SL, 2005, NEUROSCIENCE, V136, P661, DOI 10.1016/j.neuroscience.2005.05.053; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Xiong W, 2006, BRAIN RES, V1085, P68, DOI 10.1016/j.brainres.2006.02.015; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	50	136	141	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2012	8	3					253	261		10.1038/NCHEMBIO.770	http://dx.doi.org/10.1038/NCHEMBIO.770			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896VR	22267118	Green Accepted			2022-12-25	WOS:000300600000010
J	Bretschneider, T; Zocher, G; Unger, M; Scherlach, K; Stehle, T; Hertweck, C				Bretschneider, Tom; Zocher, Georg; Unger, Michelle; Scherlach, Kirstin; Stehle, Thilo; Hertweck, Christian			A ketosynthase homolog uses malonyl units to form esters in cervimycin biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN SYNTHASE-III; GENE-CLUSTER; BETA-KETOACYL; CRYSTAL-STRUCTURE; POLYKETIDE SYNTHASES; SUBSTRATE-SPECIFICITY; ESCHERICHIA-COLI; MOLECULAR ANALYSIS; ACYL-TRANSFER; STARTER UNIT	Ketosynthases produce the carbon backbones of a vast number of biologically active polyketides by catalyzing Claisen condensations of activated acyl and malonyl building blocks. Here we report that a ketosynthase homolog from Streptomyces tendae, CerJ, unexpectedly forms malonyl esters during the biosynthesis of cervimycin, a glycoside antibiotic against methicillinresistant Staphylococcus aureus (MRSA). Deletion of cerJ yielded a substantially more active cervimycin variant lacking the malonyl side chain, and in vitro biotransformations revealed that CerJ is capable of transferring malonyl, methylmalonyl and dimethylmalonyl units onto the glycoside. According to phylogenetic analyses and elucidation of the crystal structure, CerJ is functionally and structurally positioned between the ketosynthase catalyzing Claisen condensations and acyl-ACP shuttles, and it features a noncanonical catalytic triad. Site-directed mutagenesis and structures of CerJ in complex with substrates not only allowed us to establish a model for the reaction mechanism but also provided insights into the evolution of this important subclass of the thiolase superfamily.	[Zocher, Georg; Stehle, Thilo] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Bretschneider, Tom; Unger, Michelle; Scherlach, Kirstin; Hertweck, Christian] Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [Hertweck, Christian] Univ Jena, Chair Nat Prod Chem, Jena, Germany	Eberhard Karls University of Tubingen; Hans Knoll Institute (HKI); Vanderbilt University; Friedrich Schiller University of Jena	Zocher, G (corresponding author), Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany.	georg.zocher@uni-tuebingen.de; christian.hertweck@hki-jena.de	Hertweck, Christian/AAZ-8452-2021; Hertweck, Christian/G-1896-2014	Hertweck, Christian/0000-0002-0367-337X; Hertweck, Christian/0000-0002-0367-337X; Scherlach, Kirstin/0000-0002-1326-3761	German Federal Ministry of Education and Research (GenoMik)	German Federal Ministry of Education and Research (GenoMik)	We thank the German Federal Ministry of Education and Research (GenoMik) for financial support and the Swiss light source beamline X06DA for offering beamtime.	Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; Anderle C, 2007, ARCH MICROBIOL, V187, P227, DOI 10.1007/s00203-006-0190-9; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Balibar CJ, 2007, CHEM BIOL, V14, P679, DOI 10.1016/j.chembiol.2007.05.007; Bao WL, 1999, J BACTERIOL, V181, P4690, DOI 10.1128/JB.181.15.4690-4695.1999; Bao WL, 1999, BIOCHEMISTRY-US, V38, P9752, DOI 10.1021/bi990751h; Bera AK, 2009, BIOCHEMISTRY-US, V48, P8644, DOI 10.1021/bi9009055; Brown AK, 2005, J BIOL CHEM, V280, P32539, DOI 10.1074/jbc.M413216200; Daum M, 2009, CHEMBIOCHEM, V10, P1073, DOI 10.1002/cbic.200800823; Davies C, 2000, STRUCTURE, V8, P185, DOI 10.1016/S0969-2126(00)00094-0; Durr C, 2006, CHEM BIOL, V13, P365, DOI 10.1016/j.chembiol.2006.01.011; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Freitag A, 2005, CHEMBIOCHEM, V6, P2316, DOI 10.1002/cbic.200500252; Fullone MR, 2007, BIOCHEM BIOPH RES CO, V364, P201, DOI 10.1016/j.bbrc.2007.09.116; Gajiwala KS, 2009, FEBS LETT, V583, P2939, DOI 10.1016/j.febslet.2009.08.001; Haapalainen AM, 2006, TRENDS BIOCHEM SCI, V31, P64, DOI 10.1016/j.tibs.2005.11.011; He QL, 2009, CHEMBIOCHEM, V10, P813, DOI 10.1002/cbic.200800714; Heath RJ, 2002, NAT PROD REP, V19, P581, DOI 10.1039/b110221b; Herold K, 2005, CHEM-EUR J, V11, P5523, DOI 10.1002/chem.200500320; Herold K, 2004, ORG BIOMOL CHEM, V2, P2411, DOI 10.1039/b409221j; Hertweck C, 2007, NAT PROD REP, V24, P162, DOI 10.1039/b507395m; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; IGUAL JC, 1992, J MOL EVOL, V35, P147; Jia XY, 2006, CHEM BIOL, V13, P575, DOI 10.1016/j.chembiol.2006.03.008; Khosla C, 2009, J ORG CHEM, V74, P6416, DOI 10.1021/jo9012089; Kwon HJ, 2002, SCIENCE, V297, P1327, DOI 10.1126/science.1073175; MATHIEU M, 1994, STRUCTURE, V2, P797, DOI 10.1016/S0969-2126(94)00081-6; Mollmann U, 2004, German patent, Patent No. [DE 10 2004 010 219 B4 2007.02.01, 102004010219]; Moore BS, 2002, NAT PROD REP, V19, P70, DOI 10.1039/b003939j; NEISES B, 1978, ANGEW CHEM INT EDIT, V17, P522, DOI 10.1002/anie.197805221; Oke Muse, 2010, Journal of Structural and Functional Genomics, V11, P167, DOI 10.1007/s10969-010-9090-y; Pan H, 2002, STRUCTURE, V10, P1559, DOI 10.1016/S0969-2126(02)00889-4; Pojer F, 2002, MICROBIOL-SGM, V148, P3901, DOI 10.1099/00221287-148-12-3901; Qiu XY, 2005, PROTEIN SCI, V14, P2087, DOI 10.1110/ps.051501605; Qiu XY, 2001, J MOL BIOL, V307, P341, DOI 10.1006/jmbi.2000.4457; Rix U, 2002, NAT PROD REP, V19, P542, DOI 10.1039/b103920m; SERRE L, 1995, J BIOL CHEM, V270, P12961, DOI 10.1074/jbc.270.22.12961; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Strieter ER, 2007, BIOCHEMISTRY-US, V46, P7549, DOI 10.1021/bi700243h; TSAY JT, 1992, J BIOL CHEM, V267, P6807; Wang ZX, 2000, ANTIMICROB AGENTS CH, V44, P3040, DOI 10.1128/AAC.44.11.3040-3048.2000; Weitnauer G, 2001, CHEM BIOL, V8, P569, DOI 10.1016/S1074-5521(01)00040-0; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Xu Z, 2007, J AM CHEM SOC, V129, P6022, DOI 10.1021/ja069045b; Xu ZL, 2009, J BIOTECHNOL, V140, P107, DOI 10.1016/j.jbiotec.2008.10.013	46	48	49	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2012	8	2					154	161		10.1038/nchembio.746	http://dx.doi.org/10.1038/nchembio.746			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879IP	22179067				2022-12-25	WOS:000299323200007
J	Xia, DR; Wang, DZ; Kim, SH; Katoh, H; DuBois, RN				Xia, Dianren; Wang, Dingzhi; Kim, Sun-Hee; Katoh, Hiroshi; DuBois, Raymond N.			Prostaglandin E-2 promotes intestinal tumor growth via DNA methylation	NATURE MEDICINE			English	Article							METHYLTRANSFERASE EXPRESSION; CPG; HYPOMETHYLATION; PHENOTYPE; CANCER	Although aberrant DNA methylation is considered to be one of the key ways by which tumor-suppressor and DNA-repair genes are silenced during tumor initiation and progression, the mechanisms underlying DNA methylation alterations in cancer remain unclear. Here we show that prostaglandin E-2 (PGE(2)) silences certain tumor-suppressor and DNA-repair genes through DNA methylation to promote tumor growth. These findings uncover a previously unrecognized role for PGE(2) in the promotion of tumor progression.	[Xia, Dianren; Wang, Dingzhi; Kim, Sun-Hee; Katoh, Hiroshi; DuBois, Raymond N.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [DuBois, Raymond N.] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	DuBois, RN (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	rdubois@mdanderson.org	DuBois, Raymond N./AAX-8869-2020; Kim, Sun/GSN-4867-2022		US National Institutes of Health MERIT [R37 DK47297, RO1 DK62112, NCI P01 CA77839, CPRIT RP100960]; National Colorectal Cancer Research Alliance (NCCRA); National Cancer Institute [R25T CA57730]; NATIONAL CANCER INSTITUTE [P01CA077839, R25CA057730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK047297, R01DK062112] Funding Source: NIH RePORTER	US National Institutes of Health MERIT; National Colorectal Cancer Research Alliance (NCCRA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Menter and P. Yang for their suggestions and help in the measurement of PGE<INF>2</INF>. This work is supported, in part, by the US National Institutes of Health MERIT award grants R37 DK47297, RO1 DK62112, NCI P01 CA77839 and CPRIT RP100960. We also thank the National Colorectal Cancer Research Alliance (NCCRA) for its generous support (R.N.D.) and a cancer prevention fellowship (D.X.) supported by the National Cancer Institute grant R25T CA57730 (principal investigator, S. Chang).	Ahn JB, 2011, CANCER-AM CANCER SOC, V117, P1847, DOI 10.1002/cncr.25737; Baba Y, 2010, CANCER EPIDEM BIOMAR, V19, P822, DOI 10.1158/1055-9965.EPI-09-1154; De Marzo AM, 1999, CANCER RES, V59, P3855; Hamm CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008340; Ibrahim AEK, 2011, GUT, V60, P499, DOI 10.1136/gut.2010.223602; Kanai Y, 2001, INT J CANCER, V91, P205, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1040>3.0.CO;2-2; Kim MS, 2010, CANCER METAST REV, V29, P181, DOI 10.1007/s10555-010-9207-6; Kim YH, 2006, GENE CHROMOSOME CANC, V45, P781, DOI 10.1002/gcc.20341; Lin HJ, 2006, MOL CELL BIOL, V26, P2976, DOI 10.1128/MCB.26.8.2976-2983.2006; Linhart HG, 2007, GENE DEV, V21, P3110, DOI 10.1101/gad.1594007; Nosho K, 2009, CLIN CANCER RES, V15, P3663, DOI 10.1158/1078-0432.CCR-08-2383; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Pakneshan P, 2004, J BIOL CHEM, V279, P31735, DOI 10.1074/jbc.M401669200; Schmidt WM, 2007, MOL CARCINOGEN, V46, P766, DOI 10.1002/mc.20307; Shteper PJ, 2003, ONCOGENE, V22, P7737, DOI 10.1038/sj.onc.1207056; Slattery ML, 2007, INT J CANCER, V120, P656, DOI 10.1002/ijc.22342; Steine EJ, 2011, J CLIN INVEST, V121, P1748, DOI 10.1172/JCI43169; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Wang DZ, 2008, CANCER RES, V68, P6468, DOI 10.1158/0008-5472.CAN-08-0896; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809	20	128	129	0	20	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					224	226		10.1038/nm.2608	http://dx.doi.org/10.1038/nm.2608			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22270723	Green Accepted			2022-12-25	WOS:000300140300035
J	Berman, BP; Weisenberger, DJ; Aman, JF; Hinoue, T; Ramjan, Z; Liu, YP; Noushmehr, H; Lange, CPE; van Dijk, CM; Tollenaar, RAEM; Van den Berg, D; Laird, PW				Berman, Benjamin P.; Weisenberger, Daniel J.; Aman, Joseph F.; Hinoue, Toshinori; Ramjan, Zachary; Liu, Yaping; Noushmehr, Houtan; Lange, Christopher P. E.; van Dijk, Cornelis M.; Tollenaar, Rob A. E. M.; Van den Berg, David; Laird, Peter W.			Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains	NATURE GENETICS			English	Article							BODY-SPECIFIC METHYLATION; TUMOR-SUPPRESSOR; GENE; GENOME; CHROMATIN; PLURIPOTENT; EXPRESSION; BINDING	Extensive changes in DNA methylation are common in cancer and may contribute to oncogenesis through transcriptional silencing of tumor-suppressor genes(1). Genome-scale studies have yielded important insights into these changes(2-5) but have focused on CpG islands or gene promoters. We used whole-genome bisulfite sequencing (bisulfite-seq) to comprehensively profile a primary human colorectal tumor and adjacent normal colon tissue at single-basepair resolution. Regions of focal hypermethylation in the tumor were located primarily at CpG islands and were concentrated within regions of long-range (>100 kb) hypomethylation. These hypomethylated domains covered nearly half of the genome and coincided with late replication and attachment to the nuclear lamina in human cell lines. We confirmed the confluence of hypermethylation and hypomethylation within these domains in 25 diverse colorectal tumors and matched adjacent tissue. We propose that widespread DNA methylation changes in cancer are linked to silencing programs orchestrated by the three-dimensional organization of chromatin within the nucleus.	[Berman, Benjamin P.; Weisenberger, Daniel J.; Aman, Joseph F.; Hinoue, Toshinori; Ramjan, Zachary; Liu, Yaping; Noushmehr, Houtan; Van den Berg, David; Laird, Peter W.] Univ So Calif, Keck Sch Med, Univ So Calif Epigenome Ctr, Los Angeles, CA 90033 USA; [Lange, Christopher P. E.] Groene Hart Hosp, Dept Surg, Gouda, Netherlands; [Lange, Christopher P. E.; Tollenaar, Rob A. E. M.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; [van Dijk, Cornelis M.] Groene Hart Hosp, Dept Pathol, Gouda, Netherlands	University of Southern California; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Laird, PW (corresponding author), Univ So Calif, Keck Sch Med, Univ So Calif Epigenome Ctr, Los Angeles, CA 90033 USA.	plaird@usc.edu	Weisenberger, Daniel/AAA-8314-2020; Van Den Berg, David J/G-8598-2017; BERMAN, BENJAMIN/AAT-3720-2021; N, Houtan/C-9692-2013; Laird, Peter W/G-8683-2012; Berman, Benjamin P/D-5942-2014; Liu, Yaping/A-8601-2018	Weisenberger, Daniel/0000-0001-8303-2603; Van Den Berg, David J/0000-0002-5404-5218; BERMAN, BENJAMIN/0000-0002-2099-9005; N, Houtan/0000-0003-4051-8114; Laird, Peter W/0000-0001-9117-3641; Berman, Benjamin P/0000-0002-2099-9005; Liu, Yaping/0000-0003-4165-7693	NATIONAL CANCER INSTITUTE [R01CA118699, P30CA014089] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA014089, R01 CA118699] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguilera C, 2011, NATURE, V469, P231, DOI 10.1038/nature09607; Aran D, 2011, HUM MOL GENET, V20, P670, DOI 10.1093/hmg/ddq513; Balwierz PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r79; Boumber YA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000162; Chua YL, 2009, ONCOGENE, V28, P4041, DOI 10.1038/onc.2009.259; Coolen MW, 2010, NAT CELL BIOL, V12, P235, DOI 10.1038/ncb2023; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dahl E, 2007, ONCOGENE, V26, P5680, DOI 10.1038/sj.onc.1210345; Estecio MRH, 2010, GENOME RES, V20, P1369, DOI 10.1101/gr.107318.110; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Gebhard C, 2010, CANCER RES, V70, P1398, DOI 10.1158/0008-5472.CAN-09-3406; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; Irizarry RA, 2009, MAMM GENOME, V20, P674, DOI 10.1007/s00335-009-9222-5; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Sun W, 2009, NUCLEIC ACIDS RES, V37, P5365, DOI 10.1093/nar/gkp493; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Witcher M, 2009, MOL CELL, V34, P271, DOI 10.1016/j.molcel.2009.04.001; Xiang Y, 2007, CELL RES, V17, P850, DOI 10.1038/cr.2007.83	39	448	463	2	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2012	44	1					40	U62		10.1038/ng.969	http://dx.doi.org/10.1038/ng.969			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	22120008	Green Accepted			2022-12-25	WOS:000298664000011
J	Huang, XH; Zhao, Y; Wei, XH; Li, CY; Wang, A; Zhao, Q; Li, WJ; Guo, YL; Deng, LW; Zhu, CR; Fan, DL; Lu, YQ; Weng, QJ; Liu, KY; Zhou, TY; Jing, YF; Si, LZ; Dong, GJ; Huang, T; Lu, TT; Feng, Q; Qian, Q; Li, JY; Han, B				Huang, Xuehui; Zhao, Yan; Wei, Xinghua; Li, Canyang; Wang, Ahong; Zhao, Qiang; Li, Wenjun; Guo, Yunli; Deng, Liuwei; Zhu, Chuanrang; Fan, Danlin; Lu, Yiqi; Weng, Qijun; Liu, Kunyan; Zhou, Taoying; Jing, Yufeng; Si, Lizhen; Dong, Guojun; Huang, Tao; Lu, Tingting; Feng, Qi; Qian, Qian; Li, Jiayang; Han, Bin			Genome-wide association study of flowering time and grain yield traits in a worldwide collection of rice germplasm	NATURE GENETICS			English	Article							SPATIAL GENE-EXPRESSION; ARABIDOPSIS-THALIANA; NATURAL VARIATION; MAPPING POPULATION; OPEN SOFTWARE; MAJOR QTL; ENCODES; PROTEIN; LOCUS; DOMESTICATION	A high-density haplotype map recently enabled a genome-wide association study (GWAS) in a population of indica subspecies of Chinese rice landraces. Here we extend this methodology to a larger and more diverse sample of 950 worldwide rice varieties, including the Oryza sativa indica and Oryza sativa japonica subspecies, to perform an additional GWAS. We identified a total of 32 new loci associated with flowering time and with ten grain-related traits, indicating that the larger sample increased the power to detect trait-associated variants using GWAS. To characterize various alleles and complex genetic variation, we developed an analytical framework for haplotype-based de novo assembly of the low-coverage sequencing data in rice. We identified candidate genes for 18 associated loci through detailed annotation. This study shows that the integrated approach of sequence-based GWAS and functional genome annotation has the potential to match complex traits to their causal polymorphisms in rice.	[Huang, Xuehui; Zhao, Yan; Li, Canyang; Wang, Ahong; Zhao, Qiang; Li, Wenjun; Guo, Yunli; Deng, Liuwei; Zhu, Chuanrang; Fan, Danlin; Lu, Yiqi; Weng, Qijun; Liu, Kunyan; Zhou, Taoying; Jing, Yufeng; Si, Lizhen; Dong, Guojun; Huang, Tao; Lu, Tingting; Feng, Qi; Han, Bin] Chinese Acad Sci, Natl Ctr Gene Res, Natl Ctr Plant Gene Res Shanghai, Inst Plant Physiol & Ecol,Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Huang, Xuehui; Zhao, Yan; Han, Bin] Chinese Acad Sci, Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China; [Wei, Xinghua; Qian, Qian] Chinese Acad Agr Sci, China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Peoples R China; [Li, Jiayang] Chinese Acad Sci, Natl Ctr Plant Gene Res, Inst Genet & Dev Biol, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Han, B (corresponding author), Chinese Acad Sci, Natl Ctr Gene Res, Natl Ctr Plant Gene Res Shanghai, Inst Plant Physiol & Ecol,Shanghai Inst Biol Sci, Shanghai, Peoples R China.	bhan@ncgr.ac.cn	qian, qian/AAH-8708-2021; Li, Jiayang/AAG-4377-2020	Huang, Xuehui/0000-0003-0529-1532; Han, Bin/0000-0001-8695-0274	Chinese Academy of Sciences [KSCX2-YW-N-094]; Ministry of Agriculture of China [2011ZX08001-004, 2011ZX08009-002]; National Natural Science Foundation of China [30821004]; Ministry of Science and Technology of China [2011CB100205]	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	We thank the China National Rice Research Institute for providing the rice germplasm samples. We thank S. Griffiths and G. Moore for critical reading of the manuscript. We thank Z. Zhang and E.S. Buckler for helping us use the compressed MLM and Z. Ning for assistance with sequence alignment. This work was supported by the Chinese Academy of Sciences (KSCX2-YW-N-094), the Ministry of Agriculture of China (2011ZX08001-004 and 2011ZX08009-002), the National Natural Science Foundation of China (30821004) and the Ministry of Science and Technology of China (2011CB100205) to B.H.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CHURCHILL GA, 1994, GENETICS, V138, P963; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Clark RM, 2010, NAT GENET, V42, P926, DOI 10.1038/ng1110-926; Cui JJ, 2007, J INTEGR PLANT BIOL, V49, P678, DOI 10.1111/j.1744-7909.2007.00467.x; Dai LY, 2010, THEOR APPL GENET, V121, P295, DOI 10.1007/s00122-010-1310-0; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li Y, 2010, P NATL ACAD SCI USA, V107, P21199, DOI 10.1073/pnas.1007431107; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; Mills RE, 2011, GENOME RES, V21, P830, DOI 10.1101/gr.115907.110; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Pelak K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001111; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Saitoh K, 2004, GENETICS, V168, P997, DOI 10.1534/genetics.103.018390; Schneeberger K, 2011, P NATL ACAD SCI USA, V108, P10249, DOI 10.1073/pnas.1107739108; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Sun XL, 2004, PLANT J, V37, P517, DOI 10.1046/j.1365-313X.2003.01976.x; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; Tan YF, 2001, THEOR APPL GENET, V103, P1037, DOI 10.1007/s001220100665; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Tian ZX, 2009, P NATL ACAD SCI USA, V106, P21760, DOI 10.1073/pnas.0912396106; Wang D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-149; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yu YC, 2008, PLANT CELL, V20, P2946, DOI 10.1105/tpc.108.060426; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780; Zhu BF, 2011, PLANT PHYSIOL, V155, P1301, DOI 10.1104/pp.110.168500	45	663	727	29	486	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2012	44	1					32	U53		10.1038/ng.1018	http://dx.doi.org/10.1038/ng.1018			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	22138690				2022-12-25	WOS:000298664000010
J	Itzkovitz, S; Lyubimova, A; Blat, IC; Maynard, M; van Es, J; Lees, J; Jacks, T; Clevers, H; van Oudenaarden, A				Itzkovitz, Shalev; Lyubimova, Anna; Blat, Irene C.; Maynard, Mindy; van Es, Johan; Lees, Jacqueline; Jacks, Tyler; Clevers, Hans; van Oudenaarden, Alexander			Single-molecule transcript counting of stem-cell markers in the mouse intestine	NATURE CELL BIOLOGY			English	Article							GENE-EXPRESSION; BETA-CATENIN; IDENTIFICATION; EPITHELIUM; MICE; DELETION; RENEWAL; COLON	Determining the molecular identities of adult stem cells requires technologies for sensitive transcript detection in tissues. In mouse intestinal crypts, lineage-tracing studies indicated that different genes uniquely mark spatially distinct stem-cell populations, residing either at crypt bases or at position +4, but adetailed analysis of their spatial co-expression has not been feasible. Here we apply three-colour single-molecule fluorescence in situhy bridization to study a comprehensive panel of intestinal stem-cell markers during homeostasis, ageing and regeneration.We find that the expression of all markers overlaps at crypt-base cells. This co-expression includes Lgr5, Bmi1 and mTert, genes previously suggested to mark distinct stem cells. Strikingly, Dcamkl1 tuft cells, distributed through out the cryptaxis, co-express Lgr5 and other stem-cell markers that are otherwise confined to crypt bases. We also detect significant changes in the expression of some of the markers following irradiation, indicating their potentialrole in the regeneration process. Our approach can enable the sensitive detection of putative stem cells in other tissues and intumours, guiding complementary function alstudies to evaluate their stem-cell properties.	[Itzkovitz, Shalev; Lyubimova, Anna; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [Itzkovitz, Shalev; Lyubimova, Anna; Blat, Irene C.; Lees, Jacqueline; Jacks, Tyler; van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lyubimova, Anna; van Es, Johan; Clevers, Hans; van Oudenaarden, Alexander] Royal Netherlands Acad Arts & Sci, Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Lyubimova, Anna; van Es, Johan; Clevers, Hans; van Oudenaarden, Alexander] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Blat, Irene C.; Maynard, Mindy; Lees, Jacqueline; Jacks, Tyler; van Oudenaarden, Alexander] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	avano@mit.edu	van Oudenaarden, Alexander/AAA-1705-2019; van+Es, Johan/ABD-5411-2021		National Institutes of Health (NIH)/National Cancer Institute Physical Sciences Oncology Centerat MIT [U54CA143874]; NIH [1DP1OD003936, P30-CA14051]; European Molecular Biology Organization; International Human Frontiers Science Program Organization; Machiah Foundation; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [DP1CA174420, P30CA014051, U54CA143874] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003936] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Cancer Institute Physical Sciences Oncology Centerat MIT; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); International Human Frontiers Science Program Organization(Human Frontier Science Program); Machiah Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to thank H. Youk, S. Semrau, S. Klemm and K. Hilgendorf for comments on the manuscript, and X. Wu, Z. Peng Fan and A. Yang for help with the cell segmentation software. This work was supported by the National Institutes of Health (NIH)/National Cancer Institute Physical Sciences Oncology Centerat MIT (U54CA143874) and an NIH Pioneer award (1DP1OD003936) to A.v.O., and in part by Cancer Center Support (core) grant P30-CA14051 from the National Cancer Institute. S.I. acknowledges support from a European Molecular Biology Organization postdoctoral fellowship, the International Human Frontiers Science Program Organization and the Machiah Foundation. I.C.B. acknowledges support from the Howard Hughes Medical Institute Gilliam fellowship. T.J. is the D. H. Koch Professor of Biology and a D. K. Ludwig Scholar.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Capodieci P, 2005, NAT METHODS, V2, P663, DOI 10.1038/NMETH786; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Gerbe F, 2011, J CELL BIOL, V192, P767, DOI 10.1083/jcb.201010127; Gerbe F, 2009, GASTROENTEROLOGY, V137, P2179, DOI 10.1053/j.gastro.2009.06.072; Giannakis M, 2006, J BIOL CHEM, V281, P11292, DOI 10.1074/jbc.M512118200; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Kayahara T, 2003, FEBS LETT, V535, P131, DOI 10.1016/S0014-5793(02)03896-6; Kirsch DG, 2010, SCIENCE, V327, P593, DOI 10.1126/science.1166202; Kohler T, 2005, HISTOCHEM CELL BIOL, V123, P315, DOI 10.1007/s00418-004-0730-9; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; May R, 2008, STEM CELLS, V26, P630, DOI 10.1634/stemcells.2007-0621; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Potten CS, 2009, CELL PROLIFERAT, V42, P731, DOI 10.1111/j.1365-2184.2009.00642.x; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schepers AG, 2011, EMBO J, V30, P1104, DOI 10.1038/emboj.2011.26; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Zeilstra J, 2008, CANCER RES, V68, P3655, DOI 10.1158/0008-5472.CAN-07-2940; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	41	247	251	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2012	14	1					106	U193		10.1038/ncb2384	http://dx.doi.org/10.1038/ncb2384			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	866YC	22119784	Green Accepted, Green Submitted			2022-12-25	WOS:000298421100016
J	Sperka, T; Song, ZF; Morita, Y; Nalapareddy, K; Guachalla, LM; Lechel, A; Begus-Nahrmann, Y; Burkhalter, MD; Mach, M; Schlaudraff, F; Liss, B; Ju, ZY; Speicher, MR; Rudolph, KL				Sperka, Tobias; Song, Zhangfa; Morita, Yohei; Nalapareddy, Kodandaramireddy; Guachalla, Luis Miguel; Lechel, Andre; Begus-Nahrmann, Yvonne; Burkhalter, Martin D.; Mach, Monika; Schlaudraff, Falk; Liss, Birgit; Ju, Zhenyu; Speicher, Michael R.; Rudolph, K. Lenhard			Puma and p21 represent cooperating checkpoints limiting self-renewal and chromosomal instability of somatic stem cells in response to telomere dysfunction	NATURE CELL BIOLOGY			English	Article							BH3-ONLY PROTEINS PUMA; LIFE-SPAN; OXIDATIVE STRESS; SMALL-INTESTINE; APOPTOSIS; MICE; IDENTIFICATION; MUTATIONS; EVOLUTION; CARCINOMA	The tumour suppressor p53 activates Puma-dependent apoptosis and p21-dependent cell-cycle arrest in response to DNA damage. Deletion of p21 improved stem-cell function and organ maintenance in progeroid mice with dysfunctional telomeres, but the function of Pumahas not been investigated in this context. Here we show that deletion of Pumaim proves stem- and progenitor-cell function, organmaintenance and life span of telomere-dys function almice. Puma deletion impairs the clearance of stem and progenitor cells that have accumulated DNA damage as a consequence of critically short telomeres. However, further accumulation of DNA damagein these rescued progenitor cells lead stoin creasing activation of p21. RNA interference experiments show that upregulation of p21 limits prolife ration and evolution of chromosomal imbalances of Puma-deficients temand progenitor cells with dys function altelomeres. These results provide experimental evidence that p53-dependent apoptosis and cell-cyclearrest actin cooperating check points limiting tissue maintenance and evolution of chromosomalin stability at stem- and progenitor-cell levels inre sponse to telomeredys function. Selective inhibition of Puma-dependent apoptos is can resultin temporary improvement sinmaintenance of telomere-dys functional organ.	[Sperka, Tobias; Song, Zhangfa; Morita, Yohei; Nalapareddy, Kodandaramireddy; Guachalla, Luis Miguel; Lechel, Andre; Begus-Nahrmann, Yvonne; Burkhalter, Martin D.; Rudolph, K. Lenhard] Univ Ulm, Inst Mol Med, D-89081 Ulm, Germany; [Sperka, Tobias; Song, Zhangfa; Morita, Yohei; Nalapareddy, Kodandaramireddy; Guachalla, Luis Miguel; Lechel, Andre; Begus-Nahrmann, Yvonne; Burkhalter, Martin D.; Rudolph, K. Lenhard] Univ Ulm, Max Planck Res Dept Stem Cell Aging, D-89081 Ulm, Germany; [Mach, Monika; Speicher, Michael R.] Med Univ Graz, Inst Human Genet, A-8010 Graz, Austria; [Schlaudraff, Falk; Liss, Birgit] Univ Ulm, Inst Appl Physiol, D-89081 Ulm, Germany; [Ju, Zhenyu] Hangzhou Normal Univ, Coll Med, Inst Aging Res, Hangzhou 310036, Zhejiang, Peoples R China	Ulm University; Max Planck Society; Ulm University; Medical University of Graz; Ulm University; Hangzhou Normal University	Rudolph, KL (corresponding author), Univ Ulm, Inst Mol Med, D-89081 Ulm, Germany.	Lenhard.Rudolph@uni-ulm.de	Sperka, Tobias/E-2659-2017; Morita, Yohei/N-1260-2014; Lechel, André/AAQ-2041-2021; Speicher, Michael R/B-5362-2013	Morita, Yohei/0000-0003-4163-5080; Lechel, André/0000-0003-0221-6959; Speicher, Michael R/0000-0003-0105-955X; Nalapareddy, Kodandaramireddy/0000-0003-3290-5114; Guachalla, Luis Miguel/0000-0003-1152-9930; Song, Zhangfa/0000-0001-6301-1813; Burkhalter, Martin/0000-0002-8646-3131; liss, Birgit/0000-0002-6733-9207; Rudolph, Karl Lenhard/0000-0002-4839-2862	Deutsche Forschungsgemeinschaft [Klinische Forschergruppe 142, 167, Ru745/10]; European Union (GENINCA)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union (GENINCA)	We thank G. Zambetti for providing Puma<SUP>-/-</SUP> mice, C. Kuo for the R-spondin construct and H. Clevers for discussions. The Deutsche Forschungsgemeinschaft (Klinische Forschergruppe 142 & 167 and Ru745/10) and the European Union (GENINCA) supported this work.	Aggarwal S, 1998, J IMMUNOL, V160, P1627; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Begus-Nahrmann Y, 2009, NAT GENET, V41, P1138, DOI 10.1038/ng.426; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; Ciccocioppo R, 2002, GERONTOLOGY, V48, P204, DOI 10.1159/000058351; Erlacher M, 2005, BLOOD, V106, P4131, DOI 10.1182/blood-2005-04-1595; Geigl JB, 2007, NAT PROTOC, V2, P3173, DOI 10.1038/nprot.2007.476; Hamann A, 2008, TRENDS MICROBIOL, V16, P276, DOI 10.1016/j.tim.2008.03.003; Hashimoto S, 1998, ARTHRITIS RHEUM-US, V41, P1632, DOI 10.1002/1529-0131(199809)41:9<1632::AID-ART14>3.0.CO;2-A; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Jiang H, 2008, P NATL ACAD SCI USA, V105, P11299, DOI 10.1073/pnas.0801457105; Kirk KE, 1997, SCIENCE, V275, P1478, DOI 10.1126/science.275.5305.1478; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Liu DP, 2010, NAT CELL BIOL, V12, P993, DOI 10.1038/ncb2100; Michalak EM, 2008, CELL DEATH DIFFER, V15, P1019, DOI 10.1038/cdd.2008.16; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Mustata G, 2011, CURR TOP MED CHEM, V11, P281, DOI 10.2174/156802611794072641; OHYASHIKI JH, 1994, CANCER RES, V54, P3557; Perez GI, 1999, NAT GENET, V21, P200, DOI 10.1038/5985; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schaetzlein S, 2007, CELL, V130, P863, DOI 10.1016/j.cell.2007.08.029; van Beers EH, 2006, BRIT J CANCER, V94, P333, DOI 10.1038/sj.bjc.6602889; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029	37	45	50	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2012	14	1					73	U114		10.1038/ncb2388	http://dx.doi.org/10.1038/ncb2388			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	866YC	22138576				2022-12-25	WOS:000298421100012
J	Wu, C; Miao, XP; Huang, LM; Che, X; Jiang, GL; Yu, DK; Yang, XH; Cao, GW; Hu, ZB; Zhou, YJ; Zuo, CH; Wang, CY; Zhang, XH; Zhou, YF; Yu, XJ; Dai, WJ; Li, ZS; Shen, HB; Liu, LM; Chen, YL; Zhang, S; Wang, XQ; Zhai, K; Chang, J; Liu, Y; Sun, MH; Cao, W; Gao, J; Ma, Y; Zheng, XW; Cheung, ST; Jia, YF; Xu, J; Tan, W; Zhao, P; Wu, TC; Wang, CF; Lin, DX				Wu, Chen; Miao, Xiaoping; Huang, Liming; Che, Xu; Jiang, Guoliang; Yu, Dianke; Yang, Xianghong; Cao, Guangwen; Hu, Zhibin; Zhou, Yongjian; Zuo, Chaohui; Wang, Chunyou; Zhang, Xianghong; Zhou, Yifeng; Yu, Xianjun; Dai, Wanjin; Li, Zhaoshen; Shen, Hongbing; Liu, Luming; Chen, Yanling; Zhang, Sheng; Wang, Xiaoqi; Zhai, Kan; Chang, Jiang; Liu, Yu; Sun, Menghong; Cao, Wei; Gao, Jun; Ma, Ying; Zheng, Xiongwei; Cheung, Siu Tim; Jia, Yongfeng; Xu, Jian; Tan, Wen; Zhao, Ping; Wu, Tangchun; Wang, Chengfeng; Lin, Dongxin			Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations	NATURE GENETICS			English	Article							ABO BLOOD-GROUP; HEME OXYGENASE-1; GENE-EXPRESSION; GROUP ALLELES; GROWTH-FACTOR; RISK; BACH1; DAB2; VARIANTS; RECEPTOR	Pancreatic cancer has the lowest survival rate among human cancers, and there are no effective markers for its screening and early diagnosis. To identify genetic susceptibility markers for this cancer, we carried out a genome-wide association study on 981 individuals with pancreatic cancer (cases) and 1,991 cancer-free controls of Chinese descent using 666,141 autosomal SNPs. Promising associations were replicated in an additional 2,603 pancreatic cancer cases and 2,877 controls recruited from 25 hospitals in 16 provinces or cities in China. We identified five new susceptibility loci at chromosomes 21q21.3, 5p13.1, 21q22.3, 22q13.32 and 10q26.11 (P = 2.24 x 10(-13) to P = 4.18 x 10(-10)) in addition to 13q22.1 previously reported in populations of European ancestry. These results advance our understanding of the development of pancreatic cancer and highlight potential targets for the prevention or treatment of this cancer.	[Wu, Chen; Huang, Liming; Yu, Dianke; Zhai, Kan; Chang, Jiang; Liu, Yu; Xu, Jian; Tan, Wen; Lin, Dongxin] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Wu, Chen; Huang, Liming; Che, Xu; Yu, Dianke; Zhai, Kan; Chang, Jiang; Liu, Yu; Xu, Jian; Tan, Wen; Zhao, Ping; Wang, Chengfeng; Lin, Dongxin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Miao, Xiaoping; Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Che, Xu; Zhao, Ping; Wang, Chengfeng] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Abdominal Surg, Beijing 100730, Peoples R China; [Jiang, Guoliang] Fudan Univ, Canc Hosp, Dept Radiat Oncol, Shanghai 200433, Peoples R China; [Yang, Xianghong; Cao, Wei] China Med Univ, Shengjing Hosp, Dept Pathol, Shenyang, Peoples R China; [Cao, Guangwen] Second Mil Med Univ, Dept Epidemiol, Shanghai, Peoples R China; [Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Dept Epidemiol & Biostat, Ctr Canc, Nanjing, Jiangsu, Peoples R China; [Zhou, Yongjian] Fujian Med Univ, Union Hosp, Dept Gastrointestinal Surg, Fuzhou, Peoples R China; [Zuo, Chaohui] Hunan Prov Tumor Hosp, Dept Gastroduodenal & Pancreat Surg, Changsha, Hunan, Peoples R China; [Wang, Chunyou] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan 430074, Peoples R China; [Zhang, Xianghong] Hebei Med Univ, Dept Expt Pathol, Shijiazhuang, Peoples R China; [Zhou, Yifeng] Soochow Univ, Coll Med, Lab Canc Mol Genet, Suzhou, Peoples R China; [Yu, Xianjun] Fudan Univ, Canc Hosp, Dept Pancreas & Hepatobiliary Surg, Shanghai 200433, Peoples R China; [Li, Zhaoshen] Second Mil Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shanghai, Peoples R China; [Liu, Luming] Fudan Univ, Dept Integrat Oncol, Canc Hosp, Shanghai 200433, Peoples R China; [Chen, Yanling] Fujian Med Univ, Union Hosp, Dept Hepatobiliary & Pancreat Surg, Fuzhou, Peoples R China; [Zhang, Sheng] Fujian Med Univ, Affiliated Hosp 1, Dept Pathol, Fuzhou, Peoples R China; [Wang, Xiaoqi; Cheung, Siu Tim] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Sun, Menghong] Fudan Univ, Canc Hosp, Dept Pathol, Shanghai 200433, Peoples R China; [Zheng, Xiongwei] Fujian Prov Canc Hosp, Dept Pathol, Fuzhou, Peoples R China; [Jia, Yongfeng] Inner Mongolia Sch Med, Affiliated Hosp, Dept Pathol, Hohhot, Inner Mongolia, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Huazhong University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Fudan University; China Medical University; Naval Medical University; Nanjing Medical University; Fujian Medical University; Huazhong University of Science & Technology; Hebei Medical University; Soochow University - China; Fudan University; Naval Medical University; Fudan University; Fujian Medical University; Fujian Medical University; University of Hong Kong; Fudan University	Lin, DX (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China.	wangcf369@medmail.com; lindx72@cicams.ac.cn	miao, xiaoping/C-4336-2011; Cheung, Siu-Tim/C-4238-2009; Pillay, Nischalan/F-9536-2012; Chang, Jiang/AAP-6156-2020; Xu, Jian/H-5349-2019; chen, yanling/GRE-8287-2022	miao, xiaoping/0000-0002-6818-9722; Cheung, Siu-Tim/0000-0003-2147-315X; Xu, Jian/0000-0003-0274-4268; Cao, Guangwen/0000-0002-8094-1278; Lin, Dongxin/0000-0002-8723-8868; Wu, Chen/0000-0003-4954-1011; yu, xianjun/0000-0002-6697-7143; Shen, Hongbing/0000-0002-2581-5906	National High-Tech Research and Development Program of China [2009AA022706]; National Natural Science Foundation of China [81021061]	National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National High-Tech Research and Development Program of China (2009AA022706) and the National Natural Science Foundation of China (81021061) to D. L. We thank L. Liang for help in eQTL analysis. We also thank the subjects and the surgeons who recruited them; M. Yang, L. Wang, X. Wang, C. Yang, L. Du, J. Li, F. Qi, X. Song and L. Zeng.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Argani P, 2001, CANCER RES, V61, P4320; Ben QW, 2011, INT J CANCER, V128, P1179, DOI 10.1002/ijc.25426; Bjursell M, 2007, BIOCHEM BIOPH RES CO, V363, P633, DOI 10.1016/j.bbrc.2007.09.016; Chaudhury A, 2010, NAT CELL BIOL, V12, P286, DOI 10.1038/ncb2029; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; de Stahl TD, 2005, GENE CHROMOSOME CANC, V44, P161, DOI 10.1002/gcc.20226; di Magliano MP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001155; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dubeykovskaya Z, 2009, J BIOL CHEM, V284, P3650, DOI 10.1074/jbc.M804935200; Emami S, 2004, PEPTIDES, V25, P885, DOI 10.1016/j.peptides.2003.10.019; Fazili Z, 1999, ONCOGENE, V18, P3104, DOI 10.1038/sj.onc.1202649; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Gu W, 2004, J MOL NEUROSCI, V22, P93, DOI 10.1385/JMN:22:1-2:93; Hannigan A, 2010, J CLIN INVEST, V120, P2842, DOI 10.1172/JCI36125; Harusato A, 2009, J PHYSIOL PHARMACOL, V60, P149; He JQ, 2001, J BIOL CHEM, V276, P26814, DOI 10.1074/jbc.M101820200; Heiser PW, 2008, GASTROENTEROLOGY, V135, P1288, DOI 10.1053/j.gastro.2008.06.089; Huang Y, 2001, LAB INVEST, V81, P863, DOI 10.1038/labinvest.3780295; Iida A, 2009, TOHOKU J EXP MED, V217, P223, DOI 10.1620/tjem.217.223; Iodice S, 2010, EUR J CANCER, V46, P3345, DOI 10.1016/j.ejca.2010.08.009; Jiang Y, 2009, ONCOGENE, V28, P2999, DOI 10.1038/onc.2009.157; Jiao L, 2010, CANCER CAUSE CONTROL, V21, P1305, DOI 10.1007/s10552-010-9558-x; Klein AP, 2001, CANCER J, V7, P266; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li DH, 2009, JAMA-J AM MED ASSOC, V301, P2553, DOI 10.1001/jama.2009.886; Low SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011824; Nakao M, 2011, CANCER SCI, V102, P1076, DOI 10.1111/j.1349-7006.2011.01907.x; Ohshio G, 2000, DIGEST DIS SCI, V45, P659, DOI 10.1023/A:1005471005289; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Prunier C, 2005, J BIOL CHEM, V280, P17540, DOI 10.1074/jbc.M500974200; Reichard JF, 2008, J BIOL CHEM, V283, P22363, DOI 10.1074/jbc.M801784200; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Vijayan V, 2010, WORLD J GASTROENTERO, V16, P3112, DOI 10.3748/wjg.v16.i25.3112; Wolpin BM, 2010, CANCER RES, V70, P1015, DOI 10.1158/0008-5472.CAN-09-2993; Wolpin BM, 2009, J NATL CANCER I, V101, P424, DOI 10.1093/jnci/djp020; Yang DH, 2006, AM J PATHOL, V169, P258, DOI 10.2353/ajpath.2006.060036; Yang M, 2008, CLIN CANCER RES, V14, P3230, DOI 10.1158/1078-0432.CCR-08-0177; Yeh TS, 2002, GUT, V51, P712, DOI 10.1136/gut.51.5.712; Zhao D, 2009, GASTROENTEROLOGY, V136, P1659, DOI 10.1053/j.gastro.2009.01.071; Zhu X, 2010, WORLD J GASTROENTERO, V16, P2633, DOI 10.3748/wjg.v16.i21.2633	43	134	146	2	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2012	44	1					62	U90		10.1038/ng.1020	http://dx.doi.org/10.1038/ng.1020			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	22158540				2022-12-25	WOS:000298664000015
J	Zhang, ZF; Lee, JC; Lin, LP; Olivas, V; Au, V; LaFramboise, T; Abdel-Rahman, M; Wang, XQ; Levine, AD; Rho, JK; Choi, YJ; Choi, CM; Kim, SW; Jang, SJ; Park, YS; Kim, WS; Lee, DH; Lee, JS; Miller, VA; Arcila, M; Ladanyi, M; Moonsamy, P; Sawyers, C; Boggon, TJ; Ma, PC; Costa, C; Taron, M; Rosell, R; Halmos, B; Bivona, TG				Zhang, Zhenfeng; Lee, Jae Cheol; Lin, Luping; Olivas, Victor; Au, Valerie; LaFramboise, Thomas; Abdel-Rahman, Mohamed; Wang, Xiaoqi; Levine, Alan D.; Rho, Jin Kyung; Choi, Yun Jung; Choi, Chang-Min; Kim, Sang-We; Jang, Se Jin; Park, Young Soo; Kim, Woo Sung; Lee, Dae Ho; Lee, Jung-Shin; Miller, Vincent A.; Arcila, Maria; Ladanyi, Marc; Moonsamy, Philicia; Sawyers, Charles; Boggon, Titus J.; Ma, Patrick C.; Costa, Carlota; Taron, Miquel; Rosell, Rafael; Halmos, Balazs; Bivona, Trever G.			Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer	NATURE GENETICS			English	Article							RECEPTOR TYROSINE KINASES; NF-KAPPA-B; ACQUIRED-RESISTANCE; MET AMPLIFICATION; MUTANT EGFR; GEFITINIB; MUTATIONS; TUMORS; ERLOTINIB; GROWTH	Human non-small cell lung cancers (NSCLCs) with activating mutations in EGFR frequently respond to treatment with EGFRtargeted tyrosine kinase inhibitors (TKIs), such as erlotinib, but responses are not durable, as tumors acquire resistance. Secondary mutations in EGFR (such as T790M) or upregulation of the MET kinase are found in over 50% of resistant tumors. Here, we report increased activation of AXL and evidence for epithelial-to-mesenchymal transition (EMT) in multiple in vitro and in vivo EGFR-mutant lung cancer models with acquired resistance to erlotinib in the absence of the EGFR p.Thr790Met alteration or MET activation. Genetic or pharmacological inhibition of AXL restored sensitivity to erlotinib in these tumor models. Increased expression of AXL and, in some cases, of its ligand GAS6 was found in EGFR-mutant lung cancers obtained from individuals with acquired resistance to TKIs. These data identify AXL as a promising therapeutic target whose inhibition could prevent or overcome acquired resistance to EGFR TKIs in individuals with EGFR-mutant lung cancer.	[Lin, Luping; Olivas, Victor; Bivona, Trever G.] Univ Calif San Francisco, Div Hematol Oncol, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Zhang, Zhenfeng; Levine, Alan D.] Case Western Reserve Univ, Sch Med, Dept Pathol, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Zhang, Zhenfeng; LaFramboise, Thomas; Abdel-Rahman, Mohamed; Levine, Alan D.] Case Comprehens Canc Ctr, Ireland Canc Ctr, Cleveland, OH USA; [Abdel-Rahman, Mohamed] Case Western Reserve Univ, Sch Med, Div Hematol Oncol, Univ Hosp Case Med Ctr, Cleveland, OH USA; [Zhang, Zhenfeng; Au, Valerie; Wang, Xiaoqi; Halmos, Balazs] Columbia Univ, Div Hematol Oncol, Med Ctr, New York, NY USA; [Lee, Jae Cheol; Choi, Chang-Min; Kim, Sang-We; Lee, Dae Ho; Lee, Jung-Shin] Univ Ulsan, Dept Oncol, Asan Med Ctr, Coll Med, Seoul, South Korea; [LaFramboise, Thomas] Case Western Reserve Univ, Sch Med, Dept Genet, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Levine, Alan D.] Case Western Reserve Univ, Sch Med, Div Gastroenterol & Liver Dis, Univ Hosp Case Med Ctr, Cleveland, OH USA; [Rho, Jin Kyung; Choi, Yun Jung; Choi, Chang-Min; Kim, Woo Sung] Univ Ulsan, Asan Med Ctr, Coll Med, Dept Pulm & Crit Care Med, Seoul, South Korea; [Jang, Se Jin; Park, Young Soo] Univ Ulsan, Asan Med Ctr, Coll Med, Dept Pathol, Seoul, South Korea; [Arcila, Maria; Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Ladanyi, Marc; Moonsamy, Philicia; Sawyers, Charles; Bivona, Trever G.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Boggon, Titus J.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Ma, Patrick C.] Case Western Reserve Univ, Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA; [Ma, Patrick C.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Costa, Carlota; Taron, Miquel; Rosell, Rafael] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Barcelona, Spain; [Costa, Carlota; Taron, Miquel; Rosell, Rafael] USP Dexeus Univ Inst, Pangaea Biotech, Barcelona, Spain	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Columbia University; University of Ulsan; Asan Medical Center; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University Hospital; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Yale University; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Catalan Institute of Oncology; Hospital Germans Trias i Pujol	Bivona, TG (corresponding author), Univ Calif San Francisco, Div Hematol Oncol, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA.	bh2376@columbia.edu; tbivona@medicine.ucsf.edu	Arcila, Maria/ABE-2235-2021; Sawyers, Charles/G-5327-2016; Lee, Jae Cheol/AAA-2678-2021; Ladanyi, Marc/AAG-8585-2019		Korean Health Technology RD Project [A102059]; US National Institutes of Health [K08 1K08CA154787, P01 CA129243]; Uniting Against Lung Cancer Research Award; National Lung Cancer Partnership Young Investigator Award; La Caixa Foundation; American Cancer Society Research Scholar Grant [RSG-08-303-01]; NATIONAL CANCER INSTITUTE [R01CA169338, P01CA129243, K08CA154787, DP2CA174497] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007616] Funding Source: NIH RePORTER	Korean Health Technology RD Project; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uniting Against Lung Cancer Research Award; National Lung Cancer Partnership Young Investigator Award; La Caixa Foundation(La Caixa Foundation); American Cancer Society Research Scholar Grant(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank K. Shokat for assistance with structural modeling of the AXL gatekeeper mutation, W. Polkinghorn, J. Wongvipat and E. Chan for advice and technical assistance and S. Edelheit of the Case Genomics Center for technical assistance. This work was supported by the Korean Health Technology R&D Project (grant A102059 to J.C.L.), the US National Institutes of Health (K08 1K08CA154787 to T.G.B. and P01 CA129243 to M.L.), a Uniting Against Lung Cancer Research Award, a National Lung Cancer Partnership Young Investigator Award (to T.G.B.), a grant from the La Caixa Foundation (to R.R.) and an American Cancer Society Research Scholar Grant (RSG-08-303-01 to B.H.).	Arcila ME, 2011, CLIN CANCER RES, V17, P1169, DOI 10.1158/1078-0432.CCR-10-2277; AZUMI N, 1987, AM J CLIN PATHOL, V88, P286, DOI 10.1093/ajcp/88.3.286; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Bivona TG, 2011, NATURE, V471, P523, DOI 10.1038/nature09870; Brevet M, 2010, J MOL DIAGN, V12, P169, DOI 10.2353/jmoldx.2010.090140; Burchert A, 1998, ONCOGENE, V16, P3177, DOI 10.1038/sj.onc.1201865; Chitale D, 2009, ONCOGENE, V28, P2773, DOI 10.1038/onc.2009.135; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Gazdar AF, 2009, NEW ENGL J MED, V361, P1018, DOI 10.1056/NEJMe0905763; Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Keating AK, 2010, MOL CANCER THER, V9, P1298, DOI 10.1158/1535-7163.MCT-09-0707; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Linger RM, 2010, EXPERT OPIN THER TAR, V14, P1073, DOI 10.1517/14728222.2010.515980; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Qian F, 2009, CANCER RES, V69, P8009, DOI 10.1158/0008-5472.CAN-08-4889; Rosell R, 2009, CLIN LUNG CANCER, V10, P8, DOI 10.3816/CLC.2009.n.001; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Suda K, 2011, J THORAC ONCOL, V6, P1152, DOI 10.1097/JTO.0b013e318216ee52; Tai KY, 2008, ONCOGENE, V27, P4044, DOI 10.1038/onc.2008.57; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Ye X, 2010, ONCOGENE, V29, P5254, DOI 10.1038/onc.2010.268; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105	29	863	916	6	154	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2012	44	8					852	+		10.1038/ng.2330	http://dx.doi.org/10.1038/ng.2330			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	979WV	22751098	Green Submitted, Green Accepted			2022-12-25	WOS:000306854700008
J	Blattermann, S; Peters, L; Ottersbach, PA; Bock, A; Konya, V; Weaver, CD; Gonzalez, A; Schroder, R; Tyagi, R; Luschnig, P; Gab, J; Hennen, S; Ulven, T; Pardo, L; Mohr, K; Gutschow, M; Heinemann, A; Kostenis, E				Blaettermann, Stefanie; Peters, Lucas; Ottersbach, Philipp Aaron; Bock, Andreas; Konya, Viktoria; Weaver, C. David; Gonzalez, Angel; Schroeder, Ralf; Tyagi, Rahul; Luschnig, Petra; Gaeb, Juergen; Hennen, Stephanie; Ulven, Trond; Pardo, Leonardo; Mohr, Klaus; Guetschow, Michael; Heinemann, Akos; Kostenis, Evi			A biased ligand for OXE-R uncouples G alpha and G beta gamma signaling within a heterotrimer	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-COUPLED RECEPTORS; DRUG DISCOVERY; FUNCTIONAL SELECTIVITY; PHOSPHOLIPASE-C; LIVING CELLS; ACTIVATION; IDENTIFICATION; GPCR; SUBUNIT; COMPLEX	Differential targeting of heterotrimeric G protein versus beta-arrestin signaling are emerging concepts in G protein-coupled receptor (GPCR) research and drug discovery, and biased engagement by GPCR ligands of either beta-arrestin or G protein pathways has been disclosed. Herein we report on a new mechanism of ligand bias to titrate the signaling specificity of a cell-surface GPCR. Using a combination of biomolecular and virtual screening, we identified the small-molecule modulator Gue1654, which inhibits G beta gamma but not G alpha signaling triggered upon activation of G alpha(1)-beta gamma by the chemoattractant receptor OXE-R in both recombinant and human primary cells. Gue1654 does not interfere nonspecifically with signaling directly at or downstream of G beta gamma. This hitherto unappreciated mechanism of ligand bias at a GPCR highlights both a new paradigm for functional selectivity and a potentially new strategy to develop pathway-specific therapeutics.	[Blaettermann, Stefanie; Peters, Lucas; Schroeder, Ralf; Hennen, Stephanie; Kostenis, Evi] Univ Bonn, Inst Pharmaceut Biol, Mol Cellular & Pharmacobiol Sect, Bonn, Germany; [Ottersbach, Philipp Aaron; Gaeb, Juergen; Guetschow, Michael] Univ Bonn, Inst Pharmaceut, Bonn, Germany; [Konya, Viktoria; Luschnig, Petra; Heinemann, Akos] Med Univ Graz, Inst Expt & Clin Pharmacol, Graz, Austria; [Weaver, C. David] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Weaver, C. David] Vanderbilt Univ, Inst Biol Chem, Nashville, TN USA; [Gonzalez, Angel; Pardo, Leonardo] Univ Autonoma Barcelona, Fac Med, Unitat Bioestadist, Lab Med Computac, E-08193 Barcelona, Spain; [Tyagi, Rahul; Ulven, Trond] Univ So Denmark, Dept Phys & Chem, Odense, Denmark	University of Bonn; University of Bonn; Medical University of Graz; Vanderbilt University; Vanderbilt University; Autonomous University of Barcelona; University of Barcelona; University of Southern Denmark	Kostenis, E (corresponding author), Univ Bonn, Inst Pharmaceut Biol, Mol Cellular & Pharmacobiol Sect, Bonn, Germany.	akos.heinemann@medunigraz.at; kostenis@uni-bonn.de	Gonzalez, Angel/B-2492-2010; Ulven, Trond/H-5500-2015; Gonzalez, Angel/AAU-5927-2020	Gonzalez, Angel/0000-0002-2284-8307; Ulven, Trond/0000-0002-8135-1755; Gonzalez, Angel/0000-0002-2284-8307; Bock, Andreas/0000-0002-6344-6494; Konya, Viktoria/0000-0002-7999-9093; Pardo, Leonardo/0000-0003-1778-7420; Heinemann, Akos/0000-0002-8554-2372	Austrian Science Funds FWF [P-22521]; Spanish Ministerio de Ciencia e Innovacion (MICINN) [SAF2010-22198-C01-02]; L'Oreal Fellowship; German Research Foundation (Graduate College) [804]; Austrian Science Fund (FWF) [P 22521] Funding Source: researchfish	Austrian Science Funds FWF(Austrian Science Fund (FWF)); Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); L'Oreal Fellowship(L'Oreal Group); German Research Foundation (Graduate College); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank U. Rick and M. Vasmer-Ehses for excellent technical assistance and Corning Inc. for their support on the Epic system. C. D. W. acknowledges E. Days and Y. Du for valuable technical assistance with cell culture and transient transfections. All thallium flux assays were performed in the Vanderbilt Institute of Chemical Biology High-Throughput Screening Facility. This work was funded by a grant from the Austrian Science Funds FWF (P-22521 to A. H.), a grant from the Spanish Ministerio de Ciencia e Innovacion (MICINN, SAF2010-22198-C01-02 to L. Pardo), a L'Oreal Fellowship to P. L. and a fellowship of the German Research Foundation (Graduate College 804) to P.A.O.	Antony J, 2009, FASEB J, V23, P442, DOI 10.1096/fj.08-114751; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Baker JG, 2007, TRENDS PHARMACOL SCI, V28, P374, DOI 10.1016/j.tips.2007.06.011; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Bosier B, 2007, TRENDS PHARMACOL SCI, V28, P438, DOI 10.1016/j.tips.2007.06.001; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Cherfils J, 2003, TRENDS BIOCHEM SCI, V28, P13, DOI 10.1016/S0968-0004(02)00006-3; Christiansen E, 2008, J MED CHEM, V51, P7061, DOI 10.1021/jm8010178; Dowal L, 2011, P NATL ACAD SCI USA, V108, P2951, DOI 10.1073/pnas.1014863108; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Grant GE, 2009, PROSTAG OTH LIPID M, V89, P98, DOI 10.1016/j.prostaglandins.2009.05.002; Hartnell A, 2004, J IMMUNOL, V173, P6448, DOI 10.4049/jimmunol.173.10.6448; Hosoi T, 2002, J BIOL CHEM, V277, P31459, DOI 10.1074/jbc.M203194200; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jiang HP, 1996, J BIOL CHEM, V271, P13430, DOI 10.1074/jbc.271.23.13430; Jiang HP, 1997, P NATL ACAD SCI USA, V94, P7971, DOI 10.1073/pnas.94.15.7971; Jones CE, 2003, MOL PHARMACOL, V63, P471, DOI 10.1124/mol.63.3.471; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Kenakin TP, 2009, NAT REV DRUG DISCOV, V8, P617, DOI 10.1038/nrd2838; Kendall RT, 2011, J BIOL CHEM, V286, P19880, DOI 10.1074/jbc.M111.233080; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Maillet EL, 2007, FASEB J, V21, P2124, DOI 10.1096/fj.06-7683com; Mathiesen JM, 2005, MOL PHARMACOL, V68, P393, DOI 10.1124/mol.104.010520; Niswender CM, 2008, MOL PHARMACOL, V73, P1213, DOI 10.1124/mol.107.041053; O'Flaherty JT, 2000, J IMMUNOL, V164, P3345, DOI 10.4049/jimmunol.164.6.3345; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sadja R, 2003, NEURON, V39, P9, DOI 10.1016/S0896-6273(03)00402-1; Schmidt J, 2011, J BIOL CHEM, V286, P10628, DOI 10.1074/jbc.M110.210872; Schroder R, 2011, NAT PROTOC, V6, P1748, DOI 10.1038/nprot.2011.386; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Schroder R, 2009, J BIOL CHEM, V284, P1324, DOI 10.1074/jbc.M806867200; Schuligoi R, 2007, BIOCHEM PHARMACOL, V74, P107, DOI 10.1016/j.bcp.2007.03.023; Smith NJ, 2011, MOL CELL ENDOCRINOL, V331, P241, DOI 10.1016/j.mce.2010.07.009; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu DQ, 2000, J CELL SCI, V113, P2935	48	68	71	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2012	8	7					631	638		10.1038/NCHEMBIO.962	http://dx.doi.org/10.1038/NCHEMBIO.962			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961NJ	22634634				2022-12-25	WOS:000305471400010
J	Segura, V; Vilhjalmsson, BJ; Platt, A; Korte, A; Seren, U; Long, Q; Nordborg, M				Segura, Vincent; Vilhjalmsson, Bjarni J.; Platt, Alexander; Korte, Arthur; Seren, Uemit; Long, Quan; Nordborg, Magnus			An efficient multi-locus mixed-model approach for genome-wide association studies in structured populations	NATURE GENETICS			English	Article							SELECTION; REGRESSION; LOCI; STRATIFICATION; VARIANTS; GENE	Population structure causes genome-wide linkage disequilibrium between unlinked loci, leading to statistical confounding in genome-wide association studies. Mixed models have been shown to handle the confounding effects of a diffuse background of large numbers of loci of small effect well, but they do not always account for loci of larger effect. Here we propose a multi-locus mixed model as a general method for mapping complex traits in structured populations. Simulations suggest that our method outperforms existing methods in terms of power as well as false discovery rate. We apply our method to human and Arabidopsis thaliana data, identifying new associations and evidence for allelic heterogeneity. We also show how a priori knowledge from an A. thaliana linkage mapping study can be integrated into our method using a Bayesian approach. Our implementation is computationally efficient, making the analysis of large data sets (n > 10,000) practicable.	[Segura, Vincent; Vilhjalmsson, Bjarni J.; Platt, Alexander; Korte, Arthur; Seren, Uemit; Long, Quan; Nordborg, Magnus] Austrian Acad Sci, GMI, A-1010 Vienna, Austria; [Segura, Vincent] INRA, UR0588, Orleans, France; [Vilhjalmsson, Bjarni J.; Platt, Alexander; Nordborg, Magnus] Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA USA	Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); INRAE; University of Southern California	Nordborg, M (corresponding author), Austrian Acad Sci, GMI, A-1010 Vienna, Austria.	magnus.nordborg@gmi.oeaw.ac.at	Segura, Vincent/B-4656-2013; Vilhjalmsson, Bjarni/K-3971-2014; Korte, Arthur/H-3190-2019; Vilhjálmsson, Bjarni/ABC-1369-2020	Segura, Vincent/0000-0003-1860-2256; Vilhjalmsson, Bjarni/0000-0003-2277-9249; Korte, Arthur/0000-0003-0831-1463; Vilhjálmsson, Bjarni/0000-0003-2277-9249; Platt, Alexander/0000-0003-3783-4781; Nordborg, Magnus/0000-0001-7178-9748; Seren, Umit/0000-0003-4031-0428	National Heart, Lung, and Blood Institute (NHLBI); Ecologie des Forets, Prairies et milieux Aquatiques (EFPA) department of INRA; Deutsche Forschungsgemeinschaft (DFG); US National Institutes of Health [P50 HG002790]; European Union [283496]; Austrian Academy of Sciences through GMI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Ecologie des Forets, Prairies et milieux Aquatiques (EFPA) department of INRA; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); Austrian Academy of Sciences through GMI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We acknowledge the NFBC1966 Study investigators for allowing us to use their phenotype and genotype data in our study. The NFBC1966 Study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with the Broad Institute, the University of California, Los Angeles (UCLA), the University of Oulu and the National Institute for Health and Welfare in Finland. This manuscript was not prepared in collaboration with the investigators from the NFBC1966 Study and does not necessarily reflect the opinions or views of these investigators or those at the collaborating institutes. We thank N.B. Freimer and S.K. Service for their help in pre-processing the NFBC1966 data. We would also like to thank P. Forai for excellent information technology and cluster support at GMI, the INRA MIGALE bioinformatics platform for additional computational resources and D.V. Conti, D.J. Balding and S. Srivastava for useful discussions on the topic. Finally, we would like to thank the anonymous reviewers for their helpful comments on the manuscript. This work was supported by grants from the Ecologie des Forets, Prairies et milieux Aquatiques (EFPA) department of INRA to V.S. and Deutsche Forschungsgemeinschaft (DFG) to A.K. and by grants from the US National Institutes of Health (P50 HG002790) and the European Union Framework Programme 7 (TransPLANT, grant agreement 283496) to M.N., as well as by the Austrian Academy of Sciences through GMI.	Allen AS, 2010, HUM HERED, V70, P167, DOI 10.1159/000308456; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Ayers KL, 2010, GENET EPIDEMIOL, V34, P879, DOI 10.1002/gepi.20543; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Chen JH, 2008, BIOMETRIKA, V95, P759, DOI 10.1093/biomet/asn034; Cho S, 2010, ANN HUM GENET, V74, P416, DOI 10.1111/j.1469-1809.2010.00597.x; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Croiseau Pascal, 2009, BMC Proc, V3 Suppl 7, pS61; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Hastie T., 2009, UNSUPERVISED LEARNIN; Henderson C. R, 1984, APPL LINEAR MODELS A; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; Horton MW, 2012, NAT GENET, V44, P212, DOI 10.1038/ng.1042; JANSEN RC, 1993, GENETICS, V135, P205; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Malo N, 2008, AM J HUM GENET, V82, P375, DOI 10.1016/j.ajhg.2007.10.012; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Platt A, 2010, GENETICS, V186, P1045, DOI 10.1534/genetics.110.121665; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Valdar W, 2009, GENETICS, V182, P1263, DOI 10.1534/genetics.109.100727; Wang D, 2011, J AGR BIOL ENVIR ST, V16, P170, DOI 10.1007/s13253-010-0046-2; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004	42	507	522	2	140	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2012	44	7					825	U144		10.1038/ng.2314	http://dx.doi.org/10.1038/ng.2314			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967DP	22706313	Green Submitted, Green Accepted			2022-12-25	WOS:000305886900021
J	Ayres, JS; Trinidad, NJ; Vance, RE				Ayres, Janelle S.; Trinidad, Norver J.; Vance, Russell E.			Lethal inflammasome activation by a multidrug- resistant pathobiont upon antibiotic disruption of the microbiota	NATURE MEDICINE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; III SECRETION SYSTEM; ESCHERICHIA-COLI; INTESTINAL MICROBIOTA; ULCERATIVE-COLITIS; CECAL LIGATION; GUT MICROBIOTA; SEPSIS; MICE; SUSCEPTIBILITY	The mammalian intestine harbors a complex microbial community that provides numerous benefits to its host. However, the microbiota can also include potentially virulent species, termed pathobiont, which can cause disease when intestinal homeostasis is disrupted. The molecular mechanisms by which pathobionts cause disease remain poorly understood. Here we describe a sepsis-like disease that occurs upon gut injury in antibiotic-treated mice. Sepsis was associated with the systemic spread of a specific multidrug-resistant Escherichia coli pathobiont that expanded markedly in the microbiota of antibiotic-treated mice. Rapid sepsis-like death required a component of the innate immune system, the Naip5-Nlrc4 inflammasome. In accordance with Koch's postulates, we found the E. coli pathobiont was sufficient to activate Naip5-Nlrc4 and cause disease when injected intravenously into unmanipulated mice. These findings reveal how sepsis-like disease can result from recognition of pathobionts by the innate immune system.	[Ayres, Janelle S.; Trinidad, Norver J.; Vance, Russell E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Ayres, JS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.	jayres@berkeley.edu; rvance@berkeley.edu			US National Institutes of Health [AI063302, AI075039, AI080749]; National Institutes of Health Ruth L. Kirschstein National Research Service [AI091068]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080749, R01AI075039, F32AI091068, P01AI063302] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Schapiro and J. LaPan for biochemical characterization of E. coli O21:H+ and S. Brandt for helpful discussions about the isolate; K. Bodi for helpful advice about whole-genome sequencing analysis; G. Barton, D. Portnoy and K. Barry for helpful discussions and critical reading of the manuscript; E. Kofoed (University of California-Berkeley) for the flaA-IRES-GFP construct; K. Sotelo-Troha for technical help and L. Lopez for support in our mouse facility (University of California-Berkeley). Nlrc4<SUP>-/-</SUP>mice were from S. Mariathasan and V. Dixit (Genentech). Casp1<SUP>-/-</SUP> mice and S. Typhimurium LT2 Delta fliC Delta fljB were a gift from A. Van der Velden and M. Starnbach (Harvard Medical School). Il1b<SUP>-/-</SUP> mice were from the Zychlinsky lab at Max Planck Institute. This work was supported in part by US National Institutes of Health grants AI063302, AI075039 and AI080749 awarded to R.E.V. and National Institutes of Health Ruth L. Kirschstein National Research Service Award fellowship AI091068 awarded to J.S.A. R.E.V. is an Investigator of the Cancer Research Institute and a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease.	Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Boots M, 2008, TRENDS ECOL EVOL, V23, P248, DOI 10.1016/j.tree.2008.01.006; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Chow J, 2010, CELL HOST MICROBE, V7, P265, DOI 10.1016/j.chom.2010.03.004; Croswell A, 2009, INFECT IMMUN, V77, P2741, DOI 10.1128/IAI.00006-09; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; EVANS DJ, 1981, J CLIN MICROBIOL, V13, P171, DOI 10.1128/JCM.13.1.171-178.1981; EVANS DJ, 1980, J CLIN MICROBIOL, V12, P235, DOI 10.1128/JCM.12.2.235-242.1980; Fantuzzi G, 1996, J IMMUNOL, V157, P291; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; FISHER CJ, 1994, CRIT CARE MED, V22, P12, DOI 10.1097/00003246-199401000-00008; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Henderson JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000305; Hu B, 2010, P NATL ACAD SCI USA, V107, P21635, DOI 10.1073/pnas.1016814108; Ideses D, 2005, J BACTERIOL, V187, P8164, DOI 10.1128/JB.187.23.8164-8171.2005; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Korczak B, 2005, J CLIN MICROBIOL, V43, P1024, DOI 10.1128/JCM.43.3.1024-1031.2005; Lakhan SE, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-79; Lamkanfi M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000510; Larsen R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001118; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Lightfield KL, 2011, INFECT IMMUN, V79, P1606, DOI 10.1128/IAI.01187-10; Mapes S, 2007, VET REC, V161, P716, DOI 10.1136/vr.161.21.716; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Mokady D, 2005, INT J MED MICROBIOL, V295, P455, DOI 10.1016/j.ijmm.2005.07.007; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Opal SM, 1997, CRIT CARE MED, V25, P1115, DOI 10.1097/00003246-199707000-00010; OREILLY M, 1992, J SURG RES, V52, P518; ORSKOV I, 1985, J HYG-CAMBRIDGE, V95, P551, DOI 10.1017/S0022172400060678; Oteo J, 2010, CURR OPIN INFECT DIS, V23, P320, DOI 10.1097/QCO.0b013e3283398dc1; Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ramos NL, 2010, EUR J CLIN MICROBIOL, V29, P15, DOI 10.1007/s10096-009-0809-2; Ren CP, 2004, J BACTERIOL, V186, P3547, DOI 10.1128/JB.186.11.3547-3560.2004; Ren Y, 2008, J MICROBIOL METH, V75, P329, DOI 10.1016/j.mimet.2008.07.010; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Roy BA, 2000, EVOLUTION, V54, P51, DOI 10.1111/j.0014-3820.2000.tb00007.x; Russell Deborah A., 1993, Current Opinion in Biotechnology, V4, P714, DOI 10.1016/0958-1669(93)90055-2; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Sannes MR, 2004, J INFECT DIS, V190, P2121, DOI 10.1086/425984; Sarkar A, 2006, AM J RESP CRIT CARE, V174, P1003, DOI 10.1164/rccm.200604-546OC; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sherwood ER, 2004, LAB INVEST, V84, P1655, DOI 10.1038/labinvest.3700184; STEVENS P, 1983, IMMUNOLOGY, V50, P497; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; WONG WT, 1982, J HYG-CAMBRIDGE, V88, P513, DOI 10.1017/S0022172400070364; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	63	143	148	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					799	U201		10.1038/nm.2729	http://dx.doi.org/10.1038/nm.2729			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22522562	Green Submitted, Green Accepted			2022-12-25	WOS:000303763500048
J	Chandarana, K; Batterham, RL				Chandarana, Keval; Batterham, Rachel L.			Metabolic insights from cutting the gut	NATURE MEDICINE			English	Editorial Material							GLUCAGON-LIKE PEPTIDE-1; Y GASTRIC BYPASS; SLEEVE-GASTRECTOMY; BARIATRIC SURGERY; WEIGHT-LOSS		[Chandarana, Keval; Batterham, Rachel L.] UCL, Rayne Inst, Dept Med, Obes Res Ctr, London, England	University of London; King's College London; University College London	Chandarana, K (corresponding author), UCL, Rayne Inst, Dept Med, Obes Res Ctr, London, England.	r.batterham@ucl.ac.uk		Batterham, Rachel/0000-0002-5477-8585				Asmar M, 2010, CURR OPIN ENDOCRINOL, V17, P57, DOI 10.1097/MED.0b013e3283339051; Chambers AP, 2011, GASTROENTEROLOGY, V141, P950, DOI 10.1053/j.gastro.2011.05.050; Chandarana K, 2011, DIABETES, V60, P810, DOI 10.2337/db10-0566; Chandarana K, 2008, CURR OPIN ENDOCRINOL, V15, P65, DOI 10.1097/MED.0b013e3282f3f4b1; Flum DR, 2009, NEW ENGL J MED, V361, P445, DOI 10.1056/NEJMoa0901836; Gill RS, 2011, OBESITY, V19, P701, DOI 10.1038/oby.2010.261; Hutter MM, 2011, ANN SURG, V254, P410, DOI 10.1097/SLA.0b013e31822c9dac; Melissas J, 2008, OBES SURG, V18, P1251, DOI 10.1007/s11695-008-9634-4; Olivan B, 2009, ANN SURG, V249, P948, DOI 10.1097/SLA.0b013e3181a6cdb0; Peterli R, 2009, ANN SURG, V250, P234, DOI 10.1097/SLA.0b013e3181ae32e3; Rogers GJ, 2011, J PHYSIOL-LONDON, V589, P1081, DOI 10.1113/jphysiol.2010.198069; Rubino F, 2006, ANN SURG, V244, P741, DOI 10.1097/01.sla.0000224726.61448.1b; Scott WR, 2011, AM J PHYSIOL-REG I, V301, pR15, DOI 10.1152/ajpregu.00038.2011; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Tymitz K, 2011, OBES SURG, V21, P125, DOI 10.1007/s11695-010-0311-z	16	30	31	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2012	18	5					668	669		10.1038/nm.2748	http://dx.doi.org/10.1038/nm.2748			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22561824				2022-12-25	WOS:000303763500034
J	Haynes, BF; Kelsoe, G; Harrison, SC; Kepler, TB				Haynes, Barton F.; Kelsoe, Garnett; Harrison, Stephen C.; Kepler, Thomas B.			B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study	NATURE BIOTECHNOLOGY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BROADLY NEUTRALIZING ANTIBODIES; HUMAN MONOCLONAL-ANTIBODIES; SURROGATE LIGHT-CHAIN; PROXIMAL EXTERNAL REGION; MOUSE BONE-MARROW; MU HEAVY-CHAIN; INFLUENZA-VIRUS; GERMINAL-CENTER; SELF-TOLERANCE	Failure of immunization with the HIV-1 envelope to induce broadly neutralizing antibodies against conserved epitopes is a major barrier to producing a preventive HIV-1 vaccine. Broadly neutralizing monoclonal antibodies (BnAbs) from those subjects who do produce them after years of chronic HIV-1 infection have one or more unusual characteristics, including polyreactivity for host antigens, extensive somatic hypermutation and long, variable heavy-chain third complementarity-determining regions, factors that may limit their expression by host immunoregulatory mechanisms. The isolation of BnAbs from HIV-1-infected subjects and the use of computationally derived clonal lineages as templates provide a new path for HIV-1 vaccine immunogen design. This approach, which should be applicable to many infectious agents, holds promise for the construction of vaccines that can drive B cells along rare but desirable maturation pathways.	[Haynes, Barton F.] Duke Univ, Sch Med, Dept Med, Duke Human Vaccine Inst, Durham, NC 27706 USA; [Haynes, Barton F.; Kelsoe, Garnett; Kepler, Thomas B.] Duke Univ, Sch Med, Dept Immunol, Duke Human Vaccine Inst, Durham, NC USA; [Harrison, Stephen C.] Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Harrison, Stephen C.] Harvard Univ, Sch Med, Boston, MA USA; [Kepler, Thomas B.] Duke Univ, Sch Med, Ctr Computat Immunol, Duke Human Vaccine Inst, Durham, NC USA	Duke University; Duke University; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Duke University	Haynes, BF (corresponding author), Duke Univ, Sch Med, Dept Med, Duke Human Vaccine Inst, Durham, NC 27706 USA.	hayne002@mc.duke.edu		Kelsoe, Garnett/0000-0002-8770-040X; Kepler, Thomas/0000-0002-1383-6865	Vaccine Development Center from the Bill and Melinda Gates Foundation; NIH, National Institute of Allergy and Infectious Diseases (NIAID), Division of AIDS [U19 AI-067854]; NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067854, R01AI081579, U01AI067854] Funding Source: NIH RePORTER	Vaccine Development Center from the Bill and Melinda Gates Foundation; NIH, National Institute of Allergy and Infectious Diseases (NIAID), Division of AIDS; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge H.-X. Liao, M. Anthony Moody, S. Munir Alam, L. Verkoczy, M. Bonsignori and G.D. Tomaras at Duke University School of Medicine and D. Dimitrov at the National Cancer Institute, US National Institutes of Health (NIH), USA, for discussions and key collaborations on the work cited in this review; H.-X. Liao for Figure 3; and K. McClammy and S. Devine for expert secretarial assistance. This work was supported by a Vaccine Development Center grant in the Collaboration for AIDS Vaccine Discovery Program from the Bill and Melinda Gates Foundation, by the NIH, National Institute of Allergy and Infectious Diseases (NIAID), Division of AIDS grant for the Center for HIV/AIDS Vaccine Immunology, cooperative agreement U19 AI-067854, and by an NIAID 'Modeling Immunity for Biodefense' contract. S.C.H. is an investigator of the Howard Hughes Medical Institute.	ADAMS E, 1990, P NATL ACAD SCI USA, V87, P5687, DOI 10.1073/pnas.87.15.5687; Alam SM, 2011, J VIROL, V85, P11725, DOI 10.1128/JVI.05680-11; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; ALT FW, 1987, SCIENCE, V238, P1079, DOI 10.1126/science.3317825; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Azoitei ML, 2011, SCIENCE, V334, P373, DOI 10.1126/science.1209368; Bambini S, 2009, DRUG DISCOV TODAY, V14, P252, DOI 10.1016/j.drudis.2008.12.007; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Bonsignori M, 2009, J IMMUNOL, V183, P2708, DOI 10.4049/jimmunol.0901068; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; CARSETTI R, 1995, J EXP MED, V181, P2129, DOI 10.1084/jem.181.6.2129; Changela A, 2011, J VIROL, V85, P2524, DOI 10.1128/JVI.02335-10; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; CHEN C, 1994, J IMMUNOL, V152, P1970; CLARKE SH, 1985, J EXP MED, V161, P687, DOI 10.1084/jem.161.4.687; CLARKE SH, 1990, J IMMUNOL, V144, P2795; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dal Porto JM, 1998, J IMMUNOL, V161, P5373; Dal Porto JM, 2002, J EXP MED, V195, P1215, DOI 10.1084/jem.20011550; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dimitrov DS, 2010, MABS-AUSTIN, V2, P347, DOI 10.4161/mabs.2.3.11779; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Dormitzer PR, 2008, TRENDS BIOTECHNOL, V26, P659, DOI 10.1016/j.tibtech.2008.08.002; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; Garrone P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002330; Goldsby R.A., 2003, IMMUNOLOGY, P161; GOODNOW CC, 1992, ANNU REV IMMUNOL, V10, P489, DOI 10.1146/annurev.iy.10.040192.002421; Gray ES, 2011, J VIROL, V85, P7719, DOI 10.1128/JVI.00563-11; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Grigorieff N, 2011, CURR OPIN STRUC BIOL, V21, P265, DOI 10.1016/j.sbi.2011.01.008; HAN SH, 1995, J EXP MED, V182, P1635, DOI 10.1084/jem.182.6.1635; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Haynes Barton F., 2005, Human Antibodies, V14, P59; Haynes BF, 2011, TRENDS MOL MED, V17, P108, DOI 10.1016/j.molmed.2010.10.008; Haynes BF, 2010, CURR OPIN HIV AIDS, V5, P362, DOI 10.1097/COH.0b013e32833d2e90; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Hilleman MR, 2002, INTERVIROLOGY, V45, P199, DOI 10.1159/000067911; Hong M, 2012, ANNU REV PHYS CHEM, V63, P1, DOI 10.1146/annurev-physchem-032511-143731; Irving MB, 2010, MOL IMMUNOL, V47, P1137, DOI 10.1016/j.molimm.2009.10.015; Karasuyama H, 1996, ADV IMMUNOL, V63, P1, DOI 10.1016/S0065-2776(08)60853-6; KARASUYAMA H, 1993, J EXP MED, V178, P469, DOI 10.1084/jem.178.2.469; KARASUYAMA H, 1990, J EXP MED, V172, P969, DOI 10.1084/jem.172.3.969; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Kelsoe G, 1995, ADV IMMUNOL, V60, P267, DOI 10.1016/S0065-2776(08)60587-8; Kepler TB, 1997, MOL BIOL EVOL, V14, P637, DOI 10.1093/oxfordjournals.molbev.a025803; KEPLER TB, 1993, J THEOR BIOL, V164, P37, DOI 10.1006/jtbi.1993.1139; Kim JH, 2009, J IMMUNOL, V183, P3294, DOI 10.4049/jimmunol.0900398; Kwong PD, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007278; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; Li Z, 1996, IMMUNITY, V5, P575, DOI 10.1016/S1074-7613(00)80272-1; Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; LIN WC, 1993, SCIENCE, V260, P953, DOI 10.1126/science.8493533; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Ma BJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002200; Malherbe DC, 2011, J VIROL, V85, P5262, DOI 10.1128/JVI.02419-10; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Meffre E, 2004, J EXP MED, V199, P145, DOI 10.1084/jem.20031550; Mietzner B, 2008, P NATL ACAD SCI USA, V105, P9727, DOI 10.1073/pnas.0803644105; Moody MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025797; Moriel DG, 2010, P NATL ACAD SCI USA, V107, P9072, DOI 10.1073/pnas.0915077107; Morris L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023532; Mouquet H, 2012, CELL MOL LIFE SCI, V69, P1435, DOI 10.1007/s00018-011-0872-6; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; Nemazee D, 2000, J EXP MED, V191, P1813, DOI 10.1084/jem.191.11.1813; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Perez-Andres M, 2010, CYTOM PART B-CLIN CY, V78B, pS47, DOI 10.1002/cyto.b.20547; Phillips RS, 2011, BBA-PROTEINS PROTEOM, V1814, P1481, DOI 10.1016/j.bbapap.2010.12.003; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Plotkin SA, 2009, CLIN VACCINE IMMUNOL, V16, P1709, DOI 10.1128/CVI.00290-09; Polyansky AA, 2012, METHODS MOL BIOL, V819, P327, DOI 10.1007/978-1-61779-465-0_21; PULENDRAN B, 1995, NATURE, V375, P331, DOI 10.1038/375331a0; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rappuoli R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3; Ray R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002772; RETH M, 1987, EMBO J, V6, P3299, DOI 10.1002/j.1460-2075.1987.tb02649.x; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Scheid JF, 2011, P NATL ACAD SCI USA, V108, P18044, DOI 10.1073/pnas.1113395108; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Settembre EC, 2011, EMBO J, V30, P408, DOI 10.1038/emboj.2010.322; Shen XY, 2010, P NATL ACAD SCI USA, V107, P5972, DOI 10.1073/pnas.0912381107; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; SHLOMCHIK M, 1990, J EXP MED, V171, P265, DOI 10.1084/jem.171.1.265; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; tenBoekel E, 1997, IMMUNITY, V7, P357; Thimme R, 2008, BIOL CHEM, V389, P457, DOI 10.1515/BC.2008.061; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Tsuiji M, 2006, J EXP MED, V203, P393, DOI 10.1084/jem.20052033; Verkoczy L, 2011, J IMMUNOL, V187, P3785, DOI 10.4049/jimmunol.1101633; Verkoczy L, 2011, CURR OPIN IMMUNOL, V23, P383, DOI 10.1016/j.coi.2011.04.003; Verkoczy L, 2010, P NATL ACAD SCI USA, V107, P181, DOI 10.1073/pnas.0912914107; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang HS, 2007, J IMMUNOL, V179, P7544, DOI 10.4049/jimmunol.179.11.7544; Wang P, 2010, J AM CHEM SOC, V132, P17045, DOI 10.1021/ja1084628; Wardemann H, 2004, J EXP MED, V200, P191, DOI 10.1084/jem.20040818; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wardemann H, 2007, ADV IMMUNOL, V95, P83, DOI 10.1016/S0065-2776(07)95003-8; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao XD, 2009, VIRUSES-BASEL, V1, P802, DOI 10.3390/v1030802; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Yang TY, 2011, PROTEINS, V79, P1940, DOI 10.1002/prot.23018; Yuan Y, 2009, J AM CHEM SOC, V131, P5432, DOI 10.1021/ja808705v; Zhang JS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000800; Zhu ZY, 2011, J VIROL, V85, P11401, DOI 10.1128/JVI.05312-11; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	152	337	359	1	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2012	30	5					423	433		10.1038/nbt.2197	http://dx.doi.org/10.1038/nbt.2197			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	939IP	22565972	Green Accepted			2022-12-25	WOS:000303803200022
J	Taal, HR; St Pourcain, B; Thiering, E; Das, S; Mook-Kanamori, DO; Warrington, NM; Kaakinen, M; Kreiner-Moller, E; Bradfield, JP; Freathy, RM; Geller, F; Guxens, M; Cousminer, DL; Kerkhof, M; Timpson, NJ; Ikram, MA; Beilin, LJ; Bonnelykke, K; Buxton, JL; Charoen, P; Chawes, BLK; Eriksson, J; Evans, DM; Hofman, A; Kemp, JP; Kim, CE; Klopp, N; Lahti, J; Lye, SJ; McMahon, G; Mentch, FD; Muller-Nurasyid, M; O'Reilly, PF; Prokopenko, I; Rivadeneira, F; Steegers, EAP; Sunyer, J; Tiesler, C; Yaghootkar, H; Breteler, MMB; Debette, S; Fornage, M; Gudnason, V; Launer, LJ; van der Lugt, A; Mosley, TH; Seshadri, S; Smith, AV; Vernooij, MW; Blakemore, AIF; Chiavacci, RM; Feenstra, B; Fernandez-Banet, J; Grant, SFA; Hartikainen, AL; van der Heijden, AJ; Iniguez, C; Lathrop, M; McArdle, WL; Molgaard, A; Newnham, JP; Palmer, LJ; Palotie, A; Pouta, A; Ring, SM; Sovio, U; Standl, M; Uitterlinden, AG; Wichmann, HE; Vissing, NH; DeCarli, C; van Duijn, CM; McCarthy, MI; Koppelman, GH; Estivill, X; Hattersley, AT; Melbye, M; Bisgaard, H; Pennell, CE; Widen, E; Hakonarson, H; Smith, GD; Heinrich, J; Jarvelin, MR; Jaddoe, VWV; Adair, LS; Ang, W; Atalay, M; van Beijsterveldt, T; Bergen, N; Benke, K; Berry, D; Coin, L; Davis, OSP; Elliott, P; Flexeder, C; Frayling, T; Gaillard, R; Groen-Blokhuis, M; Goh, LK; Haworth, CMA; Hadley, D; Hedebrand, J; Hinney, A; Hirschhorn, JN; Holloway, JW; Holst, C; Hottenga, JJ; Horikoshi, M; Huikari, V; Hypponen, E; Kilpelainen, TO; Kirin, M; Kowgier, M; Lakka, HM; Lange, LA; Lawlor, DA; Lehtimaki, T; Lewin, A; Lindgren, C; Lindi, V; Maggi, R; Marsh, J; Middeldorp, C; Millwood, I; Murray, JC; Nivard, M; Nohr, EA; Ntalla, I; Oken, E; Panoutsopoulou, K; Pararajasingham, J; Rodriguez, A; Salem, RM; Sebert, S; Siitonen, N; Strachan, DP; Taal, HR; Teo, YY; Valcarcel, B; White, S; Willemsen, G; Zeggini, E; Boomsma, DI; Cooper, C; Gillman, M; Hocher, B; Lakka, TA; Mohlke, KL; Dedoussis, GV; Ong, KK; Pearson, ER; Price, TS; Power, C; Raitakari, OT; Saw, SM; Scherag, A; Simell, O; Sorensen, TIA; Wilson, JF; Schmidt, R; Vrooman, HA; Sigurdsson, S; Ropele, S; Coker, LH; Longstreth, WT; Niessen, WJ; DeStefano, AL; Beiser, A; Zijdenbos, AP; Struchalin, M; Jack, CR; Nalls, MA; Au, R; Gudnason, H; Harris, TB; Meeks, WM; van Buchem, MA; Catellier, D; Windham, BG; Wolf, PA; Schmidt, H				Taal, H. Rob; St Pourcain, Beate; Thiering, Elisabeth; Das, Shikta; Mook-Kanamori, Dennis O.; Warrington, Nicole M.; Kaakinen, Marika; Kreiner-Moller, Eskil; Bradfield, Jonathan P.; Freathy, Rachel M.; Geller, Frank; Guxens, Monica; Cousminer, Diana L.; Kerkhof, Marjan; Timpson, Nicholas J.; Ikram, M. Arfan; Beilin, Lawrence J.; Bonnelykke, Klaus; Buxton, Jessica L.; Charoen, Pimphen; Chawes, Bo Lund Krogsgaard; Eriksson, Johan; Evans, David M.; Hofman, Albert; Kemp, John P.; Kim, Cecilia E.; Klopp, Norman; Lahti, Jari; Lye, Stephen J.; McMahon, George; Mentch, Frank D.; Mueller-Nurasyid, Martina; O'Reilly, Paul F.; Prokopenko, Inga; Rivadeneira, Fernando; Steegers, Eric A. P.; Sunyer, Jordi; Tiesler, Carla; Yaghootkar, Hanieh; Breteler, Monique M. B.; Debette, Stephanie; Fornage, Myriam; Gudnason, Vilmundur; Launer, Lenore J.; van der Lugt, Aad; Mosley, Thomas H., Jr.; Seshadri, Sudha; Smith, Albert V.; Vernooij, Meike W.; Blakemore, Alexandra I. F.; Chiavacci, Rosetta M.; Feenstra, Bjarke; Fernandez-Banet, Julio; Grant, Struan F. A.; Hartikainen, Anna-Liisa; van der Heijden, Albert J.; Iniguez, Carmen; Lathrop, Mark; McArdle, Wendy L.; Molgaard, Anne; Newnham, John P.; Palmer, Lyle J.; Palotie, Aarno; Pouta, Annneli; Ring, Susan M.; Sovio, Ulla; Standl, Marie; Uitterlinden, Andre G.; Wichmann, H-Erich; Vissing, Nadja Hawwa; DeCarli, Charles; van Duijn, Cornelia M.; McCarthy, Mark I.; Koppelman, Gerard H.; Estivill, Xavier; Hattersley, Andrew T.; Melbye, Mads; Bisgaard, Hans; Pennell, Craig E.; Widen, Elisabeth; Hakonarson, Hakon; Smith, George Davey; Heinrich, Joachim; Jarvelin, Marjo-Riitta; Jaddoe, Vincent W. V.; Adair, Linda S.; Ang, Wei; Atalay, Mustafa; van Beijsterveldt, Toos; Bergen, Nienke; Benke, Kelly; Berry, Diane; Coin, Lachlan; Davis, Oliver S. P.; Elliott, Paul; Flexeder, Claudia; Frayling, Tim; Gaillard, Romy; Groen-Blokhuis, Maria; Goh, Liang-Kee; Haworth, Claire M. A.; Hadley, Dexter; Hedebrand, Johannes; Hinney, Anke; Hirschhorn, Joel N.; Holloway, John W.; Holst, Claus; Hottenga, Jouke Jan; Horikoshi, Momoko; Huikari, Ville; Hypponen, Elina; Kilpelainen, Tuomas O.; Kirin, Mirna; Kowgier, Matthew; Lakka, Hanna-Maaria; Lange, Leslie A.; Lawlor, Debbie A.; Lehtimaki, Terho; Lewin, Alex; Lindgren, Cecilia; Lindi, Virpi; Maggi, Reedik; Marsh, Julie; Middeldorp, Christel; Millwood, Iona; Murray, Jeffrey C.; Nivard, Michel; Nohr, Ellen Aagaard; Ntalla, Ioanna; Oken, Emily; Panoutsopoulou, Kalliope; Pararajasingham, Jennifer; Rodriguez, Alina; Salem, Rany M.; Sebert, Sylvain; Siitonen, Niina; Strachan, David P.; Taal, H. Rob; Teo, Yik-Ying; Valcarcel, Beatriz; White, Scott; Willemsen, Gonneke; Zeggini, Eleftheria; Boomsma, Dorret I.; Cooper, Cyrus; Gillman, Matthew; Hocher, Berthold; Lakka, Timo A.; Mohlke, Karen L.; Dedoussis, George V.; Ong, Ken K.; Pearson, Ewan R.; Price, Thomas S.; Power, Chris; Raitakari, Olli T.; Saw, Seang-Mei; Scherag, Andre; Simell, Olli; Sorensen, Thorkild I. A.; Wilson, James F.; Schmidt, Reinhold; Vrooman, Henri A.; Sigurdsson, Sigurdur; Ropele, Stefan; Coker, Laura H.; Longstreth, W. T., Jr.; Niessen, Wiro J.; DeStefano, Anita L.; Beiser, Alexa; Zijdenbos, Alex P.; Struchalin, Maksim; Jack, Clifford R., Jr.; Nalls, Mike A.; Au, Rhoda; Gudnason, Haukur; Harris, Tamara B.; Meeks, William M.; van Buchem, Mark A.; Catellier, Diane; Windham, B. Gwen; Wolf, Philip A.; Schmidt, Helena		Cohorts Heart Aging Res Genetic Ep; Early Genetics Lifecourse Epidemio; Early Growth Genetics EGG Consorti	Common variants at 12q15 and 12q24 are associated with infant head circumference	NATURE GENETICS			English	Article							BRAIN-DEVELOPMENT; FETAL-GROWTH; INTELLIGENCE; MUTATIONS; GENE; SIZE; IDENTIFICATION; DEGENERATION; POPULATION; DISORDERS	To identify genetic variants associated with head circumference in infancy, we performed a meta-analysis of seven genome-wide association studies (GWAS) (N = 10,768 individuals of European ancestry enrolled in pregnancy and/or birth cohorts) and followed up three lead signals in six replication studies (combined N = 19,089). rs7980687 on chromosome 12q24 (P = 8.1 x 10(-9)) and rs1042725 on chromosome 12q15 (P = 2.8 x 10(-10)) were robustly associated with head circumference in infancy. Although these loci have previously been associated with adult height(1), their effects on infant head circumference were largely independent of height (P = 3.8 x 10(-7) for rs7980687 and P = 1.3 x 10(-7) for rs1042725 after adjustment for infant height). A third signal, rs11655470 on chromosome 17q21, showed suggestive evidence of association with head circumference (P = 3.9 x 10(-6)). SNPs correlated to the 17q21 signal have shown genome-wide association with adult intracranial volume(2), Parkinson's disease and other neurodegenerative diseases(3-5), indicating that a common genetic variant in this region might link early brain growth with neurological disease in later life.	[Timpson, Nicholas J.; Evans, David M.; Kemp, John P.; McMahon, George; Lawlor, Debbie A.] Univ Bristol, MRC, Ctr Causal Anal Translat Epidemiol, Sch Social & Community Med, Bristol, Avon, England; [Taal, H. Rob; Ikram, M. Arfan; Hofman, Albert; Rivadeneira, Fernando; Breteler, Monique M. B.; Vernooij, Meike W.; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Jaddoe, Vincent W. V.; Bergen, Nienke; Gaillard, Romy; Taal, H. Rob; Struchalin, Maksim] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Taal, H. Rob; Mook-Kanamori, Dennis O.; van der Heijden, Albert J.; Jaddoe, Vincent W. V.] Erasmus MC, Dept Pediat, Rotterdam, Netherlands; [Taal, H. Rob; Mook-Kanamori, Dennis O.] Erasmus MC, Generat Study Grp R, Rotterdam, Netherlands; [Thiering, Elisabeth; Tiesler, Carla; Standl, Marie; Wichmann, H-Erich; Heinrich, Joachim; Flexeder, Claudia] German Res Ctr Environm Hlth, Inst Epidemiol 1, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Das, Shikta; Charoen, Pimphen; O'Reilly, Paul F.; Sovio, Ulla; Coin, Lachlan; Lewin, Alex; Millwood, Iona; Rodriguez, Alina; Sebert, Sylvain; Valcarcel, Beatriz] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Sch Publ Hlth, London, England; Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, Doha, Qatar; [Pennell, Craig E.; Ang, Wei; Benke, Kelly; Kowgier, Matthew; Marsh, Julie; White, Scott] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Warrington, Nicole M.; Lye, Stephen J.; Palmer, Lyle J.] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Kaakinen, Marika; Jarvelin, Marjo-Riitta; Huikari, Ville] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Kaakinen, Marika; Pouta, Annneli; Jarvelin, Marjo-Riitta; Huikari, Ville] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Kreiner-Moller, Eskil; Bonnelykke, Klaus; Chawes, Bo Lund Krogsgaard; Molgaard, Anne; Vissing, Nadja Hawwa; Bisgaard, Hans] Univ Copenhagen, Copenhagen Univ Hosp, Gentofte, Denmark; [Bradfield, Jonathan P.; Kim, Cecilia E.; Mentch, Frank D.; Chiavacci, Rosetta M.; Grant, Struan F. A.; Hakonarson, Hakon; Hadley, Dexter] Childrens Hosp Philadelphia, Ctr Appl Genom, Abramson Res Ctr, Philadelphia, PA 19104 USA; [Freathy, Rachel M.; Yaghootkar, Hanieh; Frayling, Tim] Univ Exeter, Peninsula Coll Med & Dent, Exeter, Devon, England; [Geller, Frank; Feenstra, Bjarke; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Guxens, Monica] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Guxens, Monica; Sunyer, Jordi] Hosp Mar Res Inst IMIM, Barcelona, Spain; [Guxens, Monica; Iniguez, Carmen; Estivill, Xavier] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Barcelona, Spain; [Cousminer, Diana L.; Palotie, Aarno; Widen, Elisabeth] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland; [Kerkhof, Marjan] Univ Groningen, Dept Epidemiol, Univ Med Ctr Groningen, Groningen, Netherlands; [van der Lugt, Aad; Vernooij, Meike W.; Vrooman, Henri A.] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; Netherlands Consortium Hlth Aging, Rotterdam, Netherlands; [Buxton, Jessica L.; Blakemore, Alexandra I. F.; Hypponen, Elina] Univ London Imperial Coll Sci Technol & Med, Sect Invest Med, London, England; Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [Eriksson, Johan] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Eriksson, Johan] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan] Univ Helsinki, Folkhalsan Res Ctr, Biomedicum Helsinki, Helsinki, Finland; [Klopp, Norman] German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Klopp, Norman] Hannover Med Sch, Hannover Unified Biobank, D-3000 Hannover, Germany; [Lahti, Jari] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Mueller-Nurasyid, Martina; Wichmann, H-Erich] Univ Munich, Chair Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Mueller-Nurasyid, Martina] German Res Ctr Environm Hlth, Inst Genet Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Mueller-Nurasyid, Martina] Univ Munich, Univ Hosp Grosshadern, Dept Med 1, Munich, Germany; [Prokopenko, Inga; McCarthy, Mark I.; Horikoshi, Momoko] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [McCarthy, Mark I.; Horikoshi, Momoko] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Rivadeneira, Fernando] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Steegers, Eric A. P.] Erasmus MC, Dept Obstet & Gynecol, Rotterdam, Netherlands; Pompeu Fabra Univ UPF, Dept Expt & Hlth Sci, Barcelona, Spain; Univ Munich, Div Metab Dis & Nutr Med, Dr Von Hauner Childrens Hosp, Munich, Germany; German Ctr Neurol Dis DZNE, Bonn, Germany; [Debette, Stephanie; Seshadri, Sudha; DeStefano, Anita L.; Beiser, Alexa; Au, Rhoda; Wolf, Philip A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Debette, Stephanie; DeStefano, Anita L.; Beiser, Alexa] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Debette, Stephanie] INSERM, U708, Paris, France; [Fornage, Myriam] Univ Texas Houston, Sch Publ Hlth, Inst Mol Med, Houston Hlth Sci Ctr, Houston, TX USA; [Fornage, Myriam] Univ Texas Houston, Sch Publ Hlth, Human Genet Ctr, Houston Hlth Sci Ctr, Houston, TX USA; [Fornage, Myriam] Univ Texas Houston, Sch Publ Hlth, Div Epidemiol, Houston Hlth Sci Ctr, Houston, TX USA; [Gudnason, Vilmundur; Smith, Albert V.; Sigurdsson, Sigurdur; Gudnason, Haukur] Iceland Res Inst, Kopavogur, Iceland; [Gudnason, Vilmundur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Launer, Lenore J.; Harris, Tamara B.] NIA, Lab Epidemiol Demog & Biometry, NIH, Bethesda, MD 20892 USA; [Mosley, Thomas H., Jr.; Meeks, William M.; Windham, B. Gwen] Univ Mississippi, Med Ctr, Dept Med Geriatr, Jackson, MS 39216 USA; [Wolf, Philip A.] Natl Heart Lung & Blood Inst Framingham Heart Stu, Framingham, MA USA; [Fernandez-Banet, Julio] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hartikainen, Anna-Liisa] Univ Oulu, Inst Clin Med Obstet & Gynecol, Oulu, Finland; Ctr Publ Hlth Res CSISP, Div Environm & Hlth, Valencia, Spain; [Lathrop, Mark] Ctr Natl Genotypage, Comissariat Energie Atom, Evry, France; [Lathrop, Mark] Fdn Jean Dausset, CEPH, Paris, France; [McArdle, Wendy L.; Ring, Susan M.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Palmer, Lyle J.] Ontario Inst Canc Res, Toronto, ON, Canada; [Palotie, Aarno] Univ Helsinki, Dept Med Genet, Helsinki, Finland; Broad Inst Harvard Univ & MIT, Cambridge, MA USA; [Panoutsopoulou, Kalliope; Zeggini, Eleftheria] Wellcome Trust Sanger Inst, Cambridge, England; [Pouta, Annneli; Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Lifecourse & Serv, Oulu, Finland; [Sovio, Ulla] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England; [DeCarli, Charles] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; [DeCarli, Charles] Univ Calif Davis, Ctr Neurosci, Sacramento, CA 95817 USA; Churchill Hosp, Oxford Natl Inst Hlth Res NIHR, Biomed Res Ctr, Oxford OX3 7LJ, England; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Pulmonol & Pediat Allergol, Groningen, Netherlands; UPF, Ctr Genom Regulat CRG, Genes & Dis Program, Barcelona, Spain; [Hattersley, Andrew T.] Univ Exeter, Peninsula NIHR Clin Res Facil, Peninsula Coll Med & Dent, Exeter, Devon, England; [Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, MRC Hlth Protect Agcy HPA, Ctr Environm & Hlth, London, England; [Adair, Linda S.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Atalay, Mustafa; Lindi, Virpi; Lakka, Timo A.] Univ Eastern Finland, Dept Physiol, Inst Biomed, Kuopio, Finland; [van Beijsterveldt, Toos; Groen-Blokhuis, Maria; Hottenga, Jouke Jan; Middeldorp, Christel; Nivard, Michel; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Berry, Diane; Power, Chris] UCL, Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England; [Davis, Oliver S. P.; Haworth, Claire M. A.; Pararajasingham, Jennifer; Price, Thomas S.] Kings Coll London, Inst Psychiat, MRC Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Goh, Liang-Kee; Saw, Seang-Mei] Duke Natl Univ Singapore NUS, Grad Sch Med, Singapore, Singapore; [Goh, Liang-Kee; Teo, Yik-Ying; Saw, Seang-Mei] NUS, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Hedebrand, Johannes; Hinney, Anke] Univ Duisburg Essen, Dept Child & Adolescent Psychiat, Essen, Germany; [Hirschhorn, Joel N.; Oken, Emily; Salem, Rany M.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Hirschhorn, Joel N.; Oken, Emily; Salem, Rany M.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; Childrens Hosp, Program Genom, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; Broad Inst, Metab Initiat, Cambridge, MA USA; Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Holloway, John W.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Holst, Claus; Nohr, Ellen Aagaard; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Kilpelainen, Tuomas O.; Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Kirin, Mirna; Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Lakka, Hanna-Maaria] Univ Eastern Finland, Dept Publ Hlth, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Lange, Leslie A.; Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Lehtimaki, Terho] Tampere Univ Hosp, Dept Clin Chem, FIN-33521 Tampere, Finland; [Lehtimaki, Terho] Univ Tampere, Dept Clin Chem, Sch Med, FIN-33101 Tampere, Finland; [Lindgren, Cecilia; Maggi, Reedik] Univ Oxford, Wellcome Trust Ctr Human Genet, Genet & Genom Epidemiol Unit, Oxford, England; [Maggi, Reedik] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Murray, Jeffrey C.] Univ Oxford, Epidemiol Studies Unit CTSU, Oxford, England; [Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Ntalla, Ioanna; Dedoussis, George V.] Harokopio Univ Athens, Dept Dietet Nutr, Athens, Greece; [Simell, Olli] Mid Sweden Univ, Dept Psychol, Ostersund, Sweden; [Siitonen, Niina; Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Strachan, David P.] Univ London, Div Populat Hlth Sci & Educ, London, England; [Cooper, Cyrus] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Gillman, Matthew] Harvard Univ, Sch Med, Obes Prevent Program, Dept Populat Med, Boston, MA USA; [Gillman, Matthew] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Hocher, Berthold] Univ Potsdam, Inst Nutr Sci, Potsdam, Germany; [Hocher, Berthold] Charite, Inst Pharmacol, Ctr Cardiovasc Res, D-13353 Berlin, Germany; [Ong, Ken K.] Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Pearson, Ewan R.] Univ Dundee, Biomed Res Inst, Dundee, Scotland; [Raitakari, Olli T.] Univ Turku, Dept Clin Physiol, Turku, Finland; Turku Univ Hosp, FIN-20520 Turku, Finland; Singapore Eye Res Inst, Singapore, Singapore; [Scherag, Andre] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Simell, Olli] Univ Turku, Dept Pediat, Turku, Finland; [Wilson, James F.] Univ Edinburgh, Western Gen Hosp, MRC Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Schmidt, Reinhold; Ropele, Stefan; Au, Rhoda] Med Univ Graz, Dept Neurol, Graz, Austria; [Vrooman, Henri A.; Niessen, Wiro J.] Univ Med Ctr, Erasmus Med Ctr, Dept Med Informat, Rotterdam, Netherlands; [Coker, Laura H.] Wake Forest Sch Med, Div Publ Hlth Sci, Winston Salem, NC USA; [Longstreth, W. T., Jr.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Longstreth, W. T., Jr.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Niessen, Wiro J.] Delft Univ Technol, Fac Sci Appl, Delft, Netherlands; [Zijdenbos, Alex P.] Biospective Inc, Montreal, PQ, Canada; [Jack, Clifford R., Jr.] Mayo Clin, Dept Radiol, Rochester, MN USA; [Nalls, Mike A.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [van Buchem, Mark A.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Catellier, Diane] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Schmidt, Helena] Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria	University of Bristol; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Imperial College London; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Western Australia; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Oulu; University of Oulu; University of Copenhagen; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Exeter; University of Plymouth; Statens Serum Institut; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Helsinki; University of Groningen; Erasmus University Rotterdam; Erasmus MC; Imperial College London; Mahidol University; Finland National Institute for Health & Welfare; University of Helsinki; Folkhalsan Research Center; University of Helsinki; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hannover Medical School; University of Helsinki; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Pompeu Fabra University; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Boston University; Boston University; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Iceland; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Mississippi; University of Mississippi Medical Center; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); European Molecular Biology Laboratory (EMBL); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Oulu; CEA; UDICE-French Research Universities; Universite Paris Saclay; Foundation Jean Dausset-CEPH; University of Bristol; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Helsinki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Wellcome Trust Sanger Institute; Finland National Institute for Health & Welfare; University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California Davis; University of California System; University of California Davis; University of Oxford; University of Groningen; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Exeter; University of Plymouth; Imperial College London; University of North Carolina; University of North Carolina Chapel Hill; University of Eastern Finland; Vrije Universiteit Amsterdam; University of London; University College London; University of London; King's College London; National University of Singapore; University of Duisburg Essen; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Southampton; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; University of Edinburgh; University of Eastern Finland; University of North Carolina; University of North Carolina Chapel Hill; Tampere University; Tampere University Hospital; Tampere University; University of Oxford; Wellcome Centre for Human Genetics; University of Tartu; University of Oxford; University of Oxford; University of Iowa; Harokopio University Athens; Mid-Sweden University; University of Turku; University of London; University of Southampton; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Potsdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cambridge; University of Dundee; University of Turku; University of Turku; National University of Singapore; Singapore National Eye Center; University of Duisburg Essen; University of Turku; University of Edinburgh; Medical University of Graz; Erasmus University Rotterdam; Erasmus MC; Wake Forest University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Delft University of Technology; Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of North Carolina; University of North Carolina Chapel Hill; Medical University of Graz	Smith, GD (corresponding author), Univ Bristol, MRC, Ctr Causal Anal Translat Epidemiol, Sch Social & Community Med, Bristol, Avon, England.	Julia.Mackay@bristol.ac.uk; heinrich@helmholtz-muenchen.de; m.jarvelin@imperial.ac.uk; v.jaddoe@erasmusmc.nl	van Buchem, Mark/AAC-9843-2022; Palmer, Lyle John/N-1948-2019; Schmidt, Reinhold/E-1137-2014; Scherag, Andre/B-3805-2014; Prokopenko, Inga/AAU-9895-2020; St Pourcain, Beate/K-8004-2017; Hocher, Berthold/AAC-3510-2020; Jack, Clifford R/F-2508-2010; Timpson, Nicholas John/O-7548-2015; Taal, Hendrik R/B-4847-2018; Debette, Stephanie/T-4946-2019; Heinrich, Joachim/N-1720-2013; Palmer, Lyle John/K-3196-2014; Rivadeneira, Fernando/O-5385-2015; Guxens, Monica/T-2285-2018; Lye, Stephen J/E-7269-2013; Buxton, Jessica/L-9849-2019; Gudnason, Vilmundur/K-6885-2015; Fox, Laura J/C-6249-2016; Warrington, Nicole/P-4868-2014; Coin, Lachlan JM/A-9001-2014; Study, Raine/K-4517-2013; Lahti, Jari/P-7987-2018; Iñiguez, Carmen/AAA-5866-2019; Rodriguez, Alina/B-3541-2015; Raitakari, Olli/AAQ-7389-2021; Attrill, Lauren/V-1688-2018; Wilson, James F/A-5704-2009; Lahti, Jari/P-2283-2019; Wichmann, Heinz Erich/AAA-5695-2022; Buxton, Jessica L/I-4033-2014; Pennell, Craig/ABD-6902-2020; Kronow, Joern/B-1054-2011; Blakemore, Alexandra I F/D-2253-2009; Vernooij, Meike Willemijn/E-4061-2016; Dedoussis, George/AAN-7252-2021; Breteler, Monique M.B./J-5058-2014; Davis, Oliver SP/B-9653-2008; Holloway, John W/B-5424-2009; Kemp, John P./R-3091-2018; Estivill, Xavier/A-3125-2013; Thiering, Elisabeth/B-3342-2013; Davey Smith, George/A-7407-2013; Prokopenko, Inga/H-3241-2014; Hadley, Dexter/ABB-7568-2021; Koppelman, Gerard/AAG-9187-2020; Hinney, Anke/D-6953-2011; Lehtimäki, Terho/AAD-1094-2022; DeCarli, Charles/B-5541-2009; Hypponen, Elina/B-2596-2014; Sovio, Ulla/H-8532-2019; Smith, Albert Vernon/K-5150-2015; Bisgaard, Hans/N-4761-2016; Müller-Nurasyid, Martina/I-8735-2018; Evans, David M/H-6325-2013; Catellier, Diane/AAN-2219-2021; Haworth, Claire M.A./C-7073-2009; Middeldorp, Christel M/L-7728-2017; Coin, Lachlan/O-4976-2019; Gudnason, Vilmundur/AAE-7126-2019; Ikram, M. Arfan/AAM-5225-2021; Price, Thomas S./B-7372-2008; Sunyer Deu, Jordi/G-6909-2014; McCarthy, Mark/M-3763-2015	van Buchem, Mark/0000-0003-1881-1998; Palmer, Lyle John/0000-0002-1628-3055; St Pourcain, Beate/0000-0002-4680-3517; Jack, Clifford R/0000-0001-7916-622X; Timpson, Nicholas John/0000-0002-7141-9189; Debette, Stephanie/0000-0001-8675-7968; Heinrich, Joachim/0000-0002-9620-1629; Palmer, Lyle John/0000-0002-1628-3055; Rivadeneira, Fernando/0000-0001-9435-9441; Guxens, Monica/0000-0002-8624-0333; Lye, Stephen J/0000-0002-3305-4406; Gudnason, Vilmundur/0000-0001-5696-0084; Warrington, Nicole/0000-0003-4195-775X; Coin, Lachlan JM/0000-0002-4300-455X; Lahti, Jari/0000-0002-4310-5297; Iñiguez, Carmen/0000-0003-3471-4928; Rodriguez, Alina/0000-0003-1209-8802; Wilson, James F/0000-0001-5751-9178; Lahti, Jari/0000-0002-4310-5297; Buxton, Jessica L/0000-0002-0918-9335; Pennell, Craig/0000-0002-0937-6165; Blakemore, Alexandra I F/0000-0003-0661-564X; Dedoussis, George/0000-0002-7798-6221; Breteler, Monique M.B./0000-0002-0626-9305; Davis, Oliver SP/0000-0002-6448-3684; Holloway, John W/0000-0001-9998-0464; Kemp, John P./0000-0002-9105-2249; Estivill, Xavier/0000-0002-0723-2256; Davey Smith, George/0000-0002-1407-8314; Prokopenko, Inga/0000-0003-1624-7457; Hadley, Dexter/0000-0003-0990-4674; Hinney, Anke/0000-0001-5659-0706; Lehtimäki, Terho/0000-0002-2555-4427; Hypponen, Elina/0000-0003-3670-9399; Sovio, Ulla/0000-0002-0799-1105; Smith, Albert Vernon/0000-0003-1942-5845; Bisgaard, Hans/0000-0003-4131-7592; Müller-Nurasyid, Martina/0000-0003-3793-5910; Evans, David M/0000-0003-0663-4621; Haworth, Claire M.A./0000-0002-8608-289X; Middeldorp, Christel M/0000-0002-6218-0428; Coin, Lachlan/0000-0002-4300-455X; Gudnason, Vilmundur/0000-0001-5696-0084; Price, Thomas S./0000-0001-7356-2109; Vernooij, Meike/0000-0003-4658-2176; Beiser, Alexa/0000-0001-8551-7778; Sunyer Deu, Jordi/0000-0002-2602-4110; Kaakinen, Marika/0000-0002-9228-0462; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Koppelman, Gerard/0000-0001-8567-3252; melbye, mads/0000-0001-8264-6785; Niessen, Wiro/0000-0002-5822-1995; Lindgren, Cecilia/0000-0002-4903-9374; Lakka, Timo/0000-0002-9199-2871; Feenstra, Bjarke/0000-0003-1478-649X; Nivard, Michel/0000-0003-2015-1888; Newnham, John/0000-0001-9983-7457; Hattersley, Andrew/0000-0001-5620-473X; Iniguez, Carmen/0000-0002-5156-0732; Eriksson, Johan/0000-0002-2516-2060; Fernandez Banet, Julio/0000-0003-0901-1286; Van Duijn, Cornelia/0000-0002-2374-9204; McCarthy, Mark/0000-0002-4393-0510; Kreiner, Eskil/0000-0003-1204-2438; Bonnelykke, Klaus/0000-0003-2003-1018; Seshadri, Sudha/0000-0001-6135-2622; Marsh, Julie/0000-0001-8984-6907; Willemsen, Gonneke/0000-0003-3755-0236; Thiering, Elisabeth/0000-0002-5429-9584; Freathy, Rachel/0000-0003-4152-2238; Elliott, Paul/0000-0002-7511-5684; Lawlor, Debbie A/0000-0002-6793-2262; van Beijsterveldt, Toos/0000-0002-6617-4201; Palotie, Aarno/0000-0002-2527-5874; Panoutsopoulou, Kalliope/0000-0002-5460-8025; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; , Hanieh/0000-0001-9672-9477; Lewin, Alexandra/0000-0003-0081-7582; Chawes, Bo/0000-0001-6846-6243; Scherag, Andre/0000-0002-9406-4704; Ikram, Mohammad Arfan/0000-0003-0372-8585; Geller, Frank/0000-0002-9238-3269; Pearson, Ewan/0000-0001-9237-8585; Zeggini, Eleftheria/0000-0003-4238-659X; O'Reilly, Paul/0000-0001-7515-0845; Hocher, Berthold/0000-0001-8143-0579; Grant, Struan/0000-0003-2025-5302; Cooper, Cyrus/0000-0003-3510-0709; Sebert, Sylvain/0000-0001-6681-6983	Academy of Finland [104781, 120315, 129269, 1114194, 134839, 129287]; Biocentrum Helsinki; Biocenter, University of Oulu, Finland; British Heart Foundation; Canadian Institutes of Health Research [MOP 82893]; The Children's Hospital of Philadelphia; Cotswold Foundation; Darlington Trust; Dutch Asthma Foundation; Dutch Ministry of the Environment; Erasmus Medical Center Rotterdam; Erasmus University Rotterdam; European Community [HEALTH-F4-2007-201413]; Exeter National Health Service (NHS) Research and Development; Fundacio La Marato de TV3 (Televisio de Catalunya); Helmholtz Zentrum Muenchen; German Research Center for Environment and Health; Institute of Epidemiology I; Neuherberg; Instituto de Salud Carlos III [FIS PI081151, PS09/00432]; Institut fur Umweltmedizinische Forschung (IUF) Dusseldorf; Marien-Hospital Wesel; UK MRC [G0500539, G0600331, G0600705]; Municipal Health Service Rotterdam; National Health and Medical Research Council of Australia [403981, 003209]; National Public Health Institute, Helsinki, Finland; Netherlands Organisation for Scientific Research (NWO); Netherlands Organisation for Health Research and Development (ZonMw) [SPI 56-464-14192, 904-61-090, 904-61-193, 912-03-031, 480-04-004, 400-05-717]; US NHLBI [5R01HL087679-02, 1RL1MH083268-01]; US NIH [1R01HD056465-01A1]; Peninsula NIHR Clinical Research Facility; RAINE Medical Research Foundation; Rotterdam Homecare Foundation; South West NHS Research and Development; Stichting Astmabestrijding; Stichting Trombosedienst AMP; Artsenlaboratorium Rijnmond (STAR) Rotterdam; Technical University Munich; Telethon Institute for Child Health Research; UFZ-Centre for Environmental Research Leipzig-Halle; University Hospital Oulu, Finland; University of Bristol; University of Leipzig; Wellcome Trust [GR069224, 085541/Z/08/Z, WT083431MA, WT088431MA]; Western Australian DNA Bank; Western Australian Genetic Epidemiology Resource; ZonMW [21000074]; Dutch Kidney Foundation [C08.2251]; MRC UK [G0500539, PS0476]; MRC [MRC G0800582]; Netherlands Organisation for Health Research (ZonMw) [90700303, 916.10159]; Austrian Science Fund (FWF) [P 20545] Funding Source: researchfish; Medical Research Council [G0801056B, G0600331, G0800582, G0801056, G9817803B, G0600705] Funding Source: researchfish; MRC [G0801056, G0800582, G0600331, G0600705] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056465] Funding Source: NIH RePORTER; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [U22PS000476] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG007270] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Biocentrum Helsinki; Biocenter, University of Oulu, Finland; British Heart Foundation(British Heart Foundation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); The Children's Hospital of Philadelphia; Cotswold Foundation; Darlington Trust; Dutch Asthma Foundation; Dutch Ministry of the Environment; Erasmus Medical Center Rotterdam; Erasmus University Rotterdam; European Community(European Commission); Exeter National Health Service (NHS) Research and Development; Fundacio La Marato de TV3 (Televisio de Catalunya); Helmholtz Zentrum Muenchen; German Research Center for Environment and Health; Institute of Epidemiology I; Neuherberg; Instituto de Salud Carlos III; Institut fur Umweltmedizinische Forschung (IUF) Dusseldorf; Marien-Hospital Wesel; UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Municipal Health Service Rotterdam; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Public Health Institute, Helsinki, Finland; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); US NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peninsula NIHR Clinical Research Facility; RAINE Medical Research Foundation; Rotterdam Homecare Foundation; South West NHS Research and Development; Stichting Astmabestrijding; Stichting Trombosedienst AMP; Artsenlaboratorium Rijnmond (STAR) Rotterdam; Technical University Munich; Telethon Institute for Child Health Research; UFZ-Centre for Environmental Research Leipzig-Halle; University Hospital Oulu, Finland; University of Bristol; University of Leipzig; Wellcome Trust(Wellcome TrustEuropean Commission); Western Australian DNA Bank; Western Australian Genetic Epidemiology Resource; ZonMW(Netherlands Organization for Health Research and Development); Dutch Kidney Foundation; MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Netherlands Organisation for Health Research (ZonMw)(Netherlands Organization for Health Research and Development); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Sayers for helpful discussions with respect to the conducted mediation analysis. Major funding for the research in this paper is from the Academy of Finland (project grants 104781, 120315, 129269, 1114194, 134839, 129287 and Center of Excellence in Complex Disease Genetics); Biocentrum Helsinki; Biocenter, University of Oulu, Finland; the British Heart Foundation; the Canadian Institutes of Health Research (grant MOP 82893); The Children's Hospital of Philadelphia (Institute Development Award); the Cotswold Foundation (Research Development Award); the Darlington Trust; the Dutch Asthma Foundation; the Dutch Ministry of the Environment; Erasmus Medical Center Rotterdam; Erasmus University Rotterdam; The European Community's Seventh Framework Programme (FP7/2007-2013), ENGAGE project and grant agreement HEALTH-F4-2007-201413; Exeter National Health Service (NHS) Research and Development; Fundacio La Marato de TV3 (Televisio de Catalunya); Helmholtz Zentrum Muenchen, the German Research Center for Environment and Health, Institute of Epidemiology I, Neuherberg; Instituto de Salud Carlos III (FIS PI081151 and PS09/00432); Institut fur Umweltmedizinische Forschung (IUF) Dusseldorf; Marien-Hospital Wesel; the UK MRC (G0500539, G0600331, PrevMetSyn/Salve/MRC and G0600705); the Municipal Health Service Rotterdam; the National Health and Medical Research Council of Australia (403981 and 003209); the National Public Health Institute, Helsinki, Finland; the Netherlands Organisation for Scientific Research (NWO) and the Netherlands Organisation for Health Research and Development (ZonMw) (grants SPI 56-464-14192, 904-61-090, 904-61-193, 912-03-031, 480-04-004 and 400-05-717); the US NHLBI (grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01)); the US NIH (grant 1R01HD056465-01A1); the Peninsula NIHR Clinical Research Facility; the RAINE Medical Research Foundation; the Rotterdam Homecare Foundation; South West NHS Research and Development; Stichting Astmabestrijding; Stichting Trombosedienst & Artsenlaboratorium Rijnmond (STAR) Rotterdam; Technical University Munich; the Telethon Institute for Child Health Research; UFZ-Centre for Environmental Research Leipzig-Halle; University Hospital Oulu, Finland; University of Bristol; University of Leipzig; the Wellcome Trust (project grant GR069224); the Western Australian DNA Bank; the Western Australian Genetic Epidemiology Resource and ZonMW (grant 21000074). Data exchange and deposition has been facilitated by the SIMBioMS platform. Personal funding was provided by the Dutch Kidney Foundation (C08.2251 to H. R. T.), the MRC UK (G0500539, PrevMetSyn and PS0476 to S. Das), a Sir Henry Wellcome Postdoctoral Fellowship (Wellcome Trust grant 085541/Z/08/Z to R. M. F.), a MRC New Investigator Award (MRC G0800582 to D. M. E.) and Wellcome Trust 4-year PhD studentships (WT083431MA to J.P.K. and WT088431MA to J.L.B.). I. P. and J.F.-B. are in part supported by the European Community's ENGAGE grant HEALTH-F4-2007-201413, A. T. H. is employed as a core member of the Peninsula NIHR Clinical Research Facility and V.W.V.J. is funded by the Netherlands Organisation for Health Research (ZonMw 90700303 and 916.10159). Detailed acknowledgments by study are given in the Supplementary Note.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Castellanos FX, 1996, ARCH GEN PSYCHIAT, V53, P607; Conrad C, 2004, J NEUROCHEM, V89, P179, DOI 10.1046/j.1471-4159.2004.02320.x; Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006; COYLETHOMPSON CA, 1993, DEVELOPMENT, V119, P377; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; FISCH RO, 1976, AM J DIS CHILD, V130, P481, DOI 10.1001/archpedi.1976.02120060027006; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Gale CR, 2006, PEDIATRICS, V118, P1486, DOI 10.1542/peds.2005-2629; Gale CR, 2004, BRAIN, V127, P321, DOI 10.1093/brain/awh034; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Gijselinck I, 2008, HUM MUTAT, V29, P1373, DOI 10.1002/humu.20785; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hsuchou H, 2010, ENDOCRINOLOGY, V151, P1221, DOI 10.1210/en.2009-1039; Ikram MA, 2008, NEUROBIOL AGING, V29, P882, DOI 10.1016/j.neurobiolaging.2006.12.012; Ikram MA, 2012, NAT GENET, V44, P539, DOI 10.1038/ng.2245; Ivanovic DM, 2004, NEUROPSYCHOLOGIA, V42, P1118, DOI 10.1016/j.neuropsychologia.2003.11.022; Ivanovic DM, 2000, NUTRITION, V16, P1056, DOI 10.1016/S0899-9007(00)00431-7; Kaindl AM, 2010, PROG NEUROBIOL, V90, P363, DOI 10.1016/j.pneurobio.2009.11.002; Krestyaninova M, 2009, BIOINFORMATICS, V25, P2768, DOI 10.1093/bioinformatics/btp420; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; Levecque C, 2004, J NEUROL NEUROSUR PS, V75, P478, DOI 10.1136/jnnp.2003.015750; Ligon AH, 2005, AM J HUM GENET, V76, P340, DOI 10.1086/427565; MatsumotoTaniura N, 1996, MOL BIOL CELL, V7, P1455, DOI 10.1091/mbc.7.9.1455; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Samaranch L, 2010, J ALZHEIMERS DIS, V22, P1065, DOI 10.3233/JAD-2010-101011; Saunders CL, 2006, ANN HUM BIOL, V33, P415, DOI 10.1080/03014460600742062; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Shintani S, 2000, MOL CELL BIOL, V20, P6300, DOI 10.1128/MCB.20.17.6300-6307.2000; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Smit DJA, 2010, TWIN RES HUM GENET, V13, P370, DOI 10.1375/twin.13.4.370; Suzuki C, 2007, MOL CANCER THER, V6, P542, DOI 10.1158/1535-7163.MCT-06-0659; Verburg BO, 2008, ULTRASOUND OBST GYN, V31, P388, DOI 10.1002/uog.5225; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Webb A, 2008, ARCH NEUROL-CHICAGO, V65, P1473, DOI 10.1001/archneur.65.11.1473; Wiles NJ, 2006, AM J EPIDEMIOL, V163, P829, DOI 10.1093/aje/kwj108; Williams CA, 2008, AM J MED GENET A, V146A, P2023, DOI 10.1002/ajmg.a.32434; Wolfe MS, 2009, J BIOL CHEM, V284, P6021, DOI 10.1074/jbc.R800013200; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	43	90	90	0	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2012	44	5					532	+		10.1038/ng.2238	http://dx.doi.org/10.1038/ng.2238			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	934BW	22504419	Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000303416300013
J	Pulido, J; Kottke, T; Thompson, J; Galivo, F; Wongthida, P; Diaz, RM; Rommelfanger, D; Ilett, E; Pease, L; Pandha, H; Harrington, K; Selby, P; Melcher, A; Vile, R				Pulido, Jose; Kottke, Timothy; Thompson, Jill; Galivo, Feorillo; Wongthida, Phonphimon; Diaz, Rosa Maria; Rommelfanger, Diana; Ilett, Elizabeth; Pease, Larry; Pandha, Hardev; Harrington, Kevin; Selby, Peter; Melcher, Alan; Vile, Richard			Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma	NATURE BIOTECHNOLOGY			English	Article							VESICULAR STOMATITIS-VIRUS; VACCINE VECTOR; ONCOLYTIC VIROTHERAPY; CANCER; AUTOIMMUNITY; IMMUNITY; IMMUNOTHERAPY; SELF; MELANOCYTES; PROTECTION	Multiple intravenous injections of a cDNA library, derived from human melanoma cell lines and expressed using the highly immunogenic vector vesicular stomatitis virus (VSV), cured mice with established melanoma tumors. Successful tumor eradication was associated with the ability of mouse lymphoid cells to mount a tumor-specific CD4(+) interleukin (IL)-17 recall response in vitro. We used this characteristic IL-17 response to screen the VSV-cDNA library and identified three different VSV-cDNA virus clones that, when used in combination but not alone, achieved the same efficacy against tumors as the complete parental virus library. VSV-expressed cDNA libraries can therefore be used to identify tumor rejection antigens that can cooperate to induce anti-tumor responses. This technology should be applicable to antigen discovery for other cancers, as well as for other diseases in which immune reactivity against more than one target antigen contributes to disease pathology.	[Pulido, Jose; Kottke, Timothy; Thompson, Jill; Galivo, Feorillo; Diaz, Rosa Maria; Rommelfanger, Diana; Ilett, Elizabeth; Vile, Richard] Mayo Clin, Dept Mol Med, Rochester, MN USA; [Pulido, Jose] Mayo Clin, Dept Ophthalmol & Ocular Oncol, Rochester, MN USA; [Wongthida, Phonphimon] Natl Ctr Genet Engn & Biotechnol, Pathum Thani, Thailand; [Ilett, Elizabeth; Selby, Peter; Melcher, Alan; Vile, Richard] St James Univ Hosp, Canc Res UK Clin Ctr, Leeds LS9 7TF, W Yorkshire, England; [Pease, Larry; Vile, Richard] Mayo Clin, Dept Immunol, Rochester, MN USA; [Pandha, Hardev] Univ Surrey, Guildford GU2 5XH, Surrey, England; [Harrington, Kevin] Inst Canc Res, London SW3 6JB, England	Mayo Clinic; Mayo Clinic; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Cancer Research UK; Saint James's University Hospital; University of Leeds; Mayo Clinic; University of Surrey; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Vile, R (corresponding author), Mayo Clin, Dept Mol Med, Rochester, MN USA.	vile.richard@mayo.edu		Harrington, Kevin/0000-0002-6014-348X; Galivo, Feorillo/0000-0002-0553-922X; Melcher, Alan/0000-0002-2042-3380; Ilett, Elizabeth/0000-0002-9875-0322	Richard M. Schulze Family Foundation; Mayo Foundation; Cancer Research UK; US National Institutes of Health [R01 CA107082, R01CA130878, R01 CA132734]; Cancer Research UK [13244] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA132734, R01CA107082, R01CA130878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM072474] Funding Source: NIH RePORTER	Richard M. Schulze Family Foundation; Mayo Foundation; Cancer Research UK(Cancer Research UK); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Higgins for expert secretarial assistance. This work was supported by the Richard M. Schulze Family Foundation, the Mayo Foundation, Cancer Research UK, the US National Institutes of Health grants R01 CA107082, R01CA130878 and R01 CA132734, and a grant from Terry and Judith Paul. MyD88 KO mice (MyD88<SUP>-/-</SUP>) were a kind gift from L. Pease, Mayo Clinic.	Alvarez-Breckenridge C, 2011, NAT MED, V17, P784, DOI 10.1038/nm0711-784; Braxton CL, 2010, J VIROL, V84, P3552, DOI 10.1128/JVI.01572-09; Bridle BW, 2010, MOL THER, V18, P1430, DOI 10.1038/mt.2010.98; Bridle BW, 2009, MOL THER, V17, P1814, DOI 10.1038/mt.2009.154; Cobleigh MA, 2010, J VIROL, V84, P7513, DOI 10.1128/JVI.00200-10; Daniels GA, 2004, NAT BIOTECHNOL, V22, P1125, DOI 10.1038/nbt1007; Diaz RM, 2007, CANCER RES, V67, P2840, DOI 10.1158/0008-5472.CAN-06-3974; Drake CG, 2006, ADV IMMUNOL, V90, P51, DOI 10.1016/S0065-2776(06)90002-9; Fernandez M, 2002, J VIROL, V76, P895, DOI 10.1128/JVI.76.2.895-904.2002; Ferrone S, 2004, NAT BIOTECHNOL, V22, P1096, DOI 10.1038/nbt0904-1096; Galivo F, 2010, GENE THER, V17, P158, DOI 10.1038/gt.2009.161; Galivo F, 2010, HUM GENE THER, V21, P439, DOI 10.1089/hum.2009.143; Geisbert TW, 2009, J VIROL, V83, P7296, DOI 10.1128/JVI.00561-09; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; Guevara-Patino JA, 2006, J CLIN INVEST, V116, P1382, DOI 10.1172/JCI25591; Guevara-Patino JA, 2003, ADV CANCER RES, V90, P157, DOI 10.1016/S0065-230X(03)90005-4; HALL A, 1985, NUCLEIC ACIDS RES, V13, P5255, DOI 10.1093/nar/13.14.5255; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Koos D, 2010, CELL IMMUNOL, V263, P138, DOI 10.1016/j.cellimm.2010.03.019; Kottke T, 2007, CANCER RES, V67, P11970, DOI 10.1158/0008-5472.CAN-07-2259; Kottke T, 2011, NAT MED, V17, P854, DOI 10.1038/nm.2390; Kottke T, 2009, CANCER RES, V69, P7767, DOI 10.1158/0008-5472.CAN-09-1597; Linardakis E, 2002, CANCER RES, V62, P5495; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pardoll DM, 1998, NAT MED, V4, P525, DOI 10.1038/nm0598supp-525; Park TS, 2011, TRENDS BIOTECHNOL, V29, P550, DOI 10.1016/j.tibtech.2011.04.009; Poschke I, 2011, CANCER IMMUNOL IMMUN, V60, P1161, DOI 10.1007/s00262-011-1012-8; Qiao J, 2008, NAT MED, V14, P37, DOI 10.1038/nm1681; Rausch MP, 2010, J IMMUNOL, V185, P2828, DOI 10.4049/jimmunol.1000945; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Rosenberg SA, 2009, CURR OPIN IMMUNOL, V21, P233, DOI 10.1016/j.coi.2009.03.002; Sanchez-Perez L, 2005, CANCER RES, V65, P2009, DOI 10.1158/0008-5472.CAN-04-3216; Sanchez-Perez L, 2006, J IMMUNOL, V177, P4168, DOI 10.4049/jimmunol.177.6.4168; Schwartz JA, 2010, J VIROL, V84, P4611, DOI 10.1128/JVI.02637-09; SHIBATA K, 1992, BIOCHEM BIOPH RES CO, V184, P568, DOI 10.1016/0006-291X(92)90627-W; SUZUKI H, 1989, J BIOL CHEM, V264, P1368; Tanaka S, 2000, CANCER GENE THER, V7, P1241, DOI 10.1038/sj.cgt.7700219; Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012; Turk MJ, 2002, IMMUNOL REV, V188, P122, DOI 10.1034/j.1600-065X.2002.18811.x; Uchi H, 2006, ADV IMMUNOL, V90, P215, DOI 10.1016/S0065-2776(06)90006-6; Willmon C, 2011, MOL THER, V19, P140, DOI 10.1038/mt.2010.224; Wongthida P, 2011, MOL THER, V19, P150, DOI 10.1038/mt.2010.225	42	81	88	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2012	30	4					336	343		10.1038/nbt.2157	http://dx.doi.org/10.1038/nbt.2157			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	925TR	22426030	Green Accepted			2022-12-25	WOS:000302785000021
J	Schottenfeld-Roames, J; Ghabrial, AS				Schottenfeld-Roames, Jodi; Ghabrial, Amin S.			Whacked and Rab35 polarize dynein-motor-complex-dependent seamless tube growth	NATURE CELL BIOLOGY			English	Article							GTPASE-ACTIVATING PROTEINS; TRACHEAL MORPHOGENESIS; PLASMA-MEMBRANE; CELL-MIGRATION; DROSOPHILA; IDENTIFICATION; DOMAINS; TRANSPORT; CHANNEL; PATTERN	Seamless tubes form intracellularly without cell cell or autocellular junctions. Such tubes have been described across phyla, but remain mysterious despite their simple architecture. In Drosophila, seamless tubes are found within tracheal terminal cells, which have dozens of branched protrusions extending hundreds of micrometres. We find that mutations in multiple components of the dynein motor complex block seamless tube growth, raising the possibility that the lumenal membrane forms through minus-end-directed transport of apical membrane components along microtubules. Growth of seamless tubes is polarized along the proximodistal axis by Rab35 and its apical membrane-localized GAP, Whacked. Strikingly, loss of whacked (or constitutive activation of Rab35) leads to tube overgrowth at terminal cell branch tips, whereas overexpression of Whacked (or dominant-negative Rab35) causes formation of ectopic tubes surrounding the terminal cell nucleus. Thus, vesicle trafficking has key roles in making and shaping seamless tubes.	[Schottenfeld-Roames, Jodi; Ghabrial, Amin S.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Ghabrial, AS (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, 421 Curie Blvd,1214 BRB 2-3, Philadelphia, PA 19104 USA.	ghabrial@mail.med.upenn.edu	Ghabrial, Amin S/J-4586-2013; Ghabrial, Amin/ABB-1364-2020	Ghabrial, Amin S/0000-0002-6160-3003; 	NIH [5-T32-HD007516-12, NRSA GM090438-01, 1R01GM089782-01A1]; University of Pennsylvania; March of Dimes Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089782, F32GM090438] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania; March of Dimes Foundation(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to acknowledge: D. Willis, a former Stanford undergraduate student who helped with the rough mapping of wkd; B. Levi, who helped with the third chromosome screen; and M. Krasnow, in whose laboratory the screen and early phases of these studies were carried out. We also thank J. Zhang and the laboratories of M. Scott and H. Bellen (Baylor College of Medicine, USA) for making RabCA and RabDN stocks available to us before publication, the Engels laboratory for sharing deficiency strains, and M. Metzstein (The University of Utah, USA) for sharing 4x-SRF-GAL4 flies. We thank S. DiNardo, C. Burd, E. Bi and members of the Ghabrial and DiNar do laboratories for fruitful discussions. We thank A. S. Burguete, B. Levi and N. Speck for comments on the manuscript. J.S-R. was supported by NIH training grant 5-T32-HD007516-12 and, subsequently, by an NIH postdoctoral fellowship (NRSA GM090438-01). A.S.G. gratefully acknowledges support from the University of Pennsylvania and the NIH (1R01GM089782-01A1). This work was supported in part by Basil O'Connor Starter Scholar Research Award Grant No. 5-FY09-43 from the March of Dimes Foundation.	Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; Albert S, 1999, J BIOL CHEM, V274, P33186, DOI 10.1074/jbc.274.47.33186; BAR T, 1984, CELL TISSUE RES, V235, P99; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Berry KL, 2003, SCIENCE, V302, P2134, DOI 10.1126/science.1087667; Brodu V, 2010, DEV CELL, V18, P790, DOI [10.1016/j.devcel.2010.03.015, 10.1016/j.devce1.2010.03.015]; Buechner M, 2002, TRENDS CELL BIOL, V12, P479, DOI 10.1016/S0962-8924(02)02364-4; Chevallier J, 2009, FEBS LETT, V583, P1096, DOI 10.1016/j.febslet.2009.03.012; Chua CEL, 2010, FEBS LETT, V584, P1, DOI 10.1016/j.febslet.2009.11.051; Echard A, 2008, BIOCHEM SOC T, V36, P395, DOI 10.1042/BST0360395; Fuchs E, 2007, J CELL BIOL, V177, P1133, DOI 10.1083/jcb.200612068; Gao YJ, 2010, J BIOL CHEM, V285, P17938, DOI 10.1074/jbc.M109.086553; Gervais L, 2010, CURR BIOL, V20, P359, DOI 10.1016/j.cub.2009.12.043; Ghabrial AS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002087; Grawe F, 1996, DEVELOPMENT, V122, P951; Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018; Huang J, 2009, P NATL ACAD SCI USA, V106, P8284, DOI 10.1073/pnas.0900641106; Ishibashi K, 2009, GENES CELLS, V14, P41, DOI 10.1111/j.1365-2443.2008.01251.x; Itoh T, 2006, J BIOL CHEM, V281, P31823, DOI 10.1074/jbc.M603808200; Jarecki J, 1999, CELL, V99, P211, DOI 10.1016/S0092-8674(00)81652-9; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Lee S, 2002, DEVELOPMENT, V129, P1509; Lee T, 1996, GENE DEV, V10, P2912, DOI 10.1101/gad.10.22.2912; Levi BP, 2006, DEVELOPMENT, V133, P2383, DOI 10.1242/dev.02404; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Pan F, 2007, NATURE, V445, P433, DOI 10.1038/nature05476; Patino-Lopez G, 2008, J BIOL CHEM, V283, P18323, DOI 10.1074/jbc.M800056200; Pfeffer S, 2005, NAT CELL BIOL, V7, P856, DOI 10.1038/ncb0905-856; Ribeiro C, 2004, CURR BIOL, V14, P2197, DOI 10.1016/j.cub.2004.11.056; Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Samakovlis C, 1996, DEVELOPMENT, V122, P1395; Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54; Shim J, 2010, MOL CELL BIOL, V30, P1421, DOI 10.1128/MCB.01463-09; STROM M, 1993, NATURE, V361, P736, DOI 10.1038/361736a0; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; Ulmasov B, 2009, AM J PATHOL, V174, P1084, DOI 10.2353/ajpath.2009.080625; Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7; Uytterhoeven V, 2011, CELL, V145, P117, DOI 10.1016/j.cell.2011.02.039; WatermanStorer CM, 1997, P NATL ACAD SCI USA, V94, P12180, DOI 10.1073/pnas.94.22.12180; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761; Zhang J, 2009, SCIENCE, V325, P1250, DOI 10.1126/science.1174921	43	41	42	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2012	14	4					386	+		10.1038/ncb2454	http://dx.doi.org/10.1038/ncb2454			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	921UM	22407366	Green Accepted, Green Published			2022-12-25	WOS:000302503300011
J	Trounson, A; DeWitt, ND				Trounson, Alan; DeWitt, Natalie D.			Stem cell biology: Towards the reality of cell therapeutics	NATURE CELL BIOLOGY			English	Editorial Material								Although the road to cell therapeutics is rife with uncertainties - scientific, clinical and economic - its success could transform medicine. Five years into its mission, the California Institute of Regenerative Medicine is laying a foundation for this new form of medical treatment.	[Trounson, Alan; DeWitt, Natalie D.] Calif Inst Regenerat Med, San Francisco, CA 94123 USA		Trounson, A (corresponding author), Calif Inst Regenerat Med, 210 King St, San Francisco, CA 94123 USA.	ATrounson@cirm.ca.gov; Ndewitt@cirm.ca.gov		Trounson, Alan/0000-0001-5469-0500					0	9	9	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2012	14	4					331	331		10.1038/ncb2469	http://dx.doi.org/10.1038/ncb2469			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	921UM	22469825	Bronze			2022-12-25	WOS:000302503300001
J	Pina, C; Fugazza, C; Tipping, AJ; Brown, J; Soneji, S; Teles, J; Peterson, C; Enver, T				Pina, Cristina; Fugazza, Cristina; Tipping, Alex J.; Brown, John; Soneji, Shamit; Teles, Jose; Peterson, Carsten; Enver, Tariq			Inferring rules of lineage commitment in haematopoiesis	NATURE CELL BIOLOGY			English	Article							STEM-CELLS; PROGENITOR CELLS; EXPRESSION; STATES; ERYTHROPOIESIS; PLURIPOTENCY; FIBROBLASTS; SYSTEM; GENES	How the molecular programs of differentiated cells develop as cells transit from multipotency through lineage commitment remains unexplored. This reflects the inability to access cells undergoing commitment or located in the immediate vicinity of commitment boundaries. It remains unclear whether commitment constitutes a gradual process, or else represents a discrete transition. Analyses of in vitro self-renewing multipotent systems have revealed cellular heterogeneity with individual cells transiently exhibiting distinct biases for lineage commitment(1-6). Such systems can be used to molecularly interrogate early stages of lineage affiliation and infer rules of lineage commitment. In haematopoiesis, population-based studies have indicated that lineage choice is governed by global transcriptional noise, with self-renewing multipotent cells reversibly activating transcriptome-wide lineage-affiliated programs(7). We examine this hypothesis through functional and molecular analysis of individual blood cells captured from self-renewal cultures, during cytokine-driven differentiation and from primary stem and progenitor bone marrow compartments. We show dissociation between self-renewal potential and transcriptome-wide activation of lineage programs, and instead suggest that multipotent cells experience independent activation of individual regulators resulting in a low probability of transition to the committed state.	[Pina, Cristina; Fugazza, Cristina; Tipping, Alex J.; Brown, John; Soneji, Shamit; Enver, Tariq] UCL, UCL Canc Inst, Stem Cell Lab, London WC1E 6BT, England; [Tipping, Alex J.; Brown, John; Soneji, Shamit] Univ Oxford, Weatherall Inst Mol Med, Mol Haematol Unit, Oxford OX3 9DS, England; [Teles, Jose; Peterson, Carsten] Lund Univ, Dept Theoret Phys, SE-22362 Lund, Sweden	University of London; University College London; University of Oxford; Lund University	Enver, T (corresponding author), UCL, UCL Canc Inst, Stem Cell Lab, Paul OGorman Blgd,72 Huntley St, London WC1E 6BT, England.	t.enver@ucl.ac.uk		Fugazza, Cristina/0000-0003-4242-0540; Pina, Cristina/0000-0002-2575-6301	Fundacao para a Ciencia e Tecnologia [SFRH/BD/33208/2007]; Swedish Foundation for Strategic Research; Medical Research Council of the United Kingdom; Leukaemia and Lymphoma Research; EuroSyStem; STEMEXPAND; MRC [MC_U137973817] Funding Source: UKRI; Cancer Research UK [12796] Funding Source: researchfish; Medical Research Council [MC_U137973817] Funding Source: researchfish	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Medical Research Council of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leukaemia and Lymphoma Research; EuroSyStem(European Commission); STEMEXPAND; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors would like to thank R. Gupta and G. May for conceptual discussions; C. Waugh, K. Clark, A. Pizzey and T. Adejumo for cell sorting; S. McGowan for microarray data accessibility; and J. Wray for critical reading of the manuscript. J.T. is a student of the PhD Program in Computational Biology at Instituto Gulbenkian de Ciencia, Oeiras, Portugal, and was financially supported by Fundacao para a Ciencia e Tecnologia (SFRH/BD/33208/2007). C. Peterson is supported by the Swedish Foundation for Strategic Research (Senior Individual Grant). This work was financially supported by the Medical Research Council of the United Kingdom, Leukaemia and Lymphoma Research, EuroSyStem and STEMEXPAND.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Bussmann LH, 2009, CELL STEM CELL, V5, P554, DOI 10.1016/j.stem.2009.10.004; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Capron C, 2011, EXP HEMATOL, V39, P629, DOI 10.1016/j.exphem.2011.02.014; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Coulombel L, 2004, ONCOGENE, V23, P7210, DOI 10.1038/sj.onc.1207941; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Heyworth C, 2002, EMBO J, V21, P3770, DOI 10.1093/emboj/cdf368; Hough SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007708; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Iwasaki H, 2003, IMMUNITY, V19, P451, DOI 10.1016/S1074-7613(03)00242-5; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kim SI, 2007, ONCOGENE, V26, P6777, DOI 10.1038/sj.onc.1210761; Orford K, 2008, DEV CELL, V14, P798, DOI 10.1016/j.devcel.2008.04.002; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pina C, 2008, CELL STEM CELL, V2, P264, DOI 10.1016/j.stem.2008.01.013; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Rodrigues NP, 2005, BLOOD, V106, P477, DOI 10.1182/blood-2004-08-2989; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Tipping AJ, 2009, BLOOD, V113, P2661, DOI 10.1182/blood-2008-06-161117; TSAI S, 1994, GENE DEV, V8, P2831, DOI 10.1101/gad.8.23.2831; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Ye ZJ, 2005, P NATL ACAD SCI USA, V102, P18461, DOI 10.1073/pnas.0509314102	31	131	131	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2012	14	3					287	+		10.1038/ncb2442	http://dx.doi.org/10.1038/ncb2442			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	900ZE	22344032				2022-12-25	WOS:000300930400011
J	Rodriguez, R; Miller, KM; Forment, JV; Bradshaw, CR; Nikan, M; Britton, S; Oelschlaegel, T; Xhemalce, B; Balasubramanian, S; Jackson, SP				Rodriguez, Raphael; Miller, Kyle M.; Forment, Josep V.; Bradshaw, Charles R.; Nikan, Mehran; Britton, Sebastien; Oelschlaegel, Tobias; Xhemalce, Blerta; Balasubramanian, Shankar; Jackson, Stephen P.			Small-molecule-induced DNA damage identifies alternative DNA structures in human genes	NATURE CHEMICAL BIOLOGY			English	Article							DOUBLE-STRAND BREAKS; G-QUADRUPLEX; HUMAN GENOME; IN-VIVO; HELICASE; INHIBITOR; TELOMERE; PROTEIN; CANCER; TRANSCRIPTION	Guanine-rich DNA sequences that can adopt non-Watson-Crick structures in vitro are prevalent in the human genome. Whether such structures normally exist in mammalian cells has, however, been the subject of active research for decades. Here we show that the G-quadruplex-interacting drug pyridostatin promotes growth arrest in human cancer cells by inducing replication-and transcription-dependent DNA damage. A chromatin immunoprecipitation sequencing analysis of the DNA damage marker gamma H2AX provided the genome-wide distribution of pyridostatin-induced sites of damage and revealed that pyridostatin targets gene bodies containing clusters of sequences with a propensity for G-quadruplex formation. As a result, pyridostatin modulated the expression of these genes, including the proto-oncogene SRC. We observed that pyridostatin reduced SRC protein abundance and SRC-dependent cellular motility in human breast cancer cells, validating SRC as a target of this drug. Our unbiased approach to define genomic sites of action for a drug establishes a framework for discovering functional DNA-drug interactions.	[Rodriguez, Raphael; Nikan, Mehran; Balasubramanian, Shankar] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Rodriguez, Raphael; Miller, Kyle M.; Forment, Josep V.; Bradshaw, Charles R.; Britton, Sebastien; Oelschlaegel, Tobias; Xhemalce, Blerta; Jackson, Stephen P.] Univ Cambridge, Gurdon Inst, Cambridge, England; [Miller, Kyle M.; Forment, Josep V.; Britton, Sebastien; Oelschlaegel, Tobias; Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Miller, Kyle M.; Xhemalce, Blerta] Univ Texas Austin, Inst Mol & Cellular Biol, Dept Mol Genet & Microbiol, Austin, TX 78712 USA; [Balasubramanian, Shankar] Li Ka Shing Ctr, Cambridge Res Inst, Canc Res UK, Cambridge, England; [Balasubramanian, Shankar] Univ Cambridge, Sch Clin Med, Cambridge, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Texas System; University of Texas Austin; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge	Rodriguez, R (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	sb10031@cam.ac.uk; s.jackson@gurdon.cam.ac.uk	Balasubramanian, Shankar/C-1671-2009; Jackson, Stephen Philip/R-4548-2019; Forment, Josep/J-3678-2015; Britton, Sébastien/AAL-1862-2020; Dry, Kate/I-2328-2014	Jackson, Stephen Philip/0000-0001-9317-7937; Forment, Josep/0000-0002-7797-2583; Britton, Sébastien/0000-0002-7008-5316; Rodriguez, Raphael/0000-0001-7668-446X; Balasubramanian, Shankar/0000-0002-0281-5815; Xhemalce, Blerta/0000-0002-0517-9607; Bradshaw, Charles/0000-0002-3528-458X; Miller, Kyle/0000-0002-4544-0013	Wellcome Trust [086861/Z/08/Z]; Cancer Research UK (CRUK) [C6/A11224, C9681/A11961]; Biotechnology and Biological Sciences Research Council [BB/G008337/1]; EMBO (ALTF) [93-2010]; European Research Council; European Community; Wellcome Trust; University of Cambridge; BBSRC [BB/G008337/1] Funding Source: UKRI; Cancer Research UK [11224, 11961] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Cancer Research UK (CRUK)(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EMBO (ALTF); European Research Council(European Research Council (ERC)European Commission); European Community(European Commission); Wellcome Trust(Wellcome Trust); University of Cambridge(University of Cambridge); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	We thank AstraZeneca for providing the Chk1/ChK2i (AZD7762), S. Miller for technical assistance with FRET melting experiments and the US National Cancer Institute for screening pyridostatin on a panel of 60 cancer-cell lines. R.R. is a Herchel Smith Research Fellow, K.M.M. is funded by the Wellcome Trust project grant 086861/Z/08/Z, and J.V.F. is funded by Cancer Research UK (CRUK) program grant C6/A11224. Research in the S. Balasubramanian laboratory is funded by CRUK program grant C9681/A11961 and a project grant from the Biotechnology and Biological Sciences Research Council (BB/G008337/1). S. Britton is funded by an EMBO long-term fellowship (ALTF 93-2010). Research in the S.P.J. laboratory is funded by CRUK program grant C6/A11224, the European Research Council and the European Community Seventh Framework Programme (GENICA and DDResponse). Core infrastructure funding was provided by CRUK and the Wellcome Trust. S.P.J. receives his salary from the University of Cambridge, supplemented by CRUK.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Brooks TA, 2009, NAT REV CANCER, V9, P849, DOI 10.1038/nrc2733; Cahoon LA, 2009, SCIENCE, V325, P764, DOI 10.1126/science.1175653; Cheung I, 2002, NAT GENET, V31, P405, DOI [10.1038/ng928, 10.1038/417405a]; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; DERVAN PB, 1986, SCIENCE, V232, P464, DOI 10.1126/science.2421408; Drygin D, 2009, CANCER RES, V69, P7653, DOI 10.1158/0008-5472.CAN-09-1304; Eddy J, 2008, NUCLEIC ACIDS RES, V36, P1321, DOI 10.1093/nar/gkm1138; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; Gavathiotis E, 2001, ANGEW CHEM INT EDIT, V40, P4749, DOI 10.1002/1521-3773(20011217)40:24<4749::AID-ANIE4749>3.0.CO;2-I; Gomez D, 2006, J BIOL CHEM, V281, P38721, DOI 10.1074/jbc.M605828200; Gottesfeld JM, 1997, NATURE, V387, P202, DOI 10.1038/387202a0; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Higgins ME, 2007, NUCLEIC ACIDS RES, V35, pD721, DOI 10.1093/nar/gkl811; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Koirala D, 2011, NAT CHEM, V3, P782, DOI [10.1038/NCHEM.1126, 10.1038/nchem.1126]; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Massip L, 2010, CELL CYCLE, V9, P2963, DOI 10.4161/cc.9.15.12412; Mergny JL, 2001, CHEMBIOCHEM, V2, P124, DOI 10.1002/1439-7633(20010202)2:2<124::AID-CBIC124>3.0.CO;2-L; Miller Kyle M, 2011, Expert Rev Clin Pharmacol, V4, P139, DOI 10.1586/ecp.11.4; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Muller S, 2010, NAT CHEM, V2, P1095, DOI 10.1038/NCHEM.842; Paeschke K, 2005, NAT STRUCT MOL BIOL, V12, P847, DOI 10.1038/nsmb982; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Patel DJ, 2007, NUCLEIC ACIDS RES, V35, P7429, DOI 10.1093/nar/gkm711; Pichot CS, 2009, BRIT J CANCER, V101, P38, DOI 10.1038/sj.bjc.6605101; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Rodriguez R, 2008, J AM CHEM SOC, V130, P15758, DOI 10.1021/ja805615w; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Salvati E, 2010, ONCOGENE, V29, P6280, DOI 10.1038/onc.2010.344; Sanders CM, 2010, BIOCHEM J, V430, P119, DOI 10.1042/BJ20100612; Sarkies P, 2010, MOL CELL, V40, P703, DOI 10.1016/j.molcel.2010.11.009; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Stockwell BR, 2000, NAT REV GENET, V1, P116, DOI 10.1038/35038557; Sun DY, 1997, J MED CHEM, V40, P2113, DOI 10.1021/jm970199z; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Takebayashi Y, 2001, NAT MED, V7, P961, DOI 10.1038/91008; Thomas JR, 2008, CHEM REV, V108, P1171, DOI 10.1021/cr0681546; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zabludoff SD, 2008, MOL CANCER THER, V7, P2955, DOI 10.1158/1535-7163.MCT-08-0492	50	472	476	6	215	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2012	8	3					301	310		10.1038/NCHEMBIO.780	http://dx.doi.org/10.1038/NCHEMBIO.780			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896VR	22306580	Green Accepted, Green Submitted			2022-12-25	WOS:000300600000016
J	Xia, YF; Yeddula, N; Leblanc, M; Ke, E; Zhang, YH; Oldfield, E; Shaw, RJ; Verma, IM				Xia, Yifeng; Yeddula, Narayana; Leblanc, Mathias; Ke, Eugene; Zhang, Yonghui; Oldfield, Eric; Shaw, Reuben J.; Verma, Inder M.			Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model	NATURE CELL BIOLOGY			English	Article							NF-KAPPA-B; TISSUE INHIBITORS; EXPRESSION; METALLOPROTEINASES; ACTIVATION; PHOSPHORYLATION; INFLAMMATION; REQUIREMENT; PROGRESSION; MUSCLE	Lung cancer is one of the leading cancer malignancies, with a five-year survival rate of only similar to 15%. We have developed a lentiviral-vector-mediated mouse model, which enables generation of non-small-cell lung cancer from less than 100 alveolar epithelial cells, and investigated the role of IKK2 and NF-kappa B in lung-cancer development. IKK2 depletion in tumour cells significantly attenuated tumour proliferation and significantly prolonged mouse survival. We identified Timp1, one of the NF-kappa B target genes, as a key mediator for tumour growth. Activation of the Erk signalling pathway and cell proliferation requires Timp-1 and its receptor CD63. Knockdown of either Ikbkb or Timp1 by short hairpin RNAs reduced tumour growth in both xenograft and lentiviral models. Our results thus suggest the possible application of IKK2 and Timp-1 inhibitors in treating lung cancer.	[Xia, Yifeng; Yeddula, Narayana; Leblanc, Mathias; Ke, Eugene; Verma, Inder M.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Ke, Eugene] Univ Calif San Diego, Grad Program Bioinformat, La Jolla, CA 92093 USA; [Zhang, Yonghui; Oldfield, Eric] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Oldfield, Eric] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Shaw, Reuben J.] Salk Inst Biol Studies, Mol & Cellular Biol Lab, La Jolla, CA 92037 USA; [Shaw, Reuben J.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Salk Institute; Howard Hughes Medical Institute; Salk Institute	Verma, IM (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	verma@salk.edu	Xia, Yifeng/G-9850-2011; Yeddula, Narayana/H-4893-2011		Leona and Harry Helmsley Center for Nutritional Genomics (Salk Institute); National Institutes of Health; Leducq Foundation; Merieux Foundation; Ellison Medical Foundation; Ipsen/Biomeasure; Sanofi Aventis; Prostate Cancer Foundation; Department of Defense; H.N. and Frances C. Berger Foundation; National Institute of Allergy and Infectious Diseases [R37AI048034]; Cancer Center Core Grant [P30CA014195-38]; NATIONAL CANCER INSTITUTE [R01CA158191, P30CA014195, R01CA172229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048034, R37AI048034] Funding Source: NIH RePORTER	Leona and Harry Helmsley Center for Nutritional Genomics (Salk Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation(Leducq Foundation); Merieux Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); Ipsen/Biomeasure; Sanofi Aventis(Sanofi-Aventis); Prostate Cancer Foundation; Department of Defense(United States Department of Defense); H.N. and Frances C. Berger Foundation; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cancer Center Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We appreciate the generosity of M. Pasparakis for providing the IKK2<SUP>fl/fl</SUP> mouse, and T. Takeya and H. Nakajima for tissue-specific promoter plasmids. We thank L. Ouyang for assistance with microarray preparation. We also thank G. Pao, O. Singer, F. Liu, D. Morvinski, Q. Zhu and Y. Soda for advice on lentiviral vector designing and discussions, and G. Estepa for assistance with preparing frozen sections. N.Y. is supported by a fellowship from the Leona and Harry Helmsley Center for Nutritional Genomics (Salk Institute). I.M.V. is an American Cancer Society Professor of Molecular Biology, and holds the Irwin and Joan Jacobs Chair in Exemplary Life Science. This work was supported in part by grants from the National Institutes of Health, Leducq Foundation, Merieux Foundation, Ellison Medical Foundation, Ipsen/Biomeasure, Sanofi Aventis, Prostate Cancer Foundation, Department of Defense and the H.N. and Frances C. Berger Foundation. The project described was supported in part by grant number R37AI048034 from the National Institute of Allergy and Infectious Diseases, and Cancer Center Core Grant P30CA014195-38.	Aljada IS, 2004, J CLIN ONCOL, V22, P3218, DOI 10.1200/JCO.2004.02.110; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Basseres DS, 2010, CANCER RES, V70, P3537, DOI 10.1158/0008-5472.CAN-09-4290; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Birrell MA, 2005, AM J RESP CRIT CARE, V172, P962, DOI 10.1164/rccm.200412-1647OC; Bivona TG, 2011, NATURE, V471, P523, DOI 10.1038/nature09870; Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; FLEMING RE, 1994, AM J RESP CELL MOL, V10, P499, DOI 10.1165/ajrcmb.10.5.7514010; Fong KM, 1996, CLIN CANCER RES, V2, P1369; Frese KK, 2007, NAT REV CANCER, V7, P645, DOI 10.1038/nrc2192; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Janssens S, 2006, CELL DEATH DIFFER, V13, P773, DOI 10.1038/sj.cdd.4401843; Jiang YF, 2002, ONCOGENE, V21, P2245, DOI 10.1038/sj.onc.1205291; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Kafri T, 1997, NAT GENET, V17, P314, DOI 10.1038/ng1197-314; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim CFB, 2005, COLD SH Q B, V70, P241, DOI 10.1101/sqb.2005.70.037; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Meuwissen R, 2005, GENE DEV, V19, P643, DOI 10.1101/gad.1284505; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Naka S, 2000, BIOCHEM BIOPH RES CO, V272, P808, DOI 10.1006/bbrc.2000.2838; NGUYEN Q, 1994, BIOCHEMISTRY-US, V33, P2089, DOI 10.1021/bi00174a015; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Rankin JA, 1996, P NATL ACAD SCI USA, V93, P7821, DOI 10.1073/pnas.93.15.7821; Rekhtman N, 2010, ARCH PATHOL LAB MED, V134, P1628, DOI 10.1043/2009-0583-RAR.1; Safran Michal, 2003, Mol Imaging, V2, P297, DOI 10.1162/153535003322750637; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sutherland KD, 2010, MOL ONCOL, V4, P397, DOI 10.1016/j.molonc.2010.05.002; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; Tang XM, 2006, CANCER, V107, P2637, DOI 10.1002/cncr.22315; Thomas P, 2000, J PATHOL, V190, P150; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Wilczynska KM, 2006, J BIOL CHEM, V281, P34955, DOI 10.1074/jbc.M604616200	50	100	99	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2012	14	3					257	+		10.1038/ncb2428	http://dx.doi.org/10.1038/ncb2428			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	900ZE	22327365	Green Accepted			2022-12-25	WOS:000300930400008
J	Horton, MW; Hancock, AM; Huang, YS; Toomajian, C; Atwell, S; Auton, A; Muliyati, NW; Platt, A; Sperone, FG; Vilhjalmsson, BJ; Nordborg, M; Borevitz, JO; Bergelson, J				Horton, Matthew W.; Hancock, Angela M.; Huang, Yu S.; Toomajian, Christopher; Atwell, Susanna; Auton, Adam; Muliyati, N. Wayan; Platt, Alexander; Sperone, F. Gianluca; Vilhjalmsson, Bjarni J.; Nordborg, Magnus; Borevitz, Justin O.; Bergelson, Joy			Genome-wide patterns of genetic variation in worldwide Arabidopsis thaliana accessions from the RegMap panel	NATURE GENETICS			English	Article							RECOMBINATION; SEQUENCE; ADAPTATION; POLYMORPHISMS; ASSOCIATION; EVOLUTION; SELECTION; HELITRON; CLIMATE; SWEEPS	Arabidopsis thaliana is native to Eurasia and is naturalized across the world. Its ability to be easily propagated and its high phenotypic variability make it an ideal model system for functional, ecological and evolutionary genetics. To date, analyses of the natural genetic variation of A. thaliana have involved small numbers of individual plants or genetic markers. Here we genotype 1,307 worldwide accessions, including several regional samples, using a 250K SNP chip. This allowed us to produce a high-resolution description of the global pattern of genetic variation. We applied three complementary selection tests and identified new targets of selection. Further, we characterized the pattern of historical recombination in A. thaliana and observed an enrichment of hotspots in its intergenic regions and repetitive DNA, which is consistent with the pattern that is observed for humans but which is strikingly different from that observed in other plant species. We have made the seeds we used to produce this Regional Mapping (RegMap) panel publicly available. This panel comprises one of the largest genomic mapping resources currently available for global natural isolates of a non-human species.	[Horton, Matthew W.; Hancock, Angela M.; Muliyati, N. Wayan; Sperone, F. Gianluca; Borevitz, Justin O.; Bergelson, Joy] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Huang, Yu S.; Atwell, Susanna; Platt, Alexander; Vilhjalmsson, Bjarni J.; Nordborg, Magnus] Univ So Calif, Los Angeles, CA USA; [Toomajian, Christopher] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; [Auton, Adam] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Nordborg, Magnus] Austrian Acad Sci, Gregor Mendel Inst, A-1010 Vienna, Austria	University of Chicago; University of Southern California; Kansas State University; University of Oxford; Wellcome Centre for Human Genetics; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Bergelson, J (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	jbergels@uchicago.edu	Toomajian, Christopher/ABA-2615-2021; Borevitz, Justin/B-5423-2012; Atwell, Susanna/H-8630-2016; Vilhjálmsson, Bjarni/ABC-1369-2020; Vilhjalmsson, Bjarni/K-3971-2014	Toomajian, Christopher/0000-0002-6763-0678; Borevitz, Justin/0000-0001-8408-3699; Atwell, Susanna/0000-0001-8680-9721; Vilhjálmsson, Bjarni/0000-0003-2277-9249; Vilhjalmsson, Bjarni/0000-0003-2277-9249; Nordborg, Magnus/0000-0001-7178-9748; Hancock, Angela/0000-0002-4768-3377; Platt, Alexander/0000-0003-3783-4781; Horton, Matthew/0000-0002-7537-0730; Bergelson, Joy/0000-0001-7893-7387	National Science Foundation; Graduate Assistance in Areas of National Need (GAANN) training grant; Achievement Rewards for College Scientists (ARCS) Foundation; US National Institutes of Health [GM057994, GM083068]; Dropkin Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057994, R01GM083068] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Graduate Assistance in Areas of National Need (GAANN) training grant(US Department of Education); Achievement Rewards for College Scientists (ARCS) Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dropkin Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Hubisz for the code for the CLR statistic and for help in using the software. We also thank E. Leffler for helpful discussions regarding recombination hotspots. M.W.H. was supported by a National Science Foundation Predoctoral Fellowship, a Graduate Assistance in Areas of National Need (GAANN) training grant and an Achievement Rewards for College Scientists (ARCS) Foundation Scholarship. This research was supported by US National Institutes of Health grant GM057994 (J.B.), US National Institutes of Health grant GM083068 (J.B. and M.N.), National Science Foundation 2010 grants (M.N. and J.B.) and a Dropkin Foundation Fellowship (A.M.H.). This is contribution number 11-3634-J from the Kansas Agricultural Experiment Station (C.T.).	Alonso-Blanco C, 2003, GENETICS, V164, P711; Anastasio AE, 2011, PLANT J, V67, P554, DOI 10.1111/j.1365-313X.2011.04606.x; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bakker EG, 2008, GENETICS, V178, P2031, DOI 10.1534/genetics.107.083279; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chiang GCK, 2011, MOL ECOL, V20, P3336, DOI 10.1111/j.1365-294X.2011.05181.x; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Gill KS, 1996, GENETICS, V144, P1883; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; Hartmann U, 2000, PLANT J, V21, P351, DOI 10.1046/j.1365-313x.2000.00682.x; He LM, 2009, P NATL ACAD SCI USA, V106, P8410, DOI 10.1073/pnas.0902972106; Hollister JD, 2007, MOL BIOL EVOL, V24, P2515, DOI 10.1093/molbev/msm197; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Lewandowska-Sabat AM, 2010, MOL ECOL, V19, P4753, DOI 10.1111/j.1365-294X.2010.04840.x; LEWONTIN RC, 1973, GENETICS, V74, P175; Li Y, 2010, P NATL ACAD SCI USA, V107, P21199, DOI 10.1073/pnas.1007431107; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; McDowell JM, 1998, PLANT CELL, V10, P1861, DOI 10.1105/tpc.10.11.1861; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Swigonova Z, 2004, GENOME RES, V14, P1916, DOI 10.1101/gr.2332504; Toomajian C, 2006, PLOS BIOL, V4, P732, DOI 10.1371/journal.pbio.0040137; Yandeau-Nelson MD, 2005, GENETICS, V169, P917, DOI 10.1534/genetics.104.035089; Yang SA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040003	43	329	335	2	170	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2012	44	2					212	216		10.1038/ng.1042	http://dx.doi.org/10.1038/ng.1042			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	22231484	Green Accepted			2022-12-25	WOS:000299664400022
J	Liu, PT; Wheelwright, M; Teles, R; Komisopoulou, E; Edfeldt, K; Ferguson, B; Mehta, MD; Vazirnia, A; Rea, TH; Sarno, EN; Graeber, TG; Modlin, RL				Liu, Philip T.; Wheelwright, Matthew; Teles, Rosane; Komisopoulou, Evangelia; Edfeldt, Kristina; Ferguson, Benjamin; Mehta, Manali D.; Vazirnia, Aria; Rea, Thomas H.; Sarno, Euzenir N.; Graeber, Thomas G.; Modlin, Robert L.			MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy	NATURE MEDICINE			English	Article							MYCOBACTERIUM-LEPRAE; HUMAN MACROPHAGES; CANCER-RISK; ACTIVATION; EXPRESSION; RESPONSES; PROFILES; GAMMA	Leprosy provides a model to investigate mechanisms of immune regulation in humans, given that the disease forms a spectrum of clinical presentations that correlate with host immune responses. Here we identified 13 miRNAs that were differentially expressed in the lesions of subjects with progressive lepromatous (L-lep) versus the self-limited tuberculoid (T-lep) disease, Bioinformatic analysis revealed a significant enrichment of L-lep-specific miRNAs that preferentially target key immune genes downregulated in L-lep versus T-lep lesions. The most differentially expressed miRNA in L-lep lesions, hsa-mir-21, was upregulated in Mycobacterium leprae-infected monocytes. By directly downregulating Toll-like receptor 2/1 heterodimer (TLR2/1)-induced CYP2781 and IL1B expression as well as indirectly upregulating interleukin-10 (IL-10), hsa-mir-21 inhibited expression of the genes encoding two vitamin D-dependent antimicrobial peptides, CAMP and DEFB4A. Conversely, knockdown of hsa-mir-21 in M. leprae-infected monocytes enhanced expression of CAMP and DEFB4A and restored TLR2/1-mediated antimicrobial activity against M. leprae. Therefore, the ability of M. leprae to upregulate hsa-mir-21 targets multiple genes associated with the immunologically localized disease form, providing an effective mechanism to escape from the vitamin D-dependent antimicrobial pathway.	[Liu, Philip T.] Univ Calif Los Angeles, Orthopaed Hosp, Res Ctr, Los Angeles, CA 90024 USA; [Liu, Philip T.; Wheelwright, Matthew; Teles, Rosane; Edfeldt, Kristina; Ferguson, Benjamin; Modlin, Robert L.] Univ Calif Los Angeles, David Geffen Sch Med, Div Dermatol, Dept Med, Los Angeles, CA 90095 USA; [Komisopoulou, Evangelia; Graeber, Thomas G.] Univ Calif Los Angeles, Crump Inst Mol Imaging, Los Angeles, CA USA; [Komisopoulou, Evangelia; Graeber, Thomas G.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA; [Mehta, Manali D.; Vazirnia, Aria; Modlin, Robert L.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [Rea, Thomas H.] Univ So Calif, Sch Med, Dept Dermatol, Los Angeles, CA USA; [Sarno, Euzenir N.] Inst Oswaldo Cruz, Leprosy Lab, BR-20001 Rio De Janeiro, Brazil; [Graeber, Thomas G.] Univ Calif Los Angeles, Inst Mol Med, Los Angeles, CA USA; [Graeber, Thomas G.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Graeber, Thomas G.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Southern California; Fundacao Oswaldo Cruz; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Liu, PT (corresponding author), Univ Calif Los Angeles, Orthopaed Hosp, Res Ctr, Los Angeles, CA 90024 USA.	ptliu@mednet.ucla.edu	Teles, Rosane/AAQ-3436-2020; Teles, Rosane/E-9607-2017; Liu, Philip/C-9638-2011; Modlin, Robert L/M-7941-2014	Teles, Rosane/0000-0003-2908-3244; Teles, Rosane/0000-0003-2908-3244; Modlin, Robert L/0000-0003-4720-031X; Liu, Philip/0000-0002-6144-0304; Wheelwright, Matthew/0000-0001-8883-4453; Graeber, Thomas/0000-0001-8574-9181; Nunes Sarno, Euzenir/0000-0003-0129-2159	US National Institutes of Health [AI 022553, AI 047868, AR 040312, AI 073539, AI 85025]; Wenner-Gren Foundations (Sweden); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047868, K22AI085025, R22AI022553, R01AI022553, R01AI082575, R01AI047868, R01AI073539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040312] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wenner-Gren Foundations (Sweden); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We would like to thank G. Cheng, R. O'Connell, J. Krahenbuhl, R. Lahiri and B. Bloom for their helpful discussions. The live M. leprae was provided by the US National Hansen's Disease Programs through the generous support of the American Leprosy Missions and Society of St. Lazarus of Jerusalem. This work was supported by US National Institutes of Health grants AI 022553, AI 047868, AR 040312 and AI 073539. P.T.L. is supported by US National Institutes of Health K22 Career Development Award AI 85025. K.E. is supported by a postdoctoral grant from the Wenner-Gren Foundations (Sweden). We would like to thank M. Schibler and the University of California-Los Angeles, California NanoSystems Institute, Advanced Light Microscopy Core Facility for their assistance with the confocal studies.	Adams LB, 2002, J INFECT DIS, V185, pS1, DOI 10.1086/338002; Ahn J, 2009, CARCINOGENESIS, V30, P769, DOI 10.1093/carcin/bgp055; CLARKCURTISS JE, 1989, J BACTERIOL, V171, P4844, DOI 10.1128/jb.171.9.4844-4851.1989; Cremer TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008508; CROWLE AJ, 1987, INFECT IMMUN, V55, P2945, DOI 10.1128/IAI.55.12.2945-2950.1987; Hansen GHA., 1874, NORSK MAG LAEGEVIDEN, V4, P1; HERRERA G, 1949, Int J Lepr, V17, P35; Krutzik SR, 2003, NAT MED, V9, P525, DOI 10.1038/nm864; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Liu PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005810; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Liu Z, 2010, MICROBES INFECT, V12, P854, DOI 10.1016/j.micinf.2010.06.002; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; Martinez AN, 2009, J CLIN MICROBIOL, V47, P2124, DOI 10.1128/JCM.00512-09; Montoya D, 2009, CELL HOST MICROBE, V6, P343, DOI 10.1016/j.chom.2009.09.002; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; NEILL MA, 1988, J EXP MED, V167, P30, DOI 10.1084/jem.167.1.30; Pena MT, 2008, CYTOKINE, V43, P124, DOI 10.1016/j.cyto.2008.04.014; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; ROOK GAW, 1988, AM REV RESPIR DIS, V138, P768, DOI 10.1164/ajrccm/138.4.768; Roy S, 1999, J INFECT DIS, V179, P187, DOI 10.1086/314536; SALGAME P, 1991, SCIENCE, V254, P279, DOI 10.1126/science.1681588; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Sinsimer D, 2010, INFECT IMMUN, V78, P293, DOI 10.1128/IAI.00816-09; Tabouret G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001159; VACHULA M, 1989, J IMMUNOL, V142, P1696; YAMAMURA M, 1991, SCIENCE, V254, P277, DOI 10.1126/science.1925582	27	147	153	1	31	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					267	273		10.1038/nm.2584	http://dx.doi.org/10.1038/nm.2584			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22286305	Green Accepted, Green Submitted			2022-12-25	WOS:000300140300041
J	Wang, XJ; Wei, XM; Thijssen, B; Das, J; Lipkin, SM; Yu, HY				Wang, Xiujuan; Wei, Xiaomu; Thijssen, Bram; Das, Jishnu; Lipkin, Steven M.; Yu, Haiyuan			Three-dimensional reconstruction of protein networks provides insight into human genetic disease	NATURE BIOTECHNOLOGY			English	Article							INTERACTION DATABASE; DOMAIN; MUTATIONS; WASP; POLYMERIZATION; VISUALIZATION; ACTIVATION; MAP	To better understand the molecular mechanisms and genetic basis of human disease, we systematically examine relationships between 3,949 genes, 62,663 mutations and 3,453 associated disorders by generating a three-dimensional, structurally resolved human interactome. This network consists of 4,222 high-quality binary protein-protein interactions with their atomic-resolution interfaces. We find that in-frame mutations (missense point mutations and in-frame insertions and deletions) are enriched on the interaction interfaces of proteins associated with the corresponding disorders, and that the disease specificity for different mutations of the same gene can be explained by their location within an interface. We also predict 292 candidate genes for 694 unknown disease-to-gene associations with proposed molecular mechanism hypotheses. This work indicates that knowledge of how in-frame disease mutations alter specific interactions is critical to understanding pathogenesis. Structurally resolved interaction networks should be valuable tools for interpreting the wealth of data being generated by large-scale structural genomics and disease association studies.	[Wang, Xiujuan; Das, Jishnu; Yu, Haiyuan] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14850 USA; [Wang, Xiujuan; Wei, Xiaomu; Das, Jishnu; Yu, Haiyuan] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY USA; [Wei, Xiaomu; Lipkin, Steven M.] Weill Cornell Coll Med, Dept Med, New York, NY USA; [Thijssen, Bram] Maastricht Univ, Dept Bioinformat, Maastricht, Netherlands	Cornell University; Cornell University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Maastricht University	Yu, HY (corresponding author), Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14850 USA.	haiyuan.yu@cornell.edu	Das, Jishnu/AAK-4950-2020; Das, Jishnu/C-6924-2015	Das, Jishnu/0000-0002-5747-064X; Das, Jishnu/0000-0002-5747-064X	Cornell University; National Cancer Institute [R01 CA098626, R21 CA122937]; Tata Graduate Fellowship; NATIONAL CANCER INSTITUTE [R01CA098626, R01CA167824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104424, R01GM097358] Funding Source: NIH RePORTER	Cornell University; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Tata Graduate Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Startup Fund from Cornell University (to HI), National Cancer Institute R01 CA098626 (to S.M.L.), R21 CA122937 (to S.M.L.) and a generous donation by M. Bell (to S.M.L.). J.D. is supported by the Tata Graduate Fellowship. We thank A. Paccanaro, K. Salehi-Ashtiani, M.A. Yildirim and the anonymous reviewers for critical reading and constructive comments of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Ancliff PJ, 2006, BLOOD, V108, P2182, DOI 10.1182/blood-2006-01-010249; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bougeard G, 2003, EUR J HUM GENET, V11, P700, DOI 10.1038/sj.ejhg.5201004; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Chandonia JM, 2006, SCIENCE, V311, P347, DOI 10.1126/science.1121018; Chi SW, 1999, EMBO J, V18, P4438, DOI 10.1093/emboj/18.16.4438; CLORE GM, 1995, NAT STRUCT BIOL, V2, P321, DOI 10.1038/nsb0495-321; Cusick ME, 2009, NAT METHODS, V6, P39, DOI [10.1038/NMETH.1284, 10.1038/nmeth.1284]; Dermitzakis ET, 2009, SCIENCE, V326, P239, DOI 10.1126/science.1182009; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Ferrer-Costa C, 2002, J MOL BIOL, V315, P771, DOI 10.1006/jmbi.2001.5255; Finn RD, 2005, BIOINFORMATICS, V21, P410, DOI 10.1093/bioinformatics/bti011; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Harada BT, 2008, STRUCTURE, V16, P380, DOI 10.1016/j.str.2007.12.017; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Hu ZJ, 2009, NUCLEIC ACIDS RES, V37, pW115, DOI 10.1093/nar/gkp406; Hwang D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.10; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Moulding DA, 2007, J EXP MED, V204, P2213, DOI 10.1084/jem.20062324; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Noris M, 2009, NEW ENGL J MED, V361, P1676, DOI 10.1056/NEJMra0902814; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Pasternak J., 2005, INTRO HUMAN MOL GENE; Peltomaki P, 1997, GASTROENTEROLOGY, V113, P1146, DOI 10.1053/gast.1997.v113.pm9322509; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schuster-Bockler B, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r9; Smigielski EM, 2000, NUCLEIC ACIDS RES, V28, P352, DOI 10.1093/nar/28.1.352; Stein A, 2009, NUCLEIC ACIDS RES, V37, pD300, DOI 10.1093/nar/gkn690; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Thrasher AJ, 2010, NAT REV IMMUNOL, V10, P182, DOI 10.1038/nri2724; Turinsky AL, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq026; Turner B, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq023; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wang XJ, 2011, BRIEF FUNCT GENOMICS, V10, P280, DOI 10.1093/bfgp/elr024; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yu HY, 2007, BIOINFORMATICS, V23, P2163, DOI 10.1093/bioinformatics/btm291; Yu HY, 2011, NAT METHODS, V8, P478, DOI [10.1038/NMETH.1597, 10.1038/nmeth.1597]; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	50	283	289	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2012	30	2					159	164		10.1038/nbt.2106	http://dx.doi.org/10.1038/nbt.2106			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	892EI	22252508	Green Accepted, Bronze			2022-12-25	WOS:000300269100018
J	May, D; Blow, MJ; Kaplan, T; McCulley, DJ; Jensen, BC; Akiyama, JA; Holt, A; Plajzer-Frick, I; Shoukry, M; Wright, C; Afzal, V; Simpson, PC; Rubin, EM; Black, BL; Bristow, J; Pennacchio, LA; Visel, A				May, Dalit; Blow, Matthew J.; Kaplan, Tommy; McCulley, David J.; Jensen, Brian C.; Akiyama, Jennifer A.; Holt, Amy; Plajzer-Frick, Ingrid; Shoukry, Malak; Wright, Crystal; Afzal, Veena; Simpson, Paul C.; Rubin, Edward M.; Black, Brian L.; Bristow, James; Pennacchio, Len A.; Visel, Axel			Large-scale discovery of enhancers from human heart tissue	NATURE GENETICS			English	Article							CORONARY-ARTERY-DISEASE; GENOME BROWSER DATABASE; TRANSCRIPTIONAL NETWORK; P300; ASSOCIATION; EXPRESSION; UPDATE; IDENTIFICATION; COACTIVATORS; ELEMENTS	Development and function of the human heart depend on the dynamic control of tissue-specific gene expression by distant-acting transcriptional enhancers. To generate an accurate genome-wide map of human heart enhancers, we used an epigenomic enhancer discovery approach and identified similar to 6,200 candidate enhancer sequences directly from fetal and adult human heart tissue. Consistent with their predicted function, these elements were markedly enriched near genes implicated in heart development, function and disease. To further validate their in vivo enhancer activity, we tested 65 of these human sequences in a transgenic mouse enhancer assay and observed that 43 (66%) drove reproducible reporter gene expression in the heart. These results support the discovery of a genome-wide set of noncoding sequences highly enriched in human heart enhancers that is likely to facilitate downstream studies of the role of enhancers in development and pathological conditions of the heart.	[May, Dalit; Blow, Matthew J.; Akiyama, Jennifer A.; Holt, Amy; Plajzer-Frick, Ingrid; Shoukry, Malak; Afzal, Veena; Rubin, Edward M.; Bristow, James; Pennacchio, Len A.; Visel, Axel] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Blow, Matthew J.; Wright, Crystal; Rubin, Edward M.; Bristow, James; Pennacchio, Len A.; Visel, Axel] Joint Genome Inst, US Dept Energy, Walnut Creek, CA USA; [Kaplan, Tommy] Univ Calif Berkeley, Dept Mol & Cell Biol, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Kaplan, Tommy] Hebrew Univ Jerusalem, Sch Comp Sci & Engn, Jerusalem, Israel; [McCulley, David J.; Simpson, Paul C.; Black, Brian L.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Jensen, Brian C.] Univ Calif San Francisco, Div Cardiol, San Francisco, CA USA; [Simpson, Paul C.] Virginia Med Ctr, Div Cardiol, San Francisco, CA USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Berkeley; Hebrew University of Jerusalem; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Pennacchio, LA (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA.	lapennacchio@lbl.gov; avisel@lbl.gov	Kaplan, Tommy/T-2528-2017; Blow, Matthew/G-6369-2012; Jensen, Brian/AAP-7526-2021; Visel, Axel/A-9398-2009	Kaplan, Tommy/0000-0002-1892-5461; Blow, Matthew/0000-0002-8844-9149; Visel, Axel/0000-0002-4130-7784; Black, Brian/0000-0002-6664-8913; Pennacchio, Len/0000-0002-8748-3732	National Human Genome Research Institute [HG003988]; National Heart, Lung, and Blood Institute (NHLBI) [HL64658, HL89707, HL096836]; European Molecular Biology Organization (EMBO); GlaxoSmithKline Research and Education Foundation for Cardiovascular Disease; University of California, San Francisco (UCSF) Foundation for Cardiac Research; Department of Veterans Affairs; Department of Energy [DE-AC02-05CH11231]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL096836, R01HL064658, P01HL089707] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019118] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); GlaxoSmithKline Research and Education Foundation for Cardiovascular Disease(GlaxoSmithKline); University of California, San Francisco (UCSF) Foundation for Cardiac Research(University of California System); Department of Veterans Affairs(US Department of Veterans Affairs); Department of Energy(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank R. Hosseini and S. Phouanenavong for technical support, S. Deutsch for help in retrieving human genetic data and C. Attanasio and D. Dickel for critical comments on the manuscript. L. A. P. and A. V. were supported by a grant funded by the National Human Genome Research Institute (HG003988). B. L. B. was supported by grants from the National Heart, Lung, and Blood Institute (NHLBI, HL64658 and HL89707). D. M. and T. K. were supported by European Molecular Biology Organization (EMBO) long-term postdoctoral fellowships. B.C.J. was supported by the GlaxoSmithKline Research and Education Foundation for Cardiovascular Disease, University of California, San Francisco (UCSF) Foundation for Cardiac Research and a grant from the NHLBI (HL096836). P.C.S. was supported by the NHLBI and the Department of Veterans Affairs. Research was performed at Lawrence Berkeley National Laboratory and at the United States Department of Energy Joint Genome Institute (Department of Energy Contract DE-AC02-05CH11231, University of California).	ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bentham J, 2008, ANN NY ACAD SCI, V1123, P10, DOI 10.1196/annals.1420.003; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blake JA, 2009, NUCLEIC ACIDS RES, V37, pD712, DOI 10.1093/nar/gkn886; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Conti A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-268; Coppen SR, 2003, MOL CELL BIOCHEM, V242, P121, DOI 10.1023/A:1021150014764; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Henderson DJ, 2009, PEDIATR CARDIOL, V30, P588, DOI 10.1007/s00246-009-9390-9; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Hoffman JIE, 2004, AM HEART J, V147, P425, DOI 10.1016/j.ahj.2003.05.003; KOTHARY R, 1988, NATURE, V335, P435, DOI 10.1038/335435a0; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Morimoto T, 2010, CIRC J, V74, P1059, DOI 10.1253/circj.CJ-09-1012; Narlikar L, 2010, GENOME RES, V20, P381, DOI 10.1101/gr.098657.109; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136	42	186	190	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2012	44	1					89	U125		10.1038/ng.1006	http://dx.doi.org/10.1038/ng.1006			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	22138689	Green Accepted, Green Submitted			2022-12-25	WOS:000298664000020
J	Lindhurst, MJ; Parker, VER; Payne, F; Sapp, JC; Rudge, S; Harris, J; Witkowski, AM; Zhang, QF; Groeneveld, MP; Scott, CE; Daly, A; Huson, SM; Tosi, LL; Cunningham, ML; Darling, TN; Geer, J; Gucev, Z; Sutton, VR; Tziotzios, C; Dixon, AK; Helliwell, T; O'Rahilly, S; Savage, DB; Wakelam, MJO; Barroso, I; Biesecker, LG; Semple, RK				Lindhurst, Marjorie J.; Parker, Victoria E. R.; Payne, Felicity; Sapp, Julie C.; Rudge, Simon; Harris, Julie; Witkowski, Alison M.; Zhang, Qifeng; Groeneveld, Matthijs P.; Scott, Carol E.; Daly, Allan; Huson, Susan M.; Tosi, Laura L.; Cunningham, Michael L.; Darling, Thomas N.; Geer, Joseph; Gucev, Zoran; Sutton, V. Reid; Tziotzios, Christos; Dixon, Adrian K.; Helliwell, Timothy; O'Rahilly, Stephen; Savage, David B.; Wakelam, Michael J. O.; Barroso, Ines; Biesecker, Leslie G.; Semple, Robert K.			Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA	NATURE GENETICS			English	Article							DIAGNOSTIC-CRITERIA; PROTEUS-SYNDROME; AKT1; PI3K; H1047R; DOMAIN	The phosphatidylinositol 3-kinase (PI3K)-AKT signaling pathway is critical for cellular growth and metabolism. Correspondingly, loss of function of PTEN, a negative regulator of PI3K, or activating mutations in AKT1, AKT2 or AKT3 have been found in distinct disorders featuring overgrowth or hypoglycemia. We performed exome sequencing of DNA from unaffected and affected cells from an individual with an unclassified syndrome of congenital progressive segmental overgrowth of fibrous and adipose tissue and bone and identified the cancer-associated mutation encoding p.His1047Leu in PIK3CA, the gene that encodes the p110 alpha catalytic subunit of PI3K, only in affected cells. Sequencing of PIK3CA in ten additional individuals with overlapping syndromes identified either the p.His1047Leu alteration or a second cancer-associated alteration, p.His1047Arg, in nine cases. Affected dermal fibroblasts showed enhanced basal and epidermal growth factor (EGF)-stimulated phosphatidylinositol 3,4,5-trisphosphate(PIP3) generation and concomitant activation of downstream signaling relative to their unaffected counterparts. Our findings characterize a distinct overgrowth syndrome, biochemically demonstrate activation of PI3K signaling and thereby identify a rational therapeutic target.	[Lindhurst, Marjorie J.; Sapp, Julie C.; Witkowski, Alison M.; Biesecker, Leslie G.] NHGRI, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Parker, Victoria E. R.; Harris, Julie; Groeneveld, Matthijs P.; O'Rahilly, Stephen; Savage, David B.; Barroso, Ines; Semple, Robert K.] Univ Cambridge, Metab Res Labs, Inst Metab Sci, Cambridge, England; [Payne, Felicity; Scott, Carol E.; Daly, Allan; Barroso, Ines] Wellcome Trust Sanger Inst, Cambridge, England; [Rudge, Simon; Zhang, Qifeng; Wakelam, Michael J. O.] Babraham Inst, Cambridge, England; [Huson, Susan M.] Manchester Acad Hlth Sci Ctr, Genet Unit, Manchester, Lancs, England; [Tosi, Laura L.] Childrens Natl Med Ctr, Div Orthopaed, Washington, DC 20010 USA; [Cunningham, Michael L.] Univ Washington, Sch Med, Div Craniofacial Med, Seattle, WA USA; [Darling, Thomas N.] Uniformed Serv Univ Hlth Sci, Dept Dermatol, Bethesda, MD USA; [Geer, Joseph] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Gucev, Zoran] Skopje Med Fac, Dept Endocrinol & Genet, Skopje, Macedonia; [Sutton, V. Reid] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Tziotzios, Christos] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Dixon, Adrian K.] Univ Cambridge, Sch Clin Med, Cambridge, England; [Helliwell, Timothy] Univ Liverpool, Liverpool Canc Res UK Ctr, Liverpool L69 3BX, Merseyside, England; [O'Rahilly, Stephen; Savage, David B.; Semple, Robert K.] Cambridge Biomed Res Ctr, Natl Inst Hlth Res, Cambridge, England	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Cambridge; Wellcome Trust Sanger Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Manchester; Children's National Health System; University of Washington; University of Washington Seattle; Uniformed Services University of the Health Sciences - USA; Greenwood Genetic Center; Baylor College of Medicine; University of Glasgow; University of Cambridge; University of Liverpool; University of Cambridge	Biesecker, LG (corresponding author), NHGRI, US Natl Inst Hlth, Bethesda, MD 20892 USA.	ib1@sanger.ac.uk; leslieb@helix.nih.gov; rks16@cam.ac.uk	O'Rahilly, Stephen/ABF-6509-2020; Semple, Robert/AAB-2948-2019; Lindhurst, Marjorie/AHD-3412-2022; Payne, Felicity/GKF-2573-2022	O'Rahilly, Stephen/0000-0003-2199-4449; Payne, Felicity/0000-0003-4228-581X; Helliwell, Timothy/0000-0003-2112-4128; Shew, Alison/0000-0002-3759-9630; Savage, David Bousfield/0000-0002-7857-7032; Darling, Thomas/0000-0002-5161-1974; Groeneveld, Matthijs P./0000-0002-3016-4853; Semple, Robert Kenneth/0000-0001-6539-3069; Sapp, Julie/0000-0002-4003-258X; Tziotzios, Christos/0000-0003-1662-4494; Wakelam, Michael/0000-0003-4059-9276; Barroso, Ines/0000-0001-5800-4520	Proteus Syndrome Foundations of the United States and United Kingdom; Wellcome Trust [097721/Z/11/Z, 80952/Z/06/Z, 078986/Z/06/Z, 098051/Z/05/Z, 091551/Z/10/Z]; UK Medical Research Council Centre for Obesity and Related Disorders; UK National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre; Intramural Research Program of the National Human Genome Research Institute; Biotechnology and Biological Sciences Research Council (BBSRC); Manchester NIHR Biomedical Research Centre; BBSRC [BBS/E/B/000C0415, BBS/E/B/0000C227] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0415, BBS/E/B/0000C227] Funding Source: researchfish; Medical Research Council [G0600717B] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200328] Funding Source: NIH RePORTER	Proteus Syndrome Foundations of the United States and United Kingdom; Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council Centre for Obesity and Related Disorders(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre; Intramural Research Program of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Manchester NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors thank L. Ivey, J.J. Johnston, V. Tasic, M. Walters and E. Choolun for support and advice. The authors are especially grateful to the subjects who participated in this research study and to the Proteus Syndrome Foundations of the United States and United Kingdom, who have supported and encouraged these individuals and our research efforts. V.E.R.P., S.O., D.B.S., I.B. and R.K.S. were supported by the Wellcome Trust (grants 097721/Z/11/Z, 80952/Z/06/Z, 078986/Z/06/Z, 098051/Z/05/Z and 091551/Z/10/Z), the UK Medical Research Council Centre for Obesity and Related Disorders and the UK National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre. L.G.B., M.J.L., J.C.S. and A.M.W. were supported by the Intramural Research Program of the National Human Genome Research Institute. S.R., Q.Z. and M.J.O.W. were supported by the Biotechnology and Biological Sciences Research Council (BBSRC). We are grateful for access to exome sequence data from the CoLaus cohort, which was sequenced as part of a partnership between the Wellcome Trust Sanger Institute, the CoLaus principal investigators and the Quantitative Sciences department of GlaxoSmithKline. S.M.H. is supported by the Manchester NIHR Biomedical Research Centre.	Adams JR, 2011, CANCER RES, V71, P2706, DOI 10.1158/0008-5472.CAN-10-0738; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Biesecker L, 2006, EUR J HUM GENET, V14, P1151, DOI 10.1038/sj.ejhg.5201638; Biesecker LG, 1999, AM J MED GENET, V84, P389, DOI 10.1002/(SICI)1096-8628(19990611)84:5<389::AID-AJMG1>3.0.CO;2-O; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Carty MJ, 2009, HAND CLIN, V25, P229, DOI 10.1016/j.hcl.2008.12.006; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Clark J, 2011, NAT METHODS, V8, P267, DOI 10.1038/NMETH.1564; Ellis H., 2007, HUMAN SECTIONAL ANAT, V163; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Hafner C, 2007, P NATL ACAD SCI USA, V104, P13450, DOI 10.1073/pnas.0705218104; Happle R, 2007, BRIT J DERMATOL, V156, P1089, DOI 10.1111/j.1365-2133.2007.07818.x; Happle R, 2010, J AM ACAD DERMATOL, V63, P1, DOI 10.1016/j.jaad.2010.01.017; Happle R, 2010, J AM ACAD DERMATOL, V63, P25, DOI 10.1016/j.jaad.2010.01.016; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hon WC, 2012, ONCOGENE, V31, P3655, DOI 10.1038/onc.2011.532; Hussain K, 2011, SCIENCE, V334, P474, DOI 10.1126/science.1210878; Kinross KM, 2012, J CLIN INVEST, V122, P553, DOI 10.1172/JCI59309; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Liu PX, 2011, NAT MED, V17, P1116, DOI 10.1038/nm.2402; Mandelker D, 2009, P NATL ACAD SCI USA, V106, P16996, DOI 10.1073/pnas.0908444106; Marsh DJ, 2008, NAT CLIN PRACT ONCOL, V5, P357, DOI 10.1038/ncponc1112; Meyer DS, 2011, CANCER RES, V71, P4344, DOI 10.1158/0008-5472.CAN-10-3827; Miron A, 2010, CANCER RES, V70, P5674, DOI 10.1158/0008-5472.CAN-08-2660; Oduber CNEU, 2008, ANN PLAS SURG, V60, P217, DOI 10.1097/SAP.0b013e318062abc1; Oduber CEU, 2011, EUR J MED GENET, V54, P262, DOI 10.1016/j.ejmg.2011.02.007; Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010; Raffan E, 2011, BRIT MED BULL, V99, P53, DOI 10.1093/bmb/ldr029; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Tosi LL, 2011, J CHILD ORTHOP, V5, P319, DOI 10.1007/s11832-011-0350-6; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Yamamoto S, 2011, J PATHOL, V225, P189, DOI 10.1002/path.2940; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	34	204	210	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2012	44	8					928	+		10.1038/ng.2332	http://dx.doi.org/10.1038/ng.2332			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	979WV	22729222	Green Accepted			2022-12-25	WOS:000306854700020
J	Peer, WA				Peer, Wendy Ann			PROTEIN EVOLUTION The enzyme perfected	NATURE CHEMICAL BIOLOGY			English	News Item									Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Peer, WA (corresponding author), Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA.	peerw@purdue.edu						Ikura T, 2008, PROTEIN ENG DES SEL, V21, P83, DOI 10.1093/protein/gzm087; Jakob RP, 2009, P NATL ACAD SCI USA, V106, P20282, DOI 10.1073/pnas.0909544106; Ngaki, 2012, NATURE          0513, DOI [10.1038/nature11009, DOI 10.1038/NATURE11009]; Oteiza Patricia I, 2005, Clin Dev Immunol, V12, P19, DOI 10.1080/10446670410001722168; Peer W.A., 2006, SCI FLAVONOIDS, P239, DOI [10.1007/978-0-387-28822-2_9, DOI 10.1007/978-0-387-28822-2_9]; Rausher MD., 2006, SCI FLAVONOIDS, P175, DOI [10.1007/978-0-387-28822-2_7, DOI 10.1007/978-0-387-28822-2_7]; STAFFORD HA, 1991, PLANT PHYSIOL, V96, P680, DOI 10.1104/pp.96.3.680; VERWOERT IIGS, 1992, J BACTERIOL, V174, P2851, DOI 10.1128/JB.174.9.2851-2857.1992; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485	10	2	2	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2012	8	7					607	608		10.1038/nchembio.1006	http://dx.doi.org/10.1038/nchembio.1006			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961NJ	22710308				2022-12-25	WOS:000305471400005
J	Sun, Z; Miller, RA; Patel, RT; Chen, J; Dhir, R; Wang, H; Zhang, DY; Graham, MJ; Unterman, TG; Shulman, GI; Sztalryd, C; Bennett, MJ; Ahima, RS; Birnbaum, MJ; Lazar, MA				Sun, Zheng; Miller, Russell A.; Patel, Rajesh T.; Chen, Jie; Dhir, Ravindra; Wang, Hong; Zhang, Dongyan; Graham, Mark J.; Unterman, Terry G.; Shulman, Gerald I.; Sztalryd, Carole; Bennett, Michael J.; Ahima, Rexford S.; Birnbaum, Morris J.; Lazar, Mitchell A.			Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration	NATURE MEDICINE			English	Article							DIFFERENTIATION-RELATED PROTEIN; FATTY LIVER-DISEASE; INDUCED INSULIN-RESISTANCE; HISTONE DEACETYLASES; METABOLIC-DISORDERS; VLDL SECRETION; MICE; GLUCOSE; STEATOSIS; FOXO1	Fatty liver disease is associated with obesity and type 2 diabetes, and hepatic lipid accumulation may contribute to insulin resistance. Histone deacetylase 3 (Hdac3) controls the circadian rhythm of hepatic lipogenesis. Here we show that, despite severe hepatosteatosis, mice with liver-specific depletion of Hdac3 have higher insulin sensitivity without any changes in insulin signaling or body weight compared to wild-type mice. Hdac3 depletion reroutes metabolic precursors towards lipid synthesis and storage within lipid droplets and away from hepatic glucose production. Perilipin 2, which coats lipid droplets, is markedly induced upon Hdac3 depletion and contributes to the development of both steatosis and improved tolerance to glucose. These findings suggest that the sequestration of hepatic lipids in perilipin 2-coated droplets ameliorates insulin resistance and establish Hdac3 as a pivotal epigenomic modifier that integrates signals from the circadian clock in the regulation of hepatic intermediary metabolism.	[Sun, Zheng; Miller, Russell A.; Patel, Rajesh T.; Dhir, Ravindra; Ahima, Rexford S.; Birnbaum, Morris J.; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; [Sun, Zheng; Miller, Russell A.; Patel, Rajesh T.; Dhir, Ravindra; Ahima, Rexford S.; Birnbaum, Morris J.; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Chen, Jie; Bennett, Michael J.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Wang, Hong; Sztalryd, Carole] Univ Maryland, Baltimore Vet Affairs Hlth Care Ctr, Geriatr Res Educ & Clin Ctr, Dept Med,Div Endocrinol,Sch Med, Baltimore, MD 21201 USA; [Zhang, Dongyan; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Graham, Mark J.] Isis Pharmaceut Inc, Carlsbad, CA USA; [Unterman, Terry G.] Univ Illinois, Sect Endocrinol Diabet & Metab, Chicago, IL USA; [Unterman, Terry G.] Jesse Brown Virginia Med Ctr, Chicago, IL USA; [Bennett, Michael J.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Geriatric Research Education & Clinical Center; University System of Maryland; University of Maryland Baltimore; Yale University; Isis Pharmaceuticals Inc; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Lazar, MA (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Sun, Zheng/C-1146-2012; Lazar, Mitchell A/AAF-3738-2019; Shulman, Gerald I./P-7176-2019; Ahima, Rexford/W-1394-2019	Sun, Zheng/0000-0002-6858-0633; Shulman, Gerald I./0000-0003-1529-5668; Chen, Jie/0000-0002-7887-3747; Birnbaum, Morris/0000-0001-9972-8680	US National Institutes of Health [R37 DK43806, P01 DK49210, R01 DK40936, R01 DK075017]; Department of Veteran Affairs [F32 DK079572]; JPB Foundation; Cox Institute for Medical Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075017, P01DK049210, P01DK049814, U24DK059635, R01DK056886, F32DK079572, P30DK072488, R01DK040936, P30DK019525, R37DK043806] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veteran Affairs(US Department of Veterans Affairs); JPB Foundation; Cox Institute for Medical Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Millar and the Metabolic Tracer Resource at the Penn Institute for Diabetes, Obesity and Metabolism for the lipogenesis flux assay. We thank the Mouse Metabolic Phenotyping Core and the Viral Vector Core at Penn Diabetes Research Center (P30 DK19525) and the Penn Digestives Disease Center Morphology Core (P30 DK050306) at the University of Pennsylvania. We thank the Vanderbilt (DK59637) and Yale (U24 DK059635) Mouse Metabolic Phenotyping Centers and the Children's Hospital of Philadelphia Pathology Core. We thank B. Agarwal and S. Mullican for helpful discussion. This work was supported by US National Institutes of Health grants R37 DK43806 (M. A. L.), P01 DK49210 (M. A. L., M. J. Birnbaum and R. S. A.) and R01 DK40936 (G. I. S.), R01 DK075017 (C. S.), the Department of Veteran Affairs Merit Review Program (T. G. U.), grant F32 DK079572 (R. A. M.), the JPB Foundation and the Cox Institute for Medical Research.	Banks AS, 2011, CELL METAB, V14, P587, DOI 10.1016/j.cmet.2011.09.012; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bell M, 2008, DIABETES, V57, P2037, DOI 10.2337/db07-1383; Bell P, 2011, HUM GENE THER, V22, P985, DOI 10.1089/hum.2010.194; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Bolanos JP, 2010, TRENDS BIOCHEM SCI, V35, P145, DOI 10.1016/j.tibs.2009.10.006; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brown JM, 2010, J LIPID RES, V51, P3306, DOI 10.1194/jlr.M010256; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Calvo MN, 2006, FEBS LETT, V580, P3308, DOI 10.1016/j.febslet.2006.04.093; Chang BHJ, 2010, J LIPID RES, V51, P2132, DOI 10.1194/jlr.M004515; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Haeusler RA, 2010, J BIOL CHEM, V285, P26861, DOI 10.1074/jbc.M110.134023; Hammond LE, 2005, J BIOL CHEM, V280, P25629, DOI 10.1074/jbc.M503181200; Imai Y, 2007, GASTROENTEROLOGY, V132, P1947, DOI 10.1053/j.gastro.2007.02.046; Kadereit B, 2008, P NATL ACAD SCI USA, V105, P94, DOI 10.1073/pnas.0708579105; Kantartzis K, 2009, DIABETES, V58, P2616, DOI 10.2337/db09-0279; Knutson SK, 2008, EMBO J, V27, P1017, DOI 10.1038/emboj.2008.51; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Larter CZ, 2008, J GASTROEN HEPATOL, V23, P1635, DOI 10.1111/j.1440-1746.2008.05543.x; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Lonardo A, 2011, EXPERT REV GASTROENT, V5, P279, DOI [10.1586/egh.11.19, 10.1586/EGH.11.19]; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Minehira K, 2008, J LIPID RES, V49, P2038, DOI 10.1194/jlr.M800248-JLR200; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Mutel E, 2011, DIABETES, V60, P3121, DOI 10.2337/db11-0571; Nagle CA, 2009, J LIPID RES, V50, pS74, DOI 10.1194/jlr.R800053-JLR200; NILSSON A, 1984, LIPIDS, V19, P187, DOI 10.1007/BF02534796; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sapiro JM, 2009, J LIPID RES, V50, P1621, DOI 10.1194/jlr.M800614-JLR200; Schonfeld G., 2008, T AM CLIN CLIMAT ASS, V119, P223; Schonfeld Gustav, 2008, Trans Am Clin Climatol Assoc, V119, P217; Seo YK, 2011, CELL METAB, V13, P367, DOI 10.1016/j.cmet.2011.03.005; Seo YK, 2009, P NATL ACAD SCI USA, V106, P13765, DOI 10.1073/pnas.0904246106; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Sun Z, 2011, COLD SH Q B, V76, P49, DOI 10.1101/sqb.2011.76.011494; Sztalryd C, 2006, J BIOL CHEM, V281, P34341, DOI 10.1074/jbc.M602497200; Taniguchi CM, 2006, CELL METAB, V3, P343, DOI 10.1016/j.cmet.2006.04.005; Tao RY, 2011, J BIOL CHEM, V286, P14681, DOI 10.1074/jbc.M110.201061; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Wendel AA, 2009, BBA-MOL CELL BIOL L, V1791, P501, DOI 10.1016/j.bbalip.2008.10.010; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200	61	231	234	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2012	18	6					934	+		10.1038/nm.2744	http://dx.doi.org/10.1038/nm.2744			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22561686	Green Accepted			2022-12-25	WOS:000305116600031
J	Xu, YF; Amador-Noguez, D; Reaves, ML; Feng, XJ; Rabinowitz, JD				Xu, Yi-Fan; Amador-Noguez, Daniel; Reaves, Marshall Louis; Feng, Xiao-Jiang; Rabinowitz, Joshua D.			Ultrasensitive regulation of anapleurosis via allosteric activation of PEP carboxylase	NATURE CHEMICAL BIOLOGY			English	Article							COLI PHOSPHOENOLPYRUVATE CARBOXYLASE; MULTIPLE EFFECTORS INVIVO; ESCHERICHIA-COLI; GENE KNOCKOUT; ISOCITRATE DEHYDROGENASE; PYRUVATE-KINASE; SITE; METABOLISM; EXPRESSION; DYNAMICS	Anapleurosis is the filling of the tricarboxylic acid cycle with four-carbon units. The common substrate for both anapleurosis and glucose phosphorylation in bacteria is the terminal glycolytic metabolite phosphoenolpyruvate (PEP). Here we show that Escherichia coli quickly and almost completely turns off PEP consumption upon glucose removal. The resulting buildup of PEP is used to quickly import glucose if it becomes available again. The switch-like termination of anapleurosis results from depletion of fructose-1,6-bisphosphate (FBP), an ultrasensitive allosteric activator of PEP carboxylase. E. coli expressing an FBP-insensitive point mutant of PEP carboxylase grow normally when glucose is steadily available. However, they fail to build up PEP upon glucose removal, grow poorly when glucose availability oscillates and suffer from futile cycling at the PEP node on gluconeogenic substrates. Thus, bacterial central carbon metabolism is intrinsically programmed with ultrasensitive allosteric regulation to enable rapid adaptation to changing environmental conditions.	[Xu, Yi-Fan; Amador-Noguez, Daniel; Reaves, Marshall Louis; Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Xu, Yi-Fan; Feng, Xiao-Jiang; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Reaves, Marshall Louis] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Xu, YF (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	joshr@princeton.edu	xu, yifan/GWZ-7154-2022; Rabinowitz, Joshua/GPP-4019-2022	Rabinowitz, Joshua/0000-0002-1247-4727	US National Science Foundation (NSF) CAREER [MCB-0643859]; Joint US Department of Energy-Air Force Office of Scientific Research [DOE DE-SC0002077-AFOSR FA9550-09-1-0580]; US National Institutes of Health Center for Quantitative Biology [P50 GM071508]; NSF [CBET-0941143, DGE-0646086]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	US National Science Foundation (NSF) CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); Joint US Department of Energy-Air Force Office of Scientific Research; US National Institutes of Health Center for Quantitative Biology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Princeton University colleagues C. Doucette for the ppc deletion strain and A. Hottes for the pCA24N-ppc plasmid; J. Park for the flux calculations; A. Michaelis and Z. Gitai for the microscopy; D. Perlman, W. Lu, K. Saw and H. Shwe for protein mass spectrometry; and N. Wingreen for helpful discussions. This research was funded by US National Science Foundation (NSF) CAREER award MCB-0643859, Joint US Department of Energy-Air Force Office of Scientific Research award DOE DE-SC0002077-AFOSR FA9550-09-1-0580, the US National Institutes of Health Center for Quantitative Biology award P50 GM071508 and NSF grant CBET-0941143. M.L.R. was supported by NSF Graduate Research Fellowship DGE-0646086.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bhasin M, 2003, BIOCHEMISTRY-US, V42, P13496, DOI 10.1021/bi035224j; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; BROGLIE KE, 1983, J BIOL CHEM, V258, P2940; Brown G, 2009, J BIOL CHEM, V284, P3784, DOI 10.1074/jbc.M808186200; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; EISENSTEIN E, 1994, J BIOL CHEM, V269, P29423; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Fischer E, 2003, J BIOL CHEM, V278, P46446, DOI 10.1074/jbc.M307968200; GARNAK M, 1979, SCIENCE, V203, P1111, DOI 10.1126/science.34215; Gonzalez CF, 2006, J BIOL CHEM, V281, P14514, DOI 10.1074/jbc.M600996200; GUTNICK D, 1969, J BACTERIOL, V100, P215, DOI 10.1128/JB.100.1.215-219.1969; HERRMANN KM, 1995, PLANT PHYSIOL, V107, P7, DOI 10.1104/pp.107.1.7; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Izui K, 2004, ANNU REV PLANT BIOL, V55, P69, DOI 10.1146/annurev.arplant.55.031903.141619; IZUI K, 1981, J BIOCHEM-TOKYO, V90, P1321, DOI 10.1093/oxfordjournals.jbchem.a133597; Kai Y, 2003, ARCH BIOCHEM BIOPHYS, V414, P170, DOI 10.1016/S0003-9861(03)00170-X; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Kim DH, 1996, BIOCHEMISTRY-US, V35, P4923, DOI 10.1021/bi952937w; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; KODAKI T, 1984, J BIOCHEM-TOKYO, V95, P637, DOI 10.1093/oxfordjournals.jbchem.a134652; Kotte O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.10; Lee M, 2005, J MOL BIOL, V348, P523, DOI 10.1016/j.jmb.2005.01.067; Lu W, 2008, J CHROMATOGR B, V871, P236, DOI 10.1016/j.jchromb.2008.04.031; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; MORIKAWA M, 1980, J BIOCHEM-TOKYO, V87, P441, DOI 10.1093/oxfordjournals.jbchem.a132764; Ogawa T, 2007, RES MICROBIOL, V158, P159, DOI 10.1016/j.resmic.2006.11.003; Oh MK, 2002, J BIOL CHEM, V277, P13175, DOI 10.1074/jbc.M110809200; Peng L, 2003, APPL MICROBIOL BIOT, V61, P163, DOI 10.1007/s00253-002-1202-6; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; Salleh HM, 1996, BIOCHEMISTRY-US, V35, P8942, DOI 10.1021/bi952373w; SANWAL BD, 1966, BIOCHEM BIOPH RES CO, V22, P194, DOI 10.1016/0006-291X(66)90431-1; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; Schaub J, 2008, BIOTECHNOL PROGR, V24, P1402, DOI 10.1002/btpr.59; Siddiquee KA, 2004, FEMS MICROBIOL LETT, V235, P25, DOI 10.1016/j.femsle.2004.04.004; Siddiquee KA, 2004, APPL MICROBIOL BIOT, V63, P407, DOI 10.1007/s00253-003-1357-9; SILVERSTEIN R, 1973, J BIOL CHEM, V248, P8402; SONG WJ, 1994, J BIOL CHEM, V269, P27051; Stadtman ER, 2001, J BIOL CHEM, V276, P44357, DOI 10.1074/jbc.R100055200; Takahashi-Terada A, 2005, J BIOL CHEM, V280, P11798, DOI 10.1074/jbc.M408768200; Theobald U, 1997, BIOTECHNOL BIOENG, V55, P305, DOI 10.1002/(SICI)1097-0290(19970720)55:2<305::AID-BIT8>3.0.CO;2-M; van Rijsewijk BRBH, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.9; WALSH K, 1985, J BIOL CHEM, V260, P8430; WOHL RC, 1972, J BIOL CHEM, V247, P5785; Yuan J, 2008, NAT PROTOC, V3, P1328, DOI 10.1038/nprot.2008.131; Yuan J, 2007, J AM CHEM SOC, V129, P9294, DOI 10.1021/ja072997c; Zhao J, 2004, METAB ENG, V6, P164, DOI 10.1016/j.ymben.2004.02.004; Zhu T, 2010, BIOCHIMIE, V92, P116, DOI 10.1016/j.biochi.2009.09.016	50	61	61	4	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2012	8	6					562	568		10.1038/NCHEMBIO.941	http://dx.doi.org/10.1038/NCHEMBIO.941			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	945ET	22522319	Green Accepted			2022-12-25	WOS:000304256300012
J	Zhang, GY; Liu, X; Quan, ZW; Cheng, SF; Xu, X; Pan, SK; Xie, M; Zeng, P; Yue, Z; Wang, WL; Tao, Y; Bian, C; Han, CL; Xia, QJ; Peng, XH; Cao, R; Yang, XH; Zhan, DL; Hu, JC; Zhang, YX; Li, HN; Li, H; Li, N; Wang, JY; Wang, CC; Wang, RY; Guo, T; Cai, YJ; Liu, CZ; Xiang, HT; Shi, QX; Huang, P; Chen, QC; Li, YR; Wang, J; Zhao, ZH; Wang, J				Zhang, Gengyun; Liu, Xin; Quan, Zhiwu; Cheng, Shifeng; Xu, Xun; Pan, Shengkai; Xie, Min; Zeng, Peng; Yue, Zhen; Wang, Wenliang; Tao, Ye; Bian, Chao; Han, Changlei; Xia, Qiuju; Peng, Xiaohua; Cao, Rui; Yang, Xinhua; Zhan, Dongliang; Hu, Jingchu; Zhang, Yinxin; Li, Henan; Li, Hua; Li, Ning; Wang, Junyi; Wang, Chanchan; Wang, Renyi; Guo, Tao; Cai, Yanjie; Liu, Chengzhang; Xiang, Haitao; Shi, Qiuxiang; Huang, Ping; Chen, Qingchun; Li, Yingrui; Wang, Jun; Zhao, Zhihai; Wang, Jian			Genome sequence of foxtail millet (Setaria italica) provides insights into grass evolution and biofuel potential	NATURE BIOTECHNOLOGY			English	Article							MOLECULAR EVOLUTION; CARBONIC-ANHYDRASE; GENE; IDENTIFICATION; ALIGNMENT; CONSTRUCTION; RESISTANCE; REVEALS; PROGRAM; MAPS	Foxtail millet (Setaria italica), a member of the Poaceae grass family, is an important food and fodder crop in arid regions and has potential for use as a C-4 biofuel. It is a model system for other biofuel grasses, including switchgrass and pearl millet. We produced a draft genome (similar to 423 Mb) anchored onto nine chromosomes and annotated 38,801 genes. Key chromosome reshuffling events were detected through collinearity identification between foxtail millet, rice and sorghum including two reshuffling events fusing rice chromosomes 7 and 9, 3 and 10 to foxtail millet chromosomes 2 and 9, respectively, that occurred after the divergence of foxtail millet and rice, and a single reshuffling event fusing rice chromosome 5 and 12 to foxtail millet chromosome 3 that occurred after the divergence of millet and sorghum. Rearrangements in the C-4 photosynthesis pathway were also identified.	[Zhang, Gengyun; Quan, Zhiwu; Xu, Xun; Xia, Qiuju; Peng, Xiaohua; Zhang, Yinxin; Li, Henan; Li, Hua; Li, Ning; Wang, Chanchan; Wang, Renyi; Guo, Tao; Cai, Yanjie; Liu, Chengzhang; Xiang, Haitao; Shi, Qiuxiang; Huang, Ping; Chen, Qingchun; Wang, Jian] Chinese Minist Agr, BGI Shenzhen, Key Lab Genom, Shenzhen, Peoples R China; [Xu, Xun] BGI Amer, Cambridge, MA USA; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Zhao, Zhihai] Zhangjiakou Acad Agr Sci, Inst Millet, Zhangjiakou, Peoples R China	Beijing Genomics Institute (BGI); Ministry of Agriculture & Rural Affairs; University of Copenhagen	Wang, J (corresponding author), Chinese Minist Agr, BGI Shenzhen, Key Lab Genom, Shenzhen, Peoples R China.	wangj@genomics.org.cn; zhaozhihai58@163.com; wangjian@genomics.org.cn	wang, junyi/GYA-3213-2022; XIE, MIN/P-8062-2019; Li, Yingrui/K-1064-2015; Wang, Jun/A-7261-2013; Xu, Xun/AAI-6763-2020; Ditadi, Andrea/K-3461-2016; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	XIE, MIN/0000-0002-5652-5039; Xu, Xun/0000-0002-5338-5173; Ditadi, Andrea/0000-0003-3283-8943; Liu, Xin/0000-0003-3256-2940; Wang, Jun/0000-0002-2113-5874; Hu, Jingchu/0000-0001-6144-7226; Bian, Chao/0000-0001-9904-721X; Wang, Jun/0000-0002-8540-8931	Shenzhen-National Science and Technology Plan Projects [ZYC200903240077A]; Basic Research Program of Shenzhen [JC2010526019]; Shenzhen City [CXB200903110066A]; Shenzhen Hundred-million Project; Ministry of Agriculture [2010-Z31]; National Science and Technology Ministry [2007CB815703, 2007CB815705]; National Natural Science Funds for Distinguished Young Scholar [30725008]	Shenzhen-National Science and Technology Plan Projects; Basic Research Program of Shenzhen; Shenzhen City; Shenzhen Hundred-million Project; Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); National Science and Technology Ministry; National Natural Science Funds for Distinguished Young Scholar(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	We thank L. Goodman for editing the manuscript and H.-M. Lam for providing valuable comments. This work was supported by the following funding to BGI-Shenzhen: Shenzhen-National Science and Technology Plan Projects (ZYC200903240077A), Basic Research Program of Shenzhen (JC2010526019), Key Laboratory Project Supported by Shenzhen City (CXB200903110066A), Shenzhen Hundred-million Project, Chinese 948 Program supported by the Ministry of Agriculture (2010-Z31), National Science and Technology Ministry Project -973 program (2007CB815703), National Science and Technology Ministry Project 973 program (2007CB815705), National Natural Science Funds for Distinguished Young Scholar (30725008).	Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Delye C, 2002, PLANTA, V214, P421, DOI 10.1007/s004250100633; Devos KM, 1998, THEOR APPL GENET, V96, P63, DOI 10.1007/s001220050709; Devos KM, 2000, THEOR APPL GENET, V100, P190, DOI 10.1007/s001220050026; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Fukunaga K, 2002, MOL GENET GENOMICS, V268, P214, DOI 10.1007/s00438-002-0728-8; Fukunaga K, 2002, GENET RESOUR CROP EV, V49, P95, DOI 10.1023/A:1013852007770; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jia XP, 2007, GENET RESOUR CROP EV, V54, P233, DOI 10.1007/s10722-006-9139-8; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langdale JA, 2011, PLANT CELL, V23, P3879, DOI 10.1105/tpc.111.092098; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lashbrook CC, 1998, PLANT J, V15, P243, DOI 10.1046/j.1365-313X.1998.00202.x; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ludwig M, 2012, PLANT CELL ENVIRON, V35, P22, DOI 10.1111/j.1365-3040.2011.02364.x; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McCarthy EM, 2003, BIOINFORMATICS, V19, P362, DOI 10.1093/bioinformatics/btf878; Monson RK, 2003, INT J PLANT SCI, V164, pS43, DOI 10.1086/368400; Murat F, 2010, GENOME RES, V20, P1545, DOI 10.1101/gr.109744.110; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Peng J, 2007, CROP SCI, V47, P2418, DOI 10.2135/cropsci2007.03.0137; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; PURUGGANAN MD, 1995, GENETICS, V140, P345; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Sage RF, 1999, C4 PLANT BIOL; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schontz D, 1999, PLANT BREEDING, V118, P190, DOI 10.1046/j.1439-0523.1999.118002190.x; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Tarailo-Graovac M., 2009, CURR PROT BIOINFORM, V25, P4101; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Tiwari A, 2005, PHOTOSYNTHETICA, V43, P1, DOI 10.1007/s11099-005-1011-0; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang CF, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-90; Wang TY, 1997, EUPHYTICA, V94, P69, DOI 10.1023/A:1002989725995; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang ZM, 1998, THEOR APPL GENET, V96, P31, DOI 10.1007/s001220050705; Westhoff P, 2010, PLANT PHYSIOL, V154, P598, DOI 10.1104/pp.110.161729; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Zhang JP, 2007, GENOMICS, V90, P121, DOI 10.1016/j.ygeno.2007.03.016; Zhang J, 2011, J GENET GENOMICS, V38, P95, DOI 10.1016/j.jgg.2011.02.003; Zhou SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000711; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505	78	424	514	5	132	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2012	30	6					549	+		10.1038/nbt.2195	http://dx.doi.org/10.1038/nbt.2195			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	957JV	22580950	hybrid			2022-12-25	WOS:000305158600025
J	Cummings, DE				Cummings, David E.			Metabolic surgery for type 2 diabetes	NATURE MEDICINE			English	Editorial Material							BARIATRIC SURGERY; LIFE-STYLE; MECHANISMS; MORTALITY; RISK	Clinicians note that bariatric operations can dramatically resolve type 2 diabetes, often before and out of proportion to postoperative weight loss. Now two randomized controlled trials formally show superior results from surgical compared with medical diabetes care, including among only mildly obese patients. The concept of 'metabolic surgery' to treat diabetes has taken a big step forward.	[Cummings, David E.] Univ Washington, Seattle, WA 98195 USA; [Cummings, David E.] VA Puget Sound Hlth Care Syst, Diabet & Obes Ctr Excellence, Seattle, WA USA	University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Cummings, DE (corresponding author), Univ Washington, Seattle, WA 98195 USA.	davidec@u.washington.edu						Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; GRUNDY SM, 1991, ANN INTERN MED, V115, P956; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Mingrone G, 2012, NEW ENGL J MED, DOI [10.1056/NEJMoa1200111, DOI 10.1056/NEJMOA1200111]; Rejeski WJ, 2012, NEW ENGL J MED, V366, P1209, DOI 10.1056/NEJMoa1110294; Rubino F, 2010, ANN SURG, V251, P399, DOI 10.1097/SLA.0b013e3181be34e7; Rubino F, 2010, ANNU REV MED, V61, P393, DOI 10.1146/annurev.med.051308.105148; Schauer PR, 2012, NEW ENGL J MED, DOI [10.1056/NEJMoa1200225, DOI 10.1056/NEJMOA1200225]; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914; Thaler JP, 2009, ENDOCRINOLOGY, V150, P2518, DOI 10.1210/en.2009-0367; Zimmet P, 2011, LANCET, V378, P108, DOI 10.1016/S0140-6736(11)61027-1	16	24	26	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					656	658		10.1038/nm.2773	http://dx.doi.org/10.1038/nm.2773			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22561818				2022-12-25	WOS:000303763500026
J	Liu, CX; Yin, QQ; Zhou, HC; Wu, YL; Pu, JX; Xia, L; Liu, W; Huang, X; Jiang, T; Wu, MX; He, LC; Zhao, YX; Wang, XL; Xiao, WL; Chen, HZ; Zhao, Q; Zhou, AW; Wang, LS; Sun, HD; Chen, GQ				Liu, Chuan-Xu; Yin, Qian-Qian; Zhou, Hu-Chen; Wu, Ying-Li; Pu, Jian-Xin; Xia, Li; Liu, Wei; Huang, Xin; Jiang, Tao; Wu, Ming-Xuan; He, Li-Cai; Zhao, Ya-Xue; Wang, Xiao-Lin; Xiao, Wei-Lie; Chen, Hong-Zhuan; Zhao, Qian; Zhou, Ai-Wu; Wang, Li-Shun; Sun, Han-Dong; Chen, Guo-Qiang			Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells	NATURE CHEMICAL BIOLOGY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ACTIVATED PROTEIN-KINASE; RETINOIC ACID; SIGNAL-TRANSDUCTION; ALPHA ONCOPROTEIN; PMLRAR-ALPHA; C/EBP-BETA; STRESS; H2O2; RAR	Peroxiredoxins (Prxs) are potential therapeutic targets for major diseases such as cancers. However, isotype-specific inhibitors remain to be developed. We report that adenanthin, a diterpenoid isolated from the leaves of Rabdosia adenantha, induces differentiation of acute promyelocytic leukemia (APL) cells. We show that adenanthin directly targets the conserved resolving cysteines of Prx I and Prx II and inhibits their peroxidase activities. Consequently, cellular H2O2 is elevated, leading to the activation of extracellular signal-regulated kinases and increased transcription of CCAAT/enhancer-binding protein beta, which contributes to adenanthin-induced differentiation. Adenanthin induces APL-like cell differentiation, represses tumor growth in vivo and prolongs the survival of mouse APL models that are sensitive and resistant to retinoic acid. Thus, adenanthin can serve as what is to our knowledge the first lead natural compound for the development of Prx I-and Prx II-targeted therapeutic agents, which may represent a promising approach to inducing differentiation of APL cells.	[Liu, Chuan-Xu; Wu, Ying-Li; Xia, Li; Liu, Wei; He, Li-Cai; Zhao, Qian; Zhou, Ai-Wu; Wang, Li-Shun; Chen, Guo-Qiang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Univ E Inst Chem Biol,Chinese Minist Edu, Dept Pathophysiol,Key Lab Cell Differentiat Apopt, Shanghai 200030, Peoples R China; [Yin, Qian-Qian; Huang, Xin; Chen, Guo-Qiang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Zhou, Hu-Chen; Wu, Ming-Xuan; Zhao, Ya-Xue] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China; [Pu, Jian-Xin; Xiao, Wei-Lie; Sun, Han-Dong] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources W China, Kunming, Yunnan, Peoples R China; [Jiang, Tao; Wang, Xiao-Lin; Chen, Hong-Zhuan] Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol, Shanghai 200030, Peoples R China; [Chen, Guo-Qiang] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Ren Ji Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, GQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Univ E Inst Chem Biol,Chinese Minist Edu, Dept Pathophysiol,Key Lab Cell Differentiat Apopt, Shanghai 200030, Peoples R China.	chengq@shsmu.edu.cn	Wu, Mingxuan/G-8519-2017	chen, guo qiang/0000-0003-4936-2363; Wang, Li-Shun/0000-0003-3972-683X; Liu, Chuanxu/0000-0002-3125-9547	National Basic Research Program of China [NO2009CB918404]; National Natural Science Foundation of China (NSFC) [90813034, 81070433]; Shanghai Science and Technology Commission [11IC1406800, 11JC1406500]; NSFC joint Foundation of Yunnan Province [U0832602]; Shanghai Committee of Education	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); NSFC joint Foundation of Yunnan Province; Shanghai Committee of Education	We thank S. C. Kogan at the University of California-San Francisco for providing us with leukemic blasts from transgenic mice and F. Besancon at Hopital St. Louis-Paris for providing NB4-MAD and NB4-GFP cells. We are also grateful to L. Zheng of the Department of Pathology in Shanghai Jiao Tong University School of Medicine for her technological assistance in pathologic examinations. This work was supported, in part, by grants from the National Basic Research Program of China (NO2009CB918404 to G.-Q.C.), the National Natural Science Foundation of China (NSFC; 90813034 to G.-Q.C. and 81070433 to Y.-L.W.), key projects for basic research of Shanghai Science and Technology Commission (11IC1406800 to G.-Q.C. and 11JC1406500 to Y.-L.W.), the NSFC joint Foundation of Yunnan Province (U0832602 to H.-D.S.) and grants from the Shanghai Committee of Education (to G.-Q.C). C.-X. L. and Q.-Q.Y. are PhD candidates at Shanghai Jiao Tong University and the Shanghai Institutes for Biological Sciences of the Chinese Academy of Sciences, respectively, and this work was submitted in partial fulfillment of the requirement for their PhD degrees.	Abdel-Wahab O, 2010, J EXP MED, V207, P677, DOI 10.1084/jem.20100523; Ahn K, 2009, CHEM BIOL, V16, P411, DOI 10.1016/j.chembiol.2009.02.013; Brown D, 1997, P NATL ACAD SCI USA, V94, P2551, DOI 10.1073/pnas.94.6.2551; Callens C, 2010, J EXP MED, V207, P731, DOI 10.1084/jem.20091488; Cassinat B, 2011, MOL CELL BIOL, V31, P1409, DOI 10.1128/MCB.00756-10; de las Heras B., 2009, Inflammation & Allergy Drug Targets, V8, P28; de Lera AR, 2007, NAT REV DRUG DISCOV, V6, P811, DOI 10.1038/nrd2398; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; Duprez E, 2004, CELL CYCLE, V3, P389; Duprez E, 2003, EMBO J, V22, P5806, DOI 10.1093/emboj/cdg556; Gierse JK, 1999, BIOCHEM J, V339, P607, DOI 10.1042/0264-6021:3390607; Groll M, 2008, NATURE, V452, P755, DOI 10.1038/nature06782; Guerzoni C, 2006, CELL CYCLE, V5, P1254, DOI 10.4161/cc.5.12.2808; Guibal FC, 2009, BLOOD, V114, P5415, DOI 10.1182/blood-2008-10-182071; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Hanson JR, 2009, NAT PROD REP, V26, P1156, DOI 10.1039/b807311m; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Hu XT, 2000, CELL GROWTH DIFFER, V11, P191; Ji Y, 2004, CANCER RES, V64, P370, DOI 10.1158/0008-5472.CAN-03-3029; Jiang B, 2002, J NAT PROD, V65, P1111, DOI 10.1021/np020084k; Kang SW, 2005, TRENDS MOL MED, V11, P571, DOI 10.1016/j.molmed.2005.10.006; Kim JH, 2008, CLIN CANCER RES, V14, P2326, DOI 10.1158/1078-0432.CCR-07-4457; Kogan SC, 2000, BLOOD, V95, P1541, DOI 10.1182/blood.V95.5.1541.005k28_1541_1550; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Lomenick B, 2011, ACS CHEM BIOL, V6, P34, DOI 10.1021/cb100294v; Lopez-Pedrera C, 2006, PROTEOMICS, V6, pS293, DOI 10.1002/pmic.200500384; Martens JHA, 2010, CANCER CELL, V17, P173, DOI 10.1016/j.ccr.2009.12.042; Miranda MB, 2007, LEUKEMIA, V21, P1363, DOI 10.1038/sj.leu.2404690; Nagamura-Inoue T, 2001, Int Rev Immunol, V20, P83, DOI 10.3109/08830180109056724; Nasr R, 2008, NAT MED, V14, P1333, DOI 10.1038/nm.1891; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Raelson JV, 1996, BLOOD, V88, P2826, DOI 10.1182/blood.V88.8.2826.bloodjournal8882826; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rhee SG, 2011, ANTIOXID REDOX SIGN, V15, P781, DOI 10.1089/ars.2010.3393; Roberts SC, 2007, NAT CHEM BIOL, V3, P387, DOI 10.1038/nchembio.2007.8; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Tirapelli Carlos R, 2008, Recent Pat Cardiovasc Drug Discov, V3, P1; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424	46	144	171	16	212	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2012	8	5					486	493		10.1038/NCHEMBIO.935	http://dx.doi.org/10.1038/NCHEMBIO.935			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	928DY	22484541				2022-12-25	WOS:000302962500016
J	Zhang, X; Horibata, K; Saijo, M; Ishigami, C; Ukai, A; Kanno, S; Tahara, H; Neilan, EG; Honma, M; Nohmi, T; Yasui, A; Tanaka, K				Zhang, Xue; Horibata, Katsuyoshi; Saijo, Masafumi; Ishigami, Chie; Ukai, Akiko; Kanno, Shin-ichiro; Tahara, Hidetoshi; Neilan, Edward G.; Honma, Masamitsu; Nohmi, Takehiko; Yasui, Akira; Tanaka, Kiyoji			Mutations in UVSSA cause UV-sensitive syndrome and destabilize ERCC6 in transcription-coupled DNA repair	NATURE GENETICS			English	Article							RNA-POLYMERASE-II; SYNDROME-B-PROTEIN; COCKAYNE-SYNDROME; XERODERMA-PIGMENTOSUM; NUCLEAR-MATRIX; SYNDROME CELLS; DAMAGE; CSA; TRANSLOCATION; DEGRADATION	UV-sensitive syndrome ((UVS)-S-S) is an autosomal recessive disorder characterized by photosensitivity and deficiency in transcription-coupled repair (TCR), a subpathway of nucleotide-excision repair that rapidly removes transcription-blocking DNA damage(1). Cockayne syndrome is a related disorder with defective TCR and consists of two complementation groups, Cockayne syndrome (CS)-A and CS-B, which are caused by mutations in ERCC8 (CSA) and ERCC6 (CSB), respectively(2). (UVS)-S-S comprises three groups, (UVS)-S-S/CS-A, (UVS)-S-S/CS-B and (UVS)-S-S-A, caused by mutations in ERCC8, ERCC6 and an unidentified gene, respectively(3-6). Here, we report the cloning of the gene mutated in (UVS)-S-S-A by microcell-mediated chromosome transfer. The predicted human gene UVSSA (formerly known as KIAA1530)(7) corrects defective TCR in (UVS)-S-S-A cells. We identify three nonsense and frameshift UVSSA mutations in individuals with (UVS)-S-S-A, indicating that UVSSA is the causative gene for this syndrome. The UVSSA protein forms a complex with USP7 (ref. 8), stabilizes ERCC6 and restores the hypophosphorylated form of RNA polymerase II after UV irradiation.	[Zhang, Xue; Horibata, Katsuyoshi; Saijo, Masafumi; Ishigami, Chie; Tanaka, Kiyoji] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [Horibata, Katsuyoshi; Ukai, Akiko; Honma, Masamitsu; Nohmi, Takehiko] Natl Inst Hlth Sci, Div Genet & Mutagenesis, Tokyo, Japan; [Kanno, Shin-ichiro; Yasui, Akira] Tohoku Univ, Div Dynam Proteome, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Tahara, Hidetoshi] Hiroshima Univ, Dept Cell & Mol Biol, Grad Sch Biomed Sci, Hiroshima, Japan; [Neilan, Edward G.] Childrens Hosp, Div Genet, Ctr Life Sci Boston, Boston, MA 02115 USA	Osaka University; National Institute of Health Sciences - Japan; Tohoku University; Hiroshima University; Harvard University; Boston Children's Hospital	Tanaka, K (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan.	ktanaka@fbs.osaka-u.ac.jp	Neilan, Brett A/I-5767-2012; Kanno, Shin-ichiro/AAE-4549-2019	Neilan, Brett A/0000-0001-6113-772X; 	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Health and Labor Sciences Research Grants for Research on Intractable Diseases; Grants-in-Aid for Scientific Research [22131009] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labor Sciences Research Grants for Research on Intractable Diseases; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Iwamoto and I. Kuraoka for their help in DNA sequencing and microcell-mediated chromosome transfer and M. Hoshi for her help in establishing Flp-In cells and performing immunoprecipitation. We also thank M. Yamaizumi (Kumamoto University Medical School) and N.G. Jaspers (Erasmus Medical Centre) for providing Kps3 cells and TA-24 cells, respectively. We thank G. Spivak for critical reading of the manuscript. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and by Health and Labor Sciences Research Grants for Research on Intractable Diseases (to K. T.). Part of this work was carried out under the Cooperative Research Project Program of the Institute of Development, Aging and Cancer (IDAC) at Tohoku University.	Abe K, 2004, GENOME RES, V14, P2439, DOI 10.1101/gr.2899304; Bradsher J, 2002, MOL CELL, V10, P819, DOI 10.1016/S1097-2765(02)00678-0; D'Errico M, 2007, ONCOGENE, V26, P4336, DOI 10.1038/sj.onc.1210232; Dianov GL, 1997, NUCLEIC ACIDS RES, V25, P3636, DOI 10.1093/nar/25.18.3636; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Groisman R, 2006, GENE DEV, V20, P1429, DOI 10.1101/gad.378206; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Horibata K, 2004, P NATL ACAD SCI USA, V101, P15410, DOI 10.1073/pnas.0404587101; Horibata K, 2011, GENES CELLS, V16, P101, DOI 10.1111/j.1365-2443.2010.01467.x; ITOH T, 1994, MUTAT RES, V314, P233, DOI 10.1016/0921-8777(94)90068-X; Itoh T, 2000, J INVEST DERMATOL, V114, P1022, DOI 10.1046/j.1523-1747.2000.00952.x; Kamiuchi S, 2002, P NATL ACAD SCI USA, V99, P201, DOI 10.1073/pnas.012473199; Khoronenkova SV, 2011, NUCLEIC ACIDS RES, V39, P2604, DOI 10.1093/nar/gkq1210; Lebedev A, 2008, J MOL BIOL, V382, P266, DOI 10.1016/j.jmb.2008.07.018; Meinhart A, 2004, NATURE, V430, P223, DOI 10.1038/nature02679; Nagase T, 2000, DNA RES, V7, P143, DOI 10.1093/dnares/7.2.143; Nardo T, 2009, P NATL ACAD SCI USA, V106, P6209, DOI 10.1073/pnas.0902113106; Nicholson B, 2011, CELL BIOCHEM BIOPHYS, V60, P61, DOI 10.1007/s12013-011-9185-5; Proietti-De-Santis L, 2006, EMBO J, V25, P1915, DOI 10.1038/sj.emboj.7601071; Rockx DAP, 2000, P NATL ACAD SCI USA, V97, P10503, DOI 10.1073/pnas.180169797; Saijo M, 2007, MOL CELL BIOL, V27, P2538, DOI 10.1128/MCB.01288-06; SANFORD JA, 1987, SOMAT CELL MOLEC GEN, V13, P279, DOI 10.1007/BF01535210; Schwertman P, 2012, NAT GENET, V44, P598, DOI 10.1038/ng.2230; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Spivak G, 2006, DNA REPAIR, V5, P13, DOI 10.1016/j.dnarep.2005.06.017; Spivak G, 2005, MUTAT RES-FUND MOL M, V577, P162, DOI 10.1016/j.mrfmmm.2005.03.017; Spivak G, 2002, DNA REPAIR, V1, P629, DOI 10.1016/S1568-7864(02)00056-3; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Takagi Y, 2005, MOL CELL, V18, P237, DOI 10.1016/j.molcel.2005.03.007; Wei LZ, 2011, CANCER SCI, V102, P1840, DOI 10.1111/j.1349-7006.2011.02037.x	32	118	124	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2012	44	5					593	+		10.1038/ng.2228	http://dx.doi.org/10.1038/ng.2228			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	934BW	22466612				2022-12-25	WOS:000303416300022
J	Wijnker, E; van Dun, K; de Snoo, CB; Lelivelt, CLC; Keurentjes, JJB; Naharudin, NS; Ravi, M; Chan, SWL; de Jong, H; Dirks, R				Wijnker, Erik; van Dun, Kees; de Snoo, C. Bastiaan; Lelivelt, Cilia L. C.; Keurentjes, Joost J. B.; Naharudin, Nazatul Shima; Ravi, Maruthachalam; Chan, Simon W. L.; de Jong, Hans; Dirks, Rob			Reverse breeding in Arabidopsis thaliana generates homozygous parental lines from a heterozygous plant	NATURE GENETICS			English	Article							GENOME; DNA; CONSTRUCTION; MEIOSIS; GENES; RFLP; MAP	Traditionally, hybrid seeds are produced by crossing selected inbred lines. Here we provide a proof of concept for reverse breeding, a new approach that simplifies meiosis such that homozygous parental lines can be generated from a vigorous hybrid individual. We silenced DMC1, which encodes the meiotic recombination protein DISRUPTED MEIOTIC cDNA1, in hybrids of A. thaliana, so that non-recombined parental chromosomes segregate during meiosis. We then converted the resulting gametes into adult haploid plants, and subsequently into homozygous diploids, so that each contained half the genome of the original hybrid. From 36 homozygous lines, we selected 3 (out of 6) complementing parental pairs that allowed us to recreate the original hybrid by intercrossing. In addition, this approach resulted in a complete set of chromosome-substitution lines. Our method allows the selection of a single choice offspring from a segregating population and preservation of its heterozygous genotype by generating homozygous founder lines.	[Wijnker, Erik; Keurentjes, Joost J. B.; de Jong, Hans] Wageningen Univ, Genet Lab, Wageningen, Netherlands; [van Dun, Kees; de Snoo, C. Bastiaan; Lelivelt, Cilia L. C.; Dirks, Rob] Rijk Zwaan R&D Fijnaart, Fijnaart, Netherlands; [Keurentjes, Joost J. B.] Wageningen Univ, Lab Plant Physiol, Wageningen, Netherlands; [Naharudin, Nazatul Shima] Univ Putra Malaysia, Dept Crop Sci, Fac Agr, Serdang, Malaysia; [Ravi, Maruthachalam; Chan, Simon W. L.] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Chan, Simon W. L.] Univ Calif Davis, Howard Hughes Med Inst, Davis, CA 95616 USA	Wageningen University & Research; Wageningen University & Research; Universiti Putra Malaysia; University of California System; University of California Davis; Howard Hughes Medical Institute; University of California System; University of California Davis	Wijnker, E (corresponding author), Wageningen Univ, Genet Lab, Wageningen, Netherlands.	erik.wijnker@wur.nl	Wijnker, Erik/H-4816-2011; Naharudin, Nazatul Shima/I-4909-2016	Naharudin, Nazatul Shima/0000-0003-2524-9382; Keurentjes, Joost/0000-0001-8918-0711; Maruthachalam, Ravi/0000-0003-0036-3330				Alonso-Blanco C, 1998, PLANT J, V14, P259, DOI 10.1046/j.1365-313X.1998.00115.x; Bikard D, 2009, SCIENCE, V323, P623, DOI 10.1126/science.1165917; Chen ZJ, 2010, TRENDS PLANT SCI, V15, P57, DOI 10.1016/j.tplants.2009.12.003; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Couteau F, 1999, PLANT CELL, V11, P1623, DOI 10.1105/tpc.11.9.1623; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dirks R, 2009, PLANT BIOTECHNOL J, V7, P837, DOI 10.1111/j.1467-7652.2009.00450.x; Drouaud J, 2007, PLOS GENET, V3, P1096, DOI 10.1371/journal.pgen.0030106; Forster BP, 2007, TRENDS PLANT SCI, V12, P368, DOI 10.1016/j.tplants.2007.06.007; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Hartung F, 2007, PLANT CELL, V19, P3090, DOI 10.1105/tpc.107.054817; HAUGE BM, 1993, PLANT J, V3, P745, DOI 10.1111/j.1365-313X.1993.00745.x; Koumproglou R, 2002, PLANT J, V31, P355, DOI 10.1046/j.1365-313X.2002.01353.x; LISTER C, 1993, PLANT J, V4, P745, DOI 10.1046/j.1365-313X.1993.04040745.x; Ma Hong, 2006, Arabidopsis Book, V4, pe0095, DOI 10.1199/tab.0095; Marimuthu MPA, 2011, SCIENCE, V331, P876, DOI 10.1126/science.1199682; Mercier R, 2008, CYTOGENET GENOME RES, V120, P281, DOI 10.1159/000121077; Nadeau JH, 2000, NAT GENET, V24, P221, DOI 10.1038/73427; Ravi M, 2010, NATURE, V464, P615, DOI 10.1038/nature08842; Ross KJ, 1997, CHROMOSOME RES, V5, P551, DOI 10.1023/A:1018497804129; Ross KJ, 1996, CHROMOSOME RES, V4, P507, DOI 10.1007/BF02261778; Singer T, 2006, PLOS GENET, V2, P1352, DOI 10.1371/journal.pgen.0020144; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Tang XM, 2008, GENETICS, V180, P1319, DOI 10.1534/genetics.108.093211; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Toyota M, 2011, PLANT J, V65, P589, DOI 10.1111/j.1365-313X.2010.04440.x; van Dijk P, 2000, TRENDS PLANT SCI, V5, P81, DOI 10.1016/S1360-1385(99)01545-9; Warthmann N, 2007, BIOINFORMATICS, V23, P2784, DOI 10.1093/bioinformatics/btm428	28	71	80	2	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2012	44	4					467	U156		10.1038/ng.2203	http://dx.doi.org/10.1038/ng.2203			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	916VF	22406643				2022-12-25	WOS:000302130600025
J	O'Leary, T; Heindryckx, B; Lierman, S; van Bruggen, D; Goeman, JJ; Vandewoestyne, M; Deforce, D; Lopes, SMCD; De Sutter, P				O'Leary, Thomas; Heindryckx, Bjorn; Lierman, Sylvie; van Bruggen, David; Goeman, Jelle J.; Vandewoestyne, Mado; Deforce, Dieter; Lopes, Susana M. Chuva de Sousa; De Sutter, Petra			Tracking the progression of the human inner cell mass during embryonic stem cell derivation	NATURE BIOTECHNOLOGY			English	Article							PRIMORDIAL GERM-CELLS; WNT/BETA-CATENIN; FATE DECISIONS; MOUSE EMBRYOS; EPIBLAST; PLURIPOTENCY; EXPRESSION; LINES; STATES; INACTIVATION	The different pluripotent states of mouse embryonic stem cells (ESCs) in vitro have been shown to correspond to stages of mouse embryonic development(1-6). For human cells, little is known about the events that precede the generation of ESCs or whether they correlate with in vivo developmental stages. Here we investigate the cellular and molecular changes that occur during the transition from the human inner cell mass (ICM) to ESCs in vitro. We demonstrate that human ESCs originate from a post-ICM intermediate (PICMI), a transient epiblast-like structure that has undergone X-inactivation in female cells and is both necessary and sufficient for ESC derivation. The PICMI is the result of progressive and defined ICM organization in vitro and has a distinct state of cell signaling. The PICMI can be cryopreserved without compromising ESC derivation capacity. As a closer progenitor of ESCs than the ICM, the PICMI provides insight into the pluripotent state of human stem cells.	[O'Leary, Thomas; Heindryckx, Bjorn; Lierman, Sylvie; De Sutter, Petra] Ghent Univ Hosp, Dept Reprod Med, Ghent, Belgium; [van Bruggen, David; Lopes, Susana M. Chuva de Sousa] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands; [Goeman, Jelle J.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands; [Vandewoestyne, Mado; Deforce, Dieter] Univ Ghent, Fac Pharmaceut Sci, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium	Ghent University; Ghent University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Ghent University	O'Leary, T (corresponding author), Ghent Univ Hosp, Dept Reprod Med, Ghent, Belgium.	thomas.oleary@ugent.be	Goeman, Jelle/AAT-1300-2020; Deforce, Dieter LD/J-4725-2013	Goeman, Jelle/0000-0003-4283-0259; Deforce, Dieter LD/0000-0002-0635-661X; van Bruggen, David/0000-0001-6794-7731	Flemish Foundation for Scientific Research (FWO-Vlaanderen) [FWO-3G062910]; Netherlands Organisation for Scientific Research (NWO) [Veni 916.76.015]; Interuniversity Attraction Poles (PAI) [P6/20]; Ferring Company (Aalst, Belgium)	Flemish Foundation for Scientific Research (FWO-Vlaanderen)(FWO); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Interuniversity Attraction Poles (PAI); Ferring Company (Aalst, Belgium)	This research was supported by the Flemish Foundation for Scientific Research (FWO-Vlaanderen, grant FWO-3G062910). S.M.C.d.S.L. was supported by the Netherlands Organisation for Scientific Research (NWO) (Veni 916.76.015) and the Interuniversity Attraction Poles (PAI) (P6/20). P. D. S. is holder of a fundamental clinical research mandate by the Flemish Foundation for Scientific Research (FWO-Vlaanderen). We would like to thank Ferring Company (Aalst, Belgium) for financial support of this study. We thank C. Mummery for discussions and B. Roelen for comments on the manuscript; A. Egorova, C. Visseren and E. Mello-Aho for technical help with the qRT-PCR; A. Bernardo for technical help with the confocal; M. Van der Jeught and G. Duggal for help with culture maintenance; and the medical illustrator of Anatomy/LUMC, S. Blankevoort, for preparing Figure 3h.	Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Lopes SMCD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040030; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; HOLM S, 1979, SCAND J STAT, V6, P65; Hough SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007708; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Krenke BE, 2002, J FORENSIC SCI, V47, P773; Kuijk EW, 2011, HUM REPROD UPDATE, V17, P254, DOI 10.1093/humupd/dmq035; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Lopes SMCD, 2004, GENE DEV, V18, P1838, DOI 10.1101/gad.294004; Lopes SMCD, 2010, DIFFERENTIATION, V79, P131, DOI 10.1016/j.diff.2009.11.003; Lopes SMCDS, 2010, HISTOL HISTOPATHOL, V25, P267, DOI 10.14670/HH-25.267; Mukaida T, 2003, HUM REPROD, V18, P384, DOI 10.1093/humrep/deg047; Najm FJ, 2011, CELL STEM CELL, V8, P318, DOI 10.1016/j.stem.2011.01.016; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; O'Leary T, 2011, STEM CELLS DEV, V20, P785, DOI 10.1089/scd.2010.0338; Pelton TA, 2002, J CELL SCI, V115, P329; Pera RAR, 2009, DIFFERENTIATION, V78, P18, DOI 10.1016/j.diff.2009.03.004; Rathjen J, 1999, J CELL SCI, V112, P601; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; Stephenson EL, 2007, REGEN MED, V2, P349, DOI 10.2217/17460751.2.4.349; Strom S, 2007, HUM REPROD, V22, P3051, DOI 10.1093/humrep/dem335; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tanaka SS, 2002, MECH DEVELOP, V119, pS261, DOI 10.1016/S0925-4773(03)00126-6; Tang FC, 2011, NAT METHODS, V8, pS6, DOI [10.1038/NMETH.1557, 10.1038/nmeth.1557]; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Vandewoestyne M, 2011, MITOCHONDRION, V11, P626, DOI 10.1016/j.mito.2011.03.123	41	97	97	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2012	30	3					278	+		10.1038/nbt.2135	http://dx.doi.org/10.1038/nbt.2135			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	905VI	22371082				2022-12-25	WOS:000301303800025
J	Patwardhan, RP; Hiatt, JB; Witten, DM; Kim, MJ; Smith, RP; May, D; Lee, C; Andrie, JM; Lee, SI; Cooper, GM; Ahituv, N; Pennacchio, LA; Shendure, J				Patwardhan, Rupali P.; Hiatt, Joseph B.; Witten, Daniela M.; Kim, Mee J.; Smith, Robin P.; May, Dalit; Lee, Choli; Andrie, Jennifer M.; Lee, Su-In; Cooper, Gregory M.; Ahituv, Nadav; Pennacchio, Len A.; Shendure, Jay			Massively parallel functional dissection of mammalian enhancers in vivo	NATURE BIOTECHNOLOGY			English	Article							ALDOLASE-B GENE; EXPRESSION; IDENTIFICATION; CONSTRAINT; DYNAMICS	The functional consequences of genetic variation in mammalian regulatory elements are poorly understood. We report the in vivo dissection of three mammalian enhancers at single-nucleotide resolution through a massively parallel reporter assay. For each enhancer, we synthesized a library of >100,000 mutant haplotypes with 2-3% divergence from the wild-type sequence. Each haplotype was linked to a unique sequence tag embedded within a transcriptional cassette. We introduced each enhancer library into mouse liver and measured the relative activities of individual haplotypes en masse by sequencing the transcribed tags. Linear regression analysis yielded highly reproducible estimates of the effect of every possible single-nucleotide change on enhancer activity. The functional consequence of most mutations was modest, with similar to 22% affecting activity by >1.2-fold and similar to 3% by >2-fold. Several, but not all, positions with higher effects showed evidence for purifying selection, or co-localized with known liver-associated transcription factor binding sites, demonstrating the value of empirical high-resolution functional analysis.	[Patwardhan, Rupali P.; Hiatt, Joseph B.; Lee, Choli; Andrie, Jennifer M.; Lee, Su-In; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Witten, Daniela M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Kim, Mee J.; Smith, Robin P.; Ahituv, Nadav] Univ Calif San Francisco, Inst Human Genet, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [May, Dalit; Pennacchio, Len A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Lee, Su-In] Univ Washington, Dept Comp Sci, Seattle, WA 98195 USA; [Cooper, Gregory M.] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Pennacchio, Len A.] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Washington; University of Washington Seattle; HudsonAlpha Institute for Biotechnology; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	nadav.ahituv@ucsf.edu; lapennacchio@lbl.gov; shendure@uw.edu	Shendure, Jay/AAU-3684-2021	Ahituv, Nadav/0000-0002-7434-8144; Shendure, Jay/0000-0002-1516-1865; Pennacchio, Len/0000-0002-8748-3732	National Human Genome Research Institute [HG003988]; US National Institutes of Health (NIH) [DP5OD009145]; National Institute of General Medical Sciences (NIGMS) [GM61390]; National Institute of Child Health and Human Development (NICHD) [R01HD059862]; University of California, San Francisco Liver Center [P30 DK026743]; National Institute on Aging [AG039173]; Achievement Rewards for College Scientists Foundation; NIH [T32 GM007175]; Amgen Research Excellence in Bioengineering and Therapeutic Sciences Fellowship; CIHR; Department of Energy, University of California [DE-AC02-05CH11231]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059862] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061390, U19GM061390, T32GM007175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG039173] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009145] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of California, San Francisco Liver Center(University of California System); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Achievement Rewards for College Scientists Foundation(General Electric); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amgen Research Excellence in Bioengineering and Therapeutic Sciences Fellowship(Amgen); CIHR(Canadian Institutes of Health Research (CIHR)); Department of Energy, University of California(United States Department of Energy (DOE)University of California System); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank R. Qiu and J. Kitzman for advice on experimental strategies, and B. Cohen and D. Pe'er for helpful discussions. This work was supported in part by grants HG003988 from the National Human Genome Research Institute (L. A. P.), US National Institutes of Health (NIH) grant DP5OD009145 (D. M. W.), National Institute of General Medical Sciences (NIGMS) award number GM61390 (N.A.), National Institute of Child Health and Human Development (NICHD) grant number R01HD059862 (N.A.), the Pilot/Feasibility grant from the University of California, San Francisco Liver Center (P30 DK026743) (N.A.), AG039173 from the National Institute on Aging (J. B. H.) and a fellowship from the Achievement Rewards for College Scientists Foundation (J. B. H.). M. J. K. was supported in part by NIH Training grant T32 GM007175 and the Amgen Research Excellence in Bioengineering and Therapeutic Sciences Fellowship. R. P. S. is supported by a CIHR fellowship in the area of hepatology. Parts of the research were conducted at the E.O. Lawrence Berkeley National Laboratory and performed under Department of Energy Contract DE-AC02-05CH11231, University of California. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH, NICHD, NHGRI or the NIGMS.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; BOTSTEIN D, 1985, SCIENCE, V229, P1193, DOI 10.1126/science.2994214; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; DANG Q, 1995, J BIOL CHEM, V270, P22577, DOI 10.1074/jbc.270.38.22577; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; GREGORI C, 1991, BIOCHEM BIOPH RES CO, V176, P722, DOI 10.1016/S0006-291X(05)80244-X; Gregori C, 2002, J BIOL CHEM, V277, P28618, DOI 10.1074/jbc.M204047200; Hiatt JB, 2010, NAT METHODS, V7, P119, DOI [10.1038/NMETH.1416, 10.1038/nmeth.1416]; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kim MJ, 2011, CLIN PHARMACOL THER, V89, P571, DOI 10.1038/clpt.2010.353; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Noonan JP, 2010, ANNU REV GENOM HUM G, V11, P1, DOI 10.1146/annurev-genom-082509-141651; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Sabourin JC, 1996, J BIOL CHEM, V271, P3469, DOI 10.1074/jbc.271.7.3469; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; VanderMeer JE, 2011, DEV DYNAM, V240, P920, DOI 10.1002/dvdy.22535; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734	25	320	328	3	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2012	30	3					265	+		10.1038/nbt.2136	http://dx.doi.org/10.1038/nbt.2136			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	905VI	22371081	Green Accepted, Green Submitted			2022-12-25	WOS:000301303800023
J	Little, TJ; Allen, JE; Babayan, SA; Matthews, KR; Colegrave, N				Little, Tom J.; Allen, Judith E.; Babayan, Simon A.; Matthews, Keith R.; Colegrave, Nick			Harnessing evolutionary biology to combat infectious disease	NATURE MEDICINE			English	Article							RESISTANCE; DYNAMICS; INFLAMMATION	Pathogens have remarkable abilities to flout therapeutic intervention. This characteristic is driven by evolution, either as a direct response to intervention (for example, the evolution of antibiotic resistance) or through long-term co-evolution that generates host or parasite traits that interact with therapy in undesirable or unpredicted ways. To make progress towards successful control of infectious diseases, the concepts and techniques of evolutionary biology must be deeply integrated with traditional approaches to immunology and pathogen biology. An interdisciplinary approach can inform our strategies to control pathogens or even the treatment of infected patients, positioning us to meet the current and future challenges of controlling infectious diseases.	[Little, Tom J.; Allen, Judith E.; Babayan, Simon A.; Matthews, Keith R.; Colegrave, Nick] Univ Edinburgh, Ctr Immun Infect & Evolut, Sch Biol Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh	Little, TJ (corresponding author), Univ Edinburgh, Ctr Immun Infect & Evolut, Sch Biol Sci, Edinburgh, Midlothian, Scotland.	tom.little@ed.ac.uk	Little, Tom J/B-7890-2009; Allen, Judith E/C-9198-2011; Babayan, Simon/E-1807-2011	Little, Tom J/0000-0002-8945-0416; Allen, Judith E/0000-0002-3829-066X; Babayan, Simon/0000-0002-4949-1117; Matthews FRS FMedSci FRSE, Professor Keith/0000-0003-0309-9184	Wellcome Trust [079235] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Babayan SA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000525; Brown SP, 2008, ECOL LETT, V11, P44, DOI 10.1111/j.1461-0248.2007.01125.x; Bullen JJ, 2006, J MED MICROBIOL, V55, P251, DOI 10.1099/jmm.0.46386-0; Chase-Topping M, 2008, NAT REV MICROBIOL, V6, P904, DOI 10.1038/nrmicro2029; CONRADT U, 1992, PARASITOL RES, V78, P123, DOI 10.1007/BF00931653; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Ferreira A, 2011, CELL, V145, P398, DOI 10.1016/j.cell.2011.03.049; Gandon S, 2001, NATURE, V414, P751, DOI 10.1038/414751a; Gandon S, 2008, VACCINE, V26, pC4, DOI 10.1016/j.vaccine.2008.02.007; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Graham AL, 2005, ANNU REV ECOL EVOL S, V36, P373, DOI 10.1146/annurev.ecolsys.36.102003.152622; Graham AL, 2010, SCIENCE, V330, P662, DOI 10.1126/science.1194878; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Harnett W, 2006, PARASITE IMMUNOL, V28, P535, DOI 10.1111/j.1365-3024.2006.00893.x; Hastie KM, 2011, P NATL ACAD SCI USA, V108, P2396, DOI 10.1073/pnas.1016404108; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Im EJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002041; Kafatos FC, 2004, SCIENCE, V303, P1257, DOI 10.1126/science.303.5662.1257; Koella JC, 2009, ADV PARASIT, V68, P315, DOI 10.1016/S0065-308X(08)00612-X; Leitch ECM, 2009, J VIROL, V83, P2109, DOI 10.1128/JVI.02109-08; Leslie M, 2010, SCIENCE, V327, P1573, DOI 10.1126/science.327.5973.1573; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; MacLean RC, 2010, NAT REV GENET, V11, P405, DOI 10.1038/nrg2778; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Maizels RM, 2005, CURR OPIN IMMUNOL, V17, P656, DOI 10.1016/j.coi.2005.09.001; Matthews L, 2006, P NATL ACAD SCI USA, V103, P547, DOI 10.1073/pnas.0503776103; McCarroll L, 2000, NATURE, V407, P961, DOI 10.1038/35039671; McGeer A, 2003, NAT MED, V9, P390, DOI 10.1038/nm0403-390; Nara PL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000571; Paterson S, 2010, NATURE, V464, P275, DOI 10.1038/nature08798; Pedersen A., 2010, MOL ECOL, V20, P643; Perron GG, 2006, P ROY SOC B-BIOL SCI, V273, P251, DOI 10.1098/rspb.2005.3301; Portugal S, 2011, NAT MED, V17, P732, DOI 10.1038/nm.2368; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Rayner JC, 2011, TRENDS PARASITOL, V27, P222, DOI 10.1016/j.pt.2011.01.006; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Roy BA, 2000, EVOLUTION, V54, P51, DOI 10.1111/j.0014-3820.2000.tb00007.x; Schneider P., 2010, MALARIA J, V9, pP45; Schroeder H, 2009, DEV COMP IMMUNOL, V33, P5, DOI 10.1016/j.dci.2008.07.010; SCOTT ME, 1991, PARASITOLOGY, V103, P429, DOI 10.1017/S0031182000059953; SHARP PM, 1995, PHILOS T R SOC B, V349, P41, DOI 10.1098/rstb.1995.0089; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572	46	23	23	0	35	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					217	220		10.1038/nm.2572	http://dx.doi.org/10.1038/nm.2572			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22310693	Green Accepted			2022-12-25	WOS:000300140300033
J	Nikolaev, SI; Rimoldi, D; Iseli, C; Valsesia, A; Robyr, D; Gehrig, C; Harshman, K; Guipponi, M; Bukach, O; Zoete, V; Michielin, O; Muehlethaler, K; Speiser, D; Beckmann, JS; Xenarios, I; Halazonetis, TD; Jongeneel, CV; Stevenson, BJ; Antonarakis, SE				Nikolaev, Sergey I.; Rimoldi, Donata; Iseli, Christian; Valsesia, Armand; Robyr, Daniel; Gehrig, Corinne; Harshman, Keith; Guipponi, Michel; Bukach, Olesya; Zoete, Vincent; Michielin, Olivier; Muehlethaler, Katja; Speiser, Daniel; Beckmann, Jacques S.; Xenarios, Ioannis; Halazonetis, Thanos D.; Jongeneel, C. Victor; Stevenson, Brian J.; Antonarakis, Stylianos E.			Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma	NATURE GENETICS			English	Article							MALIGNANT-MELANOMA; GERMLINE MUTATIONS; MAPK PATHWAY; HUMAN BREAST; GENE; GENOME; BRAF; METASTASIS; MECHANISMS; BYPASS	We performed exome sequencing to detect somatic mutations in protein-coding regions in seven melanoma cell lines and donor-matched germline cells. All melanoma samples had high numbers of somatic mutations, which showed the hallmark of UV-induced DNA repair. Such a hallmark was absent in tumor sample specific mutations in two metastases derived from the same individual. Two melanomas with non-canonical BRAF mutations harbored gain-of-function MAP2K1 and MAP2K2 (MEK1 and MEK2, respectively) mutations, resulting in constitutive ERK phosphorylation and higher resistance to MEK inhibitors. Screening a larger cohort of individuals with melanoma revealed the presence of recurring somatic MAP2K1 and MAP2K2 mutations, which occurred at an overall frequency of 8%. Furthermore, missense and nonsense somatic mutations were frequently found in three candidate melanoma genes, FAT4, LRP1B and DSC1.	[Nikolaev, Sergey I.; Robyr, Daniel; Gehrig, Corinne; Guipponi, Michel; Antonarakis, Stylianos E.] Univ Geneva, Dept Genet Med & Dev, Geneva, Switzerland; [Rimoldi, Donata; Iseli, Christian; Valsesia, Armand; Michielin, Olivier; Muehlethaler, Katja; Speiser, Daniel; Jongeneel, C. Victor; Stevenson, Brian J.] Univ Lausanne, Ludwig Inst Canc Res, Lausanne, Switzerland; [Iseli, Christian; Zoete, Vincent; Michielin, Olivier; Xenarios, Ioannis; Jongeneel, C. Victor; Stevenson, Brian J.] Swiss Inst Bioinformat, Lausanne, Switzerland; [Valsesia, Armand; Beckmann, Jacques S.] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Harshman, Keith] Ctr Integrat Gen, Lausanne Genom Technol Facil, Lausanne, Switzerland; [Bukach, Olesya] Univ Geneva, Dept Micorbiol & Mol Med, Geneva, Switzerland; [Michielin, Olivier] CHU Vaudois, Multidisciplinary Oncol Ctr, Lausanne, Switzerland; [Beckmann, Jacques S.] CHU Vaudois, Serv Med Genet, Lausanne, Switzerland; [Halazonetis, Thanos D.] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Jongeneel, C. Victor] Univ Illinois, Natl Ctr Supercomp Applicat, Urbana, IL 61801 USA; [Jongeneel, C. Victor] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Antonarakis, Stylianos E.] Inst Genet & Genom Geneva iGE3, Geneva, Switzerland	University of Geneva; Ludwig Institute for Cancer Research; University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nikolaev, SI (corresponding author), Univ Geneva, Dept Genet Med & Dev, Geneva, Switzerland.	serg.nikolaev@gmail.com; donata.rimoldi@unil.ch; Stylianos.Antonarakis@unige.ch	Xenarios, Ioannis/ABD-5045-2021; Nikolaev, Sergey/F-3148-2012; Beckmann, Jacques S/A-9772-2008; Valsesia, Armand/F-1724-2010; Antonarakis, Stylianos E/N-8866-2014; Michielin, Olivier/ABE-7924-2020; Iseli, Christian/AAM-3878-2020; Bukach, Olesya/GYT-9911-2022; Speiser, Daniel E./F-2173-2013	Xenarios, Ioannis/0000-0002-3413-6841; Beckmann, Jacques S/0000-0002-9741-1900; Antonarakis, Stylianos E/0000-0001-8907-5823; Iseli, Christian/0000-0002-2296-2863; Valsesia, Armand/0000-0003-0746-9664; Jongeneel, Cornelis Victor/0000-0002-3922-1906	Ludwig Institute for Cancer Research; Hilton-Ludwig Cancer Metastasis Initiative; Conrad N. Hilton Foundation; Swiss National Science Foundation (SNF) National Centres of Competence in Research (NCCR) Frontiers in Genetics; European Research Council	Ludwig Institute for Cancer Research; Hilton-Ludwig Cancer Metastasis Initiative; Conrad N. Hilton Foundation; Swiss National Science Foundation (SNF) National Centres of Competence in Research (NCCR) Frontiers in Genetics(Swiss National Science Foundation (SNSF)); European Research Council(European Research Council (ERC)European Commission)	We thank E Schutz and P. Bady for statistical discussions, P. Descombes for high-throughput sequencing, D. Martinet for aCGH data and C. Rivolta for valuable comments on the manuscript. We thank A. Simpson and R. Strausberg for their constant support. Part of the computation was performed on the cluster at the Vital-IT computing center. This work was supported by the Ludwig Institute for Cancer Research (CI. and SEA.), the Hilton-Ludwig Cancer Metastasis Initiative, funded by the Conrad N. Hilton Foundation (DR.), the Swiss National Science Foundation (SNF) National Centres of Competence in Research (NCCR) Frontiers in Genetics (SEA.) and the European Research Council (ERC; S.E.A.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; ANDERSEN LB, 1993, NAT GENET, V3, P118, DOI 10.1038/ng0293-118; Bentivegna S, 2008, HUM MUTAT, V29, P441, DOI 10.1002/humu.20672; Bhaskara S, 2010, CANCER CELL, V18, P436, DOI 10.1016/j.ccr.2010.10.022; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Daniotti M, 2004, ONCOGENE, V23, P5968, DOI 10.1038/sj.onc.1207780; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Delaney AM, 2002, MOL CELL BIOL, V22, P7593, DOI 10.1128/MCB.22.21.7593-7602.2002; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Fecher LA, 2008, CURR OPIN ONCOL, V20, P183, DOI 10.1097/CCO.0b013e3282f5271c; Fischmann TO, 2009, BIOCHEMISTRY-US, V48, P2661, DOI 10.1021/bi801898e; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Gripp KW, 2007, AM J MED GENET A, V143A, P1472, DOI 10.1002/ajmg.a.31815; Haass NK, 2005, J INVEST DERM SYMP P, V10, P153, DOI 10.1111/j.1087-0024.2005.200407.x; Jeong YH, 2010, BIOCHEM BIOPH RES CO, V392, P495, DOI 10.1016/j.bbrc.2010.01.049; Li YH, 2001, MOL NEUROBIOL, V23, P53; Liu CX, 2000, CANCER RES, V60, P1961; Mao YP, 2011, DEVELOPMENT, V138, P947, DOI 10.1242/dev.057166; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Nystrom AM, 2008, J MED GENET, V45, P500, DOI 10.1136/jmg.2008.057653; O'Donovan PJ, 2010, CARCINOGENESIS, V31, P961, DOI 10.1093/carcin/bgq069; Oshiro MM, 2005, BREAST CANCER RES, V7, pR669, DOI 10.1186/bcr1273; Pages V, 2009, GENE DEV, V23, P1438, DOI 10.1101/gad.1793409; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Prickett TD, 2009, NAT GENET, V41, P1127, DOI 10.1038/ng.438; Qi C, 2009, INT J CANCER, V124, P793, DOI 10.1002/ijc.23775; Rane SG, 2002, MOL CELL BIOL, V22, P644, DOI 10.1128/MCB.22.2.644-656.2002; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Siegel DH, 2011, BRIT J DERMATOL, V164, P521, DOI 10.1111/j.1365-2133.2010.10122.x; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solit D, 2010, NATURE, V468, P902, DOI 10.1038/468902a; Sonoda I, 2004, CANCER RES, V64, P3741, DOI 10.1158/0008-5472.CAN-04-0172; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; Timmermann B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015661; Valsesia A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018369; Wei XM, 2011, HUM MUTAT, V32, pE2148, DOI 10.1002/humu.21477; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	43	303	312	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2012	44	2					133	139		10.1038/ng.1026	http://dx.doi.org/10.1038/ng.1026			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	22197931				2022-12-25	WOS:000299664400009
J	Koyama, M; Kuns, RD; Olver, SD; Raffelt, NC; Wilson, YA; Don, ALJ; Lineburg, KE; Cheong, M; Robb, RJ; Markey, KA; Varelias, A; Malissen, B; Hammerling, GJ; Clouston, AD; Engwerda, CR; Bhat, P; MacDonald, KPA; Hill, GR				Koyama, Motoko; Kuns, Rachel D.; Olver, Stuart D.; Raffelt, Neil C.; Wilson, Yana A.; Don, Alistair L. J.; Lineburg, Katie E.; Cheong, Melody; Robb, Renee J.; Markey, Kate A.; Varelias, Antiopi; Malissen, Bernard; Haemmerling, Guenter J.; Clouston, Andrew D.; Engwerda, Christian R.; Bhat, Purnima; MacDonald, Kelli P. A.; Hill, Geoffrey R.			Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease	NATURE MEDICINE			English	Article							PLASMACYTOID DENDRITIC CELLS; MEMORY T-CELLS; ALLOANTIGEN; EXPRESSION; PREVENTION; TOLERANCE; DEPLETION; GVHD; APCS	The presentation pathways by which allogeneic peptides induce graft-versus-host disease (GVHD) are unclear. We developed a bone marrow transplant (BMT) system in mice whereby presentation of a processed recipient peptide within major histocompatibility complex (MHC) class II molecules could be spatially and temporally quantified. Whereas donor antigen presenting cells (APCs) could induce lethal acute GVHD via MHC class II, recipient APCs were 100-1,000 times more potent in this regard. After myeloablative irradiation, T cell activation and memory differentiation occurred in lymphoid organs independently of alloantigen. Unexpectedly, professional hematopoietic-derived recipient APCs within lymphoid organs had only a limited capacity to induce GVHD, and dendritic cells were not required. In contrast, nonhematopoietic recipient APCs within target organs induced universal GVHD mortality and promoted marked alloreactive donor T cell expansion within the gastrointestinal tract and inflammatory cytokine generation. These data challenge current paradigms, suggesting that experimental lethal acute GVHD can be induced by nonhematopoietic recipient APCs.	[Koyama, Motoko; Kuns, Rachel D.; Olver, Stuart D.; Raffelt, Neil C.; Wilson, Yana A.; Don, Alistair L. J.; Lineburg, Katie E.; Cheong, Melody; Robb, Renee J.; Markey, Kate A.; Varelias, Antiopi; Engwerda, Christian R.; MacDonald, Kelli P. A.; Hill, Geoffrey R.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Malissen, Bernard] Ctr Immunol Marseille Luminy, Marseille, France; [Haemmerling, Guenter J.] Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany; [Clouston, Andrew D.] Envoi Pathol, Brisbane, Qld, Australia; [Bhat, Purnima] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia; [Hill, Geoffrey R.] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Helmholtz Association; German Cancer Research Center (DKFZ); University of Queensland; Royal Brisbane & Women's Hospital	Hill, GR (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.	geoff.hill@qimr.edu.au	MacDonald, Kelli/AAV-5365-2020; Bhat, Purnima/D-9071-2012; Engwerda, Christian/I-3072-2015; Bhat, Purnima/I-5368-2016; MacDonald, Kelli PA/O-2722-2016; Wilson, Yana/AAM-9544-2021; Clouston, Andrew D/E-7199-2011; Hill, Geoffrey/O-2630-2016; Lineburg, Katie E/L-3268-2018; Robb, Renee/I-6853-2012; Varelias, Antiopi/A-6516-2015; Markey, Kate/A-5385-2016; Malissen, Bernard/AAK-4659-2020	Bhat, Purnima/0000-0002-2980-0584; MacDonald, Kelli PA/0000-0003-3451-4221; Clouston, Andrew D/0000-0002-9601-7952; Hill, Geoffrey/0000-0003-2994-0429; Lineburg, Katie E/0000-0002-5712-2610; Varelias, Antiopi/0000-0002-3437-9659; Engwerda, Christian/0000-0003-2813-4804; Markey, Kate/0000-0002-7064-2362; Wilson, Yana/0000-0002-6878-1806; Malissen, Bernard/0000-0003-1340-9342	Australian National Health and Medical Research Council (NHMRC)	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Supported by research grants from the Australian National Health and Medical Research Council (NHMRC). G.R.H. is an NHMRC Australia Fellow. C.R.E. is an NHMRC Research Fellow. K.P.A.M. is a Cancer Council of Queensland Fellow K.A.M. is an NHMRC Clinical Training Fellow. We thank C. Winterford for expert preparation of histology samples and P. Hall and G. Chojnowski for expert cell sorting. We obtained transgenic and knockout mice as follows: OT-II R. Steptoe, Diamantina Institute; H2<SUP>dlAb1-Ea</SUP>, Australian National University; beta-actin-luciferase<SUP>25</SUP>, R. Negrin, Stanford University; TEa<SUP>14</SUP>, J. Bromberg, Albert Einstein College; cfms.EGFP<SUP>12</SUP>, D. Hume, Institute of Molecular Biology; MHC class II.EGFP, B. Fazekas de St Groth, Garvan Institute.	Anderson BE, 2005, BLOOD, V105, P2227, DOI 10.1182/blood-2004-08-3032; Anderson BE, 2003, J CLIN INVEST, V112, P101, DOI 10.1172/JCI200317601; Anderson BE, 2008, BLOOD, V111, P5242, DOI 10.1182/blood-2007-09-107953; Beers C, 2005, J IMMUNOL, V174, P1205, DOI 10.4049/jimmunol.174.3.1205; Beilhack A, 2005, BLOOD, V106, P1113, DOI 10.1182/blood-2005-02-0509; Beilhack A, 2008, BLOOD, V111, P2919, DOI 10.1182/blood-2007-09-112789; Chen BJ, 2007, BLOOD, V109, P3115, DOI 10.1182/blood-2006-04-016410; Chen BJ, 2004, BLOOD, V103, P1534, DOI 10.1182/blood-2003-08-2987; Duffner UA, 2004, J IMMUNOL, V172, P7393, DOI 10.4049/jimmunol.172.12.7393; Hershberg RM, 1998, J CLIN INVEST, V102, P792, DOI 10.1172/JCI3201; Hershberg RM, 1997, J CLIN INVEST, V100, P204, DOI 10.1172/JCI119514; Hill GR, 1997, BLOOD, V90, P3204, DOI 10.1182/blood.V90.8.3204; Hochweller K, 2008, EUR J IMMUNOL, V38, P2776, DOI 10.1002/eji.200838659; Jones SC, 2003, J CLIN INVEST, V112, P1880, DOI 10.1172/JCI200319427; Juchem KW, 2011, BLOOD, V118, P6209, DOI 10.1182/blood-2011-01-330035; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Koyama M, 2009, BLOOD, V113, P2088, DOI 10.1182/blood-2008-07-168609; KUNDIG TM, 1995, SCIENCE, V268, P1343, DOI 10.1126/science.7761853; Li HM, 2011, BLOOD, V117, P697, DOI 10.1182/blood-2010-07-299073; MacDonald KPA, 2007, BLOOD, V109, P5049, DOI 10.1182/blood-2007-01-067249; MacDonald KPA, 2010, BLOOD, V116, P3955, DOI 10.1182/blood-2010-02-266296; Markey KA, 2009, BLOOD, V113, P5644, DOI 10.1182/blood-2008-12-191833; Matte CC, 2004, NAT MED, V10, P987, DOI 10.1038/nm1089; Matte-Martone C, 2010, BIOL BLOOD MARROW TR, V16, P1222, DOI 10.1016/j.bbmt.2010.03.015; Morris ES, 2009, NAT MED, V15, P436, DOI 10.1038/nm.1948; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Pinchuk IV, 2008, GASTROENTEROLOGY, V135, P1228, DOI 10.1053/j.gastro.2008.07.016; Powell DW, 2011, ANNU REV PHYSIOL, V73, P213, DOI 10.1146/annurev.physiol.70.113006.100646; Rowe V, 2006, BLOOD, V108, P2485, DOI 10.1182/blood-2006-04-016063; Saada JI, 2006, J IMMUNOL, V177, P5968, DOI 10.4049/jimmunol.177.9.5968; Sandner SE, 2005, AM J TRANSPLANT, V5, P31, DOI 10.1111/j.1600-6143.2004.00640.x; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; Teshima T, 2002, NAT MED, V8, P575, DOI 10.1038/nm0602-575; Wang H, 2010, J IMMUNOL, V184, P3401, DOI 10.4049/jimmunol.0901550; Zhang Y, 2002, J CLIN INVEST, V109, P1335, DOI 10.1172/JCI200214989	35	155	156	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					135	142		10.1038/nm.2597	http://dx.doi.org/10.1038/nm.2597			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22127134				2022-12-25	WOS:000299018600039
J	Ortiz-Zapater, E; Pineda, D; Martinez-Bosch, N; Fernandez-Miranda, G; Iglesias, M; Alameda, F; Moreno, M; Eliscovich, C; Eyras, E; Real, FX; Mendez, R; Navarro, P				Ortiz-Zapater, Elena; Pineda, David; Martinez-Bosch, Neus; Fernandez-Miranda, Gonzalo; Iglesias, Mar; Alameda, Francesc; Moreno, Mireia; Eliscovich, Carolina; Eyras, Eduardo; Real, Francisco X.; Mendez, Raul; Navarro, Pilar			Key contribution of CPEB4-mediated translational control to cancer progression	NATURE MEDICINE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; GENE-EXPRESSION; PANCREAS CANCER; CELLULAR SENESCENCE; UROKINASE RECEPTOR; CELLS; MOUSE; CPEB; POLYADENYLATION; GROWTH	Malignant transformation, invasion and angiogenesis rely on the coordinated reprogramming of gene expression in the cells from which the tumor originated. Although deregulated gene expression has been extensively studied at genomic and epigenetic scales, the contribution of the regulation of mRNA-specific translation to this reprogramming is not well understood. Here we show that cytoplasmic polyadenylation element binding protein 4 (CPEB4), an RNA binding protein that mediates meiotic mRNA cytoplasmic polyadenylation and translation, is overexpressed in pancreatic ductal adenocarcinomas and glioblastomas, where it supports tumor growth, vascularization and invasion. We also show that, in pancreatic tumors, the pro-oncogenic functions of CPEB4 originate in the translational activation of mRNAs that are silenced in normal tissue, including the mRNA of tissue plasminogen activator, a key contributor to pancreatic ductal adenocarcinoma malignancy. Taken together, our results document a key role for post-transcriptional gene regulation in tumor development and describe a detailed mechanism for gene expression reprogramming underlying malignant tumor progression.	[Ortiz-Zapater, Elena; Pineda, David; Martinez-Bosch, Neus; Iglesias, Mar; Moreno, Mireia; Real, Francisco X.; Navarro, Pilar] Hosp Mar Res Inst IMIM, Canc Res Programme, Barcelona, Spain; [Ortiz-Zapater, Elena; Real, Francisco X.] Spanish Natl Canc Res Ctr CNIO, Mol Pathol Programme, Madrid, Spain; [Ortiz-Zapater, Elena; Real, Francisco X.] UPF, Dept Expt & Hlth Sci, Barcelona, Spain; [Fernandez-Miranda, Gonzalo; Mendez, Raul] Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Iglesias, Mar; Alameda, Francesc] Univ Autonoma Barcelona, Hosp Mar, Dept Pathol, E-08193 Barcelona, Spain; [Eyras, Eduardo] UPF, Computat Genom Grp, Barcelona, Spain; [Pineda, David; Eliscovich, Carolina; Mendez, Raul] CRG, Barcelona, Spain; [Eyras, Eduardo; Mendez, Raul] ICREA, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Centro Nacional de Investigaciones Oncologicas (CNIO); Pompeu Fabra University; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Mendez, R (corresponding author), CRG, Barcelona, Spain.	raul.mendez@irbbarcelona.es; pnavarro@imim.es	Navarro, Pilar/A-2122-2010; Eyras, Eduardo/ABG-7144-2020; Navarro, Pilar/ABF-2728-2020; Martínez-Bosch, Neus/HHN-5405-2022; Eduardo, Eyras/L-1053-2014; Ortiz-Zapater, Elena/HCI-3340-2022; Gasull, Martina/J-4076-2019; Arribas, Francisco X Real/H-5275-2015	Navarro, Pilar/0000-0003-4314-4584; Eyras, Eduardo/0000-0003-0793-6218; Navarro, Pilar/0000-0003-4314-4584; Eduardo, Eyras/0000-0003-0793-6218; Arribas, Francisco X Real/0000-0001-9501-498X; Mendez, Raul/0000-0002-1952-6905; Ortiz Zapater, Elena/0000-0002-7437-4772; Martinez Bosch, Neus/0000-0003-3596-0039	Instituto de Salud Carlos-Fondos Europeos de Desarrollo Regional (FEDER) [PI080421]; Ministerio de Ciencia e Innovacion (MICINN); Fundacio La MaratoTV3 [051110]; American Institute for Cancer Research (AICR) [11-0086]; Generalitat de Catalunya [2009SGR1409, 2009SGR1436]; Consolider RNAREG from MICINN [CSD2009-00080]; AICR [11-0086]; Xarxa de Bancs de; Pla Director d'Oncologia de Catalunya; Instituto de Salud Carlos III; Departament de Sanitat de la Generalitat de Catalunya; MICINN; Fundacion Ramon Areces; DURSI (Generalitat de Catalunya); Eons Social Europeu (ESF);  [BFU2008-02373]; ICREA Funding Source: Custom; Worldwide Cancer Research [11-0086] Funding Source: researchfish	Instituto de Salud Carlos-Fondos Europeos de Desarrollo Regional (FEDER); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacio La MaratoTV3; American Institute for Cancer Research (AICR); Generalitat de Catalunya(Generalitat de Catalunya); Consolider RNAREG from MICINN; AICR; Xarxa de Bancs de; Pla Director d'Oncologia de Catalunya; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Departament de Sanitat de la Generalitat de Catalunya(Generalitat de Catalunya); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Fundacion Ramon Areces; DURSI (Generalitat de Catalunya)(Generalitat de Catalunya); Eons Social Europeu (ESF); ; ICREA(ICREA); Worldwide Cancer Research	The authors acknowledge F. Gebauer, S. Aznar-Benitah, A. Garcia de Herreros and J. Valcarcel for critical comments on the manuscript and for other valuable contributions. We also thank S. Hahn (Department of Molecular GI-Oncology, University of Bochum, Germany) and M. Buchholz (Department of Gastroenterology, Endocrinology and Metabolism, Philipps-University of Marburg, Marburg, Germany) for providing normal pancreas RNA, O. Casanovas (Translational Research Laboratory, Catalan Institute of Oncology (ICO-Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain) for his help with the T98G nude mice injections, J. R. Gonzalez-Vallinas (Computational Genomics Group, Universitat Pompeu Fabra, Parc de Recerca Biomedica de Barcelona (PRBB)) for assistance with Gene Ontology tools and E. Castillo from the Ultrasequencing Unit (Centre for Gcnomic Regulation, PRBB), S. Mojal from the Statistics Unit (IMIM, PRBB) and T. Lobato from the Histopathological Unit (IMIM, PRBB) for technical assistance. This work was funded by the research grants Instituto de Salud Carlos-Fondos Europeos de Desarrollo Regional (FEDER) (PI080421) from the Ministerio de Ciencia e Innovacion (MICINN) and grants from Fundacio La MaratoTV3 (051110), the American Institute for Cancer Research (AICR) (11-0086) and Generalitat de Catalunya (2009SGR1409) to P.N.; grants BFU2008-02373 and Consolider RNAREG CSD2009-00080 from the MICINN and grants from Fundacio La MaratoTV3 (051110), AICR (11-0086) and Generalitat de Catalunya (2009SGR1436) to R.M.; grant SAF2007-60860 and Consolider ONCOBIO from the MICINN and a grant from the VI EU Framework Programme MolDiag-PaCa project to F.X.R.; grants Consolider RNAREG CSD2009-00080 and BIO2008-01091 from the MICINN to E.E.; and grants from the Instituto de Salud Carlos III FEDER (RD09/0076/00036) and the Xarxa de Bancs de tumors sponsored by the Pla Director d'Oncologia de Catalunya to the MARBiobanc. P.N. is supported by the Instituto de Salud Carlos III and the Departament de Sanitat de la Generalitat de Catalunya. D.P. holds a Juan de Is Cierva grant from the MICINN. N.M.-B. holds a grant from the Fundacion Ramon Areces. C.E. was supported by a fellowship from the DURSI (Generalitat de Catalunya) and Eons Social Europeu (ESF).	Aguilar S, 2004, AM J PATHOL, V165, P1129, DOI 10.1016/S0002-9440(10)63374-3; Aguirre-Ghiso JA, 2001, MOL BIOL CELL, V12, P863, DOI 10.1091/mbc.12.4.863; Belloc E, 2008, NATURE, V452, P1017, DOI 10.1038/nature06809; Blasi F, 2010, FEBS LETT, V584, P1923, DOI 10.1016/j.febslet.2009.12.039; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Cooper C, 2009, NUCLEIC ACIDS RES, V37, P4518, DOI 10.1093/nar/gkp441; Diaz VM, 2002, GASTROENTEROLOGY, V122, P806, DOI 10.1053/gast.2002.31885; Eliscovich C, 2008, NAT CELL BIOL, V10, P858, DOI 10.1038/ncb1746; Gandin V, 2008, NATURE, V455, P684, DOI 10.1038/nature07267; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Gaspar C, 2008, AM J PATHOL, V172, P1363, DOI 10.2353/ajpath.2008.070851; Groisman I, 2006, GENE DEV, V20, P2701, DOI 10.1101/gad.1438906; Groppo R, 2009, CURR OPIN CELL BIOL, V21, P444, DOI 10.1016/j.ceb.2009.01.011; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hansen CN, 2009, APMIS, V117, P53, DOI 10.1111/j.1600-0463.2008.00015.x; Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322; HUARTE J, 1985, CELL, V43, P551, DOI 10.1016/0092-8674(85)90184-9; HUARTE J, 1987, GENE DEV, V1, P1201, DOI 10.1101/gad.1.10.1201; HUARTE J, 1992, CELL, V69, P1021, DOI 10.1016/0092-8674(92)90620-R; Iacobuzio-Donahue CA, 2003, CANCER RES, V63, P8614; Iacobuzio-Donahue CA, 2009, J CLIN ONCOL, V27, P1806, DOI 10.1200/JCO.2008.17.7188; Igea A, 2010, EMBO J, V29, P2182, DOI 10.1038/emboj.2010.111; Israel A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006045; Janic A, 2010, SCIENCE, V330, P1824, DOI 10.1126/science.1195481; Ji Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008419; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Karni R, 2008, P NATL ACAD SCI USA, V105, P15323, DOI 10.1073/pnas.0801376105; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Livingstone M, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/2/021001; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; McMahon B, 2007, PATHOPHYSIOL HAEMO T, V36, P184, DOI 10.1159/000175156; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Missiaglia E, 2004, INT J CANCER, V112, P100, DOI 10.1002/ijc.20376; Novoa I, 2010, NAT CELL BIOL, V12, P447, DOI 10.1038/ncb2046; OSSOWSKI L, 1988, CELL, V52, P321, DOI 10.1016/S0092-8674(88)80025-4; Paciucci R, 1996, FEBS LETT, V385, P72, DOI 10.1016/0014-5793(96)00352-3; Paciucci R, 1998, ONCOGENE, V16, P625, DOI 10.1038/sj.onc.1201564; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pio R, 2009, J THORAC ONCOL, V4, P674, DOI 10.1097/JTO.0b013e3181a520dc; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Ryu B, 2002, CANCER RES, V62, P819; Saaf AM, 2007, MOL BIOL CELL, V18, P4245, DOI 10.1091/mbc.E07-04-0309; Shin CY, 2004, J NEUROSCI, V24, P9425, DOI 10.1523/JNEUROSCI.2457-04.2004; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Srebrow A, 2006, J CELL SCI, V119, P2635, DOI 10.1242/jcs.03053; Ulisse S, 2009, CURR CANCER DRUG TAR, V9, P32, DOI 10.2174/156800909787314002; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819	55	111	120	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					83	90		10.1038/nm.2540	http://dx.doi.org/10.1038/nm.2540			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22138752				2022-12-25	WOS:000299018600033
J	Agathocleous, M; Love, NK; Randlett, O; Harris, JJ; Liu, JY; Murray, AJ; Harris, WA				Agathocleous, Michalis; Love, Nicola K.; Randlett, Owen; Harris, Julia J.; Liu, Jinyue; Murray, Andrew J.; Harris, William A.			Metabolic differentiation in the embryonic retina	NATURE CELL BIOLOGY			English	Article							AEROBIC GLYCOLYSIS; STEM-CELL; GLYCOGEN; PROLIFERATION; XENOPUS; TISSUE; COMPARTMENTALIZATION; PROGENITORS; EXPRESSION; LIVER	Unlike healthy adult tissues, cancers produce energy mainly by aerobic glycolysis instead of oxidative phosphorylation(1). This adaptation, called the Warburg effect, may be a feature of all dividing cells, both normal and cancerous(2), or it may be specific to cancers(3). It is not known whether, in a normally growing tissue during development, proliferating and postmitotic cells produce energy in fundamentally different ways. Here we show in the embryonic Xenopus retina in vivo, that dividing progenitor cells depend less on oxidative phosphorylation for ATP production than non-dividing differentiated cells, and instead use glycogen to fuel aerobic glycolysis. The transition from glycolysis to oxidative phosphorylation is connected to the cell differentiation process. Glycolysis is indispensable for progenitor proliferation and biosynthesis, even when it is not used for ATP production. These results suggest that the Warburg effect can be a feature of normal proliferation in vivo, and that the regulation of glycolysis and oxidative phosphorylation is critical for normal development.	[Agathocleous, Michalis; Love, Nicola K.; Randlett, Owen; Liu, Jinyue; Murray, Andrew J.; Harris, William A.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; [Agathocleous, Michalis] Univ Cambridge Gonville & Caius Coll, Cambridge CB2 1TA, England; [Harris, Julia J.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of Cambridge; University of Cambridge; University of London; University College London	Harris, WA (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England.	harris@mole.bio.cam.ac.uk	Murray, Andrew/B-3130-2010; Randlett, Owen/AAB-3136-2020	Murray, Andrew/0000-0002-0929-9315; Randlett, Owen/0000-0003-0181-5239; Harris, Julia Jade/0000-0002-2118-7674	Wellcome Trust; Gonville and Caius College; Royal Commission for the Exhibition of 1851	Wellcome Trust(Wellcome TrustEuropean Commission); Gonville and Caius College; Royal Commission for the Exhibition of 1851	We are grateful to F. Gallagher and H. Sladen for help with the LDH assays, N. Miller for cell sorting and D. Attwell for advice on the oxygen concentration measurements. We thank J. Bixby, C. Holt, S. Morrison, S. He and R. Johnson for comments on the manuscript. We thank the Wellcome Trust (W.A.H.) and Gonville and Caius College and the Royal Commission for the Exhibition of 1851 (M.A.) for financial support.	Agathocleous M, 2009, ANNU REV CELL DEV BI, V25, P45, DOI 10.1146/annurev.cellbio.042308.113259; Almeida A, 2010, P NATL ACAD SCI USA, V107, P738, DOI 10.1073/pnas.0913668107; Birket MJ, 2011, J CELL SCI, V124, P348, DOI 10.1242/jcs.072272; Brand KA, 1997, FASEB J, V11, P388, DOI 10.1096/fasebj.11.5.9141507; BURKE RE, 1971, SCIENCE, V174, P709, DOI 10.1126/science.174.4010.709; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Facucho-Oliveira JM, 2009, STEM CELL REV REP, V5, P140, DOI 10.1007/s12015-009-9058-0; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; GOTTLIEB TA, 1982, J BIOL CHEM, V257, P95; Hall CN, 2008, J PHYSIOL-LONDON, V586, P3597, DOI 10.1113/jphysiol.2008.154724; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; Hutcheson DA, 2001, DEV BIOL, V232, P327, DOI 10.1006/dbio.2001.0178; Jorgensen P, 2009, DEVELOPMENT, V136, P1539, DOI 10.1242/dev.032425; Klabunde T, 2005, J MED CHEM, V48, P6178, DOI 10.1021/jm049034y; Locker M, 2006, GENE DEV, V20, P3036, DOI 10.1101/gad.391106; Lopaschuk GD, 2010, J CARDIOVASC PHARM, V56, P130, DOI 10.1097/FJC.0b013e3181e74a14; Moran JH, 1996, J PHARMACOL TOXICOL, V36, P41, DOI 10.1016/1056-8719(96)00071-8; Nakada D, 2011, NEURON, V70, P703, DOI 10.1016/j.neuron.2011.05.011; Norden C, 2009, CELL, V138, P1195, DOI 10.1016/j.cell.2009.06.032; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Ozbudak EM, 2010, P NATL ACAD SCI USA, V107, P4224, DOI 10.1073/pnas.0909375107; Pellerin L., 2011, J CEREB BLOOD FLOW M; PERRY MM, 1967, J CELL SCI, V2, P257; RODRIGUEZ IR, 1990, EXP EYE RES, V51, P71, DOI 10.1016/0014-4835(90)90172-Q; Schnier JB, 2003, BIOCHEM BIOPH RES CO, V309, P126, DOI 10.1016/S0006-291X(03)01542-0; Takahashi S, 1999, J GASTROENTEROL, V34, P474, DOI 10.1007/s005350050299; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; WANG T, 1976, NATURE, V261, P702, DOI 10.1038/261702a0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yang CD, 2009, CANCER RES, V69, P7986, DOI 10.1158/0008-5472.CAN-09-2266	33	109	110	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2012	14	8					859	U180		10.1038/ncb2531	http://dx.doi.org/10.1038/ncb2531			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	983JP	22750943	Green Accepted			2022-12-25	WOS:000307115900015
J	Tenbaum, SP; Ordonez-Moran, P; Puig, I; Chicote, I; Arques, O; Landolfi, S; Fernandez, Y; Herance, JR; Gispert, JD; Mendizabal, L; Aguilar, S; Cajal, SRY; Schwartz, S; Vivancos, A; Espin, E; Rojas, S; Baselga, J; Tabernero, J; Munoz, A; Palmer, HG				Tenbaum, Stephan P.; Ordonez-Moran, Paloma; Puig, Isabel; Chicote, Irene; Arques, Oriol; Landolfi, Stefania; Fernandez, Yolanda; Raul Herance, Jose; Gispert, Juan D.; Mendizabal, Leire; Aguilar, Susana; Ramon y Cajal, Santiago; Schwartz, Simo, Jr.; Vivancos, Ana; Espin, Eloy; Rojas, Santiago; Baselga, Jose; Tabernero, Josep; Munoz, Alberto; Palmer, Hector G.			beta-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer	NATURE MEDICINE			English	Article							STEM-CELLS; E-CADHERIN; PHASE-I; TRANSCRIPTION; EXPRESSION; INDUCTION; PROTEINS; INVASION; KINASE; GROWTH	The Wnt-beta-catenin and PI3K-AKT-FOXO3a pathways have a central role in cancer. AKT phosporylates FOXO3a, relocating it from the cell nucleus to the cytoplasm, an effect that is reversed by PI3K and AKT inhibitors. Simultaneous hyperactivation of the Wnt-beta-catenin pathway and inhibition of PI3K-AKT signaling promote nuclear accumulation of beta-catenin and FOXO3a, respectively, promoting cell scattering and metastasis by regulating a defined set of target genes. Indeed, the anti-tumoral AKT inhibitor API-2 promotes nuclear FOXO3a accumulation and metastasis of cells with high nuclear beta-catenin content. Nuclear beta-catenin confers resistance to the FOXO3a-mediated apoptosis induced by PI3K and AKT inhibitors in patient-derived primary cultures and in corresponding xenograft tumors in mice. This resistance is reversed by XAV-939, an inhibitor of Wnt-beta-catenin signaling. In the presence of high nuclear beta-catenin content, activation of FOXO3a by PI3K or AKT inhibitors makes it behave as a metastasis inductor rather than a proapoptotic tumor suppressor. We show that it is possible to evaluate the beta-catenin status of patients' carcinomas and the response of patient-derived cells to target-directed drugs that accumulate FOXO3a in the nucleus before deciding on a course of treatment. We propose that this evaluation could be essential to the provision of a safer and more effective personalized treatment.	[Tenbaum, Stephan P.; Puig, Isabel; Chicote, Irene; Arques, Oriol; Palmer, Hector G.] VHIO, Stem Cell & Canc Lab, Barcelona, Spain; [Ordonez-Moran, Paloma; Munoz, Alberto] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Landolfi, Stefania; Ramon y Cajal, Santiago] Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Dept Pathol, E-08193 Barcelona, Spain; [Fernandez, Yolanda; Schwartz, Simo, Jr.] Univ Autonoma Barcelona, Hosp Univ Vall Hebron,Inst Recerca Vall Hebron, Nanomed & Networking Biomed Res Ctr Bioengn Bioma, Ctr Invest Bioquim & Biol Mol CIBBIM,Grp Drug Del, E-08193 Barcelona, Spain; [Raul Herance, Jose; Gispert, Juan D.; Rojas, Santiago] Ctr Imatge Mol CRC Corp Sanitaria, Barcelona, Spain; [Mendizabal, Leire; Vivancos, Ana] VHIO, Genom Canc Grp, Barcelona, Spain; [Aguilar, Susana] UCL, Rayne Inst, Ctr Resp Res, London, England; [Aguilar, Susana] Canc Res UK, London Res Inst, Hematopoiet Stem Cell Lab, London, England; [Espin, Eloy] Hosp Univ Vall Hebron, Gen Surg Serv, Barcelona, Spain; [Baselga, Jose] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA USA; [Baselga, Jose] Howard Hughes Med Inst, Chevy Chase, MD USA; [Tabernero, Josep] Hosp Univ Vall Hebron, Dept Med Oncol, Barcelona, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University of London; King's College London; University College London; Cancer Research UK; Hospital Universitari Vall d'Hebron; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Hospital Universitari Vall d'Hebron	Palmer, HG (corresponding author), VHIO, Stem Cell & Canc Lab, Barcelona, Spain.	hgpalmer@vhio.net	Camacho, José Raul Herance/Q-3416-2016; Vivancos, Ana/AAG-8331-2019; Munoz, Alberto/O-6393-2014; Gispert, Juan Domingo/C-6355-2008; Palmer, Héctor G./AAG-8332-2019; Schwartz, Simo/H-7776-2012; Tabernero, Josep/AAG-5026-2019; Ramon y Cajal, Santiago/H-4955-2016; Ordonez-Moran, Paloma/B-6371-2016; Seoane, Joan/AAG-9173-2019	Camacho, José Raul Herance/0000-0001-7178-3290; Vivancos, Ana/0000-0003-2888-6512; Munoz, Alberto/0000-0003-3890-4251; Gispert, Juan Domingo/0000-0002-6155-0642; Tabernero, Josep/0000-0002-2495-8139; Ramon y Cajal, Santiago/0000-0002-3867-1390; Schwartz, Simo/0000-0001-8297-7971; Espin-Basany, Eloy/0000-0002-9139-4548; Ordonez-Moran, Paloma/0000-0001-7688-1252; Landolfi, Stefania/0000-0002-1059-635X; Palmer, Hector/0000-0002-9823-5638; Puig Borreil, Isabel/0000-0001-5614-4298; Arques, Oriol/0000-0003-2603-3874; Seoane, Joan/0000-0002-6541-5974	VHIO; Instituto de Salud Carlos III (ISCIII) [FIS-PI081356, RETICC-RD06/0020/0075, RETICC-RD06/0020/0009]; Ministerio de Ciencia e Innovacion [SAF-18302]; Fundacio Olga Torres Fellowship; Fundacion Cientifica de la Asociacion Espanola Contra el Cancer (AECC)	VHIO; Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacio Olga Torres Fellowship; Fundacion Cientifica de la Asociacion Espanola Contra el Cancer (AECC)	We thank W. Shao (Novartis Institutes for BioMedical Research, Inc.) for providing the experimental drug, XAV-939, and its inactive analog, LDW-643, and we thank K. F. Becker (Technische Universitat Munchen, Germany) for providing the antibody to Snail1. We also thank P.J. Coffer (Utrecht, Netherlands) for providing the pcDNA3-FOXO3a(A3):ER (TM) expression plasmid, as well as H. Clevers (Utrecht, Netherlands) for providing L8 colon cancer cells. J. Seoane and G. Folch (VHIO, Barcelona, Spain) provided technical advice and reagents. We thank R. Luthra (Molecular Diagnostics Laboratory, MD Anderson Cancer Center, Houston, Texas, USA) for providing the CLIA panel of somatic mutations. We thank M.J. Larriba (Instituto de Investigaciones Biomedicas 'Alberto Sols', Consejo Superior de Investigaciones Cientificas-Universidad Autonoma de Madrid, Madrid, Spain) for providing the reagents necessary for the analysis of Zeb1 and Slug expression and M. Scaltriti (Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts, USA) for supplying the lentiviruses used to knock down IQGAP2 expression. We acknowledge R. Rycroft and A. Wren for their valuable assistance in the preparation of the English version of the manuscript. Experiments were supported by a VHIO starting grant and grants from Fondo de Investigaciones Sanitarias-Instituto de Salud Carlos III (ISCIII) (FIS-PI081356, RETICC-RD06/0020/0075 and RETICC-RD06/0020/0009), and Plan Nacional de Biomedicina, Ministerio de Ciencia e Innovacion (SAF-18302). S. P. T. was supported by a Fundacio Olga Torres Fellowship, I. P. was funded by the Fundacion Cientifica de la Asociacion Espanola Contra el Cancer (AECC), and H. G. P. was supported by the Miguel Servet Program, ISCIII.	Aguilar S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008013; Arques O., 2012, PROTOCOL EXCHANGE, DOI [10.1038/protex.2012.008, DOI 10.1038/PROTEX.2012.008]; Barbachano A, 2010, ONCOGENE, V29, P4800, DOI 10.1038/onc.2010.225; Barde I, 2006, MOL THER, V13, P382, DOI 10.1016/j.ymthe.2005.09.012; Bendell JC, 2012, J CLIN ONCOL, V30, P282, DOI 10.1200/JCO.2011.36.1360; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Chen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012293; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dehner M, 2008, J BIOL CHEM, V283, P19201, DOI 10.1074/jbc.M710366200; Delpuech O, 2007, MOL CELL BIOL, V27, P4917, DOI 10.1128/MCB.01789-06; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Dienstmann R, 2011, RECENT PAT ANTI-CANC, V6, P210, DOI 10.2174/157489211795328503; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Gomes AR, 2008, CELL CYCLE, V7, P3133, DOI 10.4161/cc.7.20.6920; Hoffman K, 1996, CANCER CHEMOTH PHARM, V37, P254; Hoogeboom D, 2008, J BIOL CHEM, V283, P9224, DOI 10.1074/jbc.M706638200; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Janne PA, 2000, NEW ENGL J MED, V342, P1960, DOI 10.1056/NEJM200006293422606; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jun T., 1999, SCI STKE, V1999, pPE1; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kreso A., 2008, CURR PROTOC STEM CEL, V7, P311; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Natale David R., 2002, Gene Expression Patterns, V2, P17, DOI 10.1016/S0925-4773(02)00350-7; Obexer P, 2007, CELL DEATH DIFFER, V14, P534, DOI 10.1038/sj.cdd.4402017; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Palmer HG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001483; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rochat-Steiner V, 2000, J EXP MED, V192, P1165, DOI 10.1084/jem.192.8.1165; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Storz P, 2009, MOL CELL BIOL, V29, P4906, DOI 10.1128/MCB.00077-09; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Tourneur L, 2010, TRENDS IMMUNOL, V31, P260, DOI 10.1016/j.it.2010.05.005; Tsai MS, 2000, CANCER RES, V60, P5603; Ueno H, 2002, HISTOPATHOLOGY, V40, P127, DOI 10.1046/j.1365-2559.2002.01324.x; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Cespedes MV, 2007, AM J PATHOL, V170, P1077, DOI 10.2353/ajpath.2007.060773; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Yamashiro S, 2007, DEV BIOL, V308, P485, DOI 10.1016/j.ydbio.2007.06.001; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Zheng Y., 2011, J MOL MED BERL; Zunder ER, 2008, CANCER CELL, V14, P180, DOI 10.1016/j.ccr.2008.06.014	61	282	291	0	93	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2012	18	6					892	+		10.1038/nm.2772	http://dx.doi.org/10.1038/nm.2772			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22610277	Green Submitted			2022-12-25	WOS:000305116600026
J	Umasankar, PK; Sanker, S; Thieman, JR; Chakraborty, S; Wendland, B; Tsang, M; Traub, LM				Umasankar, P. K.; Sanker, Subramaniam; Thieman, James R.; Chakraborty, Souvik; Wendland, Beverly; Tsang, Michael; Traub, Linton M.			Distinct and separable activities of the endocytic clathrin-coat components Fcho1/2 and AP-2 in developmental patterning	NATURE CELL BIOLOGY			English	Article							TGF-BETA RECEPTOR; MEDIATED ENDOCYTOSIS; ZEBRAFISH EMBRYO; MEMBRANE RECRUITMENT; ALPHA-APPENDAGE; CARGO SELECTION; DOMAIN PROTEIN; ADAPTER; GRADIENT; CELLS	Clathrin-mediated endocytosis occurs at multiple independent import sites on the plasma membrane, but how these positions are selected and how different cargo is simultaneously recognized is obscure. FCHO1 and FCHO2 are early-arriving proteins at surface clathrin assemblies and are speculated to act as compulsory coat nucleators, preceding the core clathrin adaptor AP-2. Here, we show that the mu-homology domain of FCHO1/2 represents an endocytic interaction hub. Translational silencing of fcho1 in zebrafish embryos causes strong dorsoventral patterning defects analogous to Bmp signal failure. The Fcho1 mu-homology domain interacts with the Bmp receptor Alk8, uncovering an endocytic component that positively modulates Bmp signal transmission. Still, the fcho1 morphant phenotype is distinct from severe embryonic defects apparent when AP-2 is depleted. Our data thus challenge the primacy of FCHO1/2 in coat initiation.	[Umasankar, P. K.; Sanker, Subramaniam; Thieman, James R.; Chakraborty, Souvik; Traub, Linton M.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Wendland, Beverly] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Tsang, Michael] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Traub, LM (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA.	traub@pitt.edu	Tsang, Michael/ABV-0504-2022; Tsang, Michael W/I-9305-2014; Tsang, Michael/AAG-9338-2020; TSANG, Michael/E-2758-2013	Tsang, Michael/0000-0001-7123-0063; Tsang, Michael W/0000-0001-7123-0063; TSANG, Michael/0000-0001-6384-2422; Umasankar, Perunthottathu/0000-0001-5548-1022; Traub, Linton/0000-0002-1303-0298	National Institutes of Health [R01 HL088016, R01 GM60979, R01 DK53249]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060979] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to our many colleagues for providing reagents that were essential for this study. Supported by National Institutes of Health grants R01 HL088016 (M.T.), R01 GM60979 (B.W.) and R01 DK53249 (L.M.T.).	Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Bauer H, 2001, DEVELOPMENT, V128, P849; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; Boettner DR, 2009, CURR BIOL, V19, P1979, DOI 10.1016/j.cub.2009.10.062; Borner GHH, 2007, TRAFFIC, V8, P893, DOI 10.1111/j.1600-0854.2007.00576.x; Boucrot E, 2006, EXP CELL RES, V312, P4036, DOI 10.1016/j.yexcr.2006.09.025; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Edeling MA, 2006, DEV CELL, V10, P329, DOI 10.1016/j.devcel.2006.01.016; Edeling MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008150; Feng B, 2002, EXP CELL RES, V279, P14, DOI 10.1006/excr.2002.5579; Furthauer M, 2004, DEVELOPMENT, V131, P2853, DOI 10.1242/dev.01156; HART NH, 1991, CELL TISSUE RES, V265, P317, DOI 10.1007/BF00398079; Hartung A, 2006, MOL CELL BIOL, V26, P7791, DOI 10.1128/MCB.00022-06; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Heining E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025163; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Imai Y, 2001, GENESIS, V30, P160, DOI 10.1002/gene.1055; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Jullien J, 2005, GENE DEV, V19, P2682, DOI 10.1101/gad.341605; Katoh M, 2004, INT J MOL MED, V14, P327; Kelly BT, 2011, CURR OPIN CELL BIOL, V23, P404, DOI 10.1016/j.ceb.2011.03.004; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kirchhausen T, 2009, TRENDS CELL BIOL, V19, P596, DOI 10.1016/j.tcb.2009.09.002; Koh TW, 2007, J CELL BIOL, V178, P309, DOI 10.1083/jcb.200701030; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; Little SC, 2009, NAT CELL BIOL, V11, P637, DOI 10.1038/ncb1870; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mintzer KA, 2001, DEVELOPMENT, V128, P859; Mishra SK, 2004, J BIOL CHEM, V279, P46191, DOI 10.1074/jbc.M408095200; Mitsunari T, 2005, MOL CELL BIOL, V25, P9318, DOI 10.1128/MCB.25.21.9318-9323.2005; Molina GA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-62; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Mullins MC, 1996, DEVELOPMENT, V123, P81; O'Connor-Giles KM, 2008, NEURON, V58, P507, DOI 10.1016/j.neuron.2008.03.007; Payne TL, 2001, MECH DEVELOP, V100, P275, DOI 10.1016/S0925-4773(00)00541-4; Praefcke GJK, 2004, EMBO J, V23, P4371, DOI 10.1038/sj.emboj.7600445; Reider A, 2011, J CELL SCI, V124, P1613, DOI 10.1242/jcs.073395; Reider A, 2009, EMBO J, V28, P3103, DOI 10.1038/emboj.2009.248; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Scholpp S, 2004, CURR BIOL, V14, P1834, DOI 10.1016/j.cub.2004.09.084; SchulteMerker S, 1997, NATURE, V387, P862, DOI 10.1038/43092; Sengar AS, 1999, EMBO J, V18, P1159, DOI 10.1093/emboj/18.5.1159; Shi WB, 2007, J CELL SCI, V120, P1216, DOI 10.1242/jcs.03400; Solnica-Krezel L, 2006, CURR OPIN GENET DEV, V16, P433, DOI 10.1016/j.gde.2006.06.009; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stimpson HEM, 2009, MOL BIOL CELL, V20, P4640, DOI 10.1091/mbc.E09-05-0429; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Thieman JR, 2009, J BIOL CHEM, V284, P13924, DOI 10.1074/jbc.M901017200; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Tsang M, 2004, DEVELOPMENT, V131, P2769, DOI 10.1242/dev.01157; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Tucker JA, 2008, DEV CELL, V14, P108, DOI 10.1016/j.devcel.2007.11.004; Uezu A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703815200; Uezu A, 2011, GENES CELLS, V16, P868, DOI 10.1111/j.1365-2443.2011.01536.x; von der Hardt S, 2007, CURR BIOL, V17, P475, DOI 10.1016/j.cub.2007.02.013; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wang WD, 2005, DEVELOPMENT, V132, P2883, DOI 10.1242/dev.01860; Yamabhai M, 1998, J BIOL CHEM, V273, P31401, DOI 10.1074/jbc.273.47.31401; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391; Zhou YL, 2004, MOL ENDOCRINOL, V18, P1818, DOI 10.1210/me.2004-0079; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	69	62	79	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2012	14	5					488	U108		10.1038/ncb2473	http://dx.doi.org/10.1038/ncb2473			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	936NW	22484487	Green Accepted			2022-12-25	WOS:000303598300009
J	Busino, L; Millman, SE; Scotto, L; Kyratsous, CA; Basrur, V; O'Connor, O; Hoffmann, A; Elenitoba-Johnson, KS; Pagano, M				Busino, Luca; Millman, Scott E.; Scotto, Luigi; Kyratsous, Christos A.; Basrur, Venkatesha; O'Connor, Owen; Hoffmann, Alexander; Elenitoba-Johnson, Kojo S.; Pagano, Michele			Fbxw7 alpha- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma	NATURE CELL BIOLOGY			English	Article							UBIQUITIN LIGASE; TUMOR-SUPPRESSOR; IKK-ALPHA; CELL DIFFERENTIATION; NEGATIVE FEEDBACK; BETA-TRCP; CYCLIN-E; ACTIVATION; LYMPHOTOXIN; INACTIVATION	Fbxw7 alpha is a member of the F-box family of proteins, which function as the substrate-targeting subunits of SCF (Skp1/Cul1/F-box protein) ubiquitin ligase complexes. Using differential purifications and mass spectrometry, we identified p100, an inhibitor of NF-kappa B signalling, as an interactor of Fbxw7 alpha. p100 is constitutively targeted in the nucleus for proteasomal degradation by Fbxw7 alpha, which recognizes a conserved motif phosphorylated by GSK3. Efficient activation of non-canonical NF-kappa B signalling is dependent on the elimination of nuclear p100 through either degradation by Fbxw7 alpha or exclusion by a newly identified nuclear export signal in the carboxy terminus of p100. Expression of a stable p100 mutant, expression of a constitutively nuclear p100 mutant, Fbxw7 alpha silencing or inhibition of GSK3 in multiple myeloma cells with constitutive non-canonical NF-kappa B activity results in apoptosis both in cell systems and xenotransplant models. Thus, in multiple myeloma, Fbxw7 alpha and GSK3 function as pro-survival factors through the control of p100 degradation.	[Busino, Luca; Millman, Scott E.; Scotto, Luigi; Kyratsous, Christos A.; O'Connor, Owen; Pagano, Michele] NYU, Sch Med, Inst Canc, New York, NY 10016 USA; [Kyratsous, Christos A.; Pagano, Michele] Howard Hughes Med Inst, Bethesda, MD USA; [Basrur, Venkatesha; Elenitoba-Johnson, Kojo S.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Hoffmann, Alexander] Univ Calif San Diego, Dept Chem & Biochem, Signaling Syst Lab, La Jolla, CA 92093 USA	New York University; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of California System; University of California San Diego	Pagano, M (corresponding author), NYU, Sch Med, Inst Canc, 522 1st Ave,SRB 1107, New York, NY 10016 USA.	michele.pagano@nyumc.org		Millman, Scott/0000-0002-0249-2729; Elenitoba-Johnson, Kojo/0000-0002-1082-1545; pagano, michele/0000-0003-3210-2442	National Cancer Institute [5P30CA016087-33]; American Italian Cancer Foundation; National Institutes of Health [5T32HL007151-33, T32 CA009161, R01-GM057587, R37-CA076584, R21-CA161108]; Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE [T32CA009161, R37CA076584, P30CA016087, R21CA161108] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Italian Cancer Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank I. Aifantis, H. J. Cho, G. Franzoso, W. M. Kuehl and A. Ventura for reagents; B. Aranda-Orgilles for her contribution; and I. Aifantis, G. Franzoso, K. Nakayama, S. Reed and J. R. Skaar for critically reading the manuscript. M.P. is grateful to T. M. Thor for continuous support. This work was supported in part by grant 5P30CA016087-33 from the National Cancer Institute, a fellowship from the American Italian Cancer Foundation and NIH 5T32HL007151-33 to L.B., NIH T32 CA009161 grant to S.M. and grants from the National Institutes of Health (R01-GM057587, R37-CA076584 and R21-CA161108) and the Multiple Myeloma Research Foundation to M.P. M.P. is an Investigator with the Howard Hughes Medical Institute.	Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Derudder E, 2003, J BIOL CHEM, V278, P23278, DOI 10.1074/jbc.M300106200; Fong A, 2002, J BIOL CHEM, V277, P22111, DOI 10.1074/jbc.C200151200; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Hoeck JD, 2010, NAT NEUROSCI, V13, P1365, DOI 10.1038/nn.2644; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Mavrakis KJ, 2011, NAT GENET, V43, P673, DOI 10.1038/ng.858; Milhollen MA, 2010, BLOOD, V116, P1515, DOI 10.1182/blood-2010-03-272567; Millman SE, 2011, EMBO REP, V12, P384, DOI 10.1038/embor.2011.62; Mordmuller B, 2003, EMBO REP, V4, P82, DOI 10.1038/embor710; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Muller JR, 2003, J BIOL CHEM, V278, P12006, DOI 10.1074/jbc.M210768200; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Onoyama I, 2007, J EXP MED, V204, P2875, DOI 10.1084/jem.20062299; Orian A, 2000, EMBO J, V19, P2580, DOI 10.1093/emboj/19.11.2580; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Ramakrishnan P, 2004, IMMUNITY, V21, P477, DOI 10.1016/j.immuni.2004.08.009; Razani B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000778; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Sangfelt O, 2008, CELL CYCLE, V7, P1075, DOI 10.4161/cc.7.8.5648; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shah JJ, 2009, BLOOD, V114, P735, DOI 10.1182/blood.V114.22.1854.1854; Shiha VFS, 2009, P NATL ACAD SCI USA, V106, P9619, DOI 10.1073/pnas.0812367106; Skaar JR, 2009, CELL, V137, P1358, DOI 10.1016/j.cell.2009.05.040; Solan NJ, 2002, J BIOL CHEM, V277, P1405, DOI 10.1074/jbc.M109619200; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; Weih F, 2003, IMMUNOL REV, V195, P91, DOI 10.1034/j.1600-065X.2003.00064.x; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Xie P, 2007, IMMUNITY, V27, P253, DOI 10.1016/j.immuni.2007.07.012; Zarnegar B., 2004, P NATL ACAD SCI USA, V101, P8108	48	139	143	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2012	14	4					375	+		10.1038/ncb2463	http://dx.doi.org/10.1038/ncb2463			30	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	921UM	22388891	Bronze, Green Accepted			2022-12-25	WOS:000302503300010
J	Fumagalli, M; Rosiello, F; Clerici, M; Barozzi, S; Cittaro, D; Kaplunov, JM; Bucci, G; Dobreva, M; Matti, V; Beausejour, CM; Herbig, U; Longhese, MP; di Fagagna, FD				Fumagalli, Marzia; Rosiello, Francesca; Clerici, Michela; Barozzi, Sara; Cittaro, Davide; Kaplunov, Jessica M.; Bucci, Gabriele; Dobreva, Miryana; Matti, Valentina; Beausejour, Christian M.; Herbig, Utz; Longhese, Maria Pia; di Fagagna, Fabrizio d'Adda			Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation	NATURE CELL BIOLOGY			English	Article							DOUBLE-STRAND BREAKS; ONCOGENE-INDUCED SENESCENCE; HEMATOPOIETIC STEM-CELLS; CELLULAR SENESCENCE; HUMAN FIBROBLASTS; AGING PRIMATES; ARREST; CANCER; TRF2; ATM	The DNA-damage response (DDR) arrests cell-cycle progression until damage is removed. DNA-damage-induced cellular senescence is associated with persistent DDR. The molecular bases that distinguish transient from persistent DDR are unknown. Here we show that a large fraction of exogenously induced persistent DDR markers is associated with telomeric DNA in cultured cells and mammalian tissues. In yeast, a chromosomal DNA double-strand break next to a telomeric sequence resists repair and impairs DNA ligase 4 recruitment. In mammalian cells, ectopic localization of telomeric factor TRF2 next to a double-strand break induces persistent DNA damage and DDR. Linear, but not circular, telomeric DNA or scrambled DNA induces a prolonged checkpoint in normal cells. In terminally differentiated tissues of old primates, DDR markers accumulate at telomeres that are not critically short. We propose that linear genomes are not uniformly reparable and that telomeric DNA tracts, if damaged, are irreparable and trigger persistent DDR and cellular senescence.	[Fumagalli, Marzia; Rosiello, Francesca; Dobreva, Miryana; Matti, Valentina; di Fagagna, Fabrizio d'Adda] FIRC Inst Mol Oncol Fdn, IFOM Fdn, I-20139 Milan, Italy; [Barozzi, Sara] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy; [Clerici, Michela; Longhese, Maria Pia] Univ Milano Bicocca, Dept Biotechnol & Biosci, I-20126 Milan, Italy; [Cittaro, Davide; Bucci, Gabriele] Ist Italiano Tecnol, Ctr Genom Sci IIT SEMM, I-20139 Milan, Italy; [Cittaro, Davide; Bucci, Gabriele] Cogentech, Consortium Genom Technol, I-20139 Milan, Italy; [Kaplunov, Jessica M.; Herbig, Utz] NJMS UH Canc Ctr, Dept Microbiol & Mol Genet, Newark, NJ 07103 USA; [Beausejour, Christian M.] Univ Montreal, Dept Pharmacol, Montreal, PQ H3S 2G5, Canada; [Beausejour, Christian M.] Ctr Hosp Univ St Justine, Montreal, PQ H3S 2G5, Canada; [di Fagagna, Fabrizio d'Adda] CNR, Ist Genet Mol, I-27100 Pavia, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); University of Milano-Bicocca; Istituto Italiano di Tecnologia - IIT; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR)	di Fagagna, FD (corresponding author), FIRC Inst Mol Oncol Fdn, IFOM Fdn, I-20139 Milan, Italy.	fabrizio.dadda@ifom-ieo-campus.it	bucci, gabriele/H-3002-2014; Pia, Maria/AAK-2693-2020; Rossiello, Francesca/AAA-8160-2022; Cittaro, Davide/K-2405-2018; d'Adda di Fagagna, Fabrizio/AAC-4683-2022; Clerici, Michela/AAK-2807-2020	bucci, gabriele/0000-0001-9838-7204; Rossiello, Francesca/0000-0002-6240-9907; Cittaro, Davide/0000-0003-0384-3700; d'Adda di Fagagna, Fabrizio/0000-0002-9603-5966; DADDADIFAGAGNA, FABRIZIO/0000-0002-1976-3185; Fumagalli, Marzia/0000-0002-2036-4544; Longhese, Maria Pia/0000-0003-1726-2034	FIRC (Fondazione Italiana per la Ricerca sul Cancro); AIRC (Associazione Italiana per la Ricerca sul Cancro) [8866]; European Union (GENINCA) [202230]; HFSP (Human Frontier Science Program); AICR (Association for International Cancer Research) [11407]; EMBO; MIUR/Universita di Milano-Bicocca; Canadian Institute of Health Research [IAO-79317]; Ellison Medical Foundation [AG-NS-0387-07]; National Cancer Institute [R01CA136533]; NATIONAL CANCER INSTITUTE [R01CA136533] Funding Source: NIH RePORTER; Fondazione Telethon Funding Source: Custom	FIRC (Fondazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); European Union (GENINCA)(European Commission); HFSP (Human Frontier Science Program)(Human Frontier Science Program); AICR (Association for International Cancer Research); EMBO(European Molecular Biology Organization (EMBO)); MIUR/Universita di Milano-Bicocca(Ministry of Education, Universities and Research (MIUR)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Ellison Medical Foundation(Lawrence Ellison Foundation); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fondazione Telethon(Fondazione Telethon)	We thank V. Dall'Olio and L. Tizzoni from IFOM RT-PCR Unit, A. Oldani and all the IFOM Imaging Unit, L. Rotta from IFOM Microarray and NGS Unit, IFOM Cell Biology Unit for support; V. Boccardi for discussions; P. Baumann, T. F. Halazonetis, T. Weinert, D. E. Gottschling, E. Soutoglou, E. Gilson, P. Jeggo, A. Musacchio and S. Minucci for sharing reagents; O. Le for mouse brain tissue sectioning and all F.d'A.d.F. laboratory members for discussions. F.d'A.d.F.'s laboratory is supported by FIRC (Fondazione Italiana per la Ricerca sul Cancro), AIRC (Associazione Italiana per la Ricerca sul Cancro; grant number 8866), European Union (GENINCA, contract number 202230), HFSP (Human Frontier Science Program), AICR (Association for International Cancer Research), EMBO Young Investigator Program and Telethon. M.P.L.'s laboratory is supported by AIRC (grant number 11407), Cofinanziamento 2008 MIUR/Universita di Milano-Bicocca and the European Union. C.M.B. is supported by a grant from the Canadian Institute of Health Research (number IAO-79317). U.H. is supported by a New Scholar Award from the Ellison Medical Foundation (AG-NS-0387-07) and by a grant (R01CA136533) from the National Cancer Institute.	Ancelin K, 2002, MOL CELL BIOL, V22, P3474, DOI 10.1128/MCB.22.10.3474-3487.2002; Bae NS, 2007, MOL CELL, V26, P323, DOI 10.1016/j.molcel.2007.03.023; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bombarde O, 2010, EMBO J, V29, P1573, DOI 10.1038/emboj.2010.49; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Di Micco R, 2011, NAT CELL BIOL, V13, P292, DOI 10.1038/ncb2170; Diede SJ, 2001, CURR BIOL, V11, P1336, DOI 10.1016/S0960-9822(01)00400-6; Duffy D. L., 2007, LODPLOT PLOT GENOME; Evan GI, 2009, CURR OPIN GENET DEV, V19, P25, DOI 10.1016/j.gde.2008.11.009; Francia S, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-3; Fujita K, 2010, NAT CELL BIOL, V12, P1205, DOI 10.1038/ncb2123; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Giaimo S, 2012, AGING CELL, V11, P378, DOI 10.1111/j.1474-9726.2012.00807.x; Gomes NMV, 2011, AGING CELL, V10, P761, DOI 10.1111/j.1474-9726.2011.00718.x; Gonzalo S, 2005, NAT CELL BIOL, V7, P420, DOI 10.1038/ncb1235; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708; Huang LC, 1996, P NATL ACAD SCI USA, V93, P4827, DOI 10.1073/pnas.93.10.4827; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Le ONL, 2010, AGING CELL, V9, P398, DOI 10.1111/j.1474-9726.2010.00567.x; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Marchion DC, 2005, CANCER RES, V65, P3815, DOI 10.1158/0008-5472.CAN-04-2478; Marusyk A, 2007, MOL CELL BIOL, V27, P5336, DOI 10.1128/MCB.01316-06; Meier A, 2007, EMBO J, V26, P2707, DOI 10.1038/sj.emboj.7601719; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Michelson RJ, 2005, GENE DEV, V19, P2546, DOI 10.1101/gad.1293805; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Nobuyuki O., 1979, IEEE T SYST MAN CYB, V9, P62, DOI [10.1109/TSMC.1979.4310076, DOI 10.1109/TSMC.1979.4310076]; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Petersen S, 1998, EXP CELL RES, V239, P152, DOI 10.1006/excr.1997.3893; *R DEV COR TEAM, R LANG ENV STAT COMP; Rochette PJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000926; Rodier F, 2011, J CELL SCI, V124, P68, DOI 10.1242/jcs.071340; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Schmitt CA, 2003, NAT REV CANCER, V3, P286, DOI 10.1038/nrc1044; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Viscardi V, 2007, MOL BIOL CELL, V18, P3047, DOI 10.1091/mbc.E07-03-0285; Ye J, 2010, CELL, V142, P230, DOI 10.1016/j.cell.2010.05.032; Zhou BBS, 2004, NAT REV CANCER, V4, P216, DOI 10.1038/nrc1296; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	55	493	508	0	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2012	14	4					355	+		10.1038/ncb2466	http://dx.doi.org/10.1038/ncb2466			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	921UM	22426077	Green Accepted			2022-12-25	WOS:000302503300008
J	Valente, C; Turacchio, G; Mariggio, S; Pagliuso, A; Gaibisso, R; Di Tullio, G; Santoro, M; Formiggini, F; Spano, S; Piccini, D; Polishchuk, RS; Colanzi, A; Luini, A; Corda, D				Valente, Carman; Turacchio, Gabriele; Mariggio, Stefania; Pagliuso, Alessandro; Gaibisso, Renato; Di Tullio, Giuseppe; Santoro, Michele; Formiggini, Fabio; Spano, Stefania; Piccini, Daniele; Polishchuk, Roman S.; Colanzi, Antonino; Luini, Alberto; Corda, Daniela			A 14-3-3 gamma dimer-based scaffold bridges CtBP1-S/BARS to PI(4)KIII beta to regulate post-Golgi carrier formation	NATURE CELL BIOLOGY			English	Article							NEURONAL CALCIUM SENSOR-1; PLASMA-MEMBRANE; CELL-SURFACE; PHOSPHATIDYLINOSITOL 4-KINASE-BETA; DEPENDENT FISSION; PROTEIN; TRANSPORT; CTBP/BARS; ARF; TRAFFICKING	Large pleiomorphic carriers leave the Golgi complex for the plasma membrane by en bloc extrusion of specialized tubular domains, which then undergo fission. Several components of the underlying molecular machinery have been identified, including those involved in the budding/initiation of tubular carrier precursors (for example, the phosphoinositide kinase PI(4)KIII beta, the GTPase ARF, and FAPP2), and in the fission of these precursors (for example, PKD, CtBP1-S/BARS). However, how these proteins interact to bring about carrier formation is poorly understood. Here, we describe a protein complex that mediates carrier formation and contains budding and fission molecules, as well as other molecules, such as the adaptor protein 14-3-3 gamma. Specifically, we show that 14-3-3 gamma dimers bridge CtBP1-S/BARS with PI(4)KIII beta, and that the resulting complex is stabilized by phosphorylation by PKD and PAK. Disrupting the association of these proteins inhibits the fission of elongating carrier precursors, indicating that this complex couples the carrier budding and fission processes.	[Valente, Carman; Turacchio, Gabriele; Mariggio, Stefania; Pagliuso, Alessandro; Colanzi, Antonino; Luini, Alberto; Corda, Daniela] CNR, Inst Prot Biochem, I-80131 Naples, Italy; [Valente, Carman; Pagliuso, Alessandro; Santoro, Michele; Polishchuk, Roman S.; Luini, Alberto] Telethon Inst Genet & Med, I-80131 Naples, Italy; [Valente, Carman; Turacchio, Gabriele; Mariggio, Stefania; Pagliuso, Alessandro; Gaibisso, Renato; Di Tullio, Giuseppe; Santoro, Michele; Spano, Stefania; Polishchuk, Roman S.; Colanzi, Antonino; Luini, Alberto; Corda, Daniela] Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Chieti, Italy; [Formiggini, Fabio] Fdn Ist Italiano Tecnol IIT CRIB, Ctr Adv Biomat Hlth Care, I-80125 Naples, Italy; [Formiggini, Fabio] CEINGE Biotecnol Avanzate, I-80145 Naples, Italy; [Piccini, Daniele] Fdn Ist FIRC Oncol Mol IFOM, IFOM IFO, I-20139 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Consorzio Mario Negri Sud; Istituto Italiano di Tecnologia - IIT; CEINGE Biotecnologie Avanzate; IFOM - FIRC Institute of Molecular Oncology; IRCCS Istituti Fisioterapici Ospitalieri (IFO)	Luini, A (corresponding author), CNR, Inst Prot Biochem, Via Pietro Castellino 111, I-80131 Naples, Italy.	alberto.luini@cnr.it; d.corda@ibp.cnr.it	Mariggio', Stefania/H-5467-2015; Corda, Daniela/K-6385-2016; Valente, Carmen/AAH-5261-2019; Spanò, Stefania/F-4951-2011; Luini, Alberto/L-1372-2013; Colanzi, Antonino/D-6821-2012	Mariggio', Stefania/0000-0002-6397-3016; Corda, Daniela/0000-0002-3614-751X; Valente, Carmen/0000-0002-6244-9108; Spanò, Stefania/0000-0001-9154-7463; Luini, Alberto/0000-0002-8729-2549; Colanzi, Antonino/0000-0002-5643-0216; Polishchuk, Roman/0000-0002-7698-1955; Formiggini, Fabio/0000-0002-3547-4500	Italian Association for Cancer Research [IG4664, IG10341, IG4700, IG6074, IG10233]; Telethon Italia [GGPO9274, GGPO8231, GTF08001]; European Community [HEALTH-F2-2007-201804]; FaReBio; Ministry of Economy and Finance; Italian Foundation for Cancer Research Fellowships (FIRC, Milan, Italy);  [FIT DM 24/09/2009];  [Legge 46/82]	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Telethon Italia(Fondazione Telethon); European Community(European Commission); FaReBio; Ministry of Economy and Finance; Italian Foundation for Cancer Research Fellowships (FIRC, Milan, Italy)(Fondazione AIRC per la ricerca sul cancro); ; 	The authors would like to thank all colleagues who kindly provided them with antibodies and reagents (as listed under 'Reagents'); M. A. De Matteis and C. Wilson for critical reading of the manuscript; J. Chernoff for the PAK inhibitor IPA-3 (Fox Chase Cancer Center); C. P. Berrie for critical reading of and editorial assistance with the manuscript; C. Cericola for preparation of the anti-BARS antibody; R. Le Donne and E. Fontana for preparation of the figures; the Integrated Microscopy Facility at the Institute of Genetics and Biophysics, National Research Council, Naples, and the Dynamic Imaging Microscopy Facility at the CEINGE Institute, Naples, for support in imaging microscopy, data processing and analysis; the Italian Association for Cancer Research (to D.C. IG4664 and IG10341, to A.L. IG4700, to A.C. IG6074 and to R.S.P. IG10233), Telethon Italia (to D.C. GGPO9274, to A.L. GGPO8231 and to R.S.P. GTF08001), the European Community Seventh Framework Programme FP7/2007-2013 HEALTH-F2-2007-201804 (Eucilia to A.L.), grant FIT DM 24/09/2009, Legge 46/82, and FaReBio, Ministry of Economy and Finance (to D.C.) for financial support. C.V., A.P. and S.S. were recipients of Italian Foundation for Cancer Research Fellowships (FIRC, Milan, Italy).	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Barnes CJ, 2003, NAT STRUCT BIOL, V10, P622, DOI 10.1038/nsb957; Beck R, 2008, P NATL ACAD SCI USA, V105, P11731, DOI 10.1073/pnas.0805182105; Bonazzi M, 2005, NAT CELL BIOL, V7, P570, DOI 10.1038/ncb1260; BOULAN ER, 1980, CELL, V20, P45, DOI 10.1016/0092-8674(80)90233-0; BRASELMANN S, 1995, EMBO J, V14, P4839, DOI 10.1002/j.1460-2075.1995.tb00165.x; Bruns JR, 2002, J BIOL CHEM, V277, P2012, DOI 10.1074/jbc.M108571200; Cao XW, 2009, P NATL ACAD SCI USA, V106, P21121, DOI 10.1073/pnas.0911789106; Carcedo CH, 2004, SCIENCE, V305, P93, DOI 10.1126/science.1097775; Chaudhri M, 2003, BIOCHEM BIOPH RES CO, V300, P679, DOI 10.1016/S0006-291X(02)02902-9; Colanzi A, 2007, CURR OPIN CELL BIOL, V19, P386, DOI 10.1016/j.ceb.2007.06.002; Colanzi A, 2007, EMBO J, V26, P2465, DOI 10.1038/sj.emboj.7601686; Corda D, 2006, TRENDS CELL BIOL, V16, P167, DOI 10.1016/j.tcb.2006.01.007; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Demmel L, 2008, MOL BIOL CELL, V19, P1046, DOI 10.1091/mbc.E07-02-0134; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; Anel AMD, 2007, BIOCHEM J, V406, P157, DOI 10.1042/BJ20070359; Eswaran J, 2008, TRENDS BIOCHEM SCI, V33, P394, DOI 10.1016/j.tibs.2008.06.002; Gallop JL, 2005, NATURE, V438, P675, DOI 10.1038/nature04136; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Haga Y, 2009, EMBO J, V28, P1197, DOI 10.1038/emboj.2009.78; Harlow E., 1988, ANTIBODIES LAB MANUA; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Hausser A, 2006, J CELL SCI, V119, P3613, DOI 10.1242/jcs.03104; Haynes LP, 2005, J BIOL CHEM, V280, P6047, DOI 10.1074/jbc.M413090200; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Krauss M, 2008, J BIOL CHEM, V283, P27717, DOI 10.1074/jbc.M804528200; LEELAVATHI DE, 1970, BIOCHIM BIOPHYS ACTA, V211, P124, DOI 10.1016/0005-2736(70)90087-8; Liberali P, 2008, EMBO J, V27, P970, DOI 10.1038/emboj.2008.59; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Lundmark R, 2008, BIOCHEM J, V414, P189, DOI 10.1042/BJ20081237; MALHOTRA V, 1989, CELL, V58, P329, DOI 10.1016/0092-8674(89)90847-7; Marra P, 2001, NAT CELL BIOL, V3, P1101, DOI 10.1038/ncb1201-1101; MATLIN KS, 1983, CELL, V34, P233, DOI 10.1016/0092-8674(83)90154-X; Miserey-Lenkei S, 2010, NAT CELL BIOL, V12, P645, DOI 10.1038/ncb2067; Moreau D, 2011, DEV CELL, V21, P231, DOI 10.1016/j.devcel.2011.06.014; Nardini M, 2003, EMBO J, V22, P3122, DOI 10.1093/emboj/cdg283; Ottmann C, 2007, EMBO J, V26, P902, DOI 10.1038/sj.emboj.7601530; Paglini G, 2001, EMBO REP, V2, P1139, DOI 10.1093/embo-reports/kve250; Pelkmans L, 2003, CURR OPIN CELL BIOL, V15, P414, DOI 10.1016/S0955-0674(03)00081-4; Polishchuk EV, 2003, MOL BIOL CELL, V14, P4470, DOI 10.1091/mbc.E03-01-0033; Polishchuk R, 2004, NAT CELL BIOL, V6, P297, DOI 10.1038/ncb1109; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Pulvirenti T, 2008, NAT CELL BIOL, V10, P912, DOI 10.1038/ncb1751; Pusapati GV, 2010, MOL BIOL CELL, V21, P1011, DOI 10.1091/mbc.E09-09-0814; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Rothman JE, 2002, NAT MED, V8, P1059, DOI 10.1038/nm770; Saeed MF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001110; Schekman R, 2002, NAT MED, V8, P1055, DOI 10.1038/nm769; Schmidt JA, 2009, J CELL BIOL, V186, P211, DOI 10.1083/jcb.200904147; Schwarz K, 2011, J NEUROSCI, V31, P15996, DOI 10.1523/JNEUROSCI.2965-11.2011; Steinacker P, 2005, MOL CELL BIOL, V25, P1339, DOI 10.1128/MCB.25.4.1339-1346.2005; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Valente C, 2005, METHOD ENZYMOL, V404, P296, DOI 10.1016/S0076-6879(05)04027-9; Van der Hoeven PCJ, 2000, BIOCHEM J, V345, P297, DOI 10.1042/0264-6021:3450297; Verdoodt B, 2006, CELL CYCLE, V5, P2920, DOI 10.4161/cc.5.24.3571; Vieira OV, 2005, J CELL BIOL, V170, P521, DOI 10.1083/jcb.200503078; Vincenz C, 1996, J BIOL CHEM, V271, P20029, DOI 10.1074/jbc.271.33.20029; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang JS, 2011, NAT CELL BIOL, V13, P996, DOI 10.1038/ncb2273; Yang JS, 2005, EMBO J, V24, P4133, DOI 10.1038/sj.emboj.7600873; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Zhao XH, 2001, J BIOL CHEM, V276, P40183, DOI 10.1074/jbc.M104048200; Zhou Y, 2003, J BIOL CHEM, V278, P10073, DOI 10.1074/jbc.M211907200	70	64	64	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2012	14	4					343	+		10.1038/ncb2445	http://dx.doi.org/10.1038/ncb2445			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	921UM	22366688	Green Published			2022-12-25	WOS:000302503300007
J	Wahlberg, E; Karlberg, T; Kouznetsova, E; Markova, N; Macchiarulo, A; Thorsell, AG; Pol, E; Frostell, A; Ekblad, T; Oncu, D; Kull, B; Robertson, GM; Pellicciari, R; Schuler, H; Weigelt, J				Wahlberg, Elisabet; Karlberg, Tobias; Kouznetsova, Ekaterina; Markova, Natalia; Macchiarulo, Antonio; Thorsell, Ann-Gerd; Pol, Ewa; Frostell, Asa; Ekblad, Torun; Oncu, Delal; Kull, Bjorn; Robertson, Graeme Michael; Pellicciari, Roberto; Schuler, Herwig; Weigelt, Johan			Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors	NATURE BIOTECHNOLOGY			English	Article							PROMOTE PROTEIN STABILITY; POLY(ADP-RIBOSE) POLYMERASE; THERAPEUTIC STRATEGY; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; DNA-REPAIR; POTENT; MUTATION; TUMORS	Inhibitors of poly-ADP-ribose polymerase (PARP) family proteins are currently in clinical trials as cancer therapeutics, yet the specificity of many of these compounds is unknown. Here we evaluated a series of 185 small-molecule inhibitors, including research reagents and compounds being tested clinically, for the ability to bind to the catalytic domains of 13 of the 17 human PARP family members including the tankyrases, TNKS1 and TNKS2. Many of the best-known inhibitors, including TIQ-A, 6(5H)-phenanthridinone, olaparib, ABT-888 and rucaparib, bound to several PARP family members, suggesting that these molecules lack specificity and have promiscuous inhibitory activity. We also determined X-ray crystal structures for five TNKS2 ligand complexes and four PARP14 ligand complexes. In addition to showing that the majority of PARP inhibitors bind multiple targets, these results provide insight into the design of new inhibitors.	[Wahlberg, Elisabet; Karlberg, Tobias; Kouznetsova, Ekaterina; Markova, Natalia; Thorsell, Ann-Gerd; Ekblad, Torun; Schuler, Herwig; Weigelt, Johan] Karolinska Inst, Dept Med Biochem & Biophys, Struct Genom Consortium, Stockholm, Sweden; [Macchiarulo, Antonio; Robertson, Graeme Michael; Pellicciari, Roberto] Univ Perugia, Dipartimento Chim & Tecnol Farmaco, I-06100 Perugia, Italy; [Pol, Ewa; Frostell, Asa] GE Healthcare Biosci AB, Uppsala, Sweden; [Oncu, Delal; Kull, Bjorn] Actar AB, Stockholm, Sweden	Karolinska Institutet; University of Perugia; General Electric	Schuler, H (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Struct Genom Consortium, Stockholm, Sweden.	herwig.schuler@ki.se	Macchiarulo, Antonio/L-2846-2017; Schuler, Herwig/E-5751-2011	Macchiarulo, Antonio/0000-0001-9535-4183; Schuler, Herwig/0000-0003-4059-3501; Kull, Bjorn/0000-0001-8190-1625	Canadian Institutes for Health Research; Canada Foundation for Innovation; Genome Canada through Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research [RBc08-0014]; Wellcome Trust	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada through Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission)	The Structural Genomics Consortium is a registered charity (no. 1097737) that receives funds from the Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The study was also supported by grant RBc08-0014 from the Swedish Foundation for Strategic Research.	Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Ashworth A, 2008, CANCER RES, V68, P10021, DOI 10.1158/0008-5472.CAN-08-2287; Ba XQ, 2011, AM J PATHOL, V178, P946, DOI 10.1016/j.ajpath.2010.12.004; Bell CE, 1996, BIOCHEMISTRY-US, V35, P1137, DOI 10.1021/bi9520848; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Calabrese CR, 2004, J NATL CANCER I, V96, P56, DOI 10.1093/jnci/djh005; Carden CP, 2010, CURR OPIN ONCOL, V22, P473, DOI 10.1097/CCO.0b013e32833b5126; Chiarugi A, 2003, J PHARMACOL EXP THER, V305, P943, DOI 10.1124/jpet.103.048934; Chou HYE, 2006, J BIOL CHEM, V281, P15201, DOI 10.1074/jbc.M506745200; Citarelli M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-308; Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Hans CP, 2009, J PHARMACOL EXP THER, V329, P150, DOI 10.1124/jpet.108.145938; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Iwashita A, 2005, FEBS LETT, V579, P1389, DOI 10.1016/j.febslet.2005.01.036; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Karlberg T, 2010, J MED CHEM, V53, P5352, DOI 10.1021/jm100249w; Karlberg T, 2010, BIOCHEMISTRY-US, V49, P1056, DOI 10.1021/bi902079y; Kauppinen TM, 2007, NEUROSCIENCE, V145, P1267, DOI 10.1016/j.neuroscience.2006.09.034; Kleine H, 2008, MOL CELL, V32, P57, DOI 10.1016/j.molcel.2008.08.009; Lehtio L, 2009, J MED CHEM, V52, P3108, DOI 10.1021/jm900052j; Lehtio L, 2008, J MOL BIOL, V379, P136, DOI 10.1016/j.jmb.2008.03.058; McCabe N, 2009, ONCOGENE, V28, P1465, DOI 10.1038/onc.2008.483; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Otto H, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-139; Papeo G, 2009, EXPERT OPIN THER PAT, V19, P1377, DOI 10.1517/13543770903215883; Pellicciari Roberto, 2003, Farmaco (Lausanne), V58, P851, DOI 10.1016/S0014-827X(03)00143-5; Plummer R, 2010, CLIN CANCER RES, V16, P4527, DOI 10.1158/1078-0432.CCR-10-0984; PURNELL MR, 1980, BIOCHEM J, V185, P775, DOI 10.1042/bj1850775; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Ruf A, 1996, P NATL ACAD SCI USA, V93, P7481, DOI 10.1073/pnas.93.15.7481; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Strosznajder RP, 2010, MOL NEUROBIOL, V41, P187, DOI 10.1007/s12035-010-8124-6; SUGIMURA T, 1967, BIOCHIM BIOPHYS ACTA, V138, P438, DOI 10.1016/0005-2787(67)90507-2; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Yelamos J, 2008, TRENDS MOL MED, V14, P169, DOI 10.1016/j.molmed.2008.02.003; Yu M, 2005, ONCOGENE, V24, P1982, DOI 10.1038/sj.onc.1208410	43	364	395	2	96	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2012	30	3					283	+		10.1038/nbt.2121	http://dx.doi.org/10.1038/nbt.2121			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	905VI	22343925				2022-12-25	WOS:000301303800026
J	Woo, CW; Kutzler, L; Kimball, SR; Tabas, I				Woo, Connie W.; Kutzler, Lydia; Kimball, Scot R.; Tabas, Ira			Toll-like receptor activation suppresses ER stress factor CHOP and translation inhibition through activation of elF2B	NATURE CELL BIOLOGY			English	Article							FACTOR EIF2B; C-SRC; PROTEIN; PHOSPHORYLATION; SYNTHASE; INITIATION; DEPHOSPHORYLATION; INACTIVATION; EXPRESSION; SUBUNIT	Activation of Toll-like receptors (TLRs) induces the endoplasmic reticulum (ER) unfolded protein response (UPR) to accommodate essential protein translation(1,2). However,despite increased levels of phosphorylated elF2 alpha (p-elF2 alpha), a TLR-TRIF-dependent pathway assures that the cells avoid CHOP induction, apoptosis and translational suppression of critical proteins(3). As p-elF2 alpha decreases the functional interaction of elF2 with elF2B, a guanine nucleotide exchange factor (GEF), we explored the hypothesis that TLR-TRIF signalling activates elF2B GEF activity to counteract the effects of p-elF2 alpha. We now show that TLR-TRIF signalling activates elF2B GEF through PP2A-mediated serine dephosphorylation of the elF2B epsilon-subunit. PP2A itself is activated by decreased Src-family-kinase-induced tyrosine phosphorylation of its catalytic subunit. Each of these processes is required for TLR-TRIF-mediated CHOP suppression in ER-stressed cells in vitro and in vivo. Thus, in the setting of prolonged, physiologic ER stress, a unique TLR-TRIF-dependent translational control pathway enables cells to carry out essential protein synthesis and avoid CHOP-induced apoptosis while still benefiting from the protective arms of the UPR.	[Woo, Connie W.; Tabas, Ira] Columbia Univ, Dept Med, New York, NY 10032 USA; [Woo, Connie W.; Tabas, Ira] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Woo, Connie W.; Tabas, Ira] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Kutzler, Lydia; Kimball, Scot R.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Columbia University; Columbia University; Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Tabas, I (corresponding author), Columbia Univ, Dept Med, New York, NY 10032 USA.	iat1@columbia.edu	Woo, Connie/AAX-2588-2020	Woo, Connie Wai Hong/0000-0002-9574-9828	Canadian Institutes of Health Research; Heart & Stroke Foundation of Canada; NIH-NHLBI [HL75662, HL57560]; NIH-NIDDK [DK13499, DK15658]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075662, R01HL057560, P01HL087123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK015658, R01DK013499, R37DK013499] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart & Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by postdoctoral fellowship grants from the Canadian Institutes of Health Research and the Heart & Stroke Foundation of Canada (C.W.W.); NIH-NHLBI grants HL75662 and HL57560 (LT.); and NIH-NIDDK grants DK13499 and DK15658 (S.R.K.). We thank D. Ron (University of Cambridge, UK) for helpful discussions and for providing the CHOP-GFP reporter plasmid; C. Proud (University of Southampton, UK) for recombinant GST-DYRK2; D. Ren (University of Pennsylvania, USA) for advice regarding the use of mutant Src constructs; D. L. Brautigan (University of Virginia School of Medicine, USA) for the construct encoding PP2Ac<SUP>Y307F</SUP>; B. A. Hemmings (Friedrich Miescher Institute, Basel, Switzerland) for the construct encoding PP2Ac<SUP>L199P</SUP>; and B. Berk (University of Rochester, USA) for an adenoviral vector encoding kinase-inactive Src.	Barisic S, 2010, BIOCHEM PHARMACOL, V80, P439, DOI 10.1016/j.bcp.2010.04.028; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Check J, 2010, MOL IMMUNOL, V47, P756, DOI 10.1016/j.molimm.2009.10.012; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Chung HY, 1999, BIOCHEMISTRY-US, V38, P10371, DOI 10.1021/bi990902g; Curtiss LK, 2009, J LIPID RES, V50, pS340, DOI 10.1194/jlr.R800056-JLR200; Encinas M, 2001, J NEUROSCI, V21, P1464, DOI 10.1523/JNEUROSCI.21-05-01464.2001; Evans DRH, 1999, J BIOL CHEM, V274, P24038, DOI 10.1074/jbc.274.34.24038; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Hardt SE, 2004, CIRC RES, V94, P926, DOI 10.1161/01.RES.0000124977.59827.80; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Hu XH, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-74; Kim JY, 2010, BIOCHEM PHARMACOL, V79, P431, DOI 10.1016/j.bcp.2009.09.016; Krishnamoorthy T, 2001, MOL CELL BIOL, V21, P5018, DOI 10.1128/MCB.21.15.5018-5030.2001; Lee AS, 2006, CANCER BIOL THER, V5, P721, DOI 10.4161/cbt.5.7.3120; Lee JY, 2005, BIOCHEM PHARMACOL, V70, P1231, DOI 10.1016/j.bcp.2005.07.020; LIU XQ, 1993, ONCOGENE, V8, P1119; Lu BX, 2009, NATURE, V457, P741, DOI 10.1038/nature07579; Mayhew DL, 2011, J PHYSIOL-LONDON, V589, P3023, DOI 10.1113/jphysiol.2010.202432; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Nanahoshi M, 1999, FEBS LETT, V446, P108, DOI 10.1016/S0014-5793(99)00189-1; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Potter MW, 2001, J SURG RES, V97, P54, DOI 10.1006/jsre.2001.6111; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Santa-Coloma TA, 2003, CEREBELLUM, V2, P310, DOI 10.1080/14734220310017212; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Tu S, 2003, J BIOL CHEM, V278, P49293, DOI 10.1074/jbc.M307021200; Wang XM, 2008, MOL CELL BIOL, V28, P1429, DOI 10.1128/MCB.01512-07; Welsh GI, 1998, FEBS LETT, V421, P125, DOI 10.1016/S0014-5793(97)01548-2; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996	32	97	103	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2012	14	2					192	200		10.1038/ncb2408	http://dx.doi.org/10.1038/ncb2408			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	893CF	22231169	Green Accepted			2022-12-25	WOS:000300332500014
J	Luker, KE; Mihalko, LA; Schmidt, BT; Lewin, SA; Ray, P; Shcherbo, D; Chudakov, DM; Luker, GD				Luker, Kathryn E.; Mihalko, Laura Anne; Schmidt, Bradley T.; Lewin, Sarah A.; Ray, Paramita; Shcherbo, Dmitry; Chudakov, Dmitriy M.; Luker, Gary D.			In vivo imaging of ligand receptor binding with Gaussia luciferase cornplementation	NATURE MEDICINE			English	Article							BREAST-CANCER CELLS; CHEMOKINE RECEPTOR; ANTIBODY; OVARIAN; CXCL12; CXCR7; ASSAY; RDC1	Studies of ligand-receptor binding and the development of receptor antagonists would benefit greatly from imaging techniques that translate directly from cell-based assays to living animals. We used Gaussia luciferase protein fragment complementation to quantify the binding of chemokine (C-X-C motif) ligand 12 (CXCL12) to chemokine (C-X-C motif) receptor 4 (CXCR4) and CXCR7. Studies established that smallmolecule inhibitors of CXCR4 or CXCR7 specifically blocked CXCL12 binding in cell-based assays and revealed differences in kinetics of inhibiting chemokine binding to each receptor. Bioluminescence imaging showed CXCL12-CXCR7 binding in primary and metastatic tumors in a mouse model of breast cancer. We used this imaging technique to quantify drugmediated inhibition of CXCL12-CXCR4 binding in living mice. We expect this imaging technology to advance research in areas such as ligand-receptor interactions and the development of new therapeutic agents in cell-based assays and small animals.	[Luker, Kathryn E.; Mihalko, Laura Anne; Schmidt, Bradley T.; Lewin, Sarah A.; Ray, Paramita; Luker, Gary D.] Univ Michigan, Dept Radiol, Sch Med, Ctr Mol Imaging, Ann Arbor, MI 48109 USA; [Shcherbo, Dmitry; Chudakov, Dmitriy M.] Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Shcherbo, Dmitry; Chudakov, Dmitriy M.] Nizhny Novgorod State Med Acad, Nizhnii Novgorod, Russia; [Luker, Gary D.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Privolzhsky Research Medical University; University of Michigan System; University of Michigan	Luker, GD (corresponding author), Univ Michigan, Dept Radiol, Sch Med, Ctr Mol Imaging, Ann Arbor, MI 48109 USA.	gluker@umich.edu	Shcherbo, Dmitry S/B-3549-2019; Chudakov, Dmitriy M/G-7741-2014	Chudakov, Dmitriy M/0000-0003-0430-790X; luker, gary/0000-0001-6832-2581; Schmidt, Bradley/0000-0002-4011-4630	US National Institutes of Health [R01 CA 136553, R01 CA 136829, R01 CA142750, P50 CA93990, U24 CA083099]; Russian Educational Institutions [11.G34.31.0017]; Russian Ministry of Education and Science [16.740.11.0367, 16.512.11.2139]; NATIONAL CANCER INSTITUTE [R01CA136829, R01CA136553, P50CA093990, U24CA083099, R01CA142750] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028819] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Educational Institutions; Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by the US National Institutes of Health grants R01 CA 136553, R01 CA 136829, R01 CA142750 and P50 CA93990 (G.D.L.) and Measures to Attract Leading Scientists to Russian Educational Institutions grant 11.G34.31.0017 and Russian Ministry of Education and Science grants 16.740.11.0367 and 16.512.11.2139 (D.M.C.). We thank ChemoCentryx for the monoclonal antibody 11G8 and the small-molecule inhibitors of CXCR7. We acknowledge support from the US National Institutes of Health grant U24 CA083099 to B.D. Ross for the Michigan Small Animal Imaging Resource. We thank). Jaen, M. Penfold and D. Dairaghi for helpful discussions.	Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Datema R, 1996, ANTIMICROB AGENTS CH, V40, P750, DOI 10.1128/AAC.40.3.750; Furuya M, 2007, HUM PATHOL, V38, P1676, DOI 10.1016/j.humpath.2007.03.023; Hall JM, 2003, MOL ENDOCRINOL, V17, P792, DOI 10.1210/me.2002-0438; Lin LS, 2009, J MED CHEM, V52, P3449, DOI 10.1021/jm900257b; Loening AM, 2007, NAT METHODS, V4, P641, DOI 10.1038/NMETH1070; Luker KE, 2010, ONCOGENE, V29, P4599, DOI 10.1038/onc.2010.212; McCandless EE, 2008, AM J PATHOL, V172, P799, DOI 10.2353/ajpath.2008.070918; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Mirisola V, 2009, EUR J CANCER, V45, P2579, DOI 10.1016/j.ejca.2009.06.026; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Patel KG, 2009, BIOCHEM BIOPH RES CO, V390, P971, DOI 10.1016/j.bbrc.2009.10.087; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Shcherbo D, 2010, NAT METHODS, V7, P827, DOI [10.1038/NMETH.1501, 10.1038/nmeth.1501]; Shin SY, 2010, J BIOL CHEM, V285, P30731, DOI 10.1074/jbc.M110.128124; Torisawa YS, 2010, INTEGR BIOL-UK, V2, P680, DOI 10.1039/c0ib00041h; Venisnik KM, 2007, MOL IMAGING BIOL, V9, P267, DOI 10.1007/s11307-007-0101-8; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Woska JR, 2003, J IMMUNOL METHODS, V277, P101, DOI 10.1016/S0022-1759(03)00176-5	21	56	62	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2012	18	1					172	177		10.1038/nm.2590	http://dx.doi.org/10.1038/nm.2590			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22138753	Green Accepted			2022-12-25	WOS:000299018600045
J	Ohh, M				Ohh, Michael			Cancer SUMmOns Otto's metabolism	NATURE MEDICINE			English	Editorial Material							NEDD8-ACTIVATING ENZYME; PARAGANGLIOMA; MUTATIONS; MELANOMA; OXYGEN; MITF; GENE		[Ohh, Michael] Univ Toronto, Toronto, ON, Canada	University of Toronto	Ohh, M (corresponding author), Univ Toronto, Toronto, ON, Canada.	michael.ohh@utoronto.ca						Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Bertolotto C, 2011, NATURE, V480, P94, DOI 10.1038/nature10539; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Okura T, 1996, J IMMUNOL, V157, P4277; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Swords RT, 2010, BLOOD, V115, P3796, DOI 10.1182/blood-2009-11-254862; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309	13	5	5	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					30	+		10.1038/nm.2631	http://dx.doi.org/10.1038/nm.2631			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22227664				2022-12-25	WOS:000299018600023
J	Richter, S; Muller, LM; Stierhof, YD; Mayer, U; Takada, N; Kost, B; Vieten, A; Geldner, N; Koncz, C; Jurgens, G				Richter, Sandra; Mueller, Lena M.; Stierhof, York-Dieter; Mayer, Ulrike; Takada, Nozomi; Kost, Benedikt; Vieten, Anne; Geldner, Niko; Koncz, Csaba; Juergens, Gerd			Polarized cell growth in Arabidopsis requires endosomal recycling mediated by GBF1-related ARF exchange factors	NATURE CELL BIOLOGY			English	Article							POLLEN GERMINATION; TIP GROWTH; VESICLE TRAFFICKING; TUBE GROWTH; GNOM; ENDOCYTOSIS; DYNAMICS; PROTEIN; FLUORESCENCE; COMPARTMENTS	Polarized tip growth is a fundamental cellular process in many eukaryotic organisms, mediating growth of neuronal axons and dendrites(1) or fungal hyphae(2). In plants, pollen and root hairs are cellular model systems for analysing tip growth(3-5). Cell growth depends on membrane traffic. The regulation of this membrane traffic is largely unknown for tip-growing cells, in contrast to cells exhibiting intercalary growth. Here we show that in Arabidopsis, GBF1-related exchange factors for the ARF GTPases (ARF GEFs) GNOM and GNL2 play essential roles in polar tip growth of root hairs and pollen, respectively. When expressed from the same promoter, GNL2 (incontrast to the early-secretory ARF GEF GNL1) is able to replace GNOM in polar recycling of the auxin efflux regulator PIN1 from endosomes to the basal plasma membrane in non-tip growing cells. Thus, polar recycling facilitates polar tip growth, and GNL2 seems to have evolved to meet the specific requirement of fast-growing pollen in higher plants.	[Richter, Sandra; Mueller, Lena M.; Stierhof, York-Dieter; Mayer, Ulrike; Takada, Nozomi; Vieten, Anne; Geldner, Niko; Juergens, Gerd] Univ Tubingen, ZMBP, D-72076 Tubingen, Germany; [Kost, Benedikt] Univ Erlangen Nurnberg, Dept Biol, D-91058 Erlangen, Germany; [Koncz, Csaba] Max Planck Inst Zuchtungsforsch, D-50829 Cologne, Germany	Eberhard Karls University of Tubingen; University of Erlangen Nuremberg; Max Planck Society	Jurgens, G (corresponding author), Univ Tubingen, ZMBP, Morgenstelle 3, D-72076 Tubingen, Germany.	gerd.juergens@zmbp.uni-tuebingen.de	Geldner, Niko/Y-2481-2019; Müller, Lena Maria/AAE-1414-2021	Müller, Lena Maria/0000-0002-6036-4514; Geldner, Niko/0000-0002-2300-9644	Deutsche Forschungsgemeinschaft [SFB 446 (TP A9)]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank J. Keicher, R. Gavidia and B. Maier for technical assistance, C. Knoll for formatting of data files, D. G. Robinson and S. McCormick for providing materials and members of the laboratory for critical reading of the manuscript. This work was financially supported by the Deutsche Forschungsgemeinschaft through SFB 446 (TP A9).	Anders N, 2008, PLANT CELL, V20, P142, DOI 10.1105/tpc.107.056515; Boavida LC, 2007, PLANT J, V52, P570, DOI 10.1111/j.1365-313X.2007.03248.x; Bove J, 2008, PLANT PHYSIOL, V147, P1646, DOI 10.1104/pp.108.120212; Campanoni P, 2007, J EXP BOT, V58, P65, DOI 10.1093/jxb/erl059; Carol RJ, 2002, PHILOS T ROY SOC B, V357, P815, DOI 10.1098/rstb.2002.1092; DERKSEN J, 1995, PROTOPLASMA, V188, P267, DOI 10.1007/BF01280379; Dhonukshe P, 2008, NATURE, V456, P962, DOI 10.1038/nature07409; Fischer U, 2006, CURR BIOL, V16, P2143, DOI 10.1016/j.cub.2006.08.091; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Geldner N, 2004, DEVELOPMENT, V131, P389, DOI 10.1242/dev.00926; Geldner N, 2009, PLANT J, V59, P169, DOI 10.1111/j.1365-313X.2009.03851.x; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; HESLOPHARRISON J, 1970, STAIN TECHNOL, V45, P115, DOI 10.3109/10520297009085351; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Hou WC, 1999, BOT BULL ACAD SINICA, V40, P115; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jia DJ, 2009, J INTEGR PLANT BIOL, V51, P762, DOI 10.1111/j.1744-7909.2009.00858.x; Kang BH, 2011, TRAFFIC, V12, P313, DOI 10.1111/j.1600-0854.2010.01146.x; Lauber MH, 1997, J CELL BIOL, V139, P1485, DOI 10.1083/jcb.139.6.1485; MAYER U, 1993, DEVELOPMENT, V117, P149; Moscatelli A, 2009, J INTEGR PLANT BIOL, V51, P727, DOI 10.1111/j.1744-7909.2009.00842.x; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Naramoto S, 2010, P NATL ACAD SCI USA, V107, P21890, DOI 10.1073/pnas.1016260107; Ovecka M, 2005, PROTOPLASMA, V226, P39, DOI 10.1007/s00709-005-0103-9; Parton RM, 2001, J CELL SCI, V114, P2685; PREUSS D, 1994, SCIENCE, V264, P1458, DOI 10.1126/science.8197459; Preuss ML, 2004, PLANT CELL, V16, P1589, DOI 10.1105/tpc.021634; Reichardt I, 2011, TRAFFIC, V12, P1269, DOI 10.1111/j.1600-0854.2011.01222.x; Reichardt L, 2007, CURR BIOL, V17, P2047, DOI 10.1016/j.cub.2007.10.040; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Richter S, 2007, NATURE, V448, P488, DOI 10.1038/nature05967; Rios G, 2002, PLANT J, V32, P243, DOI 10.1046/j.1365-313X.2002.01416.x; Rudall PJ, 2007, TRENDS PLANT SCI, V12, P317, DOI 10.1016/j.tplants.2007.06.004; Rutherford S, 2002, CURR OPIN PLANT BIOL, V5, P518, DOI 10.1016/S1369-5266(02)00307-2; Steinberg G, 2007, EUKARYOT CELL, V6, P351, DOI 10.1128/EC.00381-06; Szumlanski AL, 2009, PLANT CELL, V21, P526, DOI 10.1105/tpc.108.060277; Takada S, 2007, DEVELOPMENT, V134, P1141, DOI 10.1242/dev.02803; Tang BL, 2008, BBA-MOL CELL RES, V1783, P169, DOI 10.1016/j.bbamcr.2007.11.011; Teh OK, 2007, NATURE, V448, P493, DOI 10.1038/nature06023; Wang QL, 2005, PLANT PHYSIOL, V139, P1692, DOI 10.1104/pp.105.069765; Zhang Y, 2010, SEX PLANT REPROD, V23, P87, DOI 10.1007/s00497-009-0118-z; Zhang Y, 2010, PLANT PHYSIOL, V152, P2200, DOI 10.1104/pp.109.142349; Zonia L, 2008, J EXP BOT, V59, P861, DOI 10.1093/jxb/ern007	43	46	50	3	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2012	14	1					80	U130		10.1038/ncb2389	http://dx.doi.org/10.1038/ncb2389			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	866YC	22138577				2022-12-25	WOS:000298421100013
J	Adler-Abramovich, L; Vaks, L; Carny, O; Trudler, D; Magno, A; Caflisch, A; Frenkel, D; Gazit, E				Adler-Abramovich, Lihi; Vaks, Lilach; Carny, Ohad; Trudler, Dorit; Magno, Andrea; Caflisch, Amedeo; Frenkel, Dan; Gazit, Ehud			Phenylalanine assembly into toxic fibrils suggests amyloid etiology in phenylketonuria	NATURE CHEMICAL BIOLOGY			English	Article							BETA; FIBRILLOGENESIS; PENTAPEPTIDE; DISEASE; MODEL	Phenylketonuria (PKU) is characterized by phenylalanine accumulation and progressive mental retardation caused by an unknown mechanism. We demonstrate that at pathological concentrations, phenylalanine self-assembles into fibrils with amyloid-like morphology and well-ordered electron diffraction. These assemblies are specifically recognized by antibodies, show cytotoxicity that can be neutralized by the antibodies and are present in the hippocampus of model mice and in parietal cortex brain tissue from individuals with PKU. This is, to our knowledge, the first demonstration that a single amino acid can form amyloid-like deposits, suggesting a new amyloidosis-like etiology for PKU.	[Adler-Abramovich, Lihi; Vaks, Lilach; Carny, Ohad; Gazit, Ehud] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Trudler, Dorit; Frenkel, Dan] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Trudler, Dorit; Frenkel, Dan] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Magno, Andrea; Caflisch, Amedeo] Univ Zurich, Dept Biochem, Zurich, Switzerland	Tel Aviv University; Tel Aviv University; Tel Aviv University; University of Zurich	Gazit, E (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	ehudg@post.tau.ac.il	Gazit, Ehud/M-8026-2019; Adler-Abramovich, Lihi/AAN-1430-2020; Caflisch, Amedeo/I-3459-2012; Gazit, Ehud/AHE-9332-2022; Gazit, Ehud/C-3715-2011	Gazit, Ehud/0000-0001-5764-1720; Adler-Abramovich, Lihi/0000-0003-3433-0625; Gazit, Ehud/0000-0001-5764-1720	Israel Science Foundation-Legacy Heritage Biomedical Science Partnership grant [862/09]; Alzheimer's Association [NIRG-11-205535]; Swiss National Science Foundation; Colton Foundation; Medical Research Council [G1100695] Funding Source: researchfish; MRC [G1100695] Funding Source: UKRI	Israel Science Foundation-Legacy Heritage Biomedical Science Partnership grant; Alzheimer's Association(Alzheimer's Association); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Colton Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank R. Shaltiel-Karyo for confocal microscopy analysis, S. Wolf for the electron diffraction analysis, L. Buzhansky for help with the NMR and HPLC analysis, J. Delarea for help with TEM and SEM experiments, Z. Barkay for help with the SEM and ESEM analysis, S.-C. Jung (Ewha Womans University, Korea) for BTBR-Pah<SUP>enu2</SUP> mouse plasma and tissue samples, C. Troakes (London Neurodegenerative Diseases Brain Bank, King's College London and part of BrainNet Europe) and T. Arzberger (Centre for Neuropathology and Prion Research, Munchen) for brain tissue samples, I. Benhar and members of the Gazit laboratory for helpful discussions. L. A.-A. gratefully acknowledges the support of the Colton Foundation. This work was partly supported by the Israel Science Foundation-Legacy Heritage Biomedical Science Partnership grant 862/09 and the Alzheimer's Association grant NIRG-11-205535 (to D. F.). The work in the A. C. group was supported by the Swiss National Science Foundation.	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CHOI TB, 1986, J BIOL CHEM, V261, P6536; CORDERO ME, 1983, EARLY HUM DEV, V8, P157, DOI 10.1016/0378-3782(83)90072-5; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Gazit E, 2002, BIOINFORMATICS, V18, P880, DOI 10.1093/bioinformatics/18.6.880; Gazit V, 2003, BEHAV BRAIN RES, V143, P1, DOI 10.1016/S0166-4328(03)00075-5; Haberthur U, 2008, J COMPUT CHEM, V29, P701, DOI 10.1002/jcc.20832; Hanley WB, 2004, AM J MED, V117, P590, DOI 10.1016/j.amjmed.2004.03.042; Horster F, 2006, PEDIATR RES, V59, P544, DOI 10.1203/01.pdr.0000203091.45988.8d; Inouye H, 2006, BIOPHYS J, V90, P1774, DOI 10.1529/biophysj.105.070136; KRAUSE W, 1985, J CLIN INVEST, V75, P40, DOI 10.1172/JCI111695; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; MacDonald A, 2010, J INHERIT METAB DIS, V33, P665, DOI 10.1007/s10545-010-9073-y; Makin OS, 2005, FEBS J, V272, P5950, DOI 10.1111/j.1742-4658.2005.05025.x; Makin OS, 2005, P NATL ACAD SCI USA, V102, P315, DOI 10.1073/pnas.0406847102; Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387; Reches M, 2002, J BIOL CHEM, V277, P35475, DOI 10.1074/jbc.M206039200; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SHEDLOVSKY A, 1993, GENETICS, V134, P1205; Solomon B, 2007, EXPERT OPIN INV DRUG, V16, P819, DOI 10.1517/13543784.16.6.819; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; Surtees R, 2000, EUR J PEDIATR, V159, pS109, DOI 10.1007/PL00014370; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545	28	289	292	4	142	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2012	8	8					701	706		10.1038/NCHEMBIO.1002	http://dx.doi.org/10.1038/NCHEMBIO.1002			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975RC	22706200				2022-12-25	WOS:000306527600009
J	Zheng, JT; Gay, DC; Demeler, B; White, MA; Keatinge-Clay, AT				Zheng, Jianting; Gay, Darren C.; Demeler, Borries; White, Mark A.; Keatinge-Clay, Adrian T.			Divergence of multimodular polyketide synthases revealed by a didomain structure	NATURE CHEMICAL BIOLOGY			English	Article							ISOLATED KETOREDUCTASE DOMAINS; FATTY-ACID SYNTHASE; X-RAY SOLUTION; CRYSTAL-STRUCTURE; THIOESTER REDUCTASE; FUNCTIONAL-ANALYSIS; STEREOCHEMISTRY; SCATTERING; CATALYSIS; MUTAGENESIS	The enoylreductase (ER) is the final common enzyme from modular polyketide synthases (PKSs) to be structurally characterized. The 3.0 angstrom-resolution structure of the didomain comprising the ketoreductase (KR) and ER from the second module of the spinosyn PKS reveals that ER shares an similar to 600-angstrom(2) interface with KR distinct from that of the related mammalian fatty acid synthase (FAS). In contrast to the ER domains of the mammalian FAS, the ER domains of the second module of the spinosyn PKS do not make contact across the two-fold axis of the synthase. This monomeric organization may have been necessary in the evolution of multimodular PKSs to enable acyl carrier proteins to access each of their cognate enzymes. The isolated ER domain showed activity toward a substrate analog, enabling us to determine the contributions of its active site residues.	[Zheng, Jianting; Gay, Darren C.; Keatinge-Clay, Adrian T.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Demeler, Borries] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [White, Mark A.] Univ Texas Med Branch Galveston, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX USA; [White, Mark A.] Univ Texas Med Branch Galveston, Dept Biochem & Mol Biol, Galveston, TX USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Keatinge-Clay, AT (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA.	adriankc@mail.utexas.edu	White, Mark Andrew/B-1723-2012	White, Mark Andrew/0000-0003-1057-4203; Demeler, Borries/0000-0002-2414-9518	Welch Foundation [F-1712]; Sealy and Smith Foundation; US National Institutes of Health [RR022200]; US National Science Foundation [TG-MCB070038]; San Antonio Cancer Institute [P30 CA054174]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR022200] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); Sealy and Smith Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); San Antonio Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank A.F. Monzingo for helping with in-house diffraction experiments and C. D. Fage for helping optimize crystals. Synchrotron data were obtained at the ALS Beamlines 8.2.1 and 5.0.2. Financial support was provided by Welch Foundation Grant F-1712 (A.T.K.-C.) as well as the Sealy and Smith Foundation grant to the Sealy Center for Structural Biology and Molecular Biophysics (M. A. W.). The development of the UltraScan software is supported by the US National Institutes of Health through grant RR022200 (B. D.). Supercomputer time allocations were provided through the US National Science Foundation grant TG-MCB070038 (B. D.). We acknowledge the support of the San Antonio Cancer Institute grant P30 CA054174 for the Center for Analytical Ultracentrifugation of Macromolecular Assemblies at the University of Texas Health Science Center at San Antonio.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Airenne TT, 2003, J MOL BIOL, V327, P47, DOI 10.1016/S0022-2836(03)00038-X; Akey DL, 2010, STRUCTURE, V18, P94, DOI 10.1016/j.str.2009.10.018; Alekseyev VY, 2007, PROTEIN SCI, V16, P2093, DOI 10.1110/ps.073011407; Baerga-Ortiz A, 2006, CHEM BIOL, V13, P277, DOI 10.1016/j.chembiol.2006.01.004; Chakravarty B, 2004, P NATL ACAD SCI USA, V101, P15567, DOI 10.1073/pnas.0406901101; Chen ZJ, 2008, J MOL BIOL, V379, P830, DOI 10.1016/j.jmb.2008.04.041; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Keatinge-Clay A, 2008, J MOL BIOL, V384, P941, DOI 10.1016/j.jmb.2008.09.084; Keatinge-Clay AT, 2007, CHEM BIOL, V14, P898, DOI 10.1016/j.chembiol.2007.07.009; Keatinge-Clay AT, 2006, STRUCTURE, V14, P737, DOI 10.1016/j.str.2006.01.009; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Kim KH, 2011, J MOL BIOL, V406, P403, DOI 10.1016/j.jmb.2010.12.003; Kirst HA, 2010, J ANTIBIOT, V63, P101, DOI 10.1038/ja.2010.5; Kishan KVR, 1997, NAT STRUCT BIOL, V4, P739; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kwan DH, 2010, ACS CHEM BIOL, V5, P829, DOI 10.1021/cb100175a; Kwan DH, 2008, CHEM BIOL, V15, P1231, DOI 10.1016/j.chembiol.2008.09.012; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Lu H, 2010, BIOCHEMISTRY-US, V49, P1281, DOI 10.1021/bi902001a; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pedelacq JD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr548; Persson B, 2008, CELL MOL LIFE SCI, V65, P3879, DOI 10.1007/s00018-008-8587-z; Piasecki SK, 2011, CHEM BIOL, V18, P1331, DOI 10.1016/j.chembiol.2011.07.021; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Siskos AP, 2005, CHEM BIOL, V12, P1145, DOI 10.1016/j.chembiol.2005.08.017; Smith S, 2007, NAT PROD REP, V24, P1041, DOI 10.1039/b603600g; Staunton J, 1996, NAT STRUCT BIOL, V3, P188, DOI 10.1038/nsb0296-188; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; THORN JM, 1995, J MOL BIOL, V249, P785, DOI 10.1006/jmbi.1995.0337; Torkko JM, 2003, J BIOL CHEM, V278, P41213, DOI 10.1074/jbc.M307664200; Tsai SC, 2001, P NATL ACAD SCI USA, V98, P14808, DOI 10.1073/pnas.011399198; Valenzano CR, 2009, J AM CHEM SOC, V131, P18501, DOI 10.1021/ja908296m; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Witkowski A, 2004, BIOCHEMISTRY-US, V43, P10458, DOI 10.1021/bi048988n; Zheng JT, 2011, J MOL BIOL, V410, P105, DOI 10.1016/j.jmb.2011.04.065; Zheng JT, 2010, STRUCTURE, V18, P913, DOI 10.1016/j.str.2010.04.015	46	58	58	1	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2012	8	7					615	621		10.1038/NCHEMBIO.964	http://dx.doi.org/10.1038/NCHEMBIO.964			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961NJ	22634636	Green Accepted			2022-12-25	WOS:000305471400008
J	Bottcher, RT; Stremmel, C; Meves, A; Meyer, H; Widmaier, M; Tseng, HY; Fassler, R				Boettcher, Ralph Thomas; Stremmel, Christopher; Meves, Alexander; Meyer, Hannelore; Widmaier, Moritz; Tseng, Hui-Yuan; Faessler, Reinhard			Sorting nexin 17 prevents lysosomal degradation of beta(1) integrins by binding to the beta(1)-integrin tail	NATURE CELL BIOLOGY			English	Article							DOMAIN; ACTIVATION; TALIN; MEMBRANE; ALPHA-V-BETA-3; EXPRESSION; ENDOSOMES; KINDLIN-3; MIGRATION; INTERACT	Integrin functions are controlled by regulating their affinity for ligand, and by the efficient recycling of intact integrins through endosomes. Here we demonstrate that the Kindlin-binding site in the beta(1)-integrin cytoplasmic domain serves as a molecular switch enabling the sequential binding of two FERM-domain-containing proteins in different cellular compartments. When beta(1) integrins are at the plasma membrane, Kindlins control ligand-binding affinity. However, when they are internalized, Kindlins dissociate from integrins and sorting nexin 17 (SNX17) is recruited to free beta(1)-integrin tails in early endosomes to prevent beta(1)-integrin degradation, leading to their recycling back to the cell surface. Our results identify SNX17 as a beta(1)-integrin-tail-binding protein that interacts with the free Kindlin-binding site in endosomes to stabilize beta(1) integrins, resulting in their recycling to the cell surface where they can be reused.	[Boettcher, Ralph Thomas; Stremmel, Christopher; Meves, Alexander; Meyer, Hannelore; Widmaier, Moritz; Tseng, Hui-Yuan; Faessler, Reinhard] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany	Max Planck Society	Fassler, R (corresponding author), Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany.	Faessler@biochem.mpg.de	Stremmel, Christopher/ABH-5416-2020		Deutsche Forschungsgemeinschaft [SFB-914]; Tiroler Zukunftsstiftung; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tiroler Zukunftsstiftung; Max Planck Society(Max Planck Society)	We thank J. Norman and R. Ruppert for help with recycling assays and cell sorting, C. Boulegue for mass spectrometry analysis, M. Iglesias for artwork, C. Franke for His-Kindlin-2 purification and R. Zent, A. Pozzi and D. Teis for discussions and critically reading the manuscript. This work was supported by the Deutsche Forschungsgemeinschaft (SFB-914), the Tiroler Zukunftsstiftung and the Max Planck Society.	Azimifar SB, 2012, J CELL SCI, V125, P435, DOI 10.1242/jcs.091652; Bottcher RT, 2009, EMBO J, V28, P1157, DOI 10.1038/emboj.2009.58; Burden JJ, 2004, J BIOL CHEM, V279, P16237, DOI 10.1074/jbc.M313689200; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Caswell PT, 2008, J CELL BIOL, V183, P143, DOI 10.1083/jcb.200804140; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Czuchra A, 2006, J CELL BIOL, V174, P889, DOI 10.1083/jcb.200604060; Donoso M, 2009, MOL BIOL CELL, V20, P481, DOI 10.1091/mbc.E08-08-0805; Ghai R, 2011, P NATL ACAD SCI USA, V108, P7763, DOI 10.1073/pnas.1017110108; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Knauth P, 2005, J MOL BIOL, V347, P813, DOI 10.1016/j.jmb.2005.02.004; Lee JY, 2008, J BIOL CHEM, V283, P11501, DOI 10.1074/jbc.M800642200; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Liu JM, 2011, J BIOL CHEM, V286, P43334, DOI 10.1074/jbc.M111.295352; Lobert VH, 2010, DEV CELL, V19, P148, DOI 10.1016/j.devcel.2010.06.010; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Meves A, 2011, P NATL ACAD SCI USA, V108, P15213, DOI 10.1073/pnas.1105689108; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Montanez E, 2007, METHOD ENZYMOL, V426, P239, DOI 10.1016/S0076-6879(07)26012-4; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pfeifer A, 2000, P NATL ACAD SCI USA, V97, P12227, DOI 10.1073/pnas.220399597; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Roberts MS, 2004, MOL CELL BIOL, V24, P1505, DOI 10.1128/MCB.24.4.1505-1515.2004; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Stockinger W, 2002, EMBO J, V21, P4259, DOI 10.1093/emboj/cdf435; Sung BH, 2011, CURR BIOL, V21, P1460, DOI 10.1016/j.cub.2011.06.065; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Ussar S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000289; van Kerkhof P, 2005, EMBO J, V24, P2851, DOI 10.1038/sj.emboj.7600756; van Weert AWM, 2000, EUR J CELL BIOL, V79, P394, DOI 10.1078/0171-9335-00062; Williams R, 2004, MOL BIOL CELL, V15, P3095, DOI 10.1091/mbc.E04-02-0143; Woods AJ, 2004, EMBO J, V23, P2531, DOI 10.1038/sj.emboj.7600267	44	148	150	3	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2012	14	6					584	+		10.1038/ncb2501	http://dx.doi.org/10.1038/ncb2501			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	949TW	22561348				2022-12-25	WOS:000304599900008
J	Bis, JC; DeCarli, C; Smith, AV; van der Lijn, F; Crivello, F; Fornage, M; Debette, S; Shulman, JM; Schmidt, H; Srikanth, V; Schuur, M; Yu, L; Choi, SH; Sigurdsson, S; Verhaaren, BFJ; DeStefano, AL; Lambert, JC; Jack, CR; Struchalin, M; Stankovich, J; Ibrahim-Verbaas, CA; Fleischman, D; Zijdenbos, A; den Heijer, T; Mazoyer, B; Coker, LH; Enzinger, C; Danoy, P; Amin, N; Arfanakis, K; van Buchem, MA; de Bruijn, RFAG; Beiser, A; Dufouil, C; Huang, JB; Cavalieri, M; Thomson, R; Niessen, WJ; Chibnik, LB; Gislason, GK; Hofman, A; Pikula, A; Amouyel, P; Freeman, KB; Phan, TG; Oostra, BA; Stein, JL; Medland, SE; Vasquez, AA; Hibar, DP; Wright, MJ; Franke, B; Martin, NG; Thompson, PM; Nalls, MA; Uitterlinden, AG; Au, R; Elbaz, A; Beare, RJ; van Swieten, JC; Lopez, OL; Harris, TB; Chouraki, V; Breteler, MMB; De Jager, PL; Becker, JT; Vernooij, MW; Knopman, D; Fazekas, F; Wolf, PA; van der Lugt, A; Gudnason, V; Longstreth, WT; Brown, MA; Bennett, DA; van Duijn, CM; Mosley, TH; Schmidt, R; Tzourio, C; Launer, LJ; Ikram, MA; Seshadri, S				Bis, Joshua C.; DeCarli, Charles; Smith, Albert Vernon; van der Lijn, Fedde; Crivello, Fabrice; Fornage, Myriam; Debette, Stephanie; Shulman, Joshua M.; Schmidt, Helena; Srikanth, Velandai; Schuur, Maaike; Yu, Lei; Choi, Seung-Hoan; Sigurdsson, Sigurdur; Verhaaren, Benjamin F. J.; DeStefano, Anita L.; Lambert, Jean-Charles; Jack, Clifford R., Jr.; Struchalin, Maksim; Stankovich, Jim; Ibrahim-Verbaas, Carla A.; Fleischman, Debra; Zijdenbos, Alex; den Heijer, Tom; Mazoyer, Bernard; Coker, Laura H.; Enzinger, Christian; Danoy, Patrick; Amin, Najaf; Arfanakis, Konstantinos; van Buchem, Mark A.; de Bruijn, Renee F. A. G.; Beiser, Alexa; Dufouil, Carole; Huang, Juebin; Cavalieri, Margherita; Thomson, Russell; Niessen, Wiro J.; Chibnik, Lori B.; Gislason, Gauti K.; Hofman, Albert; Pikula, Aleksandra; Amouyel, Philippe; Freeman, Kevin B.; Phan, Thanh G.; Oostra, Ben A.; Stein, Jason L.; Medland, Sarah E.; Vasquez, Alejandro Arias; Hibar, Derrek P.; Wright, Margaret J.; Franke, Barbara; Martin, Nicholas G.; Thompson, Paul M.; Nalls, Michael A.; Uitterlinden, Andre G.; Au, Rhoda; Elbaz, Alexis; Beare, Richard J.; van Swieten, John C.; Lopez, Oscar L.; Harris, Tamara B.; Chouraki, Vincent; Breteler, Monique M. B.; De Jager, Philip L.; Becker, James T.; Vernooij, Meike W.; Knopman, David; Fazekas, Franz; Wolf, Philip A.; van der Lugt, Aad; Gudnason, Vilmundur; Longstreth, W. T., Jr.; Brown, Matthew A.; Bennett, David A.; van Duijn, Cornelia M.; Mosley, Thomas H.; Schmidt, Reinhold; Tzourio, Christophe; Launer, Lenore J.; Ikram, M. Arfan; Seshadri, Sudha		Enhancing Neuro Imaging Genetics M; Cohorts Heart Aging Res Genomic Ep	Common variants at 12q14 and 12q24 are associated with hippocampal volume	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GLUCAGON-LIKE PEPTIDE-1; IDENTIFIES VARIANTS; ALZHEIMERS-DISEASE; TOTAL HOMOCYSTEINE; CELL-DEATH; ATROPHY; PROTEIN; CLU; EXPRESSION	Aging is associated with reductions in hippocampal volume that are accelerated by Alzheimer's disease and vascular risk factors. Our genome-wide association study (GWAS) of dementia-free persons (n = 9,232) identified 46 SNPs at four loci with P values of < 4.0 x 10(-7). In two additional samples (n = 2,318), associations were replicated at 12q14 within MSRB3-WIF1 (discovery and replication; rs17178006; P = 5.3 x 10(-11)) and at 12q24 near HRK-FBXW8 (rs7294919; P = 2.9 x 10(-11)). Remaining associations included one SNP at 2q24 within DPP4 (rs6741949; P = 2.9 x 10(-7)) and nine SNPs at 9p33 within ASTN2 (rs7852872; P = 1.0 x 10(-7)); along with the chromosome 12 associations, these loci were also associated with hippocampal volume (P < 0.05) in a third younger, more heterogeneous sample (n = 7,794). The SNP in ASTN2 also showed suggestive association with decline in cognition in a largely independent sample (n = 1,563). These associations implicate genes related to apoptosis (HRK), development (WIF1), oxidative stress (MSR3B), ubiquitination (FBXW8) and neuronal migration (ASTN2), as well as enzymes targeted by new diabetes medications (DPP4), indicating new genetic influences on hippocampal size and possibly the risk of cognitive decline and dementia.	[Debette, Stephanie; DeStefano, Anita L.; Beiser, Alexa; Pikula, Aleksandra; Au, Rhoda; Wolf, Philip A.; Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Bis, Joshua C.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [DeCarli, Charles] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; [DeCarli, Charles] Univ Calif Davis, Ctr Neurosci, Sacramento, CA 95817 USA; [Smith, Albert Vernon; Sigurdsson, Sigurdur; Gislason, Gauti K.; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Smith, Albert Vernon; Gudnason, Vilmundur] Univ Iceland, Fac Med, Reykjavik, Iceland; [van der Lijn, Fedde; Niessen, Wiro J.] Univ Med Ctr, Erasmus Med Ctr, Dept Med Informat, Rotterdam, Netherlands; [van der Lijn, Fedde; Verhaaren, Benjamin F. J.; Niessen, Wiro J.; Vernooij, Meike W.; van der Lugt, Aad; Ikram, M. Arfan] Univ Med Ctr, Erasmus Med Ctr, Dept Radiol, Rotterdam, Netherlands; [Crivello, Fabrice; Mazoyer, Bernard] Univ Bordeaux, Neurofunct Imaging Grp, UMR 5296, Bordeaux, France; [Crivello, Fabrice; Mazoyer, Bernard] Univ Bordeaux, Neurofunct Imaging Grp, CNRS, UMR 5296, Bordeaux, France; [Crivello, Fabrice; Mazoyer, Bernard] CEA, Neurofunct Imaging Grp, UMR 5296, Bordeaux, France; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Sch Publ Hlth, Houston, TX USA; [Debette, Stephanie; Dufouil, Carole; Elbaz, Alexis] INSERM, U708, Paris, France; [Debette, Stephanie] Univ Versailles St Quentin En Yvelines, Dept Epidemiol, Paris, France; [Shulman, Joshua M.; Chibnik, Lori B.; De Jager, Philip L.] Brigham & Womens Hosp, Program Translat NeuroPsychiat Genom, Inst Neurosci, Dept Neurol, Boston, MA 02115 USA; [Shulman, Joshua M.; Chibnik, Lori B.; De Jager, Philip L.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Schmidt, Helena] Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria; [Srikanth, Velandai; Phan, Thanh G.; Beare, Richard J.] Monash Univ, Dept Med, Stroke & Ageing Res Ctr, So Clin Sch, Melbourne, Vic 3004, Australia; [Srikanth, Velandai; Stankovich, Jim; Thomson, Russell] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia; [Schuur, Maaike; Struchalin, Maksim; Ibrahim-Verbaas, Carla A.; Amin, Najaf; Oostra, Ben A.; van Duijn, Cornelia M.] Univ Med Ctr, Erasmus Med Ctr, Dept Epidemiol, Genet Epidemiol Unit, Rotterdam, Netherlands; [Schuur, Maaike; Ibrahim-Verbaas, Carla A.; den Heijer, Tom; de Bruijn, Renee F. A. G.; van Swieten, John C.] Univ Med Ctr, Erasmus Med Ctr, Dept Neurol, Rotterdam, Netherlands; [Yu, Lei; Fleischman, Debra; Arfanakis, Konstantinos; Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Choi, Seung-Hoan; DeStefano, Anita L.; Beiser, Alexa] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Verhaaren, Benjamin F. J.; den Heijer, Tom; de Bruijn, Renee F. A. G.; Hofman, Albert; Vernooij, Meike W.; Ikram, M. Arfan] Univ Med Ctr, Erasmus Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [DeStefano, Anita L.; Beiser, Alexa; Au, Rhoda; Wolf, Philip A.; Seshadri, Sudha] Natl Heart Lung & Blood Inst Framingham Heart Stu, Framingham, MA USA; [Lambert, Jean-Charles; Amouyel, Philippe; Chouraki, Vincent] INSERM, U744, F-59045 Lille, France; [Lambert, Jean-Charles; Amouyel, Philippe; Chouraki, Vincent] Inst Pasteur, F-59019 Lille, France; [Lambert, Jean-Charles; Amouyel, Philippe; Chouraki, Vincent] Univ Lille Nord France, Lille, France; [Jack, Clifford R., Jr.] Mayo Clin, Dept Radiol, Rochester, MN USA; [Fleischman, Debra] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Fleischman, Debra] Rush Univ, Med Ctr, Dept Behav Sci, Chicago, IL 60612 USA; [Zijdenbos, Alex] Biospective Inc, Montreal, PQ, Canada; [den Heijer, Tom] St Franciscus Gasthuis, Dept Neurol, Rotterdam, Netherlands; [Coker, Laura H.] Wake Forest Sch Med, Div Publ Hlth Sci, Winston Salem, NC USA; [Enzinger, Christian; Cavalieri, Margherita; Fazekas, Franz; Schmidt, Reinhold] Med Univ Graz, Dept Neurol, Graz, Austria; [Danoy, Patrick] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld, Australia; [Arfanakis, Konstantinos] Illinois Inst Technol, Dept Biomed Engn, Chicago, IL USA; [van Buchem, Mark A.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Huang, Juebin; Mosley, Thomas H.] Univ Mississippi, Med Ctr, Dept Neurol, Jackson, MS 39216 USA; [Niessen, Wiro J.] Delft Univ Technol, Fac Sci Appl, Delft, Netherlands; [Hofman, Albert; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Ikram, M. Arfan] Netherlands Consortium Hlth Ageing, Leiden, Netherlands; [Amouyel, Philippe] Ctr Hosp Reg Univ Lille, Lille, France; [Freeman, Kevin B.] Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Jackson, MS 39216 USA; [Oostra, Ben A.] Univ Med Ctr, Erasmus Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [Stein, Jason L.; Hibar, Derrek P.; Thompson, Paul M.] Univ Calif Los Angeles, David Geffen Sch Med, Lab Neuro Imaging, Los Angeles, CA 90095 USA; [Medland, Sarah E.; Wright, Margaret J.; Martin, Nicholas G.] Queensland Inst Med Res, Genet Epidemiol Lab, Brisbane, Qld 4006, Australia; [Medland, Sarah E.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Vasquez, Alejandro Arias; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Vasquez, Alejandro Arias; Franke, Barbara; Launer, Lenore J.] Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Nalls, Michael A.] NIA, Neurogenet Lab, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Uitterlinden, Andre G.] Univ Med Ctr, Erasmus Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Elbaz, Alexis] Univ Paris 06, UMR S708, Paris, France; [Beare, Richard J.] Royal Childrens Hosp, Dev Imaging Grp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Lopez, Oscar L.; Becker, James T.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Lopez, Oscar L.; Becker, James T.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Lopez, Oscar L.; Becker, James T.] Univ Pittsburgh, Sch Med, Dept Psychol, Pittsburgh, PA USA; [Harris, Tamara B.] NIH, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Breteler, Monique M. B.] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Breteler, Monique M. B.] Univ Bonn, Bonn, Germany; [Breteler, Monique M. B.] Harvard Univ, Dept Epidemiol, Harvard Sch Publ Hlth, Boston, MA 02115 USA; [De Jager, Philip L.] Harvard Univ, Sch Med, Boston, MA USA; [Knopman, David] Mayo Clin, Dept Neurol, Rochester, MN USA; [Longstreth, W. T., Jr.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Longstreth, W. T., Jr.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Brown, Matthew A.] Univ Queensland, Human Genet Grp, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld, Australia; [van Duijn, Cornelia M.] Leiden Univ, Med Ctr, Ctr Med Syst Biol, Netherlands Genom Initiat, Leiden, Netherlands; [Mosley, Thomas H.] Univ Mississippi, Med Ctr, Dept Med Geriatr, Jackson, MS 39216 USA; [Tzourio, Christophe] Univ Bordeaux, U708, Bordeaux, France; [Tzourio, Christophe] INSERM, Neuroepidemiol U708, Bordeaux, France	Boston University; University of Washington; University of Washington Seattle; University of California System; University of California Davis; University of California System; University of California Davis; Icelandic Heart Association; University of Iceland; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Medical University of Graz; Monash University; University of Tasmania; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Rush University; Boston University; Erasmus University Rotterdam; Erasmus MC; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille; Mayo Clinic; Rush University; Rush University; Franciscus Gasthuis; Wake Forest University; Medical University of Graz; University of Queensland; Illinois Institute of Technology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Mississippi; University of Mississippi Medical Center; Delft University of Technology; Universite de Lille - ISITE; CHU Lille; University of Mississippi; University of Mississippi Medical Center; Erasmus University Rotterdam; Erasmus MC; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; QIMR Berghofer Medical Research Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Radboud University Nijmegen; Radboud University Nijmegen; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Erasmus University Rotterdam; Erasmus MC; UDICE-French Research Universities; Sorbonne Universite; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Mayo Clinic; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Queensland; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Mississippi; University of Mississippi Medical Center; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm)	Seshadri, S (corresponding author), Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA.	suseshad@bu.edu	Deary, Ian J/C-6297-2009; Mazoyer, Bernard M/B-6303-2012; LICEND, CEMND/F-1296-2015; Cichon, Sven/H-8803-2013; Vasquez, Alejandro Arias/E-4762-2012; Martin, Nicholas/R-9235-2019; Thompson, Paul M/C-4194-2018; Schmidt, Reinhold/E-1137-2014; Verhaaren, Benjamin F.J./R-1450-2016; Cavalleri, Gianpiero/A-6632-2010; Breteler, Monique M.B./J-5058-2014; Matarin, Mar/F-1771-2016; Melle, Ingrid S/B-4858-2011; Hansell, Narelle K/A-4553-2016; Ramasamy, Adaikalavan/G-2632-2010; lambert, jean-charles/F-8787-2013; Medland, Sarah/AAT-7595-2020; Ryten, Mina/Q-8419-2016; Dufouil, Carole/F-5751-2014; DeCarli, Charles/B-5541-2009; Gudnason, Vilmundur/K-6885-2015; Wright, Margaret J/H-3308-2014; Gudnason, Vilmundur/AAE-7126-2019; Laje, Gonzalo/L-2654-2014; Trabzuni, Daniah M/C-4034-2012; Franke, Barbara/D-4836-2009; Crivello, Fabrice/ABB-4531-2021; Fox, Peter/B-4725-2010; Debette, Stephanie/T-4946-2019; mazoyer, bernard m/A-5369-2009; Mattheisen, Manuel/B-4949-2012; Medland, Sarah E/C-7630-2013; Mattingsdal, Morten/Q-9367-2016; Lopez, Lorna/AAR-4912-2020; Cavalieri, Margherita/G-8053-2012; Tzourio, christophe/L-6344-2019; Wright, Margaret Jane/A-4560-2016; McMahon, Francis J/A-7290-2009; Hoogman, Martine/G-8958-2015; Mattheisen, Manuel/S-3725-2019; Yu, Lei/AAT-3685-2020; Savitz, Jonathan/C-3088-2009; Vernooij, Meike Willemijn/E-4061-2016; Amin, Najaf N/D-1859-2012; Thomson, Russell J/H-5653-2012; van Buchem, Mark/AAC-9843-2022; Lourdusamy, Anbarasu/P-6606-2014; Jack, Clifford R/F-2508-2010; Pike, Bruce/K-5562-2014; Elbaz, Alexis/F-8952-2017; Brown, Matthew A/E-5749-2010; Arfanakis, Konstantinos/AAN-3148-2021; Dufouil, Carole/J-4968-2012; Roffman, Joshua/G-8228-2012; Lambert, jean-charles/A-9553-2014; Trabzuni, Daniah/AAI-2037-2021; Weale, Michael E/F-2587-2010; Rijpkema, Mark/D-1974-2010; Tzourio, christophe/B-4015-2009; Lourdusamy, Anbarasu/G-3387-2011; Hagoort, Peter/B-7417-2012; Cichon, Sven/B-9618-2014; Hardy, John/C-2451-2009; Ikram, M. Arfan/AAM-5225-2021; Smith, Albert Vernon/K-5150-2015; Hulshoff Pol, Hilleke Evertje/B-4795-2014; Veltman, Joris A/F-5128-2010; Cannon, Dara/C-1323-2009	Deary, Ian J/0000-0002-1733-263X; Mazoyer, Bernard M/0000-0003-0970-2837; Cichon, Sven/0000-0002-9475-086X; Vasquez, Alejandro Arias/0000-0002-4786-0169; Martin, Nicholas/0000-0003-4069-8020; Thompson, Paul M/0000-0002-4720-8867; Breteler, Monique M.B./0000-0002-0626-9305; Matarin, Mar/0000-0002-4717-5735; Melle, Ingrid S/0000-0002-9783-548X; Hansell, Narelle K/0000-0002-8229-9741; Ramasamy, Adaikalavan/0000-0002-7598-2892; lambert, jean-charles/0000-0003-0829-7817; Medland, Sarah/0000-0003-1382-380X; Dufouil, Carole/0000-0003-2442-4476; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Laje, Gonzalo/0000-0003-2763-3329; Trabzuni, Daniah M/0000-0003-4826-9570; Franke, Barbara/0000-0003-4375-6572; Fox, Peter/0000-0002-0465-2028; Debette, Stephanie/0000-0001-8675-7968; mazoyer, bernard m/0000-0003-0970-2837; Mattheisen, Manuel/0000-0002-8442-493X; Medland, Sarah E/0000-0003-1382-380X; Mattingsdal, Morten/0000-0003-4440-0324; Lopez, Lorna/0000-0002-0241-9783; Tzourio, christophe/0000-0002-6517-2984; Wright, Margaret Jane/0000-0001-7133-4970; McMahon, Francis J/0000-0002-9469-305X; Hoogman, Martine/0000-0002-1261-7628; Mattheisen, Manuel/0000-0002-8442-493X; Savitz, Jonathan/0000-0001-8143-182X; Thomson, Russell J/0000-0003-4949-4120; van Buchem, Mark/0000-0003-1881-1998; Jack, Clifford R/0000-0001-7916-622X; Pike, Bruce/0000-0001-8924-683X; Elbaz, Alexis/0000-0001-9724-5490; Brown, Matthew A/0000-0003-0538-8211; Arfanakis, Konstantinos/0000-0001-9705-597X; Roffman, Joshua/0000-0003-4073-532X; Lambert, jean-charles/0000-0003-0829-7817; Trabzuni, Daniah/0000-0003-4826-9570; Weale, Michael E/0000-0003-4593-1186; Rijpkema, Mark/0000-0002-8495-4703; Tzourio, christophe/0000-0002-6517-2984; Cichon, Sven/0000-0002-9475-086X; Hardy, John/0000-0002-3122-0423; Smith, Albert Vernon/0000-0003-1942-5845; Hulshoff Pol, Hilleke Evertje/0000-0002-2038-5281; Veltman, Joris A/0000-0002-3218-8250; Ibrahim-verbaas, Carla/0000-0002-4325-0857; Au, Rhoda/0000-0001-7742-4491; Seshadri, Sudha/0000-0001-6135-2622; Pikula, Aleksandra/0000-0001-7077-0148; Wolf, Philip/0000-0002-3628-301X; Niessen, Wiro/0000-0002-5822-1995; Srikanth, Velandai/0000-0002-8442-8981; Becker, James/0000-0003-4425-4726; Andreassen, Ole A./0000-0002-4461-3568; Ikram, Mohammad Arfan/0000-0003-0372-8585; Holmes, Avram/0000-0001-6583-803X; van den Heuvel, Martijn/0000-0003-1570-1195; Nothen, Markus/0000-0002-8770-2464; DeStefano, Anita/0000-0002-9335-2819; Stankovich, Jim/0000-0001-9344-7749; Beare, Richard/0000-0002-7530-5664; Donohoe, Gary/0000-0003-3037-7426; Amin, Najaf/0000-0002-8944-1771; Verhaaren, Benjamin/0000-0003-3477-9350; Beiser, Alexa/0000-0001-8551-7778; Vernooij, Meike/0000-0003-4658-2176; Chibnik, Lori/0000-0001-6293-806X; Le Hellard, Stephanie/0000-0002-8085-051X; Cannon, Dara/0000-0001-7378-3411; Van Duijn, Cornelia/0000-0002-2374-9204; Stein, Jason/0000-0003-4829-0513; Romanczuk-Seiferth, Nina/0000-0002-6931-269X; Carless, Melanie/0000-0001-8350-2302; Walter, Henrik/0000-0002-9403-6121; Crivello, Fabrice/0000-0001-6950-984X; Djurovic, Srdjan/0000-0002-8140-8061; Cavalleri, Gianpiero/0000-0002-9802-0506; Curran, Joanne/0000-0002-6898-155X; Bastin, Mark/0000-0002-0490-0845; Amouyel, Philippe/0000-0001-9088-234X; Chouraki, Vincent/0000-0002-4698-1794; Agartz, Ingrid/0000-0002-9839-5391; Pikula, Aleksandra/0000-0002-8378-5522	US National Institute on Aging (NIA) [N01-AG-12100]; US NHLBI [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, HL087641, HL59367, HL086694, HL7825, HL087652, HL105756]; National Human Genome Research Institute [U01HG004402]; NIH [HHSN268200625226C]; NIH Roadmap for Medical Research [UL1RR025005]; NHLBI [HL093029]; NIA [AG20098, AG05133, AG08122, AG16495, AG033193, AG013846, AG031287]; Austrian Science Fond (FWF) [P20545-P05, P13180]; Netherlands Organisation for Scientific Research (NWO); Internationale Stichting Alzheimer Onderzoek (ISAO); Hersenstichting Nederland (HSN); Centre for Medical Systems Biology [CMSB1, CMSB2]; US NIA [P30AG10161, AG17917, AG15819]; Illinois Department of Public Health; Rush Clinical Translational Science Consortium; National Heart, Lung and Blood Institute's Framingham Heart Study [N01-HC-25195]; Affymetrix, Inc [N02-HL-6-4278]; Robert Dawson Evans Endowment of the Department of Medicine at the Boston University School of Medicine and Boston Medical Center; NINDS [NS17950]; NWO [175.010.2005.011, 911-03-012, 918-46-615, 904-61-096, 904-61-133, 948-00-010]; Research Institute for Diseases in the Elderly (RIDE) [014-93-015]; NGI-NWO [050-060-810]; Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organisation for Health Research and Development (ZonMw); RIDE2; Dutch Ministry of Education, Culture and Science; Dutch Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; Nederlandse Hartstichting [2009B102]; Internationaal Parkinson Fonds; National Health and Medical Research Council of Australia (NHMRC) [403000, 491109, 606543, APP1024879]; Wicking Dementia Education and Research Centre, Hobart; NHMRC-National Heart Foundation [606544]; Fondation pour la Recherche Medicale; Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante; Mutuelle Generale de l'Education Nationale (MGEN); Institut de la Longevite; Conseils Regionaux de Aquitaine et Bourgogne; Fondation de France; French Ministry of Research-INSERM; National Foundation for Alzheimer's Disease and Related Disorders; Institut Pasteur de Lille; Centre National de Genotypage; MRC [G1100616, G1001245, G0700704, G0701075, G0901254] Funding Source: UKRI; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055019, N01HC025195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087652, R01HL064278, R01HL087641, R01HL059367, R01HL093029, R01HL105756, R01HL086694, T32HL007825] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017917, R01AG031287, R56AG020098, R01AG040770, R01AG020098, R01AG016495, P30AG010161, P50AG005133, RF1AG015819, P30AG013846, ZIAAG007270, R01AG033193, K08AG034290, N01AG012100, R01AG008122, R01AG015819] Funding Source: NIH RePORTER; Alzheimers Research UK [ART-PPG2011A-14] Funding Source: researchfish; Austrian Science Fund (FWF) [P 20545] Funding Source: researchfish; Medical Research Council [G1001245, G1100616, G0901254, G0701075, G0700704] Funding Source: researchfish	US National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); US NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Austrian Science Fond (FWF)(Austrian Science Fund (FWF)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Internationale Stichting Alzheimer Onderzoek (ISAO); Hersenstichting Nederland (HSN); Centre for Medical Systems Biology; US NIA; Illinois Department of Public Health; Rush Clinical Translational Science Consortium; National Heart, Lung and Blood Institute's Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Affymetrix, Inc; Robert Dawson Evans Endowment of the Department of Medicine at the Boston University School of Medicine and Boston Medical Center; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NWO(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases in the Elderly (RIDE); NGI-NWO(Netherlands Organization for Scientific Research (NWO)); Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); RIDE2; Dutch Ministry of Education, Culture and Science; Dutch Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Nederlandse Hartstichting; Internationaal Parkinson Fonds; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Wicking Dementia Education and Research Centre, Hobart; NHMRC-National Heart Foundation(National Health and Medical Research Council (NHMRC) of Australia); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante(General Electric); Mutuelle Generale de l'Education Nationale (MGEN)(General Electric); Institut de la Longevite; Conseils Regionaux de Aquitaine et Bourgogne; Fondation de France(Fondation de France); French Ministry of Research-INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)Ministry of Research, France); National Foundation for Alzheimer's Disease and Related Disorders; Institut Pasteur de Lille; Centre National de Genotypage; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Aging Gene-Environment Susceptibility-Reykjavik Study (AGES): Research was funded by the US National Institute on Aging (NIA; N01-AG-12100), with contributions from the National Eye Institute (NEI), the National Institute on Deafness and Other Communication Disorders (NIDCD), the US National Heart, Lung, and Blood Institute (NHLBI), the NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association) and the Althingi (the Icelandic Parliament).; The Atherosclerosis Risk in Communities Study (ARIC): The authors thank the staff and participants of the ARIC study for their important contributions. Research was carried out as a collaborative study supported by the US NHLBI (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, HL087641, HL59367, HL086694 and HL7825); the National Human Genome Research Institute (U01HG004402) and the NIH (HHSN268200625226C). Infrastructure was partly supported by a component of the NIH and the NIH Roadmap for Medical Research (UL1RR025005). This project was also supported by NHLBI grant HL093029.; The Cardiovascular Health Study (CHS): Coauthors were supported in part by US NHLBI grants (HL087652 and HL105756), as well as by NIA grants (AG20098 and AG05133).; The Austrian Stroke Prevention Study (ASPS): The authors thank the staff and the participants of ASPS for their valuable contributions. We thank B. Reinhart for her long-term administrative commitment and I.J. Semmler for technical assistance in creating the DNA bank. The research reported here was funded by the Austrian Science Fond (FWF; P20545-P05 and P13180). The Medical University of Graz supports the databank of ASPS.; Erasmus Rucphen Family Study (ERF): We thank the participants from the Genetic Research in Isolated Populations in the Erasmus Rucphen Family Study who made this work possible. This study is financially supported by the Netherlands Organisation for Scientific Research (NWO), the Internationale Stichting Alzheimer Onderzoek (ISAO), the Hersenstichting Nederland (HSN) and the Centre for Medical Systems Biology (CMSB1 and CMSB2) in the framework of the Netherlands Genomics Initiative (NGI).; Framingham Heart Study (FHS): This work was supported by the National Heart, Lung and Blood Institute's Framingham Heart Study (contract N01-HC-25195) and its contract with Affymetrix, Inc, for genotyping services (contract N02-HL-6-4278). A portion of this research used the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at the Boston University School of Medicine and Boston Medical Center. Analyses reflect intellectual input and resource development from the Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. This study was also supported by grants from the NINDS (NS17950) and the NIA (AG08122, AG16495, AG033193, AG013846 and AG031287).; The Religious Order Study and the Rush Memory and Aging Project: ROS and R-MAP data used in this study were obtained with support from the US NIA (grants P30AG10161, AG17917 and AG15819), the Illinois Department of Public Health and the Rush Clinical Translational Science Consortium and a gift from M. Dowd.; The Rotterdam Study (RS): The authors are grateful to the study participants, the staff from the Rotterdam Study and the participating general practitioners andpharmacists. The authors also thank P. Arp, M. Jhamai, M. Verkerk, L. Herrera and M. Peters for their help in creating the GWAS database and K. Estrada and M. V. Struchalin for their support in the creation and analysis of imputed data. The generation and management of GWAS genotype data for the Rotterdam Study are supported by NWO Investments (nr. 175.010.2005.011 and 911-03-012). This study is funded by the Research Institute for Diseases in the Elderly (RIDE2; 014-93-015) and the NGI-NWO project (nr. 050-060-810). The Rotterdam Study is funded by the Erasmus Medical Center and Erasmus University, Rotterdam, the Netherlands Organisation for Health Research and Development (ZonMw), RIDE2, the Dutch Ministry of Education, Culture and Science, the Dutch Ministry for Health, Welfare and Sports, the European Commission (DG XII) and the Municipality of Rotterdam. The Rotterdam Scan Study is supported by the NWO (project nrs. 918-46-615, 904-61-096, 904-61-133 and 948-00-010), Nederlandse Hartstichting (2009B102) and Internationaal Parkinson Fonds.; The Tasmanian Study of Gait and Cognition (TASCOG): This study is supported by project grants from the National Health and Medical Research Council of Australia (NHMRC; 403000, 491109 and 606543) and a grant from the Wicking Dementia Education and Research Centre, Hobart. V. S. is supported by an NHMRC-National Heart Foundation Career Development Fellowship (606544). M. A. B. is supported by an NHMRC Senior Principal Research Fellowship (APP1024879).; Three City Study (3C): We thank the staff and participants of the 3C Study for their important contributions. We also thank A. Boland for her technical help in preparing the DNA samples for analyses. The 3C Study is conducted under a partnership agreement between INSERM, Victor Segalen-Bordeaux II University and Sanofi-Aventis. The Fondation pour la Recherche Medicale funded the preparation and initiation of the study. The 3C Study is also supported by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, Mutuelle Generale de l'Education Nationale (MGEN), Institut de la Longevite, Conseils Regionaux de Aquitaine et Bourgogne, Fondation de France and the French Ministry of Research-INSERM Programme Cohortes et Collections de Donnees Biologiques. This work was supported by the National Foundation for Alzheimer's Disease and Related Disorders, the Institut Pasteur de Lille and the Centre National de Genotypage.	BERNSTEIN HG, 1987, INT J DEV NEUROSCI, V5, P237, DOI 10.1016/0736-5748(87)90034-7; Chibnik LB, 2011, ANN NEUROL, V69, P560, DOI 10.1002/ana.22277; Corneveaux JJ, 2010, HUM MOL GENET, V19, P3295, DOI 10.1093/hmg/ddq221; den Heijer T, 2003, BRAIN, V126, P170, DOI 10.1093/brain/awg006; den Heijer T, 2003, DIABETOLOGIA, V46, P1604, DOI 10.1007/s00125-003-1235-0; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; GASSER UE, 1990, J NEUROSCI, V10, P1276; Gault VA, 2008, EUR J PHARMACOL, V587, P112, DOI 10.1016/j.ejphar.2008.03.025; Gogolla N, 2009, NEURON, V62, P510, DOI 10.1016/j.neuron.2009.04.022; Gonzalez S, 2004, J NUTR, V134, P1736, DOI 10.1093/jn/134.7.1736; Guan QH, 2006, NEUROSCI LETT, V393, P226, DOI 10.1016/j.neulet.2005.09.075; Hamilton A, 2011, J NEUROSCI RES, V89, P481, DOI 10.1002/jnr.22565; Hamilton A, 2009, NEUROREPORT, V20, P1161, DOI 10.1097/WNR.0b013e32832fbf14; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; HenrichNoack P, 1996, STROKE, V27, P1609, DOI 10.1161/01.STR.27.9.1609; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Imaizumi K, 1999, J BIOL CHEM, V274, P7975, DOI 10.1074/jbc.274.12.7975; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; Jagust W, 2005, ARCH NEUROL-CHICAGO, V62, P1545, DOI 10.1001/archneur.62.10.1545; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Kalmijn S, 1999, AM J EPIDEMIOL, V150, P283, DOI 10.1093/oxfordjournals.aje.a010000; Kim H, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.013; Kubben N, 2010, NUCLEUS-PHILA, V1, P513, DOI 10.4161/nucl.1.6.13512; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Litterman N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001060; Lukiw WJ, 2010, MOL NEUROBIOL, V42, P10, DOI 10.1007/s12035-010-8126-4; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Okamoto OK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-230; Prins ND, 2002, NEUROLOGY, V59, P1375, DOI 10.1212/01.WNL.0000032494.05619.93; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Ridha BH, 2006, LANCET NEUROL, V5, P828, DOI 10.1016/S1474-4422(06)70550-6; Riederer BM, 2011, EXP BIOL MED, V236, P268, DOI 10.1258/ebm.2010.010327; Rohn TT, 2010, APOPTOSIS, V15, P1403, DOI 10.1007/s10495-010-0463-2; Sborgi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015575; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Segref A, 2009, EMBO REP, V10, P44, DOI 10.1038/embor.2008.229; Seshadri S, 2008, ARCH NEUROL-CHICAGO, V65, P642, DOI 10.1001/archneur.65.5.642; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Small GW, 2002, ADV DRUG DELIVER REV, V54, P1561, DOI 10.1016/S0169-409X(02)00151-5; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Sullivan EV, 2001, HIPPOCAMPUS, V11, P754, DOI 10.1002/hipo.1091; van der Lijn F, 2008, NEUROIMAGE, V43, P708, DOI 10.1016/j.neuroimage.2008.07.058; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wilson PM, 2010, J NEUROSCI, V30, P8529, DOI 10.1523/JNEUROSCI.0032-10.2010; Zapala MA, 2005, P NATL ACAD SCI USA, V102, P10357, DOI 10.1073/pnas.0503357102	51	175	177	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2012	44	5					545	+		10.1038/ng.2237	http://dx.doi.org/10.1038/ng.2237			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	934BW	22504421	Green Submitted, Green Accepted			2022-12-25	WOS:000303416300015
J	Nakazawa, Y; Sasaki, K; Mitsutake, N; Matsuse, M; Shimada, M; Nardo, T; Takahashi, Y; Ohyama, K; Ito, K; Mishima, H; Nomura, M; Kinoshita, A; Ono, S; Takenaka, K; Masuyama, R; Kudo, T; Slor, H; Utani, A; Tateishi, S; Yamashita, S; Stefanini, M; Lehmann, AR; Yoshiura, K; Ogi, T				Nakazawa, Yuka; Sasaki, Kensaku; Mitsutake, Norisato; Matsuse, Michiko; Shimada, Mayuko; Nardo, Tiziana; Takahashi, Yoshito; Ohyama, Kaname; Ito, Kosei; Mishima, Hiroyuki; Nomura, Masayo; Kinoshita, Akira; Ono, Shinji; Takenaka, Katsuya; Masuyama, Ritsuko; Kudo, Takashi; Slor, Hanoch; Utani, Atsushi; Tateishi, Satoshi; Yamashita, Shunichi; Stefanini, Miria; Lehmann, Alan R.; Yoshiura, Koh-ichiro; Ogi, Tomoo			Mutations in UVSSA cause UV-sensitive syndrome and impair RNA polymerase IIo processing in transcription-coupled nucleotide-excision repair	NATURE GENETICS			English	Article							OXIDATIVE DNA-DAMAGE; COCKAYNE-SYNDROME; XERODERMA-PIGMENTOSUM; SEQUENCING DATA; SYNDROME CELLS; DEFECT; FIBROBLASTS; IRRADIATION; INHIBITION; FRAMEWORK	UV-sensitive syndrome ((UVS)-S-S) is a genodermatosis characterized by cutaneous photosensitivity without skin carcinoma(1-4). Despite mild clinical features, cells from individuals with (UVS)-S-S, like Cockayne syndrome cells, are very UV sensitive and are deficient in transcription-coupled nucleotide-excision repair (TC-NER)(2,4,5), which removes DNA damage in actively transcribed genes(6). Three of the seven known (UVS)-S-S cases carry mutations in the Cockayne syndrome genes ERCC8 or ERCC6 (also known as CSA and CSB, respectively)(7,8). The remaining four individuals with (UVS)-S-S, one of whom is described for the first time here, formed a separate (UVS)-S-S-A complementation group(1,9,10); however, the responsible gene was unknown. Using exome sequencing(11), we determine that mutations in the UVSSA gene (formerly known as KIAA1530) cause (UVS)-S-S-A. The UVSSA protein interacts with TC-NER machinery and stabilizes the ERCC6 complex; it also facilitates ubiquitination of RNA polymerase IIo stalled at DNA damage sites. Our findings provide mechanistic insights into the processing of stalled RNA polymerase and explain the different clinical features across these TC-NER-deficient disorders.	[Nakazawa, Yuka; Mitsutake, Norisato; Matsuse, Michiko; Shimada, Mayuko; Ohyama, Kaname; Ito, Kosei; Kinoshita, Akira; Ogi, Tomoo] Nagasaki Univ, Res Ctr Genom Instabil & Carcinogenesis NRGIC, Nagasaki 852, Japan; [Nakazawa, Yuka; Shimada, Mayuko; Ogi, Tomoo] Nagasaki Univ, Dept Mol Med, Atom Bomb Dis Inst, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Nakazawa, Yuka; Mitsutake, Norisato; Matsuse, Michiko; Shimada, Mayuko; Yamashita, Shunichi; Ogi, Tomoo] Nagasaki Univ, Dept Radiat Med Sci, Atom Bomb Dis Inst, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Sasaki, Kensaku; Mishima, Hiroyuki; Nomura, Masayo; Kinoshita, Akira; Ono, Shinji; Yoshiura, Koh-ichiro] Nagasaki Univ, Dept Human Genet, Atom Bomb Dis Inst, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Nardo, Tiziana; Stefanini, Miria] CNR, Ist Genet Mol, Pavia, Italy; [Takahashi, Yoshito] Kanebo Cosmet Inc, Innovat Beauty Sci Lab, Odawara, Japan; [Ohyama, Kaname] Nagasaki Univ, Grad Sch Biomed Sci, Dept Environm & Pharmaceut Sci, Nagasaki 852, Japan; [Ito, Kosei; Masuyama, Ritsuko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cell Biol, Nagasaki 852, Japan; [Takenaka, Katsuya] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Genet, Tokyo, Japan; [Kudo, Takashi] Nagasaki Univ, Dept Radioisotope Med, Atom Bomb Dis Inst, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Slor, Hanoch] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Utani, Atsushi] Nagasaki Univ, Dept Dermatol, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Tateishi, Satoshi] Kumamoto Univ, Inst Mol Embryol & Genet, Kumamoto, Japan; [Yamashita, Shunichi] Fukushima Med Univ, Fukushima, Japan; [Lehmann, Alan R.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton, E Sussex, England	Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Kanebo Cosmetics Inc.; Nagasaki University; Nagasaki University; Tokyo Medical & Dental University (TMDU); Nagasaki University; Tel Aviv University; Sackler Faculty of Medicine; Nagasaki University; Kumamoto University; Fukushima Medical University; University of Sussex	Ogi, T (corresponding author), Nagasaki Univ, Res Ctr Genom Instabil & Carcinogenesis NRGIC, Nagasaki 852, Japan.	togi@nagasaki-u.ac.jp	Mishima, Hiroyuki/Y-2638-2019; Yamashita, Shunichi/GVS-9508-2022; Mitsutake, Norisato/U-9626-2018	Mishima, Hiroyuki/0000-0001-5050-2509; Mitsutake, Norisato/0000-0002-2744-8046; Nakazawa, Yuka/0000-0002-3835-3093; Ogi, Tomoo/0000-0002-5492-9072; matsuse, michiko/0000-0001-6178-3342; Yamashita, Shunichi/0000-0001-6399-6261	Japan Science and Technology Agency (JST); Japanese Society for the Promotion of Science [22710056]; Inamori Foundation; Sagawa Foundation for Promotion of Cancer Research; Mochida Memorial Funds for Medical and Pharmaceutical Research; Daiichi-Sankyo Foundation of Life Science; Takeda Science Foundation; JST; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare; Associazione Italiana per la Ricerca sul Cancro; Medical Research Council (MRC); EC-RTN; Grants-in-Aid for Scientific Research [22390189] Funding Source: KAKEN; Medical Research Council [G0801130B, G0501450] Funding Source: researchfish; MRC [G0501450] Funding Source: UKRI	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Inamori Foundation; Sagawa Foundation for Promotion of Cancer Research; Mochida Memorial Funds for Medical and Pharmaceutical Research; Daiichi-Sankyo Foundation of Life Science; Takeda Science Foundation(Takeda Science Foundation (TSF)); JST(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EC-RTN; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to P. Hanawalt and G. Spivak for their helpful comments on the manuscript. We are grateful to C. Hayashida, M. Kawamichi and H. Fawcett for technical assistance. This work was supported by Special Coordination Funds for Promoting Science and Technology from the Japan Science and Technology Agency (JST) (to Y.N., K.O., K. I., R. M. and T.O.), a grant-in-aid for Scientific Research KAKENHI (22710056) from the Japanese Society for the Promotion of Science, a science research grant from the Inamori Foundation, a cancer research grant from The Sagawa Foundation for Promotion of Cancer Research, a medical research grant from Mochida Memorial Funds for Medical and Pharmaceutical Research, a medical research grant from the Daiichi-Sankyo Foundation of Life Science, a medical research grant from the Takeda Science Foundation, a grant-in-aid for Seeds Innovation (Type-A) from JST (to T.O.), a Global Centers of Excellence (COE) Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to Y.N., K. S., N.M., M. M., M. Shimada, S.Y., K.Y. and T.O.), grants from the Ministry of Health, Labour and Welfare (to K.Y.), the Associazione Italiana per la Ricerca sul Cancro (to M. Stefanini), a Medical Research Council (MRC) programme grant and an EC-RTN and integrated project (to A.R.L.).	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; CLEAVER JE, 1993, ARCH DERMATOL, V129, P348, DOI 10.1001/archderm.129.3.348; D'Errico M, 2007, ONCOGENE, V26, P4336, DOI 10.1038/sj.onc.1210232; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; FUJIWARA Y, 1981, J INVEST DERMATOL, V77, P256, DOI 10.1111/1523-1747.ep12482447; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Horibata K, 2004, P NATL ACAD SCI USA, V101, P15410, DOI 10.1073/pnas.0404587101; Ito S, 2007, MOL CELL, V26, P231, DOI 10.1016/j.molcel.2007.03.013; ITOH T, 1995, AM J HUM GENET, V56, P1267; ITOH T, 1994, MUTAT RES, V314, P233, DOI 10.1016/0921-8777(94)90068-X; Itoh T, 2000, J INVEST DERMATOL, V114, P1022, DOI 10.1046/j.1523-1747.2000.00952.x; KAWADA A, 1986, PHOTODERMATOLOGY, V3, P233; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kleiman FE, 2005, GENE DEV, V19, P1227, DOI 10.1101/gad.1309505; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Limsirichaikul S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp023; Lohi O, 2002, FEBS LETT, V513, P19, DOI 10.1016/S0014-5793(01)03287-2; MAYNE LV, 1982, CANCER RES, V42, P1473; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nakazawa Y, 2010, DNA REPAIR, V9, P506, DOI 10.1016/j.dnarep.2010.01.015; Nardo T, 2009, P NATL ACAD SCI USA, V106, P6209, DOI 10.1073/pnas.0902113106; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Ren XF, 2010, EMBO J, V29, P1045, DOI 10.1038/emboj.2010.6; Rockx DAP, 2000, P NATL ACAD SCI USA, V97, P10503, DOI 10.1073/pnas.180169797; Schwertman P, 2012, NAT GENET, V44, P598, DOI 10.1038/ng.2230; Spivak G, 2006, DNA REPAIR, V5, P13, DOI 10.1016/j.dnarep.2005.06.017; Spivak G, 2005, MUTAT RES-FUND MOL M, V577, P162, DOI 10.1016/j.mrfmmm.2005.03.017; Spivak G, 2002, DNA REPAIR, V1, P629, DOI 10.1016/S1568-7864(02)00056-3; Starita LM, 2005, J BIOL CHEM, V280, P24498, DOI 10.1074/jbc.M414020200; STEFANINI M, 1993, CARCINOGENESIS, V14, P1101, DOI 10.1093/carcin/14.6.1101; Takagi Y, 2005, MOL CELL, V18, P237, DOI 10.1016/j.molcel.2005.03.007; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Zhang X, 2012, NAT GENET, V44, P593, DOI 10.1038/ng.2228	38	120	125	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2012	44	5					586	+		10.1038/ng.2229	http://dx.doi.org/10.1038/ng.2229			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	934BW	22466610	Green Submitted, Green Accepted			2022-12-25	WOS:000303416300021
J	Grzegorzewicz, AE; Pham, H; Gundi, VAKB; Scherman, MS; North, EJ; Hess, T; Jones, V; Gruppo, V; Born, SEM; Kordulakova, J; Chavadi, SS; Morisseau, C; Lenaerts, AJ; Lee, RE; McNeil, MR; Jackson, M				Grzegorzewicz, Anna E.; Ha Pham; Gundi, Vijay A. K. B.; Scherman, Michael S.; North, Elton J.; Hess, Tamara; Jones, Victoria; Gruppo, Veronica; Born, Sarah E. M.; Kordulakova, Jana; Chavadi, Sivagami Sundaram; Morisseau, Christophe; Lenaerts, Anne J.; Lee, Richard E.; McNeil, Michael R.; Jackson, Mary			Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane	NATURE CHEMICAL BIOLOGY			English	Article							CELL-WALL; DRUG-RESISTANCE; OUTER-MEMBRANE; BIOSYNTHESIS; VIRULENCE; TREHALOSE; SMEGMATIS; ARABINOGALACTAN; PERMEABILITY; BIOGENESIS	New chemotherapeutics active against multidrug-resistant Mycobacterium tuberculosis are urgently needed. We report on the identification of an adamantyl urea compound that shows potent bactericidal activity against M. tuberculosis and a unique mode of action, namely the abolition of the translocation of mycolic acids from the cytoplasm, where they are synthesized to the periplasmic side of the plasma membrane and are in turn transferred onto cell wall arabinogalactan or used in the formation of virulence-associated, outer membrane, trehalose-containing glycolipids. Whole-genome sequencing of spontaneous-resistant mutants of M. tuberculosis selected in vitro followed by genetic validation experiments revealed that our prototype inhibitor targets the inner membrane transporter MmpL3. Conditional gene expression of mmpL3 in mycobacteria and analysis of inhibitor-treated cells validate MmpL3 as essential for mycobacterial growth and support the involvement of this transporter in the translocation of trehalose monomycolate across the plasma membrane.	[Grzegorzewicz, Anna E.; Ha Pham; Gundi, Vijay A. K. B.; Scherman, Michael S.; Hess, Tamara; Jones, Victoria; Gruppo, Veronica; Born, Sarah E. M.; Chavadi, Sivagami Sundaram; Lenaerts, Anne J.; McNeil, Michael R.; Jackson, Mary] Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA; [North, Elton J.; Lee, Richard E.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Kordulakova, Jana] Comenius Univ, Fac Nat Sci, Dept Biochem, Bratislava, Slovakia; [Morisseau, Christophe] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Morisseau, Christophe] Univ Calif Davis, Ctr Canc, Davis, CA 95616 USA	Colorado State University; Comenius University Bratislava; University of California System; University of California Davis; University of California System; University of California Davis	Grzegorzewicz, AE (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA.	m.mcneil@colostate.edu; mary.jackson@colostate.edu	Gundi, Vijay A.K.B./B-6121-2013; Jackson, Mary/D-5345-2017; Lenaerts, Anne/F-1353-2017; Lee, Richard/AAX-3996-2021; Kordulakova, Jana/I-3887-2014; McNeil, Michael/G-3325-2019; Lee, Richard/J-4997-2013	Jackson, Mary/0000-0002-9212-0258; Lee, Richard/0000-0002-2397-0443; Kordulakova, Jana/0000-0003-2834-0165; Lee, Richard/0000-0002-2397-0443; Born, Sarah/0000-0001-5964-3121	NIAID; NIH [AI085992, AI063054, AI057836]; American Lebanese Syrian Associated Charities; Slovak Research and Development Agency [APVV-0441-10]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063054, P01AI057836, RC1AI085992] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Slovak Research and Development Agency(Slovak Research and Development Agency); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the NIAID and NIH grants AI085992, AI063054 and AI057836; the American Lebanese Syrian Associated Charities; and the Slovak Research and Development Agency under contract no. APVV-0441-10. We thank R. Dhiman for helpful scientific discussions and D. Dick for LC/MS analyses. Purified recombinant FbpC (Ag85C) was kindly provided by K. Dobos (Colorado State University).	Alahari A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001343; Barry C, 2001, TUBERCULOSIS, V81, P1, DOI 10.1054/tube.2001.0288; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Barry Clifton E., 2007, Infectious Disorders - Drug Targets, V7, P182; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; BESRA GS, 1994, P NATL ACAD SCI USA, V91, P12735, DOI 10.1073/pnas.91.26.12735; Bhatt A, 2008, CHEM BIOL, V15, P930, DOI 10.1016/j.chembiol.2008.07.007; Brown JR, 2011, BIOORGAN MED CHEM, V19, P5585, DOI 10.1016/j.bmc.2011.07.034; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; De Rossi E, 2006, FEMS MICROBIOL REV, V30, P36, DOI 10.1111/j.1574-6976.2005.00000.x; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Domenech P, 2004, J BIOL CHEM, V279, P21257, DOI 10.1074/jbc.M400324200; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Gavalda S, 2009, J BIOL CHEM, V284, P19255, DOI 10.1074/jbc.M109.006940; Gilleron M, 2004, J EXP MED, V199, P649, DOI 10.1084/jem.20031097; Glickman MS, 2008, MYCOBACTERIAL CELL ENVELOPE, P63; Guo XV, 2007, J BACTERIOL, V189, P4614, DOI 10.1128/JB.00216-07; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Jackson M, 2001, Methods Mol Med, V54, P59, DOI 10.1385/1-59259-147-7:059; Jackson M, 1999, MOL MICROBIOL, V31, P1573, DOI 10.1046/j.1365-2958.1999.01310.x; Jackson M, 2007, TUBERCULOSIS, V87, P78, DOI 10.1016/j.tube.2006.05.003; Jain M, 2005, PLOS PATHOG, V1, P12, DOI 10.1371/journal.ppat.0010002; Jain M, 2008, MYCOBACTERIAL CELL ENVELOPE, P201; Kalscheuer R, 2010, P NATL ACAD SCI USA, V107, P21761, DOI 10.1073/pnas.1014642108; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Lea-Smith DJ, 2007, J BIOL CHEM, V282, P11000, DOI 10.1074/jbc.M608686200; Leistikow RL, 2010, J BACTERIOL, V192, P1662, DOI 10.1128/JB.00926-09; Morisseau C, 2005, ANNU REV PHARMACOL, V45, P311, DOI 10.1146/annurev.pharmtox.45.120403.095920; Murakami S, 2008, CURR OPIN STRUC BIOL, V18, P459, DOI 10.1016/j.sbi.2008.06.007; Murphy HN, 2005, J BIOL CHEM, V280, P14524, DOI 10.1074/jbc.M414232200; Puech V, 2002, MOL MICROBIOL, V44, P1109, DOI 10.1046/j.1365-2958.2002.02953.x; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Sanki AK, 2009, GLYCOCONJUGATE J, V26, P589, DOI 10.1007/s10719-008-9211-z; SATHYAMOORTHY N, 1987, J BIOL CHEM, V262, P13417; Schroeder E. K., 2002, Current Pharmaceutical Biotechnology, V3, P197, DOI 10.2174/1389201023378328; Sennhauser G, 2009, J MOL BIOL, V389, P134, DOI 10.1016/j.jmb.2009.04.001; Stadthagen G, 2005, J BIOL CHEM, V280, P40699, DOI 10.1074/jbc.M508332200; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; Tropis M, 2005, J BIOL CHEM, V280, P26573, DOI 10.1074/jbc.M502104200; Tullius MV, 2011, P NATL ACAD SCI USA, V108, P5051, DOI 10.1073/pnas.1009516108; Vander Beken S, 2011, EUR J IMMUNOL, V41, P450, DOI 10.1002/eji.201040719; Woodruff PJ, 2004, J BIOL CHEM, V279, P28835, DOI 10.1074/jbc.M313103200; World Health Organization, 2009, GLOB TUB CONTR EP ST; Wright A., 2006, Morbidity and Mortality Weekly Report, V55, P301; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	49	303	316	4	108	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2012	8	4					334	341		10.1038/NCHEMBIO.794	http://dx.doi.org/10.1038/NCHEMBIO.794			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	913PO	22344175	Green Accepted			2022-12-25	WOS:000301890100007
J	Sakai, M; Matsumoto, M; Tujimura, T; Cao, Y; Noguchi, T; Inagaki, K; Inoue, H; Hosooka, T; Takazawa, K; Kido, Y; Yasuda, K; Hiramatsu, R; Matsuki, Y; Kasuga, M				Sakai, Mashito; Matsumoto, Michihiro; Tujimura, Tomoko; Cao Yongheng; Noguchi, Tetsuya; Inagaki, Kenjiro; Inoue, Hiroshi; Hosooka, Tetsuya; Takazawa, Kazuo; Kido, Yoshiaki; Yasuda, Kazuki; Hiramatsu, Ryuji; Matsuki, Yasushi; Kasuga, Masato			CITED2 links hormonal signaling to PGC-1 alpha acetylation in the regulation of gluconeogenesis	NATURE MEDICINE			English	Article							TRANSCRIPTION FACTOR FOXO1; HEPATIC GLUCONEOGENESIS; BINDING-PROTEIN; MICE LACKING; COACTIVATOR; METABOLISM; PGC-1; ACTIVATION; COMPLEX; KINASE	During fasting, induction of hepatic gluconeogenesis is crucial to ensure proper energy homeostasis(1). Such induction is dysregulated in type 2 diabetes, resulting in the development of fasting hyperglycemia(2). Hormonal and nutrient regulation of metabolic adaptation during fasting is mediated predominantly by the transcriptional coactivator peroxisome proliferative activated receptor gamma coactivator 1 alpha (PGC-1 alpha) in concert with various other transcriptional regulators(3-8). Although CITED2 (CBP- and p300-interacting transactivator with glutamic acid-and aspartic acid-rich COOH-terminal domain 2) interacts with many of these molecules(9-11), the role of this protein in the regulation of hepatic gluconeogenesis was previously unknown. Here we show that CITED2 is required for the regulation of hepatic gluconeogenesis through PGC-1 alpha. The abundance of CITED2 was increased in the livers of mice by fasting and in cultured hepatocytes by glucagon-cAMP-protein kinase A (PKA) signaling, and the amount of CITED2 in liver was higher in mice with type 2 diabetes than in non-diabetic mice. CITED2 inhibited the acetylation of PGC-1 alpha by blocking its interaction with the acetyltransferase general control of amino acid synthesis 5-like 2 (GCN5). The consequent downregulation of PGC-1 alpha acetylation resulted in an increase in its transcriptional coactivation activity and an increased expression of gluconeogenic genes. The interaction of CITED2 with GCN5 was disrupted by insulin in a manner that was dependent on phosphoinositide 3-kinase (PI3K)-thymoma viral proto-oncogene (Akt) signaling. Our results show that CITED2 functions as a transducer of glucagon and insulin signaling in the regulation of PGC-1 alpha activity that is associated with the transcriptional control of gluconeogenesis and that this function is mediated through the modulation of GCN5-dependent PGC-1 alpha acetylation. We also found that loss of hepatic CITED2 function suppresses gluconeogenesis in diabetic mice, suggesting it as a therapeutic target for hyperglycemia.	[Sakai, Mashito; Matsumoto, Michihiro; Tujimura, Tomoko; Cao Yongheng; Inagaki, Kenjiro] Natl Ctr Global Hlth & Med, Res Inst, Diabet Res Ctr, Dept Mol Metab Regulat, Tokyo, Japan; [Sakai, Mashito; Noguchi, Tetsuya; Hosooka, Tetsuya; Takazawa, Kazuo; Kido, Yoshiaki] Kobe Univ Grad Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol, Kobe, Hyogo, Japan; [Inoue, Hiroshi] Kanazawa Univ, Frontier Sci Org, Kanazawa, Ishikawa, Japan; [Kido, Yoshiaki] Kobe Univ Grad Sch Hlth Sci, Div Med Chem, Dept Biophys, Kobe, Hyogo, Japan; [Yasuda, Kazuki] Natl Ctr Global Hlth & Med, Res Inst, Diabet Res Ctr, Dept Metab Disorder, Tokyo, Japan; [Hiramatsu, Ryuji; Matsuki, Yasushi] Dainippon Sumitomo Pharmaceut, Pharmacol Res Labs, Suita, Osaka, Japan; [Kasuga, Masato] Natl Ctr Global Hlth & Med, Res Inst, Diabet Res Ctr, Tokyo, Japan	National Center for Global Health & Medicine - Japan; Kobe University; Kanazawa University; Kobe University; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Matsumoto, M (corresponding author), Natl Ctr Global Hlth & Med, Res Inst, Diabet Res Ctr, Dept Mol Metab Regulat, Tokyo, Japan.	mmatsumoto@ri.ncgm.go.jp; kasuga@ri.ncgm.go.jp		Sakai, Mashito/0000-0002-4908-2727; Inoue, Hiroshi/0000-0002-7724-6637	Ministry of Education, Culture, Sports, Science and Technology of Japan [21591155]; National Center for Global Health and Medicine [21S116]; Takeda Science Foundation; Novo Nordisk	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Novo Nordisk(Novo Nordisk)	We thank D. Schmoll (Sanofi-Aventis Deutschland GmbH) for the G6PC-promoter reporter plasmid, H. Shimano (University of Tsukuba) for the pcDNA3.1-3 x Flag-HNF-4 alpha plasmid and H. Takamoto for technical assistance. This work was supported by a Grant-in-Aid for Creative Scientific Research (to M.K.) and a Grant-in-Aid for Scientific Research (C) (21591155 to M.M.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a grant from the National Center for Global Health and Medicine (21S116 to M.M.), a grant from Takeda Science Foundation (to M.M.) and a Novo Nordisk Pharma Insulin Award (to M.M.).	Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Chen Y, 2007, BLOOD, V110, P2889, DOI 10.1182/blood-2007-01-066316; Dominy JE, 2010, BBA-PROTEINS PROTEOM, V1804, P1676, DOI 10.1016/j.bbapap.2009.11.023; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Jeninga EH, 2010, ONCOGENE, V29, P4617, DOI 10.1038/onc.2010.206; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kranc KR, 2009, CELL STEM CELL, V5, P659, DOI 10.1016/j.stem.2009.11.001; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Matsumoto M, 2006, NAT MED, V12, P33, DOI 10.1038/nm0106-33; Matsumoto M, 2002, DIABETES, V51, P1672, DOI 10.2337/diabetes.51.6.1672; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Miyake K, 2002, J CLIN INVEST, V110, P1483, DOI 10.1172/JCI200215880; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Qu X, 2007, EMBO J, V26, P4445, DOI 10.1038/sj.emboj.7601883; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rodgers JT, 2010, CELL METAB, V11, P23, DOI 10.1016/j.cmet.2009.11.006; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Schmoll D, 2001, BIOCHEM J, V357, P867, DOI 10.1042/0264-6021:3570867; Tien ES, 2004, J BIOL CHEM, V279, P24053, DOI 10.1074/jbc.M401489200; Yin Z, 2002, P NATL ACAD SCI USA, V99, P10488, DOI 10.1073/pnas.162371799; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhou XY, 2004, NAT MED, V10, P633, DOI 10.1038/nm1050	31	54	56	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2012	18	4					612	617		10.1038/nm.2691	http://dx.doi.org/10.1038/nm.2691			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22426420				2022-12-25	WOS:000302617800040
J	Bellenguez, C; Bevan, S; Gschwendtner, A; Spencer, CCA; Burgess, AI; Pirinen, M; Jackson, CA; Traylor, M; Strange, A; Su, Z; Band, G; Syme, PD; Malik, R; Pera, J; Norrving, B; Lemmens, R; Freeman, C; Schanz, R; James, T; Poole, D; Murphy, L; Segal, H; Cortellini, L; Cheng, YC; Woo, D; Nalls, MA; Muller-Myhsok, B; Meisinger, C; Seedorf, U; Ross-Adams, H; Boonen, S; Wloch-Kopec, D; Valant, V; Slark, J; Furie, K; Delavaran, H; Langford, C; Deloukas, P; Edkins, S; Hunt, S; Gray, E; Dronov, S; Peltonen, L; Gretarsdottir, S; Thorleifsson, G; Thorsteinsdottir, U; Stefansson, K; Boncoraglio, GB; Parati, EA; Attia, J; Holliday, E; Levi, C; Franzosi, MG; Goel, A; Helgadottir, A; Blackwell, JM; Bramon, E; Brown, MA; Casas, JP; Corvin, A; Duncanson, A; Jankowski, J; Mathew, CG; Palmer, CNA; Plomin, R; Rautanen, A; Sawcer, SJ; Trembath, RC; Viswanathan, AC; Wood, NW; Worrall, BB; Kittner, SJ; Mitchell, BD; Kissela, B; Meschia, JF; Thijs, V; Lindgren, A; Macleod, MJ; Slowik, A; Walters, M; Rosand, J; Sharma, P; Farrall, M; Sudlow, CLM; Rothwell, PM; Dichgans, M; Donnelly, P; Markus, HS				Bellenguez, Celine; Bevan, Steve; Gschwendtner, Andreas; Spencer, Chris C. A.; Burgess, Annette I.; Pirinen, Matti; Jackson, Caroline A.; Traylor, Matthew; Strange, Amy; Su, Zhan; Band, Gavin; Syme, Paul D.; Malik, Rainer; Pera, Joanna; Norrving, Bo; Lemmens, Robin; Freeman, Colin; Schanz, Renata; James, Tom; Poole, Deborah; Murphy, Lee; Segal, Helen; Cortellini, Lynelle; Cheng, Yu-Ching; Woo, Daniel; Nalls, Michael A.; Mueller-Myhsok, Bertram; Meisinger, Christa; Seedorf, Udo; Ross-Adams, Helen; Boonen, Steven; Wloch-Kopec, Dorota; Valant, Valerie; Slark, Julia; Furie, Karen; Delavaran, Hossein; Langford, Cordelia; Deloukas, Panos; Edkins, Sarah; Hunt, Sarah; Gray, Emma; Dronov, Serge; Peltonen, Leena; Gretarsdottir, Solveig; Thorleifsson, Gudmar; Thorsteinsdottir, Unnur; Stefansson, Kari; Boncoraglio, Giorgio B.; Parati, Eugenio A.; Attia, John; Holliday, Elizabeth; Levi, Chris; Franzosi, Maria-Grazia; Goel, Anuj; Helgadottir, Anna; Blackwell, Jenefer M.; Bramon, Elvira; Brown, Matthew A.; Casas, Juan P.; Corvin, Aiden; Duncanson, Audrey; Jankowski, Janusz; Mathew, Christopher G.; Palmer, Colin N. A.; Plomin, Robert; Rautanen, Anna; Sawcer, Stephen J.; Trembath, Richard C.; Viswanathan, Ananth C.; Wood, Nicholas W.; Worrall, Bradford B.; Kittner, Steven J.; Mitchell, Braxton D.; Kissela, Brett; Meschia, James F.; Thijs, Vincent; Lindgren, Arne; Macleod, Mary Joan; Slowik, Agnieszka; Walters, Matthew; Rosand, Jonathan; Sharma, Pankaj; Farrall, Martin; Sudlow, Cathie L. M.; Rothwell, Peter M.; Dichgans, Martin; Donnelly, Peter; Markus, Hugh S.		ISGC; WTCCC2	Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke	NATURE GENETICS			English	Article							ATRIAL-FIBRILLATION; HISTONE DEACETYLASES; SUSCEPTIBILITY LOCI; ALGORITHM; GENETICS; DISEASE; SIGNALS; ROLES; RISK	Genetic factors have been implicated in stroke risk, but few replicated associations have been reported. We conducted a genome-wide association study (GWAS) for ischemic stroke and its subtypes in 3,548 affected individuals and 5,972 controls, all of European ancestry. Replication of potential signals was performed in 5,859 affected individuals and 6,281 controls. We replicated previous associations for cardioembolic stroke near PITX2 and ZFHX3 and for large vessel stroke at a 9p21 locus. We identified a new association for large vessel stroke within HDAC9 (encoding histone deacetylase 9) on chromosome 7p21.1 (including further replication in an additional 735 affected individuals and 28,583 controls) (rs11984041; combined P = 1.87 x 10(-11); odds ratio (OR) = 1.42, 95% confidence interval (CI) = 1.28-1.57). All four loci exhibited evidence for heterogeneity of effect across the stroke subtypes, with some and possibly all affecting risk for only one subtype. This suggests distinct genetic architectures for different stroke subtypes.	[Bellenguez, Celine; Spencer, Chris C. A.; Pirinen, Matti; Strange, Amy; Su, Zhan; Band, Gavin; Freeman, Colin; Goel, Anuj; Helgadottir, Anna; Rautanen, Anna; Farrall, Martin; Donnelly, Peter] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Bevan, Steve; Traylor, Matthew; James, Tom; Markus, Hugh S.] St Georges Univ London, Stroke & Dementia Res Grp, London, England; [Gschwendtner, Andreas; Malik, Rainer; Dichgans, Martin] Univ Munich, Univ Munchen Klinikum, Inst Stroke & Dementia Res, Munich, Germany; [Burgess, Annette I.; Poole, Deborah; Segal, Helen; Rothwell, Peter M.] Univ Oxford, Nuffield Dept Clin Neurosci, Stroke Prevent Res Unit, Oxford, England; [Jackson, Caroline A.; Sudlow, Cathie L. M.] Univ Edinburgh, Div Clin Neurosci, Edinburgh, Midlothian, Scotland; [Syme, Paul D.; Macleod, Mary Joan] Univ Aberdeen, Div Appl Med, Aberdeen, Scotland; [Pera, Joanna; Ross-Adams, Helen; Wloch-Kopec, Dorota; Slowik, Agnieszka] Jagiellonian Univ, Coll Med, Dept Neurol, Krakow, Poland; [Norrving, Bo; Delavaran, Hossein; Lindgren, Arne] Lund Univ, Dept Clin Sci, Lund, Sweden; [Norrving, Bo; Delavaran, Hossein; Lindgren, Arne] Skane Univ Hosp, Dept Neurol, Lund, Sweden; [Lemmens, Robin; Thijs, Vincent] Univ Hosp Leuven, Dept Neurol, Louvain, Belgium; [Lemmens, Robin; Thijs, Vincent] VIB, Vesalius Res Ctr, Louvain, Belgium; [Schanz, Renata; Slark, Julia; Sharma, Pankaj] Univ London Imperial Coll Sci Technol & Med, ICCRU, London, England; [Murphy, Lee] Univ Edinburgh, Western Gen Hosp, Wellcome Trust Clin Res Facil Genet Core Lab, Edinburgh, Midlothian, Scotland; [Cortellini, Lynelle; Valant, Valerie; Furie, Karen; Rosand, Jonathan] Massachusetts Gen Hosp, Dept Neurol, Ctr Human Genet Res, Boston, MA 02114 USA; [Cortellini, Lynelle; Valant, Valerie; Rosand, Jonathan] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Cheng, Yu-Ching; Mitchell, Braxton D.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Cheng, Yu-Ching; Mitchell, Braxton D.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Woo, Daniel; Kissela, Brett] Univ Cincinnati, Coll Med, Dept Neurol, Cincinnati, OH USA; [Nalls, Michael A.] NIA, Neurogenet Lab, Intramural Res Program, Bethesda, MD 20892 USA; [Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Meisinger, Christa] German Res Ctr Environm Hlth, Inst Epidemiol 2, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Seedorf, Udo] Univ Munster, Leibniz Inst Arterioskleroseforsch, Munster, Germany; [Boonen, Steven] Univ Hosp Leuven, Div Geriatr Med, Louvain, Belgium; [Langford, Cordelia; Deloukas, Panos; Edkins, Sarah; Hunt, Sarah; Gray, Emma; Dronov, Serge; Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge, England; [Gretarsdottir, Solveig; Thorleifsson, Gudmar; Thorsteinsdottir, Unnur; Stefansson, Kari; Helgadottir, Anna] deCODE Genet, Reykjavik, Iceland; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Boncoraglio, Giorgio B.; Parati, Eugenio A.] Fdn Ist Ricovero & Cura Carattere Sci IRCCS, Ist Neurol Carlo Besta, Milan, Italy; [Attia, John; Holliday, Elizabeth; Levi, Chris] Univ Newcastle, Hunter Med Res Inst, Ctr Brain & Mental Hlth Res, Newcastle, NSW 2300, Australia; [Franzosi, Maria-Grazia] Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, Milan, Italy; [Goel, Anuj; Helgadottir, Anna; Farrall, Martin] Univ Oxford, Dept Cardiovasc Med, Oxford, England; [Blackwell, Jenefer M.] Univ Western Australia, Ctr Child Hlth Res, Perth, WA, Australia; [Blackwell, Jenefer M.] Univ Cambridge, Sch Clin Med, Cambridge Inst Med Res, Cambridge, England; [Bramon, Elvira] Kings Coll London, Inst Psychiat, Biomed Res Ctr Mental Hlth, Div Psychol Med & Psychiat, London WC2R 2LS, England; [Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld, Australia; [Casas, Juan P.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Casas, Juan P.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Corvin, Aiden] Trinity Coll Dublin, Inst Mol Med, Neuropsychiat Genet Res Grp, Dublin, Ireland; [Duncanson, Audrey] Wellcome Trust Res Labs, London, England; [Jankowski, Janusz] Barts & London Queen Marys Sch Med & Dent, Ctr Gastroenterol, London, England; [Jankowski, Janusz] Univ Oxford, Div Clin Pharmacol, Oxford, England; [Mathew, Christopher G.; Trembath, Richard C.] Kings Coll London, Guys Hosp, Sch Med, Dept Med & Mol Genet, London WC2R 2LS, England; [Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland; [Plomin, Robert] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Sawcer, Stephen J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Viswanathan, Ananth C.] Natl Hlth Serv NHS Fdn Trust, Moorfields Eye Hosp, Biomed Res Ctr Ophthalmol, Natl Inst Hlth Res NIHR, London, England; [Viswanathan, Ananth C.] UCL, Inst Ophthalmol, London, England; [Wood, Nicholas W.] UCL, Inst Neurol, Dept Mol Neuroscience, London, England; [Worrall, Bradford B.] Univ Virginia, Sch Med, Dept Neurol, Charlottesville, VA 22908 USA; [Worrall, Bradford B.] Univ Virginia, Sch Med, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA; [Kittner, Steven J.] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; [Kittner, Steven J.] Baltimore Vet Affairs Med Ctr, Baltimore Geriatr Res Educ & Clin Ctr, Baltimore, MD USA; [Meschia, James F.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Walters, Matthew] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of Oxford; Wellcome Centre for Human Genetics; St Georges University London; University of Munich; University of Oxford; University of Edinburgh; University of Aberdeen; Jagiellonian University; Collegium Medicum Jagiellonian University; Lund University; Lund University; Skane University Hospital; KU Leuven; University Hospital Leuven; Flanders Institute for Biotechnology (VIB); Imperial College London; University of Edinburgh; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munster; KU Leuven; University Hospital Leuven; Wellcome Trust Sanger Institute; University of Iceland; IRCCS Istituto Neurologico Besta; Hunter Medical Research Institute; University of Newcastle; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Oxford; University of Western Australia; University of Cambridge; University of London; King's College London; University of Queensland; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; Trinity College Dublin; University of London; Queen Mary University London; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Dundee; University of London; King's College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; University College London; University of Virginia; University of Virginia; University System of Maryland; University of Maryland Baltimore; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; Mayo Clinic; University of Glasgow; University of Oxford	Donnelly, P (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	peter.donnelly@well.ox.ac.uk; hmarkus@sgul.ac.uk	Palmer, Colin NA/C-7053-2008; Wood, Nicholas W/C-2505-2009; Jankowski, Janusz/H-2706-2012; Bellenguez, Céline/X-4004-2019; Meisinger, Christine/B-5358-2014; Parati, Eugenio Agostino/AAN-5893-2021; Sander-Effron, Samuel/AAX-2231-2020; Meschia, James/GPP-1636-2022; Attia, John R/F-5376-2013; Blackwell, Jenefer M/H-3015-2015; Belllenguez, Céline/Y-3183-2018; Mitchell, Braxton/CAF-0876-2022; Plomin, Robert/B-8911-2008; sharma, pankaj/HGE-4423-2022; Study, GoDARTS/K-9448-2016; Bramon, Elvira/A-9463-2011; Müller-Myhsok, Bertram/A-3289-2013; Stefansson, Kari/AAE-7187-2019; Deloukas, Panos/B-2922-2013; Rothwell, Peter/ABE-5913-2020; Bramon, Elvira/HHC-3809-2022; Dichgans, Martin/HCH-3247-2022; Brown, Matthew A/E-5749-2010; Jackson, Caroline/B-5954-2012; Mathew, Christopher G/G-3434-2015; Thijs, Vincent/C-3647-2009; Pera, Joanna/U-5552-2018; Boncoraglio, Giorgio Battista/B-8647-2011	Palmer, Colin NA/0000-0002-6415-6560; Wood, Nicholas W/0000-0002-9500-3348; Jankowski, Janusz/0000-0003-2130-9181; Bellenguez, Céline/0000-0002-1240-7874; Parati, Eugenio Agostino/0000-0001-5020-6523; Meschia, James/0000-0002-4475-8142; Attia, John R/0000-0001-9800-1308; Belllenguez, Céline/0000-0002-1240-7874; Deloukas, Panos/0000-0001-9251-070X; Rothwell, Peter/0000-0001-9739-9211; Bramon, Elvira/0000-0003-1369-5983; Dichgans, Martin/0000-0002-0654-387X; Brown, Matthew A/0000-0003-0538-8211; Jackson, Caroline/0000-0002-2067-2811; Mathew, Christopher G/0000-0003-4178-1838; Thijs, Vincent/0000-0002-6614-8417; Pera, Joanna/0000-0001-6142-2969; Boncoraglio, Giorgio Battista/0000-0002-2551-525X; Walters, James/0000-0002-6980-4053; Hunt, Sarah/0000-0002-8350-1235; Trembath, Richard/0000-0003-0550-3400; Slark, Julia/0000-0003-4261-3254; Norrving, Bo/0000-0002-8024-5096; Mitchell, Braxton/0000-0003-4920-4744; Traylor, Matthew/0000-0001-6624-8621; Plomin, Robert/0000-0002-0756-3629; Malik, Rainer/0000-0001-9212-2520; Macleod, Mary Joan/0000-0003-2115-8184; Sudlow, Cathie/0000-0002-7725-7520; Corvin, Aiden/0000-0001-6717-4089; Ross-Adams, Helen/0000-0003-1338-742X; Seedorf, Udo/0000-0003-4652-5358; Edkins, Sarah/0000-0003-0717-1972; Bevan, Steve/0000-0003-0490-6830; Pirinen, Matti/0000-0002-1664-1350; Murphy, Lee/0000-0001-6467-7449; Lemmens, Robin/0000-0002-4948-5956; Meisinger, Christa/0000-0002-9026-6544; Levi, Christopher/0000-0002-9474-796X; Kissela, Brett/0000-0002-9773-4013	Medical Research Council [G0000934]; Wellcome Trust [068545/Z/02, 085475/B/08/Z, 085475/Z/08/Z, WT084724MA, WTCCC2]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488] Funding Source: NIH RePORTER; Medical Research Council [G1001799, G9817803B, G0901310] Funding Source: researchfish; National Institute for Health Research [PDA/02/06/016, NF-SI-0507-10379] Funding Source: researchfish; MRC [G1001799, G0901310, G0000934] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Bertrand, J. Bryant, S. L. Clark, J. S. Conquer, T. Dibling, J. C. Eldred, S. Gamble, C. Hind, M. L. Perez, C. R. Stribling, S. Taylor and A. Wilk of the Wellcome Trust Sanger Institute's Sample and Genotyping Facilities for technical assistance. We acknowledge use of the British 1958 Birth Cohort DNA collection, which is funded by the Medical Research Council (G0000934) and the Wellcome Trust (068545/Z/02), and of the UK National Blood Service controls funded by the Wellcome Trust. We thank W. Bodmer and B. Winney for use of the People of the British Isles DNA collection, which was funded by the Wellcome Trust. We thank the following individuals who contributed to collection, phenotyping, sample processing and data management for the different cohorts: A. Burgess, A. Syed and N. Paul (Oxford Vascular Study); M. Dennis, P. Sandercock, C. Warlow, S. Hart, S. Keir, J. Wardlaw, A. Farrall, G. Potter, A. Hutchison and M. McDowall (Edinburgh Stroke Study); A. Pasdar and H. Clinkscale (Aberdeen); P. Higgins (Glasgow); T. G. Brott, R. D. Brown, S. Silliman, M. Frankel, D. Case, S. Rich, J. Hardy, A. Singleton (ISGS); M. J. Sparks, K. Ryan, J. Cole, M. Wozniak, B. Stern, R. Wityk, C. Johnson and D. Buchholz (GEOS); and J. Maguire, S. Koblar, J. Golledge, J. Surm, G. Hankey, J. Jannes, M. Lewis, R. Scott, L. Lincz; P. Moscato and R. Baker (Australian Stroke Genetics Collaborative membership). The principal funding for this study was provided by the Wellcome Trust as part of the WTCCC2 project (085475/B/08/Z, 085475/Z/08/Z and WT084724MA). For details of other funding support, see the Supplementary Note.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Bellenguez C, 2012, BIOINFORMATICS, V28, P134, DOI 10.1093/bioinformatics/btr599; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Chen Kuo, 2010, Beijing Da Xue Xue Bao Yi Xue Ban, V42, P498; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Department of Health, 2005, RED BRAIN DAM FAST A; Dichgans M, 2007, LANCET NEUROL, V6, P149, DOI 10.1016/S1474-4422(07)70028-5; Glaser KB, 2003, MOL CANCER THER, V2, P151; Gretarsdottir S, 2008, ANN NEUROL, V64, P402, DOI 10.1002/ana.21480; Gschwendtner A, 2009, ANN NEUROL, V65, P531, DOI 10.1002/ana.21590; Gudbjartsson DF, 2009, NAT GENET, V41, P876, DOI 10.1038/ng.417; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Ikram MA, 2009, NEW ENGL J MED, V360, P1718, DOI 10.1056/NEJMoa0900094; Jerrard-Dunne P, 2003, STROKE, V34, P1364, DOI 10.1161/01.STR.0000069723.17984.FD; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kubo M, 2007, NAT GENET, V39, P212, DOI 10.1038/ng1945; Langley B, 2009, STROKE, V40, P2899, DOI 10.1161/STROKEAHA.108.540229; Lemmens R, 2010, STROKE, V41, P1850, DOI 10.1161/STROKEAHA.110.587980; Markus HS, 2010, TRANSL STROKE RES, V1, P238, DOI 10.1007/s12975-010-0041-5; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Olsson S, 2011, STROKE, V42, P214, DOI 10.1161/STROKEAHA.110.594010; Rosand J, 2010, NEW ENGL J MED, V362, P1547, DOI 10.1056/NEJMc0910050; SACCO RL, 1989, ANN NEUROL, V25, P382, DOI 10.1002/ana.410250410; Spencer CCA, 2011, HUM MOL GENET, V20, P345, DOI 10.1093/hmg/ddq469; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Su Z, 2009, STAT SCI, V24, P430, DOI 10.1214/09-STS311; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609	30	320	324	0	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2012	44	3					328	U141		10.1038/ng.1081	http://dx.doi.org/10.1038/ng.1081			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	899VC	22306652	Green Accepted, Green Submitted			2022-12-25	WOS:000300843600021
J	Feenstra, B; Geller, F; Krogh, C; Hollegaard, MV; Gortz, S; Boyd, HA; Murray, JC; Hougaard, DM; Melbye, M				Feenstra, Bjarke; Geller, Frank; Krogh, Camilla; Hollegaard, Mads V.; Gortz, Sanne; Boyd, Heather A.; Murray, Jeffrey C.; Hougaard, David M.; Melbye, Mads			Common variants near MBNL1 and NKX2-5 are associated with infantile hypertrophic pyloric stenosis	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; HERITABILITY; INHERITANCE	Infantile hypertrophic pyloric stenosis (IHPS) is a severe condition characterized by hypertrophy of the pyloric sphincter muscle. We conducted a genome-wide association study (GWAS) on 1,001 surgery-confirmed cases and 2,401 controls from Denmark. The six most strongly associated loci were tested in a replication set of 796 cases and 876 controls. Three SNPs reached genome-wide significance. One of these SNPs, rs11712066 (odds ratio (OR) = 1.61; P = 1.5 x 10(-17)) at 3p25.1, is located 150 kb upstream of MBNL1, which encodes a factor that regulates splicing transitions occurring shortly after birth. The second SNP, rs573872 (OR = 1.41; P = 4.3 x 10(-12)), maps to an intergenic region at 3p25.2 approximately 1.3 Mb downstream of MBNL1. The third SNP, rs29784 (OR = 1.42; P = 1.5 x 10(-15)) at 5q35.2, is 64 kb downstream of NKX2-5, which is involved in development of cardiac muscle tissue and embryonic gut development.	[Feenstra, Bjarke; Geller, Frank; Krogh, Camilla; Gortz, Sanne; Boyd, Heather A.; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Hollegaard, Mads V.; Hougaard, David M.] Statens Serum Inst, Sect Neonatal Screening & Hormones, DK-2300 Copenhagen, Denmark; [Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA	Statens Serum Institut; Statens Serum Institut; University of Iowa	Feenstra, B (corresponding author), Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark.	fee@ssi.dk; mme@ssi.dk	Hougaard, David/AAD-6368-2019	Hollegaard, Mads Vilhelm/0000-0003-1061-0091; Geller, Frank/0000-0002-9238-3269; Feenstra, Bjarke/0000-0003-1478-649X; Boyd, Heather/0000-0001-6849-9985; melbye, mads/0000-0001-8264-6785	Lundbeck Foundation [R34-A3931]; Novo Nordisk Foundation; Danish Medical Research Council [271-06-0628]; US National Institutes of Health (NIH) Genes, Environment and Health Initiative (GEI) [U01HG004423]; NIH GEI [U01HG004438]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004423, U01HG004446, U01HG004438] Funding Source: NIH RePORTER	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health (NIH) Genes, Environment and Health Initiative (GEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH GEI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported in part by grants from the Lundbeck Foundation (R34-A3931), the Novo Nordisk Foundation and the Danish Medical Research Council (271-06-0628). The GWAS data for the control samples were generated for our study of preterm birth within the Gene, Environment Association Studies (GENEVA) consortium, with funding provided through the US National Institutes of Health (NIH) Genes, Environment and Health Initiative (GEI; U01HG004423). Assistance with genotype cleaning and general study coordination for the preterm birth project were provided by the GENEVA Coordinating Center (U01HG004446). Genotyping was performed at the Johns Hopkins University Center for Inherited Disease Research, with support from the NIH GEI (U01HG004438).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bland CS, 2010, NUCLEIC ACIDS RES, V38, P7651, DOI 10.1093/nar/gkq614; CHAKRABORTY R, 1986, GENET EPIDEMIOL, V3, P1, DOI 10.1002/gepi.1370030102; Chung E, 2008, ARCH DIS CHILD, V93, P1003, DOI 10.1136/adc.2008.141499; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Fu YC, 1998, DEVELOPMENT, V125, P4439; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Honein MA, 1999, LANCET, V354, P2101, DOI 10.1016/S0140-6736(99)10073-4; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Kasahara H, 1998, CIRC RES, V82, P936, DOI 10.1161/01.RES.82.9.936; Krogh C, 2010, JAMA-J AM MED ASSOC, V303, P2393, DOI 10.1001/jama.2010.784; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; MacMahon B, 2006, EPIDEMIOLOGY, V17, P195, DOI 10.1097/01.ede.0000192032.83843.c9; MITCHELL LE, 1993, AM J DIS CHILD, V147, P1203, DOI 10.1001/archpedi.1993.02160350077012; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Panteli C, 2009, PEDIATR SURG INT, V25, P1043, DOI 10.1007/s00383-009-2484-x; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Pisacane A, 1996, BRIT MED J, V312, P745, DOI 10.1136/bmj.312.7033.745; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ranells Judith D, 2011, Adv Pediatr, V58, P195, DOI 10.1016/j.yapd.2011.03.005; Reamon-Buettner SM, 2010, HUM MUTAT, V31, P1185, DOI 10.1002/humu.21345; Schechter R, 1997, PAEDIATR PERINAT EP, V11, P407, DOI 10.1046/j.1365-3016.1997.d01-32.x; Self M, 2009, DEV BIOL, V334, P409, DOI 10.1016/j.ydbio.2009.07.039; Smith DM, 1999, NATURE, V402, P748, DOI 10.1038/45439; Smith DM, 2000, DEVELOPMENT, V127, P3671; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340	33	29	29	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2012	44	3					334	U1601		10.1038/ng.1067	http://dx.doi.org/10.1038/ng.1067			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	899VC	22306654	Green Accepted			2022-12-25	WOS:000300843600022
J	Patti, GJ; Yanes, O; Shriver, LP; Courade, JP; Tautenhahn, R; Manchester, M; Siuzdak, G				Patti, Gary J.; Yanes, Oscar; Shriver, Leah P.; Courade, Jean-Phillipe; Tautenhahn, Ralf; Manchester, Marianne; Siuzdak, Gary			Metabolomics implicates altered sphingolipids in chronic pain of neuropathic origin	NATURE CHEMICAL BIOLOGY			English	Article							PERIPHERAL-NERVE INJURY; SPINAL-CORD; SPHINGOSINE 1-PHOSPHATE; GENE-EXPRESSION; N,N-DIMETHYLSPHINGOSINE; METABOLISM; ASTROCYTES; CERAMIDE; NEURONS; BRAIN	Neuropathic pain is a debilitating condition for which the development of effective treatments has been limited by an incomplete understanding of its chemical basis. We show by using untargeted metabolomics that sphingomyelin-ceramide metabolism is altered in the dorsal horn of rats with neuropathic pain and that the upregulated, endogenous metabolite N,N-dimethylsphingosine induces mechanical hypersensitivity in vivo. These results demonstrate the utility of metabolomics to implicate unexplored biochemical pathways in disease.	[Patti, Gary J.] Washington Univ, Sch Med, Dept Chem, St Louis, MO 63130 USA; [Patti, Gary J.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Patti, Gary J.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Yanes, Oscar; Tautenhahn, Ralf; Siuzdak, Gary] Scripps Res Inst, Dept Chem, Scripps Ctr Metabol & Mass Spectrometry, La Jolla, CA 92037 USA; [Yanes, Oscar; Tautenhahn, Ralf; Siuzdak, Gary] Scripps Res Inst, Dept Mol Biol, Scripps Ctr Metabol & Mass Spectrometry, La Jolla, CA 92037 USA; [Yanes, Oscar] Univ Rovira & Virgili, Metabol Platform Spanish Biomed Res Ctr Diabet &, Tarragona, Spain; [Shriver, Leah P.; Manchester, Marianne] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Courade, Jean-Phillipe] Pfizer Global Res & Dev, Pain Res Unit, Sandwich, Kent, England	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Scripps Research Institute; Scripps Research Institute; Universitat Rovira i Virgili; University of California System; University of California San Diego; Pfizer	Patti, GJ (corresponding author), Washington Univ, Sch Med, Dept Chem, St Louis, MO 63130 USA.	mmanchester@ucsd.edu; siuzdak@scripps.edu	Yanes, Oscar/N-3630-2016; Courade, Jean-Philippe/H-4411-2013	Yanes, Oscar/0000-0003-3695-7157; Courade, Jean-Philippe/0000-0001-6722-2263; Siuzdak, Gary/0000-0002-4749-0014; Manchester, Marianne/0000-0002-7143-5744	US National Institutes of Health (NIH) [1224 EY017540-04, P30 MH062261]; NIH-National Institute of Aging [L30 AG0 038036]; NIH-National Institute of Neurological Disorders and Stroke [F32NS068015, T32 NSO41219]; US Department of Energy [FG02-07ER64325, DE-AC0205CH11231];  [P01 DA026146-02]; NATIONAL CANCER INSTITUTE [R01CA112075] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R24EY017540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS041219, F32NS068015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA026146] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH-National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US Department of Energy(United States Department of Energy (DOE)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the US National Institutes of Health (NIH) 1224 EY017540-04 (G.S.), P30 MH062261 (M.M., G.S.) and P01 DA026146-02 (G.S.) in addition to RR025774 (MM.); NIH-National Institute of Aging L30 AG0 038036 (G.J.P.); and NIH-National Institute of Neurological Disorders and Stroke F32NS068015 and T32 NSO41219 (L.P.S.). We also acknowledge financial support front the US Department of Energy FG02-07ER64325 and DE-AC0205CH11231).	Alexander GM, 2005, PAIN, V116, P213, DOI 10.1016/j.pain.2005.04.013; Coste O, 2008, J BIOL CHEM, V283, P32442, DOI 10.1074/jbc.M806410200; Edsall LC, 1998, BIOCHEMISTRY-US, V37, P12892, DOI 10.1021/bi980744d; Gao YJ, 2009, J NEUROSCI, V29, P4096, DOI 10.1523/JNEUROSCI.3623-08.2009; Goggel R, 2004, NAT MED, V10, P155, DOI 10.1038/nm977; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hofmann HA, 2003, EUR J PHARMACOL, V470, P17, DOI 10.1016/S0014-2999(03)01753-9; IGARASHI Y, 1990, J BIOL CHEM, V265, P5385; IGARASHI Y, 1989, BIOCHEM BIOPH RES CO, V164, P1411, DOI 10.1016/0006-291X(89)91827-5; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; KNYIHARCSILLIK E, 1987, CELL TISSUE RES, V247, P599, DOI 10.1007/BF00215754; Latorre E, 1999, EUR J BIOCHEM, V262, P308, DOI 10.1046/j.1432-1327.1999.00358.x; Lee YK, 2007, MOL CELLS, V23, P11; Morales PR, 2007, DRUG CHEM TOXICOL, V30, P197, DOI 10.1080/01480540701375018; Nie H, 2010, J NEUROPHYSIOL, V103, P2570, DOI 10.1152/jn.00013.2010; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Singh OV, 2009, PROTEOMICS, V9, P1241, DOI 10.1002/pmic.200800636; Sung YJ, 2004, NEUROL RES, V26, P195, DOI 10.1179/016164104225013761; Torrance N, 2006, J PAIN, V7, P281, DOI 10.1016/j.jpain.2005.11.008; Warfield C. A., 2002, MANUAL PAIN MANAGEME, P193; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Wolf G, 2006, PAIN, V120, P315, DOI 10.1016/j.pain.2005.11.011; WOOLF CJ, 1992, NATURE, V355, P75, DOI 10.1038/355075a0; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0	25	135	151	1	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2012	8	3					232	234		10.1038/NCHEMBIO.767	http://dx.doi.org/10.1038/NCHEMBIO.767			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896VR	22267119	Green Accepted			2022-12-25	WOS:000300600000006
J	Calamini, B; Silva, MC; Madoux, F; Hutt, DM; Khanna, S; Chalfant, MA; Saldanha, SA; Hodder, P; Tait, BD; Garza, D; Balch, WE; Morimoto, RI				Calamini, Barbara; Silva, Maria Catarina; Madoux, Franck; Hutt, Darren M.; Khanna, Shilpi; Chalfant, Monica A.; Saldanha, S. Adrian; Hodder, Peter; Tait, Bradley D.; Garza, Dan; Balch, William E.; Morimoto, Richard I.			Small-molecule proteostasis regulators for protein conformational diseases	NATURE CHEMICAL BIOLOGY			English	Article							HEAT-SHOCK RESPONSE; POLYGLUTAMINE AGGREGATION; TRANSCRIPTION; INDUCTION; STRESS; MODEL; HSP90; NEURODEGENERATION; EXPRESSION; CELASTROL	Protein homeostasis (proteostasis) is essential for cellular and organismal health. Stress, aging and the chronic expression of misfolded proteins, however, challenge the proteostasis machinery and the vitality of the cell. Enhanced expression of molecular chaperones, regulated by heat shock transcription factor-1 (HSF-1), has been shown to restore proteostasis in a variety of conformational disease models, suggesting this mechanism as a promising therapeutic approach. We describe the results of a screen comprised of similar to 900,000 small molecules that identified new classes of small-molecule proteostasis regulators that induce HSF-1-dependent chaperone expression and restore protein folding in multiple conformational disease models. These beneficial effects to proteome stability are mediated by HSF-1, FOXO, Nrf-2 and the chaperone machinery through mechanisms that are distinct from current known small-molecule activators of the heat shock response. We suggest that modulation of the proteostasis network by proteostasis regulators may be a promising therapeutic approach for the treatment of a variety of protein conformational diseases.	[Calamini, Barbara; Silva, Maria Catarina; Morimoto, Richard I.] Northwestern Univ, Dept Mol Biosci, Rice Inst Biomed Res, Evanston, IL 60208 USA; [Silva, Maria Catarina] Univ Lisbon, Fac Sci, Ctr Biodivers Funct & Integrat Genom BioFIG, P-1699 Lisbon, Portugal; [Madoux, Franck; Saldanha, S. Adrian; Hodder, Peter] Scripps Res Inst, Mol Screening Ctr, Lead Identificat Div, Jupiter, FL USA; [Hutt, Darren M.; Chalfant, Monica A.; Balch, William E.] Scripps Res Inst, Dept Cell Biol & Chem Physiol, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA; [Khanna, Shilpi; Tait, Bradley D.; Garza, Dan] Proteostasis Therapeut Inc, Cambridge, MA USA	Northwestern University; Universidade de Lisboa; Scripps Research Institute; Scripps Research Institute	Morimoto, RI (corresponding author), Northwestern Univ, Dept Mol Biosci, Rice Inst Biomed Res, Evanston, IL 60208 USA.	r-morimoto@northwestern.edu			US National Institutes of Health (NIH) [T32 CA70085]; NIH [T32 AG000260, HL 079442, GM42336, DK785483, GM038109, GM081192, AG026647, NS047331]; Fundacao para a Ciencia e Tecnologia [SFRH/BD/28461/2006]; Canadian Institutes for Health Research (CIHR); NIH Molecular Library Screening Center Network [MH084512]; NATIONAL CANCER INSTITUTE [T32CA070085] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079442, R01HL095524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038109, R01GM033301, R01GM042336, R01GM038109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG026647, R01AG026647, T32AG000260] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NIH Molecular Library Screening Center Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We acknowledge J. Maddry, the SRI and the NINDS for support in performing the primary screen; P. Chase and P. Baillargeon of Scripps Florida for executing the SRIMSC screening activities; S. Fox, J. West, S. Westerheide, J. Moran, M. Beam and K. Orton for technical assistance; J. S. Pedersen for help developing the worm tracker system; and the Morimoto laboratory, in particular T. Gidalevitz, J. Kirstein, C. Voisine and A. Yu, for helpful comments. PC12 httQ74-GFP cells were provided by D. Rubinsztein (University of Cambridge). Purified Hsp90 beta was a gift of A. Chadli (Georgia Health Science University). We thank A. Ciechanover for the rabbit polyclonal ubiquitin antibody (Israel Institute of Technology). The CFBE41o-YFP cells were a gift from L. Galietta (Istituto Giannina Gaslini). This work was supported by the US National Institutes of Health (NIH) Training Grant in Signal Transduction and Cancer T32 CA70085 and the NIH Training Grant in Drug Discovery in Age Related Diseases T32 AG000260 (to B. C.), Portuguese PhD fellowship from the Fundacao para a Ciencia e Tecnologia (SFRH/BD/28461/2006) (to M. C. S.), NIH grants HL 079442, GM42336 and DK785483 (to W. E. B.), a fellowship from the Canadian Institutes for Health Research (CIHR) (to D. M. H.), the NIH Molecular Library Screening Center Network MH084512 (to F. M., S. A. S. and P. H.) and NIH grants GM038109, GM081192, AG026647 and NS047331 (to R.I.M.).	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; AMICI C, 1992, P NATL ACAD SCI USA, V89, P6227, DOI 10.1073/pnas.89.14.6227; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Butina D, 1999, J CHEM INF COMP SCI, V39, P747, DOI 10.1021/ci9803381; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dinkova-Kostova AT, 2001, P NATL ACAD SCI USA, V98, P3404, DOI 10.1073/pnas.051632198; Fujikake N, 2008, J BIOL CHEM, V283, P26188, DOI 10.1074/jbc.M710521200; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Garcia SM, 2007, GENE DEV, V21, P3006, DOI 10.1101/gad.1575307; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Gidalevitz T, 2010, CURR OPIN STRUC BIOL, V20, P23, DOI 10.1016/j.sbi.2009.11.001; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Li C, 2007, ANTIOXID REDOX SIGN, V9, P2227, DOI 10.1089/ars.2007.1783; Lichtlen P, 2001, BIOESSAYS, V23, P1010, DOI 10.1002/bies.1146; Liu Y, 2008, EMBO J, V27, P1049, DOI 10.1038/emboj.2008.42; Luo WJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-24; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Neef DW, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000291; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Parenti G, 2009, EMBO MOL MED, V1, P268, DOI 10.1002/emmm.200900036; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Roesslein M, 2008, J PHARMACOL EXP THER, V325, P217, DOI 10.1124/jpet.107.133108; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; Solit DB, 2008, CLIN CANCER RES, V14, P8302, DOI 10.1158/1078-0432.CCR-08-1002; Stringer JR, 2011, ACS COMB SCI, V13, P175, DOI 10.1021/co100053p; Taldone T, 2008, CURR OPIN PHARMACOL, V8, P370, DOI 10.1016/j.coph.2008.06.015; Tam LCS, 2010, HUM MOL GENET, V19, P4421, DOI 10.1093/hmg/ddq369; Tangallapally RP, 2004, J MED CHEM, V47, P5276, DOI 10.1021/jm049972y; Teiten MH, 2009, CANCER LETT, V279, P145, DOI 10.1016/j.canlet.2009.01.031; Trott A, 2008, MOL BIOL CELL, V19, P1104, DOI 10.1091/mbc.E07-10-1004; Vacher C, 2005, HUM MOL GENET, V14, P3425, DOI 10.1093/hmg/ddi372; Vargas MR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001094; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; WILLIAMS GT, 1990, MOL CELL BIOL, V10, P3125, DOI 10.1128/MCB.10.6.3125; Wyttenbach A, 2001, HUM MOL GENET, V10, P1829, DOI 10.1093/hmg/10.17.1829; Yadav VR, 2011, INT IMMUNOPHARMACOL, V11, P295, DOI 10.1016/j.intimp.2010.12.006; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yang H, 2003, J BIOL CHEM, V278, P35079, DOI 10.1074/jbc.M303098200; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhang YQ, 2007, J MOL MED-JMM, V85, P1421, DOI 10.1007/s00109-007-0251-9	50	171	175	0	47	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2012	8	2					185	196		10.1038/nchembio.763	http://dx.doi.org/10.1038/nchembio.763			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879IP	22198733	Green Accepted			2022-12-25	WOS:000299323200011
J	Koeberle, SC; Romir, J; Fischer, S; Koeberle, A; Schattel, V; Albrecht, W; Grutter, C; Werz, O; Rauh, D; Stehle, T; Laufer, SA				Koeberle, Solveigh C.; Romir, Johannes; Fischer, Stefan; Koeberle, Andreas; Schattel, Verena; Albrecht, Wolfgang; Gruetter, Christian; Werz, Oliver; Rauh, Daniel; Stehle, Thilo; Laufer, Stefan A.			Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor	NATURE CHEMICAL BIOLOGY			English	Article							MAP KINASE; SIGNALING PATHWAYS; KAPPA-B; CELLS; EXPRESSION; ADHESION; DESIGN; INFLAMMATION; PLAYS	Until now, a lack of inhibitors with high potency and selectivity in vivo has hampered investigation of the p38 mitogen-activated protein kinase (MAPK) signaling pathway. We describe the design of skepinone-L, which is, to our knowledge, the first ATP-competitive p38 MAPK inhibitor with excellent in vivo efficacy and selectivity. Therefore, skepinone-L is a valuable probe for chemical biology research, and it may foster the development of a unique class of kinase inhibitors.	[Romir, Johannes; Stehle, Thilo] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Koeberle, Solveigh C.; Fischer, Stefan; Schattel, Verena; Laufer, Stefan A.] Univ Tubingen, Inst Pharm, Tubingen, Germany; [Koeberle, Solveigh C.] Fritz Lipmann Inst, Inst Age Res, Jena, Germany; [Koeberle, Andreas; Werz, Oliver] Univ Jena, Inst Pharm, Jena, Germany; [Albrecht, Wolfgang] CAIR Biosci GmbH, Tubingen, Germany; [Gruetter, Christian; Rauh, Daniel] Tech Univ Dortmund, Fac Chem Chem Biol, Dortmund, Germany; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Friedrich Schiller University of Jena; Dortmund University of Technology; Vanderbilt University	Stehle, T (corresponding author), Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany.	thilo.stehle@uni-tuebingen.de; stefan.laufer@uni-tuebingen.de	Koeberle, Andreas/ABB-2356-2020; Rauh, Daniel/G-1595-2013	Koeberle, Andreas/0000-0001-6269-5088; Koeberle, Solveigh/0000-0002-8008-494X; Rauh, Daniel/0000-0002-1970-7642; Laufer, Stefan/0000-0001-6952-1486	German Federal Ministry for Education [BMBF 01GS08104]	German Federal Ministry for Education	We thank S. Luik, M Goettert and K. Bauer for biological testing. We thank M. Fecker, J.R. Simard, S. Mayer-Wrangowski and A. Richters for expert assistance during protein production and crystallization. D. R. is grateful for funds from the German Federal Ministry for Education (grant no. BMBF 01GS08104). We thank T. Joos, N. Schneiderhan-Marra, K. Hefner, M. Schmohl and G. M. Stein (Naturwissenschaftliches und Medizinisches Institut and Experimentelle und Diagnostische Immunologie Reutlingen) for cytokine profiling of skepinone-L in hPMBCs.	Cekic C, 2009, J BIOL CHEM, V284, P31982, DOI 10.1074/jbc.M109.046383; Dinarello CA, 2009, SEMIN DIALYSIS, V22, P256, DOI 10.1111/j.1525-139X.2009.00568.x; Fitzgerald CE, 2003, NAT STRUCT BIOL, V10, P764, DOI 10.1038/nsb949; Goldstein DM, 2006, J MED CHEM, V49, P1562, DOI 10.1021/jm050736c; Goldstein DM, 2005, CURR TOP MED CHEM, V5, P1017, DOI 10.2174/1568026054985939; Hill RJ, 2008, J PHARMACOL EXP THER, V327, P610, DOI 10.1124/jpet.108.139006; Ip WK, 2006, CLIN EXP IMMUNOL, V145, P162, DOI 10.1111/j.1365-2249.2006.03085.x; Ip WK, 2005, IMMUNOPHARM IMMUNOT, V27, P371, DOI 10.1080/08923970500240925; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Karcher SC, 2009, CURR TOP MED CHEM, V9, P655, DOI 10.2174/156802609789007363; Karcher SC, 2009, J MED CHEM, V52, P1778, DOI 10.1021/jm801291f; Kurihara Y, 2011, CELL IMMUNOL, V270, P25, DOI 10.1016/j.cellimm.2011.03.017; Laufer SA, 2006, J MED CHEM, V49, P7912, DOI 10.1021/jm061072p; Lee MR, 2005, CURR MED CHEM, V12, P2979, DOI 10.2174/092986705774462914; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mutou Y, 2010, J HEALTH SCI, V56, P675, DOI 10.1248/jhs.56.675; Pan SL, 2008, SHOCK, V30, P496, DOI 10.1097/SHK.0b013e3181673233; Peng H, 2011, J BIOL CHEM, V286, P24508, DOI 10.1074/jbc.M111.234062; Schett G, 2008, ANN RHEUM DIS, V67, P909, DOI 10.1136/ard.2007.074278; Schieven GL, 2009, CURR TOP MED CHEM, V9, P1038, DOI 10.2174/156802609789630974; Shimada H, 2010, J BIOL CHEM, V285, P12536, DOI 10.1074/jbc.M109.099630; Tibbles LA, 2002, J VIROL, V76, P1559, DOI 10.1128/JVI.76.4.1559-1568.2002; Veillat V, 2010, J CLIN ENDOCR METAB, V95, pE403, DOI 10.1210/jc.2010-0417; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Xie NC, 2010, NEUROPHARMACOLOGY, V59, P444, DOI 10.1016/j.neuropharm.2010.06.006	25	93	93	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2012	8	2					141	143		10.1038/nchembio.761	http://dx.doi.org/10.1038/nchembio.761			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879IP	22198732				2022-12-25	WOS:000299323200004
J	Murphy, WJ; Ferrara, JLM; Malek, T				Murphy, William J.; Ferrara, James L. M.; Malek, Thomas			A delicate balance: tweaking IL-2 immunotherapy	NATURE MEDICINE			English	Editorial Material							VERSUS-HOST-DISEASE; REGULATORY T-CELLS; INTERLEUKIN-2; EXPANSION	The cytokine interleukin-2 (IL-2) is important for the activation of several types of immune cells, including T cells, and its clinical potential has been previously explored in the context of boosting immune responses to cancer and infectious diseases. However, two recent studies provide evidence that low-dose IL-2 therapy can suppress adverse immune reactions. Koreth et al.(1) showed that IL-2 therapy reversed graft-versus-host disease (GVHD) in patients who had undergone allogeneic hematopoietic stem cell transplantation (HSCT) to treat lymphoma or leukemia. Similarly, Saadoun et al.(2) found that IL-2 treatment had clinical benefit in hepatitis C virus (HCV)-related vasculitis with IL-2. Both studies suggested that IL-2's therapeutic effects might be mediated through suppressive regulatory T cells (T-reg cells), as T-reg cell counts were higher in treated individuals. We asked three experts to comment on the implications of these studies for IL-2 immunotherapy.										Atkins MB, 1999, J CLIN ONCOL, V17, P2105, DOI 10.1200/JCO.1999.17.7.2105; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; ROSENBERG SA, 1986, ANNU REV IMMUNOL, V4, P681, DOI 10.1146/annurev.immunol.4.1.681; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Shin HJ, 2011, BLOOD, V118, P2342, DOI 10.1182/blood-2010-10-313684; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Willenbacher W, 2001, BRIT J HAEMATOL, V112, P820, DOI 10.1046/j.1365-2141.2001.02582.x; Yu AX, 2009, IMMUNITY, V30, P204, DOI 10.1016/j.immuni.2008.11.014	11	8	8	0	5	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					208	209		10.1038/nm0212-208	http://dx.doi.org/10.1038/nm0212-208			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22310686				2022-12-25	WOS:000300140300030
J	Kalhor, R; Tjong, H; Jayathilaka, N; Alber, F; Chen, L				Kalhor, Reza; Tjong, Harianto; Jayathilaka, Nimanthi; Alber, Frank; Chen, Lin			Genome architectures revealed by tethered chromosome conformation capture and population-based modeling	NATURE BIOTECHNOLOGY			English	Article							SPATIAL-ORGANIZATION; MACROMOLECULAR ASSEMBLIES; NUCLEAR ARCHITECTURE; GENE-EXPRESSION; YEAST GENOME; CHROMATIN; CELLS; TRANSCRIPTION; TERRITORIES; ASSOCIATIONS	We describe tethered conformation capture (TCC), a method for genome-wide mapping of chromatin interactions. By performing ligations on solid substrates rather than in solution, TCC substantially enhances the signal-to-noise ratio, thereby facilitating a detailed analysis of interactions within and between chromosomes. We identified a group of regions in each chromosome in human cells that account for the majority of interchromosomal interactions. These regions are marked by high transcriptional activity, suggesting that their interactions are mediated by transcriptional machinery. Each of these regions interacts with numerous other such regions throughout the genome in an indiscriminate fashion, partly driven by the accessibility of the partners. As a different combination of interactions is likely present in different cells, we developed a computational method to translate the TCC data into physical chromatin contacts in a population of three-dimensional genome structures. Statistical analysis of the resulting population demonstrates that the indiscriminate properties of interchromosomal interactions are consistent with the well-known architectural features of the human genome.	[Kalhor, Reza; Tjong, Harianto; Jayathilaka, Nimanthi; Alber, Frank; Chen, Lin] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Kalhor, Reza; Jayathilaka, Nimanthi] Univ So Calif, Keck Sch Med, Program Genet Mol & Cellular Biol, Los Angeles, CA 90033 USA; [Chen, Lin] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Chen, Lin] Univ So Calif, Keck Sch Med, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Alber, F (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	alber@usc.edu; linchen@usc.edu	Tjong, Harianto/C-6959-2011; Jayathilaka, Nimanthi/AAG-3697-2019	Tjong, Harianto/0000-0001-7992-2697; Jayathilaka, Nimanthi/0000-0001-8741-3075	Human Frontier Science Program [RGY0079/2009-C]; Alfred P. Sloan Foundation; US National Institutes of Health (NIH) [GM064642, GM077320]; NIH [GM096089, RR022220]; Pew Charitable Trusts; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064642, R01GM096089, R01GM077320] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Trusts; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to acknowledge P. Laird, J. Knowles and J. Aman and the USC Epigenome Center for assistance in high-throughput sequencing, M. Michael and A. Williams for assistance in confocal microscopy, N. Bottini and Q.-L. Ying and members of their laboratories for assistance in cell culture, A.D. Smith for access to cluster computing, I. Slaymaker for graphic design and the integrative modeling platform team for support. Structure calculations were done on USC HPCC. We also thank N. Arnheim, A.D. Smith, O. Aparicio, S. Forsburg, W. Li, M.S. Madhusudhan, K. Gong, S. Srivastava, S. Al-Bassam, M. Murphy, J. Peace and Z. Ostrow for useful discussions and comments on the manuscript. This work is supported by Human Frontier Science Program grant RGY0079/2009-C to F.A., Alfred P. Sloan Foundation grant to F.A.; US National Institutes of Health (NIH) grants GM064642 and GM077320 to L.C., NIH grant GM096089 to F.A. and NIH grant RR022220 to F.A. and L.C.F.A. is a Pew Scholar in Biomedical Sciences, supported by the Pew Charitable Trusts.	Alber F, 2005, STRUCTURE, V13, P435, DOI 10.1016/j.str.2005.01.013; Alber F, 2008, ANNU REV BIOCHEM, V77, P443, DOI 10.1146/annurev.biochem.77.060407.135530; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Alcobia I, 2003, EXP CELL RES, V290, P358, DOI 10.1016/S0014-4827(03)00335-5; Alcobia I, 2000, BLOOD, V95, P1608, DOI 10.1182/blood.V95.5.1608.005k32_1608_1615; Bau D, 2011, NAT STRUCT MOL BIOL, V18, P107, DOI 10.1038/nsmb.1936; Beatty B., 2002, FISH PRACTICAL APPRO; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211; Branco MR, 2007, TRENDS CELL BIOL, V17, P127, DOI 10.1016/j.tcb.2006.12.006; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Chotalia M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002031; Cook PR, 2010, J MOL BIOL, V395, P1, DOI 10.1016/j.jmb.2009.10.031; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Cook PR, 2002, NAT GENET, V32, P347, DOI 10.1038/ng1102-347; Cremer M, 2001, CHROMOSOME RES, V9, P541, DOI 10.1023/A:1012495201697; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Gue M, 2005, CYTOM PART A, V67A, P18, DOI 10.1002/cyto.a.20170; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kelley LA, 1996, PROTEIN ENG, V9, P1063, DOI 10.1093/protein/9.11.1063; Kreth G, 2004, BIOPHYS J, V86, P2803, DOI 10.1016/S0006-3495(04)74333-7; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Mahy NL, 2002, J CELL BIOL, V159, P753, DOI 10.1083/jcb.200207115; Mahy NL, 2002, J CELL BIOL, V157, P579, DOI 10.1083/jcb.200111071; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Misteli T, 2009, P NATL ACAD SCI USA, V106, P6885, DOI 10.1073/pnas.0902010106; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Simonis M, 2007, NAT METHODS, V4, P895, DOI 10.1038/NMETH1114; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; Srivastava S, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq670; Sullivan GJ, 2001, EMBO J, V20, P2867, DOI 10.1093/emboj/20.11.2867; Tanizawa H, 2010, NUCLEIC ACIDS RES, V38, P8164, DOI 10.1093/nar/gkq955; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tolhuis B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001343; van Steensel B, 2010, NAT BIOTECHNOL, V28, P1089, DOI 10.1038/nbt.1680; Volpi EV, 2000, J CELL SCI, V113, P1565; Wurtele H, 2006, CHROMOSOME RES, V14, P477, DOI 10.1007/s10577-006-1075-0; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	47	403	426	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2012	30	1					90	U139		10.1038/nbt.2057	http://dx.doi.org/10.1038/nbt.2057			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	876MC	22198700	Green Accepted			2022-12-25	WOS:000299110600025
J	Lee, HH; Collins, JJ				Lee, Henry H.; Collins, James J.			Microbial environments confound antibiotic efficacy	NATURE CHEMICAL BIOLOGY			English	Article							BACTERIAL PERSISTERS; ESCHERICHIA-COLI; RESISTANCE; DEATH; EMERGENCE; SPECTRUM; MUTANTS; DAMAGE; CELLS; LEADS		[Lee, Henry H.; Collins, James J.] Boston Univ, Dept Biomed Engn, Howard Hughes Med Inst, Boston, MA 02215 USA; [Lee, Henry H.; Collins, James J.] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Boston University; Howard Hughes Medical Institute; Boston University; Harvard University	Lee, HH (corresponding author), Boston Univ, Dept Biomed Engn, Howard Hughes Med Inst, Boston, MA 02215 USA.	jcollins@bu.edu	Lee, Henry/GVS-2114-2022	Lee, Henry/0000-0002-0577-2275	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIH HHS [DP1 OD003644] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Allison KR, 2011, CURR OPIN MICROBIOL, V14, P593, DOI 10.1016/j.mib.2011.09.002; Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bernier SP, 2011, MOL MICROBIOL, V81, P705, DOI 10.1111/j.1365-2958.2011.07724.x; Brogden KA, 2005, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0; Butler MM, 2010, ANTIMICROB AGENTS CH, V54, P3974, DOI 10.1128/AAC.00484-10; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157; Drlica K, 2008, ANTIMICROB AGENTS CH, V52, P385, DOI 10.1128/AAC.01617-06; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Gusarov I, 2009, SCIENCE, V325, P1380, DOI 10.1126/science.1175439; HELLING RB, 1971, J BACTERIOL, V105, P1224, DOI 10.1128/JB.105.3.1224-1226.1971; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Kim JS, 2011, ANTIMICROB AGENTS CH, V55, P5380, DOI 10.1128/AAC.00708-11; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Mulcahy LR, 2010, J BACTERIOL, V192, P6191, DOI 10.1128/JB.01651-09; Oethinger M, 1998, ANTIMICROB AGENTS CH, V42, P2089, DOI 10.1128/AAC.42.8.2089; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; Thornton RB, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-94; Zhang QC, 2011, SCIENCE, V333, P1764, DOI 10.1126/science.1208747	25	51	54	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					6	9		10.1038/nchembio.740	http://dx.doi.org/10.1038/nchembio.740			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22173343	Green Accepted			2022-12-25	WOS:000298414100003
J	Maxwell, PH				Maxwell, Patrick H.			Aspiring to prevent colon cancer	NATURE MEDICINE			English	Editorial Material							METAANALYSIS; RISK		UCL, Fac Med Sci, London, England	University of London; University College London	Maxwell, PH (corresponding author), UCL, Fac Med Sci, London, England.	p.maxwell@ucl.ac.uk	Maxwell, Patrick H/C-5557-2008	Maxwell, Patrick H/0000-0002-0338-2679	National Institute for Health Research [NF-SI-0507-10315] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Aune D, 2011, GASTROENTEROLOGY, V141, P106, DOI 10.1053/j.gastro.2011.04.013; Burn J, 2011, LANCET, V378, P2081, DOI 10.1016/S0140-6736(11)61049-0; Burn J, 2008, NEW ENGL J MED, V359, P2567, DOI 10.1056/NEJMoa0801297; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Cuzick J, 2009, LANCET ONCOL, V10, P501, DOI 10.1016/S1470-2045(09)70035-X; Duthie GG, 2011, FOOD FUNCT, V2, P515, DOI 10.1039/c1fo10128e; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; THUN MJ, 1991, NEW ENGL J MED, V325, P1593, DOI 10.1056/NEJM199112053252301; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Yeomans ND, 2011, J GASTROEN HEPATOL, V26, P426, DOI 10.1111/j.1440-1746.2010.06569.x	12	7	8	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2012	18	1					32	33		10.1038/nm.2637	http://dx.doi.org/10.1038/nm.2637			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22227665				2022-12-25	WOS:000299018600024
J	Sakaguchi, S; Powrie, F; Ransohoff, RM				Sakaguchi, Shimon; Powrie, Fiona; Ransohoff, Richard M.			Re-establishing immunological self-tolerance in autoimmune disease	NATURE MEDICINE			English	Article							REGULATORY T-CELLS; TRANSCRIPTION FACTOR FOXP3; INTESTINAL INFLAMMATION; IMMUNE-SYSTEM; TGF-BETA; IN-VIVO; NEGATIVE SELECTION; THYMIC SELECTION; INDUCTION; GENERATION	Recent progress has revealed the molecular basis of how self-reactive T cells are normally generated in the immune system and differentiate into autoimmune effector T cells and how they are controlled by central and peripheral mechanisms of self-tolerance. There is also evidence that target tissues and cells in autoimmune disease have different sensitivities to immune mediators. Here we describe how these basic findings can be clinically translated to re-establish self-tolerance in individuals with autoimmune disease.	[Sakaguchi, Shimon] Osaka Univ, World Premier Initiat Immunol Frontier Res Ctr, Expt Immunol Lab, Suita, Osaka, Japan; [Sakaguchi, Shimon] Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto, Japan; [Powrie, Fiona] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Powrie, Fiona] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Translat Gastroenterol Unit,Expt Med Div, Oxford OX3 9DU, England; [Ransohoff, Richard M.] Cleveland Clin, Lerner Res Inst, Neuroinflammat Res Ctr, Cleveland, OH 44106 USA; [Ransohoff, Richard M.] Cleveland Clin, Mellen Ctr Mississippi Treatment & Res, Neurol Inst, Cleveland, OH 44106 USA	Osaka University; Kyoto University; University of Oxford; University of Oxford; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Sakaguchi, S (corresponding author), Osaka Univ, World Premier Initiat Immunol Frontier Res Ctr, Expt Immunol Lab, Suita, Osaka, Japan.	shimon@frontier.kyoto-u.ac.jp	Sakaguchi, Shimon/C-9535-2009		Wellcome Trust [095688] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Bottini N, 2006, SEMIN IMMUNOL, V18, P207, DOI 10.1016/j.smim.2006.03.008; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen Y, 2011, IMMUNITY, V34, P409, DOI 10.1016/j.immuni.2011.02.011; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Daniel C, 2011, J EXP MED, V208, P1501, DOI 10.1084/jem.20110574; Danke NA, 2005, J AUTOIMMUN, V25, P303, DOI 10.1016/j.jaut.2005.08.007; Danke NA, 2004, J IMMUNOL, V172, P5967, DOI 10.4049/jimmunol.172.10.5967; Duarte JH, 2009, EUR J IMMUNOL, V39, P948, DOI 10.1002/eji.200839196; Fife BT, 2008, IMMUNOL REV, V224, P166, DOI 10.1111/j.1600-065X.2008.00662.x; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; HERMAN A, 1991, ANNU REV IMMUNOL, V9, P745, DOI 10.1146/annurev.iy.09.040191.003525; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kekalainen E, 2007, J IMMUNOL, V178, P1208, DOI 10.4049/jimmunol.178.2.1208; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Laakso SM, 2010, J AUTOIMMUN, V35, P351, DOI 10.1016/j.jaut.2010.07.008; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Liston A, 2007, CURR OPIN IMMUNOL, V19, P176, DOI 10.1016/j.coi.2007.02.005; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Mueller DL, 2010, NAT IMMUNOL, V11, P21, DOI 10.1038/ni.1817; Nadkarni S, 2007, J EXP MED, V204, P33, DOI 10.1084/jem.20061531; Pot C, 2011, SEMIN IMMUNOL, V23, P438, DOI 10.1016/j.smim.2011.08.003; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sakaguchi S, 2005, CURR OPIN IMMUNOL, V17, P589, DOI 10.1016/j.coi.2005.09.017; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Suri-Payer E, 2001, J AUTOIMMUN, V16, P115, DOI 10.1006/jaut.2000.0473; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Tanaka S, 2010, J IMMUNOL, V185, P2295, DOI 10.4049/jimmunol.1000848; Tang QZ, 2006, IMMUNOL REV, V212, P217, DOI 10.1111/j.0105-2896.2006.00421.x; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; Werlen G, 2003, SCIENCE, V299, P1859, DOI 10.1126/science.1067833; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wing K, 2011, TRENDS IMMUNOL, V32, P428, DOI 10.1016/j.it.2011.06.002; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165; Yamaguchi T, 2011, SEMIN IMMUNOL, V23, P424, DOI 10.1016/j.smim.2011.10.002; Zheng SG, 2002, J IMMUNOL, V169, P4183, DOI 10.4049/jimmunol.169.8.4183; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	72	58	62	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2012	18	1					54	58		10.1038/nm.2622	http://dx.doi.org/10.1038/nm.2622			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22227673				2022-12-25	WOS:000299018600028
J	Stohl, W; Hilbert, DM				Stohl, William; Hilbert, David M.			The discovery and development of belimumab: the anti-BLyS-lupus connection	NATURE BIOTECHNOLOGY			English	Article							B-LYMPHOCYTE STIMULATOR; NECROSIS-FACTOR FAMILY; HUMAN MONOCLONAL-ANTIBODY; COMMON VARIABLE IMMUNODEFICIENCY; CELL MATURATION ANTIGEN; APRIL-DEFICIENT MICE; RHEUMATOID-ARTHRITIS; TNF RECEPTOR; AUTOIMMUNE-DISEASE; T-CELL	For the first time in more than 50 years, the US Food and Drug Administration has approved a drug specifically for the treatment of systemic lupus erythematosus (SLE). This drug, belimumab (Benlysta), is a human monoclonal antibody that neutralizes the B-cell survival factor, B-lymphocyte stimulator (BLyS). The approval of belimumab combined a pioneering approach to genomics-based gene discovery, an astute appreciation of translational medicine, a disciplined clinical strategy, a willingness to take calculated risks, a devoted cadre of patients and physicians and a healthy dose of serendipity. Collectively, these efforts have provided a model for the development of a new generation of drugs to treat the broad manifestations of SLE. However, as a substantial percentage of SLE patients do not respond to belimumab, further research is needed to better characterize the pathogenetic mechanisms of SLE, identify additional therapeutic targets, and develop effective and nontoxic novel agents against these targets.	[Stohl, William] Univ So Calif, Keck Sch Med, Div Rheumatol, Los Angeles, CA 90033 USA; [Hilbert, David M.] Zyngenia Inc, Gaithersburg, MD USA	University of Southern California	Stohl, W (corresponding author), Univ So Calif, Keck Sch Med, Div Rheumatol, Los Angeles, CA 90033 USA.	stohl@usc.edu			NIH [R01 AR050193]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050193] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank T.-S. Migone and W. Freimuth of HGS for helpful discussions and assistance with the time line. The work was supported in part by NIH grant R01 AR050193 to W.S.	ADAMS MD, 1995, NATURE, V377, P3; [Anonymous], 1998, Patent No. [WO 9818921, 9818921, 98/18921]; Baker KP, 2003, ARTHRITIS RHEUM-US, V48, P3253, DOI 10.1002/art.11299; Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Becker-Merok A, 2006, LUPUS, V15, P570, DOI 10.1177/0961203306071871; Belnoue E, 2008, BLOOD, V111, P2755, DOI 10.1182/blood-2007-09-110858; BELOUSKI SS, 2007, ARTHRITIS RHEUM, V56, pS565; Benson MJ, 2008, J IMMUNOL, V180, P3655, DOI 10.4049/jimmunol.180.6.3655; Carbonatto M, 2008, TOXICOL SCI, V105, P200, DOI 10.1093/toxsci/kfn105; Carson KR, 2009, BLOOD, V113, P4834, DOI 10.1182/blood-2008-10-186999; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S; Collins CE, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1855; Cragg Mark S., 2005, V8, P140; Dall'Era M, 2007, ARTHRITIS RHEUM, V56, P4142, DOI 10.1002/art.23047; Do RKG, 2000, J EXP MED, V192, P953, DOI 10.1084/jem.192.7.953; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Furie R, 2009, ARTHRITIS RHEUM, V60, pS429; Furie R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2506; Furie R, 2011, ARTHRITIS RHEUM-US, V63, P3918, DOI 10.1002/art.30613; Furie RA, 2009, ARTHRIT RHEUM-ARTHR, V61, P1143, DOI 10.1002/art.24698; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; Haas KM, 2010, J IMMUNOL, V184, P4789, DOI 10.4049/jimmunol.0902391; Halpern WG, 2006, TOXICOL SCI, V91, P586, DOI 10.1093/toxsci/kfj148; Huard B, 2001, J IMMUNOL, V167, P6225, DOI 10.4049/jimmunol.167.11.6225; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Jacob CO, 2006, J IMMUNOL, V177, P2671, DOI 10.4049/jimmunol.177.4.2671; Jacob N, 2011, J IMMUNOL, V186, P4984, DOI 10.4049/jimmunol.1000466; Jacob N, 2009, J IMMUNOL, V182, P2532, DOI 10.4049/jimmunol.0802948; Ju SQ, 2006, CLIN BIOCHEM, V39, P1131, DOI 10.1016/j.clinbiochem.2006.09.010; Kayagaki N, 2002, IMMUNITY, V17, P515, DOI 10.1016/S1074-7613(02)00425-9; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Knight AK, 2007, CLIN IMMUNOL, V124, P182, DOI 10.1016/j.clim.2007.04.012; Leandro MJ, 2002, ARTHRITIS RHEUM-US, V46, P2673, DOI 10.1002/art.10541; Lesley R, 2004, IMMUNITY, V20, P441, DOI 10.1016/S1074-7613(04)00079-2; Looney RJ, 2010, DRUGS, V70, P529, DOI 10.2165/11535420-000000000-00000; Looney RJ, 2004, ARTHRITIS RHEUM, V50, P2580, DOI 10.1002/art.20430; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; McKay J, 2005, ARTHRITIS RHEUM-US, V52, pS710; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P222, DOI 10.1002/art.27233; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Mukhopadhyay A, 1999, J BIOL CHEM, V274, P15978, DOI 10.1074/jbc.274.23.15978; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; Ng LG, 2004, J IMMUNOL, V173, P807, DOI 10.4049/jimmunol.173.2.807; Nikbakht N, 2011, J IMMUNOL, V187, P37, DOI 10.4049/jimmunol.1003924; Ota M, 2010, J IMMUNOL, V185, P4128, DOI 10.4049/jimmunol.1002176; Petri M, 2008, ARTHRITIS RHEUM, V58, P2453, DOI 10.1002/art.23678; Ramanujam M, 2006, J CLIN INVEST, V116, P724, DOI 10.1172/JCI26385; Ramos-Casals M, 2009, ARTHRIT RHEUM-ARTHR, V61, P1281, DOI 10.1002/art.24726; Rennert P, 2000, J EXP MED, V192, P1677, DOI 10.1084/jem.192.11.1677; Roschke V, 2002, J IMMUNOL, V169, P4314, DOI 10.4049/jimmunol.169.8.4314; SABAHI R, 2007, ARTHRITIS RHEUM, V56, pS566; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; SHLOMCHIK MJ, 1994, J EXP MED, V180, P1295, DOI 10.1084/jem.180.4.1295; Shu HB, 1999, J LEUKOCYTE BIOL, V65, P680, DOI 10.1002/jlb.65.5.680; Stewart DM, 2003, CLIN IMMUNOL, V109, P137, DOI 10.1016/S1521-6616(03)00215-8; Stohl W, 2005, ARTHRITIS RHEUM-US, V52, pS444; Sutherland APR, 2005, J IMMUNOL, V174, P5537, DOI 10.4049/jimmunol.174.9.5537; Thien M, 2004, IMMUNITY, V20, P785, DOI 10.1016/j.immuni.2004.05.010; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Tribouley C, 1999, BIOL CHEM, V380, P1443, DOI 10.1515/BC.1999.186; Varfolomeev E, 2004, MOL CELL BIOL, V24, P997, DOI 10.1128/MCB.24.3.997-1006.2004; Vugmeyster Y, 2006, AM J PATHOL, V168, P476, DOI 10.2353/ajpath.2006.050600; Wallace DJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P1168, DOI 10.1002/art.24699; Wang H, 2001, NAT IMMUNOL, V2, P632, DOI 10.1038/89782; Watanabe R, 2010, J IMMUNOL, V184, P4801, DOI 10.4049/jimmunol.0902385; Wu YM, 2000, J BIOL CHEM, V275, P35478, DOI 10.1074/jbc.M005224200; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137; Yan MH, 2000, NAT IMMUNOL, V1, P37, DOI 10.1038/76889; Yan MH, 2001, CURR BIOL, V11, P1547, DOI 10.1016/S0960-9822(01)00481-X; Yu G, 2000, NAT IMMUNOL, V1, P252, DOI 10.1038/79802; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6; Zhang Z, 2009, J IMMUNOL, V183, P3160, DOI 10.4049/jimmunol.0900385; Zhou XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023629	80	99	115	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2012	30	1					69	77		10.1038/nbt.2076	http://dx.doi.org/10.1038/nbt.2076			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	876MC	22231104	Green Accepted			2022-12-25	WOS:000299110600022
J	Riviere, JB; Mirzaa, GM; O'Roak, BJ; Beddaoui, M; Alcantara, D; Conway, RL; St-Onge, J; Schwartzentruber, JA; Gripp, KW; Nikkel, SM; Worthylake, T; Sullivan, CT; Ward, TR; Butler, HE; Kramer, NA; Albrecht, B; Armour, CM; Armstrong, L; Caluseriu, O; Cytrynbaum, C; Drolet, BA; Innes, AM; Lauzon, JL; Lin, AE; Mancini, GMS; Meschino, WS; Reggin, JD; Saggar, AK; Lerman-Sagie, T; Uyanik, G; Weksberg, R; Zirn, B; Beaulieu, CL; Majewski, J; Bulman, DE; O'Driscoll, M; Shendure, J; Graham, JM; Boycott, KM; Dobyns, WB				Riviere, Jean-Baptiste; Mirzaa, Ghayda M.; O'Roak, Brian J.; Beddaoui, Margaret; Alcantara, Diana; Conway, Robert L.; St-Onge, Judith; Schwartzentruber, Jeremy A.; Gripp, Karen W.; Nikkel, Sarah M.; Worthylake, Thea; Sullivan, Christopher T.; Ward, Thomas R.; Butler, Hailly E.; Kramer, Nancy A.; Albrecht, Beate; Armour, Christine M.; Armstrong, Linlea; Caluseriu, Oana; Cytrynbaum, Cheryl; Drolet, Beth A.; Innes, A. Micheil; Lauzon, Julie L.; Lin, Angela E.; Mancini, Grazia M. S.; Meschino, Wendy S.; Reggin, James D.; Saggar, Anand K.; Lerman-Sagie, Tally; Uyanik, Goekhan; Weksberg, Rosanna; Zirn, Birgit; Beaulieu, Chandree L.; Majewski, Jacek; Bulman, Dennis E.; O'Driscoll, Mark; Shendure, Jay; Graham, John M., Jr.; Boycott, Kym M.; Dobyns, William B.		Finding Rare Dis Genes FORGE Canad	De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes	NATURE GENETICS			English	Article							MACROCEPHALY-CAPILLARY MALFORMATION; KINASE-B-GAMMA; GLUCOSE-HOMEOSTASIS; ACTIVATING MUTATION; INSULIN-RESISTANCE; CORPUS-CALLOSUM; CUTIS MARMORATA; COWDEN-DISEASE; GENE-MUTATIONS; HIGH-FREQUENCY	Megalencephaly-capillary malformation (MCAP) and megalencephaly-polymicrogyria-polydactyly-hydrocephalus (MPPH) syndromes are sporadic overgrowth disorders associated with markedly enlarged brain size and other recognizable features(1-5). We performed exome sequencing in 3 families with MCAP or MPPH, and our initial observations were confirmed in exomes from 7 individuals with MCAP and 174 control individuals, as well as in 40 additional subjects with megalencephaly, using a combination of Sanger sequencing, restriction enzyme assays and targeted deep sequencing. We identified de novo germline or postzygotic mutations in three core components of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway. These include 2 mutations in AKT3, 1 recurrent mutation in PIK3R2 in 11 unrelated families with MPPH and 15 mostly postzygotic mutations in PIK3CA in 23 individuals with MCAP and 1 with MPPH. Our data highlight the central role of PI3K-AKT signaling in vascular, limb and brain development and emphasize the power of massively parallel sequencing in a challenging context of phenotypic and genetic heterogeneity combined with postzygotic mosaicism.	[Riviere, Jean-Baptiste; St-Onge, Judith; Sullivan, Christopher T.; Ward, Thomas R.; Butler, Hailly E.; Dobyns, William B.] Seattle Childrens Hosp, Ctr Integrat Brain Res, Seattle, WA USA; [Mirzaa, Ghayda M.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [O'Roak, Brian J.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Beddaoui, Margaret; Worthylake, Thea; Beaulieu, Chandree L.; Boycott, Kym M.] Univ Ottawa, Childrens Hosp, Eastern Ontario Res Inst, Ottawa, ON, Canada; [Alcantara, Diana; O'Driscoll, Mark] Univ Sussex, Genome Damage & Stabil Ctr, Brighton, E Sussex, England; [Conway, Robert L.] Michigan State Univ, Dept Pediat & Human Dev, E Lansing, MI 48824 USA; [Schwartzentruber, Jeremy A.] McGill Univ, Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Gripp, Karen W.] Alfred I DuPont Hosp Children, Div Med Genet, Wilmington, DE USA; [Nikkel, Sarah M.; Boycott, Kym M.] Childrens Hosp Eastern Ontario, Div Genet, Ottawa, ON K1H 8L1, Canada; [Kramer, Nancy A.; Graham, John M., Jr.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Albrecht, Beate] Univ Hosp Essen, Dept Human Genet, Essen, Germany; [Armour, Christine M.] Queens Univ, Dept Paediat, Kingston, ON, Canada; [Armstrong, Linlea] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Caluseriu, Oana; Innes, A. Micheil; Lauzon, Julie L.] Univ Calgary, Dept Med Genet, Calgary, AB, Canada; [Cytrynbaum, Cheryl; Weksberg, Rosanna] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Drolet, Beth A.] Med Coll Wisconsin, Dept Dermatol, Milwaukee, WI 53226 USA; [Drolet, Beth A.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Lin, Angela E.] MassGen Hosp Children, Dept Med Genet, Boston, MA USA; [Mancini, Grazia M. S.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Meschino, Wendy S.] N York Gen Hosp, Dept Genet, Toronto, ON, Canada; [Reggin, James D.] Providence Sacred Heart Med Ctr, Spokane, WA USA; [Reggin, James D.] Childrens Hosp, Spokane, WA USA; [Saggar, Anand K.] Univ London, St Georges Hosp, Dept Clin Genet, London, England; [Lerman-Sagie, Tally] Wolfson Med Ctr, Pediat Neurol Unit, Holon, Israel; [Uyanik, Goekhan] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, Hamburg, Germany; [Zirn, Birgit] Univ Goettingen, Dept Neuropediat, Gottingen, Germany; [Majewski, Jacek] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Bulman, Dennis E.] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Dobyns, William B.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Dobyns, William B.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA	Seattle Children's Hospital; University of Chicago; University of Washington; University of Washington Seattle; University of Ottawa; Children's Hospital of Eastern Ontario; University of Sussex; Michigan State University; McGill University; Nemours Alfred I. duPont Hospital for Children; University of Ottawa; Children's Hospital of Eastern Ontario; Cedars Sinai Medical Center; University of Duisburg Essen; Queens University - Canada; University of British Columbia; University of Calgary; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Medical College of Wisconsin; Medical College of Wisconsin; Harvard University; Massachusetts General Hospital; Erasmus University Rotterdam; Erasmus MC; University of Toronto; University Toronto Affiliates; North York General Hospital; St Georges University London; University of London; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Gottingen; McGill University; University of Ottawa; Ottawa Hospital Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Dobyns, WB (corresponding author), Seattle Childrens Hosp, Ctr Integrat Brain Res, Seattle, WA USA.	wbd@uw.edu	Caluseriu, Oana/AAK-9563-2020; Dobyns, William Brian/ABC-6525-2021; Graham, John M./J-1429-2019; Lerman-Sagie, Tally/AAY-7598-2021; innes, allan micheil/A-9955-2017; Dobyns, William/AAI-2768-2020; Scherer, Stephen W./B-3785-2013; Shendure, Jay/AAU-3684-2021	Lerman-Sagie, Tally/0000-0001-6641-6875; Dobyns, William/0000-0002-7681-2844; Scherer, Stephen W./0000-0002-8326-1999; O'Driscoll, Mark/0000-0003-2765-316X; Armstrong, Linlea/0000-0002-8191-6429; Schwartzentruber, Jeremy/0000-0002-6183-2092; O'Roak, Brian/0000-0002-4141-0095; Shendure, Jay/0000-0002-1516-1865; Alcantara, Diana/0000-0003-3185-1548; Innes, Micheil/0000-0001-9881-5467	US National Institutes of Health under National Institute of Neurological Disorders and Stroke (NINDS) grant [NS058721]; National Institute of Child Health & Human Development (NICHD) grant [HD36657]; National Institute of General Medical Sciences (NIGMS) grant [5-T32-GM08243]; Government of Canada (to FORGE) through Genome Canada; Canadian Institutes of Health Research (CIHR); Ontario Genomics Institute [OGI-049]; Genome Quebec and Genome British Columbia; Banting Postdoctoral Fellowship from the CIHR; Clinical Investigatorship Award from the CIHR Institute of Genetics; Cancer Research UK (CR-UK); Medical Research Council (UK); Leukaemia Lymphoma Research (UK); Simons Foundation Autism Research Initiative (SFARI) [191889]; NIEHS Environmental Genome Project [HHSN273200800010C]; NHLBI GO Exome Sequencing Project and its ongoing studies [HL-102923, HL-102925, HL-102926, HL-103010]; Women's Health Institute (WHI) [HL-102924]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102923, UC2HL102924, RC2HL103010, UC2HL102925, RC2HL102924, RC2HL102925, RC2HL102926, UC2HL102923, UC2HL102926, UC2HL103010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046616, R01NS058721] Funding Source: NIH RePORTER	US National Institutes of Health under National Institute of Neurological Disorders and Stroke (NINDS) grant; National Institute of Child Health & Human Development (NICHD) grant; National Institute of General Medical Sciences (NIGMS) grant; Government of Canada (to FORGE) through Genome Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Genome Quebec and Genome British Columbia; Banting Postdoctoral Fellowship from the CIHR; Clinical Investigatorship Award from the CIHR Institute of Genetics(Canadian Institutes of Health Research (CIHR)); Cancer Research UK (CR-UK)(Cancer Research UK); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leukaemia Lymphoma Research (UK); Simons Foundation Autism Research Initiative (SFARI); NIEHS Environmental Genome Project; NHLBI GO Exome Sequencing Project and its ongoing studies; Women's Health Institute (WHI); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the US National Institutes of Health under National Institute of Neurological Disorders and Stroke (NINDS) grant NS058721 (to W.B.D.), National Institute of Child Health & Human Development (NICHD) grant HD36657 and National Institute of General Medical Sciences (NIGMS) grant 5-T32-GM08243 (to J.M.G.), the Government of Canada (to FORGE) through Genome Canada, the Canadian Institutes of Health Research (CIHR) and the Ontario Genomics Institute (OGI-049). Additional funding was provided to FORGE by Genome Quebec and Genome British Columbia. J.-B.R. is supported by a Banting Postdoctoral Fellowship from the CIHR. K.M.B. is supported by a Clinical Investigatorship Award from the CIHR Institute of Genetics. The laboratory of M.O. is funded by Cancer Research UK (CR-UK), the Medical Research Council (UK) and Leukaemia Lymphoma Research (UK). M.O. is a Senior CR-UK Research Fellow. We would like to thank the Simons Foundation Autism Research Initiative (SFARI) for providing control exome data (grant 191889 to J.S.). We also thank the NIEHS Environmental Genome Project (contract HHSN273200800010C) and the NHLBI GO Exome Sequencing Project and its ongoing studies-Lung GO (HL-102923), Broad GO (HL-102925), Seattle GO (HL-102926), Heart GO (HL-103010) and the Women's Health Institute (WHI; HL-102924) Sequencing Projects-for providing exome variant calls for comparison.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ballif BC, 2012, HUM GENET, V131, P145, DOI 10.1007/s00439-011-1073-y; Boland E, 2007, AM J HUM GENET, V81, P292, DOI 10.1086/519999; Brodbeck D, 1999, J BIOL CHEM, V274, P9133, DOI 10.1074/jbc.274.14.9133; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; BROWNSTEIN MJ, 1996, BIOTECHNIQUES, V20, P1008; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Cheung LWT, 2011, CANCER DISCOV, V1, P170, DOI 10.1158/2159-8290.CD-11-0039; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; ClaytonSmith J, 1997, CLIN DYSMORPHOL, V6, P291, DOI 10.1097/00019605-199710000-00001; Conway RL, 2007, AM J MED GENET A, V143A, P2981, DOI 10.1002/ajmg.a.32040; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Gripp KW, 2009, AM J MED GENET A, V149A, P868, DOI 10.1002/ajmg.a.32732; Gymnopoulos M, 2007, P NATL ACAD SCI USA, V104, P5569, DOI 10.1073/pnas.0701005104; HAPPLE R, 1987, J AM ACAD DERMATOL, V16, P899, DOI 10.1016/S0190-9622(87)80249-9; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Hussain K, 2011, SCIENCE, V334, P474, DOI 10.1126/science.1210878; Ikenoue T, 2005, CANCER RES, V65, P4562, DOI 10.1158/0008-5472.CAN-04-4114; Jaiswal BS, 2009, CANCER CELL, V16, P463, DOI 10.1016/j.ccr.2009.10.016; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kong D, 2008, CANCER SCI, V99, P1734, DOI 10.1111/j.1349-7006.2008.00891.x; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; Mirzaa G, 2004, NEUROPEDIATRICS, V35, P353, DOI 10.1055/s-2004-830497; Mirzaa GM, 2012, AM J MED GENET A, V158A, P269, DOI 10.1002/ajmg.a.34402; Moore CA, 1997, AM J MED GENET, V70, P67, DOI 10.1002/(SICI)1096-8628(19970502)70:1<67::AID-AJMG13>3.3.CO;2-4; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Oda K, 2008, CANCER RES, V68, P8127, DOI 10.1158/0008-5472.CAN-08-0755; Oduber CEU, 2011, EUR J MED GENET, V54, P262, DOI 10.1016/j.ejmg.2011.02.007; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010; Riviere J-B, 2012, NAT GENET, V44, pS1; Riviere JB, 2012, NAT GENET, V44, P440, DOI 10.1038/ng.1091; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; SCARANO E, 1967, P NATL ACAD SCI USA, V57, P1394, DOI 10.1073/pnas.57.5.1394; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tokuda S, 2011, HUM MOL GENET, V20, P988, DOI 10.1093/hmg/ddq544; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; VOLINIA S, 1994, GENOMICS, V24, P472, DOI 10.1006/geno.1994.1655	55	470	482	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2012	44	8					934	+		10.1038/ng.2331	http://dx.doi.org/10.1038/ng.2331			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	979WV	22729224	Green Accepted			2022-12-25	WOS:000306854700021
J	Bock, LJ; Pagliuca, C; Kobayashi, N; Grove, RA; Oku, Y; Shrestha, K; Alfieri, C; Golfieri, C; Oldani, A; Dal Maschio, M; Bermejo, R; Hazbun, TR; Tanaka, TU; De Wulf, P				Bock, Lucy J.; Pagliuca, Cinzia; Kobayashi, Norihiko; Grove, Ryan A.; Oku, Yusuke; Shrestha, Kriti; Alfieri, Claudio; Golfieri, Cristina; Oldani, Amanda; Dal Maschio, Marianna; Bermejo, Rodrigo; Hazbun, Tony R.; Tanaka, Tomoyuku U.; De Wulf, Peter			Cnn1 inhibits the interactions between the KMN complexes of the yeast kinetochore	NATURE CELL BIOLOGY			English	Article							SPINDLE CHECKPOINT; BUDDING YEAST; BI-ORIENTATION; SACCHAROMYCES-CEREVISIAE; MICROTUBULE ATTACHMENT; CELL-DIVISION; KINASE; CENTROMERE; PHOSPHATASE; MECHANICS	Kinetochores attach the replicated chromosomes to the mitotic spindle and orchestrate their transmission to the daughter cells. Kinetochore-spindle binding and chromosome segregation are mediated by the multi-copy KNL1(Spc105), MIS12(Mtw1) and NDC80(Ndc80) complexes that form the so-called KMN network. KMN-spindle attachment is regulated by the Aurora B-Ipl1 and MPS1(Mps1) kinases. It is unclear whether other mechanisms exist that support KMN activity during the cell cycle. Using budding yeast, we show that kinetochore protein Cnn1 localizes to the base of the Ndc80 complex and promotes a functionally competent configuration of the KMN network. Cnn1 regulates KMN activity in a spatiotemporal manner by inhibiting the interaction between its complexes. Cnn1 activity peaks in anaphase and is driven by the Cdc28, Mps1 and Ipl1 kinases.	[Bock, Lucy J.; Pagliuca, Cinzia; Alfieri, Claudio; Golfieri, Cristina; Dal Maschio, Marianna] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy; [Kobayashi, Norihiko; Oku, Yusuke; Tanaka, Tomoyuku U.] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland; [Grove, Ryan A.; Shrestha, Kriti; Hazbun, Tony R.] Purdue Univ, Ctr Canc Res, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Oldani, Amanda] FIRC Inst Mol Oncol Fdn, I-20139 Milan, Italy; [Bermejo, Rodrigo] Univ Salamanca, CSIC, Inst Biol Func & Genom, E-37008 Salamanca, Spain	IRCCS European Institute of Oncology (IEO); University of Dundee; Purdue University System; Purdue University; Purdue University West Lafayette Campus; IFOM - FIRC Institute of Molecular Oncology; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	De Wulf, P (corresponding author), European Inst Oncol, Dept Expt Oncol, Via Adamello 16, I-20139 Milan, Italy.	peter.dewulf@ifom-ieo-campus.it	Tanaka, Tomoyuki U/A-4775-2008; Hazbun, Tony/K-2597-2019; Bermejo, Rodrigo/AAG-7830-2019; Bermejo, Rodrigo/S-2445-2019; Bermejo, Rodrigo/K-6613-2014	Hazbun, Tony/0000-0003-0675-8093; Bermejo, Rodrigo/0000-0002-2692-7045; Bock, Lucy/0000-0001-8336-1909; Tanaka, Tomoyuki/0000-0002-9886-5947; De Wulf, Peter/0000-0001-9772-5881; Alfieri, Claudio/0000-0003-3215-1607	Italian Association for Cancer Research [8840]; N.I.H. [GM087461]; American Cancer Society [IRG 58-006-50]; Cancer Research U.K.; Wellcome Trust; European School of Molecular Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087461] Funding Source: NIH RePORTER	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); N.I.H.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Cancer Research U.K.(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); European School of Molecular Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank A. Amon (MIT, USA), S. Biggins (University of Washington, USA), D. Koshland (University of California, Berkeley, USA), M. Singleton (Cancer Research UK), F. Solomon (MIT, USA) and P. K. Sorger (Harvard Medical School, USA) for strains or reagents. We also thank M. Foiani, S. Ghandi, D. Lamont, J. Lechner, C. Lucca, J. Ortiz, S. ten Have and R. Visintin for technical support or discussions. We thank A. Schleiffer and S. Westermann for communicating results before publication. P.D.W. acknowledges financial support from the Italian Association for Cancer Research (grant 8840). T.R.H. recognizes support from the N.I.H. (grant GM087461) and the American Cancer Society (grant IRG 58-006-50). T.U.T. acknowledges a Cancer Research U.K. senior fellowship and Wellcome Trust program grant. L.J.B. acknowledges a doctoral fellowship from the European School of Molecular Medicine.	Akiyoshi B, 2010, NATURE, V468, P576, DOI 10.1038/nature09594; Bermejo R, 2009, METHODS MOL BIOL, V582, P103, DOI 10.1007/978-1-60761-340-4_9; Blake-Hodek KA, 2010, MOL BIOL CELL, V21, P2013, DOI 10.1091/mbc.E10-02-0083; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cho RJ, 1998, P NATL ACAD SCI USA, V95, P3752, DOI 10.1073/pnas.95.7.3752; Coffman VC, 2011, J CELL BIOL, V195, P563, DOI 10.1083/jcb.201106078; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; De Wulf P, 2009, CURR OPIN CELL BIOL, V21, P806, DOI 10.1016/j.ceb.2009.08.003; Espeut J, 2012, J CELL BIOL, V196, P469, DOI 10.1083/jcb.201111107; Foley EA, 2011, NAT CELL BIOL, V13, P1265, DOI 10.1038/ncb2327; Gascoigne KE, 2011, CELL, V145, P410, DOI 10.1016/j.cell.2011.03.031; Gillett ES, 2004, J CELL BIOL, V164, P535, DOI 10.1083/jcb.200308100; Kitamura E, 2007, GENE DEV, V21, P3319, DOI 10.1101/gad.449407; KOSHLAND D, 1987, METHOD ENZYMOL, V155, P351; Krenn V, 2012, J CELL BIOL, V196, P451, DOI 10.1083/jcb.201110013; Lampert F, 2011, NAT REV MOL CELL BIO, V12, P407, DOI 10.1038/nrm3133; Lampert F, 2010, J CELL BIOL, V189, P641, DOI 10.1083/jcb.200912021; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Lawrimore J, 2011, J CELL BIOL, V195, P573, DOI 10.1083/jcb.201106036; LECHNER J, 1991, CELL, V64, P717, DOI 10.1016/0092-8674(91)90501-O; Lingelbach LB, 2004, MOL CELL BIOL, V24, P8938, DOI 10.1128/MCB.24.20.8938-8950.2004; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; Maresca TJ, 2010, J CELL SCI, V123, P825, DOI 10.1242/jcs.064790; Maskell DP, 2010, J CELL BIOL, V190, P823, DOI 10.1083/jcb.201002059; Maure JF, 2007, CURR BIOL, V17, P2175, DOI 10.1016/j.cub.2007.11.032; Meadows JC, 2011, DEV CELL, V20, P739, DOI 10.1016/j.devcel.2011.05.008; Nishino T, 2012, CELL, V148, P487, DOI 10.1016/j.cell.2011.11.061; Ohkuni K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001617; Pagliuca C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007640; Perpelescu M, 2011, CHROMOSOMA, V120, P425, DOI 10.1007/s00412-011-0330-0; Przewloka MR, 2011, CURR BIOL, V21, P399, DOI 10.1016/j.cub.2011.02.005; Rosenberg JS, 2011, CURR BIOL, V21, P942, DOI 10.1016/j.cub.2011.04.011; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Schleiffer A, 2012, NAT CELL BIOL; Schuyler SC, 2002, METHOD ENZYMOL, V351, P150; Screpanti E, 2011, CURR BIOL, V21, P391, DOI 10.1016/j.cub.2010.12.039; Tanaka K, 2005, NATURE, V434, P987, DOI 10.1038/nature03483; Tanaka TU, 2010, EMBO J, V29, P4070, DOI 10.1038/emboj.2010.294; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tien JF, 2010, J CELL BIOL, V189, P713, DOI 10.1083/jcb.200910142; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; Wong J, 2007, MOL BIOL CELL, V18, P3800, DOI 10.1091/mbc.E07-06-0536	48	76	77	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2012	14	6					614	+		10.1038/ncb2495	http://dx.doi.org/10.1038/ncb2495			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	949TW	22561345	Green Published, Green Accepted			2022-12-25	WOS:000304599900011
J	Spira, F; Mueller, NS; Beck, G; von Olshausen, P; Beig, J; Wedlich-Soldner, R				Spira, Felix; Mueller, Nikola S.; Beck, Gisela; von Olshausen, Philipp; Beig, Joachim; Wedlich-Soeldner, Roland			Patchwork organization of the yeast plasma membrane into numerous coexisting domains	NATURE CELL BIOLOGY			English	Article							GPI-ANCHORED PROTEINS; SACCHAROMYCES-CEREVISIAE; CELL-MEMBRANES; GLOBAL ANALYSIS; STRUCTURED ILLUMINATION; LIVING CELL; LOCALIZATION; MICRODOMAINS; ENDOCYTOSIS; MICROSCOPY	The plasma membrane is made up of lipids and proteins, and serves as an active interface between the cell and its environment. Many plasma-membrane proteins are laterally segregated in the plane of the membrane, but the underlying mechanisms remain controversial. Here we investigate the distribution and dynamics of a representative set of plasma-membrane-associated proteins in yeast cells. These proteins were distributed non-homogeneously in patterns ranging from distinct patches to nearly continuous networks, and these patterns were in turn strongly influenced by the lipid composition of the plasma membrane. Most proteins segregated into distinct domains. However, proteins with similar or identical transmembrane sequences (TMSs) showed a marked tendency to co-localize. Indeed we could predictably relocate proteins by swapping their TMSs. Finally, we found that the domain association of plasma-membrane proteins has an impact on their function. Our results are consistent with self-organization of biological membranes into a patchwork of coexisting domains.	[Spira, Felix; Mueller, Nikola S.; Beck, Gisela; Beig, Joachim; Wedlich-Soeldner, Roland] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [von Olshausen, Philipp] Univ Freiburg, Dept Microsyst Engn IMTEK, Lab Bio & Nanophoton, D-79110 Freiburg, Germany	Max Planck Society; University of Freiburg	Wedlich-Soldner, R (corresponding author), Max Planck Inst Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	wedlich@biochem.mpg.de	Mueller, Nikola/I-6366-2013	Mueller, Nikola/0000-0001-8659-4548; Spira, Felix/0000-0001-5490-5508	Max Planck Society	Max Planck Society(Max Planck Society)	We are indebted to A. Rohrhach for providing access to the TIRF-SIM microscope and analysis. We thank N. Johnsson (Institute for Molecular Genetics and Cell Biology, Ulm University, Germany) for providing the plasmid ACP-Sag1 and P. Hardy for editorial assistance. This work was financially supported by the Max Planck Society.	Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Bagatolli LA, 2010, PROG LIPID RES, V49, P378, DOI 10.1016/j.plipres.2010.05.001; Bagnat M, 2002, P NATL ACAD SCI USA, V99, P14183, DOI 10.1073/pnas.172517799; Berchtold D, 2009, MOL BIOL CELL, V20, P1565, DOI 10.1091/mbc.E08-10-1001; Davierwala AP, 2005, NAT GENET, V37, P1147, DOI 10.1038/ng1640; Day CA, 2009, BBA-BIOMEMBRANES, V1788, P245, DOI 10.1016/j.bbamem.2008.10.024; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Fan J, 2010, FEBS LETT, V584, P1678, DOI 10.1016/j.febslet.2009.10.051; Fiolka R, 2008, OPT LETT, V33, P1629, DOI 10.1364/OL.33.001629; Flegelova H, 2005, FEBS LETT, V579, P4733, DOI 10.1016/j.febslet.2005.07.046; Frohlich F, 2009, J CELL BIOL, V185, P1227, DOI 10.1083/jcb.200811081; Gallego O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.87; George N, 2004, J AM CHEM SOC, V126, P8896, DOI 10.1021/ja048396s; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; GREENBERG ML, 1993, J MEMBRANE BIOL, V131, P115, DOI 10.1007/BF02791320; Grossmann G, 2008, J CELL BIOL, V183, P1075, DOI 10.1083/jcb.200806035; Heese-Peck A, 2002, MOL BIOL CELL, V13, P2664, DOI 10.1091/mbc.E02-04-0186; HIKIJI T, 1988, J BIOCHEM-TOKYO, V104, P894, DOI 10.1093/oxfordjournals.jbchem.a122579; Hirvonen LM, 2009, EUR BIOPHYS J BIOPHY, V38, P807, DOI 10.1007/s00249-009-0501-6; Hite RK, 2010, EMBO J, V29, P1652, DOI 10.1038/emboj.2010.68; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Lauwers E, 2006, TRAFFIC, V7, P1045, DOI 10.1111/j.1600-0854.2006.00445.x; Lehtonen JYA, 1996, BIOPHYS J, V70, P1753, DOI 10.1016/S0006-3495(96)79738-2; Lingwood D, 2009, BIOCHEM SOC T, V37, P955, DOI 10.1042/BST0370955; Lipowsky R., 1995, P521; Malinska K, 2004, J CELL SCI, V117, P6031, DOI 10.1242/jcs.01493; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Marco E, 2007, CELL, V129, P411, DOI 10.1016/j.cell.2007.02.043; Momoi M, 2004, BIOCHEM J, V381, P321, DOI 10.1042/BJ20040108; Opekarova M, 2005, BBA-BIOMEMBRANES, V1711, P87, DOI 10.1016/j.bbamem.2005.02.015; OPEKAROVA M, 1993, EUR J BIOCHEM, V211, P683, DOI 10.1111/j.1432-1033.1993.tb17596.x; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Thomas CL, 2008, PLOS BIOL, V6, P180, DOI 10.1371/journal.pbio.0060007; Tyteca D, 2010, BBA-BIOMEMBRANES, V1798, P909, DOI 10.1016/j.bbamem.2010.01.021; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; Walther TC, 2006, NATURE, V439, P998, DOI 10.1038/nature04472; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yu JH, 2011, J CELL SCI, V124, P1533, DOI 10.1242/jcs.079038	49	167	168	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2012	14	6					640	+		10.1038/ncb2487	http://dx.doi.org/10.1038/ncb2487			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	949TW	22544065				2022-12-25	WOS:000304599900014
J	Mutalik, VK; Qi, L; Guimaraes, JC; Lucks, JB; Arkin, AP				Mutalik, Vivek K.; Qi, Lei; Guimaraes, Joao C.; Lucks, Julius B.; Arkin, Adam P.			Rationally designed families of orthogonal RNA regulators of translation	NATURE CHEMICAL BIOLOGY			English	Article							ANTISENSE RNA; ESCHERICHIA-COLI; GENE-EXPRESSION; MESSENGER-RNA; SYNTHETIC BIOLOGY; RIBOSOME BINDING; IN-VIVO; TRANSCRIPTION; NETWORKS; PROTEIN	Our ability to routinely engineer genetic networks for applications is limited by the scarcity of highly specific and non-crossreacting (orthogonal) gene regulators with predictable behavior. Though antisense RNAs are attractive contenders for this purpose, quantitative understanding of their specificity and sequence-function relationship sufficient for their design has been limited. Here, we use rationally designed variants of the RNA-IN-RNA-OUT antisense RNA-mediated translation system from the insertion sequence IS10 to quantify >500 RNA-RNA interactions in Escherichia coli and integrate the data set with sequence-activity modeling to identify the thermodynamic stability of the duplex and the seed region as the key determinants of specificity. Applying this model, we predict the performance of an additional similar to 2,600 antisense-regulator pairs, forecast the possibility of large families of orthogonal mutants, and forward engineer and experimentally validate two RNA pairs orthogonal to an existing group of five from the training data set. We discuss the potential use of these regulators in next-generation synthetic biology applications.	[Mutalik, Vivek K.; Arkin, Adam P.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Mutalik, Vivek K.] Joint BioEnergy Inst, BioFAB, Emeryville, CA USA; [Mutalik, Vivek K.; Arkin, Adam P.] QB3 Calif Inst Quantitat Sci, Berkeley, CA USA; [Qi, Lei; Guimaraes, Joao C.; Lucks, Julius B.; Arkin, Adam P.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Guimaraes, Joao C.] Univ Minho, Dept Informat, Comp Sci & Technol Ctr, Braga, Portugal; [Lucks, Julius B.] Miller Inst Basic Sci Res, Berkeley, CA USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; University of California System; University of California Berkeley; Universidade do Minho	Mutalik, VK (corresponding author), Joint BioEnergy Inst, BioFAB, Emeryville, CA USA.	aparkin@lbl.gov	Guimaraes, Joao/A-8572-2012; Qi, Lei S/AAC-5088-2019; Arkin, Adam P/A-6751-2008; Mutalik, Vivek/AAB-6827-2021; Arkin, Adam/M-9941-2019; Lucks, Julius/L-2801-2016	Guimaraes, Joao/0000-0002-1664-472X; Arkin, Adam P/0000-0002-4999-2931; Mutalik, Vivek/0000-0001-7934-0400; Arkin, Adam/0000-0002-4999-2931; Qi, Lei S/0000-0002-3965-3223	British Petroleum at the Joint BioEnergy Institute [LB08004883]; Synthetic Biology Engineering Research Center under US National Science Foundation [04-570/0540879]; Portuguese Fundacao para a Ciencia e a Tecnologia [SFRH/BD/47819/2008]; Miller Institute for Basic Scientific Research; Office of Science, Office of Biological and Environmental Research, of the US Department of Energy [DE-AC02-05CH11231]	British Petroleum at the Joint BioEnergy Institute; Synthetic Biology Engineering Research Center under US National Science Foundation; Portuguese Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); Miller Institute for Basic Scientific Research; Office of Science, Office of Biological and Environmental Research, of the US Department of Energy(United States Department of Energy (DOE))	The authors would like to thank G. Cambray, E. Gogol, C. Liu and J. Skerker for comments on the manuscript. V. K. M. was supported by British Petroleum under contract number LB08004883 at the Joint BioEnergy Institute. A. P. A. and L. Q. acknowledge support from the Synthetic Biology Engineering Research Center under US National Science Foundation grant number 04-570/0540879. J. C. G. acknowledges financial support by the Portuguese Fundacao para a Ciencia e a Tecnologia (SFRH/BD/47819/2008). J. B. L. acknowledges the financial support of the Miller Institute for Basic Scientific Research. This work conducted by the Joint BioEnergy Institute was supported by the Office of Science, Office of Biological and Environmental Research, of the US Department of Energy under Contract No. DE-AC02-05CH11231.	Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; An WL, 2009, P NATL ACAD SCI USA, V106, P8477, DOI 10.1073/pnas.0900267106; Babiskin AH, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.4; Beisel CL, 2010, FEMS MICROBIOL REV, V34, P866, DOI 10.1111/j.1574-6976.2010.00241.x; Benenson Y, 2009, CURR OPIN BIOTECH, V20, P471, DOI 10.1016/j.copbio.2009.08.002; Carothers JM, 2011, SCIENCE, V334, P1716, DOI 10.1126/science.1212209; Carrier TA, 1999, BIOTECHNOL PROGR, V15, P58, DOI 10.1021/bp9801143; CASE CC, 1990, EMBO J, V9, P1259, DOI 10.1002/j.1460-2075.1990.tb08234.x; Chubiz LM, 2008, NUCLEIC ACIDS RES, V36, P4038, DOI 10.1093/nar/gkn354; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; DEUSCHLE U, 1986, EMBO J, V5, P2987, DOI 10.1002/j.1460-2075.1986.tb04596.x; Dixon N, 2010, P NATL ACAD SCI USA, V107, P2830, DOI 10.1073/pnas.0911209107; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Engdahl HM, 1997, NUCLEIC ACIDS RES, V25, P3218, DOI 10.1093/nar/25.16.3218; Franch T, 1999, J MOL BIOL, V294, P1115, DOI 10.1006/jmbi.1999.3306; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; JAIN C, 1995, J MOL BIOL, V246, P585, DOI 10.1006/jmbi.1994.0110; Jain C, 1997, J THEOR BIOL, V186, P431, DOI 10.1006/jtbi.1996.0371; JONSSON J, 1993, NUCLEIC ACIDS RES, V21, P733, DOI 10.1093/nar/21.3.733; Keasling JD, 2008, ACS CHEM BIOL, V3, P64, DOI 10.1021/cb7002434; KITTLE JD, 1989, J MOL BIOL, V210, P561, DOI 10.1016/0022-2836(89)90132-0; Lee TS, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-12; Liu CC, 2011, NAT BIOTECHNOL, V29, P164, DOI 10.1038/nbt.1741; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P8617, DOI 10.1073/pnas.1015741108; Lucks JB, 2008, CURR OPIN MICROBIOL, V11, P567, DOI 10.1016/j.mib.2008.10.002; MA C, 1990, EMBO J, V9, P1267, DOI 10.1002/j.1460-2075.1990.tb08235.x; Man SA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr034; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Nakashima N, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp498; Papenfort K, 2010, P NATL ACAD SCI USA, V107, P20435, DOI 10.1073/pnas.1009784107; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rackham O, 2005, NAT CHEM BIOL, V1, P159, DOI 10.1038/nchembio719; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Ruder WC, 2011, SCIENCE, V333, P1248, DOI 10.1126/science.1206843; Sahota G, 2010, BIOINFORMATICS, V26, P2672, DOI 10.1093/bioinformatics/btq501; Saito H, 2010, NAT CHEM BIOL, V6, P71, DOI [10.1038/NCHEMBIO.273, 10.1038/nchembio.273]; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Smolke CD, 2002, BIOTECHNOL BIOENG, V78, P412, DOI 10.1002/bit.10218; Tabor JJ, 2011, J MOL BIOL, V405, P315, DOI 10.1016/j.jmb.2010.10.038; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Thomason MK, 2010, ANNU REV GENET, V44, P167, DOI 10.1146/annurev-genet-102209-163523; Wagner EGH, 2002, ADV GENET, V46, P361; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Zhan JA, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.42	50	129	132	0	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2012	8	5					447	454		10.1038/NCHEMBIO.919	http://dx.doi.org/10.1038/NCHEMBIO.919			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	928DY	22446835				2022-12-25	WOS:000302962500011
J	Schenk, M; Krutzik, SR; Sieling, PA; Lee, DJ; Teles, RMB; Ochoa, MT; Komisopoulou, E; Sarno, EN; Rea, TH; Graeber, TG; Kim, S; Cheng, GH; Modlin, RL				Schenk, Mirjam; Krutzik, Stephan R.; Sieling, Peter A.; Lee, Delphine J.; Teles, Rosane M. B.; Ochoa, Maria Teresa; Komisopoulou, Evangelia; Sarno, Euzenir N.; Rea, Thomas H.; Graeber, Thomas G.; Kim, Soohyun; Cheng, Genhong; Modlin, Robert L.			NOD2 triggers an interleukin-32-dependent human dendritic cell program in leprosy	NATURE MEDICINE			English	Article							TOLL-LIKE RECEPTOR-2; MHC CLASS-II; CUTTING EDGE; LEPROMATOUS LEPROSY; ADJUVANT ACTIVITY; T-CELLS; ACTIVATION; POLYMORPHISM; DIFFERENTIATION; RESPONSES	It is unclear whether the ability of the innate immune system to recognize distinct ligands from a single microbial pathogen via multiple pattern recognition receptors (PRRs) triggers common pathways or differentially triggers specific host responses. In the human mycobacterial infection leprosy, we found that activation of monocytes via nucleotide-binding oligomerization domain-containing protein 2 (NOD2) by its ligand muramyl dipeptide, as compared to activation via heterodimeric Toll-like receptor 2 and Toll-like receptor 1 (TLR2/1) by triacylated lipopeptide, preferentially induced differentiation into dendritic cells (DCs), which was dependent on a previously unknown interleukin-32 (IL-32)-dependent mechanism. Notably, IL-32 was sufficient to induce monocytes to rapidly differentiate into DCs, which were more efficient than granulocyte-macrophage colony-stimulating factor (GM-CSF)-derived DCs in presenting antigen to major histocompatibility complex (MHC) class I-restricted CD8(+) T cells. Expression of NOD2 and IL-32 and the frequency of CD1b(+) DCs at the site of leprosy infection correlated with the clinical presentation; they were greater in patients with limited as compared to progressive disease. The addition of recombinant IL-32 restored NOD2-induced DC differentiation in patients with the progressive form of leprosy. In conclusion, the NOD2 ligand-induced, IL-32-dependent DC differentiation pathway contributes a key and specific mechanism for host defense against microbial infection in humans.	[Schenk, Mirjam; Krutzik, Stephan R.; Sieling, Peter A.; Lee, Delphine J.; Teles, Rosane M. B.; Ochoa, Maria Teresa; Modlin, Robert L.] Univ Calif Los Angeles, David Geffen Sch Med, Div Dermatol, Dept Med, Los Angeles, CA 90095 USA; [Komisopoulou, Evangelia; Graeber, Thomas G.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr,Inst Mol Med, Crump Inst Mol Imaging,Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Komisopoulou, Evangelia; Graeber, Thomas G.] Univ Calif Los Angeles, David Geffen Sch Med, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Sarno, Euzenir N.] Fundacao Oswaldo Cruz, Dept Mycobacteriosis, Rio De Janeiro, Brazil; [Rea, Thomas H.] Univ So Calif, Sch Med, Dept Dermatol, Los Angeles, CA USA; [Kim, Soohyun] Konkuk Univ, Dept Biomed Sci & Technol, Seoul, South Korea; [Cheng, Genhong; Modlin, Robert L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Fundacao Oswaldo Cruz; University of Southern California; Konkuk University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Modlin, RL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Dermatol, Dept Med, Los Angeles, CA 90095 USA.	rmodlin@mednet.ucla.edu	Teles, Rosane/E-9607-2017; Modlin, Robert L/M-7941-2014; Teles, Rosane/AAQ-3436-2020	Teles, Rosane/0000-0003-2908-3244; Modlin, Robert L/0000-0003-4720-031X; Teles, Rosane/0000-0003-2908-3244; Ochoa, Maria T/0000-0001-6550-5008; Nunes Sarno, Euzenir/0000-0003-0129-2159; Schenk, Mirjam/0000-0002-1637-0730; Graeber, Thomas/0000-0001-8574-9181	US National Institutes of Health [R01s AI022553, AR040312, AI047868]; Swiss National Science Foundation (SSMBS) [PASMP3-123256]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022553, R37AI047868, R01AI082575, R22AI022553, R01AI056154, R01AI047868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059126, R01AR040312] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation (SSMBS)(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank P. Liu, B. Bloom and F. Martinon for helpful scientific discussions, D. Vu for technical assistance and A. De Leon for help with the immunolabeling. This work was supported in parts by grants from the US National Institutes of Health (R01s AI022553, AR040312 and AI047868) and the Swiss National Science Foundation (SSMBS, PASMP3-123256).	ADAM A, 1974, BIOCHEM BIOPH RES CO, V56, P561, DOI 10.1016/0006-291X(74)90640-8; Bai XY, 2010, J IMMUNOL, V184, P3830, DOI 10.4049/jimmunol.0901913; Berrington WR, 2010, J INFECT DIS, V201, P1422, DOI 10.1086/651559; Bleharski JR, 2003, SCIENCE, V301, P1527, DOI 10.1126/science.1087785; BLOOM BR, 1986, J IMMUNOL, V137, pR1; Bochud PY, 2003, J IMMUNOL, V170, P3451, DOI 10.4049/jimmunol.170.7.3451; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Cooley W.B., 1893, AM J MED SCI, V105, P487, DOI [10.1097/00000441-189305000-00001, DOI 10.1097/00000441-189305000-00001]; ELLOUZ F, 1974, BIOCHEM BIOPH RES CO, V59, P1317, DOI 10.1016/0006-291X(74)90458-6; Ferwerda G, 2005, PLOS PATHOG, V1, P279, DOI 10.1371/journal.ppat.0010034; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; Jung MY, 2011, J IMMUNOL, V186, P6848, DOI 10.4049/jimmunol.1003996; Kang TJ, 2004, IMMUNOLOGY, V112, P674, DOI 10.1111/j.1365-2567.2004.01926.x; Kang TJ, 2002, CYTOKINE, V20, P56, DOI 10.1006/cyto.2002.1982; Kang TJ, 2001, FEMS IMMUNOL MED MIC, V31, P53, DOI 10.1111/j.1574-695X.2001.tb01586.x; KLEINERMAN ES, 1992, CANCER IMMUNOL IMMUN, V34, P211, DOI 10.1007/BF01741788; Krutzik SR, 2005, NAT MED, V11, P653, DOI 10.1038/nm1246; Krutzik SR, 2003, NAT MED, V9, P525, DOI 10.1038/nm864; Krutzik SR, 2008, J IMMUNOL, V181, P7115, DOI 10.4049/jimmunol.181.10.7115; Lee DJ, 2007, J IMMUNOL, V179, P8128, DOI 10.4049/jimmunol.179.12.8128; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001985; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Malhotra D, 2005, HUM GENET, V116, P413, DOI 10.1007/s00439-004-1249-9; Marcondes AM, 2008, P NATL ACAD SCI USA, V105, P2865, DOI 10.1073/pnas.0712391105; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Misch EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000231; MODLIN RL, 1983, J AM ACAD DERMATOL, V8, P182, DOI 10.1016/S0190-9622(83)70021-6; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Montoya D, 2009, CELL HOST MICROBE, V6, P343, DOI 10.1016/j.chom.2009.09.002; MORALES A, 1976, J UROLOGY, V116, P180, DOI 10.1016/S0022-5347(17)58737-6; MORTON DL, 1970, SURGERY, V68, P158; Netea MG, 2008, P NATL ACAD SCI USA, V105, P3515, DOI 10.1073/pnas.0712381105; Netea MG, 2006, PLOS MED, V3, P1310, DOI 10.1371/journal.pmed.0030277; Niazi KR, 2007, IMMUNOLOGY, V122, P522, DOI 10.1111/j.1365-2567.2007.02666.x; Nold MF, 2008, J IMMUNOL, V181, P557, DOI 10.4049/jimmunol.181.1.557; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; RIDLEY DS, 1974, B WORLD HEALTH ORGAN, V51, P451; SALGAME P, 1991, SCIENCE, V254, P279, DOI 10.1126/science.1681588; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schroder NWJ, 2003, J MOL MED-JMM, V81, P368, DOI 10.1007/s00109-003-0443-x; Schuring RP, 2009, J INFECT DIS, V199, P1816, DOI 10.1086/599121; Shioya M, 2007, CLIN EXP IMMUNOL, V149, P480, DOI 10.1111/j.1365-2249.2007.03439.x; Sieling PA, 1999, J IMMUNOL, V162, P1851; SIELING PA, 1993, J IMMUNOL, V150, P5501; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; SILVA CL, 1992, MICROB PATHOGENESIS, V12, P27, DOI 10.1016/0882-4010(92)90063-T; SPECTER S, 1978, Journal of Immunology, V120, P487; SUGIMOTO M, 1978, J IMMUNOL, V120, P980; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; YAMAMURA M, 1991, SCIENCE, V254, P277, DOI 10.1126/science.1925582; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753	55	86	89	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2012	18	4					555	563		10.1038/nm.2650	http://dx.doi.org/10.1038/nm.2650			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22447076	Green Accepted			2022-12-25	WOS:000302617800032
J	Yuzwa, SA; Shan, XY; Macauley, MS; Clark, T; Skorobogatko, Y; Vosseller, K; Vocadlo, DJ				Yuzwa, Scott A.; Shan, Xiaoyang; Macauley, Matthew S.; Clark, Thomas; Skorobogatko, Yuliya; Vosseller, Keith; Vocadlo, David J.			Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation	NATURE CHEMICAL BIOLOGY			English	Article							LINKED N-ACETYLGLUCOSAMINE; PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; PROTEIN-TAU; POSTTRANSLATIONAL MODIFICATIONS; TETRATRICOPEPTIDE REPEATS; NEUROFIBRILLARY TANGLES; CYTOSOLIC PROTEINS; GLUCOSE-METABOLISM; INSULIN-RESISTANCE	Oligomerization of tau is a key process contributing to the progressive death of neurons in Alzheimer's disease. Tau is modified by O-linked N-acetylglucosamine (O-GlcNAc), and O-GlcNAc can influence tau phosphorylation in certain cases. We therefore speculated that increasing tau O-GlcNAc could be a strategy to hinder pathological tau-induced neurodegeneration. Here we found that treatment of hemizygous JNPL3 tau transgenic mice with an O-GlcNAcase inhibitor increased tau O-GlcNAc, hindered formation of tau aggregates and decreased neuronal cell loss. Notably, increases in tau O-GlcNAc did not alter tau phosphorylation in vivo. Using in vitro biochemical aggregation studies, we found that O-GlcNAc modification, on its own, hinders tau oligomerization. O-GlcNAc also inhibits thermally induced aggregation of an unrelated protein, TAK-1 binding protein, suggesting that a basic biochemical function of O-GlcNAc may be to prevent protein aggregation. These results also suggest O-GlcNAcase as a potential therapeutic target that could hinder progression of Alzheimer's disease.	[Yuzwa, Scott A.; Shan, Xiaoyang; Vocadlo, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Macauley, Matthew S.; Clark, Thomas; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Skorobogatko, Yuliya; Vosseller, Keith] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA	Simon Fraser University; Simon Fraser University; Drexel University	Yuzwa, SA (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	dvocadlo@sfu.ca	Vocadlo, David J/E-5508-2014	Vocadlo, David J/0000-0001-6897-5558; Macauley, Matthew/0000-0003-4579-1048	Scottish Rite Charitable Foundation; Canadian Institutes of Health Research (CIHR); Alzheimer Society of Canada; Canada Research Chairs program; Michael Smith Foundation for Health Research (MSFHR); Natural Sciences and Engineering Research Council of Canada (NSERC); Human Frontier Science Program	Scottish Rite Charitable Foundation; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alzheimer Society of Canada; Canada Research Chairs program(Canada Research Chairs); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Human Frontier Science Program(Human Frontier Science Program)	We thank the Scottish Rite Charitable Foundation, the Canadian Institutes of Health Research (CIHR) and the Alzheimer Society of Canada for financial support of this research. The Canada Research Chairs program, the Michael Smith Foundation for Health Research (MSFHR) and the Natural Sciences and Engineering Research Council of Canada (NSERC, E.W.R. Steacie Award) are thanked for awards to D.J.V. NSERC is thanked for an award to S.A.Y. The MSFHR and the CIHR are thanked for awards to X. S. The MSFHR, NSERC and Human Frontier Science Program are thanked for awards to M. S. M. We thank the staff at the animal care facility at Simon Fraser University for assistance with the animal studies. P. Davies (Albert Einstein College of Medicine) is thanked for the kind gift of the CP27 and PHF-1 antibodies used in this work. Y. Deng, R. Kaul and E. McEachern are thanked for assistance with preliminary studies, large-scale synthesis of thiamet-G and productive discussion.	Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Arnold CS, 1996, J BIOL CHEM, V271, P28741, DOI 10.1074/jbc.271.46.28741; BIERER LM, 1995, ARCH NEUROL-CHICAGO, V52, P81, DOI 10.1001/archneur.1995.00540250089017; Chirita CN, 2005, BIOCHEMISTRY-US, V44, P5862, DOI 10.1021/bi0500123; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Conner SH, 2006, BIOCHEM J, V399, P427, DOI 10.1042/BJ20061077; Culyba EK, 2011, SCIENCE, V331, P571, DOI 10.1126/science.1198461; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Drzezga A, 2003, EUR J NUCL MED MOL I, V30, P1104, DOI 10.1007/s00259-003-1194-1; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Goedert M, 1999, FEBS LETT, V450, P306, DOI 10.1016/S0014-5793(99)00508-6; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; Hanson SR, 2009, P NATL ACAD SCI USA, V106, P3131, DOI 10.1073/pnas.0810318105; HEISS WD, 1991, ANN NY ACAD SCI, V640, P65; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Le Corre S, 2006, P NATL ACAD SCI USA, V103, P9673, DOI 10.1073/pnas.0602913103; Lefebvre T, 2003, BBA-GEN SUBJECTS, V1619, P167, DOI 10.1016/S0304-4165(02)00477-4; Lefebvre T, 2010, BBA-GEN SUBJECTS, V1800, P67, DOI 10.1016/j.bbagen.2009.08.008; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Li X, 2006, EUR J NEUROSCI, V23, P2078, DOI 10.1111/j.1460-9568.2006.04735.x; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Liu F, 2009, BRAIN, V132, P1820, DOI 10.1093/brain/awp099; Liu Y, 2009, J NEUROCHEM, V111, P242, DOI 10.1111/j.1471-4159.2009.06320.x; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Macauley MS, 2010, CHEM BIOL, V17, P949, DOI 10.1016/j.chembiol.2010.07.005; Marcus JN, 2011, J NEUROGENET, V25, P127, DOI 10.3109/01677063.2011.626471; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; MIELKE R, 1994, DEMENTIA, V5, P36, DOI 10.1159/000106692; Pickhardt M, 2005, J BIOL CHEM, V280, P3628, DOI 10.1074/jbc.M410984200; Reynolds MR, 2006, J NEUROSCI, V26, P10636, DOI 10.1523/JNEUROSCI.2143-06.2006; Robertson LA, 2004, J ALZHEIMERS DIS, V6, P489; Roquemore EP, 1996, BIOCHEMISTRY-US, V35, P3578, DOI 10.1021/bi951918j; Sahara N, 2002, J NEUROCHEM, V83, P1498, DOI 10.1046/j.1471-4159.2002.01241.x; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schubert D, 2005, AGEING RES REV, V4, P240, DOI 10.1016/j.arr.2005.02.003; Shulman JM, 2011, AM J HUM GENET, V88, P232, DOI 10.1016/j.ajhg.2011.01.006; Smet-Nocca C, 2011, MOL BIOSYST, V7, P1420, DOI 10.1039/c0mb00337a; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Taniguchi T, 2005, FEBS LETT, V579, P1399, DOI 10.1016/j.febslet.2005.01.039; Uno Y, 2009, BRAIN RES, V1296, P148, DOI 10.1016/j.brainres.2009.08.034; Vogelsberg-Ragaglia V, 2000, MOL BIOL CELL, V11, P4093, DOI 10.1091/mbc.11.12.4093; Wang ZH, 2010, MOL CELL PROTEOMICS, V9, P153, DOI 10.1074/mcp.M900268-MCP200; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; Wilson DM, 1997, AM J PATHOL, V150, P2181; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Yuzwa SA, 2011, AMINO ACIDS, V40, P857, DOI 10.1007/s00726-010-0705-1	50	384	410	6	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2012	8	4					393	399		10.1038/NCHEMBIO.797	http://dx.doi.org/10.1038/NCHEMBIO.797			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	913PO	22366723				2022-12-25	WOS:000301890100014
J	Zhang, L; Lu, XY; Lu, JY; Liang, HH; Dai, Q; Xu, GL; Luo, C; Jiang, HL; He, C				Zhang, Liang; Lu, Xingyu; Lu, Junyan; Liang, Haihua; Dai, Qing; Xu, Guo-Liang; Luo, Cheng; Jiang, Hualiang; He, Chuan			Thymine DNA glycosylase specifically recognizes 5-carboxylcytosine-modified DNA	NATURE CHEMICAL BIOLOGY			English	Article							BASE EXCISION-REPAIR; MAMMALIAN DNA; TET PROTEINS; DEMETHYLATION; 5-FORMYLCYTOSINE; 5-METHYLCYTOSINE; SUBSTRATE; CONVERSION; CHEMISTRY; CPG	Human thymine DNA glycosylase (hTDG) efficiently excises 5-carboxylcytosine (5caC), a key oxidation product of 5-methylcytosine in genomic DNA, in a recently discovered cytosine demethylation pathway. We present here the crystal structures of the hTDG catalytic domain in complex with duplex DNA containing either 5caC or a fluorinated analog. These structures, together with biochemical and computational analyses, reveal that 5caC is specifically recognized in the active site of hTDG, supporting the role of TDG in mammalian 5-methylcytosine demethylation.	[Zhang, Liang; Lu, Xingyu; Liang, Haihua; Dai, Qing; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Zhang, Liang; Lu, Xingyu; Liang, Haihua; Dai, Qing; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Lu, Junyan; Luo, Cheng; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Drug Discovery & Design Ctr, Shanghai 200031, Peoples R China; [Xu, Guo-Liang] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China	University of Chicago; University of Chicago; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhang, L (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	chuanhe@uchicago.edu	Liang, Haihua/T-2441-2017; Dai, Qing/ABD-8444-2021; Zhang, Liang/F-8064-2013	Zhang, Liang/0000-0002-7672-1168; Lu, Junyan/0000-0002-9211-0746	US National Institutes of Health [GM071440]; 973 grant [2009CB918502]; Chinese Academy of Sciences [XDA01040305]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K01HG006699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071440] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 973 grant(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the US National Institutes of Health (GM071440 to C.H.), the 973 grant (2009CB918502 to H.J.), the Chinese Academy of Sciences (XDA01040305 to C.L.) and beamlines 23ID-B (General Medicine and Cancer Institutes Collaborative Access Team) and 24ID-E (Northeastern Collaborative Access Team) at the Advanced Photon Source at Argonne National Laboratory. We thank X. Yang from the University of Chicago and D. Borek from the University of Texas Southwestern Medical Center for structure data processing and discussion.	Bennett MT, 2006, J AM CHEM SOC, V128, P12510, DOI 10.1021/ja0634829; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hardeland U, 2000, J BIOL CHEM, V275, P33449, DOI 10.1074/jbc.M005095200; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jiang YL, 2003, BIOCHEMISTRY-US, V42, P1922, DOI 10.1021/bi027014x; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Maiti A, 2008, P NATL ACAD SCI USA, V105, P8890, DOI 10.1073/pnas.0711061105; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Morgan MT, 2007, J BIOL CHEM, V282, P27578, DOI 10.1074/jbc.M704253200; Parikh SS, 2000, P NATL ACAD SCI USA, V97, P5083, DOI 10.1073/pnas.97.10.5083; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; Stivers JT, 2003, CHEM REV, V103, P2729, DOI 10.1021/cr010219b; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Wibley JEA, 2003, MOL CELL, V11, P1647, DOI 10.1016/S1097-2765(03)00235-1; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950	25	230	239	1	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2012	8	4					328	330		10.1038/NCHEMBIO.914	http://dx.doi.org/10.1038/NCHEMBIO.914			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	913PO	22327402	Green Accepted, Green Submitted			2022-12-25	WOS:000301890100005
J	Bandyopadhyay, A; Saxena, K; Kasturia, N; Dalal, V; Bhatt, N; Rajkumar, A; Maity, S; Sengupta, S; Chakraborty, K				Bandyopadhyay, Anannya; Saxena, Kanika; Kasturia, Neha; Dalal, Vijit; Bhatt, Niraj; Rajkumar, Asher; Maity, Shuvadeep; Sengupta, Shantanu; Chakraborty, Kausik			Chemical chaperones assist intracellular folding to buffer mutational variations	NATURE CHEMICAL BIOLOGY			English	Article							ESCHERICHIA-COLI K-12; IN-VITRO; CRYSTAL-STRUCTURE; SEQUENCE SPACE; PROTEIN; TREHALOSE; HSP90; MUTAGENESIS; EVOLUTION; CAPACITOR	Hidden genetic variations have the potential to lead to the evolution of new traits. Molecular chaperones, which assist protein folding, may conceal genetic variations in protein-coding regions. Here we investigate whether the chemical milieu of cells has the potential to alleviate intracellular protein folding, a possibility that could implicate osmolytes in concealing genetic variations. We found that the model osmolyte trimethylamine N-oxide (TMAO) can buffer mutations that impose kinetic traps in the folding pathways of two model proteins. Using this information, we rationally designed TMAO-dependent mutants in vivo, starting from a TMAO-independent protein. We show that different osmolytes buffer a unique spectrum of mutations. Consequently, the chemical milieu of cells may alter the folding pathways of unique mutant variants in polymorphic populations and lead to unanticipated spectra of genetic buffering.	[Bandyopadhyay, Anannya; Saxena, Kanika; Kasturia, Neha; Dalal, Vijit; Bhatt, Niraj; Rajkumar, Asher; Maity, Shuvadeep; Sengupta, Shantanu; Chakraborty, Kausik] Inst Genom & Integrat Biol, Council Sci & Ind Res, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Bandyopadhyay, A (corresponding author), Inst Genom & Integrat Biol, Council Sci & Ind Res, Delhi, India.	kausik@igib.in	Maity, Shuvadeep/I-7846-2019; dalal, vijit/A-2708-2019; Chakraborty, Kausik/AAL-5748-2021; Bhatt, Niraj/F-7658-2012	Maity, Shuvadeep/0000-0002-6031-4744; dalal, vijit/0000-0003-1624-845X; Bhatt, Niraj/0000-0001-8345-956X; chakraborty, kausik/0000-0001-6000-8379	Council of Scientific and Industrial Research (CSIR) EMPOWER; Wellcome Trust-Department of Biotechnology India alliance; CSIR	Council of Scientific and Industrial Research (CSIR) EMPOWER; Wellcome Trust-Department of Biotechnology India alliance(Wellcome Trust DBT India Alliance); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was funded by the Council of Scientific and Industrial Research (CSIR) EMPOWER program and in part by grants from the Wellcome Trust-Department of Biotechnology India alliance. K.C. acknowledges CSIR for funds to the Institute of Genomics and Integrative Biology and infrastructural support. We thank R. Varadarajan (Indian Institute of Science) for the CcdB mutant library, J. Weissman (University of California San Francisco) for the ymj003 strain and U. Hard and Si. Hayer-Hartl (Max Planck Institute of Biochemistry) for their generous gifts of DM-MBP mutant plasmids. We acknowledge the National BioResource Project-E. coli at the National Institute of Genetics (Japan) for providing strains from the Keio Collection.	Ando T, 2010, P NATL ACAD SCI USA, V107, P18457, DOI 10.1073/pnas.1011354107; Bajaj K, 2005, P NATL ACAD SCI USA, V102, P16221, DOI 10.1073/pnas.0505089102; Bajaj K, 2008, BIOCHEMISTRY-US, V47, P12964, DOI 10.1021/bi8014345; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; BERNARD P, 1993, J MOL BIOL, V234, P534, DOI 10.1006/jmbi.1993.1609; Bolen DW, 2001, J MOL BIOL, V310, P955, DOI 10.1006/jmbi.2001.4819; Camps M, 2007, CRIT REV BIOCHEM MOL, V42, P313, DOI 10.1080/10409230701597642; Chakraborty K, 2010, CELL, V142, P112, DOI 10.1016/j.cell.2010.05.027; Dao-Thi MH, 2005, J MOL BIOL, V348, P1091, DOI 10.1016/j.jmb.2005.03.049; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Diamant S, 2001, J BIOL CHEM, V276, P39586, DOI 10.1074/jbc.M103081200; Eggers DK, 2001, J MOL BIOL, V314, P911, DOI 10.1006/jmbi.2001.5166; Gunasekera TS, 2008, J BACTERIOL, V190, P3712, DOI 10.1128/JB.01990-07; Holthauzen LMF, 2010, BIOCHEMISTRY-US, V49, P1310, DOI 10.1021/bi9015499; Honda Y, 2010, AGING CELL, V9, P558, DOI 10.1111/j.1474-9726.2010.00582.x; Hong JA, 2010, J AM CHEM SOC, V132, P10445, DOI 10.1021/ja103166y; Ignatova Z, 2006, P NATL ACAD SCI USA, V103, P13357, DOI 10.1073/pnas.0603772103; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kimata Y, 2011, CURR OPIN CELL BIOL, V23, P135, DOI 10.1016/j.ceb.2010.10.008; Konopka MC, 2006, J BACTERIOL, V188, P6115, DOI 10.1128/JB.01982-05; Lindquist S, 2010, COLD SPRING HARB SYM, V74, P103; Loris R, 1999, J MOL BIOL, V285, P1667, DOI 10.1006/jmbi.1998.2395; MEURY J, 1991, J BACTERIOL, V173, P4404, DOI 10.1128/JB.173.14.4404-4410.1991; Moczek AP, 2008, BIOESSAYS, V30, P432, DOI 10.1002/bies.20754; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Nascimento C, 2008, PROTEIN J, V27, P392, DOI 10.1007/s10930-008-9149-9; Ong DST, 2010, NAT CHEM BIOL, V6, P424, DOI 10.1038/nchembio.368; Povolotskaya IS, 2010, NATURE, V465, P922, DOI 10.1038/nature09105; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; RAMAKRISHNAN C, 1965, BIOPHYS J, V5, P909, DOI 10.1016/S0006-3495(65)86759-5; ROD ML, 1988, J BACTERIOL, V170, P3601, DOI 10.1128/jb.170.8.3601-3610.1988; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Schultz T, 2007, BIOCHEM BIOPH RES CO, V355, P234, DOI 10.1016/j.bbrc.2007.01.149; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Singer MA, 1998, MOL CELL, V1, P639, DOI 10.1016/S1097-2765(00)80064-7; Street TO, 2010, PROTEIN SCI, V19, P57, DOI 10.1002/pro.282; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wang JD, 1998, P NATL ACAD SCI USA, V95, P12163, DOI 10.1073/pnas.95.21.12163; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Wolf E, 1998, CELL, V94, P439, DOI 10.1016/S0092-8674(00)81585-8; Woodruff PJ, 2004, J BIOL CHEM, V279, P28835, DOI 10.1074/jbc.M313103200; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124	47	77	79	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2012	8	3					238	245		10.1038/NCHEMBIO.768	http://dx.doi.org/10.1038/NCHEMBIO.768			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896VR	22246401	Green Accepted			2022-12-25	WOS:000300600000008
J	Kohno, T; Ichikawa, H; Totoki, Y; Yasuda, K; Hiramoto, M; Nammo, T; Sakamoto, H; Tsuta, K; Furuta, K; Shimada, Y; Iwakawa, R; Ogiwara, H; Oike, T; Enari, M; Schetter, AJ; Okayama, H; Haugen, A; Skaug, V; Chiku, S; Yamanaka, I; Arai, Y; Watanabe, SI; Sekine, I; Ogawa, S; Harris, CC; Tsuda, H; Yoshida, T; Yokota, J; Shibata, T				Kohno, Takashi; Ichikawa, Hitoshi; Totoki, Yasushi; Yasuda, Kazuki; Hiramoto, Masaki; Nammo, Takao; Sakamoto, Hiromi; Tsuta, Koji; Furuta, Koh; Shimada, Yoko; Iwakawa, Reika; Ogiwara, Hideaki; Oike, Takahiro; Enari, Masato; Schetter, Aaron J.; Okayama, Hirokazu; Haugen, Aage; Skaug, Vidar; Chiku, Suenori; Yamanaka, Itaru; Arai, Yasuhito; Watanabe, Shun-ichi; Sekine, Ikuo; Ogawa, Seishi; Harris, Curtis C.; Tsuda, Hitoshi; Yoshida, Teruhiko; Yokota, Jun; Shibata, Tatsuhiro			KIF5B-RET fusions in lung adenocarcinoma	NATURE MEDICINE			English	Article							CANCER; RET; IDENTIFICATION; THERAPY	We identified in-frame fusion transcripts of KIF5B (the kinesin family 5B gene) and the RET oncogene, which are present in 1-2% of lung adenocarcinomas (LADCs) from people from Japan and the United States, using whole-transcriptome sequencing. The KIF5B-RET fusion leads to aberrant activation of RET kinase and is considered to be a new driver mutation of LADC because it segregates from mutations or fusions in EGFR, KRAS, HER2 and ALK, and a RET tyrosine kinase inhibitor, vandetanib, suppresses the fusion-induced anchorage-independent growth activity of NIH3T3 cells.	[Kohno, Takashi; Shimada, Yoko; Ogiwara, Hideaki] Natl Canc Ctr, Res Inst, Div Genome Biol, Chuo Ku, Tokyo 104, Japan; [Ichikawa, Hitoshi; Sakamoto, Hiromi; Yoshida, Teruhiko] Natl Canc Ctr, Res Inst, Div Genet, Chuo Ku, Tokyo 104, Japan; [Totoki, Yasushi; Shibata, Tatsuhiro] Natl Canc Ctr, Res Inst, Div Canc Genom, Chuo Ku, Tokyo 104, Japan; [Yasuda, Kazuki; Hiramoto, Masaki; Nammo, Takao] Natl Ctr Global Hlth & Med, Dept Metab Disorder, Diabet Res Ctr, Res Inst,Shinjuku Ku, Tokyo, Japan; [Tsuta, Koji; Furuta, Koh; Tsuda, Hitoshi] Natl Canc Ctr, Div Pathol & Clin Labs, Chuo Ku, Tokyo, Japan; [Iwakawa, Reika; Oike, Takahiro; Okayama, Hirokazu; Yokota, Jun] Natl Canc Ctr, Res Inst, Div Multistep Carcinogenesis, Chuo Ku, Tokyo 104, Japan; [Enari, Masato] Natl Canc Ctr, Res Inst, Div Refractory Canc Res, Tokyo 104, Japan; [Schetter, Aaron J.; Okayama, Hirokazu; Harris, Curtis C.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Haugen, Aage; Skaug, Vidar] Natl Inst Occupat Hlth, Sect Toxicol, Dept Chem & Biol Working Environm, Oslo, Norway; [Chiku, Suenori] Mizuho Informat & Res Inst, Sci Solut Div, Chiyoda Ku, Tokyo, Japan; [Yamanaka, Itaru] StaGen, Stat Genet Anal Div, Taito Ku, Tokyo, Japan; [Watanabe, Shun-ichi] Natl Canc Ctr, Div Thorac Surg, Chuo Ku, Tokyo, Japan; [Sekine, Ikuo] Natl Canc Ctr, Div Thorac Oncol, Chuo Ku, Tokyo, Japan; [Ogawa, Seishi] Univ Tokyo, Bunkyo Ku, Canc Genom Project, Tokyo 113, Japan	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Center for Global Health & Medicine - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mizuho Research & Technologies, Ltd.; National Cancer Center - Japan; National Cancer Center - Japan; University of Tokyo	Kohno, T (corresponding author), Natl Canc Ctr, Res Inst, Div Genome Biol, Chuo Ku, Tokyo 104, Japan.	tkkohno@ncc.go.jp	Enari, Masato/E-5507-2014; Shibata, Tatsuhiro/ABA-8234-2020; Ogawa, Seishi/AAE-7088-2019; Shibata, Tatsuhiro/AAO-1278-2021; yamanaka, itaru/AAA-6290-2022	Enari, Masato/0000-0003-4293-3848; Arai, Yasuhito/0000-0001-6306-9409; Ogiwara, Hideaki/0000-0003-0860-1807; Okayama, Hirokazu/0000-0003-0966-4746	National Institute of Biomedical Innovation (NiBio); Ministry of Health, Labour and Welfare; National Cancer Center; Norwegian Cancer Society; National Cancer Center, Japan; NATIONAL CANCER INSTITUTE [ZIABC010874, ZIABC005480] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24390288] Funding Source: KAKEN	National Institute of Biomedical Innovation (NiBio)(National Institute of Biomedical Innovation); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); National Cancer Center; Norwegian Cancer Society(Norwegian Cancer Society); National Cancer Center, Japan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the program for promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio), Grants-in-Aid from the Ministry of Health, Labour and Welfare for the 3rd-term Comprehensive 10-year Strategy for Cancer Control, the National Cancer Center Research and Development Fund and the Norwegian Cancer Society. National Cancer Center Biobank is supported by the National Cancer Center Research and Development Fund, Japan. We thank T. Urushidate, S. Ohashi, S. Mitani, K. Yokozawa, S. Wakai, C. Otsubo and H. Isomura of the National Cancer Center and D. Suzuki and K. Nagase of the National Center for Global Health and Medicine for technical assistance. We also thank J.D. Minna and L. Girard of the University of Texas Southwestern Medical Center, K. Kumamoto of Saitama Medical University and A. Okamoto of Jikei University for RET fusion screening, N. Morii of the National Institute of Advanced Industrial Science and Technology (AIST) for thermodynamic characterization of the KIF5B protein and M. Maekawa of the GSP laboratory for rapid preparation of the FISH probes.	Bishop JA, 2010, HUM PATHOL, V41, P20, DOI 10.1016/j.humpath.2009.06.014; Carlomagno F, 2002, CANCER RES, V62, P7284; Commander H, 2011, DRUGS, V71, P1355, DOI 10.2165/11595310-000000000-00000; Croyle M, 2008, CANCER RES, V68, P4183, DOI 10.1158/0008-5472.CAN-08-0413; DeLellis R.A., 2010, IMMUNOHISTOLOGY ENDO; Gerber DE, 2010, CANCER CELL, V18, P548, DOI 10.1016/j.ccr.2010.11.033; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Janku F, 2010, NAT REV CLIN ONCOL, V7, P401, DOI 10.1038/nrclinonc.2010.64; Jhiang SM, 2000, ONCOGENE, V19, P5590, DOI 10.1038/sj.onc.1203857; Lovly CM, 2011, NAT REV CLIN ONCOL, V8, P68, DOI 10.1038/nrclinonc.2010.224; Mani RS, 2010, NAT REV GENET, V11, P819, DOI 10.1038/nrg2883; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Morii H, 1997, BIOCHEMISTRY-US, V36, P1933, DOI 10.1021/bi962392l; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; Vitagliano D, 2011, ENDOCR-RELAT CANCER, V18, P1, DOI 10.1677/ERC-09-0292; Wells SA, 2009, CLIN CANCER RES, V15, P7119, DOI 10.1158/1078-0432.CCR-08-2742	19	579	642	2	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2012	18	3					375	377		10.1038/nm.2644	http://dx.doi.org/10.1038/nm.2644			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22327624	Green Accepted			2022-12-25	WOS:000301264800036
J	Melnikov, A; Murugan, A; Zhang, XL; Tesileanu, T; Wang, L; Rogov, P; Feizi, S; Gnirke, A; Callan, CG; Kinney, JB; Kellis, M; Lander, ES; Mikkelsen, TS				Melnikov, Alexandre; Murugan, Anand; Zhang, Xiaolan; Tesileanu, Tiberiu; Wang, Li; Rogov, Peter; Feizi, Soheil; Gnirke, Andreas; Callan, Curtis G., Jr.; Kinney, Justin B.; Kellis, Manolis; Lander, Eric S.; Mikkelsen, Tarjei S.			Systematic dissection and optimization of inducible enhancers in human cells using a massively parallel reporter assay	NATURE BIOTECHNOLOGY			English	Article							NUCLEOTIDE-SEQUENCE; GENE SYNTHESIS; HUMAN GENOME; PROMOTERS; ELEMENTS; DNA; INFORMATION; EXPRESSION; SELECTION; DESIGN	Learning to read and write the transcriptional regulatory code is of central importance to progress in genetic analysis and engineering. Here we describe a massively parallel reporter assay (MPRA) that facilitates the systematic dissection of transcriptional regulatory elements. In MPRA, microarray-synthesized DNA regulatory elements and unique sequence tags are cloned into plasmids to generate a library of reporter constructs. These constructs are transfected into cells and tag expression is assayed by high-throughput sequencing. We apply MPRA to compare >27,000 variants of two inducible enhancers in human cells: a synthetic cAMP-regulated enhancer and the virus-inducible interferon-beta enhancer. We first show that the resulting data define accurate maps of functional transcription factor binding sites in both enhancers at single-nucleotide resolution. We then use the data to train quantitative sequence-activity models (QSAMs) of the two enhancers. We show that QSAMs from two cellular states can be combined to design enhancer variants that optimize potentially conflicting objectives, such as maximizing induced activity while minimizing basal activity.	[Melnikov, Alexandre; Zhang, Xiaolan; Wang, Li; Rogov, Peter; Feizi, Soheil; Gnirke, Andreas; Kellis, Manolis; Lander, Eric S.; Mikkelsen, Tarjei S.] Broad Inst, Cambridge, MA USA; [Murugan, Anand; Tesileanu, Tiberiu; Callan, Curtis G., Jr.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Tesileanu, Tiberiu; Callan, Curtis G., Jr.] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA; [Feizi, Soheil; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Kinney, Justin B.] Cold Spring Harbor Lab, Simons Ctr Quantitat Biol, Cold Spring Harbor, NY 11724 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Mikkelsen, Tarjei S.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Mikkelsen, Tarjei S.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Princeton University; Institute for Advanced Study - USA; Massachusetts Institute of Technology (MIT); Cold Spring Harbor Laboratory; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Harvard University	Mikkelsen, TS (corresponding author), Broad Inst, Cambridge, MA USA.	tarjei@broadinstitute.org	Mikkelsen, Tarjei S/A-1306-2007; Kellis, Manolis/ABE-7385-2020	Mikkelsen, Tarjei S/0000-0002-8133-3135; Kellis, Manolis/0000-0001-7113-9630; PPCT, Leo/0000-0003-0897-4830; Kinney, Justin/0000-0003-1897-3778; Tesileanu, Tiberiu/0000-0003-3107-3088	Broad Institute; Harvard Stem Cell Institute; National Human Genome Research Institute [R01HG004037]; Simons Center for Quantitative Biology at Cold Spring Harbor Laboratory; National Science Foundation (NSF) [PHY-0957573, PHY-1022140]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037] Funding Source: NIH RePORTER; Division Of Physics [0957573] Funding Source: National Science Foundation	Broad Institute; Harvard Stem Cell Institute; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Simons Center for Quantitative Biology at Cold Spring Harbor Laboratory; National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors would like to thank E. M. LeProust and S. Chen of Agilent for oligonucleotide library synthesis, R. P. Deering for assistance with Sendai virus infections and the staff of the Broad Institute and the Bauer Core facilities for assistance with data generation. This project was supported by funds from the Broad Institute, the Harvard Stem Cell Institute (T. S. M.), National Human Genome Research Institute grant R01HG004037 (M. K.), the Simons Center for Quantitative Biology at Cold Spring Harbor Laboratory (J.B.K.), National Science Foundation (NSF) grant PHY-0957573 (C. G. C., T. T.) and NSF grant PHY-1022140 (A. Mur.).	Arnosti DN, 2005, J CELL BIOCHEM, V94, P890, DOI 10.1002/jcb.20352; BENBROOK DM, 1994, NUCLEIC ACIDS RES, V22, P1463, DOI 10.1093/nar/22.8.1463; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bishop C.M., 2006, PATTERN RECOGNITION; Carey M., 2009, TRANSCRIPTIONAL REGU; De Mey M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-34; Dorer DE, 2009, ADV DRUG DELIVER REV, V61, P554, DOI 10.1016/j.addr.2009.03.013; Edelman GM, 2000, P NATL ACAD SCI USA, V97, P3038, DOI 10.1073/pnas.040569897; Falvo JV, 2000, MOL CELL BIOL, V20, P4814, DOI 10.1128/MCB.20.13.4814-4825.2000; Fan F, 2007, ASSAY DRUG DEV TECHN, V5, P127, DOI 10.1089/adt.2006.053; FINK JS, 1988, P NATL ACAD SCI USA, V85, P6662, DOI 10.1073/pnas.85.18.6662; Holland JH, 1992, ADAPTATION NATURAL A, DOI DOI 10.7551/MITPRESS/1090.001.0001; JONSSON J, 1993, NUCLEIC ACIDS RES, V21, P733, DOI 10.1093/nar/21.3.733; Kinney JB, 2010, P NATL ACAD SCI USA, V107, P9158, DOI 10.1073/pnas.1004290107; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; LeProust EM, 2010, NUCLEIC ACIDS RES, V38, P2522, DOI 10.1093/nar/gkq163; Loew R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-81; Matzas M, 2010, NAT BIOTECHNOL, V28, P1291, DOI 10.1038/nbt.1710; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Quan JY, 2011, NAT BIOTECHNOL, V29, P449, DOI 10.1038/nbt.1847; Schlabach MR, 2010, P NATL ACAD SCI USA, V107, P2538, DOI 10.1073/pnas.0914803107; SCHNEIDER TD, 1989, NUCLEIC ACIDS RES, V17, P659, DOI 10.1093/nar/17.2.659; STORMO GD, 1986, NUCLEIC ACIDS RES, V14, P6661, DOI 10.1093/nar/14.16.6661; TREVES A, 1995, NEURAL COMPUT, V7, P399, DOI 10.1162/neco.1995.7.2.399	29	383	393	5	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2012	30	3					271	+		10.1038/nbt.2137	http://dx.doi.org/10.1038/nbt.2137			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	905VI	22371084	Green Accepted, Green Submitted			2022-12-25	WOS:000301303800024
J	Lanner, JT; Georgiou, DK; Dagnino-Acosta, A; Ainbinder, A; Cheng, Q; Joshi, AD; Chen, ZW; Yarotskyy, V; Oakes, JM; Lee, CS; Monroe, TO; Santillan, A; Dong, KK; Goodyear, L; Ismailov, II; Rodney, GG; Dirksen, RT; Hamilton, SL				Lanner, Johanna T.; Georgiou, Dimitra K.; Dagnino-Acosta, Adan; Ainbinder, Alina; Cheng, Qing; Joshi, Aditya D.; Chen, Zanwen; Yarotskyy, Viktor; Oakes, Joshua M.; Lee, Chang Seok; Monroe, Tanner O.; Santillan, Arturo; Dong, Keke; Goodyear, Laurie; Ismailov, Iskander I.; Rodney, George G.; Dirksen, Robert T.; Hamilton, Susan L.			AICAR prevents heat-induced sudden death in RyR1 mutant mice independent of AMPK activation	NATURE MEDICINE			English	Article							MALIGNANT HYPERTHERMIA; PROTEIN-KINASE; RYANODINE RECEPTOR; S-NITROSYLATION; CA2+ RELEASE; IDENTIFICATION; MUTATION; GLYCOGEN; RHABDOMYOLYSIS; FLUORESCENCE	Mice with a knock-in mutation (Y524S) in the type I ryanodine receptor (Ryr1), a mutation analogous to the Y522S mutation that is associated with malignant hyperthermia in humans, die when exposed to short periods of temperature elevation (>= 37 degrees C). We show here that treatment with 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) prevents this heat-induced sudden death in this mouse model. The protection by AICAR is independent of AMP-activated protein kinase (AMPK) activation and results from a newly identified action of the compound on mutant Ryr1 to reduce Ca2+ leak from the sarcoplasmic reticulum to the sarcoplasm. AICAR thus prevents Ca2+-dependent increases in the amount of both reactive oxygen species (ROS) and reactive nitrogen species (RNS) that act to further increase resting Ca2+ concentrations. If unchecked, the temperature-driven increases in resting Ca2+ concentrations and the amounts of ROS and RNS create an amplifying cycle that ultimately triggers sustained muscle contractions, rhabdomyolysis and death. Although antioxidants are effective in reducing this cycle in vitro, only AICAR prevents heat-induced death in vivo. Our findings suggest that AICAR is probably effective in prophylactic treatment of humans with enhanced susceptibility to exercise- and/or heat-induced sudden death associated with RYR1 mutations.	[Lanner, Johanna T.; Georgiou, Dimitra K.; Dagnino-Acosta, Adan; Cheng, Qing; Joshi, Aditya D.; Chen, Zanwen; Oakes, Joshua M.; Lee, Chang Seok; Monroe, Tanner O.; Santillan, Arturo; Dong, Keke; Ismailov, Iskander I.; Rodney, George G.; Hamilton, Susan L.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Ainbinder, Alina; Yarotskyy, Viktor; Dirksen, Robert T.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Goodyear, Laurie] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA	Baylor College of Medicine; University of Rochester; Harvard University; Joslin Diabetes Center, Inc.	Hamilton, SL (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.	susanh@bcm.edu	Monroe, Tanner O./AAQ-5901-2021; Dagnino-Acosta, Adan/K-6786-2012	Monroe, Tanner/0000-0001-9117-2227; Lanner, Johanna/0000-0002-1222-9473; Rodney, George G/0000-0002-6968-1516; Hamilton, Susan/0000-0003-0241-9369; Dagnino-Acosta, Adan/0000-0001-8903-807X	US National Institutes of Health [AR053349]; Department of Defense [DAMD W81XWH-10-2-0117]; Muscular Dystrophy Association of America; The Swedish Research Council; The Mexican National Council of Science and Technology [150489]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041802, R01AR053349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Muscular Dystrophy Association of America(Muscular Dystrophy Association); The Swedish Research Council(Swedish Research Council); The Mexican National Council of Science and Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from US National Institutes of Health (AR053349), the Department of Defense (DAMD W81XWH-10-2-0117) and the Muscular Dystrophy Association of America. J.T.L. was supported by a postdoc fellowship from The Swedish Research Council. A.D.-A. was supported by a postdoctoral fellowship from The Mexican National Council of Science and Technology (150489). The model shown in Figure 6 was created by S.A. Weldon.	Aracena-Parks P, 2006, J BIOL CHEM, V281, P40354, DOI 10.1074/jbc.M600876200; Barre L, 2007, AM J PHYSIOL-ENDOC M, V292, pE802, DOI 10.1152/ajpendo.00369.2006; Boncompagni S, 2009, P NATL ACAD SCI USA, V106, P21996, DOI 10.1073/pnas.0911496106; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Capacchione JF, 2009, ANESTH ANALG, V109, P1065, DOI 10.1213/ane.0b013e3181a9d8d9; Chelu MG, 2006, FASEB J, V20, P329, DOI 10.1096/fj.05-4497fje; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Davis M, 2002, BRIT J ANAESTH, V88, P508, DOI 10.1093/bja/88.4.508; Duke AM, 2010, J BIOL CHEM, V285, P25645, DOI 10.1074/jbc.M110.104976; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; Firuzi O, 2011, CURR MED CHEM, V18, P3871, DOI 10.2174/092986711803414368; Fujii N, 2005, J BIOL CHEM, V280, P39033, DOI 10.1074/jbc.M504208200; Fujii N, 2008, DIABETES, V57, P2958, DOI 10.2337/db07-1187; Groom L, 2011, ANESTHESIOLOGY, V115, P938, DOI 10.1097/ALN.0b013e3182320068; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Holmes BF, 1999, J APPL PHYSIOL, V87, P1990, DOI 10.1152/jappl.1999.87.5.1990; HOPKINS PM, 1991, LANCET, V338, P1491, DOI 10.1016/0140-6736(91)92304-K; Jorgensen SB, 2007, AM J PHYSIOL-ENDOC M, V292, pE331, DOI 10.1152/ajpendo.00243.2006; Jurkat-Rott K, 2000, MUSCLE NERVE, V23, P4, DOI 10.1002/(SICI)1097-4598(200001)23:1<4::AID-MUS3>3.0.CO;2-D; KONISHI M, 1988, BIOPHYS J, V54, P1089, DOI 10.1016/S0006-3495(88)83045-5; Korolainen MA, 2006, NEUROBIOL AGING, V27, P42, DOI 10.1016/j.neurobiolaging.2004.11.010; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Larach MG, 2010, ANESTH ANALG, V110, P498, DOI 10.1213/ANE.0b013e3181c6b9b2; Mackrill JJ, 2010, BIOCHEM PHARMACOL, V79, P1535, DOI 10.1016/j.bcp.2010.01.014; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; Meissner G, 1997, J BIOL CHEM, V272, P1628, DOI 10.1074/jbc.272.3.1628; MEISSNER G, 1984, J BIOL CHEM, V259, P2365; MEISSNER G, 1986, BIOCHEMISTRY-US, V25, P236, DOI 10.1021/bi00349a033; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nishio Hajime, 2009, Legal Medicine, V11, P142, DOI 10.1016/j.legalmed.2008.12.004; Pirone A, 2010, AM J PHYSIOL-CELL PH, V299, pC1345, DOI 10.1152/ajpcell.00008.2010; Pold R, 2005, DIABETES, V54, P928, DOI 10.2337/diabetes.54.4.928; QUANE KA, 1994, GENOMICS, V23, P236, DOI 10.1006/geno.1994.1483; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; ROCK E, 1987, ARCH BIOCHEM BIOPHYS, V256, P703, DOI 10.1016/0003-9861(87)90628-X; Rosenberg H, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-21; Solberg G, 2005, J SPORT SCI MED, V4, P29; Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209; Tadaishi M, 2011, AM J PHYSIOL-ENDOC M, V300, pE341, DOI 10.1152/ajpendo.00400.2010; Terracciano C, 2008, FREE RADICAL BIO MED, V45, P773, DOI 10.1016/j.freeradbiomed.2008.05.030; Tobin JR, 2001, JAMA-J AM MED ASSOC, V286, P168, DOI 10.1001/jama.286.2.168; Treves S, 2005, NEUROMUSCULAR DISORD, V15, P577, DOI 10.1016/j.nmd.2005.06.008; Vladutiu GD, 2011, MOL GENET METAB, V104, P167, DOI 10.1016/j.ymgme.2011.07.001; Wappler F, 2001, ANESTHESIOLOGY, V94, P95, DOI 10.1097/00000542-200101000-00019; Wasserman K, 1990, CIRCULATION S2, V81, P1114; Wei L, 2011, FASEB J, V25, P3068, DOI 10.1096/fj.11-187252; WILLIAMS JH, 1991, AM J PHYSIOL, V261, pR782, DOI 10.1152/ajpregu.1991.261.4.R782; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219	48	81	81	1	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					244	251		10.1038/nm.2598	http://dx.doi.org/10.1038/nm.2598			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22231556	Green Accepted			2022-12-25	WOS:000300140300038
J	Nachtergaele, S; Mydock, LK; Krishnan, K; Rammohan, J; Schlesinger, PH; Covey, DF; Rohatgi, R				Nachtergaele, Sigrid; Mydock, Laurel K.; Krishnan, Kathiresan; Rammohan, Jayan; Schlesinger, Paul H.; Covey, Douglas F.; Rohatgi, Rajat			Oxysterols are allosteric activators of the oncoprotein Smoothened	NATURE CHEMICAL BIOLOGY			English	Article							HEDGEHOG SIGNAL-TRANSDUCTION; SONIC HEDGEHOG; CHOLESTEROL HOMEOSTASIS; CELL-MIGRATION; PRIMARY CILIUM; RECEPTOR; BINDING; PATHWAY; INHIBITION; MEMBRANES	Oxysterols are a class of endogenous signaling molecules that can activate the Hedgehog pathway, which has critical roles in development, regeneration and cancer. However, it has been unclear how oxysterols influence Hedgehog signaling, including whether their effects are mediated through a protein target or indirectly through effects on membrane properties. To answer this question, we synthesized the enantiomer and an epimer of the most potent oxysterol, 20(S)-hydroxycholesterol. Using these molecules, we show that the effects of oxysterols on Hedgehog signaling are exquisitely stereoselective, consistent with the hypothesis that they function through a specific protein target. We present several lines of evidence that this protein target is the seven-pass transmembrane protein Smoothened, a major drug target in oncology. Our work suggests that these enigmatic sterols, which have multiple effects on cell physiology, may act as ligands for signaling receptors and provides a generally applicable framework for probing sterol signaling mechanisms.	[Rohatgi, Rajat] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Nachtergaele, Sigrid] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Mydock, Laurel K.; Krishnan, Kathiresan; Covey, Douglas F.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA; [Rammohan, Jayan; Schlesinger, Paul H.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Stanford University; Stanford University; Washington University (WUSTL); Washington University (WUSTL)	Rohatgi, R (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.	dcovey@wustl.edu; rrohatgi@stanford.edu	Schlesinger, Paul H/C-6049-2012		NIH [RR00954, DK020579, DK056341, GM47969, HL67773, 5 T32 GM007276, 5 T32 HL007275]; Stand Up to Cancer - American Association for Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R00CA129174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067773, T32HL007275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, P30DK020579, P60DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007276, P01GM047969] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stand Up to Cancer - American Association for Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Rohatgi lab for helpful discussions, G. Luchetti for help with ligand affinity chromatography, P. Niewiadomski and A. Lebensohn for critical reading of the manuscript, E. Lee (Vanderbilt University) for Wnt-L cells, K. Mykytyn (Ohio State University) for the SSTR3-GFP and HTR6-GFP constructs, A. Sweet-Cordero for use of a Li-Cor Odyssey imager and M. Scott for support and use of a confocal microscope. MS analysis was conducted at the NIH - National Center for Research Resources MS facility at Washington University, supported by the NIH (RR00954, DK020579, DK056341). This work was supported by a Pew Scholar Award and an Innovation Research Grant from the Stand Up to Cancer - American Association for Cancer Research Foundation to R. R., by NIH grants to D. F. C. (GM47969 and HL67773) and P. H. S. (HL67773), and by NIH training grants to S.N. (5 T32 GM007276) and L.K.M. (5 T32 HL007275).	Barakat MT, 2010, TRENDS MOL MED, V16, P337, DOI 10.1016/j.molmed.2010.05.003; Brown AJ, 2007, CLIN EXP PHARMACOL P, V34, P135, DOI 10.1111/j.1440-1681.2007.04565.x; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Cooper MK, 2003, NAT GENET, V33, P508, DOI 10.1038/ng1134; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; Covey DF, 2009, STEROIDS, V74, P577, DOI 10.1016/j.steroids.2008.11.019; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Gale SE, 2009, J BIOL CHEM, V284, P1755, DOI 10.1074/jbc.M807210200; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Heretsch P, 2010, ANGEW CHEM INT EDIT, V49, P3418, DOI 10.1002/anie.200906967; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Johnson JS, 2011, J CELL BIOCHEM, V112, P1673, DOI 10.1002/jcb.23082; Kenakin T, 2009, PHARMACOLOGY PRIMER: THEORY, APPLICATIONS, AND METHODS, 3RD EDITION, P101, DOI 10.1016/B978-0-12-374585-9.00006-2; Kim J, 2010, CANCER CELL, V17, P388, DOI 10.1016/j.ccr.2010.02.027; LeBlanc MA, 2010, J BIOL CHEM, V285, P33875, DOI 10.1074/jbc.M110.147264; Lin YY, 2003, J STEROID BIOCHEM, V85, P57, DOI 10.1016/S0960-0760(03)00137-7; Liu CL, 2011, NATURE, V475, P519, DOI 10.1038/nature10226; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Mannock DA, 2003, BIOPHYS J, V84, P1038, DOI 10.1016/S0006-3495(03)74920-0; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Massey JB, 2006, BIOCHEMISTRY-US, V45, P10747, DOI 10.1021/bi060540u; MIJARES A, 1967, J ORG CHEM, V32, P810, DOI 10.1021/jo01278a066; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Olkkonen VM, 2009, MOL ASPECTS MED, V30, P123, DOI 10.1016/j.mam.2009.02.004; Panini SR, 2001, CURR OPIN LIPIDOL, V12, P529, DOI 10.1097/00041433-200110000-00008; Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Rentero C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002262; ROBERTS KD, 1969, BIOCHEMISTRY-US, V8, P1259, DOI 10.1021/bi00831a061; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Rominger CM, 2009, J PHARMACOL EXP THER, V329, P995, DOI 10.1124/jpet.109.152090; Ruprecht JJ, 2004, EMBO J, V23, P3609, DOI 10.1038/sj.emboj.7600374; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; THEUNISSEN JJH, 1986, BIOCHIM BIOPHYS ACTA, V860, P66, DOI 10.1016/0005-2736(86)90499-2; Torocsik D, 2009, MOL ASPECTS MED, V30, P134, DOI 10.1016/j.mam.2009.02.002; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Westover EJ, 2003, J BIOL CHEM, V278, P51125, DOI 10.1074/jbc.M304332200	48	199	207	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2012	8	2					211	220		10.1038/nchembio.765	http://dx.doi.org/10.1038/nchembio.765			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879IP	22231273	Green Accepted			2022-12-25	WOS:000299323200014
J	Wilkinson, TM; Li, CKF; Chui, CSC; Huang, AKY; Perkins, M; Liebner, JC; Lambkin-Williams, R; Gilbert, A; Oxford, J; Nicholas, B; Staples, KJ; Dong, T; Douek, DC; McMichael, AJ; Xu, XN				Wilkinson, Tom M.; Li, Chris K. F.; Chui, Cecilia S. C.; Huang, Arthur K. Y.; Perkins, Molly; Liebner, Julia C.; Lambkin-Williams, Rob; Gilbert, Anthony; Oxford, John; Nicholas, Ben; Staples, Karl J.; Dong, Tao; Douek, Daniel C.; McMichael, Andrew J.; Xu, Xiao-Ning			Preexisting influenza-specific CD4(+) T cells correlate with disease protection against influenza challenge in humans	NATURE MEDICINE			English	Article							VIRUS-INFECTION; IMMUNITY; RESPONSES; VACCINE; H5N1	Protective immunity against influenza virus infection is mediated by neutralizing antibodies, but the precise role of T cells in human influenza immunity is uncertain. We conducted influenza infection studies in healthy volunteers with no detectable antibodies to the challenge viruses H3N2 or H1N1. We mapped T cell responses to influenza before and during infection. We found a large increase in influenza-specific T cell responses by day 7, when virus was completely cleared from nasal samples and serum antibodies were still undetectable. Preexisting CD4(+), but not CD8(+), T cells responding to influenza internal proteins were associated with lower virus shedding and less severe illness. These CD4(+) cells also responded to pandemic H1N1 (A/CA/07/2009) peptides and showed evidence of cytotoxic activity. These cells are an important statistical correlate of homotypic and heterotypic response and may limit severity of influenza infection by new strains in the absence of specific antibody responses. Our results provide information that may aid the design of future vaccines against emerging influenza strains.	[Wilkinson, Tom M.; Nicholas, Ben; Staples, Karl J.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Li, Chris K. F.; Chui, Cecilia S. C.; Huang, Arthur K. Y.; Dong, Tao; McMichael, Andrew J.; Xu, Xiao-Ning] Univ Oxford, MRC, Human Immunol Unit, Weatherall Inst Mol Med, Oxford, England; [Huang, Arthur K. Y.] Chang Gung Childrens Hosp, Dept Paediat, Tao Yuan, Taiwan; [Perkins, Molly; Liebner, Julia C.; Douek, Daniel C.] US Natl Inst Hlth, Vaccine Res Ctr, Bethesda, MD USA; [Lambkin-Williams, Rob; Gilbert, Anthony; Oxford, John] Retroscreen Virol, London, England	University of Southampton; University of Oxford; Chang Gung Memorial Hospital; National Institutes of Health (NIH) - USA	Wilkinson, TM (corresponding author), Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England.	t.wilkinson@soton.ac.uk; xiaoning.xu@imm.ox.ac.uk	Lambkin-Williams, Robert/P-5963-2016; LI, chris/HDO-6232-2022; Lambkin-Williams, Rob/L-2397-2019	Lambkin-Williams, Robert/0000-0003-2107-0174; Lambkin-Williams, Rob/0000-0003-2107-0174; Dong, Tao/0000-0003-3545-3758; Wilkinson, Tom/0000-0003-1771-3851; Nicholas, Benjamin/0000-0003-1467-9643; Gilbert, Anthony Saul/0000-0002-6582-3820; Staples, Karl/0000-0003-3844-6457	UK Medical Research Council; Medical Research Council [G1001046, G1001047, MC_U137881015, G0600520, MC_U137884177] Funding Source: researchfish; Asthma UK [08/026] Funding Source: researchfish; MRC [G1001047, MC_U137881015, G0600520, G1001046, MC_U137884177] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Roederer, P. Chattopadhyay and J. Yu (US National Institutes of Health) for providing the antibody conjugates used for flow cytometry.. We also thank G. Balaratnam and the Retroscreen Clinical team for their expert conduct of the clinical study. In addition, we thank N. Goonetilleke for discussion of the statistics, H. Hong and L. Wang for assistance in blood separation and ELISPOT assay, and J. Ward of the Southampton Histochemistry Research Unit for assistance with immunohistochemistry. This study was partially funded by the UK Medical Research Council.	Appay V, 2002, J IMMUNOL, V168, P5954, DOI 10.4049/jimmunol.168.11.5954; Aymard M, 1999, VACCINE, V17, pS30, DOI 10.1016/S0264-410X(99)00103-6; Belshe RB, 2005, NEW ENGL J MED, V353, P2209, DOI 10.1056/NEJMp058281; Belshe RB, 2003, IMMUNOL ALLERGY CLIN, V23, P745, DOI 10.1016/S0889-8561(03)00098-5; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; BOTH GW, 1983, J VIROL, V48, P52, DOI 10.1128/JVI.48.1.52-60.1983; Casazza JP, 2006, J EXP MED, V203, P2865, DOI 10.1084/jem.20052246; Couch R B, 2003, Dev Biol (Basel), V115, P25; Creanza N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008544; de Berg PJV, 2008, CURR OPIN IMMUNOL, V20, P339, DOI 10.1016/j.coi.2008.03.007; Ge XH, 2010, J VIROL, V84, P3312, DOI 10.1128/JVI.02226-09; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; HO PPK, 1976, J GEN VIROL, V33, P143, DOI 10.1099/0022-1317-33-1-143; Holmes EC, 2003, TRENDS MICROBIOL, V11, P543, DOI 10.1016/j.tim.2003.10.006; Kalams SA, 1998, J EXP MED, V188, P2199, DOI 10.1084/jem.188.12.2199; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kreijtz JHCM, 2007, VACCINE, V25, P612, DOI 10.1016/j.vaccine.2006.08.036; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Li IW, 2010, CHEST, V137, P759, DOI 10.1378/chest.09-3072; McKinstry KK, 2011, J INTERN MED, V269, P507, DOI 10.1111/j.1365-2796.2011.02367.x; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Monto AS, 2000, AM J MANAG CARE, V6, pS255; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Newton DW, 2000, AM J MANAG CARE, V6, pS265; Oxford John S, 2005, Expert Rev Anti Infect Ther, V3, P1, DOI 10.1586/14787210.3.1.1; Richards KA, 2010, J IMMUNOL, V185, P4998, DOI 10.4049/jimmunol.1001395; Riley S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000442; Rimmelzwaan GF, 2008, VACCINE, V26, pD41, DOI 10.1016/j.vaccine.2008.07.043; Roti M, 2008, J IMMUNOL, V180, P1758, DOI 10.4049/jimmunol.180.3.1758; Schweiger B, 2006, VACCINE, V24, P6683, DOI 10.1016/j.vaccine.2006.05.105; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Stambas J, 2008, PHARMACOL THERAPEUT, V120, P186, DOI 10.1016/j.pharmthera.2008.08.007; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Topham DJ, 1997, J IMMUNOL, V159, P5197; Treanor J, 2004, NEW ENGL J MED, V350, P218, DOI 10.1056/NEJMp038238; WHO, 2009, INFL SEAS; Yang OO, 1996, J VIROL, V70, P5799, DOI 10.1128/JVI.70.9.5799-5806.1996	39	682	698	0	41	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					274	280		10.1038/nm.2612	http://dx.doi.org/10.1038/nm.2612			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22286307	Bronze			2022-12-25	WOS:000300140300042
J	Sela-Passwell, NA; Kikkeri, R; Dym, O; Rozenberg, H; Margalit, R; Arad-Yellin, R; Eisenstein, M; Brenner, O; Shoham, T; Danon, T; Shanzer, A; Sagi, I				Sela-Passwell, Nett A.; Kikkeri, Raghavendra; Dym, Orly; Rozenberg, Haim; Margalit, Raanan; Arad-Yellin, Rina; Eisenstein, Miriam; Brenner, Ori; Shoham, Tsipi; Danon, Tamar; Shanzer, Abraham; Sagi, Irit			Antibodies targeting the catalytic zinc complex of activated matrix metalloproteinases show therapeutic potential	NATURE MEDICINE			English	Article							INFLAMMATORY-BOWEL-DISEASE; EXPERIMENTAL COLITIS; CRYSTAL-STRUCTURE; CANCER-THERAPY; INHIBITORS; TISSUE; MECHANISM; EXPRESSION; TIMP-1; MICE	Endogenous tissue inhibitors of metalloproteinases (TIMPs) have key roles in regulating physiological and pathological cellular processes(1-3). Imitating the inhibitory molecular mechanisms of TIMPs while increasing selectivity has been a challenging but desired approach for antibody-based therapy(4). TIMPs use hybrid protein-protein interactions to form an energetic bond with the catalytic metal ion, as well as with enzyme surface residues(5-7). We used an innovative immunization strategy that exploits aspects of molecular mimicry to produce inhibitory antibodies that show TIMP-like binding mechanisms toward the activated forms of gelatinases (matrix metalloproteinases 2 and 9). Specifically, we immunized mice with a synthetic molecule that mimics the conserved structure of the metalloenzyme catalytic zinc-histidine complex residing within the enzyme active site. This immunization procedure yielded selective function-blocking monoclonal antibodies directed against the catalytic zinc-protein complex and enzyme surface conformational epitopes of endogenous gelatinases. The therapeutic potential of these antibodies has been demonstrated with relevant mouse models of inflammatory bowel disease(8). Here we propose a general experimental strategy for generating inhibitory antibodies that effectively target the in vivo activity of dysregulated metalloproteinases by mimicking the mechanism employed by TIMPs.	[Sela-Passwell, Nett A.; Dym, Orly; Rozenberg, Haim; Margalit, Raanan; Arad-Yellin, Rina; Shoham, Tsipi; Sagi, Irit] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Sela-Passwell, Nett A.; Dym, Orly; Rozenberg, Haim; Margalit, Raanan; Arad-Yellin, Rina; Shoham, Tsipi; Sagi, Irit] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Kikkeri, Raghavendra; Shanzer, Abraham] Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel; [Eisenstein, Miriam] Weizmann Inst Sci, Dept Chem Res Support, IL-76100 Rehovot, Israel; [Brenner, Ori] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel; [Danon, Tamar] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Sagi, I (corresponding author), Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.	irit.sagi@weizmann.ac.il			Israel Science Foundation; Minerva Foundation; Helmsley Foundation; Kimmelman Center at the Weizmann Institute	Israel Science Foundation(Israel Science Foundation); Minerva Foundation; Helmsley Foundation; Kimmelman Center at the Weizmann Institute	We would like to thank D. Tawfik and I. Shachar for critical reading of the manuscript, K. Vyacheslav for assistance in optical imaging data collection and analysis, and C. Power, O. Leger and O. Lightner for technical support in antibody production. This work was supported by the Israel Science Foundation, the Minerva Foundation, the Helmsley Foundation, the Kimmelman Center at the Weizmann Institute and funds from C. Berall and L. Berall, M. Steinberg and C. Adelson. I.S. is the Incumbent of the Maurizio Pontecorvo Professorial Chair.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Aychek T, 2011, MAGN RESON MED, V66, P235, DOI 10.1002/mrm.22798; Baugh MD, 1999, GASTROENTEROLOGY, V117, P814, DOI 10.1016/S0016-5085(99)70339-2; Berchanski A, 2004, PROTEINS, V56, P130, DOI 10.1002/prot.20145; Bertini I, 2005, P NATL ACAD SCI USA, V102, P5334, DOI 10.1073/pnas.0407106102; Castaneda FE, 2005, GASTROENTEROLOGY, V129, P1991, DOI 10.1053/j.gastro.2005.09.017; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Cuniasse P, 2005, BIOCHIMIE, V87, P393, DOI 10.1016/j.biochi.2004.09.025; Devel L, 2010, BIOCHIMIE, V92, P1501, DOI 10.1016/j.biochi.2010.07.017; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; Elkins PA, 2002, ACTA CRYSTALLOGR D, V58, P1182, DOI 10.1107/S0907444902007849; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Gao Q, 2005, DIGEST LIVER DIS, V37, P584, DOI 10.1016/j.dld.2005.02.011; Garg P, 2006, J IMMUNOL, V177, P4103, DOI 10.4049/jimmunol.177.6.4103; Garg P, 2009, AM J PHYSIOL-GASTR L, V296, pG175, DOI 10.1152/ajpgi.90454.2008; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Grossman M, 2010, BIOCHEMISTRY-US, V49, P6184, DOI 10.1021/bi902141x; Ikejiri M, 2005, J BIOL CHEM, V280, P33992, DOI 10.1074/jbc.M504303200; Johnson JL, 2011, ARTERIOSCL THROM VAS, V31, P528, DOI 10.1161/ATVBAHA.110.219147; Kirkegaard T, 2004, GUT, V53, P701, DOI 10.1136/gut.2003.017442; Korzenik JR, 2006, NAT REV DRUG DISCOV, V5, P197, DOI 10.1038/nrd1986; Kruger A, 2010, BBA-MOL CELL RES, V1803, P95, DOI 10.1016/j.bbamcr.2009.09.016; MacCallum RM, 1996, J MOL BIOL, V262, P732, DOI 10.1006/jmbi.1996.0548; Monteleone G, 2006, CURR OPIN GASTROEN, V22, P361, DOI 10.1097/01.mog.0000231808.10773.8e; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Rowsell S, 2002, J MOL BIOL, V319, P173, DOI 10.1016/S0022-2836(02)00262-0; Santana A, 2006, WORLD J GASTROENTERO, V12, P6464, DOI 10.3748/wjg.v12.i40.6464; Sela-Passwell N, 2011, EXPERT OPIN DRUG DIS, V6, P527, DOI 10.1517/17460441.2011.560936; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200	33	102	104	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2012	18	1					143	147		10.1038/nm.2582	http://dx.doi.org/10.1038/nm.2582			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22198278				2022-12-25	WOS:000299018600040
J	Gan, XQ; Wang, JY; Wang, C; Sommer, E; Kozasa, T; Srinivasula, S; Alessi, D; Offermanns, S; Simon, MI; Wu, DQ				Gan, Xiaoqing; Wang, Jiyong; Wang, Chen; Sommer, Eeva; Kozasa, Tohru; Srinivasula, Srinivasa; Alessi, Dario; Offermanns, Stefan; Simon, Melvin I.; Wu, Dianqing			PRR5L degradation promotes mTORC2-mediated PKC-delta phosphorylation and cell migration downstream of G alpha(12)	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE-C; RICTOR-MTOR COMPLEX; MAMMALIAN TARGET; BINDING PARTNER; MOTIF PHOSPHORYLATION; ACTIN CYTOSKELETON; G(12) FAMILY; MUSCLE-CELLS; GROWTH; ACTIVATION	Mammalian target of rapamycin complex 2 (mTORC2) phosphorylates AGC protein kinases including protein kinase C (PKC) and regulates cellular functions such as cell migration. However, its regulation remains poorly understood. Here we show that lysophosphatidic acid (LPA) induces two phases of PKC-delta hydrophobic motif phosphorylation. The late phase is mediated by G alpha(12), which specifically activates ARAF, leading to upregulation of the RFFL E3 ubiquitin ligase and subsequent ubiquitylation and degradation of the PRR5L subunit of mTORC2. Destabilization of PRR5L, a suppressor of mTORC2-mediated hydrophobic motif phosphorylation of PKC-delta, but not AKT, results in PKC-delta hydrophobic motif phosphorylation and activation. This G alpha(12)-mediated signalling pathway for mTORC2 regulation is critically important for fibroblast migration and pulmonary fibrosis development.	[Gan, Xiaoqing; Wang, Jiyong; Wang, Chen; Wu, Dianqing] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Gan, Xiaoqing; Wang, Jiyong; Wang, Chen; Wu, Dianqing] Yale Univ, Sch Med, Program Vasc Biol & Therapeut, New Haven, CT 06520 USA; [Sommer, Eeva; Alessi, Dario] Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; [Kozasa, Tohru] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; [Kozasa, Tohru] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo 153, Japan; [Srinivasula, Srinivasa] NCI, NIH, Bethesda, MD 20892 USA; [Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, D-61231 Bad Nauheim, Germany; [Simon, Melvin I.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Yale University; Yale University; University of Dundee; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Tokyo; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Max Planck Society; University of California System; University of California San Diego	Wu, DQ (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	dan.wu@yale.edu	; Offermanns, Stefan/L-3313-2017	Alessi, Dario/0000-0002-2140-9185; Offermanns, Stefan/0000-0001-8676-6805	National Institutes of Health [HL070694, HL080706, CA139395, GM61454, GM074001]; Ellison Medical Foundation [AG-SS-2190-08]; Medical Research Council [MC_U127015387, MC_U127070193] Funding Source: researchfish; MRC [MC_U127070193, MC_U127015387] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA139395] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080706, R01HL120465, R01HL108430, P01HL070694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061454, R01GM054597, R01GM074001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Su for discussion and the anti-MAPKAP1 antibody, and M. Orsulak for technical help. This work is supported by National Institutes of Health grants (HL070694, HL080706 and CA139395 to D.W. and GM61454 and GM074001 to T.K.) and an Ellison Medical Foundation grant (AG-SS-2190-08 to M.I.S.).	Bai X, 2010, ARTERIOSCL THROM VAS, V30, P2467, DOI 10.1161/ATVBAHA.110.215723; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Chou WH, 2004, J CLIN INVEST, V114, P49, DOI 10.1172/JC1200421655; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Coumailleau F, 2004, MOL BIOL CELL, V15, P4444, DOI 10.1091/mbc.E04-04-0274; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Gan XQ, 2011, J BIOL CHEM, V286, P10998, DOI 10.1074/jbc.M110.195016; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Herroeder S, 2009, IMMUNITY, V30, P708, DOI 10.1016/j.immuni.2009.02.010; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Karagiosis SA, 2009, J CELL PHYSIOL, V219, P716, DOI 10.1002/jcp.21720; Ki SH, 2007, J BIOL CHEM, V282, P1938, DOI 10.1074/jbc.M606080200; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Liao W, 2008, CURR BIOL, V18, P641, DOI 10.1016/j.cub.2008.04.017; Liu B, 2007, J VASC SURG, V45, P160, DOI 10.1016/j.jvs.2006.09.053; Liu LH, 2010, DEV CELL, V19, P845, DOI 10.1016/j.devcel.2010.11.004; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; McDonald ER, 2004, P NATL ACAD SCI USA, V101, P6170, DOI 10.1073/pnas.0307459101; Moers A, 2003, NAT MED, V9, P1418, DOI 10.1038/nm943; Neubert K, 2008, NAT MED, V14, P748, DOI 10.1038/nm1763; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Pearce LR, 2011, BIOCHEM J, V436, P169, DOI 10.1042/BJ20102103; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Radhika V, 2005, ONCOGENE, V24, P4597, DOI 10.1038/sj.onc.1208665; Riobo NA, 2005, TRENDS PHARMACOL SCI, V26, P146, DOI 10.1016/j.tips.2005.01.007; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schmidt A, 1996, P NATL ACAD SCI USA, V93, P13780, DOI 10.1073/pnas.93.24.13780; Shan DD, 2006, DEV CELL, V10, P707, DOI 10.1016/j.devcel.2006.03.014; Soliman GA, 2010, J BIOL CHEM, V285, P7866, DOI 10.1074/jbc.M109.096222; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Won HY, 2010, BIOCHEM BIOPH RES CO, V394, P811, DOI 10.1016/j.bbrc.2010.03.079; Woo SY, 2007, J BIOL CHEM, V282, P25604, DOI 10.1074/jbc.M704343200; Worzfeld T, 2008, TRENDS PHARMACOL SCI, V29, P582, DOI 10.1016/j.tips.2008.08.002; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yang WS, 2007, J BIOL CHEM, V282, P3273, DOI 10.1074/jbc.M610793200; Zhao CT, 2009, P NATL ACAD SCI USA, V106, P21353, DOI 10.1073/pnas.0812872106; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	56	109	120	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2012	14	7					686	696		10.1038/ncb2507	http://dx.doi.org/10.1038/ncb2507			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	967PV	22609986	Green Accepted			2022-12-25	WOS:000305921200008
J	Rillahan, CD; Antonopoulos, A; Lefort, CT; Sonon, R; Azadi, P; Ley, K; Dell, A; Haslam, SM; Paulson, JC				Rillahan, Cory D.; Antonopoulos, Aristotelis; Lefort, Craig T.; Sonon, Roberto; Azadi, Parastoo; Ley, Klaus; Dell, Anne; Haslam, Stuart M.; Paulson, James C.			Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome	NATURE CHEMICAL BIOLOGY			English	Article							CHEMOENZYMATIC SYNTHESIS; GDP-MANNOSE; E-SELECTIN; BIOSYNTHESIS; GLYCOSYLATION; ACID; SIALYLTRANSFERASE; CELLS; GLYCOSYLTRANSFERASES; ATHEROSCLEROSIS	Despite the fundamental roles of sialyl- and fucosyltransferases in mammalian physiology, there are few pharmacological tools to manipulate their function in a cellular setting. Although fluorinated analogs of the donor substrates are well-established transition state inhibitors of these enzymes, they are not membrane permeable. By exploiting promiscuous monosaccharide salvage pathways, we show that fluorinated analogs of sialic acid and fucose can be taken up and metabolized to the desired donor substrate-based inhibitors inside the cell. Because of the existence of metabolic feedback loops, they also act to prevent the de novo synthesis of the natural substrates, resulting in a global, family-wide shutdown of sialyl- and/or fucosyltransferases and remodeling of cell-surface glycans. As an example of the functional consequences, the inhibitors substantially reduce expression of the sialylated and fucosylated ligand sialyl Lewis X on myeloid cells, resulting in loss of selectin binding and impaired leukocyte rolling.	[Rillahan, Cory D.; Paulson, James C.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Antonopoulos, Aristotelis; Dell, Anne; Haslam, Stuart M.] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Mol Biosci, London, England; [Lefort, Craig T.; Ley, Klaus] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA USA; [Sonon, Roberto; Azadi, Parastoo] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Scripps Research Institute; Imperial College London; La Jolla Institute for Immunology; University System of Georgia; University of Georgia	Paulson, JC (corresponding author), Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA.	jpaulson@scripps.edu	Paulson, James/AAG-3565-2019	Dell, Anne/0000-0003-1380-2347	US National Institutes of Health [R01AI050143, P01HL107151, T32AI007606, R01HL111969]; Complex Carbohydrate Research Center [1 P41 RR018502-01]; Biotechnology and Biological Sciences Research Council [BBF0083091]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111969, P01HL107151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050143, T32AI007606, T32AI060536] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Complex Carbohydrate Research Center; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US National Institutes of Health grants to J.C.P. (R01AI050143 and P01HL107151), C. D. R. (T32AI007606), K. L. (R01HL111969), C. T. L. (T32AI060536) and the Complex Carbohydrate Research Center (1 P41 RR018502-01) as well as by funding from the Biotechnology and Biological Sciences Research Council to A. D. and S. M. H. (BBF0083091).	Alley S.C.J, 2009, US Patent Application, Patent No. 200903178691; Barthel SR, 2011, J BIOL CHEM, V286, P21717, DOI 10.1074/jbc.M110.194597; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; BEYER TA, 1979, J BIOL CHEM, V254, P2531; Brown JR, 2006, CLIN CANCER RES, V12, P2894, DOI 10.1158/1078-0432.CCR-05-2745; Burkart MD, 1997, J AM CHEM SOC, V119, P11743, DOI 10.1021/ja9723904; Burkart MD, 2000, BIOORGAN MED CHEM, V8, P1937, DOI 10.1016/S0968-0896(00)00139-5; Campbell CT, 2007, MOL BIOSYST, V3, P187, DOI 10.1039/b614939c; Chesnutt BC, 2006, MICROCIRCULATION, V13, P99, DOI 10.1080/10739680500466376; Chiaramonte M, 2001, BIOCHEMISTRY-US, V40, P14260, DOI 10.1021/bi011262w; Chiu CPC, 2004, NAT STRUCT MOL BIOL, V11, P163, DOI 10.1038/nsmb720; Dimitroff CJ, 2003, J CLIN INVEST, V112, P1008, DOI 10.1172/JCI200319220; Foster MM, 2003, CANCER RES, V63, P2775; Frantom PA, 2010, J AM CHEM SOC, V132, P6626, DOI 10.1021/ja101231a; Gainers ME, 2007, J IMMUNOL, V179, P8509, DOI 10.4049/jimmunol.179.12.8509; Gitlin JM, 2009, AM J PATHOL, V174, P343, DOI 10.2353/ajpath.2009.080036; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Grewal PK, 2006, MOL CELL BIOL, V26, P4970, DOI 10.1128/MCB.00308-06; Gross BJ, 2008, J AM CHEM SOC, V130, P440, DOI 10.1021/ja078125s; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Han S, 2005, NAT CHEM BIOL, V1, P93, DOI 10.1038/nchembio713; Hayashi T, 1997, BIOORGAN MED CHEM, V5, P497, DOI 10.1016/S0968-0896(96)00263-5; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Hinderlich S, 1997, J BIOL CHEM, V272, P24313, DOI 10.1074/jbc.272.39.24313; Homeister JW, 2004, ARTERIOSCL THROM VAS, V24, P1897, DOI 10.1161/01.ATV.0000141844.28073.df; Hosoguchi K, 2010, J MED CHEM, V53, P5607, DOI 10.1021/jm100612r; Keppler OT, 1999, SCIENCE, V284, P1372, DOI 10.1126/science.284.5418.1372; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lee LV, 2003, J AM CHEM SOC, V125, P9588, DOI 10.1021/ja0302836; Leppanen A, 2000, J BIOL CHEM, V275, P39569, DOI 10.1074/jbc.M005005200; Lowe JB, 2003, CURR OPIN CELL BIOL, V15, P531, DOI 10.1016/j.ceb.2003.08.002; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Luchansky SJ, 2004, CHEMBIOCHEM, V5, P371, DOI 10.1002/cbic.200300789; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Marathe DD, 2008, FASEB J, V22, P4154, DOI 10.1096/fj.07-104257; MENDLA K, 1988, BIOCHEM J, V250, P261, DOI 10.1042/bj2500261; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Nakayama F, 2001, J BIOL CHEM, V276, P16100, DOI 10.1074/jbc.M007272200; Ni LS, 2007, BIOCHEMISTRY-US, V46, P6288, DOI 10.1021/bi700346w; Nishimura S.I., 2012, ANGEW CHEM INT EDN E; Oetke C, 2001, EUR J BIOCHEM, V268, P4553, DOI 10.1046/j.1432-1327.2001.02379.x; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Rillahan CD, 2011, ANGEW CHEM INT EDIT, V50, P12534, DOI 10.1002/anie.201105065; RIPKA J, 1986, ARCH BIOCHEM BIOPHYS, V249, P533, DOI 10.1016/0003-9861(86)90031-7; SARKAR AK, 1995, P NATL ACAD SCI USA, V92, P3323, DOI 10.1073/pnas.92.8.3323; Sperandio M, 2009, IMMUNOL REV, V230, P97, DOI 10.1111/j.1600-065X.2009.00795.x; Sullivan FX, 1998, J BIOL CHEM, V273, P8193, DOI 10.1074/jbc.273.14.8193; Varki A., 2009, ESSENTIALS GLYCOBIOL; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Weston BW, 1999, EUR J HAEMATOL, V63, P42	50	263	274	0	100	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2012	8	7					661	668		10.1038/NCHEMBIO.999	http://dx.doi.org/10.1038/NCHEMBIO.999			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961NJ	22683610	Green Accepted			2022-12-25	WOS:000305471400014
J	Winter, JF; Hopfner, S; Korn, K; Farnung, BO; Bradshaw, CR; Marsico, G; Volkmer, M; Habermann, B; Zerial, M				Winter, Julia Franziska; Hoepfner, Sebastian; Korn, Kerstin; Farnung, Benjamin O.; Bradshaw, Charles R.; Marsico, Giovanni; Volkmer, Michael; Habermann, Bianca; Zerial, Marino			Caenorhabditis elegans screen reveals role of PAR-5 in RAB-11-recycling endosome positioning and apicobasal cell polarity	NATURE CELL BIOLOGY			English	Article							RECYCLING ENDOSOMES; C-ELEGANS; COFILIN PHOSPHORYLATION; PLASMA-MEMBRANE; PROTEIN; ACTIN; TRAFFICKING; DOMAIN; JUNCTION; RAB11	Apically enriched Rab11-positive recycling endosomes (Rab11-REs) are important for establishing and maintaining epithelial polarity. Yet, little is known about the molecules controlling trafficking of Rab11-REs in an epithelium in vivo. Here, we report a genome-wide, image-based RNA interference screen for regulators of Rab11-RE positioning and transport of an apical membrane protein (PEPT-1) in C. elegans intestine. Among the 356 screen hits was the 14-3-3 and partitioning defective protein PAR-5, which we found to be specifically required for Rab11-RE positioning and apicobasal polarity maintenance. Depletion of PAR-5 induced abnormal clustering of Rab11-REs to ectopic sites at the basolateral cortex containing F-actin and other apical domain components. This phenotype required key regulators of F-actin dynamics and polarity, such as Rho GTPases (RHO-1 and the Rac1 orthologue CED-10) and apical PAR proteins. Our data suggest that PAR-5 acts as a regulatory hub for a polarity-maintaining network required for apicobasal asymmetry of F-actin and proper Rab11-RE positioning.	[Winter, Julia Franziska; Hoepfner, Sebastian; Farnung, Benjamin O.; Bradshaw, Charles R.; Marsico, Giovanni; Volkmer, Michael; Habermann, Bianca; Zerial, Marino] MPI CBG, Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Zerial, M (corresponding author), MPI CBG, Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	zerial@mpi-cbg.de	Habermann, Bianca/N-4886-2016	Habermann, Bianca/0000-0002-2457-7504; Bradshaw, Charles/0000-0002-3528-458X	German Federal Ministry of Education and Research (InnoRegio Initiative) [03I4035A]; German Federal Ministry of Education and Research (Systems Biology Network HepatoSys) [0313082H]; German Federal Ministry of Education and Research (Virtual Liver initiative); EU [LSHG-CT-2006-019050]; Max Planck Society's inter-institutional initiative 'RNA interference'; Boehringer Ingelheim	German Federal Ministry of Education and Research (InnoRegio Initiative); German Federal Ministry of Education and Research (Systems Biology Network HepatoSys); German Federal Ministry of Education and Research (Virtual Liver initiative); EU(European Commission); Max Planck Society's inter-institutional initiative 'RNA interference'; Boehringer Ingelheim(Boehringer Ingelheim)	This study was supported by the German Federal Ministry of Education and Research (InnoRegio Initiative, grant number 03I4035A; the Systems Biology Network HepatoSys, grant number 0313082H, and the Virtual Liver initiative, www.virtual-liver.de), the EU sixth framework project 'EndoTrack' (FP6 Grant LSHG-CT-2006-019050) and the Max Planck Society's inter-institutional initiative 'RNA interference'. J.F.W. was supported by a PhD fellowship of the Boehringer Ingelheim Fonds.	Achilleos A, 2010, DEVELOPMENT, V137, P1833, DOI 10.1242/dev.047647; Ang AL, 2004, J CELL BIOL, V167, P531, DOI 10.1083/jcb.200408165; Angrand PO, 2006, MOL CELL PROTEOMICS, V5, P2211, DOI 10.1074/mcp.M600147-MCP200; Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; Arimoto M, 2011, J NEUROSCI, V31, P2216, DOI 10.1523/JNEUROSCI.2653-10.2011; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Birkenfeld J, 2003, BIOCHEM J, V369, P45, DOI 10.1042/BJ20021152; Blum H., 1967, MODELS PERCEPTION SP, P362, DOI DOI 10.1142/S0218654308001154; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Cao J, 2008, J CELL BIOL, V182, P301, DOI 10.1083/jcb.200712036; Casanova JE, 1999, MOL BIOL CELL, V10, P47, DOI 10.1091/mbc.10.1.47; Chen CCH, 2006, MOL BIOL CELL, V17, P1286, DOI 10.1091/mbc.E05-08-0787; Chen XY, 2006, J CELL BIOL, V172, P671, DOI 10.1083/jcb.200510061; Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; Croce A, 2004, NAT CELL BIOL, V6, P1173, DOI 10.1038/ncb1198; Daley WP, 2012, DEVELOPMENT, V139, P411, DOI 10.1242/dev.075366; Desclozeaux M, 2008, AM J PHYSIOL-CELL PH, V295, pC545, DOI 10.1152/ajpcell.00097.2008; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; Golachowska MR, 2010, TRENDS CELL BIOL, V20, P618, DOI 10.1016/j.tcb.2010.08.004; Goldenring JR, 1996, AM J PHYSIOL-GASTR L, V270, pG515, DOI 10.1152/ajpgi.1996.270.3.G515; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hermann GJ, 2005, MOL BIOL CELL, V16, P3273, DOI 10.1091/mbc.E05-01-0060; Horgan CP, 2010, J CELL SCI, V123, P181, DOI 10.1242/jcs.052670; Hurd TW, 2003, CURR BIOL, V13, P2082, DOI 10.1016/j.cub.2003.11.020; Husken K, 2008, DIFFERENTIATION, V76, P881, DOI 10.1111/j.1432-0436.2008.00264.x; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kligys K, 2007, J BIOL CHEM, V282, P32520, DOI 10.1074/jbc.M707041200; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Kusakabe M, 2004, EMBO J, V23, P4190, DOI 10.1038/sj.emboj.7600381; Langevin J, 2005, DEV CELL, V9, P365, DOI 10.1016/j.devcel.2005.07.013; Lundquist E. A., 2006, WORMBOOK; McGary KL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r258; McGhee James D, 2007, WormBook, P1; MCGHEE JD, 2007, WORMBOOK; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Morton DG, 2002, DEV BIOL, V241, P47, DOI 10.1006/dbio.2001.0489; Munro EM, 2006, CURR OPIN CELL BIOL, V18, P86, DOI 10.1016/j.ceb.2005.12.007; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nance J, 2011, DEVELOPMENT, V138, P799, DOI 10.1242/dev.053538; Nehrke K, 2003, J BIOL CHEM, V278, P44657, DOI 10.1074/jbc.M307351200; Ono K, 2003, J CELL SCI, V116, P2073, DOI 10.1242/jcs.00421; Prekeris R, 2000, MOL CELL, V6, P1437, DOI 10.1016/S1097-2765(00)00140-4; Provance DW, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-44; Rodal AA, 2008, J NEUROSCI, V28, P8316, DOI 10.1523/JNEUROSCI.2304-08.2008; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Rollason R, 2009, J CELL BIOL, V184, P721, DOI 10.1083/jcb.200804154; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Schuh M, 2011, NAT CELL BIOL, V13, P1431, DOI 10.1038/ncb2353; Shivas JM, 2010, TRENDS CELL BIOL, V20, P445, DOI 10.1016/j.tcb.2010.04.003; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Torkko JM, 2008, J CELL SCI, V121, P1193, DOI 10.1242/jcs.015495; Totong R, 2007, DEVELOPMENT, V134, P1259, DOI 10.1242/dev.02833; van Furden D, 2004, DEV BIOL, V272, P262, DOI 10.1016/j.ydbio.2004.05.012; Wu SY, 2005, NAT STRUCT MOL BIOL, V12, P879, DOI 10.1038/nsmb987; Zenke FT, 2004, J BIOL CHEM, V279, P18392, DOI 10.1074/jbc.M400084200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang HJ, 2011, NAT CELL BIOL, V13, P1189, DOI 10.1038/ncb2328	70	69	83	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2012	14	7					666	676		10.1038/ncb2508	http://dx.doi.org/10.1038/ncb2508			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	967PV	22634595				2022-12-25	WOS:000305921200006
J	Bennetzen, JL; Schmutz, J; Wang, H; Percifield, R; Hawkins, J; Pontaroli, AC; Estep, M; Feng, L; Vaughn, JN; Grimwood, J; Jenkins, J; Barry, K; Lindquist, E; Hellsten, U; Deshpande, S; Wang, XW; Wu, XM; Mitros, T; Triplett, J; Yang, XH; Ye, CY; Mauro-Herrera, M; Wang, L; Li, PH; Sharma, M; Sharma, R; Ronald, PC; Panaud, O; Kellogg, EA; Brutnell, TP; Doust, AN; Tuskan, GA; Rokhsar, D; Devos, KM				Bennetzen, Jeffrey L.; Schmutz, Jeremy; Wang, Hao; Percifield, Ryan; Hawkins, Jennifer; Pontaroli, Ana C.; Estep, Matt; Feng, Liang; Vaughn, Justin N.; Grimwood, Jane; Jenkins, Jerry; Barry, Kerrie; Lindquist, Erika; Hellsten, Uffe; Deshpande, Shweta; Wang, Xuewen; Wu, Xiaomei; Mitros, Therese; Triplett, Jimmy; Yang, Xiaohan; Ye, Chu-Yu; Mauro-Herrera, Margarita; Wang, Lin; Li, Pinghua; Sharma, Manoj; Sharma, Rita; Ronald, Pamela C.; Panaud, Olivier; Kellogg, Elizabeth A.; Brutnell, Thomas P.; Doust, Andrew N.; Tuskan, Gerald A.; Rokhsar, Daniel; Devos, Katrien M.			Reference genome sequence of the model plant Setaria	NATURE BIOTECHNOLOGY			English	Article							FOXTAIL MILLET; SEGREGATION DISTORTION; TRANSPOSABLE ELEMENTS; MOLECULAR PHYLOGENY; GENETIC MAPS; LINKAGE MAPS; GRASS MODEL; ITALICA; POACEAE; CONSTRUCTION	We generated a high-quality reference genome sequence for foxtail millet (Setaria italica). The similar to 400-Mb assembly covers similar to 80% of the genome and > 95% of the gene space. The assembly was anchored to a 992-locus genetic map and was annotated by comparison with > 1.3 million expressed sequence tag reads. We produced more than 580 million RNA-Seq reads to facilitate expression analyses. We also sequenced Setaria viridis, the ancestral wild relative of S. italica, and identified regions of differential single-nucleotide polymorphism density, distribution of transposable elements, small RNA content, chromosomal rearrangement and segregation distortion. The genus Setaria includes natural and cultivated species that demonstrate a wide capacity for adaptation. The genetic basis of this adaptation was investigated by comparing five sequenced grass genomes. We also used the diploid Setaria genome to evaluate the ongoing genome assembly of a related polyploid, switchgrass (Panicum virgatum).	[Bennetzen, Jeffrey L.] Univ Georgia, Dept Genet, BioEnergy Sci Ctr, Athens, GA 30602 USA; [Schmutz, Jeremy; Grimwood, Jane; Jenkins, Jerry] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Schmutz, Jeremy; Grimwood, Jane; Jenkins, Jerry; Barry, Kerrie; Lindquist, Erika; Hellsten, Uffe; Deshpande, Shweta; Rokhsar, Daniel] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA; [Estep, Matt; Triplett, Jimmy; Kellogg, Elizabeth A.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA; [Wang, Xuewen; Wu, Xiaomei; Devos, Katrien M.] Univ Georgia, Dept Crop & Soil Sci, Inst Plant Breeding Genet & Genom, Athens, GA 30602 USA; [Wang, Xuewen; Wu, Xiaomei; Devos, Katrien M.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Mitros, Therese] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Yang, Xiaohan; Ye, Chu-Yu; Tuskan, Gerald A.] Oak Ridge Natl Lab, Biosci Div, Plant Syst Biol Grp, Oak Ridge, TN USA; [Yang, Xiaohan; Ye, Chu-Yu; Tuskan, Gerald A.] Oak Ridge Natl Lab, BioEnergy Sci Ctr, Oak Ridge, TN USA; [Wang, Lin; Li, Pinghua; Brutnell, Thomas P.] Cornell Univ, Boyce Thompson Inst, Ithaca, NY USA; [Mauro-Herrera, Margarita; Doust, Andrew N.] Oklahoma State Univ, Dept Bot, Stillwater, OK 74078 USA; [Sharma, Manoj; Sharma, Rita; Ronald, Pamela C.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Sharma, Manoj; Sharma, Rita; Ronald, Pamela C.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Sharma, Manoj; Sharma, Rita; Ronald, Pamela C.] Joint Bioenergy Inst, Emeryville, CA USA; [Panaud, Olivier] Univ Perpignan, F-66025 Perpignan, France	University System of Georgia; University of Georgia; HudsonAlpha Institute for Biotechnology; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Missouri System; University of Missouri Saint Louis; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of California System; University of California Berkeley; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC); Cornell University; Boyce Thompson Institute for Plant Research; Oklahoma State University System; Oklahoma State University - Stillwater; University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Universite Perpignan Via Domitia	Bennetzen, JL (corresponding author), Univ Georgia, Dept Genet, BioEnergy Sci Ctr, Athens, GA 30602 USA.	maize@uga.edu	Kellogg, Elizabeth/M-2845-2013; Barry, Kerrie Whitelaw/AAA-5500-2020; Jenkins, Jerry/ABE-6479-2020; Li, Ping/GYV-4914-2022; Sharma, Rita/G-2425-2017; Brutnell, Thomas/M-2840-2013; Tuskan, Gerald/A-6225-2011; Yang, Xiaohan/AAM-2449-2020; Schmutz, Jeremy/N-3173-2013; Wang, Xuewen/C-1362-2016; Yang, Xiaohan/A-6975-2011; Devos, Katrien M/B-1380-2014; Feng, Liang/I-5010-2014; Ronald, Pamela/AAK-7664-2020; Grimwood, Jane/ABD-5737-2021; Wang, Hao/C-7651-2009	Kellogg, Elizabeth/0000-0003-1671-7447; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Jenkins, Jerry/0000-0002-7943-3997; Brutnell, Thomas/0000-0002-3581-8211; Tuskan, Gerald/0000-0003-0106-1289; Yang, Xiaohan/0000-0001-5207-4210; Schmutz, Jeremy/0000-0001-8062-9172; Wang, Xuewen/0000-0003-2820-9255; Yang, Xiaohan/0000-0001-5207-4210; Vaughn, Justin/0000-0002-5261-5096; Wang, Hao/0000-0002-9634-8778; Sharma, Manoj K./0000-0002-4768-8733; Rokhsar, Daniel/0000-0002-8704-2224	Office of Science of the US Department of Energy [DE-AC02-05CH11231, DE-AC05-00OR22725]; Department of Energy [DE-FG02-08ER64636]; National Institute of Food and Agriculture [2008-35504-04851]; National Science Foundation [IOS-0701736, DBI-0607123]; Oklahoma Center for the Advancement of Science and Technology [PSB08-007, PS11-035B]; University of Missouri Research Board	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Department of Energy(United States Department of Energy (DOE)); National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Science Foundation(National Science Foundation (NSF)); Oklahoma Center for the Advancement of Science and Technology; University of Missouri Research Board	The studies conducted by the US Department of Energy Joint Genome Institute, the BioEnergy Science Center and the Joint Bioenergy Institute are supported by the Office of Science of the US Department of Energy under contract numbers DE-AC02-05CH11231, DE-AC05-00OR22725 and DE-AC02-05CH11231, respectively. This research was also supported by grants from the Department of Energy (DE-FG02-08ER64636), National Institute of Food and Agriculture Plant Feedstock Genomics for Bioenergy Program (no. 2008-35504-04851), National Science Foundation (IOS-0701736 and DBI-0607123), the Oklahoma Center for the Advancement of Science and Technology (PSB08-007, PS11-035B), and the University of Missouri Research Board. We thank C. Saski at Clemson University for the construction of the Setaria italica and switchgrass BAC libraries, M. Udvardi at the Noble Foundation for providing switchgrass genomic DNA and B. Meyers at the University of Delaware for small RNA annotation advice.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Aliscioni SS, 2003, AM J BOT, V90, P796, DOI 10.3732/ajb.90.5.796; Baucom RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000732; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennetzen JL, 2005, CURR OPIN GENET DEV, V15, P621, DOI 10.1016/j.gde.2005.09.010; Bennetzen JL, 2004, CURR OPIN PLANT BIOL, V7, P732, DOI 10.1016/j.pbi.2004.09.003; Bettinger RL, 2010, EVOL ANTHROPOL, V19, P9, DOI 10.1002/evan.20236; Brutnell TP, 2010, PLANT CELL, V22, P2537, DOI 10.1105/tpc.110.075309; Chardon F, 2005, J MOL EVOL, V61, P579, DOI 10.1007/s00239-004-0179-4; Christin PA, 2007, CURR BIOL, V17, P1241, DOI 10.1016/j.cub.2007.06.036; Christin PA, 2009, PLANT PHYSIOL, V149, P82, DOI 10.1104/pp.108.128553; Clayton WD, 1986, KEW B ADDITIONAL SER, V13; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; d'Ennequin ML, 2000, THEOR APPL GENET, V100, P1061, DOI 10.1007/s001220051387; Darmency H, 2005, CROP FERALITY AND VOLUNTEERISM, P81; DARMENCY H, 1985, WEED RES, V25, P175, DOI 10.1111/j.1365-3180.1985.tb00633.x; Dekker J, 2003, WEED SCI, V51, P641, DOI 10.1614/P2002-IR; Devos KM, 2000, PLANT CELL, V12, P637, DOI 10.1105/tpc.12.5.637; Devos KM, 2005, P NATL ACAD SCI USA, V102, P19243, DOI 10.1073/pnas.0509473102; Devos KM, 1998, THEOR APPL GENET, V96, P63, DOI 10.1007/s001220050709; Doust AN, 2002, AM J BOT, V89, P1203, DOI 10.3732/ajb.89.8.1203; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; Drummond A., 2011, GENEIOUS V5 5; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Giussani LM, 2001, AM J BOT, V88, P1993, DOI 10.2307/3558427; Gojobori T, 2007, GENOME RES, V17, P175, DOI 10.1101/gr.5509507; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Han YJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq862; Harlan J.R., 1975, CROPS MAN; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Hirano R, 2011, GENOME, V54, P498, DOI [10.1139/G11-015, 10.1139/g11-015]; Hunt HV, 2008, VEG HIST ARCHAEOBOT, V17, pS5, DOI 10.1007/s00334-008-0187-1; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Jenczewski E, 1997, THEOR APPL GENET, V94, P682, DOI 10.1007/s001220050466; JUSUF M, 1985, THEOR APPL GENET, V71, P385, DOI 10.1007/BF00251177; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kellogg EA, 2009, INT J PLANT SCI, V170, P117, DOI 10.1086/593043; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim JS, 2005, GENETICS, V169, P1169, DOI 10.1534/genetics.104.035980; KIMBER G, 1967, GENET RES, V9, P111, DOI 10.1017/S0016672300010351; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lata C, 2010, BIOCHEM BIOPH RES CO, V393, P720, DOI 10.1016/j.bbrc.2010.02.068; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu RY, 2007, P NATL ACAD SCI USA, V104, P11844, DOI 10.1073/pnas.0704258104; LORIEUX M, 1995, THEOR APPL GENET, V90, P81, DOI 10.1007/BF00220999; Lu H, 2002, THEOR APPL GENET, V105, P622, DOI 10.1007/s00122-002-0970-9; Maddison D. R., 2000, MACCLADE 4 ANAL PHYL; McCarthy EM, 2003, BIOINFORMATICS, V19, P362, DOI 10.1093/bioinformatics/btf878; NACIRI Y, 1992, EUPHYTICA, V60, P97; Okada M, 2010, GENETICS, V185, P745, DOI 10.1534/genetics.110.113910; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Peterson D. G., 2000, Journal of Agricultural Genomics, V5, P1; Pontaroli AC, 2009, PLANT GENOME-US, V2, P93, DOI 10.3835/plantgenome2008.09.0007; R Development Core Team, 2009, R FDN STAT COMP; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Sang T, 2009, PLANT PHYSIOL, V149, P63, DOI 10.1104/pp.108.128827; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Scott BA, 2009, WEED TECHNOL, V23, P599, DOI 10.1614/WT-09-006.1; Sharma MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033892; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Tanaka T, 2008, NUCLEIC ACIDS RES, V36, pD1028, DOI 10.1093/nar/gkm978; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang CF, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-90; Wang ZM, 1998, THEOR APPL GENET, V96, P31, DOI 10.1007/s001220050705; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yang LX, 2009, P NATL ACAD SCI USA, V106, P19922, DOI 10.1073/pnas.0908008106; Yang LX, 2009, P NATL ACAD SCI USA, V106, P12832, DOI 10.1073/pnas.0905563106; ZAMIR D, 1986, BOT GAZ, V147, P355, DOI 10.1086/337602; Zhang JP, 2007, GENOMICS, V90, P121, DOI 10.1016/j.ygeno.2007.03.016; Zwickl D., 2006, GARLI GENETIC ALGORI	80	539	622	6	161	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2012	30	6					555	+		10.1038/nbt.2196	http://dx.doi.org/10.1038/nbt.2196			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	957JV	22580951	Green Published, hybrid			2022-12-25	WOS:000305158600026
J	Boshoff, C				Boshoff, Chris			Ephrin receptor: a door to KSHV infection	NATURE MEDICINE			English	Editorial Material							CELLULAR RECEPTOR; ENTRY RECEPTOR; SARCOMA; VIRUS; CELLS; EPHA2; HUMAN-HERPESVIRUS-8; ALPHA-3-BETA-1	Kaposi's sarcoma-associated herpesvirus is a major oncogenic virus that has been implicated in human cancers. A new study identifies ephrin receptor A2 as a key host receptor for this virus that permits infection of endothelial cells (pages 961-966).	UCL, UCL Canc Inst, London WC1E 6BT, England	University of London; University College London	Boshoff, C (corresponding author), UCL, UCL Canc Inst, London WC1E 6BT, England.	c.boshoff@ucl.ac.uk			Cancer Research UK [13100] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Akula SM, 2002, CELL, V108, P407, DOI 10.1016/S0092-8674(02)00628-1; Akula SM, 2001, VIROLOGY, V282, P245, DOI 10.1006/viro.2000.0851; Bonaparte MI, 2005, P NATL ACAD SCI USA, V102, P10652, DOI 10.1073/pnas.0504887102; Chakraborty S, 2012, P NATL ACAD SCI USA, V109, pE1163, DOI 10.1073/pnas.1119592109; Dobrzanski P, 2004, CANCER RES, V64, P910, DOI 10.1158/0008-5472.CAN-3430-2; Hahn AS, 2012, NAT MED, V18, P961, DOI 10.1038/nm.2805; HIRAI H, 1987, SCIENCE, V238, P1717, DOI 10.1126/science.2825356; Kaleeba JAR, 2006, SCIENCE, V311, P1921, DOI 10.1126/science.1120878; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; Negrete OA, 2005, NATURE, V436, P401, DOI 10.1038/nature03838; Rappocciolo G, 2006, J IMMUNOL, V176, P1741, DOI 10.4049/jimmunol.176.3.1741; Veettil MV, 2008, J VIROL, V82, P12126, DOI 10.1128/JVI.01146-08; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Zelinski DP, 2001, CANCER RES, V61, P2301	16	7	7	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2012	18	6					861	863		10.1038/nm.2803	http://dx.doi.org/10.1038/nm.2803			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22673996				2022-12-25	WOS:000305116600021
J	Varma, D; Chandrasekaran, S; Sundin, LJR; Reidy, KT; Wan, XH; Chasse, DAD; Nevis, KR; DeLuca, JG; Salmon, ED; Cook, JG				Varma, Dileep; Chandrasekaran, Srikripa; Sundin, Lynsie J. R.; Reidy, Karen T.; Wan, Xiaohu; Chasse, Dawn A. D.; Nevis, Kathleen R.; DeLuca, Jennifer G.; Salmon, E. D.; Cook, Jeanette Gowen			Recruitment of the human Cdt1 replication licensing protein by the loop domain of Hec1 is required for stable kinetochore-microtubule attachment	NATURE CELL BIOLOGY			English	Article							DNA-REPLICATION; CHROMOSOME SEGREGATION; LIVING CELLS; MITOSIS; CHECKPOINT; INITIATION; GEMININ; COMPLEX; DYNEIN; ORC6	Cdt1, a protein critical for replication origin licensing in G1 phase, is degraded during S phase but re-accumulates in G2 phase. We now demonstrate that human Cdt1 has a separable essential mitotic function. Cdtl localizes to kinetochores during mitosis through interaction with the Hec1 component of the Ndc80 complex. G2-specific depletion of Cdtl arrests cells in late prometaphase owing to abnormally unstable kinetochore-microtubule (kMT) attachments and Mad1-dependent spindle-assembly-checkpoint activity. Cdtl binds a unique loop extending from the rod domain of Hec1 that we show is also required for kMT attachment. Mutation of the loop domain prevents Cdtl kinetochore localization and arrests cells in prometaphase. Super-resolution fluorescence microscopy indicates that Cdtl binding to the Hec1 loop domain promotes a microtubule-dependent conformational change in the Ndc80 complex in vivo. These results support the conclusion that Cdtl binding to Hec1 is essential for an extended Ndc80 configuration and stable kMT attachment.	[Varma, Dileep; Wan, Xiaohu; Salmon, E. D.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Chandrasekaran, Srikripa; Cook, Jeanette Gowen] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Sundin, Lynsie J. R.; DeLuca, Jennifer G.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Reidy, Karen T.; Cook, Jeanette Gowen] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Chasse, Dawn A. D.] Duke Univ, Med Ctr, Duke Inst Genome Sci & Policy, Durham, NC 27710 USA; [Nevis, Kathleen R.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Colorado State University; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Harvard University; Massachusetts General Hospital	Salmon, ED (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	tsalmon@email.unc.edu; jean_cook@med.unc.edu		Cook, Jeanette/0000-0003-0849-7405	NIH [K01 CA094907, GM083024, GM24364, GM088371]; Pew Scholars Program in the Biomedical Sciences; NATIONAL CANCER INSTITUTE [K01CA094907, P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024364, R01GM088371, R01GM083024, R01GM024364] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars Program in the Biomedical Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Desai for providing Krill, Nsl1, Dsn1 and Spindly antibodies, A. Musacchio (Max Planck Institute of Molecular Physiology, Dortmund, Germany) for anti-Mad1, Zwint1 and ZW10 antibodies, B. Stillman (Cold Spring Harbor Laboratory, New York, USA) for anti-Orc6 antibody, S. Taylor (University of Manchester, UK) for anti-Bub1 and BubR1 antibodies, T. Stukenberg (University of Virginia at Charlottesville, Virginia, USA) for anti-Spc24 antibody, T. Yen (Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA) for anti-CENP-E antibody and I. Cheeseman (Whitehead Institute of Biomedical Research and MIT, Cambridge, Massachusetts, USA) for anti-Ska3 antibody. We are grateful to A. Desai (University of California San Diego, La Jolla, CA, USA), D. Cheerambathur, T. Stukenberg, K. Slep and T. Maresca for helpful discussions and to J. Mick for generating Hec1 constructs. We would also like to thank other members of the Salmon, Cook, A. Desai and J. Nevins laboratories for their support during this project. J.G.C. was supported by NIH K01 CA094907 and NIH GM083024, E.D.S. was supported by NIH GM24364 and J.G.D. was supported by NIH GM088371 and a grant from the Pew Scholars Program in the Biomedical Sciences.	Alushin GM, 2010, NATURE, V467, P805, DOI 10.1038/nature09423; Arentson E, 2002, ONCOGENE, V21, P1150, DOI 10.1038/sj.onc.1205175; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Bernal JA, 2011, J CELL BIOL, V192, P969, DOI 10.1083/jcb.201008125; Chandrasekaran S, 2011, MOL CELL BIOL, V31, P4405, DOI 10.1128/MCB.06163-11; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Chen S, 2007, GENE DEV, V21, P2897, DOI 10.1101/gad.1596807; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Clay-Farrace L, 2003, EMBO J, V22, P704, DOI 10.1093/emboj/cdg046; Cook JG, 2004, J BIOL CHEM, V279, P9625, DOI 10.1074/jbc.M311933200; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Devault A, 2002, CURR BIOL, V12, P689, DOI 10.1016/S0960-9822(02)00768-6; Feng DR, 2003, CANCER RES, V63, P7356; Fitch MJ, 2003, J BIOL CHEM, V278, P25408, DOI 10.1074/jbc.M300699200; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; HOFMANN JFX, 1994, EMBO J, V13, P425, DOI 10.1002/j.1460-2075.1994.tb06277.x; Hsu KS, 2011, CURR BIOL, V21, P214, DOI 10.1016/j.cub.2010.12.048; James P, 1996, GENETICS, V144, P1425; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Liontos M, 2007, CANCER RES, V67, P10899, DOI 10.1158/0008-5472.CAN-07-2837; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Maddox PS, 2003, METHOD ENZYMOL, V360, P597; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Maure JF, 2011, CURR BIOL, V21, P207, DOI 10.1016/j.cub.2010.12.050; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Miller SA, 2008, CURR BIOL, V18, P1785, DOI 10.1016/j.cub.2008.11.007; Nevis KR, 2009, CELL CYCLE, V8, P1952, DOI 10.4161/cc.8.12.8811; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Prasanth SG, 2004, EMBO J, V23, P2651, DOI 10.1038/sj.emboj.7600255; Prasanth SG, 2002, SCIENCE, V297, P1026, DOI 10.1126/science.1072802; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Snyder M, 2005, P NATL ACAD SCI USA, V102, P14539, DOI 10.1073/pnas.0507479102; Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763; Tachibana KEK, 2005, EMBO REP, V6, P1052, DOI 10.1038/sj.embor.7400527; Varma D, 2008, J CELL BIOL, V182, P1045, DOI 10.1083/jcb.200710106; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yang ZY, 2007, CURR BIOL, V17, P973, DOI 10.1016/j.cub.2007.04.056; Yoshida K, 2010, J CELL SCI, V123, P225, DOI 10.1242/jcs.058693	43	62	67	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2012	14	6					593	+		10.1038/ncb2489	http://dx.doi.org/10.1038/ncb2489			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	949TW	22581055	Green Accepted, Green Submitted			2022-12-25	WOS:000304599900009
J	Yang, WY; Novembre, J; Eskin, E; Halperin, E				Yang, Wen-Yun; Novembre, John; Eskin, Eleazar; Halperin, Eran			A model-based approach for analysis of spatial structure in genetic data	NATURE GENETICS			English	Article							RECENT POSITIVE SELECTION; HUMAN-POPULATIONS; GENOME; HAPLOTYPE; PATTERNS; DISEASE; SAMPLE; EUROPE	Characterizing genetic diversity within and between populations has broad applications in studies of human disease and evolution. We propose a new approach, spatial ancestry analysis, for the modeling of genotypes in two-or three-dimensional space. In spatial ancestry analysis (SPA), we explicitly model the spatial distribution of each SNP by assigning an allele frequency as a continuous function in geographic space. We show that the explicit modeling of the allele frequency allows individuals to be localized on the map on the basis of their genetic information alone. We apply our SPA method to a European and a worldwide population genetic variation data set and identify SNPs showing large gradients in allele frequency, and we suggest these as candidate regions under selection. These regions include SNPs in the well-characterized LCT region, as well as at loci including FOXP2, OCA2 and LRP1B.	[Yang, Wen-Yun; Novembre, John; Eskin, Eleazar] Univ Calif Los Angeles, Interdept Program Bioinformat, Los Angeles, CA 90095 USA; [Yang, Wen-Yun; Eskin, Eleazar] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90024 USA; [Novembre, John] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Eskin, Eleazar] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Halperin, Eran] Int Comp Sci Inst, Berkeley, CA 94704 USA; [Halperin, Eran] Tel Aviv Univ, Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Halperin, Eran] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Tel Aviv University; Tel Aviv University	Eskin, E (corresponding author), Univ Calif Los Angeles, Interdept Program Bioinformat, Los Angeles, CA 90095 USA.	eeskin@cs.ucla.edu	Eskin, Eleazar/J-9187-2012	Eskin, Eleazar/0000-0003-1149-4758	US National Science Foundation [0513612, 0731455, 0729049, 0916676, 1065276]; US National Institutes of Health [K25 HL080079, U01 DA024417, P01 HL30568, PO1 HL28481]; National Science Foundation [0933731]; Searle Scholars Program; Israeli Science Foundation [04514831]; IBM; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568, P01HL028481, K25HL080079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA024417] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [0916676] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Searle Scholars Program; Israeli Science Foundation(Israel Science Foundation); IBM(International Business Machines (IBM)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	W.-Y.Y. and E. E. are supported by grants from the US National Science Foundation (0513612, 0731455, 0729049, 0916676 and 1065276) and the US National Institutes of Health (K25 HL080079, U01 DA024417, P01 HL30568 and PO1 HL28481). J.N. is supported by National Science Foundation grant (0933731) and by the Searle Scholars Program. E. H. is a faculty fellow of the Edmond J. Safra Program at Tel Aviv University and was supported in part by the Israeli Science Foundation (grant 04514831) and by IBM open collaborative research award program.	Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Coop G, 2010, GENETICS, V185, P1411, DOI 10.1534/genetics.110.114819; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; LEWONTIN RC, 1973, GENETICS, V74, P175; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Liu CX, 2000, GENOMICS, V69, P271, DOI 10.1006/geno.2000.6331; McVean G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000686; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Nocedal J., 2000, NUMERICAL OPTIMIZATI; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Novembre J, 2009, NAT REV GENET, V10, P745, DOI 10.1038/nrg2632; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Seldin MF, 2011, NAT REV GENET, V12, P523, DOI 10.1038/nrg3002; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072	22	103	106	0	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2012	44	6					725	U163		10.1038/ng.2285	http://dx.doi.org/10.1038/ng.2285			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	949BT	22610118	Green Accepted			2022-12-25	WOS:000304551100024
J	Fujita, K; Iwasaki, M; Ochi, H; Fukuda, T; Ma, CS; Miyamoto, T; Takitani, K; Negishi-Koga, T; Sunamura, S; Kodama, T; Takayanagi, H; Tamai, H; Kato, S; Arai, H; Shinomiya, K; Itoh, H; Okawa, A; Takeda, S				Fujita, Koji; Iwasaki, Makiko; Ochi, Hiroki; Fukuda, Toru; Ma, Chengshan; Miyamoto, Takeshi; Takitani, Kimitaka; Negishi-Koga, Takako; Sunamura, Satoko; Kodama, Tatsuhiko; Takayanagi, Hiroshi; Tamai, Hiroshi; Kato, Shigeaki; Arai, Hiroyuki; Shinomiya, Kenichi; Itoh, Hiroshi; Okawa, Atsushi; Takeda, Shu			Vitamin E decreases bone mass by stimulating osteoclast fusion	NATURE MEDICINE			English	Article							TOCOPHEROL TRANSFER PROTEIN; NORMAL-MALE RATS; ALPHA-TOCOPHEROL; ASCORBIC-ACID; OXIDATIVE STRESS; IMMUNE-SYSTEM; GIANT-CELLS; OC-STAMP; DIFFERENTIATION; SUPPLEMENTATION	Bone homeostasis is maintained by the balance between osteoblastic bone formation and osteoclastic bone resorption(1-3). Osteoclasts are multinucleated cells that are formed by mononuclear preosteoclast fusion(1,2,4,5). Fat-soluble vitamins such as vitamin D are pivotal in maintaining skeletal integrity. However, the role of vitamin E in bone remodeling is unknown. Here, we show that mice deficient in alpha-tocopherol transfer protein (Ttpa(-/-) mice), a mouse model of genetic vitamin E deficiency(6), have high bone mass as a result of a decrease in bone resorption. Cell-based assays indicated that alpha-tocopherol stimulated osteoclast fusion, independent of its antioxidant capacity, by inducing the expression of dendritic-cell-specific transmembrane protein, an essential molecule for osteoclast fusion, through activation of mitogen-activated protein kinase 14 (p38) and microphthalmia-associated transcription factor, as well as its direct recruitment to the Tm7sf4 (a gene encoding DC-STAMP) promoter(7-9). Indeed, the bone abnormality seen in Ttpa(-/-) mice was rescued by a Tm7sf4 transgene. Moreover, wild-type mice or rats fed an alpha-tocopherol-supplemented diet, which contains a comparable amount of alpha-tocopherol to supplements consumed by many people, lost bone mass. These results show that serum vitamin E is a determinant of bone mass through its regulation of osteoclast fusion.	[Ochi, Hiroki; Fukuda, Toru; Sunamura, Satoko; Itoh, Hiroshi; Takeda, Shu] Keio Univ, Sch Med, Dept Internal Med, Sect Nephrol Endocrinol & Metab, Tokyo, Japan; [Fujita, Koji; Iwasaki, Makiko; Ma, Chengshan; Shinomiya, Kenichi; Okawa, Atsushi] Tokyo Med & Dent Univ, Dept Orthoped Surg, Tokyo, Japan; [Fujita, Koji; Ma, Chengshan] Tokyo Med & Dent Univ, Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence GCOE Program, Tokyo, Japan; [Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo, Japan; [Takitani, Kimitaka; Tamai, Hiroshi] Osaka Med Coll, Dept Pediat, Osaka, Japan; [Negishi-Koga, Takako; Takayanagi, Hiroshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cell Signaling, Tokyo, Japan; [Kodama, Tatsuhiko] Univ Tokyo, Lab Syst Biol & Med, Tokyo, Japan; [Kato, Shigeaki] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan; [Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Tokyo, Japan	Keio University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Keio University; Osaka Medical College; Tokyo Medical & Dental University (TMDU); University of Tokyo; University of Tokyo; University of Tokyo	Takeda, S (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Sect Nephrol Endocrinol & Metab, Tokyo, Japan.	shu-tky@umin.ac.jp	TAKITANI, Kimitaka/AAP-1250-2021; Fujita, Koji/K-3905-2019	Fujita, Koji/0000-0003-3733-0188	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science; Takeda Scientific Foundation; Funding Program for Next Generation World-Leading Researchers (NEXT Program); Grants-in-Aid for Scientific Research [22890178] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Scientific Foundation(Takeda Science Foundation (TSF)); Funding Program for Next Generation World-Leading Researchers (NEXT Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank G. Karsenty, R. Baron and S. Tanaka for discussions; Y. Hotta, K. Miyamoto, H. Inose, S. Sato, A. Kimura, R. Xu and C. Xu for technical assistance; and T. Kitamura (Divisions of Cellular Therapy and Hematopoietic Factors, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan) and I. Takada (Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan) for plasmids. This work was supported by the Funding Program for Next Generation World-Leading Researchers (NEXT Program), grant-in-aid for scientific research from the Japan Society for the Promotion of Science, a grant for Global Center of Excellence Program from the Ministry of Education, Culture, Sports, Science and a Takeda Scientific Foundation grant.	Arjmandi BH, 2002, J NUTR BIOCHEM, V13, P543, DOI 10.1016/S0955-2863(02)00199-7; Azzi A, 2000, J NUTR, V130, P1649, DOI 10.1093/jn/130.7.1649; Bruzzaniti A, 2006, REV ENDOCR METAB DIS, V7, P123, DOI 10.1007/s11154-006-9009-x; Chuin A, 2009, OSTEOPOROSIS INT, V20, P1253, DOI 10.1007/s00198-008-0798-5; Cockayne S, 2006, ARCH INTERN MED, V166, P1256, DOI 10.1001/archinte.166.12.1256; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Horne WC, 2005, IMMUNOL REV, V208, P106, DOI 10.1111/j.0105-2896.2005.00335.x; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Iwasaki R, 2008, BIOCHEM BIOPH RES CO, V377, P899, DOI 10.1016/j.bbrc.2008.10.076; Jishage K, 2001, J BIOL CHEM, V276, P1669, DOI 10.1074/jbc.C000676200; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kato S, 2003, J BONE MINER METAB, V21, P323, DOI 10.1007/s00774-003-0453-3; Kim MH, 2011, AMINO ACIDS, V40, P1447, DOI 10.1007/s00726-010-0755-4; Kimura A, 2010, DEVELOPMENT, V137, P1159, DOI 10.1242/dev.045005; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Le Nihouannen D, 2010, BONE, V46, P1336, DOI 10.1016/j.bone.2009.11.021; Lee JH, 2009, J BIOL CHEM, V284, P13725, DOI 10.1074/jbc.M806941200; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; McNally AK, 2008, EXP MOL PATHOL, V84, P37, DOI 10.1016/j.yexmp.2007.10.005; Mehat MZ, 2010, J BONE MINER METAB, V28, P503, DOI 10.1007/s00774-010-0159-2; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Ostman B, 2009, FREE RADICAL BIO MED, V47, P668, DOI 10.1016/j.freeradbiomed.2009.05.031; Radimer K, 2004, AM J EPIDEMIOL, V160, P339, DOI 10.1093/aje/kwh207; Ragab AA, 1998, J BONE MINER RES, V13, P970, DOI 10.1359/jbmr.1998.13.6.970; Ruiz-Ramos M, 2010, J NUTR HEALTH AGING, V14, P467, DOI 10.1007/s12603-010-0099-5; Sato S, 2007, NAT MED, V13, P1234, DOI 10.1038/nm1640; Shuid AN, 2010, J BONE MINER METAB, V28, P149, DOI 10.1007/s00774-009-0122-2; Steingrimsson E, 2002, P NATL ACAD SCI USA, V99, P4477, DOI 10.1073/pnas.072071099; Takayanagi H, 2009, NAT REV RHEUMATOL, V5, P667, DOI 10.1038/nrrheum.2009.217; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Tsuneto M, 2005, BIOCHEM BIOPH RES CO, V335, P1239, DOI 10.1016/j.bbrc.2005.08.016; Vignery A, 2005, J EXP MED, V202, P337, DOI 10.1084/jem.20051123; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Weilbaecher KN, 2001, MOL CELL, V8, P749, DOI 10.1016/S1097-2765(01)00360-4; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yang M, 2008, J CELL PHYSIOL, V215, P497, DOI 10.1002/jcp.21331; Yokota T, 2001, P NATL ACAD SCI USA, V98, P15185, DOI 10.1073/pnas.261456098; Zou W, 2010, ANN NY ACAD SCI, V1192, P27, DOI 10.1111/j.1749-6632.2009.05245.x; Zu K, 2005, MOL CANCER THER, V4, P43	40	127	136	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2012	18	4					589	594		10.1038/nm.2659	http://dx.doi.org/10.1038/nm.2659			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22388090				2022-12-25	WOS:000302617800036
J	Georghiou, G; Kleiner, RE; Pulkoski-Gross, M; Liu, DR; Seeliger, MA				Georghiou, George; Kleiner, Ralph E.; Pulkoski-Gross, Michael; Liu, David R.; Seeliger, Markus A.			Highly specific, bisubstrate-competitive Src inhibitors from DNA-templated macrocycles	NATURE CHEMICAL BIOLOGY			English	Article							KINASE DOMAIN MUTATIONS; TYROSINE KINASE; CRYSTAL-STRUCTURE; ORGANIC-SYNTHESIS; PROTEIN-KINASES; IMATINIB; ABL; CONFORMATION; RESISTANCE; LIBRARY	Protein kinases are attractive therapeutic targets, but their high sequence and structural conservation complicates the development of specific inhibitors. We recently identified, in a DNA-templated macrocycle library, inhibitors with unusually high selectivity among Src-family kinases. Starting from these compounds, we developed and characterized in molecular detail potent macrocyclic inhibitors of Src kinase and its cancer-associated 'gatekeeper' mutant. We solved two cocrystal structures of macro-cycles bound to Src kinase. These structures reveal the molecular basis of the combined ATP- and substrate peptide-competitive inhibitory mechanism and the remarkable kinase specificity of the compounds. The most potent compounds inhibit Src activity in cultured mammalian cells. Our work establishes that macrocycles can inhibit protein kinases through a bisubstrate-competitive mechanism with high potency and exceptional specificity, reveals the precise molecular basis for their desirable properties and provides new insights into the development of Src-specific inhibitors with potential therapeutic relevance.	[Georghiou, George; Pulkoski-Gross, Michael; Seeliger, Markus A.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Kleiner, Ralph E.; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Kleiner, Ralph E.; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Harvard University; Harvard University; Howard Hughes Medical Institute	Georghiou, G (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.	drliu@fas.harvard.edu; markus@pharm.stonybrook.edu	Liu, David R./HCH-3132-2022; Seeliger, Markus A/D-6409-2013	Georghiou, George/0000-0001-5067-3199; Seeliger, Markus/0000-0003-0990-1756; Pulkoski-Gross, Michael/0000-0003-4644-1795	US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; Howard Hughes Medical Institute; US National Institutes of Health (NIH)-National Institute of General Medical Sciences [GM065865, GM080097]; NIH; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM080097, K99GM080097, T32GM007518, R01GM065865] Funding Source: NIH RePORTER	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health (NIH)-National Institute of General Medical Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	3T3 (Src<SUP>-/-</SUP>) cells transfected with a plasmid encoding c-Src<SUP>Y529F</SUP> or null vector were a gift from J. Cooper (Fred Hutchinson Cancer Research Center). We thank the beamline staff at X29A at the National Synchrotron Light Source at Brookhaven National Laboratory, the use of which was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences contract DE-AC02-98CH10886. G.G. and M.A.S. thank L. Malone for her assistance. This research was supported by the Howard Hughes Medical Institute (D.R.L.) and US National Institutes of Health (NIH)-National Institute of General Medical Sciences grants GM065865 (D.R.L.) and GM080097 (M.A.S.). R.E.K. acknowledges NIH training grant support to the Harvard University Training Program in Molecular, Cellular and Chemical Biology. G.G. acknowledges NIH training grant support to the Graduate Program in Molecular and Cellular Pharmacology at Stony Brook University.	Abbott L, 2007, BIOORG MED CHEM LETT, V17, P1167, DOI 10.1016/j.bmcl.2006.12.035; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Bamborough P, 2008, J MED CHEM, V51, P7898, DOI 10.1021/jm8011036; BARKER SC, 1995, BIOCHEMISTRY-US, V34, P14843, DOI 10.1021/bi00045a027; Barouch-Bentov R, 2009, MOL CELL, V33, P43, DOI 10.1016/j.molcel.2008.12.024; Bikker JA, 2009, J MED CHEM, V52, P1493, DOI 10.1021/jm8010542; Biron E, 2006, J PEPT SCI, V12, P213, DOI 10.1002/psc.711; Burchat AF, 2002, BIOORG MED CHEM LETT, V12, P1687, DOI 10.1016/S0960-894X(02)00196-8; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Cools J, 2003, CANCER CELL, V3, P459, DOI 10.1016/S1535-6108(03)00108-9; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Doyon JB, 2003, J AM CHEM SOC, V125, P12372, DOI 10.1021/ja036065u; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gartner ZJ, 2004, SCIENCE, V305, P1601, DOI 10.1126/science.1102629; Gartner ZJ, 2001, J AM CHEM SOC, V123, P6961, DOI 10.1021/ja015873n; GAZIT A, 1989, J MED CHEM, V32, P2344, DOI 10.1021/jm00130a020; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kleiner RE, 2011, CHEM SOC REV, V40, P5707, DOI 10.1039/c1cs15076f; Kleiner RE, 2010, J AM CHEM SOC, V132, P11779, DOI 10.1021/ja104903x; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Krishnamurty R, 2010, ACS CHEM BIOL, V5, P121, DOI 10.1021/cb9002656; Laszlo GS, 2009, CURR BIOL, V19, P157, DOI 10.1016/j.cub.2008.12.007; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Levitzki A, 1999, PHARMACOL THERAPEUT, V82, P231, DOI 10.1016/S0163-7258(98)00066-7; Li XY, 2004, ANGEW CHEM INT EDIT, V43, P4848, DOI 10.1002/anie.200400656; Maly DJ, 2000, P NATL ACAD SCI USA, V97, P2419, DOI 10.1073/pnas.97.6.2419; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Seeliger MA, 2007, STRUCTURE, V15, P299, DOI 10.1016/j.str.2007.01.015; Shan YB, 2011, J AM CHEM SOC, V133, P9181, DOI 10.1021/ja202726y; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Songyang Zhou, 1995, Trends in Biochemical Sciences, V20, P470, DOI 10.1016/S0968-0004(00)89103-3; Soverini S, 2006, CLIN CANCER RES, V12, P7374, DOI 10.1158/1078-0432.CCR-06-1516; Tse BN, 2008, J AM CHEM SOC, V130, P15611, DOI 10.1021/ja805649f; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	46	55	59	3	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2012	8	4					366	374		10.1038/NCHEMBIO.792	http://dx.doi.org/10.1038/NCHEMBIO.792			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	913PO	22344177	Green Accepted, Green Submitted			2022-12-25	WOS:000301890100011
J	Sarparanta, J; Jonson, PH; Golzio, C; Sandell, S; Luque, H; Screen, M; McDonald, K; Stajich, JM; Mahjneh, I; Vihola, A; Raheem, O; Penttila, S; Lehtinen, S; Huovinen, S; Palmio, J; Tasca, G; Ricci, E; Hackman, P; Hauser, M; Katsanis, N; Udd, B				Sarparanta, Jaakko; Jonson, Per Harald; Golzio, Christelle; Sandell, Satu; Luque, Helena; Screen, Mark; McDonald, Kristin; Stajich, Jeffrey M.; Mahjneh, Ibrahim; Vihola, Anna; Raheem, Olayinka; Penttila, Sini; Lehtinen, Sara; Huovinen, Sanna; Palmio, Johanna; Tasca, Giorgio; Ricci, Enzo; Hackman, Peter; Hauser, Michael; Katsanis, Nicholas; Udd, Bjarne			Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy	NATURE GENETICS			English	Article							PROTEIN; MRJ; IDENTIFICATION; HUNTINGTIN; AUTOPHAGY; MYOTILIN; ISOFORM; BINDING; STRESS; BODIES	Limb-girdle muscular dystrophy type 1D (LGMD1D) was linked to chromosome 7q36 over a decade ago(1), but its genetic cause has remained elusive. Here we studied nine LGMD-affected families from Finland, the United States and Italy and identified four dominant missense mutations leading to p. Phe93Leu or p. Phe89Ile changes in the ubiquitously expressed co-chaperone DNAJB6. Functional testing in vivo showed that the mutations have a dominant toxic effect mediated specifically by the cytoplasmic isoform of DNAJB6. In vitro studies demonstrated that the mutations increase the half-life of DNAJB6, extending this effect to the wild-type protein, and reduce its protective anti-aggregation effect. Further, we show that DNAJB6 interacts with members of the CASA complex, including the myofibrillar myopathy-causing protein BAG3. Our data identify the genetic cause of LGMD1D, suggest that its pathogenesis is mediated by defective chaperone function and highlight how mutations in a ubiquitously expressed gene can exert effects in a tissue-, isoform- and cellular compartment-specific manner.	[Sarparanta, Jaakko; Jonson, Per Harald; Luque, Helena; Screen, Mark; Vihola, Anna; Lehtinen, Sara; Hackman, Peter; Udd, Bjarne] Univ Helsinki, Folkhalsan Inst Genet, Helsinki, Finland; [Sarparanta, Jaakko; Jonson, Per Harald; Luque, Helena; Screen, Mark; Vihola, Anna; Lehtinen, Sara; Hackman, Peter; Udd, Bjarne] Univ Helsinki, Dept Med Genet, Haartman Inst, Helsinki, Finland; [Golzio, Christelle; Katsanis, Nicholas] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC USA; [Sandell, Satu; Raheem, Olayinka; Penttila, Sini; Huovinen, Sanna; Palmio, Johanna; Udd, Bjarne] Tampere Univ Hosp, Dept Neurol, Neuromuscular Res Unit, Tampere, Finland; [Sandell, Satu] Seinajoki Cent Hosp, Dept Neurol, Seinajoki, Finland; [McDonald, Kristin; Stajich, Jeffrey M.; Hauser, Michael] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [McDonald, Kristin; Hauser, Michael] Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC USA; [Mahjneh, Ibrahim] Pietarsaari Hosp, Dept Neurol, Pietarsaari, Finland; [Mahjneh, Ibrahim] Univ Oulu, Dept Neurol, Oulu, Finland; [Huovinen, Sanna] Tampere Univ Hosp, Dept Pathol, Tampere, Finland; [Sandell, Satu; Raheem, Olayinka; Penttila, Sini; Huovinen, Sanna; Palmio, Johanna; Udd, Bjarne] Univ Tampere, FIN-33101 Tampere, Finland; [Tasca, Giorgio] Don Carlo Gnocchi Onlus Fdn, Milan, Italy; [Ricci, Enzo] Catholic Univ, Inst Neurol, Sch Med, Rome, Italy; [Udd, Bjarne] Vaasa Cent Hosp, Dept Neurol, Vaasa, Finland	University of Helsinki; University of Helsinki; Duke University; Tampere University; Tampere University Hospital; Seinajoki Central Hospital; Duke University; Duke University; University of Oulu; Tampere University; Tampere University Hospital; IRCCS Fondazione Don Carlo Gnocchi Onlus; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Vaasa Central Hospital	Udd, B (corresponding author), Univ Helsinki, Folkhalsan Inst Genet, Helsinki, Finland.	bjarne.udd@netikka.fi	Jonson, pH/GPX-1306-2022; Ricci, Enzo/AAC-4448-2020; Sarparanta, Jaakko/AAQ-1713-2020; Katsanis, Nicholas/E-1837-2012; Tasca, Giorgio/J-5153-2018	Sarparanta, Jaakko/0000-0002-5497-5255; Golzio, Christelle/0000-0002-4420-3921; Katsanis, Nicholas/0000-0002-2480-0171; McDonald Gibson, Kristin/0000-0002-3297-2002; RICCI, Enzo/0000-0003-3092-3597; Mahjneh, Ibrahim/0000-0002-0752-9949; Huovinen, Sanna/0000-0001-7659-7921; Tasca, Giorgio/0000-0003-0849-9144; Jonson, Per Harald/0000-0003-2423-359X	Folkhalsan Research Foundation [504]; Academy of Finland [138491]; Sigrid Juselius Foundation [23816]; Liv och Halsa Foundation [LoH G017]; Helsinki Graduate School in Biotechnology and Molecular Biology; Alfred Kordelin Foundation; Don Carlo Gnocchi Onlus Foundation [RF 2007 convenzione 41]; American Heart Association (AHA) [11POST7160006]; Duke Perinatal and Neonatal Research Institute; National Institutes of Health [UL1 RR024128-01, R01HD042601-10]; Muscular Dystrophy Association [MDA4090, MDA2010]; Distinguished Brumley Professorship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER	Folkhalsan Research Foundation; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Liv och Halsa Foundation; Helsinki Graduate School in Biotechnology and Molecular Biology; Alfred Kordelin Foundation; Don Carlo Gnocchi Onlus Foundation; American Heart Association (AHA)(American Heart Association); Duke Perinatal and Neonatal Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Distinguished Brumley Professorship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by the Folkhalsan Research Foundation (504; B.U.), the Academy of Finland (138491; B.U.), the Sigrid Juselius Foundation (23816; B.U.), the Liv och Halsa Foundation (LoH G017; B.U.), Helsinki Graduate School in Biotechnology and Molecular Biology (J.S.), the Alfred Kordelin Foundation (J.S.), the Don Carlo Gnocchi Onlus Foundation (RF 2007 convenzione 41; G.T., E.R.), the American Heart Association (AHA MAA spring 2011 #11POST7160006; C.G.), the Duke Perinatal and Neonatal Research Institute (N.K.), the National Institutes of Health (UL1 RR024128-01; N.K., M.H., and R01HD042601-10; C.G.) and the Muscular Dystrophy Association (MDA4090, MDA2010; M.H.). N.K. is supported by a Distinguished Brumley Professorship. We thank O. Carpen (Department of Pathology, University of Helsinki) for the myotilin antibody; A. Norremolle (Faculty of Health Sciences, University of Copenhagen) for the pEGFP/HD-120Q construct; C. Patterson (School of Medicine, University of North Carolina) for the STUB1 construct; M. Sarparanta (Laboratory of Radiochemistry, University of Helsinki) for rat muscle tissue samples; and M. Soininen, M. Ritala and A. Evil for technical assistance. Confocal microscopy was carried out with instruments of the Biomedicum Imaging Unit, University of Helsinki, and electron microscopy at the Department of Pathology, University of Helsinki.	Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Cajo GC, 2006, J BIOL CHEM, V281, P12436, DOI 10.1074/jbc.M511192200; Chuang JZ, 2002, J BIOL CHEM, V277, P19831, DOI 10.1074/jbc.M109613200; Dai YS, 2005, MOL CELL BIOL, V25, P9936, DOI 10.1128/MCB.25.22.9936-9948.2005; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Durrenberger PF, 2009, J NEUROSCI RES, V87, P238, DOI 10.1002/jnr.21819; Gordon E., 2000, GENEREVIEWS; Hackman P, 2011, NEUROMUSCULAR DISORD, V21, P338, DOI 10.1016/j.nmd.2011.02.008; Hageman J, 2011, BIOCHEM J, V435, P127, DOI 10.1042/BJ20101247; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Hanai R, 2003, MOL BIOL REP, V30, P149, DOI 10.1023/A:1024916223616; Hasholt L, 2003, J GENE MED, V5, P528, DOI 10.1002/jgm.378; Ianzano L, 2004, HUM MUTAT, V23, P170, DOI 10.1002/humu.10306; Izawa I, 2000, J BIOL CHEM, V275, P34521, DOI 10.1074/jbc.M003492200; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kettern N, 2010, BIOL CHEM, V391, P481, DOI 10.1515/BC.2010.058; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Li ZF, 2008, J NEUROL SCI, V264, P77, DOI 10.1016/j.jns.2007.07.027; Mitra A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1874; Mologni L, 2005, BIOCHEM BIOPH RES CO, V329, P1001, DOI 10.1016/j.bbrc.2005.02.074; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Perales-Calvo J, 2010, J BIOL CHEM, V285, P34231, DOI 10.1074/jbc.M110.144642; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Rose JM, 2011, HUM MOL GENET, V20, P16, DOI 10.1093/hmg/ddq428; Sandell S, 2010, J NEUROL NEUROSUR PS, V81, P834, DOI 10.1136/jnnp.2009.192351; Sarparanta J, 2010, J BIOL CHEM, V285, P30304, DOI 10.1074/jbc.M110.108720; Seki N, 1999, J HUM GENET, V44, P185, DOI 10.1007/s100380050139; Selcen D, 2004, NEUROLOGY, V62, P1363, DOI 10.1212/01.WNL.0000123576.74801.75; Selcen D, 2009, ANN NEUROL, V65, P83, DOI 10.1002/ana.21553; SPEER MC, 1995, AM J HUM GENET, V57, P1371; Speer MC, 1999, AM J HUM GENET, V64, P556, DOI 10.1086/302252; WALL D, 1995, J BIOL CHEM, V270, P2139, DOI 10.1074/jbc.270.5.2139; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Watson ED, 2007, DEVELOPMENT, V134, P1809, DOI 10.1242/dev.02843; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Yan W, 1999, MOL CELL BIOL, V19, P7751; Zhang YF, 2008, BIOCHEM J, V413, P239, DOI 10.1042/BJ20071510; Zhu K, 2010, ONCOGENE, V29, P451, DOI 10.1038/onc.2009.343	38	165	173	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2012	44	4					450	U136		10.1038/ng.1103	http://dx.doi.org/10.1038/ng.1103			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	916VF	22366786	Green Accepted			2022-12-25	WOS:000302130600022
J	Grembecka, J; He, SH; Shi, AB; Purohit, T; Muntean, AG; Sorenson, RJ; Showalter, HD; Murai, MJ; Belcher, AM; Hartley, T; Hess, JL; Cierpicki, T				Grembecka, Jolanta; He, Shihan; Shi, Aibin; Purohit, Trupta; Muntean, Andrew G.; Sorenson, Roderick J.; Showalter, Hollis D.; Murai, Marcelo J.; Belcher, Amalia M.; Hartley, Thomas; Hess, Jay L.; Cierpicki, Tomasz			Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia	NATURE CHEMICAL BIOLOGY			English	Article							MIXED LINEAGE LEUKEMIA; HOX GENE-EXPRESSION; HISTONE METHYLTRANSFERASE COMPLEX; ACUTE MYELOID-LEUKEMIA; HEMATOPOIESIS; TRANSFORMATION; LEUKEMOGENESIS; TRANSLOCATIONS; MEIS1; IMMORTALIZATION	Translocations involving the mixed lineage leukemia (MLL) gene result in human acute leukemias with very poor prognosis. The leukemogenic activity of MLL fusion proteins is critically dependent on their direct interaction with menin, a product of the multiple endocrine neoplasia (MEND gene. Here we present what are to our knowledge the first small-molecule inhibitors of the menin-MLL fusion protein interaction that specifically bind menin with nanomolar affinities. These compounds effectively reverse MLL fusion protein-mediated leukemic transformation by downregulating the expression of target genes required for MLL fusion protein oncogenic activity. They also selectively block proliferation and induce both apoptosis and differentiation of leukemia cells harboring MLL translocations. Identification of these compounds provides a new tool for better understanding MLL-mediated leukemogenesis and represents a new approach for studying the role of menin as an oncogenic cofactor of MLL fusion proteins. Our findings also highlight a new therapeutic strategy for aggressive leukemias with MLL rearrangements.	[Grembecka, Jolanta; He, Shihan; Shi, Aibin; Purohit, Trupta; Muntean, Andrew G.; Murai, Marcelo J.; Hartley, Thomas; Hess, Jay L.; Cierpicki, Tomasz] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Sorenson, Roderick J.; Showalter, Hollis D.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Belcher, Amalia M.] Univ Virginia, Charlottesville, VA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Virginia	Grembecka, J (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	jolantag@umich.edu; tomaszc@umich.edu	he, shihan/N-8067-2014	he, shihan/0000-0001-5806-8583; Muntean, Andrew/0000-0003-3034-0682	Leukemia and Lymphoma Society [6070-09]; Leukemia and Lymphoma Society Specialized Center of Research; US National Institutes of Health [R01 (1R01 CA-160467-01)]; Cancer Center (University of Virginia); Children's Leukemia Research Association; American Cancer Society [RSG-11-082-01-DMC]; Department of Pathology (University of Michigan); University of Virginia; NATIONAL CANCER INSTITUTE [R01CA160467, R01CA151425, P50CA130810] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Leukemia and Lymphoma Society Specialized Center of Research(Leukemia and Lymphoma Society); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center (University of Virginia); Children's Leukemia Research Association; American Cancer Society(American Cancer Society); Department of Pathology (University of Michigan)(University of Michigan System); University of Virginia; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Leukemia and Lymphoma Society (Translational Research Program grant 6070-09 to J.G. and Leukemia and Lymphoma Society Specialized Center of Research grant to J.L.H.), US National Institutes of Health R01 (1R01 CA-160467-01 to J.G.), Cancer Center (University of Virginia to J.G. and T.C.), Children's Leukemia Research Association (to J.G.), American Cancer Society (RSG-11-082-01-DMC to T.C.) and startup funds to J.G. and T.C. provided by the Department of Pathology (University of Michigan). The authors greatly appreciate support from J. Bushweller (University of Virginia) for providing the research environment for carrying out part of these studies. We are grateful to M. Larsen from the Center for Chemical Genomics, University of Michigan, for technical expertise during HTS. We would like to thank). Tan (University of Michigan) for discussion of experimental procedures and R. Craig from the Department of Pathology (University of Michigan) for technical support with flow cytometry experiments.	Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Caslini C, 2007, CANCER RES, V67, P7275, DOI 10.1158/0008-5472.CAN-06-2369; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chen YX, 2006, P NATL ACAD SCI USA, V103, P1018, DOI 10.1073/pnas.0510347103; Cox MC, 2004, AM J CLIN PATHOL, V122, P298, DOI 10.1309/RX27R8GJQM330C22; Drabkin H, 2002, LEUKEMIA, V16, P186, DOI 10.1038/sj.leu.2402354; Ernst P, 2002, CURR OPIN HEMATOL, V9, P282, DOI 10.1097/00062752-200207000-00004; Fiskus W, 2006, MOL CANCER THER, V5, P3096, DOI 10.1158/1535-7163.MCT-06-0418; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Grembecka J, 2010, J BIOL CHEM, V285, P40690, DOI 10.1074/jbc.M110.172783; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Hess JL, 1997, BLOOD, V90, P1799, DOI 10.1182/blood.V90.5.1799; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; Liu H, 2009, CANCER BIOL THER, V8, P1204, DOI 10.4161/cbt.8.13.8924; Marx SJ, 2005, NAT REV CANCER, V5, P367, DOI 10.1038/nrc1610; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muntean AG, 2010, CANCER CELL, V17, P609, DOI 10.1016/j.ccr.2010.04.012; Murai MJ, 2011, J BIOL CHEM, V286, P31742, DOI 10.1074/jbc.M111.258186; Popovic R, 2005, J CELL BIOCHEM, V95, P234, DOI 10.1002/jcb.20430; Pui CH, 2002, LANCET, V359, P1909, DOI 10.1016/S0140-6736(02)08782-2; Quentmeier H, 2004, LEUKEMIA LYMPHOMA, V45, P567, DOI 10.1080/10428190310001609942; Rice KL, 2007, J CLIN INVEST, V117, P865, DOI 10.1172/JCI31861; Rozovskaia T, 2001, ONCOGENE, V20, P874, DOI 10.1038/sj.onc.1204174; Slany RK, 2005, HEMATOL ONCOL, V23, P1, DOI 10.1002/hon.739; Slany RK, 2009, HAEMATOL-HEMATOL J, V94, P984, DOI 10.3324/haematol.2008.002436; SORENSEN PHB, 1994, J CLIN INVEST, V93, P429, DOI 10.1172/JCI116978; Thiel AT, 2010, CANCER CELL, V17, P148, DOI 10.1016/j.ccr.2009.12.034; Thomas M, 2005, BLOOD, V106, P3559, DOI 10.1182/blood-2005-03-1283; Thompson A, 2003, BLOOD, V101, P1558, DOI 10.1182/blood.V101.4.1558; Wong P, 2007, GENE DEV, V21, P3017; Wong P, 2007, GENE DEV, V21, P2762, DOI 10.1101/gad.1602107; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; Zeisig BB, 2004, MOL CELL BIOL, V24, P617, DOI 10.1128/MCB.24.2.617-628.2004	43	273	291	1	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2012	8	3					277	284		10.1038/NCHEMBIO.773	http://dx.doi.org/10.1038/NCHEMBIO.773			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896VR	22286128	Green Accepted			2022-12-25	WOS:000300600000013
J	Okada, Y; Kubo, M; Ohmiya, H; Takahashi, A; Kumasaka, N; Hosono, N; Maeda, S; Wen, WQ; Dorajoo, R; Go, MJ; Zheng, W; Kato, N; Wu, JY; Lu, Q; Tsunoda, T; Yamamoto, K; Nakamura, Y; Kamatani, N; Tanaka, T				Okada, Yukinori; Kubo, Michiaki; Ohmiya, Hiroko; Takahashi, Atsushi; Kumasaka, Natsuhiko; Hosono, Naoya; Maeda, Shiro; Wen, Wanqing; Dorajoo, Rajkumar; Go, Min Jin; Zheng, Wei; Kato, Norihiro; Wu, Jer-Yuarn; Lu, Qi; Tsunoda, Tatsuhiko; Yamamoto, Kazuhiko; Nakamura, Yusuke; Kamatani, Naoyuki; Tanaka, Toshihiro		GIANT Consortium	Common variants at CDKAL1 and KLF9 are associated with body mass index in east Asian populations	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-VARIATION; ADULT OBESITY; HHEX-IDE; WEIGHT; RISK; LOCI; HEIGHT; MC4R	Obesity is a disorder with a complex genetic etiology, and its epidemic is a worldwide problem. Although multiple genetic loci associated with body mass index, the most common measure of obesity, have been identified in European populations, few studies have focused on Asian populations. Here we report a genome-wide association study and replication studies with 62,245 east Asian subjects, which identified two new body mass index-associated loci in the CDKAL1 locus at 6p22 (rs2206734, P = 1.4 x 10(-11)) and the KLF9 locus at 9q21 (rs11142387, P = 1.3 x 10(-9)), as well as several previously reported loci (the SEC16B, BDNF, FTO, MC4R and GIPR loci, P < 5.0 x 10(-8)). We subsequently performed gene-gene interaction analyses and identified an interaction (P = 2.0 x 10(-8)) between a SNP in the KLF9 locus (rs11142387) and one in the MSTN (also known as GDF8) locus at 2q32 (rs13034723). These findings should provide useful insights into the etiology of obesity.	[Okada, Yukinori; Ohmiya, Hiroko; Takahashi, Atsushi; Kumasaka, Natsuhiko; Kamatani, Naoyuki] RIKEN, CGM, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Okada, Yukinori; Yamamoto, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; [Kubo, Michiaki; Hosono, Naoya] RIKEN, CGM, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Maeda, Shiro] RIKEN, CGM, Lab Endocrinol & Metab, Yokohama, Kanagawa, Japan; [Wen, Wanqing; Zheng, Wei] Vanderbilt Univ, Dept Med, Div Epidemiol, Vanderbilt Ctr Epidemiol, Nashville, TN USA; [Wen, Wanqing; Zheng, Wei] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Dorajoo, Rajkumar] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Dorajoo, Rajkumar] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Genom Common Dis, Sch Publ Hlth, London, England; [Go, Min Jin] Natl Inst Hlth, Ctr Genome Sci, Chungcheongbuk Do, South Korea; [Kato, Norihiro] Natl Ctr Global Hlth & Med, Dept Gene Diagnost & Therapeut, Res Inst, Tokyo, Japan; [Wu, Jer-Yuarn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Wu, Jer-Yuarn] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Lu, Qi] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Tsunoda, Tatsuhiko] RIKEN, CGM, Lab Med Informat, Yokohama, Kanagawa, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Mol Med, Tokyo, Japan; [Tanaka, Toshihiro] RIKEN, CGM, Lab Cardiovasc Dis, Yokohama, Kanagawa, Japan	RIKEN; University of Tokyo; RIKEN; RIKEN; Vanderbilt University; Vanderbilt University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Imperial College London; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; National Center for Global Health & Medicine - Japan; Academia Sinica - Taiwan; China Medical University Taiwan; Harvard University; Harvard T.H. Chan School of Public Health; RIKEN; University of Tokyo; RIKEN	Okada, Y (corresponding author), RIKEN, CGM, Lab Stat Anal, Yokohama, Kanagawa, Japan.	yokada@src.riken.jp	Zheng, Wei/O-3351-2013; Wu, Jer-Yuarn/S-7010-2018; zhang, weihua/GXV-1334-2022; Tanaka, Toshihiro/J-9310-2014; Tsunoda, Tatsuhiko/K-2061-2014; Kubo, Michiaki/N-7947-2015	Zheng, Wei/0000-0003-1226-070X; Tanaka, Toshihiro/0000-0001-6201-9784; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Dorajoo, Rajkumar/0000-0001-6608-2051	Ministry of Education, Culture, Sports, Science and Technology, Japan; NATIONAL CANCER INSTITUTE [R01CA148667, R01CA064277] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072507, R01HL090682, R01HL087263] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank K. Tobe and M. Iwata at the First Department of Internal Medicine, Faculty of Medicine, Toyama University, H. Hirose at Health Center, Keio University School of Medicine and all the staff of the Laboratory for Endocrinology, Metabolism and Statistical Analysis at CGM, RIKEN for their assistance. This study was supported by the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Andersson EA, 2010, DIABETOLOGIA, V53, P1908, DOI 10.1007/s00125-010-1790-0; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Grade CVC, 2009, DEV GENES EVOL, V219, P497, DOI 10.1007/s00427-009-0312-x; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Elkasrawy MN, 2010, J MUSCULOSKEL NEURON, V10, P56; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hinney A, 2010, EUR CHILD ADOLES PSY, V19, P297, DOI 10.1007/s00787-010-0096-6; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Liu XG, 2009, AM J HUM GENET, V84, P418, DOI 10.1016/j.ajhg.2009.02.004; Liu YJ, 2008, HUM MOL GENET, V17, P1803, DOI 10.1093/hmg/ddn072; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Nakamura K, 1999, J BIOSOC SCI, V31, P555, DOI 10.1017/S0021932099005556; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Okada Y, 2011, HUM MOL GENET, V20, P1224, DOI 10.1093/hmg/ddq551; Pei H, 2011, CELL DEATH DIFFER, V18, P315, DOI 10.1038/cdd.2010.100; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Wada K, 2005, INT J OBESITY, V29, P1093, DOI 10.1038/sj.ijo.0803012; Wen W., 2012, NAT GENET       0212, DOI [10.1038/ng.1086, DOI 10.1038/NG.1086]; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Winkler C, 2010, DIABETES, V59, P2063, DOI 10.2337/db10-0099; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Zabel DP, 2009, EUR J ENDOCRINOL, V160, P603, DOI 10.1530/EJE-08-0688	38	183	193	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2012	44	3					302	U105		10.1038/ng.1086	http://dx.doi.org/10.1038/ng.1086			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	899VC	22344221	Green Accepted			2022-12-25	WOS:000300843600016
J	Abe, A; Kosugi, S; Yoshida, K; Natsume, S; Takagi, H; Kanzaki, H; Matsumura, H; Yoshida, K; Mitsuoka, C; Tamiru, M; Innan, H; Cano, L; Kamoun, S; Terauchi, R				Abe, Akira; Kosugi, Shunichi; Yoshida, Kentaro; Natsume, Satoshi; Takagi, Hiroki; Kanzaki, Hiroyuki; Matsumura, Hideo; Yoshida, Kakoto; Mitsuoka, Chikako; Tamiru, Muluneh; Innan, Hideki; Cano, Liliana; Kamoun, Sophien; Terauchi, Ryohei			Genome sequencing reveals agronomically important loci in rice using MutMap	NATURE BIOTECHNOLOGY			English	Article							IDENTIFICATION; ARABIDOPSIS; MUTATION; GENES; POPULATIONS; MARKERS; DNA	The majority of agronomic traits are controlled by multiple genes that cause minor phenotypic effects, making the identification of these genes difficult. Here we introduce MutMap, a method based on whole-genome resequencing of pooled DNA from a segregating population of plants that show a useful phenotype. In MutMap, a mutant is crossed directly to the original wild-type line and then selfed, allowing unequivocal segregation in second filial generation (F-2) progeny of subtle phenotypic differences. This approach is particularly amenable to crop species because it minimizes the number of genetic crosses (n = 1 or 0) and mutant F-2 progeny that are required. We applied MutMap to seven mutants of a Japanese elite rice cultivar and identified the unique genomic positions most probable to harbor mutations causing pale green leaves and semidwarfism, an agronomically relevant trait. These results show that MutMap can accelerate the genetic improvement of rice and other crop plants.	[Kosugi, Shunichi; Yoshida, Kentaro; Natsume, Satoshi; Takagi, Hiroki; Kanzaki, Hiroyuki; Matsumura, Hideo; Yoshida, Kakoto; Mitsuoka, Chikako; Tamiru, Muluneh; Terauchi, Ryohei] Iwate Biotechnol Res Ctr, Kitakami, Iwate, Japan; [Abe, Akira] Iwate Agr Res Ctr, Kitakami, Iwate, Japan; [Abe, Akira; Takagi, Hiroki] Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 020, Japan; [Matsumura, Hideo] Shinshu Univ, Ctr Gene Res, Ueda, Nagano, Japan; [Innan, Hideki] Grad Univ Adv Studies, Hayama, Japan; [Cano, Liliana; Kamoun, Sophien] Sainsbury Lab, Norwich, Norfolk, England	Iwate Biotechnology Research Center; Iwate University; Shinshu University; Graduate University for Advanced Studies - Japan; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Terauchi, R (corresponding author), Iwate Biotechnol Res Ctr, Kitakami, Iwate, Japan.	terauchi@ibrc.or.jp	Terauchi, Ryohei/Y-2992-2019; Cano, Liliana M/O-7041-2016; Kamoun, Sophien/B-3529-2009	Terauchi, Ryohei/0000-0002-0095-4651; Cano, Liliana M/0000-0002-7996-4181; Kamoun, Sophien/0000-0002-0290-0315; Matsumura, Hideo/0000-0003-4849-1016; Yoshida, Kentaro/0000-0002-3614-1759; Innan, Hideki/0000-0001-6375-9231; Kosugi, Shunichi/0000-0002-5882-9255	Program for Promotion of Basic Research Activities for Innovative Biosciences; Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation) [PMI-0010]; Ministry of Education, Culture, Sports, Science and Technology of Japan [23113009]; Gatsby Charitable Foundation; Grants-in-Aid for Scientific Research [23580065, 22380009, 22510217] Funding Source: KAKEN	Program for Promotion of Basic Research Activities for Innovative Biosciences; Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation)(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Gatsby Charitable Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Program for Promotion of Basic Research Activities for Innovative Biosciences, to R.T., H.I. and A.A. Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation PMI-0010), Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in-Aid for Scientific Research on Innovative Areas 23113009) to R.T. and a Daiwa Adrian Prize to S. Kamoun and R.T.L.C. and S. Kamoun were supported by the Gatsby Charitable Foundation. We thank S. Kuroda for general support and M.J. Terry, B. Wulff and K. Tsunewaki for suggestions to improve the paper.	Ashelford K, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r28; Austin RS, 2011, PLANT J, V67, P715, DOI 10.1111/j.1365-313X.2011.04619.x; Baulcombe D, 2010, SCIENCE, V327, P761, DOI 10.1126/science.1186705; Falconer D. S, 1996, INTRO QUANTITATIVE G; GIOVANNONI JJ, 1991, NUCLEIC ACIDS RES, V19, P6553, DOI 10.1093/nar/19.23.6553; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Lee S, 2005, PLANT MOL BIOL, V57, P805, DOI 10.1007/s11103-005-2066-9; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; PIENKOWSKA M, 1993, MUTAT RES, V288, P123, DOI 10.1016/0027-5107(93)90214-Z; ROBERTSON DS, 1985, J THEOR BIOL, V117, P1, DOI 10.1016/S0022-5193(85)80161-2; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Sujay Rakshit, 2010, The handbook of plant mutation screening: mining of natural and induced alleles, P187; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Zuryn S, 2010, GENETICS, V186, P427, DOI 10.1534/genetics.110.119230	17	716	786	27	374	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2012	30	2					174	178		10.1038/nbt.2095	http://dx.doi.org/10.1038/nbt.2095			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	892EI	22267009	Bronze			2022-12-25	WOS:000300269100020
J	Grall, A; Guaguere, E; Planchais, S; Grond, S; Bourrat, E; Hausser, I; Hitte, C; Le Gallo, M; Derbois, C; Kim, GJ; Lagoutte, L; Degorce-Rubiales, F; Radner, FPW; Thomas, A; Kury, S; Bensignor, E; Fontaine, J; Pin, D; Zimmermann, R; Zechner, R; Lathrop, M; Galibert, F; Andre, C; Fischer, J				Grall, Anais; Guaguere, Eric; Planchais, Sandrine; Grond, Susanne; Bourrat, Emmanuelle; Hausser, Ingrid; Hitte, Christophe; Le Gallo, Matthieu; Derbois, Celine; Kim, Gwang-Jin; Lagoutte, Laetitia; Degorce-Rubiales, Frederique; Radner, Franz P. W.; Thomas, Anne; Kury, Sebastien; Bensignor, Emmanuel; Fontaine, Jacques; Pin, Didier; Zimmermann, Robert; Zechner, Rudolf; Lathrop, Mark; Galibert, Francis; Andre, Catherine; Fischer, Judith			PNPLA1 mutations cause autosomal recessive congenital ichthyosis in golden retriever dogs and humans	NATURE GENETICS			English	Article							LIPID STORAGE DISEASE; TRIGLYCERIDE LIPASE PNPLA2; LAMELLAR ICHTHYOSIS; GENE-MUTATIONS; FAMILY; TRANSGLUTAMINASE; IDENTIFICATION; PATHOGENESIS; HYDROLASE; CGI-58	Ichthyoses comprise a heterogeneous group of genodermatoses characterized by abnormal desquamation over the whole body, for which the genetic causes of several human forms remain unknown. We used a spontaneous dog model in the golden retriever breed, which is affected by a lamellar ichthyosis resembling human autosomal recessive congenital ichthyoses (ARCI), to carry out a genome-wide association study. We identified a homozygous insertion-deletion (indel) mutation in PNPLA1 that leads to a premature stop codon in all affected golden retriever dogs. We subsequently found one missense and one nonsense mutation in the catalytic domain of human PNPLA1 in six individuals with ARCI from two families. Further experiments highlighted the importance of PNPLA1 in the formation of the epidermal lipid barrier. This study identifies a new gene involved in human ichthyoses and provides insights into the localization and function of this yet uncharacterized member of the PNPLA protein family.	[Grall, Anais; Planchais, Sandrine; Hitte, Christophe; Le Gallo, Matthieu; Lagoutte, Laetitia; Kury, Sebastien; Galibert, Francis; Andre, Catherine] CNRS, Inst Genet & Dev Rennes, Rennes, France; [Grall, Anais; Planchais, Sandrine; Hitte, Christophe; Le Gallo, Matthieu; Lagoutte, Laetitia; Kury, Sebastien; Galibert, Francis; Andre, Catherine] Univ Rennes 1, Inst Federatif Rech IFR 140, Fac Med, Rennes, France; [Guaguere, Eric] Clin Vet St Bernard, Lomme Les Lille, France; [Grond, Susanne; Radner, Franz P. W.; Zimmermann, Robert; Zechner, Rudolf] Karl Franzens Univ Graz, Inst Mol Biosci, Graz, Austria; [Bourrat, Emmanuelle] Hop St Louis, Dept Dermatol, Paris, France; [Hausser, Ingrid] Univ Clin Heidelberg, Dept Dermatol, Heidelberg, Germany; [Hausser, Ingrid] Heidelberg Univ, Electron Microscopy Core Facil, Heidelberg, Germany; [Derbois, Celine; Lathrop, Mark; Fischer, Judith] Commissariat Energie Atom & Energies Alternat CEA, CNG, Inst Genom, Evry, France; [Kim, Gwang-Jin; Fischer, Judith] Univ Clin Freiburg, Inst Human Genet, Freiburg, Germany; [Kim, Gwang-Jin] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Degorce-Rubiales, Frederique] Lab Anat Pathol Vet Sud Ouest, Toulouse, France; [Thomas, Anne] Antagene, Anim Genet Lab, Limonest, France; [Kury, Sebastien] Ctr Hosp Univ CHU Nantes, Serv Genet Med, Nantes, France; [Bensignor, Emmanuel] Clin Vet Boulais, Cesson Sevigne, France; [Fontaine, Jacques] Clin Vet, Brussels, Belgium; [Pin, Didier] VetAgro Sup Campus Vet Lyon, Unite Dermatol, Marcy Letoile, France; [Lathrop, Mark] CEPH, Fdn Jean Dausset, Paris, France; [Fischer, Judith] Univ Freiburg, Zentrum Biosyst Anal, D-79106 Freiburg, Germany	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; University of Graz; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Freiburg; University of Freiburg; Nantes Universite; CHU de Nantes; VetAgro Sup; Foundation Jean Dausset-CEPH; University of Freiburg	Andre, C (corresponding author), CNRS, Inst Genet & Dev Rennes, Rennes, France.	catherine.andre@univ-rennes1.fr; judith.fischer@uniklinik-freiburg.de	KÜRY, Sébastien/G-5971-2015; Le Gallo, Matthieu/F-7188-2012; Pin, Didier/AAO-5487-2020; Fischer, Judith/E-6327-2016; Le Gallo, Matthieu/T-4181-2019	KÜRY, Sébastien/0000-0001-5497-0465; Le Gallo, Matthieu/0000-0001-9085-8155; Fischer, Judith/0000-0002-8580-8118; Zechner, Rudolf/0000-0001-5483-1182; Radner, Franz/0000-0003-3466-0181; Zimmermann, Robert/0000-0002-7354-870X; Hitte, Christophe/0000-0003-1714-437X; Grond, Susanne/0000-0002-7121-9013	CNRS; European Commission [GA-201370]; FWF [F30 SFB Lipotox, Z136 Wittgenstein]; GEN-AU GOLD by the Austrian Ministry of Science and Research; NIRK Network (German BMBF) [01GM0904]; Austrian Science Fund (FWF) [W 901, Z 136, F 3002] Funding Source: researchfish	CNRS(Centre National de la Recherche Scientifique (CNRS)); European Commission(European CommissionEuropean Commission Joint Research Centre); FWF(Austrian Science Fund (FWF)); GEN-AU GOLD by the Austrian Ministry of Science and Research; NIRK Network (German BMBF)(Federal Ministry of Education & Research (BMBF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank A.S. Lequarre, an excellent coordinator for the European FP7 LUPA project, A. Boland and D. Zelenika for the genotyping performed at CNG (Evry, France); dermatologists, especially F. Caux, and Genethon, for patient DNA processing; J. Abadie (AMaROC research unit, Oniris, Ecole Nationale Veterinaire de Nantes, France) and practitioners T. Bord, X. Langon, P. Prelaud, M.D. Vailliant, A. Muller and other veterinarians for providing us with clinical data and samples, as well as dog owners and breeders, especially J. Robidou, B. Facq, V. d'Alcantara and C. de Vinck. We thank P. Roosje and T. Leeb (University of Bern, Switzerland) for providing six Swiss golden retriever samples. We thank A. Fautrel and P. Bellaud, from the histopathology platform H<SUP>2</SUP>P<SUP>2</SUP>, IFR140 Biogenouest, (Rennes, France), M.D. Vignon-Pennamen from the anatomopathology laboratory of Saint Louis Hospital (Paris, France) and M. Werner from the Institute of Pathology at the University Hospital of Freiburg (Freiburg, Germany) who kindly provided paraffin human skin sections, as well as the Vebiotel laboratory (Arcueil, France) for dog sample biochemical analyses. We are grateful to G. Queney (Antagene, Lyon, France) and P. Quignon, G. Rabut and E. Watrin (Institut de Genetique et Developpement de Rennes, France) for helpful discussions. Finally, we warmly thank S. Cure from Genoscope (Evry, France) for her several careful readings and English corrections and her kind availability, as well as D. Morris-Rosendahl (Institute for Human Genetics, Freiburg, Germany). This study was supported by CNRS, the European Commission (FP7-LUPA, GA-201370). R. Zechner and R. Zimmermann were supported by the FWF F30 SFB Lipotox, Z136 Wittgenstein, the GEN-AU project GOLD by the Austrian Ministry of Science and Research and FFG. I.H. was supported by the NIRK Network (German BMBF 01GM0904).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akiyama M, 2008, AM J PATHOL, V173, P1349, DOI 10.2353/ajpath.2008.080005; Akiyama M, 2008, EXP DERMATOL, V17, P373, DOI 10.1111/j.1600-0625.2007.00691.x; Akiyama M, 2007, MUSCLE NERVE, V36, P856, DOI 10.1002/mus.20869; Baulande S, 2010, M S-MED SCI, V26, P177, DOI 10.1051/medsci/2010262177; Cadiergues MC, 2008, VET DERMATOL, V19, P120, DOI 10.1111/j.1365-3164.2008.00667.x; Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; Credille KM, 2009, BRIT J DERMATOL, V161, P265, DOI 10.1111/j.1365-2133.2009.09161.x; Credille KM, 2005, BRIT J DERMATOL, V153, P51, DOI 10.1111/j.1365-2133.2005.06735.x; Demerjian M, 2006, J INVEST DERMATOL, V126, P2032, DOI 10.1038/sj.jid.5700332; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; Elias PM, 2008, J LIPID RES, V49, P697, DOI 10.1194/jlr.R800002-JLR200; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Fischer J, 2009, J INVEST DERMATOL, V129, P1319, DOI 10.1038/jid.2009.57; Galibert F, 2008, COMP BIOCHEM PHYS D, V3, P67, DOI 10.1016/j.cbd.2007.06.001; Gao JG, 2009, MOL GENET METAB, V96, P253, DOI 10.1016/j.ymgme.2008.12.007; Gregory A, 2008, NEUROLOGY, V71, P1402, DOI 10.1212/01.wnl.0000327094.67726.28; Guaguere E, 2009, J SMALL ANIM PRACT, V50, P227, DOI 10.1111/j.1748-5827.2009.00730.x; Guaguere E., 2007, VET DERMATOL, V18, P382; Hitomi K, 2005, EUR J DERMATOL, V15, P313; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; Israeli S, 2011, AM J HUM GENET, V88, P482, DOI 10.1016/j.ajhg.2011.02.011; Johansson LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005327; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; Klar J, 2009, AM J HUM GENET, V85, P248, DOI 10.1016/j.ajhg.2009.06.021; Laiho E, 1999, EUR J HUM GENET, V7, P625, DOI 10.1038/sj.ejhg.5200353; Lake AC, 2005, J LIPID RES, V46, P2477, DOI 10.1194/jlr.M500290-JLR200; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; Mauldin EA, 2008, VET PATHOL, V45, P174, DOI 10.1354/vp.45-2-174; Mauldin E.A., 2007, VET DERMATOL, V18, P187; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Mubaidin A, 2003, J MED GENET, V40, P543, DOI 10.1136/jmg.40.7.543; Ohkuma A, 2008, NEUROMUSCULAR DISORD, V18, P671, DOI 10.1016/j.nmd.2008.06.382; Oji V, 2010, J AM ACAD DERMATOL, V63, P607, DOI 10.1016/j.jaad.2009.11.020; Parker HG, 2009, SCIENCE, V325, P995, DOI 10.1126/science.1173275; PARMENTIER L, 1995, HUM MOL GENET, V4, P1391, DOI 10.1093/hmg/4.8.1391; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rainier S, 2008, AM J HUM GENET, V82, P780, DOI 10.1016/j.ajhg.2007.12.018; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; RUSSELL LJ, 1995, NAT GENET, V9, P279, DOI 10.1038/ng0395-279; Schweiger M, 2008, J BIOL CHEM, V283, P17211, DOI 10.1074/jbc.M710566200; Sutter NB, 2004, NAT REV GENET, V5, P900, DOI 10.1038/nrg1492; Tan EK, 2010, ANN NEUROL, V67, P148, DOI 10.1002/ana.21663; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Toulza E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r107; Wilson PA, 2006, J LIPID RES, V47, P1940, DOI 10.1194/jlr.M600185-JLR200; Yamaguchi T, 2009, BBA-MOL CELL BIOL L, V1791, P519, DOI 10.1016/j.bbalip.2008.10.012; Ziblat R, 2010, J AM CHEM SOC, V132, P9920, DOI 10.1021/ja103975g; Zimmermann R, 2009, BBA-MOL CELL BIOL L, V1791, P494, DOI 10.1016/j.bbalip.2008.10.005	50	163	168	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2012	44	2					140	147		10.1038/ng.1056	http://dx.doi.org/10.1038/ng.1056			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	22246504				2022-12-25	WOS:000299664400010
J	Yu, XQ; Li, M; Zhang, H; Low, HQ; Wei, X; Wang, JQ; Sun, LD; Sim, KS; Li, Y; Foo, JN; Wang, W; Li, ZJ; Yin, XY; Tang, XQ; Fan, L; Chen, J; Li, RS; Wan, JX; Liu, ZS; Lou, TQ; Zhu, L; Huang, XJ; Zhang, XJ; Liu, ZH; Liu, JJ				Yu, Xue-Qing; Li, Ming; Zhang, Hong; Low, Hui-Qi; Wei, Xin; Wang, Jin-Quan; Sun, Liang-Dan; Sim, Kar-Seng; Li, Yi; Foo, Jia-Nee; Wang, Wei; Li, Zhi-Jian; Yin, Xian-Yong; Tang, Xue-Qing; Fan, Li; Chen, Jian; Li, Rong-Shan; Wan, Jian-Xin; Liu, Zhang-Suo; Lou, Tan-Qi; Zhu, Li; Huang, Xiao-Jun; Zhang, Xue-Jun; Liu, Zhi-Hong; Liu, Jian-Jun			A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy	NATURE GENETICS			English	Article							IMMUNOGLOBULIN-A NEPHROPATHY; GENETIC-FACTORS; URINARY LEVELS; B-CELL; HLA; GLOMERULONEPHRITIS; ALLELES; APRIL; PROGRESSION; HAPLOTYPES	We performed a two-stage genome-wide association study of IgA nephropathy (IgAN) in Han Chinese, with 1,434 affected individuals (cases) and 4,270 controls in the discovery phase and follow-up of the top 61 SNPs in an additional 2,703 cases and 3,464 controls. We identified associations at 17p13 (rs3803800, P = 9.40 x 10(-11), OR = 1.21; rs4227, P = 4.31 x 10(-10), OR = 1.23) and 8p23 (rs2738048, P = 3.18 x 10(-14), OR = 0.79) that implicated the genes encoding tumor necrosis factor (TNFSF13) and alpha-defensin (DEFA) as susceptibility genes. In addition, we found multiple associations in the major histocompatibility complex (MHC) region (rs660895, P = 4.13 x 10(-20), OR = 1.34; rs1794275, P = 3.43 x 10(-13), OR = 1.30; rs2523946, P = 1.74 x 10(-11), OR = 1.21) and confirmed a previously reported association at 22q12 (rs12537, P = 1.17 x 10(-11), OR = 0.78). We also found that rs660895 was associated with clinical subtypes of IgAN (P = 0.003), proteinuria (P = 0.025) and IgA levels (P = 0.047). Our findings show that IgAN is associated with variants near genes involved in innate immunity and inflammation.	[Yu, Xue-Qing; Li, Ming; Wei, Xin; Wang, Wei; Li, Zhi-Jian; Tang, Xue-Qing; Fan, Li] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Xue-Qing; Li, Ming; Wei, Xin; Wang, Wei; Li, Zhi-Jian; Tang, Xue-Qing; Fan, Li] Minist Hlth, Key Lab Nephrol, Guangzhou, Guangdong, Peoples R China; [Zhang, Hong; Zhu, Li] Peking Univ, Hosp 1, Renal Div, Inst Nephrol, Beijing 100871, Peoples R China; [Low, Hui-Qi; Sim, Kar-Seng; Li, Yi; Foo, Jia-Nee; Liu, Jian-Jun] Genome Inst Singapore, Singapore, Singapore; [Wang, Jin-Quan; Liu, Zhi-Hong] Nanjing Mil Command, Nanjing Gen Hosp, Dept Nephrol, Nanjing, Jiangsu, Peoples R China; [Sun, Liang-Dan; Yin, Xian-Yong; Zhang, Xue-Jun] Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Anhui, Peoples R China; [Sun, Liang-Dan; Yin, Xian-Yong; Zhang, Xue-Jun] Anhui Med Univ, Hosp 1, Dept Dermatol, Hefei, Anhui, Peoples R China; [Sun, Liang-Dan; Yin, Xian-Yong; Zhang, Xue-Jun] Minist Natl Sci & Technol, State Key Lab Incubat Base Dermatol, Hefei, Anhui, Peoples R China; [Chen, Jian] Nanjing Mil Command, Fuzhou Gen Hosp, Dept Nephrol, Fuzhou, Fujian, Peoples R China; [Li, Rong-Shan] Shanxi Med Univ, Hosp 2, Dept Nephrol, Taiyuan, Shanxi, Peoples R China; [Wan, Jian-Xin] Fujian Med Univ, Affiliated Hosp 1, Dept Nephrol, Fuzhou, Fujian, Peoples R China; [Liu, Zhang-Suo] Zhengzhou Univ, Affiliated Hosp 1, Dept Nephrol, Zhengzhou, Henan, Peoples R China; [Lou, Tan-Qi] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Nephrol, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Xiao-Jun] Peking Univ, Peoples Hosp, Dept Hematol, Beijing 100871, Peoples R China; [Liu, Jian-Jun] Anhui Med Univ, Sch Life Sci, Hefei, Anhui, Peoples R China	Sun Yat Sen University; Peking University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Nanjing General Hospital; Anhui Medical University; Anhui Medical University; Shanxi Medical University; Fujian Medical University; Zhengzhou University; Sun Yat Sen University; Peking University; Anhui Medical University	Yu, XQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Guangzhou 510275, Guangdong, Peoples R China.	yuxq@mail.sysu.edu.cn; liuj3@gis.a-star.edu.sg	Chen, Gang/G-2722-2010; Foo, Jia Nee/D-6069-2014; Liu, Jianjun/AAK-4989-2020; Liu, Zhihong/ABB-6918-2021	Foo, Jia Nee/0000-0001-9899-2308; Liu, Jianjun/0000-0002-3255-3019; Liu, Zhihong/0000-0001-6093-0726; Sim, Kar Seng/0000-0002-3822-7759	Major State Basic Research Development Program of China (973 program) [2012CB517700-2012CB517706]; National Natural Science Foundation of China [81130012]; National Natural Science Foundation of China for Distinguished Young Scholars [30925019]; Agency for Science & Technology and Research of Singapore (A*STAR)	Major State Basic Research Development Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Agency for Science & Technology and Research of Singapore (A*STAR)(Agency for Science Technology & Research (A*STAR))	We are grateful to all the subjects and healthy volunteers who participated in this work. We thank the staff in The First Affiliated Hospital of Sun Yat-sen University for help with sample collection, DNA extraction and sample storage; WY. Meah, X. Chen, H.B. Toh, C.H. Wong, P.L. Ng and I.D. Irwan for performing the genotyping; Z.X. Zhang and Z. B. Hu for providing the control samples in the validation study and R. Johnson for reviewing the manuscript and providing constructive suggestions. This work was funded by the Major State Basic Research Development Program of China (973 program) (2012CB517700-2012CB517706), Key Program of National Natural Science Foundation of China (81130012), National Natural Science Foundation of China for Distinguished Young Scholars (30925019) and the Agency for Science & Technology and Research of Singapore (A*STAR) (to J.-J.L.).	Alexopoulos E, 1996, AM J KIDNEY DIS, V27, P327, DOI 10.1016/S0272-6386(96)90354-6; Barratt J, 2005, J AM SOC NEPHROL, V16, P2088, DOI 10.1681/ASN.2005020134; Beerman I, 2007, NAT CLIN PRACT NEPHR, V3, P325, DOI 10.1038/ncpneph0492; BERTHOUX FC, 1978, NEW ENGL J MED, V298, P1034; BERTHOUX FC, 1988, NEW ENGL J MED, V319, P1609; Bisceglia L, 2006, AM J HUM GENET, V79, P1130, DOI 10.1086/510135; Cao HX, 2008, AM J NEPHROL, V28, P684, DOI 10.1159/000122111; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; DAMICO G, 1987, Q J MED, V64, P709; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; Fennessy M, 1996, KIDNEY INT, V49, P477, DOI 10.1038/ki.1996.67; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Geetha D, 2007, AM J TRANSPLANT, V7, P2657, DOI 10.1111/j.1600-6143.2007.01988.x; Gharavi AG, 2000, NAT GENET, V26, P354, DOI 10.1038/81677; Gharavi AG, 2011, NAT GENET, V43, P321, DOI 10.1038/ng.787; Gupta SK, 2009, J INFECT DIS, V200, P614, DOI 10.1086/600890; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; Hei AL, 2009, INT J IMMUNOGENET, V36, P275, DOI 10.1111/j.1744-313X.2009.00866.x; Hsu SIH, 2000, KIDNEY INT, V57, P1818, DOI 10.1046/j.1523-1755.2000.00032.x; Hsu SIH, 2008, SEMIN NEPHROL, V28, P48, DOI 10.1016/j.semnephrol.2007.10.006; Izzi C, 2006, KIDNEY INT, V69, P1033, DOI 10.1038/sj.ki.5000185; Kawabata Y, 2009, DIABETOLOGIA, V52, P2513, DOI 10.1007/s00125-009-1539-9; Kiryluk Krzysztof, 2010, Pediatr Nephrol, V25, P2257, DOI 10.1007/s00467-010-1500-7; LEVY M, 1988, AM J KIDNEY DIS, V12, P340, DOI 10.1016/S0272-6386(88)80021-0; Maruhashi Y, 2004, CLIN NEPHROL, V62, P336; Neusser MA, 2011, MODERN PATHOL, V24, P98, DOI 10.1038/modpathol.2010.184; Paterson AD, 2007, J AM SOC NEPHROL, V18, P2408, DOI 10.1681/ASN.2007020241; RAGUENES O, 1995, TISSUE ANTIGENS, V45, P246, DOI 10.1111/j.1399-0039.1995.tb02447.x; Ramanujam M, 2006, J CLIN INVEST, V116, P724, DOI 10.1172/JCI26385; Rehaume LM, 2008, CRIT REV IMMUNOL, V28, P185, DOI 10.1615/CritRevImmunol.v28.i3.10; Saraheimo M, 2008, NEPHROL DIAL TRANSPL, V23, P914, DOI 10.1093/ndt/gfm711; Scolari F, 2003, J NEPHROL, V16, P317; Stangou M, 2009, NEPHROLOGY, V14, P613, DOI 10.1111/j.1440-1797.2008.01051.x; Stein JV, 2002, J CLIN INVEST, V109, P1587, DOI 10.1172/JCI200215034; Trachtenberg E, 2007, TISSUE ANTIGENS, V70, P455, DOI 10.1111/j.1399-0039.2007.00932.x; Tsuchiya N, 2006, GENES IMMUN, V7, P81, DOI 10.1038/sj.gene.6364262; Tsukamoto Y, 2009, CLIN EXP NEPHROL, V13, P249, DOI 10.1007/s10157-009-0156-8; Vordenbaumen S, 2010, LUPUS, V19, P1648, DOI 10.1177/0961203310377089; Yokoyama H, 1998, J LEUKOCYTE BIOL, V63, P493, DOI 10.1002/jlb.63.4.493; Yu HH, 2011, CLIN REV ALLERG IMMU, V41, P198, DOI 10.1007/s12016-010-8232-0	40	200	223	1	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2012	44	2					178	182		10.1038/ng.1047	http://dx.doi.org/10.1038/ng.1047			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	22197929				2022-12-25	WOS:000299664400016
J	Chih, B; Liu, P; Chinn, Y; Chalouni, C; Komuves, LG; Hass, PE; Sandoval, W; Peterson, AS				Chih, Ben; Liu, Peter; Chinn, Yvonne; Chalouni, Cecile; Komuves, Laszlo G.; Hass, Philip E.; Sandoval, Wendy; Peterson, Andrew S.			A ciliopathy complex at the transition zone protects the cilia as a privileged membrane domain	NATURE CELL BIOLOGY			English	Article							OUTER SEGMENT DEVELOPMENT; DISEASE GENES; CILIOGENESIS; MKS1; DISRUPTION; GENERATION; REGULATOR; PROTEINS; CC2D2A; BODY	Using RNAi screening, proteomics, cell biological and mouse genetics approaches, we have identified a complex of nine proteins, seven of which are disrupted in human ciliopathies. A transmembrane component, TMEM231, localizes to the basal body before and independently of intraflagellar transport in a Septin 2 (Sept2)-regulated fashion. The localizations of TMEM231, B9D1 (B9 domain-containing protein 1) and CC2D2A (coiled-coil and C2 domain-containing protein 2A) at the transition zone are dependent on one another and on Sept2. Disruption of the complex in vitro causes a reduction in cilia formation and a loss of signalling receptors from the remaining cilia. Mouse knockouts of B9D1 and TMEM231 have identical defects in Sonic hedgehog (Shh) signalling and ciliogenesis. Strikingly, disruption of the complex increases the rate of diffusion into the ciliary membrane and the amount of plasma-membrane protein in the cilia. The complex that we have described is essential for normal cilia function and acts as a diffusion barrier to maintain the cilia membrane as a compartmentalized signalling organelle.	[Chih, Ben; Peterson, Andrew S.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Liu, Peter; Chinn, Yvonne; Hass, Philip E.; Sandoval, Wendy] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Chalouni, Cecile; Komuves, Laszlo G.] Genentech Inc, Ctr Adv Light Microscopy, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Peterson, AS (corresponding author), Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA.	peterson.andrew@gene.com			Genentech	Genentech(Roche HoldingGenentech)	We thank M. Roose-Girma (Genentech) for generating B9D1-knockout mouse; J. Miller, S. Mukhopadhyay and P. Jackson (all Genentech) for various LAP tagging constructs and advice on tandem affinity purification technology; S. Francis (Genentech) for GFP-CEACAM1 and GFP-GPI retroviral particles; B. Bingol for help with Image J analysis; D. Grant, M. Solloway and H. Tian for help with histology; J. Ernst and H. Li for octyl-Shh; and the Genentech research community for their advice and assistance. TMEM231-knockout mice were produced in a collaboration between Genentech and Lexicon Pharmaceuticals (The Woodlands) to analyse the function of about 500 secreted and transmembrane proteins. Genentech provided financial support.	Ashique AM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000602; Bachmann-Gagescu R, 2011, HUM MOL GENET, V20, P4041, DOI 10.1093/hmg/ddr332; Bialas NJ, 2009, J CELL SCI, V122, P611, DOI 10.1242/jcs.028621; Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; Cardenas-Rodriguez M, 2009, AM J MED GENET C, V151C, P263, DOI 10.1002/ajmg.c.30227; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; Cui C, 2011, DIS MODEL MECH, V4, P43, DOI 10.1242/dmm.006262; Davenport JR, 2005, AM J PHYSIOL-RENAL, V289, pF1159, DOI 10.1152/ajprenal.00118.2005; Dowdle WE, 2011, AM J HUM GENET, V89, P94, DOI 10.1016/j.ajhg.2011.06.003; Eley L, 2005, CURR OPIN GENET DEV, V15, P308, DOI 10.1016/j.gde.2005.04.008; Evangelista M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1162925; Fliegauf M, 2006, J AM SOC NEPHROL, V17, P2424, DOI 10.1681/ASN.2005121351; Francis SS, 2011, J CELL BIOL, V193, P219, DOI 10.1083/jcb.201009001; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; GILULA NB, 1972, J CELL BIOL, V53, P494, DOI 10.1083/jcb.53.2.494; Gorden NT, 2008, AM J HUM GENET, V83, P559, DOI 10.1016/j.ajhg.2008.10.002; Hopp K, 2011, HUM MOL GENET, V20, P2524, DOI 10.1093/hmg/ddr151; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; HUNNICUTT GR, 1990, J CELL BIOL, V111, P1605, DOI 10.1083/jcb.111.4.1605; Lancaster MA, 2009, NAT MED, V15, P1046, DOI 10.1038/nm.2010; Louie CM, 2010, NAT GENET, V42, P175, DOI 10.1038/ng.519; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Nachury MV, 2008, METHOD ENZYMOL, V439, P501, DOI 10.1016/S0076-6879(07)00434-X; Pan JM, 2005, LAB INVEST, V85, P452, DOI 10.1038/labinvest.3700253; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Reiter JF, 2006, GENE DEV, V20, P22, DOI 10.1101/gad.1363606; RINGO DL, 1967, J CELL BIOL, V33, P543, DOI 10.1083/jcb.33.3.543; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rohatgi R, 2010, CURR OPIN CELL BIOL, V22, P541, DOI 10.1016/j.ceb.2010.03.010; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; SOROKIN SP, 1968, J CELL SCI, V3, P207; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Torres JZ, 2009, PROTEOMICS, V9, P2888, DOI 10.1002/pmic.200800873; Town T, 2008, P NATL ACAD SCI USA, V105, P2853, DOI 10.1073/pnas.0712385105; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; VALENTE FM, 2001, NAT GENET, V42, P619; Vieira OV, 2006, P NATL ACAD SCI USA, V103, P18556, DOI 10.1073/pnas.0608291103; Weatherbee SD, 2009, HUM MOL GENET, V18, P4565, DOI 10.1093/hmg/ddp422; Williams CL, 2008, MOL BIOL CELL, V19, P2154, DOI 10.1091/mbc.E07-10-1070; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116; Williams CL, 2010, J AM SOC NEPHROL, V21, P782, DOI 10.1681/ASN.2009060597; Won J, 2011, HUM MOL GENET, V20, P482, DOI 10.1093/hmg/ddq494	44	245	264	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2012	14	1					61	U97		10.1038/ncb2410	http://dx.doi.org/10.1038/ncb2410			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	866YC	22179047				2022-12-25	WOS:000298421100011
J	Quade, N; Huo, LJ; Rachid, S; Heinz, DW; Muller, R				Quade, Nick; Huo, Liujie; Rachid, Shwan; Heinz, Dirk W.; Mueller, Rolf			Unusual carbon fixation gives rise to diverse polyketide extender units	NATURE CHEMICAL BIOLOGY			English	Article							CROTONYL-COA CARBOXYLASE/REDUCTASE; ACYL CARRIER PROTEIN; BIOSYNTHESIS; SUBSTRATE; ORIGIN; ACP	Polyketides are structurally diverse and medically important natural products that have various biological activities. During biosynthesis, chain elongation uses activated dicarboxylic acid building blocks, and their availability therefore limits side chain variation in polyketides. Recently, the crotonyl-CoA carboxylase-reductase (CCR) class of enzymes was identified in primary metabolism and was found to be involved in extender-unit biosynthesis of polyketides. These enzymes are, in theory, capable of forming dicarboxylic acids that show any side chain from the respective unsaturated fatty acid precursor. To our knowledge, we here report the first crystal structure of a CCR, the hexylmalonyl-CoA synthase from Streptomyces sp. JS360, in complex with its substrate. Structural analysis and biochemical characterization of the enzyme, including active site mutations, are reported. Our analysis reveals how primary metabolic CCRs can evolve to produce various dicarboxylic acid building blocks, setting the stage to use CCRs for the production of unique extender units and, consequently, altered polyketides.	[Quade, Nick; Heinz, Dirk W.] Helmholtz Ctr Infect Res, Dept Mol Struct Biol, Braunschweig, Germany; [Huo, Liujie; Rachid, Shwan; Mueller, Rolf] Univ Saarland, Helmholtz Inst Pharmaceut Res Saarland, Helmholtz Ctr Infect Res & Pharmaceut Biotechnol, Dept Microbial Nat Prod, D-6600 Saarbrucken, Germany; [Rachid, Shwan] Univ Koya, Fac Sci & Hlth, Koya, Kurdistan, Iraq	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Saarland University	Quade, N (corresponding author), Helmholtz Ctr Infect Res, Dept Mol Struct Biol, Braunschweig, Germany.	dirk.heinz@helmholtz-hzi.de; rom@helmholtz-hzi.de	Müller, Rolf/B-1559-2008; Huo, Liujie/L-6090-2019	Müller, Rolf/0000-0002-1042-5665; Huo, Liujie/0000-0002-1406-8466; Rachid, Shwan/0000-0003-0834-5153	Fonds der Chemischen Industrie; Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung und Forschung (BMBF)	Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	D.W.H. acknowledges support from the Fonds der Chemischen Industrie. Research in R.M.'s laboratory was funded by the Deutsche Forschungsgemeinschaft and the Bundesministerium fur Bildung und Forschung (BMBF). We thank V. Wray for critically reviewing this manuscript. We also would like to thank T. Hoffmann for technical support, K. Harmrolfs for the NMR measurement and S. C. Wenzel for advice during the course of this project. In addition, we appreciate the work of A. Ullrich and K. Schultz from U. Kazmaier's work group for the syntheses of 2-octenoyl-CoA and 2-octenoyl-SNAC.	Buntin K, 2010, CHEM BIOL, V17, P342, DOI 10.1016/j.chembiol.2010.02.013; Chan YA, 2006, P NATL ACAD SCI USA, V103, P14349, DOI 10.1073/pnas.0603748103; Dorrestein PC, 2006, J AM CHEM SOC, V128, P10386, DOI 10.1021/ja0639362; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Erb TJ, 2009, P NATL ACAD SCI USA, V106, P8871, DOI 10.1073/pnas.0903939106; Esposito L, 2003, BIOCHEMISTRY-US, V42, P14397, DOI 10.1021/bi035271b; Eustaquio AS, 2009, P NATL ACAD SCI USA, V106, P12295, DOI 10.1073/pnas.0901237106; Goranovic D, 2010, J BIOL CHEM, V285, P14292, DOI 10.1074/jbc.M109.059600; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Kopp M, 2011, MOL BIOSYST, V7, P1549, DOI 10.1039/c0mb00240b; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li X, 2007, P NATL ACAD SCI USA, V104, P19279, DOI 10.1073/pnas.0709710104; Mo S, 2011, J AM CHEM SOC, V133, P976, DOI 10.1021/ja108399b; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Porte S, 2009, J BIOL CHEM, V284, P17194, DOI 10.1074/jbc.M109.001800; Qu XD, 2011, MOL BIOSYST, V7, P852, DOI 10.1039/c0mb00234h; Rachid S, 2011, CHEMBIOCHEM, V12, P922, DOI 10.1002/cbic.201100024; Song LJ, 2006, J AM CHEM SOC, V128, P14754, DOI 10.1021/ja065247w; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Verdonk ML, 2005, J MED CHEM, V48, P6504, DOI 10.1021/jm050543p; Weissman KJ, 2005, NAT REV MICROBIOL, V3, P925, DOI 10.1038/nrmicro1287; Wenzel SC, 2006, J AM CHEM SOC, V128, P14325, DOI 10.1021/ja064408t; Wilson MC, 2011, J AM CHEM SOC, V133, P1971, DOI 10.1021/ja109226s; Xu LH, 2010, J BIOL CHEM, V285, P16844, DOI 10.1074/jbc.M109.092460; Xu ZL, 2011, ANGEW CHEM INT EDIT, V50, P4667, DOI 10.1002/anie.201008265; Yoo HG, 2011, BIOSCI BIOTECH BIOCH, V75, P1191, DOI 10.1271/bbb.110003	26	52	52	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					117	124		10.1038/nchembio.734	http://dx.doi.org/10.1038/nchembio.734			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22138621				2022-12-25	WOS:000298414100020
J	Lippmann, ES; Azarin, SM; Kay, JE; Nessler, RA; Wilson, HK; Al-Ahmad, A; Palecek, SP; Shusta, EV				Lippmann, Ethan S.; Azarin, Samira M.; Kay, Jennifer E.; Nessler, Randy A.; Wilson, Hannah K.; Al-Ahmad, Abraham; Palecek, Sean P.; Shusta, Eric V.			Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							PROTEIN-COUPLED RECEPTOR; TIGHT JUNCTION PROTEINS; IN-VITRO MODEL; CNS; DIFFERENTIATION; ANGIOGENESIS; FRIZZLED-4; TRANSPORTERS; EXPRESSION; INDUCTION	The blood-brain barrier (BBB) is crucial to the health of the brain and is often compromised in neurological disease. Moreover, because of its barrier properties, this endothelial interface restricts uptake of neurotherapeutics. Thus, a renewable source of human BBB endothelium could spur brain research and pharmaceutical development. Here we show that endothelial cells derived from human pluripotent stem cells (hPSCs) acquire BBB properties when co-differentiated with neural cells that provide relevant cues, including those involved in Wnt/beta-catenin signaling. The resulting endothelial cells have many BBB attributes, including well-organized tight junctions, appropriate expression of nutrient transporters and polarized efflux transporter activity. Notably, they respond to astrocytes, acquiring substantial barrier properties as measured by transendothelial electrical resistance (1,450 +/- 140 Omega cm(2)), and they possess molecular permeability that correlates well with in vivo rodent blood-brain transfer coefficients.	[Lippmann, Ethan S.; Azarin, Samira M.; Kay, Jennifer E.; Wilson, Hannah K.; Al-Ahmad, Abraham; Palecek, Sean P.; Shusta, Eric V.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA; [Nessler, Randy A.] Univ Iowa, Cent Microscopy Res Facil, Iowa City, IA USA	University of Wisconsin System; University of Wisconsin Madison; University of Iowa	Shusta, EV (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA.	palecek@engr.wisc.edu; shusta@engr.wisc.edu	Alahmad, Abraham/K-3031-2012; Al-Ahmad/Alahmad, Abraham Jacob/E-1088-2013	Alahmad, Abraham/0000-0002-7716-4412; Al-Ahmad/Alahmad, Abraham Jacob/0000-0001-7463-3204; Song, Hannah/0000-0002-7238-7553	US National Institutes of Health (NIH) [NS056249, AA020476, EB007534]; US National Science Foundation (NSF) [EFRI-0735903]; NIH Chemistry Biology Interface traineeship [T32 GM008505]; NSF; WiCell Research Institute; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [RC4AA020476] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation (NSF)(National Science Foundation (NSF)); NIH Chemistry Biology Interface traineeship; NSF(National Science Foundation (NSF)); WiCell Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was funded in part by US National Institutes of Health (NIH) grants NS056249 (E.V.S.), AA020476 (E.V.S.) and EB007534 (S.P.P.) and US National Science Foundation (NSF) grant EFRI-0735903 (S.P.P.). E.S.L. is a recipient of a NIH Chemistry Biology Interface traineeship (T32 GM008505) and S.M.A. is the recipient of a NSF Graduate Research fellowship. We thank the WiCell Research Institute for providing research support and W.M. Pardridge (University of California-Los Angeles) for the gift of GLUT-1 antiserum.	Anderson KD, 2011, P NATL ACAD SCI USA, V108, P2807, DOI 10.1073/pnas.1019761108; BAUER HC, 1993, DEV BRAIN RES, V75, P269, DOI 10.1016/0165-3806(93)90031-5; BUTT AM, 1990, J PHYSIOL-LONDON, V429, P47, DOI 10.1113/jphysiol.1990.sp018243; Calabria AR, 2006, J NEUROCHEM, V97, P922, DOI 10.1111/j.1471-4159.2006.03793.x; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; Choi KD, 2009, STEM CELLS, V27, P559, DOI 10.1634/stemcells.2008-0922; Cleaver O, 2003, NAT MED, V9, P661, DOI 10.1038/nm0603-661; Cullen M, 2011, P NATL ACAD SCI USA, V108, P5759, DOI 10.1073/pnas.1017192108; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Forster C, 2008, J PHYSIOL-LONDON, V586, P1937, DOI 10.1113/jphysiol.2007.146852; Goldman O, 2009, STEM CELLS, V27, P1750, DOI 10.1002/stem.100; James D, 2010, NAT BIOTECHNOL, V28, P161, DOI 10.1038/nbt.1605; Kane NM, 2010, ARTERIOSCL THROM VAS, V30, P1389, DOI 10.1161/ATVBAHA.110.204800; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kuhnert F, 2010, SCIENCE, V330, P985, DOI 10.1126/science.1196554; Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999; Liebner S, 2000, EUR J CELL BIOL, V79, P707, DOI 10.1078/0171-9335-00101; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Malina KCK, 2009, BRAIN RES, V1284, P12, DOI 10.1016/j.brainres.2009.05.072; Man S, 2008, CLIN DEV IMMUNOL, P1, DOI 10.1155/2008/384982; Nakahara M, 2009, CLONING STEM CELLS, V11, P509, DOI 10.1089/clo.2009.0023; Pardridge W. M., 2003, MOL INTERV, V3, P151; Pardridge William M, 2003, Mol Interv, V3, P90, DOI 10.1124/mi.3.2.90; Perriere N, 2007, BRAIN RES, V1150, P1, DOI 10.1016/j.brainres.2007.02.091; Roberts LM, 2008, ENDOCRINOLOGY, V149, P6251, DOI 10.1210/en.2008-0378; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; RUBIN LL, 1991, J CELL BIOL, V115, P1725, DOI 10.1083/jcb.115.6.1725; Shimomura Y, 2010, NATURE, V464, P1043, DOI 10.1038/nature08875; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; STEWART PA, 1994, DEV BRAIN RES, V78, P25, DOI 10.1016/0165-3806(94)90005-1; Syvanen S, 2009, DRUG METAB DISPOS, V37, P635, DOI 10.1124/dmd.108.024745; Szeto W, 2001, CANCER RES, V61, P4197; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Uchida Y, 2011, J NEUROCHEM, V117, P333, DOI 10.1111/j.1471-4159.2011.07208.x; Vittet D, 1996, BLOOD, V88, P3424, DOI 10.1182/blood.V88.9.3424.bloodjournal8893424; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Wang LS, 2004, IMMUNITY, V21, P31, DOI 10.1016/j.immuni.2004.06.006; Wang ZZ, 2007, NAT BIOTECHNOL, V25, P317, DOI 10.1038/nbt1287; Warren MS, 2009, PHARMACOL RES, V59, P404, DOI 10.1016/j.phrs.2009.02.007; Weidenfeller C, 2007, J NEUROCHEM, V101, P555, DOI 10.1111/j.1471-4159.2006.04394.x; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	51	430	451	6	110	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2012	30	8					783	791		10.1038/nbt.2247	http://dx.doi.org/10.1038/nbt.2247			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	987KX	22729031	Green Accepted			2022-12-25	WOS:000307416900022
J	Chen, SL; Novick, P; Ferro-Novick, S				Chen, Shuliang; Novick, Peter; Ferro-Novick, Susan			ER network formation requires a balance of the dynamin-like GTPase Sey1p and the Lunapark family member Lnp1p	NATURE CELL BIOLOGY			English	Article							CORTICAL ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL FUSION; MEMBRANE-PROTEINS; YEAST; INHERITANCE; MECHANISMS; CURVATURE; ATLASTIN	Although studies on endoplasmic reticulum (ER) structure and dynamics have focused on the ER tubule-forming proteins (reticulons and DP1/Yop1p) and the tubule fusion protein atlastin, nothing is known about the proteins and processes that act to counterbalance this machinery. Here we show that Lnp1p, a member of the conserved Lunapark family, plays a role in ER network formation. Lnp1p binds to the reticulons and Yop1p and resides at ER tubule junctions in both yeast and mammalian cells. In the yeast Saccharomyces cerevisiae, the interaction of Lnp1p with the reticulon protein, Rtn1p, and the localization of Lnp1p to ER junctions are regulated by Sey1p, the yeast orthologue of atlastin. We propose that Lnp1p and Sey1p act antagonistically to balance polygonal network formation. In support of this proposal, we show that the collapsed, densely reticulated ER network in Inp1 Delta cells is partially restored when the GTPase activity of Sey1p is abrogated.	[Chen, Shuliang; Novick, Peter; Ferro-Novick, Susan] Univ Calif San Diego, George Palade Labs, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Chen, Shuliang; Ferro-Novick, Susan] Univ Calif San Diego, George Palade Labs, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Novick, P (corresponding author), Univ Calif San Diego, George Palade Labs, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	pnovick@ucsd.edu; sfnovick@ucsd.edu	Chen, Shuliang/N-9498-2013	Chen, Shuliang/0000-0002-7175-7604	National Institutes of Health [GM073892]; Howard Hughes Medical Institute;  [P30 NS047101]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073892, R01GM035370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Voeltz (Department of Molecular, Cellular and Developmental Biology, University of Colorado at Boulder, USA) for plasmids. We also thank Y. Jones in the Electron Microscopy Facility in the Department of Cellular and Molecular Medicine at the University of California at San Diego, USA, headed by M. Farquhar, for the preparation of electron microscopy samples, and we acknowledge use of the UCSD Neuroscience Microscopy Facility funded by grant P30 NS047101. This work was supported by a grant from the National Institutes of Health (GM073892) and the Howard Hughes Medical Institute. Salary support for S.C. and S.F-N. was provided by the Howard Hughes Medical Institute.	Barrowman J, 2000, EMBO J, V19, P862, DOI 10.1093/emboj/19.5.862; Beetz C, 2008, BRAIN, V131, P1078, DOI 10.1093/brain/awn026; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; De Craene JO, 2006, MOL BIOL CELL, V17, P3009, DOI 10.1091/mbc.e06-01-0080; Du YR, 2004, J CELL SCI, V117, P2871, DOI 10.1242/jcs.01286; Du YR, 2001, MOL BIOL CELL, V12, P2614, DOI 10.1091/mbc.12.9.2614; Estrada P, 2003, J CELL BIOL, V163, P1255, DOI 10.1083/jcb.200304030; Ghila L, 2008, EUR J NEUROSCI, V27, P621, DOI 10.1111/j.1460-9568.2008.06049.x; Grote Eric, 2008, V475, P165, DOI 10.1007/978-1-59745-250-2_10; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; LEE C, 1988, CELL, V54, P37, DOI 10.1016/0092-8674(88)90177-8; Loewen CJR, 2007, J CELL BIOL, V179, P467, DOI 10.1083/jcb.200708205; Moss TJ, 2011, P NATL ACAD SCI USA, V108, P11133, DOI 10.1073/pnas.1105056108; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461; Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; West M, 2011, J CELL BIOL, V193, P333, DOI 10.1083/jcb.201011039	26	98	100	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2012	14	7					707	716		10.1038/ncb2523	http://dx.doi.org/10.1038/ncb2523			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	967PV	22729086	Green Accepted			2022-12-25	WOS:000305921200010
J	Doyle, SL; Campbell, M; Ozaki, E; Salomon, RG; Mori, A; Kenna, PF; Farrar, GJ; Kiang, AS; Humphries, MM; Lavelle, EC; O'Neill, LAJ; Hollyfield, JG; Humphries, P				Doyle, Sarah L.; Campbell, Matthew; Ozaki, Ema; Salomon, Robert G.; Mori, Andres; Kenna, Paul F.; Farrar, Gwyneth Jane; Kiang, Anna-Sophia; Humphries, Marian M.; Lavelle, Ed C.; O'Neill, Luke A. J.; Hollyfield, Joe G.; Humphries, Peter			NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components	NATURE MEDICINE			English	Article							OXIDATIVE STRESS; INTRAVITREAL INFLIXIMAB; NALP3 INFLAMMASOME; PROTEIN; CELLS; C1Q; ACTIVATION; CRYSTALS; BINDING; RETINA	Age-related macular degeneration (AMD) is the leading cause of central vision loss worldwide. Drusen accumulation is the major pathological hallmark common to both dry and wet AMD. Although activation of the immune system has been implicated in disease progression, the pathways involved are unclear. Here we show that drusen isolated from donor AMD eyes activates the NACHT, LRR and PYD domains-containing protein 3 (NLRP3) inflammasome, causing secretion of interleukin-1 beta (IL-1 beta) and IL-18. Drusen component C1Q also activates the NLRP3 inflammasome. Moreover, the oxidative-stress-related protein-modification carboxyethylpyrrole (CEP), a biomarker of AMD, primes the inflammasome. We found cleaved caspase-1 and NLRP3 in activated macrophages in the retinas of mice immunized with CEP-adducted mouse serum albumin, modeling a dry-AMD-like pathology. We show that laser-induced choroidal neovascularization (CNV), a mouse model of wet AMD, is exacerbated in Nlrp3(-/-) but not Il1r1(-/-) mice, directly implicating IL-18 in the regulation of CNV development. These findings indicate a protective role for NLRP3 and IL-18 in the progression of AMD.	[Campbell, Matthew; Ozaki, Ema; Kenna, Paul F.; Farrar, Gwyneth Jane; Kiang, Anna-Sophia; Humphries, Marian M.; Humphries, Peter] Trinity Coll Dublin, Smurfit Inst Genet, Ocular Genet Unit, Dublin 2, Ireland; [Doyle, Sarah L.; Mori, Andres; Lavelle, Ed C.; O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland; [Salomon, Robert G.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Kenna, Paul F.] Royal Victoria Eye & Ear Hosp, Res Fdn, Dublin 2, Ireland; [Hollyfield, Joe G.] Cleveland Clin, Lerner Coll Med, Cole Eye Inst, Dept Ophthalmol, Cleveland, OH 44106 USA	Trinity College Dublin; Trinity College Dublin; Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation	Campbell, M (corresponding author), Trinity Coll Dublin, Smurfit Inst Genet, Ocular Genet Unit, Lincoln Pl Gate, Dublin 2, Ireland.	matthew.campbell@tcd.ie	Lavelle, Ed/A-1716-2008; Doyle, Sarah/C-1453-2014; Salomon, Robert G/C-3463-2008; Bateson, Jane Farrar/AAO-6147-2020	Lavelle, Ed/0000-0002-3167-1080; Doyle, Sarah/0000-0002-6294-9380; Salomon, Robert/0000-0001-9456-3557; O'Neill, Luke/0000-0002-4333-2748	American Health Assistance Foundation (AHAF); Science Foundation Ireland (SFI) [07/SRC/B1144, 08/RFP/MBT1363]; Health Research Board of Ireland (HRB); Irish Research Council for Science Engineering and Technology (IRCSET); Enterprise Ireland (EI); Telemedicine and Advanced Technology Research Center (TATRC); Fighting Blindness Ireland (FB-Ireland); SFI Immunology Research Centre (IRC); US National Institutes of Health [EY014240, GM021249, EY016813]; Macular Vision Research Foundation; Research to Prevent Blindness; Llura and Gordon Gund Foundation; NATIONAL EYE INSTITUTE [R56EY014240, R01EY014240, R01EY016813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021249] Funding Source: NIH RePORTER	American Health Assistance Foundation (AHAF); Science Foundation Ireland (SFI)(Science Foundation Ireland); Health Research Board of Ireland (HRB); Irish Research Council for Science Engineering and Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology); Enterprise Ireland (EI); Telemedicine and Advanced Technology Research Center (TATRC); Fighting Blindness Ireland (FB-Ireland); SFI Immunology Research Centre (IRC)(Science Foundation Ireland); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Macular Vision Research Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Llura and Gordon Gund Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Ocular Genetics Unit at Trinity College Dublin is supported by the American Health Assistance Foundation (AHAF), Science Foundation Ireland (SFI), The Health Research Board of Ireland (HRB), Irish Research Council for Science Engineering and Technology (IRCSET), Enterprise Ireland (EI), Telemedicine and Advanced Technology Research Center (TATRC) and Fighting Blindness Ireland (FB-Ireland). S.L.D. and L.A.J.O. are supported by the SFI Immunology Research Centre (IRC) and the SFI Strategic Research Cluster (07/SRC/B1144). Support for the laboratory of J.G.H. was provided by the US National Institutes of Health through grant EY014240, the Macular Vision Research Foundation, Research to Prevent Blindness and the Llura and Gordon Gund Foundation. Support for the laboratory of R.G.S. was provided by the US National Institutes of Health through grants GM021249 and EY016813. Support for the laboratory of E.C.L. was from SFI grant number 08/RFP/MBT1363 and SFI Strategic Research Cluster 07/SRC/B1144. We would like to thank C. Woods, C. Murray, D. Flynn and R. Robertson for animal husbandry. The authors would also like to thank the Research Foundation at the Royal Victoria Eye and Ear Hospital for assistance in the acquisition of the Iridex laser system. We thank E. Latz (University of Bonn) for the provision of BMDMs expressing YFP-labeled ASC. We would like to acknowledge the expertise of K. Shadrach in isolating drusen from AMD donor eyes.	Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Anderson DH, 2004, EXP EYE RES, V78, P243, DOI 10.1016/j.exer.2003.10.011; Arias L, 2010, RETINA-J RET VIT DIS, V30, P1601, DOI 10.1097/IAE.0b013e3181e9f942; Blanquet-Grossard F, 2005, BIOCHEMISTRY-US, V44, P4349, DOI 10.1021/bi047370a; BRESSLER SB, 1990, ARCH OPHTHALMOL-CHIC, V108, P1442, DOI 10.1001/archopht.1990.01070120090035; Campbell M, 2011, EMBO MOL MED, V3, P235, DOI 10.1002/emmm.201100126; Canter JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002091; Chen YH, 2010, MOL INTERV, V10, P271, DOI 10.1124/mi.10.5.4; Coughlin CM, 1998, J CLIN INVEST, V101, P1441, DOI 10.1172/JCI1555; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Edwards Albert O., 2007, Angiogenesis, V10, P119, DOI 10.1007/s10456-007-9064-2; GAO H, 1992, INVEST OPHTH VIS SCI, V33, P1; Giganti M, 2010, RETINA-J RET VIT DIS, V30, P71, DOI 10.1097/IAE.0b013e3181bcef3b; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; Gu XR, 2003, J ORG CHEM, V68, P3749, DOI 10.1021/jo026721t; Hageman GS, 1999, MOL VIS, V5; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Holz FG, 2001, INVEST OPHTH VIS SCI, V42, P1051; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Ishii T, 1984, Appl Pathol, V2, P370; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jiang HR, 2001, INVEST OPHTH VIS SCI, V42, P177; Leveziel N, 2011, OPHTHALMOLOGICA, V226, DOI 10.1159/000328981; Lin HJ, 2011, INVEST OPHTH VIS SCI, V52, P3521, DOI 10.1167/iovs.10-6163; Luibl V, 2006, J CLIN INVEST, V116, P378, DOI 10.1172/JCI25843; Luo XG, 2003, J NEUROIMMUNOL, V135, P62, DOI 10.1016/S0165-5728(02)00444-7; Ma WX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007945; Mallat Z, 2002, CIRC RES, V91, P441, DOI 10.1161/01.RES.0000033592.11674.D8; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Nauta AJ, 2002, EUR J IMMUNOL, V32, P1726, DOI 10.1002/1521-4141(200206)32:6<1726::AID-IMMU1726>3.0.CO;2-R; PERCOPO CM, 1990, J IMMUNOL, V145, P4101; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qiao H, 2004, LAB INVEST, V84, P973, DOI 10.1038/labinvest.3700115; Qiao H, 2007, J LEUKOCYTE BIOL, V81, P1012, DOI 10.1189/jlb.0506342; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; SARKS SH, 1980, T OPHTHAL SOC UK, V100, P414; Seddon JM, 2006, ARCH OPHTHALMOL-CHIC, V124, P995, DOI 10.1001/archopht.124.7.995; Swaroop A, 2009, ANNU REV GENOM HUM G, V10, P19, DOI 10.1146/annurev.genom.9.081307.164350; Ten VS, 2010, J NEUROSCI, V30, P2077, DOI 10.1523/JNEUROSCI.5249-09.2010; VINDING T, 1990, ACTA OPHTHALMOL, V68, P410; Wang AL, 2009, AUTOPHAGY, V5, P563, DOI 10.4161/auto.5.4.8163; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	56	290	327	0	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					791	U191		10.1038/nm.2717	http://dx.doi.org/10.1038/nm.2717			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22484808	Green Accepted			2022-12-25	WOS:000303763500047
J	Gudesblat, GE; Schneider-Pizon, J; Betti, C; Mayerhofer, J; Vanhoutte, I; van Dongen, W; Boeren, S; Zhiponova, M; de Vries, S; Jonak, C; Russinova, E				Gudesblat, Gustavo E.; Schneider-Pizon, Joanna; Betti, Camilla; Mayerhofer, Juliane; Vanhoutte, Isabelle; van Dongen, Walter; Boeren, Sjef; Zhiponova, Miroslava; de Vries, Sacco; Jonak, Claudia; Russinova, Eugenia			SPEECHLESS integrates brassinosteroid and stomata signalling pathways	NATURE CELL BIOLOGY			English	Article							ASYMMETRIC CELL-DIVISION; ARABIDOPSIS-THALIANA; PHOSPHORYLATION SITES; SECRETORY PEPTIDE; GSK3-LIKE KINASES; RECEPTOR KINASES; DIFFERENTIATION; IDENTIFICATION; TRANSDUCTION; INHIBITION	Stomatal formation is regulated by multiple developmental and environmental signals, but how these signals are integrated to control this process is not fully understood(1). In Arabidopsis thaliana, the basic helix-loop-helix transcription factor SPEECHLESS (SPCH) regulates the entry, amplifying and spacing divisions that occur during stomatal lineage development. SPCH activity is negatively regulated by mitogen-activated protein kinase (MAPK)-mediated phosphorylation(2). Here, we show that in addition to MAPKs, SPCH activity is also modulated by brassinosteroid (BR) signalling. The GSK3/SHAGGY-like kinase BIN2 (BR INSENSITIVE2) phosphorylates residues overlapping those targeted by the MAPKs, as well as four residues in the amino-terminal region of the protein outside the MAPK target domain. These phosphorylation events antagonize SPCH activity and limit epidermal cell proliferation. Conversely, inhibition of BIN2 activity in vivo stabilizes SPCH and triggers excessive stomatal and non-stomatal cell formation. We demonstrate that through phosphorylation inputs from both MAPKs and BIN2, SPCH serves as an integration node for stomata and BR signalling pathways to control stomatal development in Arabidopsis.	[Gudesblat, Gustavo E.; Schneider-Pizon, Joanna; Betti, Camilla; Vanhoutte, Isabelle; Zhiponova, Miroslava; Russinova, Eugenia] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Gudesblat, Gustavo E.; Schneider-Pizon, Joanna; Betti, Camilla; Vanhoutte, Isabelle; Zhiponova, Miroslava; Russinova, Eugenia] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Mayerhofer, Juliane; Jonak, Claudia] Austrian Acad Sci, GMI Gregor Mendel Inst Mol Plant Biol, A-1030 Vienna, Austria; [van Dongen, Walter; Boeren, Sjef; de Vries, Sacco] Wageningen Univ, Biochem Lab, NL-6703 HA Wageningen, Netherlands	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); Wageningen University & Research	Russinova, E (corresponding author), Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium.	jenny.russinova@psb.vib-ugent.be	Betti, Camilla/Y-6733-2019; Jonak, Claudia/G-1362-2016; Zhiponova, Miroslava/P-5354-2016	Betti, Camilla/0000-0003-3522-6440; Zhiponova, Miroslava/0000-0001-7333-6558; Russinova, Eugenia/0000-0002-0569-1977; Jonak, Claudia/0000-0001-9605-6751	Marie-Curie Initial Training Network 'BRAVISSIMO' [PITN-GA-2008-215118]; Research Foundation-Flanders [G.0065.08]; Agency for Innovation by Science and Technology [60839]; Centre for BioSystems Genomics Proteomics [CBSG2012-AA6]; Austrian Academy of Sciences; Belgian Science Policy Office (BELSPO)	Marie-Curie Initial Training Network 'BRAVISSIMO'; Research Foundation-Flanders(FWO); Agency for Innovation by Science and Technology; Centre for BioSystems Genomics Proteomics; Austrian Academy of Sciences; Belgian Science Policy Office (BELSPO)(Belgian Federal Science Policy Office)	We thank D. Bergmann (Stanford University, USA), K. Toni (University of Washington, USA), F. Sack (University of British Columbia, Canada), G. Vert (CNRS, France), S. Mora-Garcia (FIL, Argentina), A. I. Cano-Delgado (CSIC-IRTA-UAB, Spain), H-Q. Yang (Chinese Academy of Sciences, China) and T. Kakimoto (Osaka University, Japan) for providing materials; K. Mechtler and N. Li for help in mass spectrometry; E. Mylle for technical assistance; and M. De Cock, A. Bleys, G. Van Isterdael and K. Van Lierde for help in preparing the manuscript. This work is supported by the Marie-Curie Initial Training Network 'BRAVISSIMO' (grant no. PITN-GA-2008-215118), the Research Foundation-Flanders (grant no. G.0065.08), the Agency for Innovation by Science and Technology ('Strategisch Basisonderzoek' grant no. 60839), the Centre for BioSystems Genomics Proteomics project CBSG2012-AA6 (S.d.V.) and the Austrian Academy of Sciences (J.M. and C.J.). G.E.G. and M.Z. are indebted to the Belgian Science Policy Office (BELSPO) and the Agency for Innovation by Science and Technology for a postdoctoral fellowship, respectively. G.E.G. is a Career Investigator of the Consejo Nacional de Investigaciones Cientificas y Tecnicas.	Asami T, 2000, PLANT PHYSIOL, V123, P93, DOI 10.1104/pp.123.1.93; Berger D, 2000, GENE DEV, V14, P1119; Berger F, 1998, DEV BIOL, V194, P226, DOI 10.1006/dbio.1997.8836; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Bergmann DC, 2007, ANNU REV PLANT BIOL, V58, P163, DOI 10.1146/annurev.arplant.58.032806.104023; Bhave NS, 2009, PLANTA, V229, P357, DOI 10.1007/s00425-008-0835-9; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; De Rybel B, 2009, CHEM BIOL, V16, P594, DOI 10.1016/j.chembiol.2009.04.008; Dong J, 2009, CELL, V137, P1320, DOI 10.1016/j.cell.2009.04.018; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Gonzalez N, 2010, PLANT PHYSIOL, V153, P1261, DOI 10.1104/pp.110.156018; Gonzalez-Garcia MP, 2011, DEVELOPMENT, V138, P849, DOI 10.1242/dev.057331; Gudesblat GE, 2011, CURR OPIN PLANT BIOL, V14, P530, DOI 10.1016/j.pbi.2011.05.004; Hacham Y, 2011, DEVELOPMENT, V138, P839, DOI 10.1242/dev.061804; Hara K, 2007, GENE DEV, V21, P1720, DOI 10.1101/gad.1550707; Hara K, 2009, PLANT CELL PHYSIOL, V50, P1019, DOI 10.1093/pcp/pcp068; Hunt L, 2009, CURR BIOL, V19, P864, DOI 10.1016/j.cub.2009.03.069; Karimi M, 2007, PLANT PHYSIOL, V145, P1183, DOI 10.1104/pp.107.110411; Karlova R, 2009, PROTEOMICS, V9, P368, DOI 10.1002/pmic.200701059; Kim TW, 2012, NATURE, V482, P419, DOI 10.1038/nature10794; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Kim TW, 2009, NAT CELL BIOL, V11, P1254, DOI 10.1038/ncb1970; Kuppusamy KT, 2009, P NATL ACAD SCI USA, V106, DOI 10.1073/pnas.0811633106; Lampard GR, 2008, SCIENCE, V322, P1113, DOI 10.1126/science.1162263; Lampard GR, 2009, PLANT CELL, V21, P3506, DOI 10.1105/tpc.109.070110; Lee JS, 2012, GENE DEV, V26, P126, DOI 10.1101/gad.179895.111; Li JM, 2002, SCIENCE, V295, P1299; MacAlister CA, 2007, NATURE, V445, P537, DOI 10.1038/nature05491; Mazanek M, 2007, NAT PROTOC, V2, P1059, DOI 10.1038/nprot.2006.280; Mazanek M, 2010, J CHROMATOGR B, V878, P515, DOI 10.1016/j.jchromb.2009.12.017; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Ohashi-Ito K, 2006, PLANT CELL, V18, P2493, DOI 10.1105/tpc.106.046136; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; Pillitteri LJ, 2011, PLANT CELL, V23, P3260, DOI 10.1105/tpc.111.088583; Robinson S, 2011, SCIENCE, V333, P1436, DOI 10.1126/science.1202185; Rozhon W, 2010, PLANT J, V62, P215, DOI 10.1111/j.1365-313X.2010.04145.x; Serna L, 2005, J EXP BOT, V56, P1983, DOI 10.1093/jxb/eri213; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Vert G, 2006, NATURE, V441, P96, DOI 10.1038/nature04681; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Yan ZY, 2009, PLANT PHYSIOL, V150, P710, DOI 10.1104/pp.109.138099; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3	47	216	233	3	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2012	14	5					548	U214		10.1038/ncb2471	http://dx.doi.org/10.1038/ncb2471			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	936NW	22466366				2022-12-25	WOS:000303598300016
J	Sample, V; DiPilato, LM; Yang, JH; Ni, Q; Saucerman, JJ; Zhang, J				Sample, Vedangi; DiPilato, Lisa M.; Yang, Jason H.; Ni, Qiang; Saucerman, Jeffrey J.; Zhang, Jin			Regulation of nuclear PKA revealed by spatiotemporal manipulation of cyclic AMP	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-KINASE-A; SOLUBLE ADENYLYL-CYCLASE; CATALYTIC SUBUNIT; GENE-EXPRESSION; CELLULAR CAMP; ACTIVATION; DYNAMICS; CELLS; STIMULATION; COMPLEXES	Understanding how specific cyclic AMP (cAMP) signals are organized and relayed to their effectors in different compartments of the cell to achieve functional specificity requires molecular tools that allow precise manipulation of cAMP in these compartments. Here we characterize a new method using bicarbonate-activatable and genetically targetable soluble adenylyl cyclase to control the location, kinetics and magnitude of the cAMP signal. Using this live-cell cAMP manipulation in conjunction with fluorescence imaging and mechanistic modeling, we uncovered the activation of a resident pool of protein kinase A (PKA) holoenzyme in the nuclei of HEK-293 cells, modifying the existing dogma of cAMP-PKA signaling in the nucleus. Furthermore, we show that phosphodiesterases and A-kinase anchoring proteins (AKAPs) are critical in shaping nuclear PKA responses. Collectively, our data suggest a new model in which AKAP-localized phosphodiesterases tune an activation threshold for nuclear PKA holoenzyme, thereby converting spatially distinct second messenger signals to temporally controlled nuclear kinase activity.	[Sample, Vedangi; DiPilato, Lisa M.; Ni, Qiang; Zhang, Jin] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Yang, Jason H.; Saucerman, Jeffrey J.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA; [Zhang, Jin] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Zhang, Jin] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; University of Virginia; Johns Hopkins University; Johns Hopkins University	Sample, V (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	jsaucerman@virginia.edu; jzhang32@jhmi.edu	Yang, Jason H./AAB-2608-2019	Yang, Jason H./0000-0003-0921-4657; Saucerman, Jeffrey/0000-0001-9464-8374	US National Institutes of Health (NIH) [R01 DK073368, DP1 OD006419, F31 DK074381, R01 HL094476]; American Heart Association [0830470N]; NIH [GM08715]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK074381, R01DK073368, P30DK079637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008715] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006419] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. Levin (Weill Cornell Medical College, Cornell University) for the gift of sAC<INF>t</INF> cDNA. We thank M. Houslay (Institute of Biomedical and Life Sciences, University of Glasgow) and K. Xiang (University of Illinois, Urbana-Champaign) for the gift of dnPDE4 isoforms. We thank L. Hersh (University of Kentucky College of Medicine) for giving us the A126.1B2 and A126.1B2 Cat beta cell line. We also thank S. Mehta, G. Mo, T. Ueno, C. Pohlmeyer and T. Inoue for their technical help. This work was funded by US National Institutes of Health (NIH) grants R01 DK073368, DP1 OD006419 (to J.Z.), F31 DK074381 (to L.M.D.) and R01 HL094476, American Heart Association grant 0830470N (to J.J.S.) and NIH grant GM08715 (to J.H.Y.).	Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; BEAVO JA, 1974, P NATL ACAD SCI USA, V71, P3580, DOI 10.1073/pnas.71.9.3580; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Burnham KP, 2002, MODEL SELECTION MULT, P66; Carnegie GK, 2009, IUBMB LIFE, V61, P394, DOI 10.1002/iub.168; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Chuang HY, 2010, ANNU REV CELL DEV BI, V26, P721, DOI 10.1146/annurev-cellbio-100109-104122; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; DiPilato LM, 2009, MOL BIOSYST, V5, P832, DOI 10.1039/b823243a; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072; Greenberg M.E., 2007, CURR PROTOC MOL BIOL, V4, P410; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; HAROOTUNIAN AT, 1993, MOL BIOL CELL, V4, P993, DOI 10.1091/mbc.4.10.993; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Jarnaess E, 2009, J BIOL CHEM, V284, P35154, DOI 10.1074/jbc.M109.056465; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kvissel AK, 2007, EXP CELL RES, V313, P2795, DOI 10.1016/j.yexcr.2007.05.014; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; Martin BR, 2007, CHEM BIOL, V14, P1031, DOI 10.1016/j.chembiol.2007.07.017; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McCahill A, 2005, CELL SIGNAL, V17, P1158, DOI 10.1016/j.cellsig.2005.04.003; Meoli E, 2008, CANCER RES, V68, P3133, DOI 10.1158/0008-5472.CAN-08-0064; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Ni QA, 2011, NAT CHEM BIOL, V7, P34, DOI 10.1038/NCHEMBIO.478; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Rich TC, 2007, AM J PHYSIOL-CELL PH, V292, pC319, DOI 10.1152/ajpcell.00121.2006; Saucerman JJ, 2006, P NATL ACAD SCI USA, V103, P12923, DOI 10.1073/pnas.0600137103; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Shimojo M, 1999, MOL CELL BIOL, V19, P6788; Steegborn C, 2005, NAT STRUCT MOL BIOL, V12, P32, DOI 10.1038/nsmb880; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Terrin A, 2006, J CELL BIOL, V175, P441, DOI 10.1083/jcb.200605050; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Xin WK, 2008, J GEN PHYSIOL, V131, P349, DOI 10.1085/jgp.200709881; Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119	42	95	95	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2012	8	4					375	382		10.1038/NCHEMBIO.799	http://dx.doi.org/10.1038/NCHEMBIO.799			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	913PO	22366721	Green Accepted			2022-12-25	WOS:000301890100012
J	Economou, AD; Ohazama, A; Porntaveetus, T; Sharpe, PT; Kondo, S; Basson, MA; Gritli-Linde, A; Cobourne, MT; Green, JBA				Economou, Andrew D.; Ohazama, Atsushi; Porntaveetus, Thantrira; Sharpe, Paul T.; Kondo, Shigeru; Basson, M. Albert; Gritli-Linde, Amel; Cobourne, Martyn T.; Green, Jeremy B. A.			Periodic stripe formation by a Turing mechanism operating at growth zones in the mammalian palate	NATURE GENETICS			English	Article							REACTION-DIFFUSION MODEL; LATERAL INHIBITION; PATTERN; MOUSE; RUGAE; SHH; WNT; TOOTH; SEGMENTATION; PRIMORDIA	We present direct evidence of an activator-inhibitor system in the generation of the regularly spaced transverse ridges of the palate. We show that new ridges, called rugae, that are marked by stripes of expression of Shh (encoding Sonic hedgehog), appear at two growth zones where the space between previously laid rugae increases. However, inter-rugal growth is not absolutely required: new stripes of Shh expression still appeared when growth was inhibited. Furthermore, when a ruga was excised, new Shh expression appeared not at the cut edge but as bifurcating stripes branching from the neighboring stripe of Shh expression, diagnostic of a Turing-type reaction-diffusion mechanism. Genetic and inhibitor experiments identified fibroblast growth factor (FGF) and Shh as components of an activator-inhibitor pair in this system. These findings demonstrate a reaction-diffusion mechanism that is likely to be widely relevant in vertebrate development.	[Economou, Andrew D.; Ohazama, Atsushi; Porntaveetus, Thantrira; Sharpe, Paul T.; Basson, M. Albert; Cobourne, Martyn T.; Green, Jeremy B. A.] Kings Coll London, Dept Craniofacial Dev, London WC2R 2LS, England; [Kondo, Shigeru] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Gritli-Linde, Amel] Univ Gothenburg, Sahlgrenska Acad, Dept Oral Biochem, Gothenburg, Sweden	University of London; King's College London; Osaka University; University of Gothenburg	Green, JBA (corresponding author), Kings Coll London, Dept Craniofacial Dev, London WC2R 2LS, England.	jeremy.green@kcl.ac.uk	Cobourne, Martyn/R-1165-2019; Green, Jeremy/F-3630-2010; Porntaveetus, Thantrira/ABF-6854-2020; Basson, M. Albert/C-5565-2009	Green, Jeremy/0000-0002-6102-2620; porntaveetus, thantrira/0000-0003-0145-9801; Kondo, Shigeru/0000-0003-0192-5526; Cobourne, Martyn/0000-0003-2857-0315; Sharpe, Paul/0000-0003-2116-9561; Basson, M. Albert/0000-0001-9834-7528	Medical Research Council (MRC; UK) [G0801154]; BBSRC [BB/J009105/1] Funding Source: UKRI; MRC [G0600041, G0601104, G0801154] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J009105/1] Funding Source: researchfish; Medical Research Council [MR/J006742/1, G0600041, G0801154, G0601104] Funding Source: researchfish; Grants-in-Aid for Scientific Research [22370079] Funding Source: KAKEN	Medical Research Council (MRC; UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We would like to thank A. Lander and M. Cohen for useful advice on models, G. Martin (University of California, San Francisco) for the Spry2 mutant mice, M. Kawasaki, Y. Otsuka-Tanaka and K. Kawasaki for assistance with in situ hybridization and M. Miodownik and M. Rubock for critical reading of the manuscript. This work was funded by a Medical Research Council (MRC; UK) grant (G0801154 to J. B. A. G. and M.T.C.).	Ahn Y, 2010, DEVELOPMENT, V137, P3221, DOI 10.1242/dev.054668; Asai R, 1999, MECH DEVELOP, V89, P87, DOI 10.1016/S0925-4773(99)00211-7; Axelrod JD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145pe38; Baker RE, 2009, INT J DEV BIOL, V53, P783, DOI 10.1387/ijdb.072493rb; Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Cohen M, 2010, DEV CELL, V19, P78, DOI 10.1016/j.devcel.2010.06.006; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Goldbeter A, 2008, J THEOR BIOL, V252, P574, DOI 10.1016/j.jtbi.2008.01.006; Hosokawa R, 2009, J EXP ZOOL PART B, V312B, P343, DOI 10.1002/jez.b.21274; IKEMI N, 1995, REPROD TOXICOL, V9, P369, DOI 10.1016/0890-6238(95)00024-5; Ishihara S, 2006, J THEOR BIOL, V238, P683, DOI 10.1016/j.jtbi.2005.06.016; Jiang TX, 1999, DEVELOPMENT, V126, P4997; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Kulesa PM, 1996, J THEOR BIOL, V180, P287, DOI 10.1006/jtbi.1996.0103; Lin CX, 2011, DEV BIOL, V356, P40, DOI 10.1016/j.ydbio.2011.05.002; MARTIN P, 1990, International Journal of Developmental Biology, V34, P323; Meinhardt H., 2009, ALGORITHMIC BEAUTY S; Miura T, 2006, J THEOR BIOL, V240, P562, DOI 10.1016/j.jtbi.2005.10.016; Mootoosamy RC, 2002, DEVELOPMENT, V129, P573; Newman SA, 2009, INT J DEV BIOL, V53, P693, DOI 10.1387/ijdb.072481sn; Pantalacci S, 2009, EVOL DEV, V11, P422, DOI 10.1111/j.1525-142X.2009.00348.x; Pantalacci S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-116; Porntaveetus T, 2010, GENE EXPR PATTERNS, V10, P193, DOI 10.1016/j.gep.2010.03.004; Pospieszny N., 2003, EJPAU, V6; Rice DPC, 2003, BONE, V33, P14, DOI 10.1016/S8756-3282(03)00163-7; Sala FG, 2011, DEVELOPMENT, V138, P273, DOI 10.1242/dev.051680; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Shoji H, 2003, J THEOR BIOL, V224, P339, DOI 10.1016/S0022-5193(03)00170-X; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; Simrick S, 2011, DEV BIOL, V358, P147, DOI 10.1016/j.ydbio.2011.07.024; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Welsh IC, 2009, DEV BIOL, V336, P53, DOI 10.1016/j.ydbio.2009.09.028; Zhang ZY, 2002, DEVELOPMENT, V129, P4135	34	168	170	2	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2012	44	3					348	U163		10.1038/ng.1090	http://dx.doi.org/10.1038/ng.1090			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	899VC	22344222	Green Accepted			2022-12-25	WOS:000300843600025
J	Eichhorn, PJA; Rodon, L; Gonzalez-Junca, A; Dirac, A; Gili, M; Martinez-Saez, E; Aura, C; Barba, I; Peg, V; Prat, A; Cuartas, I; Jimenez, J; Garcia-Dorado, D; Sahuquillo, J; Bernards, R; Baselga, J; Seoane, J				Eichhorn, Pieter J. A.; Rodon, Laura; Gonzalez-Junca, Alba; Dirac, Annette; Gili, Maguei; Martinez-Saez, Elena; Aura, Claudia; Barba, Ignasi; Peg, Vicente; Prat, Aleix; Cuartas, Isabel; Jimenez, Jose; Garcia-Dorado, David; Sahuquillo, Juan; Bernards, Rene; Baselga, Jose; Seoane, Joan			USP15 stabilizes TGF-beta receptor I and promotes oncogenesis through the activation of TGF-beta signaling in glioblastoma	NATURE MEDICINE			English	Article							E3 UBIQUITIN LIGASE; GROWTH-FACTOR-BETA; GLIOMA; SMURF2; DEGRADATION; PATHWAY; SMAD7; GENETICS; TARGETS; BIOLOGY	In advanced cancer, including glioblastoma, the transforming growth factor beta (TGF-beta) pathway acts as an oncogenic factor and is considered to be a therapeutic target. Using a functional RNAi screen, we identified the deubiquitinating enzyme ubiquitin-specific peptidase 15 (USP15) as a key component of the TGF-beta signaling pathway. USP15 binds to the SMAD7-SMAD specific E3 ubiquitin protein ligase 2 (SMURF2) complex and deubiquitinates and stabilizes type I TGF-beta receptor (T beta R-I), leading to an enhanced TGF-beta signal. High expression of USP15 correlates with high TGF-beta activity, and the USP15 gene is found amplified in glioblastoma, breast and ovarian cancer. USP15 amplification confers poor prognosis in individuals with glioblastoma. Downregulation or inhibition of USP15 in a patient-derived orthotopic mouse model of glioblastoma decreases TGF-beta activity. Moreover, depletion of USP15 decreases the oncogenic capacity of patient-derived glioma-initiating cells due to the repression of TGF-beta signaling. Our results show that USP15 regulates the TGF-beta pathway and is a key factor in glioblastoma pathogenesis.	[Seoane, Joan] Vall dHebron Univ Hosp, VHIO, Barcelona, Spain; [Dirac, Annette; Bernards, Rene] Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands; [Dirac, Annette; Bernards, Rene] Netherlands Canc Inst, Ctr Biomed Genet, Amsterdam, Netherlands; [Martinez-Saez, Elena; Barba, Ignasi; Peg, Vicente; Garcia-Dorado, David; Sahuquillo, Juan] Vall dHebron Univ Hosp, VHIR, Barcelona, Spain; [Prat, Aleix] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Baselga, Jose; Seoane, Joan] Univ Autonoma Barcelona, Cerdanyola Del Valless, Spain; [Baselga, Jose] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA USA; [Seoane, Joan] ICREA, Barcelona, Spain	Hospital Universitari Vall d'Hebron; Netherlands Cancer Institute; Netherlands Cancer Institute; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University of North Carolina; University of North Carolina Chapel Hill; Autonomous University of Barcelona; Harvard University; Harvard Medical School; Massachusetts General Hospital; ICREA	Seoane, J (corresponding author), Vall dHebron Univ Hosp, VHIO, Barcelona, Spain.	jseoane@vhio.net	Martinez-Saez, Elena/E-9097-2018; Peg, Vicente/E-9160-2018; Sahuquillo, Juan/B-3577-2008; Prat, Aleix/P-8561-2014; Barba, Ignasi/A-5221-2011; Peg., Vicente/AAC-9447-2020; Barba, Ignasi/H-5104-2013; Seoane, Joan/AAG-9173-2019	Martinez-Saez, Elena/0000-0001-6004-5364; Peg, Vicente/0000-0002-5203-6166; Sahuquillo, Juan/0000-0003-0713-5875; Prat, Aleix/0000-0003-2377-540X; Barba, Ignasi/0000-0001-9886-3776; Peg., Vicente/0000-0002-5203-6166; Seoane, Joan/0000-0002-6541-5974; Eichhorn, Pieter/0000-0001-5840-943X; Bernards, Rene/0000-0001-8677-3423; Jimenez, Jose/0000-0002-2576-1776	Medical Oncology department; Neurosurgery department; Pathology department of the Vall d'Hebron Hospital; Instituto Carlos III [CM09/143, FIS (PI070648)]; Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares (RECAVA, ISCIII); European Research Council [ERC 205819]; Ministry of Science and Innovation [CSD2009-00080]; Asociacion Espanola Contra el Cancer (AECC); ICREA Funding Source: Custom	Medical Oncology department; Neurosurgery department; Pathology department of the Vall d'Hebron Hospital; Instituto Carlos III(Instituto de Salud Carlos III); Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares (RECAVA, ISCIII); European Research Council(European Research Council (ERC)European Commission); Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Asociacion Espanola Contra el Cancer (AECC); ICREA(ICREA)	We thank A. Saez-Border as and A. Arias for technical support. We also thank the Medical Oncology department, the Neurosurgery department and the Pathology department of the Vall d'Hebron Hospital for support. E. M. S. is supported by the Instituto Carlos III (CM09/143). I. B. and D.G.-D. were supported by the Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares (RECAVA, ISCIII). This work was supported by the European Research Council grant (ERC 205819), Instituto Carlos III grant FIS (PI070648), Ministry of Science and Innovation grant Consolider Ingenio 2010 program (CSD2009-00080) and the Asociacion Espanola Contra el Cancer (AECC) grant.	Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Holland EC, 2001, NAT REV GENET, V2, P120, DOI 10.1038/35052535; Huang XH, 2009, J MOL BIOL, V391, P691, DOI 10.1016/j.jmb.2009.06.066; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Inui M, 2011, NAT CELL BIOL, V13, P1368, DOI 10.1038/ncb2346; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Moretti J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000545; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Oettle, 2011, AM SOC CLIN ONCOLOGY; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Rich JN, 2003, FRONT BIOSCI-LANDMRK, V8, pE245, DOI 10.2741/992; Rodon, 2011, J CLIN ONCOL S, V29; Schweitzer K, 2007, EMBO J, V26, P1532, DOI 10.1038/sj.emboj.7601600; Seoane J, 2008, CLIN TRANSL ONCOL, V10, P14, DOI 10.1007/s12094-008-0148-2; van der Eb A J, 1980, Methods Enzymol, V65, P826; Wicks SJ, 2006, BIOCHEM SOC T, V34, P761, DOI 10.1042/BST0340761; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Xu ML, 2009, BIOCHEM BIOPH RES CO, V388, P366, DOI 10.1016/j.bbrc.2009.08.015; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293; Zhu YA, 2002, NAT REV CANCER, V2, P616, DOI 10.1038/nrc866	37	278	291	3	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2012	18	3					429	U192		10.1038/nm.2619	http://dx.doi.org/10.1038/nm.2619			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22344298				2022-12-25	WOS:000301264800045
J	Guan, M; Yao, W; Liu, RW; Lam, KS; Nolta, J; Jia, JJ; Panganiban, B; Meng, LP; Zhou, P; Shahnazari, M; Ritchie, RO; Lane, NE				Guan, Min; Yao, Wei; Liu, Ruiwu; Lam, Kit S.; Nolta, Jan; Jia, Junjing; Panganiban, Brian; Meng, Liping; Zhou, Ping; Shahnazari, Mohammad; Ritchie, Robert O.; Lane, Nancy E.			Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass	NATURE MEDICINE			English	Article							IN-VIVO DISTRIBUTION; PARATHYROID-HORMONE; MARROW; INTEGRIN; DIFFERENTIATION; MATRIX; TRANSPLANTATION; REGENERATION; EXPRESSION; PREVENTS	Aging reduces the number of mesenchymal stem cells (MSCs) that can differentiate into osteoblasts in the bone marrow, which leads to impairment of osteogenesis. However, if MSCs could be directed toward osteogenic differentiation, they could be a viable therapeutic option for bone regeneration. We have developed a method to direct MSCs to the bone surface by attaching a synthetic high-affinity and specific peptidomimetic ligand (LLP2A) against integrin alpha 4 beta 1 on the MSC surface to a bisphosphonate (alendronate, Ale) that has a high affinity for bone. LLP2A-Ale induced MSC migration and osteogenic differentiation in vitro. A single intravenous injection of LLP2A-Ale increased trabecular bone formation and bone mass in both xenotransplantation studies and in immunocompetent mice. Additionally, LLP2A-Ale prevented trabecular bone loss after peak bone acquisition was achieved or as a result of estrogen deficiency. These results provide proof of principle that LLP2A-Ale can direct MSCs to the bone to form new bone and increase bone strength.	[Guan, Min; Yao, Wei; Lam, Kit S.; Jia, Junjing; Shahnazari, Mohammad; Lane, Nancy E.] Univ Calif, Davis Med Ctr, Dept Internal Med, Musculoskeletal Res Grp, Sacramento, CA USA; [Lam, Kit S.; Meng, Liping] Univ Calif, Davis Med Ctr, Dept Biochem & Mol Med, Sacramento, CA USA; [Nolta, Jan; Zhou, Ping] Univ Calif, Davis Med Ctr, Dept Internal Med, Stem Cell Program, Sacramento, CA USA; [Nolta, Jan; Zhou, Ping] Univ Calif, Davis Med Ctr, Inst Regenerat Cures, Sacramento, CA USA; [Panganiban, Brian; Ritchie, Robert O.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Yao, W (corresponding author), Univ Calif, Davis Med Ctr, Dept Internal Med, Musculoskeletal Res Grp, Sacramento, CA USA.	wei.yao@ucdmc.ucdavis.edu	Shahnazari, Mohammad Reza/AAU-8573-2020; Yao, Wei/O-8187-2019; yao, wei/GVS-3913-2022; meng, li/GVT-2063-2022; Ritchie, Robert O/A-8066-2008	Shahnazari, Mohammad Reza/0000-0001-8647-5426; Yao, Wei/0000-0002-1198-1161; yao, wei/0000-0002-1198-1161; Ritchie, Robert O/0000-0002-0501-6998; Nolta, Jan/0000-0003-4576-8542; Guan, Min/0000-0003-3851-8553	National Center for Research Resources of the US National Institutes of Health [P40RR017447]; US National Institutes of Health [NIAMS-5R21AR057515, NIAM-R01AR043052, 1K12HD05195801]; US National Institute of Child Health and Human Development (NICHD); Office of Research on Women's Health (ORWH); Office of Dietary Supplements (ODS); US National Institute of Aging (NIA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD051958] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR017447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR063043, R01AR043052, R21AR057515, R01AR061366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099688] Funding Source: NIH RePORTER	National Center for Research Resources of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Office of Research on Women's Health (ORWH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); Office of Dietary Supplements (ODS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of Aging (NIA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The mouse MSCs used in this work were provided by the Texas A&M Health Science Center College of Medicine Institute for Regenerative Medicine at Scott & White through a grant from National Center for Research Resources of the US National Institutes of Health grant P40RR017447. This work was funded by the US National Institutes of Health grants NIAMS-5R21AR057515 (to W.Y.), NIAM-R01AR043052 (to N.E.L.) and 1K12HD05195801 and was co-funded by the US National Institute of Child Health and Human Development (NICHD), the Office of Research on Women's Health (ORWH), the Office of Dietary Supplements (ODS) and the US National Institute of Aging (NIA).	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Bonyadi M, 2003, P NATL ACAD SCI USA, V100, P5840, DOI 10.1073/pnas.1036475100; Brooke G, 2008, STEM CELLS DEV, V17, P929, DOI 10.1089/scd.2007.0156; BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303; Cao J, 2003, J BONE MINER RES, V18, P270, DOI 10.1359/jbmr.2003.18.2.270; Chapel A, 2003, J GENE MED, V5, P1028, DOI 10.1002/jgm.452; Chen XD, 2007, J BONE MINER RES, V22, P1943, DOI 10.1359/JBMR.070725; Cho SW, 2009, MOL THER, V17, P1979, DOI 10.1038/mt.2009.153; Dao MA, 1998, P NATL ACAD SCI USA, V95, P13006, DOI 10.1073/pnas.95.22.13006; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Granero-Molto F, 2009, STEM CELLS, V27, P1887, DOI 10.1002/stem.103; Gronthos S, 1997, J BONE MINER RES, V12, P1189, DOI 10.1359/jbmr.1997.12.8.1189; Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5; GRZESIK WJ, 1994, J BONE MINER RES, V9, P487, DOI 10.1002/jbmr.5650090408; Gutwald R, 2010, BRIT J ORAL MAX SURG, V48, P285, DOI 10.1016/j.bjoms.2009.06.226; Halleux C., 2001, Journal of Musculoskeletal & Neuronal Interactions, V2, P71; Hamidouche Z, 2009, P NATL ACAD SCI USA, V106, P18587, DOI 10.1073/pnas.0812334106; Kamibayashi L.K., 1999, J BONE MINER RES, V14, P1; Katsara O, 2011, STEM CELLS DEV, V20, P1550, DOI 10.1089/scd.2010.0280; Kumar S, 2007, FASEB J, V21, P3917, DOI 10.1096/fj.07-8275com; Li HX, 2009, CELLS TISSUES ORGANS, V190, P94, DOI 10.1159/000166547; Longobardi L, 2009, GROWTH FACTORS, V27, P309, DOI 10.1080/08977190903138874; Luo JT, 2008, J COMB CHEM, V10, P599, DOI 10.1021/cc8000663; Meyerrose TE, 2007, STEM CELLS, V25, P220, DOI 10.1634/stemcells.2006-0243; Mukherjee S, 2008, J CLIN INVEST, V118, P491, DOI [10.1172/JCI33102, 10.1172/JC133102]; Muraglia A, 2000, J CELL SCI, V113, P1161; OWEN M, 1988, CIBA F SYMP, V136, P42; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pedram MS, 2010, SPINAL CORD, V48, P457, DOI 10.1038/sc.2009.153; Peng L, 2006, NAT CHEM BIOL, V2, P381, DOI 10.1038/nchembio798; Sato M, 2002, ENDOCRINOLOGY, V143, P3230, DOI 10.1210/en.2002-220149; Seeman E, 2003, NEW ENGL J MED, V349, P320, DOI 10.1056/NEJMp038101; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Vertenten G, 2009, TISSUE ENG PT A, V15, P1501, DOI 10.1089/ten.tea.2008.0367; VUKICEVIC S, 1990, CELL, V63, P437, DOI 10.1016/0092-8674(90)90176-F; Yao W, 2008, ARTHRITIS RHEUM, V58, P3485, DOI 10.1002/art.23954; Yao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011410; Yao W, 2010, J BONE MINER RES, V25, P190, DOI 10.1359/jbmr.090719; Zhang YJ, 2010, BIOMATERIALS, V31, P5312, DOI 10.1016/j.biomaterials.2010.03.029	39	197	211	2	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2012	18	3					456	U159		10.1038/nm.2665	http://dx.doi.org/10.1038/nm.2665			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22306732	Green Accepted, Green Submitted			2022-12-25	WOS:000301264800050
J	Raychaudhuri, S; Sandor, C; Stahl, EA; Freudenberg, J; Lee, HS; Jia, XM; Alfredsson, L; Padyukov, L; Klareskog, L; Worthington, J; Siminovitch, KA; Bae, SC; Plenge, RM; Gregersen, PK; de Bakker, PIW				Raychaudhuri, Soumya; Sandor, Cynthia; Stahl, Eli A.; Freudenberg, Jan; Lee, Hye-Soon; Jia, Xiaoming; Alfredsson, Lars; Padyukov, Leonid; Klareskog, Lars; Worthington, Jane; Siminovitch, Katherine A.; Bae, Sang-Cheol; Plenge, Robert M.; Gregersen, Peter K.; de Bakker, Paul I. W.			Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis	NATURE GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; GENOME-WIDE ASSOCIATION; GENETICS; SUSCEPTIBILITY; METAANALYSIS; RISK; LOCI	The genetic association of the major histocompatibility complex (MHC) to rheumatoid arthritis risk has commonly been attributed to alleles in HLA-DRB1. However, debate persists about the identity of the causal variants in HLA-DRB1 and the presence of independent effects elsewhere in the MHC. Using existing genome-wide SNP data in 5,018 individuals with seropositive rheumatoid arthritis (cases) and 14,974 unaffected controls, we imputed and tested classical alleles and amino acid polymorphisms in HLA-A, HLA-B, HLA-C, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQB1 and HLA-DRB1, as well as 3,117 SNPs across the MHC. Conditional and haplotype analyses identified that three amino acid positions (11, 71 and 74) in HLA-DR beta 1 and single-amino-acid polymorphisms in HLA-B (at position 9) and HLA-DP beta 1 (at position 9), which are all located in peptide-binding grooves, almost completely explain the MHC association to rheumatoid arthritis risk. This study shows how imputation of functional variation from large reference panels can help fine map association signals in the MHC.	[Raychaudhuri, Soumya; Sandor, Cynthia; Stahl, Eli A.; Jia, Xiaoming; Plenge, Robert M.; de Bakker, Paul I. W.] Harvard Univ, Brigham & Womens Hosp, Div Genet, Sch Med, Boston, MA 02115 USA; [Raychaudhuri, Soumya; Sandor, Cynthia; Stahl, Eli A.; Plenge, Robert M.] Harvard Univ, Brigham & Womens Hosp, Div Rheumatol, Sch Med, Boston, MA 02115 USA; [Raychaudhuri, Soumya; Sandor, Cynthia] Partners HealthCare Ctr Personalized Genet Med, Boston, MA USA; [Raychaudhuri, Soumya; Sandor, Cynthia; Stahl, Eli A.; Jia, Xiaoming; Plenge, Robert M.; de Bakker, Paul I. W.] Broad Inst Harvard & Massachusetts Inst Technol, Program Med & Populat Genet, Cambridge, MA USA; [Freudenberg, Jan; Gregersen, Peter K.] N Shore Long Isl Jewish Hlth Syst, Robert S Boas Ctr Genom & Human Genet, Feinstein Inst Med Res, Manhasset, NY USA; [Lee, Hye-Soon; Bae, Sang-Cheol] Hanyang Univ Hosp Rheumat Dis, Dept Rheumatol, Seoul, South Korea; [Jia, Xiaoming] Harvard Massachusetts Inst Technol Div Hlth Sci &, Boston, MA USA; [Alfredsson, Lars] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Padyukov, Leonid; Klareskog, Lars] Karolinska Univ Hosp Solna, Rheumatol Unit, Dept Med, Karolinska Inst, Stockholm, Sweden; [Worthington, Jane] Univ Manchester, Arthrit Res UK Epidemiol Unit, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Siminovitch, Katherine A.] Univ Toronto, Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Siminovitch, Katherine A.] Univ Hlth Network, Toronto, ON, Canada; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Partners Healthcare System; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Northwell Health; Hanyang University; Hanyang University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Manchester; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Raychaudhuri, S (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Genet, Sch Med, Boston, MA 02115 USA.	soumya@broadinstitute.org; pdebakker@rics.bwh.harvard.edu	Alfredsson, Lars/AAC-9007-2019; Siminovitch, Katherine/K-1475-2013; Worthington, Jane/M-9770-2014; Bae, Sang-Cheol/P-2051-2015; de Bakker, Paul IW/B-8730-2009; Padyukov, Leonid/A-4890-2009	Alfredsson, Lars/0000-0003-1688-6697; Worthington, Jane/0000-0003-0544-042X; de Bakker, Paul IW/0000-0001-7735-7858; Bae, Sang-Cheol/0000-0003-4658-1093; Jia, Xiaoming/0000-0002-5104-5431; Raychaudhuri, Soumya/0000-0002-1901-8265; Klareskog, Lars/0000-0001-9601-6186; Padyukov, Leonid/0000-0003-2950-5670	US National Institutes of Health [K08AR055688, R01-AR44422, R01-AR057108, U01-GM092691]; Korea Healthcare Technology Research and Development Project [A102065, A111218-11-GM01]; Burroughs Wellcome Fund; Arthritis Foundation; Eileen Ludwig Greenland Center for Rheumatoid Arthritis; MRC [G1001799] Funding Source: UKRI; Medical Research Council [G1001799] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057108, R01AR056768, R01AR044422, K08AR055688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092691] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Healthcare Technology Research and Development Project; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Arthritis Foundation; Eileen Ludwig Greenland Center for Rheumatoid Arthritis; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Type 1 Diabetes Genetics Consortium and the Wellcome Trust Case Control Consortium for data access. We acknowledge use of the HLA genotyping data performed by the Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory on the British 1958 Birth Cohort DNA collection. This project is supported by grants from the US National Institutes of Health (K08AR055688 (S. R.), R01-AR44422 (P. K. G.), R01-AR057108 and U01-GM092691 (R. M. P.)), the Korea Healthcare Technology Research and Development Project (A102065 and A111218-11-GM01 (H.-S. L. and S.-C. B.)), the Burroughs Wellcome Fund (R. M. P.), the Arthritis Foundation (S. R.) and by the Eileen Ludwig Greenland Center for Rheumatoid Arthritis (P.K.G.).	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Brown WM, 2009, DIABETES OBES METAB, V11, P2, DOI 10.1111/j.1463-1326.2008.00997.x; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Ding B, 2009, ARTHRITIS RHEUM, V60, P30, DOI 10.1002/art.24135; Freudenberg J, 2011, ARTHRITIS RHEUM-US, V63, P884, DOI 10.1002/art.30235; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Isenerg D, 2004, OXFORD TXB RHEUMATOL, V1278; Jawaheer D, 2002, AM J HUM GENET, V71, P585, DOI 10.1086/342407; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Lee HS, 2006, GENES IMMUN, V7, P533, DOI 10.1038/sj.gene.6364325; Lee HS, 2008, MOL MED, V14, P293, DOI 10.2119/2007-00123.Lee; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Newton JL, 2004, GENES IMMUN, V5, P151, DOI 10.1038/sj.gene.6364045; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price P, 1999, IMMUNOL REV, V167, P257, DOI 10.1111/j.1600-065X.1999.tb01398.x; Raychaudhuri S, 2010, CURR OPIN RHEUMATOL, V22, P109, DOI 10.1097/BOR.0b013e328336474d; REINSMOEN NL, 1982, HUM IMMUNOL, V4, P249, DOI 10.1016/0198-8859(82)90040-4; Robinson J, 2011, NUCLEIC ACIDS RES, V39, pD1171, DOI 10.1093/nar/gkq998; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stastny P, 1978, Arthritis Rheum, V21, pS139, DOI 10.1002/art.1780210921; Trowsdale J, 2011, IMMUNOL LETT, V137, P1, DOI 10.1016/j.imlet.2011.01.002; van der Woude D, 2010, ARTHRITIS RHEUM-US, V62, P1236, DOI 10.1002/art.27366; van der Woude D, 2009, ARTHRITIS RHEUM-US, V60, P916, DOI 10.1002/art.24385; Vignal C, 2009, ARTHRITIS RHEUM-US, V60, P53, DOI 10.1002/art.24138; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004	29	593	613	5	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2012	44	3					291	U91		10.1038/ng.1076	http://dx.doi.org/10.1038/ng.1076			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	899VC	22286218	Green Accepted			2022-12-25	WOS:000300843600014
J	Wang, Y; Barker, K; Shi, SP; Diaz, M; Mo, B; Gutstein, HB				Wang, Yan; Barker, Katherine; Shi, Shanping; Diaz, Miguel; Mo, Bing; Gutstein, Howard B.			Blockade of PDGFR-beta activation eliminates morphine analgesic tolerance	NATURE MEDICINE			English	Article							GROWTH-FACTOR RECEPTOR; INHIBITION; DEPENDENCE; CHANNEL; BRAIN; CELLS	For centuries, opioid drugs have been the mainstay of chronic pain treatment. However, over time analgesic tolerance develops, leaving few treatment options. Here we show that platelet-derived growth factor receptor-beta (PDGFR-beta)-mediated signaling plays a key role in morphine tolerance. PDGFR-beta inhibition selectively eliminates morphine tolerance in rats. PDGFR-beta inhibitors are widely used and well tolerated, suggesting that clinical translation of our findings could reduce the suffering endured by individuals with intractable pain.	[Wang, Yan; Barker, Katherine; Shi, Shanping; Diaz, Miguel; Mo, Bing; Gutstein, Howard B.] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol, Houston, TX 77030 USA; [Wang, Yan; Barker, Katherine; Shi, Shanping; Diaz, Miguel; Mo, Bing; Gutstein, Howard B.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Gutstein, Howard B.] Univ Texas MD Anderson Canc Ctr, Genes & Dev Grad Program, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Gutstein, HB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol, Houston, TX 77030 USA.	hgutstein@mdanderson.org			US National Institute on Drug Abuse [R01DA15146]; US National Institute on Alcohol Abuse and Alcoholism [R01AA16157]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015146] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Dulin, T. Sylvester and C. Schultz for technical support. This work was funded by grants from the US National Institute on Drug Abuse R01DA15146 and the US National Institute on Alcohol Abuse and Alcoholism R01AA16157 to H. B. G. We dedicate this work to the memory of our colleague and dear friend Bing Mo, who tragically passed away before these studies were completed.	AGHAJANIAN GK, 1987, NEUROPHARMACOLOGY, V26, P793, DOI 10.1016/0028-3908(87)90054-2; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Belcheva MM, 2001, J BIOL CHEM, V276, P33847, DOI 10.1074/jbc.M101535200; Black MJ, 2003, J NEUROSCI RES, V74, P23, DOI 10.1002/jnr.10748; Chen C, 2006, CURR NEUROVASC RES, V3, P171, DOI 10.2174/156720206778018767; CODERRE TJ, 1994, PAIN, V59, P345, DOI 10.1016/0304-3959(94)90020-5; Dai HQ, 2003, J PHARMACOL EXP THER, V304, P1085, DOI 10.1124/jpet.102.045260; FRACE AM, 1989, P NATL ACAD SCI USA, V86, P2511, DOI 10.1073/pnas.86.7.2511; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; GOLD LH, 1994, EUR J PHARMACOL, V253, P45, DOI 10.1016/0014-2999(94)90755-2; Gutstein HB, 2006, GOODMAN GILMANS PHAR, P547; Herrlich A, 1998, P NATL ACAD SCI USA, V95, P8985, DOI 10.1073/pnas.95.15.8985; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kolesnikov Y, 1998, J PHARMACOL EXP THER, V284, P455; MALMBERG AB, 1993, PAIN, V54, P291, DOI 10.1016/0304-3959(93)90028-N; Rice ASC, 2006, ANNU REV MED, V57, P535, DOI 10.1146/annurev.med.57.121304.131324; TIMPE LC, 1994, J NEUROSCI, V14, P1195, DOI 10.1523/JNEUROSCI.14-03-01195.1994; TRUJILLO KA, 1991, SCIENCE, V251, P85, DOI 10.1126/science.1824728; Valenzuela CF, 1996, J BIOL CHEM, V271, P16151, DOI 10.1074/jbc.271.27.16151; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299	20	42	44	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2012	18	3					385	387		10.1038/nm.2633	http://dx.doi.org/10.1038/nm.2633			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22344297	Green Accepted			2022-12-25	WOS:000301264800039
J	Lei, P; Ayton, S; Finkelstein, DI; Spoerri, L; Ciccotosto, GD; Wright, DK; Wong, BXW; Adlard, PA; Cherny, RA; Lam, LQ; Roberts, BR; Volitakis, I; Egan, GF; McLean, CA; Cappai, R; Duce, JA; Bush, AI				Lei, Peng; Ayton, Scott; Finkelstein, David I.; Spoerri, Loredana; Ciccotosto, Giuseppe D.; Wright, David K.; Wong, Bruce X. W.; Adlard, Paul A.; Cherny, Robert A.; Lam, Linh Q.; Roberts, Blaine R.; Volitakis, Irene; Egan, Gary F.; McLean, Catriona A.; Cappai, Roberto; Duce, James A.; Bush, Ashley I.			Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export	NATURE MEDICINE			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMER-DISEASE; MOUSE MODEL; NEURONS; IMPAIRMENT; VARIANTS; MRI	The microtubule-associated protein tau has risk alleles for both Alzheimer's disease and Parkinson's disease and mutations that cause brain degenerative diseases termed tauopathies(1-4). Aggregated tau forms neurofibrillary tangles in these pathologies(3,5), but little is certain about the function of tau or its mode of involvement in pathogenesis. Neuronal iron accumulation has been observed pathologically in the cortex in Alzheimer's disease(6,7), the substantia nigra (SN) in Parkinson's disease(8-11) and various brain regions in the tauopathies(11,12). Here we report that tau-knockout mice develop age-dependent brain atrophy, iron accumulation and SN neuronal loss, with concomitant cognitive deficits and parkinsonism. These changes are prevented by oral treatment with a moderate iron chelator, clioquinol. Amyloid precursor protein (APP) ferroxidase activity couples with surface ferroportin to export iron, but its activity is inhibited in Alzheimer's disease, thereby causing neuronal iron accumulation(7). In primary neuronal culture, we found loss of tau also causes iron retention, by decreasing surface trafficking of APP. Soluble tau levels fall in affected brain regions in Alzheimer's disease and tauopathies(13-15), and we found a similar decrease of soluble tau in the SN in both Parkinson's disease and the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model. These data suggest that the loss of soluble tau could contribute to toxic neuronal iron accumulation in Alzheimer's disease, Parkinson's disease and tauopathies, and that it can be rescued pharmacologically.	[Lei, Peng; Ayton, Scott; Finkelstein, David I.; Ciccotosto, Giuseppe D.; Wong, Bruce X. W.; Adlard, Paul A.; Cherny, Robert A.; Lam, Linh Q.; Roberts, Blaine R.; Volitakis, Irene; Duce, James A.; Bush, Ashley I.] Univ Melbourne, Mental Hlth Res Inst, Melbourne, Vic 3010, Australia; [Lei, Peng; Spoerri, Loredana; Ciccotosto, Giuseppe D.; Adlard, Paul A.; McLean, Catriona A.; Cappai, Roberto; Bush, Ashley I.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Ayton, Scott; Finkelstein, David I.; Duce, James A.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic 3010, Australia; [Spoerri, Loredana; Ciccotosto, Giuseppe D.; Cappai, Roberto] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Wright, David K.; Egan, Gary F.] Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic 3010, Australia	University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Bush, AI (corresponding author), Univ Melbourne, Mental Hlth Res Inst, Melbourne, Vic 3010, Australia.	ashleyib@unimelb.edu.au	Bush, Ashley I/A-1186-2007; Bush, Ashley/Y-2457-2019; Wong, Bruce/AAY-5884-2020; Spoerri, Loredana/G-4862-2014; Egan, Gary F./A-1381-2013; Ayton, Scott/J-8000-2015; Lei, Peng/F-6326-2010; Finkelstein, David/B-9617-2009; Ayton, Scott/AAJ-3414-2021; Cappai, Roberto/B-3347-2010	Bush, Ashley I/0000-0001-8259-9069; Bush, Ashley/0000-0001-8259-9069; Wong, Bruce/0000-0002-1687-4138; Spoerri, Loredana/0000-0003-0756-9390; Ayton, Scott/0000-0002-3479-2427; Lei, Peng/0000-0001-5652-1962; Finkelstein, David/0000-0002-8167-4917; Egan, Gary/0000-0002-3186-4026; Volitakis, Irene/0000-0003-0766-817X; Cappai, Roberto/0000-0002-9505-8496; Duce, James/0000-0002-8762-2245; Wright, David/0000-0002-7535-8651; Roberts, Blaine/0000-0001-5466-0053; McLean, Catriona/0000-0002-0302-5727	Australian Research Council; National Health & Medical Research Council of Australia (NHMRC); Alzheimer's Association; The University of Melbourne; The Mental Health Research Institute; The Alfred Hospital; Victorian Forensic Institute of Medicine; Neurosciences Australia; NHMRC; Alzheimers Research UK [ART-SRF2011-1] Funding Source: researchfish	Australian Research Council(Australian Research Council); National Health & Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Alzheimer's Association(Alzheimer's Association); The University of Melbourne(University of Melbourne); The Mental Health Research Institute; The Alfred Hospital; Victorian Forensic Institute of Medicine; Neurosciences Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	This work was supported by funds from the Australian Research Council, the National Health & Medical Research Council of Australia (NHMRC) and the Alzheimer's Association. The Victorian Brain Bank Network is supported by The University of Melbourne, The Mental Health Research Institute, The Alfred Hospital and the Victorian Forensic Institute of Medicine, and funded by Neurosciences Australia and the NHMRC. The authors thank Y-H. Hung, H. Kim, S.H. Bush and A. Sedjahtera for helpful discussion and technical assistance, H.N. Dawson (Duke University) for providing the tau-knockout mice, and TA. Rouault and D.L. Zhang (US National Institutes of Health) for MAP23 antibody.	Bartzokis G, 1999, MAGN RESON IMAGING, V17, P213, DOI 10.1016/S0730-725X(98)00155-6; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson HN, 2001, J CELL SCI, V114, P1179; DEXTER DT, 1992, ANN NEUROL, V32, pS94, DOI 10.1002/ana.410320716; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; Hoglinger GU, 2011, NAT GENET, V43, P699, DOI 10.1038/ng.859; Ikegami S, 2000, NEUROSCI LETT, V279, P129, DOI 10.1016/S0304-3940(99)00964-7; Ittner LM, 2008, P NATL ACAD SCI USA, V105, P15997, DOI 10.1073/pnas.0808084105; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; KHATOON S, 1994, FEBS LETT, V351, P80, DOI 10.1016/0014-5793(94)00829-9; KSIEZAKREDING H, 1988, J BIOL CHEM, V263, P7948; Laws SM, 2008, NEUROBIOL AGING, V29, P1276, DOI 10.1016/j.neurobiolaging.2007.02.019; Laws SM, 2007, MOL PSYCHIATR, V12, P510, DOI 10.1038/sj.mp.4001935; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lei P, 2010, INT J BIOCHEM CELL B, V42, P1775, DOI 10.1016/j.biocel.2010.07.016; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Mandel SA, 2005, NEUROSIGNALS, V14, P46, DOI 10.1159/000085385; O'Neill J, 2002, MOVEMENT DISORD, V17, P917, DOI 10.1002/mds.10214; Oakley AE, 2007, NEUROLOGY, V68, P1820, DOI 10.1212/01.wnl.0000262033.01945.9a; Paisan-Ruiz C., NEUROBIOL A IN PRESS; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rogers JT, 2002, J BIOL CHEM, V277, P45518, DOI 10.1074/jbc.M207435200; Sedelis M, 2001, BEHAV BRAIN RES, V125, P109, DOI 10.1016/S0166-4328(01)00309-6; SMITH MA, 1995, NAT MED, V1, P365, DOI 10.1038/nm0495-365; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhukareva V, 2003, ACTA NEUROPATHOL, V105, P469, DOI 10.1007/s00401-002-0668-8	32	391	405	2	91	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					291	295		10.1038/nm.2613	http://dx.doi.org/10.1038/nm.2613			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22286308				2022-12-25	WOS:000300140300045
J	Saison, C; Helias, V; Ballif, BA; Peyrard, T; Puy, H; Miyazaki, T; Perrot, S; Vayssier-Taussat, M; Waldner, M; Le Pennec, PY; Cartron, JP; Arnaud, L				Saison, Carole; Helias, Virginie; Ballif, Bryan A.; Peyrard, Thierry; Puy, Herve; Miyazaki, Toru; Perrot, Sebastien; Vayssier-Taussat, Muriel; Waldner, Mauro; Le Pennec, Pierre-Yves; Cartron, Jean-Pierre; Arnaud, Lionel			Null alleles of ABCG2 encoding the breast cancer resistance protein define the new blood group system Junior	NATURE GENETICS			English	Article							FUNCTIONAL ASSESSMENT; MULTIDRUG-RESISTANCE; HEMOLYTIC-DISEASE; TRANSPORTER ABCG2; HUMAN PLACENTA; POLYMORPHISMS; EXPRESSION; GENE; IDENTIFICATION; POPULATION	The breast cancer resistance protein, also known as ABCG2, is one of the most highly studied ATP-binding cassette (ABC) transporters because of its ability to confer multidrug resistance(1,2). The lack of information on the physiological role of ABCG2 in humans severely limits cancer chemotherapeutic approaches targeting this transporter. We report here that ABCG2 comprises the molecular basis of a new blood group system (Junior, Jr) and that individuals of the Jr(a) blood type have inherited two null alleles of ABCG2. We identified five frameshift and three nonsense mutations in ABCG2. We also show that the prevalence of the Jr(a) blood type in the Japanese and European Gypsy populations is related to the p.Gln126* and p.Arg236* protein alterations, respectively. The identification of ABCG2(-/-) (Jr(a-)) individuals who appear phenotypically normal is an essential step toward targeting ABCG2 in cancer and also in understanding the physiological and pharmacological roles of this promiscuous transporter in humans.	[Saison, Carole; Helias, Virginie; Peyrard, Thierry; Le Pennec, Pierre-Yves; Cartron, Jean-Pierre; Arnaud, Lionel] Natl Inst Blood Transfus INTS, Paris, France; [Ballif, Bryan A.] Univ Vermont, Dept Biol, Burlington, VT USA; [Peyrard, Thierry; Le Pennec, Pierre-Yves] Natl Reference Ctr Blood Grp CNRGS, Paris, France; [Puy, Herve] Univ Paris 07, Assistance Publ Hop Paris, Ctr Francais Porphyries, INSERM,Ctr Rech Biomed Bichat Beaujon,U 773, Paris, France; [Miyazaki, Toru] Japanese Red Cross Hokkaido Blood Ctr, Sapporo, Hokkaido, Japan; [Perrot, Sebastien] Univ Paris Est, Enva, Maisons Alfort, France; [Vayssier-Taussat, Muriel] Inst Sci Rech Agron Inra, Unite Contrat Bartonella, Maisons Alfort, France; [Waldner, Mauro] SIT Osped Santa Chiara, Lab Immunoematologia, Trento, Italy	University of Vermont; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Santa Chiara Hospital	Arnaud, L (corresponding author), Natl Inst Blood Transfus INTS, Paris, France.	larnaud@ints.fr	PUY, HERVE/O-1785-2017; Perrot, Sébastien/HDO-4475-2022	PUY, HERVE/0000-0003-3362-2634; Perrot, Sébastien/0000-0003-3217-8375; PEYRARD, THIERRY/0000-0002-7715-568X; Saison, Carole/0000-0001-5898-7176	INTS; Inserm; Paris Diderot University (Paris 7); Vermont Genetics Network through the US National Institutes of Health/National Center for Research Resources [P20 RR16462]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103449] Funding Source: NIH RePORTER	INTS; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Paris Diderot University (Paris 7); Vermont Genetics Network through the US National Institutes of Health/National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are indebted to all present and past members of the CNRGS for identifying and conserving Jr(a-) blood samples and extracting genomic DNA. We greatly appreciate M. Le Gall for her thoughtful comments on the manuscript. This study was supported in part by the INTS, Inserm and Paris Diderot University (Paris 7). B.A.B. was funded by the Vermont Genetics Network through a grant from the US National Institutes of Health/National Center for Research Resources (P20 RR16462).	Allikmets R, 1998, CANCER RES, V58, P5337; Cusatis G, 2008, PHARMACOGENOMICS, V9, P1005, DOI 10.2217/14622416.9.8.1005; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Helms V., 2012, NAT GENET, DOI [10.1038/mg.1069, DOI 10.1038/MG.1069]; Huls M, 2008, KIDNEY INT, V73, P220, DOI 10.1038/sj.ki.5002645; Imai Y, 2002, MOL CANCER THER, V1, P611; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Kobayashi D, 2005, DRUG METAB DISPOS, V33, P94, DOI 10.1124/dmd.104.001628; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Kwon MY, 2004, TRANSFUSION, V44, P197, DOI 10.1111/j.1537-2995.2004.00643.x; Lee SS, 2007, DRUG METAB DISPOS, V35, P623, DOI 10.1124/dmd.106.012302; Maliepaard M, 2001, CANCER RES, V61, P3458; Matsuo H, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000237; Miyake K, 1999, CANCER RES, V59, P8; MIYAZAKI T, 1994, VOX SANG, V66, P51, DOI 10.1111/j.1423-0410.1994.tb00277.x; NAKAJIMA H, 1978, VOX SANG, V35, P265, DOI 10.1111/j.1423-0410.1978.tb02932.x; Noguchi K, 2009, ADV DRUG DELIVER REV, V61, P26, DOI 10.1016/j.addr.2008.07.003; Peyrard T, 2008, TRANSFUSION, V48, P1906, DOI 10.1111/j.1537-2995.2008.01787.x; Pisacka M, 2000, P 26 C INT SOC BLOOD, V78, P146; Polgar O, 2008, EXPERT OPIN DRUG MET, V4, P1, DOI 10.1517/17425255.4.1.1 ; Puy H, 2010, LANCET, V375, P924, DOI 10.1016/S0140-6736(09)61925-5; Scharenberg CW, 2002, BLOOD, V99, P507, DOI 10.1182/blood.V99.2.507; Tamura A, 2007, CANCER SCI, V98, P231, DOI 10.1111/j.1349-7006.2006.00371.x; Vlaming MLH, 2009, ADV DRUG DELIVER REV, V61, P14, DOI 10.1016/j.addr.2008.08.007; Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106; Zhou S, 2005, BLOOD, V105, P2571, DOI 10.1182/blood-2004-04-1566	27	76	80	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2012	44	2					174	177		10.1038/ng.1070	http://dx.doi.org/10.1038/ng.1070			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	22246505	Green Accepted			2022-12-25	WOS:000299664400015
J	Netz, DJA; Stith, CM; Stumpfig, M; Kopf, G; Vogel, D; Genau, HM; Stodola, JL; Lill, R; Burgers, PMJ; Pierik, AJ				Netz, Daili J. A.; Stith, Carrie M.; Stuempfig, Martin; Koepf, Gabriele; Vogel, Daniel; Genau, Heide M.; Stodola, Joseph L.; Lill, Roland; Burgers, Peter M. J.; Pierik, Antonio J.			Eukaryotic DNA polymerases require an iron-sulfur cluster for the formation of active complexes	NATURE CHEMICAL BIOLOGY			English	Article							CELL NUCLEAR ANTIGEN; REPLICATION FACTOR-C; SACCHAROMYCES-CEREVISIAE; RIBONUCLEOTIDE REDUCTASE; TRANSLESION SYNTHESIS; PROTEIN BIOGENESIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; STRUCTURAL BASIS; ZINC-FINGER	The eukaryotic replicative DNA polymerases (Pol alpha, delta and epsilon) and the major DNA mutagenesis enzyme Pol zeta contain two conserved cysteine-rich metal-binding motifs (CysA and CysB) in the C-terminal domain (CTD) of their catalytic subunits. Here we demonstrate by in vivo and in vitro approaches the presence of an essential [4Fe-4S] cluster in the CysB motif of all four yeast B-family DNA polymerases. Loss of the [4Fe-4S] cofactor by cysteine ligand mutagenesis in Pol3 destabilized the CTD and abrogated interaction with the Pol31 and Pol32 subunits. Reciprocally, overexpression of accessory subunits increased the amount of the CTD-bound Fe-S cluster. This implies an important physiological role of the Fe-S cluster in polymerase complex stabilization. Further, we demonstrate that the Zn-binding CysA motif is required for PCNA-mediated Pol d processivity. Together, our findings show that the function of eukaryotic replicative DNA polymerases crucially depends on different metallocenters for accessory subunit recruitment and replisome stability.	[Netz, Daili J. A.; Stuempfig, Martin; Koepf, Gabriele; Vogel, Daniel; Genau, Heide M.; Lill, Roland; Pierik, Antonio J.] Univ Marburg, Inst Zytobiol & Zytopathol, Marburg, Germany; [Stith, Carrie M.; Stodola, Joseph L.; Burgers, Peter M. J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Philipps University Marburg; Washington University (WUSTL)	Netz, DJA (corresponding author), Univ Marburg, Inst Zytobiol & Zytopathol, Marburg, Germany.	lill@staff.uni-marburg.de; burgers@biochem.wustl.edu; pierik@staff.uni-marburg.de	Burgers, Peter M/AAW-6621-2021; Pierik, Antonio J/G-1108-2010	Pierik, Antonio J/0000-0002-1509-6370; Lill, Roland/0000-0002-8345-6518; Duevel, Heide Marika/0000-0002-7687-8683	US National Institutes of Health [GM032431]; Deutsche Forschungsgemeinschaft [SFB 593, GRK 1216]; Rhon Klinikum, von Behring-Rontgen Stiftung; LOEWE-Program of State Hessen; Max-Planck Gesellschaft; Fonds der Chemischen Industrie; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032431] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Rhon Klinikum, von Behring-Rontgen Stiftung; LOEWE-Program of State Hessen; Max-Planck Gesellschaft(Max Planck Society); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Yoder for yeast two-hybrid analysis and M. Reuter for help with cloning. This work was supported by grant GM032431 from the US National Institutes of Health (P.M.J.B.), the Deutsche Forschungsgemeinschaft (SFB 593, Gottfried-Wilhelm Leibniz program, and GRK 1216), Rhon Klinikum, von Behring-Rontgen Stiftung, LOEWE-Program of State Hessen, Max-Planck Gesellschaft and Fonds der Chemischen Industrie.	Abbouni B, 2009, FREE RADICAL RES, V43, P943, DOI 10.1080/10715760903140568; AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Baranovskiy AG, 2008, CELL CYCLE, V7, P3026, DOI 10.4161/cc.7.19.6720; Bemark M, 2000, CURR BIOL, V10, P1213, DOI 10.1016/S0960-9822(00)00724-7; Boal AK, 2010, SCIENCE, V329, P1526, DOI 10.1126/science.1190187; BURGERS PMJ, 1991, J BIOL CHEM, V266, P22698; Burgers PMJ, 2001, J BIOL CHEM, V276, P43487, DOI 10.1074/jbc.R100056200; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Chanet R, 2003, CURR GENET, V43, P337, DOI 10.1007/s00294-003-0407-2; Dauter Z, 1996, P NATL ACAD SCI USA, V93, P8836, DOI 10.1073/pnas.93.17.8836; Dua R, 1999, J BIOL CHEM, V274, P22283, DOI 10.1074/jbc.274.32.22283; Evanics F, 2003, BBA-PROTEINS PROTEOM, V1651, P163, DOI 10.1016/S1570-9639(03)00266-8; Fortune JM, 2006, NUCLEIC ACIDS RES, V34, P4335, DOI 10.1093/nar/gkl403; Garcia JS, 2004, NUCLEIC ACIDS RES, V32, P3005, DOI 10.1093/nar/gkh623; Garg P, 2005, J BIOL CHEM, V280, P23446, DOI 10.1074/jbc.C500173200; Gomes XV, 2000, J BIOL CHEM, V275, P14541, DOI 10.1074/jbc.275.19.14541; Hara K, 2010, J BIOL CHEM, V285, P12299, DOI 10.1074/jbc.M109.092403; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Johansson E, 2004, J BIOL CHEM, V279, P1907, DOI 10.1074/jbc.M310362200; Johansson E, 2010, TRENDS BIOCHEM SCI, V35, P339, DOI 10.1016/j.tibs.2010.01.004; KENT TA, 1982, P NATL ACAD SCI-BIOL, V79, P1096, DOI 10.1073/pnas.79.4.1096; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Klinge S, 2009, EMBO J, V28, P1978, DOI 10.1038/emboj.2009.150; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Makiniemi M, 1999, TRENDS BIOCHEM SCI, V24, P14, DOI 10.1016/S0968-0004(98)01327-9; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; Mizuno T, 1999, MOL CELL BIOL, V19, P7886; Montecucco A, 1998, EMBO J, V17, P3786, DOI 10.1093/emboj/17.13.3786; NAR H, 1992, EUR J BIOCHEM, V205, P1123, DOI 10.1111/j.1432-1033.1992.tb16881.x; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; ORMEJOHNSON WH, 1982, IRON SULFUR PROTEINS, P67; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Ramelot TA, 2004, J MOL BIOL, V344, P567, DOI 10.1016/j.jmb.2004.08.038; Roy A, 2003, EMBO J, V22, P4826, DOI 10.1093/emboj/cdg455; Swan MK, 2009, NAT STRUCT MOL BIOL, V16, P979, DOI 10.1038/nsmb.1663; Tahirov TH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-11; TSURIMOTO T, 1989, EMBO J, V8, P3883, DOI 10.1002/j.1460-2075.1989.tb08567.x; Urzica E, 2009, BIOCHEMISTRY-US, V48, P4946, DOI 10.1021/bi900312x; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; WONG SW, 1989, J BIOL CHEM, V264, P5924; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08	49	277	287	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					125	132		10.1038/nchembio.721	http://dx.doi.org/10.1038/nchembio.721			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22119860	Green Accepted			2022-12-25	WOS:000298414100021
J	Phelan, VV; Liu, WT; Pogliano, K; Dorrestein, PC				Phelan, Vanessa V.; Liu, Wei-Ting; Pogliano, Kit; Dorrestein, Pieter C.			Microbial metabolic exchange-the chemotype-to-phenotype link	NATURE CHEMICAL BIOLOGY			English	Article							IMAGING MASS-SPECTROMETRY; COMPLETE GENOME SEQUENCE; PROTEIN SECRETION; STREPTOMYCES-COELICOLOR; INDUSTRIAL APPLICATIONS; BACTERIAL INTERACTIONS; BACILLUS-SUBTILIS; MEMBRANE; SIGNALS; NETWORK	The function of microbial interactions is to enable microorganisms to survive by establishing a homeostasis between microbial neighbors and local environments. A microorganism can respond to environmental stimuli using metabolic exchange-the transfer of molecular factors, including small molecules and proteins. Microbial interactions not only influence the survival of the microbes but also have roles in morphological and developmental processes of the organisms themselves and their neighbors. This, in turn, shapes the entire habitat of these organisms. Here we highlight our current understanding of metabolic exchange as well as the emergence of new technologies that are allowing us to eavesdrop on microbial conversations comprising dozens to hundreds of secreted metabolites that control the behavior, survival and differentiation of members of the community. The goal of the rapidly advancing field studying multifactorial metabolic exchange is to devise a microbial 'Rosetta stone' in order to understand the language by which microbial interactions are negotiated and, ultimately, to control the outcome of these conversations.	[Phelan, Vanessa V.; Dorrestein, Pieter C.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA; [Liu, Wei-Ting; Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem & Biochem, San Diego, CA 92103 USA; [Pogliano, Kit] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92103 USA; [Dorrestein, Pieter C.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography	Phelan, VV (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA.		Dorrestein, Pieter/ABF-2930-2020; Dorrestein, Pieter/D-5012-2012	Pogliano, Kit/0000-0002-7868-3345; Phelan, Vanessa/0000-0001-7156-9294	US National Institutes of Health [GM094802, GM086283, AI095125, GM057045]; Beckman Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057045, R01GM094802, R01GM086283] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to acknowledge J. Yang, W. Moree and C. Rath (University of California, San Diego) for providing critical reviews of the manuscript and E. Shank (Harvard Medical School) for insightful discussions. The P.C.D. laboratory is supported by US National Institutes of Health grants GM094802, GM086283 and AI095125 and by the Beckman Foundation. The K. P. laboratory is supported by US National Institutes of Health grants GM057045 and AI095125.	Allison DG, 2003, BIOFOULING, V19, P139, DOI [10.1080/0892701031000072190, 10.1038/nrmicro2415]; Angelini TE, 2009, P NATL ACAD SCI USA, V106, P18109, DOI 10.1073/pnas.0905890106; Ansari MZ, 2004, NUCLEIC ACIDS RES, V32, pW405, DOI 10.1093/nar/gkh359; Antunes LCM, 2010, MICROBIOL-SGM, V156, P2271, DOI 10.1099/mic.0.038794-0; Babalola OO, 2010, BIOTECHNOL LETT, V32, P1559, DOI 10.1007/s10529-010-0347-0; Baltz RH, 2008, CURR OPIN PHARMACOL, V8, P557, DOI 10.1016/j.coph.2008.04.008; Banat IM, 2000, APPL MICROBIOL BIOT, V53, P495, DOI 10.1007/s002530051648; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Boedicker JQ, 2009, ANGEW CHEM INT EDIT, V48, P5908, DOI 10.1002/anie.200901550; Bores-Walmsley MI, 2000, TRENDS MICROBIOL, V8, P133, DOI 10.1016/S0966-842X(00)01698-X; Boyd EF, 2002, TRENDS MICROBIOL, V10, P521, DOI 10.1016/S0966-842X(02)02459-9; Boyer M, 2009, FEMS MICROBIOL ECOL, V70, P1, DOI 10.1111/j.1574-6941.2009.00745.x; Champion PAD, 2007, CELL MICROBIOL, V9, P1376, DOI 10.1111/j.1462-5822.2007.00943.x; COLEMAN DC, 1989, J GEN MICROBIOL, V135, P1679; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Currie CR, 2003, SCIENCE, V299, P386, DOI 10.1126/science.1078155; D'Onofrio A, 2010, CHEM BIOL, V17, P254, DOI 10.1016/j.chembiol.2010.02.010; Davies J, 2009, CLIN MICROBIOL INFEC, V15, P1, DOI 10.1111/j.1469-0691.2008.02682.x; Dayan FE, 2009, BIOORGAN MED CHEM, V17, P4022, DOI 10.1016/j.bmc.2009.01.046; de Jong A, 2010, NUCLEIC ACIDS RES, V38, pW647, DOI 10.1093/nar/gkq365; De Sordi L, 2009, FEMS YEAST RES, V9, P990, DOI 10.1111/j.1567-1364.2009.00573.x; Dubey GP, 2011, CELL, V144, P590, DOI 10.1016/j.cell.2011.01.015; Fajardo A, 2008, CURR OPIN MICROBIOL, V11, P161, DOI 10.1016/j.mib.2008.02.006; Fujinami S, 2010, ENVIRON TECHNOL, V31, P845, DOI 10.1080/09593331003762807; Fusetani N, 2011, NAT PROD REP, V28, P400, DOI 10.1039/c0np00034e; GILTURNES MS, 1989, SCIENCE, V246, P116, DOI 10.1126/science.2781297; Gonzalez DJ, 2011, MICROBIOL-SGM, V157, P2485, DOI 10.1099/mic.0.048736-0; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Green Tringe Susannah, 2005, Nature Reviews Genetics, V6, P805, DOI 10.1038/nrg1709; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Haeder S, 2009, P NATL ACAD SCI USA, V106, P4742, DOI 10.1073/pnas.0812082106; Hasan F, 2006, ENZYME MICROB TECH, V39, P235, DOI 10.1016/j.enzmictec.2005.10.016; Haurat MF, 2011, J BIOL CHEM, V286, P1269, DOI 10.1074/jbc.M110.185744; Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Holland IB, 2010, METHODS MOL BIOL, V619, P1, DOI 10.1007/978-1-60327-412-8_1; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kai M, 2009, APPL MICROBIOL BIOT, V81, P1001, DOI 10.1007/s00253-008-1760-3; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kearns DB, 2003, MOL MICROBIOL, V49, P581, DOI 10.1046/j.1365-2958.2003.03584.x; Kersten RD, 2011, NAT CHEM BIOL, V7, P794, DOI 10.1038/nchembio.684; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Lewis K, 2010, J ANTIBIOT, V63, P468, DOI 10.1038/ja.2010.87; Little AEF, 2008, ANNU REV MICROBIOL, V62, P375, DOI 10.1146/annurev.micro.030608.101423; Liu WT, 2010, P NATL ACAD SCI USA, V107, P16286, DOI 10.1073/pnas.1008368107; Lopez D, 2010, FEMS MICROBIOL REV, V34, P134, DOI 10.1111/j.1574-6976.2009.00199.x; Lopez D, 2009, MOL MICROBIOL, V74, P609, DOI 10.1111/j.1365-2958.2009.06882.x; Lowery CA, 2008, CHEM SOC REV, V37, P1337, DOI 10.1039/b702781h; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; McLean JS, 2008, J MICROBIOL METH, V74, P47, DOI 10.1016/j.mimet.2008.02.015; McLean JS, 2008, ISME J, V2, P121, DOI 10.1038/ismej.2007.107; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Minerdi D, 2009, ENVIRON MICROBIOL, V11, P844, DOI 10.1111/j.1462-2920.2008.01805.x; Moter A, 2000, J MICROBIOL METH, V41, P85, DOI 10.1016/S0167-7012(00)00152-4; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Nett M, 2009, NAT PROD REP, V26, P1362, DOI 10.1039/b817069j; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Oh DC, 2009, NAT CHEM BIOL, V5, P391, DOI 10.1038/nchembio.159; Ohnishi Y, 2008, J BACTERIOL, V190, P4050, DOI 10.1128/JB.00204-08; Omura S, 2001, P NATL ACAD SCI USA, V98, P12215, DOI 10.1073/pnas.211433198; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; Piel J, 2009, NAT PROD REP, V26, P338, DOI 10.1039/b703499g; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ratcliff WC, 2011, SCIENCE, V332, P547, DOI 10.1126/science.1205970; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Rickard AH, 2006, MOL MICROBIOL, V60, P1446, DOI 10.1111/j.1365-2958.2006.05202.x; Rigali S, 2008, EMBO REP, V9, P670, DOI 10.1038/embor.2008.83; Roze LV, 2011, FUNGAL GENET BIOL, V48, P35, DOI 10.1016/j.fgb.2010.05.006; Schloss PD, 2007, ANNU REV MICROBIOL, V61, P23, DOI 10.1146/annurev.micro.61.011507.151712; Schoenian I, 2011, P NATL ACAD SCI USA, V108, P1955, DOI 10.1073/pnas.1008441108; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Schulz S, 2007, NAT PROD REP, V24, P814, DOI 10.1039/b507392h; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; Shank EA, 2009, CURR OPIN MICROBIOL, V12, P205, DOI 10.1016/j.mib.2009.01.003; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; Singh A, 2011, CELL MICROBIOL, V13, P177, DOI 10.1111/j.1462-5822.2010.01550.x; Snyder EE, 2007, NUCLEIC ACIDS RES, V35, pD401, DOI 10.1093/nar/gkl858; Straight PD, 2006, J BACTERIOL, V188, P4918, DOI 10.1128/JB.00162-06; Straight PD, 2009, ANNU REV MICROBIOL, V63, P99, DOI 10.1146/annurev.micro.091208.073248; Strauss E, 2010, NAT CHEM BIOL, V6, P873, DOI 10.1038/nchembio.483; Ubbink J, 2005, MICRON, V36, P293, DOI 10.1016/j.micron.2004.11.005; Valm AM, 2011, P NATL ACAD SCI USA, V108, P4152, DOI 10.1073/pnas.1101134108; van Wezel GP, 2011, NAT PROD REP, V28, P1311, DOI 10.1039/c1np00003a; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Watrous JD, 2011, NAT REV MICROBIOL, V9, P683, DOI 10.1038/nrmicro2634; Winter JM, 2011, CURR OPIN CHEM BIOL, V15, P22, DOI 10.1016/j.cbpa.2010.10.020; Yang YL, 2011, ANGEW CHEM INT EDIT, V50, P5839, DOI 10.1002/anie.201101225; Yang YL, 2009, NAT CHEM BIOL, V5, P885, DOI 10.1038/nchembio.252; Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044	98	156	161	4	127	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					26	35		10.1038/nchembio.739	http://dx.doi.org/10.1038/nchembio.739			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22173357	Green Accepted			2022-12-25	WOS:000298414100009
J	Amps, K; Andrews, PW; Anyfantis, G; Armstrong, L; Avery, S; Baharvand, H; Baker, J; Baker, D; Munoz, MB; Beil, S; Benvenisty, N; Ben-Yosef, D; Biancotti, JC; Bosman, A; Brena, RM; Brison, D; Caisander, G; Camarasa, MV; Chen, JM; Chiao, E; Choi, YM; Choo, ABH; Collins, D; Colman, A; Crook, JM; Daley, GQ; Dalton, A; De Sousa, PA; Denning, C; Downie, J; Dvorak, P; Montgomery, KD; Feki, A; Ford, A; Fox, V; Fraga, AM; Frumkin, T; Ge, L; Gokhale, PJ; Golan-Lev, T; Gourabi, H; Gropp, M; Lu, GX; Hampl, A; Harron, K; Healy, L; Herath, W; Holm, F; Hovatta, O; Hyllner, J; Inamdar, MS; Irwanto, AK; Ishii, T; Jaconi, M; Jin, Y; Kimber, S; Kiselev, S; Knowles, BB; Kopper, O; Kukharenko, V; Kuliev, A; Lagarkova, MA; Laird, PW; Lako, M; Laslett, AL; Lavon, N; Lee, DR; Lee, JE; Li, CL; Lim, LS; Ludwig, TE; Ma, Y; Maltby, E; Mateizel, I; Mayshar, Y; Mileikovsky, M; Minger, SL; Miyazaki, T; Moon, SY; Moore, H; Mummery, C; Nagy, A; Nakatsuji, N; Narwani, K; Oh, SKW; Oh, SK; Olson, C; Otonkoski, T; Pan, F; Park, IH; Pells, S; Pera, MF; Pereira, LV; Qi, O; Raj, GS; Reubinoff, B; Robins, A; Robson, P; Rossant, J; Salekdeh, GH; Schulz, TC; Sermon, K; Mohamed, JS; Shen, H; Sherrer, E; Sidhu, K; Sivarajah, S; Skottman, H; Spits, C; Stacey, GN; Strehl, R; Strelchenko, N; Suemori, H; Sun, BW; Suuronen, R; Takahashi, K; Tuuri, T; Venu, P; Verlinsky, Y; Ward-van Oostwaard, D; Weisenberger, DJ; Wu, Y; Yamanaka, S; Young, L; Zhou, Q				Amps, Katherine; Andrews, Peter W.; Anyfantis, George; Armstrong, Lyle; Avery, Stuart; Baharvand, Hossein; Baker, Julie; Baker, Duncan; Munoz, Maria B.; Beil, Stephen; Benvenisty, Nissim; Ben-Yosef, Dalit; Biancotti, Juan-Carlos; Bosman, Alexis; Brena, Romulo Martin; Brison, Daniel; Caisander, Gunilla; Camarasa, Maria V.; Chen, Jieming; Chiao, Eric; Choi, Young Min; Choo, Andre B. H.; Collins, Daniel; Colman, Alan; Crook, Jeremy M.; Daley, George Q.; Dalton, Anne; De Sousa, Paul A.; Denning, Chris; Downie, Janet; Dvorak, Petr; Montgomery, Karen D.; Feki, Anis; Ford, Angela; Fox, Victoria; Fraga, Ana M.; Frumkin, Tzvia; Ge, Lin; Gokhale, Paul J.; Golan-Lev, Tamar; Gourabi, Hamid; Gropp, Michal; Lu Guangxiu; Hampl, Ales; Harron, Katie; Healy, Lyn; Herath, Wishva; Holm, Frida; Hovatta, Outi; Hyllner, Johan; Inamdar, Maneesha S.; Irwanto, Astrid Kresentia; Ishii, Tetsuya; Jaconi, Marisa; Jin, Ying; Kimber, Susan; Kiselev, Sergey; Knowles, Barbara B.; Kopper, Oded; Kukharenko, Valeri; Kuliev, Anver; Lagarkova, Maria A.; Laird, Peter W.; Lako, Majlinda; Laslett, Andrew L.; Lavon, Neta; Lee, Dong Ryul; Lee, Jeoung Eun; Li, Chunliang; Lim, Linda S.; Ludwig, Tenneille E.; Ma, Yu; Maltby, Edna; Mateizel, Ileana; Mayshar, Yoav; Mileikovsky, Maria; Minger, Stephen L.; Miyazaki, Takamichi; Moon, Shin Yong; Moore, Harry; Mummery, Christine; Nagy, Andras; Nakatsuji, Norio; Narwani, Kavita; Oh, Steve K. W.; Oh, Sun Kyung; Olson, Cia; Otonkoski, Timo; Pan, Fei; Park, In-Hyun; Pells, Steve; Pera, Martin F.; Pereira, Lygia V.; Qi, Ouyang; Raj, Grace Selva; Reubinoff, Benjamin; Robins, Alan; Robson, Paul; Rossant, Janet; Salekdeh, Ghasem H.; Schulz, Thomas C.; Sermon, Karen; Mohamed, Jameelah Sheik; Shen, Hui; Sherrer, Eric; Sidhu, Kuldip; Sivarajah, Shirani; Skottman, Heli; Spits, Claudia; Stacey, Glyn N.; Strehl, Raimund; Strelchenko, Nick; Suemori, Hirofumi; Sun, Bowen; Suuronen, Riitta; Takahashi, Kazutoshi; Tuuri, Timo; Venu, Parvathy; Verlinsky, Yuri; Ward-van Oostwaard, Dorien; Weisenberger, Daniel J.; Wu, Yue; Yamanaka, Shinya; Young, Lorraine; Zhou, Qi		Int Stem Cell Initiative	Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage	NATURE BIOTECHNOLOGY			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; HUMAN ES CELLS; DNA-SEQUENCE; CULTURE; GENES; LINES; PLURIPOTENCY; REVEALS; NANOG	The International Stem Cell Initiative analyzed 125 human embryonic stem (ES) cell lines and 11 induced pluripotent stem (iPS) cell lines, from 38 laboratories worldwide, for genetic changes occurring during culture. Most lines were analyzed at an early and late passage. Single-nucleotide polymorphism (SNP) analysis revealed that they included representatives of most major ethnic groups. Most lines remained karyotypically normal, but there was a progressive tendency to acquire changes on prolonged culture, commonly affecting chromosomes 1, 12, 17 and 20. DNA methylation patterns changed haphazardly with no link to time in culture. Structural variants, determined from the SNP arrays, also appeared sporadically. No common variants related to culture were observed on chromosomes 1, 12 and 17, but a minimal amplicon in chromosome 20q11.21, including three genes expressed in human ES cells, ID1, BCL2L1 and HM13, occurred in >20% of the lines. Of these genes, BCL2L1 is a strong candidate for driving culture adaptation of ES cells.	[Amps, Katherine; Andrews, Peter W.; Ford, Angela; Gokhale, Paul J.; Moore, Harry] Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England; [Anyfantis, George; Armstrong, Lyle; Lako, Majlinda] Int Ctr Life, NE England Stem Cell Inst Life, Newcastle Upon Tyne, Tyne & Wear, England; [Avery, Stuart; Colman, Alan; Crook, Jeremy M.; Knowles, Barbara B.] ASTAR, Inst Med Biol, Immunos, Singapore; [Baharvand, Hossein; Gourabi, Hamid] Royan Inst Reprod Biomed, Dept Genet, Tehran, Iran; [Baker, Julie; Chiao, Eric] Stanford Univ, Stanford, CA 94305 USA; [Baker, Duncan; Dalton, Anne; Maltby, Edna] Sheffield Childrens NHS Trust, Sheffield Diagnost Genet Serv, Sheffield, S Yorkshire, England; [Munoz, Maria B.; Denning, Chris; Young, Lorraine] Univ Nottingham, Ctr Biomol Sci, Wolfson Ctr Stem Cells Tissue Engn & Modelling ST, Nottingham NG7 2RD, England; [Beil, Stephen; Fox, Victoria] Univ So Calif, Keck Sch Med, USC Stem Cell Core Facil, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA; [Benvenisty, Nissim; Golan-Lev, Tamar; Kopper, Oded; Mayshar, Yoav] Hebrew Univ Jerusalem, Dept Genet, Alexander Silberman Inst Life Sci, Stem Cell Unit, IL-91904 Jerusalem, Israel; [Ben-Yosef, Dalit; Frumkin, Tzvia] Lis Matern Hosp, Tel Aviv Sourasky Med Ctr, Racine IVF Unit, Tel Aviv, Israel; [Ben-Yosef, Dalit] Tel Aviv Univ, Sackler Fac Med, Dept Cell Dev Biol, IL-69978 Tel Aviv, Israel; [Biancotti, Juan-Carlos; Lavon, Neta; Narwani, Kavita] Cedars Sinai Med Inst, Regenerat Med Inst, Los Angeles, CA USA; [Bosman, Alexis; Jaconi, Marisa] Univ Geneva, Fac Med, Dept Pathol & Immunol, Geneva, Switzerland; [Brena, Romulo Martin; Laird, Peter W.; Pan, Fei; Shen, Hui; Weisenberger, Daniel J.] Univ So Calif, Keck Sch Med, USC Epigenome Ctr, Los Angeles, CA 90033 USA; [Brison, Daniel] Cent Manchester NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, St Maryss Hosp, Dept Reprod Med, Manchester, Lancs, England; [Caisander, Gunilla; Hyllner, Johan; Strehl, Raimund] Cellartis AB, Gothenburg, Sweden; [Camarasa, Maria V.; Kimber, Susan] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Chen, Jieming; Herath, Wishva; Irwanto, Astrid Kresentia; Lim, Linda S.; Robson, Paul; Mohamed, Jameelah Sheik] Genome Inst Singapore, Singapore, Singapore; [Chiao, Eric] Hoffmann LaRoche, Nutley, NJ USA; [Choi, Young Min; Moon, Shin Yong] Seoul Natl Univ, Coll Med, Dept Obstet & Gynaecol, Seoul, South Korea; [Choo, Andre B. H.; Oh, Steve K. W.] Bioproc Technol Inst, Singapore, Singapore; [Collins, Daniel; De Sousa, Paul A.; Downie, Janet] Roslin Cells Ltd, Roslin Bioctr, Roslin, Midlothian, Scotland; [Colman, Alan; Crook, Jeremy M.; Raj, Grace Selva; Sivarajah, Shirani] ASTAR, Singapore Stem Cell Consortium, Singapore, Singapore; [Crook, Jeremy M.; Sivarajah, Shirani] Univ Melbourne, Ctr Neural Engn, Parkville, Vic 3052, Australia; [Crook, Jeremy M.; Sivarajah, Shirani] Univ Melbourne, Opt & Nanoelect Res Grp, NICTA Victorian Res Lab, Parkville, Vic 3052, Australia; [Crook, Jeremy M.] Univ Melbourne, St Vincents Hosp, Dept Surg, Fitzroy, Vic 3065, Australia; [Daley, George Q.] Childrens Hosp, Howard Hughes Med Inst, Stem Cell Transplantat Program, Div Pediat Hematol Oncol,Manton Ctr Orphan Dis Re, Boston, MA 02115 USA; [Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Daley, George Q.] Harvard Stem Cell Inst, Boston, MA USA; [De Sousa, Paul A.; Pells, Steve] Univ Edinburgh, MRC, Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Dvorak, Petr] Masaryk Univ, Dept Biol, Fac Med, Brno, Czech Republic; [Montgomery, Karen D.; Ludwig, Tenneille E.] WiCell Res Inst, Madison, WI USA; [Feki, Anis] Hop Cantonal Fribourgois, Dept Obstet & Gynecol, Freibourg, Switzerland; [Fraga, Ana M.; Pereira, Lygia V.] Univ Sao Paulo, Dept Genet & Evolutionary Biol, Natl Lab Embryon Stem Cell Res LaNCE, Sao Paulo, Brazil; [Ge, Lin; Lu Guangxiu; Qi, Ouyang] Cent S Univ, Inst Reprod & Stem Cell Engn, Reprod & Genet Hosp CITIC XIANGYA, Changsha, Hunan, Peoples R China; [Gropp, Michal; Reubinoff, Benjamin] Hadassah Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, Hadassah Human Embryon Stem Cell Res Ctr, Jerusalem, Israel; [Hampl, Ales] Masaryk Univ, Fac Med, Dept Histol & Embryol, Brno, Czech Republic; [Hampl, Ales] Inst Expt Med ASCR, Prague, Czech Republic; [Harron, Katie] UCL, Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, London, England; [Healy, Lyn; Stacey, Glyn N.] Natl Inst Biol Stand & Controls, Div Cell Biol & Imaging, UK Stem Cell Bank, S Mimms, Herts, England; [Holm, Frida; Hovatta, Outi] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Inamdar, Maneesha S.; Venu, Parvathy] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India; [Ishii, Tetsuya; Takahashi, Kazutoshi; Yamanaka, Shinya] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan; [Jin, Ying] CAS Shanghai Jiao Tong Univ, Shanghai Inst Biol Sci, Key Lab Stem Cell Biol, Inst Hlth Sci,Sch Med, Shanghai, Peoples R China; [Kiselev, Sergey] NRC Kurchatov Inst, Stem Cell Dept, Moscow, Russia; [Kiselev, Sergey; Lagarkova, Maria A.] Vavilov Inst Gen Genet, Moscow, Russia; [Kukharenko, Valeri; Kuliev, Anver; Strelchenko, Nick; Verlinsky, Yuri] Illinois Masonic Med Ctr, Inst Reprod Genet, Chicago, IL 60657 USA; [Laslett, Andrew L.; Zhou, Qi] CSIRO Mat Sci & Engn, Clayton, Vic, Australia; [Laslett, Andrew L.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Lee, Dong Ryul] CHA Univ, CHA Stem Cell Inst, Dept Biomed Sci, Seoul, South Korea; [Li, Chunliang; Ma, Yu; Sun, Bowen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Stem Cell Inst, Shanghai 200030, Peoples R China; [Mateizel, Ileana; Sermon, Karen; Spits, Claudia] Vrije Univ Brussel, Dept Embryol & Genet, Brussels, Belgium; [Mileikovsky, Maria; Nagy, Andras] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Minger, Stephen L.; Wu, Yue] Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England; [Minger, Stephen L.; Wu, Yue] GE Healthcare, Cardiff, S Glam, Wales; [Miyazaki, Takamichi; Suemori, Hirofumi] Kyoto Univ, Inst Frontier Med Sci, Stem Cell Res Ctr, Lab Embryon Stem Cell Res, Kyoto, Japan; [Mummery, Christine; Ward-van Oostwaard, Dorien] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands; [Nakatsuji, Norio; Yamanaka, Shinya] Kyoto Univ, Inst Integrated Cell Mat Sci, Sakyo Ku, Kyoto, Japan; [Oh, Sun Kyung] Seoul Natl Univ, Med Res Ctr, Inst Reprod Med & Populat, Seoul, South Korea; [Olson, Cia; Otonkoski, Timo; Tuuri, Timo] Univ Helsinki, Res Programs Unit, Biomedicum Stem Cell Ctr, FIN-00014 Helsinki, Finland; [Otonkoski, Timo] Univ Helsinki, Childrens Hosp, FIN-00014 Helsinki, Finland; [Otonkoski, Timo] Univ Helsinki, Cent Hosp, FIN-00014 Helsinki, Finland; [Park, In-Hyun] Yale Univ, Sch Med, Dept Genet, Yale Stem Cell Ctr, New Haven, CT 06510 USA; [Robins, Alan; Schulz, Thomas C.; Sherrer, Eric] Viacyte, Athens, GA USA; [Rossant, Janet] Hosp Sick Children, Program Dev Biol, Toronto, ON M5G 1X8, Canada; [Salekdeh, Ghasem H.] ACECR, Royan Inst Stem Cell Biol & Technol, Cell Sci Res Ctr, Dept Mol Syst Biol, Tehran, Iran; [Sidhu, Kuldip] Univ New S Wales, Fac Med, Stem Cell Lab, Sydney, NSW 2052, Australia; [Skottman, Heli; Suuronen, Riitta] Univ Tampere, Inst Regenerat Med, FIN-33101 Tampere, Finland; [Yamanaka, Shinya] Japan Sci & Technol Agcy, Yamanaka iPS Cell Special Project, Kawaguchi, Saitama, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA	University of Sheffield; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Stanford University; Sheffield Children's NHS Foundation Trust; University of Nottingham; University of Southern California; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Cedars Sinai Medical Center; University of Geneva; University of Southern California; University of Manchester; Takara Bio Inc.; Cellartis; University of Manchester; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Seoul National University (SNU); Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; Agency for Science Technology & Research (A*STAR); University of Melbourne; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; University of Edinburgh; Masaryk University Brno; WiCell Research Institute; Universidade de Sao Paulo; Central South University; Hebrew University of Jerusalem; Hadassah University Medical Center; Masaryk University Brno; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; University of London; University College London; National Institute for Biological Standards & Control; Karolinska Institutet; Karolinska University Hospital; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore; Kyoto University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; National Research Centre - Kurchatov Institute; Russian Academy of Sciences; Vavilov Institute of General Genetics; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Monash University; Pochon Cha University; Shanghai Jiao Tong University; Vrije Universiteit Brussel; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of London; King's College London; General Electric; Kyoto University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Kyoto University; Seoul National University (SNU); University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Yale University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Academic Center for Education, Culture & Research (ACECR); University of New South Wales Sydney; Tampere University; Japan Science & Technology Agency (JST); University of California System; University of California San Francisco; The J David Gladstone Institutes	Amps, K (corresponding author), Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England.		Seppänen-Kaijasinkko, Riitta/AAE-1476-2021; SIDHU, kuldip/AAI-8361-2020; Kiselev, Sergey/AAO-1247-2020; Hampl, Ales/N-1632-2016; Weisenberger, Daniel/AAA-8314-2020; Armstrong, Lyle/B-7812-2013; Kuliev, Anver/P-5666-2018; Dvorak, Petr/G-2509-2013; Robson, Paul/A-3464-2009; Laslett, Andrew L/A-9760-2011; PERA, MARTIN/A-9812-2012; Takahashi, Kazutoshi/ABE-5504-2020; , chunliang.li@stjude.org/P-4373-2018; Dvorak, Petr/N-8936-2016; Salekdeh, Ghasem Hosseini/E-4198-2012; Vopenkova, Katerina/C-7133-2012; Camarasa, Maria V/L-3886-2014; De Sousa, Paul A/H-7416-2013; denning, chris/D-4777-2013; Shen, Hui/AAO-4387-2020; Lako, Majlinda/B-6297-2013; Choi, Young Min/J-2794-2012; Laird, Peter W/G-8683-2012; Moon, Shin-Yong/J-5467-2012; Spits, Claudia/J-1964-2014; Nagy, Andras/G-6465-2013; Jaconi, Marisa EE/J-4392-2013; Pereira, Lygia V/C-1049-2012; Crook, Jeremy Micah/AAH-8441-2020; Lagarkova, Maria/A-3296-2014	Hampl, Ales/0000-0002-8963-9235; Weisenberger, Daniel/0000-0001-8303-2603; Kuliev, Anver/0000-0002-2486-9339; Dvorak, Petr/0000-0002-3229-140X; Robson, Paul/0000-0002-0191-3958; Laslett, Andrew L/0000-0003-4729-8193; PERA, MARTIN/0000-0001-6239-0428; Takahashi, Kazutoshi/0000-0002-5329-8395; , chunliang.li@stjude.org/0000-0002-5938-5510; Dvorak, Petr/0000-0002-3229-140X; Salekdeh, Ghasem Hosseini/0000-0002-5124-4721; De Sousa, Paul A/0000-0003-0745-2504; Laird, Peter W/0000-0001-9117-3641; Spits, Claudia/0000-0002-0187-5138; Nagy, Andras/0000-0003-4311-0413; Pereira, Lygia V/0000-0002-0002-725X; Crook, Jeremy Micah/0000-0002-6415-1639; Jaconi, Marisa/0000-0002-2004-8226; Reubinoff, Benjamin/0000-0003-0353-1299; Harron, Katie/0000-0002-3418-2856; Healy, Lyn/0000-0002-7044-8789; Young, Lorraine/0000-0001-5450-5723; Gokhale, Paul/0000-0001-7225-4403; kiselev, sergey/0000-0001-7921-6987; Sermon, Karen/0000-0002-2311-9034; Ishii, Tetsuya/0000-0002-7085-7750; Anyfantis, George/0000-0001-5647-3841; Choo, Andre/0000-0001-9648-0755; Denning, Chris/0000-0003-0802-8617; Andrews, Peter/0000-0001-7215-4410; Seppanen-Kaijansinkko, Riitta/0000-0001-5348-7121; Skottman, Heli/0000-0002-4127-8792; Pells, Stephen/0000-0001-5866-5759; armstrong, lyle/0000-0002-7234-9362; Mummery, Christine/0000-0002-4549-6535; Mayshar, Yoav/0000-0002-5553-2472; Kimber, Susan/0000-0002-0568-6342; INAMDAR, MANEESHA/0000-0002-8243-2821; Knowles, Barbara B./0000-0002-2597-5619; Feki, Anis/0000-0002-9817-9445; Shen, Hui/0000-0001-9767-4084; Lagarkova, Maria/0000-0001-9594-1134; lako, majlinda/0000-0003-1327-8573; Chen, Jieming/0000-0003-3767-9486	International Stem Cell Forum; Ministry of Science and Technology of China [2006AA02A102]; Japan Society for the Promotion of Science (JSPS); MEXT; Swiss National Science Foundation [4046-114410]; North West Science Fund, UK; One North East Regional Developmental Agency; Medical Research Council, UK; Newcastle University; Australian Stem Cell Centre; Netherlands Proteomics Consortium [T4-3]; Stem Cell Network, Canada; MEXT, Japan; Singapore Stem Cell Consortium (SSCC); Agency for Science Technology and Research (A<SUP>star</SUP>STAR); Genome Institute of Singapore Core Genotyping Lab; Academy of Finland [218050]; Sigrid Juselius Foundation; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Departamento de Ciencia e Tecnologia do Ministerio da Saude (CNPq/MS/DECIT); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Judy; Sidney Swartz; Faculty of Medicine; University of New South Wales (UNSW); National Health and Medical Research Council (NHMRC) [568969]; South Eastern Sydney and Illawarra Area Health Service (SEIAHS); Tampere University Hospital [9F217]; Biotechnology and Biological Sciences Research Council [BB/E006159/1] Funding Source: researchfish; British Heart Foundation [PG/09/027/27141] Funding Source: researchfish; Medical Research Council [G0801059, G0700092, G0301182, G0700785, G0801098, MC_qA137914, G113/30, G0300484, G1001045, MC_qA137916, MC_qA137863, G0801057] Funding Source: researchfish; BBSRC [BB/E006159/1] Funding Source: UKRI; MRC [G113/30, MC_qA137914, MC_qA137916, G0300484, G0801098, G0700785, G0801059, G0301182, G0700092, G1001045, G0801057] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM085354] Funding Source: NIH RePORTER	International Stem Cell Forum; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); North West Science Fund, UK; One North East Regional Developmental Agency; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Newcastle University; Australian Stem Cell Centre; Netherlands Proteomics Consortium; Stem Cell Network, Canada; MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Singapore Stem Cell Consortium (SSCC); Agency for Science Technology and Research (A<SUP>star</SUP>STAR)(Agency for Science Technology & Research (A*STAR)); Genome Institute of Singapore Core Genotyping Lab; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Departamento de Ciencia e Tecnologia do Ministerio da Saude (CNPq/MS/DECIT)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Judy; Sidney Swartz; Faculty of Medicine; University of New South Wales (UNSW); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); South Eastern Sydney and Illawarra Area Health Service (SEIAHS); Tampere University Hospital; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The International Stem Cell Initiative is funded by The International Stem Cell Forum. The authors would like to acknowledge the following: Medical Research Council, UK (P. W. A., H. M.); Mohammad Pakzad & Adeleh Taei, Royan Institute (H. B., G. H. S.); California Institute for Regenerative Medicine (CIRM) (E. C., P. W. L.); Institute of Medical Biology, A<SUP>star</SUP>STAR, Singapore (J.M.C.); Ministry of Education, Youth and Sports of the Czech Republic (P. D., A. H.); Stem Cell Research Center of the 21st Century Frontier Research Program, Ministry of Education, Science & Technology, Republic of Korea (SC-1140) (D. R. L., S.K.O.); Ministry of Science and Technology of China (863 program 2006AA02A102) (L. G.); Swedish Research Council, Cellartis (O.H.); Department of Biotechnology, Government of India, UK-India Education and Research Initiative and the Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, India (M. I.); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, Leading Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) of the Japan Society for the Promotion of Science (JSPS), Grants in-Aid for Scientific Research of JSPS and MEXT (T. I., S.Y., K. T.); Swiss National Science Foundation (grant no. 4046-114410) (M.J.); Shanghai Science and Technology Developmental Foundation (06DJ14001), Chinese Ministry of Science and Technology (2007CB948004) (Y.J.); funding from the North West Science Fund, UK (S. K.); One North East Regional Developmental Agency, Medical Research Council, UK, Newcastle University (M. L.); research funding from the Australian Stem Cell Centre (A. L. L.); The Netherlands Proteomics Consortium grant T4-3 (C. M.); Stem Cell Network, Canada (A.N.); National BioResource Project, MEXT, Japan (N.N.); Singapore Stem Cell Consortium (SSCC) & the Agency for Science Technology and Research (A<SUP>star</SUP>STAR) (S. K. W.O., P. R.) and the Genome Institute of Singapore Core Genotyping Lab (P. R.); Academy of Finland, Sigrid Juselius Foundation (T.O.); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Departamento de Ciencia e Tecnologia do Ministerio da Saude (CNPq/MS/DECIT), and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (L. V. P.); supported by the kind donation of Judy and Sidney Swartz (B. R.); financial support from the Faculty of Medicine, University of New South Wales (UNSW) and the National Health and Medical Research Council (NHMRC) Program Grant no. 568969 (Perminder Sachdev), South Eastern Sydney and Illawarra Area Health Service (SEIAHS) for making hES cell line Endeavour-2 available for this study, and H. Chung and J. Kim for their help in preparing the samples (K. S.); Academy of Finland (grant 218050), the Competitive Research Funding of the Tampere University Hospital (grant 9F217) (H. Skottman).	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Allegrucci C, 2007, HUM MOL GENET, V16, P1253, DOI 10.1093/hmg/ddm074; Andrews PW, 2009, STEM CELL REV REP, V5, P301, DOI 10.1007/s12015-009-9085-x; Andrews PW, 2005, NAT BIOTECHNOL, V23, P795, DOI 10.1038/nbt0705-798; ANDREWS PW, 1980, INT J CANCER, V26, P269, DOI 10.1002/ijc.2910260304; Ardehali R, 2011, P NATL ACAD SCI USA, V108, P3282, DOI 10.1073/pnas.1019047108; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; ATKIN NB, 1982, LANCET, V2, P1349; Bai H, STEM CELL R IN PRESS; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Buzzard JJ, 2004, NAT BIOTECHNOL, V22, P381, DOI 10.1038/nbt0404-381; Caisander G, 2006, CHROMOSOME RES, V14, P131, DOI 10.1007/s10577-006-1019-8; Calvanese V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003294; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; Deloukas P, 2001, NATURE, V414, P865, DOI 10.1038/414865a; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102; HOOK EB, 1977, AM J HUM GENET, V29, P94; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Inzunza J, 2004, MOL HUM REPROD, V10, P461, DOI 10.1093/molehr/gah051; Kim KP, 2007, GENOME RES, V17, P1731, DOI 10.1101/gr.6609207; Korkola JE, 2006, CANCER RES, V66, P820, DOI 10.1158/0008-5472.CAN-05-2445; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Laurent LC, 2010, NAT METHODS, V7, P6, DOI 10.1038/nmeth0110-06; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lefort N, 2008, NAT BIOTECHNOL, V26, P1364, DOI 10.1038/nbt.1509; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Liu X, 1997, DEV DYNAM, V209, P85; Longo L, 1997, TRANSGENIC RES, V6, P321, DOI 10.1023/A:1018418914106; Looijenga LHJ, 2000, J PATHOL, V191, P187, DOI 10.1002/(SICI)1096-9896(200006)191:2<187::AID-PATH584>3.0.CO;2-T; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; MARTIN GR, 1974, CELL, V2, P163, DOI 10.1016/0092-8674(74)90090-7; Martins-Taylor K, 2011, NAT BIOTECHNOL, V29, P488, DOI 10.1038/nbt.1890; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Misceo D, 2005, MOL BIOL EVOL, V22, P360, DOI 10.1093/molbev/msi021; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Mosher JT, 2010, NEW ENGL J MED, V362, P183, DOI 10.1056/NEJMc0910371; Mostert M, 2000, LAB INVEST, V80, P1055, DOI 10.1038/labinvest.3780110; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Nottke A, 2009, DEVELOPMENT, V136, P879, DOI 10.1242/dev.020966; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Olariu V, 2010, STEM CELL RES, V4, P50, DOI 10.1016/j.scr.2009.09.001; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RODRIGUEZ E, 1993, GENE CHROMOSOME CANC, V8, P230, DOI 10.1002/gcc.2870080405; Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430; Rugg-Gunn PJ, 2007, HUM MOL GENET, V16, pR243, DOI 10.1093/hmg/ddm245; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Schneider DT, 2001, KLIN PADIATR, V213, P204, DOI 10.1055/s-2001-16852; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Skotheim RI, 2002, CANCER RES, V62, P2359; Spits C, 2008, NAT BIOTECHNOL, V26, P1361, DOI 10.1038/nbt.1510; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; WANG N, 1980, CANCER RES, V40, P796; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wu H, 2008, STEM CELLS, V26, P1484, DOI 10.1634/stemcells.2007-0993; Zody MC, 2006, NATURE, V440, P1045, DOI 10.1038/nature04689	69	367	382	1	167	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2011	29	12					1132	U113		10.1038/nbt.2051	http://dx.doi.org/10.1038/nbt.2051			15	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	861SE	22119741	Green Accepted, Green Published			2022-12-25	WOS:000298038700025
J	Kunisaki, Y; Frenette, PS				Kunisaki, Yuya; Frenette, Paul S.			Enigmatic niche brings challenge for HSC expansion	NATURE MEDICINE			English	Editorial Material							HEMATOPOIETIC STEM-CELL; BONE-MARROW NICHE	The bone marrow niche keeps puzzling scientists in cancer and regenerative medicine. What elements constitute the niche and how it affects neighbor cells in different disease contexts remain to be a matter of debate and extensive investigation. The translational use of hematopoietic stem cells (HSCs) in transplantation biology poses a challenge, given the propensity of these cells to remain quiescent. Although the niche is a good candidate to exploit for reprogramming HSCs and controlling their expansion, new studies have added to its complexity. In 'Bench to Bedside', Paul S. Frenette and Yuya Kunisaki examine these studies to discuss how new players and their signals are involved in HSC maintenance and what the implications are for the development of HSC-based therapies. Among the alterations occurring in leukemias, metabolic events seem to foster cancer progression but may also be involved in cancer predisposition. Rushdia Z. Yusuf, Ying-Hua Wang and David T. Scadden peruse recent clinical and experimental studies that look at myelodysplastic syndromes and secondary leukemias and argue how metabolic changes in these cancers may not only be cell autonomous but also can emanate from the bone marrow stroma. Targeting this niche may open new avenues to reduce the risk for secondary leukemias in cancer survivors.	[Kunisaki, Yuya; Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10467 USA; [Kunisaki, Yuya; Frenette, Paul S.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Kunisaki, Yuya; Frenette, Paul S.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Kunisaki, Y (corresponding author), Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10467 USA.	paul.frenette@einstein.yu.edu	Frenette, Paul S/J-8272-2012	Frenette, Paul S/0000-0003-0862-9922	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069438] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL069438] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; Brunstein CG, 2010, BLOOD, V116, P4693, DOI 10.1182/blood-2010-05-285304; Byrd DT, 2009, SEMIN CELL DEV BIOL, V20, P1107, DOI 10.1016/j.semcdb.2009.09.005; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480	12	23	25	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2012	18	6					864	865		10.1038/nm.2825	http://dx.doi.org/10.1038/nm.2825			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22673997	Green Accepted			2022-12-25	WOS:000305116600022
J	Maryanovich, M; Oberkovitz, G; Niv, H; Vorobiyov, L; Zaltsman, Y; Brenner, O; Lapidot, T; Jung, S; Gross, A				Maryanovich, Maria; Oberkovitz, Galia; Niv, Hagit; Vorobiyov, Lidiya; Zaltsman, Yehudit; Brenner, Ori; Lapidot, Tsvee; Jung, Steffen; Gross, Atan			The ATM-BID pathway regulates quiescence and survival of haematopoietic stem cells	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE; SELF-RENEWAL; DEFICIENT MICE; PARADIGM; BMI-1; CYCLE	BID, a BH3-only BCL2 family member, functions in apoptosis as well as the DNA-damage response(1). Our previous data demonstrated that BID is an ATM effector acting to induce cell-cycle arrest and inhibition of apoptosis following DNA damage(2,3). Here we show that ATM-mediated BID phosphorylation plays an unexpected role in maintaining the quiescence of haematopoietic stem cells (HSCs). Loss of BID phosphorylation leads to escape from quiescence of HSCs, resulting in exhaustion of the HSC pool and a marked reduction of HSC repopulating potential in vivo. We also demonstrate that BID phosphorylation plays a role in protecting HSCs from irradiation, and that regulating both quiescence and survival of HSCs depends on BID's ability to regulate oxidative stress. Moreover, loss of BID phosphorylation, ATM knockout or exposing mice to irradiation leads to an increase in mitochondria! BID, which correlates with an increase in mitochondrial oxidative stress. These results show that the ATM BID pathway serves as a critical checkpoint for coupling HSC homeostasis and the DNA-damage stress response to enable long-term regenerative capacity.	[Maryanovich, Maria; Oberkovitz, Galia; Niv, Hagit; Vorobiyov, Lidiya; Zaltsman, Yehudit; Gross, Atan] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Brenner, Ori] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel; [Lapidot, Tsvee; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Gross, A (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	atan.gross@weizmann.ac.il	Jung, Steffen/K-1409-2012; Lapidot, Tsvee/A-1812-2010; Gross, Atan/ABC-2640-2020	Jung, Steffen/0000-0003-4290-5716; 	Israel Science Foundation; USA-Israel Binational Science Foundation; German-Israel Foundation; German-Israel Research Program in Cancer Research; Israel Cancer Association; Minerva Stiftung; MDM ICR	Israel Science Foundation(Israel Science Foundation); USA-Israel Binational Science Foundation(US-Israel Binational Science Foundation); German-Israel Foundation(German-Israeli Foundation for Scientific Research and Development); German-Israel Research Program in Cancer Research; Israel Cancer Association; Minerva Stiftung; MDM ICR	We are grateful to A. Harmelin, R. Haffner, A. Maizenberg, G. Damari, Y. Chermesh, C. Raanan and N. Nevo for help with the animal studies, and I. Ino, O. Amram and E. Gamil for animal maintenance. We are especially grateful to Y. Shilo (Tel Aviv University) for ATM<SUP>-/-</SUP> mice, and to T. Lapidot (Weizmann Institute) for advice and for reading the manuscript. We also thank A. Sharp, E. Ariel and Z. Porat for assistance with flow-cytometric studies and cell sorting and J. Lotem for advice regarding some of the studies. This study was supported in part by the Israel Science Foundation, USA-Israel Binational Science Foundation, German-Israel Foundation, German-Israel Research Program in Cancer Research, Israel Cancer Association, Minerva Stiftung and MDM ICR Research Award. A.G. is the incumbent of the Armour Family Career Development Chair of Cancer Research.	Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; George TC, 2006, J IMMUNOL METHODS, V311, P117, DOI 10.1016/j.jim.2006.01.018; Grinberg M, 2005, MOL CELL BIOL, V25, P4579, DOI 10.1128/MCB.25.11.4579-4590.2005; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Juntilla MM, 2010, BLOOD, V115, P4030, DOI 10.1182/blood-2009-09-241000; Kamer I, 2005, CELL, V122, P593, DOI 10.1016/j.cell.2005.06.014; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Mihara Motohiro, 2003, Methods Mol Biol, V234, P203; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Tesio M, 2011, BLOOD, V117, P419, DOI 10.1182/blood-2009-06-230359; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Whetton AD, 2004, NAT MED, V10, P1166, DOI 10.1038/nm1104-1166; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zaltsman Y, 2010, NAT CELL BIOL, V12, P553, DOI 10.1038/ncb2057; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zinkel SS, 2005, CELL, V122, P579, DOI 10.1016/j.cell.2005.06.022	36	106	111	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2012	14	5					535	U185		10.1038/ncb2468	http://dx.doi.org/10.1038/ncb2468			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	936NW	22446738				2022-12-25	WOS:000303598300014
J	Kudo, M; Melton, AC; Chen, C; Engler, MB; Huang, KE; Ren, X; Wang, YL; Bernstein, X; Li, JT; Atabai, K; Huang, XZ; Sheppard, D				Kudo, Makoto; Melton, Andrew C.; Chen, Chun; Engler, Mary B.; Huang, Katherine E.; Ren, Xin; Wang, Yanli; Bernstein, Xin; Li, John T.; Atabai, Kamran; Huang, Xiaozhu; Sheppard, Dean			IL-17A produced by alpha beta T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction	NATURE MEDICINE			English	Article							GROWTH-FACTOR-BETA; ROR-GAMMA-T; ALLERGIC-ASTHMA; GENE POLYMORPHISMS; T(H)17 CELLS; RHO-KINASE; RECEPTOR; INFLAMMATION; INTERLEUKIN-17; ASSOCIATION	Emerging evidence suggests that the T helper 17 (T(H)17) subset of alpha beta T cells contributes to the development of allergic asthma. In this study, we found that mice lacking the alpha v beta 8 integrin on dendritic cells did not generate T(H)17 cells in the lung and were protected from airway hyper-responsiveness in response to house dust mite and ovalbumin sensitization and challenge. Because loss of T(H)17 cells inhibited airway narrowing without any obvious effects on airway inflammation or epithelial morphology, we examined the direct effects of T(H)17 cytokines on mouse and human airway smooth muscle function. Interleukin-17A (IL-17A), but not IL-17F or IL-22, enhanced contractile force generation of airway smooth muscle through an IL-17 receptor A (IL-17RA)-IL-17RC, nuclear factor kappa light-chain enhancer of activated B cells (NF-kappa B)-ras homolog gene family, member A (RhoA)-Rho-associated coiled-coil containing protein kinase 2 (ROCK2) signaling cascade. Mice lacking integrin alpha v beta 8 on dendritic cells showed impaired activation of this pathway after ovalbumin sensitization and challenge, and the diminished contraction of the tracheal rings in these mice was reversed by IL-17A. These data indicate that the IL-17A produced by T(H)17 cells contributes to allergen-induced airway hyper-responsiveness through direct effects on airway smooth muscle.	[Kudo, Makoto; Melton, Andrew C.; Chen, Chun; Huang, Katherine E.; Ren, Xin; Wang, Yanli; Bernstein, Xin; Li, John T.; Atabai, Kamran; Huang, Xiaozhu; Sheppard, Dean] Univ Calif San Francisco, Dept Med, Lung Biol Ctr, San Francisco, CA 94143 USA; [Kudo, Makoto] Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Kanazawa Ku, Yokohama, Kanagawa 232, Japan; [Engler, Mary B.] Univ Calif San Francisco, Dept Physiol Nursing, San Francisco, CA USA; [Li, John T.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Atabai, Kamran] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Yokohama City University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Sheppard, D (corresponding author), Univ Calif San Francisco, Dept Med, Lung Biol Ctr, San Francisco, CA 94143 USA.	dean.sheppard@ucsf.edu			US National Institutes of Health (NIH) [HL64353, HL53949, HL083950, AI024674, U19 AI077439]; NIH Ruth L. Kirschstein National Research Service [HL095314]; American Lung Association of California; University of California, San Francisco (UCSF) Strategic Asthma Basic Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL053949, R01HL064353, R01HL102292, R01HL053949, F32HL095314, R01HL083950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439, R01AI024674, R37AI024674] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association of California; University of California, San Francisco (UCSF) Strategic Asthma Basic Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US National Institutes of Health (NIH) grants HL64353, HL53949, HL083950, AI024674 and U19 AI077439 (to D.S.), a NIH Ruth L. Kirschstein National Research Service Award HL095314 (to A.C.M.), an American Lung Association of California Research Training Fellowship Award (to A.C.M.) and funds from the University of California, San Francisco (UCSF) Strategic Asthma Basic Research Center. Deidentified human lung was kindly provided by M. Matthay (UCSF) and P. Wolters (UCSF). IL-17RC knockout mice were kindly provided by W. Ouyang (Genentech).	Alcorn JF, 2010, ANNU REV PHYSIOL, V72, P495, DOI 10.1146/annurev-physiol-021909-135926; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Bai Y, 2006, AM J PHYSIOL-LUNG C, V291, pL208, DOI 10.1152/ajplung.00494.2005; BARNES PJ, 1985, BRIT J PHARMACOL, V86, P685, DOI 10.1111/j.1476-5381.1985.tb08946.x; BARNETT K, 1988, AM REV RESPIR DIS, V138, P780, DOI 10.1164/ajrccm/138.4.780; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Blaho VA, 2009, J IMMUNOL, V183, P5644, DOI 10.4049/jimmunol.0901499; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Chen XY, 2009, PHARMACOLOGY, V83, P67, DOI 10.1159/000178814; Chiba Yoshihiko, 2004, Journal of Smooth Muscle Research, V40, P155, DOI 10.1540/jsmr.40.155; de Faria ICJ, 2008, J PEDIAT-BRAZIL, V84, P203, DOI [10.2223/JPED.1783, 10.1590/S0021-75572008000300004]; Ely LK, 2009, NAT IMMUNOL, V10, P1245, DOI 10.1038/ni.1813; Finkelman FD, 2010, J IMMUNOL, V184, P1663, DOI 10.4049/jimmunol.0902185; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Goto K, 2010, PHARMACOL RES, V61, P466, DOI 10.1016/j.phrs.2009.12.001; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hellings PW, 2003, AM J RESP CELL MOL, V28, P42, DOI 10.1165/rcmb.4832; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Khromov A, 2009, J BIOL CHEM, V284, P21569, DOI 10.1074/jbc.M109.019729; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Melton AC, 2010, J CLIN INVEST, V120, P4436, DOI 10.1172/JCI43786; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Oda N, 2005, AM J RESP CRIT CARE, V171, P12, DOI 10.1164/rccm.200406-778OC; Ohama T, 2003, J BIOL CHEM, V278, P48794, DOI 10.1074/jbc.M310166200; Parris JRM, 1999, J PHYSIOL-LONDON, V518, P561, DOI 10.1111/j.1469-7793.1999.0561p.x; Patil SB, 2006, AM J PHYSIOL-GASTR L, V290, pG83, DOI 10.1152/ajpgi.00178.2005; Pulleyn LJ, 2001, HUM GENET, V109, P623, DOI 10.1007/s00439-001-0617-y; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Settin A, 2008, INDIAN J PEDIATR, V75, P1019, DOI 10.1007/s12098-008-0161-z; Shimada H, 2010, J BIOL CHEM, V285, P12536, DOI 10.1074/jbc.M109.099630; Silverman ES, 2004, AM J RESP CRIT CARE, V169, P214, DOI 10.1164/rccm.200307-973OC; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Sonder SU, 2011, J BIOL CHEM, V286, P12881, DOI 10.1074/jbc.M110.199547; Song CW, 2008, J IMMUNOL, V181, P6117, DOI 10.4049/jimmunol.181.9.6117; Souwer Y, 2010, CURR OPIN IMMUNOL, V22, P821, DOI 10.1016/j.coi.2010.10.013; Tliba O, 2003, BRIT J PHARMACOL, V140, P1159, DOI 10.1038/sj.bjp.0705558; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wilson RH, 2009, AM J RESP CRIT CARE, V180, P720, DOI 10.1164/rccm.200904-0573OC; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Zeyrek D, 2008, ALLERGY ASTHMA PROC, V29, P468, DOI 10.2500/aap.2008.29.3154; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	55	325	345	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2012	18	4					547	554		10.1038/nm.2684	http://dx.doi.org/10.1038/nm.2684			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22388091	Green Accepted, Green Submitted			2022-12-25	WOS:000302617800031
J	Louis-Dit-Picard, H; Barc, J; Trujillano, D; Miserey-Lenkei, S; Bouatia-Naji, N; Pylypenko, O; Beaurain, G; Bonnefond, A; Sand, O; Simian, C; Vidal-Petiot, E; Soukaseum, C; Mandet, C; Broux, F; Chabre, O; Delahousse, M; Esnault, V; Fiquet, B; Houillier, P; Bagnis, CI; Koenig, J; Konrad, M; Landais, P; Mourani, C; Niaudet, P; Probst, V; Thauvin, C; Unwin, RJ; Soroka, SD; Ehret, G; Ossowski, S; Caulfield, M; Bruneval, P; Estivill, X; Froguel, P; Hadchouel, J; Schott, JJ; Jeunemaitre, X				Louis-Dit-Picard, Helene; Barc, Julien; Trujillano, Daniel; Miserey-Lenkei, Stephanie; Bouatia-Naji, Nabila; Pylypenko, Olena; Beaurain, Genevieve; Bonnefond, Amelie; Sand, Olivier; Simian, Christophe; Vidal-Petiot, Emmanuelle; Soukaseum, Christelle; Mandet, Chantal; Broux, Francoise; Chabre, Olivier; Delahousse, Michel; Esnault, Vincent; Fiquet, Beatrice; Houillier, Pascal; Bagnis, Corinne Isnard; Koenig, Jens; Konrad, Martin; Landais, Paul; Mourani, Chebel; Niaudet, Patrick; Probst, Vincent; Thauvin, Christel; Unwin, Robert J.; Soroka, Steven D.; Ehret, Georg; Ossowski, Stephan; Caulfield, Mark; Bruneval, Patrick; Estivill, Xavier; Froguel, Philippe; Hadchouel, Juliette; Schott, Jean-Jacques; Jeunemaitre, Xavier		Int Consortium Blood Pressure ICBP	KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron	NATURE GENETICS			English	Article							NA+-CL-COTRANSPORTER; BLOOD-PRESSURE; MOLECULAR-MECHANISMS; PROTEIN; STIMULATION; EXPRESSION; DISEASE; KIDNEY	Familial hyperkalemic hypertension (FHHt) is a Mendelian form of arterial hypertension that is partially explained by mutations in WNK1 and WNK4 that lead to increased activity of the Na+-Cl- cotransporter (NCC) in the distal nephron. Using combined linkage analysis and whole-exome sequencing in two families, we identified KLHL3 as a third gene responsible for FHHt. Direct sequencing of 43 other affected individuals revealed 11 additional missense mutations that were associated with heterogeneous phenotypes and diverse modes of inheritance. Polymorphisms at KLHL3 were not associated with blood pressure. The KLHL3 protein belongs to the BTB-BACK-kelch family of actin-binding proteins that recruit substrates for Cullin3-based ubiquitin ligase complexes. KLHL3 is coexpressed with NCC and downregulates NCC expression at the cell surface. Our study establishes a role for KLHL3 as a new member of the complex signaling pathway regulating ion homeostasis in the distal nephron and indirectly blood pressure.	[Louis-Dit-Picard, Helene; Bouatia-Naji, Nabila; Beaurain, Genevieve; Vidal-Petiot, Emmanuelle; Soukaseum, Christelle; Mandet, Chantal; Bruneval, Patrick; Hadchouel, Juliette; Jeunemaitre, Xavier] Paris Ctr Rech Cardiovasc PARCC, INSERM, Unite Mixte Rech Sci UMRS 970, Paris, France; [Louis-Dit-Picard, Helene; Bouatia-Naji, Nabila; Beaurain, Genevieve; Vidal-Petiot, Emmanuelle; Soukaseum, Christelle; Mandet, Chantal; Houillier, Pascal; Landais, Paul; Niaudet, Patrick; Bruneval, Patrick; Hadchouel, Juliette; Jeunemaitre, Xavier] Univ Paris 05, Fac Med, Paris, France; [Beaurain, Genevieve; Simian, Christophe; Jeunemaitre, Xavier] HEGP, AP HP, Dept Genet, Paris, France; [Barc, Julien; Probst, Vincent; Schott, Jean-Jacques] Univ Nantes, INSERM, Unite Mixte Rech UMR 1087, Inst Thorax, Nantes, France; [Barc, Julien; Probst, Vincent; Schott, Jean-Jacques] Univ Nantes, Fac Med, Nantes, France; [Barc, Julien; Probst, Vincent; Schott, Jean-Jacques] CNRS, Equipe Rech Labellisee ERL 3147, Nantes, France; [Trujillano, Daniel; Estivill, Xavier; Schott, Jean-Jacques] Pompeu Fabra Univ, Genes & Dis Program, CGR, Barcelona, Spain; [Trujillano, Daniel; Estivill, Xavier] Biomed Res Ctr CIBERESP, Publ Hlth & Epidemiol Network, Barcelona, Spain; [Miserey-Lenkei, Stephanie; Pylypenko, Olena] Inst Curie, CNRS, UMR 144, F-75231 Paris, France; [Bonnefond, Amelie; Sand, Olivier; Froguel, Philippe] Lille Pasteur Inst, CNRS, UMR 8199, Lille, France; [Bonnefond, Amelie; Sand, Olivier; Froguel, Philippe] Lille Nord France Univ, Fac Med, Lille, France; [Broux, Francoise] Univ Rouen, Ctr Hosp Univ CHU Charles Nicolle, Dept Pediat Med, Rouen, France; [Chabre, Olivier] Univ Grenoble 1, CHU Grenoble, Grenoble, France; [Delahousse, Michel] Hop Foch, Dept Nephrol, Suresnes, France; [Esnault, Vincent] Hop Louis Pasteur, Serv Nephrol, CHU Nice, Nice, France; [Esnault, Vincent] Univ Nice Sophia Antipolis, Fac Med, Nice, France; [Fiquet, Beatrice] HEGP, AP HP, Serv Hypertens & Med Vasc, Paris, France; [Houillier, Pascal] HEGP, AP HP, Serv Explorat Fonctionnelles Renales, Paris, France; [Houillier, Pascal] Inst Biomed Cordeliers, INSERM, UMR S872, Paris, France; [Bagnis, Corinne Isnard] Hop La Pitie Salpetriere, AP HP, Dept Nephrol, Paris, France; [Koenig, Jens; Konrad, Martin] Univ Childrens Hosp Munster, Dept Gen Pediat, Munster, Germany; [Landais, Paul; Niaudet, Patrick] Hop Necker Enfants Malad, AP HP, Serv Nephrol, Paris, France; [Niaudet, Patrick] Hop Necker Enfants Malad, AP HP, Serv Nephrol Pediat, Paris, France; [Landais, Paul] Hop Necker Enfants Malad, INSERM, U507, Paris, France; [Mourani, Chebel] Hotel Dieu France, Dept Pediat, Beirut, Lebanon; [Probst, Vincent; Schott, Jean-Jacques] CHU Nantes, Serv Cardiol Nantes, Inst Thorax, F-44035 Nantes 01, France; [Thauvin, Christel] CHU Dijon, Ctr Genet, Dijon, France; [Thauvin, Christel] Univ Bourgogne, Fac Med, Dijon, France; [Unwin, Robert J.] UCL, Ctr Nephrol, Sch Med, Royal Free Campus & Hosp, London, England; [Soroka, Steven D.] Dalhousie Univ, Fac Med, Halifax, NS, Canada; [Ehret, Georg] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Ehret, Georg] Univ Geneva, Dept Specialties Internal Med, Geneva, Switzerland; [Ossowski, Stephan] Univ Pompeu Fabra, Ctr Genom Regulat, Genom & Epigen Variat Dis Grp, Barcelona, Spain; [Caulfield, Mark] Queen Mary Univ London, Genome Ctr, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Bruneval, Patrick] HEGP, AP HP, Serv Anat Pathol, Paris, France; [Estivill, Xavier] Pompeu Fabra Univ, Dept Hlth & Life Sci, Barcelona, Spain; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, Hammersmith Hosp, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; Centre National de la Recherche Scientifique (CNRS); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; CHU de Rouen; Universite de Rouen Normandie; CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Hospital Foch; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Munster; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; American University of Beirut; Nantes Universite; CHU de Nantes; CHU Dijon Bourgogne; Universite de Bourgogne; University of London; University College London; UCL Medical School; Dalhousie University; Johns Hopkins University; University of Geneva; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of London; Queen Mary University London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Pompeu Fabra University; Imperial College London	Jeunemaitre, X (corresponding author), Paris Ctr Rech Cardiovasc PARCC, INSERM, Unite Mixte Rech Sci UMRS 970, Paris, France.	xavier.jeunemaitre@inserm.fr	Bouatia-Naji, Nabila/AGF-1400-2022; Hadchouel, Juliette/K-4593-2016; Schott, jean-Jacques/F-8842-2013; probst, vincent/D-4996-2015; BOUATIA-NAJI, NABILA/D-5863-2013; Houillier, Pascal/AAD-4903-2019; barc, julien/K-5495-2014; Ossowski, Stephan/E-2139-2011; Estivill, Xavier/A-3125-2013; Bonnefond, Amélie/O-2784-2017; EHRET, Georg B/A-9532-2009; Estivill, Xavier/E-2957-2012; FROGUEL, Philippe/O-6799-2017; Bagnis, corinne/AAY-1034-2020; JEUNEMAITRE, Xavier/AAQ-4853-2021	Bouatia-Naji, Nabila/0000-0001-5424-2134; Schott, jean-Jacques/0000-0002-9578-9475; probst, vincent/0000-0002-5492-8619; Houillier, Pascal/0000-0003-4953-6917; barc, julien/0000-0003-4106-5946; Ossowski, Stephan/0000-0002-7416-9568; Estivill, Xavier/0000-0002-0723-2256; Bonnefond, Amélie/0000-0001-9976-3005; EHRET, Georg B/0000-0002-5730-0675; FROGUEL, Philippe/0000-0003-2972-0784; Bagnis, corinne/0000-0002-1048-6636; JEUNEMAITRE, Xavier/0000-0001-5925-381X; Caulfield, Mark/0000-0001-9295-3594; Vidal-Petiot, Emmanuelle/0000-0001-9356-7302; CHABRE, Olivier/0000-0001-8756-7218; Pylypenko, Olena/0000-0001-7073-5238; Esnault, Vincent, Louis, Marie/0000-0002-7418-5672; Sand, Olivier/0000-0003-1465-1640	INSERM; Agence Nationale pour la Recherche (ANR) [05-MRAR-010-01]; European Union [HEALTH-F4-2007-201550, HEALTH-261123]; Leducq Foundation (Transatlantic Network on Hypertension) [07 CVD 01]; Fondation Leducq Trans-Atlantic Network of Excellence [05 CVD 01]; Groupe de Reflexion sur la Recherche Cardiovasculaire and Biotronik; Ministry of Science and Innovation (MICINN) [SAF2008-00357]; MRC [G9521010] Funding Source: UKRI; Medical Research Council [G9521010] Funding Source: researchfish	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); European Union(European Commission); Leducq Foundation (Transatlantic Network on Hypertension)(Leducq Foundation); Fondation Leducq Trans-Atlantic Network of Excellence(Leducq Foundation); Groupe de Reflexion sur la Recherche Cardiovasculaire and Biotronik; Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank C. Busst for her critical reading of the manuscript, E. Clauser, F. Aurade and C. Auzan for helpful discussions, E. Durand, S. Lecointe and F. De Graeve for their contribution to whole-exome sequencing and M. Longepee-Dupas for assistance in family screening. This work was supported by INSERM, the Agence Nationale pour la Recherche (ANR; 05-MRAR-010-01), the European Union Framework Programme 7 through the HYPERGENE project (HEALTH-F4-2007-201550) and through the GEUVADIS project (HEALTH-261123), the Leducq Foundation (Transatlantic Network on Hypertension; 07 CVD 01), the Fondation Leducq Trans-Atlantic Network of Excellence (05 CVD 01; Preventing Sudden Death), the Groupe de Reflexion sur la Recherche Cardiovasculaire and Biotronik and the Ministry of Science and Innovation (MICINN; SAF2008-00357).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; CHARRU A, 1994, J HYPERTENS, V12, P981; Cheval L, 2011, PHYSIOL GENOMICS, V43, P161, DOI 10.1152/physiolgenomics.00093.2010; Del Nery E, 2006, TRAFFIC, V7, P394, DOI 10.1111/j.1600-0854.2006.00395.x; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; FRIEDMAN PA, 1995, KIDNEY INT, V48, P1427, DOI 10.1038/ki.1995.432; Frindt G, 2009, AM J PHYSIOL-RENAL, V297, pF1249, DOI 10.1152/ajprenal.00401.2009; Gordon Richard D., 1995, P2111; Hadchouel J, 2006, J AM SOC NEPHROL, V17, P208, DOI 10.1681/ASN.2005030314; Hamm-Alvarez SF, 1998, PHYSIOL REV, V78, P1109, DOI 10.1152/physrev.1998.78.4.1109; Kelso RJ, 2002, J CELL BIOL, V156, P703, DOI 10.1083/jcb.200110063; Kigoshi Y, 2011, J BIOL CHEM, V286, P33613, DOI 10.1074/jbc.M111.245126; Ko B, 2010, AM J PHYSIOL-RENAL, V299, pF300, DOI 10.1152/ajprenal.00441.2009; Lai F, 2000, GENOMICS, V66, P65, DOI 10.1006/geno.2000.6181; Lalioti MD, 2006, NAT GENET, V38, P1124, DOI 10.1038/ng1877; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lindner TH, 2005, BIOINFORMATICS, V21, P405, DOI 10.1093/bioinformatics/bti009; Loiodice I, 2004, MOL BIOL CELL, V15, P3333, DOI 10.1091/mbc.E03-12-0878; Meneton P, 2005, PHYSIOL REV, V85, P679, DOI 10.1152/physrev.00056.2003; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Arroyo JP, 2011, J AM SOC NEPHROL, V22, P1707, DOI 10.1681/ASN.2011020132; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Prag S, 2007, INT J BIOCHEM CELL B, V39, P366, DOI 10.1016/j.biocel.2006.09.003; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sobel E, 1996, AM J HUM GENET, V58, P1323; Soltysik-Espanola M, 1999, MOL BIOL CELL, V10, P2361, DOI 10.1091/mbc.10.7.2361; Ulgen A, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S13; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Yang SS, 2007, CELL METAB, V5, P331, DOI 10.1016/j.cmet.2007.03.009	36	222	231	0	39	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2012	44	4					456	+		10.1038/ng.2218	http://dx.doi.org/10.1038/ng.2218			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	916VF	22406640				2022-12-25	WOS:000302130600023
J	Zhang, L; Yan, F; Zhang, SL; Lei, DS; Charles, MA; Cavigiolio, G; Oda, M; Krauss, RM; Weisgraber, KH; Rye, KA; Pownall, HJ; Qiu, XY; Ren, G				Zhang, Lei; Yan, Feng; Zhang, Shengli; Lei, Dongsheng; Charles, M. Arthur; Cavigiolio, Giorgio; Oda, Michael; Krauss, Ronald M.; Weisgraber, Karl H.; Rye, Kerry-Anne; Pownall, Henry J.; Qiu, Xiayang; Ren, Gang			Structural basis of transfer between lipoproteins by cholesteryl ester transfer protein	NATURE CHEMICAL BIOLOGY			English	Article							HIGH-DENSITY-LIPOPROTEIN; NEGATIVE-STAINING PROTOCOL; ELECTRON-MICROSCOPY; MOLECULAR-DYNAMICS; NEUTRAL LIPIDS; HEART-DISEASE; A-I; RESOLUTION; VISUALIZATION; BINDING	Human cholesteryl ester transfer protein (CETP) mediates the net transfer of cholesteryl ester mass from atheroprotective high-density lipoproteins to atherogenic low-density lipoproteins by an unknown mechanism. Delineating this mechanism would be an important step toward the rational design of new CETP inhibitors for treating cardiovascular diseases. Using EM, single-particle image processing and molecular dynamics simulation, we discovered that CETP bridges a ternary complex with its N-terminal beta-barrel domain penetrating into high-density lipoproteins and its C-terminal domain interacting with low-density lipoprotein or very-low-density lipoprotein. In our mechanistic model, the CETP lipoprotein-interacting regions, which are highly mobile, form pores that connect to a hydrophobic central cavity, thereby forming a tunnel for transfer of neutral lipids from donor to acceptor lipoproteins. These new insights into CETP transfer provide a molecular basis for analyzing mechanisms for CETP inhibition.	[Zhang, Lei; Ren, Gang] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA; [Zhang, Lei; Yan, Feng; Charles, M. Arthur; Ren, Gang] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Zhang, Lei; Zhang, Shengli; Lei, Dongsheng; Ren, Gang] Xi An Jiao Tong Univ, Dept Appl Phys, Xian 710049, Peoples R China; [Cavigiolio, Giorgio; Oda, Michael; Krauss, Ronald M.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; [Weisgraber, Karl H.] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94143 USA; [Rye, Kerry-Anne] Heart Res Inst, Lipid Res Grp, Sydney, NSW, Australia; [Rye, Kerry-Anne] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia; [Rye, Kerry-Anne] Univ Melbourne, Dept Med, Melbourne, Vic 3010, Australia; [Pownall, Henry J.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Qiu, Xiayang] Pfizer Inc, Groton, CT 06340 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco; Xi'an Jiaotong University; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Sydney; Heart Research Institute; University of Sydney; University of Melbourne; Baylor College of Medicine; Pfizer	Zhang, L (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA.	gren@lbl.gov	Zhang, Lei/G-6427-2012; Ren, Gang/B-1567-2012; Zhang, Shengli/G-5219-2010; Lei, Dongsheng/AAH-4177-2020; Lei, Dongsheng/K-3485-2012	Zhang, Lei/0000-0002-4880-824X; Ren, Gang/0000-0002-8036-2321; Zhang, Shengli/0000-0002-5866-7591; Lei, Dongsheng/0000-0003-1640-0693; Pownall, Henry/0000-0001-8412-506X; Cavigiolio, Giorgio/0000-0002-1622-0628	Basic Energy Sciences-US Department of Energy [DE-AC02-05CH11231]; W. M. Keck Foundation [011808]; Chinese Ministry of Education [708082]; US National Institutes of Health [NIH-HL077268]; Tobacco-Related Disease Research Program of California [16FT-0163]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115153, R01HL077268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104427] Funding Source: NIH RePORTER	Basic Energy Sciences-US Department of Energy(United States Department of Energy (DOE)); W. M. Keck Foundation(W.M. Keck Foundation); Chinese Ministry of Education(Ministry of Education, China); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco-Related Disease Research Program of California(University of California System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D.A. Agard, I. Bahar and K. Dill for valuable discussions and A. Cheng and J. Song for helpful comments. This work was supported by Basic Energy Sciences-US Department of Energy (DE-AC02-05CH11231) and the W. M. Keck Foundation (no. 011808); the Keygrant Project of the Chinese Ministry of Education no. 708082 (S.Z.); US National Institutes of Health grant NIH-HL077268 and Tobacco-Related Disease Research Program of California grant 16FT-0163 (M.O.).	Adrian M, 1998, MICRON, V29, P145, DOI 10.1016/S0968-4328(97)00068-1; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Barter PJ, 2003, ARTERIOSCL THROM VAS, V23, P160, DOI 10.1161/01.ATV.0000054658.91146.64; BARTER PJ, 1980, J LIPID RES, V21, P238; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; BROWN ML, 1989, NATURE, V342, P448, DOI 10.1038/342448a0; CAMEJO G, 1976, ATHEROSCLEROSIS, V24, P341, DOI 10.1016/0021-9150(76)90126-X; Chen B, 2009, PROTEIN SCI, V18, P921, DOI 10.1002/pro.101; Doruker P, 2000, PROTEINS, V40, P512, DOI 10.1002/1097-0134(20000815)40:3<512::AID-PROT180>3.3.CO;2-D; Flemming D, 2010, NAT STRUCT MOL BIOL, V17, P775, DOI 10.1038/nsmb.1811; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Galkin VE, 2008, P NATL ACAD SCI USA, V105, P1494, DOI 10.1073/pnas.0708667105; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Han M, 2009, BIOCHEMISTRY-US, V48, P1481, DOI 10.1021/bi802287q; Hayat M.A.M., 1990, NEGATIVE STAINING; HAYEK T, 1993, J CLIN INVEST, V92, P1143, DOI 10.1172/JCI116683; IHM J, 1982, J LIPID RES, V23, P1328; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; Kappelle PJWH, 2011, CARDIOVASC THER, V29, pE89, DOI 10.1111/j.1755-5922.2010.00201.x; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mehta R, 2003, J MOL BIOL, V328, P183, DOI 10.1016/S0022-2836(03)00155-4; Miyares MA, 2011, ANN PHARMACOTHER, V45, P84, DOI 10.1345/aph.1P446; Morton RE, 2003, J LIPID RES, V44, P1364, DOI 10.1194/jlr.M300063-JLR200; Niesor EJ, 2011, CURR OPIN LIPIDOL, V22, P288, DOI 10.1097/MOL.0b013e3283475e00; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qiu XY, 2007, NAT STRUCT MOL BIOL, V14, P106, DOI 10.1038/nsmb1197; Ren G, 2000, J MOL BIOL, V301, P369, DOI 10.1006/jmbi.2000.3949; Ren G, 2001, P NATL ACAD SCI USA, V98, P1398, DOI 10.1073/pnas.041489198; Ren G, 2010, P NATL ACAD SCI USA, V107, P1059, DOI 10.1073/pnas.0908004107; Saito H, 2003, J BIOL CHEM, V278, P23227, DOI 10.1074/jbc.M303365200; Silva RAGD, 2008, P NATL ACAD SCI USA, V105, P12176, DOI 10.1073/pnas.0803626105; SWENSON TL, 1988, J BIOL CHEM, V263, P5150; TALL AR, 1993, J LIPID RES, V34, P1255; WANG SK, 1995, J BIOL CHEM, V270, P612, DOI 10.1074/jbc.270.2.612; Weers PMM, 2006, INSECT BIOCHEM MOLEC, V36, P231, DOI 10.1016/j.ibmb.2006.01.001; Zhang L, 2011, J LIPID RES, V52, P175, DOI 10.1194/jlr.D010959; Zhang L, 2010, J LIPID RES, V51, P1228, DOI 10.1194/jlr.D002493	41	103	104	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2012	8	4					342	349		10.1038/NCHEMBIO.796	http://dx.doi.org/10.1038/NCHEMBIO.796			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	913PO	22344176	Green Accepted			2022-12-25	WOS:000301890100008
J	Das, A; Slaughter, BD; Unruh, JR; Bradford, WD; Alexander, R; Rubinstein, B; Li, R				Das, Arupratan; Slaughter, Brian D.; Unruh, Jay R.; Bradford, William D.; Alexander, Richard; Rubinstein, Boris; Li, Rong			Flippase-mediated phospholipid asymmetry promotes fast Cdc42 recycling in dynamic maintenance of cell polarity	NATURE CELL BIOLOGY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; GDP DISSOCIATION INHIBITOR; GTPASE-ACTIVATING PROTEINS; YEAST PLASMA-MEMBRANE; SACCHAROMYCES-CEREVISIAE; FLUCTUATION SPECTROSCOPY; LOCALIZATION; PHOSPHATIDYLETHANOLAMINE; RING; PHOSPHATIDYLSERINE	Lipid asymmetry at the plasma membrane is essential for such processes as cell polarity, cytokinesis and phagocytosis(1-3). Here we find that a lipid flippase complex, composed of Lem3, Dnfl or Dnf2 (ref. 4), has a role in the dynamic recycling of the Cdc42 GTPase, a key regulator of cell polarity(5), in yeast. By using quantitative microscopy methods, we show that the flippase complex is required for fast dissociation of Cdc42 from the polar cortex by the guanine nucleotide dissociation inhibitor. A loss of flippase activity, or pharmacological blockage of the inward flipping of phosphatidylethanolamine, a phospholipid with a neutral head group, disrupts Cdc42 polarity maintained by guanine nucleotide dissociation inhibitor-mediated recycling. Phosphatidylethanolamine flipping may reduce the charge interaction between a Cdc42 carboxy-terminal cationic region with the plasma membrane inner leaflet, enriched for the negatively charged lipid phosphatidylserine. Using a reconstituted system with supported lipid bilayers, we show that the relative composition of phosphatidylethanolamine versus phosphatidylserine directly modulates Cdc42 extraction from the membrane by guanine nucleotide dissociation inhibitor.	[Das, Arupratan; Slaughter, Brian D.; Unruh, Jay R.; Bradford, William D.; Alexander, Richard; Rubinstein, Boris; Li, Rong] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Li, Rong] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Li, R (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	rli@stowers.org		Unruh, Jay/0000-0003-3077-4990	NIH [RO1-GM057063]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057063] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank W. Wiegraebe (Stowers Institute for Medical Research) for advice on imaging, K. Lee (Harvard Medical School) for advice on supported lipid bilayer preparation and N. Pavelka for assistance in genome screening data analysis. This study was done to fulfil, in part, requirements for A.D.'s PhD thesis as a student registered with the Open University. This work was supported by NIH grant RO1-GM057063 to R.L.	AOKI Y, 1994, J BIOCHEM-TOKYO, V116, P291, DOI 10.1093/oxfordjournals.jbchem.a124522; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Bevington P.R., 2003, DATA REDUCTION ERROR, P194; Caviston JP, 2003, MOL BIOL CELL, V14, P4051, DOI 10.1091/mbc.E03-04-0247; COLES BA, 1983, J ELECTROANAL CHEM, V144, P87, DOI 10.1016/S0022-0728(83)80146-6; DALY PJ, 1983, ANAL CHEM, V55, P1191, DOI 10.1021/ac00258a053; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Emoto K, 2000, J CELL BIOL, V149, P1215, DOI 10.1083/jcb.149.6.1215; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Fairn GD, 2011, NAT CELL BIOL, V13, P1424, DOI 10.1038/ncb2351; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Gibson RM, 2001, BIOCHEM J, V359, P285, DOI 10.1042/0264-6021:3590285; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Grossmann G, 2008, J CELL BIOL, V183, P1075, DOI 10.1083/jcb.200806035; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; Hess ST, 2002, BIOPHYS J, V83, P2300, DOI 10.1016/S0006-3495(02)73990-8; Iwamoto K, 2004, GENES CELLS, V9, P891, DOI 10.1111/j.1365-2443.2004.00782.x; Johnson JL, 2009, J BIOL CHEM, V284, P23860, DOI 10.1074/jbc.M109.031815; Kato U, 2002, J BIOL CHEM, V277, P37855, DOI 10.1074/jbc.M205564200; Kim SA, 2007, NAT METHODS, V4, P963, DOI 10.1038/NMETH1104; Lee K, 2010, SCIENCE, V329, P1341, DOI 10.1126/science.1191710; Marco E, 2007, CELL, V129, P411, DOI 10.1016/j.cell.2007.02.043; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; MASUDA T, 1994, J BIOL CHEM, V269, P19713; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Poste G., 1976, METHOD CELL BIOL, P34; Richman TJ, 2004, CURR GENET, V45, P339, DOI 10.1007/s00294-004-0505-9; Saito K, 2007, DEV CELL, V13, P743, DOI 10.1016/j.devcel.2007.09.014; Slaughter BD, 2007, P NATL ACAD SCI USA, V104, P20320, DOI 10.1073/pnas.0710336105; Slaughter BD, 2010, MOL BIOL CELL, V21, P4306, DOI 10.1091/mbc.E10-05-0451; Slaughter BD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003384; Slaughter BD, 2009, DEV CELL, V17, P823, DOI 10.1016/j.devcel.2009.10.022; Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476; Stevens HC, 2008, J BIOL CHEM, V283, P35060, DOI 10.1074/jbc.M802379200; Thompson, 1991, FLUORESCENCE CORRELA, P337; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066	40	75	76	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2012	14	3					304	+		10.1038/ncb2444	http://dx.doi.org/10.1038/ncb2444			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	900ZE	22344035	Green Accepted			2022-12-25	WOS:000300930400013
J	Hantschel, O; Warsch, W; Eckelhart, E; Kaupe, I; Grebien, F; Wagner, KU; Superti-Furga, G; Sexl, V				Hantschel, Oliver; Warsch, Wolfgang; Eckelhart, Eva; Kaupe, Ines; Grebien, Florian; Wagner, Kay-Uwe; Superti-Furga, Giulio; Sexl, Veronika			BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia	NATURE CHEMICAL BIOLOGY			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; PATIENTS RECEIVING IMATINIB; DNA-BINDING ACTIVITY; JAK2 INHIBITOR; KINASE INHIBITOR; MYELOPROLIFERATIVE NEOPLASMS; TYROSINE PHOSPHORYLATION; PHILADELPHIA-CHROMOSOME; POLYCYTHEMIA-VERA; FOLLOW-UP	Constitutive activation of STAT5 is critical for the maintenance of chronic myeloid leukemia (CML) characterized by the BCR-ABL oncoprotein. Tyrosine kinase inhibitors (TKIs) for the STAT5-activating kinase JAK2 have been discussed as a treatment option for CML patients. Using murine leukemia models combined with inducible ablation of JAK2, we show JAK2 dependence for initial lymphoid transformation, which is lost once leukemia is established. In contrast, initial myeloid transformation and leukemia maintenance were independent of JAK2. Nevertheless, several JAK2 TKIs induced apoptosis in BCR-ABL(+) cells irrespective of the presence of JAK2. This is caused by the previously unknown direct 'off-target' inhibition of BCR-ABL. Cellular and enzymatic analyses suggest that BCR-ABL phosphorylates STAT5 directly. Our findings suggest uncoupling of the canonical JAK2-STAT5 module upon BCR-ABL expression, thereby making JAK2 targeting dispensable. Thus, attempts to pharmacologically target STAT5 in BCR-ABL+ diseases need to focus on STAT5 itself.	[Hantschel, Oliver; Kaupe, Ines; Grebien, Florian; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Hantschel, Oliver] Ecole Polytech Fed Lausanne, Sch Life Sci, Swiss Inst Expt Canc Res, Lausanne, Switzerland; [Warsch, Wolfgang; Sexl, Veronika] Vet Univ Vienna, Inst Pharmacol & Toxicol, A-1030 Vienna, Austria; [Eckelhart, Eva] Med Univ Vienna, Ctr Pharmacol & Physiol, Vienna, Austria; [Wagner, Kay-Uwe] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; University of Veterinary Medicine Vienna; Medical University of Vienna; University of Nebraska System; University of Nebraska Medical Center	Hantschel, O (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria.	gsuperti@cemm.oeaw.ac; veronika.sexl@vetmeduni.ac.at	Hantschel, Oliver/M-7016-2019; Grebien, Florian/H-9234-2019; Wagner, Kay-Uwe/B-6044-2009; Superti-Furga, Giulio/AAE-5681-2019; Hantschel, Oliver D/H-4705-2013; Superti-Furga, Giulio/F-4755-2015; Sexl, Veronika/B-8657-2016	Hantschel, Oliver/0000-0001-8569-8169; Grebien, Florian/0000-0003-4289-2281; Hantschel, Oliver D/0000-0001-8569-8169; Superti-Furga, Giulio/0000-0002-0570-1768; Sexl, Veronika/0000-0001-9363-0412; Wagner, Kay-Uwe/0000-0002-5081-0226	GenAU-PLACEBO;  [WWTF-LS037];  [SFB-28-10]	GenAU-PLACEBO; ; 	This work was supported by grants WWTF-LS037 and SFB-28-10 to VS. and GenAU-PLACEBO to G.S-F. and V.S. We thank S. Georgeon for expert technical assistance. We thank all members of participating laboratories and R. Moriggl and T. Decker for continuous support and discussions.	Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Brehme M, 2009, P NATL ACAD SCI USA, V106, P7414, DOI 10.1073/pnas.0900653106; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Carlesso N, 1996, J EXP MED, V183, P811, DOI 10.1084/jem.183.3.811; deJong R, 1997, ONCOGENE, V14, P507, DOI 10.1038/sj.onc.1200885; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Geron I, 2008, CANCER CELL, V13, P321, DOI 10.1016/j.ccr.2008.02.017; Goldman JM, 2003, NEW ENGL J MED, V349, P1451, DOI 10.1056/NEJMra020777; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Hoelbl A, 2006, BLOOD, V107, P4898, DOI 10.1182/blood-2005-09-3596; Hoelbl A, 2010, EMBO MOL MED, V2, P98, DOI 10.1002/emmm.201000062; Ihle JN, 2007, CURR OPIN GENET DEV, V17, P8, DOI 10.1016/j.gde.2006.12.009; Ilaria RL, 1996, J BIOL CHEM, V271, P31704, DOI 10.1074/jbc.271.49.31704; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Kralovics R, 2008, LEUKEMIA, V22, P1841, DOI 10.1038/leu.2008.233; Lasho TL, 2008, LEUKEMIA, V22, P1790, DOI 10.1038/leu.2008.56; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; Miyamoto N, 2001, LEUKEMIA, V15, P1758, DOI 10.1038/sj.leu.2402260; Nelson EA, 2011, BLOOD, V117, P3421, DOI 10.1182/blood-2009-11-255232; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Nicolini FE, 2009, BLOOD, V114, P5271, DOI 10.1182/blood-2009-04-219410; Nieborowska-Skorska M, 1999, J EXP MED, V189, P1229, DOI 10.1084/jem.189.8.1229; Pardanani A, 2008, LEUKEMIA, V22, P23, DOI 10.1038/sj.leu.2404948; Pardanani A, 2007, LEUKEMIA, V21, P1658, DOI 10.1038/sj.leu.2404750; Pardanani A, 2011, LEUKEMIA, V25, P218, DOI 10.1038/leu.2010.269; Quintas-Cardama A, 2010, BLOOD, V115, P3109, DOI 10.1182/blood-2009-04-214957; Rix LLR, 2009, LEUKEMIA, V23, P477, DOI 10.1038/leu.2008.334; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Samanta A, 2011, LEUKEMIA, V25, P463, DOI 10.1038/leu.2010.287; Samanta AK, 2009, ONCOGENE, V28, P1669, DOI 10.1038/onc.2009.7; Samanta AK, 2006, CANCER RES, V66, P6468, DOI 10.1158/0008-5472.CAN-06-0025; Scherr M, 2006, BLOOD, V107, P3279, DOI 10.1182/blood-2005-08-3087; Shah NP, 2003, ONCOGENE, V22, P7389, DOI 10.1038/sj.onc.1206942; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; Shuai K, 1996, ONCOGENE, V13, P247; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Titz B, 2010, ONCOGENE, V29, P5895, DOI 10.1038/onc.2010.331; Wagner KU, 2004, MOL CELL BIOL, V24, P5510, DOI 10.1128/MCB.24.12.5510-5520.2004; Warsch W, 2011, BLOOD, V117, P3409, DOI 10.1182/blood-2009-10-248211; Weisberg E, 2007, NAT REV CANCER, V7, P345, DOI 10.1038/nrc2126; Werning G, 2008, CANCER CELL, V13, P311, DOI 10.1016/j.ccr.2008.02.009; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Xie SH, 2001, ONCOGENE, V20, P6188, DOI 10.1038/sj.onc.1204834; Ye D, 2006, BLOOD, V107, P4917, DOI 10.1182/blood-2005-10-4110	50	128	129	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2012	8	3					285	293		10.1038/NCHEMBIO.775	http://dx.doi.org/10.1038/NCHEMBIO.775			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896VR	22286129				2022-12-25	WOS:000300600000014
J	Kiyomitsu, T; Cheeseman, IM				Kiyomitsu, Tomomi; Cheeseman, Iain M.			Chromosome- and spindle-pole-derived signals generate an intrinsic code for spindle position and orientation	NATURE CELL BIOLOGY			English	Article							ASYMMETRIC CELL-DIVISION; MITOTIC SPINDLE; IMPORTIN-BETA; PROTEIN; RAN; KINETOCHORE; SEGREGATION; ACTIVATION; MECHANISM; GRADIENT	Mitotic spindle positioning by cortical pulling forces(1) defines the cell division axis and location(2), which is critical for proper cell division and development(3). Although recent work has identified developmental and extrinsic cues that regulate spindle orientation(4-6), the contribution of intrinsic signals to spindle positioning and orientation remains unclear. Here, we demonstrate that cortical force generation in human cells is controlled by distinct spindle-pole- and chromosome-derived signals that regulate cytoplasmic dynein localization. First, dynein exhibits a dynamic asymmetric cortical localization that is negatively regulated by spindle-pole proximity, resulting in spindle oscillations to centre the spindle within the cell. We find that this signal comprises the spindle-pole-localized polo-like kinase (Plk1), which regulates dynein localization by controlling the interaction between dynein-dynactin and its upstream cortical targeting factors NuMA and LGN. Second, a chromosome-derived RanGTP gradient restricts the localization of NuMA-LGN to the lateral cell cortex to define and maintain the spindle orientation axis. RanGTP acts in part through the nuclear localization sequence of NuMA to locally alter the ability of NuMA-LGN to associate with the cell cortex in the vicinity of chromosomes. We propose that these chromosome- and spindle-pole-derived gradients generate an intrinsic code to control spindle position and orientation.	[Kiyomitsu, Tomomi; Cheeseman, Iain M.] Whitehead Inst, Cambridge Ctr 9, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Cheeseman, IM (corresponding author), Whitehead Inst, Cambridge Ctr 9, Cambridge, MA 02142 USA.	icheese@wi.mit.edu		Cheeseman, Iain/0000-0002-3829-5612	Massachusetts Life Sciences Center; Searle Scholars Program; Human Frontiers Science Foundation; National Institute of General Medical Sciences [GM088313]; American Cancer Society [121776]; Human Frontiers Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088313] Funding Source: NIH RePORTER	Massachusetts Life Sciences Center; Searle Scholars Program; Human Frontiers Science Foundation; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Cancer Society(American Cancer Society); Human Frontiers Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Meraldi, D. Penman, D. Yarar, K. Ribbeck and members of the Cheeseman and Hochwagen laboratories for discussions and critical reading of the manuscript, and T. DiCesare for help with generating the movie. We also thank D. Compton, T. Hyman-Mitocheck, C. Basilico and A. C. Groen for reagents. This work was supported by awards to I.M.C. from the Massachusetts Life Sciences Center, the Searle Scholars Program and the Human Frontiers Science Foundation, a grant from the National Institute of General Medical Sciences (GM088313) and a Research Scholar Grant (121776) from the American Cancer Society. I.M.C. is a Thomas D. and Virginia W. Cabot Career Development Professor of Biology. T.K. is supported by a long-term fellowship of the Human Frontiers Science Program.	Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; CHEESEMAN IM, 2005, SCI STKE; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Fink J, 2011, NAT CELL BIOL, V13, P771, DOI 10.1038/ncb2269; Glotzer M, 1997, CURR OPIN CELL BIOL, V9, P815, DOI 10.1016/S0955-0674(97)80082-8; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Grill SW, 2005, DEV CELL, V8, P461, DOI 10.1016/j.devcel.2005.03.014; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kline SL, 2006, J CELL BIOL, V173, P9, DOI 10.1083/jcb.200509158; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; KORNBLUTH S, 1994, J CELL BIOL, V125, P705, DOI 10.1083/jcb.125.4.705; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; NISHITANI H, 1991, EMBO J, V10, P1555, DOI 10.1002/j.1460-2075.1991.tb07675.x; Schmidt JC, 2010, J CELL BIOL, V191, P269, DOI 10.1083/jcb.201006129; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wee B, 2011, J CELL BIOL, V195, P369, DOI 10.1083/jcb.201102130; Weis K, 1996, EMBO J, V15, P7120, DOI 10.1002/j.1460-2075.1996.tb01103.x; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Woodard GE, 2010, MOL CELL BIOL, V30, P3519, DOI 10.1128/MCB.00394-10	28	226	231	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2012	14	3					311	+		10.1038/ncb2440	http://dx.doi.org/10.1038/ncb2440			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	900ZE	22327364	Green Published, Green Accepted			2022-12-25	WOS:000300930400014
J	Cai, KJ; Haris, M; Singh, A; Kogan, F; Greenberg, JH; Hariharan, H; Detre, JA; Reddy, R				Cai, Kejia; Haris, Mohammad; Singh, Anup; Kogan, Feliks; Greenberg, Joel H.; Hariharan, Hari; Detre, John A.; Reddy, Ravinder			Magnetic resonance imaging of glutamate	NATURE MEDICINE			English	Article							CEREBRAL-ARTERY OCCLUSION; GAMMA-AMINOBUTYRIC-ACID; IN-VIVO; HUMAN BRAIN; CONTRAST AGENTS; MRI; PH; QUANTIFICATION; SPECTROSCOPY; PENUMBRA	Glutamate, a major neurotransmitter in the brain, shows a pH- and concentration-dependent chemical exchange saturation transfer effect (GluCEST) between its amine group and bulk water, with potential for in vivo imaging by nuclear magnetic resonance. GluCEST asymmetry is observed similar to 3 p.p.m. downfield from bulk water. Middle cerebral artery occlusion in the rat brain resulted in an similar to 100% elevation of GluCEST in the ipsilateral side compared with the contralateral side, predominantly owing to pH changes. In a rat brain tumor model with blood-brain barrier disruption, intravenous glutamate injection resulted in a clear elevation of GluCEST and a similar increase in the proton magnetic resonance spectroscopy signal of glutamate. GluCEST maps from healthy human brain were also obtained. These results demonstrate the feasibility of using GluCEST for mapping relative changes in glutamate concentration, as well as pH, in vivo. Contributions from other brain metabolites to the GluCEST effect are also discussed.	[Cai, Kejia; Haris, Mohammad; Singh, Anup; Kogan, Feliks; Hariharan, Hari; Detre, John A.; Reddy, Ravinder] Univ Penn, Dept Radiol, Ctr Magnet Resonance & Opt Imaging, Philadelphia, PA 19104 USA; [Greenberg, Joel H.; Detre, John A.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Detre, John A.] Univ Penn, Dept Radiol, Ctr Funct Neuroimaging, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Reddy, R (corresponding author), Univ Penn, Dept Radiol, Ctr Magnet Resonance & Opt Imaging, Philadelphia, PA 19104 USA.	ravi@mail.mmrrcc.upenn.edu	Kogan, Feliks/AAH-5814-2019	Kogan, Feliks/0000-0003-0580-7308; Reddy, Ravinder/0000-0003-4580-2392; Haris, Mohammad/0000-0002-4945-2935; Hariharan, Hari/0000-0002-7032-6968; Singh, Anup/0000-0001-6744-8326	US National Institutes of Health;  [P41RR002305]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002305] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We gratefully acknowledge stimulating discussions with R.N. Bryan, M.D. Schnall, J.D. Glickson and WS. Englander. We thank W. Liu and S. Pickup for their technical assistance in using the 9.4 T research scanners, W.R.T. Witschey for technical support, P. Waghray for experimental help and D. Reddy, K. Nath and T. Hiraki for help with animal models. This work was carried out at a US National Institutes of Health-supported resource, with funding from P41RR002305.	Ametamey SM, 2007, J NUCL MED, V48, P247; Choi IY, 2006, NEUROIMAGE, V33, P85, DOI 10.1016/j.neuroimage.2006.06.016; Chojnacka-Wojcik E, 2001, Curr Opin Investig Drugs, V2, P1112; Chu WJ, 1996, NEUROLOGY, V47, P756, DOI 10.1212/WNL.47.3.756; Davalos A, 2000, J Stroke Cerebrovasc Dis, V9, P2, DOI 10.1053/jscd.2000.18908; ENGLANDER SW, 1972, ANNU REV BIOCHEM, V41, P903, DOI 10.1146/annurev.bi.41.070172.004351; FORSEN S, 1963, J CHEM PHYS, V39, P2892, DOI 10.1063/1.1734121; Gilad AA, 2007, NAT BIOTECHNOL, V25, P217, DOI 10.1038/nbt1277; Gottschalk M, 2008, NMR BIOMED, V21, P507, DOI 10.1002/nbm.1219; Haris M, 2011, NEUROIMAGE, V54, P2079, DOI 10.1016/j.neuroimage.2010.10.017; Harrison PJ, 2008, BRIT J PSYCHIAT, V192, P86, DOI 10.1192/bjp.bp.107.045088; Hua J, 2007, MAGN RESON MED, V58, P786, DOI 10.1002/mrm.21387; Hurd R, 2004, MAGNET RESON MED, V51, P435, DOI 10.1002/mrm.20007; Jones CK, 2006, MAGN RESON MED, V56, P585, DOI 10.1002/mrm.20989; Kiewert C, 2010, BRAIN RES, V1312, P101, DOI 10.1016/j.brainres.2009.11.068; Ling W, 2008, P NATL ACAD SCI USA, V105, P2266, DOI 10.1073/pnas.0707666105; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; McMahon MT, 2008, MAGN RESON MED, V60, P803, DOI 10.1002/mrm.21683; Melani A, 1999, STROKE, V30, P2448, DOI 10.1161/01.STR.30.11.2448; MICHAELIS T, 1993, RADIOLOGY, V187, P219, DOI 10.1148/radiology.187.1.8451417; Paul IA, 2003, ANN NY ACAD SCI, V1003, P250, DOI 10.1196/annals.1300.016; Petroff O A, 2000, Adv Neurol, V83, P261; Petroff OAC, 2002, NEUROSCIENTIST, V8, P562, DOI 10.1177/1073858402238515; ROTHMAN DL, 1993, P NATL ACAD SCI USA, V90, P5662, DOI 10.1073/pnas.90.12.5662; RYNER LN, 1995, J MAGN RESON SER B, V107, P126, DOI 10.1006/jmrb.1995.1068; RYNER LN, 1995, MAGN RESON IMAGING, V13, P853, DOI 10.1016/0730-725X(95)00031-B; Sherry AD, 2008, ANNU REV BIOMED ENG, V10, P391, DOI 10.1146/annurev.bioeng.9.060906.151929; Sun PZ, 2008, MAGN RESON MED, V60, P390, DOI 10.1002/mrm.21653; Sun PZ, 2007, J CEREBR BLOOD F MET, V27, P1129, DOI 10.1038/sj.jcbfm.9600424; Tuor UI, 2008, J CEREBR BLOOD F MET, V28, P1613, DOI 10.1038/jcbfm.2008.49; van Zijl PCM, 2007, P NATL ACAD SCI USA, V104, P4359, DOI 10.1073/pnas.0700281104; Ward KM, 2000, J MAGN RESON, V143, P79, DOI 10.1006/jmre.1999.1956; Woessner DE, 2005, MAGN RESON MED, V53, P790, DOI 10.1002/mrm.20408; Zhou JY, 2006, PROG NUCL MAG RES SP, V48, P109, DOI 10.1016/j.pnmrs.2006.01.001; Zhou JY, 2003, NAT MED, V9, P1085, DOI 10.1038/nm907	35	425	437	3	99	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					302	306		10.1038/nm.2615	http://dx.doi.org/10.1038/nm.2615			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22270722	Green Accepted			2022-12-25	WOS:000300140300047
J	Helias, V; Saison, C; Ballif, BA; Peyrard, T; Takahashi, J; Takahashi, H; Tanaka, M; Deybach, JC; Puy, H; Le Gall, M; Sureau, C; Pham, BN; Le Pennec, PY; Tani, Y; Cartron, JP; Arnaud, L				Helias, Virginie; Saison, Carole; Ballif, Bryan A.; Peyrard, Thierry; Takahashi, Junko; Takahashi, Hideo; Tanaka, Mitsunobu; Deybach, Jean-Charles; Puy, Herve; Le Gall, Maude; Sureau, Camille; Pham, Bach-Nga; Le Pennec, Pierre-Yves; Tani, Yoshihiko; Cartron, Jean-Pierre; Arnaud, Lionel			ABCB6 is dispensable for erythropoiesis and specifies the new blood group system Langereis	NATURE GENETICS			English	Article							ANTI-LAN; TRANSPORTER; RESISTANCE; DISEASE; NEWBORN; CANCER; GENES; CELLS	The human ATP-binding cassette (ABC) transporter ABCB6 has been described as a mitochondrial porphyrin transporter essential for heme biosynthesis(1), but it is also suspected to contribute to anticancer drug resistance(2-4), as do other ABC transporters located at the plasma membrane. We identified ABCB6 as the genetic basis of the Lan blood group antigen expressed on red blood cells but also at the plasma membrane of hepatocellular carcinoma (HCC) cells, and we established that ABCB6 encodes a new blood group system (Langereis, Lan). Targeted sequencing of ABCB6 in 12 unrelated individuals of the Lan(-) blood type identified 10 different ABCB6 null mutations. This is the first report of deficient alleles of this human ABC transporter gene. Of note, Lan(-) (ABCB6(-/-)) individuals do not suffer any clinical consequences, although their deficiency in ABCB6 may place them at risk when determining drug dosage.	[Helias, Virginie; Saison, Carole; Peyrard, Thierry; Sureau, Camille; Pham, Bach-Nga; Le Pennec, Pierre-Yves; Cartron, Jean-Pierre; Arnaud, Lionel] Natl Inst Blood Transfus INTS, Paris, France; [Ballif, Bryan A.] Univ Vermont, Dept Biol, Burlington, VT USA; [Peyrard, Thierry; Pham, Bach-Nga; Le Pennec, Pierre-Yves] Natl Reference Ctr Blood Grp CNRGS, Paris, France; [Takahashi, Junko; Takahashi, Hideo; Tanaka, Mitsunobu; Tani, Yoshihiko] Japanese Red Cross Osaka Blood Ctr, Osaka, Japan; [Deybach, Jean-Charles; Puy, Herve] Univ Paris 07, Assistance Publ Hop Paris, Ctr Francais Porphyries, INSERM,Ctr Rech Biomed Bichat Beaujon,U 773, Paris, France; [Le Gall, Maude] Univ Paris 06, Ctr Rech Cordeliers, INSERM, Unite Mixte Rech UMR S 872, Paris, France	University of Vermont; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Arnaud, L (corresponding author), Natl Inst Blood Transfus INTS, Paris, France.	larnaud@ints.fr	PUY, HERVE/O-1785-2017; Le Gall, Maude/W-2593-2019; Le Gall, Maude/C-3917-2017	PUY, HERVE/0000-0003-3362-2634; Le Gall, Maude/0000-0002-5372-4585; Le Gall, Maude/0000-0002-5372-4585; PEYRARD, THIERRY/0000-0002-7715-568X; Saison, Carole/0000-0001-5898-7176	INTS; Inserm; Paris Diderot University (Paris 7); Vermont Genetics Network from the US National Institutes of Health/National Center for Research Resources [P20 RR16462]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103449] Funding Source: NIH RePORTER	INTS; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Paris Diderot University (Paris 7); Vermont Genetics Network from the US National Institutes of Health/National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are indebted to all present and past members of the CNRGS for identifying and cryopreserving Lan(-) blood samples. They would like to thank G. Nicolas for his helpful comments on the manuscript. This study was supported in part by the INTS, Inserm and Paris Diderot University (Paris 7). B.A.B. was funded by the Vermont Genetics Network through a grant from the US National Institutes of Health/National Center for Research Resources (P20 RR16462).	Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; CARTRON JP, 2008, HEM ED ED PROGR ANN, V2, P158; Daniels G, 2009, HUM GENET, V126, P729, DOI 10.1007/s00439-009-0738-2; Emadi-Konjin HP, 2002, BBA-GENE STRUCT EXPR, V1574, P117, DOI 10.1016/S0167-4781(01)00340-2; Holland I. B., 2003, ABC PROTEINS BACTERI; Kelter G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000798; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; OKUBO Y, 1984, TRANSFUSION, V24, P534, DOI 10.1046/j.1537-2995.1984.24685066820.x; PAGE PL, 1983, TRANSFUSION, V23, P256, DOI 10.1046/j.1537-2995.1983.23383224909.x; Paterson JK, 2007, BIOCHEMISTRY-US, V46, P9443, DOI 10.1021/bi700015m; Puy H, 2010, LANCET, V375, P924, DOI 10.1016/S0140-6736(09)61925-5; Saison C, 2012, NAT GENET, V44, P174, DOI 10.1038/ng.1070; SMITH DS, 1969, BRIT MED J, V3, P90, DOI 10.1136/bmj.3.5662.90; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Van der Hart M, 1962, P 8 C EUR SOC HAEM V, P493; Yasui K, 2004, CANCER RES, V64, P1403, DOI 10.1158/0008-5472.CAN-3263-2; Zhou S, 2005, BLOOD, V105, P2571, DOI 10.1182/blood-2004-04-1566	18	105	110	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2012	44	2					170	173		10.1038/ng.1069	http://dx.doi.org/10.1038/ng.1069			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	22246506	Green Accepted			2022-12-25	WOS:000299664400014
J	Stubbs, JL; Vladar, EK; Axelrod, JD; Kintner, C				Stubbs, J. L.; Vladar, E. K.; Axelrod, J. D.; Kintner, C.			Multicilin promotes centriole assembly and ciliogenesis during multiciliate cell differentiation	NATURE CELL BIOLOGY			English	Article							NOTCH SIGNALING CONTROLS; CILIATED CELLS; XENOPUS; PROTEIN; PLK4; TRANSCRIPTION; SELECTION; SCAFFOLD; GEMININ; SKIN	Multiciliate cells function prominently in the respiratory system, brain ependyma and female reproductive tract to produce vigorous fluid flow along epithelial surfaces. These specialized cells form during development when epithelial progenitors undergo an unusual form of ciliogenesis, in which they assemble and project hundreds of motile cilia. Notch inhibits multiciliate cell formation in diverse epithelia, but how progenitors overcome lateral inhibition and initiate multiciliate cell differentiation is unknown. Here we identify a coiled-coil protein, termed multicilin, which is regulated by Notch and highly expressed in developing epithelia where multiciliate cells form. Inhibiting multicilin function specifically blocks multiciliate cell formation in Xenopus skin and kidney, whereas ectopic expression induces the differentiation of multiciliate cells in ectopic locations. Multicilin localizes to the nucleus, where it directly activates the expression of genes required for multiciliate cell formation, including foxj1 and genes mediating centriole assembly. Multicilin is also necessary and sufficient to promote multiciliate cell differentiation in mouse airway epithelial cultures. These findings indicate that multicilin initiates multiciliate cell differentiation in diverse tissues, by coordinately promoting the transcriptional changes required for motile ciliogenesis and centriole assembly.	[Stubbs, J. L.; Kintner, C.] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Vladar, E. K.; Axelrod, J. D.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Salk Institute; Stanford University	Kintner, C (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA.	kintner@salk.edu		Vladar, Eszter/0000-0002-4160-8894	NIH [ROI GM096021, ROI GM059823]; AP Giannini Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [T32CA009151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096021, R01GM098582, R01GM059823] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AP Giannini Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work described here was supported by NIH grants ROI GM096021 (C.K.) and ROI GM059823 (J.D.A.) and an AP Giannini Postdoctoral Fellowship (E.K.V). The authors thank E. Campbell for technical assistance and members of the laboratory for comments on the manuscript.	Balestrini A, 2010, NAT CELL BIOL, V12, P484, DOI 10.1038/ncb2050; Basu B, 2008, CURR TOP DEV BIOL, V85, P151, DOI 10.1016/S0070-2153(08)00806-5; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Brody SL, 2000, AM J RESP CELL MOL, V23, P45, DOI 10.1165/ajrcmb.23.1.4070; Chen JC, 1998, J CLIN INVEST, V102, P1077, DOI 10.1172/JCI4786; Cizmecioglu O, 2010, J CELL BIOL, V191, P731, DOI 10.1083/jcb.201007107; Deblandre GA, 1999, DEVELOPMENT, V126, P4715; DIRKSEN ER, 1991, BIOL CELL, V72, P31, DOI 10.1016/0248-4900(91)90075-X; Dubaissi E, 2011, DIS MODEL MECH, V4, P179, DOI 10.1242/dmm.006494; Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445; Fawcett SR, 2004, GENE EXPR PATTERNS, V4, P29, DOI 10.1016/j.modgep.2003.08.003; Guseh JS, 2009, DEVELOPMENT, V136, P1751, DOI 10.1242/dev.029249; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hatch EM, 2010, J CELL BIOL, V191, P721, DOI 10.1083/jcb.201006049; Hayes JM, 2007, DEV BIOL, V312, P115, DOI 10.1016/j.ydbio.2007.09.031; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; KOLM PJ, 1995, DEV BIOL, V171, P267, DOI 10.1006/dbio.1995.1279; Lim JW, 2011, DEVELOPMENT, V138, P33, DOI 10.1242/dev.059824; Liu Y, 2007, DEVELOPMENT, V134, P1111, DOI 10.1242/dev.02806; Ma M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030018; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; Marshall WF, 2008, CURR TOP DEV BIOL, V85, P1, DOI 10.1016/S0070-2153(08)00801-6; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Pefani DE, 2011, J BIOL CHEM, V286, P23234, DOI 10.1074/jbc.M110.207688; Quigley IK, 2011, DEVELOPMENT, V138, P705, DOI 10.1242/dev.055699; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Schweickert A, 2007, CURR BIOL, V17, P60, DOI 10.1016/j.cub.2006.10.067; Seo S, 2006, CELL CYCLE, V5, P374, DOI 10.4161/cc.5.4.2438; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Stubbs JL, 2006, DEVELOPMENT, V133, P2507, DOI 10.1242/dev.02417; Stubbs JL, 2008, NAT GENET, V40, P1454, DOI 10.1038/ng.267; Thomas J, 2010, BIOL CELL, V102, P499, DOI 10.1042/BC20100035; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002; Yu XW, 2008, NAT GENET, V40, P1445, DOI 10.1038/ng.263	36	159	165	3	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2012	14	2					140	147		10.1038/ncb2406	http://dx.doi.org/10.1038/ncb2406			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	893CF	22231168	Green Accepted			2022-12-25	WOS:000300332500008
J	Cunnington, AJ; de Souza, JB; Walther, M; Riley, EM				Cunnington, Aubrey J.; de Souza, J. Brian; Walther, Michael; Riley, Eleanor M.			Malaria impairs resistance to Salmonella through heme- and heme oxygenase-dependent dysfunctional granulocyte mobilization	NATURE MEDICINE			English	Article							CARBON-MONOXIDE; TYPHIMURIUM INFECTION; OXIDATIVE STRESS; CEREBRAL MALARIA; NADPH OXIDASE; IN-VIVO; SUSCEPTIBILITY; MICE; PROTOPORPHYRIN; INDUCTION	In sub-Saharan Africa, invasive nontyphoid Salmonella (NTS) infection is a common and often fatal complication of Plasmodium falciparum infection. Induction of heme oxygenase-1 (HO-1) mediates tolerance to the cytotoxic effects of heme during malarial hemolysis but might impair resistance to NTS by limiting production of bactericidal reactive oxygen species. We show that co-infection of mice with Plasmodium yoelii 17XNL (Py17XNL) and Salmonella enterica serovar Typhimurium 12023 (Salmonella typhimurium) causes acute, fatal bacteremia with high bacterial load, features reproduced by phenylhydrazine-induced hemolysis or hemin administration. S. typhimurium localized predominantly in granulocytes. Py17XNL, phenylhydrazine and hemin caused premature mobilization of granulocytes from bone marrow with a quantitative defect in the oxidative burst. Inhibition of HO by tin protoporphyrin abrogated the impairment of resistance to S. typhimurium by hemolysis. Thus, a mechanism of tolerance to one infection, malaria, impairs resistance to another, NTS. Furthermore, HO inhibitors may be useful adjunctive therapy for NTS infection in the context of hemolysis.	[Cunnington, Aubrey J.; de Souza, J. Brian; Riley, Eleanor M.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, London WC1, England; [de Souza, J. Brian] UCL, Sch Med, Div Infect & Immun, London W1N 8AA, England; [Walther, Michael] MRC Labs, Banjul, Gambia	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; UCL Medical School; MRC Laboratory Molecular Biology	Riley, EM (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, London WC1, England.	eleanor.riley@Ishtm.ac.uk	Riley, Eleanor M/C-8960-2013; Riley, Eleanor/AAL-1382-2020	Riley, Eleanor M/0000-0003-3447-3570; Riley, Eleanor/0000-0003-3447-3570; Cunnington, Aubrey/0000-0002-1305-3529	UK Medical Research Council [G0701427]; European Society for Pediatric Infectious Diseases; Medical Research Council [G0701427] Funding Source: researchfish; MRC [G0701427] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Society for Pediatric Infectious Diseases; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a UK Medical Research Council Clinical Research Training Fellowship (G0701427) and a small grant award from the European Society for Pediatric Infectious Diseases awarded to A.J.C. We wish to thank D. Holden (Imperial College, London) for providing GFP-expressing S. typhimurium and R. Motterlini, S. Baines, H. Kaur, L. King, C. Stanley, R. Gregory, L. McCarthy, K. Couper, J. Hafalla, E. Findlay and D. Blount for technical advice and assistance.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Ayres JS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000150; Belcher JD, 2006, J CLIN INVEST, V116, P808, DOI 10.1172/JCI26857; Belyaev NN, 2010, NAT IMMUNOL, V11, P477, DOI 10.1038/ni.1869; Berkley JA, 2009, CLIN INFECT DIS, V49, P336, DOI 10.1086/600299; Bilban M, 2008, J MOL MED, V86, P267, DOI 10.1007/s00109-007-0276-0; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; Chauveau C, 2005, BLOOD, V106, P1694, DOI 10.1182/blood-2005-02-0494; Datla SR, 2007, HYPERTENSION, V50, P636, DOI 10.1161/HYPERTENSIONAHA.107.092296; DEHAAS M, 1994, BLOOD, V84, P3885, DOI 10.1182/blood.V84.11.3885.bloodjournal84113885; DeLeo FR, 2000, J BIOL CHEM, V275, P13986, DOI 10.1074/jbc.275.18.13986; Epiphanio S, 2008, CELL HOST MICROBE, V3, P331, DOI 10.1016/j.chom.2008.04.003; Ferreira A, 2011, CELL, V145, P398, DOI 10.1016/j.cell.2011.03.049; GLASSER L, 1987, BLOOD, V69, P937; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Graca-Souza AV, 2002, BLOOD, V99, P4160, DOI 10.1182/blood.V99.11.4160; HESTDAL K, 1991, J IMMUNOL, V147, P22; KAPPAS A, 1988, PEDIATRICS, V81, P485; KAYE D, 1963, J IMMUNOL, V91, P65; KAYE D, 1965, P SOC EXP BIOL MED, V120, P810, DOI 10.3181/00379727-120-30661; KAYE D, 1963, J IMMUNOL, V91, P518; Larsen R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001118; Li XL, 2008, J IMMUNOL, V180, P6933, DOI 10.4049/jimmunol.180.10.6933; MABEY DCW, 1987, J INFECT DIS, V155, P1319, DOI 10.1093/infdis/155.6.1319; MAINES MD, 1984, BIOCHEM J, V217, P409, DOI 10.1042/bj2170409; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; Mastroeni P, 2009, NAT REV MICROBIOL, V7, P73, DOI 10.1038/nrmicro2034; Morpeth SC, 2009, CLIN INFECT DIS, V49, P606, DOI 10.1086/603553; MURPHY JR, 1981, INFECT IMMUN, V31, P396, DOI 10.1128/IAI.31.1.396-407.1981; Nairz M, 2007, CELL MICROBIOL, V9, P2126, DOI 10.1111/j.1462-5822.2007.00942.x; Otterbein LE, 2009, RESP CARE, V54, P925, DOI 10.4187/002013209793800394; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Pamplona A, 2009, INT J BIOCHEM CELL B, V41, P711, DOI 10.1016/j.biocel.2008.09.020; Pham NK, 2005, INFECT IMMUN, V73, P8322, DOI 10.1128/IAI.73.12.8322-8333.2005; Porto BN, 2007, J BIOL CHEM, V282, P24430, DOI 10.1074/jbc.M703570200; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Read AF, 2008, PLOS BIOL, V6, P2638, DOI 10.1371/journal.pbio.1000004; Richardson MP, 1998, J IMMUNOL METHODS, V219, P187, DOI 10.1016/S0022-1759(98)00136-7; Roux CM, 2010, INFECT IMMUN, V78, P1520, DOI 10.1128/IAI.00887-09; Roy MF, 2007, J EXP MED, V204, P2949, DOI 10.1084/jem.20062606; Ryter SW, 2009, AM J RESP CELL MOL, V41, P251, DOI 10.1165/rcmb.2009-0170TR; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; Shan Y, 2006, FASEB J, V20, P2651, DOI 10.1096/fj.06-6346fje; Sheppard FR, 2005, J LEUKOCYTE BIOL, V78, P1025, DOI 10.1189/jlb.0804442; Soares MP, 2009, TRENDS MOL MED, V15, P50, DOI 10.1016/j.molmed.2008.12.004; Sponaas AM, 2009, BLOOD, V114, P5522, DOI 10.1182/blood-2009-04-217489; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802; Wright J, 1997, J PEDIATR-US, V130, P394, DOI 10.1016/S0022-3476(97)70201-4; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Zaki MH, 2009, J IMMUNOL, V182, P3746, DOI 10.4049/jimmunol.0803363	55	173	174	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2012	18	1					120	127		10.1038/nm.2601	http://dx.doi.org/10.1038/nm.2601			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22179318	Green Accepted			2022-12-25	WOS:000299018600037
J	Clark, AT; Phillips, BT; Orwig, KE				Clark, Amander T.; Phillips, Bart T.; Orwig, Kyle E.			Fruitful progress to fertility Male fertility in the test tube	NATURE MEDICINE			English	Editorial Material							PLURIPOTENT STEM-CELLS; GERMLINE TRANSMISSION; CULTURE; FETAL		[Clark, Amander T.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Clark, Amander T.] Univ Calif Los Angeles, Eli & Edythe Broad, Ctr Regenerat Med & Stem Cell Res, Los Angeles, CA USA; [Phillips, Bart T.; Orwig, Kyle E.] Univ Pittsburgh, Sch Med, Magee Womens Res Inst, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Clark, AT (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	orwigke@upmc.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055475] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD055475] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARDEKANI HS, 2011, JAMA-J AM MED ASSOC, V305, P2416; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hermann BP, 2007, STEM CELLS, V25, P2330, DOI 10.1634/stemcells.2007-0143; Hermann BP, 2011, HUM REPROD, V26, P3222, DOI 10.1093/humrep/der343; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Moragianni VA, 2010, CURR OPIN OBSTET GYN, V22, P189, DOI 10.1097/GCO.0b013e328338493f; Panula S, 2011, HUM MOL GENET, V20, P752, DOI 10.1093/hmg/ddq520; Park TS, 2009, STEM CELLS, V27, P783, DOI 10.1002/stem.13; Richardson TE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006308; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; TROWELL OA, 1959, EXP CELL RES, V16, P118, DOI 10.1016/0014-4827(59)90201-0; Woodruff TK, 2010, NAT REV CLIN ONCOL, V7, P466, DOI 10.1038/nrclinonc.2010.81; Wu X, 2009, P NATL ACAD SCI USA, V106, P21672, DOI 10.1073/pnas.0912432106; Wyns C, 2011, HUM REPROD, V26, P737, DOI 10.1093/humrep/deq387	16	20	20	2	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2011	17	12					1564	1565		10.1038/nm.2594	http://dx.doi.org/10.1038/nm.2594			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860WC	22146462				2022-12-25	WOS:000297978000025
J	Jiao, YP; Zhao, HN; Ren, LH; Song, WB; Zeng, B; Guo, JJ; Wang, BB; Liu, ZP; Chen, J; Li, W; Zhang, M; Xie, SJ; Lai, JS				Jiao, Yinping; Zhao, Hainan; Ren, Longhui; Song, Weibin; Zeng, Biao; Guo, Jinjie; Wang, Baobao; Liu, Zhipeng; Chen, Jing; Li, Wei; Zhang, Mei; Xie, Shaojun; Lai, Jinsheng			Genome-wide genetic changes during modern breeding of maize	NATURE GENETICS			English	Article							ASSOCIATION MAPPING POPULATION; RICE GRAIN WIDTH; ARTIFICIAL SELECTION; QUANTITATIVE RESISTANCE; ARABIDOPSIS-THALIANA; CROP IMPROVEMENT; INBRED LINES; LEAF-BLIGHT; MAJOR QTL; DOMESTICATION	The success of modern maize breeding has been demonstrated by remarkable increases in productivity over the last four decades. However, the underlying genetic changes correlated with these gains remain largely unknown. We report here the sequencing of 278 temperate maize inbred lines from different stages of breeding history, including deep resequencing of 4 lines with known pedigree information. The results show that modern breeding has introduced highly dynamic genetic changes into the maize genome. Artificial selection has affected thousands of targets, including genes and non-genic regions, leading to a reduction in nucleotide diversity and an increase in the proportion of rare alleles. Genetic changes during breeding happen rapidly, with extensive variation (SNPs, indels and copy-number variants (CNVs)) occurring, even within identity-by-descent regions. Our genome-wide assessment of genetic changes during modern maize breeding provides new strategies as well as practical targets for future crop breeding and biotechnology.	[Jiao, Yinping; Zhao, Hainan; Ren, Longhui; Song, Weibin; Zeng, Biao; Guo, Jinjie; Wang, Baobao; Liu, Zhipeng; Chen, Jing; Li, Wei; Zhang, Mei; Xie, Shaojun; Lai, Jinsheng] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Jiao, Yinping; Zhao, Hainan; Ren, Longhui; Song, Weibin; Zeng, Biao; Guo, Jinjie; Wang, Baobao; Liu, Zhipeng; Chen, Jing; Li, Wei; Zhang, Mei; Xie, Shaojun; Lai, Jinsheng] China Agr Univ, Natl Maize Improvement Ctr, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University	Lai, JS (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	jlai@cau.edu.cn	LIU, ZHIPENG/GWQ-5972-2022; Li, Wei/AAL-5488-2020; liu, zhipeng/HCI-3638-2022	Li, Wei/0000-0002-4210-8306; Ren, Longhui/0000-0003-3699-5946	National Basic Research Program (973 program) [2009CB118400]; Direct For Biological Sciences [0820619] Funding Source: National Science Foundation	National Basic Research Program (973 program)(National Basic Research Program of China); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank E.S. Buckler and J. Ross-Ibarra for helpful discussions, E.S. Buckler, T.R. Rocheford, M. Bohn and P. Becraft for assistance in making some of the Ex-PVP lines available and J. Dai, S. Wang and T. Wang for sharing Chinese germplasm. Research is supported by the National Basic Research Program (973 program) (2009CB118400).	Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Clark RM, 2005, MOL BIOL EVOL, V22, P2304, DOI 10.1093/molbev/msi228; Denver DR, 2009, P NATL ACAD SCI USA, V106, P16310, DOI 10.1073/pnas.0904895106; Doebley J, 2004, ANNU REV GENET, V38, P37, DOI 10.1146/annurev.genet.38.072902.092425; Duvick DN, 2005, ADV AGRON, V86, P83, DOI 10.1016/S0065-2113(05)86002-X; Duvick DN, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P295; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; FELSENSTEIN, 1989, CLADISTICS, V5, P164; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; GROTEWOLD E, 1991, MOL GEN GENET, V230, P329, DOI 10.1007/BF00290684; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Liu KJ, 2003, GENETICS, V165, P2117; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moose SP, 2008, PLANT PHYSIOL, V147, P969, DOI 10.1104/pp.108.118232; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Palmer LE, 2003, SCIENCE, V302, P2115, DOI 10.1126/science.1091265; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Poland JA, 2011, P NATL ACAD SCI USA, V108, P6893, DOI 10.1073/pnas.1010894108; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Roberts A, 2007, BIOINFORMATICS, V23, pI401, DOI 10.1093/bioinformatics/btm220; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; SCANLON MJ, 1994, GENETICS, V136, P281; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schneeberger K, 2011, P NATL ACAD SCI USA, V108, P10249, DOI 10.1073/pnas.1107739108; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Tian ZX, 2010, P NATL ACAD SCI USA, V107, P8563, DOI 10.1073/pnas.1000088107; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Yamasaki M, 2005, PLANT CELL, V17, P2859, DOI 10.1105/tpc.105.037242; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109; You YH, 1999, J MOL BIOL, V293, P493, DOI 10.1006/jmbi.1999.3174; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zheng P, 2008, NAT GENET, V40, P367, DOI 10.1038/ng.85	50	240	258	3	139	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2012	44	7					812	U124		10.1038/ng.2312	http://dx.doi.org/10.1038/ng.2312			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967DP	22660547				2022-12-25	WOS:000305886900018
J	Tompa, P				Tompa, Peter			On the supertertiary structure of proteins	NATURE CHEMICAL BIOLOGY			English	Article							BINDING; DOMAIN; KINASE; AUTOINHIBITION; ALLOSTERY; DYNAMICS; DISORDER; AFFINITY		[Tompa, Peter] Vrije Univ Brussel, VIB Dept Struct Biol, Brussels, Belgium; [Tompa, Peter] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Tompa, P (corresponding author), Vrije Univ Brussel, VIB Dept Struct Biol, Brussels, Belgium.	ptompa@vub.ac.be		Tompa, Peter/0000-0001-8042-9939				Atkins AR, 2004, J BIOL CHEM, V279, P49633, DOI 10.1074/jbc.M409159200; Berman HM, 2008, ACTA CRYSTALLOGR A, V64, P88, DOI 10.1107/S0108767307035623; Burmann BM, 2011, BIOCHEM J, V435, P783, DOI 10.1042/BJ20101679; Chandonia JM, 2006, SCIENCE, V311, P347, DOI 10.1126/science.1121018; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fisher CK, 2011, CURR OPIN STRUC BIOL, V21, P426, DOI 10.1016/j.sbi.2011.04.001; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Leung DW, 2005, P NATL ACAD SCI USA, V102, P5685, DOI 10.1073/pnas.0406472102; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; Lim RWL, 1999, BIOCHEMISTRY-US, V38, P16323, DOI 10.1021/bi991100o; LITVINOVICH SV, 1995, J MOL BIOL, V248, P611, DOI 10.1006/jmbi.1995.0246; Luo R, 2008, CELL SIGNAL, V20, P1968, DOI 10.1016/j.cellsig.2008.07.007; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Smock RG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.65; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tompa P, 2011, CURR OPIN STRUC BIOL, V21, P419, DOI 10.1016/j.sbi.2011.03.012; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Yang SC, 2010, P NATL ACAD SCI USA, V107, P15757, DOI 10.1073/pnas.1004569107; Zhang J, 2011, J BIOL CHEM, V286, P41776, DOI 10.1074/jbc.M111.272583	25	55	56	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2012	8	7					597	600		10.1038/nchembio.1009	http://dx.doi.org/10.1038/nchembio.1009			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961NJ	22710296				2022-12-25	WOS:000305471400001
J	Rigo, F; Hua, YM; Chun, SJ; Prakash, TP; Krainer, AR; Bennett, CF				Rigo, Frank; Hua, Yimin; Chun, Seung J.; Prakash, Thazha P.; Krainer, Adrian R.; Bennett, C. Frank			Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicing	NATURE CHEMICAL BIOLOGY			English	Article							LOCKED NUCLEIC-ACID; SINGLE-STRANDED RNA; ANTISENSE OLIGONUCLEOTIDES; BINDING PROTEINS; PYRUVATE-KINASE; HIGH-AFFINITY; GENE; THERAPEUTICS; MECHANISMS; EXPRESSION	We describe a new technology for recruiting specific proteins to RNA through selective recognition of heteroduplexes formed with chemically modified antisense oligonucleotides (ASOs). Typically, ASOs function by hybridizing to their RNA targets and blocking the binding of single-stranded RNA-binding proteins. Unexpectedly, we found that ASOs with 2'-deoxy-2'-fluoro (2'-F) nucleotides, but not with other 2' chemical modifications, have an additional property: they form heteroduplexes with RNA that are specifically recognized by the interleukin enhancer-binding factor 2 and 3 complex (ILF2/3). 2'-F ASO-directed recruitment of ILF2/3 to RNA can be harnessed to control gene expression by modulating alternative splicing of target transcripts. ILF2/3 recruitment to precursor mRNA near an exon results in omission of the exon from the mature mRNA, both in cell culture and in mice. We discuss the possibility of using chemically engineered ASOs that recruit specific proteins to modulate gene expression for therapeutic intervention.	[Rigo, Frank; Chun, Seung J.; Prakash, Thazha P.; Bennett, C. Frank] ISIS Pharmaceut, Carlsbad, CA 92008 USA; [Hua, Yimin; Krainer, Adrian R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Isis Pharmaceuticals Inc; Cold Spring Harbor Laboratory	Rigo, F (corresponding author), ISIS Pharmaceut, 2280 Faraday Ave, Carlsbad, CA 92008 USA.	fbennett@isisph.com	Hua, Yimin/U-6911-2018	Hua, Yimin/0000-0003-0905-7989; Krainer, Adrian/0000-0001-9024-9501	NCI NIH HHS [P30 CA045508] Funding Source: Medline; NIGMS NIH HHS [R37 GM042699, R01 GM042699] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620; Barber GN, 2009, RNA BIOL, V6, P35, DOI 10.4161/rna.6.1.7565; Baughan TD, 2009, HUM MOL GENET, V18, P1600, DOI 10.1093/hmg/ddp076; Bauman J, 2009, OLIGONUCLEOTIDES, V19, P1, DOI 10.1089/oli.2008.0161; Bennett C. F., 2009, GENE CELL THERAPY TH, P497; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Calarco JA, 2011, RNA, V17, P775, DOI 10.1261/rna.2603911; Cartegni L, 2003, NAT STRUCT BIOL, V10, P120, DOI 10.1038/nsb887; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cohen J S, 1991, Antisense Res Dev, V1, P191; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Crooke S.T, 2008, ANTISENSE DRUG TECHN, V2nd, P183; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; Goraczniak R, 2009, NAT BIOTECHNOL, V27, P257, DOI 10.1038/nbt.1525; Guan DY, 2008, MOL CELL BIOL, V28, P4629, DOI 10.1128/MCB.00120-08; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Hua YM, 2010, GENE DEV, V24, P1634, DOI 10.1101/gad.1941310; INOUE H, 1987, NUCLEIC ACIDS RES, V15, P6131, DOI 10.1093/nar/15.15.6131; Jepsen JS, 2004, OLIGONUCLEOTIDES, V14, P130, DOI 10.1089/1545457041526317; KAWASAKI AM, 1993, J MED CHEM, V36, P831, DOI 10.1021/jm00059a007; Li F, 2006, BIOCHEMISTRY-US, V45, P4141, DOI 10.1021/bi052322r; Liao HJ, 1998, P NATL ACAD SCI USA, V95, P8514, DOI 10.1073/pnas.95.15.8514; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Liu J, 2012, NUCLEIC ACIDS RES, V40, P1240, DOI 10.1093/nar/gkr780; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Mackay JP, 2011, NAT STRUCT MOL BIOL, V18, P256, DOI 10.1038/nsmb.2005; NOGUCHI T, 1986, J BIOL CHEM, V261, P3807; Pandya-Jones A, 2009, RNA, V15, P1896, DOI 10.1261/rna.1714509; Rademakers R, 2004, HUM MUTAT, V24, P277, DOI 10.1002/humu.20086; Seth PP, 2010, J ORG CHEM, V75, P1569, DOI 10.1021/jo902560f; Singh NK, 2006, MOL CELL BIOL, V26, P1333, DOI 10.1128/MCB.26.4.1333-1346.2006; Skordis LA, 2003, P NATL ACAD SCI USA, V100, P4114, DOI 10.1073/pnas.0633863100; Swayze EE., 2008, ANTISENSE DRUG TECHN, P143; Teplova M, 1999, NAT STRUCT BIOL, V6, P535; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; Vester B, 2004, BIOCHEMISTRY-US, V43, P13233, DOI 10.1021/bi0485732; Villemaire J, 2003, J BIOL CHEM, V278, P50031, DOI 10.1074/jbc.M308897200; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wang Y, 2009, NAT METHODS, V6, P825, DOI [10.1038/nmeth.1379, 10.1038/NMETH.1379]; Wilds CJ, 2000, NUCLEIC ACIDS RES, V28, P3625, DOI 10.1093/nar/28.18.3625; Win MN, 2009, CHEM BIOL, V16, P298, DOI 10.1016/j.chembiol.2009.02.011	47	71	73	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2012	8	6					555	561		10.1038/NCHEMBIO.939	http://dx.doi.org/10.1038/NCHEMBIO.939			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	945ET	22504300	Green Accepted			2022-12-25	WOS:000304256300011
J	Stein, JL; Medland, SE; Vasquez, AA; Hibar, DP; Senstad, RE; Winkler, AM; Toro, R; Appel, K; Bartecek, R; Bergmann, O; Bernard, M; Brown, AA; Cannon, DM; Chakravarty, MM; Christoforou, A; Domin, M; Grimm, O; Hollinshead, M; Holmes, AJ; Homuth, G; Hottenga, JJ; Langan, C; Lopez, LM; Hansell, NK; Hwang, KS; Kim, S; Laje, G; Lee, PH; Liu, XM; Loth, E; Lourdusamy, A; Mattingsdal, M; Mohnke, S; Maniega, SM; Nho, K; Nugent, AC; O'Brien, C; Papmeyer, M; Putz, B; Ramasamy, A; Rasmussen, J; Rijpkema, M; Risacher, SL; Roddey, JC; Rose, EJ; Ryten, M; Shen, L; Sprooten, E; Strengman, E; Teumer, A; Trabzuni, D; Turner, J; van Eijk, K; van Erp, TGM; van Tol, MJ; Wittfeld, K; Wolf, C; Woudstra, S; Aleman, A; Alhusaini, S; Almasy, L; Binder, EB; Brohawn, DG; Cantor, RM; Carless, MA; Corvin, A; Czisch, M; Curran, JE; Davies, G; de Almeida, MAA; Delanty, N; Depondt, C; Duggirala, R; Dyer, TD; Erk, S; Fagerness, J; Fox, PT; Freimer, NB; Gill, M; Goring, HHH; Hagler, DJ; Hoehn, D; Holsboer, F; Hoogman, M; Hosten, N; Jahanshad, N; Johnson, MP; Kasperaviciute, D; Kent, JW; Kochunov, P; Lancaster, JL; Lawrie, SM; Liewald, DC; Mandl, R; Matarin, M; Mattheisen, M; Meisenzahl, E; Melle, I; Moses, EK; Muhleisen, TW; Nauck, M; Nothen, MM; Olvera, RL; Pandolfo, M; Pike, GB; Puls, R; Reinvang, I; Renteria, ME; Rietschel, M; Roffman, JL; Royle, NA; Rujescu, D; Savitz, J; Schnack, HG; Schnell, K; Seiferth, N; Smith, C; Steen, VM; Hernandez, MCV; Van den Heuvel, M; van der Wee, NJ; Van Haren, NEM; Veltman, JA; Volzke, H; Walker, R; Westlye, LT; Whelan, CD; Agartz, I; Boomsma, DI; Cavalleri, GL; Dale, AM; Djurovic, S; Drevets, WC; Hagoort, P; Hall, J; Heinz, A; Jack, CR; Foroud, TM; Le Hellard, S; Macciardi, F; Montgomery, GW; Poline, JB; Porteous, DJ; Sisodiya, SM; Starr, JM; Sussmann, J; Toga, AW; Veltman, DJ; Walter, H; Weiner, MW; Bis, JC; Ikram, MA; Smith, AV; Gudnason, V; Tzourio, C; Vernooij, MW; Launer, LJ; DeCarli, C; Seshadri, S; Andreassen, OA; Apostolova, LG; Bastin, ME; Blangero, J; Brunner, HG; Buckner, RL; Cichon, S; Coppola, G; de Zubicaray, GI; Deary, IJ; Donohoe, G; de Geus, EJC; Espeseth, T; Fernandez, G; Glahn, DC; Grabe, HJ; Hardy, J; Pol, HEH; Jenkinson, M; Kahn, RS; McDonald, C; McIntosh, AM; McMahon, FJ; McMahon, KL; Meyer-Lindenberg, A; Morris, DW; Muller-Myhsok, B; Nichols, TE; Ophoff, RA; Paus, T; Pausova, Z; Penninx, BW; Potkin, SG; Samann, PG; Saykin, AJ; Schumann, G; Smoller, JW; Wardlaw, JM; Weale, ME; Martin, NG; Franke, B; Wright, MJ; Thompson, PM				Stein, Jason L.; Medland, Sarah E.; Vasquez, Alejandro Arias; Hibar, Derrek P.; Senstad, Rudy E.; Winkler, Anderson M.; Toro, Roberto; Appel, Katja; Bartecek, Richard; Bergmann, Orjan; Bernard, Manon; Brown, Andrew A.; Cannon, Dara M.; Chakravarty, M. Mallar; Christoforou, Andrea; Domin, Martin; Grimm, Oliver; Hollinshead, Marisa; Holmes, Avram J.; Homuth, Georg; Hottenga, Jouke-Jan; Langan, Camilla; Lopez, Lorna M.; Hansell, Narelle K.; Hwang, Kristy S.; Kim, Sungeun; Laje, Gonzalo; Lee, Phil H.; Liu, Xinmin; Loth, Eva; Lourdusamy, Anbarasu; Mattingsdal, Morten; Mohnke, Sebastian; Maniega, Susana Munoz; Nho, Kwangsik; Nugent, Allison C.; O'Brien, Carol; Papmeyer, Martina; Putz, Benno; Ramasamy, Adaikalavan; Rasmussen, Jerod; Rijpkema, Mark; Risacher, Shannon L.; Roddey, J. Cooper; Rose, Emma J.; Ryten, Mina; Shen, Li; Sprooten, Emma; Strengman, Eric; Teumer, Alexander; Trabzuni, Daniah; Turner, Jessica; van Eijk, Kristel; van Erp, Theo G. M.; van Tol, Marie-Jose; Wittfeld, Katharina; Wolf, Christiane; Woudstra, Saskia; Aleman, Andre; Alhusaini, Saud; Almasy, Laura; Binder, Elisabeth B.; Brohawn, David G.; Cantor, Rita M.; Carless, Melanie A.; Corvin, Aiden; Czisch, Michael; Curran, Joanne E.; Davies, Gail; de Almeida, Marcio A. A.; Delanty, Norman; Depondt, Chantal; Duggirala, Ravi; Dyer, Thomas D.; Erk, Susanne; Fagerness, Jesen; Fox, Peter T.; Freimer, Nelson B.; Gill, Michael; Goering, Harald H. H.; Hagler, Donald J.; Hoehn, David; Holsboer, Florian; Hoogman, Martine; Hosten, Norbert; Jahanshad, Neda; Johnson, Matthew P.; Kasperaviciute, Dalia; Kent, Jack W., Jr.; Kochunov, Peter; Lancaster, Jack L.; Lawrie, Stephen M.; Liewald, David C.; Mandl, Rene; Matarin, Mar; Mattheisen, Manuel; Meisenzahl, Eva; Melle, Ingrid; Moses, Eric K.; Muehleisen, Thomas W.; Nauck, Matthias; Noethen, Markus M.; Olvera, Rene L.; Pandolfo, Massimo; Pike, G. Bruce; Puls, Ralf; Reinvang, Ivar; Renteria, Miguel E.; Rietschel, Marcella; Roffman, Joshua L.; Royle, Natalie A.; Rujescu, Dan; Savitz, Jonathan; Schnack, Hugo G.; Schnell, Knut; Seiferth, Nina; Smith, Colin; Steen, Vidar M.; Hernandez, Maria C. Valdes; Van den Heuvel, Martijn; van der Wee, Nic J.; Van Haren, Neeltje E. M.; Veltman, Joris A.; Voelzke, Henry; Walker, Robert; Westlye, Lars T.; Whelan, Christopher D.; Agartz, Ingrid; Boomsma, Dorret I.; Cavalleri, Gianpiero L.; Dale, Anders M.; Djurovic, Srdjan; Drevets, Wayne C.; Hagoort, Peter; Hall, Jeremy; Heinz, Andreas; Jack, Clifford R., Jr.; Foroud, Tatiana M.; Le Hellard, Stephanie; Macciardi, Fabio; Montgomery, Grant W.; Poline, Jean Baptiste; Porteous, David J.; Sisodiya, Sanjay M.; Starr, John M.; Sussmann, Jessika; Toga, Arthur W.; Veltman, Dick J.; Walter, Henrik; Weiner, Michael W.; Bis, Joshua C.; Ikram, M. Arfan; Smith, Albert V.; Gudnason, Vilmundur; Tzourio, Christophe; Vernooij, Meike W.; Launer, Lenore J.; DeCarli, Charles; Seshadri, Sudha; Andreassen, Ole A.; Apostolova, Liana G.; Bastin, Mark E.; Blangero, John; Brunner, Han G.; Buckner, Randy L.; Cichon, Sven; Coppola, Giovanni; de Zubicaray, Greig I.; Deary, Ian J.; Donohoe, Gary; de Geus, Eco J. C.; Espeseth, Thomas; Fernandez, Guillen; Glahn, David C.; Grabe, Hans J.; Hardy, John; Pol, Hilleke E. Hulshoff; Jenkinson, Mark; Kahn, Rene S.; McDonald, Colm; McIntosh, Andrew M.; McMahon, Francis J.; McMahon, Katie L.; Meyer-Lindenberg, Andreas; Morris, Derek W.; Mueller-Myhsok, Bertram; Nichols, Thomas E.; Ophoff, Roel A.; Paus, Tomas; Pausova, Zdenka; Penninx, Brenda W.; Potkin, Steven G.; Saemann, Philipp G.; Saykin, Andrew J.; Schumann, Gunter; Smoller, Jordan W.; Wardlaw, Joanna M.; Weale, Michael E.; Martin, Nicholas G.; Franke, Barbara; Wright, Margaret J.; Thompson, Paul M.		ADNI; EPIGEN Consortium; IMAGEN Consortium; Saguenay Youth Study Grp SYS; Cohorts Heart Aging Res Genomic Ep; Enhancing Neuro Imaging Genetics M	Identification of common variants associated with human hippocampal and intracranial volumes	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TEMPORAL-LOBE EPILEPSY; AUTOMATED SEGMENTATION; GENOTYPE IMPUTATION; ALZHEIMERS-DISEASE; BRAIN VOLUME; HUMAN HEIGHT; FUNCTIONAL IMPLICATIONS; NA+/H+ EXCHANGER; UNIFIED APPROACH	Identifying genetic variants influencing human brain structures may reveal new biological mechanisms underlying cognition and neuropsychiatric illness. The volume of the hippocampus is a biomarker of incipient Alzheimer's disease(1,2) and is reduced in schizophrenia(3), major depression(4) and mesial temporal lobe epilepsy(5). Whereas many brain imaging phenotypes are highly heritable(6,7), identifying and replicating genetic influences has been difficult, as small effects and the high costs of magnetic resonance imaging (MRI) have led to underpowered studies. Here we report genome-wide association meta-analyses and replication for mean bilateral hippocampal, total brain and intracranial volumes from a large multinational consortium. The intergenic variant rs7294919 was associated with hippocampal volume (12q24.22; N = 21,151; P = 6.70 x 10(-16)) and the expression levels of the positional candidate gene TESC in brain tissue. Additionally, rs10784502, located within HMGA2, was associated with intracranial volume (12q14.3; N = 15,782; P = 1.12 x 10(-12)). We also identified a suggestive association with total brain volume at rs10494373 within DDR2 (1q23.3; N = 6,500; P = 5.81 x 10(-7)).	[Stein, Jason L.; Hibar, Derrek P.; Senstad, Rudy E.; Hwang, Kristy S.; Jahanshad, Neda; Toga, Arthur W.; Apostolova, Liana G.; Thompson, Paul M.] Univ Calif Los Angeles, David Geffen Sch Med, Lab Neuro Imaging, Los Angeles, CA 90095 USA; [Medland, Sarah E.; Hansell, Narelle K.; Renteria, Miguel E.; Montgomery, Grant W.; Martin, Nicholas G.; Wright, Margaret J.] Queensland Inst Med Res, Genet Epidemiol Lab, Brisbane, Qld 4006, Australia; [Medland, Sarah E.] Queensland Inst Med Res, Quantitat Genet Lab, Brisbane, Qld 4006, Australia; [Medland, Sarah E.] Broad Inst Harvard Univ & MIT, Cambridge, MA USA; [Vasquez, Alejandro Arias; Hoogman, Martine; Veltman, Joris A.; Brunner, Han G.; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Vasquez, Alejandro Arias; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, NL-6525 ED Nijmegen, Netherlands; [Vasquez, Alejandro Arias; Rijpkema, Mark; Hoogman, Martine; Hagoort, Peter; Fernandez, Guillen; Franke, Barbara] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Winkler, Anderson M.; Glahn, David C.] Hartford Hosp, Olin Neuropsychiat Res Ctr, Inst Living, Hartford, CT 06115 USA; [Winkler, Anderson M.; Glahn, David C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Toro, Roberto] Inst Pasteur, Lab Human Genet & Cognit Funct, Paris, France; [Toro, Roberto] Inst Pasteur, CNRS, URA Genes Synapses & Cognit 2182, Paris, France; [Toro, Roberto] Univ Paris Diderot, Dept Neurosci, Paris, France; [Appel, Katja; Wittfeld, Katharina; Grabe, Hans J.] Ernst Moritz Arndt Univ Greifswald, Dept Psychiat & Psychotherapy, Greifswald, Germany; [Appel, Katja] Univ Heidelberg, Inst Psychol, Dept Clin Psychol & Psychotherapy, Heidelberg, Germany; [Bartecek, Richard; Mandl, Rene; Schnack, Hugo G.; Van den Heuvel, Martijn; Van Haren, Neeltje E. M.; Pol, Hilleke E. Hulshoff; Kahn, Rene S.; Ophoff, Roel A.] Univ Med Ctr Utrecht, Dept Psychiat, Rudolf Magnus Inst, Utrecht, Netherlands; [Bergmann, Orjan; Brown, Andrew A.; Mattingsdal, Morten; Melle, Ingrid; Agartz, Ingrid; Djurovic, Srdjan; Andreassen, Ole A.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Bernard, Manon; Pausova, Zdenka] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Brown, Andrew A.] Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo, Norway; [Cannon, Dara M.] Natl Univ Ireland Galway, Clin Neuroimaging Lab, Dept Anat, Galway, Ireland; [Langan, Camilla; McDonald, Colm] Natl Univ Ireland Galway, Clin Neuroimaging Lab, Dept Psychiat, Galway, Ireland; [Chakravarty, M. Mallar; Paus, Tomas] Univ Toronto, Rotman Res Inst, Toronto, ON, Canada; [Christoforou, Andrea; Steen, Vidar M.; Le Hellard, Stephanie] Univ Bergen, Dr Einar Martens Res Grp Biol Psychiat, Dept Clin Med, Bergen, Norway; [Christoforou, Andrea; Steen, Vidar M.; Le Hellard, Stephanie] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Domin, Martin; Hosten, Norbert; Puls, Ralf] Ernst Moritz Arndt Univ Greifswald, Dept Diagnost Radiol & Neuroradiol, Greifswald, Germany; [Grimm, Oliver; Rietschel, Marcella; Meyer-Lindenberg, Andreas] Univ Heidelberg, Cent Inst Mental Hlth, Med Fac Mannheim, D-6800 Mannheim, Germany; [Hollinshead, Marisa; Holmes, Avram J.; Buckner, Randy L.] Harvard Univ, Dept Psychol, Ctr Brain Sci, Cambridge, MA 02138 USA; [Hollinshead, Marisa; Buckner, Randy L.] Howard Hughes Med Inst, Cambridge, MA USA; [Homuth, Georg; Teumer, Alexander] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Hottenga, Jouke-Jan; Boomsma, Dorret I.; de Geus, Eco J. C.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Lopez, Lorna M.; Maniega, Susana Munoz; Liewald, David C.; Royle, Natalie A.; Hernandez, Maria C. Valdes; Porteous, David J.; Starr, John M.; Bastin, Mark E.; Deary, Ian J.; Wardlaw, Joanna M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Lopez, Lorna M.; Davies, Gail; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Hwang, Kristy S.; Apostolova, Liana G.; Coppola, Giovanni] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Kim, Sungeun; Nho, Kwangsik; Risacher, Shannon L.; Shen, Li; Saykin, Andrew J.] Indiana Univ Sch Med, Ctr Neuroimaging, Dept Radiol & Imaging Sci, Indianapolis, IN USA; [Kim, Sungeun; Shen, Li; Foroud, Tatiana M.; Saykin, Andrew J.] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN USA; [Laje, Gonzalo; Liu, Xinmin; McMahon, Francis J.] NIMH, Mood & Anxiety Disorders Sect, Human Genet Branch,US Dept HHS, Intramural Res Program,US Natl Inst Hlth NIH, Bethesda, MD 20892 USA; [Lee, Phil H.; Brohawn, David G.; Fagerness, Jesen; Smoller, Jordan W.] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Ctr Human Genet Res, Boston, MA 02114 USA; [Lee, Phil H.; Roffman, Joshua L.; Buckner, Randy L.; Smoller, Jordan W.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Liu, Xinmin] Columbia Univ, Med Ctr, Taub Inst Res Alzheimer Dis & Aging Brain, New York, NY USA; [Loth, Eva; Lourdusamy, Anbarasu; Schumann, Gunter] Kings Coll London, MRC, Social Genet & Dev Psychiat SGDP Ctr, Inst Psychiat, London WC2R 2LS, England; [Mattingsdal, Morten] Sorlandet Hosp, Res Unit, Kristiansand, Norway; [Mohnke, Sebastian; Erk, Susanne; Seiferth, Nina; Heinz, Andreas; Walter, Henrik] Charite, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany; [Maniega, Susana Munoz; Royle, Natalie A.; Hernandez, Maria C. Valdes; Bastin, Mark E.; Wardlaw, Joanna M.] Univ Edinburgh, Brain Res Imaging Ctr, Edinburgh, Midlothian, Scotland; [Nho, Kwangsik] Regenstrief Inst Hlth Care, Div Med Informat, Indianapolis, IN USA; [Nugent, Allison C.; Savitz, Jonathan; Drevets, Wayne C.] NIMH, Sect Neuroimaging Mood & Anxiety Disorders, Intramural Res Program, NIH,US Dept HHS, Bethesda, MD 20892 USA; [O'Brien, Carol; Rose, Emma J.; Corvin, Aiden; Gill, Michael; Donohoe, Gary; Morris, Derek W.] Trinity Coll Dublin, Neuropsychiat Genet Res Grp, Dept Psychiat, Inst Mol Med, Dublin, Ireland; [O'Brien, Carol; Rose, Emma J.; Corvin, Aiden; Gill, Michael; Donohoe, Gary; Morris, Derek W.] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland; [Papmeyer, Martina; Sprooten, Emma; Lawrie, Stephen M.; Hall, Jeremy; Sussmann, Jessika; McIntosh, Andrew M.] Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Edinburgh, Midlothian, Scotland; [Putz, Benno; Wolf, Christiane; Binder, Elisabeth B.; Czisch, Michael; Hoehn, David; Holsboer, Florian; Mueller-Myhsok, Bertram; Saemann, Philipp G.] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Ramasamy, Adaikalavan; Weale, Michael E.] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England; [Rasmussen, Jerod; van Erp, Theo G. M.; Macciardi, Fabio; Potkin, Steven G.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA; [Rijpkema, Mark; Hagoort, Peter; Fernandez, Guillen] Radboud Univ Nijmegen, Donders Ctr Cognit Neuroimaging, NL-6525 ED Nijmegen, Netherlands; [Roddey, J. Cooper; Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Ryten, Mina; Trabzuni, Daniah; Hardy, John] UCL, Dept Mol Neurosci, London, England; [Ryten, Mina; Trabzuni, Daniah; Hardy, John] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Strengman, Eric; van Eijk, Kristel] Univ Med Ctr Utrecht, Rudolf Magnus Inst, Utrecht, Netherlands; [Trabzuni, Daniah] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Turner, Jessica] Mind Res Network, Albuquerque, NM USA; [van Tol, Marie-Jose; van der Wee, Nic J.; Penninx, Brenda W.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [van Tol, Marie-Jose; van der Wee, Nic J.; Penninx, Brenda W.] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [van Tol, Marie-Jose; Aleman, Andre] Univ Groningen, Univ Med Ctr Groningen, Behav & Cognit Neurosci Neuroimaging Ctr, NL-9713 AV Groningen, Netherlands; [Woudstra, Saskia; Veltman, Dick J.; Penninx, Brenda W.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Alhusaini, Saud; Delanty, Norman; Whelan, Christopher D.; Cavalleri, Gianpiero L.] Royal Coll Surgeons Ireland, Dept Mol & Cellular Therapeut, Dublin 2, Ireland; [Almasy, Laura; Carless, Melanie A.; Curran, Joanne E.; de Almeida, Marcio A. A.; Duggirala, Ravi; Dyer, Thomas D.; Johnson, Matthew P.; Kent, Jack W., Jr.; Moses, Eric K.; Blangero, John] Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA; [Cantor, Rita M.; Freimer, Nelson B.; Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA; [Delanty, Norman] Beaumont Hosp, Div Neurol, Dublin 9, Ireland; [Depondt, Chantal; Pandolfo, Massimo] Univ Libre Brussels, Dept Neurol, Hop Erasme, Brussels, Belgium; [Buckner, Randy L.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02114 USA; [Fox, Peter T.; Kochunov, Peter; Lancaster, Jack L.] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA; [Hagler, Donald J.; Dale, Anders M.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Hoogman, Martine; Fernandez, Guillen] Radboud Univ Nijmegen, Dept Cognit Neurosci, Med Ctr, Nijmegen, Netherlands; [Hoogman, Martine; Hagoort, Peter] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Kasperaviciute, Dalia; Matarin, Mar; Sisodiya, Sanjay M.] UCL, Dept Clin & Expt Epilepsy, Inst Neurol, London, England; [Kochunov, Peter] Univ Maryland, Sch Med, Dept Psychiat, Maryland Psychiat Res Ctr, Baltimore, MD 21201 USA; [Mattheisen, Manuel; Muehleisen, Thomas W.; Noethen, Markus M.; Cichon, Sven] Univ Bonn, Dept Genom, Life & Brain Ctr, Bonn, Germany; [Mattheisen, Manuel; Muehleisen, Thomas W.; Noethen, Markus M.; Cichon, Sven] Univ Bonn, Inst Human Genet, Bonn, Germany; [Mattheisen, Manuel] Univ Bonn, Inst Genom Math, Bonn, Germany; [Meisenzahl, Eva; Rujescu, Dan] Univ Munich, Dept Psychiat, D-80804 Munich, Germany; [Melle, Ingrid; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [Nauck, Matthias] Ernst Moritz Arndt Univ Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Noethen, Markus M.] German Ctr Neurodegenerat Disorders DZNE, Bonn, Germany; [Olvera, Rene L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Pike, G. Bruce] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Reinvang, Ivar; Westlye, Lars T.; Espeseth, Thomas] Univ Oslo, Dept Psychol, Ctr Study Human Cognit, Oslo, Norway; [Reinvang, Ivar; Espeseth, Thomas] Ctr Adv Study, Oslo, Norway; [Renteria, Miguel E.; de Zubicaray, Greig I.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Savitz, Jonathan; Drevets, Wayne C.] Laureate Inst Brain Res, Tulsa, OK USA; [Schnell, Knut] Univ Heidelberg, Univ Heidelberg Hosp, Dept Gen Psychiat, Heidelberg, Germany; [Schnell, Knut; Walter, Henrik] Univ Bonn, Dept Psychiat, Div Med Psychol, Bonn, Germany; [Smith, Colin; Walker, Robert] Univ Edinburgh, Dept Pathol, MRC Sudden Death Tissue Bank Edinburgh, Edinburgh, Midlothian, Scotland; [Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, Greifswald, Germany; [Agartz, Ingrid] Diakonhjemmet Hosp, Dept Res & Dev, Oslo, Norway; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Jack, Clifford R., Jr.] Mayo Clin & Mayo Fdn, Aging & Dementia Imaging Res Lab, Dept Radiol, Rochester, MN USA; [Foroud, Tatiana M.; Saykin, Andrew J.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN USA; [Poline, Jean Baptiste] Commissariat Energie Atom, Inst Imagerie Biomed I2BM, Gif Sur Yvette, France; [Porteous, David J.] Univ Edinburgh, Western Gen Hosp, Med Genet Sect, Mol Med Ctr,Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Starr, John M.] Univ Edinburgh, Royal Victoria Hosp, Geriatr Med Unit, Edinburgh, Midlothian, Scotland; [Weiner, Michael W.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Weiner, Michael W.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Bis, Joshua C.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Ikram, M. Arfan; Vernooij, Meike W.] Univ Med Ctr, Erasmus Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Ikram, M. Arfan; Vernooij, Meike W.] Univ Med Ctr, Erasmus Med Ctr, Dept Radiol, Rotterdam, Netherlands; [Ikram, M. Arfan; Vernooij, Meike W.] Netherlands Consortium Hlth Aging, Leiden, Netherlands; [Smith, Albert V.; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Smith, Albert V.; Gudnason, Vilmundur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Tzourio, Christophe] Univ Bordeaux, U708, Bordeaux, France; [Tzourio, Christophe] INSERM, U708, Bordeaux, France; [Launer, Lenore J.] NIH, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [DeCarli, Charles] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; [DeCarli, Charles] Univ Calif Davis, Ctr Neurosci, Sacramento, CA 95817 USA; [Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Seshadri, Sudha] Natl Heart Lung & Blood Inst Framingham Heart Stu, Framingham, MA USA; [Bastin, Mark E.] Univ Edinburgh, Div Hlth Sci Med Phys, Edinburgh, Midlothian, Scotland; [Cichon, Sven] Res Ctr Juelich, Inst Neurosci & Med INM 1, Julich, Germany; [Coppola, Giovanni] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Espeseth, Thomas] Univ Bergen, Dept Biol & Med Psychol, Fac Psychol, Bergen, Norway; [Grabe, Hans J.] German Ctr Neurodegenerat Dis DZNE, Greifswald, Germany; [Jenkinson, Mark; Nichols, Thomas E.] Univ Oxford, FMRIB, Oxford, England; [McMahon, Katie L.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia; [Nichols, Thomas E.] Univ Warwick, Dept Stat, Coventry CV4 7AL, W Midlands, England; [Penninx, Brenda W.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9713 AV Groningen, Netherlands	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Hartford Hospital; Yale University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Ernst Moritz Arndt Universitat Greifswald; Ruprecht Karls University Heidelberg; Utrecht University; Utrecht University Medical Center; University of Oslo; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Oslo; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; University of Toronto; University Toronto Affiliates; Baycrest; University of Bergen; University of Bergen; Haukeland University Hospital; Ernst Moritz Arndt Universitat Greifswald; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Harvard University; Howard Hughes Medical Institute; Ernst Moritz Arndt Universitat Greifswald; Vrije Universiteit Amsterdam; University of Edinburgh; University of Edinburgh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Columbia University; University of London; King's College London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Edinburgh; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Trinity College Dublin; Trinity College Dublin; Royal Infirmary of Edinburgh; University of Edinburgh; Max Planck Society; University of London; King's College London; University of California System; University of California Irvine; Radboud University Nijmegen; University of California System; University of California San Diego; University of London; University College London; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; King Faisal Specialist Hospital & Research Center; Lovelace Respiratory Research Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; Vrije Universiteit Amsterdam; Royal College of Surgeons - Ireland; Texas Biomedical Research Institute; University of California System; University of California Los Angeles; Universite Libre de Bruxelles; Harvard University; Massachusetts General Hospital; University of Texas System; University of Texas Health San Antonio; University of California System; University of California San Diego; Radboud University Nijmegen; Max Planck Society; University of London; University College London; University System of Maryland; University of Maryland Baltimore; University of Bonn; University of Bonn; University of Bonn; University of Munich; University of Oslo; Ernst Moritz Arndt Universitat Greifswald; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Texas System; University of Texas Health San Antonio; McGill University; University of Oslo; University of Queensland; Laureate Institute for Brain Research, Inc.; Ruprecht Karls University Heidelberg; University of Bonn; University of Edinburgh; Ernst Moritz Arndt Universitat Greifswald; Diakonhjemmet Hospital; University of Oslo; Mayo Clinic; Indiana University System; Indiana University Bloomington; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Edinburgh; University of Edinburgh; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Washington; University of Washington Seattle; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Icelandic Heart Association; University of Iceland; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); National Institutes of Health (NIH) - USA; University of California System; University of California Davis; University of California System; University of California Davis; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Edinburgh; Helmholtz Association; Research Center Julich; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Bergen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Oxford; University of Queensland; University of Warwick; University of Groningen	Thompson, PM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Lab Neuro Imaging, Los Angeles, CA 90095 USA.	thompson@loni.ucla.edu	Veltman, Joris A/F-5128-2010; Hsiung, Robin/AAT-1661-2021; Teumer, Alexander/S-7438-2019; de Geus, Eco J.C./M-9318-2015; Hernandez, María/GYU-3543-2022; Lawrie, Stephen MacGregor/AAD-1607-2021; Bartečků, Elis/E-1906-2012; Poustka, Luise/D-9299-2017; Pütz, Benno/P-2630-2016; McMahon, Francis J/A-7290-2009; McDonald, Colm/C-1430-2009; Donohoe, Gary/J-6481-2013; Finsterbusch, Jürgen/M-2969-2016; Trabzuni, Daniah M/C-4034-2012; Wittfeld, Katharina/AFB-1549-2022; Hulshoff Pol, Hilleke Evertje/B-4795-2014; Breteler, Monique M.B./J-5058-2014; Penninx, Brenda WJH/S-7627-2017; Cavalieri, Margherita/G-8053-2012; van den Heuvel, Martijn/AFR-3213-2022; Pike, Bruce/K-5562-2014; Almasy, Laura/V-3156-2019; Ryten, Mina/Q-8419-2016; Wright, Margaret J/H-3308-2014; Hardy, John/C-2451-2009; Hansell, Narelle K/A-4553-2016; Porteous, David J/C-7289-2013; Cichon, Sven/H-8803-2013; Vollstädt-Klein, Sabine/C-6744-2012; Sprooten, Emma/N-3836-2017; Matarin, Mar/F-1771-2016; Turner, Jessica A/N-2228-2017; Ramasamy, Adaikalavan/G-2632-2010; Rentería, Miguel E./M-6671-2017; Wardlaw, Joanna M/Y-3456-2019; Shen, Li/AAB-6870-2021; Cavalleri, Gianpiero/A-6632-2010; Vernooij, Meike Willemijn/E-4061-2016; Walter, Henrik/O-2612-2013; Vasquez, Alejandro Arias/E-4762-2012; Weale, Michael E/F-2587-2010; Romanczuk-Seiferth, Nina/AFN-7029-2022; Hagoort, Peter/B-7417-2012; Melle, Ingrid S/B-4858-2011; Romanczuk-Seiferth, Nina/AFN-0829-2022; Schumann, Gunter/H-1013-2013; Müller-Myhsok, Bertram/A-3289-2013; Thompson, Paul M/C-4194-2018; Rujescu, Dan/GRS-3875-2022; Porteous, David/AAA-3446-2021; Savitz, Jonathan/C-3088-2009; DeCarli, Charles/B-5541-2009; Blangero, John/ABA-7175-2021; Wright, Margaret Jane/A-4560-2016; Medland, Sarah/AAT-7595-2020; Jahanshad, Neda/ABD-5944-2021; Ikram, M. Arfan/AAM-5225-2021; Nichols, Thomas E./N-9902-2017; Stacey, David/AFX-6013-2022; Lopez, Lorna M/F-7265-2010; Preda, Adrian/K-8889-2013; Fernandez, Guillen/B-3771-2009; Mattheisen, Manuel/S-3725-2019; Rijpkema, Mark/D-1974-2010; Binder, Elisabeth B/K-8905-2014; Rose, Emma J/A-9960-2010; Tzourio, christophe/L-6344-2019; Brunner, Han/C-9928-2013; Medland, Sarah E/C-7630-2013; Artiges, Eric/AAT-7219-2021; Fox, Peter/B-4725-2010; Desrivieres, Sylvane/B-7399-2011; Desrivières, Sylvane/ABC-4336-2021; Mattingsdal, Morten/Q-9367-2016; Boomsma, Dorret I/AAX-4470-2020; Jenkinson, Mark/AAC-8861-2019; Roffman, Joshua/G-8228-2012; Heinz, Andreas/ABB-7736-2020; Risacher, Shannon/AAI-2141-2019; Potkin, Steven G/A-2021-2013; Morris, Derek/AAW-8343-2021; Mattheisen, Manuel/B-4949-2012; Mandl, René C.W./AAU-7037-2020; Artiges, Eric/C-2815-2019; Lourdusamy, Anbarasu/P-6606-2014; Cichon, Sven/B-9618-2014; Andreassen, Ole A./AAY-7531-2020; Smith, Albert Vernon/K-5150-2015; /ABD-6198-2020; Trabzuni, Daniah/AAI-2037-2021; de Zubicaray, Greig/ABC-8955-2021; LICEND, CEMND/F-1296-2015; Macciardi, Fabio/N-3768-2014; Martin, Nicholas/R-9235-2019; Cannon, Dara M/C-1323-2009; Lourdusamy, Anbarasu/G-3387-2011; Gudnason, Vilmundur/AAE-7126-2019; Kochunov, Peter/GQH-9532-2022; Lopez, Lorna/AAR-4912-2020; Dufouil, Carole/J-4968-2012; McIntosh, Andrew M/B-9379-2008; Levey, Allan/F-2104-2011; lambert, jean-charles/F-8787-2013; Laje, Gonzalo/L-2654-2014; van Haren, Neeltje/AAC-7656-2020; de Zubicaray, Greig I/B-1763-2008; Turner, Jessica A/H-7282-2015; Winkler, Anderson M/P-7773-2016; Maniega, Susana Muñoz/I-8730-2014; Deary, Ian J/C-6297-2009; Gudnason, Vilmundur/K-6885-2015; Tzourio, christophe/B-4015-2009; Jack, Clifford R/F-2508-2010; Hoogman, Martine/G-8958-2015; Montgomery, Grant W/B-7148-2008; McMahon, Katie L/C-6440-2009; Franke, Barbara/D-4836-2009; Saykin, Andrew/A-1318-2007; Moreno, Margarita/K-9869-2014; Smolka, Michael/B-4865-2011; Meyer-Lindenberg, Andreas/H-1076-2011	Veltman, Joris A/0000-0002-3218-8250; Hsiung, Robin/0000-0002-8017-0856; Teumer, Alexander/0000-0002-8309-094X; de Geus, Eco J.C./0000-0001-6022-2666; Lawrie, Stephen MacGregor/0000-0002-2444-5675; Bartečků, Elis/0000-0001-9148-2145; Pütz, Benno/0000-0002-2208-209X; McMahon, Francis J/0000-0002-9469-305X; McDonald, Colm/0000-0003-1661-5192; Donohoe, Gary/0000-0003-3037-7426; Trabzuni, Daniah M/0000-0003-4826-9570; Wittfeld, Katharina/0000-0003-4383-5043; Hulshoff Pol, Hilleke Evertje/0000-0002-2038-5281; Breteler, Monique M.B./0000-0002-0626-9305; Penninx, Brenda WJH/0000-0001-7779-9672; Pike, Bruce/0000-0001-8924-683X; Hardy, John/0000-0002-3122-0423; Hansell, Narelle K/0000-0002-8229-9741; Porteous, David J/0000-0003-1249-6106; Cichon, Sven/0000-0002-9475-086X; Vollstädt-Klein, Sabine/0000-0002-6210-672X; Sprooten, Emma/0000-0002-1691-9105; Matarin, Mar/0000-0002-4717-5735; Turner, Jessica A/0000-0003-0076-8434; Ramasamy, Adaikalavan/0000-0002-7598-2892; Rentería, Miguel E./0000-0003-4626-7248; Wardlaw, Joanna M/0000-0002-9812-6642; Vasquez, Alejandro Arias/0000-0002-4786-0169; Weale, Michael E/0000-0003-4593-1186; Melle, Ingrid S/0000-0002-9783-548X; Romanczuk-Seiferth, Nina/0000-0002-6931-269X; Thompson, Paul M/0000-0002-4720-8867; Porteous, David/0000-0003-1249-6106; Savitz, Jonathan/0000-0001-8143-182X; Wright, Margaret Jane/0000-0001-7133-4970; Medland, Sarah/0000-0003-1382-380X; Nichols, Thomas E./0000-0002-4516-5103; Stacey, David/0000-0002-9392-9235; Preda, Adrian/0000-0003-3373-2438; Fernandez, Guillen/0000-0002-5522-0604; Mattheisen, Manuel/0000-0002-8442-493X; Rijpkema, Mark/0000-0002-8495-4703; Rose, Emma J/0000-0001-5365-4794; Tzourio, christophe/0000-0002-6517-2984; Medland, Sarah E/0000-0003-1382-380X; Artiges, Eric/0000-0003-4461-7646; Fox, Peter/0000-0002-0465-2028; Desrivieres, Sylvane/0000-0002-9120-7060; Desrivières, Sylvane/0000-0002-9120-7060; Mattingsdal, Morten/0000-0003-4440-0324; Jenkinson, Mark/0000-0001-6043-0166; Roffman, Joshua/0000-0003-4073-532X; Heinz, Andreas/0000-0001-5405-9065; Morris, Derek/0000-0002-3413-570X; Mattheisen, Manuel/0000-0002-8442-493X; Artiges, Eric/0000-0003-4461-7646; Cichon, Sven/0000-0002-9475-086X; Smith, Albert Vernon/0000-0003-1942-5845; Trabzuni, Daniah/0000-0003-4826-9570; de Zubicaray, Greig/0000-0003-4506-0579; Macciardi, Fabio/0000-0003-0537-4266; Martin, Nicholas/0000-0003-4069-8020; Cannon, Dara M/0000-0001-7378-3411; Gudnason, Vilmundur/0000-0001-5696-0084; Lopez, Lorna/0000-0002-0241-9783; McIntosh, Andrew M/0000-0002-0198-4588; Levey, Allan/0000-0002-3153-502X; lambert, jean-charles/0000-0003-0829-7817; Laje, Gonzalo/0000-0003-2763-3329; van Haren, Neeltje/0000-0002-3090-7653; de Zubicaray, Greig I/0000-0003-4506-0579; Turner, Jessica A/0000-0003-0076-8434; Winkler, Anderson M/0000-0002-4169-9781; Maniega, Susana Muñoz/0000-0001-5185-6384; Deary, Ian J/0000-0002-1733-263X; Gudnason, Vilmundur/0000-0001-5696-0084; Tzourio, christophe/0000-0002-6517-2984; Jack, Clifford R/0000-0001-7916-622X; Hoogman, Martine/0000-0002-1261-7628; Montgomery, Grant W/0000-0002-4140-8139; McMahon, Katie L/0000-0002-6357-615X; Franke, Barbara/0000-0003-4375-6572; Curran, Joanne/0000-0002-6898-155X; Le Hellard, Stephanie/0000-0002-8085-051X; Bastin, Mark/0000-0002-0490-0845; Becker, James/0000-0003-4425-4726; Nees, Frauke/0000-0002-7796-8234; Grimm, Oliver/0000-0002-0767-0301; Erk, Susanne/0000-0003-0961-3543; Banaschewski, Tobias/0000-0003-4595-1144; Vernooij, Meike/0000-0003-4658-2176; Ikram, Mohammad Arfan/0000-0003-0372-8585; Kent, Jack/0000-0002-0758-7639; Holmes, Avram/0000-0001-6583-803X; Van Duijn, Cornelia/0000-0002-2374-9204; Beiser, Alexa/0000-0001-8551-7778; Lemaitre, Herve/0000-0002-5952-076X; Moses, Eric/0000-0001-7781-4465; Gill, Michael/0000-0003-0206-5337; Agartz, Ingrid/0000-0002-9839-5391; Cavalleri, Gianpiero/0000-0002-9802-0506; Delaney, Norman/0000-0002-3953-9842; Walker, Robert/0000-0001-7383-7846; Westlye, Lars T./0000-0001-8644-956X; Walters, James/0000-0002-6980-4053; Whelan, Christopher/0000-0003-0308-5583; Robbins, Trevor/0000-0003-0642-5977; Saykin, Andrew/0000-0002-1376-8532; Stein, Jason/0000-0003-4829-0513; Seshadri, Sudha/0000-0001-6135-2622; Djurovic, Srdjan/0000-0002-8140-8061; Moreno, Margarita/0000-0001-7336-6167; Flor, Herta/0000-0003-4809-5398; Carless, Melanie/0000-0001-8350-2302; Corvin, Aiden/0000-0001-6717-4089; Loth, Eva/0000-0001-9458-9167; Andreassen, Ole A./0000-0002-4461-3568; Nugent, Allison/0000-0003-2569-2480; Amouyel, Philippe/0000-0001-9088-234X; MIRANDA, RUBEN/0000-0002-9445-7348; Walter, Henrik/0000-0002-9403-6121; Nothen, Markus/0000-0002-8770-2464; Risacher, Shannon/0000-0002-3304-7943; Lourdusamy, Anbarasu/0000-0002-1978-6301; Chouraki, Vincent/0000-0002-4698-1794; Smolka, Michael/0000-0001-5398-5569; Afonso de Almeida, Marcio Augusto/0000-0002-8114-3892; O'Brien, Carol/0000-0002-0828-5376; Hall, Jeremy/0000-0002-0403-3278; Shen, Li/0000-0002-5443-0503; van den Heuvel, Martijn/0000-0003-1570-1195; Meyer-Lindenberg, Andreas/0000-0001-5619-1123; Toro, Roberto/0000-0002-6671-858X	Eli Lilly Company; Wyeth; Bristol-Myers Squibb; AstraZeneca; GlaxoSmithKline; German Research Foundation; Federal Ministry of Education and Research Germany; Janssen-Cilag; Novartis; Lundbeck; SALUS-Institute for Trend-Research and Therapy Evaluation in Mental Health; Federal Ministry of Education and Research, Germany; BioRad Laboratories; Siemens AG; Zeitschrift fur Laboratoriumsmedizin; Bruker Daltronics; Abbott; Jurilab Kuopio; Roche Diagnostics; Instand; Becton Dickinson; Hofmann La Roche; Humboldt Foundation; Araclon; Medivation/Pfizer; Ipsen; TauRx Therapeutics; Bayer Healthcare; Biogen Idec; Exonhit Therapeutics; SA; Servier; Synarc; Pfizer; Janssen; Merck; Avid; DoD; VA; Alzheimer's Disease Neuroimaging Initiative; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Anonymous Foundation; BioClinica (ADNI 2); Cure Alzheimer's Fund; Eisai; Elan; Gene Network Sciences; Genentech; GE Healthcare; Innogenetics; Johnson Johnson; Medpace; Roche; Schering Plough; US NIH [U01 AG024904, U24 RR21992, MH0708143, MH083824, MH078111, MH59490, C06 RR13556, C06 RR017515, R01D0042157-01A, MH079799]; Foundation for the NIH; NIH [U01 AG024904, RC2 AG036535-01, P30 AG010129, K01 AG030514, EB006395, AG040060, EB008432, P41 RR013642, HD050735, AG036535, AG020098, EB008281]; NIA [R01 AG019771-09]; NCRAD [U24AG021886]; ADNI (NIH) [U01 AG024904]; NIA; National Institute of Biomedical Imaging and Bioengineering (NIBIB); Dana Foundation; Biobanking and Biomolecular Resources Research Infrastructure Netherlands (BBMRI-NL); Netherlands Organisation for Scientific Research (NWO) [93511010]; National Alliance for Research on Schizophrenia and Depression (NARSAD); Health Foundation; Italian Ministry of University and Research [RBIN04SWHR]; European Commission [PL037286]; UK Department of Health National Institute of Health Research (NIHR)-Biomedical Research Centre; MRC [93558]; NIA at the University of California, Los Angeles [AG16570]; Age UK's Disconnected Mind programme; Research Into Ageing [251, 285]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F019394/1]; UK MRC [G1001401, 8200, G0901254]; Engineering and Physical Sciences Research Council (EPSRC); Economic and Social Research Council (ESRC); Scottish Funding Council through the SINAPSE Collaboration; AXA; German Federal Ministry of Education and Research (BMBF); Exzellenz-Stiftung of the Max Planck Society; BMBF in the framework of the National Genome Research Network (NGFN) [FKZ 01GS0481]; Research Council of Norway [154313/ V50, 177458/V50, 167153/V50, 163070/V50, 183782/V50]; Bergen Research Foundation; University of Bergen; Research Council of Norway (FUGE; Psykisk Helse), Helse Vest Regionalt Helseforetak (RHF); Dr Einar Martens Fund; NWO (MagW/ZonMW) [904-61-090, 985-10-002, 904-61-193, 480-04-004, 400-05-717, Addiction-31160008, 911-09-032, SPI 56-464-14192, 10-000-1002]; Center for Medical Systems Biology (CMSB; NWO Genomics); Biobanking and Biomolecular Resources Research Infrastructure; VU University; EMGO Institute for Health and Care Research and Neuroscience Campus Amsterdam; European Science Foundation [EU/QLRT-2001-01254]; European Community [HEALTH-F4-2007-201413]; European Science Council (ERC) Genetics of Mental Illness [230374]; Rutgers University Cell; DNA Repository (NIMH) [U24 MH068457-06]; Genetic Association Information Network (a public-private partnership between the NIH and Pfizer, Affymetrix and Abbott Laboratories); National Institute of Mental Health (NIMH) from NIH; US Department of Health and Human Services [K99 MH085098, 1ZIA MH002810, 1ZIA MH002790]; US National Institute of Child Health and Human Development [R01 HD050735]; Australian National Health and Medical Research Council (NHMRC) [496682]; NHMRC [389891, 613667]; Australian Research Council (ARC) [FT0991634, FT110100548]; Achievement Rewards for College Scientists foundation; US NIMH [F31 MH087061, MH078075]; National Science Foundation (NSF) [DGE-0707424]; Canadian Institutes of Health Research; Heart and Stroke Foundation of Quebec; Canadian Foundation for Innovation; German Federal Ministry of Education and Research [01ZZ9603, 01ZZ0103, 01ZZ0403]; German Research Foundation (DFG) [GR 1912/5-1]; Federal Ministry of Education and Research [03ZIK012, 03IS2061A]; Siemens Healthcare, Erlangen, Germany; Federal State of Mecklenburg-West Pomerania; German Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Simons Foundation; Howard Hughes Medical Institute; Oslo University Hospital-Ulleval; Eastern Norway Health Authority [2004-123]; Wellcome Trust [072894/z/03/z-Gill, 084730]; Science Foundation Ireland [08/IN.1/B1916_Corvin, 08/RFP/GEN1538]; University College London (UCL)/University College London Hospitals (UCLH) Comprehensive Biomedical Research Centre/Specialist Biomedical Research Centres (CBRC/SBRC) [114]; European Union Marie Curie Reintegration; UK NIHR [08-08-SCC]; Comprehensive Local Research Network (CLRN) [CEL1300]; The Big Lottery Fund; Wolfson Trust; Epilepsy Society; UK Department of Health's NIHR Biomedical Research Centres; Brainwave-the Irish Epilepsy Association; Fonds National de la Recherche Scientifique [FC 63574 / 3.4.620.06 F]; Fonds Erasme pour la Recherche Medicale at the Universite Libre de Bruxelles; MRC Sudden Death Brain and Tissue Bank; Sun Health Research Institute Brain Bank; Netherlands Organization for Health Research and Development ZonMw [917.46.370];  [NBIC/BioAssist/RK/2008.024]; BBSRC [BB/F019394/1] Funding Source: UKRI; MRC [G0600429, G1001401, G0901254, G0700704, G0901858, G0802462, G0900908, G1001245, G0701075] Funding Source: UKRI; Alzheimers Research UK [ART-PPG2011A-14] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/F019394/1] Funding Source: researchfish; Medical Research Council [G0801418B, G0901858, G0901254, G1001245, G0600429, G0802462, G9817803B, G0900908, G1001401, G0700704, G0701075] Funding Source: researchfish; Chief Scientist Office [SCD/10] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050735] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117, UL1TR001998] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017515, C06RR013556, S10RR029392, U24RR021992, P41RR013642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K01EB006395, R01EB008281, R01EB015611, R01EB008432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH068457, R01MH083824, F31MH087061, R01MH097268, R01MH079799, R01MH059490, R37MH059490, ZIAMH002810, ZIAMH002790, R01MH078075, R01MH078111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036535, P50AG016570, P30AG019610, ZIAAG007270, U19AG010483, R01AG040770, R01AG020098, R56AG020098, P30AG013846, R01AG019771, U24AG021886, R01AG040060, K01AG030514, U01AG024904, P30AG010129] Funding Source: NIH RePORTER	Eli Lilly Company(Eli Lilly); Wyeth(Wyeth); Bristol-Myers Squibb(Bristol-Myers Squibb); AstraZeneca(AstraZeneca); GlaxoSmithKline(GlaxoSmithKline); German Research Foundation(German Research Foundation (DFG)); Federal Ministry of Education and Research Germany(Federal Ministry of Education & Research (BMBF)); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novartis(Novartis); Lundbeck(Lundbeck Corporation); SALUS-Institute for Trend-Research and Therapy Evaluation in Mental Health; Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); BioRad Laboratories; Siemens AG(Siemens AG); Zeitschrift fur Laboratoriumsmedizin; Bruker Daltronics; Abbott(Abbott Laboratories); Jurilab Kuopio; Roche Diagnostics; Instand; Becton Dickinson; Hofmann La Roche; Humboldt Foundation(Alexander von Humboldt Foundation); Araclon; Medivation/Pfizer(Pfizer); Ipsen(Ipsen); TauRx Therapeutics; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Biogen Idec(Biogen); Exonhit Therapeutics; SA; Servier(Servier); Synarc; Pfizer(Pfizer); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); Avid; DoD(United States Department of Defense); VA(US Department of Veterans Affairs); Alzheimer's Disease Neuroimaging Initiative; Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Anonymous Foundation; BioClinica (ADNI 2); Cure Alzheimer's Fund; Eisai(Eisai Co Ltd); Elan; Gene Network Sciences; Genentech(Roche HoldingGenentech); GE Healthcare(General ElectricGE Healthcare); Innogenetics; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Medpace; Roche(Roche Holding); Schering Plough(Merck & CompanySchering Plough Corporation); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRAD; ADNI (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Dana Foundation; Biobanking and Biomolecular Resources Research Infrastructure Netherlands (BBMRI-NL); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); Health Foundation; Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); European Commission(European CommissionEuropean Commission Joint Research Centre); UK Department of Health National Institute of Health Research (NIHR)-Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIA at the University of California, Los Angeles; Age UK's Disconnected Mind programme(General Electric); Research Into Ageing; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Scottish Funding Council through the SINAPSE Collaboration; AXA; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Exzellenz-Stiftung of the Max Planck Society; BMBF in the framework of the National Genome Research Network (NGFN)(Federal Ministry of Education & Research (BMBF)); Research Council of Norway(Research Council of Norway); Bergen Research Foundation; University of Bergen; Research Council of Norway (FUGE; Psykisk Helse), Helse Vest Regionalt Helseforetak (RHF)(Research Council of Norway); Dr Einar Martens Fund; NWO (MagW/ZonMW); Center for Medical Systems Biology (CMSB; NWO Genomics); Biobanking and Biomolecular Resources Research Infrastructure; VU University; EMGO Institute for Health and Care Research and Neuroscience Campus Amsterdam; European Science Foundation(European Science Foundation (ESF)European Commission); European Community(European Commission); European Science Council (ERC) Genetics of Mental Illness(European Research Council (ERC)); Rutgers University Cell; DNA Repository (NIMH); Genetic Association Information Network (a public-private partnership between the NIH and Pfizer, Affymetrix and Abbott Laboratories); National Institute of Mental Health (NIMH) from NIH; US Department of Health and Human Services; US National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Achievement Rewards for College Scientists foundation(General Electric); US NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec; Canadian Foundation for Innovation(Canada Foundation for Innovation); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Siemens Healthcare, Erlangen, Germany(Siemens AG); Federal State of Mecklenburg-West Pomerania; German Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Simons Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Oslo University Hospital-Ulleval; Eastern Norway Health Authority; Wellcome Trust(Wellcome TrustEuropean Commission); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); University College London (UCL)/University College London Hospitals (UCLH) Comprehensive Biomedical Research Centre/Specialist Biomedical Research Centres (CBRC/SBRC); European Union Marie Curie Reintegration(European Commission); UK NIHR(National Institute for Health Research (NIHR)); Comprehensive Local Research Network (CLRN); The Big Lottery Fund; Wolfson Trust; Epilepsy Society; UK Department of Health's NIHR Biomedical Research Centres(National Institute for Health Research (NIHR)); Brainwave-the Irish Epilepsy Association; Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Fonds Erasme pour la Recherche Medicale at the Universite Libre de Bruxelles; MRC Sudden Death Brain and Tissue Bank(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sun Health Research Institute Brain Bank; Netherlands Organization for Health Research and Development ZonMw(Netherlands Organization for Health Research and Development); ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Some authors received commercial funding unrelated to the topic of this paper. N.J.v.d. W. received speaking fees from Eli Lilly & Company and Wyeth and served on advisory panels of Eli Lilly & Company, Pfizer, Wyeth and Servier. A. A. received an investigator-initiated unrestricted research grant from Bristol-Myers Squibb and speaker's fees from AstraZeneca, Bristol-Myers Squibb and GlaxoSmithKline. H.J.G. received external research support from the German Research Foundation, the Federal Ministry of Education and Research Germany, speaker's honoraria from Bristol-Myers Squibb, Eli Lilly & Company, Novartis, Eisai, Boehringer Ingelheim and Servier and travel funds from Janssen-Cilag, Eli Lilly & Company, Novartis, AstraZeneca, Lundbeck and the SALUS-Institute for Trend-Research and Therapy Evaluation in Mental Health. M.N. received research grants from the Federal Ministry of Education and Research, Germany, the German Research Foundation, BioRad Laboratories, Siemens AG, Zeitschrift fur Laboratoriumsmedizin, Bruker Daltronics, Abbott, Jurilab Kuopio, Roche Diagnostics, Instand and Becton Dickinson. H. V. received external research support via research grants from Hofmann La Roche, the Humboldt Foundation, the Federal Ministry of Education and Research (Germany) and the German Research Foundation. M. W. is on the following scientific advisory boards: Lilly, Araclon and Institut Catala de Neurociencies Aplicades, the Gulf War Veterans Illnesses Advisory Committee, VACO, Biogen Idec and Pfizer. M. W. received funding for consulting from Astra Zeneca, Araclon, Medivation/Pfizer, Ipsen, TauRx Therapeutics, Bayer Healthcare, Biogen Idec, Exonhit Therapeutics, SA, Servier, Synarc, Pfizer and Janssen; for travel from NeuroVigil, CHRU-Hopital Roger Salengro, Siemens, AstraZeneca, Geneva University Hospitals, Lilly, the University of California, San Diego-ADNI, Paris University, Institut Catala de Neurociencies Aplicades, the University of New Mexico School of Medicine, Ipsen, Clinical Trials on Alzheimer's Disease (CTAD), Pfizer, AD PD Meeting, Paul Sabatier University, Novartis and Tohoku University; and research support from: Merck, Avid, DoD, VA. M. W. received honoraria from PMDA/the Japanese Ministry of Health, Labour, and Welfare, Tohoku University, Neuro Vigil, Insitut Catala de Neurociencies Aplicades. M. W. owns stock options for Synarc, Elan. Organizations contributing to the Foundation for the US NIH and thus to the National Institute on Aging (NIA)-funded Alzheimer's Disease Neuroimaging Initiative included Abbott, the Alzheimer's Association, the Alzheimer's Drug Discovery Foundation, Anonymous Foundation, AstraZeneca, Bayer Healthcare, BioClinica (ADNI 2), Bristol-Myers Squibb, the Cure Alzheimer's Fund, Eisai, Elan, Gene Network Sciences, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson & Johnson, Eli Lilly & Company, Medpace, Merck, Novartis, Pfizer, Roche, Schering Plough, Synarc and Wyeth.; ADNI: The ADNI study was supported by the US NIH (U01 AG024904) and the Foundation for the NIH for genotype and phenotype data collection, the NIH (RC2 AG036535-01) for data analysis, the NIA (R01 AG019771-09) for additional data analysis and NCRAD (U24AG021886) for DNA used in part for the GWAS. Data used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (see URLs). As such, the investigators within ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. The ADNI sample wishes to acknowledge the investigators who contributed to the design and implementation of ADNI (see URLs). Data collection and sharing for this project were funded by ADNI (NIH grant U01 AG024904). ADNI is funded by the NIA, the National Institute of Biomedical Imaging and Bioengineering (NIBIB) and through generous contributions from Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson & Johnson, Eli Lilly & Company, Medpace, Merck and Cocpany, Novartis AG, Pfizer, F. Hoffman-La Roche, Schering-Plough and Synarc, as well as from nonprofit partners at the Alzheimer's Association and the Alzheimer's Drug Discovery Foundation, with participation from the US Food and Drug Administration (FDA). Private sector contributions to ADNI are facilitated by the Foundation for the NIH (see URLs). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory of Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants (P30 AG010129 and K01 AG030514) and by the Dana Foundation. ADNI was launched in 2003 by the NIA, the NIBIB, the FDA, private pharmaceutical companies and nonprofit organizations as a 5-year public-private partnership. The primary goal of ADNI has been to test whether serial MRI), positron emission tomography (PET), other biological markers and clinical and neuropsychological assessments can be combined to measure the progression of mild cognitive impairment (MCI) and early Alzheimer's disease. Determination of sensitive and specific markers of very early Alzheimer's disease progression is intended to aid researchers and clinicians in developing new treatments and monitoring their effectiveness, as well as lessening the time and cost of clinical trials. The Principal Investigator of this initiative is M. W. Weiner. ADNI is the result of efforts of many coinvestigators from a broad range of academic institutions and private corporations, and subjects have been recruited from over 50 sites across the United States and Canada. The initial goal of ADNI was to recruit 800 adults ages 55 to 90 to participate in the research-approximately 200 cognitively normal older individuals to be followed for 3 years, 400 people with MCI to be followed for 3 years and 200 people with early Alzheimer's disease to be followed for 2 years. For up-to-date information, please visit the ADNI website (see URLs).; BIG: The BIG study wishes to acknowledge S. Kooijman for coordination of sample collection and A. Heister, M. Naber, R. Makkinje, M. Hakobjan and M. Steehouwer for genotyping. The BIG study was supported by a Biobanking and Biomolecular Resources Research Infrastructure Netherlands (BBMRI-NL) complementation grant for brain segmentation and the Netherlands Organisation for Scientific Research (NWO) Horizon Breakthrough grant (grant number 93511010 (to A. A. V.).; Bipolar Family Study: The Bipolar Family Study wishes to thank the Scottish Mental Health Research Network for research assistant support, the Brain Research Imaging Centre Edinburgh (see URLs), a center in the Scottish Funding Council Scottish Imaging Network-A Platform for Scientific Excellence (SINAPSE) Collaboration (see URLs), for image acquisition and the Wellcome Trust Clinical Research Facility for genotyping. Genotyping was supported by the National Alliance for Research on Schizophrenia and Depression (NARSAD) Independent Investigator Award (to A. M. M.), and data collection was supported by the Health Foundation Clinician Scientist Fellowship.; fBIRN: fBIRN wishes to acknowledge D. B. Keator for leading fBIRN neuroinformatics development, B. A. Mueller for image calibration and quality assurance and A. Belger, V. D. Calhoun, G. G. Brown, J. M. Ford, G. H. Glover, R. Kikinis, K. Lim, J. Laurriello, J. Bustillo, G. McCarthy, D. S. O'Leary, B. Rosen, A. W. T. and J. T. Voyvodic for their leadership contributions to fBIRN scanner and sequence calibration, tool development and data collection efforts. The fBIRN study was supported by the US NIH (U24 RR21992) for phenotypic data collection. Genotyping was performed with the support of the grant RBIN04SWHR to F. M. from the Italian Ministry of University and Research.; GOBS: The GOBS study was supported by the US NIH (MH0708143 and MH083824 to D. C. G., MH078111 and MH59490 to J. B., C06 RR13556 and C06 RR017515). P. K. was also supported by an NIH grant (EB006395).; IMAGEN: IMAGEN is funded by the European Commission Framework Programme 6 (FP-6) Integrated Project IMAGEN (PL037286), the European Commission Framework Programme 7 (FP-7) Project Alzheimer's Disease, Alcoholism, Memory, Schizophrenia (ADAMS), the FP-7 Innovative Medicine Initiative Project European Autism Interventions (AIMS), the UK Department of Health National Institute of Health Research (NIHR)-Biomedical Research Centre Mental Health program and the MRC programme grant Developmental Pathways into Adolescent Substance Abuse (93558).; ImaGene: ImaGene wishes to acknowledge J. Lee and J. Lane for processing the blood samples, The Easton Consortium for Alzheimer's Disease Drug Discovery and Biomarker Development and the Alzheimer's Disease Research Center (ADRC) funded by the NIA at the University of California, Los Angeles (AG16570).; LBC1936: We thank the participants in LBC1936. We thank C. Murray, A. J. Gow, S. E. Harris, M. Luciano, P. Redmond, E. Sandeman, I. Gerrish, J. Boyd-Ellison, N. Leslie, A. Howden and C. Scott for data collection and preparation. This project is funded by the Age UK's Disconnected Mind programme and also by Research Into Ageing (251 and 285). The entire genome association part of the study was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/F019394/1). Analysis of brain images was funded by UK MRC grants (G1001401 and 8200). The work was undertaken by The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (G0700704/ 84698). Imaging was performed at the Brain Research Imaging Centre, Edinburgh, a center in the SINAPSE Collaboration. Funding from BBSRC, the Engineering and Physical Sciences Research Council (EPSRC), the Economic and Social Research Council (ESRC) and the MRC and Scottish Funding Council through the SINAPSE Collaboration is gratefully acknowledged. L. M. L. is the beneficiary of a postdoctoral grant from the AXA Research Fund.; MooDS: This work was funded by the German Federal Ministry of Education and Research (BMBF) in the National Genome Research Network (NGFN-plus) through the MooDs grant Molecular Causes of Major Mood Disorders and Schizophrenia (coordinator M. M. N.). Additional funding for genotyping was provided by a NARSAD Distinguished Investigator award to A. M.-L.; MPIP: The MPIP Munich Morphometry Sample comprises images acquired as part of the Munich Antidepressant Response Signature Study and the Recurrent Unipolar Depression (RUD) Case-Control Study performed at the MPIP and control subjects acquired at the Department of Psychiatry at the Ludwig-Maximilians-University. We wish to acknowledge A. Olynyik and radiographers R. Schirmer, E. Schreiter and R. Borschke for image acquisition and data preparation. We thank D. P. Auer for local study management in the initial phase of the RUD study. We are grateful to GlaxoSmithKline for providing the genotypes of the RUD Case-Control Sample. We thank the staff of the Center of Applied Genotyping (CAGT) for generating the genotypes of the MARS cohort. The study is supported by a grant from the Exzellenz-Stiftung of the Max Planck Society. This work has also been funded by the BMBF in the framework of the National Genome Research Network (NGFN) (FKZ 01GS0481).; NCNG: We would like to thank the personnel involved in recruitment and data collection and, in particular, P. Due-Tonnessen for clinical assessment of the MRI images. The NCNG study was supported by Research Council of Norway grants (154313/ V50 and 177458/V50). The NCNG GWAS was financed by grants from the Bergen Research Foundation, the University of Bergen, the Research Council of Norway (FUGE; Psykisk Helse), Helse Vest Regionalt Helseforetak (RHF) and the Dr Einar Martens Fund.; NESDA-NTR: Funding was obtained from the NWO (MagW/ZonMW 904-61-090; 985-10-002; 904-61-193; 480-04-004; 400-05-717, Addiction-31160008; 911-09-032; SPI 56-464-14192 and Geestkracht Program, 10-000-1002), the Center for Medical Systems Biology (CMSB; NWO Genomics), NBIC/BioAssist/RK/2008.024, BBMRI-NL, Biobanking and Biomolecular Resources Research Infrastructure, the VU University, the EMGO Institute for Health and Care Research and Neuroscience Campus Amsterdam, the European Science Foundation (EU/QLRT-2001-01254), the European Community's FP7 (HEALTH-F4-2007-201413), the European Science Council (ERC) Genetics of Mental Illness (230374), Rutgers University Cell and DNA Repository (cooperative agreement NIMH U24 MH068457-06), the US NIH (R01D0042157-01A) and the Genetic Association Information Network (a public-private partnership between the NIH and Pfizer, Affymetrix and Abbott Laboratories).; NIMH-IRP: This study was supported by funding from the Intramural Research Program of the National Institute of Mental Health (NIMH) from the NIH and the US Department of Health and Human Services (K99 MH085098 to G. L., 1ZIA MH002810 to F. J. M. and 1ZIA MH002790 to W. C. D.). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US government.; QTIM: We are extremely grateful to the twins for their participation, the radiographers at the Centre for Advanced Imaging at the University of Queensland for image acquisition and the many research assistants and support staff at the Queensland Institute of Medical Research for twin recruitment and daily management, and we especially thank K. Johnson for MRI scanning and processing, A. Henders for DNA processing and preparation and S. Gordon for quality control and management of the genotypes. Phenotyping was funded by the US National Institute of Child Health and Human Development (R01 HD050735) and the Australian National Health and Medical Research Council (NHMRC) (project grant 496682). Genotyping was funded by the NHMRC (Medical Bioinformatics Genomics Proteomics Program, 389891). G. M. was supported by an NHMRC Fellowship (613667), and G.Z. was supported by Australian Research Council (ARC) Future Fellowship (FT0991634). S. E. M. is funded by an ARC Future Fellowship (FT110100548). J.L.S. was supported by the Achievement Rewards for College Scientists foundation and the US NIMH (F31 MH087061). D. P. H. is partially supported by a National Science Foundation (NSF) Graduate Research Fellowhip Program (GRFP) grant (DGE-0707424). P. T. was also supported by the NIH (grants U01 AG024904, AG040060, EB008432, P41 RR013642, HD050735, AG036535, AG020098 and EB008281).; SYS: The Saguenay Youth Study Group wishes to thank the following individuals for their contribution in acquiring and analyzing the data: N. Arbour, M.-E. Bouchard, A. Houde, A. Gauthier and H. Simard for the recruitment and assessment of participating families, M. Berube, S. Masson, S. Castonguay and M.-J. Morin for MRI acquisition and E. Ding and N. Qiu for MR data management. We thank J. Mathieu for the medical follow up of participants in whom we detected any medically relevant abnormalities. We are grateful to all families for participating in the study. The Saguenay Youth Study Group is supported by the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Quebec and the Canadian Foundation for Innovation. For more information, please see the study website (see URLs).; SHIP: The Study of Health in Pomerania (SHIP) is supported by the German Federal Ministry of Education and Research (grants 01ZZ9603, 01ZZ0103 and 01ZZ0403) and the German Research Foundation (DFG; GR 1912/5-1). Genome-wide data and MRI scans were supported by the Federal Ministry of Education and Research (grant 03ZIK012) and a joint grant from Siemens Healthcare, Erlangen, Germany, and the Federal State of Mecklenburg-West Pomerania. The University of Greifswald is a member of the Center of Knowledge Interchange program of the Siemens AG. We thank all staff members and participants of the SHIP study, as well as all of the genotyping staff for generating the SHIP SNP data set. The genetic data analysis workflow was created using the Software InforSense. Genetic data were stored using the database Cache (InterSystems).; SHIP-TREND: The authors from SHIP are grateful to M. Stanke for the opportunity to use his Server Cluster for SNP Imputation. This cohort is part of the Community Medicine Research net (CMR) of the University of Greifswald, which is funded by the German Federal Ministry of Education and Research and the German Ministry of Cultural Affairs, as well as by the Social Ministry of the Federal State of Mecklenburg-West Pomerania. CMR encompasses several research projects that share data from the population-based Study of Health in Pomerania (SHIP; see URLs). The work is also supported by the German Research Foundation (DFG; GR 1912/5-1) and the Greifswald Approach to Individualized Medicine (GANI_MED) network funded by the Federal Ministry of Education and Research (grant 03IS2061A). Genome-wide data and MRI scans were supported by the Federal Ministry of Education and Research (grant 03ZIK012) and a joint grant from Siemens Healthcare, Erlangen, Germany, and the Federal State of Mecklenburg-West Pomerania. The University of Greifswald is a member of the Center of Knowledge Interchange program of the Siemens AG.; Superstruct: We thank the investigators and participants who contributed to the brain genomics data collection for Superstruct at Massachusetts General Hospital and Harvard University, with funding from the Simons Foundation, the Howard Hughes Medical Institute and the US NIH (grant MH079799).; TOP: We thank the study participants of TOP and the personnel involved in data collection and logistics, especially T. D. Bjella. This work was supported by the Oslo University Hospital-Ulleval, the Eastern Norway Health Authority (2004-123), the Research Council of Norway (167153/V50, 163070/V50 and 183782/V50), and by Eli Lilly & Company (who covered part of the genotyping costs).; TCD: We wish to express our sincere thanks to all participants and to clinical staff who facilitated patients' involvement. In particular, we acknowledge colleagues from the Trinity College Institute of Neuroscience A. Bodke, J. McGrath, F. Newell, H. Garavan, and J. O'Doherty for their support in sample collection. Collection and analysis of these samples were funded by the Wellcome Trust (072894/z/03/z-Gill) and the Science Foundation Ireland (08/IN.1/B1916_Corvin).; EPIGEN: Work from the London Cohort was supported by research grants from the Wellcome Trust (grant 084730 to S. M. S.), University College London (UCL)/University College London Hospitals (UCLH) Comprehensive Biomedical Research Centre/Specialist Biomedical Research Centres (CBRC/SBRC) (grant 114 to S. M. S.), the European Union Marie Curie Reintegration (to M. Matarin and S. M. S.), the UK NIHR (08-08-SCC), the Comprehensive Local Research Network (CLRN) Flexibility and Sustainability Funding (FSF) (grant CEL1300 to S. M. S.), The Big Lottery Fund, the Wolfson Trust and the Epilepsy Society. This work was undertaken at UCLH/UCL, which received a proportion of funding from the UK Department of Health's NIHR Biomedical Research Centres funding scheme. Work from the Royal College of Surgeons in Ireland was supported by research grants from the Science Foundation Ireland (Research Frontiers Programme award 08/RFP/GEN1538) and Brainwave-the Irish Epilepsy Association. The collection of Belgian subjects was supported by the Fonds National de la Recherche Scientifique (grant FC 63574 / 3.4.620.06 F) and the Fonds Erasme pour la Recherche Medicale at the Universite Libre de Bruxelles.; UCL Institute of Neurology Control Brain Tissue Collection: Funding was provided by the UK MRC (grant G0901254), the MRC Sudden Death Brain and Tissue Bank and the Sun Health Research Institute Brain Bank.; UMCU: The UMCU study was supported by the Netherlands Organization for Health Research and Development ZonMw (917.46.370 to H. E. H.) and the US NIMH (MH078075 to R.A.O.).	Allen AS, 2006, GENET EPIDEMIOL, V30, P248, DOI 10.1002/gepi.20141; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Bao Y, 2009, GENE EXPR PATTERNS, V9, P273, DOI 10.1016/j.gep.2009.03.004; Baumgartner M, 2004, AM J PHYSIOL-CELL PH, V287, pC844, DOI 10.1152/ajpcell.00094.2004; Bis JC, 2012, NAT GENET, V44, P545, DOI 10.1038/ng.2237; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dick DM, 2011, MOL PSYCHIATR, V16, P800, DOI 10.1038/mp.2010.73; Durston S, 2005, MOL PSYCHIATR, V10, P678, DOI 10.1038/sj.mp.4001649; Fears SC, 2009, J NEUROSCI, V29, P2867, DOI 10.1523/JNEUROSCI.5153-08.2009; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Freitag CM, 2009, BIOL PSYCHIAT, V66, P316, DOI 10.1016/j.biopsych.2009.03.011; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hammond SM, 2008, CELL, V135, P1013, DOI 10.1016/j.cell.2008.11.026; Han B, 2011, AM J HUM GENET, V88, P586, DOI 10.1016/j.ajhg.2011.04.014; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P474, DOI 10.1016/j.jalz.2011.04.007; Jackson DN, 1984, MAB MULTIDIMENSIONAL; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kasperaviciute D, 2010, BRAIN, V133, P2136, DOI 10.1093/brain/awq130; Keller SS, 2008, EPILEPSIA, V49, P741, DOI 10.1111/j.1528-1167.2007.01485.x; Kremen WS, 2010, NEUROIMAGE, V49, P1213, DOI 10.1016/j.neuroimage.2009.09.043; Levay K, 2007, J CLIN INVEST, V117, P2672, DOI 10.1172/JCI27465; Levay K, 2010, EXP CELL RES, V316, P1254, DOI 10.1016/j.yexcr.2010.01.007; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Li MX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014480; Litterman N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001060; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Morey RA, 2010, HUM BRAIN MAPP, V31, P1751, DOI 10.1002/hbm.20973; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Morra JH, 2008, NEUROIMAGE, V43, P59, DOI 10.1016/j.neuroimage.2008.07.003; Pantel J, 2000, HIPPOCAMPUS, V10, P752, DOI 10.1002/1098-1063(2000)10:6<752::AID-HIPO1012>3.0.CO;2-Y; Pardoe HR, 2009, EPILEPSIA, V50, P2586, DOI 10.1111/j.1528-1167.2009.02243.x; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pei YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003551; Peper JS, 2007, HUM BRAIN MAPP, V28, P464, DOI 10.1002/hbm.20398; Posthuma D, 2002, NAT NEUROSCI, V5, P83, DOI 10.1038/nn0202-83; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rogers J, 2010, NEUROIMAGE, V53, P1103, DOI 10.1016/j.neuroimage.2010.02.020; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Simic G, 1997, J COMP NEUROL, V379, P482, DOI 10.1002/(SICI)1096-9861(19970324)379:4<482::AID-CNE2>3.0.CO;2-Z; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; Stein JL, 2011, MOL PSYCHIATR, V16, P927, DOI 10.1038/mp.2011.32; Trabzuni D, 2011, J NEUROCHEM, V119, P275, DOI 10.1111/j.1471-4159.2011.07432.x; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; Vogel W, 1999, FASEB J, V13, pS77, DOI 10.1096/fasebj.13.9001.s77; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Wright MJ, 2004, AUST J PSYCHOL, V56, P65, DOI 10.1080/00049530410001734865; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	68	462	469	3	189	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2012	44	5					552	+		10.1038/ng.2250	http://dx.doi.org/10.1038/ng.2250			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	934BW	22504417	Green Published, Green Accepted			2022-12-25	WOS:000303416300016
J	Stadtfeld, M; Apostolou, E; Ferrari, F; Choi, J; Walsh, RM; Chen, TP; Ooi, SSK; Kim, SY; Bestor, TH; Shioda, T; Park, PJ; Hochedlinger, K				Stadtfeld, Matthias; Apostolou, Effie; Ferrari, Francesco; Choi, Jiho; Walsh, Ryan M.; Chen, Taiping; Ooi, Steen S. K.; Kim, Sang Yong; Bestor, Timothy H.; Shioda, Toshi; Park, Peter J.; Hochedlinger, Konrad			Ascorbic acid prevents loss of Dlk1-Dio3 imprinting and facilitates generation of all-iPS cell mice from terminally differentiated B cells	NATURE GENETICS			English	Article							PLURIPOTENT STEM-CELLS; MOUSE; METHYLATION; DOMAIN; GENES; COMPLEMENTATION; ACTIVATION; SEQUENCES; GENOME; DNMT3A	The generation of induced pluripotent stem cells (iPSCs) often results in aberrant epigenetic silencing of the imprinted Dlk1-Dio3 gene cluster, compromising the ability to generate entirely iPSC-derived adult mice ('all-iPSC mice'). Here, we show that reprogramming in the presence of ascorbic acid attenuates hypermethylation of Dlk1-Dio3 by enabling a chromatin configuration that interferes with binding of the de novo DNA methyltransferase Dnmt3a. This approach allowed us to generate all-iPSC mice from mature B cells, which have until now failed to support the development of exclusively iPSC-derived postnatal animals. Our data show that transcription factor-mediated reprogramming can endow a defined, terminally differentiated cell type with a developmental potential equivalent to that of embryonic stem cells. More generally, these findings indicate that culture conditions during cellular reprogramming can strongly influence the epigenetic and biological properties of the resultant iPSCs.	[Stadtfeld, Matthias; Apostolou, Effie; Choi, Jiho; Walsh, Ryan M.; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Regenerat Med, Harvard Stem Cell Inst, Boston, MA 02114 USA; [Stadtfeld, Matthias; Apostolou, Effie; Choi, Jiho; Walsh, Ryan M.; Shioda, Toshi; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Stadtfeld, Matthias; Apostolou, Effie; Choi, Jiho; Walsh, Ryan M.; Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Ferrari, Francesco; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA USA; [Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Chen, Taiping] Novartis Inst Biomed Res, Cambridge, MA USA; [Ooi, Steen S. K.] UCL, Inst Canc, London, England; [Ooi, Steen S. K.; Bestor, Timothy H.] Columbia Univ, Dept Genet & Dev, Coll Phys & Surg, New York, NY USA; [Kim, Sang Yong] Cold Spring Harbor Lab, Transgen Facil, Woodbury, NY USA; [Hochedlinger, Konrad] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Novartis; University of London; University College London; Columbia University; Cold Spring Harbor Laboratory; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute	Hochedlinger, K (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Harvard Stem Cell Inst, Boston, MA 02114 USA.	khochedlinger@helix.mgh.harvard.edu	Ferrari, Francesco/H-5007-2012; Apostolou, Effie/AAG-1559-2020	Ferrari, Francesco/0000-0002-9811-3753; Stadtfeld, Matthias/0000-0002-5852-9906; Choi, Jiho/0000-0001-8839-4056; Kim, Sang Yong/0000-0001-7326-7505; Park, Peter/0000-0001-9378-960X; Ooi, Steen/0000-0003-4198-9014	Howard Hughes Medical Institute (HHMI); Jane Coffin Childs; US National Institutes of Health [DP2OD003266, R01HD058013]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058013] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003266] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/H022546/1] Funding Source: researchfish; BBSRC [BB/H022546/1] Funding Source: UKRI	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Jane Coffin Childs; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We are grateful to B. Payer (Harvard University) for providing M. musculus x M. castaneus fibroblasts, D. Wesemann for advice on B-cell isolation and immunoglobulin rearrangements, A. Foudi for genomic DNA from B cells, H. Su for technical assistance and A. Riley for help with blastocyst injections. We thank past and present members of the Hochedlinger laboratory for suggestions. M.S. was supported by a postdoctoral fellowship from the Howard Hughes Medical Institute (HHMI), E.A. was supported by a Jane Coffin Childs postdoctoral fellowship, and support to K.H. was from the US National Institutes of Health (DP2OD003266 and R01HD058013).	ATKINSON MJ, 1991, J IMMUNOL, V146, P2805; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Chung TL, 2010, STEM CELLS, V28, P1848, DOI 10.1002/stem.493; Coser KR, 2003, P NATL ACAD SCI USA, V100, P13994, DOI 10.1073/pnas.2235866100; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kang L, 2011, CELL RES, V21, P546, DOI 10.1038/cr.2010.164; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li W, 2011, CELL RES, V21, P550, DOI 10.1038/cr.2011.25; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; NAGY A, 1990, DEVELOPMENT, V110, P815; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wu SM, 2011, NAT CELL BIOL, V13, P497, DOI 10.1038/ncb0511-497; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147; Zhou YL, 2010, DEVELOPMENT, V137, P2643, DOI 10.1242/dev.045724	34	211	221	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2012	44	4					398	U205		10.1038/ng.1110	http://dx.doi.org/10.1038/ng.1110			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	916VF	22387999	Green Submitted, Green Accepted			2022-12-25	WOS:000302130600013
J	Yang, WH; Lan, HY; Huang, CH; Tai, SK; Tzeng, CH; Kao, SY; Wu, KJ; Hung, MC; Yang, MH				Yang, Wen-Hao; Lan, Hsin-Yi; Huang, Chi-Hung; Tai, Shyh-Kuan; Tzeng, Cheng-Hwai; Kao, Shou-Yen; Wu, Kou-Juey; Hung, Mien-Chie; Yang, Muh-Hwa			RAC1 activation mediates Twist1-induced cancer cell migration	NATURE CELL BIOLOGY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; MICRORNAS; MYOSIN; LET-7; TWIST; HEAD; PHOSPHORYLATION; INACTIVATION; CONTRIBUTES	Epithelial mesenchymal transition (EMT), which is characterized by the suppression of the adhesion protein E-cadherin, is a crucial process that promotes metastasis and stem-like properties of cancer cells. However, the dissociation of cellular aggregates is not sufficient to explain why cancer cells move, and the motile nature of cancer cells undergoing EMT remains elusive. Here, we identify a mechanism in which the EMT inducer Twist1 elicits cancer cell movement through activation of RAC1. Twist1 cooperates with BMI1 to suppress let-7i expression, which results in upregulation of NEDD9 and DOCK3, leading to RAC1 activation and enabling mesenchymal-mode movement in three-dimensional environments. Moreover, the suppression of let-7i contributes to Twist1-induced stem-like properties. Clinically, activation of the Twist1-let-7i-NEDD9 axis in head and neck cancer patients correlates with tumour invasiveness and worse outcome. Our results uncover an essential mechanism to explain how Twist1 induces the motile stem-like cancer cell phenotype beyond simply suppressing E-cadherin.	[Huang, Chi-Hung] Taiwan Adv Biopharm, New Taipei City 22180, Taiwan; [Huang, Chi-Hung] Hung Kuang Univ, Grad Sch Biotechnol, Taichung 43302, Taiwan; [Tai, Shyh-Kuan] Taipei Vet Gen Hosp, Dept Otolaryngol, Taipei 11217, Taiwan; [Tzeng, Cheng-Hwai; Yang, Muh-Hwa] Taipei Vet Gen Hosp, Dept Med, Div Hematol Oncol, Taipei 11217, Taiwan; [Kao, Shou-Yen] Taipei Vet Gen Hosp, Dept Stomatol, Taipei 11217, Taiwan; [Wu, Kou-Juey] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 11221, Taiwan; [Wu, Kou-Juey; Yang, Muh-Hwa] Natl Yang Ming Univ, Head & Neck Canc Res Program, Taipei 11221, Taiwan; [Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Ctr Mol Med, Taichung 40402, Taiwan; [Yang, Muh-Hwa] Natl Yang Ming Univ, Inst Biotechnol Med, Taipei 11221, Taiwan; [Yang, Wen-Hao; Lan, Hsin-Yi; Yang, Muh-Hwa] Natl Yang Ming Univ, Inst Clin Med, Taipei 11221, Taiwan	Hungkuang University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; University of Texas System; UTMD Anderson Cancer Center; China Medical University Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Yang, MH (corresponding author), Natl Yang Ming Univ, Inst Clin Med, 155,Sec 2,Li Nong St, Taipei 112, Taiwan.	mhyang2@vghtpe.gov.tw	Yang, Muh-Hwa/AAE-4691-2020; Hung, Mien-Chie/ABD-5911-2021; Wu, Kou-Juey/P-4654-2015; Yang, wenhao/GXG-5965-2022	Hung, Mien-Chie/0000-0003-4317-4740; Yang, Wen-Hao/0000-0002-6292-9048	National Health Research Institutes [NHRI-EX100-10037BI, NHRI-EX100-9931BI]; National Science Council (NSC) [99-2314-B-010-007-MY3, DOH101-TD-C-111-005, 100-2321-B-039-002]; Taipei Veterans General Hospital [VGH 100-C-088, 101-C-005]; Veterans General Hospitals University System of Taiwan [VGHUST101-G7-4-1]; Ministry of Education; Department of Health, Center of Excellence for Cancer Research [DOH101-TD-C-111-005, DOH100-TD-C-111-007]; China Medical University and Hospital; MD Anderson Cancer Center	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council (NSC)(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Veterans General Hospitals University System of Taiwan; Ministry of Education; Department of Health, Center of Excellence for Cancer Research; China Medical University and Hospital(China Medical University); MD Anderson Cancer Center	We thank M. F. Olson (The Beaston Institute for Cancer Research, UK) for providing the ROCK-ER-WT and ROCK-ER-K121G plasmids, and H. Kimura (National Institute of Neuroscience, Tokyo, Japan) for the pC1-neo-DOCK3HA plasmid. We thank T. Z. Huang, Y. B. Khotskaya, C. W. Lee and S. S. Chang (M. D. Anderson Cancer Center, Texas, USA) for critical comments on the manuscript. We thank C. H. Lin and H. W. Liu (National Yang-Ming University, Taiwan) for supporting the time-lapse microscopy techniques. This work was supported by the National Health Research Institutes (NHRI-EX100-10037BI to M-H.Y.; NHRI-EX100-9931BI to K-J.W.); the National Science Council (NSC 99-2314-B-010-007-MY3 and 100-2321-B-010-015 to M-H.Y.; NSC 100-2321-B-039-002 to M-C.H.); Taipei Veterans General Hospital (VGH 100-C-088, 101-C-005 to M-H.Y.); Veterans General Hospitals University System of Taiwan Joint Research Program (VGHUST101-G7-4-1 to M-H.Y.); a grant from the Ministry of Education, Aim for the Top University Plan (to M-H.Y.); a grant from the Department of Health, Center of Excellence for Cancer Research (DOH100-TD-C-111-007 to M-H.Y; DOH101-TD-C-111-005 to M-C.H.); and the Sister Institution Fund of China Medical University and Hospital and MD Anderson Cancer Center.	Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Belgiovine C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014154; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Chang CJ, 2011, ONCOL REP, V26, P1003, DOI 10.3892/or.2011.1360; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Croft DR, 2006, METHOD ENZYMOL, V406, P541, DOI 10.1016/S0076-6879(06)06042-3; Dykxhoorn DM, 2010, CANCER RES, V70, P6401, DOI 10.1158/0008-5472.CAN-10-1346; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Furlong EEM, 2001, SCIENCE, V293, P1629, DOI 10.1126/science.1062660; Garavello W, 2006, ARCH OTOLARYNGOL, V132, P762, DOI 10.1001/archotol.132.7.762; GREENE FL, 2002, AJCC CANC STAGING MA, P17; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hsu DSS, 2010, CLIN CANCER RES, V16, P4561, DOI 10.1158/1078-0432.CCR-10-0593; Huang CH, 2009, NEOPLASIA, V11, P1371, DOI 10.1593/neo.91326; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Namekata K, 2004, J BIOL CHEM, V279, P14331, DOI 10.1074/jbc.M311275200; O'Hara SP, 2010, J BIOL CHEM, V285, P216, DOI 10.1074/jbc.M109.041640; Pankova K, 2010, CELL MOL LIFE SCI, V67, P63, DOI 10.1007/s00018-009-0132-1; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; REMMELE W, 1993, PATHOL RES PRACT, V189, P862; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; Slorach EM, 2011, GENE DEV, V25, P471, DOI 10.1101/gad.1998111; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Yamazaki D, 2009, ONCOGENE, V28, P1570, DOI 10.1038/onc.2009.2; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	45	184	188	3	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2012	14	4					366	+		10.1038/ncb2455	http://dx.doi.org/10.1038/ncb2455			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	921UM	22407364				2022-12-25	WOS:000302503300009
J	Della Gatta, G; Palomero, T; Perez-Garcia, A; Ambesi-Impiombato, A; Bansal, M; Carpenter, ZW; De Keersmaecker, K; Sole, X; Xu, LY; Paietta, E; Racevskis, J; Wiernik, PH; Rowe, JM; Meijerink, JP; Califano, A; Ferrando, AA				Della Gatta, Giusy; Palomero, Teresa; Perez-Garcia, Arianne; Ambesi-Impiombato, Alberto; Bansal, Mukesh; Carpenter, Zachary W.; De Keersmaecker, Kim; Sole, Xavier; Xu, Luyao; Paietta, Elisabeth; Racevskis, Janis; Wiernik, Peter H.; Rowe, Jacob M.; Meijerink, Jules P.; Califano, Andrea; Ferrando, Adolfo A.			Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL	NATURE MEDICINE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; FAMILIAL PLATELET DISORDER; POINT MUTATIONS; REGULATORY NETWORKS; CELL LEUKEMIA; GENE; TRANSFORMATION; EXPRESSION; HOX11	The TLX1 and TLX3 transcription factor oncogenes have a key role in the pathogenesis of T cell acute lymphoblastic leukemia (T-ALL)(1,2). Here we used reverse engineering of global transcriptional networks to decipher the oncogenic regulatory circuit controlled by TLX1 and TLX3. This systems biology analysis defined T cell leukemia homeobox 1 (TLX1) and TLX3 as master regulators of an oncogenic transcriptional circuit governing T-ALL. Notably, a network structure analysis of this hierarchical network identified RUNX1 as a key mediator of the T-ALL induced by TLX1 and TLX3 and predicted a tumor-suppressor role for RUNX1 in T cell transformation. Consistent with these results, we identified recurrent somatic loss-of-function mutations in RUNX1 in human T-ALL. Overall, these results place TLX1 and TLX3 at the top of an oncogenic transcriptional network controlling leukemia development, show the power of network analyses to identify key elements in the regulatory circuits governing human cancer and identify RUNX1 as a tumor-suppressor gene in T-ALL.	[Della Gatta, Giusy; Palomero, Teresa; Perez-Garcia, Arianne; Ambesi-Impiombato, Alberto; Carpenter, Zachary W.; Xu, Luyao; Califano, Andrea; Ferrando, Adolfo A.] Columbia Univ, Inst Canc Genet, New York, NY 10027 USA; [Palomero, Teresa; Ferrando, Adolfo A.] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA; [Bansal, Mukesh; Califano, Andrea] Columbia Univ, Joint Ctr Syst Biol, New York, NY USA; [De Keersmaecker, Kim] Vlaams Inst Biotechnol VIB, Dept Mol & Dev Genet, Louvain, Belgium; [De Keersmaecker, Kim] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Sole, Xavier] Inst Invest Biomed Bellvitge IDIBELL, Biomarkers & Susceptibil Unit, Catalan Inst Oncol, Barcelona, Spain; [Paietta, Elisabeth; Racevskis, Janis; Wiernik, Peter H.] Montefiore Med Ctr N, New York, NY USA; [Paietta, Elisabeth; Racevskis, Janis; Wiernik, Peter H.] New York Med Coll, New York, NY USA; [Rowe, Jacob M.] Rambam Med Ctr, Haifa, Israel; [Rowe, Jacob M.] Technion Israel Inst Technol, Israel Inst Technol, Haifa, Israel; [Meijerink, Jules P.] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Pediat Oncol & Hematol, Rotterdam, Netherlands; [Ferrando, Adolfo A.] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; Flanders Institute for Biotechnology (VIB); KU Leuven; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Montefiore Medical Center; New York Medical College; Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Columbia University	Ferrando, AA (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10027 USA.	af2196@columbia.edu	xu, Luyao/F-2381-2015; Meijerink, Jules P/D-4393-2017; Solé, Xavier/AAF-3015-2019; De Keersmaecker, Kim/W-9702-2018	Meijerink, Jules P/0000-0002-6860-798X; Solé, Xavier/0000-0002-2197-3325; De Keersmaecker, Kim/0000-0002-7420-9531; Califano, Andrea/0000-0003-4742-3679	US National Institutes of Health [R01CA120196, R01CA129382, U24 CA114737]; New York Community Trust; Stand Up to Cancer Foundation; Eastern Cooperative Oncology Group tumor bank; Leukemia and Lymphoma Society; Stichting Kinderen Kankervrij (KiKa) [2007-012]; Dutch Cancer Society [KWF-EMCR 2006-3500]; Rally Foundation; Marie Curie International Outgoing fellowship; NATIONAL CANCER INSTITUTE [R01CA120196, R01CA129382, U24CA114737] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Community Trust; Stand Up to Cancer Foundation; Eastern Cooperative Oncology Group tumor bank; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Stichting Kinderen Kankervrij (KiKa); Dutch Cancer Society(KWF Kankerbestrijding); Rally Foundation; Marie Curie International Outgoing fellowship(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the US National Institutes of Health (grants R01CA120196 and R01CA129382 to A. A. F.; and U24 CA114737 to E. P.), the New York Community Trust (A. A. F.), the Innovative Research Award by the Stand Up to Cancer Foundation (A. A. F.), the Eastern Cooperative Oncology Group tumor bank, the Leukemia and Lymphoma Society Scholar Award (A. A. F.), the Stichting Kinderen Kankervrij (KiKa; grant 2007-012) (J.P.M.) and the Dutch Cancer Society (KWF-EMCR 2006-3500) (J.P.M.). A. P.-G. is a postdoctoral researcher funded by the Rally Foundation. G. D. G. was supported by a Marie Curie International Outgoing fellowship. We thank S. Nimer (Memorial Sloan Kettering Cancer Center) for the pCDNA3 RUNX1 expression vector, D. Zhang (University of California, San Diego) for the pM-CSF-R-luc promoter reporter and the pCMV CBFB plasmids and J. Downing (St. Jude Children's Research Hospital) for the Runx1 knockout mice.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Auewarakul CU, 2007, HAEMATOLOGICA, V92, P861, DOI 10.3324/haematol.10914; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bernard OA, 2001, LEUKEMIA, V15, P1495, DOI 10.1038/sj.leu.2402249; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Christiansen DH, 2004, BLOOD, V104, P1474, DOI 10.1182/blood-2004-02-0754; De Keersmaecker K, 2010, NAT MED, V16, P1321, DOI 10.1038/nm.2246; Ferrando AA, 2004, LANCET, V363, P535, DOI 10.1016/S0140-6736(04)15542-6; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Fischer M, 2011, NUCLEIC ACIDS RES, V39, pW357, DOI 10.1093/nar/gkr468; Grossmann V, 2011, HAEMATOL-HEMATOL J, V96, P1874, DOI 10.3324/haematol.2011.043919; HATANO M, 1991, SCIENCE, V253, P79, DOI 10.1126/science.1676542; KENNEDY MA, 1991, P NATL ACAD SCI USA, V88, P8900, DOI 10.1073/pnas.88.20.8900; Langabeer SE, 2002, GENE CHROMOSOME CANC, V34, P24, DOI 10.1002/gcc.10031; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Margolin AA, 2009, P NATL ACAD SCI USA, V106, P244, DOI 10.1073/pnas.0806445106; Nishimoto N, 2010, INT J HEMATOL, V92, P194, DOI 10.1007/s12185-010-0612-y; Osato M, 2004, ONCOGENE, V23, P4284, DOI 10.1038/sj.onc.1207779; Osato M, 1999, BLOOD, V93, P1817, DOI 10.1182/blood.V93.6.1817.406k36_1817_1824; Osato M, 2001, INT J HEMATOL, V74, P245, DOI 10.1007/BF02982056; Owen CJ, 2008, BLOOD, V112, P4639, DOI 10.1182/blood-2008-05-156745; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Preudhomme C, 2009, BLOOD, V113, P5583, DOI 10.1182/blood-2008-07-168260; Rocquain J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-401; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; Speck NA, 2002, NAT REV CANCER, V2, P502, DOI 10.1038/nrc840; Su XY, 2004, GENE CHROMOSOME CANC, V41, P243, DOI 10.1002/gcc.20088; Van Vlierberghe P, 2008, BLOOD, V111, P4668, DOI 10.1182/blood-2007-09-111872; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	31	103	108	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2012	18	3					436	U198		10.1038/nm.2610	http://dx.doi.org/10.1038/nm.2610			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22366949	Green Accepted			2022-12-25	WOS:000301264800046
J	Logarinho, E; Maffini, S; Barisic, M; Marques, A; Toso, A; Meraldi, P; Maiato, H				Logarinho, Elsa; Maffini, Stefano; Barisic, Marin; Marques, Andrea; Toso, Alberto; Meraldi, Patrick; Maiato, Helder			CLASPs prevent irreversible multipolarity by ensuring spindle-pole resistance to traction forces during chromosome alignment	NATURE CELL BIOLOGY			English	Article							CENTROSOME INTEGRITY; MICROTUBULE DYNAMICS; KINETOCHORE FIBERS; CHROMOKINESIN KID; CELLS; ORGANIZATION; MITOSIS; METAPHASE; PROTEIN; ASTRIN	Loss of spindle-pole integrity during mitosis leads to multipolarity independent of centrosome amplification(1-4). Multipolar-spindle conformation favours incorrect kinetochore microtubule attachments, compromising faithful chromosome segregation and daughter-cell viability(5,6). Spindle-pole organization influences and is influenced by kinetochore activity(7,8), but the molecular nature behind this critical force balance is unknown. CLASPs are microtubule-, kinetochore- and centrosome-associated proteins whose functional perturbation leads to three main spindle abnormalities: monopolarity, short spindles and multipolarity(9-13). The first two reflect a role at the kinetochore microtubule interface through interaction with specific kinetochore partners(10,11,14), but how CLASPs prevent spindle multipolarity remains unclear. Here we found that human CLASPs ensure spindle-pole integrity after bipolarization in response to CENP-E- and Kid-mediated forces from misaligned chromosomes. This function is independent of end-on kinetochore microtubule attachments and involves the recruitment of ninein to residual pericentriolar satellites. Distinctively, multipolarity arising through this mechanism often persists through anaphase. We propose that CLASPs and ninein confer spindle-pole resistance to traction forces exerted during chromosome congression, thereby preventing irreversible spindle multipolarity and aneuploidy.	[Logarinho, Elsa; Maffini, Stefano; Barisic, Marin; Marques, Andrea; Maiato, Helder] Univ Porto, Inst Biol Mol & Celular, P-4150180 Oporto, Portugal; [Toso, Alberto; Meraldi, Patrick] ETH, Inst Biochem, CH-8093 Zurich, Switzerland; [Maiato, Helder] Univ Porto, Fac Med, Dept Expt Biol, P-4200319 Oporto, Portugal	Universidade do Porto; Swiss Federal Institutes of Technology Domain; ETH Zurich; Universidade do Porto	Maiato, H (corresponding author), Univ Porto, Inst Biol Mol & Celular, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	maiato@ibmc.up.pt	Maiato, Helder/J-9466-2013; Meraldi, Patrick/D-6190-2013; Logarinho, Elsa/I-5616-2013; Barisic, Marin/K-2301-2013	Maiato, Helder/0000-0002-6200-9997; Logarinho, Elsa/0000-0002-8741-0744; Meraldi, Patrick/0000-0001-9742-8756; Barisic, Marin/0000-0001-7587-3867	Programa Ciencia; Programa Operacional Potencial Human (POPH)/QREN; Fundacao para a Ciencia e a Tecnologia of Portugal [PTDC/SAU-OBD/100261/2008, SFRH/BPD/26780/2006, PTDC/SAU-GMG/099704/2008, PTDC/SAU-ONC/112917/2009]; EURYI; Human Frontier Research Program; European Research Council	Programa Ciencia(Spanish Government); Programa Operacional Potencial Human (POPH)/QREN; Fundacao para a Ciencia e a Tecnologia of Portugal(Portuguese Foundation for Science and Technology); EURYI(European Science Foundation (ESF)); Human Frontier Research Program(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission)	The authors would like to thank J. Macedo and P. Sampaio for technical help, A. Pereira for expertise in statistical analysis and all colleagues that provided invaluable reagents. E.L. is supported by Programa Ciencia funded by Programa Operacional Potencial Human (POPH)/QREN, as well as grant PTDC/SAU-OBD/100261/2008 from Fundacao para a Ciencia e a Tecnologia of Portugal (COMPETE-FEDER). S.M. held a fellowship from the Fundacao para a Ciencia e a Tecnologia (FCT) of Portugal (SFRH/BPD/26780/2006). P.M. holds an SNF-Professorship and a EURYI award. Work in the laboratory of H.M. is financially supported by grants PTDC/SAU-GMG/099704/2008 and PTDC/SAU-ONC/112917/2009 from Fundacao para a Ciencia e a Tecnologia of Portugal (COMPETE-FEDER), the Human Frontier Research Program and the seventh framework programme grant PRECISE from the European Research Council.	Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; BRENNER S, 1977, J CELL BIOL, V72, P368, DOI 10.1083/jcb.72.2.368; Cai S, 2009, NAT CELL BIOL, V11, P832, DOI 10.1038/ncb1890; Cassimeris L, 2004, MOL BIOL CELL, V15, P1580, DOI 10.1091/mbc.E03-07-0544; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Compton DA, 1998, J CELL SCI, V111, P1477; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Daum JR, 2011, CURR BIOL, V21, P1018, DOI 10.1016/j.cub.2011.05.032; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Garrett S, 2002, CURR BIOL, V12, P2055, DOI 10.1016/S0960-9822(02)01277-0; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Gordon MB, 2001, J CELL BIOL, V152, P425, DOI 10.1083/jcb.152.3.425; Gruber J, 2002, J CELL SCI, V115, P4053, DOI 10.1242/jcs.00088; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; KERYER G, 1984, J CELL BIOL, V98, P2222, DOI 10.1083/jcb.98.6.2222; Kim K, 2011, J CELL SCI, V124, P338, DOI 10.1242/jcs.078329; Kubo A, 1999, J CELL BIOL, V147, P969, DOI 10.1083/jcb.147.5.969; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Levesque AA, 2003, MOL BIOL CELL, V14, P3541, DOI 10.1091/mbc.E03-02-0082; Levesque AA, 2001, J CELL BIOL, V154, P1135, DOI 10.1083/jcb.200106093; Maffini S, 2009, CURR BIOL, V19, P1566, DOI 10.1016/j.cub.2009.07.059; Magidson V, 2011, CELL, V146, P555, DOI 10.1016/j.cell.2011.07.012; Maiato H, 2005, NAT CELL BIOL, V7, P42, DOI 10.1038/ncb1207; Maiato H, 2003, CELL, V113, P891, DOI 10.1016/S0092-8674(03)00465-3; Manning AL, 2007, CURR BIOL, V17, P260, DOI 10.1016/j.cub.2006.11.071; Manning AL, 2010, EMBO J, V29, P3531, DOI 10.1038/emboj.2010.230; Mattiuzzo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016307; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Mimori-Kiyosue Y, 2006, GENES CELLS, V11, P845, DOI 10.1111/j.1365-2443.2006.00990.x; Oshimori N, 2006, NAT CELL BIOL, V8, P1095, DOI 10.1038/ncb1474; Oshimori N, 2009, EMBO J, V28, P2066, DOI 10.1038/emboj.2009.161; Pereira AL, 2006, MOL BIOL CELL, V17, P4526, DOI 10.1091/mbc.E06-07-0579; Pereira AJ, 2010, METHODS, V51, P214, DOI 10.1016/j.ymeth.2010.01.016; Sardar HS, 2010, CURR BIOL, V20, P1648, DOI 10.1016/j.cub.2010.08.001; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Stevens D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022969; Thein KH, 2007, J CELL BIOL, V178, P345, DOI 10.1083/jcb.200701163; Tokai-Nishizumi N, 2005, MOL BIOL CELL, V16, P5455, DOI 10.1091/mbc.E05-03-0244; Wood KW, 2010, P NATL ACAD SCI USA, V107, P5839, DOI 10.1073/pnas.0915068107	40	62	62	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2012	14	3					295	+		10.1038/ncb2423	http://dx.doi.org/10.1038/ncb2423			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	900ZE	22307330	Green Published			2022-12-25	WOS:000300930400012
J	Lusser, M; Parisi, C; Plan, D; Rodriguez-Cerezo, E				Lusser, Maria; Parisi, Claudia; Plan, Damien; Rodriguez-Cerezo, Emilio			Deployment of new biotechnologies in plant breeding	NATURE BIOTECHNOLOGY			English	Article							ZINC-FINGER NUCLEASES; MUTAGENESIS; GENOMICS; GENES	The first crops obtained through new plant breeding techniques are close to commercialization. Regulatory issues will determine the adoption of the techniques by breeders.	[Lusser, Maria; Parisi, Claudia; Rodriguez-Cerezo, Emilio] European Commiss Joint Res Ctr, Inst Prospect Technol Studies, AGRILIFE, Seville, Spain; [Plan, Damien] European Commiss JRC IHCP, Inst Hlth & Consumer Protect, Ispra, Italy	European Commission Joint Research Centre; EC JRC Institute for Prospective Technological Studies (IPTS); European Commission Joint Research Centre; EC JRC ISPRA Site	Lusser, M (corresponding author), European Commiss Joint Res Ctr, Inst Prospect Technol Studies, AGRILIFE, Seville, Spain.	maria.lusser@ec.europa.eu						Andersson HC, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2561; [Anonymous], 2011, NAT BIOTECHNOL, V29, P681, DOI 10.1038/nbt.1935; [Anonymous], DATABASE NOTIFICATIO; Aufsatz W, 2002, P NATL ACAD SCI USA, V99, P16499, DOI 10.1073/pnas.162371499; Beetham PR, 1999, P NATL ACAD SCI USA, V96, P8774, DOI 10.1073/pnas.96.15.8774; Bradford KJ, 2005, NAT BIOTECHNOL, V23, P439, DOI 10.1038/nbt1084; Cantley M, 2007, OVERVIEW REGULATORY; COGEM, 2006, CGM06102402 COGEM; Curtin SJ, 2011, PLANT PHYSIOL, V156, P466, DOI 10.1104/pp.111.172981; D'Halluin K, 2008, PLANT BIOTECHNOL J, V6, P93, DOI 10.1111/j.1467-7652.2007.00305.x; de Pater S, 2009, PLANT BIOTECHNOL J, V7, P821, DOI 10.1111/j.1467-7652.2009.00446.x; Dirks R, 2009, PLANT BIOTECHNOL J, V7, P837, DOI 10.1111/j.1467-7652.2009.00450.x; Durai S, 2005, NUCLEIC ACIDS RES, V33, P5978, DOI 10.1093/nar/gki912; European Commission, 2001, OFFICIAL J EUROPEA L, P1; Flachowsky H, 2009, PLANT BREEDING, V128, P217, DOI 10.1111/j.1439-0523.2008.01591.x; Food and Agriculture Organization of the United Nations, 2009, EXP M FEED WORLD 205; Glandorf B., 2011, NEW PLANT BREEDING T, P141; International Service for the Acquisition of Agribiotech Applications (ISAAA), 2010, AGR BIOT LOT MOR JUS; Kalaitzandonakes N, 2007, NAT BIOTECHNOL, V25, P509, DOI 10.1038/nbt0507-509; Kuzma J, 2011, EMBO REP, V12, P883, DOI 10.1038/embor.2011.160; Li J, 2007, CURR OPIN PLANT BIOL, V10, P131, DOI 10.1016/j.pbi.2007.01.007; Lusser M., 2011, NEW PLANT BREEDING T, P157; Lusser M., 2011, 24760 JRC EUR EN; Martinez C, 2010, 20102 STI ORG EC COO; McDougall P., 2011, GETTING BIOTECH CROP; McElroy D, 2003, NAT BIOTECHNOL, V21, P996, DOI 10.1038/nbt0903-996; Miller JK, 2010, NAT BIOTECHNOL, V28, P1012, DOI 10.1038/nbt1010-1012; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Schaart J.G., 2010, PLANT TRANSFORMATION; Schaart J. G., 2009, 200902 COGEM; Schouten HJ, 2008, TRENDS PLANT SCI, V13, P260, DOI 10.1016/j.tplants.2008.04.005; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Stegemann S, 2009, SCIENCE, V324, P649, DOI 10.1126/science.1170397; Stein A.J., 2009, GLOBAL PIPELINE NEW; Stein AJ, 2010, NAT BIOTECHNOL, V28, P23, DOI 10.1038/nbt0110-23b; Tait J, 2011, EMBO REP, V12, P763, DOI 10.1038/embor.2011.135; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Varshney RK, 2005, TRENDS PLANT SCI, V10, P621, DOI 10.1016/j.tplants.2005.10.004; Vezina LP, 2009, PLANT BIOTECHNOL J, V7, P442, DOI 10.1111/j.1467-7652.2009.00414.x; Zhu T, 2000, NAT BIOTECHNOL, V18, P555, DOI 10.1038/75435	41	196	214	3	107	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2012	30	3					231	239		10.1038/nbt.2142	http://dx.doi.org/10.1038/nbt.2142			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	905VI	22398616	Bronze, Green Published			2022-12-25	WOS:000301303800015
J	Christianson, JC; Olzmann, JA; Shaler, TA; Sowa, ME; Bennett, EJ; Richter, CM; Tyler, RE; Greenblatt, EJ; Harper, JW; Kopito, RR				Christianson, John C.; Olzmann, James A.; Shaler, Thomas A.; Sowa, Mathew E.; Bennett, Eric J.; Richter, Caleb M.; Tyler, Ryan E.; Greenblatt, Ethan J.; Harper, J. Wade; Kopito, Ron R.			Defining human ERAD networks through an integrative mapping strategy	NATURE CELL BIOLOGY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; UBIQUITIN-PROTEASOME PATHWAY; UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; MISFOLDED PROTEINS; MEMBRANE-PROTEINS; MUTANT ALPHA-1-ANTITRYPSIN; LIGASE COMPLEX; DISLOCATION	Proteins that fail to correctly fold or assemble into oligomeric complexes in the endoplasmic reticulum (ER) are degraded by a ubiquitin- and proteasome-dependent process known as ER-associated degradation (ERAD). Although many individual components of the ERAD system have beenidentified, how these proteins are organized into a functional network that coordinates recognition, ubiquitylation and dislocation of substrates across the ER membrane is not well understood. We have investigated the functional organization of the mammalian ERAD system using a systems-level strategy that integrates proteomics, functional genomics and the transcriptional response to ER stress. This analysis supports an adaptive organization for the mammalian ERAD machinery and reveals a number of metazoan-specific genes not previously linked to ERAD.	[Christianson, John C.; Olzmann, James A.; Richter, Caleb M.; Tyler, Ryan E.; Greenblatt, Ethan J.; Kopito, Ron R.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Christianson, John C.; Olzmann, James A.; Richter, Caleb M.; Tyler, Ryan E.; Greenblatt, Ethan J.; Kopito, Ron R.] Stanford Univ, Bio X Program, Stanford, CA 94305 USA; [Christianson, John C.] Univ Oxford, ORCRB, Ludwig Inst Canc Res, Oxford OX3 7DQ, England; [Shaler, Thomas A.] SRI Int, Menlo Pk, CA 94025 USA; [Sowa, Mathew E.; Bennett, Eric J.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Stanford University; Stanford University; Ludwig Institute for Cancer Research; University of Oxford; SRI International; Harvard University; Harvard Medical School	Kopito, RR (corresponding author), Stanford Univ, Dept Biol, Lorry Lokey Bldg,337 Campus Dr, Stanford, CA 94305 USA.	kopito@stanford.edu	Christianson, John C/Y-4567-2019	Greenblatt, Ethan/0000-0002-3805-0113; Olzmann, James/0000-0001-7751-8316; Harper, Jeffrey/0000-0002-6944-7236; Christianson, John/0000-0002-0474-1207	NIH; Ludwig Institute for Cancer Research; NRSA from NIH; Damon Runyon Cancer Research Foundation [DRG 1974-08]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070565, R01GM074874, R01GM054137, F32GM086026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; NRSA from NIH; Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the NIH to R.R.K. and J.W.H. J.C.C. was supported by funding from the Ludwig Institute for Cancer Research. J.A.O. and R.E.T were supported by NRSA fellowships from NIH. E.J.B. was supported by a fellowship from the Damon Runyon Cancer Research Foundation (DRG 1974-08). We thank the members of the Kopito laboratory for helpful discussion, and M. Pearce, J. Hwang and C. Beveridge for critical reading of the manuscript.	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Aridor M, 2007, ADV DRUG DELIVER REV, V59, P759, DOI 10.1016/j.addr.2007.06.002; Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Bernardi KM, 2010, MOL BIOL CELL, V21, P140, DOI 10.1091/mbc.E09-07-0586; Blickwedehl J, 2008, P NATL ACAD SCI USA, V105, P16165, DOI 10.1073/pnas.0803145105; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Carrel D, 2008, J NEUROSCI, V28, P8063, DOI 10.1523/JNEUROSCI.4487-07.2008; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Deng M, 2006, NATURE, V443, P827, DOI 10.1038/nature05170; Fiebiger E, 2004, MOL BIOL CELL, V15, P1635, DOI 10.1091/mbc.E03-07-0506; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Goder V, 2008, FEBS LETT, V582, P1575, DOI 10.1016/j.febslet.2008.03.056; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Greenblatt EJ, 2011, NAT STRUCT MOL BIOL, V18, P1147, DOI 10.1038/nsmb.2111; Hampton RY, 1996, P NATL ACAD SCI USA, V93, P828, DOI 10.1073/pnas.93.2.828; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Hosokawa N, 2003, J BIOL CHEM, V278, P26287, DOI 10.1074/jbc.M303395200; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Jo Y, 2011, J BIOL CHEM, V286, P15022, DOI 10.1074/jbc.M110.211326; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Lee JN, 2008, J BIOL CHEM, V283, P33772, DOI 10.1074/jbc.M806108200; Li GT, 2006, P NATL ACAD SCI USA, V103, P8348, DOI 10.1073/pnas.0602747103; Liang J, 2006, J CELL SCI, V119, P4011, DOI 10.1242/jcs.03163; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Liu Y, 1997, J BIOL CHEM, V272, P7946, DOI 10.1074/jbc.272.12.7946; Mehnert M, 2010, BIOESSAYS, V32, P905, DOI 10.1002/bies.201000046; Min SW, 2007, P NATL ACAD SCI USA, V104, P3823, DOI 10.1073/pnas.0611725104; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Nguyen AD, 2009, J BIOL CHEM, V284, P26778, DOI 10.1074/jbc.M109.032342; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Pettersson M, 2000, GENOMICS, V68, P351, DOI 10.1006/geno.2000.6278; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Ravid T, 2000, J BIOL CHEM, V275, P35840, DOI 10.1074/jbc.M004793200; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Riemer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017037; Riemer J, 2009, P NATL ACAD SCI USA, V106, P14831, DOI 10.1073/pnas.0900742106; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stagg HR, 2009, J CELL BIOL, V186, P685, DOI 10.1083/jcb.200906110; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Ustrell V, 2002, EMBO J, V21, P3516, DOI 10.1093/emboj/cdf333; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Xie W, 2010, SEMIN CELL DEV BIOL, V21, P533, DOI 10.1016/j.semcdb.2010.02.007; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	71	330	356	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2012	14	1					93	U176		10.1038/ncb2383	http://dx.doi.org/10.1038/ncb2383			32	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	866YC	22119785	Green Accepted, Green Submitted			2022-12-25	WOS:000298421100015
J	Guo, GW; Gui, YT; Gao, SJ; Tang, AF; Hu, XD; Huang, Y; Jia, WL; Li, ZS; He, MH; Sun, L; Song, PF; Sun, XJ; Zhao, XK; Yang, SM; Liang, CZ; Wan, SQ; Zhou, FJ; Chen, C; Zhu, JL; Li, XX; Jian, MH; Zhou, L; Ye, R; Huang, PD; Chen, J; Jiang, T; Liu, X; Wang, Y; Zou, J; Jiang, ZM; Wu, RH; Wu, S; Fan, F; Zhang, ZF; Liu, L; Yang, RL; Liu, XW; Wu, HB; Yin, WH; Zhao, X; Liu, YC; Peng, HH; Jiang, BH; Feng, QX; Li, CL; Xie, J; Lu, JX; Kristiansen, K; Li, YR; Zhang, XQ; Li, SG; Wang, J; Yang, HM; Cai, ZM; Wang, J				Guo, Guangwu; Gui, Yaoting; Gao, Shengjie; Tang, Aifa; Hu, Xueda; Huang, Yi; Jia, Wenlong; Li, Zesong; He, Minghui; Sun, Liang; Song, Pengfei; Sun, Xiaojuan; Zhao, Xiaokun; Yang, Sangming; Liang, Chaozhao; Wan, Shengqing; Zhou, Fangjian; Chen, Chao; Zhu, Jialou; Li, Xianxin; Jian, Minghan; Zhou, Liang; Ye, Rui; Huang, Peide; Chen, Jing; Jiang, Tao; Liu, Xiao; Wang, Yong; Zou, Jing; Jiang, Zhimao; Wu, Renhua; Wu, Song; Fan, Fan; Zhang, Zhongfu; Liu, Lin; Yang, Ruilin; Liu, Xingwang; Wu, Haibo; Yin, Weihua; Zhao, Xia; Liu, Yuchen; Peng, Huanhuan; Jiang, Binghua; Feng, Qingxin; Li, Cailing; Xie, Jun; Lu, Jingxiao; Kristiansen, Karsten; Li, Yingrui; Zhang, Xiuqing; Li, Songgang; Wang, Jian; Yang, Huanming; Cai, Zhiming; Wang, Jun			Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma	NATURE GENETICS			English	Article							SOMATIC MUTATIONS	We sequenced whole exomes of ten clear cell renal cell carcinomas (ccRCCs) and performed a screen of similar to 1,100 genes in 88 additional ccRCCs, from which we discovered 12 previously unidentified genes mutated at elevated frequencies in ccRCC. Notably, we detected frequent mutations in the ubiquitin-mediated proteolysis pathway (UMPP), and alterations in the UMPP were significantly associated with overexpression of HIF1 alpha and HIF2 alpha in the tumors (P = 0.01 and 0.04, respectively). Our findings highlight the potential contribution of UMPP to ccRCC tumorigenesis through the activation of the hypoxia regulatory network.	[Guo, Guangwu; Gao, Shengjie; Hu, Xueda; Jia, Wenlong; He, Minghui; Song, Pengfei; Yang, Sangming; Wan, Shengqing; Chen, Chao; Zhu, Jialou; Jian, Minghan; Ye, Rui; Huang, Peide; Jiang, Tao; Liu, Xiao; Zou, Jing; Wu, Renhua; Fan, Fan; Liu, Lin; Liu, Xingwang; Wu, Haibo; Zhao, Xia; Peng, Huanhuan; Kristiansen, Karsten; Li, Yingrui; Zhang, Xiuqing; Li, Songgang; Wang, Jian; Yang, Huanming; Wang, Jun] BGI Shenzhen, Shenzhen Key Lab Trans Biotechnol, Shenzhen, Peoples R China; [Gui, Yaoting; Tang, Aifa; Huang, Yi; Li, Zesong; Sun, Liang; Li, Xianxin; Zhou, Liang; Chen, Jing; Wang, Yong; Jiang, Zhimao; Wu, Song; Zhang, Zhongfu; Yang, Ruilin; Yin, Weihua; Liu, Yuchen; Jiang, Binghua; Feng, Qingxin; Li, Cailing; Xie, Jun; Lu, Jingxiao; Cai, Zhiming] Peking Univ, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Inst Urol, Shenzhen Hosp,Shenzhen PKU HKUST Med Ctr, Shenzhen, Peoples R China; [Tang, Aifa; Huang, Yi; Li, Zesong; Sun, Xiaojuan; Cai, Zhiming] Shenzhen Univ, Shenzhen Peoples Hosp 2, Affiliated Hosp 1, Shenzhen, Peoples R China; [Zhao, Xiaokun] Central So Univ, Xiangya Hosp 2, Dept Urol, Changsha, Peoples R China; [Liang, Chaozhao] Anhui Med Univ, Affiliated Hosp 1, Dept Urol, Hefei, Peoples R China; [Zhou, Fangjian] Sun Yat Sen Univ, Ctr Canc, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Jialou] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark	Beijing Genomics Institute (BGI); Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Shenzhen University; Central South University; Anhui Medical University; Sun Yat Sen University; Wuhan University; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen	Wang, J (corresponding author), BGI Shenzhen, Shenzhen Key Lab Trans Biotechnol, Shenzhen, Peoples R China.	yanghm@genomics.org.cn; caizhiming2000@yahoo.com.cn; wangj@genomics.org.cn	Jia, Justin/AAV-4349-2021; gui, yaoting/GLT-3684-2022; Wang, Jun/A-7261-2013; Liu, Xiao/P-2732-2015; Zhu, Jialou/Q-5218-2016; Kristiansen, Karsten/J-5148-2014; liu, yuchen/GYQ-6286-2022; Li, Yingrui/K-1064-2015; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016; Gao, Shengjie/S-4016-2017	Jia, Justin/0000-0002-7136-9919; Liu, Xiao/0000-0002-8073-0534; Zhu, Jialou/0000-0003-0630-4964; Kristiansen, Karsten/0000-0002-6024-0917; Peide, Huang/0000-0001-6108-5069; Wang, Jun/0000-0002-8540-8931; Liang, Chaozhao/0000-0003-2317-1323; Chen, Chao/0000-0003-2640-6415; Wang, Jun/0000-0002-2113-5874; Jiang, Bing-Hua/0000-0003-4526-2031; Ye, Rui/0000-0002-4866-088X; Gao, Shengjie/0000-0002-5221-8381	National Basic Research Program of China (973 program) [2011CB809200]; National Natural Science Foundation of China [30725008, 30890032, 30811130531]; Chinese 863 program [2006AA02A301, 2006AA02A302, 2009AA022707]; Shenzhen Municipal Government of China [JC200903190767A, JC200903190772A, ZYC200903240076A, CXB200903110066A, ZYC200903240077A, ZYC200903240080A]; Promotion Program for Shenzhen Key Laboratory, Shenzhen, China [CXB200903090055A, CXB201005250016A]; Biobank of Complex Diseases in Shenzhen [CXC201005260001A]; Shenzhen municipal government; local government of the Yantian District of Shenzhen	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 863 program(National High Technology Research and Development Program of China); Shenzhen Municipal Government of China; Promotion Program for Shenzhen Key Laboratory, Shenzhen, China; Biobank of Complex Diseases in Shenzhen; Shenzhen municipal government; local government of the Yantian District of Shenzhen	This work was supported by the National Basic Research Program of China (973 program 2011CB809200), the National Natural Science Foundation of China (30725008, 30890032 and 30811130531), the Chinese 863 program (2006AA02A301, 2006AA02A302 and 2009AA022707), the Shenzhen Municipal Government of China (JC200903190767A, JC200903190772A, ZYC200903240076A, CXB200903110066A, ZYC200903240077A and ZYC200903240080A), the Promotion Program for Shenzhen Key Laboratory, Shenzhen, China (CXB200903090055A and CXB201005250016A) and the Biobank of Complex Diseases in Shenzhen (CXC201005260001A). This project was also funded by the Shenzhen municipal government and the local government of the Yantian District of Shenzhen.	Banks RE, 2006, CANCER RES, V66, P2000, DOI 10.1158/0008-5472.CAN-05-3074; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Linehan WM, 2010, ANNU REV MED, V61, P329, DOI 10.1146/annurev.med.042808.171650; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Sonoda I, 2004, CANCER RES, V64, P3741, DOI 10.1158/0008-5472.CAN-04-0172; Szymanska K, 2010, CANCER LETT, V293, P92, DOI 10.1016/j.canlet.2009.11.024; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639	14	240	241	0	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2012	44	1					17	19		10.1038/ng.1014	http://dx.doi.org/10.1038/ng.1014			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	22138691				2022-12-25	WOS:000298664000007
J	Steinman, L; Merrill, JT; McInnes, IB; Peakman, M				Steinman, Lawrence; Merrill, Joan T.; McInnes, Iain B.; Peakman, Mark			Optimization of current and future therapy for autoimmune diseases	NATURE MEDICINE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTIGEN-SPECIFIC IMMUNOTHERAPY; RELAPSING MULTIPLE-SCLEROSIS; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; MYELIN BASIC-PROTEIN; RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; NEUROMYELITIS-OPTICA; INTERFERON-BETA	There are multiple immune-based therapeutics available for some of the most prevalent autoimmune diseases, but for others, there are few or no approved immune therapies. This dichotomy poses discrete challenges. First, for diseases in which multiple therapy choices exist, a rational decision tree is required to select the best therapy. Second, we must devise new strategies for the autoimmune diseases that have the highest unmet clinical need. This commentary outlines new strategies for designing more efficient and selective approaches for immune therapy of autoimmune diseases.	[Steinman, Lawrence] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Merrill, Joan T.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Med Res Fdn, Clin Pharmacol Res Program, Oklahoma City, OK USA; [McInnes, Iain B.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Peakman, Mark] Kings Coll London, Dept Immunobiol, London WC2R 2LS, England; [Peakman, Mark] Guys & St Thomas Natl Hlth Serv Fdn Trust, Natl Inst Hlth Res, Comprehens Biomed Res Ctr, London, England	Stanford University; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Glasgow; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Steinman, L (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	steinman@stanford.edu	Merrill, Joan/HDL-9141-2022	McInnes, Iain/0000-0002-6462-4280; Steinman, Lawrence/0000-0002-2437-2250; Peakman, Mark/0000-0003-3328-3513	Medical Research Council [MR/J006742/1] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; Arnon R, 2003, J MOL RECOGNIT, V16, P412, DOI 10.1002/jmr.628; Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Bar-Or A, 2007, ARCH NEUROL-CHICAGO, V64, P1407, DOI 10.1001/archneur.64.10.nct70002; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Campbell JD, 2009, J EXP MED, V206, P1535, DOI 10.1084/jem.20082901; Coles AJ, 2008, NEW ENGL J MED, V359, P1786, DOI 10.1056/NEJMoa0802670; Comi G, 2010, MULT SCLER, V16, P1360, DOI 10.1177/1352458510378127; Crane JM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227298; Dorner T, 2009, NAT REV RHEUMATOL, V5, P433, DOI 10.1038/nrrheum.2009.141; Dolgin E, 2010, NAT MED, V16, P740, DOI 10.1038/nm0710-740; Dudley JT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002648; Dunn SE, 2006, J EXP MED, V203, P401, DOI 10.1084/jem.20051129; Dunoyer M, 2011, NAT REV DRUG DISCOV, V10, P475, DOI 10.1038/nrd3493; Eisenbarth George S., 2002, Autoimmunity Reviews, V1, P139, DOI 10.1016/S1568-9972(02)00035-6; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Feldmann M, 2005, NATURE, V435, P612, DOI 10.1038/nature03727; Feldmann M, 2009, ANNU REV IMMUNOL, V27, P1, DOI 10.1146/annurev-immunol-082708-100732; Fourlanos S, 2011, DIABETES, V60, P1237, DOI 10.2337/db10-1360; Garren H, 2008, ANN NEUROL, V63, P611, DOI 10.1002/ana.21370; Genovese MC, 2008, ARTHRITIS RHEUM-US, V58, P2968, DOI 10.1002/art.23940; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; Getts DR, 2011, J IMMUNOL, V187, P2405, DOI 10.4049/jimmunol.1004175; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Gorelik L, 2010, ANN NEUROL, V68, P295, DOI 10.1002/ana.22128; Graham KL, 2008, ARTHRITIS RHEUM, V58, P2098, DOI 10.1002/art.23605; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Grigor C, 2004, LANCET, V364, P263, DOI 10.1016/S0140-6736(04)16676-2; Grozinsky-Glasberg S, 2006, J CLIN ENDOCR METAB, V91, P2592, DOI 10.1210/jc.2006-0448; Hayday AC, 2008, NAT IMMUNOL, V9, P575, DOI 10.1038/ni0608-575; Hinson SR, 2009, ARCH NEUROL-CHICAGO, V66, P1164, DOI 10.1001/archneurol.2009.188; Hueber W, 2002, ARTHRITIS RES, V4, P290, DOI 10.1186/ar426; Hueber W, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2706; Illa I, 2008, J NEUROIMMUNOL, V201, P90, DOI 10.1016/j.jneuroim.2008.04.039; Ishizu T, 2005, BRAIN, V128, P988, DOI 10.1093/brain/awh453; Jones JL, 2009, J CLIN INVEST, V119, P2052, DOI 10.1172/JCI37878; Kagan JM, 2011, J AM MED INFORM ASSN, V18, pI161, DOI 10.1136/amiajnl-2011-000114; Kappos L, 2008, LANCET, V372, P1463, DOI 10.1016/S0140-6736(08)61619-0; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Laurberg P, 2008, EUR J ENDOCRINOL, V158, P69, DOI 10.1530/EJE-07-0450; Lee LF, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002400; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lozanoska-Ochser B, 2006, DIABETES, V55, P1004, DOI 10.2337/diabetes.55.04.06.db05-1261; Lutterotti A, 2008, J NEUROL SCI, V274, P18, DOI 10.1016/j.jns.2008.05.021; Mannon PJ, 2011, GUT, V60, P449, DOI 10.1136/gut.2010.226860; Mantegazza R, 2011, NEUROPSYCH DIS TREAT, V7, P151, DOI 10.2147/NDT.S8915; Matthews JB, 2010, CLIN EXP IMMUNOL, V160, P176, DOI 10.1111/j.1365-2249.2010.04153.x; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Merrill JT, 2011, LUPUS, V20, P709, DOI 10.1177/0961203310395802; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P222, DOI 10.1002/art.27233; Michels AW, 2011, SEMIN IMMUNOL, V23, P214, DOI 10.1016/j.smim.2011.07.003; Muller S, 2008, ARTHRITIS RHEUM-US, V58, P3873, DOI 10.1002/art.24027; Nam JL, 2010, ANN RHEUM DIS, V69, P976, DOI 10.1136/ard.2009.126573; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; O'Connor PW, 2006, NEUROLOGY, V66, P894, DOI 10.1212/01.wnl.0000203121.04509.31; OSSERMAN K E, 1956, J Mt Sinai Hosp N Y, V23, P711; Owczarczyk K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002432; Palace J, 2010, ARCH NEUROL-CHICAGO, V67, P1016, DOI 10.1001/archneurol.2010.188; Peakman M, 2010, DIABETES, V59, P2087, DOI 10.2337/db10-0630; Platten M, 2009, P NATL ACAD SCI USA, V106, P14948, DOI 10.1073/pnas.0903958106; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Raz I, 2001, LANCET, V358, P1749, DOI 10.1016/S0140-6736(01)06801-5; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295; Sabatos-Peyton CA, 2010, CURR OPIN IMMUNOL, V22, P609, DOI 10.1016/j.coi.2010.08.006; Sattar N, 2005, CURR OPIN RHEUMATOL, V17, P286, DOI 10.1097/01.bor.0000158150.57154.f9; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Shimizu Y, 2008, J NEUROL, V255, P305, DOI 10.1007/s00415-007-0730-5; Solvason N, 2008, J IMMUNOL, V181, P8298, DOI 10.4049/jimmunol.181.12.8298; Stanley JR, 2006, NEW ENGL J MED, V355, P1800, DOI 10.1056/NEJMra061111; Stegbauer J, 2009, P NATL ACAD SCI USA, V106, P14942, DOI 10.1073/pnas.0903602106; STEINMAN L, 1993, SCI AM, V269, P106, DOI 10.1038/scientificamerican0993-106; Steinman L, 2005, NAT REV DRUG DISCOV, V4, P510, DOI 10.1038/nrd1752; Steinman L, 2010, J INTERN MED, V267, P441, DOI 10.1111/j.1365-2796.2010.02224.x; Steinman L., ANN NEUROL IN PRESS; Steinman L, 2010, NAT IMMUNOL, V11, P41, DOI 10.1038/ni.1803; Steinman L, 2009, NAT REV IMMUNOL, V9, P440, DOI 10.1038/nri2548; Sthoeger ZM, 2009, J AUTOIMMUN, V33, P77, DOI 10.1016/j.jaut.2009.03.009; Strober BE, 2011, BRIT J DERMATOL, V165, P661, DOI 10.1111/j.1365-2133.2011.10419.x; Thrower SL, 2009, CLIN EXP IMMUNOL, V155, P156, DOI 10.1111/j.1365-2249.2008.03814.x; TOYKA KV, 1977, NEW ENGL J MED, V296, P125, DOI 10.1056/NEJM197701202960301; Tradtrantip L., ANN NEUROL IN PRESS; van Holten J, 2004, ARTHRITIS RES THER, V6, pR239, DOI 10.1186/ar1165; Vehik K, 2011, DIABETES CARE, V34, P1585, DOI 10.2337/dc11-0523; Velthuis JH, 2010, DIABETES, V59, P1721, DOI 10.2337/db09-1486; Wagner JA, 2010, CLIN PHARMACOL THER, V87, P539, DOI 10.1038/clpt.2009.227; Wallace DJ, 2004, LUPUS, V13, P323, DOI 10.1191/0961203304lu1020oa; Warabi Y, 2007, J NEUROL SCI, V252, P57, DOI 10.1016/j.jns.2006.10.008; Wherrett DK, 2011, LANCET, V378, P319, DOI 10.1016/S0140-6736(11)60895-7	89	62	66	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					59	65		10.1038/nm.2625	http://dx.doi.org/10.1038/nm.2625			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22227674				2022-12-25	WOS:000299018600029
J	Betz, K; Malyshev, DA; Lavergne, T; Welte, W; Diederichs, K; Dwyer, TJ; Ordoukhanian, P; Romesberg, FE; Marx, A				Betz, Karin; Malyshev, Denis A.; Lavergne, Thomas; Welte, Wolfram; Diederichs, Kay; Dwyer, Tammy J.; Ordoukhanian, Phillip; Romesberg, Floyd E.; Marx, Andreas			KlenTaq polymerase replicates unnatural base pairs by inducing a Watson-Crick geometry	NATURE CHEMICAL BIOLOGY			English	Article							DNA-REPLICATION; GENETIC ALPHABET; HYDROPHOBIC BASE; FIDELITY; OPTIMIZATION; MECHANISM; EXPANSION; RECOGNITION; SELECTION; FRAGMENT	Many candidate unnatural DNA base pairs have been developed, but some of the best-replicated pairs adopt intercalated structures in free DNA that are difficult to reconcile with known mechanisms of polymerase recognition. Here we present crystal structures of KlenTaq DNA polymerase at different stages of replication for one such pair, dNaM-d5SICS, and show that efficient replication results from the polymerase itself, inducing the required natural-like structure.	[Betz, Karin; Marx, Andreas] Univ Konstanz, Dept Chem, Constance, Germany; [Betz, Karin; Welte, Wolfram; Diederichs, Kay; Marx, Andreas] Univ Konstanz, Konstanz Res Sch Chem Biol, Constance, Germany; [Malyshev, Denis A.; Lavergne, Thomas; Romesberg, Floyd E.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Welte, Wolfram; Diederichs, Kay] Univ Konstanz, Dept Biol, Constance, Germany; [Dwyer, Tammy J.] Univ Calif San Diego, Dept Chem & Biochem, San Diego, CA 92103 USA; [Ordoukhanian, Phillip] Scripps Res Inst, Ctr Prot & Nucle Acid Res, La Jolla, CA 92037 USA	University of Konstanz; University of Konstanz; Scripps Research Institute; University of Konstanz; University of California System; University of California San Diego; Scripps Research Institute	Marx, A (corresponding author), Univ Konstanz, Dept Chem, Constance, Germany.	floyd@scripps.edu; andreas.marx@uni-konstanz.de	Malyshev, Denis/K-6756-2012; LAVERGNE, Thomas G/N-8896-2013; Romesberg, Floyd/M-2821-2017	Malyshev, Denis/0000-0002-0670-9905; LAVERGNE, Thomas G/0000-0002-0029-0015; Romesberg, Floyd/0000-0001-6317-1315	Konstanz Research School Chemical Biology; US National Institutes of Health [GM060005]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060005] Funding Source: NIH RePORTER	Konstanz Research School Chemical Biology; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the beamline staff of the Swiss Light Source at the Paul Scherrer Institute for their assistance during data collection. This work was supported by the Konstanz Research School Chemical Biology (to K.B.) and the US National Institutes of Health (GM060005 to F.E.R.).	Brotschi C, 2001, ANGEW CHEM INT EDIT, V40, P3012, DOI 10.1002/1521-3773(20010817)40:16<3012::AID-ANIE3012>3.0.CO;2-Y; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; Goodman MF, 1997, P NATL ACAD SCI USA, V94, P10493, DOI 10.1073/pnas.94.20.10493; Hirao I, 2006, NAT METHODS, V3, P729, DOI 10.1038/nmeth915; Hollenstein M, 2009, NUCLEIC ACIDS RES, V37, P1638, DOI 10.1093/nar/gkn1070; Kool ET, 2002, ANNU REV BIOCHEM, V71, P191, DOI 10.1146/annurev.biochem.71.110601.135453; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Lavergne T, 2012, CHEM-EUR J, V18, P1231, DOI 10.1002/chem.201102066; Leconte AM, 2008, J AM CHEM SOC, V130, P2336, DOI 10.1021/ja078223d; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Malyshev DA, 2010, CHEM-EUR J, V16, P12650, DOI 10.1002/chem.201000959; Malyshev DA, 2009, J AM CHEM SOC, V131, P14620, DOI 10.1021/ja906186f; Matsuda S, 2007, J AM CHEM SOC, V129, P10466, DOI 10.1021/ja072276d; McMinn DL, 1999, J AM CHEM SOC, V121, P11585, DOI 10.1021/ja9925150; Meyer AS, 2004, J BIOL CHEM, V279, P33043, DOI 10.1074/jbc.C400232200; Moran S, 1997, J AM CHEM SOC, V119, P2056, DOI 10.1021/ja963718g; PICCIRILLI JA, 1990, NATURE, V343, P33, DOI 10.1038/343033a0; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; Seo YJ, 2009, J AM CHEM SOC, V131, P3246, DOI 10.1021/ja807853m; Seo YJ, 2009, J AM CHEM SOC, V131, P5046, DOI 10.1021/ja9006996; Wojciechowski F, 2011, CHEM SOC REV, V40, P5669, DOI 10.1039/c1cs15027h; Wu EY, 2011, J BIOL CHEM, V286, P19758, DOI 10.1074/jbc.M110.191130; Xie JM, 2006, NAT REV MOL CELL BIO, V7, P775, DOI 10.1038/nrm2005	25	105	119	0	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2012	8	7					612	614		10.1038/NCHEMBIO.966	http://dx.doi.org/10.1038/NCHEMBIO.966			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	961NJ	22660438	Green Accepted, Green Submitted			2022-12-25	WOS:000305471400007
J	Dominici, N; Keller, U; Vallery, H; Friedli, L; van den Brand, R; Starkey, ML; Musienko, P; Riener, R; Courtine, G				Dominici, Nadia; Keller, Urs; Vallery, Heike; Friedli, Lucia; van den Brand, Rubia; Starkey, Michelle L.; Musienko, Pavel; Riener, Robert; Courtine, Gregoire			Versatile robotic interface to evaluate, enable and train locomotion and balance after neuromotor disorders	NATURE MEDICINE			English	Article							LUMBOSACRAL SPINAL-CORD; GAIT; RECOVERY; WALKING; INJURY; STROKE	Central nervous system (CNS) disorders distinctly impair locomotor pattern generation and balance, but technical limitations prevent independent assessment and rehabilitation of these subfunctions. Here we introduce a versatile robotic interface to evaluate, enable and train pattern generation and balance independently during natural walking behaviors in rats. In evaluation mode, the robotic interface affords detailed assessments of pattern generation and dynamic equilibrium after spinal cord injury (SCI) and stroke. In enabling mode, the robot acts as a propulsive or postural neuroprosthesis that instantly promotes unexpected locomotor capacities including overground walking after complete SCI, stair climbing following partial SCI and precise paw placement shortly after stroke. In training mode, robot-enabled rehabilitation, epidural electrical stimulation and monoamine agonists reestablish weight-supported locomotion, coordinated steering and balance in rats with a paralyzing SCI. This new robotic technology and associated concepts have broad implications for both assessing and restoring motor functions after CNS disorders, both in animals and in humans.	[Dominici, Nadia; Friedli, Lucia; van den Brand, Rubia; Musienko, Pavel; Courtine, Gregoire] Univ Zurich, Dept Neurol, Zurich, Switzerland; [Dominici, Nadia; Friedli, Lucia; van den Brand, Rubia; Musienko, Pavel; Courtine, Gregoire] Swiss Fed Inst Technol, Sch Life Sci, Ctr Neuroprosthet, CH-1015 Lausanne, Switzerland; [Dominici, Nadia; Friedli, Lucia; van den Brand, Rubia; Musienko, Pavel; Courtine, Gregoire] Swiss Fed Inst Technol, Sch Life Sci, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Keller, Urs; Vallery, Heike; Riener, Robert] Swiss Fed Inst Technol, Inst Robot & Intelligent Syst, Sensory Motor Syst Lab, Zurich, Switzerland; [Vallery, Heike] Khalifa Univ, Dept Biomed Engn, Abu Dhabi, U Arab Emirates; [Starkey, Michelle L.] Univ Zurich, Brain Res Inst, Zurich, Switzerland; [Starkey, Michelle L.; Riener, Robert] Univ Zurich, Balgrist Univ Hosp, Spinal Cord Injury Ctr, Zurich, Switzerland; [Musienko, Pavel] IP Pavlov Physiol Inst, St Petersburg 199034, Russia	University of Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; ETH Zurich; Khalifa University of Science & Technology; University of Zurich; University of Zurich; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Pavlov Institute of Physiology Russian Academy of Sciences	Courtine, G (corresponding author), Univ Zurich, Dept Neurol, Zurich, Switzerland.	gregoire.courtine@epfl.ch	Vallery, Heike/A-4254-2013; courtine, gregoire/AAJ-1694-2020; Riener, Robert/B-9868-2016; Musienko, Pavel/L-6677-2015	Vallery, Heike/0000-0002-0305-398X; courtine, gregoire/0000-0002-5744-4142; Keller, Urs/0000-0001-6615-6452; Dominici, Nadia/0000-0003-2312-915X; Musienko, Pavel/0000-0002-7324-9021	National Centers of Competence in Research "Neural Plasticity and Repair" and "Robotics" of the Swiss National Science Foundation; European Research Council [ERC 261247]; European Community's Seventh Framework Programme [CP-IP 258654]; Christopher and Dana Reeve Foundation; Swiss National Science Foundation [310030_130850]	National Centers of Competence in Research "Neural Plasticity and Repair" and "Robotics" of the Swiss National Science Foundation; European Research Council(European Research Council (ERC)European Commission); European Community's Seventh Framework Programme(European Commission); Christopher and Dana Reeve Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We would like to acknowledge the excellent technical help provided by J. Heutschi, N. Wenger, M. Hurlimann, Q. Barraud and S. Duis for data collection and care of the rats, as well as A.S. Tafreshi for the design of the user interface to control the robotic system and A. Brunschweiler, A. Rotta and M. Fritschi for the realization of the suspension system. This work was supported by the National Centers of Competence in Research "Neural Plasticity and Repair" and "Robotics" of the Swiss National Science Foundation, the European Research Council (ERC 261247, "Walk Again"), European Community's Seventh Framework Programme (CP-IP 258654, NeuWALK), the Christopher and Dana Reeve Foundation and the Swiss National Science Foundation (subside 310030_130850).	Ada L, 2010, J PHYSIOTHER, V56, P153, DOI 10.1016/S1836-9553(10)70020-5; Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343; COLGATE E, 1989, PROCEEDINGS - 1989 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOL 1-3, P404, DOI 10.1109/ROBOT.1989.100021; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; Drew T, 2008, BRAIN RES REV, V57, P199, DOI 10.1016/j.brainresrev.2007.07.017; Duschau-Wicke A, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-43; Edgerton VR, 2009, BRAIN RES BULL, V78, P4, DOI 10.1016/j.brainresbull.2008.09.018; Frey M, 2006, IEEE T NEUR SYS REH, V14, P311, DOI 10.1109/TNSRE.2006.881556; Harkema SJ, 1997, J NEUROPHYSIOL, V77, P797, DOI 10.1152/jn.1997.77.2.797; Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3; Hidler J, 2011, J REHABIL RES DEV, V48, P287, DOI 10.1682/JRRD.2010.05.0098; Kwakkel G, 2008, NEUROREHAB NEURAL RE, V22, P111, DOI 10.1177/1545968307305457; Musienko P, 2011, J NEUROSCI, V31, P9264, DOI 10.1523/JNEUROSCI.5796-10.2011; Musselman K, 2011, NEUROREHAB NEURAL RE, V25, P285, DOI 10.1177/1545968310381250; Nessler JA, 2005, IEEE T NEUR SYS REH, V13, P497, DOI 10.1109/TNSRE.2005.858432; Pearson KG, 2004, PROG BRAIN RES, V143, P123, DOI 10.1016/S0079-6123(03)43012-4; Pratt G., 1995, INT S EXP ROB, DOI 10.1.1.26.3136; Reinkensmeyer DJ, 2006, J REHABIL RES DEV, V43, P657, DOI 10.1682/JRRD.2005.04.0073; Shetty D., 2008, uS Patent, Patent No. [7,462,138, 7462138]; Timoszyk WK, 2005, BRAIN RES, V1050, P180, DOI 10.1016/j.brainres.2005.05.041; Vallery H, 2008, IEEE ROBOT AUTOM MAG, V15, P60, DOI 10.1109/MRA.2008.927689; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; Wessels M, 2010, J REHABIL MED, V42, P513, DOI 10.2340/16501977-0525; Winter DA, 1993, PROG BRAIN RES, V97, P359, DOI 10.1016/s0079-6123(08)62295-5; Zorner B, 2010, NAT METHODS, V7, P701, DOI 10.1038/nmeth.1484	26	77	84	3	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2012	18	7					1142	+		10.1038/nm.2845	http://dx.doi.org/10.1038/nm.2845			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22653117	Green Published, Green Submitted			2022-12-25	WOS:000306121600046
J	Xian, LL; Wu, XW; Pang, LJ; Lou, M; Rosen, CJ; Qiu, T; Crane, J; Frassica, F; Zhang, LM; Rodriguez, JP; Jia, XF; Yakar, S; Xuan, SH; Efstratiadis, A; Wan, M; Cao, X				Xian, Lingling; Wu, Xiangwei; Pang, Lijuan; Lou, Michael; Rosen, Clifford J.; Qiu, Tao; Crane, Janet; Frassica, Frank; Zhang, Liming; Pablo Rodriguez, Juan; Jia, Xiaofeng; Yakar, Shoshana; Xuan, Shouhong; Efstratiadis, Argiris; Wan, Mei; Cao, Xu			Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells	NATURE MEDICINE			English	Article							GROWTH-FACTOR-I; POSTMENOPAUSAL WOMEN; OSTEOBLAST PROGENITORS; INSULIN-RECEPTOR; LIFE-SPAN; OSTEOPOROSIS; RESORPTION; PHYSIOLOGY; FRACTURES; RELEVANCE	Insulin-like growth factor 1 (IGF-1), the most abundant growth factor in the bone matrix, maintains bone mass in adulthood. We now report that IGF-1 released from the bone matrix during bone remodeling stimulates osteoblastic differentiation of recruited mesenchymal stem cells (MSCs) by activation of mammalian target of rapamycin (mTOR), thus maintaining proper bone microarchitecture and mass. Mice with knockout of the IGF-1 receptor (Igf1r) in their pre-osteoblastic cells showed lower bone mass and mineral deposition rates than wild-type mice. Further, MSCs from Igf1r(flox/flox) mice with Igf1r deleted by a Cre adenovirus in vitro, although recruited to the bone surface after implantation, were unable to differentiate into osteoblasts. We also found that the concentrations of IGF-1 in the bone matrix and marrow of aged rats were lower than in those of young rats and directly correlated with the age-related decrease in bone mass. Likewise, in age-related osteoporosis in humans, we found that bone marrow IGF-1 concentrations were 40% lower in individuals with osteoporosis than in individuals without osteoporosis. Notably, injection of IGF-1 plus IGF binding protein 3 (IGFBP3), but not injection of IGF-1 alone, increased the concentration of IGF-1 in the bone matrix and stimulated new bone formation in aged rats. Together, these results provide mechanistic insight into how IGF-1 maintains adult bone mass, while also providing a further rationale for its therapeutic targeting to treat age-related osteoporosis.	[Xian, Lingling; Wu, Xiangwei; Pang, Lijuan; Lou, Michael; Qiu, Tao; Crane, Janet; Frassica, Frank; Zhang, Liming; Wan, Mei; Cao, Xu] Johns Hopkins Univ, Dept Orthopaed Surg, Sch Med, Baltimore, MD 21218 USA; [Xian, Lingling; Wu, Xiangwei; Pang, Lijuan] Shihezi Univ, Sch Med, Shihezi, Xinjiang, Peoples R China; [Rosen, Clifford J.] Maine Med Ctr Res Inst, Ctr Clin & Translat Res, Scarborough, ME USA; [Crane, Janet] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Pablo Rodriguez, Juan] Univ Chile, INTA, Lab Biol Celular, Santiago, Chile; [Jia, Xiaofeng] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Yakar, Shoshana] Mt Sinai Sch Med, Div Endocrinol Diabet & Bone Dis, New York, NY USA; [Xuan, Shouhong; Efstratiadis, Argiris] Columbia Univ, Dept Genet & Dev, New York, NY USA	Johns Hopkins University; Shihezi University; Maine Medical Center; Johns Hopkins University; Universidad de Chile; Johns Hopkins University; Icahn School of Medicine at Mount Sinai; Columbia University	Cao, X (corresponding author), Johns Hopkins Univ, Dept Orthopaed Surg, Sch Med, Baltimore, MD 21218 USA.	xcao11@jhmi.edu	zhang, xu/GRX-9733-2022; Jia, Xiaofeng/B-2145-2008; zhang, xu/GYE-3558-2022; Sui, Yanwei/AAH-9928-2021; Zhang, Li/GWM-7501-2022; Rodríguez, J. Pablo/I-2155-2013	Jia, Xiaofeng/0000-0003-1445-8525; Crane, Janet/0000-0001-7713-0936	NIAMS/NIH [AR 053973]; US National Institutes of Health [T32DK007751v]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045433, K01AR060433, R01AR053973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007751, R01DK057501, R01DK080898] Funding Source: NIH RePORTER	NIAMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The project described was supported by grant AR 053973 (X.C.) from NIAMS/NIH. J.C. is supported by grant T32DK007751v from the US National Institutes of Health. The authors thank B.J. Canning (Asthma and Allergy Center, Johns Hopkins University) for providing guinea pig marrow cells.	Abe E, 2003, CELL, V115, P151, DOI 10.1016/S0092-8674(03)00771-2; Agnusdei D, 2005, J Endocrinol Invest, V28, P32; Amin S, 2007, J BONE MINER RES, V22, P799, DOI 10.1359/JBMR.070306; BAUTISTA CM, 1990, METABOLISM, V39, P96, DOI 10.1016/0026-0495(90)90154-5; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bonjour JP, 2009, SALUD PUBLICA MEXICO, V51, pS5; Boonen S, 2002, J CLIN ENDOCR METAB, V87, P1593, DOI 10.1210/jc.87.4.1593; Callewaert F, 2010, J ENDOCRINOL, V207, P127, DOI 10.1677/JOE-10-0209; CANALIS E, 1993, ENDOCRINOLOGY, V133, P33, DOI 10.1210/en.133.1.33; Di Gregorio GB, 2001, J CLIN INVEST, V107, P803, DOI 10.1172/JCI11653; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; HAUSCHKA PV, 1986, J BIOL CHEM, V261, P2665; HAYDEN JM, 1995, BONE, V17, P93; Hill P A, 1998, Br J Orthod, V25, P101; Kuznetsov S, 1996, CALCIFIED TISSUE INT, V59, P265, DOI 10.1007/s002239900121; Lamberts SWJ, 1997, SCIENCE, V278, P419, DOI 10.1126/science.278.5337.419; Liu JM, 2008, J BONE MINER METAB, V26, P159, DOI 10.1007/s00774-007-0799-z; Liu LH, 2011, J CELL BIOL, V194, P815, DOI 10.1083/jcb.201102090; Mohan S, 1997, ENDOCRINE, V7, P87, DOI 10.1007/BF02778070; Mundy GR, 2006, CELL, V126, P441, DOI 10.1016/j.cell.2006.07.015; Ohlsson C, 2011, J BONE MINER RES, V26, P865, DOI 10.1002/jbmr.281; Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010; PFEILSCHIFTER J, 1995, J CLIN INVEST, V96, P767, DOI 10.1172/JCI118121; Rizzoli R, 2010, BONE, V46, P294, DOI 10.1016/j.bone.2009.10.005; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Russell RC, 2011, DEVELOPMENT, V138, P3343, DOI 10.1242/dev.058230; Schettler Andrea Elise, 2004, J Am Acad Nurse Pract, V16, P274, DOI 10.1111/j.1745-7599.2004.tb00450.x; Seck T, 1998, J CLIN ENDOCR METAB, V83, P2331, DOI 10.1210/jc.83.7.2331; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yakar S, 2005, ENDOCR DEV, V9, P11, DOI 10.1159/000085718; Yakar S, 2003, EXP BIOL MED, V228, P245, DOI 10.1177/153537020322800302; Yamaguchi T, 2006, CALCIFIED TISSUE INT, V78, P18, DOI 10.1007/s00223-005-0163-z; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Ziv E, 2011, AGEING RES REV, V10, P201, DOI 10.1016/j.arr.2010.09.002	40	400	424	3	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2012	18	7					1095	+		10.1038/nm.2793	http://dx.doi.org/10.1038/nm.2793			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22729283	Green Accepted			2022-12-25	WOS:000306121600039
J	Modarresi, F; Faghihi, MA; Lopez-Toledano, MA; Fatemi, RP; Magistri, M; Brothers, SP; van der Brug, MP; Wahlestedt, C				Modarresi, Farzaneh; Faghihi, Mohammad Ali; Lopez-Toledano, Miguel A.; Fatemi, Roya Pedram; Magistri, Marco; Brothers, Shaun P.; van der Brug, Marcel P.; Wahlestedt, Claes			Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation	NATURE BIOTECHNOLOGY			English	Article							NEUROTROPHIC FACTOR; NONCODING RNAS; ALZHEIMERS-DISEASE; BDNF GENES; EXPRESSION; ASSOCIATIONS; MODULATION; MATURATION; LOCUS; MODEL	The ability to specifically upregulate genes in vivo holds great therapeutic promise. Here we show that inhibition or degradation of natural antisense transcripts (NATs) by single-stranded oligonucleotides or siRNAs can transiently and reversibly upregulate locus-specific gene expression. Brain-derived neurotrophic factor (BDNF) is normally repressed by a conserved noncoding antisense RNA transcript, BDNF-AS. Inhibition of this transcript upregulates BDNF mRNA by two- to sevenfold, alters chromatin marks at the BDNF locus, leads to increased protein levels and induces neuronal outgrowth and differentiation both in vitro and in vivo. We also show that inhibition of NATs leads to increases in glial-derived neurotrophic factor (GDNF) and ephrin receptor B2 (EPHB2) mRNA. Our data suggest that pharmacological approaches targeting NATs can confer locus-specific gene upregulation effects.	[Modarresi, Farzaneh; Faghihi, Mohammad Ali; Fatemi, Roya Pedram; Magistri, Marco; Brothers, Shaun P.; Wahlestedt, Claes] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [Modarresi, Farzaneh; Faghihi, Mohammad Ali; Fatemi, Roya Pedram; Magistri, Marco; Brothers, Shaun P.; Wahlestedt, Claes] Univ Miami, Miller Sch Med, Ctr Therapeut Innovat, John P Hussman Inst Human Genom, Miami, FL 33136 USA	University of Miami; University of Miami	Wahlestedt, C (corresponding author), Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA.	cwahlestedt@med.miami.edu	Lopez-Toledano, Miguel A./C-3471-2008; Faghihi, Mohammad Ali/AAD-7159-2020; Brothers, Shaun/G-8690-2012; Faghihi, Mohammad Ali/AAH-3139-2019	Lopez-Toledano, Miguel A./0000-0002-5743-3750; Faghihi, Mohammad Ali/0000-0002-8330-9067; Brothers, Shaun/0000-0003-2184-4037	US National Institutes of Health [5R01NS063974, 5RC2AG036596]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036596] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Q.-R. Liu from the National Institute of Drug Abuse kindly provided us with constructs that contain three splice variants of the human BDNF-AS transcript. We thank C. Coito, P. Frost, J. Hsiao and O. Khorkova at OPKO-CURNA for helpful discussions. The US National Institutes of Health (5R01NS063974 and 5RC2AG036596) funded this work. A significant portion of this study was carried out when the investigators were employed at The Scripps Research Institute and/or the Karolinska Institutet.	Abuhatzira L, 2007, EPIGENETICS-US, V2, P214, DOI 10.4161/epi.2.4.5212; Ortega JA, 2010, CEREB CORTEX, V20, P2132, DOI 10.1093/cercor/bhp275; Antal A, 2010, BRAIN STIMUL, V3, P230, DOI 10.1016/j.brs.2009.12.003; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Castillo DV, 2011, BEHAV BRAIN RES, V217, P248, DOI 10.1016/j.bbr.2010.10.013; Chapleau CA, 2009, J NEURODEV DISORD, V1, P185, DOI 10.1007/s11689-009-9027-6; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002; Choi DC, 2010, P NATL ACAD SCI USA, V107, P2675, DOI 10.1073/pnas.0909359107; Dell'Osso L, 2010, NEUROPSYCHOBIOLOGY, V62, P207, DOI 10.1159/000319946; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Frade JM, 2010, CELL CYCLE, V9, P1934, DOI 10.4161/cc.9.10.11582; Gonul AS, 2011, WORLD J BIOL PSYCHIA, V12, P110, DOI 10.3109/15622975.2010.507786; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; Hawkins PG, 2010, TRANSCR-AUSTIN, V1, P165, DOI 10.4161/trns.1.3.13332; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Im SH, 2010, NEUROSCIENCE, V169, P259, DOI 10.1016/j.neuroscience.2010.04.038; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Khalil AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001486; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Laske C, 2011, INT J NEUROPSYCHOPH, V14, P399, DOI 10.1017/S1461145710001008; Liu QR, 2005, AM J MED GENET B, V134B, P93, DOI 10.1002/ajmg.b.30109; Liu QR, 2006, BRAIN RES, V1067, P1, DOI 10.1016/j.brainres.2005.10.004; Lopez-Toledano MA, 2004, J NEUROSCI, V24, P5439, DOI 10.1523/JNEUROSCI.0974-04.2004; Luo KR, 2010, PROG NEURO-PSYCHOPH, V34, P1433, DOI 10.1016/j.pnpbp.2010.07.033; Massa SM, 2010, J CLIN INVEST, V120, P1774, DOI 10.1172/JCI41356; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Mehler MF, 2006, J PHYSIOL-LONDON, V575, P333, DOI 10.1113/jphysiol.2006.113191; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Morris KV, 2009, EPIGENETICS-US, V4, P296, DOI 10.4161/epi.4.5.9282; Morris KV, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000258; Nikolakopoulou AM, 2010, J COMP NEUROL, V518, P972, DOI 10.1002/cne.22258; Ogier M, 2007, J NEUROSCI, V27, P10912, DOI 10.1523/JNEUROSCI.1869-07.2007; Park HR, 2010, NEUROSCI LETT, V482, P235, DOI 10.1016/j.neulet.2010.07.046; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Scheele C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-74; Trzaska KA, 2009, J NEUROCHEM, V110, P1058, DOI 10.1111/j.1471-4159.2009.06201.x; Wahlestedt C, 2000, P NATL ACAD SCI USA, V97, P5633, DOI 10.1073/pnas.97.10.5633; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Watts JK, 2010, NUCLEIC ACIDS RES, V38, P5242, DOI 10.1093/nar/gkq258; Wu SY, 2011, BRAIN BEHAV IMMUN, V25, P135, DOI 10.1016/j.bbi.2010.09.006; Yang LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009851; Yoshimura R, 2009, NEUROSCI LETT, V450, P262, DOI 10.1016/j.neulet.2008.12.010; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zeng Y, 2010, J ALZHEIMERS DIS, V21, P823, DOI 10.3233/JAD-2010-100264; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	50	440	486	3	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2012	30	5					453	+		10.1038/nbt.2158	http://dx.doi.org/10.1038/nbt.2158			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	939IP	22446693	Green Accepted			2022-12-25	WOS:000303803200026
J	Boulter, L; Govaere, O; Bird, TG; Radulescu, S; Ramachandran, P; Pellicoro, A; Ridgway, RA; Seo, SS; Spee, B; Van Rooijen, N; Sansom, OJ; Iredale, JP; Lowell, S; Roskams, T; Forbes, SJ				Boulter, Luke; Govaere, Olivier; Bird, Tom G.; Radulescu, Sorina; Ramachandran, Prakash; Pellicoro, Antonella; Ridgway, Rachel A.; Seo, Sang Soo; Spee, Bart; Van Rooijen, Nico; Sansom, Owen J.; Iredale, John P.; Lowell, Sally; Roskams, Tania; Forbes, Stuart J.			Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease	NATURE MEDICINE			English	Article							BILE-DUCT DEVELOPMENT; ALAGILLE-SYNDROME; REGULATES FORMATION; CHOLINE-DEFICIENT; GENE-EXPRESSION; HUMAN JAGGED1; MOUSE MODEL; OVAL CELLS; DIFFERENTIATION; NUMB	During chronic injury a population of bipotent hepatic progenitor cells (HPCs) become activated to regenerate both cholangiocytes and hepatocytes. Here we show in human diseased liver and mouse models of the ductular reaction that Notch and Wnt signaling direct specification of HPCs via their interactions with activated myofibroblasts or macrophages. In particular, we found that during biliary regeneration, expression of Jagged 1 (a Notch ligand) by myofibroblasts promoted Notch signaling in HPCs and thus their biliary specification to cholangiocytes. Alternatively, during hepatocyte regeneration, macrophage engulfment of hepatocyte debris induced Wnt3a expression. This resulted in canonical Wnt signaling in nearby HPCs, thus maintaining expression of Numb (a cell fate determinant) within these cells and the promotion of their specification to hepatocytes. By these two pathways adult parenchymal regeneration during chronic liver injury is promoted.	[Boulter, Luke; Bird, Tom G.; Seo, Sang Soo; Lowell, Sally; Forbes, Stuart J.] Univ Edinburgh, Med Res Council Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Boulter, Luke; Bird, Tom G.; Ramachandran, Prakash; Pellicoro, Antonella; Iredale, John P.; Forbes, Stuart J.] Univ Edinburgh, Med Res Council Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Govaere, Olivier; Van Rooijen, Nico; Roskams, Tania] Katholieke Univ Leuven, Dept Morphol & Mol Pathol, Louvain, Belgium; [Radulescu, Sorina; Ridgway, Rachel A.; Sansom, Owen J.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Spee, Bart] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Animals, Utrecht, Netherlands; [Van Rooijen, Nico] Vrije Univ Med Ctr, Dept Mol Cell Biol, Fac Med, Amsterdam, Netherlands	University of Edinburgh; University of Edinburgh; KU Leuven; Beatson Institute; Utrecht University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Forbes, SJ (corresponding author), Univ Edinburgh, Med Res Council Ctr Regenerat Med, Edinburgh, Midlothian, Scotland.	stuart.forbes@ed.ac.uk	Van Rooijen, Nico/Z-1578-2019; Bird, Tom/H-3840-2019; Lowell, Sally/AAW-2992-2020; Ramachandran, Prakash/AAR-9600-2021; Govaere, Olivier/R-9372-2019	Bird, Tom/0000-0002-6120-1581; Lowell, Sally/0000-0002-4018-9480; Govaere, Olivier/0000-0002-4426-6930; Forbes, Stuart/0000-0003-3715-2561; Roskams, Tania/0000-0002-2816-1530; Sansom, Owen J./0000-0001-9540-3010; Ramachandran, Prakash/0000-0001-5996-2413; Iredale, John/0000-0003-2174-5127	MRC; Sir Jules Thorn Trust; Wellcome Trust; Cancer Research UK [12481] Funding Source: researchfish; Medical Research Council [G0600033, G1000868, G0901697, MR/J010766/1, G0700711B] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [07JTA] Funding Source: researchfish; MRC [G1000868, G0600033, MR/J010766/1, G0901697] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sir Jules Thorn Trust; Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Sir Jules Thorn Charitable Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Clodronate (Cl<INF>2</INF>MDP) was a gift of Roche Diagnostics (Mannheim, Germany). Thanks to R. Aucott (UK Medical Research Council (MRC)/University of Edinburgh Centre for Inflammation Research) for the donation of mouse hepatic fibroblasts. Krt19CreER<SUP>T</SUP> mice were a kind gift from G. Gu (Vanderbilt University), and the Ctnnb1<SUP>Delta Ex3</SUP> strain was provided by O. Sansom (The Beatson Institute for Cancer Research, Glasgow). S.J.F. is supported by the MRC, Sir Jules Thorn Trust and Wellcome Trust; L.G.B. is funded through an MRC project grant and was supported through an MRC studentship.	Akhurst B, 2001, HEPATOLOGY, V34, P519, DOI 10.1053/jhep.2001.26751; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Burke ZD, 2009, GASTROENTEROLOGY, V136, P2316, DOI 10.1053/j.gastro.2009.02.063; Cardinale V, 2011, HEPATOLOGY, V54, P2159, DOI 10.1002/hep.24590; Cheng X, 2008, DEVELOPMENT, V135, P3447, DOI 10.1242/dev.025916; Choi SS, 2011, INT J BIOCHEM CELL B, V43, P238, DOI 10.1016/j.biocel.2010.10.015; Chung EY, 2006, CELL RES, V16, P154, DOI 10.1038/sj.cr.7310021; Clotman F, 2002, DEVELOPMENT, V129, P1819; Crosnier C, 2000, HEPATOLOGY, V32, P574, DOI 10.1053/jhep.2000.16600; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Fallowfield JA, 2007, J IMMUNOL, V178, P5288, DOI 10.4049/jimmunol.178.8.5288; Fellous TG, 2009, HEPATOLOGY, V49, P1655, DOI 10.1002/hep.22791; Fickert P, 2007, AM J PATHOL, V171, P525, DOI 10.2353/ajpath.2007.061133; Fletcher J, 2008, CLONING STEM CELLS, V10, P331, DOI 10.1089/clo.2007.0094; Frise E, 1996, P NATL ACAD SCI USA, V93, P11925, DOI 10.1073/pnas.93.21.11925; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Glise B, 2002, DEV BIOL, V248, P93, DOI 10.1006/dbio.2002.0720; Goessling W, 2008, DEV BIOL, V320, P161, DOI 10.1016/j.ydbio.2008.05.526; Gouw ASH, 2011, HEPATOLOGY, V54, P1853, DOI 10.1002/hep.24613; Hay DC, 2010, GASTROENTEROLOGY, V139, P729, DOI 10.1053/j.gastro.2010.07.013; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hofmann JJ, 2010, DEVELOPMENT, V137, P4061, DOI 10.1242/dev.052118; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Karner CM, 2009, NAT GENET, V41, P793, DOI 10.1038/ng.400; Katoh M, 2006, INT J MOL MED, V18, P517; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; Lee YJ, 1999, J BIOL CHEM, V274, P1566, DOI 10.1074/jbc.274.3.1566; Lemaigre FP, 2008, HEPATOLOGY, V48, P358, DOI 10.1002/hep.22480; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; Lorenzini S, 2010, GUT, V59, P645, DOI 10.1136/gut.2009.182345; Lozier J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001851; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; McCright B, 2002, DEVELOPMENT, V129, P1075; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; McGill MA, 2009, J BIOL CHEM, V284, P26427, DOI 10.1074/jbc.M109.014845; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Nijjar SS, 2001, HEPATOLOGY, V34, P1184, DOI 10.1053/jhep.2001.29399; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Omenetti A, 2008, GUT, V57, P1275, DOI 10.1136/gut.2008.148619; Omenetti A, 2011, CURR OPIN GASTROEN, V27, P268, DOI 10.1097/MOG.0b013e32834550b4; Park J, 2010, DEV DYNAM, V239, P514, DOI 10.1002/dvdy.22192; Polakos NK, 2006, AM J PATHOL, V168, P1169, DOI 10.2353/ajpath.2006.050875; Reddy SM, 2002, J IMMUNOL, V169, P702, DOI 10.4049/jimmunol.169.2.702; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; Sparks EE, 2010, HEPATOLOGY, V51, P1391, DOI 10.1002/hep.23431; Spee B, 2010, GUT, V59, P247, DOI 10.1136/gut.2009.188367; Tanimizu N, 2004, J CELL SCI, V117, P3165, DOI 10.1242/jcs.01169; Tirnitz-Parker JEE, 2007, INT J BIOCHEM CELL B, V39, P2226, DOI 10.1016/j.biocel.2007.06.008; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Van Hul NKM, 2009, HEPATOLOGY, V49, P1625, DOI 10.1002/hep.22820; VANHOUTE L, 1993, J BIOL CHEM, V268, P18083; VanRooijen N, 1996, HEPATOLOGY, V23, P1239; Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100; *WHO, 2009, DIS INJ COUNTR EST B; Yamasaki H, 2006, DEVELOPMENT, V133, P4233, DOI 10.1242/dev.02591	59	524	546	3	124	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2012	18	4					572	579		10.1038/nm.2667	http://dx.doi.org/10.1038/nm.2667			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22388089	Green Accepted			2022-12-25	WOS:000302617800034
J	Kalivas, PW; Brady, K				Kalivas, Peter W.; Brady, Kathleen			Hatching the addiction egg	NATURE MEDICINE			English	Editorial Material							NUCLEUS-ACCUMBENS; COCAINE; IMPULSIVITY; PLASTICITY		[Kalivas, Peter W.; Brady, Kathleen] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Kalivas, Peter W.; Brady, Kathleen] Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Kalivas, PW (corresponding author), Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA.	kalivasp@musc.edu		Brady, Kathleen/0000-0002-3944-8051	NIDA NIH HHS [R01 DA003906, R01 DA012513] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA003906, R01DA012513] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Ersche KD, 2012, SCIENCE, V335, P601, DOI 10.1126/science.1214463; Goldstein RZ, 2009, TRENDS COGN SCI, V13, P372, DOI 10.1016/j.tics.2009.06.004; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kasanetz F, 2010, SCIENCE, V328, P1709, DOI 10.1126/science.1187801; Knackstedt LA, 2010, J NEUROSCI, V30, P7984, DOI 10.1523/JNEUROSCI.1244-10.2010; Martin M, 2006, NAT NEUROSCI, V9, P868, DOI 10.1038/nn1713; Merikangas KR, 1998, ARCH GEN PSYCHIAT, V55, P973, DOI 10.1001/archpsyc.55.11.973; Moussawi K, 2009, NAT NEUROSCI, V12, P182, DOI 10.1038/nn.2250; Olive M Foster, 2009, Curr Drug Abuse Rev, V2, P83; Perry JL, 2008, PSYCHOPHARMACOLOGY, V200, P1, DOI 10.1007/s00213-008-1173-0; Wolf ME, 2010, TRENDS NEUROSCI, V33, P391, DOI 10.1016/j.tins.2010.06.003	14	7	7	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2012	18	4					502	503		10.1038/nm.2726	http://dx.doi.org/10.1038/nm.2726			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22481410				2022-12-25	WOS:000302617800025
J	Blank, M; Tang, Y; Yamashita, M; Burkett, SS; Cheng, SY; Zhang, YE				Blank, Michael; Tang, Yi; Yamashita, Motozo; Burkett, Sandra S.; Cheng, Steven Y.; Zhang, Ying E.			A tumor suppressor function of Smurf2 associated with controlling chromatin landscape and genome stability through RNF20	NATURE MEDICINE			English	Article							UBIQUITIN LIGASE SMURF2; BREAST-CANCER CELLS; HISTONE H2B; DEPENDENT DEGRADATION; H3 METHYLATION; UBIQUITYLATION; DNA; MONOUBIQUITINATION; ELONGATION; EXPRESSION	In addition to allelic mutations, cancers are known to harbor alterations in their chromatin landscape. Here we show that genomic ablation of Smad ubiquitin regulatory factor 2 (Smurf2), a HECT-domain E3 ubiquitin ligase, results in dysregulation of both the DNA damage response and genomic stability, culminating in increased susceptibility to various types of cancers in aged mice. We show that Smurf2 regulates the monoubiquitination of histone H2B as well as the trimethylation of histone H3 at Lys4 and Lys79 by targeting ring finger protein 20 (RNF20) for proteasomal degradation in both mouse and human cells. We also show that Smurf2 and RNF20 are colocalized at the gamma-H2AX foci of double-stranded DNA breaks in the nucleus. Thus, Smurf2 has a tumor suppression function that normally maintains genomic stability by controlling the epigenetic landscape of histone modifications through RNF20.	[Blank, Michael; Tang, Yi; Yamashita, Motozo; Zhang, Ying E.] NCI, Cellular & Mol Biol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Burkett, Sandra S.] NCI, Mouse Canc Genet Program, Frederick, MD 21701 USA; [Cheng, Steven Y.] Nanjing Med Univ, Dept Dev Genet, Sch Basic Med Sci, Nanjing, Jiangsu, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Nanjing Medical University	Zhang, YE (corresponding author), NCI, Cellular & Mol Biol Lab, Ctr Canc Res, Bldg 37, Bethesda, MD 20892 USA.	zhangyin@mail.nih.gov	Zhang, Ying E/G-3657-2015	Zhang, Ying E/0000-0003-2753-7601; Burkett, Sandra/0000-0002-5476-4028	US National Cancer Institute, US National Institutes of Health, Center for Cancer Research; Japan Society for the Promotion of Science [21689053]; NATIONAL CANCER INSTITUTE [ZIABC011168] Funding Source: NIH RePORTER	US National Cancer Institute, US National Institutes of Health, Center for Cancer Research; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Anver for pathology services, V. Barr for assistance with microscope, X. Wu for assistance with the microarray experiments, N. Morris for the animal husbandry and N. Teja for assistance with cell culture. We also thank K. Sixt for comments on the manuscript. This research is supported by the Intramural Research Program of the US National Cancer Institute, US National Institutes of Health, Center for Cancer Research. M.Y. was partially supported by the Japan Society for the Promotion of Science grant 21689053.	Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Falk M, 2008, BBA-MOL CELL RES, V1783, P2398, DOI 10.1016/j.bbamcr.2008.07.010; Fierz B, 2011, NAT CHEM BIOL, V7, P113, DOI 10.1038/NCHEMBIO.501; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Fukuchi M, 2002, CANCER RES, V62, P7162; Fukunaga E, 2008, J BIOL CHEM, V283, P35660, DOI 10.1074/jbc.M710496200; Haber D, 1997, NAT GENET, V16, P320, DOI 10.1038/ng0897-320; HARVEY DM, 1991, GENE DEV, V5, P2375, DOI 10.1101/gad.5.12b.2375; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Jin CY, 2009, CANCER RES, V69, P735, DOI 10.1158/0008-5472.CAN-08-1463; Johnstone SE, 2010, NAT REV GENET, V11, P806, DOI 10.1038/nrg2881; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Li HX, 2004, ONCOGENE, V23, P1801, DOI 10.1038/sj.onc.1207319; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Montecucco A, 2007, CANCER LETT, V252, P9, DOI 10.1016/j.canlet.2006.11.005; Moyal L, 2011, MOL CELL, V41, P529, DOI 10.1016/j.molcel.2011.02.015; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Nakamura K, 2011, MOL CELL, V41, P515, DOI 10.1016/j.molcel.2011.02.002; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Schwamborn JC, 2007, EMBO J, V26, P1410, DOI 10.1038/sj.emboj.7601580; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tang LY, 2011, EMBO J, V30, P4777, DOI 10.1038/emboj.2011.393; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Zhang H, 2004, GENE DEV, V18, P3028, DOI 10.1101/gad.1253004; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	38	114	122	1	19	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2012	18	2					227	234		10.1038/nm.2596	http://dx.doi.org/10.1038/nm.2596			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	890JG	22231558	Green Accepted			2022-12-25	WOS:000300140300036
J	Dimova, NV; Hathaway, NA; Lee, BH; Kirkpatrick, DS; Berkowitz, ML; Gygi, SP; Finley, D; King, RW				Dimova, Nevena V.; Hathaway, Nathaniel A.; Lee, Byung-Hoon; Kirkpatrick, Donald S.; Berkowitz, Marie Lea; Gygi, Steven P.; Finley, Daniel; King, Randall W.			APC/C-mediated multiple monoubiquitylation provides an alternative degradation signal for cyclin B1	NATURE CELL BIOLOGY			English	Article							POLYUBIQUITIN CHAINS; UBIQUITIN CHAINS; PROTEIN; RECOGNITION; PROTEASOME; REVEALS; COMPLEX; BINDING; RPN10; MONOUBIQUITINATION	The anaphase-promoting complex or cyclosome (APC/C) initiates mitotic exit by ubiquitylating cell-cycle regulators such as cyclin B1 and securin. Lys 48-linked ubiquitin chains represent the canonical signal targeting proteins for degradation by the proteasome, but they are not required for the degradation of cyclin B1. Lys 11-linked ubiquitin chains have been implicated in degradation of APC/C substrates, but the Lys 11-chain-forming E2 UBE2S is not essential for mitotic exit, raising questions about the nature of the ubiquitin signal that targets APC/C substrates for degradation. Here we demonstrate that multiple monoubiquitylation of cyclin B1, catalysed by UBCH10 or UBC4/5, is sufficient to target cyclin B1 for destruction by the proteasome. When the number of ubiquitylatable lysines in cyclin B1 is restricted, Lys 11-linked ubiquitin polymers elaborated by UBE2S become increasingly important. We therefore explain how a substrate that contains multiple ubiquitin acceptor sites confers flexibility in the requirement for particular E2 enzymes in modulating the rate of ubiquitin-dependent proteolysis.	[Dimova, Nevena V.; Hathaway, Nathaniel A.; Lee, Byung-Hoon; Kirkpatrick, Donald S.; Berkowitz, Marie Lea; Gygi, Steven P.; Finley, Daniel; King, Randall W.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	King, RW (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	randy_king@hms.harvard.edu		Kirkpatrick, Donald/0000-0003-3091-2804; King, Randall/0000-0001-7882-8180; Lee, Byung-Hoon/0000-0002-7101-0471	NIH [GM66492, GM095526]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043601, R56GM066492, R01GM095526, R01GM066492] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Morgan (UCSF, USA) for baculoviruses encoding human cyclin B1 and CDK1. Human ubiquitin cloned in pET3a was a gift from C. M. Pickart (Johns Hopkins University, USA). Antibody for UBCH10 immunodepletion was a gift from H. Yu (UT Southwestern, USA). We thank M. Aguiar (Gygi laboratory, Harvard Medical School, USA) for carrying out mass spectrometry to confirm the presence of UBE2S and USP14 in Xenopus egg extract, and H. Besche and S. Elsasser (Harvard Medical School, USA), as well as K. Sackton and F. Sigoillot and the remaining members of the King laboratory, for helpful discussions. This work was financially supported by NIH GM66492 to R.W.K. and GM095526 to D.F.	Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Beal RE, 1998, BIOCHEMISTRY-US, V37, P2925, DOI 10.1021/bi972514p; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Boutet SC, 2007, CELL, V130, P349, DOI 10.1016/j.cell.2007.05.044; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Choi E, 2009, EMBO J, V28, P2077, DOI 10.1038/emboj.2009.123; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Guterman A, 2004, J BIOL CHEM, V279, P1729, DOI 10.1074/jbc.M307050200; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Huang XD, 2011, MOL CELL, V42, P511, DOI 10.1016/j.molcel.2011.03.027; Isasa M, 2010, MOL CELL, V38, P733, DOI 10.1016/j.molcel.2010.05.001; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kirkpatrick DS, 2005, METHODS, V35, P265, DOI 10.1016/j.ymeth.2004.08.018; Kravtsova-Ivantsiv Y, 2009, MOL CELL, V33, P496, DOI 10.1016/j.molcel.2009.01.023; Lam YA, 1997, J BIOL CHEM, V272, P28438, DOI 10.1074/jbc.272.45.28438; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lee S, 2006, NAT STRUCT MOL BIOL, V13, P264, DOI 10.1038/nsmb1064; Matiuhin Y, 2008, MOL CELL, V32, P415, DOI 10.1016/j.molcel.2008.10.011; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Rao H, 2002, J BIOL CHEM, V277, P11691, DOI 10.1074/jbc.M200245200; Riedinger C, 2010, J BIOL CHEM, V285, P33992, DOI 10.1074/jbc.M110.134510; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Shang F, 2005, J BIOL CHEM, V280, P20365, DOI 10.1074/jbc.M414356200; Shih SC, 2000, EMBO J, V19, P187, DOI 10.1093/emboj/19.2.187; Sims JJ, 2009, NAT STRUCT MOL BIOL, V16, P883, DOI 10.1038/nsmb.1637; Skaar JR, 2009, CURR OPIN CELL BIOL, V21, P816, DOI 10.1016/j.ceb.2009.08.004; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Wu T, 2010, P NATL ACAD SCI USA, V107, P1355, DOI 10.1073/pnas.0912802107; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065	55	101	103	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2012	14	2					168	176		10.1038/ncb2425	http://dx.doi.org/10.1038/ncb2425			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	893CF	22286100	Green Submitted, Green Accepted			2022-12-25	WOS:000300332500011
J	Amson, R; Pece, S; Lespagnol, A; Vyas, R; Mazzarol, G; Tosoni, D; Colaluca, I; Viale, G; Rodrigues-Ferreira, S; Wynendaele, J; Chaloin, O; Hoebeke, J; Marine, JC; Di Fiore, PP; Telerman, A				Amson, Robert; Pece, Salvatore; Lespagnol, Alexandra; Vyas, Rajesh; Mazzarol, Giovanni; Tosoni, Daniela; Colaluca, Ivan; Viale, Giuseppe; Rodrigues-Ferreira, Sylvie; Wynendaele, Jessika; Chaloin, Olivier; Hoebeke, Johan; Marine, Jean-Christophe; Di Fiore, Pier Paolo; Telerman, Adam			Reciprocal repression between P53 and TCTP	NATURE MEDICINE			English	Article							CONTROLLED TUMOR PROTEIN; TRANSCRIPTIONAL REPRESSION; EXOSOME SECRETION; CELL-CYCLE; IN-VIVO; APOPTOSIS; GENE; REVERSION; CANCER; ACTIVATION	Screening for genes that reprogram cancer cells for the tumor reversion switch identified TCTP (encoding translationally controlled tumor protein) as a crucial regulator of apoptosis. Here we report a negative feedback loop between P53 and TCTP. TCTP promotes P53 degradation by competing with NUMB for binding to P53-MDM2-containing complexes. TCTP inhibits MDM2 auto-ubiquitination and promotes MDM2-mediated ubiquitination and degradation of P53. Notably, Tctp haploinsufficient mice are sensitized to P53-dependent apoptosis. In addition, P53 directly represses TCTPtranscription. In 508 breast cancers, high-TCTP status associates with poorly differentiated, aggressive G3-grade tumors, predicting poor prognosis (P < 0.0005). Tctp knockdown in primary mammary tumor cells from ErbB2 transgenic mice results in increased P53 expression and a decreased number of stem-like cancer cells. The pharmacological compounds sertraline and thioridazine increase the amount of P53 by neutralizing TCTP's action on the MDM2-P53 axis. This study links TCTP and P53 in a previously unidentified regulatory circuitry that may underlie the relevance of TCTP in cancer.	[Amson, Robert; Lespagnol, Alexandra; Rodrigues-Ferreira, Sylvie; Telerman, Adam] Ecole Normale Super, Lab Biotechnol & Pharmacol Genet Appl LBPA, CNRS, UMR 8113, Cachan, France; [Pece, Salvatore; Mazzarol, Giovanni; Tosoni, Daniela; Colaluca, Ivan; Viale, Giuseppe; Di Fiore, Pier Paolo] Ist Fdn Italiana Ric Canc FIRC Oncol Mol, Milan, Italy; [Pece, Salvatore; Mazzarol, Giovanni; Tosoni, Daniela; Colaluca, Ivan; Viale, Giuseppe; Di Fiore, Pier Paolo] Ist Europeo Oncol, Milan, Italy; [Pece, Salvatore; Mazzarol, Giovanni; Tosoni, Daniela; Colaluca, Ivan; Viale, Giuseppe; Di Fiore, Pier Paolo] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, Milan, Italy; [Vyas, Rajesh; Wynendaele, Jessika; Marine, Jean-Christophe] VIB Katholieke Univ Leuven KULeuven, Ctr Biol Dis, Lab Mol Canc Biol, Louvain, Belgium; [Chaloin, Olivier; Hoebeke, Johan] Unite Propre UPR CNRS 9021, Inst Biol Mol & Cellulaire, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); University of Milan; Flanders Institute for Biotechnology (VIB)	Telerman, A (corresponding author), Ecole Normale Super, Lab Biotechnol & Pharmacol Genet Appl LBPA, CNRS, UMR 8113, Cachan, France.	telerman@noos.fr	Marine, Jean Christophe/J-2237-2015; Viale, Giuseppe/AAE-8921-2019; Pece, Salvatore/B-9609-2013; Marine, Jean-Christophe/K-3292-2016; Di Fiore, Pier Paolo/K-2130-2012; Tosoni, Daniela/K-4524-2014; 高, 雨莉/HGU-8187-2022; colaluca, ivan nicola/AAB-2571-2019; Colaluca, Ivan Nicola/K-9776-2016	Pece, Salvatore/0000-0003-1764-3929; Marine, Jean-Christophe/0000-0003-2433-9837; Di Fiore, Pier Paolo/0000-0002-2252-0950; Vyas, Rajesh/0000-0001-9427-5942; Colaluca, Ivan Nicola/0000-0002-3371-112X	Agence Nationale de la Recherche Programme Blanc [ANR-09-BLAN-0292-01]; European Union; Association Sclerose Tubereuse de Bourneville; Associazione Italiana per la Ricerca sul Cancro; Italian Ministries of Education University Research (MIUR); Italian Ministry of Health; European Community; European Research Council; Ferrari Foundation; Monzino Foundation and the Cassa Risparmio Provincie Lombarde (CARIPLO) Foundation; Vollaro Foundation; Agency for Innovation by Science and Technology (IWT)	Agence Nationale de la Recherche Programme Blanc(French National Research Agency (ANR)); European Union(European Commission); Association Sclerose Tubereuse de Bourneville; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministries of Education University Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy); European Community(European Commission); European Research Council(European Research Council (ERC)European Commission); Ferrari Foundation; Monzino Foundation and the Cassa Risparmio Provincie Lombarde (CARIPLO) Foundation; Vollaro Foundation; Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	A.T. and R.A. dedicate this work to G. Schnek for his sustained care. We thank C. Auclair for constant support; D. Galvagno for technical assistance; G. D'Ario and S. Confalonieri for statistical analyses; and B. Vogelstein (Johns Hopkins University), M. Oren (Weizmann Institute of Science) and B. Wasilyk and C. lArasilyk (IGBMC Illkirch) for HCT116, H1299 Trp53-null, temperature-sensitive P53 Val138 mutant cells, and P53 protein and plasmids, respectively. This work was supported by grants from the Agence Nationale de la Recherche Programme Blanc (ANR-09-BLAN-0292-01), the European Union Network of Excellence CONTICANET and the Association Sclerose Tubereuse de Bourneville to A.T. and R.A., the Associazione Italiana per la Ricerca sul Cancro and the Italian Ministries of Education University Research (MIUR) and the Italian Ministry of Health to S.P. and P.P.D.F., the European Community (FP6 and FP7), the European Research Council, the Ferrari Foundation, the Monzino Foundation and the Cassa Risparmio Provincie Lombarde (CARIPLO) Foundation to P.P.D.F. and the G. Vollaro Foundation to S.P. J.W. received support from Agency for Innovation by Science and Technology (IWT).	Amson RB, 1996, P NATL ACAD SCI USA, V93, P3953, DOI 10.1073/pnas.93.9.3953; Amson R, 2011, CELL CYCLE, V10, P1, DOI 10.4161/cc.10.1.14288; Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Baltzis D, 2007, J BIOL CHEM, V282, P31675, DOI 10.1074/jbc.M704491200; Bazile F, 2009, CARCINOGENESIS, V30, P555, DOI 10.1093/carcin/bgp022; Bommer UA, 2010, ONCOGENE, V29, P763, DOI 10.1038/onc.2009.380; Bommer UA, 2002, RNA, V8, P478, DOI 10.1017/S1355838202022586; Bommer UA, 2004, INT J BIOCHEM CELL B, V36, P379, DOI 10.1016/S1357-2725(03)00213-9; Brioudes F, 2010, P NATL ACAD SCI USA, V107, P16384, DOI 10.1073/pnas.1007926107; Chen SH, 2007, MOL BIOL CELL, V18, P2525, DOI 10.1091/mbc.E07-02-0188; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Deng Shi-Shan, 2006, Genomics Proteomics & Bioinformatics, V4, P165, DOI 10.1016/S1672-0229(06)60029-6; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FISCELLA M, 1993, ONCOGENE, V8, P1519; Fiucci G, 2004, P NATL ACAD SCI USA, V101, P3510, DOI 10.1073/pnas.0400177101; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARPER JW, 1993, CELL, V75, P805; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Johnson RA, 2001, J BIOL CHEM, V276, P27716, DOI 10.1074/jbc.C100121200; Juven-Gershon T, 1998, MOL CELL BIOL, V18, P3974, DOI 10.1128/MCB.18.7.3974; Koziol MJ, 2007, CURR BIOL, V17, P801, DOI 10.1016/j.cub.2007.03.062; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; Lespagnol A, 2008, CELL DEATH DIFFER, V15, P1723, DOI 10.1038/cdd.2008.104; Li F, 2001, J BIOL CHEM, V276, P47542, DOI 10.1074/jbc.M108954200; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Linares-Cruz G, 1998, P NATL ACAD SCI USA, V95, P1131, DOI 10.1073/pnas.95.3.1131; Liu H, 2005, MOL CELL BIOL, V25, P3117, DOI 10.1128/MCB.25.8.3117-3126.2005; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nemani M, 1996, P NATL ACAD SCI USA, V93, P9039, DOI 10.1073/pnas.93.17.9039; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Passer BJ, 2003, P NATL ACAD SCI USA, V100, P2284, DOI 10.1073/pnas.0530298100; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Rho SB, 2011, FEBS LETT, V585, P29, DOI 10.1016/j.febslet.2010.11.014; Roperch JP, 1998, NAT MED, V4, P835, DOI 10.1038/nm0798-835; Sanchez JC, 1997, ELECTROPHORESIS, V18, P150, DOI 10.1002/elps.1150180127; SELVAKUMARAN M, 1994, ONCOGENE, V9, P1791; Susini L, 2008, CELL DEATH DIFFER, V15, P1211, DOI 10.1038/cdd.2008.18; Susini L, 2001, P NATL ACAD SCI USA, V98, P15067, DOI 10.1073/pnas.261571998; TELERMAN A, 1993, P NATL ACAD SCI USA, V90, P8702, DOI 10.1073/pnas.90.18.8702; Telerman A, 2009, NAT REV CANCER, V9, P206, DOI 10.1038/nrc2589; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tuynder M, 2004, P NATL ACAD SCI USA, V101, P15364, DOI 10.1073/pnas.0406776101; Tuynder M, 2002, P NATL ACAD SCI USA, V99, P14976, DOI 10.1073/pnas.222470799; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Yoon CH, 2009, P NATL ACAD SCI USA, V106, P7852, DOI 10.1073/pnas.0812148106; Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579	60	143	149	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					91	99		10.1038/nm.2546	http://dx.doi.org/10.1038/nm.2546			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22157679				2022-12-25	WOS:000299018600034
J	Broderick, P; Chubb, D; Johnson, DC; Weinhold, N; Forsti, A; Lloyd, A; Olver, B; Ma, YP; Dobbins, SE; Walker, BA; Davies, FE; Gregory, WA; Child, JA; Ross, FM; Jackson, GH; Neben, K; Jauch, A; Hoffmann, P; Muhleisen, TW; Nothen, MM; Moebus, S; Tomlinson, IP; Goldschmidt, H; Hemminki, K; Morgan, GJ; Houlston, RS				Broderick, Peter; Chubb, Daniel; Johnson, David C.; Weinhold, Niels; Foersti, Asta; Lloyd, Amy; Olver, Bianca; Ma, Yussanne P.; Dobbins, Sara E.; Walker, Brian A.; Davies, Faith E.; Gregory, Walter A.; Child, J. Anthony; Ross, Fiona M.; Jackson, Graham H.; Neben, Kai; Jauch, Anna; Hoffmann, Per; Muehleisen, Thomas W.; Noethen, Markus M.; Moebus, Susanne; Tomlinson, Ian P.; Goldschmidt, Hartmut; Hemminki, Kari; Morgan, Gareth J.; Houlston, Richard S.			Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; UNDETERMINED SIGNIFICANCE; MONOCLONAL GAMMOPATHY; SUSCEPTIBILITY LOCI; STRATIFICATION; CLASSIFICATION; ABNORMALITIES; PATHOGENESIS; METAANALYSIS; PROGNOSIS	To identify risk variants for multiple myeloma, we conducted a genome-wide association study of 1,675 individuals with multiple myeloma and 5,903 control subjects. We identified risk loci for multiple myeloma at 3p22.1 (rs1052501 in ULK4; odds ratio (OR) = 1.32; P = 7.47 x 10(-9)) and 7p15.3 (rs4487645, OR = 1.38; P = 3.33 x 10(-15)). In addition, we observed a promising association at 2p23.3 (rs6746082, OR = 1.29; P = 1.22 x 10(-7)). Our study identifies new genomic regions associated with multiple myeloma risk that may lead to new etiological insights.	[Broderick, Peter; Chubb, Daniel; Lloyd, Amy; Olver, Bianca; Ma, Yussanne P.; Dobbins, Sara E.; Houlston, Richard S.] Inst Canc Res, Div Genet & Epidemiol, Surrey, England; [Johnson, David C.; Walker, Brian A.; Davies, Faith E.; Morgan, Gareth J.; Houlston, Richard S.] Inst Canc Res, Div Mol Pathol, Haematooncol Res Unit, Surrey, England; [Weinhold, Niels; Neben, Kai; Goldschmidt, Hartmut] Univ Heidelberg, Dept Internal Med 5, Heidelberg, Germany; [Foersti, Asta] German Canc Res Ctr, D-6900 Heidelberg, Germany; [Gregory, Walter A.; Child, J. Anthony] Univ Leeds, Clin Trials Res Unit, Leeds, W Yorkshire, England; [Ross, Fiona M.] Wessex Reg Cytogenet Lab, Cytogenet Grp, Salisbury, Wilts, England; [Jackson, Graham H.] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Jauch, Anna] Univ Heidelberg, Inst Human Genet, Heidelberg, Germany; [Hoffmann, Per; Muehleisen, Thomas W.; Noethen, Markus M.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Noethen, Markus M.] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Moebus, Susanne] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Tomlinson, Ian P.] Wellcome Trust Ctr Human Genet, Oxford, England; [Goldschmidt, Hartmut] Natl Ctr Tumour Dis, Heidelberg, Germany; [Hemminki, Kari] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden	University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Leeds; Newcastle University - UK; Ruprecht Karls University Heidelberg; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Duisburg Essen; University of Oxford; Wellcome Centre for Human Genetics; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Lund University	Houlston, RS (corresponding author), Inst Canc Res, Div Genet & Epidemiol, Surrey, England.	richard.houlston@icr.ac.uk	Walker, Brian/A-4984-2013; Jackson, Graham/GMW-7638-2022; Goldschmidt, Hartmut/AAL-8069-2021; Hoffmann, Per/A-5149-2010	Jackson, Graham/0000-0003-0756-969X; Hoffmann, Per/0000-0002-6573-983X; Davies, Faith/0000-0002-3971-2393; Houlston, Richard/0000-0002-5268-0242; Nothen, Markus/0000-0002-8770-2464; morgan, gareth/0000-0002-4271-6360; Broderick, Peter/0000-0002-8348-5829; Moebus, Susanne/0000-0002-0072-5410; Walker, Brian/0000-0002-8615-6254	Heinz-Nixdorf Foundation; German Centre for Neurodegenerative Disorders (DZNE), Bonn; Myeloma UK; Cancer Research UK [C1298/A8362]; Bobby Moore Fund; Leukaemia Lymphoma Research Fund; National Health Services (NHS) through the Biological Research Centre of the National Institute for Health Research at the Royal Marsden Hospital NHS Trust; APO-STS (European Union) [Health-F4-2007-200767]; German Ministry of Education and Science; German Research Council (DFG) [SI 236/8-1, SI236/9-1, ER 155/6-1]	Heinz-Nixdorf Foundation; German Centre for Neurodegenerative Disorders (DZNE), Bonn; Myeloma UK; Cancer Research UK(Cancer Research UK); Bobby Moore Fund; Leukaemia Lymphoma Research Fund; National Health Services (NHS) through the Biological Research Centre of the National Institute for Health Research at the Royal Marsden Hospital NHS Trust; APO-STS (European Union); German Ministry of Education and Science; German Research Council (DFG)(German Research Foundation (DFG))	We are grateful to all study participants and investigators at the individual centers for taking part. We are extremely grateful to all investigators who contributed to the generation of this data set. We also thank the staff of the Clinical Trials Research Unit (CTRU), University of Leeds, and the National Cancer Research Institute (NCRI) Haematology Clinical Studies Group. We are grateful to all investigators who contributed to the Colorectal Tumour Gene Identification (CORGI) consortium, from which controls in the replication analysis were drawn. The current study made use of genotyping data on the 1958 Birth Cohort. Genotyping data for control subjects was generated by the Wellcome Trust Sanger Institute. A full list of the investigators who contributed to the generation of the data is available from the WTCCC website (see URLs). The GWAS made use of genotyping data from the population-based HNR study. The HNR study was supported by the Heinz-Nixdorf Foundation. The genotyping of the HNR subjects on Illumina HumanOmni1-Quad BeadChips was financed by the German Centre for Neurodegenerative Disorders (DZNE), Bonn. Myeloma UK provided the main funding for the study. Additional funding was provided by Cancer Research UK (C1298/A8362 supported by the Bobby Moore Fund), the Leukaemia Lymphoma Research Fund and the National Health Services (NHS) through the Biological Research Centre of the National Institute for Health Research at the Royal Marsden Hospital NHS Trust. In Germany, funding was provided to Dietmar-Hopp-Stiftung in Walldorf, the University Hospital Heidelberg and a grant from APO-STS (European Union Health-F4-2007-200767). Additionally, the study was funded by the German Ministry of Education and Science and the German Research Council (DFG; Projects SI 236/8-1, SI236/9-1 and ER 155/6-1).	Altieri A, 2006, EUR J CANCER, V42, P1661, DOI 10.1016/j.ejca.2005.11.033; Blake DJ, 1998, P NATL ACAD SCI USA, V95, P241, DOI 10.1073/pnas.95.1.241; Chiecchio L, 2006, LEUKEMIA, V20, P1610, DOI 10.1038/sj.leu.2404304; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Crowther-Swanepoel D, 2010, NAT GENET, V42, P132, DOI 10.1038/ng.510; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Debes-Marun CS, 2003, LEUKEMIA, V17, P427, DOI 10.1038/sj.leu.2402797; DEWALD GW, 1985, BLOOD, V66, P380; Dib Amel, 2008, J Natl Cancer Inst Monogr, P25, DOI 10.1093/jncimonographs/lgn011; Enciso-Mora V, 2010, NAT GENET, V42, P1126, DOI 10.1038/ng.696; Ferretti V, 2007, NUCLEIC ACIDS RES, V35, pD122, DOI 10.1093/nar/gkl879; Fonseca R, 2009, LEUKEMIA, V23, P2210, DOI 10.1038/leu.2009.174; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Houlston RS, 1996, QJM-INT J MED, V89, P737, DOI 10.1093/qjmed/89.10.737; Huang A, 2005, CANCER RES, V65, P5607, DOI 10.1158/0008-5472.CAN-05-0500; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Kyle RA, 2002, NEW ENGL J MED, V346, P564, DOI 10.1056/NEJMoa01133202; Landgren O, 2009, LEUKEMIA, V23, P1691, DOI 10.1038/leu.2009.134; Landgren O, 2009, BLOOD, V114, P791, DOI 10.1182/blood-2008-12-191676; Liang CY, 2010, CURR OPIN CELL BIOL, V22, P226, DOI 10.1016/j.ceb.2009.11.003; Maertens GN, 2006, J CELL SCI, V119, P2563, DOI 10.1242/jcs.02995; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Morgan GJ, 2010, LANCET, V376, P1989, DOI 10.1016/S0140-6736(10)62051-X; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Neben K, 2010, HAEMATOL-HEMATOL J, V95, P1150, DOI 10.3324/haematol.2009.016436; Ocio EM, 2008, LANCET ONCOL, V9, P1157, DOI 10.1016/S1470-2045(08)70304-8; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Pettiti D, 1994, METAANALYSIS DECISIO; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schmermund A, 2002, AM HEART J, V144, P212, DOI 10.1067/mhj.2002.123579; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Taddesse-Heath L, 2010, MODERN PATHOL, V23, P991, DOI 10.1038/modpathol.2010.72; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Walker BA, 2006, BLOOD, V108, P1733, DOI 10.1182/blood-2006-02-005496; Walker BA, 2010, BLOOD, V116, pE56, DOI 10.1182/blood-2010-04-279596; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wuilleme S, 2005, LEUKEMIA, V19, P275, DOI 10.1038/sj.leu.2403586	43	112	113	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2012	44	1					58	U83		10.1038/ng.993	http://dx.doi.org/10.1038/ng.993			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	22120009	Green Accepted			2022-12-25	WOS:000298664000014
J	Connell, JL; Whiteley, M; Shear, JB				Connell, Jodi L.; Whiteley, Marvin; Shear, Jason B.			Sociomicrobiology in engineered landscapes	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN HYDROGELS; QUORUM; FABRICATION; BIOFILMS		[Connell, Jodi L.; Shear, Jason B.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Connell, Jodi L.; Whiteley, Marvin; Shear, Jason B.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Whiteley, Marvin] Univ Texas Austin, Dept Mol Genet & Microbiol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Connell, JL (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA.	mwhiteley@austin.utexas.edu; jshear@mail.utexas.edu			NIAID NIH HHS [5R01AI075068, 5R03AI081216] Funding Source: Medline; NIDCR NIH HHS [R01 DE020100] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI081216, R01AI075068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020100] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Boedicker JQ, 2009, ANGEW CHEM INT EDIT, V48, P5908, DOI 10.1002/anie.200901550; Carnes EC, 2010, NAT CHEM BIOL, V6, P41, DOI [10.1038/NCHEMBIO.264, 10.1038/nchembio.264]; Chun CK, 2004, P NATL ACAD SCI USA, V101, P3587, DOI 10.1073/pnas.0308750101; Connell JL, 2010, MBIO, V1, DOI 10.1128/mBio.00202-10; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; De Kievit TR, 2001, APPL ENVIRON MICROB, V67, P1865, DOI 10.1128/AEM.67.4.1865-1873.2001; Donnenberg MS, 2001, J CLIN INVEST, V107, P539, DOI 10.1172/JCI12404; Hall-Stoodley L, 2005, TRENDS MICROBIOL, V13, P7, DOI 10.1016/j.tim.2004.11.004; Hense BA, 2007, NAT REV MICROBIOL, V5, P230, DOI 10.1038/nrmicro1600; Hill RT, 2005, J AM CHEM SOC, V127, P10707, DOI 10.1021/ja052211f; Horswill AR, 2007, ANAL BIOANAL CHEM, V387, P371, DOI 10.1007/s00216-006-0720-y; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kaehr B, 2004, P NATL ACAD SCI USA, V101, P16104, DOI 10.1073/pnas.0407204101; Kaehr B, 2008, P NATL ACAD SCI USA, V105, P8850, DOI 10.1073/pnas.0709571105; Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130; Khripin CY, 2010, SOFT MATTER, V6, P2842, DOI 10.1039/c001193b; Kuebler S. M., 2001, Journal of Photopolymer Science and Technology, V14, P657, DOI 10.2494/photopolymer.14.657; Liu XH, 2011, P NATL ACAD SCI USA, V108, P2668, DOI 10.1073/pnas.1018391108; Loka Bharathi P.A., 2004, MARINE MICROBIOLOGY, P27; Nielson R, 2009, SMALL, V5, P120, DOI 10.1002/smll.200801084; Pitts JD, 2000, MACROMOLECULES, V33, P1514, DOI 10.1021/ma9910437; Ramsey MM, 2009, P NATL ACAD SCI USA, V106, P1578, DOI 10.1073/pnas.0809533106; RITSCHDORFF ET, 2010, MAT RES SOC S P SERI, V1272; Seidlits SK, 2009, ADV FUNCT MATER, V19, P3543, DOI 10.1002/adfm.200901115; ten Cate JM, 2006, ODONTOLOGY, V94, P1, DOI 10.1007/s10266-006-0063-3	25	19	20	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					10	13		10.1038/nchembio.749	http://dx.doi.org/10.1038/nchembio.749			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22173344				2022-12-25	WOS:000298414100004
J	Jiang, ML; Wang, JW; Fu, JR; Du, L; Jeong, H; West, T; Xiang, L; Peng, Q; Hou, ZP; Cai, H; Seredenina, T; Arbez, N; Zhu, SS; Sommers, K; Qian, J; Zhang, JY; Mori, S; Yang, XW; Tamashiro, KLK; Aja, S; Moran, TH; Luthi-Carter, R; Martin, B; Maudsley, S; Mattson, MP; Cichewicz, RH; Ross, CA; Holtzman, DM; Krainc, D; Duan, WZ				Jiang, Mali; Wang, Jiawei; Fu, Jinrong; Du, Lin; Jeong, Hyunkyung; West, Tim; Xiang, Lan; Peng, Qi; Hou, Zhipeng; Cai, Huan; Seredenina, Tamara; Arbez, Nicolas; Zhu, Shanshan; Sommers, Katherine; Qian, Jennifer; Zhang, Jiangyang; Mori, Susumu; Yang, X. William; Tamashiro, Kellie L. K.; Aja, Susan; Moran, Timothy H.; Luthi-Carter, Ruth; Martin, Bronwen; Maudsley, Stuart; Mattson, Mark P.; Cichewicz, Robert H.; Ross, Christopher A.; Holtzman, David M.; Krainc, Dimitri; Duan, Wenzhen			Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets	NATURE MEDICINE			English	Article							TRANSCRIPTION FACTOR FOXO3A; NEUROTROPHIC FACTOR; MUTANT HUNTINGTIN; IN-VIVO; PGC-1-ALPHA; METABOLISM; FORKHEAD; GLUCOSE; RESTRICTION; PROTECTS	Huntington's disease is a fatal neurodegenerative disorder caused by an expanded polyglutamine repeat in huntingtin (HIT) protein. We previously showed that calorie restriction ameliorated Huntington's disease pathogenesis and slowed disease progression in mice that model Huntington's disease (Huntington's disease mice)'. We now report that overexpression of sirtuin 1 (Sirt1), a mediator of the beneficial metabolic effects of calorie restriction, protects neurons against mutant HIT toxicity, whereas reduction of Sirt1 exacerbates mutant HIT toxicity. Overexpression of Sirt1 improves motor function, reduces brain atrophy and attenuates mutant-HTT-mediated metabolic abnormalities in Huntington's disease mice. Further mechanistic studies suggested that Sirt1 prevents the mutantHIT-induced decline in brain-derived neurotrophic factor (BDNF) concentrations and the signaling of its receptor, TrkB, and restores dopamine- and cAMP-regulated phosphoprotein, 32 kDa (DARPP32) concentrations in the striatum. Sirt1 deacetylase activity is required for Sirt1-mediated neuroprotection in Huntington's disease cell models. Notably, we show that mutant HIT interacts with Sirt1 and inhibits Sirti deacetylase activity, which results in hyperacetylation of Sirt1 substrates such as forkhead box O3A (Foxo3a), thereby inhibiting its pro-survival function. Overexpression of Sirt1 counteracts the mutant-HIT-induced deacetylase deficit, enhances the deacetylation of Foxo3a and facilitates cell survival. These findings show a neuroprotective role for Sirt1 in mammalian Huntington's disease models and open new avenues for the development of neuroprotective strategies in Huntington's disease.	[Jiang, Mali; Wang, Jiawei; Fu, Jinrong; Xiang, Lan; Peng, Qi; Arbez, Nicolas; Zhu, Shanshan; Sommers, Katherine; Qian, Jennifer; Ross, Christopher A.; Duan, Wenzhen] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Neurobiol, Baltimore, MD 21205 USA; [Wang, Jiawei] Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China; [Du, Lin; Cichewicz, Robert H.] Univ Oklahoma, Dept Chem & Biochem, Nat Prod Discovery Grp, Norman, OK 73019 USA; [Jeong, Hyunkyung; Krainc, Dimitri] Harvard Univ, Sch Med, Dept Neurol, MassGen Inst Neurodegenerat Dis,Massachusetts Gen, Boston, MA 02115 USA; [West, Tim; Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [West, Tim; Holtzman, David M.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO USA; [Hou, Zhipeng; Zhang, Jiangyang; Mori, Susumu] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA; [Cai, Huan; Martin, Bronwen] NIA, Metab Unit, Lab Clin Invest, US Natl Inst Hlth NIH, Baltimore, MD 21224 USA; [Seredenina, Tamara; Luthi-Carter, Ruth] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Switzerland; [Yang, X. William] Univ Calif Los Angeles, Brain Res Inst, Dept Psychiat & Behav Sci, Los Angeles, CA 90024 USA; [Aja, Susan] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD USA; [Maudsley, Stuart; Mattson, Mark P.] NIA, Neurosci Lab, NIH, Baltimore, MD 21224 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21205 USA; [Ross, Christopher A.; Duan, Wenzhen] Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD USA	Johns Hopkins University; Capital Medical University; University of Oklahoma System; University of Oklahoma - Norman; Harvard University; Harvard Medical School; Washington University (WUSTL); Washington University (WUSTL); Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of California System; University of California Los Angeles; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Duan, WZ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Neurobiol, Baltimore, MD 21205 USA.	wduan2@jhmi.edu	Du, Lin/G-7889-2011; Jiang, Mali/B-2631-2012; Ross, Christopher A/H-8395-2013; Cichewicz, Robert H/H-5233-2012; Maudsley, Stuart/Q-4782-2019; Mattson, Mark P/F-6038-2012; Maudsley, Stuart/AAV-9929-2021; Cai, Huan/B-6578-2016	Maudsley, Stuart/0000-0002-1868-184X; Cai, Huan/0000-0001-7731-8891; Zhang, Jiangyang/0000-0003-4146-8163; Cichewicz, Robert/0000-0003-0744-4117; Zhang, Jiangyang/0000-0003-0740-2662; Martin, Bronwen/0000-0002-9185-6925; Tamashiro, Kellie/0000-0002-9398-8796	Hereditary Disease Foundation; CHDI Foundation [A-2120]; NIH [NS 16375, NS35902, ROINS051303, EB003543, ES012665, NS065306]; NIA; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051303, P50NS016375, R21NS065306, P01NS016375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000319, ZIAAG000916, ZIAAG000915, ZIAAG000314, ZIAAG000318, ZIAAG000313, ZIAAG000325, ZIAAG000917, ZIAAG000331, ZIAAG000315] Funding Source: NIH RePORTER	Hereditary Disease Foundation; CHDI Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank L. Tsai at Massachusetts Institute of Technology for providing Sirt1 and H363Y retrovirus constructs, S. Imai at Washington University for providing Sir2 complementary DNAs (cDNAs), M. Macdonald at Harvard Medical School for providing STHdh<SUP>Q7/Q7</SUP> and STHdh<SUP>Q111/Q111</SUP> cells, S. Li and X. Li at Emory University for providing antibodies to EM48 and E. Waldron, C. Berlinicke, Y. Chen and J. Jin at Johns Hopkins University School of Medicine for their technical assistance. This work was supported by the Hereditary Disease Foundation (W.D.), CHDI Foundation grant A-2120 (W.D.), NIH grant NS 16375 (C.A.R.), NIH grant NS35902 (D.M.H.), the NIA Intramural Research Program (B.M., H.C., S. Maudesley and M.P.M.), NIH grant ROINS051303 (D.K.), NIH grant EB003543 and ES012665 (S. Mori) and NIH grant NS065306 (J.Z.).	Bibb JA, 2000, P NATL ACAD SCI USA, V97, P6809, DOI 10.1073/pnas.120166397; Browne SE, 2006, ANTIOXID REDOX SIGN, V8, P2061, DOI 10.1089/ars.2006.8.2061; Chaturvedi RK, 2010, HUM MOL GENET, V19, P3190, DOI 10.1093/hmg/ddq229; Chopra V, 2007, P NATL ACAD SCI USA, V104, P16685, DOI 10.1073/pnas.0707842104; Chou SY, 2005, J NEUROCHEM, V93, P310, DOI 10.1111/j.1471-4159.2005.03029.x; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; de Oliveira RM, 2010, CURR DRUG TARGETS, V11, P1270; DELAMONTE SM, 1988, J NEUROPATH EXP NEUR, V47, P516, DOI 10.1097/00005072-198809000-00003; Duan WZ, 2003, P NATL ACAD SCI USA, V100, P2911, DOI 10.1073/pnas.0536856100; Fienberg AA, 1998, SCIENCE, V281, P838, DOI 10.1126/science.281.5378.838; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Ivkovic S, 1997, NEUROSCIENCE, V79, P509, DOI 10.1016/S0306-4522(96)00684-7; JEONG H, 2011, NAT MED         1218, DOI DOI 10.1038/NM.2558; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Li M, 2009, NEUROBIOL DIS, V36, P413, DOI 10.1016/j.nbd.2009.06.011; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; McGill JK, 2006, CELL, V127, P465, DOI 10.1016/j.cell.2006.10.023; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mojsilovic-Petrovic J, 2009, J NEUROSCI, V29, P8236, DOI 10.1523/JNEUROSCI.1805-09.2009; Morris BJ, 2005, J HYPERTENS, V23, P1285, DOI 10.1097/01.hjh.0000173509.45363.dd; Nakagawa T, 2002, DIABETES-METAB RES, V18, P185, DOI 10.1002/dmrr.290; Pallos J, 2008, HUM MOL GENET, V17, P3767, DOI 10.1093/hmg/ddn273; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Peng K, 2010, NEUROSCI LETT, V484, P98, DOI 10.1016/j.neulet.2010.07.068; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ross CA, 2006, NAT MED, V12, P1239, DOI 10.1038/nm1106-1239; Satoh A, 2010, J NEUROSCI, V30, P10220, DOI 10.1523/JNEUROSCI.1385-10.2010; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Simmons DA, 2011, NEUROBIOL DIS, V41, P436, DOI 10.1016/j.nbd.2010.10.015; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wang WF, 2005, NEUROBIOL DIS, V20, P500, DOI 10.1016/j.nbd.2005.03.026; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Zhang JY, 2010, NEUROIMAGE, V49, P2340, DOI 10.1016/j.neuroimage.2009.10.027; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	41	254	261	1	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					153	158		10.1038/nm.2558	http://dx.doi.org/10.1038/nm.2558			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22179319	Green Accepted			2022-12-25	WOS:000299018600042
J	Trowbridge, JJ; Orkin, SH				Trowbridge, Jennifer J.; Orkin, Stuart H.			Dnmt3a silences hematopoietic stem cell self-renewal	NATURE GENETICS			English	Editorial Material							NOVO DNA METHYLTRANSFERASE; MUTATIONS		[Trowbridge, Jennifer J.] Childrens Hosp Boston, Dept Pediat Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; Childrens Hosp Boston, Div Hematol Oncol, Boston, MA USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital	Trowbridge, JJ (corresponding author), Childrens Hosp Boston, Dept Pediat Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA.	trowbridge@bloodgroup.tch.harvard.edu; stuart_orkin@dfci.harvard.edu						Bhattacharya D, 2009, J EXP MED, V206, P2837, DOI 10.1084/jem.20090778; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Gao Q, 2011, P NATL ACAD SCI USA, V108, P18061, DOI 10.1073/pnas.1114946108; Hervouet E, 2009, EPIGENETICS-US, V4, P487, DOI 10.4161/epi.4.7.9883; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Ndlovu MN, 2011, TRENDS BIOCHEM SCI, V36, P381, DOI 10.1016/j.tibs.2011.03.002; Tadokoro Y, 2007, J EXP MED, V204, P715, DOI 10.1084/jem.20060750; Trowbridge JJ, 2009, CELL STEM CELL, V5, P442, DOI 10.1016/j.stem.2009.08.016; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485	12	27	27	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2012	44	1					13	14		10.1038/ng.1043	http://dx.doi.org/10.1038/ng.1043			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	22200773				2022-12-25	WOS:000298664000006
J	von Roth, P; Canny, BJ; Volk, HD; Noble, JA; Prober, CG; Perka, C; Duda, GN				von Roth, Philipp; Canny, Benedict J.; Volk, Hans-Dieter; Noble, J. Alison; Prober, Charles G.; Perka, Carsten; Duda, Georg N.			The challenges of modern interdisciplinary medical research	NATURE BIOTECHNOLOGY			English	Editorial Material							ORTHOPEDIC CLINICIAN-SCIENTIST	The increasing complexity of medical science poses significant challenges to medical education, leading to a growing gap between medical researchers and treating practitioners.	[von Roth, Philipp; Perka, Carsten; Duda, Georg N.] Charite Univ Med Berlin, Berlin Brandenburg Sch Regenerat Therapies, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [von Roth, Philipp; Perka, Carsten; Duda, Georg N.] Charite Univ Med Berlin, Julius Wolff Inst, Berlin, Germany; [von Roth, Philipp; Perka, Carsten; Duda, Georg N.] Charite Univ Med Berlin, Ctr Musculoskeletal Surg, Berlin, Germany; [Canny, Benedict J.] Monash Univ, Fac Med Nursing & Hlth Sci, Clayton, Vic 3800, Australia; [Volk, Hans-Dieter] Charite Univ Med Berlin, Inst Med Immunol, Berlin, Germany; [Noble, J. Alison] Univ Oxford, Inst Biomed Engn, Oxford, England; [Noble, J. Alison] Univ Oxford, RCUK Ctr Doctoral Training Healthcare Innovat, Dept Engn Sci, Oxford, England; [Prober, Charles G.] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Monash University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Oxford; University of Oxford; Stanford University	von Roth, P (corresponding author), Charite Univ Med Berlin, Berlin Brandenburg Sch Regenerat Therapies, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany.	georg.duda@charite.de	Perka, Carsten/ABG-6505-2021; volk, hans-dieter/AAV-8053-2021; Duda, Georg N/H-2085-2016	volk, hans-dieter/0000-0002-7743-6668; Duda, Georg N/0000-0001-7605-3908; Perka, Carsten/0000-0002-0993-581X; Noble, Alison/0000-0002-3060-3772				Ahn J, 2008, J BONE JOINT SURG AM, V90A, P1794, DOI 10.2106/JBJS.G.00460; Butler D, 2008, NATURE, V453, P840, DOI 10.1038/453840a; GOLDSTEIN JL, 1986, J CLIN INVEST, V78, P848, DOI 10.1172/JCI112652; Jayasundera T, 2003, CLIN EXP OPHTHALMOL, V31, P294, DOI 10.1046/j.1442-9071.2003.00678.x; McKelvie J, 2009, CLIN EXP OPHTHALMOL, V37, P247, DOI 10.1111/j.1442-9071.2009.02040.x; Moran CJ, 2010, ARTHROSCOPY, V26, P1417, DOI 10.1016/j.arthro.2010.09.002; Sherwin T, 2003, CLIN EXP OPHTHALMOL, V31, P284, DOI 10.1046/j.1442-9071.2003.00680.x	7	9	9	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2011	29	12					1145	1148		10.1038/nbt.2062	http://dx.doi.org/10.1038/nbt.2062			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	861SE	22158370				2022-12-25	WOS:000298038700026
J	Keniry, A; Oxley, D; Monnier, P; Kyba, M; Dandolo, L; Smits, G; Reik, W				Keniry, Andrew; Oxley, David; Monnier, Paul; Kyba, Michael; Dandolo, Luisa; Smits, Guillaume; Reik, Wolf			The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and lgf1r	NATURE CELL BIOLOGY			English	Article							RNA-BINDING-PROTEINS; NONCODING RNA; NULL MUTATIONS; EXPRESSION; INSULIN; HUR; MICRORNAS; DELETION; RECEPTOR; GENE	The H19 large intergenic non-coding RNA (lincRNA) is one of the most highly abundant and conserved transcripts in mammalian development, being expressed in both embryonic and extra-embryonic cell lineages, yet its physiological function is unknown. Here we show that miR-675, a microRNA (miRNA) embedded in H19's first exon, is expressed exclusively in the placenta from the gestational time point when placental growth normally ceases, and placentas that lack H19 continue to grow. Overexpression of miR-675 in a range of embryonic and extra-embryonic cell lines results in their reduced proliferation; targets of the miRNA are upregulated in the H19 null placenta, including the growth-promoting insulin-like growth factor 1 receptor (lgf1r) gene. Moreover, the excision of miR-675 from H19 is dynamically regulated by the stress-response RNA-binding protein HuR. These results suggest that H19's main physiological role is in limiting growth of the placenta before birth, by regulated processing of miR-675. The controlled release of miR-675 from H19 may also allow rapid inhibition of cell proliferation in response to cellular stress or oncogenic signals.	[Keniry, Andrew; Reik, Wolf] Babraham Inst, Epigenet Programme, Cambridge CB22 3AT, England; [Oxley, David] Babraham Inst, Prote Grp, Cambridge CB22 3AT, England; [Monnier, Paul; Dandolo, Luisa] Univ Paris 05, Inst Cochin, CNRS, Genet & Dev Dept,Inserm,U1016,UMR 8104, F-75014 Paris, France; [Kyba, Michael] Univ Minnesota, Lillehei Heart Inst, Minneapolis, MN 55455 USA; [Kyba, Michael] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Smits, Guillaume] Univ Libre Bruxelles, HUDERF ULB Genet Ctr, B-1020 Brussels, Belgium; [Reik, Wolf] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 3EG, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Universite Libre de Bruxelles; University of Cambridge	Reik, W (corresponding author), Babraham Inst, Epigenet Programme, Cambridge CB22 3AT, England.	wolf.reik@babraham.ac.uk	Reik, Wolf/I-6794-2012	Kyba, Michael/0000-0002-5579-7534; Smits, Guillaume/0000-0003-2845-6758; Reik, Wolf/0000-0003-0216-9881	BBSRC; Wellcome Trust; MRC; EU NoE EpiGeneSys; EU BLUEPRINT; NIH/NHLBI [U01HL100407]; Cambridge Commonwealth Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100407] Funding Source: NIH RePORTER; BBSRC [BB/H008071/1, BBS/E/B/0000H109] Funding Source: UKRI; MRC [G0801156] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C214, BBS/E/B/0000H109, BB/H008071/1, BBS/E/B/0000S119] Funding Source: researchfish; Medical Research Council [G0801156] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU NoE EpiGeneSys; EU BLUEPRINT; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cambridge Commonwealth Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank D. L. Kontoyiannis (Alexander Fleming Biomedical Sciences Research Center, Greece) for supplying HuR<SUP>-/-</SUP> MEF cells. We also thank H. Jammes and A. Gabory for assisting with collection of the H19<SUP>Delta 3</SUP> phenotypic data, J. Webster for preparing samples for mass spectrometry and W. Dean for tissue collections. The authors would also like to thank K. Tabbada, A. Segonds-Pichon and S. Andrews for RNA sequencing, statistical and bioinformatic assistance, respectively. We thank M. lacovino for creating the A2lox-cre ES cell line. We would also like to thank T. Hore, C. Krueger and J. Houseley for critical reading of the manuscript and all members of the laboratories of W. Reik, M. Hemberger, E. Vigorito and). Houseley for helpful discussions. This work was supported by BBSRC, the Wellcome Trust, MRC, EU NoE EpiGeneSys, EU BLUEPRINT, NIH/NHLBI (U01HL100407) and the Cambridge Commonwealth Trust.	Angiolini E, 2011, FASEB J, V25, P1737, DOI 10.1096/fj.10-175273; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartolomei MS, 2009, GENE DEV, V23, P2124, DOI 10.1101/gad.1841409; Blaxall BC, 2000, MOL CARCINOGEN, V28, P76; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Coan PM, 2004, BIOL REPROD, V70, P1806, DOI 10.1095/biolreprod.103.024166; Dudek KA, 2010, J BIOL CHEM, V285, P24381, DOI 10.1074/jbc.M110.111328; Esquiliano DR, 2009, PLACENTA, V30, P693, DOI 10.1016/j.placenta.2009.05.004; Gabory A, 2010, BIOESSAYS, V32, P473, DOI 10.1002/bies.200900170; Gabory A, 2009, DEVELOPMENT, V136, P3413, DOI 10.1242/dev.036061; HAO Y, 1993, NATURE, V365, P764, DOI 10.1038/365764a0; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jeyaraj SC, 2006, AM J PHYSIOL-RENAL, V291, pF1255, DOI 10.1152/ajprenal.00440.2005; Jiang L, 2010, BIOCHEM J, V432, P199, DOI 10.1042/BJ20100859; Katsanou V, 2009, MOL CELL BIOL, V29, P2762, DOI 10.1128/MCB.01393-08; Kim HH, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/981487; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Knox K, 2008, GENOME RES, V18, P695, DOI 10.1101/gr.071407.107; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Lim DHK, 2010, ADV GENET, V70, P145, DOI [10.1016/B978-0-12-380866-0.60006-X, 10.1016/S0065-2660(10)70006-7]; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Mallanna SK, 2010, STEM CELLS, V28, P1715, DOI 10.1002/stem.494; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Pan YX, 2005, J BIOL CHEM, V280, P34609, DOI 10.1074/jbc.M507802200; Reddy SDN, 2008, CANCER RES, V68, P8195, DOI 10.1158/0008-5472.CAN-08-2103; Ripoche MA, 1997, GENE DEV, V11, P1596, DOI 10.1101/gad.11.12.1596; Runge S, 2000, J BIOL CHEM, V275, P29562, DOI 10.1074/jbc.M001156200; Saydam O, 2011, CANCER RES, V71, P852, DOI 10.1158/0008-5472.CAN-10-1219; Seidl CIM, 2006, EMBO J, V25, P3565, DOI 10.1038/sj.emboj.7601245; Smits G, 2008, NAT GENET, V40, P971, DOI 10.1038/ng.168; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Yang JH, 2010, NUCLEIC ACIDS RES, V38, pD123, DOI 10.1093/nar/gkp943; Yoshimizu T, 2008, P NATL ACAD SCI USA, V105, P12417, DOI 10.1073/pnas.0801540105; Zhao ZQ, 2000, NUCLEIC ACIDS RES, V28, P2695, DOI 10.1093/nar/28.14.2695	42	588	626	3	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2012	14	7					659	665		10.1038/ncb2521	http://dx.doi.org/10.1038/ncb2521			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	967PV	22684254	Green Accepted			2022-12-25	WOS:000305921200005
J	Meimaridou, E; Kowalczyk, J; Guasti, L; Hughes, CR; Wagner, F; Frommolt, P; Nurnberg, P; Mann, NP; Banerjee, R; Saka, HN; Chapple, JP; King, PJ; Clark, AJL; Metherell, LA				Meimaridou, Eirini; Kowalczyk, Julia; Guasti, Leonardo; Hughes, Claire R.; Wagner, Florian; Frommolt, Peter; Nuernberg, Peter; Mann, Nicholas P.; Banerjee, Ritwik; Saka, H. Nurcin; Chapple, J. Paul; King, Peter J.; Clark, Adrian J. L.; Metherell, Louise A.			Mutations in NNT encoding nicotinamide nucleotide transhydrogenase cause familial glucocorticoid deficiency	NATURE GENETICS			English	Article							HOMEOSTASIS; METABOLISM; LACKING	Using targeted exome sequencing, we identified mutations in NNT, an antioxidant defense gene, in individuals with familial glucocorticoid deficiency. In mice with Nnt loss, higher levels of adrenocortical cell apoptosis and impaired glucocorticoid production were observed. NNT knockdown in a human adrenocortical cell line resulted in impaired redox potential and increased reactive oxygen species (ROS) levels. Our results suggest that NNT may have a role in ROS detoxification in human adrenal glands.	[Meimaridou, Eirini; Kowalczyk, Julia; Guasti, Leonardo; Hughes, Claire R.; Chapple, J. Paul; King, Peter J.; Clark, Adrian J. L.; Metherell, Louise A.] Univ London, William Harvey Res Inst, Ctr Endocrinol, Barts & London Sch Med & Dent, London, England; [Wagner, Florian; Nuernberg, Peter] ATLAS Biolabs, Berlin, Germany; [Frommolt, Peter; Nuernberg, Peter] Univ Cologne, Cluster Excellence Cellular Stress Responses Agin, D-50931 Cologne, Germany; [Mann, Nicholas P.] Royal Berkshire Hosp, Reading RG1 5AN, Berks, England; [Banerjee, Ritwik] NHS Fdn Trust, Luton & Dunstable Hosp, Dept Diabet & Endocrinol, Luton, Beds, England; [Saka, H. Nurcin] Istanbul Univ, Dept Pediat, Istanbul Fac Med, Pediat Endocrinol Unit, Istanbul, Turkey	University of London; Queen Mary University London; University of Cologne; Royal Berkshire Hospital; Oxford University Hospitals NHS Foundation Trust; Istanbul University	Clark, AJL (corresponding author), Univ London, William Harvey Res Inst, Ctr Endocrinol, Barts & London Sch Med & Dent, London, England.	a.j.clark@qmul.ac.uk	Metherell, Louise A/E-8695-2012; Frommolt, Peter/L-9656-2016	Metherell, Louise A/0000-0002-0530-3524; Frommolt, Peter/0000-0002-1966-8014; Guasti, Leonardo/0000-0002-4616-6044; GUASTI, LUIGINA/0000-0002-4524-4864; Chapple, Paul/0000-0003-1876-1505	Medical Research Council UK [G0801265, G0901980, G0700767]; MRC [G0801265, G0901980, G0700767] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102925, UC2HL102924, UC2HL102926, RC2HL102923, UC2HL102923, RC2HL102924, RC2HL103010, UC2HL103010, UC2HL102925, RC2HL102926] Funding Source: NIH RePORTER; Medical Research Council [G0801265, G0901980, G0700767] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank J. Altmuller for running samples on a Genome Analyzer IIx, G. Nurnberg for performing the linkage analysis and the NHLBI GO Exome Sequencing Project and its ongoing studies, which produced and provided exome variant calls for comparison, including the Lung GO Sequencing Project (HL-102923), the Womens Health Initiative (WHI) Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926) and the Heart GO Sequencing Project (HL-103010). This study was approved by the Outer North East London Research Ethics Committee (09/H0701/12). Affected individuals and/or their parents gave written informed consent to DNA studies at the outset of the study. This work has been supported by the Medical Research Council UK (New Investigator Research Grant G0801265 to L.A.M., Clinical Research Training Fellowship Grant G0901980 to C.R.H. and Project Grant G0700767 to P.J.K.).	Arkblad EL, 2005, FREE RADICAL BIO MED, V38, P1518, DOI 10.1016/j.freeradbiomed.2005.02.012; Clark AJL, 2009, BEST PRACT RES CL EN, V23, P159, DOI 10.1016/j.beem.2008.09.006; Cooray Sadani N., 2008, V13, P99, DOI 10.1159/000134828; Dezso Z, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-49; Freeman H, 2006, BIOCHEM SOC T, V34, P806, DOI 10.1042/BST0340806; Hirano M, 2006, P NATL ACAD SCI USA, V103, P2298, DOI 10.1073/pnas.0505598103; Huebner A, 2006, MOL CELL BIOL, V26, P1879, DOI 10.1128/MCB.26.5.1879-1887.2006; Metherell LA, 2005, NAT GENET, V37, P166, DOI 10.1038/ng1501; Metherell LA, 2009, J CLIN ENDOCR METAB, V94, P3865, DOI 10.1210/jc.2009-0467; Storr HL, 2009, MOL ENDOCRINOL, V23, P2086, DOI 10.1210/me.2009-0056; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Walker JR, 2004, GENOME RES, V14, P742, DOI 10.1101/gr.2161804; Yin F, 2012, BBA-BIOENERGETICS, V1817, P401, DOI 10.1016/j.bbabio.2011.12.004	14	149	157	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2012	44	7					740	742		10.1038/ng.2299	http://dx.doi.org/10.1038/ng.2299			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967DP	22634753	Green Submitted, Green Accepted			2022-12-25	WOS:000305886900005
J	Kiefer, FW; Vernochet, C; O'Brien, P; Spoerl, S; Brown, JD; Nallamshetty, S; Zeyda, M; Stulnig, TM; Cohen, DE; Kahn, CR; Plutzky, J				Kiefer, Florian W.; Vernochet, Cecile; O'Brien, Patrick; Spoerl, Steffen; Brown, Jonathan D.; Nallamshetty, Shriram; Zeyda, Maximilian; Stulnig, Thomas M.; Cohen, David E.; Kahn, C. Ronald; Plutzky, Jorge			Retinaldehyde dehydrogenase 1 regulates a thermogenic program in white adipose tissue	NATURE MEDICINE			English	Article							RETINOIC ACID; BROWN FAT; RECEPTOR ANTAGONISTS; OBESITY; MICE; ADIPOGENESIS; METABOLISM; RECRUITMENT; HOMEOSTASIS; ADIPOCYTES	Promoting brown adipose tissue (BAT) formation and function may reduce obesity. Recent data link retinoids to energy balance, but a specific role for retinoid metabolism in white versus brown fat is unknown. Retinaldehyde dehydrogenases (Aldhs), also known as aldehyde dehydrogenases, are rate-limiting enzymes that convert retinaldehyde (Rald) to retinoic acid. Here we show that Aldh1a1 is expressed predominately in white adipose tissue (WAT), including visceral depots in mice and humans. Deficiency of the Aldh1a1 gene induced a BAT-like transcriptional program in WAT that drove uncoupled respiration and adaptive thermogenesis. WAT-selective Aldh1a1 knockdown conferred this BAT program in obese mice, limiting weight gain and improving glucose homeostasis. Rald induced uncoupling protein-1 (Ucp1) mRNA and protein levels in white adipocytes by selectively activating the retinoic acid receptor (RAR), recruiting the coactivator PGC-1 alpha and inducing Ucp1 promoter activity. These data establish Aldh1a1 and its substrate Rald as previously unrecognized determinants of adipocyte plasticity and adaptive thermogenesis, which may have potential therapeutic implications.	[Kiefer, Florian W.; O'Brien, Patrick; Spoerl, Steffen; Brown, Jonathan D.; Nallamshetty, Shriram; Plutzky, Jorge] Harvard Univ, Brigham & Womens Hosp, Sch Med, Cardiovasc Div,Dept Med, Boston, MA 02115 USA; [Vernochet, Cecile; Kahn, C. Ronald] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA; [Zeyda, Maximilian; Stulnig, Thomas M.] Christian Doppler Lab Cardiometab Immunotherapy, Vienna, Austria; [Zeyda, Maximilian; Stulnig, Thomas M.] Med Univ Vienna, Dept Med, Clin Div Endocrinol & Metab, Vienna, Austria; [Cohen, David E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol,Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Medical University of Vienna; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Plutzky, J (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Cardiovasc Div,Dept Med, Boston, MA 02115 USA.	jplutzky@rics.bwh.harvard.edu	Plutzky, Jorge/V-3410-2019; Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228; Zeyda, Maximilian/0000-0001-5000-1974; O'Brien, Patrick/0000-0002-9692-8019; Stulnig, Thomas/0000-0003-3300-6161; Kiefer, Florian/0000-0003-2191-025X	US National Institutes of Health [HL048743, AR054604-03S1, 5P30DK057521-12]; Mary K. Iacocca Professorship [DK082659]; National Institute of Diabetes and Digestive and Kidney Diseases [DK056626, DK048873, DK048873-14S2]; Austrian Science Fund (FWF) [J3107-B19]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK048873, R01DK056626, R01DK048873, R01DK082659, R37DK048873, P30DK057521] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary K. Iacocca Professorship; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Wang, G. Sukhova, E. Shvartz, T. A. Dang and V. Demchev for excellent technical support, R. Koza (Pennington Biomedical Research Center) for providing the Ucp1 promoter luciferase construct, H. Kagechika (University of Tokyo) for providing HX531 and G. Duester (Burnham Medical Research Institute) for the Aldh1a1<SUP>-/-</SUP> mice and helpful discussions. This work was supported by the US National Institutes of Health grants HL048743, AR054604-03S1, 5P30DK057521-12 (J.P.); Mary K. Iacocca Professorship DK082659 and the National Institute of Diabetes and Digestive and Kidney Diseases DK056626 (C. R. K.); DK048873 and DK048873-14S2 (D. E. C.); the Austrian Science Fund (FWF); J3107-B19 (F.W.K.).	Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; ALVAREZ R, 1995, J BIOL CHEM, V270, P5666, DOI 10.1074/jbc.270.10.5666; Baker BF, 1997, J BIOL CHEM, V272, P11994, DOI 10.1074/jbc.272.18.11994; Bray GA, 2006, ENDOCRINE, V29, P109, DOI 10.1385/ENDO:29:1:109; Brown JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021209; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chute JP, 2006, P NATL ACAD SCI USA, V103, P11707, DOI 10.1073/pnas.0603806103; Cinti S, 2011, ANN MED, V43, P104, DOI 10.3109/07853890.2010.535557; Crooke ST, 2004, ANNU REV MED, V55, P61, DOI 10.1146/annurev.med.55.091902.104408; Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Duester G, 2003, CHEM-BIOL INTERACT, V143, P201, DOI 10.1016/S0009-2797(02)00204-1; Fang S, 2011, P NATL ACAD SCI USA, V108, P3412, DOI 10.1073/pnas.1017707108; Farmer SR, 2008, GENE DEV, V22, P1269, DOI 10.1101/gad.1681308; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Hodges MR, 2008, J NEUROSCI, V28, P2495, DOI 10.1523/JNEUROSCI.4729-07.2008; Johnson AT, 1999, BIOORG MED CHEM LETT, V9, P573, DOI 10.1016/S0960-894X(99)00047-5; Kane MA, 2011, MOL CELL BIOL, V31, P3277, DOI 10.1128/MCB.05516-11; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Klein S, 2007, DIABETES CARE, V30, P1647, DOI 10.2337/dc07-9921; Langin D, 2010, BBA-MOL CELL BIOL L, V1801, P372, DOI 10.1016/j.bbalip.2009.09.008; Mensah GA, 2004, CARDIOL CLIN, V22, P485, DOI 10.1016/j.ccl.2004.06.005; Molotkov A, 2003, J BIOL CHEM, V278, P36085, DOI 10.1074/jbc.M303709200; Park KW, 2008, CELL METAB, V8, P454, DOI 10.1016/j.cmet.2008.11.001; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; REPA JJ, 1993, P NATL ACAD SCI USA, V90, P7293, DOI 10.1073/pnas.90.15.7293; ROSS AC, 1993, J NUTR, V123, P346, DOI 10.1093/jn/123.suppl_2.346; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Silva JE, 1997, EUR J ENDOCRINOL, V136, P251, DOI 10.1530/eje.0.1360251; Takahashi B, 2002, J MED CHEM, V45, P3327, DOI 10.1021/jm0255320; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Villarroya F, 2004, CURR MED CHEM, V11, P795, DOI 10.2174/0929867043455747; Wernstedt I, 2006, AM J PHYSIOL-REG I, V291, pR551, DOI 10.1152/ajpregu.00514.2005; WIEGAND G, 1986, ANNU REV BIOPHYS BIO, V15, P97; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yehuda-Shnaidman E, 2010, DIABETES, V59, P2474, DOI 10.2337/db10-0245; Ziouzenkova O, 2008, FEBS LETT, V582, P32, DOI 10.1016/j.febslet.2007.11.081; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	48	144	150	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2012	18	6					918	+		10.1038/nm.2757	http://dx.doi.org/10.1038/nm.2757			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22561685	Green Accepted			2022-12-25	WOS:000305116600029
J	Laurie, CC; Laurie, CA; Rice, K; Doheny, KF; Zelnick, LR; McHugh, CP; Ling, H; Hetrick, KN; Pugh, EW; Amos, C; Wei, QY; Wang, LE; Lee, JE; Barnes, KC; Hansel, NN; Mathias, R; Daley, D; Beaty, TH; Scott, AF; Ruczinski, I; Scharpf, RB; Bierut, LJ; Hartz, SM; Landi, MT; Freedman, ND; Goldin, LR; Ginsburg, D; Li, J; Desch, KC; Strom, SS; Blot, WJ; Signorello, LB; Ingles, SA; Chanock, SJ; Berndt, SI; Le Marchand, L; Henderson, BE; Monroe, KR; Heit, JA; de Andrade, M; Armasu, SM; Regnier, C; Lowe, WL; Hayes, MG; Marazita, ML; Feingold, E; Murray, JC; Melbye, M; Feenstra, B; Kang, JH; Wiggs, JL; Jarvik, GP; McDavid, AN; Seshan, VE; Mirel, DB; Crenshaw, A; Sharopova, N; Wise, A; Shen, J; Crosslin, DR; Levine, DM; Zheng, XW; Udren, JI; Bennett, S; Nelson, SC; Gogarten, SM; Conomos, MP; Heagerty, P; Manolio, T; Pasquale, LR; Haiman, CA; Caporaso, N; Weir, BS				Laurie, Cathy C.; Laurie, Cecelia A.; Rice, Kenneth; Doheny, Kimberly F.; Zelnick, Leila R.; McHugh, Caitlin P.; Ling, Hua; Hetrick, Kurt N.; Pugh, Elizabeth W.; Amos, Chris; Wei, Qingyi; Wang, Li-E; Lee, Jeffrey E.; Barnes, Kathleen C.; Hansel, Nadia N.; Mathias, Rasika; Daley, Denise; Beaty, Terri H.; Scott, Alan F.; Ruczinski, Ingo; Scharpf, Rob B.; Bierut, Laura J.; Hartz, Sarah M.; Landi, Maria Teresa; Freedman, Neal D.; Goldin, Lynn R.; Ginsburg, David; Li, Jun; Desch, Karl C.; Strom, Sara S.; Blot, William J.; Signorello, Lisa B.; Ingles, Sue A.; Chanock, Stephen J.; Berndt, Sonja I.; Le Marchand, Loic; Henderson, Brian E.; Monroe, Kristine R.; Heit, John A.; de Andrade, Mariza; Armasu, Sebastian M.; Regnier, Cynthia; Lowe, William L.; Hayes, M. Geoffrey; Marazita, Mary L.; Feingold, Eleanor; Murray, Jeffrey C.; Melbye, Mads; Feenstra, Bjarke; Kang, Jae H.; Wiggs, Janey L.; Jarvik, Gail P.; McDavid, Andrew N.; Seshan, Venkatraman E.; Mirel, Daniel B.; Crenshaw, Andrew; Sharopova, Nataliya; Wise, Anastasia; Shen, Jess; Crosslin, David R.; Levine, David M.; Zheng, Xiuwen; Udren, Jenna I.; Bennett, Siiri; Nelson, Sarah C.; Gogarten, Stephanie M.; Conomos, Matthew P.; Heagerty, Patrick; Manolio, Teri; Pasquale, Louis R.; Haiman, Christopher A.; Caporaso, Neil; Weir, Bruce S.			Detectable clonal mosaicism from birth to old age and its relationship to cancer	NATURE GENETICS			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; COPY-NUMBER VARIATION; POLYMORPHISM ARRAY ANALYSIS; B-CELL LYMPHOCYTOSIS; STEM-CELLS; GENOME; MALIGNANCIES; ASSOCIATION; GENE; POPULATIONS	We detected clonal mosaicism for large chromosomal anomalies (duplications, deletions and uniparental disomy) using SNP microarray data from over 50,000 subjects recruited for genome-wide association studies. This detection method requires a relatively high frequency of cells with the same abnormal karyotype (>5-10%; presumably of clonal origin) in the presence of normal cells. The frequency of detectable clonal mosaicism in peripheral blood is low (<0.5%) from birth until 50 years of age, after which it rapidly rises to 2-3% in the elderly. Many of the mosaic anomalies are characteristic of those found in hematological cancers and identify common deleted regions with genes previously associated with these cancers. Although only 3% of subjects with detectable clonal mosaicism had any record of hematological cancer before DNA sampling, those without a previous diagnosis have an estimated tenfold higher risk of a subsequent hematological cancer (95% confidence interval = 6-18).	[Laurie, Cathy C.; Laurie, Cecelia A.; Rice, Kenneth; Zelnick, Leila R.; McHugh, Caitlin P.; Shen, Jess; Crosslin, David R.; Levine, David M.; Zheng, Xiuwen; Udren, Jenna I.; Bennett, Siiri; Nelson, Sarah C.; Gogarten, Stephanie M.; Conomos, Matthew P.; Heagerty, Patrick; Weir, Bruce S.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Doheny, Kimberly F.; Ling, Hua; Hetrick, Kurt N.; Pugh, Elizabeth W.] Johns Hopkins Univ, Ctr Inherited Dis Res, Baltimore, MD USA; [Amos, Chris; Wei, Qingyi; Wang, Li-E] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Div Canc Prevent & Populat Sci, Houston, TX 77030 USA; [Lee, Jeffrey E.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Div Surg, Houston, TX 77030 USA; [Barnes, Kathleen C.; Hansel, Nadia N.; Mathias, Rasika] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Daley, Denise] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Beaty, Terri H.] Johns Hopkins Univ, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Scott, Alan F.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD USA; [Ruczinski, Ingo] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; [Scharpf, Rob B.] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA; [Bierut, Laura J.; Hartz, Sarah M.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Landi, Maria Teresa; Freedman, Neal D.; Goldin, Lynn R.; Chanock, Stephen J.; Berndt, Sonja I.; Caporaso, Neil] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Ginsburg, David] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Li, Jun] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Desch, Karl C.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Blot, William J.; Signorello, Lisa B.] Vanderbilt Univ, Dept Med, Vanderbilt Epidemiol Ctr, Div Epidemiol, Nashville, TN USA; [Ingles, Sue A.; Henderson, Brian E.; Monroe, Kristine R.; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA; [Le Marchand, Loic] Univ Hawaii, Canc Res Ctr, Program Epidemiol, Honolulu, HI 96813 USA; [Heit, John A.] Mayo Clin, Dept Internal Med, Rochester, MN USA; [de Andrade, Mariza; Armasu, Sebastian M.] Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA; [Regnier, Cynthia] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA; [Regnier, Cynthia] Mayo Clin, Mayo Hyperoxaluria Ctr, Rochester, MN USA; [Lowe, William L.; Hayes, M. Geoffrey] Northwestern Univ, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA; [Marazita, Mary L.] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Ctr Craniofacial & Dent Genet, Pittsburgh, PA USA; [Feingold, Eleanor] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; [Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Melbye, Mads; Feenstra, Bjarke] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Kang, Jae H.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Wiggs, Janey L.; Pasquale, Louis R.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA USA; [Jarvik, Gail P.] Univ Washington, Div Med Genet, Seattle, WA 98195 USA; [McDavid, Andrew N.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Seshan, Venkatraman E.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Mirel, Daniel B.; Crenshaw, Andrew] Broad Inst Harvard & MIT, Cambridge, MA USA; [Sharopova, Nataliya] Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; [Wise, Anastasia; Manolio, Teri] NHGRI, Off Populat Genom, NIH, Bethesda, MD 20892 USA	University of Washington; University of Washington Seattle; Johns Hopkins University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Johns Hopkins University; University of British Columbia; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Vanderbilt University; University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Northwestern University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Iowa; Statens Serum Institut; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Laurie, CC (corresponding author), Univ Washington, Dept Biostat, Seattle, WA 98195 USA.	cclaurie@u.washington.edu	Weir, Bruce S/A-2894-2013; Hartz, Sarah/AAD-4073-2019; Nelson, Sarah Catherine/AAN-9814-2020; Freedman, Neal David/B-9741-2015; Zheng, Xiuwen/J-4047-2019; Berndt, Sonja I/J-8423-2016; Bierut, Laura Jean/W-6806-2019; Hartz, Sarah M/AAD-7662-2020; Conomos, Matthew P./A-8136-2019; Rice, Kenneth M/A-4150-2013; Jarvik, Gail P/N-6476-2014	Hartz, Sarah/0000-0002-5429-3799; Nelson, Sarah Catherine/0000-0002-2109-6465; Freedman, Neal David/0000-0003-0074-1098; Zheng, Xiuwen/0000-0002-1390-0708; Bierut, Laura Jean/0000-0002-9952-4810; Conomos, Matthew P./0000-0001-9744-0851; Rice, Kenneth M/0000-0001-5779-4495; Jarvik, Gail P/0000-0002-6710-8708; Gogarten, Stephanie/0000-0002-7231-9745; McDavid, Andrew/0000-0002-6581-1213; Feingold, Eleanor/0000-0003-2898-6484; Hayes, M Geoffrey/0000-0002-4617-3981; Ginsburg, David/0000-0002-6436-8942; Zelnick, Leila/0000-0002-8461-5111; Feenstra, Bjarke/0000-0003-1478-649X; Li, Jun/0000-0001-6727-0812; melbye, mads/0000-0001-8264-6785	US National Institutes of Health (NIH) Genes, Environment and Health Initiative (GEI); NIH (NCI) [R29CA70334, R01CA100264, P50CA093459, U10AA008401, CA63464, CA54281, CA1326792, RC2 CA148085]; NIH [U01HG004738, HHSN268200782096C, U01HG004726, U01HG004735, U01HG004415, U01HG004423]; NIH (National Institute Dental and Craniofacial Research (NIDCR) [U01DE018993]; NIH, National Institute on Alcohol Abuse and Alcoholism (NIAAA) [U01HG004422]; NIH, National Institute on Drug Abuse (NIDA) [P01CA089392, R01DA013423, R01DA019963]; NIH (NIDCR) [U01DE018903, R01DE014899]; NIH, NIH Center for Inherited Disease Research (CIDR) [HHSN268200-782096C]; NIH, National Eye Institute (NEI) [U01HG004728, R01EY015473, R01EY015872]; NIH, GENEVA Coordinating Center [U01 HG004446]; NIG, CIDR [HHSN268200782096C, U01HG004438]; NIH, Broad Center for Genotyping and Analysis [U01HG04424]; NIH, the National Library of Medicine; Division of Cancer Epidemiology and Genetics, NCI, NIH; Research to Prevent Blindness in NYC; Harvard Medical School; Harvard Glaucoma Center of Excellence; NCI [T32 CA09168]; NATIONAL CANCER INSTITUTE [R01CA063464, P50CA093459, R01CA092447, Z01CP010200, U01CA063464, R29CA070334, R01CA100264, RC2CA148085, R37CA054281, P01CA089392, T32CA009168, R01CA054281] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000450] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY014104, R01EY015473, R01EY015872] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL039693, R01HL039693] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004415, U01HG004446, U01HG004726, U01HG004738, U01HG004423, U01HG004424, U01HG004728, U01HG004735, U01HG004422, U01HG004438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014899, R01DE016148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [U01DE018993, U01DE018903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U10AA008401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013423, R01DA019963, K08DA032680] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) Genes, Environment and Health Initiative (GEI); NIH (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (National Institute Dental and Craniofacial Research (NIDCR); NIH, National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIH, National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH, NIH Center for Inherited Disease Research (CIDR); NIH, National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH, GENEVA Coordinating Center; NIG, CIDR; NIH, Broad Center for Genotyping and Analysis; NIH, the National Library of Medicine; Division of Cancer Epidemiology and Genetics, NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Research to Prevent Blindness in NYC; Harvard Medical School; Harvard Glaucoma Center of Excellence; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The GENEVA Consortium thanks the subjects and the staff of all GENEVA studies for their important contributions. We thank the following state cancer registries for their help: Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Nebraska, New Hampshire, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Virginia, Washington and Wyoming. We thank C. Laird and G. Marti for helpful comments on the manuscript and B. Wakimoto and D. Gottschling for enlightening discussions. We also thank K. Jacobs for exchanging ideas and for working with us to estimate cross-method concordance of mosaic detection using the PLCO/GENEVA Lung Cancer study. Support for the GENEVA genome-wide association studies was provided through the US National Institutes of Health (NIH) Genes, Environment and Health Initiative (GEI). Some studies also received support from individual NIH Institutes. The grant numbers are: Melanoma (NCI R29CA70334, R01CA100264 and P50CA093459); Lung Health (U01HG004738); Cleft Lip/Palate (National Institute Dental and Craniofacial Research (NIDCR): U01DE018993 and NIH contract: HHSN268200782096C); Addiction (U01HG004422, National Institute on Alcohol Abuse and Alcoholism (NIAAA): U10AA008401, National Cancer Institute (NCI): P01CA089392, National Institute on Drug Abuse (NIDA): R01DA013423 and R01DA019963); Lung Cancer (Z01CP010200); Blood Clotting (R37 HL 039693); Prostate Cancer (U01HG004726, NCI: CA63464, CA54281, CA1326792 and RC2 CA148085); Venous Thromboembolism (U01HG004735); Birth Weight (U01HG004415); Dental Caries (NIDCR: U01DE018903 and R01DE014899, NIH Center for Inherited Disease Research (CIDR) contract: HHSN268200-782096C); Prematurity (U01HG004423); Glaucoma (U01HG004728, National Eye Institute (NEI): R01EY015473 and R01EY015872); GENEVA Coordinating Center (U01 HG004446); CIDR (U01HG004438 and HHSN268200782096C); Broad Center for Genotyping and Analysis (U01HG04424); the Intramural Research Program of the NIH, the National Library of Medicine; and the Intramural Research Program of the Division of Cancer Epidemiology and Genetics, NCI, NIH. L. R. P. was also supported by a Physician Scientist award from Research to Prevent Blindness in NYC and an Ophthalmology Scholar Award from Harvard Medical School and from the Harvard Glaucoma Center of Excellence. L.R.Z. was supported by the NCI (T32 CA09168).	Balliff BC, 2006, AM J MED GENET A, V140A, P2757, DOI 10.1002/ajmg.a.31539; Bejar R, 2011, J CLIN ONCOL, V29, P504, DOI 10.1200/JCO.2010.31.1175; Cogle CR, 2011, BLOOD, V117, P7121, DOI 10.1182/blood-2011-02-337964; Conlin LK, 2010, HUM MOL GENET, V19, P1263, DOI 10.1093/hmg/ddq003; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cornelis MC, 2010, GENET EPIDEMIOL, V34, P364, DOI 10.1002/gepi.20492; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Delhanty JDA, 2005, CYTOGENET GENOME RES, V111, P237, DOI 10.1159/000086894; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Dougherty MJ, 2011, CANCER GENET-NY, V204, P26, DOI 10.1016/j.cancergencyto.2010.10.007; Fischbach F, 1992, MANUAL LAB DIAGNOSTI; Forsberg LA, 2012, AM J HUM GENET, V90, P217, DOI 10.1016/j.ajhg.2011.12.009; Gardner RJ, 2004, CHROMOSOME ABNORMALI; Gunn SR, 2009, LEUKEMIA RES, V33, P1276, DOI 10.1016/j.leukres.2008.10.010; Gurvich N, 2010, P NATL ACAD SCI USA, V107, P22552, DOI 10.1073/pnas.1017092108; HASSOLD T, 1982, HUM GENET, V61, P31, DOI 10.1007/BF00291327; Heim S., 2009, CANC CYTOGENETICS, P25; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Landgren O, 2009, NEW ENGL J MED, V360, P659, DOI 10.1056/NEJMoa0806122; Lin P, 2011, HUM HERED, V71, P141, DOI 10.1159/000324683; Lindstrom DL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002015; Ma XM, 2008, AM J HEMATOL, V83, P359, DOI 10.1002/ajh.21129; Maciejewski JP, 2009, BRIT J HAEMATOL, V146, P479, DOI 10.1111/j.1365-2141.2009.07757.x; Marti GE, 2005, BRIT J HAEMATOL, V130, P325, DOI 10.1111/j.1365-2141.2005.05550.x; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Miller O.J., 2001, HUMAN CHROMOSOMES; Mukherjee AB, 1997, EXP CELL RES, V235, P161, DOI 10.1006/excr.1997.3673; Neukirchen J, 2011, LEUKEMIA RES, V35, P1591, DOI 10.1016/j.leukres.2011.06.001; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; O'Keefe C, 2010, BLOOD, V115, P2731, DOI 10.1182/blood-2009-10-201848; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Pekarsky Y, 2010, SEMIN CANCER BIOL, V20, P370, DOI 10.1016/j.semcancer.2010.09.003; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Prchal JT, 1996, J EXP MED, V183, P561, DOI 10.1084/jem.183.2.561; Raghavan M, 2010, ADV ENZYME REGUL, V50, P96, DOI 10.1016/j.advenzreg.2009.10.030; Rodriguez-Santiago B, 2010, AM J HUM GENET, V87, P129, DOI 10.1016/j.ajhg.2010.06.002; Rossi DJ, 2007, CELL CYCLE, V6, P2371, DOI 10.4161/cc.6.19.4759; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Shanafelt TD, 2010, LEUKEMIA, V24, P512, DOI 10.1038/leu.2009.287; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; Strachan T., 2004, HUM MOL GENET, V3; Swierczek SI, 2008, BLOOD, V112, P3186, DOI 10.1182/blood-2008-03-143925; TRACY ND, 1992, J QUAL TECHNOL, V24, P88, DOI 10.1080/00224065.1992.12015232; Tuna M, 2009, TRENDS MOL MED, V15, P120, DOI 10.1016/j.molmed.2009.01.005; Vandewoestyne ML, 2011, LEUKEMIA, V25, P883, DOI 10.1038/leu.2011.14; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Vorobtsova I, 2001, MECH AGEING DEV, V122, P1373, DOI 10.1016/S0047-6374(01)00275-5; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788	53	396	402	0	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2012	44	6					642	U58		10.1038/ng.2271	http://dx.doi.org/10.1038/ng.2271			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	949BT	22561516	Green Accepted, Green Submitted			2022-12-25	WOS:000304551100010
J	Turnbull, C; Perdeaux, ER; Pernet, D; Naranjo, A; Renwick, A; Seal, S; Munoz-Xicola, RM; Hanks, S; Slade, I; Zachariou, A; Warren-Perry, M; Ruark, E; Gerrard, M; Hale, J; Hewitt, M; Kohler, J; Lane, S; Levitt, G; Madi, M; Morland, B; Neefjes, V; Nicholdson, J; Picton, S; Pizer, B; Ronghe, M; Stevens, M; Traunecker, H; Stiller, CA; Pritchard-Jones, K; Dome, J; Grundy, P; Rahman, N				Turnbull, Clare; Perdeaux, Elizabeth R.; Pernet, David; Naranjo, Arlene; Renwick, Anthony; Seal, Sheila; Munoz-Xicola, Rosa Maria; Hanks, Sandra; Slade, Ingrid; Zachariou, Anna; Warren-Perry, Margaret; Ruark, Elise; Gerrard, Mary; Hale, Juliet; Hewitt, Martin; Kohler, Janice; Lane, Sheila; Levitt, Gill; Madi, Mabrook; Morland, Bruce; Neefjes, Veronica; Nicholdson, James; Picton, Susan; Pizer, Barry; Ronghe, Milind; Stevens, Michael; Traunecker, Heidi; Stiller, Charles A.; Pritchard-Jones, Kathy; Dome, Jeffrey; Grundy, Paul; Rahman, Nazneen			A genome-wide association study identifies susceptibility loci for Wilms tumor	NATURE GENETICS			English	Article							CELL POLARITY; ABNORMALITIES; MUTATIONS; MYCN	Wilms tumor is the most common renal malignancy of childhood. To identify common variants that confer susceptibility to Wilms tumor, we conducted a genome-wide association study in 757 individuals with Wilms tumor (cases) and 1,879 controls. We evaluated ten SNPs in regions significantly associated at P < 5 x 10(-5) in two independent replication series from the UK (769 cases and 2,814 controls) and the United States (719 cases and 1,037 controls). We identified clear significant associations at 2p24 (rs3755132, P = 1.03 x 10(-14); rs807624, P = 1.32 x 10(-14)) and 11q14 (rs790356, P = 4.25 x 10(-15)). Both regions contain genes that are plausibly related to Wilms tumorigenesis. We also identified candidate association signals at 5q14, 22q12 and Xp22.	[Turnbull, Clare; Perdeaux, Elizabeth R.; Pernet, David; Renwick, Anthony; Seal, Sheila; Munoz-Xicola, Rosa Maria; Hanks, Sandra; Slade, Ingrid; Zachariou, Anna; Warren-Perry, Margaret; Ruark, Elise; Rahman, Nazneen] Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England; [Naranjo, Arlene] Univ Florida, Childrens Oncol Grp Stat & Data Ctr, Gainesville, FL USA; [Gerrard, Mary] Sheffield Childrens Natl Hlth Serv NHS Trust, Sheffield, S Yorkshire, England; [Hale, Juliet] Royal Victoria Infirm, Dept Paediat Oncol, Newcastle Upon Tyne, Tyne & Wear, England; [Hewitt, Martin] Univ Nottingham Hosp, Dept Paediat Oncol, Nottingham NG7 2UH, England; [Kohler, Janice] Southampton Gen Hosp, Reg Paediat Oncol Ctr, Southampton SO9 4XY, Hants, England; [Lane, Sheila] John Radcliffe Hosp, Dept Paediat Oncol, Oxford Childrens Hosp, Oxford OX3 9DU, England; [Levitt, Gill] Great Ormond St Hosp Sick Children, Dept Paediat Oncol, London WC1N 3JH, England; [Madi, Mabrook] Leicester Royal Infirm, Dept Paediat Oncol, Leicester, Leics, England; [Morland, Bruce] Birmingham Childrens Hosp, Dept Paediat Oncol, Birmingham, W Midlands, England; [Neefjes, Veronica] Royal Aberdeen Childrens Hosp, Dept Paediat Oncol, Aberdeen, Scotland; [Nicholdson, James] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Dept Paediat Oncol, Cambridge, England; [Picton, Susan] Leeds Gen Infirm, Dept Paediat Oncol, Leeds, W Yorkshire, England; [Pizer, Barry] Alder Hey Childrens NHS Fdn Trust, Dept Paediat Oncol, Liverpool, Merseyside, England; [Ronghe, Milind] Royal Hosp Sick Children, Dept Paediat Oncol, Glasgow G3 8SJ, Lanark, Scotland; [Stevens, Michael] Bristol Royal Hosp Children, Dept Paediat Oncol, Bristol, Avon, England; [Traunecker, Heidi] Childrens Hosp Wales, Paediat Oncol Unit, Cardiff, S Glam, Wales; [Stiller, Charles A.] Univ Oxford, Childhood Canc Res Grp, Oxford, England; [Pritchard-Jones, Kathy] UCL, Inst Child Hlth, Mol Haematol & Canc Biol Unit, London, England; [Dome, Jeffrey] Childrens Natl Med Ctr, Div Oncol, Washington, DC 20010 USA; [Grundy, Paul] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Grundy, Paul] Univ Alberta, Dept Oncol, Edmonton, AB, Canada	University of London; Institute of Cancer Research - UK; Children's Oncology Group (COG); State University System of Florida; University of Florida; Newcastle University - UK; University of Nottingham; University of Southampton; University of Oxford; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Leicester; University of Birmingham; University of Aberdeen; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Leeds General Infirmary; University of Leeds; Alder Hey Children's NHS Foundation Trust; University of Glasgow; Bristol Royal Hospital For Children; University of Oxford; University of London; University College London; Children's National Health System; University of Alberta; University of Alberta	Rahman, N (corresponding author), Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England.	nazneen.rahman@icr.ac.uk	Turnbull, Clare/AAA-6596-2019; Dome, Jeffrey/AAH-7825-2019; Pritchard-Jones, Kathy/F-4286-2014; Rahman, Nazneen/D-2802-2013	Pritchard-Jones, Kathy/0000-0002-2384-9475; Rahman, Nazneen/0000-0003-4376-0440; Stiller, Charles/0000-0002-3006-7869; Turnbull, Clare/0000-0002-1734-5772; Loh, Mignon/0000-0003-4099-4700; Perdeaux, Elizabeth/0000-0001-7042-830X	Wellcome Trust Case Control Consortium 3 (WTCCC3) initiative [088804/Z/09/Z]; National Cancer Institute at the US National Institutes of Health [U10 CA98543, U10 CA98413, U24 CA114766]; Cancer Research UK [C8620/A9024, C8620_A8857]; UK Department of Health; National Cancer Intelligence Network; Scottish Government; Children with Cancer UK; NHS; Michael and Betty Kadoorie Cancer Genetics; Rosetrees Trust [M28-F1-CD2] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U24CA196173, U24CA114766, U10CA098543, P50CA093459, U10CA098413, P50CA097007, R01CA133996] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011740] Funding Source: NIH RePORTER	Wellcome Trust Case Control Consortium 3 (WTCCC3) initiative; National Cancer Institute at the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); UK Department of Health; National Cancer Intelligence Network; Scottish Government; Children with Cancer UK; NHS; Michael and Betty Kadoorie Cancer Genetics; Rosetrees Trust(Rosetrees Trust); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank the families and the physicians and nurses that recruited them for their participation in this study, which was funded by the Wellcome Trust Case Control Consortium 3 (WTCCC3) initiative (grant reference 088804/Z/09/Z). We thank P. Donnelly for statistical advice throughout the design and execution of the study. We thank D. Dudakia, J. Bull, R. Linger, B. Ebbs, D. Hughes from Institute of Cancer Research (ICR) and Y. Mistry (from the Children's Cancer and Leukaemia Group (CCLG) tumor bank) for assistance in sample collection, DNA extraction and genotyping. The US samples and data were provided by the Children's Oncology Group (study AREN09B1) supported by the Chair's grant U10 CA98543, SDC grant U10 CA98413 and Human Specimen Banking grant U24 CA114766 from the National Cancer Institute at the US National Institutes of Health. The UK samples were collected through the Factors Associated with Childhood Tumors (FACT) study, which is a CCLG Study (Multicentre Research Ethics Committee (MREC) 05/MRE02/17) and is supported by Cancer Research UK (grant references C8620/A9024 and C8620_A8857). A full list of collaborators is given in the Supplementary Note. The CCRG receives funding from the UK Department of Health, the National Cancer Intelligence Network, the Scottish Government and Children with Cancer UK. The views expressed in this publication are those of the authors and not necessarily of any of these organizations. We acknowledge use of DNA from the British 1958 Birth Cohort DNA collection. We acknowledge NHS funding to the ICR/Royal Marsden Hospital (RMH)/National Institute for Health Research (NIHR) Specialist Biomedical Cancer Research Centre. I. S. is supported by Michael and Betty Kadoorie Cancer Genetics. C. T. is a Medical Research Council Clinical Research Fellow. This study was conducted at the Institution of Cancer Research, UK.	Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Breslow NE, 2006, PEDIATR BLOOD CANCER, V47, P260, DOI 10.1002/pbc.20891; D'Angio GJ, 2007, LIFETIME DATA ANAL, V13, P463, DOI 10.1007/s10985-007-9062-0; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; Li L, 2008, MOL CELL BIOL, V28, P6413, DOI 10.1128/MCB.01053-08; Little SE, 2004, J CLIN ONCOL, V22, P4140, DOI 10.1200/JCO.2004.02.136; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Schaub R, 2007, CANCER GENET CYTOGEN, V172, P61, DOI 10.1016/j.cancergencyto.2006.08.010; Scott RH, 2006, J MED GENET, V43, P705, DOI 10.1136/jmg.2006.041723; Scott RH, 2008, NAT GENET, V40, P1329, DOI 10.1038/ng.243; SQUIRE JA, 1995, ONCOGENE, V10, P1417; STILLER CA, 1990, BRIT J CANCER, V62, P1026, DOI 10.1038/bjc.1990.432; Wells J, 2010, MOL CANCER RES, V8, P975, DOI 10.1158/1541-7786.MCR-10-0033	15	57	59	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2012	44	6					681	U100		10.1038/ng.2251	http://dx.doi.org/10.1038/ng.2251			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	949BT	22544364	Green Accepted			2022-12-25	WOS:000304551100015
J	Wan, JJ; Yourshaw, M; Mamsa, H; Rudnik-Schoneborn, S; Menezes, MP; Hong, JE; Leong, DW; Senderek, J; Salman, MS; Chitayat, D; Seeman, P; von Moers, A; Graul-Neumann, L; Kornberg, AJ; Castro-Gago, M; Sobrido, MJ; Sanefuji, M; Shieh, PB; Salamon, N; Kim, RC; Vinters, HV; Chen, ZG; Zerres, K; Ryan, MM; Nelson, SF; Jen, JC				Wan, Jijun; Yourshaw, Michael; Mamsa, Hafsa; Rudnik-Schoeneborn, Sabine; Menezes, Manoj P.; Hong, Ji Eun; Leong, Derek W.; Senderek, Jan; Salman, Michael S.; Chitayat, David; Seeman, Pavel; von Moers, Arpad; Graul-Neumann, Luitgard; Kornberg, Andrew J.; Castro-Gago, Manuel; Sobrido, Maria-Jesus; Sanefuji, Masafumi; Shieh, Perry B.; Salamon, Noriko; Kim, Ronald C.; Vinters, Harry V.; Chen, Zugen; Zerres, Klaus; Ryan, Monique M.; Nelson, Stanley F.; Jen, Joanna C.			Mutations in the RNA exosome component gene EXOSC3 cause pontocerebellar hypoplasia and spinal motor neuron degeneration	NATURE GENETICS			English	Article							HORN CELL DISEASE; CEREBELLAR HYPOPLASIA; HEXANUCLEOTIDE REPEAT; ATROPHY; GENOME; EXPANSION; FRAMEWORK; C9ORF72; TYPE-1; REGION	RNA exosomes are multi-subunit complexes conserved throughout evolution(1) and are emerging as the major cellular machinery for processing, surveillance and turnover of a diverse spectrum of coding and noncoding RNA substrates essential for viability(2). By exome sequencing, we discovered recessive mutations in EXOSC3 (encoding exosome component 3) in four siblings with infantile spinal motor neuron disease, cerebellar atrophy, progressive microcephaly and profound global developmental delay, consistent with pontocerebellar hypoplasia type 1 (PCH1; MIM 607596)(3-6). We identified mutations in EXOSC3 in an additional 8 of 12 families with PCH1. Morpholino knockdown of exosc3 in zebrafish embryos caused embryonic maldevelopment, resulting in small brain size and poor motility, reminiscent of human clinical features, and these defects were largely rescued by co-injection with wild-type but not mutant exosc3 mRNA. These findings represent the first example of an RNA exosome core component gene that is responsible for a human disease and further implicate dysregulation of RNA processing in cerebellar and spinal motor neuron maldevelopment and degeneration.	[Wan, Jijun; Mamsa, Hafsa; Hong, Ji Eun; Leong, Derek W.; Shieh, Perry B.; Vinters, Harry V.; Jen, Joanna C.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Yourshaw, Michael; Chen, Zugen; Nelson, Stanley F.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Rudnik-Schoeneborn, Sabine; Zerres, Klaus] Univ Hosp Rhein Westfal TH RWTH Aachen, Fac Med, Inst Human Genet, Aachen, Germany; [Menezes, Manoj P.] Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Westmead, NSW, Australia; [Senderek, Jan] Univ Hosp RWTH Aachen, Fac Med, Inst Neuropathol, Aachen, Germany; [Salman, Michael S.] Childrens Hosp, Sect Pediat Neurol, Winnipeg, MB R3A 1S1, Canada; [Salman, Michael S.] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada; [Chitayat, David] Univ Toronto, Mt Sinai Hosp, Dept Obstet & Gynecol, Prenatal Diag & Med Genet Program, Toronto, ON M5G 1X5, Canada; [Chitayat, David] Univ Toronto, Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Seeman, Pavel] Charles Univ Prague, Sch Med 2, Dept Child Neurol, DNA Lab, Prague, Czech Republic; [Seeman, Pavel] Univ Hosp Motol, Prague, Czech Republic; [von Moers, Arpad] Deutsch Rotes Kreuz DRK Kliniken Berlin Westend, Dept Pediat, Berlin, Germany; [Graul-Neumann, Luitgard] Charite, Inst Med & Human Genet, D-13353 Berlin, Germany; [Kornberg, Andrew J.; Ryan, Monique M.] Univ Melbourne, Murdoch Childrens Res Inst, Royal Childrens Hosp, Melbourne, Qld, Australia; [Castro-Gago, Manuel] Univ Santiago de Compostela, Fac Med, Dept Pediat, Serv Neuropediat,Hosp Clin Univ, Santiago De Compostela, Spain; [Sobrido, Maria-Jesus] Clin Hosp Santiago de Compostela, Serv Galego Saude SERGAS, Fdn Publ Galega Med Xen, Santiago De Compostela, Spain; [Sobrido, Maria-Jesus] Inst Hlth Carlos III, Ctr Biomed Network Res Rare Dis CIBERER, Barcelona, Spain; [Sanefuji, Masafumi] Kyushu Univ, Grad Sch Med Sci, Fukuoka 812, Japan; [Salamon, Noriko] Univ Calif Los Angeles, Dept Radiol, Los Angeles, CA USA; [Kim, Ronald C.] Univ Calif Irvine, Dept Pathol, Irvine, CA 92717 USA; [Kim, Ronald C.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Vinters, Harry V.; Nelson, Stanley F.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Nelson, Stanley F.] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Sydney; RWTH Aachen University; RWTH Aachen University Hospital; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Charles University Prague; Motol University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Murdoch Children's Research Institute; Royal Children's Hospital Brisbane; Royal Children's Hospital Melbourne; University of Melbourne; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Kyushu University; University of California System; University of California Los Angeles; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Jen, JC (corresponding author), Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA.	jjen@ucla.edu	Nelson, Stanley F/D-4771-2009; Senderek, Jan/F-8405-2015; Sanefuji, Masafumi/GRO-5252-2022; Ryan, Monique Marie/AAG-9870-2019; Rudnik-Schöneborn, Sabine/F-8473-2015; Menezes, Manoj/K-6372-2012; Yourshaw, Michael/F-9807-2015	Nelson, Stanley F/0000-0002-2082-3114; Senderek, Jan/0000-0002-8263-1783; Sanefuji, Masafumi/0000-0001-6036-5528; Menezes, Manoj/0000-0003-3160-6112; Ryan, Monique/0000-0001-6397-1910; Salman, Michael S./0000-0002-0564-7044; Yourshaw, Michael/0000-0001-7612-0437	NIH/National Eye Institute (NEI) [R01 EY015311, NINDS R01 NS064183]; Deutsche Forschungsgemeinschaft [Ru-746/1-1]; IZKF Aachen [N5-4]; Australian National Health and Medical Research Council (NHMRC) Centre for Research Excellence; Internal Grant Agency of the Ministry of Health of the Czech Republic [NS 10552-3]; Xunta de Galicia-Plan Galego de InvestigaCion, Desenvolvemento e Innovacion Tecnoloxica (INCITE) [10PXIB9101280PR]; NATIONAL EYE INSTITUTE [R01EY015311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064183] Funding Source: NIH RePORTER	NIH/National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IZKF Aachen; Australian National Health and Medical Research Council (NHMRC) Centre for Research Excellence(National Health and Medical Research Council (NHMRC) of Australia); Internal Grant Agency of the Ministry of Health of the Czech Republic; Xunta de Galicia-Plan Galego de InvestigaCion, Desenvolvemento e Innovacion Tecnoloxica (INCITE); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are grateful for the generosity of the families who participated in this study. The sequencing and analytical work were supported by the Bioinformatics and Genomics Core of the UCLA Muscular Dystrophy Core Center (US National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) P30AR057230) within the Center for Duchenne Muscular Dystrophy. We appreciate fibroblasts from three subjects from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) Brain and Tissue Bank for Developmental Disorders. We acknowledge the contribution of clinical data by P. Carpenter (University of California, Irvine). The work was supported by the NIH/National Eye Institute (NEI) (R01 EY015311 and NINDS R01 NS064183 to J.C.J.), Deutsche Forschungsgemeinschaft (Ru-746/1-1 to S.R.-S. and K.Z.), IZKF Aachen (N5-4 to S.R.-S. and J.S.), the Australian National Health and Medical Research Council (NHMRC) Centre for Research Excellence (M. M. R.), the Internal Grant Agency of the Ministry of Health of the Czech Republic (NS 10552-3 to P. S.) and Xunta de Galicia-Plan Galego de InvestigaCion, Desenvolvemento e Innovacion Tecnoloxica (INCITE) (10PXIB9101280PR to M.-J.S.).	Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; BARTH PG, 1993, BRAIN DEV-JPN, V15, P411, DOI 10.1016/0387-7604(93)90080-R; Bhagwat M., 2010, CURR PROTOC BIOINFOR, P19, DOI DOI 10.1002/0471250953.BI0119S32; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brouwer R, 2001, J BIOL CHEM, V276, P6177, DOI 10.1074/jbc.M007603200; Budde BS, 2008, NAT GENET, V40, P1113, DOI 10.1038/ng.204; CHOU SM, 1990, CLIN NEUROPATHOL, V9, P21; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; DELEON GA, 1984, ACTA NEUROPATHOL, V63, P282, DOI 10.1007/BF00687334; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Gomez-Lado C, 2007, REV NEUROLOGIA, V45, P639, DOI 10.33588/rn.4510.2007519; Gorgen-Pauly U, 1999, Eur J Paediatr Neurol, V3, P33, DOI 10.1053/ejpn.1999.0177; GOUTIERES F, 1977, J NEUROL NEUROSUR PS, V40, P370, DOI 10.1136/jnnp.40.4.370; Jensen TH, 2010, ADV EXP MED BIOL, V702, P1, DOI 10.1007/978-1-4419-7841-7; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kani S, 2010, DEV BIOL, V343, P1, DOI 10.1016/j.ydbio.2010.03.024; Kobayashi H, 2011, AM J HUM GENET, V89, P121, DOI 10.1016/j.ajhg.2011.05.015; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lev D, 2008, EUR J PAEDIATR NEURO, V12, P97, DOI 10.1016/j.ejpn.2007.06.005; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MELKI J, 1994, SCIENCE, V264, P1474, DOI 10.1126/science.7910982; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Muntoni F, 1999, NEUROPEDIATRICS, V30, P243, DOI 10.1055/s-2007-973498; Namavar Y, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-50; Namavar Y, 2011, BRAIN, V134, P143, DOI 10.1093/brain/awq287; NORMAN RM, 1961, ARCH DIS CHILD, V36, P96, DOI 10.1136/adc.36.185.96; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Rankin J, 2010, AM J MED GENET A, V152A, P2079, DOI 10.1002/ajmg.a.33531; Renbaum P, 2009, AM J HUM GENET, V85, P281, DOI 10.1016/j.ajhg.2009.07.006; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rudnik-Schoneborn S, 2003, AM J MED GENET A, V117A, P10, DOI 10.1002/ajmg.a.10863; Ryan MM, 2000, PEDIATR NEUROL, V23, P180, DOI 10.1016/S0887-8994(00)00166-1; Salman MS, 2003, J CHILD NEUROL, V18, P220, DOI 10.1177/08830738030180031201; Sanefuji M, 2010, J CHILD NEUROL, V25, P1429, DOI 10.1177/0883073810372991; Simonati A, 2011, ACTA NEUROPATHOL, V121, P671, DOI 10.1007/s00401-011-0823-1; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Szabo N, 2008, PEDIATR NEUROL, V39, P286, DOI 10.1016/j.pediatrneurol.2008.06.017; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tsao CY, 2008, SEMIN PEDIATR NEUROL, V15, P151, DOI 10.1016/j.spen.2008.09.001; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; WOLFE JF, 1977, J CLIN INVEST, V59, P176, DOI 10.1172/JCI108616; Xie LH, 2008, CANCER IMMUNOL IMMUN, V57, P1029, DOI 10.1007/s00262-007-0434-9; Yang XF, 2002, CANCER RES, V62, P5517	47	167	169	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2012	44	6					704	U134		10.1038/ng.2254	http://dx.doi.org/10.1038/ng.2254			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	949BT	22544365	Green Submitted, Green Accepted			2022-12-25	WOS:000304551100020
J	Mine-Hattab, J; Rothstein, R				Mine-Hattab, Judith; Rothstein, Rodney			Increased chromosome mobility facilitates homology search during recombination	NATURE CELL BIOLOGY			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; BUDDING YEAST; REPAIR; CHROMATIN; DYNAMICS; LOCALIZATION; SEQUENCES	Homologous recombination, an essential process for preserving genomic integrity, uses intact homologous sequences to repair broken chromosomes. To explore the mechanism of homologous pairing in vivo, we tagged two homologous loci in diploid yeast Saccharomyces cerevisiae cells and investigated their dynamic organization in the absence and presence of DNA damage. When neither locus is damaged, homologous loci occupy largely separate regions, exploring only 2.7% of the nuclear volume. Following the induction of a double-strand break, homologous loci co-localize ten times more often. The mobility of the cut chromosome markedly increases, allowing it to explore a nuclear volume that is more than ten times larger. Interestingly, the mobility of uncut chromosomes also increases, allowing them to explore a four times larger volume. We propose a model for homology search in which increased chromosome mobility facilitates homologous pairing. Finally, we find that the increase in DNA dynamics is dependent on early steps of homologous recombination.	[Mine-Hattab, Judith; Rothstein, Rodney] Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA	Columbia University	Rothstein, R (corresponding author), Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA.	rothstein@columbia.edu		Rothstein, Rodney/0000-0002-4107-9654	EMBO; Marie Curie International Outgoing Fellowship; Bettencourt Foundation; Philippe Foundation; NIH [GM67055]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067055] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); Marie Curie International Outgoing Fellowship(European Commission); Bettencourt Foundation; Philippe Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank M. Lisby and X. Darzacq for fruitful comments about this work as well V. Dion and S. Gasser for sharing results before publication. The LacI<SUP>R197K</SUP> mutant protein was engineered by C. Muller. We also thank L. Symington and G. Mazon for help in performing the genomic blots. Thanks are also due to L. Symington, I. Izeddin, V. Recamier, A. Gupta, P. Thorpe, M. Chang, R. Reid, N. Mandriota and K. Bernstein for helpful discussions and comments on the manuscript. This work was financially supported by an EMBO Long-Term fellowship (J.M-H.), a Marie Curie International Outgoing Fellowship (J.M-H.), the Bettencourt Foundation (J.M-H.), a postdoctoral award from the Philippe Foundation (J.M-H.) and a grant from the NIH (GM67055 to R.R.).	Agarwal S, 2006, DNA REPAIR, V5, P1075, DOI 10.1016/j.dnarep.2006.05.029; Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Barzel A, 2008, NAT REV GENET, V9, P27, DOI 10.1038/nrg2224; Benichou O, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3264122; Berger AB, 2008, NAT METHODS, V5, P1031, DOI 10.1038/nmeth.1266; Burgess SM, 1999, GENE DEV, V13, P1627, DOI 10.1101/gad.13.12.1627; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Courty S, 2006, METHOD ENZYMOL, V414, P211, DOI 10.1016/S0076-6879(06)14012-4; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Dion V., 2012, NAT CELL BIOL; Dorfman KD, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.268102; Dutreix Marie, 2003, ComPlexUs, V1, P89, DOI 10.1159/000070465; Gasser SM, 2002, SCIENCE, V296, P1412, DOI 10.1126/science.1067703; Hajjoul H, 2009, LAB CHIP, V9, P3054, DOI 10.1039/b909016a; HERSKOWITZ I, 1991, METHOD ENZYMOL, V194, P132; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; Houston PL, 2006, PLOS GENET, V2, P896, DOI 10.1371/journal.pgen.0020098; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Ma WJ, 2008, NUCLEIC ACIDS RES, V36, P1836, DOI 10.1093/nar/gkm1148; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Meister P, 2010, METHOD ENZYMOL, V470, P535, DOI 10.1016/S0076-6879(10)70021-5; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; Oza P, 2009, GENE DEV, V23, P912, DOI 10.1101/gad.1782209; Rassool FV, 2003, CANCER LETT, V193, P1, DOI 10.1016/S0304-3835(02)00692-4; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Savir Y, 2010, MOL CELL, V40, P388, DOI 10.1016/j.molcel.2010.10.020; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Soutoglou E, 2007, CURR OPIN GENET DEV, V17, P435, DOI 10.1016/j.gde.2007.08.004; Soutoglou Evi, 2008, J Natl Cancer Inst Monogr, P16, DOI 10.1093/jncimonographs/lgn017; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Thorslund T, 2007, ONCOGENE, V26, P7720, DOI 10.1038/sj.onc.1210870; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Zimmer C, 2011, J CELL BIOL, V192, P723, DOI 10.1083/jcb.201010058; Zou H, 1997, CELL, V90, P87, DOI 10.1016/S0092-8674(00)80316-5	36	230	233	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2012	14	5					510	U136		10.1038/ncb2472	http://dx.doi.org/10.1038/ncb2472			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	936NW	22484485				2022-12-25	WOS:000303598300011
J	Reyon, D; Tsai, SQ; Khayter, C; Foden, JA; Sander, JD; Joung, JK				Reyon, Deepak; Tsai, Shengdar Q.; Khayter, Cyd; Foden, Jennifer A.; Sander, Jeffry D.; Joung, J. Keith			FLASH assembly of TALENs for high-throughput genome editing	NATURE BIOTECHNOLOGY			English	Article							ZINC-FINGER NUCLEASES; DNA-BINDING SPECIFICITY; EFFECTORS; CELLS; PROTEINS; KNOCKOUT	Engineered transcription activator-like effector nucleases (TALENs) have shown promise as facile and broadly applicable genome editing tools. However, no publicly available high-throughput method for constructing TALENs has been published, and large-scale assessments of the success rate and targeting range of the technology remain lacking. Here we describe the fast ligation-based automatable solid-phase high-throughput (FLASH) system, a rapid and cost-effective method for large-scale assembly of TALENs. We tested 48 FLASH-assembled TALEN pairs in a human cell-based EGFP reporter system and found that all 48 possessed efficient gene-modification activities. We also used FLASH to assemble TALENs for 96 endogenous human genes implicated in cancer and/or epigenetic regulation and found that 84 pairs were able to efficiently introduce targeted alterations. Our results establish the robustness of TALEN technology and demonstrate that FLASH facilitates high-throughput genome editing at a scale not currently possible with other genome modification technologies.	[Reyon, Deepak; Tsai, Shengdar Q.; Khayter, Cyd; Foden, Jennifer A.; Sander, Jeffry D.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Computat & Integrat Biol, Charlestown, MA 02129 USA; [Reyon, Deepak; Tsai, Shengdar Q.; Khayter, Cyd; Foden, Jennifer A.; Sander, Jeffry D.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA; [Reyon, Deepak] Iowa State Univ, Dept Genet Dev & Cell Biol, Interdept Grad Program Bioinformat & Computat Bio, Ames, IA USA; [Reyon, Deepak; Tsai, Shengdar Q.; Sander, Jeffry D.; Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Iowa State University; Harvard University; Harvard Medical School	Joung, JK (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Computat & Integrat Biol, Charlestown, MA 02129 USA.	jsander@partners.org; jjoung@partners.org	Tsai, Shengdar Q./G-4600-2012; Reyon, Deepak/HCH-3183-2022; Ha, Dat Thinh/D-4995-2015	Tsai, Shengdar Q./0000-0001-9161-3993; Ha, Dat Thinh/0000-0003-4260-4876	US National Institutes of Health (NIH) [DP1 OD006862]; NIH [P50HG005550, T32 CA009216]; Jim and Ann Orr MGH Research Scholar Award; National Science Foundation [DBI-0923827]; NATIONAL CANCER INSTITUTE [T32CA009216] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM105378] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006862] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jim and Ann Orr MGH Research Scholar Award; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank T. Cathomen for providing polyclonal U2OS-EGFP reporter cells and a T7EI protocol, Y. Fu for deriving the clonal U2OS-EGFP cell line, D. Dobbs for support and encouragement, and M. Maeder, J. Angstman and C. Ramirez for helpful comments. This work was supported by a US National Institutes of Health (NIH) Director's Pioneer Award DP1 OD006862 (J.K.J.), NIH P50HG005550 (J.K.J.), the Jim and Ann Orr MGH Research Scholar Award (J.K.J.), NIH T32 CA009216 (J.D.S.) and National Science Foundation DBI-0923827 (D.R.).	Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Geissler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019509; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Morbitzer R, 2011, NUCLEIC ACIDS RES, V39, P5790, DOI 10.1093/nar/gkr151; Morbitzer R, 2010, P NATL ACAD SCI USA, V107, P21617, DOI 10.1073/pnas.1013133107; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Scholze H, 2011, CURR OPIN MICROBIOL, V14, P47, DOI 10.1016/j.mib.2010.12.001; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019722; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	32	777	976	13	270	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2012	30	5					460	+		10.1038/nbt.2170	http://dx.doi.org/10.1038/nbt.2170			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	939IP	22484455	Green Accepted			2022-12-25	WOS:000303803200027
J	Amrute-Nayak, M; Bullock, SL				Amrute-Nayak, Mamta; Bullock, Simon L.			Single-molecule assays reveal that RNA localization signals regulate dynein-dynactin copy number on individual transcript cargoes	NATURE CELL BIOLOGY			English	Article							OSKAR MESSENGER-RNA; DROSOPHILA EMBRYOS; CYTOPLASMIC DYNEIN; SPINDLE CHECKPOINT; VESICLE TRANSPORT; IN-VITRO; MOTOR; OOCYTE; PROTEIN; COMPLEXES	Subcellular localization of mRNAs by cytoskeletal motors plays critical roles in the spatial control of protein function(1). However, optical limitations of studying mRNA transport in vivo mean that there is little mechanistic insight into how transcripts are packaged and linked to motors, and how the movement of mRNA motor complexes on the cytoskeleton is orchestrated. Here, we have reconstituted transport of mRNPs containing specific RNAs in vitro. We show directly that mRNAs that are either apically localized or non-localized in Drosophila melanogaster embryos associate with the dynein motor and move bidirectionally on individual microtubules, with localizing mRNPs exhibiting a strong minus-end-directed bias. Single-molecule fluorescence measurements reveal that RNA localization signals increase the average number of dynein and dynactin components recruited to individual mRNPs. We find that, surprisingly, individual RNA molecules are present in motile mRNPs in vitro and provide evidence that this is also the case in vivo. Thus, RNA oligomerization is not obligatory for transport. Our findings lead to a model in which RNA localization signals produce highly polarized distributions of transcript populations through modest changes in motor copy number on single mRNA molecules.	[Amrute-Nayak, Mamta; Bullock, Simon L.] MRC Lab Mol Biol, Div Cell Biol, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Bullock, SL (corresponding author), MRC Lab Mol Biol, Div Cell Biol, Hills Rd, Cambridge CB2 0QH, England.	sbullock@mrc-lmb.cam.ac.uk	Amrute-Nayak, Mamta/P-7447-2019; Bullock, Simon/K-6885-2012	Bullock, Simon/0000-0001-9491-4548	UK Medical Research Council [U105178790]; Lister Institute prize fellowship; Medical Research Council [MC_U105178790] Funding Source: researchfish; MRC [MC_U105178790] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lister Institute prize fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was financially supported by the UK Medical Research Council (project U105178790) and a Lister Institute prize fellowship (to S.L.B.). We are very grateful to A. Carter, A. Guichet, T. Hays, R. Lehmann, E. Miska, C. Navarro, I. Palacios, J. Raft, C. Samakovlis, B. Suter and R. Warrior for providing reagents, A. Pare for advice on in situ hybridization, N. Barry for advice on microscopy, A. Nicol and D. Zicha for help with mRNP tracking software, M. Dogterom for the Stepfinder algorithm, and members of the Bullock laboratory, D. St Johnston and A. Carter for their valuable insights.	Bullock SL, 2006, CURR BIOL, V16, P1447, DOI 10.1016/j.cub.2006.05.055; Bullock SL, 2010, NAT STRUCT MOL BIOL, V17, P703, DOI 10.1038/nsmb.1813; Bullock SL, 2001, NATURE, V414, P611, DOI 10.1038/414611a; Cohen RS, 2005, RNA, V11, P1017, DOI 10.1261/rna.7218905; Cole K, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh085; Coy DL, 1999, NAT CELL BIOL, V1, P288, DOI 10.1038/13001; Das SK, 2007, CHEMBIOCHEM, V8, P994, DOI 10.1002/cbic.200600474; Delanoue R, 2007, DEV CELL, V13, P523, DOI 10.1016/j.devcel.2007.08.022; Dienstbier M, 2009, GENE DEV, V23, P1546, DOI 10.1101/gad.531009; Duncan JE, 2002, CURR BIOL, V12, P1982, DOI 10.1016/S0960-9822(02)01303-9; EDGAR BA, 1986, CELL, V47, P747, DOI 10.1016/0092-8674(86)90517-9; Ferrandon D, 1997, EMBO J, V16, P1751, DOI 10.1093/emboj/16.7.1751; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Holt CE, 2009, SCIENCE, V326, P1212, DOI 10.1126/science.1176488; Hoogenraad CC, 2001, EMBO J, V20, P4041, DOI 10.1093/emboj/20.15.4041; INGHAM PW, 1985, NATURE, V318, P439, DOI 10.1038/318439a0; Jain A, 2011, NATURE, V473, P484, DOI 10.1038/nature10016; Januschke J, 2002, CURR BIOL, V12, P1971, DOI 10.1016/S0960-9822(02)01302-7; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; King SJ, 2002, PROTEIN SCI, V11, P1239, DOI 10.1110/ps.2520102; Lange S, 2008, TRAFFIC, V9, P1256, DOI 10.1111/j.1600-0854.2008.00763.x; Larsen KS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003763; Lecuyer Eric, 2008, V420, P289, DOI 10.1007/978-1-59745-583-1_18; Loiseau P, 2010, DEVELOPMENT, V137, P2763, DOI 10.1242/dev.048108; Mach JM, 1997, GENE DEV, V11, P423, DOI 10.1101/gad.11.4.423; Mallik R, 2005, CURR BIOL, V15, P2075, DOI 10.1016/j.cub.2005.10.039; Mhlanga MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006241; Mikl M, 2011, EMBO REP, V12, P1077, DOI 10.1038/embor.2011.149; Mische S, 2008, MOL BIOL CELL, V19, P4918, DOI 10.1091/mbc.E08-05-0483; Nasiadka A., 2002, AD DEV BIOL, V12, P155; Navarro C, 2004, NAT CELL BIOL, V6, P427, DOI 10.1038/ncb1122; Pandey R, 2007, J CELL SCI, V120, P2807, DOI 10.1242/jcs.007690; Pare A, 2009, CURR BIOL, V19, P2037, DOI 10.1016/j.cub.2009.10.028; Ross JL, 2008, BIOPHYS J, V94, P3115, DOI 10.1529/biophysj.107.120014; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Roth P, 2003, J CELL BIOL, V163, P701, DOI 10.1083/jcb.200304046; SCHAFER DA, 1994, J CELL BIOL, V126, P403, DOI 10.1083/jcb.126.2.403; Schuster M, 2011, P NATL ACAD SCI USA, V108, P3618, DOI 10.1073/pnas.1015839108; Schuster M, 2011, EMBO J, V30, P652, DOI 10.1038/emboj.2010.360; SERANO T, 1995, DEVELOPMENT, V121, P3809; Sharp DJ, 2000, MOL BIOL CELL, V11, P241, DOI 10.1091/mbc.11.1.241; Shu D, 2007, EMBO J, V26, P527, DOI 10.1038/sj.emboj.7601506; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Srisawat C, 2001, RNA, V7, P632, DOI 10.1017/S135583820100245X; SUTER B, 1991, CELL, V67, P917, DOI 10.1016/0092-8674(91)90365-6; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; Vendra G, 2007, RNA, V13, P1860, DOI 10.1261/rna.509007; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; Wilkie GS, 1999, CURR BIOL, V9, P1263, DOI 10.1016/S0960-9822(99)80509-0; Wilkie GS, 2001, CELL, V105, P209, DOI 10.1016/S0092-8674(01)00312-9; Zimyanin VL, 2008, CELL, V134, P843, DOI 10.1016/j.cell.2008.06.053	54	62	65	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2012	14	4					416	+		10.1038/ncb2446	http://dx.doi.org/10.1038/ncb2446			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	921UM	22366687	Green Accepted			2022-12-25	WOS:000302503300015
J	Jin, YM; Ratnam, K; Chuang, PY; Fan, Y; Zhong, YF; Dai, Y; Mazloom, AR; Chen, EY; D'Agati, V; Xiong, HB; Ross, MJ; Chen, N; Ma'ayan, A; He, JC				Jin, Yuanmeng; Ratnam, Krishna; Chuang, Peter Y.; Fan, Ying; Zhong, Yifei; Dai, Yan; Mazloom, Amin R.; Chen, Edward Y.; D'Agati, Vivette; Xiong, Huabao; Ross, Michael J.; Chen, Nan; Ma'ayan, Avi; He, John Cijiang			A systems approach identifies HIPK2 as a key regulator of kidney fibrosis	NATURE MEDICINE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HIV-ASSOCIATED NEPHROPATHY; DNA-DAMAGE RESPONSE; TGF-BETA; INTERSTITIAL FIBROSIS; N-ACETYLCYSTEINE; APOPTOSIS; TRANSCRIPTION; ACTIVATION; GROWTH	Kidney fibrosis is a common process that leads to the progression of various types of kidney disease. We used an integrated computational and experimental systems biology approach to identify protein kinases that regulate gene expression changes in the kidneys of human immunodeficiency virus (HIV) transgenic mice (Tg26 mice), which have both tubulointerstitial fibrosis and glomerulosclerosis. We identified homeo-domain interacting protein kinase 2 (HIPK2) as a key regulator of kidney fibrosis. HIPK2 was upregulated in the kidneys of Tg26 mice and in those of patients with various kidney diseases. HIV infection increased the protein concentrations of HIPK2 by promoting oxidative stress, which inhibited the seven in absentia homolog 1 (SIAH1)-mediated proteasomal degradation of HIPK2. HIPK2 induced apoptosis and the expression of epithelial-to-mesenchymal transition markers in kidney epithelial cells by activating the p53, transforming growth factor beta (TGF-beta)-SMAD family member 3 (Smad3) and Wnt-Notch pathways. Knockout of HIPK2 improved renal function and attenuated proteinuria and kidney fibrosis in Tg26 mice, as well as in other murine models of kidney fibrosis. We therefore conclude that HIPK2 is a potential target for anti-fibrosis therapy.	[Jin, Yuanmeng; Ratnam, Krishna; Chuang, Peter Y.; Fan, Ying; Zhong, Yifei; Dai, Yan; Ross, Michael J.; He, John Cijiang] Mt Sinai Sch Med, Dept Med, Div Nephrol, New York, NY 10029 USA; [Jin, Yuanmeng; Chen, Nan] Jiao Tong Univ Sch Med, Ruijin Hosp, Dept Nephrol, Shanghai, Peoples R China; [Mazloom, Amin R.; Chen, Edward Y.; Ma'ayan, Avi; He, John Cijiang] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY USA; [Mazloom, Amin R.; Chen, Edward Y.; Ma'ayan, Avi] SBCNY, New York, NY USA; [D'Agati, Vivette] Columbia Univ, Dept Pathol, New York, NY USA; [Xiong, Huabao] Mt Sinai Sch Med, Immunobiol Ctr, New York, NY USA; [He, John Cijiang] James J Peters Vet Adm Med Ctr, New York, NY USA	Icahn School of Medicine at Mount Sinai; Shanghai Jiao Tong University; Icahn School of Medicine at Mount Sinai; Columbia University; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	He, JC (corresponding author), Mt Sinai Sch Med, Dept Med, Div Nephrol, New York, NY 10029 USA.	avi.maayan@mssm.edu; cijiang.he@mssm.edu	Ma'ayan, Avi/AAG-3131-2019	Ma'ayan, Avi/0000-0002-6904-1017	US National Institutes of Health (NIH) [1R01DK078897]; Veterans Affairs Merit Award; NIH [1R01DK088541, P01-DK-56492, 1RC4DK090860, RC2OD006536, 5P50GM071558, 5K08DK082760]; Chinese 973 fund [2012CB517601]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088541, P01DK056492, K08DK065495, K08DK082760, R01DK078897, RC4DK090860, R01DK078510] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese 973 fund(National Basic Research Program of China); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge and thank G.L. Gusella (Mount Sinai School of Medicine, New York) for providing the lentiviral construct, E. Huang (University of California San Francisco) for providing the HIPK2 KO mice, P. Mundel (Massachusetts General Hospital, Boston) for synaptopodin antibody and conditionally immortalized murine podocyte cell line, L. Holzman (University of Pennsylvania, Philadelphia) for nephrin antibody and R.H. Goodman (Oregon Health and Science University, Portland) for WT-HIPK2 and KD-HIPK2 constructs. We also thank R. Iyengar and P. Klotman for critical suggestions on experimental design and for other valuable contributions. J.C.H. is supported by US National Institutes of Health (NIH) grant 1R01DK078897 and a Veterans Affairs Merit Award; J.C.H. and A.M. are supported by NIH 1R01DK088541, NIH P01-DK-56492 and NIH 1RC4DK090860; A.M. is supported by NIH RC2OD006536 and 5P50GM071558; P.Y.C. is supported by NIH 5K08DK082760. N.C. is supported by Chinese 973 fund 2012CB517601.	Berger SI, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-372; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Bruggeman LA, 2000, J AM SOC NEPHROL, V11, P2079, DOI 10.1681/ASN.V11112079; Calzado MA, 2007, CELL CYCLE, V6, P139, DOI 10.4161/cc.6.2.3788; D'Agati V, 2003, SEMIN NEPHROL, V23, P117, DOI 10.1053/snep.2003.50012; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Di Stefano V, 2004, ONCOGENE, V23, P5185, DOI 10.1038/sj.onc.1207656; DICKIE P, 1991, VIROLOGY, V185, P109, DOI 10.1016/0042-6822(91)90759-5; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF4, DOI 10.1152/ajprenal.00045.2005; Doi K, 2006, AM J PATHOL, V168, P1413, DOI 10.2353/ajpath.2006.050634; He JCJ, 2004, J CLIN INVEST, V114, P643, DOI 10.1172/JCI200421004; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Hertig A, 2008, NEPHROL THER, V4, pS25, DOI 10.1016/S1769-7255(08)73648-4; Hertig A, 2010, TRANSPL P, V42, pS7, DOI 10.1016/j.transproceed.2010.07.040; Hikasa H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.185280; Hofmann TG, 2003, CANCER RES, V63, P8271; Husain M, 2009, J BIOL CHEM, V284, P16648, DOI 10.1074/jbc.M109.008482; Inazaki K, 2004, KIDNEY INT, V66, P597, DOI 10.1111/j.1523-1755.2004.00779.x; Isono K, 2006, MOL CELL BIOL, V26, P2758, DOI 10.1128/MCB.26.7.2758-2771.2006; Ivanovski O, 2005, KIDNEY INT, V67, P2288, DOI 10.1111/j.1523-1755.2005.00332.x; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; KOPP JB, 1992, P NATL ACAD SCI USA, V89, P1577, DOI 10.1073/pnas.89.5.1577; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Lachmann A, 2009, BIOINFORMATICS, V25, P684, DOI 10.1093/bioinformatics/btp026; Lee W, 2009, DEV BIOL, V325, P263, DOI 10.1016/j.ydbio.2008.10.029; Lee W, 2009, DEVELOPMENT, V136, P241, DOI 10.1242/dev.025460; Leventhal JS, 2008, SEMIN NEPHROL, V28, P523, DOI 10.1016/j.semnephrol.2008.08.003; Long DA, 2008, KIDNEY INT, V74, P300, DOI 10.1038/ki.2008.179; Mainra R, 2007, NEPHROLOGY, V12, P510, DOI 10.1111/j.1440-1797.2007.00833.x; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mizui M, 2006, KIDNEY INT, V70, P298, DOI 10.1038/sj.ki.5001541; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Quaggin SE, 2011, KIDNEY INT, V80, P41, DOI 10.1038/ki.2011.77; Ratnam KK, 2011, KIDNEY INT, V79, P624, DOI 10.1038/ki.2010.470; Rinaldo C, 2007, BIOCHEM CELL BIOL, V85, P411, DOI 10.1139/O07-071; Rosenstiel PE, 2008, KIDNEY INT, V74, P1049, DOI 10.1038/ki.2008.303; Rosenstiel PE, 2009, AIDS, V23, P2054, DOI 10.1097/QAD.0b013e32833088a0; Ross MJ, 2006, J AM SOC NEPHROL, V17, P996, DOI 10.1681/ASN.2005070692; Seth R, 2005, J BIOL CHEM, V280, P31230, DOI 10.1074/jbc.M503305200; Snyder A, 2010, AIDS, V24, P1107, DOI 10.1097/QAD.0b013e328337b0ab; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Wei GW, 2007, P NATL ACAD SCI USA, V104, P13040, DOI 10.1073/pnas.0703213104; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743; Wyatt CM, 2007, AM J MED, V120, P488, DOI 10.1016/j.amjmed.2007.01.025; Yadav A, 2010, AM J PHYSIOL-RENAL, V298, pF734, DOI 10.1152/ajprenal.00415.2009; Yang JW, 2002, J AM SOC NEPHROL, V13, P2464, DOI 10.1097/01.ASN.0000031827.16102.C1; Yoo JY, 2003, J BIOL CHEM, V278, P43001, DOI 10.1074/jbc.M307869200; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhang JS, 2007, NAT NEUROSCI, V10, P77, DOI 10.1038/nn1816; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X	56	111	116	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2012	18	4					580	588		10.1038/nm.2685	http://dx.doi.org/10.1038/nm.2685			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	923KI	22406746	Green Accepted			2022-12-25	WOS:000302617800035
J	Cummings, DE; Bloom, SR; Rubino, F				Cummings, David E.; Bloom, Stephen R.; Rubino, Francesco			At the heart of the benefits of bariatric surgery	NATURE MEDICINE			English	Editorial Material							MORTALITY; WEIGHT; OBESE	Obesity is associated with an increased risk of cardiovascular events, thus weight loss would be expected to have a beneficial effect on cardiovascular disease. This view is supported by a recent paper that used participants from the ongoing Swedish Obese Subjects (SOS) study, a nonrandomized, prospective study to investigate the effects of bariatric surgery on cardiovascular disease(1). Individuals who underwent bariatric surgery had a significantly reduced number of total and fatal cardiovascular events compared with matched obese controls who did not undergo surgery. Surprisingly, the reduction in cardiovascular events was not related to the baseline body mass index (BMI) or the weight loss experienced by the treated patients. We asked three experts how this study affects understanding of the relationship between weight loss, metabolic and cardiovascular disease, as well as how bariatric surgery may mediate its effects on human health.	[Cummings, David E.] Univ Washington, Diabet & Obes Ctr Excellence, Seattle, WA 98195 USA; [Cummings, David E.] Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA; [Bloom, Stephen R.] Imperial Coll London Hammersmith, London, England; [Rubino, Francesco] New York Presbyterian Hosp, Weill Cornell Med Coll, New York, NY USA	University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Imperial College London; Cornell University; NewYork-Presbyterian Hospital	Cummings, DE (corresponding author), Univ Washington, Diabet & Obes Ctr Excellence, Seattle, WA 98195 USA.							Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Flum DR, 2009, NEW ENGL J MED, V361, P445, DOI 10.1056/NEJMoa0901836; Picot J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13410; Pinkney JH, 2010, DIABETOLOGIA, V53, P1815, DOI 10.1007/s00125-010-1845-2; Rubino F, 2010, ANN SURG, V251, P399, DOI 10.1097/SLA.0b013e3181be34e7; Rubino F, 2010, ANNU REV MED, V61, P393, DOI 10.1146/annurev.med.051308.105148; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Zimmet P, 2011, LANCET, V378, P108, DOI 10.1016/S0140-6736(11)61027-1	10	1	1	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2012	18	3					358	359		10.1038/nm0312-358	http://dx.doi.org/10.1038/nm0312-358			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	905IF	22395701				2022-12-25	WOS:000301264800034
J	Gudmundsson, J; Sulem, P; Gudbjartsson, DF; Jonasson, JG; Masson, G; He, HL; Jonasdottir, A; Sigurdsson, A; Stacey, SN; Johannsdottir, H; Helgadottir, HT; Li, W; Nagy, R; Ringel, MD; Kloos, RT; de Visser, MCH; Plantinga, TS; den Heijer, M; Aguillo, E; Panadero, A; Prats, E; Garcia-Castano, A; De Juan, A; Rivera, F; Walters, GB; Bjarnason, H; Tryggvadottir, L; Eyjolfsson, GI; Bjornsdottir, US; Holm, H; Olafsson, I; Kristjansson, K; Kristvinsson, H; Magnusson, OT; Thorleifsson, G; Gulcher, JR; Kong, A; Kiemeney, LALM; Jonsson, T; Hjartarson, H; Mayordomo, JI; Netea-Maier, RT; de la Chapelle, A; Hrafnkelsson, J; Thorsteinsdottir, U; Rafnar, T; Stefansson, K				Gudmundsson, Julius; Sulem, Patrick; Gudbjartsson, Daniel F.; Jonasson, Jon G.; Masson, Gisli; He, Huiling; Jonasdottir, Aslaug; Sigurdsson, Asgeir; Stacey, Simon N.; Johannsdottir, Hrefna; Helgadottir, Hafdis Th; Li, Wei; Nagy, Rebecca; Ringel, Matthew D.; Kloos, Richard T.; de Visser, Marieke C. H.; Plantinga, Theo S.; den Heijer, Martin; Aguillo, Esperanza; Panadero, Angeles; Prats, Enrique; Garcia-Castano, Almudena; De Juan, Ana; Rivera, Fernando; Walters, G. Bragi; Bjarnason, Hjordis; Tryggvadottir, Laufey; Eyjolfsson, Gudmundur I.; Bjornsdottir, Unnur S.; Holm, Hilma; Olafsson, Isleifur; Kristjansson, Kristleifur; Kristvinsson, Hoskuldur; Magnusson, Olafur T.; Thorleifsson, Gudmar; Gulcher, Jeffrey R.; Kong, Augustine; Kiemeney, Lambertus A. L. M.; Jonsson, Thorvaldur; Hjartarson, Hannes; Mayordomo, Jose I.; Netea-Maier, Romana T.; de la Chapelle, Albert; Hrafnkelsson, Jon; Thorsteinsdottir, Unnur; Rafnar, Thorunn; Stefansson, Kari			Discovery of common variants associated with low TSH levels and thyroid cancer risk	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCUS; GENE-EXPRESSION; SERUM TSH; CARCINOMA; INDIVIDUALS; POPULATIONS; ICELAND; DISEASE	To search for sequence variants conferring risk of nonmedullary thyroid cancer, we focused our analysis on 22 SNPs with a P < 5 x 10(-8) in a genome-wide association study on levels of thyroid stimulating hormone (TSH) in 27,758 Icelanders. Of those, rs965513 has previously been shown to associate with thyroid cancer. The remaining 21 SNPs were genotyped in 561 Icelandic individuals with thyroid cancer (cases) and up to 40,013 controls. Variants suggestively associated with thyroid cancer (P < 0.05) were genotyped in an additional 595 non-Icelandic cases and 2,604 controls. After combining the results, three variants were shown to associate with thyroid cancer: rs966423 on 2q35 (OR = 1.34; P-combined = 1.3 x 10(-9)), rs2439302 on 8p12 (OR = 1.36; P-combined = 2.0 x 10(-9)) and rs116909374 on 14q13.3 (OR = 2.09; P-combined = 4.6 x 10(-11)), a region previously reported to contain an uncorrelated variant conferring risk of thyroid cancer. A strong association (P = 9.1 x 10(-91)) was observed between rs2439302 on 8p12 and expression of NRG1, which encodes the signaling protein neuregulin 1, in blood.	[Gudmundsson, Julius; Sulem, Patrick; Gudbjartsson, Daniel F.; Masson, Gisli; Jonasdottir, Aslaug; Sigurdsson, Asgeir; Stacey, Simon N.; Johannsdottir, Hrefna; Helgadottir, Hafdis Th; Walters, G. Bragi; Bjarnason, Hjordis; Holm, Hilma; Kristjansson, Kristleifur; Magnusson, Olafur T.; Thorleifsson, Gudmar; Gulcher, Jeffrey R.; Kong, Augustine; Thorsteinsdottir, Unnur; Rafnar, Thorunn; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Jonasson, Jon G.; Olafsson, Isleifur; Kristvinsson, Hoskuldur; Jonsson, Thorvaldur; Hjartarson, Hannes; Hrafnkelsson, Jon] Lanspitali Univ Hosp, Reykjavik, Iceland; [Jonasson, Jon G.; Tryggvadottir, Laufey; Bjornsdottir, Unnur S.; Jonsson, Thorvaldur; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Jonasson, Jon G.; Tryggvadottir, Laufey] Iceland Canc Registry, Reykjavik, Iceland; [He, Huiling; Li, Wei; Nagy, Rebecca; de la Chapelle, Albert] Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Columbus, OH 43210 USA; [Ringel, Matthew D.; Kloos, Richard T.] Ohio State Univ, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA; [de Visser, Marieke C. H.; den Heijer, Martin; Kiemeney, Lambertus A. L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, NL-6525 ED Nijmegen, Netherlands; [Plantinga, Theo S.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Aguillo, Esperanza] Univ Hosp, Div Endocrinol, Zaragoza, Spain; [Panadero, Angeles] Ciudad Coria Hosp, Div Med Oncol, Coria, Spain; [Prats, Enrique] Univ Hosp, Div Nucl Med, Zaragoza, Spain; [Garcia-Castano, Almudena; De Juan, Ana; Rivera, Fernando] Marques de Valdecilla Univ Hosp, Div Med Oncol, Santander, Spain; [Eyjolfsson, Gudmundur I.] Lab Mjodd, Reykjavik, Iceland; [Mayordomo, Jose I.] Univ Zaragoza, Div Med Oncol, Zaragoza, Spain; [den Heijer, Martin; Netea-Maier, Romana T.] Radboud Univ Nijmegen, Med Ctr, Dept Endocrinol, NL-6525 ED Nijmegen, Netherlands	Landspitali National University Hospital; University of Iceland; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Radboud University Nijmegen; Radboud University Nijmegen; Hospital Universitario Marques de Valdecilla (HUMV); University of Zaragoza; Radboud University Nijmegen	Stefansson, K (corresponding author), deCODE Genet, Reykjavik, Iceland.	julius.gudmundsson@decode.is; kstefans@decode.is	Stefansson, Kari/AAE-7187-2019; Walters, G. Bragi/L-4215-2013; Netea-Maier, R.T./L-4543-2015; Pillay, Nischalan/F-9536-2012; Netea, Mihai/N-5155-2014; Plantinga, Theo S./A-6895-2015; Kiemeney, Lambertus A./D-3357-2009; Mayordomo, Jose/K-3453-2013; de Visser, Marieke/AAC-5167-2020; Nagy, Rebecca Shrigley/E-4088-2011; Kloos, Richard/Q-9963-2019; den Heijer, Martin/J-8036-2015	Walters, G. Bragi/0000-0002-5415-6487; Plantinga, Theo S./0000-0003-4990-6084; Kiemeney, Lambertus A./0000-0002-2368-1326; Ringel, Matthew/0000-0001-8672-3266; Tryggvadottir, Laufey/0000-0001-8067-9030; Helgadottir, Hafdis/0000-0003-4352-152X; Kong, Augustine/0000-0001-8193-5438; den Heijer, Martin/0000-0003-3620-5617; Gudbjartsson, Daniel/0000-0002-5222-9857; Jonasson, Jon G./0000-0002-2635-5032	US National Institutes of Health [CA16058, CA124570]; NATIONAL CANCER INSTITUTE [P30CA016058, P01CA124570] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the affected individuals whose contribution made this work possible. This project was funded in part by US National Institutes of Health contract numbers CA16058 and CA124570.	Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; Arnaud-Lopez L, 2008, AM J HUM GENET, V82, P1270, DOI 10.1016/j.ajhg.2008.04.019; Baida A, 2008, CANCER EPIDEM BIOMAR, V17, P1499, DOI 10.1158/1055-9965.EPI-07-0235; Czene K, 2002, INT J CANCER, V99, P260, DOI 10.1002/ijc.10332; Delellis RA, 2006, J SURG ONCOL, V94, P662, DOI 10.1002/jso.20700; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Garcia-Barcelo MM, 2009, P NATL ACAD SCI USA, V106, P2694, DOI 10.1073/pnas.0809630105; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; He HL, 2005, THYROID, V15, P660, DOI 10.1089/thy.2005.15.660; He HL, 2009, CANCER RES, V69, P625, DOI 10.1158/0008-5472.CAN-08-1071; Hrafnkelsson J, 2001, J MED GENET, V38, P189, DOI 10.1136/jmg.38.3.189; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Landa I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000637; Medici M, 2011, EUR J ENDOCRINOL, V164, P781, DOI 10.1530/EJE-10-1130; Panicker V, 2010, AM J HUM GENET, V87, P430, DOI 10.1016/j.ajhg.2010.08.005; Parlato R, 2004, DEV BIOL, V276, P464, DOI 10.1016/j.ydbio.2004.08.048; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; Stacey SN, 2011, NAT GENET, V43, P1098, DOI 10.1038/ng.926; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Sulem P, 2011, NAT GENET, V43, P1127, DOI 10.1038/ng.972; Takahashi M, 2010, HUM MOL GENET, V19, P2516, DOI 10.1093/hmg/ddq123; Teumer A, 2011, AM J HUM GENET, V88, P664, DOI 10.1016/j.ajhg.2011.04.015; Wetzels JFM, 2007, KIDNEY INT, V72, P632, DOI 10.1038/sj.ki.5002374	30	169	172	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2012	44	3					319	U126		10.1038/ng.1046	http://dx.doi.org/10.1038/ng.1046			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	899VC	22267200	Green Accepted			2022-12-25	WOS:000300843600019
J	Wacker, SA; Houghtaling, BR; Elemento, O; Kapoor, TM				Wacker, Sarah A.; Houghtaling, Benjamin R.; Elemento, Olivier; Kapoor, Tarun M.			Using transcriptome sequencing to identify mechanisms of drug action and resistance	NATURE CHEMICAL BIOLOGY			English	Article							BORTEZOMIB RESISTANCE; MOLECULAR-BASIS; GENE MUTATION; BCR-ABL; INHIBITOR; PROTEASOME; DISCOVERY; PROTEIN; AURORA; CELLS	Determining mechanisms of drug action in human cells remains a major challenge. Here we describe an approach in which multiple-drug-resistant clones are isolated and transcriptome sequencing is used to find mutations in each clone. Further analysis of mutations common to more than one clone can identify a drug's physiological target and indirect resistance mechanisms, as indicated by our proof-of-concept studies of the cytotoxic anticancer drugs BI 2536 and bortezomib.	[Wacker, Sarah A.; Houghtaling, Benjamin R.; Kapoor, Tarun M.] Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10021 USA; [Elemento, Olivier] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY USA	Rockefeller University; Cornell University	Wacker, SA (corresponding author), Rockefeller Univ, Lab Chem & Cell Biol, 1230 York Ave, New York, NY 10021 USA.	ole2001@med.cornell.edu; kapoor@rockefeller.edu			US National Science Foundation [1054964]; US National Institutes of Health [GM98579, GM65933]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098579, R01GM065933] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Genomics Resources Core Facility of Weill Cornell Medical College for conducting the RNA-seq and D. Soong (Weill Cornell Medical College) for providing custom analysis software. This work was supported by the US National Science Foundation CAREER grant 1054964 (O.E.) and US National Institutes of Health GM98579 and GM65933 (T.M.K.).	Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Chan JNY, 2010, TRENDS PHARMACOL SCI, V31, P82, DOI 10.1016/j.tips.2009.11.002; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791; Girdler F, 2008, CHEM BIOL, V15, P552, DOI 10.1016/j.chembiol.2008.04.013; Glaab WE, 1997, CARCINOGENESIS, V18, P1, DOI 10.1093/carcin/18.1.1; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Groll M, 2006, STRUCTURE, V14, P451, DOI 10.1016/j.str.2005.11.019; Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534; Kothe M, 2007, CHEM BIOL DRUG DES, V70, P540, DOI 10.1111/j.1747-0285.2007.00594.x; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lu SQ, 2008, J PHARMACOL EXP THER, V326, P423, DOI 10.1124/jpet.108.138131; Oerlemans R, 2008, BLOOD, V112, P2489, DOI 10.1182/blood-2007-08-104950; Ong SE, 2009, P NATL ACAD SCI USA, V106, P4617, DOI 10.1073/pnas.0900191106; Rickert KW, 2008, ARCH BIOCHEM BIOPHYS, V469, P220, DOI 10.1016/j.abb.2007.10.016; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Scutt PJ, 2009, J BIOL CHEM, V284, P15880, DOI 10.1074/jbc.M109.005694; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; Teraishi F, 2005, CANCER RES, V65, P6380, DOI 10.1158/0008-5472.CAN-05-0575; WALKER GM, 1982, J GEN MICROBIOL, V128, P61; Weiss WA, 2007, NAT CHEM BIOL, V3, P739, DOI 10.1038/nchembio1207-739; Wood KW, 2010, P NATL ACAD SCI USA, V107, P5839, DOI 10.1073/pnas.0915068107; Yusuf RZ, 2003, CURR CANCER DRUG TAR, V3, P1, DOI 10.2174/1568009033333754	23	121	123	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2012	8	3					235	237		10.1038/NCHEMBIO.779	http://dx.doi.org/10.1038/NCHEMBIO.779			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896VR	22327403	Green Accepted			2022-12-25	WOS:000300600000007
J	Wu, G; Broniscer, A; McEachron, TA; Lu, C; Paugh, BS; Becksfort, J; Qu, CX; Ding, L; Huether, R; Parker, M; Zhang, JY; Gajjar, A; Dyer, MA; Mullighan, CG; Gilbertson, RJ; Mardis, ER; Wilson, RK; Downing, JR; Ellison, DW; Zhang, JH; Baker, SJ				Wu, Gang; Broniscer, Alberto; McEachron, Troy A.; Lu, Charles; Paugh, Barbara S.; Becksfort, Jared; Qu, Chunxu; Ding, Li; Huether, Robert; Parker, Matthew; Zhang, Junyuan; Gajjar, Amar; Dyer, Michael A.; Mullighan, Charles G.; Gilbertson, Richard J.; Mardis, Elaine R.; Wilson, Richard K.; Downing, James R.; Ellison, David W.; Zhang, Jinghui; Baker, Suzanne J.		St Jude Children's Res Hosp	Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas	NATURE GENETICS			English	Article								To identify somatic mutations in pediatric diffuse intrinsic pontine glioma (DIPG), we performed whole-genome sequencing of DNA from seven DIPGs and matched germline tissue and targeted sequencing of an additional 43 DIPGs and 36 non-brainstem pediatric glioblastomas (non-BS-PGs). We found that 78% of DIPGs and 22% of non-BS-PGs contained a mutation in H3F3A, encoding histone H3.3, or in the related HIST1H3B, encoding histone H3.1, that caused a p. Lys27Met amino acid substitution in each protein. An additional 14% of non-BS-PGs had somatic mutations in H3F3A causing a p. Gly34Arg alteration.	[Lu, Charles; Ding, Li; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63130 USA; [Wu, Gang; Huether, Robert; Parker, Matthew; Zhang, Jinghui] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Broniscer, Alberto; Gajjar, Amar] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [McEachron, Troy A.; Paugh, Barbara S.; Zhang, Junyuan; Dyer, Michael A.; Gilbertson, Richard J.; Baker, Suzanne J.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Becksfort, Jared; Qu, Chunxu] St Jude Childrens Res Hosp, Hartwell Ctr Biotechnol & Bioinformat, Memphis, TN 38105 USA; [Mullighan, Charles G.; Downing, James R.; Ellison, David W.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA	Washington University (WUSTL); St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Wilson, RK (corresponding author), Washington Univ, Sch Med, Genome Inst, St Louis, MO 63130 USA.	rwilson@wustl.edu; james.downing@stjude.org; jinghui.zhang@stjude.org; suzanne.baker@stjude.org	Mardis, Elaine/W-2202-2019; Mullighan, Charles/H-3253-2011; Ellison, David/N-4806-2018; Huether, Robert/E-9638-2012; Gajjar, Amar/N-8059-2018; Gilbertson, Richard James/ABE-1346-2021; Dyer, Michael/N-8134-2018; Zhang, Jing/GWZ-7332-2022; Ganesh, Dunna Sai/AGX-5170-2022; Wilson, Richard K./AAF-4139-2019; Baker, Suzanne J/N-8167-2018; Downing, James R./N-8102-2018; Wu, Gang/M-8012-2014	Mullighan, Charles/0000-0002-1871-1850; Huether, Robert/0000-0001-7077-7470; Gilbertson, Richard James/0000-0001-7539-9472; Wilson, Richard K./0000-0002-1992-1358; Wu, Gang/0000-0002-1678-5864; Broniscer, Alberto/0000-0001-9646-0463; Parker, Matthew/0000-0003-2999-3870	St. Jude Children's Research Hospital-Washington University; American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital; US National Institutes of Health (NIH) [CA096832]; Sydney Schlobohm Chair of Research from National Brain Tumor Society; Cure Starts Now Foundation; Smile for Sophie Forever Foundation; Tyler's Treehouse Foundation; Musicians Against Childhood Cancer; Noyes Brain Tumor Foundation; NATIONAL CANCER INSTITUTE [P01CA096832, R01CA135554, R01CA129541] Funding Source: NIH RePORTER	St. Jude Children's Research Hospital-Washington University; American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sydney Schlobohm Chair of Research from National Brain Tumor Society; Cure Starts Now Foundation; Smile for Sophie Forever Foundation; Tyler's Treehouse Foundation; Musicians Against Childhood Cancer; Noyes Brain Tumor Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank X. Zhu and A. Diaz for assistance with PCR reactions, J. Partridge for helpful discussions, the Hartwell Center of Biotechnology and Bioinformatics at St. Jude Children's Research Hospital and Beckman Coulter Genomics. This work was supported by the St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project and the American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital and by grants from the US National Institutes of Health (NIH) (CA096832), the Sydney Schlobohm Chair of Research from the National Brain Tumor Society, the Cure Starts Now Foundation, the Smile for Sophie Forever Foundation, Tyler's Treehouse Foundation, the Musicians Against Childhood Cancer and the Noyes Brain Tumor Foundation.	Barrow J, 2011, NEURO-ONCOLOGY, V13, P212, DOI 10.1093/neuonc/noq158; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bax DA, 2010, CLIN CANCER RES, V16, P3368, DOI 10.1158/1078-0432.CCR-10-0438; Broniscer A, 2004, ONCOLOGIST, V9, P197, DOI 10.1634/theoncologist.9-2-197; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Fullgrabe J, 2011, ONCOGENE, V30, P3391, DOI 10.1038/onc.2011.121; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Paugh BS, 2011, J CLIN ONCOL, V29, P3999, DOI 10.1200/JCO.2011.35.5677; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Qu HQ, 2010, NEURO-ONCOLOGY, V12, P153, DOI 10.1093/neuonc/nop001; Reynolds N, 2012, EMBO J, V31, P593, DOI 10.1038/emboj.2011.431; Warren KE, 2012, NEURO-ONCOLOGY, V14, P326, DOI 10.1093/neuonc/nor190; Zarghooni M, 2010, J CLIN ONCOL, V28, P1337, DOI 10.1200/JCO.2009.25.5463	14	1018	1043	0	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2012	44	3					251	253		10.1038/ng.1102	http://dx.doi.org/10.1038/ng.1102			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	899VC	22286216	Green Accepted			2022-12-25	WOS:000300843600007
J	Ahfeldt, T; Schinzel, RT; Lee, YK; Hendrickson, D; Kaplan, A; Lum, DH; Camahort, R; Xia, F; Shay, J; Rhee, EP; Clish, CB; Deo, RC; Shen, T; Lau, FH; Cowley, A; Mowrer, G; Al-Siddiqi, H; Nahrendorf, M; Musunuru, K; Gerszten, RE; Rinn, JL; Cowan, CA				Ahfeldt, Tim; Schinzel, Robert T.; Lee, Youn-Kyoung; Hendrickson, David; Kaplan, Adam; Lum, David H.; Camahort, Raymond; Xia, Fang; Shay, Jennifer; Rhee, Eugene P.; Clish, Clary B.; Deo, Rahul C.; Shen, Tony; Lau, Frank H.; Cowley, Alicia; Mowrer, Greg; Al-Siddiqi, Heba; Nahrendorf, Matthias; Musunuru, Kiran; Gerszten, Robert E.; Rinn, John L.; Cowan, Chad A.			Programming human pluripotent stem cells into white and brown adipocytes	NATURE CELL BIOLOGY			English	Article							ADIPOSE-TISSUE; PPAR-GAMMA; TRANSCRIPTIONAL CONTROL; DIFFERENTIATION; GENE; DERIVATION; IDENTIFICATION; FIBROBLASTS; VIVO	The utility of human pluripotent stem cells is dependent on efficient differentiation protocols that convert these cells into relevant adult cell types. Here we report the robust and efficient differentiation of human pluripotent stem cells into white or brown adipocytes. We found that inducible expression of PPARG2 alone or combined with CEBPB and/or PRDM16 in mesenchymal progenitor cells derived from pluripotent stem cells programmed their development towards a white or brown adipocyte cell fate with efficiencies of 85%-90%. These adipocytes retained their identity independent of transgene expression, could be maintained in culture for several weeks, expressed mature markers and had mature functional properties such as lipid catabolism and insulin-responsiveness. When transplanted into mice, the programmed cells gave rise to ectopic fat pads with the morphological and functional characteristics of white or brown adipose tissue. These results indicate that the cells could be used to faithfully model human disease.	[Ahfeldt, Tim; Schinzel, Robert T.; Lee, Youn-Kyoung; Hendrickson, David; Kaplan, Adam; Camahort, Raymond; Xia, Fang; Shay, Jennifer; Shen, Tony; Cowley, Alicia; Al-Siddiqi, Heba; Musunuru, Kiran; Rinn, John L.; Cowan, Chad A.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Ahfeldt, Tim; Schinzel, Robert T.; Lee, Youn-Kyoung; Kaplan, Adam; Camahort, Raymond; Xia, Fang; Shay, Jennifer; Shen, Tony; Lau, Frank H.; Cowley, Alicia; Mowrer, Greg; Al-Siddiqi, Heba; Cowan, Chad A.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Ahfeldt, Tim; Schinzel, Robert T.; Lee, Youn-Kyoung; Kaplan, Adam; Camahort, Raymond; Xia, Fang; Shay, Jennifer; Rhee, Eugene P.; Lau, Frank H.; Mowrer, Greg; Al-Siddiqi, Heba; Gerszten, Robert E.; Cowan, Chad A.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Schinzel, Robert T.] Free Univ Berlin, Fachbereich Biol, Inst Biol Mikrobiol, D-14195 Berlin, Germany; [Hendrickson, David; Rhee, Eugene P.; Clish, Clary B.; Musunuru, Kiran; Gerszten, Robert E.; Rinn, John L.; Cowan, Chad A.] 7 Cambridge Ctr, Broad Inst, Cambridge, MA 02142 USA; [Lum, David H.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Lum, David H.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Deo, Rahul C.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Deo, Rahul C.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Deo, Rahul C.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Al-Siddiqi, Heba] Qatar Fdn, Div Res, Doha, Qatar; [Nahrendorf, Matthias] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Nahrendorf, Matthias] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Musunuru, Kiran] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Free University of Berlin; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Qatar Foundation (QF); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Cowan, CA (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	ccowan@fas.harvard.edu	Clish, Clary/AAB-7124-2019; Clish, Clary B/ABB-9374-2021; Ahfeldt, Tim/E-2935-2017	Clish, Clary B/0000-0001-8259-9245; Shen, Tony/0000-0002-7740-6389; Cowley, Alicia/0000-0001-8136-169X; Rinn, John/0000-0002-7231-7539; Ahfeldt, Tim/0000-0001-6377-7376	Roberto and Allison Mignone Fund for Stem Cell Research; Harvard Stem Cell Institute, Hoffman-La Roche; Stowers Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095384, P30DK043351] Funding Source: NIH RePORTER	Roberto and Allison Mignone Fund for Stem Cell Research; Harvard Stem Cell Institute, Hoffman-La Roche; Stowers Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank T. Holm, A. Foudi and E. Hanson for critical reading, insight and suggestions; M. Henderson, J. Horn, K. Horn, I. Pomerantseva, A. Tseng and K. Kulig for their technical help; L. Prickett-Rice and K. Folz-Donahue of the HSCI-CRM Flow Cytometry Core Facility; D. Lieber and V. Mootha for assistance with cellular bioenergetic measurements; and J. Truelove and R. Weissleder for assistance with PET-CT imaging. T. Ahfeldt was supported by the Roberto and Allison Mignone Fund for Stem Cell Research. This work was financially sponsored in part by the Harvard Stem Cell Institute, Hoffman-La Roche and the Stowers Medical Institute.	Altiok S, 1997, GENE DEV, V11, P1987, DOI 10.1101/gad.11.15.1987; Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Barberi T, 2006, METHOD ENZYMOL, V418, P194, DOI 10.1016/S0076-6879(06)18012-X; Bermingham JR, 2002, J NEUROSCI, V22, P10217; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dani C, 1999, CELLS TISSUES ORGANS, V165, P173, DOI 10.1159/000016697; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Hannan NRF, 2009, STEM CELLS DEV, V18, P653, DOI 10.1089/scd.2008.0160; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jiao P, 2011, OBESITY, V19, P483, DOI 10.1038/oby.2010.200; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; LAZARUS HM, 1995, BONE MARROW TRANSPL, V16, P557; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Olivier EN, 2006, STEM CELLS, V24, P1914, DOI 10.1634/stemcells.2005-0648; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rhee EP, 2010, J AM SOC NEPHROL, V21, P1041, DOI 10.1681/ASN.2009111132; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Sen A, 2001, J CELL BIOCHEM, V81, P312, DOI 10.1002/1097-4644(20010501)81:2<312::AID-JCB1046>3.0.CO;2-Q; Simpson F, 2010, INT J BIOCHEM CELL B, V42, P785, DOI 10.1016/j.biocel.2009.12.021; Svensson PA, 2011, INT J MOL MED, V27, P227, DOI 10.3892/ijmm.2010.566; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tashiro K, 2008, J GENE MED, V10, P498, DOI 10.1002/jgm.1171; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Trivedi P, 2008, EXP HEMATOL, V36, P350, DOI 10.1016/j.exphem.2007.10.007; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Harmelen V, 2007, OBESITY, V15, P846, DOI 10.1038/oby.2007.595; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Xiong C, 2005, STEM CELLS DEV, V14, P671, DOI 10.1089/scd.2005.14.671; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	47	168	188	4	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2012	14	2					209	219		10.1038/ncb2411	http://dx.doi.org/10.1038/ncb2411			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	893CF	22246346	Green Accepted, Green Published			2022-12-25	WOS:000300332500016
J	Chait, R; Vetsigian, K; Kishony, R				Chait, Remy; Vetsigian, Kalin; Kishony, Roy			What counters antibiotic resistance in nature?	NATURE CHEMICAL BIOLOGY			English	Article							SELECTION; AGENTS; ACID		[Chait, Remy; Vetsigian, Kalin; Kishony, Roy] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02215 USA; [Kishony, Roy] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Chait, R (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02215 USA.	roy_kishony@hms.harvard.edu		Chait, Remy/0000-0003-0876-3187				Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Bacon CW, 1996, APPL ENVIRON MICROB, V62, P4039, DOI 10.1128/AEM.62.11.4039-4043.1996; BANNISTE.D, 1970, J GEN MICROBIOL, V61, P273, DOI 10.1099/00221287-61-2-273; BOCHNER BR, 1980, J BACTERIOL, V143, P926, DOI 10.1128/JB.143.2.926-933.1980; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; Chait R, 2007, NATURE, V446, P668, DOI 10.1038/nature05685; Chait R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015179; Clardy J, 2009, CURR BIOL, V19, pR437, DOI 10.1016/j.cub.2009.04.001; CRAINE BL, 1982, J BACTERIOL, V151, P487, DOI 10.1128/JB.151.1.487-490.1982; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Hopwood DA, 2007, STREPTOMYCES NATURE; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Kroiss J, 2010, NAT CHEM BIOL, V6, P261, DOI [10.1038/NCHEMBIO.331, 10.1038/nchembio.331]; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Linares JF, 2006, P NATL ACAD SCI USA, V103, P19484, DOI 10.1073/pnas.0608949103; Palmer AC, 2010, NAT CHEM BIOL, V6, P105, DOI [10.1038/NCHEMBIO.289, 10.1038/nchembio.289]; READING C, 1977, ANTIMICROB AGENTS CH, V11, P852, DOI 10.1128/AAC.11.5.852; Shank EA, 2009, CURR OPIN MICROBIOL, V12, P205, DOI 10.1016/j.mib.2009.01.003; SZYBALSKI W, 1952, J BACTERIOL, V64, P489, DOI 10.1128/JB.64.4.489-499.1952; Taubes G, 2008, SCIENCE, V321, P356, DOI 10.1126/science.321.5887.356; Vetsigian K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001184; Wright GD, 2010, CURR OPIN MICROBIOL, V13, P589, DOI 10.1016/j.mib.2010.08.005; Xiao Y, 2011, J BACTERIOL, V193, P4626, DOI 10.1128/JB.05052-11; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755	25	34	38	1	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2012	8	1					2	5		10.1038/nchembio.745	http://dx.doi.org/10.1038/nchembio.745			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866VL	22173342				2022-12-25	WOS:000298414100002
J	Quesada, V; Conde, L; Villamor, N; Ordonez, GR; Jares, P; Bassaganyas, L; Ramsay, AJ; Bea, S; Pinyol, M; Martinez-Trillos, A; Lopez-Guerra, M; Colomer, D; Navarro, A; Baumann, T; Aymerich, M; Rozman, M; Delgado, J; Gine, E; Hernandez, JM; Gonzalez-Diaz, M; Puente, DA; Velasco, G; Freije, JMP; Tubio, JMC; Royo, R; Gelpi, JL; Orozco, M; Pisano, DG; Zamora, J; Vazquez, M; Valencia, A; Himmelbauer, H; Bayes, M; Heath, S; Gut, M; Gut, I; Estivill, X; Lopez-Guillermo, A; Puente, XS; Campo, E; Lopez-Otin, C				Quesada, Victor; Conde, Laura; Villamor, Neus; Ordonez, Gonzalo R.; Jares, Pedro; Bassaganyas, Laia; Ramsay, Andrew J.; Bea, Silvia; Pinyol, Magda; Martinez-Trillos, Alejandra; Lopez-Guerra, Monica; Colomer, Dolors; Navarro, Alba; Baumann, Tycho; Aymerich, Marta; Rozman, Maria; Delgado, Julio; Gine, Eva; Hernandez, Jesus M.; Gonzalez-Diaz, Marcos; Puente, Diana A.; Velasco, Gloria; Freije, Jose M. P.; Tubio, Jose M. C.; Royo, Romina; Gelpi, Josep L.; Orozco, Modesto; Pisano, David G.; Zamora, Jorge; Vazquez, Miguel; Valencia, Alfonso; Himmelbauer, Heinz; Bayes, Monica; Heath, Simon; Gut, Marta; Gut, Ivo; Estivill, Xavier; Lopez-Guillermo, Armando; Puente, Xose S.; Campo, Elias; Lopez-Otin, Carlos			Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia	NATURE GENETICS			English	Article							PRE-MESSENGER-RNA; CANCER GENOME; SOMATIC MUTATIONS; MYELODYSPLASIA; SPLICEOSTATIN; ACTIVATION; EXPRESSION; PATHWAYS	Here we perform whole-exome sequencing of samples from 105 individuals with chronic lymphocytic leukemia (CLL)(1,2), the most frequent leukemia in adults in Western countries. We found 1,246 somatic mutations potentially affecting gene function and identified 78 genes with predicted functional alterations in more than one tumor sample. Among these genes, SF3B1, encoding a subunit of the spliceosomal U2 small nuclear ribonucleoprotein (snRNP), is somatically mutated in 9.7% of affected individuals. Further analysis in 279 individuals with CLL showed that SF3B1 mutations were associated with faster disease progression and poor overall survival. This work provides the first comprehensive catalog of somatic mutations in CLL with relevant clinical correlates and defines a large set of new genes that may drive the development of this common form of leukemia. The results reinforce the idea that targeting several well-known genetic pathways, including mRNA splicing, could be useful in the treatment of CLL and other malignancies.	[Quesada, Victor; Ordonez, Gonzalo R.; Ramsay, Andrew J.; Puente, Diana A.; Velasco, Gloria; Freije, Jose M. P.; Puente, Xose S.; Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol, Dept Bioquim & Biol Mol, Oviedo, Spain; [Conde, Laura; Villamor, Neus; Jares, Pedro; Bea, Silvia; Lopez-Guerra, Monica; Colomer, Dolors; Navarro, Alba; Aymerich, Marta; Rozman, Maria; Campo, Elias] Univ Barcelona, Unidad Hematopatol, Serv Anat Patol, Hosp Clin,Inst Invest Biomed August Pi & Sunyer I, Barcelona, Spain; [Bassaganyas, Laia; Tubio, Jose M. C.; Estivill, Xavier] Pompeu Fabra Univ CRG UPF, Ctr Genom Regulat, Genes & Dis Programme, Barcelona, Spain; [Pinyol, Magda] IDIBAPS, Unidad Genom, Barcelona, Spain; [Baumann, Tycho; Delgado, Julio; Gine, Eva] Univ Barcelona, Serv Hematol, Hosp Clin, Barcelona, Spain; [Hernandez, Jesus M.; Gonzalez-Diaz, Marcos] Univ Salamanca, Serv Hematol, Univ Hosp, Ctr Invest Canc, E-37008 Salamanca, Spain; [Royo, Romina; Gelpi, Josep L.; Orozco, Modesto] Univ Barcelona, Programa Conjunto Biol Computac, BSC, IRB,Spanish Natl Bioinformat Inst, Barcelona, Spain; [Pisano, David G.; Zamora, Jorge; Vazquez, Miguel; Valencia, Alfonso] Spanish Natl Bioinformat Inst, Spanish Natl Canc Res Ctr CNIO, Struct Biol & Biocomp Programme, Madrid, Spain; [Himmelbauer, Heinz] CRG UPF, Ultrasequencing Unit, Barcelona, Spain; [Bayes, Monica; Heath, Simon; Gut, Marta; Gut, Ivo] Ctr Nacl Anal Genom, Barcelona, Spain	University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Salamanca; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; Centro Nacional de Investigaciones Oncologicas (CNIO); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Lopez-Otin, C (corresponding author), Univ Oviedo, Inst Univ Oncol, Dept Bioquim & Biol Mol, Oviedo, Spain.	ecampo@clinic.ub.es; clo@uniovi.es	Hernández, Jesus M/B-5459-2017; Freije, José M.P./A-6535-2008; Tubio, Jose/AAG-7345-2019; Velasco, Gloria/AAS-5842-2021; Lopez-Guillermo, Armando/Z-5684-2019; Heath, Simon C/J-4138-2012; Valencia, Alfonso/I-3127-2015; Campo, Elias/AAC-5593-2019; Pisano, David/N-5817-2014; Tubio, Jose M.C./H-5076-2015; Quesada, Víctor/B-6557-2014; Delgado, Julio/D-4891-2013; bea, silvia/K-7699-2014; Estivill, Xavier/A-3125-2013; Jares, Pedro/T-3778-2019; Gut, Ivo/ABF-3188-2020; COLOMER, DOLORS/ABG-6894-2020; Navarro, Alba/H-2611-2015; Gelpí, Josep Ll./M-6401-2013; Puente, Xosé S./ADB-0672-2022; Estivill, Xavier/E-2957-2012; López-Otín, Carlos/AAB-2106-2020; Vazquez, Miguel/I-2593-2015	Hernández, Jesus M/0000-0002-9661-9371; Freije, José M.P./0000-0002-4688-8266; Tubio, Jose/0000-0003-3540-2459; Velasco, Gloria/0000-0001-8032-5056; Heath, Simon C/0000-0002-9550-0897; Valencia, Alfonso/0000-0002-8937-6789; Campo, Elias/0000-0001-9850-9793; Pisano, David/0000-0002-4895-4124; Tubio, Jose M.C./0000-0003-3540-2459; Quesada, Víctor/0000-0002-8398-3457; Delgado, Julio/0000-0002-5157-4376; bea, silvia/0000-0001-7192-2385; Estivill, Xavier/0000-0002-0723-2256; Gut, Ivo/0000-0001-7219-632X; Navarro, Alba/0000-0002-4041-0974; Gelpí, Josep Ll./0000-0002-0566-7723; Puente, Xosé S./0000-0001-9525-1483; López-Otín, Carlos/0000-0001-6964-1904; Royo, Romina/0000-0003-3493-0874; Gonzalez Diaz, Marcos/0000-0001-6637-1072; Himmelbauer, Heinz/0000-0001-8897-2928; Orozco Lopez, Modesto/0000-0002-8608-3278; COLOMER, DOLORS/0000-0001-7486-8484; BASSAGANYAS, LAIA/0000-0002-4575-0214; Rozman, Maria/0000-0002-2641-1110; Baumann, Tycho Stephan/0000-0003-4421-0088; Vazquez, Miguel/0000-0002-5713-1058; JARES, PEDRO/0000-0002-8401-579X	Spanish Ministry of Science and Innovation (MICINN) through the Instituto de Salud Carlos III (ISCIII); Red Tematica de Investigacion del Cancer (RTICC) del ISCIII	Spanish Ministry of Science and Innovation (MICINN) through the Instituto de Salud Carlos III (ISCIII); Red Tematica de Investigacion del Cancer (RTICC) del ISCIII	We are grateful to P. Klatt for continuous support, E. Montserrat, J. Valcarcel, P. Nicolas and C. Romeo-Casabona for helpful comments, S. Guijarro, S. Martin, C. Capdevila, M. Sanchez and L. Pla for excellent technical assistance, and N. Villahoz and C. Muro for excellent work in the coordination of the CLL Spanish Consortium. We are also very grateful to all the individuals with CLL who participated in this study. This work was funded by the Spanish Ministry of Science and Innovation (MICINN) through the Instituto de Salud Carlos III (ISCIII) and Red Tematica de Investigacion del Cancer (RTICC) del ISCIII. C.L-O. is an Investigator of the Botin Foundation.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baudot A, 2010, EMBO REP, V11, P805, DOI 10.1038/embor.2010.133; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Brown PJ, 2008, BLOOD, V111, P2816, DOI 10.1182/blood-2007-09-115113; Bulwin GC, 2006, J IMMUNOL, V177, P6833, DOI 10.4049/jimmunol.177.10.6833; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen AA, 2009, CARCINOGENESIS, V30, P977, DOI 10.1093/carcin/bgp076; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Folco EG, 2011, GENE DEV, V25, P440, DOI 10.1101/gad.2009411; Golan-Gerstl R, 2011, CANCER RES, V71, P4464, DOI 10.1158/0008-5472.CAN-10-4410; Golas MM, 2003, SCIENCE, V300, P980, DOI 10.1126/science.1084155; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Greif PA, 2011, LEUKEMIA, V25, P821, DOI 10.1038/leu.2011.19; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; PETO R, 1973, BIOMETRICS, V29, P579, DOI 10.2307/2529177; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Prazeres H, 2011, ONCOGENE, V30, P1302, DOI 10.1038/onc.2010.512; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; ROZMAN C, 1995, NEW ENGL J MED, V333, P1052, DOI 10.1056/NEJM199510193331606; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Visconte V, 2012, LEUKEMIA, V26, P542, DOI 10.1038/leu.2011.232; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang H, 2011, J BIOL CHEM, V286, P7479, DOI 10.1074/jbc.M110.205641; Wu ST, 2008, PROTEINS, V72, P547, DOI 10.1002/prot.21945; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zainuddin N, 2011, LEUKEMIA RES, V35, P272, DOI 10.1016/j.leukres.2010.08.023; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764; Zhang X, 2011, LEUKEMIA, V25, P1908, DOI 10.1038/leu.2011.163	43	730	755	3	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2012	44	1					47	52		10.1038/ng.1032	http://dx.doi.org/10.1038/ng.1032			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	22158541				2022-12-25	WOS:000298664000012
J	Lowy, DR; Kim, J; Smith-McCune, KK; Melief, CJM				Lowy, Douglas R.; Kim, Jane; Smith-McCune, Karen K.; Melief, Cornelis J. M.			The value of HPV vaccination	NATURE MEDICINE			English	Editorial Material							HUMAN-PAPILLOMAVIRUS INFECTION; IMMUNOGENICITY; IMPACT		[Lowy, Douglas R.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Lowy, Douglas R.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Lowy, DR (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.			Chun, Hyung/0000-0003-3508-2678	Howard Hughes Medical Institute Funding Source: Medline; NCATS NIH HHS [UL1 TR000439] Funding Source: Medline; NHLBI NIH HHS [R37 HL060917, P30 HL101284, HL101284, HL093362, R01 HL113005, R01 HL069170, HL113005, K08 HL095654, K08 HL093362, HL069170, HL095654, U10 HL109250] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P626; Barr E, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.001; Brotherton JML, 2011, LANCET, V377, P2085, DOI 10.1016/S0140-6736(11)60551-5; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Einstein MH, 2011, HUM VACCINES, V7, P1359, DOI 10.4161/hv.7.12.18282; Gee J, 2011, VACCINE, V29, P8279, DOI 10.1016/j.vaccine.2011.08.106; Goldie SJ, 2008, VACCINE, V26, P4080, DOI 10.1016/j.vaccine.2008.04.053; Hoy T, 2009, CURR MED RES OPIN, V25, P2343, DOI 10.1185/03007990903136378; Kjaer SK, 2010, JNCI-J NATL CANCER I, V102, P1478, DOI 10.1093/jnci/djq356; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Lowy DR, 2008, CANCER-AM CANCER SOC, V113, P1980, DOI 10.1002/cncr.23704; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; Romanowski B, 2009, LANCET, V374, P1975, DOI 10.1016/S0140-6736(09)61567-1; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X	14	35	39	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					28	29						2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22227663				2022-12-25	WOS:000299018600021
